Citrus Sinensis ID: 042149

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-----
Protein Sequence
MQFLVRIPRNLIWVIWMFIITLSMFVSRSHSSSRSSESLYKCGPPAKVSDNRNFRQNFDAVMGNISEQIMDDHHYHFALHYVVSPAPQVYAYMQCHEDLSQTDCESCFSALKQKANRCLPSDSARIFLDGCFLRYDNYDFFGEAVDPIHDKFNCSARHLDDESLSKQFEEKVIEVITNVTIVTKSNGRFGQVEGKGGIATVYALAQCLKFLDNKGCSQCLDEAALRLKGCSKSGEGRAMFAGCYVRFSTERFFNPNYQKKETRYKRLSEMRKGQVLLGTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNASVISPSDNSKDSMMSSFKSFVAESPEIDHSLKMKAFEPS
Secondary Structure (PSIPRED)
ccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccHHHHHHHHHHHHHHHHHccccccEEEEEEEccccccEEEEEEccccccHHHHHHHHHHHHHHHHHccccccEEEEEccEEEEEEccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHccccccccccEEEEccccccEEEEEEEEcccccHHHHHHHHHHHHHHccccccccccEEEccEEEEEEEEcccccccccccHHHHHHHHHHHccccccccccccccccccHHHHHHHHccccccccccccccccccEEEcccccEEEEEEcccccHHHHHHHHHHHHHHHcccccccccEEccccccccEEEEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEcccccccccccccccccccccccccccccccccccccEEcccccccHHHHcccccccccccccccEEEEEEEccccccccccccccHHHHHHHHHccccccccccccccccccHHHHHHHHHHcEEcccccccccccHHHHHHHHccccccccccccccEEEcccccccccccccccccccEEEEccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccHHHHHHHHHHHHHHHHccccccccEEEEEccccccEEEEEEEEcccccHHHHHHHHHHHHHHHccccccccEEEEEccEEEEEccccHHccccccccccEcccccccccHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccEEEEEEEEcccccHHHHHHHHHHHHHHcHHHccccccEEEEccEEEEEEccccccccccccccccccccccccccccccccccccccEccHHHHHHHHccccHHccccccccccEEccccccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEEcccccHcEEEEcccHcccccHHHHHHHHHHHHHHHHHHHccccEEEEcccccHHHEEEcccccEEEccccccEEcccccEEccccccccHHHccHHHHHHcEEcHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHccccccccEEEccHcccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHccccccccccccccEEEEcccccccccccccccccccccccccccccccEEcccccc
Coil and Loop (DISEMBL)
mqflvripRNLIWVIWMFIITLSMFVsrshsssrsseslykcgppakvsdnrnfrQNFDAVMGNISEQIMDDHHYHFALHyvvspapqvyaymqchedlsqtdCESCFSALKQkanrclpsdsarifldgcflrydnydffgeavdpihdkfncsarhlddesLSKQFEEKVIEVITNVTIVtksngrfgqvegkgGIATVYALAQCLKFldnkgcsqcLDEAALRLKgcsksgegramFAGCYVrfsterffnpnyqkkeTRYKRLSEMRKGQVLLGTVLCTSSLNFKYEILERATdffdnsrklgqggagsvfrgtlpdgrniAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGcsiegpesllvyeyvpnrsldqILFVKNTIHILSWQQRFTIICGTAeglahlhggsgiKIIHRDiktsnilldekltpkiadfglarhvapdkthvstgiagtlgymapeylvrgqltekadVYAFGVLVIEVASGrrnsvfsegsssVLHTVWKHYKanritqsmdpgltgrfpeneASRVLQIGLLCtqapvalrPSMAEVVHMLNnidyeipppkqppflnasvispsdnskdsmMSSFKSFvaespeidhslkmkafeps
Flexible Loop (DISEMBL)
MQFLVRIPRNLIWVIWMFIITLSMFVSRSHSSSRSSESLYKCGPPAKVSDNRNFRQNFDAVMGNISEQIMDDHHYHFALHYVVSPAPQVYAYMQCHEDLSQTDCESCFSALKQKANRCLPSDSARIFLDGCFLRYDNYDFFGEAVDPIHDKFNCSARHLDDESLSKQFEEKVIEVITNVtivtksngrfgqveGKGGIATVYALAQCLKFLDNKGCSQCLDEAALRLKGCSKSGEGRAMFAGCYVRfsterffnpnyqkkETRYKRLSEMRKGQVLLGTVLCTSSLNFKYEILERATDFFDNSRKLGQggagsvfrgtlpdgRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGlarhvapdkthVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNASVISPSDNSKDSMMSSFKSFvaespeidhslkmkafeps
Low Complexity Region (SEG)
MQFLVRIPRNLIWVIWMFIITLSMFVsrshsssrssesLYKCGPPAKVSDNRNFRQNFDAVMGNISEQIMDDHHYHFALHYVVSPAPQVYAYMQCHEDLSQTDCESCFSALKQKANRCLPSDSARIFLDGCFLRYDNYDFFGEAVDPIHDKFNCSARHLDDESLSKQFeekvievitnvtivtkSNGRFGQVEGKGGIATVYALAQCLKFLDNKGCSQCLDEAALRLKGCSKSGEGRAMFAGCYVRFSTERFFNPNYQKKETRYKRLSEMRKGQVLLGTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNASVIspsdnskdsmmssfksfVAESPEIDHSLKMKAFEPS
Disordered region (IsUnstruct)
**FLVRIPRNLIWVIWMFIITLSMFV****************************RQNFDAVMGNISEQIMDDHHYHFALHYVVSPAPQVYAYMQCHEDLSQTDCESCFSALKQKANRCLPSDSARIFLDGCFLRYDNYDFFGEAVDPIHDKFNCSARHLDDESLSKQFEEKVIEVITNVTIVTKSNGRFGQVEGKGGIATVYALAQCLKFLDNKGCSQCLDEAALRLKGCSKSGEGRAMFAGCYVRFSTERFFNPNYQKKETRYKRLSEMRKGQVLLGTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS****LTGRF**NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEI**************************************************
Disordered Region (DISOPRED)
*********NLIWVIWMFIITLSMFVSRSHSSSRSSESLYKCGPPAKVSDNRNFRQNFDAVMGNISEQIMDDHHYHFALHYVVSPAPQVYAYMQCHEDLSQTDCESCFSALKQKANRCLPSDSARIFLDGCFLRYDNYDFFGEAVDPIHDKFNCSARHLDDESLSKQFEEKVIEVITNVTIVTKSN*RFGQVEGKGGIATVYALAQCLKFLDNKGCSQCLDEAALRLKGCSKSGEGRAMFAGCYVRFSTERFFNPNYQK**********************CTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPF***********************************M******
Disordered Region (DISEMBL)
MQFLVRIPRNLIWVIWMFIITLSMFV***************CGPPAKVSDNRNFRQNFDAVMGNISEQIMDDHHYHFALHYVVSPAPQVYAYMQCHEDLSQTDCESCFSALKQKANRCLPSDSARIFLDGCFLRYDNYDFFGEAVDPIHDKFNCSARHLDDESLSKQFEEKVIEVITNVTIVTKSNGRFGQVEGKGGIATVYALAQCLKFLDNKGCSQCLDEAALRLKGCSKSGEGRAMFAGCYVRFSTERFFNPNYQKKETRYKRLSEMRKGQVLLGTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNASVISPSDNSKDSMMSSFKSFVAESPEIDHSLKMKAFEPS
Disordered Region (DISPRO)
MQFLVRIPRNLIWVIWMFIITLSMFVSRSHSSSRSSESLYKCGPPAKVSDNRNFRQNFDAVMGNISEQIMDDHHYHFALHYVVSPAPQVYAYMQCHEDLSQTDCESCFSALKQKANRCLPSDSARIFLDGCFLRYDNYDFFGEAVDPIHDKFNCSARHLDDESLSKQFEEKVIEVITNVTIVTKSNGRFGQVEGKGGIATVYALAQCLKFLDNKGCSQCLDEAALRLKGCSKSGEGRAMFAGCYVRFSTERFFNPNYQ*********************VLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNASV*************************************
Transmembrane Helix (TMHMM)
iiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MQFLVRIPRNLIWVIWMFIITLSMFVSRSHSSSRSSESLYKCGPPAKVSDNRNFRQNFDAVMGNISEQIMDDHHYHFALHYVVSPAPQVYAYMQCHEDLSQTDCESCFSALKQKANRCLPSDSARIFLDGCFLRYDNYDFFGEAVDPIHDKFNCSARHLDDESLSKQFEEKVIEVITNVTIVTKSNGRFGQVEGKGGIATVYALAQCLKFLDNKGCSQCLDEAALRLKGCSKSGEGRAMFAGCYVRFSTERFFNPNYQKKETRYKRLSEMRKGQVLLGTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNASVISPSDNSKDSMMSSFKSFVAESPEIDHSLKMKAFEPS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	625	2.2.26 [Sep-21-2011]
Q9LMB9	615	Cysteine-rich receptor-li	yes	no	0.918	0.933	0.492	1e-165
Q9FNE1	651	Cysteine-rich receptor-li	yes	no	0.907	0.870	0.477	1e-158
Q9CAL2	646	Cysteine-rich receptor-li	no	no	0.808	0.781	0.458	1e-141
Q9CAL3	649	Cysteine-rich receptor-li	no	no	0.92	0.885	0.406	1e-128
Q9M0G5	625	Putative cysteine-rich re	no	no	0.833	0.833	0.386	1e-104
O65476	662	Putative cysteine-rich re	no	no	0.900	0.850	0.321	2e-84
Q8S9L6	679	Cysteine-rich receptor-li	no	no	0.953	0.877	0.316	1e-83
Q9M0X5	675	Cysteine-rich receptor-li	no	no	0.790	0.731	0.337	7e-83
O49564	642	Cysteine-rich receptor-li	no	no	0.803	0.781	0.344	3e-78
O65405	683	Cysteine-rich receptor-li	no	no	0.820	0.751	0.329	4e-78

>sp|Q9LMB9|CRK1_ARATH Cysteine-rich receptor-like protein kinase 1 OS=Arabidopsis thaliana GN=CRK1 PE=2 SV=2

 Score =  582 bits (1501), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 313/636 (49%), Positives = 407/636 (63%), Gaps = 62/636 (9%)

Query: 1   MQFLVRIPRNLIWVIWMFIITLSMFVSRSHSSSRSSESLYKCGPPAKVSDNRNFRQNFDA 60
           MQ    I + L WV ++ ++        +  SS SSESL  C P      N +    F  
Sbjct: 1   MQICASIAQFLAWVSFLVLLA-------TVGSSSSSESLLNCQPLDHHLVNPSRLLGFLR 53

Query: 61  VMGNISEQIMDDHHYHFALHYVVSPAPQVYAYMQCHEDLSQTDCESCFSALKQKANRCLP 120
            M ++++ I +D  +   +  +   +P +Y ++QC EDLS +DC  CF+  + +  R   
Sbjct: 54  AMSSVNDFITNDKLW--VVSSITDVSPPIYVFLQCREDLSVSDCRHCFNESRLELERKCS 111

Query: 121 SDSARIFLDGCFLRYDNYDFFGEAVDPIHDKFNCSARHLDDESLSKQFEEKVIEVITNVT 180
               RI  D CFLR+D+ DF  E VDP  DK NC     +  +   +F   + E + NVT
Sbjct: 112 GSGGRIHSDRCFLRFDDRDFSEEFVDPTFDKANCE----ETGTGFGEFWRFLDEALVNVT 167

Query: 181 IVTKSNGRFGQVEGKGGIATVYALAQCLKFLDNKGCSQCLDEAALRLKGCSKSGEGRAMF 240
           +    NG FG        A VYALAQC + LD   C +CL  A   L+ C    E RA F
Sbjct: 168 LKAVKNGGFGAASVIKTEA-VYALAQCWQTLDENTCRECLVNARSSLRACD-GHEARAFF 225

Query: 241 AGCYVRFSTERFFNPNYQKKE---------------------TR---------------- 263
            GCY+++ST +FF+   + K                      TR                
Sbjct: 226 TGCYLKYSTHKFFDDAAEHKPDADQRNFIRSSFFPHLSDRDVTRLAIAAISLSILTSLGA 285

Query: 264 ---YKRLSEMRKGQVLLGTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLP 320
              Y+R+S  RK QV        S +NFKYE+LE+AT+ F +S KLGQGGAGSV++G LP
Sbjct: 286 FISYRRVSRKRKAQV-------PSCVNFKYEMLEKATESFHDSMKLGQGGAGSVYKGILP 338

Query: 321 DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRS 380
           DGR +AVK+LFFN+R+W DQFFNEVNLISG+QHKN+VRLLGCSIEGP+SLLVYEYV NRS
Sbjct: 339 DGRIVAVKKLFFNTREWADQFFNEVNLISGVQHKNLVRLLGCSIEGPKSLLVYEYVHNRS 398

Query: 381 LDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPK 440
           LDQILF+KNT+HILSW+QRF II G +EGL +LH GS +KIIHRDIKTSNILLD  L+PK
Sbjct: 399 LDQILFMKNTVHILSWKQRFNIIIGISEGLEYLHRGSEVKIIHRDIKTSNILLDRNLSPK 458

Query: 441 IADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRN 500
           IADFGL R +  DKT  +TGIAGTLGY+APEYL++GQLTEKADVYAFGVL+IE+ +G++N
Sbjct: 459 IADFGLIRSMGTDKTQTNTGIAGTLGYLAPEYLIKGQLTEKADVYAFGVLIIEIVTGKKN 518

Query: 501 SVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPS 560
           + F++G+SSVL++VW+H+KAN + +S+DP L G F E EA +VLQIGLLC Q+ V LRPS
Sbjct: 519 NAFTQGTSSVLYSVWEHFKANTLDRSIDPRLKGSFVEEEALKVLQIGLLCVQSSVELRPS 578

Query: 561 MAEVVHMLNNIDYEIPPPKQPPFLNASVISPSDNSK 596
           M+E+V ML N D +   PKQPPFL+ASV+ P + ++
Sbjct: 579 MSEIVFMLQNKDSKFEYPKQPPFLSASVLMPDEETR 614

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FNE1|CRK42_ARATH Cysteine-rich receptor-like protein kinase 42 OS=Arabidopsis thaliana GN=CRK42 PE=2 SV=1

 Score =  560 bits (1443), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 295/618 (47%), Positives = 389/618 (62%), Gaps = 51/618 (8%)

Query: 9   RNLIWVIWMFIITLSMFVSRSHSSSRSSESLYKCGPPAKVSDNRNFRQNFDAVMGNISEQ 68
           R+  +VI  +      F+S S    R++ S   CG  +K S + N+   F   M ++S +
Sbjct: 8   RSFHYVIIFYSFFFLPFLSSSSDDQRTTVSGLFCGGRSKSSADPNYIPTFVEDMHSLSLK 67

Query: 69  IMDDHHYHFALHYVVSPAPQVYAYMQCHEDLSQTDCESCFSALKQKANRCLPSDSARIFL 128
           +        +L+   S    +YA +QCH+DLS +DC+ C++  + +  RCLPS SARIFL
Sbjct: 68  LTTRRFATESLNSTTS----IYALIQCHDDLSPSDCQLCYAIARTRIPRCLPSSSARIFL 123

Query: 129 DGCFLRYDNYDFFGEAVDPIHDKFNCSARHLDDESLSKQFEEKVIEVITNVTIVTKSNGR 188
           DGCFLRY+ Y+F+ E+V    D F+CS    +D  L  +F  +V E    V +     G 
Sbjct: 124 DGCFLRYETYEFYDESVSDASDSFSCS----NDTVLDPRFGFQVSETAARVAV---RKGG 176

Query: 189 FGQVEGKGGIATVYALAQCLKFLDNKGCSQCLDEAALRLKGCSKSGEGRAMFAGCYVRFS 248
           FG V G+ G   V+ALAQC + L  + C  CL++A   +K C    EGRAM  GCY+R+S
Sbjct: 177 FG-VAGENG---VHALAQCWESLGKEDCRVCLEKAVKEVKRCVSRREGRAMNTGCYLRYS 232

Query: 249 TERFFNPNYQKK-------------------------------ETRYKRLSEMRKGQVLL 277
             +F+N +   K                                T+  +  + ++   L+
Sbjct: 233 DHKFYNGDGHHKFHVLFNKGVIVAIVLTTSAFVMLILLATYVIMTKVSKTKQEKRNLGLV 292

Query: 278 GTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQW 337
                 S   FKYE LE+ATD+F + + LGQGG G+VF G LP+G+N+AVKRL FN+R W
Sbjct: 293 SRKFNNSKTKFKYETLEKATDYFSHKKMLGQGGNGTVFLGILPNGKNVAVKRLVFNTRDW 352

Query: 338 VDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ 397
           V++FFNEVNLISGIQHKN+V+LLGCSIEGPESLLVYEYVPN+SLDQ LF ++   +L+W 
Sbjct: 353 VEEFFNEVNLISGIQHKNLVKLLGCSIEGPESLLVYEYVPNKSLDQFLFDESQSKVLNWS 412

Query: 398 QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV 457
           QR  II GTAEGLA+LHGGS ++IIHRDIKTSN+LLD++L PKIADFGLAR    DKTH+
Sbjct: 413 QRLNIILGTAEGLAYLHGGSPVRIIHRDIKTSNVLLDDQLNPKIADFGLARCFGLDKTHL 472

Query: 458 STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKH 517
           STGIAGTLGYMAPEY+VRGQLTEKADVY+FGVLV+E+A G R + F   +  +L  VW  
Sbjct: 473 STGIAGTLGYMAPEYVVRGQLTEKADVYSFGVLVLEIACGTRINAFVPETGHLLQRVWNL 532

Query: 518 YKANRITQSMDPGLTGRF-----PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID 572
           Y  NR+ +++DP L   F      E EA +VL++GLLCTQA  +LRPSM EV+ ML   D
Sbjct: 533 YTLNRLVEALDPCLKDEFLQVQGSEAEACKVLRVGLLCTQASPSLRPSMEEVIRMLTERD 592

Query: 573 YEIPPPKQPPFLNASVIS 590
           Y IP P  PPFL  S ++
Sbjct: 593 YPIPSPTSPPFLRVSSLT 610

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9CAL2|CRK3_ARATH Cysteine-rich receptor-like protein kinase 3 OS=Arabidopsis thaliana GN=CRK3 PE=2 SV=1

 Score =  502 bits (1292), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 256/558 (45%), Positives = 362/558 (64%), Gaps = 53/558 (9%)

Query: 89  VYAYMQCHEDLSQTDCESCFSALKQKANRCLP----SDSARIFLDGCFLRYDNYDFFGEA 144
           VYAY +C +DL + DC+ CF+ +K K  RCLP    +   ++F DGC++RYD+Y+F+ E 
Sbjct: 76  VYAYGECIKDLDKKDCDLCFAQIKAKVPRCLPFQKGTRGGQVFSDGCYIRYDDYNFYNET 135

Query: 145 VDPIHDKFNCSARHLDDESLSKQFEEKVIEVITNVTIVTKSNGRF--GQVEGKGGIATVY 202
           +  + D+  C+ + +   + +  F +   E++ N+++    NG F  G V+      TV+
Sbjct: 136 LS-LQDRTVCAPKEITGVNRT-VFRDNAAELVKNMSVEAVRNGGFYAGFVDRHN--VTVH 191

Query: 203 ALAQCLKFLDNKGCSQCLDEAALRLKGCSKSGEGRAMFAGCYVRFSTERFFNPNYQKKET 262
            LAQC + L+  GC +CL +A++R+  C  + EGR + AGCY+RFST++F+N +      
Sbjct: 192 GLAQCWETLNRSGCVECLSKASVRIGSCLVNEEGRVLSAGCYMRFSTQKFYNNSGNSTSD 251

Query: 263 -------------------------------RYKRLSEMRKGQVLLGTVLC---TSSLNF 288
                                            KR ++ ++ +  LG++      S+L F
Sbjct: 252 GNGGHNHLGVILAVTSSVVAFVLLVSAAGFLLKKRHAKKQREKKQLGSLFMLANKSNLCF 311

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLI 348
            YE LERATD+F +  KLGQGG+GSV++G L +G+ +AVKRLFFN++QWVD FFNEVNLI
Sbjct: 312 SYENLERATDYFSDKNKLGQGGSGSVYKGVLTNGKTVAVKRLFFNTKQWVDHFFNEVNLI 371

Query: 349 SGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAE 408
           S + HKN+V+LLGCSI GPESLLVYEY+ N+SL   LFV+  +  L+W +RF II GTAE
Sbjct: 372 SQVDHKNLVKLLGCSITGPESLLVYEYIANQSLHDYLFVRKDVQPLNWAKRFKIILGTAE 431

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           G+A+LH  S ++IIHRDIK SNILL++  TP+IADFGLAR    DKTH+ST IAGTLGYM
Sbjct: 432 GMAYLHEESNLRIIHRDIKLSNILLEDDFTPRIADFGLARLFPEDKTHISTAIAGTLGYM 491

Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMD 528
           APEY+VRG+LTEKADVY+FGVL+IEV +G+RN+ F + + S+L +VW  Y+ + + +++D
Sbjct: 492 APEYVVRGKLTEKADVYSFGVLMIEVITGKRNNAFVQDAGSILQSVWSLYRTSNVEEAVD 551

Query: 529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNAS- 587
           P L   F + EASR+LQIGLLC QA    RP+M+ VV M+     EI  P QPPFLN   
Sbjct: 552 PILGDNFNKIEASRLLQIGLLCVQAAFDQRPAMSVVVKMMKG-SLEIHTPTQPPFLNPGS 610

Query: 588 -------VISPSDNSKDS 598
                  +++P+ N  +S
Sbjct: 611 VVEMRKMMMTPTTNQSNS 628

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9CAL3|CRK2_ARATH Cysteine-rich receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=CRK2 PE=2 SV=1

 Score =  460 bits (1184), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 257/632 (40%), Positives = 356/632 (56%), Gaps = 57/632 (9%)

Query: 12  IWVIWMFIITLSMFVSRS----HSSSRSSESLYKCGPPAKVSDNRNFRQNFDAVMGNISE 67
           + ++ +++  L MF+  S       +R+      C P  + ++   +  NF A M  IS 
Sbjct: 6   VHILPLYLPCLLMFLLSSLRQITGDARARAVKVTCSPLLEHNETA-YVPNFVATMEKIST 64

Query: 68  QIMDDHHYHFALHYVVSPAPQVYAYMQCHEDLSQTDCESCFSALKQKANRCLPSDSARIF 127
           Q+       F +    +     Y   QC+ DL   DC  C++  +    +C P +  RIF
Sbjct: 65  QVQTSG---FGVALTGTGPDANYGLAQCYGDLPLNDCVLCYAEARTMLPQCYPQNGGRIF 121

Query: 128 LDGCFLRYDNYDFFGEAVDPIHDKFNCSARHLDDESLSKQFEEKVIEVITNVTIVTKSNG 187
           LDGCF+R +NY F+ E   P  D   C     +    +K F + V + + N        G
Sbjct: 122 LDGCFMRAENYSFYNEYKGP-EDSIVCG----NTTRKNKTFGDAVRQGLRNAVTEASGTG 176

Query: 188 RFGQVEGKGGIA---TVYALAQCLKFLDNKGCSQCLDEA-ALRLKGCSKSGEGRAMFAGC 243
            + +   K G +   + + LA C + L    C QCL+ A A  +KGC    EGRA+  GC
Sbjct: 177 GYARASAKAGESESESAFVLANCWRTLSPDSCKQCLENASASVVKGCLPWSEGRALHTGC 236

Query: 244 YVRFSTERFFNPNYQKKETRYKRLSEMRKGQ---------VLLGTVLCT----------- 283
           ++R+S + F N   +   +R   +  +             V +   +C            
Sbjct: 237 FLRYSDQDFLNKIPRNGRSRGSVVVIVVSVLSSVVVFMIGVAVSVYICKRRTIKRKRRGS 296

Query: 284 ------------SSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLF 331
                       SSLNFKY  LE+AT  FDN+ KLGQGG G+V++G LPDGR+IAVKRLF
Sbjct: 297 KDVEKMAKTLKDSSLNFKYSTLEKATGSFDNANKLGQGGFGTVYKGVLPDGRDIAVKRLF 356

Query: 332 FNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI 391
           FN+R     F+NEVN+IS ++HKN+VRLLGCS  GPESLLVYEY+ N+SLD+ +F  N  
Sbjct: 357 FNNRHRATDFYNEVNMISTVEHKNLVRLLGCSCSGPESLLVYEYLQNKSLDRFIFDVNRG 416

Query: 392 HILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA 451
             L WQ+R+TII GTAEGL +LH  S +KIIHRDIK SNILLD KL  KIADFGLAR   
Sbjct: 417 KTLDWQRRYTIIVGTAEGLVYLHEQSSVKIIHRDIKASNILLDSKLQAKIADFGLARSFQ 476

Query: 452 PDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRN--SVFSEGSSS 509
            DK+H+ST IAGTLGYMAPEYL  GQLTE  DVY+FGVLV+E+ +G++N  S  S+ S S
Sbjct: 477 DDKSHISTAIAGTLGYMAPEYLAHGQLTEMVDVYSFGVLVLEIVTGKQNTKSKMSDYSDS 536

Query: 510 VLHTVWKHYKANRITQSMDPGLTGR------FPENEASRVLQIGLLCTQAPVALRPSMAE 563
           ++   WKH+++  + +  DP L  +        + E +RV+QIGLLCTQ   +LRP M++
Sbjct: 537 LITEAWKHFQSGELEKIYDPNLDWKSQYDSHIIKKEIARVVQIGLLCTQEIPSLRPPMSK 596

Query: 564 VVHMLNNIDYEIPPPKQPPFLNASVISPSDNS 595
           ++HML N +  +P P  PPF++  V+   D S
Sbjct: 597 LLHMLKNKEEVLPLPSNPPFMDERVMELRDGS 628

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9M0G5|CRK43_ARATH Putative cysteine-rich receptor-like protein kinase 43 OS=Arabidopsis thaliana GN=CRK43 PE=3 SV=1

 Score =  378 bits (970), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 229/593 (38%), Positives = 322/593 (54%), Gaps = 72/593 (12%)

Query: 52  RNFRQNFDAVMGNISEQIMDDHHYHFALHYVVSPAPQVYAYMQCHEDLSQTDCESCFSAL 111
           R+++ N DA+ G       D  H  F  H    P  ++Y   QC  DLS  +C  C+S  
Sbjct: 49  RSYQINLDAIRG-------DMRHVKFGTHEHGDPPERMYVLSQCVSDLSSDECSLCWSRA 101

Query: 112 KQKANRCLPSDSARIFLDGCFLRYDNYDFFGEAVDPIHDKFNCSARHLDDESLSKQFEEK 171
               ++C P+      LDGCF+R DNY F+ E V     K   S     D+  S +F+  
Sbjct: 102 TDLLSQCFPATGGWFHLDGCFVRADNYSFYQEPVSHQDTKICAS-----DKEKSAEFKGL 156

Query: 172 VIEVITNVTIVTKSNGRFGQVEGKGGI--ATVYALAQCLKFLDNKGCSQCLDEAALRLKG 229
           V EV    +IV  +    G    K GI   TVY L  C + L+++ C  CL + AL +  
Sbjct: 157 VKEVTK--SIVEAAPYSRGFSVAKMGIRDLTVYGLGVCWRTLNDELCKLCLADGALSVTS 214

Query: 230 CSKSGEGRAMFAGCYVRFSTERFFNP------NYQKKETRY------------------K 265
           C  S EG A+ AGCY+R+S   F+N       ++ K+   Y                   
Sbjct: 215 CLPSKEGFALNAGCYLRYSNYTFYNERGLLAMSFTKENLTYIFVISMVGVLAIAAGFWCG 274

Query: 266 RLSEMRKGQV------------LLGTV--------LCTSS--LNFKYEILERATDFFDNS 303
           +   MR                L G +        +CT S  ++F+Y  L++AT+ F+ S
Sbjct: 275 KCFYMRTSPKKKIKGTKTKKFHLFGHLRIEKESESICTESHLMSFEYSTLKKATNNFNES 334

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
            KLG GG G VF+GTL DGR IA+KRL  + ++  D+  NE+++IS  QHKN+VRLLGC 
Sbjct: 335 CKLGVGGYGEVFKGTLSDGREIAIKRLHVSGKKPRDEIHNEIDVISRCQHKNLVRLLGCC 394

Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
                S +VYE++ N SLD ILF       L W++R TII GTAEGL +LH     KIIH
Sbjct: 395 FTNMNSFIVYEFLANTSLDHILFNPEKKKELDWKKRRTIILGTAEGLEYLH--ETCKIIH 452

Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVA------PDKTHVSTGIAGTLGYMAPEYLVRGQ 477
           RDIK SNILLD K  PKI+DFGLA+         P  +   + IAGTLGYMAPEY+ +G+
Sbjct: 453 RDIKASNILLDLKYKPKISDFGLAKFYPEGGKDIPASSLSPSSIAGTLGYMAPEYISKGR 512

Query: 478 LTEKADVYAFGVLVIEVASGRRNSVFSEGSS--SVLHTVWKHYKANRITQSMDPGLTGRF 535
           L+ K D Y+FGVLV+E+ SG RN+ F   +S  +++  VWK + +N++ + +D  +    
Sbjct: 513 LSNKIDAYSFGVLVLEITSGFRNNKFRSDNSLETLVTQVWKCFASNKMEEMIDKDMGEDT 572

Query: 536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNASV 588
            + E  RV+QIGLLCTQ    LRP+M++V+ M+++ D  +P P +PPFL+ S+
Sbjct: 573 DKQEMKRVMQIGLLCTQESPQLRPTMSKVIQMVSSTDIVLPTPTKPPFLHDSM 625

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65476|CRK16_ARATH Putative cysteine-rich receptor-like protein kinase 16 OS=Arabidopsis thaliana GN=CRK16 PE=3 SV=2

 Score =  313 bits (803), Expect = 2e-84,   Method: Compositional matrix adjust.
 Identities = 207/644 (32%), Positives = 318/644 (49%), Gaps = 81/644 (12%)

Query: 1   MQFLVRIPRNLIWVIWMFIITLSMFVSRSHSSSRSSESLYKCGPPAKVSDNRNFRQNFDA 60
           M F++++ +NL+ +   F+++ S+             S  KCG       N  +  N   
Sbjct: 1   MIFIMKL-KNLLPIFCFFLVSFSI------------SSAQKCGKTGLFKPNDKYDINRHL 47

Query: 61  VMGNISEQIMDDHHYHFALHYVVSPAP-QVYAYMQCHEDLSQTDCESCF-SALKQKANRC 118
           ++ +++  +     ++ A    +   P ++YA   C +      C +C  SA  +   +C
Sbjct: 48  LLSSLASNVSARGGFYNA---SIGQGPDRLYASGTCIQGSEPELCSACIDSAFIRVIKKC 104

Query: 119 LPSDSARIFLDG--------CFLRYDNYDFFGE-AVDPIHDKFNCSARHLDDESLSKQFE 169
                A   LD         C +RY N  FFG   + P    +N +   ++     +++E
Sbjct: 105 HNQTEA---LDWSSFNEEYPCMIRYSNRSFFGLLEMTPFFKNYNATDFQVNLTEFYQKWE 161

Query: 170 EKVIEVITNVTIVTKSNGRF-GQVEGKGGIATVYALAQCLKFLDNKGCSQCLDEAALRLK 228
             ++ VI +   ++  N +F G   GK GI TVYA   C K +    CS+CL       K
Sbjct: 162 ALMLGVIADA--ISSPNPKFYGAGTGKIGIQTVYAFVLCSKDISPWNCSRCLRGNVDNYK 219

Query: 229 -GCSKSGEGRAMFAGCYVRFSTERFF-------NPNYQKKETRYKRLSE----------- 269
             CS    G +    CY+R+   +F+       +P   +++ R   LS+           
Sbjct: 220 LSCSGKPRGHSFSPSCYMRWDLYQFYGFIEYRASPTLPREKGRISELSDDGGKISTRNIL 279

Query: 270 ----------------------MRKGQVLLGT---VLCTSSLNFKYEILERATDFFDNSR 304
                                  RK      T   +  + SL F ++ +E AT+ F  S 
Sbjct: 280 GITVALAFFITVLLVLGYALSRRRKAYQEFATENDITTSGSLQFDFKAIEAATNNFQKSN 339

Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           KLG GG G VF+GT P+G  +AVKRL   S Q  ++F NEV L++ +QH+N+VRLLG S+
Sbjct: 340 KLGHGGFGEVFKGTFPNGTEVAVKRLSKISGQGEEEFKNEVLLVAKLQHRNLVRLLGFSV 399

Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHR 424
           EG E +LVYEY+PN+SLD  LF       L W+ R+ II G   G+ +LH  S + IIHR
Sbjct: 400 EGEEKILVYEYMPNKSLDYFLFDHRRRGQLDWRTRYNIIRGVTRGILYLHQDSRLTIIHR 459

Query: 425 DIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG-IAGTLGYMAPEYLVRGQLTEKAD 483
           D+K  NILLD  + PKIADFG+AR+   D+T  +TG + GT GYM PEY+  GQ + K+D
Sbjct: 460 DLKAGNILLDVDMNPKIADFGVARNFRVDQTEATTGRVVGTFGYMPPEYVANGQFSMKSD 519

Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSV---LHTVWKHYKANRITQSMDPGLTGRFPENEA 540
           VY+FGVL++E+  G+++S F E   SV   +  VW+ +      + +DP +   + ++E 
Sbjct: 520 VYSFGVLILEIIVGKKSSSFHEIDGSVGNLVTYVWRLWNNESFLELVDPAMGESYDKDEV 579

Query: 541 SRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFL 584
            R + I LLC Q   A RP+M+ V  ML N    +P P+ P F+
Sbjct: 580 IRCIHISLLCVQENPADRPTMSTVFQMLTNTFLTLPVPQLPGFV 623

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8S9L6|CRK29_ARATH Cysteine-rich receptor-like protein kinase 29 OS=Arabidopsis thaliana GN=CRK29 PE=2 SV=1

 Score =  311 bits (797), Expect = 1e-83,   Method: Compositional matrix adjust.
 Identities = 213/674 (31%), Positives = 322/674 (47%), Gaps = 78/674 (11%)

Query: 12  IWVIWMF--IITLSMFVSRSHSSSRSSESLYKCGPPAKVSDNRNFRQNFDAVMGNISEQI 69
           + VI+ F   +TL+ F + +   S   +  + C      + N  F  N + ++ ++S   
Sbjct: 4   VRVIFFFACFLTLAPFHAFAQVDSYEFDPDFNCVDRGNFTANSTFAGNLNRLVSSLSSLK 63

Query: 70  MDDHHYHFALHYVVSPAPQVYAYMQCHEDLSQTDCESCF-SALKQKANRCLPSDSARIFL 128
              + + + L    S   + YA   C  ++ + DC SC  +A +    +C  +  A ++ 
Sbjct: 64  SQAYGF-YNLSSGDSSGERAYAIGLCRREVKRDDCVSCIQTAARNLTKQCPLTKQAVVWY 122

Query: 129 DGCFLRYDNYDFFGEAVDPIHDKFNCSARHLDDESLSKQFEEKVIEVITNVTIVTKSNGR 188
             C  RY N   +G         F        +    ++ +  +++ +  +      N +
Sbjct: 123 THCMFRYSNRTIYGRKETNPTKAFIAGEEISANRDDFERLQRGLLDRLKGIAAAGGPNRK 182

Query: 189 FGQVEGKG--GIATVYALAQCLKFLDNKGCSQCLDEAALRLKGCSKSGEGRAMFA-GCYV 245
           + Q  G    G    Y   QC   L  + C+ CL      +  C  +  G   F+  C  
Sbjct: 183 YAQGNGSASAGYRRFYGTVQCTPDLSEQDCNDCLVFGFENIPSCCDAEIGLRWFSPSCNF 242

Query: 246 RFSTERFFN---------PNYQKKET-----RYKRLSEMRKGQ-------------VLLG 278
           RF T RF+          P  Q  ++     R +R  + + G               LL 
Sbjct: 243 RFETWRFYEFDADLEPDPPAIQPADSPQSAARTERTGKGKGGSKVIIAIVIPILLVALLA 302

Query: 279 TVLC---------------------------------TSSLNFKYEILERATDFFDNSRK 305
             LC                                 T SL   +E L+ ATD F +  +
Sbjct: 303 ICLCLVLKWRKNKSGYKNKVLGKSPLSGSIAEDEFSNTESLLVHFETLKTATDNFSSENE 362

Query: 306 LGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE 365
           LG+GG GSV++G  P G+ IAVKRL  NS Q  ++F NE+ L++ +QH+N+VRL+G  I+
Sbjct: 363 LGRGGFGSVYKGVFPQGQEIAVKRLSGNSGQGDNEFKNEILLLAKLQHRNLVRLIGFCIQ 422

Query: 366 GPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRD 425
           G E LLVYE++ N SLDQ +F      +L W  R+ +I G A GL +LH  S  +IIHRD
Sbjct: 423 GEERLLVYEFIKNASLDQFIFDTEKRQLLDWVVRYKMIGGIARGLLYLHEDSRFRIIHRD 482

Query: 426 IKTSNILLDEKLTPKIADFGLARHVAPDKT---HVSTGIAGTLGYMAPEYLVRGQLTEKA 482
           +K SNILLD+++ PKIADFGLA+     +T     ++ IAGT GYMAPEY + GQ + K 
Sbjct: 483 LKASNILLDQEMNPKIADFGLAKLFDSGQTMTHRFTSRIAGTYGYMAPEYAMHGQFSVKT 542

Query: 483 DVYAFGVLVIEVASGRRN----SVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPEN 538
           DV++FGVLVIE+ +G+RN    S   E +  +L  VW+ ++ + I   +DP LT     N
Sbjct: 543 DVFSFGVLVIEIITGKRNNNGGSNGDEDAEDLLSWVWRSWREDTILSVIDPSLTAG-SRN 601

Query: 539 EASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNASVISPSDNSKDS 598
           E  R + IGLLC Q   A RP+MA V  MLN+  + +P P +P F+  SV+ PS+ S  +
Sbjct: 602 EILRCIHIGLLCVQESAATRPTMATVSLMLNSYSFTLPTPLRPAFVLESVVIPSNVSSST 661

Query: 599 ---MMSSFKSFVAE 609
               MSS    V+E
Sbjct: 662 EGLQMSSNDVTVSE 675

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1

 Score =  308 bits (790), Expect = 7e-83,   Method: Compositional matrix adjust.
 Identities = 188/557 (33%), Positives = 285/557 (51%), Gaps = 63/557 (11%)

Query: 88  QVYAYMQCHEDLSQTDCESCFS-ALKQKANRCLPSDSARIFLDGCFLRYDNYDFFGEA-V 145
           +VY    C  D+S   C  C + A  +   RC     A I+ D C +RY N    G+  +
Sbjct: 81  RVYGVFLCRGDVSAEICRDCVAFAANETLQRCPREKVAVIWYDECMVRYSNQSIVGQMRI 140

Query: 146 DPIHDKFNCSARHLDDESLSKQFEEKVIEVITNVTI-VTKSNGRFGQVEGKGGI-ATVYA 203
            P    F  + +++ +  +S+ F E +  ++ +V +    S+ +F   +    +  T+Y+
Sbjct: 141 RP--GVFLTNKQNITENQVSR-FNESLPALLIDVAVKAALSSRKFATEKANFTVFQTIYS 197

Query: 204 LAQCLKFLDNKGCSQCLDEAALRL-KGCSKSGEGRAMFAGCYVRFSTERFFNPNYQKKET 262
           L QC   L N+ C  CL +    L + C +S  GR +   C  R+    F+N        
Sbjct: 198 LVQCTPDLTNQDCESCLRQVINYLPRCCDRSVGGRVIAPSCSFRYELYPFYNETIAAAPM 257

Query: 263 RYKRLS-----------EMRKGQ----------------VLLGTVLC------------- 282
                S           E  KG+                VLL   +C             
Sbjct: 258 APPPSSTVTAPPLNIPSEKGKGKNLTVIVTAIAVPVSVCVLLLGAMCWLLARRRNNKLSA 317

Query: 283 ------------TSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRL 330
                       T +L F++  +E AT+ F  S KLG GG G V++G L  G  +A+KRL
Sbjct: 318 ETEDLDEDGITSTETLQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIKRL 377

Query: 331 FFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNT 390
              S Q  ++F NEV++++ +QH+N+ +LLG  ++G E +LVYE+VPN+SLD  LF    
Sbjct: 378 SQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEK 437

Query: 391 IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV 450
             +L WQ+R+ II G A G+ +LH  S + IIHRD+K SNILLD  + PKI+DFG+AR  
Sbjct: 438 RRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIF 497

Query: 451 APDKTHVSTG-IAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSE--GS 507
             D+T  +T  I GT GYM+PEY + G+ + K+DVY+FGVLV+E+ +G++NS F E  G 
Sbjct: 498 GVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFYEEDGL 557

Query: 508 SSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM 567
             ++  VWK +  N   + +D  + G F  NE  R + I LLC Q   + RPSM +++ M
Sbjct: 558 GDLVTYVWKLWVENSPLELVDEAMRGNFQTNEVIRCIHIALLCVQEDSSERPSMDDILVM 617

Query: 568 LNNIDYEIPPPKQPPFL 584
           +N+    +P PK+  FL
Sbjct: 618 MNSFTVTLPIPKRSGFL 634

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O49564|CRK27_ARATH Cysteine-rich receptor-like protein kinase 27 OS=Arabidopsis thaliana GN=CRK27 PE=3 SV=2

 Score =  293 bits (750), Expect = 3e-78,   Method: Compositional matrix adjust.
 Identities = 193/561 (34%), Positives = 288/561 (51%), Gaps = 59/561 (10%)

Query: 81  YVVSPAPQVYAYMQCHEDLS-QTDCESCFS-ALKQKANRCLPSDSARIFLDGCFLRYDNY 138
           Y +S   +V A   C  D+    DC SC + A KQ    C     A I+L+ C  RY + 
Sbjct: 69  YNISINGEVNAIALCRGDVKPNQDCISCITTAAKQLVESCPNIIEANIWLEKCMFRYTSR 128

Query: 139 DFFGEAVDPIHDKFNCSARHLDDESLSKQFEEKVIEVITNVTIVTKSNGRFGQVEGKGGI 198
              G+ ++P+   +  S   + D+   + F + + +++ ++     +     +V+   G+
Sbjct: 129 IILGQ-MEPVPFSYTSSNVSVTDK---EGFSKGLGDLLDSLGAKIDAANETKEVKFAAGV 184

Query: 199 -ATVYALAQCLKFLDNKGCSQCLDEAALRLKGC--SKSGEGRAMFAGCYVRFSTERFFNP 255
             T+YALAQC   L    C  CL +    +  C   K+G G      CY RF    FF+ 
Sbjct: 185 KGTIYALAQCTPDLSESDCRICLAQIFAGVPTCCDGKTG-GWWTNPSCYFRFEVYPFFDL 243

Query: 256 NYQKKETR-------YKRLSEMRKGQ---------------VLLGTVL------------ 281
           +   ++ +         R S+  K +               ++LG V             
Sbjct: 244 SVTSEQKQPLSSHNNNTRRSDQGKSKDRSKTLIFAVVPIVAIILGLVFLFIYLKRRRKKK 303

Query: 282 -----------CTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRL 330
                       T SL+F +E +  ATD F  + K+G+GG G V++G LPDG  IAVKRL
Sbjct: 304 TLKENAENEFESTDSLHFDFETIRVATDDFSLTNKIGEGGFGVVYKGHLPDGLEIAVKRL 363

Query: 331 FFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNT 390
             +S Q   +F  EV L++ +QHKN+V+L G SI+  E LLVYE++PN SLD+ LF    
Sbjct: 364 SIHSGQGNAEFKTEVLLMTKLQHKNLVKLFGFSIKESERLLVYEFIPNTSLDRFLFDPIK 423

Query: 391 IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV 450
              L W++R+ II G + GL +LH GS   IIHRD+K+SN+LLDE++ PKI+DFG+AR  
Sbjct: 424 QKQLDWEKRYNIIVGVSRGLLYLHEGSEFPIIHRDLKSSNVLLDEQMLPKISDFGMARQF 483

Query: 451 APDKTH-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSS 509
             D T  V+  + GT GYMAPEY + G+ + K DVY+FGVLV+E+ +G+RNS    G  +
Sbjct: 484 DFDNTQAVTRRVVGTYGYMAPEYAMHGRFSVKTDVYSFGVLVLEIITGKRNSGLGLGEGT 543

Query: 510 VLHT-VWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHML 568
            L T  W+++      + +DP L     + E+ + L+I L C Q     RP+M  VV ML
Sbjct: 544 DLPTFAWQNWIEGTSMELIDPVLLQTHDKKESMQCLEIALSCVQENPTKRPTMDSVVSML 603

Query: 569 --NNIDYEIPPPKQPPFLNAS 587
             ++   ++P P QP F   S
Sbjct: 604 SSDSESRQLPKPSQPGFFRRS 624

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65405|CRK28_ARATH Cysteine-rich receptor-like protein kinase 28 OS=Arabidopsis thaliana GN=CRK28 PE=3 SV=2

 Score =  293 bits (749), Expect = 4e-78,   Method: Compositional matrix adjust.
 Identities = 194/588 (32%), Positives = 280/588 (47%), Gaps = 75/588 (12%)

Query: 84  SPAPQVYAYMQCHEDLSQTDCESCFS-ALKQKANRCLPSDSARIFLDGCFLRYDNYDFFG 142
           S   + YA   C  ++ + DC SC   A +    +C  ++ A ++   C  RY N   +G
Sbjct: 79  SSGERAYAIGLCRREVKRDDCLSCIQIAARNLIEQCPLTNQAVVWYTHCMFRYSNMIIYG 138

Query: 143 EAVDPIHDKFNCSARHLDDESLSKQFEEKVIEVITNVTIVTKSNGRFGQVEGKG--GIAT 200
                    F        +     + + ++++ +  +      N ++ Q  G G  G   
Sbjct: 139 RKETTPTLSFQAGKNISANRDEFDRLQIELLDRLKGIAAAGGPNRKYAQGSGSGVAGYPQ 198

Query: 201 VYALAQCLKFLDNKGCSQCLDEAALRLKGCSKSGEG-RAMFAGCYVRFSTERFFN----- 254
            Y  A C   L  + C+ CL     ++ GC     G R  F  C  RF T RF+      
Sbjct: 199 FYGSAHCTPDLSEQDCNDCLVFGFEKIPGCCAGQVGLRWFFPSCSYRFETWRFYEFDADL 258

Query: 255 ----PNYQKKET-----RYKRLSEMRKGQ-------------VLLGTVLC---------- 282
               P  Q  ++     R +R  + + G               L    LC          
Sbjct: 259 EPDPPAIQPADSPTSAARTERTGKGKGGSKVIVAIVIPIVFVALFAICLCLLLKWKKNKS 318

Query: 283 -------------------------TSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRG 317
                                    + SL   +E L+ ATD F    +LG+GG GSV++G
Sbjct: 319 VGRVKGNKHNLLLLVIVILLQKDEFSDSLVVDFETLKAATDNFSPENELGRGGFGSVYKG 378

Query: 318 TLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVP 377
               G+ IAVKRL   S Q   +F NE+ L++ +QH+N+VRLLG  IEG E +LVYE++ 
Sbjct: 379 VFSGGQEIAVKRLSCTSGQGDSEFKNEILLLAKLQHRNLVRLLGFCIEGQERILVYEFIK 438

Query: 378 NRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL 437
           N SLD  +F      +L W  R+ +I G A GL +LH  S  +IIHRD+K SNILLD+++
Sbjct: 439 NASLDNFIFDLKKRQLLDWGVRYKMIGGVARGLLYLHEDSRYRIIHRDLKASNILLDQEM 498

Query: 438 TPKIADFGLARHVAPDKTHV---STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEV 494
            PKIADFGLA+    D+T     ++ IAGT GYMAPEY + GQ + K DV++FGVLVIE+
Sbjct: 499 NPKIADFGLAKLYDTDQTSTHRFTSKIAGTYGYMAPEYAIYGQFSVKTDVFSFGVLVIEI 558

Query: 495 ASGRRN----SVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLC 550
            +G+ N    S   E + ++L  VW+ ++ + I   +DP LT     +E  R + IGLLC
Sbjct: 559 ITGKGNNNGRSNDDEEAENLLSWVWRCWREDIILSVIDPSLTTG-SRSEILRCIHIGLLC 617

Query: 551 TQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNASVISPSDNSKDS 598
            Q   A RP+M  V  MLN+  Y +P P +P F   SV+ PS N   S
Sbjct: 618 VQESPASRPTMDSVALMLNSYSYTLPTPSRPAFALESVM-PSMNVSSS 664

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	625
255540615	614	BRASSINOSTEROID INSENSITIVE 1-associated	0.828	0.843	0.605	0.0
224121806	532	predicted protein [Populus trichocarpa]	0.803	0.943	0.616	0.0
147810367	668	hypothetical protein VITISV_034611 [Viti	0.971	0.908	0.553	0.0
297733755	696	unnamed protein product [Vitis vinifera]	0.939	0.843	0.555	0.0
225456979	611	PREDICTED: cysteine-rich receptor-like p	0.854	0.873	0.586	0.0
225452394	659	PREDICTED: cysteine-rich receptor-like p	0.942	0.893	0.536	0.0
147765625	653	hypothetical protein VITISV_038880 [Viti	0.856	0.819	0.559	0.0
356573847	673	PREDICTED: cysteine-rich receptor-like p	0.926	0.860	0.502	1e-174
255567375	605	kinase, putative [Ricinus communis] gi|2	0.851	0.879	0.545	1e-171
356513949	598	PREDICTED: cysteine-rich receptor-like p	0.804	0.841	0.567	1e-171

>gi|255540615|ref|XP_002511372.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223550487|gb|EEF51974.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis]

 Score =  683 bits (1763), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 332/548 (60%), Positives = 402/548 (73%), Gaps = 30/548 (5%)

Query: 82  VVSPAPQVYAYMQCHEDLSQTDCESCFSALKQKANRCLPSDSARIFLDGCFLRYDNYDFF 141
           V  PAP+VYA  QCH DLS  DC+ CFS  + K  RCLP  +ARI+LDGCF+RYDNY FF
Sbjct: 18  VTFPAPEVYALAQCHGDLSSLDCKLCFSQGRVKLPRCLPKSAARIYLDGCFIRYDNYSFF 77

Query: 142 GEAVDPIHDKFNCSARH--LDDESLSKQFEEKVIEVITNVTIVTKSNGRFGQVEGKGGIA 199
            E+++P +D  NCS     L D SL  +F++KV EVI NVT     NG F  VE K G  
Sbjct: 78  HESINPDYDSVNCSQPTGVLVDNSLHMEFKKKVAEVIKNVTEKALENGTFATVEAKAGAI 137

Query: 200 TVYALAQCLKFLDNKGCSQCLDEAALRLKGCSKSGEGRAMFAGCYVRFSTERFFNPNYQK 259
             YALAQC   L    C  CL  A   L+ C+  G G+A++ GCY+R+STERFFN + + 
Sbjct: 138 PAYALAQCWNSLTYAECRDCLVMAGSPLRQCAPGGGGQALYTGCYMRYSTERFFNTSSES 197

Query: 260 KETR----------------------------YKRLSEMRKGQVLLGTVLCTSSLNFKYE 291
            +                              Y+RLS+ +K Q  L     TS++NFKYE
Sbjct: 198 NDEDDSDAGIIGAIALAAVAFIVLASFGAFIGYERLSKRKKDQDNLRRFPETSNMNFKYE 257

Query: 292 ILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI 351
           +LE+AT+FF++  KLGQGGAGSV++G+LPDGR +AVKRL +N+RQWVDQFFNEVNLISGI
Sbjct: 258 VLEKATNFFNDETKLGQGGAGSVYKGSLPDGRTVAVKRLVYNTRQWVDQFFNEVNLISGI 317

Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N+V+LLGCSIEGPESLLVYEYVPNRSLDQILFVK+TIHILSWQQR+ II GTAEGLA
Sbjct: 318 RHANLVKLLGCSIEGPESLLVYEYVPNRSLDQILFVKSTIHILSWQQRYHIILGTAEGLA 377

Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           +LHGG G+KIIHRDIKTSNILLDEKL PKIADFGLAR  A D TH++TGIAGTLGYMAPE
Sbjct: 378 YLHGGCGVKIIHRDIKTSNILLDEKLIPKIADFGLARCFAADNTHITTGIAGTLGYMAPE 437

Query: 472 YLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL 531
           YL+RGQLTEKADVY+FGVLV+E+ASG++NSV+S+GS S+LH VWKHYKA  + +++DP L
Sbjct: 438 YLIRGQLTEKADVYSFGVLVLEIASGKKNSVYSQGSGSILHNVWKHYKARTLAEAIDPAL 497

Query: 532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNASVISP 591
               P  +A  VLQIGLLCTQA  +LRPSM EVV ML N + EIP P QPPFLNASV+S 
Sbjct: 498 KDEHPGKDAENVLQIGLLCTQASASLRPSMTEVVEMLTNKECEIPTPMQPPFLNASVLSA 557

Query: 592 SDNSKDSM 599
             ++++S+
Sbjct: 558 GGSTENSI 565

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224121806|ref|XP_002318677.1| predicted protein [Populus trichocarpa] gi|222859350|gb|EEE96897.1| predicted protein [Populus trichocarpa]

 Score =  672 bits (1733), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 328/532 (61%), Positives = 392/532 (73%), Gaps = 30/532 (5%)

Query: 89  VYAYMQCHEDLSQTDCESCFSALKQKANRCLPSDSARIFLDGCFLRYDNYDFFGEAVDPI 148
           +Y   QCH+DLS  DC+ CF   + K  RCLP+ SARI+L+GCF+RYDNY+FF EA+DP+
Sbjct: 1   IYGLAQCHDDLSSLDCKICFFQGRVKLPRCLPATSARIYLNGCFIRYDNYNFFHEAIDPM 60

Query: 149 HDKFNCS--ARHLDDESLSKQFEEKVIEVITNVTIVTKSNGRFGQVEGKGGIATVYALAQ 206
           +D   C      L D  L  +F++++   I NVT +   NG F   E KG + +VYALAQ
Sbjct: 61  NDAVVCGEPTNALTDSFLHMEFKQRLAAAIQNVTAMALGNGTFAAAEAKGRVFSVYALAQ 120

Query: 207 CLKFLDNKGCSQCLDEAALRLKGCSKSGEGRAMFAGCYVRFSTERFFNPNYQKKE----- 261
           C   LD   C +CL +A  +L  C+    G A FAGCY+++ST  FF  + + K      
Sbjct: 121 CWNTLDKDECRKCLAKAGSKLSQCAPGSGGSAFFAGCYMKYSTRHFFKKSVESKARYDNT 180

Query: 262 ----------------------TRYKRLSEMRKGQVLLGTVLCTSSLNFKYEILERATDF 299
                                   Y+RLS+ RKG      +   SSLNF YE+LE++T+ 
Sbjct: 181 GIIVAVTLSTVVVVVLASFGAFIGYERLSK-RKGDKTNLRLSPNSSLNFTYEVLEKSTEC 239

Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           FD+SRKLGQGGAGSVF+GTLPDGR +AVKRL +++RQWVDQFFNEVNLISGIQHKN+V L
Sbjct: 240 FDDSRKLGQGGAGSVFKGTLPDGRTVAVKRLVYSTRQWVDQFFNEVNLISGIQHKNLVIL 299

Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
           LGCSIEGPESLLVYEYVPNRSLDQILF+KNT+HIL+WQQRF II GTA GLA+LHGG G+
Sbjct: 300 LGCSIEGPESLLVYEYVPNRSLDQILFIKNTLHILNWQQRFNIILGTARGLAYLHGGCGV 359

Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLT 479
            IIHRDIKTSNILLDEKLTPKIADFGLAR VA D TH+STGIAGTLGYMAPEYLVRGQLT
Sbjct: 360 TIIHRDIKTSNILLDEKLTPKIADFGLARCVATDNTHISTGIAGTLGYMAPEYLVRGQLT 419

Query: 480 EKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENE 539
           EK DVY FGVL++E+A+G++NSVFS+GSSS+LH+VWKHYKAN IT  +DPGL G F + +
Sbjct: 420 EKVDVYGFGVLLLEIATGKKNSVFSQGSSSILHSVWKHYKANTITDMVDPGLRGMFSQKQ 479

Query: 540 ASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNASVISP 591
           A +VLQIGLLCTQA   LRPSM EVV ML +   EIP PKQPPFLNASV+SP
Sbjct: 480 AEKVLQIGLLCTQASSRLRPSMNEVVQMLTDAQCEIPSPKQPPFLNASVLSP 531

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147810367|emb|CAN61087.1| hypothetical protein VITISV_034611 [Vitis vinifera]

 Score =  668 bits (1724), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 354/640 (55%), Positives = 434/640 (67%), Gaps = 33/640 (5%)

Query: 1   MQFLVRIPRNLIWVIWMFIITLSMFVSRSHSSSRSSESLYKCGPPAKVSDNRNFRQNFDA 60
           M F +RIP+  +W+  ++ + L    S S S  R S++   CG     S    +  NF  
Sbjct: 1   MHFSIRIPQCKVWISLVYSMLLF---SLSLSDPRISQAGLLCGDTK--SAPSIYIPNFIQ 55

Query: 61  VMGNISEQIMDDHHYHFALHYVVSPAPQVYAYMQCHEDLSQTDCESCFSALKQKANRCLP 120
           VM  I++  M    + +A    ++ +P ++   QC+ DLS+ DC SCF+  + K  RCLP
Sbjct: 56  VMEAIAKS-MVQQGWGYA---NITKSPVIFGLSQCYSDLSKDDCLSCFAESRTKLPRCLP 111

Query: 121 SDSARIFLDGCFLRYDNYDFFGEAVDPIH-DKFNCSARH--LDDESLSKQFEEKVIEVIT 177
           + +ARI+LDGCFLRYDNY FF E++DP H D   CS     L D     +F +KV EVI 
Sbjct: 112 AIAARIYLDGCFLRYDNYSFFNESIDPNHMDMVRCSEPSGVLKDNYTRSEFSKKVDEVIN 171

Query: 178 NVTIVTKSNGRFGQVEGKGGIATVYALAQCLKFLDNKGCSQCLDEAALRLKGCSKSGEGR 237
           NVT        F     KGG    YALAQC K +D KGC  CL  A   ++ C    EGR
Sbjct: 172 NVTKTAVQKQGFAVAGMKGGAVVAYALAQCWKTVDQKGCRDCLVNAESAVRRCLPGSEGR 231

Query: 238 AMFAGCYVRFSTERFFNPNYQKKETRYKRLSEMRKGQVLLGTVLC--------------- 282
           A+ AGCY+R+STE+F+N    KK  +    + M    +L    +C               
Sbjct: 232 ALNAGCYLRYSTEKFYNDGTAKKSGKGLSDTGMIIAFILSVLAVCLLAFJGAFVGYILLS 291

Query: 283 ----TSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWV 338
               + +LNFKYE LERAT+FFD+SRKLGQGGAGSVF+GTLPDGR +AVKRLFFN+RQWV
Sbjct: 292 KRKRSLNLNFKYETLERATNFFDSSRKLGQGGAGSVFKGTLPDGRTVAVKRLFFNTRQWV 351

Query: 339 DQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQ 398
           D+FFNEVNLIS IQHKN+V LLGCSIEGPESLLVYEYVPN+S+DQILF K+    LSWQQ
Sbjct: 352 DEFFNEVNLISRIQHKNLVGLLGCSIEGPESLLVYEYVPNKSVDQILFGKDGTQGLSWQQ 411

Query: 399 RFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS 458
           RF II GTAEGLA+LHGGS +KIIHRDIK SNILLDE L PKIADFGLAR VAPDK+HVS
Sbjct: 412 RFEIIVGTAEGLAYLHGGSEVKIIHRDIKGSNILLDENLNPKIADFGLARCVAPDKSHVS 471

Query: 459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHY 518
           TGIAGTLGYMAPEYLVRGQL+EKADVYA+GVL++E+  GR+N +F +GS SVL TVWKHY
Sbjct: 472 TGIAGTLGYMAPEYLVRGQLSEKADVYAYGVLILEIVCGRKNCIFVQGSDSVLQTVWKHY 531

Query: 519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPP 578
           K+N + +S+DP L G FP NEA  V+QIGLLCTQA  ALRPSM++VV ML + +  IP P
Sbjct: 532 KSNSVVRSVDPSLKGDFPLNEARNVVQIGLLCTQASFALRPSMSQVVQMLTDQNSVIPEP 591

Query: 579 KQPPFLNASVISPSDNSKDSMMSSFK-SF-VAESPEIDHS 616
            QPPFLNASV+ PS++ K+S+  +   SF  A  P   HS
Sbjct: 592 MQPPFLNASVLDPSNSLKNSITRNLTPSFHTATEPPSTHS 631

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297733755|emb|CBI15002.3| unnamed protein product [Vitis vinifera]

 Score =  667 bits (1721), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 350/630 (55%), Positives = 424/630 (67%), Gaps = 43/630 (6%)

Query: 24  MFVSRSHSSSRSSESLYKCGPPAKVSDNRNFRQNFDAVMGNISEQIMDDHHYHFALHYVV 83
           +  S S S  R S++   CG     S    +  NF  VM  I++  M    + +A    +
Sbjct: 2   LLFSLSLSDPRISQAGLLCGDTK--SAPSIYIPNFIQVMEAIAKS-MVQQGWGYA---NI 55

Query: 84  SPAPQVYAYMQCHEDLSQTDCESCFSALKQKANRCLPSDSARIFLDGCFLRYDNYDFFGE 143
           + +P ++   QC+ DLS+ DC SCF+  + K  RCLP+ +ARI+LDGCFLRYDNY FF E
Sbjct: 56  TKSPVIFGLSQCYSDLSKDDCLSCFAESRTKLPRCLPAIAARIYLDGCFLRYDNYSFFNE 115

Query: 144 AVDPIHDKFNCS--ARHLDDESLSKQFEEKVIEVITNVTIVTKSNGRFGQVEGKGGIATV 201
           ++DP HD   CS  +  L D     +F +KV EVI NVT        F     KGG    
Sbjct: 116 SIDPNHDMVRCSEPSGVLKDNYTRSEFSKKVDEVINNVTKTAVQKQGFAVAGMKGGAVVA 175

Query: 202 YALAQCLKFLDNKGCSQCLDEAALRLKGCSKSGEGRAMFAGCYVRFSTERFFNPNYQKKE 261
           YALAQC K +D KGC  CL  A   ++ C    EGRA+ AGCY+R+STE+F+N    KK 
Sbjct: 176 YALAQCWKTVDQKGCRDCLVNAESAVRRCLPGSEGRALNAGCYLRYSTEKFYNDGTAKKS 235

Query: 262 TR-----------------------------YKRLSEMRKGQ----VLLGTVLCTSSLNF 288
            +                             Y  LS+ ++        + T +  S LNF
Sbjct: 236 GKGLSDTGMIIAFILSVLAVCLLAFLGAFVGYILLSKRKRNNNNALARIPTCINRSDLNF 295

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLI 348
           KYE LERAT+FFD+SRKLGQGGAGSVF+GTLPDGR +AVKRLFFN+RQWVD+FFNEVNLI
Sbjct: 296 KYETLERATNFFDSSRKLGQGGAGSVFKGTLPDGRTVAVKRLFFNTRQWVDEFFNEVNLI 355

Query: 349 SGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAE 408
           S IQHKN+V LLGCSIEGPESLLVYEYVPN+S+DQILF KN    LSWQQRF II GTAE
Sbjct: 356 SRIQHKNLVGLLGCSIEGPESLLVYEYVPNKSVDQILFGKNPTSCLSWQQRFEIIVGTAE 415

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           GLA+LHGGS +KIIHRDIK SNILLDE L PKIADFGLAR VAPDK+HVSTGIAGTLGYM
Sbjct: 416 GLAYLHGGSEVKIIHRDIKGSNILLDENLNPKIADFGLARCVAPDKSHVSTGIAGTLGYM 475

Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMD 528
           APEYLVRGQL+EKADVYA+GVL++E+  GR+N +F +GS SVL TVWKHYK+N + +S+D
Sbjct: 476 APEYLVRGQLSEKADVYAYGVLILEIVCGRKNCIFVQGSDSVLQTVWKHYKSNSVVRSVD 535

Query: 529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNASV 588
           P L G FP NEA  V+QIGLLCTQA  ALRPSM++VV ML + +  IP P QPPFLNASV
Sbjct: 536 PSLKGDFPLNEARNVVQIGLLCTQASFALRPSMSQVVQMLTDQNSVIPEPMQPPFLNASV 595

Query: 589 ISPSDNSKDSMMSSFK-SF-VAESPEIDHS 616
           + PS++ K+S+  +   SF  A  P   HS
Sbjct: 596 LDPSNSLKNSITRNLTPSFHTATEPPSTHS 625

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225456979|ref|XP_002278823.1| PREDICTED: cysteine-rich receptor-like protein kinase 1-like [Vitis vinifera]

 Score =  666 bits (1718), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 335/571 (58%), Positives = 400/571 (70%), Gaps = 37/571 (6%)

Query: 83  VSPAPQVYAYMQCHEDLSQTDCESCFSALKQKANRCLPSDSARIFLDGCFLRYDNYDFFG 142
           ++ +P ++   QC+ DLS+ DC SCF+  + K  RCLP+ +ARI+LDGCFLRYDNY FF 
Sbjct: 18  ITKSPVIFGLSQCYSDLSKDDCLSCFAESRTKLPRCLPAIAARIYLDGCFLRYDNYSFFN 77

Query: 143 EAVDPIHDKFNCSARH--LDDESLSKQFEEKVIEVITNVTIVTKSNGRFGQVEGKGGIAT 200
           E++DP HD   CS     L D     +F +KV EVI NVT        F     KGG   
Sbjct: 78  ESIDPNHDMVRCSEPSGVLKDNYTRSEFSKKVDEVINNVTKTAVQKQGFAVAGMKGGAVV 137

Query: 201 VYALAQCLKFLDNKGCSQCLDEAALRLKGCSKSGEGRAMFAGCYVRFSTERFFNPNYQKK 260
            YALAQC K +D KGC  CL  A   ++ C    EGRA+ AGCY+R+STE+F+N    KK
Sbjct: 138 AYALAQCWKTVDQKGCRDCLVNAESAVRRCLPGSEGRALNAGCYLRYSTEKFYNDGTAKK 197

Query: 261 ETR-----------------------------YKRLSEMRKGQ----VLLGTVLCTSSLN 287
             +                             Y  LS+ ++        + T +  S LN
Sbjct: 198 SGKGLSDTGMIIAFILSVLAVCLLAFLGAFVGYILLSKRKRNNNNALARIPTCINRSDLN 257

Query: 288 FKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNL 347
           FKYE LERAT+FFD+SRKLGQGGAGSVF+GTLPDGR +AVKRLFFN+RQWVD+FFNEVNL
Sbjct: 258 FKYETLERATNFFDSSRKLGQGGAGSVFKGTLPDGRTVAVKRLFFNTRQWVDEFFNEVNL 317

Query: 348 ISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTA 407
           IS IQHKN+V LLGCSIEGPESLLVYEYVPN+S+DQILF KN    LSWQQRF II GTA
Sbjct: 318 ISRIQHKNLVGLLGCSIEGPESLLVYEYVPNKSVDQILFGKNPTSCLSWQQRFEIIVGTA 377

Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGY 467
           EGLA+LHGGS +KIIHRDIK SNILLDE L PKIADFGLAR VAPDK+HVSTGIAGTLGY
Sbjct: 378 EGLAYLHGGSEVKIIHRDIKGSNILLDENLNPKIADFGLARCVAPDKSHVSTGIAGTLGY 437

Query: 468 MAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM 527
           MAPEYLVRGQL+EKADVYA+GVL++E+  GR+N +F +GS SVL TVWKHYK+N + +S+
Sbjct: 438 MAPEYLVRGQLSEKADVYAYGVLILEIVCGRKNCIFVQGSDSVLQTVWKHYKSNSVVRSV 497

Query: 528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNAS 587
           DP L G FP NEA  V+QIGLLCTQA  ALRPSM++VV ML + +  IP P QPPFLNAS
Sbjct: 498 DPSLKGDFPLNEARNVVQIGLLCTQASFALRPSMSQVVQMLTDQNSVIPEPMQPPFLNAS 557

Query: 588 VISPSDNSKDSMMSSFK-SF-VAESPEIDHS 616
           V+ PS++ K+S+  +   SF  A  P   HS
Sbjct: 558 VLDPSNSLKNSITRNLTPSFHTATEPPSTHS 588

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225452394|ref|XP_002273718.1| PREDICTED: cysteine-rich receptor-like protein kinase 42 [Vitis vinifera]

 Score =  660 bits (1703), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 343/639 (53%), Positives = 438/639 (68%), Gaps = 50/639 (7%)

Query: 5   VRIPRNLIWVIWMFIITLSMFVSRSHSSSRSSESLYKCGPPAKVSDNRNFRQNFDAVMGN 64
           +++     W+I  FI+      S S S  R+SE+   C P AK +D +NF   F   M  
Sbjct: 5   IKVHSKPTWLISFFIL-----FSLSSSDPRTSEAGLYCSP-AKSTD-KNFVPVFVKEMEF 57

Query: 65  ISEQI-MDDHHYHFALHYVVSPAPQVYAYMQCHEDLSQTDCESCFSALKQKANRCLPSDS 123
           +S+ + ++    HF     V+  P +Y   QCH+DLS  DC  C++A + K  RCLP+ S
Sbjct: 58  LSQLVTLNLWGSHF-----VNSTPPMYGLAQCHQDLSHLDCLLCYAAGRTKLPRCLPATS 112

Query: 124 ARIFLDGCFLRYDNYDFFGEAVDPIHDKFNCSARH--LDDESLSKQFEEKVIEVITNVTI 181
           ARI+LDGCFLRYDNY FF E+VDP HD  NCS+    + D+    +F + V  VI NVT 
Sbjct: 113 ARIYLDGCFLRYDNYSFFSESVDPDHDTVNCSSGSGAIVDQVAKLEFVKNVHRVINNVTA 172

Query: 182 VTKSNGRFGQVEGKGGIATVYALAQCLKFLDNKGCSQCLDEAALRLKGCSKSGEGRAMFA 241
              +NG +G    +GG   VYALA+C K +++ GC  CL +A+  ++GC    EGR + A
Sbjct: 173 TAVANGGYGVAVVEGGAVGVYALAECWKTVNSSGCRACLQKASNEVRGCLPGKEGRGLNA 232

Query: 242 GCYVRFSTERFFNPNYQKKETR-----------------------------YKRLSEMRK 272
           GCY+R+STE+F++   + +                                Y  LS++++
Sbjct: 233 GCYLRYSTEKFYDNGGESEGGSGSSRTGLTIAIVLAAAALILVSLFAAYAGYASLSKIKE 292

Query: 273 GQVLLG---TVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKR 329
            +  LG   +++  SSLNFKYE LERAT++F+ SRKLGQGGAGSV+ GTLP+G  +AVKR
Sbjct: 293 ERKNLGKVASIINKSSLNFKYETLERATEYFNPSRKLGQGGAGSVYMGTLPNGEIVAVKR 352

Query: 330 LFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKN 389
           L FN+RQWVD+FFNEVNLISGIQHKN+V+LLGCSIEGPESLLVYEYVPNRSLDQ +F KN
Sbjct: 353 LIFNTRQWVDEFFNEVNLISGIQHKNLVKLLGCSIEGPESLLVYEYVPNRSLDQFMFDKN 412

Query: 390 TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH 449
            I  L+W+QRF II GTAEGLA+LHGG  ++IIHRDIK SNILLDE LTPKIADFGLAR 
Sbjct: 413 KIQTLNWEQRFDIIVGTAEGLAYLHGGLQMRIIHRDIKGSNILLDENLTPKIADFGLARC 472

Query: 450 VAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSS 509
           +  DKTH+STGIAGTLGYMAPEYLVRGQLTEKADVY+FGVLV+E+  GR+NSVF++ S S
Sbjct: 473 LGADKTHLSTGIAGTLGYMAPEYLVRGQLTEKADVYSFGVLVLEIVCGRKNSVFTQDSGS 532

Query: 510 VLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLN 569
           +L  VWK YK+N++ +++D  L   FPE EAS VL+IGLLCTQA VALRPSM EVV ML 
Sbjct: 533 LLQRVWKLYKSNKLVEAIDDCLKDDFPEKEASDVLRIGLLCTQASVALRPSMTEVVWMLT 592

Query: 570 NIDYEIPPPKQPPFLNASVISPS---DNSKDSMMSSFKS 605
           + D+EIPPP QPPFLNA V+  +    NS ++ MS+  +
Sbjct: 593 HKDWEIPPPNQPPFLNAHVLESAISRSNSANTSMSNMAT 631

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147765625|emb|CAN69244.1| hypothetical protein VITISV_038880 [Vitis vinifera]

 Score =  644 bits (1660), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 324/579 (55%), Positives = 408/579 (70%), Gaps = 44/579 (7%)

Query: 81  YVVSPAPQVYAYMQCHEDLSQTDCESCFSALKQKANRCLPSDSARIFLDGCFLRYDNYDF 140
           + V+  P +Y   QCH+DLS  DC  C++A + K  RCLP+ SARI+LDGCFLRYDNY F
Sbjct: 16  HFVNSTPPMYGLAQCHQDLSHLDCLLCYAAGRTKLPRCLPATSARIYLDGCFLRYDNYSF 75

Query: 141 FGEAVDPIHDKFNCSARH--LDDESLSKQFEEKVIEVITNVTIVTKSNGRFGQVEGKGGI 198
           F E+VDP HD  NCS+    + D+    +F + V  VI NVT    +NG +G    +GG 
Sbjct: 76  FSESVDPDHDTVNCSSGSGAIVDQVAKLEFVKNVHRVINNVTATAVANGGYGVAVVEGGA 135

Query: 199 ATVYALAQCLKFLDNKGCSQCLDEAALRLKGCSKSGEGRAMFAGCYVRFSTERFFNPNYQ 258
             VYALA+C K +++ GC  CL +A+  ++GC    EGR + AGCY+R+STE+F++   +
Sbjct: 136 VGVYALAECWKTVNSSGCRACLQKASNEVRGCLPGKEGRGLNAGCYLRYSTEKFYDNGGE 195

Query: 259 KKETR-----------------------------YKRLSEMRKGQVLLG---TVLCTSSL 286
            +                                Y  LS++++ +  LG   +++  SSL
Sbjct: 196 SEGGSGSSRTGLTIAIVLAAAALILVSLFAAYAGYASLSKIKEERKNLGKVASIINKSSL 255

Query: 287 NFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVN 346
           NFKYE LERAT++F+ SRKLGQGGAGSV+ GTLP+G  +AVKRL FN+RQWVD+FFNEVN
Sbjct: 256 NFKYETLERATEYFNPSRKLGQGGAGSVYMGTLPNGEIVAVKRLIFNTRQWVDEFFNEVN 315

Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGT 406
           LISGIQHKN+V+LLGCSIEGPESLLVYEYVPNRSJDQ +F KN I  L+W+QRF II GT
Sbjct: 316 LISGIQHKNLVKLLGCSIEGPESLLVYEYVPNRSJDQFMFDKNKIQTLNWEQRFDIIVGT 375

Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG 466
           AEGLA+LHGG  ++IIHRDIK SNILLDE LTPKIADFGLAR +  DKTH+STGIAGTLG
Sbjct: 376 AEGLAYLHGGLQMRIIHRDIKGSNILLDENLTPKIADFGLARCLGADKTHLSTGIAGTLG 435

Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS 526
           YMAPEYLVRGQLTEKADVY+FGVLV+E+  GR+NSVF++ S S+L  VWK YK+N++ ++
Sbjct: 436 YMAPEYLVRGQLTEKADVYSFGVLVLEIVCGRKNSVFTQDSGSLLQRVWKLYKSNKLVEA 495

Query: 527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNA 586
           +D  L   FPE EAS VL+IGLLCTQA VALRPSM EVV ML + D+EIPPP QPPFLNA
Sbjct: 496 IDDCLKDDFPEKEASDVLRIGLLCTQASVALRPSMTEVVWMLTHKDWEIPPPNQPPFLNA 555

Query: 587 SVISPSDNSKDSMMSSFKSFVAESP--EIDHSLKMKAFE 623
            V+       +S +S F ++  E P   +D   + K  E
Sbjct: 556 HVL-------ESAISRFXTY-EEDPCXAVDTGDRFKXLE 586

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356573847|ref|XP_003555067.1| PREDICTED: cysteine-rich receptor-like protein kinase 42-like [Glycine max]

 Score =  619 bits (1595), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 313/623 (50%), Positives = 421/623 (67%), Gaps = 44/623 (7%)

Query: 31  SSSRSSESLYKCGPPAKVSDNRNFRQNFDAVMGNISEQIMDDHHYHFALHYVVSPAP-QV 89
           S+ R +E+   CG  +K     N+  +F   M ++S+ +  ++    ++    S +   +
Sbjct: 37  SNPRITEAGLYCGT-SKAPLKANYIPSFIKEMESLSQLVTSNNWGTHSVKISGSGSSIPI 95

Query: 90  YAYMQCHEDLSQTDCESCFSALKQKANRCLPSDSARIFLDGCFLRYDNYDFFGEAVDPIH 149
           Y + QC  DLS TDC  C++A + +  RCLPS SARI+LDGCFLRYDNY F+ E  DP  
Sbjct: 96  YGFAQCFRDLSHTDCLLCYAASRTRLPRCLPSVSARIYLDGCFLRYDNYSFYSEGTDPSR 155

Query: 150 DKFNCSARHLDDESLSKQFEEKVIEVITNVTIVTKSNGR---FGQVEGKGGIATVYALAQ 206
           D  NC+     DE+   + +E+V  V+ NV  + + +G     G+VEG      VYALAQ
Sbjct: 156 DAVNCTGVAAGDEAERVELQERVGRVVDNVVNIAERDGNGFGVGEVEG------VYALAQ 209

Query: 207 CLKFLDNKGCSQCLDEAALRLKGCSKSGEGRAMFAGCYVRFSTERFFNPN---------- 256
           C   L + GC +CL +A   +KGC    EGRA+ AGCY+R+ST++F+N +          
Sbjct: 210 CWNTLGSGGCRECLRKAGREVKGCLPKKEGRALNAGCYLRYSTQKFYNEDGDAGGGNGFL 269

Query: 257 --------------------YQKKETRYKRLSEMRKGQVLLG---TVLCTSSLNFKYEIL 293
                                      + + S+++K    LG   + +  SSLN+KYE L
Sbjct: 270 RRRGVIVAEVLAAAAVIMLALSASYAAFTKFSKIKKENNNLGQISSSISKSSLNYKYETL 329

Query: 294 ERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQH 353
           E+ATD+F++SRK+GQGGAGSVF+G LP+G+ +AVKRL FN+RQWVD+FFNEVNLISGI+H
Sbjct: 330 EKATDYFNSSRKVGQGGAGSVFKGILPNGKVVAVKRLIFNNRQWVDEFFNEVNLISGIEH 389

Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
           KN+V+LLGCSIEGPESLLVYEY+P +SLDQ +F KN   IL+W+QRF II GTAEGLA+L
Sbjct: 390 KNLVKLLGCSIEGPESLLVYEYLPKKSLDQFIFEKNRTQILNWKQRFNIILGTAEGLAYL 449

Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H G+ I+IIHRDIK+SN+LLDE LTPKIADFGLAR    DK+H+STGIAGTLGYMAPEYL
Sbjct: 450 HEGTKIRIIHRDIKSSNVLLDENLTPKIADFGLARCFGGDKSHLSTGIAGTLGYMAPEYL 509

Query: 474 VRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG 533
           +RGQLT+KADVY++GVLV+E+ SGRRN+VF E S S+L T WK Y++N +T+++DP L  
Sbjct: 510 IRGQLTDKADVYSYGVLVLEIVSGRRNNVFREDSGSLLQTAWKLYRSNTLTEAVDPSLGD 569

Query: 534 RFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNASVISPSD 593
            FP +EASRVLQIGLLCTQA  +LRPSM++VV+ML+N + ++P P QPPFLN  ++    
Sbjct: 570 DFPPSEASRVLQIGLLCTQASASLRPSMSQVVYMLSNTNLDVPTPNQPPFLNTGMLDSDS 629

Query: 594 NSKDSMMSSFKSFVAESPEIDHS 616
           + K    +SF S   +   + +S
Sbjct: 630 SIKSYSTNSFISNALKKIGVSYS 652

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255567375|ref|XP_002524667.1| kinase, putative [Ricinus communis] gi|223536028|gb|EEF37686.1| kinase, putative [Ricinus communis]

 Score =  609 bits (1571), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 312/572 (54%), Positives = 388/572 (67%), Gaps = 40/572 (6%)

Query: 76  HFALHYVVSPAPQVYAYMQCHEDLSQTDCESCFSALKQKANRCLPSDSARIFLDGCFLRY 135
           HFA +++ S  P +Y   QCH+DLSQTDC  C++  + K  RCLPS SARIFLDGCFLRY
Sbjct: 12  HFATYHLNSSLP-MYVLAQCHQDLSQTDCLLCYAVSRTKIPRCLPSVSARIFLDGCFLRY 70

Query: 136 DNYDFFGEAVDPIHDKFNCSARHL---DDESLSKQFEEKVIEVITNVTIVTKSNGRFGQV 192
           DNY+FF E+V    D+  CS  ++   + E+   +F + V   I NV+     NG FG V
Sbjct: 71  DNYNFFEESVSVSFDEVKCSQENVSGSNGENDKLRFVKSVEHAIGNVSSKAVENGGFGVV 130

Query: 193 EGKGGIATVYALAQCLKFLDNKGCSQCLDEAALRLKGCSKSGEGRAMFAGCYVRFSTERF 252
               GI  VYALAQC + +   GC +CL +A   +KGC    EGR + AGCY+R+STERF
Sbjct: 131 ----GIEGVYALAQCWESVGKDGCRECLRKAGKEVKGCGAKKEGRGLNAGCYLRYSTERF 186

Query: 253 FNPNYQKKETR-----------------------------YKRLSEMRKGQVLLGTV--- 280
           +N   + +                                Y R  + +  ++ L  +   
Sbjct: 187 YNVGGELEAGHTISGLGVAIAVVLAAAAVLMLSIFAVYAVYVRRMKNKAERINLEKISIN 246

Query: 281 LCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQ 340
              +SLNFKYE LE+ATD+F+ SRK+GQGGAGSV+ GTLP+G  +AVKRL FN+RQWVD+
Sbjct: 247 FSKTSLNFKYETLEKATDYFNASRKIGQGGAGSVYAGTLPNGETVAVKRLTFNTRQWVDE 306

Query: 341 FFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRF 400
           FFNEVNLISGIQHKN+V+LLGCSIEGPESLLVYEYVPN+SLDQ +F K+    L+W+QRF
Sbjct: 307 FFNEVNLISGIQHKNLVKLLGCSIEGPESLLVYEYVPNKSLDQFIFGKDKPTTLNWKQRF 366

Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG 460
            II GTAEGLA+LHGGS  +IIHRDIK+SN+LLDE  TPKIADFGL R    DK+H+STG
Sbjct: 367 DIIVGTAEGLAYLHGGSQERIIHRDIKSSNVLLDEDFTPKIADFGLVRCFGADKSHLSTG 426

Query: 461 IAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKA 520
           IAGT+GYMAPEYL+RGQLTEKADVY+FGVLV+E+  G+R + F+E S S+L TVW+ Y+ 
Sbjct: 427 IAGTMGYMAPEYLIRGQLTEKADVYSFGVLVLEIVMGKRCNAFTEDSKSLLQTVWQLYRL 486

Query: 521 NRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQ 580
           NR+ ++ DP L   F   E SRVLQ GLLCTQA VALRPSMAEVV ML N   EIP P Q
Sbjct: 487 NRLVEAADPSLRDDFSAEEVSRVLQTGLLCTQASVALRPSMAEVVVMLTNSGGEIPLPSQ 546

Query: 581 PPFLNASVISPSDNSKDSMMSSFKSFVAESPE 612
           PPF+NA+ + P  + +    SSF S  A   E
Sbjct: 547 PPFMNATSLEPESSRRSYSTSSFVSNAARKLE 578

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356513949|ref|XP_003525670.1| PREDICTED: cysteine-rich receptor-like protein kinase 42-like [Glycine max]

 Score =  607 bits (1566), Expect = e-171,   Method: Compositional matrix adjust.
 Identities = 303/534 (56%), Positives = 383/534 (71%), Gaps = 31/534 (5%)

Query: 83  VSPAPQVYAYMQCHEDLSQTDCESCFSALKQKANRCLPSDSARIFLDGCFLRYDNYDFFG 142
           +S    +Y   QC +DLS  DC  CF++ + K  RCLPS SARI+LDGCFLRYDNY F+ 
Sbjct: 20  MSSTTPIYGLAQCFQDLSSIDCLQCFASSRTKLPRCLPSVSARIYLDGCFLRYDNYSFYT 79

Query: 143 EAVDPIHDKFNCSARHL----DDESLSKQFEEKVIEVITNVTIVTKSNGRFGQVEGKGGI 198
           E  DP+ D  NC++++     D E L   F E V +V+ +V  V  + GR     G+GG 
Sbjct: 80  EDTDPLRDTVNCTSQYGAVVGDGEKLV--FAESVAKVVESVVRVAVNEGRGIFAVGEGG- 136

Query: 199 ATVYALAQCLKFLDNKGCSQCLDEAALRLKGCSKSGEGRAMFAGCYVRFSTERFFNPNYQ 258
             VYALAQC K +  KGCS CL +A   +KGC    EGRA+  GCY+R+ST +F+N   +
Sbjct: 137 -GVYALAQCWKTVGVKGCSDCLRKAENEVKGCLPKREGRALNTGCYLRYSTVKFYNQGGE 195

Query: 259 KKE---------------------TRYKRLSEMRKGQVLLGT--VLCTSSLNFKYEILER 295
             +                       Y   ++ RK    +     L  SSLN+KYE LE+
Sbjct: 196 DGQGDAIVAAGSVLAAAVVVLTLAASYVAFTKKRKKNNFIEAPPSLKNSSLNYKYETLEK 255

Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKN 355
           ATD+F +SRK+GQGGAGSV++GTLP+G ++AVKRL FN+RQWVD FFNEVNLISG+QHKN
Sbjct: 256 ATDYFSSSRKIGQGGAGSVYKGTLPNGNDVAVKRLVFNNRQWVDDFFNEVNLISGMQHKN 315

Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           +V+LLGCSIEGPESL+VYEY+PN+SLDQ +F K+   IL W+QRF II GTAEGLA+LHG
Sbjct: 316 LVKLLGCSIEGPESLIVYEYLPNKSLDQFIFEKDITRILKWKQRFEIILGTAEGLAYLHG 375

Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
           GS I+IIHRDIK+SN+LLDE L PKIADFGLAR    DKTH+STGIAGTLGYMAPEYL++
Sbjct: 376 GSEIRIIHRDIKSSNVLLDENLNPKIADFGLARCFGTDKTHLSTGIAGTLGYMAPEYLIQ 435

Query: 476 GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF 535
           GQLT+KADVY+FGVLV+E+ASGR+N+VF E S S+L TVWK Y++NR+ +++DPGL   F
Sbjct: 436 GQLTDKADVYSFGVLVLEIASGRKNNVFREDSGSLLQTVWKLYQSNRLGEAVDPGLGEDF 495

Query: 536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNASVI 589
           P  EASRV QIGLLCTQA  +LRPSM +VV +L+N + + P PKQPPFLN+ ++
Sbjct: 496 PAREASRVFQIGLLCTQASASLRPSMTQVVSILSNSNLDAPIPKQPPFLNSRLL 549

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	625
TAIR|locus:2026785	646	CRK3 "cysteine-rich RLK (RECEP	0.518	0.501	0.580	2e-130
TAIR|locus:2026821	649	CRK2 "cysteine-rich RLK (RECEP	0.532	0.513	0.548	9.5e-120
TAIR|locus:2139845	625	AT4G28670 [Arabidopsis thalian	0.489	0.489	0.487	5.3e-98
TAIR|locus:2115728	675	CRK25 "cysteine-rich RLK (RECE	0.488	0.451	0.438	7.4e-82
TAIR|locus:2141201	679	CRK29 "cysteine-rich RLK (RECE	0.489	0.450	0.471	1.9e-81
TAIR|locus:2141762	665	CRK26 "cysteine-rich RLK (RECE	0.491	0.461	0.463	2.5e-79
TAIR|locus:2121676	669	CRK10 "cysteine-rich RLK (RECE	0.483	0.451	0.459	6.6e-79
TAIR|locus:2121651	676	CRK8 "cysteine-rich RLK (RECEP	0.491	0.454	0.456	5.9e-78
TAIR|locus:2123126	666	CRK31 "cysteine-rich RLK (RECE	0.476	0.447	0.460	9.5e-78
TAIR|locus:2127323	642	CRK27 "cysteine-rich RLK (RECE	0.52	0.506	0.434	9.5e-78

TAIR|locus:2026785 CRK3 "cysteine-rich RLK (RECEPTOR-like protein kinase) 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 978 (349.3 bits), Expect = 2.0e-130, Sum P(2) = 2.0e-130
 Identities = 191/329 (58%), Positives = 249/329 (75%)

Query:   265 KRLSEMRKGQVLLGTVLCT---SSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPD 321
             KR ++ ++ +  LG++      S+L F YE LERATD+F +  KLGQGG+GSV++G L +
Sbjct:   285 KRHAKKQREKKQLGSLFMLANKSNLCFSYENLERATDYFSDKNKLGQGGSGSVYKGVLTN 344

Query:   322 GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSL 381
             G+ +AVKRLFFN++QWVD FFNEVNLIS + HKN+V+LLGCSI GPESLLVYEY+ N+SL
Sbjct:   345 GKTVAVKRLFFNTKQWVDHFFNEVNLISQVDHKNLVKLLGCSITGPESLLVYEYIANQSL 404

Query:   382 DQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKI 441
                LFV+  +  L+W +RF II GTAEG+A+LH  S ++IIHRDIK SNILL++  TP+I
Sbjct:   405 HDYLFVRKDVQPLNWAKRFKIILGTAEGMAYLHEESNLRIIHRDIKLSNILLEDDFTPRI 464

Query:   442 ADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNS 501
             ADFGLAR    DKTH+ST IAGTLGYMAPEY+VRG+LTEKADVY+FGVL+IEV +G+RN+
Sbjct:   465 ADFGLARLFPEDKTHISTAIAGTLGYMAPEYVVRGKLTEKADVYSFGVLMIEVITGKRNN 524

Query:   502 VFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSM 561
              F + + S+L +VW  Y+ + + +++DP L   F + EASR+LQIGLLC QA    RP+M
Sbjct:   525 AFVQDAGSILQSVWSLYRTSNVEEAVDPILGDNFNKIEASRLLQIGLLCVQAAFDQRPAM 584

Query:   562 AEVVHMLNNIDYEIPPPKQPPFLN-ASVI 589
             + VV M+     EI  P QPPFLN  SV+
Sbjct:   585 SVVVKMMKG-SLEIHTPTQPPFLNPGSVV 612

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

TAIR|locus:2026821 CRK2 "cysteine-rich RLK (RECEPTOR-like protein kinase) 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 933 (333.5 bits), Expect = 9.5e-120, Sum P(2) = 9.5e-120
 Identities = 187/341 (54%), Positives = 238/341 (69%)

Query:   257 YQKKETRYKRLSEMRKGQVLLGTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFR 316
             Y  K    KR     K    +   L  SSLNFKY  LE+AT  FDN+ KLGQGG G+V++
Sbjct:   282 YICKRRTIKRKRRGSKDVEKMAKTLKDSSLNFKYSTLEKATGSFDNANKLGQGGFGTVYK 341

Query:   317 GTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV 376
             G LPDGR+IAVKRLFFN+R     F+NEVN+IS ++HKN+VRLLGCS  GPESLLVYEY+
Sbjct:   342 GVLPDGRDIAVKRLFFNNRHRATDFYNEVNMISTVEHKNLVRLLGCSCSGPESLLVYEYL 401

Query:   377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEK 436
              N+SLD+ +F  N    L WQ+R+TII GTAEGL +LH  S +KIIHRDIK SNILLD K
Sbjct:   402 QNKSLDRFIFDVNRGKTLDWQRRYTIIVGTAEGLVYLHEQSSVKIIHRDIKASNILLDSK 461

Query:   437 LTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
             L  KIADFGLAR    DK+H+ST IAGTLGYMAPEYL  GQLTE  DVY+FGVLV+E+ +
Sbjct:   462 LQAKIADFGLARSFQDDKSHISTAIAGTLGYMAPEYLAHGQLTEMVDVYSFGVLVLEIVT 521

Query:   497 GRRN--SVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP------ENEASRVLQIGL 548
             G++N  S  S+ S S++   WKH+++  + +  DP L  +        + E +RV+QIGL
Sbjct:   522 GKQNTKSKMSDYSDSLITEAWKHFQSGELEKIYDPNLDWKSQYDSHIIKKEIARVVQIGL 581

Query:   549 LCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNASVI 589
             LCTQ   +LRP M++++HML N +  +P P  PPF++  V+
Sbjct:   582 LCTQEIPSLRPPMSKLLHMLKNKEEVLPLPSNPPFMDERVM 622

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010193 "response to ozone" evidence=IEP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006457 "protein folding" evidence=RCA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0009408 "response to heat" evidence=RCA

GO:0009644 "response to high light intensity" evidence=RCA

GO:0034976 "response to endoplasmic reticulum stress" evidence=RCA

GO:0042542 "response to hydrogen peroxide" evidence=RCA

TAIR|locus:2139845 AT4G28670 [Arabidopsis thaliana (taxid:3702)]

 Score = 732 (262.7 bits), Expect = 5.3e-98, Sum P(2) = 5.3e-98
 Identities = 155/318 (48%), Positives = 212/318 (66%)

Query:   281 LCTSS--LNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWV 338
             +CT S  ++F+Y  L++AT+ F+ S KLG GG G VF+GTL DGR IA+KRL  + ++  
Sbjct:   310 ICTESHLMSFEYSTLKKATNNFNESCKLGVGGYGEVFKGTLSDGREIAIKRLHVSGKKPR 369

Query:   339 DQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQ 398
             D+  NE+++IS  QHKN+VRLLGC      S +VYE++ N SLD ILF       L W++
Sbjct:   370 DEIHNEIDVISRCQHKNLVRLLGCCFTNMNSFIVYEFLANTSLDHILFNPEKKKELDWKK 429

Query:   399 RFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA------P 452
             R TII GTAEGL +LH     KIIHRDIK SNILLD K  PKI+DFGLA+         P
Sbjct:   430 RRTIILGTAEGLEYLH--ETCKIIHRDIKASNILLDLKYKPKISDFGLAKFYPEGGKDIP 487

Query:   453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVF-SEGSSSVL 511
               +   + IAGTLGYMAPEY+ +G+L+ K D Y+FGVLV+E+ SG RN+ F S+ S   L
Sbjct:   488 ASSLSPSSIAGTLGYMAPEYISKGRLSNKIDAYSFGVLVLEITSGFRNNKFRSDNSLETL 547

Query:   512 HT-VWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN 570
              T VWK + +N++ + +D  +     + E  RV+QIGLLCTQ    LRP+M++V+ M+++
Sbjct:   548 VTQVWKCFASNKMEEMIDKDMGEDTDKQEMKRVMQIGLLCTQESPQLRPTMSKVIQMVSS 607

Query:   571 IDYEIPPPKQPPFLNASV 588
              D  +P P +PPFL+ S+
Sbjct:   608 TDIVLPTPTKPPFLHDSM 625

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 689 (247.6 bits), Expect = 7.4e-82, Sum P(2) = 7.4e-82
 Identities = 135/308 (43%), Positives = 198/308 (64%)

Query:   280 VLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVD 339
             +  T +L F++  +E AT+ F  S KLG GG G V++G L  G  +A+KRL   S Q  +
Sbjct:   327 ITSTETLQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGSTQGAE 386

Query:   340 QFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQR 399
             +F NEV++++ +QH+N+ +LLG  ++G E +LVYE+VPN+SLD  LF      +L WQ+R
Sbjct:   387 EFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRVLDWQRR 446

Query:   400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVST 459
             + II G A G+ +LH  S + IIHRD+K SNILLD  + PKI+DFG+AR    D+T  +T
Sbjct:   447 YKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQTQANT 506

Query:   460 G-IAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSE--GSSSVLHTVWK 516
               I GT GYM+PEY + G+ + K+DVY+FGVLV+E+ +G++NS F E  G   ++  VWK
Sbjct:   507 KRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFYEEDGLGDLVTYVWK 566

Query:   517 HYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIP 576
              +  N   + +D  + G F  NE  R + I LLC Q   + RPSM +++ M+N+    +P
Sbjct:   567 LWVENSPLELVDEAMRGNFQTNEVIRCIHIALLCVQEDSSERPSMDDILVMMNSFTVTLP 626

Query:   577 PPKQPPFL 584
              PK+  FL
Sbjct:   627 IPKRSGFL 634

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)]

 Score = 699 (251.1 bits), Expect = 1.9e-81, Sum P(2) = 1.9e-81
 Identities = 148/314 (47%), Positives = 201/314 (64%)

Query:   283 TSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFF 342
             T SL   +E L+ ATD F +  +LG+GG GSV++G  P G+ IAVKRL  NS Q  ++F 
Sbjct:   340 TESLLVHFETLKTATDNFSSENELGRGGFGSVYKGVFPQGQEIAVKRLSGNSGQGDNEFK 399

Query:   343 NEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI 402
             NE+ L++ +QH+N+VRL+G  I+G E LLVYE++ N SLDQ +F      +L W  R+ +
Sbjct:   400 NEILLLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNASLDQFIFDTEKRQLLDWVVRYKM 459

Query:   403 ICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR--HVAPDKTHVSTG 460
             I G A GL +LH  S  +IIHRD+K SNILLD+++ PKIADFGLA+        TH  T 
Sbjct:   460 IGGIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIADFGLAKLFDSGQTMTHRFTS 519

Query:   461 -IAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRN----SVFSEGSSSVLHTVW 515
              IAGT GYMAPEY + GQ + K DV++FGVLVIE+ +G+RN    S   E +  +L  VW
Sbjct:   520 RIAGTYGYMAPEYAMHGQFSVKTDVFSFGVLVIEIITGKRNNNGGSNGDEDAEDLLSWVW 579

Query:   516 KHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEI 575
             + ++ + I   +DP LT     NE  R + IGLLC Q   A RP+MA V  MLN+  + +
Sbjct:   580 RSWREDTILSVIDPSLTAG-SRNEILRCIHIGLLCVQESAATRPTMATVSLMLNSYSFTL 638

Query:   576 PPPKQPPFLNASVI 589
             P P +P F+  SV+
Sbjct:   639 PTPLRPAFVLESVV 652

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005773 "vacuole" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2141762 CRK26 "cysteine-rich RLK (RECEPTOR-like protein kinase) 26" [Arabidopsis thaliana (taxid:3702)]

 Score = 685 (246.2 bits), Expect = 2.5e-79, Sum P(2) = 2.5e-79
 Identities = 145/313 (46%), Positives = 200/313 (63%)

Query:   281 LCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQ 340
             + T S+ F + +L+ AT  F    KLG+GG G+V++G L DG+ IAVKRL  N++Q   +
Sbjct:   325 ISTDSMKFDFSVLQDATSHFSLENKLGEGGFGAVYKGVLSDGQKIAVKRLSKNAQQGETE 384

Query:   341 FFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRF 400
             F NE  L++ +QH+N+V+LLG SIEG E LLVYE++P+ SLD+ +F     + L W+ R+
Sbjct:   385 FKNEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEFLPHTSLDKFIFDPIQGNELEWEIRY 444

Query:   401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT--HVS 458
              II G A GL +LH  S ++IIHRD+K SNILLDE++TPKIADFG+AR    D T    +
Sbjct:   445 KIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEMTPKIADFGMARLFDIDHTTQRYT 504

Query:   459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSS--SVLHTVWK 516
               I GT GYMAPEY++ GQ + K DVY+FGVLV+E+ SG++NS FS   S   ++   W+
Sbjct:   505 NRIVGTFGYMAPEYVMHGQFSFKTDVYSFGVLVLEIISGKKNSGFSSEDSMGDLISFAWR 564

Query:   517 HYKANRITQSMDPGLT--GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYE 574
             ++K       +D  L     +  N   R + IGLLC Q  VA RPSMA VV ML+     
Sbjct:   565 NWKEGVALNLVDKILMTMSSYSSNMIMRCINIGLLCVQEKVAERPSMASVVLMLDGHTIA 624

Query:   575 IPPPKQPPFLNAS 587
             +  P +P F + S
Sbjct:   625 LSEPSKPAFFSHS 637

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 684 (245.8 bits), Expect = 6.6e-79, Sum P(2) = 6.6e-79
 Identities = 140/305 (45%), Positives = 194/305 (63%)

Query:   280 VLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVD 339
             +    SL   Y  ++ ATD F  S K+GQGG G V++GTL DG  +AVKRL  +S Q   
Sbjct:   328 ITTADSLQLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQGEV 387

Query:   340 QFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQR 399
             +F NEV L++ +QH+N+VRLLG  ++G E +LVYEYVPN+SLD  LF       L W +R
Sbjct:   388 EFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWTRR 447

Query:   400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVST 459
             + II G A G+ +LH  S + IIHRD+K SNILLD  + PKIADFG+AR    D+T  +T
Sbjct:   448 YKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENT 507

Query:   460 G-IAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVF--SEGSSSVLHTVWK 516
               I GT GYM+PEY + GQ + K+DVY+FGVLV+E+ SG++NS F  ++G+  ++   W 
Sbjct:   508 SRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSYAWG 567

Query:   517 HYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIP 576
              +   R  + +DP +      NE  R + IGLLC Q   A RP+++ +V ML +    +P
Sbjct:   568 LWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNTVTLP 627

Query:   577 PPKQP 581
              P+QP
Sbjct:   628 VPRQP 632

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 689 (247.6 bits), Expect = 5.9e-78, Sum P(2) = 5.9e-78
 Identities = 142/311 (45%), Positives = 199/311 (63%)

Query:   277 LGTVLCTS-SLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR 335
             +G  + T+ SL   Y  ++ AT+ F  S K+G+GG G V++GT  +G+ +AVKRL  NSR
Sbjct:   329 VGDDMATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSR 388

Query:   336 QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILS 395
             Q   +F  EV +++ +QH+N+VRLLG S++G E +LVYEY+PN+SLD +LF       L 
Sbjct:   389 QGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLD 448

Query:   396 WQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT 455
             W QR+ II G A G+ +LH  S + IIHRD+K SNILLD  + PKIADFG+AR    D+T
Sbjct:   449 WMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQT 508

Query:   456 HVSTG-IAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVF--SEGSSSVLH 512
               +T  I GT GYMAPEY + GQ + K+DVY+FGVLV+E+ SGR+NS F  S+G+  +L 
Sbjct:   509 QDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQDLLT 568

Query:   513 TVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID 572
               W+ +        +DP +      +E  R + IGLLC Q   A RP+++ V  ML +  
Sbjct:   569 HTWRLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVFMMLTSNT 628

Query:   573 YEIPPPKQPPF 583
               +P P+QP F
Sbjct:   629 VTLPVPRQPGF 639

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2123126 CRK31 "cysteine-rich RLK (RECEPTOR-like protein kinase) 31" [Arabidopsis thaliana (taxid:3702)]

 Score = 683 (245.5 bits), Expect = 9.5e-78, Sum P(2) = 9.5e-78
 Identities = 140/304 (46%), Positives = 189/304 (62%)

Query:   285 SLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNE 344
             SL F +  +E ATD F  + KLGQGG G V++G LP+   IAVKRL  NS Q   +F NE
Sbjct:   324 SLQFDFTTIEVATDNFSRNNKLGQGGFGEVYKGMLPNETEIAVKRLSSNSGQGTQEFKNE 383

Query:   345 VNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIIC 404
             V +++ +QHKN+VRLLG  IE  E +LVYE+V N+SLD  LF       L W++R+ II 
Sbjct:   384 VVIVAKLQHKNLVRLLGFCIERDEQILVYEFVSNKSLDYFLFDPKMKSQLDWKRRYNIIG 443

Query:   405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG-IAG 463
             G   GL +LH  S + IIHRDIK SNILLD  + PKIADFG+AR+   D+T   TG + G
Sbjct:   444 GVTRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIADFGMARNFRVDQTEDQTGRVVG 503

Query:   464 TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSE----GSSSVLHTVWKHYK 519
             T GYM PEY+  GQ + K+DVY+FGVL++E+  G++NS F +    G + V H VW+ + 
Sbjct:   504 TFGYMPPEYVTHGQFSTKSDVYSFGVLILEIVCGKKNSSFFQMDDSGGNLVTH-VWRLWN 562

Query:   520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPK 579
              +     +DP +   +  +E  R + IG+LC Q   A RP M+ +  ML N    +P P+
Sbjct:   563 NDSPLDLIDPAIKESYDNDEVIRCIHIGILCVQETPADRPEMSTIFQMLTNSSITLPVPR 622

Query:   580 QPPF 583
              P F
Sbjct:   623 PPGF 626

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2127323 CRK27 "cysteine-rich RLK (RECEPTOR-like protein kinase) 27" [Arabidopsis thaliana (taxid:3702)]

 Score = 661 (237.7 bits), Expect = 9.5e-78, Sum P(2) = 9.5e-78
 Identities = 146/336 (43%), Positives = 205/336 (61%)

Query:   257 YQKKETRYKRLSEMRKGQVLLGTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFR 316
             Y K+  + K L E  + +        T SL+F +E +  ATD F  + K+G+GG G V++
Sbjct:   295 YLKRRRKKKTLKENAENEFE-----STDSLHFDFETIRVATDDFSLTNKIGEGGFGVVYK 349

Query:   317 GTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV 376
             G LPDG  IAVKRL  +S Q   +F  EV L++ +QHKN+V+L G SI+  E LLVYE++
Sbjct:   350 GHLPDGLEIAVKRLSIHSGQGNAEFKTEVLLMTKLQHKNLVKLFGFSIKESERLLVYEFI 409

Query:   377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEK 436
             PN SLD+ LF       L W++R+ II G + GL +LH GS   IIHRD+K+SN+LLDE+
Sbjct:   410 PNTSLDRFLFDPIKQKQLDWEKRYNIIVGVSRGLLYLHEGSEFPIIHRDLKSSNVLLDEQ 469

Query:   437 LTPKIADFGLARHVAPDKTH-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVA 495
             + PKI+DFG+AR    D T  V+  + GT GYMAPEY + G+ + K DVY+FGVLV+E+ 
Sbjct:   470 MLPKISDFGMARQFDFDNTQAVTRRVVGTYGYMAPEYAMHGRFSVKTDVYSFGVLVLEII 529

Query:   496 SGRRNSVFSEGSSSVLHT-VWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAP 554
             +G+RNS    G  + L T  W+++      + +DP L     + E+ + L+I L C Q  
Sbjct:   530 TGKRNSGLGLGEGTDLPTFAWQNWIEGTSMELIDPVLLQTHDKKESMQCLEIALSCVQEN 589

Query:   555 VALRPSMAEVVHMLNNIDYE---IPPPKQPPFLNAS 587
                RP+M  VV ML++ D E   +P P QP F   S
Sbjct:   590 PTKRPTMDSVVSMLSS-DSESRQLPKPSQPGFFRRS 624

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9FNE1	CRK42_ARATH	2, ., 7, ., 1, 1, ., -	0.4773	0.9072	0.8709	yes	no
Q9LMB9	CRK1_ARATH	2, ., 7, ., 1, 1, ., 1	0.4921	0.9184	0.9333	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: gw1.XII.1358.1 hypothetical protein (532 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	625
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-47
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-47
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-46
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-45
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	9e-45
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-44
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-43
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-43
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-39
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-32
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-30
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-29
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-29
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-27
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-27
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	8e-27
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-26
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-25
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-25
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-24
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-24
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-24
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-23
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-23
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-23
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-23
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-23
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-23
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-22
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-22
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-22
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-22
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-22
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-22
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	9e-22
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	9e-22
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-21
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-21
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-21
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-21
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-21
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-21
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-21
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-21
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-21
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-21
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-21
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-21
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-20
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-20
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-20
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-20
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-20
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-20
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-20
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-20
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-20
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	6e-20
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	7e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-20
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-20
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	8e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-20
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-19
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-19
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-19
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-19
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-19
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-19
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-19
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-19
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-19
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-19
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-18
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-18
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-18
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	3e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-18
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-18
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-17
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-17
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-17
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-17
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-17
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-17
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-17
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-17
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-17
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-17
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	8e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	9e-17
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-16
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-16
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-16
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-16
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-16
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	6e-16
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-16
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	7e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-15
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-15
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-15
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-15
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-15
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-15
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-15
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-14
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-14
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-14
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-14
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-14
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-14
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	8e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-13
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-13
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-13
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-13
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-13
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-13
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-13
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-13
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	8e-13
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	9e-13
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-12
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-12
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-12
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-12
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-12
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-12
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-12
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-12
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-12
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-12
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-12
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-12
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-12
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-11
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	8e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	9e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	9e-11
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	9e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-10
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	8e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-10
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	9e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-09
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-09
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-09
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-08
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-08
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-08
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-08
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	2e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-08
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	6e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	9e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-07
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	6e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	9e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-06
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-06
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-06
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-05
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-05
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	8e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	9e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	6e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	0.002
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	0.003
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.003
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.003

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  165 bits (419), Expect = 3e-47
 Identities = 69/223 (30%), Positives = 113/223 (50%), Gaps = 20/223 (8%)

Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFF-NSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           LG+GG G+V+       G+ +A+K +   +S   +++   E+ ++  + H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
            +     LV EY    SL  +L  K     LS  +   I+    EGL +LH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLH---SNGIIH 115

Query: 424 RDIKTSNILLDEK-LTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL-VRGQLTEK 481
           RD+K  NILLD      K+ADFGL++ +  DK+ + T I GT  YMAPE L  +G  +EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSEK 174

Query: 482 ADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRIT 524
           +D+++ GV++ E+   +           ++  + +     R +
Sbjct: 175 SDIWSLGVILYELPELK----------DLIRKMLQKDPEKRPS 207

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  165 bits (421), Expect = 5e-47
 Identities = 77/272 (28%), Positives = 123/272 (45%), Gaps = 24/272 (8%)

Query: 303 SRKLGQGGAGSVFRGTL-----PDGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNV 356
            +KLG+G  G V++G L          +AVK L  + S Q +++F  E  ++  + H NV
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           V+LLG   E     +V EY+    L    +++     LS     +     A G+ +L   
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLS--YLRKNRPKLSLSDLLSFALQIARGMEYLES- 120

Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG 476
                IHRD+   N L+ E L  KI+DFGL+R +  D  +   G    + +MAPE L  G
Sbjct: 121 --KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178

Query: 477 QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP 536
           + T K+DV++FGVL+ E        +F+ G        +       + + +  G     P
Sbjct: 179 KFTSKSDVWSFGVLLWE--------IFTLGEQP-----YPGMSNEEVLEYLKNGYRLPQP 225

Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHML 568
            N    +  + L C       RP+ +E+V +L
Sbjct: 226 PNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  164 bits (417), Expect = 2e-46
 Identities = 82/282 (29%), Positives = 123/282 (43%), Gaps = 38/282 (13%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNI----AVKRL-FFNSRQWVDQFFNEVNLISGIQHKNVVR 358
           +KLG+G  G V++G L          AVK L    S +    F  E  ++  + H NVVR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQIL------FVKNTIHILSWQQRFTIICGTAEGLAH 412
           LLG   E     LV EY+    L   L      F       LS +   +     A+G+ +
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT-LGYMAPE 471
           L      K +HRD+   N L+ E L  KI+DFGL+R V  D  +         + +MAPE
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 472 YLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSS----VLHTVWKHYKA-NRITQS 526
            L  G  T K+DV++FGVL+ E        +F+ G++         V ++ +   R+ + 
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWE--------IFTLGATPYPGLSNEEVLEYLRKGYRLPK- 228

Query: 527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHML 568
                    PE     + ++ L C Q     RP+ +E+V  L
Sbjct: 229 ---------PEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  161 bits (410), Expect = 2e-45
 Identities = 69/204 (33%), Positives = 98/204 (48%), Gaps = 13/204 (6%)

Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQHKN 355
           ++  RKLG G  G+V++      G+ +AVK L      S++       E+ ++  + H N
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQ-TARREIRILRRLSHPN 59

Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           +VRL+    +     LV EY     L   L        LS  +   I      GL +LH 
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG---PLSEDEAKKIALQILRGLEYLHS 116

Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
                IIHRD+K  NILLDE    KIADFGLA+      +   T   GT  YMAPE L+ 
Sbjct: 117 ---NGIIHRDLKPENILLDENGVVKIADFGLAK-KLLKSSSSLTTFVGTPWYMAPEVLLG 172

Query: 476 GQL-TEKADVYAFGVLVIEVASGR 498
           G     K DV++ GV++ E+ +G+
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  159 bits (405), Expect = 9e-45
 Identities = 81/271 (29%), Positives = 127/271 (46%), Gaps = 23/271 (8%)

Query: 304 RKLGQGGAGSVFRGTL-----PDGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVV 357
           +KLG+G  G V++GTL          +AVK L  + S Q +++F  E  ++  + H N+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64

Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
           +LLG   E    ++V EY+P   L   L  KN    LS     +     A G+ +L    
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLES-- 121

Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQ 477
               IHRD+   N L+ E L  KI+DFGL+R +  D  +   G    + +MAPE L  G+
Sbjct: 122 -KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180

Query: 478 LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE 537
            T K+DV++FGVL+ E+        F+ G        +       + + +  G     P 
Sbjct: 181 FTSKSDVWSFGVLLWEI--------FTLGEEP-----YPGMSNAEVLEYLKKGYRLPKPP 227

Query: 538 NEASRVLQIGLLCTQAPVALRPSMAEVVHML 568
           N    + ++ L C       RP+ +E+V +L
Sbjct: 228 NCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  159 bits (404), Expect = 1e-44
 Identities = 80/280 (28%), Positives = 128/280 (45%), Gaps = 41/280 (14%)

Query: 304 RKLGQGGAGSVFRGTL---PDGRNI--AVKRL--FFNSRQWVDQFFNEVNLISGIQHKNV 356
           +KLG+G  G V++GTL    +G     AVK L    +  +  + F  E +++  + H N+
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREE-FLEEASIMKKLSHPNI 63

Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           VRLLG   +G    +V EY+P   L    F++     L+ +    +    A+G+ +L   
Sbjct: 64  VRLLGVCTQGEPLYIVTEYMPGGDLLD--FLRKHGEKLTLKDLLQMALQIAKGMEYLES- 120

Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG---YMAPEYL 473
                +HRD+   N L+ E L  KI+DFGL+R +  D  +   G  G      +MAPE L
Sbjct: 121 --KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPIKWMAPESL 176

Query: 474 VRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSS-----SVLHTVWKHYKANRITQSMD 528
             G+ T K+DV++FGVL+ E        +F+ G       S    +       R+ +   
Sbjct: 177 KDGKFTSKSDVWSFGVLLWE--------IFTLGEQPYPGMSNEEVLELLEDGYRLPR--- 225

Query: 529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHML 568
                  PEN    + ++ L C       RP+ +E+V  L
Sbjct: 226 -------PENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  155 bits (395), Expect = 2e-43
 Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 12/202 (5%)

Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL-FFNSRQWVDQFFNEVNLISGIQHKNVV 357
           ++   KLG+G  G V+       G+ +A+K +     ++  ++   E+ ++  ++H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 358 RLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           RL     E  + L LV EY     L  +L  K    +   + RF  +      L +LH  
Sbjct: 61  RLYD-VFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARF-YLRQILSALEYLHS- 115

Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG 476
               I+HRD+K  NILLDE    K+ADFGLAR + P +    T   GT  YMAPE L+  
Sbjct: 116 --KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPEYMAPEVLLGK 171

Query: 477 QLTEKADVYAFGVLVIEVASGR 498
              +  D+++ GV++ E+ +G+
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  155 bits (394), Expect = 4e-43
 Identities = 70/209 (33%), Positives = 110/209 (52%), Gaps = 26/209 (12%)

Query: 304 RKLGQGGAGSVFRGTLPD-GRNIAVKRLFF--NSRQWVDQFFNEVNLISGIQHKNVVRLL 360
             LG+G  GSV+     D G  +AVK +    +S + ++    E+ ++S +QH N+VR  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 361 GCSI-EGPESLLVY-EYVPNRSLDQIL-----FVKNTIHILSWQQRFT--IICGTAEGLA 411
           G    E   +L ++ EYV   SL  +L       +  I      +++T  I+    EGLA
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI------RKYTRQIL----EGLA 115

Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG-IAGTLGYMAP 470
           +LH      I+HRDIK +NIL+D     K+ADFG A+ +   +T   TG + GT  +MAP
Sbjct: 116 YLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172

Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASGRR 499
           E +   +    AD+++ G  VIE+A+G+ 
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  144 bits (366), Expect = 2e-39
 Identities = 62/200 (31%), Positives = 106/200 (53%), Gaps = 8/200 (4%)

Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVR 358
           F+   K+G+GG G V++      G+ +A+K +   S++  ++  NE+ ++   +H N+V+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
             G  ++  E  +V E+    SL  +L  K+T   L+  Q   +     +GL +LH    
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHS--- 116

Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL 478
             IIHRDIK +NILL      K+ DFGL+  ++  K   +  + GT  +MAPE +     
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT--MVGTPYWMAPEVINGKPY 174

Query: 479 TEKADVYAFGVLVIEVASGR 498
             KAD+++ G+  IE+A G+
Sbjct: 175 DYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  126 bits (318), Expect = 2e-32
 Identities = 59/203 (29%), Positives = 108/203 (53%), Gaps = 10/203 (4%)

Query: 297 TDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKN 355
            + + N  K+G+G +G V++ T    G+ +A+K++     Q  +   NE+ ++   +H N
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76

Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           +V      + G E  +V EY+   SL  I  +      ++  Q   +     +GL +LH 
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTDI--ITQNFVRMNEPQIAYVCREVLQGLEYLHS 134

Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
                +IHRDIK+ NILL +  + K+ADFG A  +  +K+  ++ + GT  +MAPE +++
Sbjct: 135 Q---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-VVGTPYWMAPE-VIK 189

Query: 476 GQL-TEKADVYAFGVLVIEVASG 497
            +    K D+++ G++ IE+A G
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  119 bits (300), Expect = 3e-30
 Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 36/224 (16%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKR--LFFNSRQWVDQFFNEV 345
           KYEI+          +++G+G  G V+      DG+   +K   L   S +  +   NEV
Sbjct: 1   KYEII----------KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEV 50

Query: 346 NLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIH---------ILSW 396
            ++  + H N+++      E  +  +V EY     L Q +  K             IL W
Sbjct: 51  KILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKI--KKQKKEGKPFPEEQILDW 108

Query: 397 QQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH 456
              F  +C     L +LH     KI+HRDIK  NI L      K+ DFG+++ ++     
Sbjct: 109 ---FVQLC---LALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159

Query: 457 VSTGIAGTLGYMAPEYLVRGQ-LTEKADVYAFGVLVIEVASGRR 499
             T + GT  Y++PE L + +    K+D+++ G ++ E+ + + 
Sbjct: 160 AKT-VVGTPYYLSPE-LCQNKPYNYKSDIWSLGCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  118 bits (295), Expect = 8e-29
 Identities = 79/333 (23%), Positives = 128/333 (38%), Gaps = 21/333 (6%)

Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQH-KN 355
           +   RKLG+G  G V+     D + +A+K L     +  + V++F  E+ +++ + H  N
Sbjct: 2   YRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59

Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           +V+L     +     LV EYV   SL+ +L        LS  +   I+      L +LH 
Sbjct: 60  IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119

Query: 416 GSGIKIIHRDIKTSNILLDEKLT-PKIADFGLARHVAPDKTHVS-----TGIAGTLGYMA 469
                IIHRDIK  NILLD      K+ DFGLA+ +    +  S     +   GT GYMA
Sbjct: 120 KG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 470 PEYL---VRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS 526
           PE L        +  +D+++ G+ + E+ +G       E +SS      K       T S
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLP-PFEGEKNSSATSQTLKI-ILELPTPS 234

Query: 527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVV-HMLNNIDYEIPPPKQPPFLN 585
           +   L+   PE  +     +           R S +  + H L                 
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKP 294

Query: 586 ASVISPSDNSKDSMMSSFKSFVAESPEIDHSLK 618
                   +   S+ +   S  + +        
Sbjct: 295 DDSAPLRLSLPPSLEALISSLNSLAISGSDLKL 327

Length = 384

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  115 bits (289), Expect = 8e-29
 Identities = 57/202 (28%), Positives = 102/202 (50%), Gaps = 20/202 (9%)

Query: 305 KLGQGGAGSVFRG-TLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLG 361
            +G+G  G V++G  L  G  +A+K++       + +     E++L+  ++H N+V+ +G
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 362 CSIEGPESLLVYEYVPNRSLDQIL-----FVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
                    ++ EY  N SL QI+     F ++ + +  +Q          +GLA+LH  
Sbjct: 67  SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ--------VLQGLAYLHEQ 118

Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG 476
               +IHRDIK +NIL  +    K+ADFG+A  +  D +     + GT  +MAPE +   
Sbjct: 119 ---GVIHRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIEMS 174

Query: 477 QLTEKADVYAFGVLVIEVASGR 498
             +  +D+++ G  VIE+ +G 
Sbjct: 175 GASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  111 bits (280), Expect = 1e-27
 Identities = 71/266 (26%), Positives = 122/266 (45%), Gaps = 23/266 (8%)

Query: 306 LGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE 365
           +G+G  G V  G    G+ +AVK L  +S      F  E ++++ ++H N+V+LLG  ++
Sbjct: 14  IGKGEFGDVMLGDY-RGQKVAVKCLKDDSTA-AQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 366 GPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRD 425
           G    +V EY+   SL   L  +    +++  Q+        EG+ +L        +HRD
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127

Query: 426 IKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVY 485
           +   N+L+ E L  K++DFGLA+  +  +      +  T    APE L   + + K+DV+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKSDVW 183

Query: 486 AFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQ 545
           +FG+L+ E+ S  R          V+  V K Y+       M+       PE     V +
Sbjct: 184 SFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR-------MEA------PEGCPPEVYK 230

Query: 546 IGLLCTQAPVALRPSMAEVVHMLNNI 571
           +   C +   A RP+  ++   L  I
Sbjct: 231 VMKDCWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  109 bits (274), Expect = 8e-27
 Identities = 62/202 (30%), Positives = 104/202 (51%), Gaps = 9/202 (4%)

Query: 298 DFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNV 356
           + FD   KLG+G  GSV++      G+ +A+K       + + +   E++++       +
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIK--VVPVEEDLQEIIKEISILKQCDSPYI 60

Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           V+  G   +  +  +V EY    S+  I  +K T   L+ ++   I+  T +GL +LH  
Sbjct: 61  VKYYGSYFKNTDLWIVMEYCGAGSVSDI--MKITNKTLTEEEIAAILYQTLKGLEYLHS- 117

Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG 476
              K IHRDIK  NILL+E+   K+ADFG++  +       +T I GT  +MAPE +   
Sbjct: 118 --NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEI 174

Query: 477 QLTEKADVYAFGVLVIEVASGR 498
               KAD+++ G+  IE+A G+
Sbjct: 175 GYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  109 bits (275), Expect = 8e-27
 Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 15/206 (7%)

Query: 303 SRKLGQGGAGSVFRG-TLPDGRNIAVKRLFF--NSRQWVDQFFNEVNLISGIQHKNVVRL 359
             K+G G  G V+    L  G  +AVK +    N  + + +  +E+ ++  ++H N+V+ 
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G  +   +  +  EY    +L+++L     I      + +T+     EGLA+LH     
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTLEELLEHGR-ILDEHVIRVYTL--QLLEGLAYLHSH--- 118

Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG---YMAPEYLVRG 476
            I+HRDIK +NI LD     K+ DFG A  +  + T +   +    G   YMAPE +  G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178

Query: 477 QLTEK---ADVYAFGVLVIEVASGRR 499
           +       AD+++ G +V+E+A+G+R
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  109 bits (273), Expect = 1e-26
 Identities = 84/282 (29%), Positives = 126/282 (44%), Gaps = 62/282 (21%)

Query: 306 LGQGGAGSVFRG-TLPDGRNIAVKRLFF-----NSRQWVDQFFNEVNLISGIQHKNVVRL 359
           LG G  GSV+ G  L DG   AVK +         ++ V Q   E+ L+S +QH N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 360 LGCSIEGPESLLVY-EYVPNRSLDQIL---------FVKN-TIHILSWQQRFTIICGTAE 408
           LG   E  ++L ++ E VP  SL ++L          ++  T  IL              
Sbjct: 68  LGTEREE-DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL------------- 113

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           GL +LH       +HRDIK +NIL+D     K+ADFG+A+ V       S    G+  +M
Sbjct: 114 GLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWM 168

Query: 469 APEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM 527
           APE + + G     AD+++ G  V+E+A+G+      EG ++V                 
Sbjct: 169 APEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI-------------- 214

Query: 528 DPGLTGRFPE------NEASRVLQIGLLCTQAPVALRPSMAE 563
             G +   P       +EA   +   L C Q   +LRP+ AE
Sbjct: 215 --GRSKELPPIPDHLSDEAKDFI---LKCLQRDPSLRPTAAE 251

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  106 bits (265), Expect = 3e-25
 Identities = 85/278 (30%), Positives = 129/278 (46%), Gaps = 41/278 (14%)

Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLFFNSRQ----WVDQFFNEVNLISGIQ 352
           F + R++G G  G+V+     D R    +A+K++ ++ +Q    W D    EV  +  ++
Sbjct: 17  FTDLREIGHGSFGAVYFAR--DVRTNEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQQLR 73

Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIIC-GTAEGLA 411
           H N +   GC +    + LV EY    + D +   K  +     +     IC G  +GLA
Sbjct: 74  HPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQ----EVEIAAICHGALQGLA 129

Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           +LH     + IHRDIK  NILL E  T K+ADFG A  V+P  + V     GT  +MAPE
Sbjct: 130 YLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPE 181

Query: 472 YLV---RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMD 528
            ++    GQ   K DV++ G+  IE+A  R+  +F+  + S L+          I Q+  
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALY---------HIAQNDS 231

Query: 529 PGLTGRFPENEASRVL-QIGLLCTQAPVALRPSMAEVV 565
           P L      N+ S         C Q     RPS  E++
Sbjct: 232 PTL----SSNDWSDYFRNFVDSCLQKIPQDRPSSEELL 265

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  103 bits (260), Expect = 7e-25
 Identities = 71/216 (32%), Positives = 101/216 (46%), Gaps = 21/216 (9%)

Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ-WVDQFFNEVNL 347
           YE++E           +G G    V+    LP+   +A+KR+     Q  VD+   EV  
Sbjct: 3   YELIE----------VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQA 52

Query: 348 ISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTA 407
           +S   H NVV+     + G E  LV  Y+   SL  I+        L      T++    
Sbjct: 53  MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVL 112

Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD---KTHVSTGIAGT 464
           +GL +LH       IHRDIK  NILL E  + KIADFG++  +A        V     GT
Sbjct: 113 KGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169

Query: 465 LGYMAPEYL--VRGQLTEKADVYAFGVLVIEVASGR 498
             +MAPE +  V G    KAD+++FG+  IE+A+G 
Sbjct: 170 PCWMAPEVMEQVHG-YDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  101 bits (254), Expect = 4e-24
 Identities = 68/193 (35%), Positives = 98/193 (50%), Gaps = 9/193 (4%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLG-C 362
           RKLG G  G V+ GT      +AVK L   +    + F  E  ++  ++H  +V+L   C
Sbjct: 12  RKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYAVC 70

Query: 363 SIEGPESLLVYEYVPNRSLDQILFVKN-TIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
           S E P   +V EY+   SL    F+K+     L   Q   +    AEG+A+L        
Sbjct: 71  SEEEP-IYIVTEYMSKGSLLD--FLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNY 124

Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEK 481
           IHRD+   NIL+ E L  KIADFGLAR +  D+     G    + + APE    G+ T K
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIK 184

Query: 482 ADVYAFGVLVIEV 494
           +DV++FG+L+ E+
Sbjct: 185 SDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 5e-24
 Identities = 64/202 (31%), Positives = 98/202 (48%), Gaps = 21/202 (10%)

Query: 306 LGQGGAGSVF----RGTLPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQHKNVVR 358
           LG+G  G V     + T   G+  A+K L       R+ V+    E N++S I H  +V+
Sbjct: 1   LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57

Query: 359 LLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILS-WQQRFTIICGTAEGLAHLHGG 416
           L   + +  E L LV EY P   L   L   +     S  + RF         L +LH  
Sbjct: 58  LH-YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARF-YAAEIVLALEYLHS- 111

Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG 476
             + II+RD+K  NILLD     K+ DFGLA+ ++ + +  +T   GT  Y+APE L+  
Sbjct: 112 --LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGK 168

Query: 477 QLTEKADVYAFGVLVIEVASGR 498
              +  D ++ GVL+ E+ +G+
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  101 bits (253), Expect = 5e-24
 Identities = 67/217 (30%), Positives = 108/217 (49%), Gaps = 39/217 (17%)

Query: 306 LGQGGAGSVFRG-TLPDGRNIAVKRLFFNS---------RQWVDQFFNEVNLISGIQHKN 355
           +G G  GSV+ G     G  +AVK++   S         R  +D    E+ L+  +QH+N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQIL---------FVKNTIHILSWQQRFTIICGT 406
           +V+ LG S++     +  EYVP  S+  +L          V+N +               
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR------------QI 115

Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIA---- 462
            +GL +LH      IIHRDIK +NIL+D K   KI+DFG+++ +  +     T  A    
Sbjct: 116 LKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL 172

Query: 463 -GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
            G++ +MAPE + +   T KAD+++ G LV+E+ +G+
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  101 bits (252), Expect = 7e-24
 Identities = 66/197 (33%), Positives = 103/197 (52%), Gaps = 9/197 (4%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           +KLG G  G V+ G       +A+K L   S    + F  E NL+  +QH  +VRL    
Sbjct: 12  KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVV 70

Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTI-HILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
            + P   ++ EY+ N SL  + F+K      L+  +   +    AEG+A +   +    I
Sbjct: 71  TQEP-IYIITEYMENGSL--VDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YI 124

Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKA 482
           HRD++ +NIL+ E L  KIADFGLAR +  ++     G    + + APE +  G  T K+
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184

Query: 483 DVYAFGVLVIEVAS-GR 498
           DV++FG+L+ E+ + GR
Sbjct: 185 DVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 1e-23
 Identities = 75/272 (27%), Positives = 133/272 (48%), Gaps = 26/272 (9%)

Query: 306 LGQGGAGSVFRGTL--PDGRNI--AVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRL 359
           +G G  G V RG L  P  + I  A+K L   S  +Q +D F  E +++    H N++RL
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFDHPNIIRL 70

Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G   +    +++ EY+ N SLD+  F++      +  Q   ++ G A G+ +L   S +
Sbjct: 71  EGVVTKSRPVMIITEYMENGSLDK--FLRENDGKFTVGQLVGMLRGIASGMKYL---SEM 125

Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMAPEYLVRGQL 478
             +HRD+   NIL++  L  K++DFGL+R +   + T+ + G    + + APE +   + 
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185

Query: 479 TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPEN 538
           T  +DV++FG+++ EV S      +   +  V+  V   Y+       + P      P +
Sbjct: 186 TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR-------LPP------PMD 232

Query: 539 EASRVLQIGLLCTQAPVALRPSMAEVVHMLNN 570
             S + Q+ L C Q     RP+ +++V  L+ 
Sbjct: 233 CPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  100 bits (251), Expect = 1e-23
 Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 20/207 (9%)

Query: 300 FDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVD-QFFNEVNLISGIQHKNVV 357
            +  + LGQG +G V++    P G+  A+K++  +  +    Q   E+  +   +   VV
Sbjct: 3   LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVV 62

Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI--HILSWQQRFTIICGTAEGLAHLHG 415
           +  G   +  E  +V EY+   SL  +L     I   +L+      I     +GL +LH 
Sbjct: 63  KCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-----YIARQILKGLDYLH- 116

Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV----APDKTHVSTGIAGTLGYMAPE 471
            +   IIHRDIK SN+L++ K   KIADFG+++ +        T V     GT+ YM+PE
Sbjct: 117 -TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSPE 170

Query: 472 YLVRGQLTEKADVYAFGVLVIEVASGR 498
            +     +  AD+++ G+ ++E A G+
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  100 bits (250), Expect = 1e-23
 Identities = 76/274 (27%), Positives = 139/274 (50%), Gaps = 27/274 (9%)

Query: 306 LGQGGAGSVFRGTLP-DGRN---IAVKRLF--FNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +G G  G VFRG L   GR    +A+K L   +  +Q  D F +E +++    H N++RL
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD-FLSEASIMGQFSHHNIIRL 71

Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G   +   ++++ EY+ N +LD+  ++++     S  Q   ++ G A G+ +L   S +
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDK--YLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDM 126

Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVA--PDKTHVSTGIAGTLGYMAPEYLVRGQ 477
             +HRD+   NIL++  L  K++DFGL+R +   P+ T+ ++G    + + APE +   +
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186

Query: 478 LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE 537
            T  +DV++FG+++ EV S      +   +  V+  +   +   R+   MD         
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF---RLPAPMDC-------- 235

Query: 538 NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
              S V Q+ L C Q   A RP   ++V++L+ +
Sbjct: 236 --PSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 98.7 bits (246), Expect = 3e-23
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 8/202 (3%)

Query: 300 FDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQ--FFNEVNLISGIQHKNV 356
           F+   K+G+G  G VF+     D R  A+K++  +     ++    +E  +++ +    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +R     ++  +  +V EY  N  L ++L        L   Q +        GLAHLH  
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG 476
              KI+HRDIK+ N+ LD     KI D G+A+ ++ +    +T I GT  Y++PE     
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELCEDK 176

Query: 477 QLTEKADVYAFGVLVIEVASGR 498
              EK+DV+A GV++ E  +G+
Sbjct: 177 PYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 99.2 bits (248), Expect = 5e-23
 Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 14/206 (6%)

Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRL-FFNSRQWVDQFF-NEVNLISGIQHKNV 356
           ++   ++G+G  G V++      G  +A+K++   N ++        E+ L+  ++H N+
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 357 VRLLG--CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH 414
           VRL     S       +V+EY+ +   D    + +     +  Q    +    EGL +LH
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDH---DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH 117

Query: 415 GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLV 474
                 I+HRDIK SNIL++     K+ADFGLAR      +   T    TL Y  PE L+
Sbjct: 118 S---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLL 174

Query: 475 RG--QLTEKADVYAFGVLVIEVASGR 498
            G  +   + D+++ G ++ E+  G+
Sbjct: 175 -GATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 98.4 bits (245), Expect = 7e-23
 Identities = 67/220 (30%), Positives = 106/220 (48%), Gaps = 26/220 (11%)

Query: 293 LERATDFFDNSRK--LGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQWVDQFFNEVNLIS 349
           LE   ++ +N  +  LG+G  G V+    L     IA+K +     ++V     E+ L S
Sbjct: 1   LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS 60

Query: 350 GIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVK--------NTIHILSWQQRFT 401
            ++H+N+V+ LG   E     +  E VP  SL  +L  K         TI   + Q    
Sbjct: 61  YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ---- 116

Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE-KLTPKIADFGLARHVAPDKTHVSTG 460
                 EGL +LH     +I+HRDIK  N+L++      KI+DFG ++ +A       T 
Sbjct: 117 ----ILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET- 168

Query: 461 IAGTLGYMAPEYLVRGQ--LTEKADVYAFGVLVIEVASGR 498
             GTL YMAPE + +G       AD+++ G  ++E+A+G+
Sbjct: 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 98.0 bits (245), Expect = 1e-22
 Identities = 53/224 (23%), Positives = 92/224 (41%), Gaps = 32/224 (14%)

Query: 300 FDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGI-QHK 354
           F   + +G+G   +V         +  A+K L        + V     E  +++ +  H 
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 355 NVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
            +++L   + +  E+L  V EY PN  L Q +        L  +            L +L
Sbjct: 63  GIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALEYL 118

Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIA----------- 462
           H      IIHRD+K  NILLD+ +  KI DFG A+ + P+ +  S               
Sbjct: 119 HS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175

Query: 463 --------GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
                   GT  Y++PE L      + +D++A G ++ ++ +G+
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 97.7 bits (244), Expect = 2e-22
 Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 20/214 (9%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQ-WV-DQFFNEV 345
           +Y+IL R          +G+G  G VF+      G  +A+K++     +  + +Q   E+
Sbjct: 1   RYKILGR----------IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREI 50

Query: 346 NLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICG 405
             +   QH  VV+LL     G   +LV EY+P   L ++L  ++    L   Q  + +  
Sbjct: 51  KALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVL--RDEERPLPEAQVKSYMRM 107

Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTL 465
             +G+A++H      I+HRD+K +N+L+      KIADFGLAR  + ++  + +    T 
Sbjct: 108 LLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR 164

Query: 466 GYMAPEYLVRGQ-LTEKADVYAFGVLVIEVASGR 498
            Y APE L   +      D++A G +  E+ +G 
Sbjct: 165 WYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 96.7 bits (241), Expect = 2e-22
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 15/208 (7%)

Query: 294 ERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQH 353
           ER  + F   RKLG G  G V+ G   +   +A+K L  +       F  EV  +  ++H
Sbjct: 2   ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRH 61

Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILF-----VKNTIHILSWQQRFTIICGTAE 408
           K+++ L      G    ++ E +   SL   L      V     ++       + C  AE
Sbjct: 62  KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLID------MACQVAE 115

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           G+A+L        IHRD+   NIL+ E L  K+ADFGLAR +  +  ++S+       + 
Sbjct: 116 GMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLAR-LIKEDVYLSSDKKIPYKWT 171

Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVAS 496
           APE    G  + K+DV++FG+L+ E+ +
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 96.8 bits (241), Expect = 3e-22
 Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 32/214 (14%)

Query: 306 LGQGGAGSVFRG-TLPDGRNIAVKRLFFN--------SRQ--WVDQFFNEVNLISGIQHK 354
           +G+G  G V+    +  G  +AVK++           SRQ   V    +E+  +  + H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 355 NVVRLLGCSIEGPESLLVY-EYVPNRSLDQIL-----FVKNTIHILSWQQRFTIICGTAE 408
           N+V+ LG      E L ++ EYVP  S+   L     F +  +   + Q          E
Sbjct: 69  NIVQYLGFE-TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VLE 119

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS-TGIAGTLGY 467
           GLA+LH      I+HRD+K  N+L+D     KI+DFG+++       +     + G++ +
Sbjct: 120 GLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176

Query: 468 MAPE--YLVRGQLTEKADVYAFGVLVIEVASGRR 499
           MAPE  +      + K D+++ G +V+E+ +GRR
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 96.0 bits (239), Expect = 6e-22
 Identities = 61/199 (30%), Positives = 101/199 (50%), Gaps = 9/199 (4%)

Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVR 358
            DN  K+G+G  G V   T    GR +AVK++    +Q  +  FNEV ++   QH N+V 
Sbjct: 21  LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVE 80

Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
           +    + G E  +V E++   +L  I+    T   ++ +Q  T+     + L+ LH    
Sbjct: 81  MYSSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLAVLKALSFLHAQ-- 134

Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL 478
             +IHRDIK+ +ILL      K++DFG    V+ +       + GT  +MAPE + R   
Sbjct: 135 -GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE-VPRRKSLVGTPYWMAPEVISRLPY 192

Query: 479 TEKADVYAFGVLVIEVASG 497
             + D+++ G++VIE+  G
Sbjct: 193 GTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 95.3 bits (237), Expect = 7e-22
 Identities = 73/270 (27%), Positives = 121/270 (44%), Gaps = 23/270 (8%)

Query: 305 KLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           KLG G  G V+ G        +AVK L  ++ + V++F  E  ++  I+H N+V+LLG  
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 71

Query: 364 IEGPESLLVYEYVPNRSLDQILFV--KNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
              P   ++ E++   +L   L    +  ++ +      T I   +  + +L   +    
Sbjct: 72  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI---SSAMEYLEKKN---F 125

Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEK 481
           IHRD+   N L+ E    K+ADFGL+R +  D      G    + + APE L   + + K
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 185

Query: 482 ADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEAS 541
           +DV+AFGVL+ E+A+   +       S V   + K Y+  R             PE    
Sbjct: 186 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMER-------------PEGCPP 232

Query: 542 RVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +V ++   C Q   + RPS AE+      +
Sbjct: 233 KVYELMRACWQWNPSDRPSFAEIHQAFETM 262

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 95.1 bits (236), Expect = 9e-22
 Identities = 65/220 (29%), Positives = 108/220 (49%), Gaps = 5/220 (2%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           +KLG G  G V+ G   +   +AVK L   +   V  F  E NL+  +QH  +VRL    
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
            +     ++ EY+   SL   L       +L   +        AEG+A++   +    IH
Sbjct: 71  TKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKN---YIH 126

Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +N+L+ E L  KIADFGLAR +  ++     G    + + APE +  G  T K+D
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186

Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRI 523
           V++FG+L+ E+ +  +       +S V+  + + Y+  R+
Sbjct: 187 VWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRM 226

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 95.6 bits (237), Expect = 9e-22
 Identities = 56/194 (28%), Positives = 101/194 (52%), Gaps = 9/194 (4%)

Query: 305 KLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           K+GQG +G+VF    +  G+ +A+K++    +   +   NE+ ++  +++ N+V  L   
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85

Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           + G E  +V EY+   SL  ++    T   +   Q   +     + L  LH     ++IH
Sbjct: 86  LVGDELFVVMEYLAGGSLTDVV----TETCMDEAQIAAVCRECLQALEFLHAN---QVIH 138

Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RDIK+ N+LL    + K+ DFG    + P+++  ST + GT  +MAPE + R     K D
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVD 197

Query: 484 VYAFGVLVIEVASG 497
           +++ G++ IE+  G
Sbjct: 198 IWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 95.2 bits (237), Expect = 1e-21
 Identities = 73/286 (25%), Positives = 122/286 (42%), Gaps = 35/286 (12%)

Query: 304 RKLGQGGAGSVFRGTL----PDGRN--IAVKRLF-FNSRQWVDQFFNEVNLISGIQHKNV 356
           R+LG+G  G VF G      P+     +AVK L    S      F  E  L++  QH+N+
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQIL-----------FVKNTIHILSWQQRFTIICG 405
           V+  G   EG   ++V+EY+ +  L++ L              + +  L+  Q   I   
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGT 464
            A G+ +L   +    +HRD+ T N L+   L  KI DFG++R V   D   V       
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187

Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRIT 524
           + +M PE ++  + T ++DV++FGV++ E        +F+ G        W       + 
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWE--------IFTYGKQP-----WYGLSNEEVI 234

Query: 525 QSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN 570
           + +  G   + P    S V  I L C +     R ++ ++   L  
Sbjct: 235 ECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 21/207 (10%)

Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSR-QWVDQFFNEVNLISGIQHKNVV 357
            +   +LG G +G V +    P G+ +AVK +          Q   E++++       +V
Sbjct: 3   LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIV 62

Query: 358 RLLG-CSIEGPESLLVYEYVPNRSLDQIL-FVKNTI--HILSWQQRFTIICGTAEGLAHL 413
              G     G  S+ + EY+   SLD+IL  V+  I   IL       I     +GL +L
Sbjct: 63  GFYGAFYNNGDISICM-EYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYL 116

Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD--KTHVSTGIAGTLGYMAPE 471
           H     KIIHRD+K SNIL++ +   K+ DFG++  +     KT V     GT  YMAPE
Sbjct: 117 H--EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPE 169

Query: 472 YLVRGQLTEKADVYAFGVLVIEVASGR 498
            +     + K+D+++ G+ +IE+A+GR
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 69/280 (24%), Positives = 119/280 (42%), Gaps = 33/280 (11%)

Query: 304 RKLGQGGAGSVFRGT--LPDGR--NIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVR 358
           ++LG G  GSV +G   +  G+   +AVK L          +F  E ++++ + H  +VR
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGLAHLHG 415
           L+G   +G   +LV E  P   L + L  +  I    +     +       A G+A+L  
Sbjct: 61  LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES 113

Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT--LGYMAPEYL 473
                 +HRD+   N+LL  +   KI+DFG++R +     +     AG   L + APE +
Sbjct: 114 ---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170

Query: 474 VRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG 533
             G+ + K+DV+++GV + E         FS G+       +   K   +   ++ G   
Sbjct: 171 NYGKFSSKSDVWSYGVTLWE--------AFSYGAKP-----YGEMKGAEVIAMLESGERL 217

Query: 534 RFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY 573
             PE     +  I L C +     RP+ +E+         
Sbjct: 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDPE 257

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 28/217 (12%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQWVDQFFNEVNL 347
            YE+++R          +G G  G V++   +  G  +A+K +        +    E+++
Sbjct: 4   DYELIQR----------IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISM 53

Query: 348 ISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTA 407
           +   +H N+V   G  +   +  +V EY    SL  I  V  T   LS  Q   +   T 
Sbjct: 54  LKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQV--TRGPLSELQIAYVCRETL 111

Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA----RHVAPDKTHVSTGIAG 463
           +GLA+LH       IHRDIK +NILL E    K+ADFG++      +A  K+ +     G
Sbjct: 112 KGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-----G 163

Query: 464 TLGYMAPEYL---VRGQLTEKADVYAFGVLVIEVASG 497
           T  +MAPE      +G    K D++A G+  IE+A  
Sbjct: 164 TPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAEL 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 94.2 bits (235), Expect = 2e-21
 Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 37/227 (16%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFN--SRQWVDQFFNEV 345
            YE+LE           +G+G  G+V +     DG+ +  K + +   + +   Q  +EV
Sbjct: 1   DYEVLE----------TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEV 50

Query: 346 NLISGIQHKNVVRLLGCSIEGPESLLVY---EYVPNRSLDQIL--FVKNTIHI---LSWQ 397
           N++  ++H N+VR     I    +  +Y   EY     L Q++    K   +I     W+
Sbjct: 51  NILRELKHPNIVRYYD-RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWR 109

Query: 398 QRFTIICGTAEGLAHLHGGS--GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-- 453
               I+      L   H  S  G  ++HRD+K +NI LD     K+ DFGLA+ +  D  
Sbjct: 110 ----ILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS 165

Query: 454 --KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
             KT+V     GT  YM+PE L      EK+D+++ G L+ E+ +  
Sbjct: 166 FAKTYV-----GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 95.2 bits (236), Expect = 2e-21
 Identities = 71/226 (31%), Positives = 113/226 (50%), Gaps = 25/226 (11%)

Query: 299 FFDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLFFNSRQ----WVDQFFNEVNLISGI 351
            F + R++G G  G+V+     D R    +A+K++ ++ +Q    W D    EV  +  I
Sbjct: 26  LFTDLREIGHGSFGAVYFAR--DVRTNEVVAIKKMSYSGKQSNEKWQD-IIKEVKFLQRI 82

Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N +   GC +    + LV EY    + D +   K  +  +   +   I  G  +GLA
Sbjct: 83  KHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV---EIAAITHGALQGLA 139

Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           +LH  +   +IHRDIK  NILL E    K+ADFG A   +P  + V     GT  +MAPE
Sbjct: 140 YLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPE 191

Query: 472 YLV---RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV 514
            ++    GQ   K DV++ G+  IE+A  R+  +F+  + S L+ +
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHI 236

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 55/208 (26%), Positives = 108/208 (51%), Gaps = 26/208 (12%)

Query: 306 LGQGGAGSVFRGT-LPDGRNI----AVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRL 359
           LG G  G+V++G  +P+G  +    A+K L   +  +   +  +E  +++ + H +VVRL
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKN------TIHILSWQQRFTIICGTAEGLAHL 413
           LG  +   +  L+ + +P   L    +V+N      + ++L+W  +       A+G+++L
Sbjct: 75  LGICL-SSQVQLITQLMPLGCLLD--YVRNHKDNIGSQYLLNWCVQI------AKGMSYL 125

Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV-STGIAGTLGYMAPEY 472
                 +++HRD+   N+L+      KI DFGLA+ +  D+    + G    + +MA E 
Sbjct: 126 ---EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182

Query: 473 LVRGQLTEKADVYAFGVLVIEVAS-GRR 499
           ++    T K+DV+++GV V E+ + G +
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 93.7 bits (233), Expect = 3e-21
 Identities = 65/216 (30%), Positives = 108/216 (50%), Gaps = 26/216 (12%)

Query: 303 SRKLGQGGAGSVFRGTL--PDGR----NIAVKRLF-FNSRQWVDQFFNEVNLISGIQHKN 355
             +LG+G  G V++G L  P+ R    ++A+K L      +   +F  E  L+S +QH N
Sbjct: 10  LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPN 69

Query: 356 VVRLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTI-------------HILSWQQRFT 401
           +V LLG C+ E P  +L +EY+ +  L + L   +                 L       
Sbjct: 70  IVCLLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128

Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTG 460
           I    A G+ +L   S    +HRD+   N L+ E LT KI+DFGL+R + + D   V + 
Sbjct: 129 IAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185

Query: 461 IAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
               + +M PE ++ G+ T ++D+++FGV++ E+ S
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 94.0 bits (233), Expect = 4e-21
 Identities = 80/303 (26%), Positives = 138/303 (45%), Gaps = 48/303 (15%)

Query: 299 FFDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLFFNSRQ----WVDQFFNEVNLISGI 351
            F + R++G G  G+V+     D RN   +A+K++ ++ +Q    W D    EV  +  +
Sbjct: 16  LFSDLREIGHGSFGAVYFAR--DVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKL 72

Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N ++  GC +    + LV EY    + D +   K  +  +   +   +  G  +GLA
Sbjct: 73  RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV---EIAAVTHGALQGLA 129

Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           +LH  +   +IHRD+K  NILL E    K+ DFG A  +AP    V     GT  +MAPE
Sbjct: 130 YLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPE 181

Query: 472 YLV---RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV------------WK 516
            ++    GQ   K DV++ G+  IE+A  R+  +F+  + S L+ +            W 
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHIAQNESPALQSGHWS 240

Query: 517 HYKANRITQSMDPGLTGRFPENEASR--VLQIGLLCTQAPVA----LRPSMAEVVHMLNN 570
            Y  N +   +      + P++  +   +L+   +  + P      L     + V  L+N
Sbjct: 241 EYFRNFVDSCLQ-----KIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDN 295

Query: 571 IDY 573
           + Y
Sbjct: 296 LQY 298

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 92.8 bits (231), Expect = 5e-21
 Identities = 75/279 (26%), Positives = 116/279 (41%), Gaps = 40/279 (14%)

Query: 305 KLGQGGAGSVFRGTL--PDGR--NIAVKRLFFNSRQ-WVDQFFNEVNLISGIQHKNVVRL 359
           KLG G  G V RG      G+   +AVK L  +     +D F  E  ++  + H+N++RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 360 LGCSIEGPESLLVYEYVPNRSLDQIL-------FVKNTIHILSWQQRFTIICGTAEGLAH 412
            G  +  P  ++V E  P  SL   L       F+ +T+   + Q         A G+ +
Sbjct: 62  YGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQ--------IANGMRY 112

Query: 413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTL--GYMAP 470
           L      + IHRD+   NILL      KI DFGL R +  ++ H        +   + AP
Sbjct: 113 LESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAP 169

Query: 471 EYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP 529
           E L     +  +DV+ FGV + E+ + G        G S +L  + K  +  R+ +    
Sbjct: 170 ESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-SQILKKIDKEGE--RLER---- 222

Query: 530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHML 568
                 PE     +  + L C     A RP+ A +   L
Sbjct: 223 ------PEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 92.5 bits (230), Expect = 5e-21
 Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 16/204 (7%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLG-C 362
           ++LG G  G V  G      ++A+K +   +    D F  E  ++  + H N+V+L G C
Sbjct: 10  KELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 363 SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
           + + P   +V EY+ N  L    +++     L  +    +     E + +L        I
Sbjct: 69  TKQRP-IFIVTEYMANGCLLN--YLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FI 122

Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKA 482
           HRD+   N L+ E    K++DFGLAR+V  D+   S G    + +  PE     + + K+
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKS 182

Query: 483 DVYAFGVLVIEVASGRRNSVFSEG 506
           DV++FGVL+ E        VFSEG
Sbjct: 183 DVWSFGVLMWE--------VFSEG 198

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 92.8 bits (230), Expect = 6e-21
 Identities = 65/216 (30%), Positives = 109/216 (50%), Gaps = 8/216 (3%)

Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           KLGQG  G V+ GT      +A+K L   +    + F  E  ++  ++H+ +V+L     
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 365 EGPESLLVYEYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           E P   +V EY+   SL  + F+K      L   Q   +    A G+A++     +  +H
Sbjct: 72  EEP-IYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 125

Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +NIL+ E L  K+ADFGLAR +  ++     G    + + APE  + G+ T K+D
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
           V++FG+L+ E+ +  R       +  VL  V + Y+
Sbjct: 186 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 221

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 93.0 bits (231), Expect = 8e-21
 Identities = 57/194 (29%), Positives = 100/194 (51%), Gaps = 9/194 (4%)

Query: 305 KLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           K+GQG +G+V+    +  G+ +A+K++    +   +   NE+ ++   +H N+V  L   
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           + G E  +V EY+   SL  ++    T   +   Q   +     + L  LH     ++IH
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVIH 138

Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RDIK+ NILL    + K+ DFG    + P+++  ST + GT  +MAPE + R     K D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVD 197

Query: 484 VYAFGVLVIEVASG 497
           +++ G++ IE+  G
Sbjct: 198 IWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 91.9 bits (228), Expect = 1e-20
 Identities = 68/263 (25%), Positives = 123/263 (46%), Gaps = 21/263 (7%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLG-C 362
           ++LG G  G V  G      ++A+K +   S    D+F  E  ++  + H+ +V+L G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 363 SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
           + + P   +V EY+ N  L  + +++         Q   +     EG+A+L      + I
Sbjct: 69  TKQRP-IYIVTEYMSNGCL--LNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFI 122

Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKA 482
           HRD+   N L+D++   K++DFGL+R+V  D+   S G    + +  PE L+  + + K+
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182

Query: 483 DVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASR 542
           DV+AFGVL+ E        V+S G        ++ +  +   + +  GL    P   + +
Sbjct: 183 DVWAFGVLMWE--------VYSLGKMP-----YERFNNSETVEKVSQGLRLYRPHLASEK 229

Query: 543 VLQIGLLCTQAPVALRPSMAEVV 565
           V  I   C       RP+  +++
Sbjct: 230 VYAIMYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 92.4 bits (229), Expect = 1e-20
 Identities = 60/200 (30%), Positives = 103/200 (51%), Gaps = 9/200 (4%)

Query: 299 FFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVV 357
           + DN  K+G+G  G V   T+   G+ +AVK++    +Q  +  FNEV ++   QH+NVV
Sbjct: 21  YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVV 80

Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
            +    + G E  +V E++   +L  I+    T   ++ +Q   +     + L+ LH   
Sbjct: 81  EMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLKALSVLHAQG 136

Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQ 477
              +IHRDIK+ +ILL      K++DFG    V+ +       + GT  +MAPE + R  
Sbjct: 137 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKSLVGTPYWMAPELISRLP 192

Query: 478 LTEKADVYAFGVLVIEVASG 497
              + D+++ G++VIE+  G
Sbjct: 193 YGPEVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 91.5 bits (227), Expect = 2e-20
 Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 39/215 (18%)

Query: 306 LGQGGAGSVFRGTLPDGRNIAVKRLFFNS-------RQWVDQFFNEVNLISGIQHKNVVR 358
           LG+G  G+V+ G    G+ IAVK++  ++       +++ ++   EV+L+  ++H N+V+
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEY-EKLQEEVDLLKSLKHVNIVQ 66

Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQIL----------FVKNTIHILSWQQRFTIICGTAE 408
            LG  ++     +  E+VP  S+  IL          F K T  IL             +
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL-------------D 113

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS-----TGIAG 463
           G+A+LH      ++HRDIK +N++L      K+ DFG AR +A    H +       + G
Sbjct: 114 GVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHG 170

Query: 464 TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           T  +MAPE +       K+D+++ G  V E+A+G+
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 15/205 (7%)

Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKR--LFFNSRQWVDQFFNEVNLISGIQHKNV 356
           +    K+G+G  G V++      G  +A+K+  L F S         E+ L+  + H N+
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQIL--FVKNTIHILSWQQRFTIICGTAEGLAHLH 414
           ++LL       +  LV+E+     +D  L   +K+    L      + +    +GLA  H
Sbjct: 61  IKLLDVFRHKGDLYLVFEF-----MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115

Query: 415 GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLV 474
                 I+HRD+K  N+L++ +   K+ADFGLAR         +  +  T  Y APE L+
Sbjct: 116 SHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLL 171

Query: 475 R-GQLTEKADVYAFGVLVIEVASGR 498
                +   D+++ G +  E+ S R
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 91.4 bits (228), Expect = 2e-20
 Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 53/229 (23%)

Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNS----------RQWV 338
           YE LE          KLG+G  G V++      G  +A+K++  ++          R   
Sbjct: 1   YEKLE----------KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR--- 47

Query: 339 DQFFNEVNLISGIQHKNVVRLLGCSIEGPESL-LVYEYVPNRSLDQIL------FVKNTI 391
                E++L+  ++H N+V+LL   I     L LV+EY  +  L + L         N I
Sbjct: 48  -----EISLLKELKHPNIVKLL-DVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLI 100

Query: 392 HILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR-HV 450
             + +Q    ++ G    LA+ H     +I+HRD+K  NIL++     K+ADFGLAR   
Sbjct: 101 KSIMYQ----LLRG----LAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFG 149

Query: 451 APDKTHVSTGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGR 498
            P +T+ +  +  TL Y APE L+  +  +   D+++ G +  E+ +G+
Sbjct: 150 IPLRTY-THEVV-TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 90.8 bits (225), Expect = 2e-20
 Identities = 75/271 (27%), Positives = 124/271 (45%), Gaps = 39/271 (14%)

Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
            +G+G  G+V +G    G+ +AVK +  +       F  E  +++ + HKN+VRLLG  I
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGV-I 68

Query: 365 EGPESLLVYEYVPNRSLDQIL-----FVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
                 +V E +   +L   L      + + I +L    +F++    AEG+ +L      
Sbjct: 69  LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLL----QFSL--DVAEGMEYLESK--- 119

Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLAR--HVAPDKTHVSTGIAGTLGYMAPEYLVRGQ 477
           K++HRD+   NIL+ E    K++DFGLAR   +  D + +       + + APE L   +
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP------VKWTAPEALKHKK 173

Query: 478 LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE 537
            + K+DV+++GVL+ EV S  R          V   V K Y+       M+P      PE
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR-------MEP------PE 220

Query: 538 NEASRVLQIGLLCTQAPVALRPSMAEVVHML 568
              + V  +   C +     RPS  ++   L
Sbjct: 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKL 251

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 92.0 bits (228), Expect = 2e-20
 Identities = 69/225 (30%), Positives = 112/225 (49%), Gaps = 21/225 (9%)

Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNI-AVKRLFFNSRQ----WVDQFFNEVNLISGIQ 352
           + F    ++G G  G+V+  T      + AVK++ ++ +Q    W D    EV  +  ++
Sbjct: 21  EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQD-IIKEVKFLQQLK 79

Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
           H N +   GC ++   + LV EY    + D +   K  +  +   +   I  G  +GLA+
Sbjct: 80  HPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEV---EIAAITHGALQGLAY 136

Query: 413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEY 472
           LH  +   +IHRDIK  NILL E    K+ADFG A   +P  + V     GT  +MAPE 
Sbjct: 137 LHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEV 188

Query: 473 LV---RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV 514
           ++    GQ   K DV++ G+  IE+A  R+  +F+  + S L+ +
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHI 232

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 91.3 bits (227), Expect = 2e-20
 Identities = 84/290 (28%), Positives = 132/290 (45%), Gaps = 51/290 (17%)

Query: 304 RKLGQGGAGSVFRGTL-------PDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHK 354
           R+LGQG  G V+ G         P+ R +A+K +  N   R+ + +F NE +++      
Sbjct: 12  RELGQGSFGMVYEGLAKGVVKGEPETR-VAIKTVNENASMRERI-EFLNEASVMKEFNCH 69

Query: 355 NVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVK-------NTIHILSWQQRFTIICGTA 407
           +VVRLLG    G  +L+V E +    L   L  +         +   + Q+   +    A
Sbjct: 70  HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129

Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG- 466
           +G+A+L      K +HRD+   N ++ E LT KI DFG+ R +     +   G  G L  
Sbjct: 130 DGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGG-KGLLPV 185

Query: 467 -YMAPEYLVRGQLTEKADVYAFGVLVIEVAS-------GRRNSVFSEGSSSVLHTVWKHY 518
            +MAPE L  G  T K+DV++FGV++ E+A+       G  N         VL  V    
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-------EEVLKFV---- 234

Query: 519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHML 568
                   +D G     PEN   ++L++  +C Q    +RP+  E+V  L
Sbjct: 235 --------IDGGHLDL-PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 90.2 bits (224), Expect = 3e-20
 Identities = 70/269 (26%), Positives = 125/269 (46%), Gaps = 32/269 (11%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKR----LFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
            K+G+G  G V++G L     +AVK     L  + ++   +F  E  ++    H N+V+L
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKR---KFLQEAEILKQYDHPNIVKL 57

Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
           +G  ++     +V E VP  SL  + F++   + L+ ++   +    A G+ +L   +  
Sbjct: 58  IGVCVQKQPIYIVMELVPGGSL--LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN-- 113

Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT-LGYMAPEYLVRGQL 478
             IHRD+   N L+ E    KI+DFG++R        VS G+    + + APE L  G+ 
Sbjct: 114 -CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172

Query: 479 TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK--ANRITQSM-DPGLTGRF 535
           T ++DV+++G+L+ E         FS G +         Y   +N+ T+   + G     
Sbjct: 173 TSESDVWSYGILLWE--------TFSLGDTP--------YPGMSNQQTRERIESGYRMPA 216

Query: 536 PENEASRVLQIGLLCTQAPVALRPSMAEV 564
           P+     + ++ L C       RPS +E+
Sbjct: 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEI 245

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 90.5 bits (225), Expect = 4e-20
 Identities = 73/281 (25%), Positives = 126/281 (44%), Gaps = 20/281 (7%)

Query: 298 DFFDNSRKLGQGGAGSVFRGTL-PDGRN----IAVKRLFFNS-RQWVDQFFNEVNLISGI 351
                 ++LG+G  G V      P G N    +AVK L  +   Q    F  E+ ++  +
Sbjct: 4   RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL 63

Query: 352 QHKNVVRLLGCSIE--GPESLLVYEYVPNRSLDQIL-FVKNTIHILSWQQRFTI-ICGTA 407
            H+N+V+  G   +  G    L+ EY+P+ SL   L   ++ I+ L     F+  IC   
Sbjct: 64  DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQIN-LKRLLLFSSQIC--- 119

Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG- 466
           +G+ +L      + IHRD+   NIL++ +   KI+DFGLA+ +  DK +      G    
Sbjct: 120 KGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI 176

Query: 467 -YMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRIT 524
            + APE L   + +  +DV++FGV + E+ + G  +         ++          R+ 
Sbjct: 177 FWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236

Query: 525 QSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVV 565
           + +  G     P +    V  +  LC +A    RPS A+++
Sbjct: 237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 90.5 bits (224), Expect = 5e-20
 Identities = 76/290 (26%), Positives = 128/290 (44%), Gaps = 33/290 (11%)

Query: 304 RKLGQGGAGSVFRGTL----PDGRNI--AVKRLFFNSRQWVDQFFNEVNLISGIQHKNVV 357
           R+LG+G  G VF        P+   I  AVK L   S      F  E  L++ +QH+++V
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70

Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVK----------NTIHILSWQQRFTIICGTA 407
           +  G  +EG   ++V+EY+ +  L++ L             N    L+  Q   I    A
Sbjct: 71  KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130

Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLG 466
            G+ +L   +    +HRD+ T N L+ E L  KI DFG++R V + D   V       + 
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187

Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS 526
           +M PE ++  + T ++DV++ GV++ E        +F+ G        W     N + + 
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWE--------IFTYGKQP-----WYQLSNNEVIEC 234

Query: 527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIP 576
           +  G   + P      V  + L C Q    +R ++ E+  +L N+    P
Sbjct: 235 ITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASP 284

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 89.8 bits (223), Expect = 5e-20
 Identities = 83/281 (29%), Positives = 132/281 (46%), Gaps = 35/281 (12%)

Query: 304 RKLGQGGAGSVFRGTL--PDGRNI--AVKRLFFNSR----QWVDQFFNEVNLISGIQHKN 355
           R +G+G  G V+ GTL   DG+ I  AVK L   +R    + V+QF  E  ++    H N
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL---NRITDLEEVEQFLKEGIIMKDFSHPN 57

Query: 356 VVRLLGCSI--EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
           V+ LLG  +  EG   L+V  Y+ +  L    F+++  H  + +         A+G+ +L
Sbjct: 58  VLSLLGICLPSEG-SPLVVLPYMKHGDLRN--FIRSETHNPTVKDLIGFGLQVAKGMEYL 114

Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP---DKTHVSTGIAGTLGYMAP 470
              +  K +HRD+   N +LDE  T K+ADFGLAR +        H  TG    + +MA 
Sbjct: 115 ---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171

Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG 530
           E L   + T K+DV++FGVL+ E        + + G+       +    +  IT  +  G
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWE--------LMTRGAPP-----YPDVDSFDITVYLLQG 218

Query: 531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
                PE     + ++ L C      +RP+ +E+V  +  I
Sbjct: 219 RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 89.7 bits (222), Expect = 6e-20
 Identities = 63/220 (28%), Positives = 108/220 (49%), Gaps = 8/220 (3%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           +KLG G  G V+  T      +AVK +   S   V+ F  E N++  +QH  +V+L    
Sbjct: 12  KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 70

Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTI-HILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
            + P   ++ E++   SL  + F+K+         +        AEG+A +   +    I
Sbjct: 71  TKEP-IYIITEFMAKGSL--LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YI 124

Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKA 482
           HRD++ +NIL+   L  KIADFGLAR +  ++     G    + + APE +  G  T K+
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184

Query: 483 DVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR 522
           DV++FG+L++E+ +  R       +  V+  + + Y+  R
Sbjct: 185 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR 224

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 89.5 bits (222), Expect = 7e-20
 Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 38/209 (18%)

Query: 306 LGQGGAGSVFRGTLPD-GRNIAVKRLFFN-----SRQWVDQFFNEVNLISGIQHKNVVRL 359
           LGQG  G V+     D GR +AVK++ F+     +++ V+    E+ L+  +QH+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 360 LGCSIEGPESLLVY-EYVPNRSL-DQI---------LFVKNTIHILSWQQRFTIICGTAE 408
            GC +   E+L ++ EY+P  S+ DQ+         +  K T  IL             E
Sbjct: 70  YGC-LRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL-------------E 115

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIA---GTL 465
           G+ +LH      I+HRDIK +NIL D     K+ DFG ++ +    +   TG+    GT 
Sbjct: 116 GVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS-GTGMKSVTGTP 171

Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEV 494
            +M+PE +       KADV++ G  V+E+
Sbjct: 172 YWMSPEVISGEGYGRKADVWSVGCTVVEM 200

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 89.3 bits (221), Expect = 7e-20
 Identities = 65/217 (29%), Positives = 109/217 (50%), Gaps = 8/217 (3%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           +KLG G  G V+ GT      +AVK L   +    + F  E  ++  ++H  +V+L    
Sbjct: 12  KKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-PESFLEEAQIMKKLRHDKLVQLYAVV 70

Query: 364 IEGPESLLVYEYVPNRSLDQILFVKN-TIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
            E P   +V EY+   SL  + F+K+     L       +    A G+A++     +  I
Sbjct: 71  SEEP-IYIVTEYMSKGSL--LDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYI 124

Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKA 482
           HRD++++NIL+ + L  KIADFGLAR +  ++     G    + + APE  + G+ T K+
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 483 DVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
           DV++FG+L+ E+ +  R       +  VL  V + Y+
Sbjct: 185 DVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR 221

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 89.3 bits (222), Expect = 8e-20
 Identities = 45/112 (40%), Positives = 58/112 (51%), Gaps = 11/112 (9%)

Query: 394 LSWQQRFT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA 447
           LS + +F+       IC     L +LH      IIHRDIK  NILLDE+    I DF +A
Sbjct: 91  LSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIA 147

Query: 448 RHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRR 499
             V PD   ++T  +GT GYMAPE L R   +   D ++ GV   E   G+R
Sbjct: 148 TKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 90.1 bits (223), Expect = 8e-20
 Identities = 59/200 (29%), Positives = 99/200 (49%), Gaps = 9/200 (4%)

Query: 299 FFDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVV 357
             +N  K+G+G  G V        GR +AVK +    +Q  +  FNEV ++   QH+NVV
Sbjct: 22  LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVV 81

Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
            +    + G E  ++ E++   +L  I+        L+ +Q  T+     + L +LH   
Sbjct: 82  EMYKSYLVGEELWVLMEFLQGGALTDIVSQTR----LNEEQIATVCESVLQALCYLHSQG 137

Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQ 477
              +IHRDIK+ +ILL      K++DFG    ++ D       + GT  +MAPE + R  
Sbjct: 138 ---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRTP 193

Query: 478 LTEKADVYAFGVLVIEVASG 497
              + D+++ G++VIE+  G
Sbjct: 194 YGTEVDIWSLGIMVIEMVDG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 88.9 bits (220), Expect = 9e-20
 Identities = 68/268 (25%), Positives = 125/268 (46%), Gaps = 23/268 (8%)

Query: 303 SRKLGQGGAGSVFRGTLPDGRNIAVK--RLFFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
            +++G G  G V+ G   + R +A+K  R    S +    F  E  ++  + H  +V+L 
Sbjct: 9   VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQLY 65

Query: 361 GCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIK 420
           G   E     LV+E++ +  L    +++      S +    +     EG+A+L   +   
Sbjct: 66  GVCTERSPICLVFEFMEHGCLSD--YLRAQRGKFSQETLLGMCLDVCEGMAYLESSN--- 120

Query: 421 IIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTE 480
           +IHRD+   N L+ E    K++DFG+ R V  D+   STG    + + +PE     + + 
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180

Query: 481 KADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEA 540
           K+DV++FGVL+ E        VFSEG      T +++   + + ++++ G     P   +
Sbjct: 181 KSDVWSFGVLMWE--------VFSEGK-----TPYENRSNSEVVETINAGFRLYKPRLAS 227

Query: 541 SRVLQIGLLCTQAPVALRPSMAEVVHML 568
             V ++   C +     RPS + ++H L
Sbjct: 228 QSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 89.0 bits (221), Expect = 1e-19
 Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 8/197 (4%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLG-C 362
           RKLG G  G V+ G   +   +AVK L   +      F  E  ++  ++H  +++L   C
Sbjct: 12  RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 363 SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
           ++E P   +V E +   SL + L        L   Q   +    A G+A+L   +    I
Sbjct: 71  TLEEP-IYIVTELMKYGSLLEYL-QGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YI 125

Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKA 482
           HRD+   N+L+ E    K+ADFGLAR +  D      G    + + APE  +  + + K+
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185

Query: 483 DVYAFGVLVIE-VASGR 498
           DV++FG+L+ E V  GR
Sbjct: 186 DVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 89.2 bits (221), Expect = 1e-19
 Identities = 71/277 (25%), Positives = 129/277 (46%), Gaps = 29/277 (10%)

Query: 304 RKLGQGGAGSVFRG--TLPDGRNIAVK----RLFFNSRQWVDQFFNEVNLISGIQHKNVV 357
           + +G G  G V  G   LP  R I V     +  +  +Q  D F +E +++    H N++
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD-FLSEASIMGQFDHPNII 68

Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
            L G   +    ++V EY+ N SLD   F++      +  Q   ++ G A G+ +L   S
Sbjct: 69  HLEGVVTKSKPVMIVTEYMENGSLDA--FLRKHDGQFTVIQLVGMLRGIASGMKYL---S 123

Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA--PDKTHVSTGIAGTLGYMAPEYLVR 475
            +  +HRD+   NIL++  L  K++DFGL+R +   P+  + + G    + + APE +  
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183

Query: 476 GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMD-PGLTGR 534
            + T  +DV+++G+++ EV S      +   +  V+  + + Y   R+   MD P     
Sbjct: 184 RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY---RLPAPMDCPAA--- 237

Query: 535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
                   + Q+ L C Q     RP   ++V +L+ +
Sbjct: 238 --------LHQLMLDCWQKDRNERPKFEQIVSILDKL 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 89.6 bits (222), Expect = 1e-19
 Identities = 80/283 (28%), Positives = 132/283 (46%), Gaps = 37/283 (13%)

Query: 304 RKLGQGGAGSVFRGTL-------PDGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHK 354
           R+LGQG  G V+ G          + R +AVK +  ++  R+ + +F NE +++ G    
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERI-EFLNEASVMKGFTCH 69

Query: 355 NVVRLLGCSIEGPESLLVYEYVPNRSLDQILFV------KNTIHIL-SWQQRFTIICGTA 407
           +VVRLLG   +G  +L+V E + +  L   L         N      + Q+   +    A
Sbjct: 70  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129

Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTL-- 465
           +G+A+L+     K +HRD+   N ++    T KI DFG+ R +  +  +   G  G L  
Sbjct: 130 DGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY-ETDYYRKGGKGLLPV 185

Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQ 525
            +MAPE L  G  T  +D+++FGV++ E+ S          +  VL  V           
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV----------- 234

Query: 526 SMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHML 568
            MD G   + P+N   RV  +  +C Q    +RP+  E+V++L
Sbjct: 235 -MDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 89.5 bits (222), Expect = 1e-19
 Identities = 77/292 (26%), Positives = 123/292 (42%), Gaps = 43/292 (14%)

Query: 304 RKLGQGGAGSVFRGTLP------DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNV 356
           R +GQG  G VF+   P          +AVK L    S      F  E  L++   H N+
Sbjct: 11  RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNI 70

Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKN--TIHILSWQQRFTIICG--------- 405
           V+LLG    G    L++EY+    L++ L  ++      LS        CG         
Sbjct: 71  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130

Query: 406 --------TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTH 456
                    A G+A+L   S  K +HRD+ T N L+ E +  KIADFGL+R++ + D   
Sbjct: 131 EQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187

Query: 457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWK 516
            S   A  + +M PE +   + T ++DV+A+GV++ E+ S      +      V+     
Sbjct: 188 ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI----Y 243

Query: 517 HYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHML 568
           + +   +            P+N    +  +  LC     + RPS A +  +L
Sbjct: 244 YVRDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRIL 286

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 89.5 bits (222), Expect = 1e-19
 Identities = 77/296 (26%), Positives = 127/296 (42%), Gaps = 33/296 (11%)

Query: 304 RKLGQGGAGSVFR-GTLPDGRNIAVKRLFFNSRQWV-DQFFNEVNLISGIQHKNVVRLLG 361
             LG G  GSV +   +P G  +A K +   ++  V  Q   E+ ++   +   +V   G
Sbjct: 11  SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70

Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKN--TIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
             +      +  E++   SLD+I        + IL       I     EGL +L+  +  
Sbjct: 71  AFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLY--NVH 123

Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLT 479
           +I+HRDIK SNIL++ +   K+ DFG++  +      ++    GT  YM+PE +  G+ T
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELI---NSIADTFVGTSTYMSPERIQGGKYT 180

Query: 480 EKADVYAFGVLVIEVASGRRNSVFSEG-SSSVLHTVWKHYKANRITQSMDPGL-TGRFPE 537
            K+DV++ G+ +IE+A G+    FS          +       +I Q   P L +  FPE
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE 240

Query: 538 NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNASVISPSD 593
            +    +   LL        RP+  ++  M             PPF+ A   S  D
Sbjct: 241 -DLRDFVDACLLKDP---TERPTPQQLCAM-------------PPFIQALRASNVD 279

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 90.3 bits (224), Expect = 1e-19
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 18/209 (8%)

Query: 289 KYEILERATDF-FDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNL 347
           K +  E      +   + L  G  G VF  T P   +  V ++       +     E  L
Sbjct: 56  KQKAREVVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLI-----EAML 110

Query: 348 ISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTA 407
           +  + H +V+R+    + G  + +V   +P+ S D   ++      L   Q   I     
Sbjct: 111 LQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEKQIL 167

Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH--VAPDKTHVSTGIAGTL 465
           EGL +LH     +IIHRD+KT NI +++     I D G A+   VAP       G+AGT+
Sbjct: 168 EGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA----FLGLAGTV 220

Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEV 494
              APE L R +   KAD+++ G+++ E+
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 89.0 bits (220), Expect = 2e-19
 Identities = 56/194 (28%), Positives = 100/194 (51%), Gaps = 9/194 (4%)

Query: 305 KLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           K+GQG +G+V+    +  G+ +A+K++    +   +   NE+ ++   ++ N+V  L   
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           + G E  +V EY+   SL  ++    T   +   Q   +     + L  LH     ++IH
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALDFLHSN---QVIH 138

Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RDIK+ NILL    + K+ DFG    + P+++  ST + GT  +MAPE + R     K D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVD 197

Query: 484 VYAFGVLVIEVASG 497
           +++ G++ IE+  G
Sbjct: 198 IWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 60/221 (27%), Positives = 89/221 (40%), Gaps = 34/221 (15%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFN---- 343
           KYE+L            +G+G  G V +      G  +A+K+  F   +  +        
Sbjct: 2   KYEVLGV----------VGEGAYGVVLKCRNKATGEIVAIKK--FKESEDDEDVKKTALR 49

Query: 344 EVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKN-----TIHILSWQQ 398
           EV ++  ++H+N+V L           LV+EYV    L+ +           +    WQ 
Sbjct: 50  EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ- 108

Query: 399 RFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS 458
                    + +A+ H      IIHRDIK  NIL+ E    K+ DFG AR +        
Sbjct: 109 -------LLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158

Query: 459 TGIAGTLGYMAPEYLVRGQLTEKA-DVYAFGVLVIEVASGR 498
           T    T  Y APE LV      K  DV+A G ++ E+  G 
Sbjct: 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 87.0 bits (215), Expect = 4e-19
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 6/215 (2%)

Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           KLGQG  G V+ GT      +A+K L   +    + F  E  ++  ++H  +V L     
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHR 424
           E P   +V E++   SL   L   +  + L   Q   +    A+G+A++     +  IHR
Sbjct: 72  EEP-IYIVTEFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAYIER---MNYIHR 126

Query: 425 DIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADV 484
           D++ +NIL+ + L  KIADFGLAR +  ++     G    + + APE  + G+ T K+DV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 485 YAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
           ++FG+L+ E+ +  R       +  VL  V + Y+
Sbjct: 187 WSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR 221

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 87.8 bits (217), Expect = 4e-19
 Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 9/201 (4%)

Query: 298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNV 356
           ++ D+  K+G+G  G V   T    G+ +AVK++    +Q  +  FNEV ++    H+NV
Sbjct: 22  EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENV 81

Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           V +    + G E  +V E++   +L  I+    T   ++ +Q  T+       L++LH  
Sbjct: 82  VDMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLSVLRALSYLHNQ 137

Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG 476
               +IHRDIK+ +ILL      K++DFG    V+ +       + GT  +MAPE + R 
Sbjct: 138 G---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSLVGTPYWMAPEVISRL 193

Query: 477 QLTEKADVYAFGVLVIEVASG 497
               + D+++ G++VIE+  G
Sbjct: 194 PYGTEVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 87.0 bits (215), Expect = 6e-19
 Identities = 77/281 (27%), Positives = 132/281 (46%), Gaps = 37/281 (13%)

Query: 303 SRKLGQGGAGSVFRGTL-------PDGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQH 353
           SR+LGQG  G V+ G         P+ R +A+K +   +  R+ + +F NE +++     
Sbjct: 11  SRELGQGSFGMVYEGIAKGVVKDEPETR-VAIKTVNEAASMRERI-EFLNEASVMKEFNC 68

Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQIL------FVKNTIHILSWQQRFTIICG-T 406
            +VVRLLG   +G  +L++ E +    L   L         N +      ++   + G  
Sbjct: 69  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128

Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG 466
           A+G+A+L+     K +HRD+   N ++ E  T KI DFG+ R +  +  +   G  G L 
Sbjct: 129 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-ETDYYRKGGKGLLP 184

Query: 467 --YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRIT 524
             +M+PE L  G  T  +DV++FGV++ E+A+          +  VL  V          
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV---------- 234

Query: 525 QSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVV 565
             M+ GL  + P+N    + ++  +C Q    +RPS  E++
Sbjct: 235 --MEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 86.8 bits (215), Expect = 7e-19
 Identities = 73/284 (25%), Positives = 129/284 (45%), Gaps = 32/284 (11%)

Query: 304 RKLGQGGAGSVFRGTL--PDGR--NIAVK--RLFFNSRQWVDQFFNEVNLISGIQHKNVV 357
           + LG+G  GSV  G L   DG    +AVK  +L  ++   +++F +E   +    H NV+
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 358 RLLGCSIEG------PESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAE 408
           +L+G   E       P+ +++  ++ +  L   L       +   L  Q     +   A 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT-LGY 467
           G+ +L   S    IHRD+   N +L E +T  +ADFGL++ +     +    IA   + +
Sbjct: 125 GMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181

Query: 468 MAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM 527
           +A E L     T K+DV+AFGV + E+A+ R  + +    +  ++   +H   NR+ Q  
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIAT-RGQTPYPGVENHEIYDYLRH--GNRLKQ-- 236

Query: 528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
                   PE+    +  +   C +A    RP+  ++  +L NI
Sbjct: 237 --------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 85.7 bits (212), Expect = 2e-18
 Identities = 72/282 (25%), Positives = 132/282 (46%), Gaps = 41/282 (14%)

Query: 306 LGQGGAGSVFRGTL-PDGRN---IAVKRLF--FNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +G G  G V RG L   G+    +A+K L   +  +Q  D F +E +++    H N++ L
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFDHPNIIHL 70

Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIIC------GTAEGLAHL 413
            G   +    +++ E++ N +LD  L   +         +FT+I       G A G+ +L
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYL 122

Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV---APDKTHVST-GIAGTLGYMA 469
              S +  +HRD+   NIL++  L  K++DFGL+R +     D T+ S+ G    + + A
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179

Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP 529
           PE +   + T  +DV+++G+++ EV S      +   +  V++ + + Y   R+   MD 
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY---RLPPPMDC 236

Query: 530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
                      + + Q+ L C Q     RP   ++V  L+ +
Sbjct: 237 ----------PTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 59/200 (29%), Positives = 105/200 (52%), Gaps = 18/200 (9%)

Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQW-VDQFFNEVNLISGIQH---KNVVRLL 360
           +G+G  G+V+RG  +P GR +A+K +  ++    V     EV L+S ++     N+ +  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 361 GCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFT--IICGTAEGLAHLHGGSG 418
           G  ++GP   ++ EY    S+ + L     I      +++   II      L ++H    
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSV-RTLMKAGPI-----AEKYISVIIREVLVALKYIHK--- 119

Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL 478
           + +IHRDIK +NIL+      K+ DFG+A  +  + +  ST   GT  +MAPE +  G+ 
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVITEGKY 178

Query: 479 TE-KADVYAFGVLVIEVASG 497
            + KAD+++ G+ + E+A+G
Sbjct: 179 YDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 85.5 bits (211), Expect = 3e-18
 Identities = 55/194 (28%), Positives = 100/194 (51%), Gaps = 9/194 (4%)

Query: 305 KLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           K+GQG +G+V+    +  G+ +A++++    +   +   NE+ ++   ++ N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           + G E  +V EY+   SL  ++    T   +   Q   +     + L  LH     ++IH
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139

Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RDIK+ NILL    + K+ DFG    + P+++  ST + GT  +MAPE + R     K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVD 198

Query: 484 VYAFGVLVIEVASG 497
           +++ G++ IE+  G
Sbjct: 199 IWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 84.3 bits (208), Expect = 3e-18
 Identities = 60/193 (31%), Positives = 100/193 (51%), Gaps = 8/193 (4%)

Query: 306 LGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVD-QFFNEVNLISGIQHKNVVRLLGCSI 364
           LG+G  G VF+GTL D   +AVK    +  Q +  +F +E  ++    H N+V+L+G   
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHR 424
           +     +V E VP    D + F++     L  +Q        A G+A+L   +    IHR
Sbjct: 63  QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 425 DIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT-LGYMAPEYLVRGQLTEKAD 483
           D+   N L+ E    KI+DFG++R    D  + S+G+    + + APE L  G+ + ++D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQ-EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176

Query: 484 VYAFGVLVIEVAS 496
           V+++G+L+ E  S
Sbjct: 177 VWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score = 79.8 bits (197), Expect = 3e-18
 Identities = 31/105 (29%), Positives = 46/105 (43%), Gaps = 4/105 (3%)

Query: 40  YKCGPPAK---VSDNRNFRQNFDAVMGNISEQIMDDHHYHFALHYVVSPAPQVYAYMQCH 96
           + C         + N  F  N +A++ ++S          FA     +    VY   QC 
Sbjct: 2   HLCSSNTSGNYTTANSTFESNLNALLSSLSSNAASSSGKGFAAGTSGAAPDTVYGLAQCR 61

Query: 97  EDLSQTDCESCF-SALKQKANRCLPSDSARIFLDGCFLRYDNYDF 140
            DLS +DC SC  +A+ +    C      RI+ D CFLRY++Y F
Sbjct: 62  GDLSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 84.8 bits (210), Expect = 4e-18
 Identities = 77/293 (26%), Positives = 128/293 (43%), Gaps = 48/293 (16%)

Query: 306 LGQGGAGSVFRGTL-----PDGR-NIAVKRLFFN-SRQWVDQFFNEVNLISGI-QHKNVV 357
           LG+G  G V +        P+    +AVK L  + + + +    +E+ ++  I +HKN++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 358 RLLG-CSIEGPESLLVYEYVPNRSLDQIL-----------FVKNTIHILSWQQRFTIICG 405
            LLG C+ EGP  ++V EY  + +L   L                    +  Q+  +   
Sbjct: 80  NLLGVCTQEGPLYVVV-EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 406 --TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG 463
              A G+  L   +  K IHRD+   N+L+ E    KIADFGLAR +     +  T   G
Sbjct: 139 YQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT-NG 194

Query: 464 TLGY--MAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSS---SVLHTVWKHY 518
            L    MAPE L     T ++DV++FGVL+ E        +F+ G S    +   V + +
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWE--------IFTLGGSPYPGI--PVEELF 244

Query: 519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           K  +    M+       P+N    +  +   C     + RP+  ++V  L+ +
Sbjct: 245 KLLKEGYRMEK------PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 84.4 bits (209), Expect = 5e-18
 Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 11/200 (5%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFF--NSRQWVDQFFNEVNLISGIQHKNVVRLLG 361
            +LG+G  GSV +  L +   I   +      +     Q   E+ +    +   +V+  G
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66

Query: 362 CSIEGPESLL--VYEYVPNRSLDQIL-FVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
             ++   S +    EY    SLD I   VK     +  +    I     +GL++LH    
Sbjct: 67  AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR-- 124

Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL 478
            KIIHRDIK SNILL  K   K+ DFG++  +      ++    GT  YMAPE +     
Sbjct: 125 -KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV---NSLAGTFTGTSFYMAPERIQGKPY 180

Query: 479 TEKADVYAFGVLVIEVASGR 498
           +  +DV++ G+ ++EVA  R
Sbjct: 181 SITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 83.0 bits (205), Expect = 1e-17
 Identities = 66/212 (31%), Positives = 99/212 (46%), Gaps = 29/212 (13%)

Query: 299 FFDNSRKLGQGGAGSVF--------RGTLPDGRNIAVKRLFF-NSRQWVDQFFNEVNLIS 349
           +    R LG+G  G V          GT   G  +AVK L     +Q    +  E+N++ 
Sbjct: 5   YLKKIRVLGEGHFGKVSLYCYDPANDGT---GEMVAVKTLKRECGQQNTSGWKKEINILK 61

Query: 350 GIQHKNVVRLLGCSIEGPES--LLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIIC 404
            + H+N+V+  GC  E       L+ EYVP  SL   L  K+ +    +L + Q+   IC
Sbjct: 62  TLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQ---IC 117

Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH--VSTGIA 462
              EG+A+LH       IHRD+   N+LLD     KI DFGLA+ V     +  V     
Sbjct: 118 ---EGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171

Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEV 494
             + + A E L   + +  +DV++FGV + E+
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYEL 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 82/290 (28%), Positives = 116/290 (40%), Gaps = 49/290 (16%)

Query: 304 RKLGQGGAGSVFRGTL--PDGRN----IAVKRL-FFNSRQWVDQFFNEVNLISGIQHKNV 356
           R LG G  G V+ G     DG      +AVK L    S Q    F  E  ++S   H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVK------NTIHILSWQQRFTIICGTAEGL 410
           VRL+G S E     ++ E +    L    F++           L+ +         A+G 
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKS--FLRENRPRPERPSSLTMKDLLFCARDVAKGC 129

Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEK---LTPKIADFGLARHVAPDKTHVSTGIAG-TLG 466
            +L        IHRDI   N LL  K      KIADFG+AR +     +   G A   + 
Sbjct: 130 KYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186

Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVAS-------GRRNSVFSEGSSSVLHTVWKHYK 519
           +M PE  + G  T K DV++FGVL+ E+ S       GR N         V+  V     
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-------QEVMEFV---TG 236

Query: 520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLN 569
             R    +DP      P+     V +I   C Q     RP+ A ++  + 
Sbjct: 237 GGR----LDP------PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 83.0 bits (206), Expect = 2e-17
 Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 16/198 (8%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN-----EVNLISGIQHKNVV 357
           +KLG+G    V++      GR +A+K++    R+      N     E+ L+  ++H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
            LL          LV+E++    L+++  +K+   +L+     + +  T  GL +LH   
Sbjct: 66  GLLDVFGHKSNINLVFEFMET-DLEKV--IKDKSIVLTPADIKSYMLMTLRGLEYLHSNW 122

Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG- 476
              I+HRD+K +N+L+      K+ADFGLAR        ++  +  T  Y APE L  G 
Sbjct: 123 ---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLF-GA 177

Query: 477 -QLTEKADVYAFGVLVIE 493
                  D+++ G +  E
Sbjct: 178 RHYGVGVDMWSVGCIFAE 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 61/199 (30%), Positives = 102/199 (51%), Gaps = 10/199 (5%)

Query: 304 RKLGQGGAGSVFR-GTLPDGRNIAVKR--LFFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
           +KLG+G  GSV++   L D +  A+K   L   S++  +   NE+ +++ + H N++   
Sbjct: 6   KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65

Query: 361 GCSIEGPESLLVYEYVPNRSLDQ-ILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
              ++G +  +V EY P   L + I   K    ++  Q+ + I      GL  LH     
Sbjct: 66  EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---Q 122

Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLT 479
           KI+HRD+K++NILL      KI D G+++ +   K    T I GT  YMAPE       +
Sbjct: 123 KILHRDLKSANILLVANDLVKIGDLGISKVLK--KNMAKTQI-GTPHYMAPEVWKGRPYS 179

Query: 480 EKADVYAFGVLVIEVASGR 498
            K+D+++ G L+ E+A+  
Sbjct: 180 YKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 82.6 bits (205), Expect = 2e-17
 Identities = 63/204 (30%), Positives = 93/204 (45%), Gaps = 21/204 (10%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQF-FNEVNLISGIQ-HKNVVRLL 360
           ++LG G  GSV+       G  +A+K++      W +     EV  +  +  H N+V+L 
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64

Query: 361 GCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH--GGSG 418
               E  E   V+EY+   +L Q L         S     +II    +GLAH+H  G   
Sbjct: 65  EVFRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--- 119

Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHV---APDKTHVSTGIAGTLGYMAPEYLVR 475
               HRD+K  N+L+      KIADFGLAR +    P   +VS     T  Y APE L+R
Sbjct: 120 --FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVS-----TRWYRAPEILLR 172

Query: 476 GQLTEKA-DVYAFGVLVIEVASGR 498
                   D++A G ++ E+ + R
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 82.1 bits (203), Expect = 3e-17
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 30/209 (14%)

Query: 308 QGGAGSVFRGTLPDG-----RNIAVKRLFFNSRQ-WVDQFFNEVNLISGIQHKNVVRLLG 361
           +G  G +F G L D        + VK +  ++ +  V     E  L+ G+ H+N++ +L 
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 362 CSIEGPESLLV-YEYVPNRSLDQIL-----FVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
             IE  E   V Y Y+   +L   L        N    LS QQ   +    A G+++LH 
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135

Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG--------Y 467
                +IH+DI   N ++DE+L  KI D  L+R + P   H        LG        +
Sbjct: 136 ---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH-------CLGDNENRPVKW 185

Query: 468 MAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
           MA E LV  + +  +DV++FGVL+ E+ +
Sbjct: 186 MALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 82.0 bits (202), Expect = 3e-17
 Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 22/209 (10%)

Query: 305 KLGQGGAGSVF----RGTLPDGRN--IAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVR 358
           +LG+G  G VF       LP+     +AVK L   S      F  E  L++ +QH+++VR
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKN-TIHIL-----------SWQQRFTIICGT 406
             G   EG   L+V+EY+ +  L++ L        IL           +  Q   I    
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTL 465
           A G+ +L   + +  +HRD+ T N L+ + L  KI DFG++R + + D   V       +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEV 494
            +M PE ++  + T ++D+++FGV++ E+
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 82.9 bits (205), Expect = 4e-17
 Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 18/202 (8%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWV-DQFFNEVNLISGIQHKNVVRLLG 361
            ++G G  G+V++    P GR  A+K ++ N    V  Q   E+ ++  + H NVV+   
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
                 E  ++ E++   SL+         HI   Q    +      G+A+LH      I
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLE-------GTHIADEQFLADVARQILSGIAYLHRR---HI 189

Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEY----LVRGQ 477
           +HRDIK SN+L++     KIADFG++R +A      ++ + GT+ YM+PE     L  G 
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNHGA 248

Query: 478 LTEKA-DVYAFGVLVIEVASGR 498
               A D+++ GV ++E   GR
Sbjct: 249 YDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 82.6 bits (205), Expect = 4e-17
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 32/217 (14%)

Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHKNV 356
           ++  + +G G  G V        GR +A+K++   F+      +   E+ L+  ++H+N+
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 357 VRLLGCSIEGPESL-------LVYEYVPNRSLDQILFVKNTI---HILSWQQRFT--IIC 404
           + LL   I  P S        +V E +    L +++     +   HI    Q F   I+ 
Sbjct: 62  IGLL--DILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHI----QYFLYQILR 114

Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS--TGIA 462
           G    L +LH      +IHRD+K SNIL++     KI DFGLAR V PD+      T   
Sbjct: 115 G----LKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYV 167

Query: 463 GTLGYMAPE-YLVRGQLTEKADVYAFGVLVIEVASGR 498
            T  Y APE  L   + T+  D+++ G +  E+ + +
Sbjct: 168 VTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 81.9 bits (202), Expect = 5e-17
 Identities = 62/216 (28%), Positives = 106/216 (49%), Gaps = 29/216 (13%)

Query: 305 KLGQGGAGSV----------FRGTLP---DGRN--IAVKRLFFN-SRQWVDQFFNEVNLI 348
           KLG+G  G V          F G      DG+   +AVK L  + ++   + F  E+ ++
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 349 SGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQIL--------FVK-NTIHILSWQQR 399
           S +++ N++RLLG  +      ++ EY+ N  L+Q L        F   N I  +S    
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131

Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVS 458
             +    A G+ +L   + +  +HRD+ T N L+    T KIADFG++R++ + D   + 
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188

Query: 459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEV 494
                 + +MA E ++ G+ T  +DV+AFGV + E+
Sbjct: 189 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 84.5 bits (209), Expect = 7e-17
 Identities = 57/229 (24%), Positives = 105/229 (45%), Gaps = 15/229 (6%)

Query: 343 NEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI 402
           +E+  +  +QH N+V+L+G       + L++EY+  ++L ++L        LSW++R  I
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL------RNLSWERRRKI 785

Query: 403 ICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIA 462
             G A+ L  LH      ++  ++    I++D K  P +    L   +  D     +   
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-- 842

Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNS-VFSEGSSSVLHTVWKHYKAN 521
               Y+APE      +TEK+D+Y FG+++IE+ +G+  +        S++      Y   
Sbjct: 843 ---AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC 899

Query: 522 RITQSMDPGLTGRFP--ENEASRVLQIGLLCTQAPVALRPSMAEVVHML 568
            +   +DP + G     +NE   V+ + L CT      RP   +V+  L
Sbjct: 900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 81.6 bits (202), Expect = 8e-17
 Identities = 72/251 (28%), Positives = 115/251 (45%), Gaps = 43/251 (17%)

Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQWVDQF----FNE 344
           YEIL           KLG+G  G V++   +  GR +A+K++  ++ +  D F      E
Sbjct: 10  YEILG----------KLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALRE 57

Query: 345 VNLISGIQHKNVVRLLGCSIEGPESLL-----VYEYVPNRSLDQILFVKNTIHILSWQQR 399
           + ++  ++H NVV L+  ++E P+        VY   P    D    ++N    L+  Q 
Sbjct: 58  IKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQI 117

Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK----- 454
              +    EG+ +LH      I+HRDIK +NIL+D +   KIADFGLAR           
Sbjct: 118 KCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174

Query: 455 -----THVSTGIAGTLGYMAPEYLVRG--QLTEKADVYAFGVLVIEVASGRRNSVFSEGS 507
                T   T +  T  Y  PE L+ G  + T   D++  G +  E+ + R   +  +G 
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPE-LLLGERRYTTAVDIWGIGCVFAEMFTRR--PIL-QGK 230

Query: 508 SSV--LHTVWK 516
           S +  LH ++K
Sbjct: 231 SDIDQLHLIFK 241

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 80.6 bits (199), Expect = 9e-17
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 15/207 (7%)

Query: 297 TDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL-FFN-----SRQWVDQFFNEVNLIS 349
              F   +K+G+G    V++   L DGR +A+K++  F      +RQ       E++L+ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLK 57

Query: 350 GIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQ-ILFVKNTIHILSWQQRFTIICGTAE 408
            + H NV++ L   IE  E  +V E      L + I   K    ++  +  +        
Sbjct: 58  QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
            L H+H     +I+HRDIK +N+ +      K+ D GL R  +  KT  +  + GT  YM
Sbjct: 118 ALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYM 173

Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVA 495
           +PE +       K+D+++ G L+ E+A
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMA 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 80.3 bits (198), Expect = 1e-16
 Identities = 78/284 (27%), Positives = 122/284 (42%), Gaps = 36/284 (12%)

Query: 306 LGQGGAGSVFRGTLPD-------GRNIAVKRLFFNSR-QWVDQFFNEVNLISGIQHKNVV 357
           LG G  G V+ GT  D          +AVK L   +  Q   +F  E +L+S   H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQIL----FVKNTIHILSWQQRFTIICGTAEGLAHL 413
           +LLG  +      ++ E +    L   L      +    +L+ ++   I    A+G  +L
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 414 HGGSGIKIIHRDIKTSNILLDEK-----LTPKIADFGLARHVAPDKTHVSTGIAGTLG-- 466
                +  IHRD+   N L+ EK        KI DFGLAR +     +   G  G L   
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG-EGLLPVR 178

Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS 526
           +MAPE L+ G+ T ++DV++FGVL+ E+ +  +    +  +  VL     H  A    Q 
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQ----HVTAGGRLQK 234

Query: 527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN 570
                    PEN   ++ Q+   C     + RP+   +  +L N
Sbjct: 235 ---------PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 70/281 (24%), Positives = 112/281 (39%), Gaps = 34/281 (12%)

Query: 306 LGQGGAGSVFRGTLP------DGRNIAVKRLFFNSRQWVDQFFN-EVNLISGIQHKNVVR 358
           LG+G  G VF               + VK L     + +   F  E+++   + HKNVVR
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFV------KNTIHILSWQQRFTIICGTAEGLAH 412
           LLG   E     ++ EY     L Q L        K     LS +Q+  +    A G+ H
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEY 472
           L   S  + +HRD+   N L+  +   K++   L++ V   + +        L ++APE 
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189

Query: 473 LVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR---ITQSMDP 529
           +     + K+DV++FGVL+ E        VF+             Y  +    + +    
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWE--------VFT-------QGELPFYGLSDEEVLNRLQAG 234

Query: 530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN 570
            L    PE   SR+ ++   C       RPS +E+V  L  
Sbjct: 235 KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 72/289 (24%), Positives = 124/289 (42%), Gaps = 47/289 (16%)

Query: 306 LGQGGAGSVFRGT------LPDGRNIAVKRLFFNSRQW-VDQFFNEVNLISGIQHKNVVR 358
           LG+G  G V + T            +AVK L  N+    +    +E NL+  + H +V++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 359 LLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQR--------------- 399
           L G CS +GP  LL+ EY    SL   L     +   ++ S   R               
Sbjct: 68  LYGACSQDGP-LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 400 ---FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH 456
               +     + G+ +L   + +K++HRD+   N+L+ E    KI+DFGL+R V  + ++
Sbjct: 127 GDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183

Query: 457 VSTGIAGT-LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVW 515
           V        + +MA E L     T ++DV++FGVL+ E+ +   N         + + + 
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLK 243

Query: 516 KHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEV 564
             Y+  R             PEN +  +  + L C +     RP+ A++
Sbjct: 244 TGYRMER-------------PENCSEEMYNLMLTCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 18/211 (8%)

Query: 297 TDFFDNSRKLGQGGAGSVF----RGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ 352
            D ++   +LG G  G V+    + T   G   A K +   S + ++ F  E++++S  +
Sbjct: 4   NDIWEIIGELGDGAFGKVYKAQHKET---GLFAAAKIIQIESEEELEDFMVEIDILSECK 60

Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
           H N+V L        +  ++ E+    +LD I  +      L+  Q   +     E L  
Sbjct: 61  HPNIVGLYEAYFYENKLWILIEFCDGGALDSI--MLELERGLTEPQIRYVCRQMLEALNF 118

Query: 413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEY 472
           LH     K+IHRD+K  NILL      K+ADFG++           T I GT  +MAPE 
Sbjct: 119 LHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEV 174

Query: 473 LVRGQLTE-----KADVYAFGVLVIEVASGR 498
           +      +     KAD+++ G+ +IE+A   
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 80.8 bits (199), Expect = 2e-16
 Identities = 62/187 (33%), Positives = 89/187 (47%), Gaps = 30/187 (16%)

Query: 396 WQQRFTI---ICGT---AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH 449
           W+   T+   IC +   A G+  L   +  K IHRD+   NILL E    KI DFGLAR 
Sbjct: 167 WKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARD 223

Query: 450 VAPDKTHVSTGIAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSS 508
           +  D  +V  G A   L +MAPE +     T ++DV++FGVL+ E        +FS G+S
Sbjct: 224 IYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWE--------IFSLGAS 275

Query: 509 SVLHTVWKHYKANRIT----QSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEV 564
                    Y   +I     Q +  G   R PEN    + +I L C Q     RP+ + +
Sbjct: 276 P--------YPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSAL 327

Query: 565 VHMLNNI 571
           V +L ++
Sbjct: 328 VEILGDL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 79.9 bits (198), Expect = 2e-16
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 30/210 (14%)

Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRNI-AVKRLFFN----SRQWVDQFFNEVNLISGIQHK 354
           F+  + LG G  G V            A+K L        +Q V+   NE  ++  I+H 
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHP 61

Query: 355 NVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICG---TAE-- 408
            +V L G S +   +L LV EYVP   L      K+         RF         A+  
Sbjct: 62  FLVNLYG-SFQDDSNLYLVMEYVPGGELFS-HLRKS--------GRFPEPVARFYAAQVV 111

Query: 409 -GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGY 467
             L +LH    + I++RD+K  N+LLD     KI DFG A+ V   +T+    + GT  Y
Sbjct: 112 LALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRV-KGRTYT---LCGTPEY 164

Query: 468 MAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           +APE ++     +  D +A G+L+ E+ +G
Sbjct: 165 LAPEIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 59/231 (25%), Positives = 106/231 (45%), Gaps = 23/231 (9%)

Query: 304 RKLGQGGAGSVFRGT------LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVV 357
           R+LG+G  G VF           D   +AVK L   +      F  E  L++ +QH+++V
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70

Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI-------------LSWQQRFTIIC 404
           +  G   +G   ++V+EY+ +  L++ L       +             L   Q   I  
Sbjct: 71  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130

Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAG 463
             A G+ +L   +    +HRD+ T N L+   L  KI DFG++R V + D   V      
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187

Query: 464 TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV 514
            + +M PE ++  + T ++DV++FGV++ E+ +  +   F   ++ V+  +
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 64/272 (23%), Positives = 124/272 (45%), Gaps = 30/272 (11%)

Query: 304 RKLGQGGAGS--VFRGTLPDG----RNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVV 357
           R LG+G  G   ++R T  D     + + + RL   S +      NE+ ++S +QH N++
Sbjct: 6   RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL---SEKERRDALNEIVILSLLQHPNII 62

Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
                 ++    L+  EY    +L   + V+    +   +     +      ++++H   
Sbjct: 63  AYYNHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG 121

Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG- 476
              I+HRDIKT NI L +    K+ DFG+++ +  + +   T + GT  YM+PE L +G 
Sbjct: 122 ---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPE-LCQGV 176

Query: 477 QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP 536
           +   K+D++A G ++ E+ + +R   F   +++ L+ V K  + N       P ++    
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKR--TFD--ATNPLNLVVKIVQGNY-----TPVVSVY-- 225

Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHML 568
              +S ++ +     Q     RP+  EV+   
Sbjct: 226 ---SSELISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 78/290 (26%), Positives = 132/290 (45%), Gaps = 42/290 (14%)

Query: 306 LGQGGAGSVFR---GTLPD--GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
           LG+G  GSV       L D  G  +AVK+L  ++ + +  F  E+ ++  +QH N+V+  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 361 G-CSIEGPESL-LVYEYVPNRSLDQILFVKN-------TIHILSWQQRFTIICGTAEGLA 411
           G C   G  +L LV EY+P  SL   L  K+        + + + Q     IC   +G+ 
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYL-QKHRERLDHRKLLLYASQ-----IC---KGME 122

Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT--LGYMA 469
           +L      + +HRD+ T NIL++ +   KI DFGL + +  DK +      G   + + A
Sbjct: 123 YL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179

Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP 529
           PE L   + +  +DV++FGV++ E+ +      +S+ S S      +    ++  Q +  
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYELFT------YSDKSCSPPAEFMRMMGNDKQGQMIVY 233

Query: 530 GL------TGRFPENEA--SRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            L       GR P      + +  I   C     + RPS +E+   +  I
Sbjct: 234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 78.1 bits (192), Expect = 4e-16
 Identities = 71/272 (26%), Positives = 124/272 (45%), Gaps = 31/272 (11%)

Query: 305 KLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWV-----DQFFNEVNLISGIQHKNVVR 358
           ++G+G  G VF G L  D   +AVK    + R+ +      +F  E  ++    H N+VR
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIVR 57

Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
           L+G   +     +V E V  +  D + F++     L  ++   ++   A G+ +L     
Sbjct: 58  LIGVCTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH- 114

Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTL--GYMAPEYLVRG 476
              IHRD+   N L+ EK   KI+DFG++R    D  + STG    +   + APE L  G
Sbjct: 115 --CIHRDLAARNCLVTEKNVLKISDFGMSREEE-DGVYASTGGMKQIPVKWTAPEALNYG 171

Query: 477 QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP 536
           + + ++DV++FG+L+ E         FS G+       + +    +  ++++ G+    P
Sbjct: 172 RYSSESDVWSFGILLWE--------AFSLGAVP-----YANLSNQQTREAIEQGVRLPCP 218

Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHML 568
           E     V ++   C +     RPS + V   L
Sbjct: 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 79.4 bits (196), Expect = 5e-16
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 35/218 (16%)

Query: 304 RKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRL--- 359
           R LG G  G VF     D  + +AVK++     Q V     E+ +I  + H N+V++   
Sbjct: 11  RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70

Query: 360 -------LGCSIEGPESL----LVYEYVPN---RSLDQILFVKNTIHILSWQQRFTIICG 405
                  L   +     L    +V EY+       L+Q    +    +  +Q        
Sbjct: 71  LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQ-------- 122

Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPD---KTHVSTGI 461
              GL ++H  +   ++HRD+K +N+ ++ E L  KI DFGLAR V P    K ++S G+
Sbjct: 123 LLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL 179

Query: 462 AGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGR 498
             T  Y +P  L+     T+  D++A G +  E+ +G+
Sbjct: 180 V-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 78.2 bits (192), Expect = 6e-16
 Identities = 71/272 (26%), Positives = 125/272 (45%), Gaps = 28/272 (10%)

Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRL-FFNSRQWVDQFFNEVNLISGIQH 353
           + F    ++G+G  G VF+G   D R    +A+K +    +   ++    E+ ++S    
Sbjct: 4   ELFTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 61

Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
             V +  G  ++G +  ++ EY+   S   +L            Q  T++    +GL +L
Sbjct: 62  PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEF----QIATMLKEILKGLDYL 117

Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H     K IHRDIK +N+LL E+   K+ADFG+A  +   +   +T   GT  +MAPE +
Sbjct: 118 HSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVI 173

Query: 474 VRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG 533
            +     KAD+++ G+  IE+A G       E  +S +H +   +    I ++  P LTG
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKG-------EPPNSDMHPMRVLF---LIPKNNPPTLTG 223

Query: 534 RFPENEASRVLQIGLLCTQAPVALRPSMAEVV 565
            F +       +    C     + RP+  E++
Sbjct: 224 EFSKP----FKEFIDACLNKDPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 77.7 bits (192), Expect = 6e-16
 Identities = 50/173 (28%), Positives = 78/173 (45%), Gaps = 25/173 (14%)

Query: 338 VDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL-LVYEYVPNRSLDQIL-----FVKNTI 391
           VDQ   E +++S  Q   VV+L   S +G ++L LV EY+P   L  +L       ++  
Sbjct: 37  VDQVLTERDILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVA 95

Query: 392 HILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA---- 447
            I   +            L +LH      IIHRD+K  NIL+D     K+ DFGL+    
Sbjct: 96  RIYIAE--------IVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGL 144

Query: 448 --RHVAPDKTHVSTG-IAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             R +  +        I GT  Y+APE ++    ++  D ++ G ++ E   G
Sbjct: 145 VRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.0 bits (193), Expect = 7e-16
 Identities = 53/202 (26%), Positives = 94/202 (46%), Gaps = 10/202 (4%)

Query: 298 DFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKN 355
           + F     +G+G  G V++       + +A+K +    +   ++    E+  +S  +   
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           + +  G  ++G +  ++ EY    S   +L        L       I+     GL +LH 
Sbjct: 61  ITKYYGSFLKGSKLWIIMEYCGGGSCLDLL----KPGKLDETYIAFILREVLLGLEYLHE 116

Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
                 IHRDIK +NILL E+   K+ADFG++  +    +  +T   GT  +MAPE + +
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-FVGTPFWMAPEVIKQ 172

Query: 476 GQLTEKADVYAFGVLVIEVASG 497
               EKAD+++ G+  IE+A G
Sbjct: 173 SGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 77.6 bits (191), Expect = 7e-16
 Identities = 63/270 (23%), Positives = 115/270 (42%), Gaps = 29/270 (10%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           ++LG G  G V  G       +A+K +   +    + F  E  ++  + H  +V+L G  
Sbjct: 10  KELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
            +     +V E++ N  L  + +++     LS     ++     EG+ +L   S    IH
Sbjct: 69  TQQKPLYIVTEFMENGCL--LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIH 123

Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD+   N L+      K++DFG+ R+V  D+   S+G    + +  PE     + + K+D
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183

Query: 484 VYAFGVLVIEVASGRRNSVFSEG-----SSSVLHTVWKHYKANRITQSMDPGLTGRFPEN 538
           V++FGVL+ E        VF+EG       S    V    +  R+ +          P+ 
Sbjct: 184 VWSFGVLMWE--------VFTEGKMPFEKKSNYEVVEMISRGFRLYR----------PKL 225

Query: 539 EASRVLQIGLLCTQAPVALRPSMAEVVHML 568
            +  V ++   C       RP+ AE++  +
Sbjct: 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 76.5 bits (188), Expect = 3e-15
 Identities = 51/182 (28%), Positives = 90/182 (49%), Gaps = 20/182 (10%)

Query: 341 FFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVK------------ 388
           F  EV ++S ++  N++RLLG  ++     ++ EY+ N  L+Q L               
Sbjct: 66  FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125

Query: 389 ----NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADF 444
               + +  +S+     +    A G+ +L   S +  +HRD+ T N L+ E LT KIADF
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADF 182

Query: 445 GLARHV-APDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVF 503
           G++R++ A D   +       + +MA E ++ G+ T  +DV+AFGV + E+    +   +
Sbjct: 183 GMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242

Query: 504 SE 505
            E
Sbjct: 243 GE 244

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 76.4 bits (188), Expect = 3e-15
 Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 15/203 (7%)

Query: 304 RKLGQGGAGSVFRGTL------PDGRNIAVKRLFFNSRQWVDQ-FFNEVNLISGI-QHKN 355
           + LG G  G V   T            +AVK L   +     +   +E+ ++S +  H+N
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100

Query: 356 VVRLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH 414
           +V LLG C+I GP  L++ EY     L   L  +     L+ +   +     A+G+A L 
Sbjct: 101 IVNLLGACTIGGP-ILVITEYCCYGDLLNFLR-RKRESFLTLEDLLSFSYQVAKGMAFLA 158

Query: 415 GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG-TLGYMAPEYL 473
             +    IHRD+   N+LL      KI DFGLAR +  D  +V  G A   + +MAPE +
Sbjct: 159 SKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215

Query: 474 VRGQLTEKADVYAFGVLVIEVAS 496
                T ++DV+++G+L+ E+ S
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 75.6 bits (186), Expect = 4e-15
 Identities = 39/97 (40%), Positives = 52/97 (53%), Gaps = 9/97 (9%)

Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGI 461
           IICG    L HLH     +I++RD+K  N+LLD+    +I+D GLA  +   K     G 
Sbjct: 104 IICG----LEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGR 154

Query: 462 AGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           AGT GYMAPE L         D +A G  + E+ +GR
Sbjct: 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 75.3 bits (185), Expect = 4e-15
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 33/205 (16%)

Query: 310 GAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQ------FFNEVNLISGIQHKNVVRLLGCS 363
            A  V  GTL     +AVK++ +      +Q         E+ L++ + H +++R+LG +
Sbjct: 18  QARDVKTGTL-----MAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT 72

Query: 364 IEGPESLLVYEYVPNRSLDQILF----VKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            E     L  E++   S+  +L      K  + I   +Q    +     GL++LH     
Sbjct: 73  CEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQ----LL---RGLSYLHEN--- 122

Query: 420 KIIHRDIKTSNILLDEK-LTPKIADFGLARHVAPDKTHVSTG-----IAGTLGYMAPEYL 473
           +IIHRD+K +N+L+D      +IADFG A  +A   T    G     + GT+ +MAPE L
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT--GAGEFQGQLLGTIAFMAPEVL 180

Query: 474 VRGQLTEKADVYAFGVLVIEVASGR 498
              Q     DV++ G ++IE+A+ +
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 76.6 bits (188), Expect = 5e-15
 Identities = 53/157 (33%), Positives = 75/157 (47%), Gaps = 21/157 (13%)

Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG-TLGYMAPEYLVRGQL 478
           K IHRD+   NILL E    KI DFGLAR +  D  +V  G A   L +MAPE +     
Sbjct: 199 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 258

Query: 479 TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS----MDPGLTGR 534
           T ++DV++FGVL+ E        +FS G+S         Y   +I +     +  G   R
Sbjct: 259 TIQSDVWSFGVLLWE--------IFSLGASP--------YPGVKIDEEFCRRLKEGTRMR 302

Query: 535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            P+     + Q  L C     + RP+ +E+V  L N+
Sbjct: 303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 75.4 bits (185), Expect = 5e-15
 Identities = 72/280 (25%), Positives = 128/280 (45%), Gaps = 36/280 (12%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNI----AVKRLFFNSRQWVD-QFFNEVNLISGIQHKNVV 357
           + LG G  G+V++G  +PDG N+    A+K L  N+    + +  +E  +++G+    V 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 358 RLLGCSIEGPESLLVYEYVPNRSL-DQILFVKNTI---HILSWQQRFTIICGTAEGLAHL 413
           RLLG  +     L V + +P   L D +   K+ I    +L+W  +       A+G+++L
Sbjct: 73  RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYL 125

Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT--HVSTGIAGTLGYMAPE 471
                ++++HRD+   N+L+      KI DFGLAR +  D+T  H   G    + +MA E
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV-PIKWMALE 181

Query: 472 YLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL 531
            ++  + T ++DV+++GV V E        + + G+       +    A  I   ++ G 
Sbjct: 182 SILHRRFTHQSDVWSYGVTVWE--------LMTFGAKP-----YDGIPAREIPDLLEKGE 228

Query: 532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
               P      V  I + C       RP   E+V   + +
Sbjct: 229 RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 75.8 bits (187), Expect = 5e-15
 Identities = 50/165 (30%), Positives = 83/165 (50%), Gaps = 12/165 (7%)

Query: 341 FFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQIL--------FVKNTIH 392
           F  EV ++S +   N+ RLLG     P   ++ EY+ N  L+Q L         +     
Sbjct: 66  FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125

Query: 393 ILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-A 451
            LS+     +    A G+ +L     +  +HRD+ T N L+ +  T KIADFG++R++ +
Sbjct: 126 SLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182

Query: 452 PDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
            D   V       + +MA E ++ G+ T K+DV+AFGV + E+ +
Sbjct: 183 SDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 75.5 bits (185), Expect = 5e-15
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 14/204 (6%)

Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRL-FFNSRQWVDQFFNEVNLISGIQH 353
           + F    K+G+G  G VF+G   D R    +A+K +    +   ++    E+ ++S    
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 61

Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
             V +  G  ++  +  ++ EY+   S   +L        L   Q  TI+    +GL +L
Sbjct: 62  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYL 117

Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H     K IHRDIK +N+LL E    K+ADFG+A  +  D         GT  +MAPE +
Sbjct: 118 HSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNTFVGTPFWMAPEVI 173

Query: 474 VRGQLTEKADVYAFGVLVIEVASG 497
            +     KAD+++ G+  IE+A G
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 7e-15
 Identities = 59/224 (26%), Positives = 97/224 (43%), Gaps = 29/224 (12%)

Query: 293 LERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI 351
           L   T  F+    +G+G  G V++      G+ +A+K +     +  ++   E N++   
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKY 59

Query: 352 -QHKNVVRLLGC------SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFT--- 401
             H N+    G            +  LV E     S+  +  VK         +R     
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDL--VKGL---RKKGKRLKEEW 114

Query: 402 ---IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS 458
              I+  T  GLA+LH     K+IHRDIK  NILL +    K+ DFG++  +       +
Sbjct: 115 IAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN 171

Query: 459 TGIAGTLGYMAPEYLVRGQLTE-----KADVYAFGVLVIEVASG 497
           T I GT  +MAPE +   +  +     ++DV++ G+  IE+A G
Sbjct: 172 TFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 74.8 bits (184), Expect = 7e-15
 Identities = 55/221 (24%), Positives = 95/221 (42%), Gaps = 28/221 (12%)

Query: 290 YEILERATDFFDNSRKLGQGGAGSVF--RGTLPDGRNIAVKRLFFN----------SRQW 337
           Y +LE           LG G  G V+  R        +A+K +  +            + 
Sbjct: 2   YAVLEH----------LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKS 51

Query: 338 VDQFFNEVNLI-SGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSL-DQILFVKNTIHILS 395
           +    +EV +I   ++H N+VR     +E     +V + +    L +    +K      +
Sbjct: 52  IGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT 111

Query: 396 WQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT 455
            ++ + I       L +LH     +I+HRD+  +NI+L E     I DFGLA+   P+  
Sbjct: 112 EERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK 169

Query: 456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
              T + GT+ Y  PE +      EKADV+AFG ++ ++ +
Sbjct: 170 --LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 56/214 (26%), Positives = 105/214 (49%), Gaps = 26/214 (12%)

Query: 305 KLGQGGAGSVFRGTL-----PDGRNIAVKRL--FFNSRQWVDQFFNEVNLISGIQHKNVV 357
           +LG+   G +++G L        + +A+K L    N +QW + F  E +L++ + H N+V
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE-FQQEASLMAELHHPNIV 70

Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKN-------------TIHI-LSWQQRFTII 403
            LLG   +     +++EY+    L + L +++             T+   L       I 
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIA 462
              A G+ +L   S    +H+D+   NIL+ E+L  KI+D GL+R + + D   V     
Sbjct: 131 IQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
             + +M PE ++ G+ +  +D+++FGV++ E+ S
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 75.0 bits (184), Expect = 1e-14
 Identities = 60/198 (30%), Positives = 103/198 (52%), Gaps = 12/198 (6%)

Query: 305 KLGQGGAGSVFRGTLPDGRN-IAVKRLFFNSRQWVD-QFFNEVNLISGIQHKNVVRLLGC 362
           KLG+G   +VF+G      N +A+K +     +        EV+L+  ++H N+V L   
Sbjct: 13  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 363 SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
                   LV+EY+ ++ L Q  ++ +  +I+S       +     GLA+ H     K++
Sbjct: 73  VHTDKSLTLVFEYL-DKDLKQ--YMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVL 126

Query: 423 HRDIKTSNILLDEKLTPKIADFGLAR-HVAPDKTHVSTGIAGTLGYMAPEYLV-RGQLTE 480
           HRD+K  N+L++E+   K+ADFGLAR    P KT+ +  +  TL Y  P+ L+   + + 
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYST 184

Query: 481 KADVYAFGVLVIEVASGR 498
           + D++  G +  E+ASGR
Sbjct: 185 QIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 74.0 bits (181), Expect = 1e-14
 Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 24/203 (11%)

Query: 306 LGQGGAGSVFRGTLPD-GRNIAVKRLFFN-----SRQWVDQFFNEVNLISGIQHKNVVRL 359
           LGQG  G V+     D GR +A K++ F+     + + V     E+ L+  +QH+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 360 LGCSIE-GPESLLVY-EYVPNRSL-DQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
            GC  +   ++L ++ EY+P  S+ DQ+         ++ +    I+    EG+++LH  
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EGMSYLHSN 125

Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG-----IAGTLGYMAPE 471
               I+HRDIK +NIL D     K+ DFG ++ +   +T   +G     + GT  +M+PE
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRL---QTICMSGTGIRSVTGTPYWMSPE 179

Query: 472 YLVRGQLTEKADVYAFGVLVIEV 494
            +       KADV++ G  V+E+
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 13/200 (6%)

Query: 303 SRKLGQGGAGSVFRGTL----PDGRNIAVKRLFFNSRQWVDQ-FFNEVNLISGIQHKNVV 357
            R +G+G  G V++G       +   +AVK     +   V + F  E  ++    H ++V
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFV-KNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +L+G   E P   +V E  P   L   L V K ++ + S       +  TA  LA+L   
Sbjct: 71  KLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLS-TA--LAYLES- 125

Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG 476
              + +HRDI   N+L+      K+ DFGL+R++  +  + ++     + +MAPE +   
Sbjct: 126 --KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183

Query: 477 QLTEKADVYAFGVLVIEVAS 496
           + T  +DV+ FGV + E+  
Sbjct: 184 RFTSASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 74.9 bits (184), Expect = 1e-14
 Identities = 53/157 (33%), Positives = 75/157 (47%), Gaps = 21/157 (13%)

Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG-TLGYMAPEYLVRGQL 478
           K IHRD+   NILL E    KI DFGLAR +  D  +V  G A   L +MAPE +     
Sbjct: 193 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVY 252

Query: 479 TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRIT----QSMDPGLTGR 534
           T ++DV++FGVL+ E        +FS G+S         Y   +I     + +  G   R
Sbjct: 253 TTQSDVWSFGVLLWE--------IFSLGASP--------YPGVQIDEEFCRRLKEGTRMR 296

Query: 535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            PE     +  I L C       RP+ +E+V +L ++
Sbjct: 297 APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 62/208 (29%), Positives = 109/208 (52%), Gaps = 19/208 (9%)

Query: 299 FFDNSRKLGQGGAGSVFRGTL-PDGRN----IAVKRLFFNSR-QWVDQFFNEVNLISGIQ 352
           F    R LG+G  G V      P+G N    +AVK L   S    +     E+ ++  + 
Sbjct: 5   FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 64

Query: 353 HKNVVRLLG-CSIEGPESL-LVYEYVPNRSLDQILFVKNTIHI-LSWQQRFTI-ICGTAE 408
           H+N+V+  G C+ +G   + L+ E++P+ SL + L  +N   I L  Q ++ + IC   +
Sbjct: 65  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQIC---K 120

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH--VSTGIAGTLG 466
           G+ +L  GS  + +HRD+   N+L++ +   KI DFGL + +  DK +  V   +   + 
Sbjct: 121 GMDYL--GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF 177

Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEV 494
           + APE L++ +    +DV++FGV + E+
Sbjct: 178 WYAPECLIQSKFYIASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 76.0 bits (187), Expect = 3e-14
 Identities = 53/171 (30%), Positives = 85/171 (49%), Gaps = 18/171 (10%)

Query: 340 QFFNEVNLISGIQHKNVVRLLGCSIEGPESLL-VYEYVPNRSLDQILFVKNTIHILSWQQ 398
           +F  E  L + + H N+V LL      P  L  V+EYVP R+L ++L        L   +
Sbjct: 24  RFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL---AADGALPAGE 80

Query: 399 RFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEK-LTP--KIADFGL------ARH 449
              ++    + LA  H      I+HRD+K  NI++ +  + P  K+ DFG+       R 
Sbjct: 81  TGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRD 137

Query: 450 VAPDKTHVSTGIAGTLGYMAPEYLVRGQ-LTEKADVYAFGVLVIEVASGRR 499
                   +T + GT  Y APE L RG+ +T  +D+YA+G++ +E  +G+R
Sbjct: 138 ADVATLTRTTEVLGTPTYCAPEQL-RGEPVTPNSDLYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 57/197 (28%), Positives = 96/197 (48%), Gaps = 17/197 (8%)

Query: 306 LGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE 365
           +G+G  G V  G    G  +AVK +  ++      F  E ++++ ++H N+V+LLG  +E
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 366 GPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHR 424
               L +V EY+   SL   L  +    +L             E + +L   +    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126

Query: 425 DIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTL--GYMAPEYLVRGQLTEKA 482
           D+   N+L+ E    K++DFGL +  +      ST   G L   + APE L   + + K+
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREKKFSTKS 180

Query: 483 DVYAFGVLVIEVAS-GR 498
           DV++FG+L+ E+ S GR
Sbjct: 181 DVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 73.9 bits (181), Expect = 4e-14
 Identities = 63/231 (27%), Positives = 114/231 (49%), Gaps = 29/231 (12%)

Query: 290 YEILERATDFFDNSRKLGQGGAG---SVFRGTLPDGRNIAVKRLF--FNSRQWVDQFFNE 344
           + +L+R    +   + +G G  G   + F   L  G N+AVK+L   F ++    + + E
Sbjct: 17  FTVLKR----YQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRE 70

Query: 345 VNLISGIQHKNVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQR 399
           + L+  + HKN++ LL       S+E  + + +   + + +L Q++ ++     +S+   
Sbjct: 71  LVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLL- 129

Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVST 459
           + ++CG    + HLH      IIHRD+K SNI++    T KI DFGLAR    +   + T
Sbjct: 130 YQMLCG----IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMT 180

Query: 460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSV 510
               T  Y APE ++     E  D+++ G ++ E+  G   SV  +G+  +
Sbjct: 181 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG---SVIFQGTDHI 228

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 72.4 bits (177), Expect = 4e-14
 Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 18/208 (8%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNI---AVK--RLFFNSRQWVDQFFNEVNLISGIQHKNVVR 358
           + LG+G  GSV  G L    +I   AVK  ++   +R  ++ F +E   +    H NV+R
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 359 LLGCSIEG------PESLLVYEYVPNRSLDQILF---VKNTIHILSWQQRFTIICGTAEG 409
           L+G  ++       P  +++  ++ +  L   L    + +    L  Q     +   A G
Sbjct: 65  LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124

Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT-LGYM 468
           + +L   S    IHRD+   N +L+E +   +ADFGL++ +     +    IA   + ++
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181

Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVAS 496
           A E L     T K+DV++FGV + E+A+
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIAT 209

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 72.8 bits (179), Expect = 5e-14
 Identities = 80/293 (27%), Positives = 131/293 (44%), Gaps = 39/293 (13%)

Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSR--QWVDQF-FNEVNLISGIQHKN 355
           ++N   +G+G  G V +    + G+ +A+K+ F  S   + V +    E+ ++  ++H+N
Sbjct: 3   YENLGLVGEGSYGMVMKCKHKETGQIVAIKK-FLESEDDKMVKKIAMREIRMLKQLRHEN 61

Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQR-FTIICGTAEGLAHLH 414
           +V L+          LV+E+V +  LD +    N +     ++  F I+ G      H H
Sbjct: 62  LVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGI--EFCHSH 119

Query: 415 GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLV 474
                 IIHRDIK  NIL+ +    K+ DFG AR +A     V T    T  Y APE LV
Sbjct: 120 -----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYTDYVATRWYRAPELLV 173

Query: 475 RGQLTEKA-DVYAFGVLVIEVASGRRNSVFSEGSSSV--LHTVWK-------HYKA---- 520
                 +A D++A G LV E+ +G    +F  G S +  L+ + K        ++     
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTG--EPLFP-GDSDIDQLYHIIKCLGNLIPRHQEIFQK 230

Query: 521 NRITQSMD-------PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH 566
           N +   M          L  RFP+     VL +   C +     RPS ++++H
Sbjct: 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGL-VLDLAKQCLRIDPDDRPSSSQLLH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 72.4 bits (177), Expect = 5e-14
 Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 24/207 (11%)

Query: 306 LGQGGAGSVFRGTLPD-GRNIAVKRLFFN-----SRQWVDQFFNEVNLISGIQHKNVVRL 359
           LGQG  G V+     D GR +AVK++ F+     + + V+    E+ L+  + H+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 360 LGCSIEGPESLL--VYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
            GC  +  E  L    E++P  S+ DQ+         ++ +    I+    EG+++LH  
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGVSYLHSN 125

Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG-----IAGTLGYMAPE 471
               I+HRDIK +NIL D     K+ DFG ++ +   +T   +G     + GT  +M+PE
Sbjct: 126 ---MIVHRDIKGANILRDSVGNVKLGDFGASKRL---QTICLSGTGMKSVTGTPYWMSPE 179

Query: 472 YLVRGQLTEKADVYAFGVLVIEVASGR 498
            +       KAD+++ G  V+E+ + +
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 5e-14
 Identities = 61/202 (30%), Positives = 90/202 (44%), Gaps = 39/202 (19%)

Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFF-NSRQWVDQF-FNEVNLISGIQ---HKNVVRL 359
           +G+G  G+V++   L  GR +A+K++    S + +      E+ L+  ++   H N+VRL
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66

Query: 360 L----GCSIEGPESL-LVYEYVPNRSLDQIL-------FVKNTIHILSWQQRFTIICGTA 407
           L    G   +    L LV+E+V ++ L   L           TI  L  Q          
Sbjct: 67  LDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQ--------LL 117

Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGY 467
            G+  LH     +I+HRD+K  NIL+      KIADFGLAR          T +  TL Y
Sbjct: 118 RGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTSVVVTLWY 172

Query: 468 MAPEYLVRGQLTEKADVYAFGV 489
            APE L++         YA  V
Sbjct: 173 RAPEVLLQ-------SSYATPV 187

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 72.0 bits (176), Expect = 7e-14
 Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 23/209 (11%)

Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFF------NSRQWVDQFFNEVNLISGIQ 352
           F   +K+G+G    V+R T L D + +A+K++         +RQ       E++L+  + 
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQLN 60

Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQ-ILFVKNTIHILS----WQQRFTIICGTA 407
           H NV++ L   IE  E  +V E      L Q I + K    ++     W+  F  +C   
Sbjct: 61  HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY-FVQLCSAV 119

Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGY 467
           E   H+H     +++HRDIK +N+ +      K+ D GL R  +  KT  +  + GT  Y
Sbjct: 120 E---HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYY 172

Query: 468 MAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
           M+PE +       K+D+++ G L+ E+A+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAA 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 72.8 bits (178), Expect = 8e-14
 Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 36/218 (16%)

Query: 298 DFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + + N   +G G  GSV        G  +AVK+L   F S     + + E+ L+  ++H+
Sbjct: 17  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76

Query: 355 NVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QRFT------ 401
           NV+ LL              + P RSL++   V    H++          Q+ T      
Sbjct: 77  NVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF 124

Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGI 461
           +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +     TG 
Sbjct: 125 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGY 177

Query: 462 AGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
             T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 178 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 71.8 bits (176), Expect = 9e-14
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 15/195 (7%)

Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           LG G  G+V++   L   R +AVK +  + + +   Q  +E+ ++       ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
                  +  E++   SLD  ++ K   H+L       I     +GL +L     +KI+H
Sbjct: 69  FVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWS---LKILH 118

Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD+K SN+L++ +   K+ DFG++  +      ++    GT  YMAPE +   Q    +D
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTYVGTNAYMAPERISGEQYGIHSD 175

Query: 484 VYAFGVLVIEVASGR 498
           V++ G+  +E+A GR
Sbjct: 176 VWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 11/203 (5%)

Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL----FFNSRQWVDQFFNEVNLISGIQHK 354
           F   +K+G+G    V+R T L DG  +A+K++      +++   D    E++L+  + H 
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARAD-CIKEIDLLKQLNHP 62

Query: 355 NVVRLLGCSIEGPESLLVYEYVPNRSLDQIL-FVKNTIHILSWQQRFTIICGTAEGLAHL 413
           NV++     IE  E  +V E      L +++   K    ++  +  +         L H+
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H     +++HRDIK +N+ +      K+ D GL R  +  KT  +  + GT  YM+PE +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI 178

Query: 474 VRGQLTEKADVYAFGVLVIEVAS 496
                  K+D+++ G L+ E+A+
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAA 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 72.2 bits (178), Expect = 1e-13
 Identities = 70/238 (29%), Positives = 114/238 (47%), Gaps = 42/238 (17%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLF--FNSRQWVDQFFN 343
           KYEIL          +KLG+G  G V++    D R    +A+K++F  F +     + F 
Sbjct: 8   KYEIL----------QKLGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFR 55

Query: 344 EVNLISGI-QHKNVVRLLGC--SIEGPESLLVYEYVPNRSLDQILFV---KNTIHILSWQ 397
           E+  +  +  H N+V+LL    +    +  LV+EY     ++  L      N   IL   
Sbjct: 56  EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEY-----METDLHAVIRAN---ILEDV 107

Query: 398 QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA----PD 453
            +  I+    + L ++H G    +IHRD+K SNILL+     K+ADFGLAR ++      
Sbjct: 108 HKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP 164

Query: 454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKA-DVYAFGVLVIEVASGRRNSVFSEGSSSV 510
           +  V T    T  Y APE L+      K  D+++ G ++ E+  G+   +F  G+S++
Sbjct: 165 ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK--PLF-PGTSTL 219

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 19/201 (9%)

Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVD-QFFNEVN----LISGIQHKNVVRL 359
           LG G  G+V +G  +P+G +I +       +     Q F E+      +  + H  +VRL
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 360 LG-CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL--HGG 416
           LG C   G    LV +  P  SL     V+     L  Q+        A+G+ +L  H  
Sbjct: 75  LGICP--GASLQLVTQLSPLGSLLD--HVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR- 129

Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVSTGIAGTLGYMAPEYLVR 475
               ++HR++   NILL      +IADFG+A  + P DK +  +     + +MA E ++ 
Sbjct: 130 ----MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF 185

Query: 476 GQLTEKADVYAFGVLVIEVAS 496
           G+ T ++DV+++GV V E+ S
Sbjct: 186 GRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 10/202 (4%)

Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRL--FFNSRQWVDQFFNEVNLISGIQHKN 355
           + F    ++G+G  G V++G     + +   ++     +   ++    E+ ++S      
Sbjct: 4   ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63

Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           + R  G  ++G +  ++ EY+   S   +L        L      TI+    +GL +LH 
Sbjct: 64  ITRYYGSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHS 119

Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               + IHRDIK +N+LL E+   K+ADFG+A  +   +   +T   GT  +MAPE + +
Sbjct: 120 E---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQ 175

Query: 476 GQLTEKADVYAFGVLVIEVASG 497
                KAD+++ G+  IE+A G
Sbjct: 176 SAYDFKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 69/205 (33%), Positives = 107/205 (52%), Gaps = 27/205 (13%)

Query: 306 LGQGGAGSVF---RGTLPD-GRNIAVKRLFFNSRQWVDQF--FNEVNLISGIQHKNVVRL 359
           LGQG  G VF   + T PD G+  A+K L   + +  D+     E ++++ + H  +V+L
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 360 -LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFT------IICGTAEGLAH 412
                 EG +  L+ +++  R  D  LF +     LS +  FT       +   A  L H
Sbjct: 64  HYAFQTEG-KLYLILDFL--RGGD--LFTR-----LSKEVMFTEEDVKFYLAELALALDH 113

Query: 413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEY 472
           LH    + II+RD+K  NILLDE+   K+ DFGL++  + D    +    GT+ YMAPE 
Sbjct: 114 LHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPEV 169

Query: 473 LVRGQLTEKADVYAFGVLVIEVASG 497
           + R   T+ AD ++FGVL+ E+ +G
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 72.3 bits (178), Expect = 1e-13
 Identities = 65/219 (29%), Positives = 98/219 (44%), Gaps = 38/219 (17%)

Query: 298 DFFDNSRKLGQGGAGSV----FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGI 351
           D + N   +G G  G V       T   GR +A+K+L   F S     + + E+ L+  +
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKT---GRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM 71

Query: 352 QHKNVVRLLGC-----SIEGPESLLVYEYVP--NRSLDQIL----FVKNTIHILSWQQRF 400
            H+NV+ LL       S+E  +   VY         L+ I+       + I  L +Q   
Sbjct: 72  DHENVIGLLDVFTPASSLEDFQD--VYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQ--- 126

Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG 460
            I+     GL ++H      IIHRD+K SNI ++E    KI DFGLARH         TG
Sbjct: 127 -IL----RGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARH----TDDEMTG 174

Query: 461 IAGTLGYMAPE-YLVRGQLTEKADVYAFGVLVIEVASGR 498
              T  Y APE  L      +  D+++ G ++ E+ +G+
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 61/199 (30%), Positives = 103/199 (51%), Gaps = 14/199 (7%)

Query: 305 KLGQGGAGSVFRGTLPDGRN-IAVKRLFFNSRQWVD-QFFNEVNLISGIQHKNVVRLLGC 362
           KLG+G   +VF+G      N +A+K +     +        EV+L+  ++H N+V L   
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 363 SIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
            I     L LV+EY+ +   D   ++ N  +++S       +     GL++ H     KI
Sbjct: 72  -IHTERCLTLVFEYLDS---DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KI 124

Query: 422 IHRDIKTSNILLDEKLTPKIADFGLAR-HVAPDKTHVSTGIAGTLGYMAPEYLV-RGQLT 479
           +HRD+K  N+L++EK   K+ADFGLAR    P KT+ +  +  TL Y  P+ L+   + +
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEYS 182

Query: 480 EKADVYAFGVLVIEVASGR 498
              D++  G ++ E+A+GR
Sbjct: 183 TPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 70.7 bits (173), Expect = 1e-13
 Identities = 50/165 (30%), Positives = 84/165 (50%), Gaps = 21/165 (12%)

Query: 343 NEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQI-------LFVKNTIHILS 395
           NE  ++  + H N++      +E    ++V EY P  +L +        L  ++TI    
Sbjct: 48  NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTI---- 103

Query: 396 WQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE-KLTPKIADFGLARHVAPDK 454
               F  I      L H+H      I+HRD+KT NILLD+ K+  KI DFG+++ ++  K
Sbjct: 104 -LHFFVQIL---LALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SK 155

Query: 455 THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRR 499
           +   T + GT  Y++PE        +K+D++A G ++ E+AS +R
Sbjct: 156 SKAYT-VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 40/213 (18%)

Query: 305 KLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQWVDQ-----FFNEVNLISGIQHKNVVR 358
           K+G+G  G V++      G  +A+K++   +    D+        E++L+  + H N+VR
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETE---DEGVPSTAIREISLLKELNHPNIVR 62

Query: 359 LLGCSIEGPESLLVYEY-----------VPNRSLDQILFVKNTIHILSWQQRFTIICGTA 407
           LL       +  LV+E+            P   LD  L       +L             
Sbjct: 63  LLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQ------------ 110

Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLG 466
            G+A+ H     +++HRD+K  N+L+D +   K+ADFGLAR    P +T+    +  TL 
Sbjct: 111 -GIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLW 164

Query: 467 YMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
           Y APE L+   Q +   D+++ G +  E+ + R
Sbjct: 165 YRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 71.5 bits (175), Expect = 2e-13
 Identities = 82/294 (27%), Positives = 130/294 (44%), Gaps = 44/294 (14%)

Query: 304 RKLGQGGAGSVFR----GTLPDGRN----IAVKRLFFN-SRQWVDQFFNEVNLISGI-QH 353
           + LG+G  G V R    G      +    +AVK L  N + + +    +E+ L+  I +H
Sbjct: 18  KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77

Query: 354 KNVVRLLG-CSIEGPESLLVYEYVPNRSLDQIL-------------FVKNTIHILSWQQR 399
           KN++ LLG C+ EGP  ++V EY    +L + L               K     LS++  
Sbjct: 78  KNIINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136

Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVS 458
            +     A G+ +L      + IHRD+   N+L+ E    KIADFGLAR V   D    +
Sbjct: 137 VSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193

Query: 459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT-VWKH 517
           +     + +MAPE L     T ++DV++FG+L+ E        +F+ G S      V + 
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWE--------IFTLGGSPYPGIPVEEL 245

Query: 518 YKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +K  R    MD       P N    +  +   C  A    RP+  ++V  L+ +
Sbjct: 246 FKLLREGHRMDK------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 27/217 (12%)

Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +EI  R  D     + +G G  G V        G+N+A+K++   F++     + + E+ 
Sbjct: 6   FEITNRYVDL----QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61

Query: 347 LISGIQHKNVVRLLGCSIEGPESL-LVYEYVP---NRSLDQILFVKNTIHILSWQQRFTI 402
           L+  ++H+N++ L    I   E +  V E +    +R L      K  I    +Q     
Sbjct: 62  LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQ----- 116

Query: 403 ICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIA 462
                 GL ++H      ++HRD+K SNIL++E    KI DFGLAR     +    TG  
Sbjct: 117 ---ILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR----IQDPQMTGYV 166

Query: 463 GTLGYMAPEYLVRGQ-LTEKADVYAFGVLVIEVASGR 498
            T  Y APE ++  Q    + D+++ G +  E+  G+
Sbjct: 167 STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 70.7 bits (173), Expect = 2e-13
 Identities = 49/171 (28%), Positives = 88/171 (51%), Gaps = 15/171 (8%)

Query: 333 NSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQIL------- 385
           N+R   + F  E+ ++S ++  N++RLL   I      ++ EY+ N  L+Q L       
Sbjct: 61  NAR---NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQE 117

Query: 386 -FVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADF 444
              K  +  +S+     +    A G+ +L   S +  +HRD+ T N L+ +  T KIADF
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADF 174

Query: 445 GLARHVAPDKTHVSTGIAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEV 494
           G++R++     +   G A   + +M+ E ++ G+ T  +DV+AFGV + E+
Sbjct: 175 GMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 70.9 bits (174), Expect = 3e-13
 Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 35/211 (16%)

Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFF-NSRQWVD-QFFNEVNLISGIQHKNV 356
           F+   ++G+G  G V+R      G  +A+K++   N R  +      E+ L+  ++H N+
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68

Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFV------------KNTIHILSWQQRFTIIC 404
           V L              E V  + LD I  V             N     S  Q   ++ 
Sbjct: 69  VELK-------------EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLML 115

Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT 464
               GL +LH      IIHRD+K SN+LL +K   KIADFGLAR        ++  +  T
Sbjct: 116 QLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-T 171

Query: 465 LGYMAPEYLVRGQL--TEKADVYAFGVLVIE 493
           L Y APE L+ G    T   D++A G ++ E
Sbjct: 172 LWYRAPE-LLLGCTTYTTAIDMWAVGCILAE 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 70.3 bits (172), Expect = 3e-13
 Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 19/206 (9%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIA---VKRLFFNSR-QWVDQFFNEVNLISGIQHKNVVRL 359
            ++G G  G V  G    G + A   VK L  ++       F  EV     + H NV++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTII---CGTAEGLAHLHGG 416
           LG  IE    LLV E+ P   L   L   N   +    Q+  +    C  A GL  LH  
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQRMACEVASGLLWLH-- 117

Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG-IAGTLGYMAPEYL-V 474
                IH D+   N  L   L+ KI D+GLA    P+  +++    A  L ++APE + +
Sbjct: 118 -QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176

Query: 475 RGQ------LTEKADVYAFGVLVIEV 494
           RGQ       T+K+++++ GV + E+
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 70.7 bits (173), Expect = 4e-13
 Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 11/197 (5%)

Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHKNVVRLLGC 362
           +G G  GSV        G  +A+K+L   F S  +  + + E+ L+  +QH+NV+ LL  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 363 SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
                      ++       Q    K   H LS  +   ++     GL ++H      II
Sbjct: 83  FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---II 139

Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG-QLTEK 481
           HRD+K  N+ ++E    KI DFGLARH   +     TG   T  Y APE ++      + 
Sbjct: 140 HRDLKPGNLAVNEDCELKILDFGLARHADAEM----TGYVVTRWYRAPEVILNWMHYNQT 195

Query: 482 ADVYAFGVLVIEVASGR 498
            D+++ G ++ E+ +G+
Sbjct: 196 VDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 70.0 bits (171), Expect = 4e-13
 Identities = 57/187 (30%), Positives = 95/187 (50%), Gaps = 21/187 (11%)

Query: 325 IAVKRLFFN-SRQWVDQFFNEVNLISGI-QHKNVVRLLG-CSIEGPESLLVYEYVPNRSL 381
           +AVK L  + + + +    +E+ ++  I +HKN++ LLG C+ +GP  ++V EY    +L
Sbjct: 53  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIV-EYASKGNL 111

Query: 382 DQILFVK-------------NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKT 428
            + L  +                  LS++   +     A G+ +L   +  K IHRD+  
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 168

Query: 429 SNILLDEKLTPKIADFGLARHVAP-DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAF 487
            N+L+ E    KIADFGLAR +   D    +T     + +MAPE L     T ++DV++F
Sbjct: 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 228

Query: 488 GVLVIEV 494
           GVL+ E+
Sbjct: 229 GVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 69.6 bits (171), Expect = 6e-13
 Identities = 60/200 (30%), Positives = 90/200 (45%), Gaps = 44/200 (22%)

Query: 295 RATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQF----FNEVNLIS 349
           R+ D ++   ++ +G  G V+R      G  +A+K+L     +  + F      E+N++ 
Sbjct: 2   RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK--EGFPITSLREINILL 59

Query: 350 GIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI-HIL-----SWQQRFTII 403
            +QH N+V              V E V   +LD+I  V   + H L     + +Q F   
Sbjct: 60  KLQHPNIVT-------------VKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQ- 105

Query: 404 CGTAE----------GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
              +E          G+AHLH      I+HRD+KTSN+LL+ +   KI DFGLAR     
Sbjct: 106 ---SEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY-GS 158

Query: 454 KTHVSTGIAGTLGYMAPEYL 473
                T +  TL Y APE L
Sbjct: 159 PLKPYTQLVVTLWYRAPELL 178

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 68.8 bits (168), Expect = 8e-13
 Identities = 55/186 (29%), Positives = 84/186 (45%), Gaps = 28/186 (15%)

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           GL H+H      +++RD+K +NILLDE    +I+D GLA   +  K H S    GT GYM
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162

Query: 469 APEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM 527
           APE L +G      AD ++ G ++ ++  G  +S F +  +   H +      +R+T +M
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRG--HSPFRQHKTKDKHEI------DRMTLTM 214

Query: 528 DPGLTGRFPENEASRVLQIGLLCTQAPVAL-----RPSMAEVVHMLNNIDYEI------P 576
              L   F      R L  GLL       L          +      ++D+++      P
Sbjct: 215 AVELPDSFSPE--LRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYP 272

Query: 577 PPKQPP 582
           PP  PP
Sbjct: 273 PPLIPP 278

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 68.5 bits (167), Expect = 8e-13
 Identities = 71/276 (25%), Positives = 123/276 (44%), Gaps = 27/276 (9%)

Query: 305 KLGQGGAGSVFRG---TLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +LG G  G+V +G        + +AVK L    N     D+   E N++  + +  +VR+
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
           +G   E    +LV E      L++  F++   H+   +    ++   + G+ +L   +  
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNK--FLQKNKHVTE-KNITELVHQVSMGMKYLEETN-- 115

Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT--LGYMAPEYLVRGQ 477
             +HRD+   N+LL  +   KI+DFGL++ +  D+ +      G   + + APE +   +
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174

Query: 478 LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE 537
            + K+DV++FGVL+ E         FS G        +K  K N +TQ ++ G     P+
Sbjct: 175 FSSKSDVWSFGVLMWE--------AFSYGQKP-----YKGMKGNEVTQMIESGERMECPQ 221

Query: 538 NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY 573
                +  +  LC    V  RP  A V   L N  Y
Sbjct: 222 RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYYY 257

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 69.4 bits (170), Expect = 9e-13
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 16/203 (7%)

Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRNI-AVKRLFFNSRQWVDQ---FFNEVNLISGIQHKN 355
           F    ++GQGG G VF     D   I A+KR+  +    +++      E ++++  + + 
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 356 VVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH 414
           +V+LL  + +  E L L  EYVP      +L     +       RF +    AE    + 
Sbjct: 63  LVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLS--EDHARFYM----AEMFEAVD 115

Query: 415 GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLV 474
               +  IHRD+K  N L+D     K+ DFGL++ +       +  + G+  YMAPE L 
Sbjct: 116 ALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI----VTYANSVVGSPDYMAPEVLR 171

Query: 475 RGQLTEKADVYAFGVLVIEVASG 497
                   D ++ G ++ E   G
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 69.7 bits (170), Expect = 1e-12
 Identities = 60/219 (27%), Positives = 109/219 (49%), Gaps = 26/219 (11%)

Query: 290 YEILERATDFFDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNE 344
           + +L+R    + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E
Sbjct: 20  FTVLKR----YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRE 73

Query: 345 VNLISGIQHKNVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQR 399
           + L+  + HKN++ LL       S+E  + + +   + + +L Q++ ++     +S+   
Sbjct: 74  LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL- 132

Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVST 459
           + ++CG    + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T
Sbjct: 133 YQMLCG----IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMT 183

Query: 460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
               T  Y APE ++     E  D+++ G ++ E+  G 
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 68/214 (31%), Positives = 98/214 (45%), Gaps = 33/214 (15%)

Query: 306 LGQGGAGSVFRGTLP-DGR--NIAVKRLF-FNSRQWVDQFFNEVNLISGI-QHKNVVRLL 360
           +G+G  G V R  +  DG   N A+K L  F S      F  E+ ++  +  H N++ LL
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 361 GCSIEGPESLLVYEYVPNRSLDQIL-----------FVKN--TIHILSWQQRFTIICGTA 407
           G         +  EY P  +L   L           F K   T   L+ QQ        A
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG- 466
            G+ +L   S  + IHRD+   N+L+ E L  KIADFGL+R    ++ +V      T+G 
Sbjct: 130 TGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG---EEVYVKK----TMGR 179

Query: 467 ----YMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
               +MA E L     T K+DV++FGVL+ E+ S
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 62/220 (28%), Positives = 108/220 (49%), Gaps = 30/220 (13%)

Query: 294 ERATDFFDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQF----FNEVNLI 348
           +R  D FD   ++G+G  G V++    D G  +A+K++  ++ +  + F      E+ ++
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKIL 60

Query: 349 SGIQHKNVVRLLGCSIEGPESL----------LVYEYVPNR---SLDQILFVKNTIHILS 395
             + H+N+V L     +  ++L          LV+EY+ +     L+  L   +  HI S
Sbjct: 61  RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120

Query: 396 WQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT 455
           + ++        EGL + H  +    +HRDIK SNILL+ K   K+ADFGLAR    +++
Sbjct: 121 FMKQLL------EGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171

Query: 456 HVSTGIAGTLGYMAPEYLV-RGQLTEKADVYAFGVLVIEV 494
              T    TL Y  PE L+   +     DV++ G ++ E+
Sbjct: 172 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 23/208 (11%)

Query: 300 FDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSR--QWVDQFFNEVNLISGIQHKNV 356
           ++  +K+G+G  G ++      D  +  +K +       +  +    EV L++ ++H N+
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61

Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQ-------ILFVKNTIHILSWQQRFTIICGTAEG 409
           V       E     +V EY     L +       +LF ++   ILSW   F  I   + G
Sbjct: 62  VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSED--QILSW---FVQI---SLG 113

Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEK-LTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           L H+H     KI+HRDIK+ NI L +  +  K+ DFG+AR    D   ++    GT  Y+
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYTCVGTPYYL 169

Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVAS 496
           +PE         K D+++ G ++ E+ +
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 76/269 (28%), Positives = 115/269 (42%), Gaps = 47/269 (17%)

Query: 300 FDNSRKLGQGGAGSV----FRGTLPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQ 352
           F   R LG+GG G V     R T   G+  A K+L       R+      NE  ++  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGESMALNEKQILEKVN 58

Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKN----TIHILSWQQ----RFTIIC 404
            + VV L             Y Y    +L  +L + N      HI    +        + 
Sbjct: 59  SRFVVSL------------AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF 106

Query: 405 GTAE---GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGI 461
             AE   GL  LH     +I++RD+K  NILLD+    +I+D GLA HV   +T    G 
Sbjct: 107 YAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGR 161

Query: 462 AGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN 521
            GT+GYMAPE +   + T   D +A G L+ E+ +G+  S F +    +     K  +  
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ--SPFQQRKKKI-----KREEVE 214

Query: 522 RITQSMDPGLTGRFPENEASRVLQIGLLC 550
           R+ + +    + +F  +  +R L   LLC
Sbjct: 215 RLVKEVQEEYSEKFSPD--ARSLCKMLLC 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 14/198 (7%)

Query: 305 KLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           +LG G  G V++    + G   A K +   S + ++ +  E+ +++   H  +V+LLG  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
               +  ++ E+ P  ++D I+   +    L+  Q   I     E L +LH    +KIIH
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHS---MKIIH 133

Query: 424 RDIKTSNILLDEKLTPKIADFGL-ARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTE-- 480
           RD+K  N+LL      K+ADFG+ A++V   +   S    GT  +MAPE ++   + +  
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMCETMKDTP 191

Query: 481 ---KADVYAFGVLVIEVA 495
              KAD+++ G+ +IE+A
Sbjct: 192 YDYKADIWSLGITLIEMA 209

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 72/265 (27%), Positives = 124/265 (46%), Gaps = 36/265 (13%)

Query: 325 IAVKRLFFNSRQW-VDQFFNEVNLISGI-QHKNVVRLLG-CSIEGPESLLVYEYVPNRSL 381
           +AVK L  ++ +  +    +E+ ++  I +HKN++ LLG C+ +GP  ++V EY    +L
Sbjct: 50  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV-EYASKGNL 108

Query: 382 DQILFVKNTIHI-------------LSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKT 428
            + L  +    +             ++++   +     A G+ +L   +  K IHRD+  
Sbjct: 109 REYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAA 165

Query: 429 SNILLDEKLTPKIADFGLARHVAP-DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAF 487
            N+L+ E    KIADFGLAR V   D    +T     + +MAPE L     T ++DV++F
Sbjct: 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 225

Query: 488 GVLVIEVASGRRNSVFSEGSSSVLHT-VWKHYKANRITQSMDPGLTGRFPENEASRVLQI 546
           GVL+ E        +F+ G S      V + +K  +    MD       P N  + +  +
Sbjct: 226 GVLMWE--------IFTLGGSPYPGIPVEELFKLLKEGHRMDK------PANCTNELYMM 271

Query: 547 GLLCTQAPVALRPSMAEVVHMLNNI 571
              C  A  + RP+  ++V  L+ I
Sbjct: 272 MRDCWHAIPSHRPTFKQLVEDLDRI 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 27/211 (12%)

Query: 306 LGQGGAGSVFRGTL-PDG--RNIAVKRLF-FNSRQWVDQFFNEVNLISGI-QHKNVVRLL 360
           +G+G  G V +  +  DG   + A+KR+  + S+     F  E+ ++  +  H N++ LL
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 361 GCSIEGPESLLVYEYVPNRSLDQIL-------------FVKNTIHILSWQQRFTIICGTA 407
           G         L  EY P+ +L   L                +T   LS QQ        A
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR--HVAPDKTHVSTGIAGTL 465
            G+ +L   S  + IHRD+   NIL+ E    KIADFGL+R   V   KT     +    
Sbjct: 135 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR--- 188

Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
            +MA E L     T  +DV+++GVL+ E+ S
Sbjct: 189 -WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 22/211 (10%)

Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLF-FNSRQWVDQFFNEVNLISGIQHKNVV 357
           + N   +G+G  G V   T  P G  +A+K++  F  + +  +   E+ ++   +H+N++
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66

Query: 358 RLLGCSIEGPESL-------LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGL 410
            +L   I  P S        +V E +    L +++  ++    LS       +     GL
Sbjct: 67  GIL--DIIRPPSFESFNDVYIVQELMET-DLYKLIKTQH----LSNDHIQYFLYQILRGL 119

Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS--TGIAGTLGYM 468
            ++H  +   ++HRD+K SN+LL+     KI DFGLAR   P+  H    T    T  Y 
Sbjct: 120 KYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYR 176

Query: 469 APEYLVRGQLTEKA-DVYAFGVLVIEVASGR 498
           APE ++  +   KA D+++ G ++ E+ S R
Sbjct: 177 APEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 55/202 (27%), Positives = 99/202 (49%), Gaps = 17/202 (8%)

Query: 305 KLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNVVRLLG 361
           K+G+G  G V++G     G+ +A+K++   S +         E++L+  +QH N+V L  
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 362 CSIEGPESLLVYEYVP---NRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
             ++     L++E++     + LD +   +     L     + I+    +G+   H    
Sbjct: 67  VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL----QGILFCHSR-- 120

Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLVRGQ 477
            +++HRD+K  N+L+D K   K+ADFGLAR    P    V T    TL Y APE L+   
Sbjct: 121 -RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VRVYTHEVVTLWYRAPEVLLGSP 177

Query: 478 L-TEKADVYAFGVLVIEVASGR 498
             +   D+++ G +  E+A+ +
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 53/205 (25%), Positives = 103/205 (50%), Gaps = 19/205 (9%)

Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLFFNSRQWVDQ-FFNEVNLISGIQH 353
           F   + LG G  G+V++G  +P+G  +    A+K L   +    ++   +E  +++ + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L+         LD +   K+ I   ++L+W  +       A+G+
Sbjct: 69  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 122

Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFGLA+ + A +K + + G    + +MA
Sbjct: 123 NYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179

Query: 470 PEYLVRGQLTEKADVYAFGVLVIEV 494
            E ++    T ++DV+++GV V E+
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 71/236 (30%), Positives = 109/236 (46%), Gaps = 34/236 (14%)

Query: 352 QHKNVVRLLG-CSIEGPESLLVYEYVPNRSLDQILFVK---------NTIHILSWQQRFT 401
           +HKN++ LLG C+ +GP  +LV EY    +L + L  +         +T  +   Q  F 
Sbjct: 76  KHKNIINLLGACTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134

Query: 402 --IICG--TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTH 456
             + C    A G+ +L   +  K IHRD+   N+L+ E    KIADFGLAR V   D   
Sbjct: 135 DLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK 191

Query: 457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT-VW 515
            +T     + +MAPE L     T ++DV++FGVL+ E        +F+ G S      V 
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWE--------IFTLGGSPYPGIPVE 243

Query: 516 KHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           + +K  +    MD       P N    +  I   C  A  + RP+  ++V  L+ +
Sbjct: 244 ELFKLLKEGHRMDK------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 69/226 (30%), Positives = 107/226 (47%), Gaps = 30/226 (13%)

Query: 291 EILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN-EVNLI 348
           E L   TD ++    +G+G  G V++ T   DG   AVK L  +    VD+    E N++
Sbjct: 15  ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL--DPISDVDEEIEAEYNIL 72

Query: 349 SGI-QHKNVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFT- 401
             +  H NVV+  G       + G +  LV E     S+ ++  VK    +L   QR   
Sbjct: 73  QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTEL--VKG---LLICGQRLDE 127

Query: 402 -----IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH 456
                I+ G   GL HLH     +IIHRD+K +NILL  +   K+ DFG++  +   +  
Sbjct: 128 AMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 184

Query: 457 VSTGIAGTLGYMAPEYLVRGQLTE-----KADVYAFGVLVIEVASG 497
            +T + GT  +MAPE +   Q  +     + DV++ G+  IE+  G
Sbjct: 185 RNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 33/88 (37%), Positives = 48/88 (54%), Gaps = 18/88 (20%)

Query: 421 IIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE--------- 471
           +IHRD+K SNILLD     K+ DFG++  +   K    T  AG   YMAPE         
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERIDPPDPNP 193

Query: 472 -YLVRGQLTEKADVYAFGVLVIEVASGR 498
            Y +R      ADV++ G+ ++E+A+G+
Sbjct: 194 KYDIR------ADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 54/234 (23%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLFFNSRQWVDQF---- 341
            + +L+R    + N + +G G  G V   +      G+N+A+K+L   SR + +      
Sbjct: 11  TFTVLKR----YQNLKPIGSGAQGIVCAAYDTVT--GQNVAIKKL---SRPFQNVTHAKR 61

Query: 342 -FNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQI--------LFVKN--- 389
            + E+ L+  + HKN++ LL              + P +SL++         L   N   
Sbjct: 62  AYRELVLMKLVNHKNIIGLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQ 109

Query: 390 TIHILSWQQR-----FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADF 444
            I +    +R     + ++CG    + HLH      IIHRD+K SNI++    T KI DF
Sbjct: 110 VIQMDLDHERMSYLLYQMLCG----IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 162

Query: 445 GLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           GLAR        + T    T  Y APE ++     E  D+++ G ++ E+  G 
Sbjct: 163 GLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 67.0 bits (164), Expect = 3e-12
 Identities = 39/97 (40%), Positives = 54/97 (55%), Gaps = 18/97 (18%)

Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARH----VAPDKTHVSTGIAGTLGYMAPEYL- 473
           +KIIHRD+K SNILLD     K+ DFG++      +A  KT      AG   YMAPE + 
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA--KTRD----AGCRPYMAPERID 180

Query: 474 --VRGQLTEKADVYAFGVLVIEVASGRR-----NSVF 503
              R     ++DV++ G+ + EVA+G+      NSVF
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF 217

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 67.7 bits (165), Expect = 4e-12
 Identities = 58/228 (25%), Positives = 108/228 (47%), Gaps = 44/228 (19%)

Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLF--FNSRQWVDQFFNE 344
           +E+ +R  D     +++G G  G+V      D R    +A+K+L+  F S  +  + + E
Sbjct: 11  WEVPDRYRDL----KQVGSGAYGTVCSAL--DRRTGAKVAIKKLYRPFQSELFAKRAYRE 64

Query: 345 VNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQ-------ILFVKNTIHILSWQ 397
           + L+  ++H+NV+ LL              + P+ SLD+       + F+   +  L   
Sbjct: 65  LRLLKHMKHENVIGLLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKH 112

Query: 398 QRFT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA 451
           ++ +      ++    +GL ++H      IIHRD+K  N+ ++E    KI DFGLAR   
Sbjct: 113 EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTD 169

Query: 452 PDKTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
            +     TG   T  Y APE ++     T+  D+++ G ++ E+ +G+
Sbjct: 170 SEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 67.0 bits (164), Expect = 4e-12
 Identities = 66/227 (29%), Positives = 116/227 (51%), Gaps = 34/227 (14%)

Query: 305 KLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQWVD-QFFNEVNLISGIQHKNVVRLLGC 362
           KLG+G   +V++G +   G+ +A+K +     +        E +L+  ++H N+V  L  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV-TLHD 70

Query: 363 SIEGPESL-LVYEYVPNRSLDQ-------ILFVKNTIHILSWQQRFTIICGTAEGLAHLH 414
            I   ++L LV+EY+ +  L Q        L + N    L     F ++     GLA+ H
Sbjct: 71  IIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFL-----FQLL----RGLAYCH 120

Query: 415 GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYL 473
                +++HRD+K  N+L+ E+   K+ADFGLAR  + P KT+ +  +  TL Y  P+ L
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVL 175

Query: 474 V-RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSV---LHTVWK 516
           +   + +   D++  G +  E+A+GR   +F  GS+ V   LH +++
Sbjct: 176 LGSTEYSTSLDMWGVGCIFYEMATGR--PLFP-GSTDVEDQLHKIFR 219

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 67.8 bits (165), Expect = 4e-12
 Identities = 59/215 (27%), Positives = 108/215 (50%), Gaps = 26/215 (12%)

Query: 290 YEILERATDFFDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNE 344
           + +L+R    + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E
Sbjct: 13  FTVLKR----YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRE 66

Query: 345 VNLISGIQHKNVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQR 399
           + L+  + HKN++ LL       S+E  + + +   + + +L Q++ ++     +S+   
Sbjct: 67  LVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL- 125

Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVST 459
           + ++CG    + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T
Sbjct: 126 YQMLCG----IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMT 176

Query: 460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEV 494
               T  Y APE ++     E  D+++ G ++ E+
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 67.8 bits (166), Expect = 4e-12
 Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 24/208 (11%)

Query: 304 RKLGQGGAGSVFRGTLP-DGRNIAVKRL--FFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
           R +G G  G V+  T P DG+ +A+K++   F +     + F E+ ++   +H NV+  L
Sbjct: 6   RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65

Query: 361 GCSIEGPESLLVYE--YVPNRSLDQILFVKNTIH-ILSWQQRFT------IICGTAEGLA 411
              I  P  +  +E  YV    + +++  ++ +H I+   Q  +       +     GL 
Sbjct: 66  --DILQPPHIDPFEEIYV----VTELM--QSDLHKIIVSPQPLSSDHVKVFLYQILRGLK 117

Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           +LH      I+HRDIK  N+L++     KI DFGLAR   PD++   T    T  Y APE
Sbjct: 118 YLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174

Query: 472 YLVRGQ-LTEKADVYAFGVLVIEVASGR 498
            L+  +  T   D+++ G +  E+   R
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 66.7 bits (163), Expect = 4e-12
 Identities = 35/102 (34%), Positives = 58/102 (56%), Gaps = 10/102 (9%)

Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGI 461
           I     + L +LH  S + +IHRD+K SN+L++     K+ DFG++ ++        T  
Sbjct: 108 IAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV--AKTID 163

Query: 462 AGTLGYMAPEYLVRGQLTE-----KADVYAFGVLVIEVASGR 498
           AG   YMAPE  +  +L +     K+DV++ G+ +IE+A+GR
Sbjct: 164 AGCKPYMAPER-INPELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 66.9 bits (163), Expect = 4e-12
 Identities = 69/237 (29%), Positives = 122/237 (51%), Gaps = 18/237 (7%)

Query: 302 NSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQWVD-QFFNEVNLISGIQHKNVVRL 359
           N  KLG+G   +V++G +  +G+ +A+K +   + + V      E +L+ G++H N+V L
Sbjct: 9   NLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV-L 67

Query: 360 LGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
           L   I   E+L  V+EY+ +  L Q + +++   +  +  R  +      GLA++HG   
Sbjct: 68  LHDIIHTKETLTFVFEYM-HTDLAQYM-IQHPGGLHPYNVRLFMF-QLLRGLAYIHGQ-- 122

Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLVRG- 476
             I+HRD+K  N+L+      K+ADFGLAR  + P +T+ S  +  TL Y  P+ L+   
Sbjct: 123 -HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGAT 179

Query: 477 QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRI-TQSMDPGLT 532
             +   D++  G + IE+  G+    F  G S V   + K +    + T+   PG++
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQ--PAFP-GVSDVFEQLEKIWTVLGVPTEDTWPGVS 233

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 60/200 (30%), Positives = 107/200 (53%), Gaps = 16/200 (8%)

Query: 305 KLGQGGAGSVFRGTLPDGRN-IAVKRLFFNSRQWVD-QFFNEVNLISGIQHKNVVRLLGC 362
           KLG+G   +V++G      N +A+K +     +        EV+L+  ++H N+V L   
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 363 SIEGPESL-LVYEYVPNRSLDQILF-VKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIK 420
            I   +SL LV+EY+ ++ L Q L    N+I++ + +     +     GL + H     K
Sbjct: 73  -IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVK---LFLFQLLRGLNYCHRR---K 124

Query: 421 IIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLV-RGQL 478
           ++HRD+K  N+L++E+   K+ADFGLAR  + P KT+ +  +  TL Y  P+ L+     
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDY 182

Query: 479 TEKADVYAFGVLVIEVASGR 498
           + + D++  G +  E+++GR
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 25/210 (11%)

Query: 306 LGQGGAGSVFRGTLP-DG--RNIAVKRLF-FNSRQWVDQFFNEVNLISGI-QHKNVVRLL 360
           +G+G  G V +  +  DG   + A+KR+  + S+     F  E+ ++  +  H N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 361 GCSIEGPESLLVYEYVPNRSLDQIL-----------FVKN--TIHILSWQQRFTIICGTA 407
           G         L  EY P+ +L   L           F     T   LS QQ        A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG-TLG 466
            G+ +L   S  + IHRD+   NIL+ E    KIADFGL+R     + +V   +    + 
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMGRLPVR 176

Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
           +MA E L     T  +DV+++GVL+ E+ S
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 66.5 bits (162), Expect = 4e-12
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 23/215 (10%)

Query: 300 FDNSRKLGQGGAGSVFRGTLP----DGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQH 353
           F   R LG+G  GSV    L       + +AVK L     S   +++F  E   +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 354 KNVVRLLGCSIEG------PESLLVYEYVPNRSLDQILFV----KNTIHILSWQQRFTII 403
            NV++L+G S+        P  +++  ++ +  L   L +    +     L  Q     +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT-LPLQTLVRFM 119

Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG 463
              A G+ +L   S    IHRD+   N +L+E +T  +ADFGL++ +     +   G A 
Sbjct: 120 IDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD-YYRQGCAS 175

Query: 464 TL--GYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
            L   ++A E L     T  +DV+AFGV + E+ +
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 66.2 bits (161), Expect = 5e-12
 Identities = 60/205 (29%), Positives = 104/205 (50%), Gaps = 28/205 (13%)

Query: 306 LGQGGAGSVFRGTLPD-GRNIAVKRLFFN-----SRQWVDQFFNEVNLISGIQHKNVVRL 359
           LG+G  G V+     D GR +AVK++ F+     + + V+    E+ L+  ++H  +V+ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 360 LGCSIEGPE----SLLVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICGTAEGLAHLH 414
            GC +  PE    S+ V EY+P  S+ DQ+         ++ +    I+    +G+++LH
Sbjct: 70  YGC-LRDPEEKKLSIFV-EYMPGGSIKDQLKAYGALTENVTRRYTRQIL----QGVSYLH 123

Query: 415 GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG-----IAGTLGYMA 469
                 I+HRDIK +NIL D     K+ DFG ++ +   +T   +G     + GT  +M+
Sbjct: 124 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI---QTICMSGTGIKSVTGTPYWMS 177

Query: 470 PEYLVRGQLTEKADVYAFGVLVIEV 494
           PE +       KADV++    V+E+
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEM 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 66.2 bits (161), Expect = 6e-12
 Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 24/213 (11%)

Query: 305 KLGQGGAGSVFRGTL------PDGRNIAVKRLFFNSRQWV-DQFFNEVNLISGIQHKNVV 357
           +LG+   G V++G L         + +A+K L   +   + ++F +E  + S +QH N+V
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFV-------------KNTIHILSWQQRFTIIC 404
            LLG   +     +++ Y  +  L + L +             K     L       I+ 
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAG 463
             A G+  L   S   ++H+D+ T N+L+ +KL  KI+D GL R V A D   +      
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188

Query: 464 TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
            + +M+PE ++ G+ +  +D++++GV++ EV S
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 66.2 bits (161), Expect = 7e-12
 Identities = 54/198 (27%), Positives = 102/198 (51%), Gaps = 13/198 (6%)

Query: 306 LGQGGAGSVFRGT-LPDGRNI----AVKRLFFNSRQWVD-QFFNEVNLISGIQHKNVVRL 359
           LG G  G+V++G  +P+G  +    A+K L   +    + +F +E  +++ + H ++VRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
           LG  +  P   LV + +P+  L  + +V      +  Q         A+G+ +L      
Sbjct: 75  LGVCLS-PTIQLVTQLMPHGCL--LDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER--- 128

Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-KTHVSTGIAGTLGYMAPEYLVRGQL 478
           +++HRD+   N+L+      KI DFGLAR +  D K + + G    + +MA E +   + 
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188

Query: 479 TEKADVYAFGVLVIEVAS 496
           T ++DV+++GV + E+ +
Sbjct: 189 THQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 66.6 bits (162), Expect = 7e-12
 Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 14/209 (6%)

Query: 294 ERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWV-DQFFNEVNLISGI 351
           E   D F+   +LG G  G VF+ +  P G  +A K +    +  + +Q   E+ ++   
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI--HILSWQQRFTIICGTAEG 409
               +V   G      E  +  E++   SLDQ+L     I   IL       +     +G
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKG 115

Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           L +L      KI+HRD+K SNIL++ +   K+ DFG++  +      ++    GT  YM+
Sbjct: 116 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMS 170

Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           PE L     + ++D+++ G+ ++E+A GR
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 65.3 bits (160), Expect = 1e-11
 Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 20/201 (9%)

Query: 306 LGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVD-----QFFNEVNLISGIQHKNVVRL 359
           LG GG G V    +    R  A+K      R  V+       F+E  ++    H  +V+L
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKC--VKKRHIVETGQQEHIFSEKEILEECNHPFIVKL 58

Query: 360 LGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
              + +  + + ++ EY     L  IL  +       +  RF I C       +LH    
Sbjct: 59  Y-RTFKDKKYIYMLMEYCLGGELWTILRDRG--LFDEYTARFYIACVV-LAFEYLHNRG- 113

Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVSTGIAGTLGYMAPEYLVRGQ 477
             II+RD+K  N+LLD     K+ DFG A+ +    KT       GT  Y+APE ++   
Sbjct: 114 --IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILNKG 168

Query: 478 LTEKADVYAFGVLVIEVASGR 498
                D ++ G+L+ E+ +GR
Sbjct: 169 YDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 35/92 (38%), Positives = 52/92 (56%), Gaps = 5/92 (5%)

Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG 466
             G+ HLH    + I++RD+K  N+LLD++   +++D GLA  +   KT   T  AGT G
Sbjct: 105 TCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNG 159

Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           YMAPE L     +   D +A G  + E+ +GR
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 11/200 (5%)

Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVR 358
           F+  +++G G  G V++   +  G   A+K +     +       E+ ++   +H N+V 
Sbjct: 11  FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70

Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
             G  +   +  +  E+    SL  I  V      LS  Q   +   T +GL +LH    
Sbjct: 71  YFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP---LSESQIAYVSRETLQGLYYLHSKGK 127

Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLV---R 475
           +   HRDIK +NILL +    K+ADFG++  +        + I GT  +MAPE      +
Sbjct: 128 M---HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERK 183

Query: 476 GQLTEKADVYAFGVLVIEVA 495
           G   +  D++A G+  IE+A
Sbjct: 184 GGYNQLCDIWAVGITAIELA 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 22/204 (10%)

Query: 344 EVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTII 403
           E++++  I H+ ++ L+          +V   +P    D   +V +    L  +Q  TI 
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYV-DRSGPLPLEQAITIQ 191

Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA-RHVAPDKTHVSTGIA 462
               E LA+LHG     IIHRD+KT NI LDE     + DFG A +  A   T    G +
Sbjct: 192 RRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS 248

Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFS---EGSSSVLHTVWKHYK 519
           GTL   +PE L       K D+++ G+++ E++     ++F    + SSS L ++ +  +
Sbjct: 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV-TLFGKQVKSSSSQLRSIIRCMQ 307

Query: 520 ANRITQSMDPGLTGRFPENEASRV 543
            + +           FP+N ++ +
Sbjct: 308 VHPL----------EFPQNGSTNL 321

Length = 392

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 36/216 (16%)

Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVK--RLFFNSRQWVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K  RL   +         E++L+  + H N+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 357 VRLLGCSIEGPESL-LVYEYVPNRSLDQIL-----------FVKNTIHILSWQQRFTIIC 404
           V+LL   I     L LV+E++ ++ L + +            +K+ +  L          
Sbjct: 62  VKLLDV-IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQL---------- 109

Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAG 463
              +GLA  H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  
Sbjct: 110 --LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-- 162

Query: 464 TLGYMAPEYLVRGQLTEKA-DVYAFGVLVIEVASGR 498
           TL Y APE L+  +    A D+++ G +  E+ + R
Sbjct: 163 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 52/205 (25%), Positives = 100/205 (48%), Gaps = 14/205 (6%)

Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLF-FNSRQWVDQFFNEVNLISGIQHKNV 356
           +F++   +LG G  G V++    +   +A  ++    S + ++ +  E+++++   H N+
Sbjct: 5   EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64

Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICG-TAEGLAHLHG 415
           V+LL          ++ E+    ++D ++     +     + +  ++C  T E L +LH 
Sbjct: 65  VKLLDAFYYENNLWILIEFCAGGAVDAVML---ELERPLTEPQIRVVCKQTLEALNYLHE 121

Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               KIIHRD+K  NIL       K+ADFG++           + I GT  +MAPE ++ 
Sbjct: 122 N---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMC 177

Query: 476 GQLTE-----KADVYAFGVLVIEVA 495
               +     KADV++ G+ +IE+A
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMA 202

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 43/218 (19%)

Query: 299 FFDNSRKLGQGGAGSVF---RGTLPDGRNIAVKRLFFNSRQWVDQF-------FNEVNLI 348
            ++    +G+G  G V+   R    DG+  A+K+     +   +Q+         E+ L+
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF----KGDKEQYTGISQSACREIALL 56

Query: 349 SGIQHKNVVRLLGCSIEGPESL--LVYEYVP---------NRSLDQILFVKNTIHILSWQ 397
             ++H+NVV L+   +E  +    L+++Y           +R   ++    + +  L WQ
Sbjct: 57  RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116

Query: 398 QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL----DEKLTPKIADFGLARHV-AP 452
               I+ G    + +LH      ++HRD+K +NIL+     E+   KI D GLAR   AP
Sbjct: 117 ----ILNG----VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165

Query: 453 DKTHVS-TGIAGTLGYMAPEYLVRGQLTEKA-DVYAFG 488
            K       +  T+ Y APE L+  +   KA D++A G
Sbjct: 166 LKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 16/158 (10%)

Query: 343 NEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRF-- 400
           NE  ++  + H  ++RL     +     ++ EYVP   L    +++N+    +    F  
Sbjct: 50  NEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYA 107

Query: 401 -TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVST 459
             I+C     L +LH      I++RD+K  NILLD++   K+ DFG A+ +  D+T    
Sbjct: 108 SEIVCA----LEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLR-DRTWT-- 157

Query: 460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
            + GT  Y+APE +      +  D +A G+L+ E+  G
Sbjct: 158 -LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 40/153 (26%), Positives = 65/153 (42%), Gaps = 16/153 (10%)

Query: 371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSN 430
           LV EY+       ++    T+  L        I     G+  LH      IIHRDIK  N
Sbjct: 74  LVMEYLNGGDCASLI---KTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPEN 127

Query: 431 ILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVL 490
           +L+D+    K+ DFGL+R+        +    GT  Y+APE ++     + +D ++ G +
Sbjct: 128 LLIDQTGHLKLTDFGLSRNG-----LENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCV 182

Query: 491 VIEVASGRRNSVFSEGSSSVLHTVWKHYKANRI 523
           + E   G     F   +      V+ +  + RI
Sbjct: 183 IFEFLFGYPP--FHAETPD---AVFDNILSRRI 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 5/90 (5%)

Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           L HLH    + II+RDIK  NILLD +    + DFGL++    ++   +    GT+ YMA
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174

Query: 470 PEYLVRGQL--TEKADVYAFGVLVIEVASG 497
           PE +  G     +  D ++ GVL  E+ +G
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 22/201 (10%)

Query: 304 RKLGQGGAG-SVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLL 360
           +K+G+G  G ++   +  DG+   +K +  +  S +  ++   EV ++S ++H N+V+  
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65

Query: 361 GCSIEGPESLLVYEYVPNRSLDQ-------ILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
               E     +V +Y     L +       +LF ++   IL W   F  IC     L H+
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPED--QILDW---FVQIC---LALKHV 117

Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H     KI+HRDIK+ NI L +  T K+ DFG+AR V      ++    GT  Y++PE  
Sbjct: 118 HDR---KILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELARTCIGTPYYLSPEIC 173

Query: 474 VRGQLTEKADVYAFGVLVIEV 494
                  K+D++A G ++ E+
Sbjct: 174 ENRPYNNKSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 4/90 (4%)

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           GL HLH     +II+RD+K  N+LLD     +I+D GLA  +  D    + G AGT G+M
Sbjct: 109 GLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELK-DGQSKTKGYAGTPGFM 164

Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           APE L   +     D +A GV + E+ + R
Sbjct: 165 APELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 29/211 (13%)

Query: 304 RKLGQGGAGSVFRGTLPDGRN---IAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRL 359
           +++G G  G V  G +  G     + VK L  + S Q   +F  E      +QH N+++ 
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRF--TIICGTAEGLAHLHGGS 417
           LG   E    LLV E+ P   L   L       +++        + C  A GL HLH  +
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120

Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLAR-------HVAPDKTHVSTGIAGTLGYMAP 470
               IH D+   N LL   LT KI D+GL+        +V PD+  V       L ++AP
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVP------LRWIAP 171

Query: 471 EYL--VRGQL-----TEKADVYAFGVLVIEV 494
           E +  V G L     T++++V++ GV + E+
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 83/336 (24%), Positives = 141/336 (41%), Gaps = 38/336 (11%)

Query: 294 ERATDFFDNSRKLGQGGAGSVFR-GTLPDGRNIAVKRLFFNSRQWV-DQFFNEVNLISGI 351
           E   D F+   +LG G  G V +    P G  +A K +    +  + +Q   E+ ++   
Sbjct: 1   ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI--HILSWQQRFTIICGTAEG 409
               +V   G      E  +  E++   SLDQ+L     I   IL       +      G
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRG 115

Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           LA+L      +I+HRD+K SNIL++ +   K+ DFG++  +      ++    GT  YM+
Sbjct: 116 LAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMS 170

Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP 529
           PE L     + ++D+++ G+ ++E+A GR      +          K  +A      +D 
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA---------KELEAIFGRPVVDG 221

Query: 530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQP-------- 581
                 P + + R    G   +   +  RP+MA +  +L+ I  E PPPK P        
Sbjct: 222 E--EGEPHSISPRPRPPGRPVSGHGMDSRPAMA-IFELLDYIVNE-PPPKLPNGVFTPDF 277

Query: 582 -PFLNASVISPSDNSKDSMMSSFKSFV--AESPEID 614
             F+N  +I       D  M    +F+  +E  E+D
Sbjct: 278 QEFVNKCLIKNPAERADLKMLMNHTFIKRSEVEEVD 313

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 63.7 bits (155), Expect = 4e-11
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 46/221 (20%)

Query: 300 FDNSRKLGQGGAGSV----FRGTLPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQ 352
           F + R LG+GG G V     R T   G+  A K+L       R+      NE  ++  + 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 58

Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKN----TIHILSW------QQRFT- 401
            + VV L             Y Y    +L  +L + N      HI +       ++R   
Sbjct: 59  SRFVVSL------------AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF 106

Query: 402 ----IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV 457
               I CG    L  LH     +I++RD+K  NILLD+    +I+D GLA  + P+   +
Sbjct: 107 YAAEITCG----LEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGETI 158

Query: 458 STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
             G  GT+GYMAPE +   + T   D +  G L+ E+  G+
Sbjct: 159 R-GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 13/201 (6%)

Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVR 358
           ++  +++G G  G V++   L  G   AVK +             E+ ++   +H N+V 
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVA 70

Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIIC-GTAEGLAHLHGGS 417
             G  +   +  +  EY    SL  I  V   +  L    +   +C  T +GLA+LH   
Sbjct: 71  YFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL----QIAYVCRETLQGLAYLHSKG 126

Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLV--- 474
            +   HRDIK +NILL +    K+ADFG+A  +        + I GT  +MAPE      
Sbjct: 127 KM---HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEK 182

Query: 475 RGQLTEKADVYAFGVLVIEVA 495
            G   +  D++A G+  IE+A
Sbjct: 183 NGGYNQLCDIWAVGITAIELA 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 63.0 bits (153), Expect = 5e-11
 Identities = 71/272 (26%), Positives = 117/272 (43%), Gaps = 32/272 (11%)

Query: 304 RKLGQGGAGSVF---------RGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHK 354
           ++LG+G  G+V+            L   + I V  L  N     +Q   E  L+S + H 
Sbjct: 6   QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ---EAQLLSKLDHP 62

Query: 355 NVVRLLGCSIEGPESLLVYEYVPNRSLD-QILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
            +V+     +E     ++ EY   R LD ++  +K+T   LS  Q          G+ ++
Sbjct: 63  AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122

Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H     +I+HRD+K  NI L   L  KI DFG++R +      ++T   GT  YM+PE L
Sbjct: 123 HQR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLM-GSCDLATTFTGTPYYMSPEAL 177

Query: 474 VRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG 533
                  K+D+++ G ++ E+             S VL          RI +   P L  
Sbjct: 178 KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVL----------RIVEGPTPSLPE 227

Query: 534 RFPENEASRVLQIGLLCTQAPVALRPSMAEVV 565
            +   + + ++Q  L       +LRPS AE++
Sbjct: 228 TYSR-QLNSIMQSML---NKDPSLRPSAAEIL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 63.0 bits (153), Expect = 6e-11
 Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 11/202 (5%)

Query: 304 RKLGQGGAGSVFRG--TLPDGRN--IAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVR 358
           R LG G  G + RG   LP  R   +A+  L    S +    F  E   +    H N+VR
Sbjct: 11  RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70

Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
           L G    G   ++V EY+ N +LD   F++     L   Q   ++ G A G+ +L   S 
Sbjct: 71  LEGVITRGNTMMIVTEYMSNGALDS--FLRKHEGQLVAGQLMGMLPGLASGMKYL---SE 125

Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL 478
           +  +H+ +    +L++  L  KI+ F   +    +  + +      + + APE +     
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHF 185

Query: 479 TEKADVYAFGVLVIEVAS-GRR 499
           +  +DV++FG+++ EV S G R
Sbjct: 186 SSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 62.8 bits (152), Expect = 8e-11
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 19/205 (9%)

Query: 306 LGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI-QHKNVVRLLGCSI 364
           +G G  G V++G       +A  ++   +    ++   E+N++     H+N+    G  I
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 365 E-GPESL-----LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIIC-GTAEGLAHLHGGS 417
           +  P  +     LV E+    S+  +  +KNT      ++    IC     GL+HLH   
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDL--IKNTKGNTLKEEWIAYICREILRGLSHLHQH- 130

Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQ 477
             K+IHRDIK  N+LL E    K+ DFG++  +       +T I GT  +MAPE +   +
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDE 187

Query: 478 LTE-----KADVYAFGVLVIEVASG 497
             +     K+D+++ G+  IE+A G
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 62.8 bits (153), Expect = 9e-11
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 43/226 (19%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNI-AVKRLFFNSR-QWVDQF-FNEV 345
           KYE LE          K+G+G  G+VF+    +   I A+KR+  +   + V      E+
Sbjct: 1   KYEKLE----------KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI 50

Query: 346 NLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQIL----------FVKNTIHILS 395
            L+  ++HKN+VRL        +  LV+EY      DQ L               +    
Sbjct: 51  CLLKELKHKNIVRLYDVLHSDKKLTLVFEYC-----DQDLKKYFDSCNGDIDPEIVKSFM 105

Query: 396 WQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDK 454
           +Q          +GLA  H      ++HRD+K  N+L+++    K+ADFGLAR    P +
Sbjct: 106 FQ--------LLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154

Query: 455 THVSTGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGRR 499
            + +  +  TL Y  P+ L   +L +   D+++ G +  E+A+  R
Sbjct: 155 CYSAEVV--TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 62.7 bits (152), Expect = 9e-11
 Identities = 44/131 (33%), Positives = 70/131 (53%), Gaps = 16/131 (12%)

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           GL H+H      +++RD+K +NILLDE    +I+D GLA   +  K H S    GT GYM
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162

Query: 469 APEYLVRGQLTE-KADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM 527
           APE L +G   +  AD ++ G ++ ++  G  +S F +      H     ++ +R+T ++
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRG--HSPFRQ------HKTKDKHEIDRMTLTV 214

Query: 528 DPGLTGRF-PE 537
           +  L   F PE
Sbjct: 215 NVELPDSFSPE 225

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 63.8 bits (155), Expect = 9e-11
 Identities = 48/150 (32%), Positives = 70/150 (46%), Gaps = 17/150 (11%)

Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG-TLGYMAPEYLVRGQLTE 480
           IHRD+   NILL      KI DFGLAR +  D  +V  G A   + +MAPE +     T 
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTF 295

Query: 481 KADVYAFGVLVIEVASGRRNSVFSEGSSSV--LHTVWKHYKANRITQSMDPGLTGRFPEN 538
           ++DV+++G+L+ E        +FS GSS    +    K YK  +    M        PE 
Sbjct: 296 ESDVWSYGILLWE--------IFSLGSSPYPGMPVDSKFYKMIKEGYRMLS------PEC 341

Query: 539 EASRVLQIGLLCTQAPVALRPSMAEVVHML 568
             S +  I   C  A    RP+  ++V ++
Sbjct: 342 APSEMYDIMKSCWDADPLKRPTFKQIVQLI 371

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 64.8 bits (158), Expect = 1e-10
 Identities = 60/234 (25%), Positives = 93/234 (39%), Gaps = 58/234 (24%)

Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQHKN 355
           +D  R +G+GG G V+    P   R +A+K++      +     +F  E  + + + H  
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63

Query: 356 VVRLLGCSIEGPESLLVY---EYVPNRSLDQILFVKNTIHILSWQQR------------- 399
           +V +   SI   +   VY    Y+   +L  +L  K+      WQ+              
Sbjct: 64  IVPVY--SICS-DGDPVYYTMPYIEGYTLKSLL--KSV-----WQKESLSKELAEKTSVG 113

Query: 400 -----FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA------- 447
                F  IC T E   H  G     ++HRD+K  NILL       I D+G A       
Sbjct: 114 AFLSIFHKICATIE-YVHSKG-----VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEE 167

Query: 448 ----------RHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLV 491
                     R++      +   I GT  YMAPE L+    +E  D+YA GV++
Sbjct: 168 EDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVIL 221

Length = 932

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 50/190 (26%), Positives = 87/190 (45%), Gaps = 24/190 (12%)

Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQWVDQF----FNEVNLISGIQHK 354
           ++   K+GQG  G VF+       + +A+K++   + +  + F      E+ ++  ++H+
Sbjct: 14  YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK--EGFPITALREIKILQLLKHE 71

Query: 355 NVVRLLG-CSIEG-------PESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGT 406
           NVV L+  C  +            LV+E+  +   D    + N     +  +   ++   
Sbjct: 72  NVVNLIEICRTKATPYNRYKGSFYLVFEFCEH---DLAGLLSNKNVKFTLSEIKKVMKML 128

Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR-HVAP--DKTHVSTGIAG 463
             GL ++H     KI+HRD+K +NIL+ +    K+ADFGLAR        K +  T    
Sbjct: 129 LNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185

Query: 464 TLGYMAPEYL 473
           TL Y  PE L
Sbjct: 186 TLWYRPPELL 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 39/218 (17%)

Query: 304 RKLGQGGAGSV----FRGTLPDGRNIAVKRL--FFNSRQWVDQFFNEVNLISGIQ-HKNV 356
           ++LGQG  G V       T  +   +A+K++   F+ +    +   E+ L+   + HKN+
Sbjct: 6   KELGQGAYGIVCSARNAETSEEET-VAIKKITNVFSKKILAKRALRELKLLRHFRGHKNI 64

Query: 357 VRLLGCSIEGPES---LLVYEYVPNRSLDQILFVKNTIHILSWQ-------QRFT--IIC 404
             L    I  P +   L +YE +    L QI        I S Q       Q F   I+C
Sbjct: 65  TCLYDMDIVFPGNFNELYLYEELMEADLHQI--------IRSGQPLTDAHFQSFIYQILC 116

Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS---TGI 461
           G    L ++H  +   ++HRD+K  N+L++     KI DFGLAR  + +    +   T  
Sbjct: 117 G----LKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEY 169

Query: 462 AGTLGYMAPEYLVRGQLTEKA-DVYAFGVLVIEVASGR 498
             T  Y APE ++  Q   KA DV++ G ++ E+   +
Sbjct: 170 VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 65/221 (29%), Positives = 95/221 (42%), Gaps = 46/221 (20%)

Query: 300 FDNSRKLGQGGAGSV----FRGTLPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQ 352
           F   R LG+GG G V     R T   G+  A KRL       R+      NE  ++  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRAT---GKMYACKRLEKKRIKKRKGESMALNEKQILEKVN 58

Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKN----TIHILSW------QQRFT- 401
            + VV L             Y Y    +L  +L + N      HI +       ++R   
Sbjct: 59  SQFVVNL------------AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF 106

Query: 402 ----IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV 457
               I+CG    L  LH  +    ++RD+K  NILLD+    +I+D GLA  + P+   +
Sbjct: 107 YAAEILCG----LEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKI-PEGESI 158

Query: 458 STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
             G  GT+GYMAPE L   + T   D +  G L+ E+  G+
Sbjct: 159 R-GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 34/215 (15%)

Query: 304 RKLGQGGAGSVFRGTL---PDGRN------IAVKRLFFNSRQWVD-QFFNEVNLISGIQH 353
             LGQG   ++++G L    D         ++V      S       FF   +L+S + H
Sbjct: 1   EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60

Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI-LSWQQRFTIICGTAEGLAH 412
           K++V+L G  +   E+++V EYV    LD  L  +   ++ L W      +   A+ LA 
Sbjct: 61  KHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLH-REKNNVSLHW---KLDV---AKQLAS 112

Query: 413 -LHGGSGIKIIHRDIKTSNILL-----DEKLTP--KIADFGLARHVAPDKTHVSTGIAGT 464
            LH     K++H ++   NIL+     +E   P  K++D G+   V   +  V       
Sbjct: 113 ALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE-----R 167

Query: 465 LGYMAPEYLVRGQ--LTEKADVYAFGVLVIEVASG 497
           + ++APE +  GQ  LT  AD ++FG  ++E+ S 
Sbjct: 168 IPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 61.6 bits (150), Expect = 3e-10
 Identities = 35/89 (39%), Positives = 47/89 (52%), Gaps = 4/89 (4%)

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           GL +LH     KI++RD+K  N+LLD +   KIADFGL +         ST   GT  ++
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEFL 168

Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASG 497
           APE L     T   D +  GVL+ E+  G
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 62.0 bits (150), Expect = 3e-10
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 32/222 (14%)

Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRN-IAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        R  +AVK+L   F S     + + E+ 
Sbjct: 11  WEVPER----YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELR 66

Query: 347 LISGIQHKNVVRLL-----GCSIEGPESLLVYEYVPNRSLDQIL----FVKNTIHILSWQ 397
           L+  ++H+NV+ LL       SIE    + +   +    L+ I+         +  L +Q
Sbjct: 67  LLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQ 126

Query: 398 QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV 457
                      GL ++H      IIHRD+K SN+ ++E    +I DFGLAR  A D+   
Sbjct: 127 --------LLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEM-- 172

Query: 458 STGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
            TG   T  Y APE ++      +  D+++ G ++ E+  G+
Sbjct: 173 -TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 61.4 bits (149), Expect = 3e-10
 Identities = 65/243 (26%), Positives = 105/243 (43%), Gaps = 60/243 (24%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVK--RLFFNSRQWVDQFFNEV 345
            YE LE          K+G+G  G V++      G+ +A+K  RL  +          E+
Sbjct: 2   AYEKLE----------KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREI 51

Query: 346 NLISGIQHKN-VVRLLGCSIEGPES-------LLVYEYV--------------PNRSLDQ 383
           +L+  +     +VRLL   +E  E         LV+EY+              P R L  
Sbjct: 52  SLLQMLSESIYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLP- 108

Query: 384 ILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIA 442
                 TI    +Q     +    +G+AH H      ++HRD+K  N+L+D +K   KIA
Sbjct: 109 ----AKTIKSFMYQ-----LL---KGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIA 153

Query: 443 DFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRN 500
           D GL R  + P K++    +  TL Y APE L+     +   D+++ G +  E++  R+ 
Sbjct: 154 DLGLGRAFSIPVKSYTHEIV--TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS--RKQ 209

Query: 501 SVF 503
            +F
Sbjct: 210 PLF 212

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 19/211 (9%)

Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI-QHKNVVR 358
           F+    +G G  G V++G       +A  ++   +    ++   E+N++     H+N+  
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77

Query: 359 LLGCSIEGP------ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIIC-GTAEGLA 411
             G  I+        +  LV E+    S+  +  VKNT      +     IC     GLA
Sbjct: 78  YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDL--VKNTKGNALKEDWIAYICREILRGLA 135

Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           HLH     K+IHRDIK  N+LL E    K+ DFG++  +       +T I GT  +MAPE
Sbjct: 136 HLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPE 191

Query: 472 YLVRGQLTE-----KADVYAFGVLVIEVASG 497
            +   +  +     ++D+++ G+  IE+A G
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 6/93 (6%)

Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR-HVAPDKTHVSTGIAGTL 465
           A GL  LH      II+RD+K  N++LD +   KIADFG+ + ++   KT  +    GT 
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGTP 165

Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
            Y+APE +      +  D +AFGVL+ E+ +G+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 37/92 (40%), Positives = 53/92 (57%), Gaps = 7/92 (7%)

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
            L HLH    + II+RDIK  NILLD      + DFGL++    D+   +    GT+ YM
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173

Query: 469 APEYLVRGQLT--EKA-DVYAFGVLVIEVASG 497
           AP+ +VRG     +KA D ++ GVL+ E+ +G
Sbjct: 174 APD-IVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 65/219 (29%), Positives = 96/219 (43%), Gaps = 42/219 (19%)

Query: 300 FDNSRKLGQGGAGSV----FRGTLPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQ 352
           F + R LG+GG G V     R T   G+  A K+L       R+      NE  ++  + 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN 58

Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKN----TIHILSW------QQRFTI 402
            + VV L             Y Y    +L  +L + N      HI +       +QR   
Sbjct: 59  SRFVVSL------------AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQR--A 104

Query: 403 ICGTAE---GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVST 459
           I   AE   GL  L      +I++RD+K  NILLD++   +I+D GLA  +   +T    
Sbjct: 105 IFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VR 159

Query: 460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           G  GT+GYMAPE +   + T   D +  G L+ E+  G+
Sbjct: 160 GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 61.0 bits (148), Expect = 4e-10
 Identities = 55/210 (26%), Positives = 105/210 (50%), Gaps = 34/210 (16%)

Query: 305 KLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQWV-DQFFNEVNLISGIQHKNVVRLLGC 362
           KLG+G   +V++G     G  +A+K +  ++ +        E++L+  ++H+N+VRL   
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66

Query: 363 SIEGPESLLVYEYVPN------------RSLDQILFVKNTIHILSWQQRFTIICGTAEGL 410
                + +LV+EY+               +LD      NT+   ++Q          +G+
Sbjct: 67  IHTENKLMLVFEYMDKDLKKYMDTHGVRGALD-----PNTVKSFTYQ--------LLKGI 113

Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMA 469
           A  H     +++HRD+K  N+L++++   K+ADFGLAR    P  T  +  +  TL Y A
Sbjct: 114 AFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRA 168

Query: 470 PEYLVRGQL-TEKADVYAFGVLVIEVASGR 498
           P+ L+  +  +   D+++ G ++ E+ +GR
Sbjct: 169 PDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 27/216 (12%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQF-----F 342
           KYE L           K+G+G  G VF+    + G+ +A+K+ F  S    D        
Sbjct: 2   KYEKLS----------KIGEGSYGVVFKCRNRETGQIVAIKK-FVESED--DPVIKKIAL 48

Query: 343 NEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI 402
            E+ ++  ++H N+V L+       +  LV+EY  +  L+++   KN    +       I
Sbjct: 49  REIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNEL--EKNP-RGVPEHLIKKI 105

Query: 403 ICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIA 462
           I  T + +   H       IHRD+K  NIL+ ++   K+ DFG AR +       +  +A
Sbjct: 106 IWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA 162

Query: 463 GTLGYMAPEYLV-RGQLTEKADVYAFGVLVIEVASG 497
            T  Y APE LV   Q     DV+A G +  E+ +G
Sbjct: 163 -TRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 51/200 (25%), Positives = 99/200 (49%), Gaps = 16/200 (8%)

Query: 305 KLGQGGAGSVFRGTLPDGR---NIAVKRLFFNSRQWV-DQFFNEVNLISGIQHKNVVRLL 360
           +LG G  G V +G     +   ++A+K L   + + V D+   E  ++  + +  +VR++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 361 G-CSIEGPESLLVYEYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
           G C  E    +LV E      L++ L  K + I +        ++   + G+ +L G + 
Sbjct: 62  GVCEAEA--LMLVMEMASGGPLNKFLSGKKDEITV---SNVVELMHQVSMGMKYLEGKN- 115

Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT--LGYMAPEYLVRG 476
              +HRD+   N+LL  +   KI+DFGL++ +  D ++     AG   L + APE +   
Sbjct: 116 --FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173

Query: 477 QLTEKADVYAFGVLVIEVAS 496
           + + ++DV+++G+ + E  S
Sbjct: 174 KFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 60.5 bits (146), Expect = 6e-10
 Identities = 56/204 (27%), Positives = 100/204 (49%), Gaps = 12/204 (5%)

Query: 298 DFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQWVD-QFFNEVNLISGIQHKN 355
           D ++   KLG+G   +V++G +  +G+ +A+K +     +        E +L+ G++H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 356 VVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH 414
           +V LL   I   E+L LV+EYV     D   ++      L  +     +     GL+++H
Sbjct: 65  IV-LLHDIIHTKETLTLVFEYV---HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH 120

Query: 415 GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLV 474
                 I+HRD+K  N+L+ +    K+ADFGLAR      +H  +    TL Y  P+ L+
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLL 176

Query: 475 -RGQLTEKADVYAFGVLVIEVASG 497
              + +   D++  G + +E+  G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 60.6 bits (147), Expect = 6e-10
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 31/210 (14%)

Query: 304 RKLGQGGAGSVFRGTLPDGRN----IAVKRL----FFNSRQWVDQFFNEVNLISGIQHKN 355
           + LG+GG G VF+     G +     A+K L       +++       E N++  ++H  
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQIL-----FVKNTIHI-LSWQQRFTIICGTAEG 409
           +V L+     G +  L+ EY+    L   L     F+++T    LS      I       
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-----EISLA---- 112

Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD--KTHVSTGIAGTLGY 467
           L HLH      II+RD+K  NILLD +   K+ DFGL +    +   TH      GT+ Y
Sbjct: 113 LEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEY 166

Query: 468 MAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           MAPE L+R    +  D ++ G L+ ++ +G
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 60.2 bits (146), Expect = 8e-10
 Identities = 51/183 (27%), Positives = 80/183 (43%), Gaps = 32/183 (17%)

Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH-VAPDKTHVSTGIAGTLGYMAP 470
           H HG     +I+RD+K  NILLD +   K+ADFG+ +  +    T  +T   GT  Y+AP
Sbjct: 113 HRHG-----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAP 165

Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASGR-------RNSVF-SEGSSSVLHTVWKHYKANR 522
           E L   +     D +A GVL+ E+ +G+        + +F S     VL+ VW   +A  
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVS 225

Query: 523 ITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQ-- 580
           I       L     +N   R+  +     +  +   P   E       ID+ +   ++  
Sbjct: 226 I-------LKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE-------IDWVLLEQRKIK 271

Query: 581 PPF 583
           PPF
Sbjct: 272 PPF 274

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 60.1 bits (146), Expect = 8e-10
 Identities = 41/127 (32%), Positives = 69/127 (54%), Gaps = 12/127 (9%)

Query: 374 EYVPNRSLDQILFVKNTI--HILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNI 431
           E++   SLDQ+L     I  +IL    + +I      GL +L      KI+HRD+K SNI
Sbjct: 79  EHMDGGSLDQVLKKAGRIPENILG---KISI--AVLRGLTYLR--EKHKIMHRDVKPSNI 131

Query: 432 LLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLV 491
           L++ +   K+ DFG++  +      ++    GT  YM+PE L     T ++D+++ G+ +
Sbjct: 132 LVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSL 188

Query: 492 IEVASGR 498
           +E+A GR
Sbjct: 189 VEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 60.1 bits (146), Expect = 9e-10
 Identities = 34/91 (37%), Positives = 49/91 (53%), Gaps = 6/91 (6%)

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH-VAPDKTHVSTGIAGTLGY 467
           GL  LH      II+RD+K  N+LLD +   KIADFG+ +  +    T  ++   GT  Y
Sbjct: 108 GLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDY 162

Query: 468 MAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           +APE L         D +A GVL+ E+ +G+
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 33/91 (36%), Positives = 52/91 (57%), Gaps = 4/91 (4%)

Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG-TL 465
           A+G+  L   +    IHRD+   N+LL +    KI DFGLAR +  D  +V  G A   +
Sbjct: 222 AQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278

Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
            +MAPE +     T ++DV+++G+L+ E+ S
Sbjct: 279 KWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 25/213 (11%)

Query: 298 DFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVK--RLFFNSRQWVDQFFNEVNLISGIQHK 354
           D ++   K+G+G  G V++         IA+K  RL             E++L+  +QH 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 355 NVVRLLGCSIEGPESLLVYEYVP---NRSLDQI-LFVKN--TIHILSWQQRFTIICGTAE 408
           N+VRL           LV+EY+     + +D    F KN   I    +Q    I+ G A 
Sbjct: 62  NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQ----ILRGIA- 116

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKL-TPKIADFGLARHVA-PDKTHVSTGIAGTLG 466
              H H     +++HRD+K  N+L+D +    K+ADFGLAR    P +T     +  TL 
Sbjct: 117 -YCHSH-----RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLW 168

Query: 467 YMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
           Y APE L+     +   D+++ G +  E+ + +
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 60.7 bits (147), Expect = 1e-09
 Identities = 44/160 (27%), Positives = 75/160 (46%), Gaps = 24/160 (15%)

Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT-HVSTGIAGTLGYMAP 470
           H+H      +IHRDIK++NILL      K+ DFG ++  A   +  V     GT  Y+AP
Sbjct: 158 HVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAP 214

Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG 530
           E   R   ++KAD+++ GVL+ E                 L T+ + +    + + M   
Sbjct: 215 EIWRRKPYSKKADMFSLGVLLYE-----------------LLTLKRPFDGENMEEVMHKT 257

Query: 531 LTGRF---PENEASRVLQIGLLCTQAPVALRPSMAEVVHM 567
           L GR+   P + +  + +I      +    RPS +++++M
Sbjct: 258 LAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297

Length = 496

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 65/230 (28%), Positives = 106/230 (46%), Gaps = 38/230 (16%)

Query: 305 KLGQGGAGSVFRGT-LPDGRNIAVK--RLFFNSRQWVDQFFNEVNLISGIQHKNV----V 357
           +LG+G  GSV++    P G  +A+K  RL  +     +  FN++ +   I HK V    V
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD-----ESKFNQIIMELDILHKAVSPYIV 62

Query: 358 RLLGC-SIEGPESLLVY---EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
              G   IEG     VY   EY+   SLD++         +       I     +GL  L
Sbjct: 63  DFYGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118

Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
                  IIHRD+K +N+L++     K+ DFG++ ++    +   T I G   YMAPE +
Sbjct: 119 K--EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV--ASLAKTNI-GCQSYMAPERI 173

Query: 474 ------VRGQLTEKADVYAFGVLVIEVASGR-------RNSVFSEGSSSV 510
                      T ++DV++ G+ ++E+A GR         ++F++ S+ V
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIV 223

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 39/97 (40%), Positives = 53/97 (54%), Gaps = 8/97 (8%)

Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGI 461
           IICG    L  LH      II+RD+K  N+LLD+    KIADFG+ +     +   ST  
Sbjct: 105 IICG----LQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-F 156

Query: 462 AGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
            GT  Y+APE L   +  E  D ++FGVL+ E+  G+
Sbjct: 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 59.6 bits (145), Expect = 1e-09
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 8/95 (8%)

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP---DKTHVSTGIAGTL 465
           GL ++H      +IHRD+K SN+L++E    +I DFG+AR ++    +  +  T    T 
Sbjct: 119 GLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175

Query: 466 GYMAPE-YLVRGQLTEKADVYAFGVLVIEVASGRR 499
            Y APE  L   + T   D+++ G +  E+  GRR
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 41/152 (26%), Positives = 74/152 (48%), Gaps = 15/152 (9%)

Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG-TLGYMAPEYLVRGQLTE 480
           +HRD+   N+L+ E    KI DFGLAR +  D  ++S G     L +MAPE +     T 
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320

Query: 481 KADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN-RITQSMDPGLTGRFPENE 539
            +DV++FG+L+ E+        F+ G      T +     N +   ++  G     P + 
Sbjct: 321 LSDVWSFGILLWEI--------FTLGG-----TPYPELPMNEQFYNAIKRGYRMAKPAHA 367

Query: 540 ASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +  + +I   C +    +RP  +++VH++ ++
Sbjct: 368 SDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 52/182 (28%), Positives = 83/182 (45%), Gaps = 30/182 (16%)

Query: 344 EVNLISGIQHKNVVRLLGCSIEGPESL-LVYEYVPNRSLDQI-------LFVKNTIHILS 395
           E  L++ ++H N+V     S E    L +V EY     L Q        LF ++TI  L 
Sbjct: 48  EAVLLAKMKHPNIVAFKE-SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI--LQ 104

Query: 396 WQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT 455
           W   F  +C    G+ H+H     +++HRDIK+ NI L +    K+ DFG AR +     
Sbjct: 105 W---FVQMC---LGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155

Query: 456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVW 515
           +  T + GT  Y+ PE         K+D+++ G ++ E+ + +    F   S       W
Sbjct: 156 YACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP--FQANS-------W 205

Query: 516 KH 517
           K+
Sbjct: 206 KN 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 23/204 (11%)

Query: 304 RKLGQGGAGSVFRGTL----PDGRNIAVKRLFFNS-----RQWVDQFFNEVNLISGIQHK 354
           R +G+G  G V   +L     DG+   +K+L   +     R+  +Q   E  L+S ++H 
Sbjct: 6   RVVGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQ---EAQLLSQLKHP 59

Query: 355 NVVRLLGCSIEGPESLL--VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
           N+V     S EG + LL  V  +     L   L  +    +L   Q        A  L +
Sbjct: 60  NIVAYRE-SWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEWFVQIAMALQY 117

Query: 413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEY 472
           LH      I+HRD+KT N+ L      K+ D G+AR V  ++  +++ + GT  YM+PE 
Sbjct: 118 LHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTPYYMSPEL 173

Query: 473 LVRGQLTEKADVYAFGVLVIEVAS 496
                   K+DV+A G  V E+A+
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMAT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 58.4 bits (141), Expect = 3e-09
 Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 34/222 (15%)

Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGI 461
           I+CG    L  LH      II+RD+K  N++LD     KIADFG+ +         ST  
Sbjct: 105 IVCG----LQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-F 156

Query: 462 AGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWK----H 517
            GT  Y+APE L   + T   D ++FGVL+ E+  G+  S F       L    +    H
Sbjct: 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ--SPFHGDDEDELFESIRVDTPH 214

Query: 518 YKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPP 577
           Y      +S D  +  +  E + +R L +        +   P   + ++       E+ P
Sbjct: 215 YPRWITKESKD--ILEKLFERDPTRRLGV-----VGNIRGHP-FFKTINWTALEKRELDP 266

Query: 578 PKQPPFLNASVISPSDNSKDSMMSSF-KSFVAESPEIDHSLK 618
           P +P      V SPSD       S+F + F++E P + +S K
Sbjct: 267 PFKP-----KVKSPSD------YSNFDREFLSEKPRLSYSDK 297

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 60/223 (26%), Positives = 98/223 (43%), Gaps = 38/223 (17%)

Query: 306 LGQGGAGSVFRG--TLPDGRNIAVKRLFFN--------SRQWVDQ------FFNEVNLIS 349
           LG+G  G V +   TL  G+ +A+K++            RQ V           E+ +++
Sbjct: 17  LGEGTYGKVEKAYDTL-TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75

Query: 350 GIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
            I+H+N++ L+   +EG    LV + +    L ++  V   I  L+  Q   I+     G
Sbjct: 76  EIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKV--VDRKIR-LTESQVKCILLQILNG 131

Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-------------KTH 456
           L  LH       +HRD+  +NI ++ K   KIADFGLAR                  +  
Sbjct: 132 LNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188

Query: 457 VSTGIAGTLGYMAPEYLVRGQLTEKA-DVYAFGVLVIEVASGR 498
             T    TL Y APE L+  +    A D+++ G +  E+ +G+
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)

Query: 297 TDFFDNSRKLGQGGAGSVFR-GTLPDGRNIAVKRL--FFNSRQWVDQFFNEVNLISGIQH 353
           +D ++    +G+G  G VF+     +G   AVK L    +  + ++  +N +  +S   H
Sbjct: 17  SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS--DH 74

Query: 354 KNVVRLLGC-----SIEGPESLLVYEYVPNRSLDQIL--FVKNTIHILSWQQRFTIICGT 406
            NVV+  G         G +  LV E     S+  ++  F+K    +      + I+   
Sbjct: 75  PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-ILHEA 133

Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG 466
             GL HLH     K IHRD+K +NILL  +   K+ DFG++  +   +   +T + GT  
Sbjct: 134 LMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPF 189

Query: 467 YMAPEYLVRGQ-----LTEKADVYAFGVLVIEVASG 497
           +MAPE +   Q        + DV++ G+  IE+  G
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 58.3 bits (141), Expect = 4e-09
 Identities = 38/110 (34%), Positives = 56/110 (50%), Gaps = 8/110 (7%)

Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG 466
           AE +  +H    +  +HRDIK  N+L+D     K+ADFG A  +  +K   S    GT  
Sbjct: 109 AELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPD 168

Query: 467 YMAPEYLV------RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSV 510
           Y+APE L       +G    + D ++ GV+  E+  GR  S F EG+S+ 
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR--SPFHEGTSAK 216

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 56.9 bits (137), Expect = 8e-09
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 42/227 (18%)

Query: 305 KLGQGGAGSVFRGTLPD-GRNIAVK--RLFFNSRQWVDQFFNEVNLISGIQ---HKNVVR 358
           ++G G  G+V++   P  G  +A+K  R+  N          EV L+  ++   H N+VR
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 359 LLG-CSIEGPES----LLVYEYVPNRSLDQIL-------FVKNTIHILSWQQRFTIICGT 406
           L+  C+    +      LV+E+V ++ L   L           TI  L  Q     + G 
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQ----FLRG- 120

Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR----HVAPDKTHVSTGIA 462
              L  LH      I+HRD+K  NIL+      K+ADFGLAR     +A     V     
Sbjct: 121 ---LDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV----- 169

Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSS 509
            TL Y APE L++       D+++ G +  E+   RR  +F   S +
Sbjct: 170 -TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNSEA 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 23/207 (11%)

Query: 300 FDNSRKLGQGGAGSVFRGTLPDGR--NIAVKRL----FFNSRQWVDQFFNEVNLISGIQH 353
           F+  R LG G  G V   T  +     +A+KR         +Q VD  F+E  +++ I H
Sbjct: 32  FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQ-VDHVFSERKILNYINH 90

Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICG---TAEGL 410
              V L G   +     LV E+V                 L   +RF    G    A+ +
Sbjct: 91  PFCVNLYGSFKDESYLYLVLEFVIGGEF---------FTFLRRNKRFPNDVGCFYAAQIV 141

Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAP 470
                   + I++RD+K  N+LLD+    K+ DFG A+ V   +T+    + GT  Y+AP
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK-VVDTRTYT---LCGTPEYIAP 197

Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASG 497
           E L+     + AD +  G+ + E+  G
Sbjct: 198 EILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 32/90 (35%), Positives = 53/90 (58%), Gaps = 6/90 (6%)

Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           L HLH    + I++RDIK  NILLD +    + DFGL++    ++   +    GT+ YMA
Sbjct: 118 LEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMA 174

Query: 470 PEYLVRGQL--TEKADVYAFGVLVIEVASG 497
           PE ++RG+    +  D ++ G+L+ E+ +G
Sbjct: 175 PE-IIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 56.5 bits (137), Expect = 1e-08
 Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 51/216 (23%)

Query: 305 KLGQGGAGSVFRG-TLPDGRNIAVKRL--FFNSRQWVDQFFNEVNLISGIQ-------HK 354
           K+G+G    V +  +   G+  A+K +   F S   ++Q    VN +  IQ       H 
Sbjct: 6   KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS---LEQ----VNNLREIQALRRLSPHP 58

Query: 355 NVVRLLGCSIEGPESLL----------VYEYVPNRSLDQILFVKNTIHILSWQQRFTIIC 404
           N++RL+    +     L          +YE +  R   +    +  +    +Q    ++ 
Sbjct: 59  NILRLIEVLFDRKTGRLALVFELMDMNLYELIKGR---KRPLPEKRVKSYMYQ----LLK 111

Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA---PDKTHVSTGI 461
                L H+H  +GI   HRDIK  NIL+ + +  K+ADFG  R +    P   ++S   
Sbjct: 112 S----LDHMHR-NGI--FHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPYTEYIS--- 160

Query: 462 AGTLGYMAPE-YLVRGQLTEKADVYAFGVLVIEVAS 496
             T  Y APE  L  G    K D++A G +  E+ S
Sbjct: 161 --TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 66/225 (29%), Positives = 103/225 (45%), Gaps = 36/225 (16%)

Query: 305 KLGQGGAGSVF--RGTLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQ---HKNVV 357
           ++G+G  G VF  R     GR +A+KR+   + +         EV ++  ++   H NVV
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 358 RLLG-CSIEGPES----LLVYEYVPNRSLDQIL-------FVKNTIHILSWQQRFTIICG 405
           RL   C++   +      LV+E+V ++ L   L           TI  + +Q        
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQ-------- 118

Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTL 465
              GL  LH     +++HRD+K  NIL+      K+ADFGLAR  +       T +  TL
Sbjct: 119 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTL 173

Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSV 510
            Y APE L++       D+++ G +  E+   RR  +F  GSS V
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEMF--RRKPLF-RGSSDV 215

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 56.9 bits (138), Expect = 1e-08
 Identities = 59/231 (25%), Positives = 89/231 (38%), Gaps = 52/231 (22%)

Query: 306 LGQGGAGSVFRGTLPDGRNI-AVKRLFFNSRQWV----DQ---FFNEVNLISGIQHKNVV 357
           +G+G  G V+     D   + A+K L    R+      +Q      E ++++      +V
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVL----RKSDMIKRNQIAHVRAERDILADADSPWIV 64

Query: 358 RLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTI--HILSWQQRFTIICGTAEGLAHLH 414
           +L   S +  E L LV EY+P   L  +L  K+           RF I    AE +  L 
Sbjct: 65  KLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA----RFYI----AELVLALD 115

Query: 415 GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA--------------------------- 447
               +  IHRDIK  NIL+D     K+ADFGL                            
Sbjct: 116 SVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 448 -RHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
            R     +   +    GT  Y+APE L       + D ++ GV++ E+  G
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 31/211 (14%)

Query: 306 LGQGGAGSVFRGT---LPDGRN-----IAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVV 357
           LGQG    +F+G    + D        + +K L  + R + + FF   +++S + HK++V
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFV-KNTIHILSWQQRFTIICGTAEGLAH-LHG 415
              G  + G ES++V EYV   SLD  L   KN I+I SW+         A+ LA  LH 
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINI-SWKLE------VAKQLAWALHF 115

Query: 416 GSGIKIIHRDIKTSNILL----DEKL-TP---KIADFGLARHVAPDKTHVSTGIAGTLGY 467
                + H ++   N+LL    D K   P   K++D G++  V P +  +       + +
Sbjct: 116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLE-----RIPW 170

Query: 468 MAPEYLVRGQ-LTEKADVYAFGVLVIEVASG 497
           + PE +   Q L+  AD ++FG  + E+ SG
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 29/76 (38%), Positives = 45/76 (59%), Gaps = 1/76 (1%)

Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG-TLGYMAPEYLVRGQLTE 480
           +HRD+   N+LL +    KI DFGLAR +  D  +VS G     + +MAPE +     T 
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT 318

Query: 481 KADVYAFGVLVIEVAS 496
            +DV+++G+L+ E+ S
Sbjct: 319 LSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 37/97 (38%), Positives = 50/97 (51%), Gaps = 8/97 (8%)

Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGI 461
           IICG    L  LH      I++RD+K  NILLD     KIADFG+ +          T  
Sbjct: 105 IICG----LQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-F 156

Query: 462 AGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
            GT  Y+APE L+  +     D ++FGVL+ E+  G+
Sbjct: 157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score = 52.1 bits (125), Expect = 2e-08
 Identities = 19/54 (35%), Positives = 25/54 (46%), Gaps = 1/54 (1%)

Query: 200 TVYALAQCLKFLDNKGCSQCLDEAALRL-KGCSKSGEGRAMFAGCYVRFSTERF 252
           TVY LAQC   L    C  CL  A   L + C     GR  +  C++R+ +  F
Sbjct: 53  TVYGLAQCRGDLSASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 57.2 bits (138), Expect = 2e-08
 Identities = 55/194 (28%), Positives = 83/194 (42%), Gaps = 14/194 (7%)

Query: 304 RKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGC 362
           R L  G  G VF  + PD  + + VK        W     +E  L+  + H  V+ LL  
Sbjct: 175 RALTPGSEGCVFESSHPDYPQRVVVKA------GWYASSVHEARLLRRLSHPAVLALLDV 228

Query: 363 SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
            + G  + LV   +P    D   ++   +  L   Q   +       + ++HG     II
Sbjct: 229 RVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---II 282

Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDK-THVSTGIAGTLGYMAPEYLVRGQLTEK 481
           HRDIKT N+L++      + DFG A        T    GIAGT+   APE L     T  
Sbjct: 283 HRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPS 342

Query: 482 ADVYAFGVLVIEVA 495
            D+++ G+++ E A
Sbjct: 343 VDIWSAGLVIFEAA 356

Length = 461

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 55.9 bits (134), Expect = 2e-08
 Identities = 33/90 (36%), Positives = 47/90 (52%), Gaps = 4/90 (4%)

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
            L +LH G   KI++RD+K  N++LD+    KI DFGL +    D   + T   GT  Y+
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYL 162

Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           APE L         D +  GV++ E+  GR
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 31/77 (40%), Positives = 44/77 (57%), Gaps = 4/77 (5%)

Query: 421 IIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTE 480
           II+RD+K  N+LLD K   K+ DFG A+ V PD+T     + GT  Y+APE +      +
Sbjct: 139 IIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRTFT---LCGTPEYLAPEVIQSKGHGK 194

Query: 481 KADVYAFGVLVIEVASG 497
             D +  GVL+ E  +G
Sbjct: 195 AVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 54.9 bits (132), Expect = 4e-08
 Identities = 35/115 (30%), Positives = 54/115 (46%), Gaps = 9/115 (7%)

Query: 421 IIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTE 480
           II+RD+K  N+LLD +   K+ADFG+ +    +    ST   GT  Y+APE L       
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST-FCGTPDYIAPEILQEMLYGP 175

Query: 481 KADVYAFGVLVIEVASGR-------RNSVFSE-GSSSVLHTVWKHYKANRITQSM 527
             D +A GVL+ E+  G         + +F    +  V++  W    A  I ++ 
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAF 230

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 55.0 bits (132), Expect = 5e-08
 Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 4/92 (4%)

Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG 466
           A GL  LH      II+RD+K  N++LD +   KIADFG+ +    D     T   GT  
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT-FCGTPD 166

Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           Y+APE +      +  D +AFGVL+ E+ +G+
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 54.1 bits (131), Expect = 6e-08
 Identities = 37/131 (28%), Positives = 56/131 (42%), Gaps = 16/131 (12%)

Query: 370 LLVYEYVPNRSLDQILF--VKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIK 427
           +L+ +Y+     D  LF  +K    +   + +  II    E L  LH      IIH DIK
Sbjct: 85  VLIMDYIK----DGDLFDLLKKEGKLSEAEVKK-IIRQLVEALNDLHK---HNIIHNDIK 136

Query: 428 TSNILLDEKLTP-KIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYA 486
             N+L D       + D+GL + +     +      GTL Y +PE +         D +A
Sbjct: 137 LENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSPEKIKGHNYDVSFDWWA 191

Query: 487 FGVLVIEVASG 497
            GVL  E+ +G
Sbjct: 192 VGVLTYELLTG 202

Length = 267

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 54.0 bits (130), Expect = 7e-08
 Identities = 30/89 (33%), Positives = 45/89 (50%), Gaps = 4/89 (4%)

Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           L +LH      +++RD+K  N++LD+    KI DFGL +    D   + T   GT  Y+A
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLA 163

Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           PE L         D +  GV++ E+  GR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 54.0 bits (130), Expect = 9e-08
 Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 6/92 (6%)

Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH-VAPDKTHVSTGIAGTL 465
           A  L +LH    + II+RD+K  NILLD +    + DFGL +  +   KT  ++   GT 
Sbjct: 106 ASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTP 160

Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
            Y+APE L +       D +  G ++ E+  G
Sbjct: 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 53.8 bits (129), Expect = 1e-07
 Identities = 41/167 (24%), Positives = 71/167 (42%), Gaps = 22/167 (13%)

Query: 344 EVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTII 403
           E +++  I H ++++L G       + L+   +P    D   ++          +R   I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAA--------KRNIAI 181

Query: 404 C-------GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH 456
           C            + +LH      IIHRDIK  NI ++      + DFG A        +
Sbjct: 182 CDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238

Query: 457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVF 503
              G AGT+   APE L R       D+++ G+++ E+A+   +S+F
Sbjct: 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC-HDSLF 284

Length = 391

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 34/90 (37%), Positives = 51/90 (56%), Gaps = 7/90 (7%)

Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR-HVAPDKTHVSTGIAGTLGYM 468
           L HLH      I++RD+K  NILLD      + DFGL++ ++  +KT  +    GT  Y+
Sbjct: 109 LEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYL 163

Query: 469 APEYLVRGQ-LTEKADVYAFGVLVIEVASG 497
           APE L+  +  T+  D ++ GVLV E+  G
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 4/92 (4%)

Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG 466
           + GL  LH      II+RD+K  N++LD +   KIADFG+ +    D     T   GT  
Sbjct: 111 SVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT-FCGTPD 166

Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           Y+APE +      +  D +A+GVL+ E+ +G+
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 48/184 (26%), Positives = 88/184 (47%), Gaps = 29/184 (15%)

Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT-HVSTGIAGTLGYMAPEYLVRGQL 478
           K++HRD+K++NI L      K+ DFG ++  +   +  V++   GT  Y+APE   R + 
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248

Query: 479 TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPEN 538
           ++KAD+++ GV++ E+ +              LH  +K      I Q +  G    FP  
Sbjct: 249 SKKADMWSLGVILYELLT--------------LHRPFKGPSQREIMQQVLYGKYDPFPCP 294

Query: 539 EASRVLQI-GLLCTQAPVALRPSMAEVVHM-----LNNIDYEIPPPKQPPFLNASVISPS 592
            +S +  +   L ++ P ALRP+  +++H      + N+  +I         ++  ISP 
Sbjct: 295 VSSGMKALLDPLLSKNP-ALRPTTQQLLHTEFLKYVANLFQDI-------VRHSETISPH 346

Query: 593 DNSK 596
           D  +
Sbjct: 347 DREE 350

Length = 478

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 57/200 (28%), Positives = 88/200 (44%), Gaps = 19/200 (9%)

Query: 306 LGQGGAGSVFRGTLPDGRNI----AVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLG 361
           +G+G  G V +    D + I     +++    SR  V     E  +++ +    +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59

Query: 362 CSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICG---TAEGLAHLHGGS 417
            S + PE L LV  ++    L          H L  + RF +      TAE L  L    
Sbjct: 60  FSFQSPEKLYLVLAFINGGEL---------FHHLQREGRFDLSRARFYTAELLCALENLH 110

Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQ 477
              +I+RD+K  NILLD +    + DFGL +    D    +T   GT  Y+APE L+   
Sbjct: 111 KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLGHG 169

Query: 478 LTEKADVYAFGVLVIEVASG 497
            T+  D +  GVL+ E+ +G
Sbjct: 170 YTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 52.4 bits (126), Expect = 4e-07
 Identities = 32/87 (36%), Positives = 47/87 (54%), Gaps = 5/87 (5%)

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           GL ++H  +   ++HRD+K SN+LL+     KI DFGLAR    +K    T    T  Y 
Sbjct: 120 GLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRWYR 175

Query: 469 APEYLVR-GQLTEKADVYAFGVLVIEV 494
           APE L+   + T   DV++ G +  E+
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAEL 202

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 68/283 (24%), Positives = 112/283 (39%), Gaps = 36/283 (12%)

Query: 304 RKLGQGGAGSVFRGTL---PDGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRL 359
           +++G G  G V    +        + VK L  N S +  ++F  + +    +QH N+++ 
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 360 LGCSIEGPESLLVYEYVPNRSL------DQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
           LG  +E    LLV+EY     L      +Q     + + +L   QR    C  A G+ H+
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLL---QRMA--CEIAAGVTHM 115

Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA-RHVAPDKTHVSTGIAGTLGYMAPEY 472
           H       +H D+   N  L   LT K+ D+G+       D           L ++APE 
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPEL 172

Query: 473 -------LVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQ 525
                  L+  + T+ ++V+A GV + E+               VL+ V K  +      
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKP 232

Query: 526 SMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHML 568
            ++   + R+ E     VLQ   L        R + AE VH L
Sbjct: 233 QLELPYSERWYE-----VLQFCWL----SPEKRAT-AEEVHRL 265

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 51.6 bits (123), Expect = 6e-07
 Identities = 29/79 (36%), Positives = 45/79 (56%), Gaps = 3/79 (3%)

Query: 421 IIHRDIKTSNILLDEKLTPKIADFGLARH-VAPDKTHVSTGIAGTLGYMAPEYLVRGQLT 479
           II+RD+K  N+LLD     K+ D+G+ +  + P  T  ++   GT  Y+APE L   +  
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAPEILRGEEYG 174

Query: 480 EKADVYAFGVLVIEVASGR 498
              D +A GVL+ E+ +GR
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 50.8 bits (121), Expect = 9e-07
 Identities = 31/89 (34%), Positives = 45/89 (50%), Gaps = 4/89 (4%)

Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           L +LH      +++RDIK  N++LD+    KI DFGL +    D   + T   GT  Y+A
Sbjct: 108 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLA 163

Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           PE L         D +  GV++ E+  GR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 3/90 (3%)

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
            L +LH  S   +++RD+K  N++LD+    KI DFGL +    D   + T   GT  Y+
Sbjct: 107 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYL 163

Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           APE L         D +  GV++ E+  GR
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 29/79 (36%), Positives = 45/79 (56%), Gaps = 3/79 (3%)

Query: 421 IIHRDIKTSNILLDEKLTPKIADFGLARH-VAPDKTHVSTGIAGTLGYMAPEYLVRGQLT 479
           II+RD+K  N+LLD +   K+ D+G+ +  + P  T  ++   GT  Y+APE L      
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEILRGEDYG 174

Query: 480 EKADVYAFGVLVIEVASGR 498
              D +A GVL+ E+ +GR
Sbjct: 175 FSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 36/173 (20%), Positives = 81/173 (46%), Gaps = 17/173 (9%)

Query: 333 NSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL----LVYEYVPNRSLDQILFVK 388
             +  +D   NE+  +  I   N++++ G  I+  + L    L+ EY     L ++L  +
Sbjct: 57  GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE 116

Query: 389 NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR 448
                LS++ +  +     +GL +L+        ++++ + + L+ E    KI   GL +
Sbjct: 117 KD---LSFKTKLDMAIDCCKGLYNLY--KYTNKPYKNLTSVSFLVTENYKLKIICHGLEK 171

Query: 449 HVA-PDKTHVSTGIAGTLGYMAPEYL--VRGQLTEKADVYAFGVLVIEVASGR 498
            ++ P   +V+      + Y + + L  +  + T K D+Y+ GV++ E+ +G+
Sbjct: 172 ILSSPPFKNVN-----FMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 32/89 (35%), Positives = 45/89 (50%), Gaps = 4/89 (4%)

Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           L  LH      II+RD+K  N+LLD +   K+ D+G+ +         ST   GT  Y+A
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYIA 164

Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           PE L         D +A GVL+ E+ +GR
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 35/106 (33%), Positives = 54/106 (50%), Gaps = 12/106 (11%)

Query: 356 VVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQ-RFTIICGTAEGLAHL 413
           VV+L   S +    L L+ EY+P   +  +L  K+T    + ++ RF I    AE +  +
Sbjct: 63  VVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDT---FTEEETRFYI----AETILAI 114

Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVST 459
                +  IHRDIK  N+LLD K   K++DFGL   +   K+H + 
Sbjct: 115 DSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL--KKSHRTE 158

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 48.8 bits (116), Expect = 4e-06
 Identities = 45/196 (22%), Positives = 88/196 (44%), Gaps = 9/196 (4%)

Query: 306 LGQGGAGSVFRGTLPDGRNIAVKRLFFNSR---QWVDQFFNEVNLISGIQHKNVVRLLGC 362
           +G+G  G V +    + + I   + F +S    +  +    E+ ++  ++ +N+V L   
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 363 SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
                +  LV+EYV    L+  L  +    +   + R  I     + +  +H      I+
Sbjct: 69  FRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIY----QLIKAIHWCHKNDIV 122

Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKA 482
           HRDIK  N+L+      K+ DFG AR+++       T    T  Y +PE L+     +  
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAV 182

Query: 483 DVYAFGVLVIEVASGR 498
           D+++ G ++ E++ G+
Sbjct: 183 DMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 48.9 bits (116), Expect = 4e-06
 Identities = 47/165 (28%), Positives = 79/165 (47%), Gaps = 19/165 (11%)

Query: 341 FFNEVNLISGIQHKNVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQR 399
           F+ E ++++      VV+L  C+ +  + L +V EY+P   L  ++   N      W + 
Sbjct: 90  FWEERDIMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKF 146

Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT---H 456
           +T     AE +  L     + +IHRD+K  N+LLD+    K+ADFG    +  D+T    
Sbjct: 147 YT-----AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVR 199

Query: 457 VSTGIAGTLGYMAPEYLVR----GQLTEKADVYAFGVLVIEVASG 497
             T + GT  Y++PE L      G    + D ++ GV + E+  G
Sbjct: 200 CDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 48.6 bits (116), Expect = 4e-06
 Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 26/217 (11%)

Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN-IAVKRLFFNS---RQWVDQFFNEVNLISGIQHKN 355
           F+  + +  G  G+V+     + R   A+K++   +   R  + Q F E ++++  ++  
Sbjct: 3   FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62

Query: 356 VVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH 414
           VV +  CS E    L +V EYV       +L  KN I  L           T   L +LH
Sbjct: 63  VVSMF-CSFETKRHLCMVMEYVEGGDCATLL--KN-IGALPVDMARMYFAETVLALEYLH 118

Query: 415 GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR-------------HVAPD-KTHVSTG 460
                 I+HRD+K  N+L+      K+ DFGL++             H+  D +  +   
Sbjct: 119 N---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175

Query: 461 IAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           + GT  Y+APE ++R    +  D +A G+++ E   G
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 48.8 bits (116), Expect = 4e-06
 Identities = 29/91 (31%), Positives = 46/91 (50%), Gaps = 4/91 (4%)

Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG 466
           A  L +LH    I I++RD+K  NILLD +    + DFGL +     ++  +T   GT  
Sbjct: 106 ASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPE 161

Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           Y+APE + +       D +  G ++ E+  G
Sbjct: 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 48.5 bits (115), Expect = 6e-06
 Identities = 29/92 (31%), Positives = 48/92 (52%), Gaps = 6/92 (6%)

Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR-HVAPDKTHVSTGIAGTL 465
           A  L +LH    + I++RD+K  NILLD +    + DFGL + ++  + T  ++   GT 
Sbjct: 106 ASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTP 160

Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
            Y+APE L +       D +  G ++ E+  G
Sbjct: 161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 48.4 bits (115), Expect = 6e-06
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 11/153 (7%)

Query: 347 LISGIQHKNVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICG 405
           L+  ++H  +V L   S +  E L  V +YV    L     ++     L  + RF     
Sbjct: 49  LLKNLKHPFLVGL-HYSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARF-YAAE 104

Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH-VAPDKTHVSTGIAGT 464
            A  + +LH    + II+RD+K  NILLD +    + DFGL +  V P++T  ++   GT
Sbjct: 105 VASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGT 159

Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y+APE L +       D +  G ++ E+  G
Sbjct: 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.9 bits (114), Expect = 7e-06
 Identities = 28/81 (34%), Positives = 43/81 (53%), Gaps = 5/81 (6%)

Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLV-----RG 476
           +HRDIK  N+LLD+    ++ADFG    +  D T  S    GT  Y++PE L      +G
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183

Query: 477 QLTEKADVYAFGVLVIEVASG 497
           +   + D ++ GV + E+  G
Sbjct: 184 RYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 39/166 (23%), Positives = 72/166 (43%), Gaps = 20/166 (12%)

Query: 340 QFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE---YVPNRSLDQILFVKNTIHILSW 396
           Q  NE+  +  + H+N++++        E +L  E   Y+  +  D  L+         W
Sbjct: 209 QLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDW 260

Query: 397 Q------QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV 450
           +      Q   I+      + ++H     K+IHRDIK  NI L+      + DFG A   
Sbjct: 261 KDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPF 317

Query: 451 APDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
             ++     G  GT+   +PE L      E  D+++ G++++++ S
Sbjct: 318 EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 5/96 (5%)

Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG 466
           AE +  +H    +  +HRDIK  N+LLD     ++ADFG    +  D T  S+   GT  
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPD 168

Query: 467 YMAPEYLV-----RGQLTEKADVYAFGVLVIEVASG 497
           Y++PE L       G+   + D ++ GV + E+  G
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 11/161 (6%)

Query: 341 FFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRF 400
           F+ E ++++      VV+L     +     +V EY+P   L  ++   N      W + +
Sbjct: 90  FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFY 147

Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG 460
           T     AE +  L     +  IHRD+K  N+LLD+    K+ADFG    +  +       
Sbjct: 148 T-----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 202

Query: 461 IAGTLGYMAPEYLVR----GQLTEKADVYAFGVLVIEVASG 497
             GT  Y++PE L      G    + D ++ GV + E+  G
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 33/147 (22%), Positives = 58/147 (39%), Gaps = 15/147 (10%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVV--RLLG 361
           + L  G    V+     D     +K     SR+       EV ++  +  K +   ++L 
Sbjct: 4   KLLKGGLTNRVYLLGTKDED-YVLK--INPSREKGADREREVAILQLLARKGLPVPKVLA 60

Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
                  S L+ E++   +LD+          +S +++  I    AE LA LH    + +
Sbjct: 61  SGESDGWSYLLMEWIEGETLDE----------VSEEEKEDIAEQLAELLAKLHQLPLLVL 110

Query: 422 IHRDIKTSNILLDEKLTPKIADFGLAR 448
            H D+   NIL+D+     I D+  A 
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAG 137

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 28/81 (34%), Positives = 43/81 (53%), Gaps = 5/81 (6%)

Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLV-----RG 476
           +HRDIK  NIL+D     ++ADFG    +  D T  S+   GT  Y++PE L      +G
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183

Query: 477 QLTEKADVYAFGVLVIEVASG 497
           +   + D ++ GV + E+  G
Sbjct: 184 KYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 40/163 (24%), Positives = 81/163 (49%), Gaps = 20/163 (12%)

Query: 341 FFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI-LSWQQR 399
           FF   +L+S + H ++  + G  + G E+++V E+V +  LD +   K    + ++W  +
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD-VCLRKEKGRVPVAW--K 119

Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNIL-----LDEKLTP--KIADFGLARHVAP 452
            T+    A  L++L   +   ++H ++   NIL     L E  +P  K++D G++     
Sbjct: 120 ITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS 176

Query: 453 DKTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEV 494
            +  V       + ++APE +  G  L+  AD ++FG  ++E+
Sbjct: 177 REERVE-----RIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 47.4 bits (112), Expect = 2e-05
 Identities = 47/187 (25%), Positives = 87/187 (46%), Gaps = 32/187 (17%)

Query: 340 QFFNEVNLISGIQHKNVVRLLGCSIEGPESLL--VYEYVPNRSLDQILFVKNTIHILSWQ 397
           Q   EVN++  ++HKN+VR +   +      L  + E+     L +   ++    +    
Sbjct: 58  QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSR--NIQKCYKMFGKI 115

Query: 398 QRFTIICGTAE---GLAHLH----GGSGIKIIHRDIKTSNILLDE------KLT------ 438
           +   I+  T +    LA+ H    G +G +++HRD+K  NI L        K+T      
Sbjct: 116 EEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175

Query: 439 -----PKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR--GQLTEKADVYAFGVLV 491
                 KI DFGL++++  +   ++    GT  Y +PE L+       +K+D++A G ++
Sbjct: 176 NGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCII 233

Query: 492 IEVASGR 498
            E+ SG+
Sbjct: 234 YELCSGK 240

Length = 1021

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 46.3 bits (110), Expect = 3e-05
 Identities = 26/80 (32%), Positives = 39/80 (48%), Gaps = 4/80 (5%)

Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL----VRGQ 477
           IHRD+K  N+LLD+    K+ADFG    +  +         GT  Y++PE L      G 
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGY 223

Query: 478 LTEKADVYAFGVLVIEVASG 497
              + D ++ GV + E+  G
Sbjct: 224 YGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 45.2 bits (107), Expect = 7e-05
 Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 9/95 (9%)

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS---TGIAGTL 465
            L ++H  +   + HRD+K  NIL +     KI DFGLAR VA + T  +   T    T 
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR-VAFNDTPTAIFWTDYVATR 170

Query: 466 GYMAPEYL--VRGQLTEKADVYAFGVLVIEVASGR 498
            Y APE       + T   D+++ G +  EV +G+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 44.2 bits (104), Expect = 8e-05
 Identities = 42/162 (25%), Positives = 79/162 (48%), Gaps = 18/162 (11%)

Query: 341 FFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRF 400
           FF   +++  + HK++V L G  +   E+++V E+V    LD  LF+     +L+   +F
Sbjct: 51  FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKF 108

Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL-----DEKLTP--KIADFGLARHVAPD 453
            +    A  L++L       ++H ++ T NILL     D +  P  K++D G+   V   
Sbjct: 109 KVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR 165

Query: 454 KTHVSTGIAGTLGYMAPEYLVRGQ-LTEKADVYAFGVLVIEV 494
           +  V       + ++APE +   + L+  AD ++FG  + E+
Sbjct: 166 QECVE-----RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 44.6 bits (106), Expect = 9e-05
 Identities = 41/215 (19%), Positives = 80/215 (37%), Gaps = 37/215 (17%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLG 361
           +         + +   P    +AVK++  +  S++ +     E+     +QH N++  + 
Sbjct: 8   KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66

Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFT----------IICGTAEGLA 411
             I   E  +V   +   S + +L  K           F           I+      L 
Sbjct: 67  SFIVDSELYVVSPLMAYGSCEDLL--KTH---------FPEGLPELAIAFILKDVLNALD 115

Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH-VAPDKTHV-----STGIAGTL 465
           ++H       IHR +K S+ILL       ++    +   +   K               L
Sbjct: 116 YIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172

Query: 466 GYMAPEYL---VRGQLTEKADVYAFGVLVIEVASG 497
            +++PE L   ++G   EK+D+Y+ G+   E+A+G
Sbjct: 173 PWLSPEVLQQNLQG-YNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 39/161 (24%), Positives = 67/161 (41%), Gaps = 40/161 (24%)

Query: 371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSN 430
           L+ E++P   +  +L  K+T   L+ ++    I  T   +  +H    +  IHRDIK  N
Sbjct: 78  LIMEFLPGGDMMTLLMKKDT---LTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDN 131

Query: 431 ILLDEKLTPKIADFGLA---------------RHVAP-------------------DKTH 456
           +LLD K   K++DFGL                 H  P                   ++  
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191

Query: 457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           ++    GT  Y+APE  ++    +  D ++ GV++ E+  G
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 40/161 (24%), Positives = 66/161 (40%), Gaps = 40/161 (24%)

Query: 371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSN 430
           L+ E++P   +  +L  K+T   LS +     I  T   +  +H    +  IHRDIK  N
Sbjct: 78  LIMEFLPGGDMMTLLMKKDT---LSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDN 131

Query: 431 ILLDEKLTPKIADFGLA---------------RHVAP-------------------DKTH 456
           +LLD K   K++DFGL                 H  P                   ++  
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191

Query: 457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           ++    GT  Y+APE  ++    +  D ++ GV++ E+  G
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 42.1 bits (99), Expect = 6e-04
 Identities = 30/119 (25%), Positives = 44/119 (36%), Gaps = 42/119 (35%)

Query: 422 IHRDIKTSNILLDEKLTPKIADFGLA---------------------------RHVAPDK 454
           IHRDIK  NIL+D     K+ DFGL                                 D+
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 455 THVST---------------GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
             +                  + GT  Y+APE L+R   T+  D ++ GV++ E+  G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 24/208 (11%)

Query: 305 KLGQGGAGSVFRGTLPDGRN---IAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLG 361
           K+G+G  G V++    DG++    A+K++             E+ L+  ++H NV+ L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQI--EGTGISMSACREIALLRELKHPNVISLQK 65

Query: 362 CSIEGPES--LLVYEYVPNRSLDQILF------VKNTIHILSWQQRFTIICGTAEGLAHL 413
             +   +    L+++Y  +     I F       K  + +     + +++    +G+ +L
Sbjct: 66  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK-SLLYQILDGIHYL 124

Query: 414 HGGSGIKIIHRDIKTSNILL----DEKLTPKIADFGLARHV-APDKTHVSTG-IAGTLGY 467
           H      ++HRD+K +NIL+     E+   KIAD G AR   +P K       +  T  Y
Sbjct: 125 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 468 MAPEYLVRGQLTEKA-DVYAFGVLVIEV 494
            APE L+  +   KA D++A G +  E+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 40.1 bits (93), Expect = 0.003
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 22/207 (10%)

Query: 305 KLGQGGAGSVFRGTLPDGRN---IAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRL-- 359
           K+G+G  G V++    DG++    A+K++             E+ L+  ++H NV+ L  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELKHPNVIALQK 65

Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTI-----HILSWQQRFTIICGTAEGLAHLH 414
           +  S    +  L+++Y  +     I F + +        L      +++    +G+ +LH
Sbjct: 66  VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 415 GGSGIKIIHRDIKTSNILL----DEKLTPKIADFGLARHV-APDKTHVSTG-IAGTLGYM 468
                 ++HRD+K +NIL+     E+   KIAD G AR   +P K       +  T  Y 
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 469 APEYLVRGQLTEKA-DVYAFGVLVIEV 494
           APE L+  +   KA D++A G +  E+
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 33/123 (26%), Positives = 45/123 (36%), Gaps = 46/123 (37%)

Query: 422 IHRDIKTSNILLDEKLTPKIADFGL---------------ARHVAPDKTHVST------- 459
           IHRDIK  NIL+D     K+ DFGL                 HV  D    S        
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 460 ------------------------GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVA 495
                                    + GT  Y+APE L+R   T+  D ++ GV++ E+ 
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 496 SGR 498
            G+
Sbjct: 243 VGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 33/123 (26%), Positives = 48/123 (39%), Gaps = 46/123 (37%)

Query: 422 IHRDIKTSNILLDEKLTPKIADFGL---------------ARHVAPD------------- 453
           IHRDIK  NIL+D     K+ DFGL                 H+  D             
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 454 ---------------KTH---VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVA 495
                          K H   ++  + GT  Y+APE L+R   T+  D ++ GV++ E+ 
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 496 SGR 498
            G+
Sbjct: 243 VGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	625
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.98
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.98
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.98
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.91
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.87
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.86
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.85
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.84
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.79
PRK10345	210	hypothetical protein; Provisional	99.79
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.79
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.78
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.77
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.76
smart00090	237	RIO RIO-like kinase.	99.75
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.75
PRK14879	211	serine/threonine protein kinase; Provisional	99.74
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.74
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.73
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.71
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.71
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.65
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.65
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.64
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.59
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.56
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.51
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.39
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.38
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.36
KOG1243	690	consensus Protein kinase [General function predict	99.3
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.27
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.22
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.2
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.17
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.12
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.06
KOG3087	229	consensus Serine/threonine protein kinase [General	99.0
COG4248	637	Uncharacterized protein with protein kinase and he	98.98
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.96
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.95
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.88
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.87
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.82
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.77
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.62
PRK09902	216	hypothetical protein; Provisional	98.59
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.55
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.5
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.46
PF01636	239	APH: Phosphotransferase enzyme family This family	98.42
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.39
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.31
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.25
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.21
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.19
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.11
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.09
PLN02876	822	acyl-CoA dehydrogenase	98.09
PRK10593	297	hypothetical protein; Provisional	98.09
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.88
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.87
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.84
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.7
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.68
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.68
PRK05231	319	homoserine kinase; Provisional	97.55
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.51
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.51
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.44
PLN02236	344	choline kinase	97.31
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.27
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.21
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.11
PLN02756	418	S-methyl-5-thioribose kinase	96.88
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.77
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.74
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.72
KOG2270	520	consensus Serine/threonine protein kinase involved	96.66
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.65
PRK12396	409	5-methylribose kinase; Reviewed	96.43
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.42
COG2334	331	Putative homoserine kinase type II (protein kinase	96.06
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.86
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.86
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.73
PRK11768	325	serine/threonine protein kinase; Provisional	95.72
PRK06148	1013	hypothetical protein; Provisional	95.57
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.56
KOG1093	725	consensus Predicted protein kinase (contains TBC a	95.41

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-52  Score=432.64  Aligned_cols=288  Identities=43%  Similarity=0.723  Sum_probs=252.0

Q ss_pred             cCccccHHHHHHHhcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeee
Q 042149          284 SSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS  363 (625)
Q Consensus       284 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  363 (625)
                      ....|+|++++.+|++|...++||+|+||.||+|.+.+++.||||++.........+|.+|++++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            34568999999999999999999999999999999999999999988765433134599999999999999999999999


Q ss_pred             eeCC-eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEe
Q 042149          364 IEGP-ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIA  442 (625)
Q Consensus       364 ~~~~-~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~  442 (625)
                      .+.+ ..+||+|||++|+|+++|+..... .++|..|++|+.++|+||+|||.....+||||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9999 599999999999999999876544 68999999999999999999999877789999999999999999999999


Q ss_pred             ecccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCC--CCccchhhHHHhhhc
Q 042149          443 DFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSE--GSSSVLHTVWKHYKA  520 (625)
Q Consensus       443 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~--~~~~~~~~~~~~~~~  520 (625)
                      |||+++..........+...||.+|+|||+...+..+.|+|||||||++.||+||+++.....  ....+..|.+..+..
T Consensus       220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~  299 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE  299 (361)
T ss_pred             CccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence            999997654312222211179999999999999999999999999999999999998876543  334578888889999


Q ss_pred             cccccccCCCCC-CCCCh-HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          521 NRITQSMDPGLT-GRFPE-NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       521 ~~~~~~i~~~~~-~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      ..+.+++|+.+. ..++. .....+..++.+|++.+|++||+|.||+++|+.+.
T Consensus       300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            999999999987 56564 67888999999999999999999999999996554

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2e-47  Score=393.90  Aligned_cols=260  Identities=33%  Similarity=0.462  Sum_probs=215.3

Q ss_pred             ccccccccccCceEEEEEEeCCCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC-eeEEEEEec
Q 042149          300 FDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP-ESLLVYEYV  376 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lV~e~~  376 (625)
                      ..+.+.||+|+||+||+|.++....||||++....  ....+.|.+|+.+|++++|||||+++|++.+.. ...|||||+
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            34455699999999999999654559999997543  222679999999999999999999999999988 799999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC-ceEEeecccceeeCCCCc
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL-TPKIADFGLARHVAPDKT  455 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-~~kl~Dfgla~~~~~~~~  455 (625)
                      ++|+|.++++.. ....+++..++.|+.+|++||.|||++..  ||||||||+||||+.++ ++||+|||+++...... 
T Consensus       123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-  198 (362)
T KOG0192|consen  123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-  198 (362)
T ss_pred             CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence            999999999774 33459999999999999999999997742  99999999999999997 99999999998765432 


Q ss_pred             eeeecCCCCccccCccccc--cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLV--RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                      ...+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||..... ....            ..++....+.
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~------------~~v~~~~~Rp  265 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVA------------SAVVVGGLRP  265 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHH------------HHHHhcCCCC
Confidence            2233468999999999999  56999999999999999999999999764432 1111            1122233444


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCC
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIP  576 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~  576 (625)
                      ..|..++..+..++.+||+.||+.||++.+|+..|+.+.....
T Consensus       266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence            5566688899999999999999999999999999987765443

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-47  Score=373.31  Aligned_cols=251  Identities=26%  Similarity=0.374  Sum_probs=209.1

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC-eeEEEEEe
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP-ESLLVYEY  375 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lV~e~  375 (625)
                      +.+.++.||+|..|+||+++++ +++.+|+|.+..+ +....+++.+|++++++.+||+||++||.|..+. ...|+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            3445778999999999999986 6888999999665 4566788999999999999999999999999988 59999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      |++|+|++++...+   .+++...-+++.++++||.|||..  ++||||||||+||||+..|.|||+|||.++.+...  
T Consensus       160 MDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             cCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            99999999986553   389999999999999999999963  36999999999999999999999999999876544  


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                       ...+++||..|||||.+.+..|+.++||||||++++|+.+|+.|+.................        ++ ...+..
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I--------v~-~ppP~l  302 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI--------VD-EPPPRL  302 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH--------hc-CCCCCC
Confidence             34567899999999999999999999999999999999999999766422111111111111        11 112333


Q ss_pred             ChH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          536 PEN-EASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       536 ~~~-~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      |.. .++++..++..||++||.+||++.|+++
T Consensus       303 P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  303 PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             CcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            554 7888999999999999999999999985

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-47  Score=373.45  Aligned_cols=249  Identities=26%  Similarity=0.423  Sum_probs=206.1

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      .++|.+.++||+|.|++||+|+++ ++..||||.+...  .++..+.+..|+.+|+.++|||||++++++...+.++|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            567889999999999999999976 6899999999766  6777888999999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCC------CceEEeecccc
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEK------LTPKIADFGLA  447 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~------~~~kl~Dfgla  447 (625)
                      |||+||+|.++++.++.   +++..+..++.||+.||++||+++   ||||||||+||||+..      -.+||+|||+|
T Consensus        89 EyC~gGDLs~yi~~~~~---l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGR---LPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            99999999999987664   999999999999999999999875   9999999999999754      46899999999


Q ss_pred             eeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccccccc
Q 042149          448 RHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM  527 (625)
Q Consensus       448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  527 (625)
                      +.+....  .....+|+|-|||||+++.++|+.|+|+||+|+|+|++++|+.|+...... ++.    ..++.+      
T Consensus       163 R~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~-eL~----~~~~k~------  229 (429)
T KOG0595|consen  163 RFLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK-ELL----LYIKKG------  229 (429)
T ss_pred             hhCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH-HHH----HHHhcc------
Confidence            9887443  334589999999999999999999999999999999999999997533221 111    111111      


Q ss_pred             CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042149          528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVV  565 (625)
Q Consensus       528 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~  565 (625)
                       .......+......+.+++...++.+|.+|-++.+..
T Consensus       230 -~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~  266 (429)
T KOG0595|consen  230 -NEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF  266 (429)
T ss_pred             -ccccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence             1122223444455566777778888888887776554

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-46  Score=386.97  Aligned_cols=247  Identities=25%  Similarity=0.373  Sum_probs=211.5

Q ss_pred             cCccccccccccCceEEEEEEe-CCCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      .+|...+.||+|||..+|+++. .+|..||+|++.+.   .....+.+.+||+|.+.|+|||||+++++|++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688999999999999999997 78999999999653   4455788999999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      |+|+.++|.+++..   .+.+++.+++.++.||+.||.|||+.+   |||||||..|+||+++.+|||+|||||..+..+
T Consensus        98 ELC~~~sL~el~Kr---rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLKR---RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHHh---cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            99999999998863   345999999999999999999999764   999999999999999999999999999988755


Q ss_pred             CceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                      .... .+.+|||.|+|||++.....+..+||||+||++|-||.|++||....    + .......+..+          -
T Consensus       172 ~Erk-~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~----v-kety~~Ik~~~----------Y  235 (592)
T KOG0575|consen  172 GERK-KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT----V-KETYNKIKLNE----------Y  235 (592)
T ss_pred             cccc-ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch----H-HHHHHHHHhcC----------c
Confidence            4433 34899999999999999999999999999999999999999975321    1 11111111111          1


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ..|...+.+-.+||.++|+++|.+|||+++|+.
T Consensus       236 ~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  236 SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            125566777889999999999999999999985

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-47  Score=387.52  Aligned_cols=256  Identities=29%  Similarity=0.438  Sum_probs=221.7

Q ss_pred             cCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecC
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVP  377 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~  377 (625)
                      +.+..++.||+|.||.||.|.++....||+|.+..... ..+.|.+|+.+|++|+|+|||++++++..+..++||||||+
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~  284 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP  284 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence            34556788999999999999998778999999976532 24678899999999999999999999999889999999999


Q ss_pred             CCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCcee
Q 042149          378 NRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV  457 (625)
Q Consensus       378 ~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  457 (625)
                      .|+|.++|... .+..+...+.+.++.|||+||+||+++   ++|||||...||||+++..+||+|||||+....+....
T Consensus       285 ~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~  360 (468)
T KOG0197|consen  285 KGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA  360 (468)
T ss_pred             cCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence            99999999763 344589999999999999999999976   49999999999999999999999999999766666655


Q ss_pred             eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCC
Q 042149          458 STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP  536 (625)
Q Consensus       458 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  536 (625)
                      .........|.|||.+..+.++.|||||||||+||||+| |+.|++.              ....++.+.++.+.+.+.|
T Consensus       361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~--------------msn~ev~~~le~GyRlp~P  426 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG--------------MSNEEVLELLERGYRLPRP  426 (468)
T ss_pred             cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC--------------CCHHHHHHHHhccCcCCCC
Confidence            556667789999999999999999999999999999999 5555432              2333444556666777779


Q ss_pred             hHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       537 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      ..++..+.+||..||+.+|++|||++.+...|+++.
T Consensus       427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  427 EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence            999999999999999999999999999999888764

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-46  Score=369.84  Aligned_cols=255  Identities=24%  Similarity=0.300  Sum_probs=207.0

Q ss_pred             HHHhcCccccccccccCceEEEEEEe-CCCCEEEEEEeecCChH-------HHHHHHHHHHHHhcCCCCceeeeeeeeee
Q 042149          294 ERATDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQ-------WVDQFFNEVNLISGIQHKNVVRLLGCSIE  365 (625)
Q Consensus       294 ~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~hpniv~l~~~~~~  365 (625)
                      +...+.|.+.+.||+|+||.|-+|.. ++|+.||||++....-.       ......+|+++|++|+|||||+++++|+.
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~  247 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV  247 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence            34567899999999999999999985 57999999999754211       12335799999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCC---CceEEe
Q 042149          366 GPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEK---LTPKIA  442 (625)
Q Consensus       366 ~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~---~~~kl~  442 (625)
                      .+..|+||||++||.|.+.+-....   +.+.....++.|++.|+.|||++|   |+||||||+|||+..+   ..+||+
T Consensus       248 ~ds~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKIt  321 (475)
T KOG0615|consen  248 PDSSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKIT  321 (475)
T ss_pred             CCceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEec
Confidence            9999999999999999998865543   778888999999999999999886   9999999999999755   789999


Q ss_pred             ecccceeeCCCCceeeecCCCCccccCccccccCcc---cccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhh
Q 042149          443 DFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL---TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK  519 (625)
Q Consensus       443 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~  519 (625)
                      |||+|+...  ......+++|||.|.|||++.+...   ..++|+||+||+||-+|+|.+||........+.    +...
T Consensus       322 DFGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~----eQI~  395 (475)
T KOG0615|consen  322 DFGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLK----EQIL  395 (475)
T ss_pred             ccchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHH----HHHh
Confidence            999999876  3344556899999999999987643   348899999999999999999976443333222    1111


Q ss_pred             ccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       520 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .++..      ..+......+++..++|.+||..||++|||+.|+++
T Consensus       396 ~G~y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  396 KGRYA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             cCccc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            11111      111223567888999999999999999999999885

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-47  Score=358.06  Aligned_cols=256  Identities=24%  Similarity=0.396  Sum_probs=209.9

Q ss_pred             cCccccccccccCceEEEEEE-eCCCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeee-eeeeCCe-eEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLG-CSIEGPE-SLLV  372 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~-~~~~~~~-~~lV  372 (625)
                      .+|+++++||.|.||+||++. +.+|..+|.|.+...  +.+..+....|+.+|++|+|||||++++ .+.+++. ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            357888899999999999998 468999999999765  4566678899999999999999999998 4555554 8999


Q ss_pred             EEecCCCCcchhhhc-cCCcCCCCHHHHHHHHHHHHHHHHHhhcCCC-ceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          373 YEYVPNRSLDQILFV-KNTIHILSWQQRFTIICGTAEGLAHLHGGSG-IKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      |||+.+|+|..++.. +...+.+++..+|+++.|++.||.++|++-+ .-|+||||||.||+|+.+|.+||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999998864 3445669999999999999999999998421 23999999999999999999999999999988


Q ss_pred             CCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          451 APDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                      ...... ....+|||.||+||.+.+.+|+.||||||+||++|||..-+.||...    ++. .+-+....         .
T Consensus       179 ~s~~tf-A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~----n~~-~L~~KI~q---------g  243 (375)
T KOG0591|consen  179 SSKTTF-AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD----NLL-SLCKKIEQ---------G  243 (375)
T ss_pred             cchhHH-HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc----cHH-HHHHHHHc---------C
Confidence            655443 34689999999999999999999999999999999999999987533    111 11122222         2


Q ss_pred             CCCCCC-hHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042149          531 LTGRFP-ENEASRVLQIGLLCTQAPVALRPSMAEVVHML  568 (625)
Q Consensus       531 ~~~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  568 (625)
                      -.++.| ...+..+.+||..|+..||+.||+...++..+
T Consensus       244 d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  244 DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence            223345 56789999999999999999999865555444

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3e-45  Score=359.69  Aligned_cols=248  Identities=25%  Similarity=0.300  Sum_probs=207.3

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .++|+++++||+|+||+||+++.+ +++.+|+|++.+.   ....++...+|..||.+++||.||+++..|.+...+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            578999999999999999999965 5889999998654   345678899999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      +||+.||.|..+|+..+.   +++..+.-++.+|+.||.|||+++   ||||||||+|||||.+|+++|+|||+++....
T Consensus       104 ld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            999999999999976654   899999999999999999999886   99999999999999999999999999986544


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      .+.. ...++||+.|||||++.+..|+..+|+||||+++|||++|.+||......     ...+....++         .
T Consensus       178 ~~~~-t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~-----~~~~~I~~~k---------~  242 (357)
T KOG0598|consen  178 DGDA-TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-----KMYDKILKGK---------L  242 (357)
T ss_pred             CCCc-cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH-----HHHHHHhcCc---------C
Confidence            3332 23489999999999999999999999999999999999999997543211     1111111111         1


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCC----CHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRP----SMAEVV  565 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RP----t~~ev~  565 (625)
                      ...|.-.+.+..+++.+.++.+|++|.    .+.+|.
T Consensus       243 ~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik  279 (357)
T KOG0598|consen  243 PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIK  279 (357)
T ss_pred             CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhh
Confidence            222444677889999999999999995    455543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2e-43  Score=335.58  Aligned_cols=262  Identities=22%  Similarity=0.284  Sum_probs=203.8

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      +.|+.+.++|+|+||+||+++++ +|+.||||++....  +...+-..+|+++|++|+|||+|.++++|.....++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            46788889999999999999976 69999999996543  4445567899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      ||+..-|+++-....   .++.....+++.|++.|+.|+|++   ++|||||||+||||+.+|.+||+|||+|+.+.. .
T Consensus        82 ~~dhTvL~eLe~~p~---G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-p  154 (396)
T KOG0593|consen   82 YCDHTVLHELERYPN---GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-P  154 (396)
T ss_pred             ecchHHHHHHHhccC---CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-C
Confidence            998876666443222   288999999999999999999976   499999999999999999999999999998875 3


Q ss_pred             ceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhH----------HHhhhcccc
Q 042149          455 THVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV----------WKHYKANRI  523 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~----------~~~~~~~~~  523 (625)
                      ....+..+.|.+|.|||.+.+ .+|+..+|||++||++.||++|.+-++...+.+.+....          ...+.....
T Consensus       155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence            344556789999999999988 699999999999999999999997665433222211110          111111111


Q ss_pred             cc-ccCCCC-----CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          524 TQ-SMDPGL-----TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       524 ~~-~i~~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .. +.-|..     ....-+....-+.+++..|++.||.+|++-+|++.
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            11 111111     11111344556889999999999999999988864

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-43  Score=358.19  Aligned_cols=249  Identities=26%  Similarity=0.438  Sum_probs=213.5

Q ss_pred             cCccccccccccCceEEEEEEe-CCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      ..|....+||+|+.|.||.|.. .+++.||||++........+-+.+|+.+|+..+|+|||++++.+...+.+|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            4577788999999999999984 578999999998877766788999999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      +||+|.+++...    .+++.++..|+++++.||+|||.++   |+|||||.+|||++.+|.+||+|||++..+......
T Consensus       353 ~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K  425 (550)
T KOG0578|consen  353 EGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK  425 (550)
T ss_pred             CCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence            999999988433    3899999999999999999999886   999999999999999999999999999988776653


Q ss_pred             eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP  536 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  536 (625)
                      . ...+|||.|||||+.....|++|.||||||++++||+.|.+|+.....    +...+....++.      +  .-..+
T Consensus       426 R-~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P----lrAlyLIa~ng~------P--~lk~~  492 (550)
T KOG0578|consen  426 R-STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP----LRALYLIATNGT------P--KLKNP  492 (550)
T ss_pred             c-ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh----HHHHHHHhhcCC------C--CcCCc
Confidence            3 347899999999999999999999999999999999999999754222    111122111111      1  12336


Q ss_pred             hHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          537 ENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       537 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      +..+..+.+++.+||+.|+++||++.|+++
T Consensus       493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  493 EKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             cccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            778899999999999999999999999986

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=346.78  Aligned_cols=255  Identities=26%  Similarity=0.369  Sum_probs=205.9

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC--eeEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP--ESLLVY  373 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~lV~  373 (625)
                      ..+|...+.||+|.||.||++... +|...|||.+...+....+.+.+|+.+|++++|||||+.+|......  .++|.|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            345777889999999999999965 48999999987664444778999999999999999999999754444  689999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC-CCceEEeecccceeeCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE-KLTPKIADFGLARHVAP  452 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~-~~~~kl~Dfgla~~~~~  452 (625)
                      ||+++|+|.+++...+.  .+++..+..+..||++||+|||+++   ||||||||+||||+. ++.+||+|||+++....
T Consensus        96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES  170 (313)
T ss_pred             eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence            99999999999976554  4999999999999999999999775   999999999999999 79999999999987663


Q ss_pred             --CCceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          453 --DKTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       453 --~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                        ..........||+.|||||++..+ ....++|||||||++.||+||++|+...   ..........         ...
T Consensus       171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~---~~~~~~~~~i---------g~~  238 (313)
T KOG0198|consen  171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF---FEEAEALLLI---------GRE  238 (313)
T ss_pred             ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh---cchHHHHHHH---------hcc
Confidence              222223357899999999999864 3346999999999999999999886532   0001111111         111


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHML  568 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  568 (625)
                      ...+.+|...+.+..+++.+|++.+|+.|||++++++..
T Consensus       239 ~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  239 DSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             CCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence            122355777888899999999999999999999999754

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-42  Score=347.86  Aligned_cols=262  Identities=24%  Similarity=0.368  Sum_probs=207.9

Q ss_pred             HhcCccccccccccCceEEEEEEe-CCCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--CeeE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG--PESL  370 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~  370 (625)
                      -.+.|+.+++||+|.||.||+|++ .+|+.||+|++....  ........+||.||++|+||||+++.+...+.  ..+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            356678888999999999999994 589999999998764  45566778999999999999999999988876  6899


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      +|+|||+. +|.-++..  +.-.++..++..++.|++.||+|+|.++   |+|||||.+|||||++|.+||+|||||+++
T Consensus       195 lVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence            99999965 77776643  2234899999999999999999999775   999999999999999999999999999998


Q ss_pred             CCCCceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHh--------hhcc
Q 042149          451 APDKTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKH--------YKAN  521 (625)
Q Consensus       451 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~  521 (625)
                      ........+..+-|++|.|||.+.+. .|+.++|+||.||||.||++|++.+......+ .++.+++.        |...
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve-Ql~kIfklcGSP~e~~W~~~  347 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE-QLHKIFKLCGSPTEDYWPVS  347 (560)
T ss_pred             cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH-HHHHHHHHhCCCChhccccc
Confidence            87777667777889999999999874 79999999999999999999997754333222 22222222        1111


Q ss_pred             ccc--cccCCCCCCCCC-------hHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          522 RIT--QSMDPGLTGRFP-------ENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       522 ~~~--~~i~~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .+.  ....+  ...+.       ...+....+|+..+|..||.+|.|+.++++
T Consensus       348 kLP~~~~~kp--~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  348 KLPHATIFKP--QQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             cCCcccccCC--CCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            111  11111  11111       123455789999999999999999999875

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=354.55  Aligned_cols=278  Identities=24%  Similarity=0.354  Sum_probs=223.3

Q ss_pred             HHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCee
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPES  369 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~  369 (625)
                      +...+|...+.||+|.|++|++|+.+ +++.||||++.+.   .+..++.+..|-.+|.+| .||.|++|+-.|.++..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            34567999999999999999999954 7999999988543   233456678899999999 799999999999999999


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      |+|+||+++|+|.++|...+.   +++.....++.+|+.||+|||+.|   ||||||||+|||||++|++||+|||.|+.
T Consensus       150 YFvLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             EEEEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence            999999999999999976654   899999999999999999999775   99999999999999999999999999998


Q ss_pred             eCCCCce----------e--eecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHh
Q 042149          450 VAPDKTH----------V--STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKH  517 (625)
Q Consensus       450 ~~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~  517 (625)
                      +......          .  ...++||..|.+||++..+..++.+|+|+||||+|+|+.|++||.....-  +   .++.
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney--l---iFqk  298 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY--L---IFQK  298 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH--H---HHHH
Confidence            7543222          1  13589999999999999999999999999999999999999997533211  1   1111


Q ss_pred             hhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HccccC----CCCCCCCCCCcccccCCC
Q 042149          518 YKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM--LNNIDY----EIPPPKQPPFLNASVISP  591 (625)
Q Consensus       518 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~--L~~~~~----~l~~~~~~~~~~~~~~~~  591 (625)
                           +..     +.-++|+..++...+|+.+.|..||.+|+|..+|.+.  ++++.+    +.+||.-.++.+....++
T Consensus       299 -----I~~-----l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP~l~py~p~~~~s~  368 (604)
T KOG0592|consen  299 -----IQA-----LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPPKLQPYKPATSISP  368 (604)
T ss_pred             -----HHH-----hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcCCCcccCCCCcccCCc
Confidence                 111     1123455666788999999999999999999999864  355543    456666656655444443


Q ss_pred             CC
Q 042149          592 SD  593 (625)
Q Consensus       592 ~~  593 (625)
                      +.
T Consensus       369 e~  370 (604)
T KOG0592|consen  369 EY  370 (604)
T ss_pred             cc
Confidence            33

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.6e-43  Score=376.74  Aligned_cols=259  Identities=29%  Similarity=0.429  Sum_probs=214.6

Q ss_pred             hcCccccccccccCceEEEEEEeC------CCCEEEEEEeecCChH-HHHHHHHHHHHHhcCCCCceeeeeeeeeeCCee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFNSRQ-WVDQFFNEVNLISGIQHKNVVRLLGCSIEGPES  369 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  369 (625)
                      ..+-+..++||+|+||+||+|+..      +...||||.++..... ...+|++|+++|..|+|||||+++|+|.+++.+
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            345566788999999999999842      3567999999876544 778999999999999999999999999999999


Q ss_pred             EEEEEecCCCCcchhhhccCC-----------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCc
Q 042149          370 LLVYEYVPNRSLDQILFVKNT-----------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLT  438 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~  438 (625)
                      ++|+|||..|+|.++|....+           ...|+..+.+.|+.|||.||+||-++.   +|||||...|+||.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence            999999999999999975432           233888999999999999999999764   999999999999999999


Q ss_pred             eEEeecccceeeCCCCceeee-cCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHH
Q 042149          439 PKIADFGLARHVAPDKTHVST-GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWK  516 (625)
Q Consensus       439 ~kl~Dfgla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~  516 (625)
                      |||+||||++.+-..+..... .-.-..+|||||.+..++|+.+||||||||+|||+++ |+.|+.              
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~--------------  707 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYY--------------  707 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccc--------------
Confidence            999999999876443332222 3345679999999999999999999999999999999 555632              


Q ss_pred             hhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          517 HYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       517 ~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      +..++++.+.+..+-.-+.|+++|.++.+||..||+.+|++||+++||-..|+...
T Consensus       708 glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~  763 (774)
T KOG1026|consen  708 GLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA  763 (774)
T ss_pred             ccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence            22233333333333334568999999999999999999999999999999997764

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-41  Score=339.78  Aligned_cols=261  Identities=24%  Similarity=0.324  Sum_probs=210.7

Q ss_pred             hcCccccccccccCceEEEEEE-eCCCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      .+.|++..+||.|..++||+|+ .+.+..||||++..+. ....+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            4679999999999999999999 4578999999998653 4447899999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      ||.+|++.+++...-+.. +++..+..|++++++||.|||.+|   .||||||+.||||+.+|.|||+|||.+..+...+
T Consensus       105 fMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            999999999997654443 899999999999999999999876   9999999999999999999999999887765544


Q ss_pred             ceee---ecCCCCccccCcccccc--CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          455 THVS---TGIAGTLGYMAPEYLVR--GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       455 ~~~~---~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      ....   ..+.||+.|||||++..  ..|+.|+||||||++..||.+|..||.-.....-++...    .+ ........
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL----qn-~pp~~~t~  255 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL----QN-DPPTLLTS  255 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh----cC-CCCCcccc
Confidence            3322   35689999999999644  479999999999999999999999976443332222111    11 11111111


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .+..+........+.+++..||+.||.+|||++++++
T Consensus       256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            1111112234557899999999999999999999875

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1e-41  Score=319.04  Aligned_cols=278  Identities=24%  Similarity=0.323  Sum_probs=212.1

Q ss_pred             cCccccccccccCceEEEEEEe-CCCCEEEEEEeecCChH--HHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      ++|...++||+|.||+||+|++ ++|+.||||++......  .-....+|++.|+.++||||+.++++|-..+.+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4677788999999999999995 57999999999765322  23467899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      ||+ .+|+..+..+.  ..++..++..++.++++||+|||.+.   |+||||||.|+||+.+|.+||+|||+++.+....
T Consensus        82 fm~-tdLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             ecc-ccHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            995 58999886554  34899999999999999999999775   9999999999999999999999999999887654


Q ss_pred             ceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccc---cc---cc-
Q 042149          455 THVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR---IT---QS-  526 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~---~~-  526 (625)
                      ... +..+-|..|.|||.+.+ .+|+..+||||.|||+.||+.|.+-++...+. +.+...+.......   +.   .+ 
T Consensus       156 ~~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi-dQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  156 RIQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI-DQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             ccc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH-HHHHHHHHHcCCCCcccCccccccc
Confidence            432 23368999999999987 57999999999999999999987544322221 22222222211111   11   11 


Q ss_pred             --------cCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCCCCCCCCCccc
Q 042149          527 --------MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNA  586 (625)
Q Consensus       527 --------i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~~~~~~~~~~~  586 (625)
                              -.+.+.. .-..++.+..+++..++..||.+|+|+.|++++  ..-.++|.|..|.-.+.
T Consensus       234 dY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~--~yf~~~P~pt~~~~lp~  298 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH--PYFKSLPLPTPPSKLPI  298 (318)
T ss_pred             cHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc--hhhhcCCCCCChhhCcC
Confidence                    0111111 123445667899999999999999999999864  23334566555554433

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.6e-41  Score=355.07  Aligned_cols=260  Identities=28%  Similarity=0.396  Sum_probs=205.0

Q ss_pred             hcCccccccccccCceEEEEEEe------CCCCEEEEEEeecCC-hHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeC-C
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL------PDGRNIAVKRLFFNS-RQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEG-P  367 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-~  367 (625)
                      .++|++.++||+|+||.||+|.+      .+++.||||++.... ......+.+|+.+++.+ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            56899999999999999999974      235689999986542 34456789999999999 899999999988764 4


Q ss_pred             eeEEEEEecCCCCcchhhhccCC---------------------------------------------------------
Q 042149          368 ESLLVYEYVPNRSLDQILFVKNT---------------------------------------------------------  390 (625)
Q Consensus       368 ~~~lV~e~~~~~sL~~~l~~~~~---------------------------------------------------------  390 (625)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            68899999999999998864321                                                         


Q ss_pred             --cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCcee-eecCCCCccc
Q 042149          391 --IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV-STGIAGTLGY  467 (625)
Q Consensus       391 --~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y  467 (625)
                        ...+++..+..++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++......... .....+++.|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              124778889999999999999999775   9999999999999999999999999998654332221 1223467889


Q ss_pred             cCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHH
Q 042149          468 MAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQI  546 (625)
Q Consensus       468 ~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l  546 (625)
                      +|||++.+..++.++||||||+++|||++ |..|+........    .......+.         ....+...+..+.++
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~----~~~~~~~~~---------~~~~~~~~~~~l~~l  309 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE----FCQRLKDGT---------RMRAPENATPEIYRI  309 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH----HHHHHhcCC---------CCCCCCCCCHHHHHH
Confidence            99999999999999999999999999997 8888654322111    111111111         112234556779999


Q ss_pred             HhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          547 GLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       547 i~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      +.+||+.+|++|||+.||++.|+++.
T Consensus       310 i~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         310 MLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHH
Confidence            99999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-41  Score=320.91  Aligned_cols=237  Identities=26%  Similarity=0.337  Sum_probs=203.9

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .++|+..+.||.|.||.|.+++.+ +|..+|+|++.+..   .+.++...+|..+|+.+.||.++++++.+.+.+.+++|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            357888999999999999999976 68899999997653   45567888999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||++||.|-.+++..++   +++..+.-++.+|+.||+|||+.+   |++|||||+|||||.+|.+||+|||+|+....
T Consensus       123 meyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             EeccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            999999999999975554   899999999999999999999775   99999999999999999999999999998754


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      .    .-..+|||.|+|||++....++.++|.|+|||++|||+.|.+||.....    + .........+          
T Consensus       197 r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----~-~iY~KI~~~~----------  257 (355)
T KOG0616|consen  197 R----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----I-QIYEKILEGK----------  257 (355)
T ss_pred             c----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----H-HHHHHHHhCc----------
Confidence            3    3357999999999999999999999999999999999999999754332    1 1122222211          


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCC
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALR  558 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~R  558 (625)
                      -.+|.....++.+|+.+.++.|-.+|
T Consensus       258 v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  258 VKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence            23577778889999999999999999

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.2e-41  Score=346.72  Aligned_cols=246  Identities=27%  Similarity=0.363  Sum_probs=211.1

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      ++|.+.+.||+|.||.||||+.+ +.+.||+|.+.+.  .++.+..+.+|++|++.++|||||.++++|+...++++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            56888889999999999999965 6888999988654  45567889999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+.| +|..+|...+.   +++..+..++.+++.||.|||+.+   |+|||+||.|||++.+|.+|++|||+|+.+.. +
T Consensus        82 ~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-N  153 (808)
T ss_pred             hhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-C
Confidence            9977 99999976665   999999999999999999999764   99999999999999999999999999998765 4


Q ss_pred             ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          455 THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                      +.+.+.+.|||-|||||.+.++.|+..+|+||||||+||+.+|++||...    ++.+.+ +.+..       |+   .+
T Consensus       154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~----si~~Lv-~~I~~-------d~---v~  218 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR----SITQLV-KSILK-------DP---VK  218 (808)
T ss_pred             ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH----HHHHHH-HHHhc-------CC---CC
Confidence            56667789999999999999999999999999999999999999997421    111111 11111       11   12


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .|...+..+.+++...+++||.+|.|..+++.
T Consensus       219 ~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  219 PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            35677888999999999999999999999875

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=346.47  Aligned_cols=250  Identities=22%  Similarity=0.315  Sum_probs=206.3

Q ss_pred             HHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC----Ch-HHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCC
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN----SR-QWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEGP  367 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~  367 (625)
                      ...+.|.+.+.||+|.||+|+.|++. ++..||||.+...    .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            34568999999999999999999865 6899999966543    12 34557778999999999 999999999999999


Q ss_pred             eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCC-CceEEeeccc
Q 042149          368 ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEK-LTPKIADFGL  446 (625)
Q Consensus       368 ~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~-~~~kl~Dfgl  446 (625)
                      ..++||||+.||+|.+.+...+   .+.+.++..++.|++.|++|+|+.+   |+||||||+|||++.+ +++||+|||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence            9999999999999999997643   3888999999999999999999775   9999999999999999 9999999999


Q ss_pred             ceeeCCCCceeeecCCCCccccCccccccCc-cc-ccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccc
Q 042149          447 ARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQ-LT-EKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRIT  524 (625)
Q Consensus       447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  524 (625)
                      +.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...    ..... ......+.  
T Consensus       168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~----~~~~l-~~ki~~~~--  239 (370)
T KOG0583|consen  168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS----NVPNL-YRKIRKGE--  239 (370)
T ss_pred             ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc----cHHHH-HHHHhcCC--
Confidence            99874 2223344579999999999999876 75 7899999999999999999997642    11111 11111111  


Q ss_pred             cccCCCCCCCCChHH-HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          525 QSMDPGLTGRFPENE-ASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       525 ~~i~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                              -.+|... +.++..++.+|+..+|.+|+|+.+|++
T Consensus       240 --------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  240 --------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             --------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence                    1224444 788999999999999999999999993

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-42  Score=345.53  Aligned_cols=260  Identities=25%  Similarity=0.353  Sum_probs=205.6

Q ss_pred             HhcCccccccccccCceEEEEEEe-CCCCEEEEEEeecCChHHHHH-HHHHHHHHhcCC-CCceeeeeeeeeeCC-eeEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQ-FFNEVNLISGIQ-HKNVVRLLGCSIEGP-ESLL  371 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~-~~~E~~~l~~l~-hpniv~l~~~~~~~~-~~~l  371 (625)
                      ..++|.++++||.|.||.||+|+. .++..||||+++..-..+.+. -.+|+..|++|. |||||++.+++.+.+ .+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            356788899999999999999995 478999999987653332222 258999999998 999999999999888 9999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||||| ..+|.+++..+  ...+++..+..|+.||++||+|+|.+|   +.||||||+|||+..+..+||+|||+|+.+.
T Consensus        88 VfE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   88 VFEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eHHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence            99999 56999999766  456999999999999999999999776   9999999999999988899999999999876


Q ss_pred             CCCceeeecCCCCccccCccccc-cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHh-----------hh
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLV-RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKH-----------YK  519 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~-----------~~  519 (625)
                      ....  .+..+.|.+|.|||++. .+.|+.+.|||++|||++||.+-++-|+.....+    ..|+.           |.
T Consensus       162 SkpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D----qi~KIc~VLGtP~~~~~~  235 (538)
T KOG0661|consen  162 SKPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID----QIYKICEVLGTPDKDSWP  235 (538)
T ss_pred             cCCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH----HHHHHHHHhCCCccccch
Confidence            5544  35578999999999885 5789999999999999999999987665332222    11211           11


Q ss_pred             c-cccccccCCCCC-------CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          520 A-NRITQSMDPGLT-------GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       520 ~-~~~~~~i~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      . ..+...+.-.+.       ...-++.+.+..++|.+|+..||++|||++|.+++
T Consensus       236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            1 011111111110       11123477889999999999999999999999874

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=350.29  Aligned_cols=271  Identities=26%  Similarity=0.401  Sum_probs=219.1

Q ss_pred             cHHHHHHHhcCccccccccccCceEEEEEEeCCCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC
Q 042149          289 KYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG  366 (625)
Q Consensus       289 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  366 (625)
                      ..++++...+...+...||+|.||+||+|+|.  ..||||++...  ..+..+.|++|+.++++-+|.||+-+.|++...
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            34566666777888999999999999999985  47999999765  456788999999999999999999999999887


Q ss_pred             CeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccc
Q 042149          367 PESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGL  446 (625)
Q Consensus       367 ~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgl  446 (625)
                      +. .||..+|+|.+|..+|+....  .++....++|+.||++|+.|||.+.   |||||||..|||+.++++|||+|||+
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGL  534 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGL  534 (678)
T ss_pred             ce-eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccc
Confidence            77 999999999999999986653  4889999999999999999999874   99999999999999999999999999


Q ss_pred             ceeeCCC-CceeeecCCCCccccCccccccC---cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccc
Q 042149          447 ARHVAPD-KTHVSTGIAGTLGYMAPEYLVRG---QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR  522 (625)
Q Consensus       447 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  522 (625)
                      +..-... .........|...|||||+++.+   +|++.+||||||+++|||+||..|+. ....+.++..+-.++...+
T Consensus       535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd  613 (678)
T KOG0193|consen  535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPD  613 (678)
T ss_pred             eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCcc
Confidence            8643221 11111223578899999998643   68999999999999999999999987 4444443322222222222


Q ss_pred             cccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCCC
Q 042149          523 ITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPP  577 (625)
Q Consensus       523 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~~  577 (625)
                      ..         ....++++++.+|+..||..++++||.+.+|+.+|+.+...+|.
T Consensus       614 ~s---------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pk  659 (678)
T KOG0193|consen  614 LS---------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPK  659 (678)
T ss_pred             ch---------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccc
Confidence            11         12346788999999999999999999999999988887655443

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-42  Score=361.43  Aligned_cols=301  Identities=25%  Similarity=0.351  Sum_probs=240.2

Q ss_pred             ccccccccccCceEEEEEEeCC----CCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          300 FDNSRKLGQGGAGSVFRGTLPD----GRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      -.+.++||.|.||.|++|+++.    ...||||.++.. .++....|+.|+.||-+++||||++|.|+........||.|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            4678999999999999999752    356899999876 45556789999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      ||++|+|+.+|..+..  .+.+.+...++++|+.|++||.+.   ++|||||...||||+.+...|++|||+++.+.++.
T Consensus       711 yMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  711 YMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  785 (996)
T ss_pred             hhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence            9999999999976653  489999999999999999999955   59999999999999999999999999999876555


Q ss_pred             ceeee--cCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          455 THVST--GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       455 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      ....+  +-....+|.|||.+...+++.++||||+|+++||.++ |.+|+..              +.++++...|+.+.
T Consensus       786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd--------------mSNQdVIkaIe~gy  851 (996)
T KOG0196|consen  786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD--------------MSNQDVIKAIEQGY  851 (996)
T ss_pred             CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc--------------cchHHHHHHHHhcc
Confidence            33322  2344679999999999999999999999999999776 8888653              33344455566677


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCCCCCCCCCcccccCCCCCCCCCCccccccccccCCc
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNASVISPSDNSKDSMMSSFKSFVAESP  611 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ss~~s~~~~~~  611 (625)
                      +.+.|.+++..|.+||+.|||+|..+||.+.+|+..|+++-..-..-......   ...++.+-.+ .+.+.-....+..
T Consensus       852 RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~~---~~r~s~~lld-~~~~~~~~f~sv~  927 (996)
T KOG0196|consen  852 RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAPE---SPRPSQPLLD-RSGSDFTPFRSVG  927 (996)
T ss_pred             CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCCC---CCCCcccccC-CCCCCCcccCCHH
Confidence            77779999999999999999999999999999999999874321111111111   1111111111 2233334456788


Q ss_pred             cccccccccccC
Q 042149          612 EIDHSLKMKAFE  623 (625)
Q Consensus       612 ~~~~~~~~~~~~  623 (625)
                      +|..+|+|.++.
T Consensus       928 ~WL~aIkm~rY~  939 (996)
T KOG0196|consen  928 DWLEAIKMGRYK  939 (996)
T ss_pred             HHHHHhhhhHHH
Confidence            899999998763

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-42  Score=347.36  Aligned_cols=243  Identities=26%  Similarity=0.379  Sum_probs=204.8

Q ss_pred             cccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCCC
Q 042149          301 DNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRS  380 (625)
Q Consensus       301 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~s  380 (625)
                      ..++.||+|+.|.||+|++++ +.||||++....       +.+|+-|++|+||||+.+.|+|.....++||||||..|-
T Consensus       127 sELeWlGSGaQGAVF~Grl~n-etVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRLHN-ETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhhhccCcccceeeeeccC-ceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            346789999999999999854 889999874322       347888999999999999999999999999999999999


Q ss_pred             cchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceeeec
Q 042149          381 LDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG  460 (625)
Q Consensus       381 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  460 (625)
                      |..+|.....   +.......|..+||.|+.|||.+   +|||||||.-||||..+..|||+|||-++......  ....
T Consensus       199 L~~VLka~~~---itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S--TkMS  270 (904)
T KOG4721|consen  199 LYEVLKAGRP---ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS--TKMS  270 (904)
T ss_pred             HHHHHhccCc---cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhh--hhhh
Confidence            9999976554   78888899999999999999966   59999999999999999999999999988765442  2335


Q ss_pred             CCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHH
Q 042149          461 IAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEA  540 (625)
Q Consensus       461 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  540 (625)
                      ++||..|||||++...+.++|+|||||||||||||||..|+..-+..             .-|.-+-...+..+.|..++
T Consensus       271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-------------AIIwGVGsNsL~LpvPstcP  337 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-------------AIIWGVGSNSLHLPVPSTCP  337 (904)
T ss_pred             hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-------------eeEEeccCCcccccCcccCc
Confidence            89999999999999999999999999999999999999996422111             11122223344455678889


Q ss_pred             HHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          541 SRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       541 ~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      +.+.-|+.+||+..|.+||++.+|+..|+-..
T Consensus       338 ~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~  369 (904)
T KOG4721|consen  338 DGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS  369 (904)
T ss_pred             hHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence            99999999999999999999999999886543

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=7.2e-41  Score=341.63  Aligned_cols=261  Identities=22%  Similarity=0.278  Sum_probs=208.2

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      ..++|++++.||+|+||.||+|+.+ +|..+|+|++.+..   ...++.+..|-.+|...++|.||++|-.|.+...+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            4678999999999999999999965 69999999998763   4567788899999999999999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||||++||++..+|...+.   |++..+..++.+++.|+..||+.|   +|||||||+|+|||..|++||+||||+.-+.
T Consensus       219 iMEylPGGD~mTLL~~~~~---L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKDT---LTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHHhcCc---CchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence            9999999999999976655   999999999999999999999665   9999999999999999999999999984321


Q ss_pred             C-----------------------CCc-----ee------------------eecCCCCccccCccccccCcccccCcEE
Q 042149          452 P-----------------------DKT-----HV------------------STGIAGTLGYMAPEYLVRGQLTEKADVY  485 (625)
Q Consensus       452 ~-----------------------~~~-----~~------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~  485 (625)
                      .                       +..     ..                  ....+|||.|||||++.+..|+...|+|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            0                       000     00                  0135799999999999999999999999


Q ss_pred             eehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCC---HH
Q 042149          486 AFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPS---MA  562 (625)
Q Consensus       486 SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~  562 (625)
                      |||||+||||.|-+||.......     .|..+..-+.      .+.-+.......+..+||.+|+. ||++|.-   ++
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~-----T~rkI~nwr~------~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~  440 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQE-----TYRKIVNWRE------TLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAE  440 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHhh------hccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHH
Confidence            99999999999999986543322     2222211110      01111122334678899999998 9999974   67


Q ss_pred             HHHHH--HccccCC
Q 042149          563 EVVHM--LNNIDYE  574 (625)
Q Consensus       563 ev~~~--L~~~~~~  574 (625)
                      ||.++  ++++.|+
T Consensus       441 EIK~HPfF~~v~W~  454 (550)
T KOG0605|consen  441 EIKKHPFFKGVDWD  454 (550)
T ss_pred             HHhcCCccccCCcc
Confidence            76653  4555554

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-42  Score=341.54  Aligned_cols=247  Identities=24%  Similarity=0.380  Sum_probs=212.3

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      .|...++||+|.||.||+|.+. +++.||+|++..+ .+..++.+.+|+.+|..++++||.++|+.+..+..++++||||
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~   93 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC   93 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence            4666789999999999999964 6899999999776 4556788999999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      .||++.++|.....   +.+..+.-++++++.||.|||.++   .+|||||+.|||+..+|.+||+|||.+.........
T Consensus        94 ~gGsv~~lL~~~~~---~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   94 GGGSVLDLLKSGNI---LDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             cCcchhhhhccCCC---CccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            99999999865443   578888889999999999999775   999999999999999999999999999887765554


Q ss_pred             eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP  536 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  536 (625)
                      . ..++|||.|||||+++...|+.|+||||||++.+||.+|.+|+.-              .-..++.-+|.....+...
T Consensus       168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~--------------~hPmrvlflIpk~~PP~L~  232 (467)
T KOG0201|consen  168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSK--------------LHPMRVLFLIPKSAPPRLD  232 (467)
T ss_pred             c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcc--------------cCcceEEEeccCCCCCccc
Confidence            4 568999999999999988999999999999999999999999542              2223444444444444445


Q ss_pred             hHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          537 ENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       537 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ...+..+.+++..||++||+.||++.++++
T Consensus       233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  233 GDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             cccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            567788999999999999999999998874

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.4e-40  Score=338.98  Aligned_cols=265  Identities=25%  Similarity=0.380  Sum_probs=204.3

Q ss_pred             hcCccccccccccCceEEEEEEeCC-----------------CCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPD-----------------GRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVR  358 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~  358 (625)
                      .++|.+.++||+|+||.||++.+++                 +..||||.+... .......+.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3578889999999999999997532                 336999988764 3444567999999999999999999


Q ss_pred             eeeeeeeCCeeEEEEEecCCCCcchhhhccC----------------CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEE
Q 042149          359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKN----------------TIHILSWQQRFTIICGTAEGLAHLHGGSGIKII  422 (625)
Q Consensus       359 l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ii  422 (625)
                      +++++.+.+..++||||+++++|.+++....                ....+++..++.++.||+.||.|||+.+   |+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            9999999999999999999999999885422                1134788899999999999999999775   99


Q ss_pred             EeeeccCcEEEcCCCceEEeecccceeeCCCCcee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCC
Q 042149          423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNS  501 (625)
Q Consensus       423 HrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~  501 (625)
                      ||||||+|||++.++.+||+|||+++......... .....++..|+|||++..+.++.++||||||+++|||+++..+.
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            99999999999999999999999998654433221 22345678999999998889999999999999999999865443


Q ss_pred             CCCCCC-ccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcc
Q 042149          502 VFSEGS-SSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN  570 (625)
Q Consensus       502 ~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  570 (625)
                      ++.... ...............      .......++.++..+.+++.+||+.+|++|||+.+|.+.|++
T Consensus       241 p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         241 PYGELTDEQVIENAGEFFRDQG------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCcCCHHHHHHHHHHHhhhcc------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            333221 112111111111110      001111234456789999999999999999999999998853

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-40  Score=331.04  Aligned_cols=255  Identities=22%  Similarity=0.246  Sum_probs=201.3

Q ss_pred             HHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCCh--------------HHHHHHHHHHHHHhcCCCCceeee
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSR--------------QWVDQFFNEVNLISGIQHKNVVRL  359 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~hpniv~l  359 (625)
                      ...+.|++.+.||+|.||.|-+|+.. +++.||||++.+...              ..+++..+||.||++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            34578999999999999999999964 789999999854321              124688999999999999999999


Q ss_pred             eeeeee--CCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC
Q 042149          360 LGCSIE--GPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL  437 (625)
Q Consensus       360 ~~~~~~--~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~  437 (625)
                      +++..+  .+.+|||+|||..|.+...-   .....++..++++++++++.||+|||.++   ||||||||+|+||+++|
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence            998865  45799999999988876532   22222899999999999999999999986   99999999999999999


Q ss_pred             ceEEeecccceeeCCCCc----eeeecCCCCccccCccccccCc----ccccCcEEeehhhhHHHHhCCCCCCCCCCCcc
Q 042149          438 TPKIADFGLARHVAPDKT----HVSTGIAGTLGYMAPEYLVRGQ----LTEKADVYAFGVLVIEVASGRRNSVFSEGSSS  509 (625)
Q Consensus       438 ~~kl~Dfgla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~  509 (625)
                      ++||+|||.+..+.....    .......|||.|+|||...++.    .+.+.||||+||+||-|+.|+.||....    
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~----  323 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF----  323 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch----
Confidence            999999999886632211    1112368999999999997743    3578999999999999999999974221    


Q ss_pred             chhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042149          510 VLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHML  568 (625)
Q Consensus       510 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  568 (625)
                       ....+..        +++..+.-+..+++.+.+.+||+++|++||++|.+..+|....
T Consensus       324 -~~~l~~K--------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  324 -ELELFDK--------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             -HHHHHHH--------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence             1111222        2222232222345678899999999999999999999998655

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.7e-40  Score=331.56  Aligned_cols=256  Identities=27%  Similarity=0.394  Sum_probs=207.8

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      .++|++.++||+|+||.||+|..+++..||+|.+..... ..+.+.+|+.++++++||||+++++.+......++||||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            467899999999999999999988888999998865433 3578899999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      ++++|.+++.... ...+++..+..++.+++.||+|||+.+   ++||||||+||+++.++.++|+|||++.........
T Consensus        84 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          84 AKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            9999999886543 234889999999999999999999775   999999999999999999999999999876543322


Q ss_pred             eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                      ......++..|+|||++..+.++.++||||||+++|+|+| |+.|+..... ...    .......         ...+.
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-~~~----~~~~~~~---------~~~~~  225 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN-SDV----MSALQRG---------YRMPR  225 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH-HHH----HHHHHcC---------CCCCC
Confidence            2223346778999999988889999999999999999999 8877643211 111    1111111         11111


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      ....+..+.+++.+||+.+|++||+++++.+.|+++
T Consensus       226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         226 MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            234566789999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-40  Score=346.21  Aligned_cols=243  Identities=26%  Similarity=0.324  Sum_probs=205.6

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~  370 (625)
                      ..++|..+++||+|.||+|+++..+ +++.+|||.+++.   .++.++..+.|.+|+... +||.++.++.+|..+++++
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            4578999999999999999999976 6789999999876   467788999999998877 4999999999999999999


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      +||||+.||++..+.    ....+++..+.-++..|+.||.|||+++   |||||||.+|||||.+|.+||+|||+++.-
T Consensus       446 fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence            999999999954433    2344999999999999999999999876   999999999999999999999999999875


Q ss_pred             CCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          451 APDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                      ...+. ...+++|||.|||||++.++.|+.++|+|||||+|||||.|+.||...+..     .++..+...+        
T Consensus       519 m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-----e~FdsI~~d~--------  584 (694)
T KOG0694|consen  519 MGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-----EVFDSIVNDE--------  584 (694)
T ss_pred             CCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHhcCC--------
Confidence            43333 344689999999999999999999999999999999999999997643321     1122222111        


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCCH
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPSM  561 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~  561 (625)
                        ..+|...+.+..+|+.+++.++|++|.-+
T Consensus       585 --~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  585 --VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             --CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence              23577888899999999999999999755

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-40  Score=343.59  Aligned_cols=248  Identities=25%  Similarity=0.324  Sum_probs=209.8

Q ss_pred             cCccccccccccCceEEEEEEe-CCCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      .-|++.+.||.|+.|.|-+|++ .+|+.+|||++.+.   .......+.+||.||+.+.|||++++|+++++...+|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            4578889999999999999996 48999999999654   2233456889999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||++||-|.+++..+++   +++.++.+++.||+.|+.|+|..   +|+||||||+|+|||..+++||+|||+|..-.++
T Consensus        92 Eyv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             EecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            99999999999977765   89999999999999999999955   5999999999999999999999999999865443


Q ss_pred             CceeeecCCCCccccCccccccCccc-ccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLT-EKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      ..  ..+.||+|.|++||++.+.+|. .++||||.|||||.||||+.||. +++    +..+......+..         
T Consensus       166 kl--LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd-DdN----ir~LLlKV~~G~f---------  229 (786)
T KOG0588|consen  166 KL--LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD-DDN----IRVLLLKVQRGVF---------  229 (786)
T ss_pred             cc--ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-Ccc----HHHHHHHHHcCcc---------
Confidence            32  3346999999999999999885 79999999999999999999975 111    2222222333221         


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHML  568 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  568 (625)
                       +.|.+++.+..+|+.+|+..||++|.|++||++..
T Consensus       230 -~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  230 -EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             -cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence             23667788899999999999999999999999753

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=346.34  Aligned_cols=260  Identities=27%  Similarity=0.392  Sum_probs=211.3

Q ss_pred             cCccccccccccCceEEEEEEeCC--C---CEEEEEEeec---CChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCee
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLPD--G---RNIAVKRLFF---NSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPES  369 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~~--~---~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  369 (625)
                      ++-...++||+|+||.||+|+++.  +   ..||||....   ..++.+..|.+|+++|+.++|||||++||+...+..+
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl  236 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL  236 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence            344456899999999999999642  2   2389998875   3477788999999999999999999999999999999


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      +||||+|+||+|+++|.....  .++..++..++.+.+.||+|||++.   +|||||..+|+|++.++.+||+|||+++.
T Consensus       237 ~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  237 MLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA  311 (474)
T ss_pred             EEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence            999999999999999976543  4899999999999999999999775   99999999999999999999999999875


Q ss_pred             eCCCCceeee-cCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhcccccccc
Q 042149          450 VAPDKTHVST-GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSM  527 (625)
Q Consensus       450 ~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  527 (625)
                      -...  .... ...-...|+|||.+..+-++.++|||||||++||+++ |..|+......              .+..-+
T Consensus       312 ~~~~--~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------------~v~~kI  375 (474)
T KOG0194|consen  312 GSQY--VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------------EVKAKI  375 (474)
T ss_pred             Ccce--eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--------------HHHHHH
Confidence            4311  1111 1235679999999999999999999999999999999 67765432211              111111


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCCCC
Q 042149          528 -DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPP  578 (625)
Q Consensus       528 -~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~~~  578 (625)
                       ....+...|...+..+..++.+||..+|++||+|.++.+.|+.+.....++
T Consensus       376 ~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~  427 (474)
T KOG0194|consen  376 VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF  427 (474)
T ss_pred             HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence             223344445677888999999999999999999999999998876555543

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3e-40  Score=333.45  Aligned_cols=256  Identities=25%  Similarity=0.357  Sum_probs=204.8

Q ss_pred             hcCccccccccccCceEEEEEEeC----CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP----DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      .++|++.+.||+|+||.||+|.++    .+..||+|.+... .......+.+|+.++++++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            356889999999999999999853    3568999998755 33445678999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||||+++++|.+++....  ..+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.++++|||.+....
T Consensus        84 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          84 VTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            999999999999886432  34899999999999999999999775   9999999999999999999999999876543


Q ss_pred             CCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                      ...........++..|+|||.+.+..++.++||||||+++||+++ |+.|+..... ...    .+...         ..
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-~~~----~~~~~---------~~  224 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-QDV----IKAVE---------DG  224 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-HHH----HHHHH---------CC
Confidence            222111112345678999999999999999999999999999775 8888643211 111    11111         11


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      ...+.+...+..+.+++.+||+.+|++||++++|++.|.++
T Consensus       225 ~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            11223455677899999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9e-41  Score=342.20  Aligned_cols=251  Identities=23%  Similarity=0.347  Sum_probs=214.4

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCe-eEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPE-SLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-~~lV~  373 (625)
                      ++|+.++++|+|+||.++..+++ +++.+++|++....  ....+...+|+.++++++|||||.+++.|++++. ++|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57888999999999999999976 68899999997553  3334578899999999999999999999999888 99999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      +|++||+|.+.+.... +..+++..+..|+.|++.|+.|||++   +|+|||||+.|||++.++.|||+|||+|+.+...
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999997665 44589999999999999999999966   4999999999999999999999999999998766


Q ss_pred             CceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                      ... ...+.|||.||.||++.+.+|+.|+|||||||++|||++-+++|...+...    ..          .-+.+....
T Consensus       160 ~~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~----Li----------~ki~~~~~~  224 (426)
T KOG0589|consen  160 DSL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE----LI----------LKINRGLYS  224 (426)
T ss_pred             hhh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH----HH----------HHHhhccCC
Confidence            533 345789999999999999999999999999999999999998865433211    11          111222334


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      +.|...+.++..++..|++.+|+.||++.+++.+
T Consensus       225 Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  225 PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            5577889999999999999999999999999875

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4e-40  Score=335.61  Aligned_cols=247  Identities=18%  Similarity=0.286  Sum_probs=199.7

Q ss_pred             cccccccCceEEEEEEeCCCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeee----CCeeEEEEEe
Q 042149          303 SRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIE----GPESLLVYEY  375 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lV~e~  375 (625)
                      ...||+|++|.||+|.+ +|+.||||++....   ....+.+.+|+.+|++++||||+++++++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999998 68899999986542   3336788899999999999999999999876    3578999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++|+|.+++....   .+++.....++.+++.||.|||...  +++||||||+|||+++++.+||+|||+++...... 
T Consensus       104 ~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        104 CTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            99999999986543   4889999999999999999999742  48899999999999999999999999987654322 


Q ss_pred             eeeecCCCCccccCcccccc--CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVR--GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                         ....|++.|+|||++.+  ..++.++||||||+++|||++|+.|+...... .    .......        .....
T Consensus       178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-~----~~~~i~~--------~~~~~  241 (283)
T PHA02988        178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-E----IYDLIIN--------KNNSL  241 (283)
T ss_pred             ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-H----HHHHHHh--------cCCCC
Confidence               12468899999999976  68999999999999999999999997532211 1    1111110        11111


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      ..+...+..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus       242 ~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        242 KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            223356778999999999999999999999999997653

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=7.5e-40  Score=340.98  Aligned_cols=246  Identities=23%  Similarity=0.269  Sum_probs=202.2

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .++|++.+.||+|+||.||+|+++ +++.||||++...   .....+.+.+|+.++++++||||+++++.+.+++..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            357899999999999999999975 6889999998653   223456788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+++++|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        97 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             EcCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            99999999999886543   3788999999999999999999775   99999999999999999999999999987643


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      ...    ...||+.|+|||++.+..++.++|||||||++|||++|+.|+.....     ...+.......          
T Consensus       171 ~~~----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~~~~~i~~~~----------  231 (329)
T PTZ00263        171 RTF----TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-----FRIYEKILAGR----------  231 (329)
T ss_pred             Ccc----eecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-----HHHHHHHhcCC----------
Confidence            322    35799999999999998999999999999999999999999743211     11111111111          


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPS-----MAEVVHM  567 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~~  567 (625)
                      ...|...+..+.+++.+||+.||++||+     +++++..
T Consensus       232 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        232 LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            1123345567899999999999999997     6777643

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=7.1e-40  Score=347.02  Aligned_cols=258  Identities=28%  Similarity=0.371  Sum_probs=203.4

Q ss_pred             hcCccccccccccCceEEEEEEe------CCCCEEEEEEeecC-ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL------PDGRNIAVKRLFFN-SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPE  368 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~  368 (625)
                      .++|++.++||+|+||.||+|++      .++..||||++... .....+.+.+|+.+++.+ +||||+++++++.....
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45688999999999999999963      24568999998644 234456788999999999 89999999999999999


Q ss_pred             eEEEEEecCCCCcchhhhccCC----------------------------------------------------------
Q 042149          369 SLLVYEYVPNRSLDQILFVKNT----------------------------------------------------------  390 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~----------------------------------------------------------  390 (625)
                      .++||||+++|+|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999988864321                                                          


Q ss_pred             --------------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          391 --------------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       391 --------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                                    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          124788899999999999999999775   999999999999999999999999999876443322


Q ss_pred             ee-ecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          457 VS-TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       457 ~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                      .. ....++..|+|||++.+..++.++||||||+++|||++ |..|+.........    ++....+         ....
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~----~~~~~~~---------~~~~  337 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF----YKMIKEG---------YRML  337 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHH----HHHHHhC---------ccCC
Confidence            11 12345678999999999999999999999999999998 66665432221111    1111111         1111


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcc
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN  570 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  570 (625)
                      .+...+.++.+|+.+||+.+|++||++.||+++|++
T Consensus       338 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         338 SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            223345678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-40  Score=365.88  Aligned_cols=260  Identities=31%  Similarity=0.411  Sum_probs=211.4

Q ss_pred             cCccccccccccCceEEEEEEeC--CCC----EEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP--DGR----NIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  370 (625)
                      ++-...+.||+|.||.||.|...  ++.    .||||.+... +.+....|.+|..+|++++|||||+++|++.+....+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            34566788999999999999853  343    4899998765 5677889999999999999999999999999999999


Q ss_pred             EEEEecCCCCcchhhhccC----CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccc
Q 042149          371 LVYEYVPNRSLDQILFVKN----TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGL  446 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgl  446 (625)
                      |++|||++|+|..+|+...    ....++..+.+.++.+||+|+.||++++   +|||||..+|+||++...|||+||||
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence            9999999999999997542    1345899999999999999999999775   99999999999999999999999999


Q ss_pred             ceeeCCCCceeee-cCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccc
Q 042149          447 ARHVAPDKTHVST-GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRIT  524 (625)
Q Consensus       447 a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  524 (625)
                      |+.+......... ...-...|||||.++.+.++.|+|||||||++||++| |..|+... ...+++..+    .     
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~-~n~~v~~~~----~-----  918 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR-SNFEVLLDV----L-----  918 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc-chHHHHHHH----H-----
Confidence            9954433322222 1234569999999999999999999999999999999 55554322 221221111    1     


Q ss_pred             cccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCC
Q 042149          525 QSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYE  574 (625)
Q Consensus       525 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  574 (625)
                          ..-+.+.|..++..+.+||..||+.+|++||++..|++.+..+...
T Consensus       919 ----~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  919 ----EGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             ----hCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence                1113445889999999999999999999999999999988777543

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.8e-40  Score=316.63  Aligned_cols=280  Identities=23%  Similarity=0.309  Sum_probs=209.9

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHH--HHHHHHHHHHHhcCCCCceeeeeeeeee--CCeeEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQW--VDQFFNEVNLISGIQHKNVVRLLGCSIE--GPESLL  371 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~l  371 (625)
                      .+.|+.+++|++|.||.||+|+++ +++.||+|+++....+.  --.-.+||.+|.+.+|||||.+-.+.+.  -+.+|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            356888999999999999999975 68899999997654221  1245799999999999999999887764  457999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      |||||+. +|..++....  ..+...++..+..|+++|++|||.+.   |+||||||+|+|+++.|.+||+|||+|+.+.
T Consensus       155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence            9999965 8888886544  45889999999999999999999776   9999999999999999999999999999887


Q ss_pred             CCCceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhH-----------HHhhh
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV-----------WKHYK  519 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~-----------~~~~~  519 (625)
                      .... ..+..+-|.+|.|||.+.+. .|+.+.|+||+|||+.||+++++-+......+.+ ...           |.++.
T Consensus       229 sp~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl-~~If~llGtPte~iwpg~~  306 (419)
T KOG0663|consen  229 SPLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQL-DKIFKLLGTPSEAIWPGYS  306 (419)
T ss_pred             CCcc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHH-HHHHHHhCCCccccCCCcc
Confidence            6533 34456789999999999875 6899999999999999999999765543222221 111           22222


Q ss_pred             cccccc------ccCCCCCCCCChH-HHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCCCCCCCCCccc
Q 042149          520 ANRITQ------SMDPGLTGRFPEN-EASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNA  586 (625)
Q Consensus       520 ~~~~~~------~i~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~~~~~~~~~~~  586 (625)
                      .-....      .--..+...++.. ..+.-.+|+..++..||++|.|++|.++.  +.-.+.|.|..|.+.+.
T Consensus       307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~P~~~Pt  378 (419)
T KOG0663|consen  307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPIDPSMFPT  378 (419)
T ss_pred             ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCChhhcCC
Confidence            211111      0011122222222 44667889999999999999999998752  33344555555554443

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-40  Score=327.24  Aligned_cols=248  Identities=20%  Similarity=0.278  Sum_probs=208.6

Q ss_pred             hcCccccccccccCceEEEEEEe-CCCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      ..+|++.+.||+|.||.|-+|.. ..|+.||||.+.+.   +++++-.+.+||+||+.|+||||+.+|++|++.+.+.||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            45677788899999999999984 68999999988654   566777899999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||..+|.|.+++...+.   |++.++..+++||..|+.|+|.++   ++|||||.+|||+|.++++||+|||++.++..
T Consensus       132 MEYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  132 MEYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            999999999999976665   999999999999999999999774   99999999999999999999999999988765


Q ss_pred             CCceeeecCCCCccccCccccccCcc-cccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      ...  ...++|+|-|.+||++.+.+| ++.+|-||||++||-|+.|..||...+..     .+.+....+...       
T Consensus       206 ~kf--LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-----~lvrQIs~GaYr-------  271 (668)
T KOG0611|consen  206 KKF--LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-----RLVRQISRGAYR-------  271 (668)
T ss_pred             ccH--HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-----HHHHHhhccccc-------
Confidence            432  345899999999999999888 58999999999999999999997543211     111222222211       


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHML  568 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  568 (625)
                          .+..+....-||.+||-.||++|.|+++|....
T Consensus       272 ----EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  272 ----EPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             ----CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence                112234456899999999999999999998765

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.1e-39  Score=336.68  Aligned_cols=241  Identities=23%  Similarity=0.263  Sum_probs=196.3

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCC
Q 042149          304 RKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNR  379 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~  379 (625)
                      +.||+|+||.||+++.+ +|+.||+|++...   .......+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999965 6899999998653   2344567788999999999999999999999999999999999999


Q ss_pred             CcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceeee
Q 042149          380 SLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVST  459 (625)
Q Consensus       380 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  459 (625)
                      +|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++........ ..
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~  153 (323)
T cd05595          81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MK  153 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc-cc
Confidence            9988875443   3899999999999999999999775   999999999999999999999999998753322221 22


Q ss_pred             cCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHH
Q 042149          460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENE  539 (625)
Q Consensus       460 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  539 (625)
                      ...||+.|+|||++.+..++.++||||||+++|||++|+.|+......     ..........          ...+...
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~~~~~~~~~----------~~~p~~~  218 (323)
T cd05595         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELILMEE----------IRFPRTL  218 (323)
T ss_pred             cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcCC----------CCCCCCC
Confidence            357999999999999999999999999999999999999987432211     1111111111          1124455


Q ss_pred             HHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042149          540 ASRVLQIGLLCTQAPVALRP-----SMAEVVH  566 (625)
Q Consensus       540 ~~~l~~li~~cl~~~p~~RP-----t~~ev~~  566 (625)
                      +..+.+++.+||+.+|++||     ++.++++
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         219 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            67789999999999999998     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.3e-39  Score=336.52  Aligned_cols=241  Identities=22%  Similarity=0.259  Sum_probs=197.0

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCC
Q 042149          304 RKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNR  379 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~  379 (625)
                      +.||+|+||.||+++.+ +++.||||++...   .......+.+|+.++++++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999965 6899999998753   2344567889999999999999999999999999999999999999


Q ss_pred             CcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceeee
Q 042149          380 SLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVST  459 (625)
Q Consensus       380 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  459 (625)
                      +|.+++....   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... ...
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~  153 (323)
T cd05571          81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK  153 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-ccc
Confidence            9998886443   3899999999999999999999775   99999999999999999999999999875332222 122


Q ss_pred             cCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHH
Q 042149          460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENE  539 (625)
Q Consensus       460 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  539 (625)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.|+..... .    .........          ...++...
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-~----~~~~~~~~~----------~~~~p~~~  218 (323)
T cd05571         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-E----KLFELILME----------EIRFPRTL  218 (323)
T ss_pred             ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-H----HHHHHHHcC----------CCCCCCCC
Confidence            35799999999999999999999999999999999999998743211 0    111111111          11234456


Q ss_pred             HHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042149          540 ASRVLQIGLLCTQAPVALRP-----SMAEVVH  566 (625)
Q Consensus       540 ~~~l~~li~~cl~~~p~~RP-----t~~ev~~  566 (625)
                      +..+.+++.+||+.||++||     ++.++++
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            77889999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.8e-39  Score=329.81  Aligned_cols=251  Identities=25%  Similarity=0.294  Sum_probs=201.7

Q ss_pred             CccccccccccCceEEEEEEe-CCCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      .|+..+.||+|+||.||+|.+ .+++.||||++....   ......+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            377889999999999999996 478999999886542   2233467899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+++++|.+++..... ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++.......
T Consensus        81 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            9999999887754332 34899999999999999999999775   9999999999999999999999999998754322


Q ss_pred             ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          455 THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                      .  .....|++.|+|||++.+..++.++|||||||++|||++|+.|+........ ..........          ....
T Consensus       157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~----------~~~~  223 (285)
T cd05631         157 T--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEVDRRVKE----------DQEE  223 (285)
T ss_pred             e--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHHHHHHhhc----------cccc
Confidence            2  2345789999999999999999999999999999999999999754322111 1111111100          1112


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRPS-----MAEVVH  566 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~  566 (625)
                      ++...+..+.+|+.+||+.+|++||+     ++++++
T Consensus       224 ~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         224 YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            33445677899999999999999997     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-39  Score=338.60  Aligned_cols=253  Identities=23%  Similarity=0.307  Sum_probs=204.1

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ++|++.++||+|+||.||+|++. +++.||||++....   ......+.+|+.++..++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36899999999999999999976 58899999987542   234567889999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++++|.+++....   .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..... 
T Consensus        81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            9999999999986443   3889999999999999999999775   99999999999999999999999999976543 


Q ss_pred             CceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                         ......||+.|+|||++.+..++.++|||||||++|||++|+.|+.......     .+......  ...+......
T Consensus       154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-----~~~~i~~~--~~~~~~~~~~  223 (333)
T cd05600         154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-----TWENLKYW--KETLQRPVYD  223 (333)
T ss_pred             ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH-----HHHHHHhc--cccccCCCCC
Confidence               2234579999999999999999999999999999999999999975322111     11111110  0001111111


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      ......+..+.+++.+||+.+|++||++.++++.
T Consensus       224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            1112456778999999999999999999999875

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=6.5e-40  Score=347.03  Aligned_cols=259  Identities=27%  Similarity=0.392  Sum_probs=205.0

Q ss_pred             hcCccccccccccCceEEEEEEeC------CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPE  368 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~  368 (625)
                      .++|++.+.||+|+||.||+|++.      ++..||||++... .....+.+.+|+.+++.+ +||||+++++.+.....
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            457999999999999999999742      3457999999754 334456788999999999 89999999999999999


Q ss_pred             eEEEEEecCCCCcchhhhccC-----------------------------------------------------------
Q 042149          369 SLLVYEYVPNRSLDQILFVKN-----------------------------------------------------------  389 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~-----------------------------------------------------------  389 (625)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999998875321                                                           


Q ss_pred             --------CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceee-ec
Q 042149          390 --------TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS-TG  460 (625)
Q Consensus       390 --------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~~  460 (625)
                              ....+++.+++.++.||++||.|||+++   |+||||||+|||+++++.+||+|||+++.......... ..
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                    1124788899999999999999999775   99999999999999999999999999986543322211 12


Q ss_pred             CCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHH
Q 042149          461 IAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENE  539 (625)
Q Consensus       461 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  539 (625)
                      ..+++.|+|||++.+..++.++||||||+++|||++ |+.|+........    .+....         .......+...
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~----~~~~~~---------~~~~~~~~~~~  340 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK----FYKMVK---------RGYQMSRPDFA  340 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH----HHHHHH---------cccCccCCCCC
Confidence            345678999999998899999999999999999997 9888654322111    111111         11111123334


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          540 ASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       540 ~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      +.++.+++.+||+.+|++|||+.+|+++|+++
T Consensus       341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            57789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=5.5e-40  Score=330.24  Aligned_cols=258  Identities=29%  Similarity=0.416  Sum_probs=212.3

Q ss_pred             HHhcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      +...+|++.++||+|+||.||+|..++++.+++|.+........+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            34567889999999999999999988899999999987766567789999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+++++|.+++..... ..+++..+..++.+++.||.|||+.+   ++||||||+||++++++.+||+|||++.......
T Consensus        83 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          83 LMEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             ecccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            9999999999865432 44899999999999999999999775   9999999999999999999999999997664322


Q ss_pred             ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          455 THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                      .. .....++..|+|||.+....++.++||||||+++|+|++ |+.|+.... .....    ....         .....
T Consensus       159 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-~~~~~----~~~~---------~~~~~  223 (261)
T cd05148         159 YL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-NHEVY----DQIT---------AGYRM  223 (261)
T ss_pred             cc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-HHHHH----HHHH---------hCCcC
Confidence            21 123346778999999988889999999999999999998 777764322 11111    1111         11112


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      +.+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            22445567889999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.3e-39  Score=332.38  Aligned_cols=263  Identities=19%  Similarity=0.255  Sum_probs=202.2

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      ++|++.+.||+|+||.||+|+++ +++.||||++....  ....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46899999999999999999976 67889999986542  3345678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |++++.+..+....   ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            99998776554322   34889999999999999999999775   9999999999999999999999999998764433


Q ss_pred             ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhh----------HHHhhh-cccc
Q 042149          455 THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT----------VWKHYK-ANRI  523 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~----------~~~~~~-~~~~  523 (625)
                      ........|++.|+|||++.+..++.++|||||||++|||++|+.|+......+.....          .++.+. ....
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence            32233457899999999999888999999999999999999999887543221111000          000000 0000


Q ss_pred             ccccCCCCC------CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          524 TQSMDPGLT------GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       524 ~~~i~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .....+...      .......+..+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000      0111234567999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.5e-39  Score=326.34  Aligned_cols=251  Identities=24%  Similarity=0.339  Sum_probs=201.9

Q ss_pred             cCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecC
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVP  377 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~  377 (625)
                      +.|++.+.||+|+||.||+++++++..+|+|.+.... ...+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4588889999999999999998888899999876433 224578899999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCcee
Q 042149          378 NRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV  457 (625)
Q Consensus       378 ~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  457 (625)
                      +++|.+++....  ..+++..+..++.+++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.........
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            999999886433  24889999999999999999999775   9999999999999999999999999988654333222


Q ss_pred             eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCC
Q 042149          458 STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP  536 (625)
Q Consensus       458 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  536 (625)
                      .....++..|+|||.+....++.++||||||+++|||++ |+.|+..... ....    .......         ....+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-~~~~----~~i~~~~---------~~~~~  223 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-YEVV----EMISRGF---------RLYRP  223 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-HHHH----HHHHCCC---------CCCCC
Confidence            223345678999999988889999999999999999999 7777542211 1111    1111111         01112


Q ss_pred             hHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042149          537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHML  568 (625)
Q Consensus       537 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  568 (625)
                      ...+..+.+++.+||+.+|++||++.++++.|
T Consensus       224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            23356789999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.7e-39  Score=330.82  Aligned_cols=256  Identities=27%  Similarity=0.431  Sum_probs=206.4

Q ss_pred             cCccccccccccCceEEEEEEeCC------CCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLPD------GRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  370 (625)
                      ++|++.+.||+|+||.||+|....      ...||+|.+.... ......+.+|+.++++++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468889999999999999998642      2578999886543 344567899999999999999999999999999999


Q ss_pred             EEEEecCCCCcchhhhccCC-------------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC
Q 042149          371 LVYEYVPNRSLDQILFVKNT-------------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL  437 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~  437 (625)
                      ++|||+++++|.+++.....             ...+++..++.++.|++.||.|||+.+   ++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999998865322             144888999999999999999999775   99999999999999999


Q ss_pred             ceEEeecccceeeCCCCc-eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHH
Q 042149          438 TPKIADFGLARHVAPDKT-HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVW  515 (625)
Q Consensus       438 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~  515 (625)
                      .++|+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..|+..... .+    ..
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-~~----~~  236 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-QE----VI  236 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-HH----HH
Confidence            999999999986543322 12223456889999999988899999999999999999998 8877642211 11    11


Q ss_pred             HhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcc
Q 042149          516 KHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN  570 (625)
Q Consensus       516 ~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  570 (625)
                      ..         +........+...+..+.+|+.+||+.+|++||++.||++.|++
T Consensus       237 ~~---------i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         237 EM---------IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HH---------HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            11         11111222355667889999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-39  Score=333.01  Aligned_cols=239  Identities=22%  Similarity=0.256  Sum_probs=194.1

Q ss_pred             ccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCCCc
Q 042149          306 LGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSL  381 (625)
Q Consensus       306 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~sL  381 (625)
                      ||+|+||.||+|+.. +++.||+|++...   .......+.+|+.++++++||||+++++.+.+.+..++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999975 5889999998643   344566788999999999999999999999999999999999999999


Q ss_pred             chhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceeeecC
Q 042149          382 DQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGI  461 (625)
Q Consensus       382 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  461 (625)
                      .+++....   .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....... .....
T Consensus        81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~  153 (312)
T cd05585          81 FHHLQREG---RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTF  153 (312)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccc
Confidence            99886543   3899999999999999999999775   99999999999999999999999999875432222 22345


Q ss_pred             CCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHH
Q 042149          462 AGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEAS  541 (625)
Q Consensus       462 ~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  541 (625)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.|+.....     ..........          ....+...+.
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~~~~~~~----------~~~~~~~~~~  218 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMYRKILQE----------PLRFPDGFDR  218 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcC----------CCCCCCcCCH
Confidence            799999999999999999999999999999999999999753211     1111111111          1123445567


Q ss_pred             HHHHHHhhccCCCCCCCCCH---HHHHH
Q 042149          542 RVLQIGLLCTQAPVALRPSM---AEVVH  566 (625)
Q Consensus       542 ~l~~li~~cl~~~p~~RPt~---~ev~~  566 (625)
                      .+.+++.+||+.||++||++   .|++.
T Consensus       219 ~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         219 DAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            78999999999999999864   55543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.9e-39  Score=336.89  Aligned_cols=262  Identities=21%  Similarity=0.276  Sum_probs=205.1

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      .++|++.++||+|+||.||+++++ ++..+|+|.+... .....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            468999999999999999999976 6888999988765 34455789999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+++++|.+++....   .+++..+..++.+++.||.|||+.+  +|+||||||+|||++.++.+||+|||++.......
T Consensus        84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  158 (331)
T cd06649          84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (331)
T ss_pred             cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence            999999999986543   3889999999999999999999753  59999999999999999999999999987654322


Q ss_pred             ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhc--c-----------
Q 042149          455 THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKA--N-----------  521 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~--~-----------  521 (625)
                         .....|++.|+|||++.+..++.++||||||+++|||++|+.|+...... .+..........  .           
T Consensus       159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-ELEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhcccccccccCCccccCcccc
Confidence               22356899999999999889999999999999999999999997533211 110000000000  0           


Q ss_pred             --------------------ccccccCCCCCCC-CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          522 --------------------RITQSMDPGLTGR-FPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       522 --------------------~~~~~i~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                                          ...+.+....... .....+.++.+++.+||+.||++|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                0000000000011 112346779999999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-39  Score=327.07  Aligned_cols=255  Identities=25%  Similarity=0.349  Sum_probs=206.6

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      .++|++.+.||+|++|.||+|..++++.||||.+..... ..+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            467899999999999999999987788999999865432 3467889999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      ++++|.+++.... ...+++..+..++.+++.||.+||+.+   ++||||||+||++++++.++|+|||+++........
T Consensus        84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            9999999986543 334899999999999999999999775   999999999999999999999999999876533222


Q ss_pred             eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                      .......+..|+|||+..+..++.++||||||+++|||++ |+.|+.....     .........         ......
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~~~~---------~~~~~~  225 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-----AEVLQQVDQ---------GYRMPC  225 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHHc---------CCCCCC
Confidence            1222233468999999988899999999999999999999 7777542211     111111111         111122


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcc
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN  570 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  570 (625)
                      +...+..+.+++.+||+.+|++||++.++++.|++
T Consensus       226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         226 PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            34456789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-39  Score=321.36  Aligned_cols=272  Identities=22%  Similarity=0.220  Sum_probs=220.0

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .+.|+++++||.|.-|+||+++++ ++..+|+|++.+.   .++...+...|-+||+.++||.++.+|..|+.+...++|
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            356788889999999999999976 4688999999765   345567788899999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      ||||+||+|..+++ +++.+.+++..+.-++.+++-||+|||-.|   ||+|||||+||||.++|++-|+||.|+.....
T Consensus       156 meyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             EecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            99999999999775 455567999999999999999999999665   99999999999999999999999998632210


Q ss_pred             ---------------------------------CCc----------------------eeeecCCCCccccCccccccCc
Q 042149          453 ---------------------------------DKT----------------------HVSTGIAGTLGYMAPEYLVRGQ  477 (625)
Q Consensus       453 ---------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~  477 (625)
                                                       ...                      ..+..++||.+|+|||++.+..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence                                             000                      0112467999999999999999


Q ss_pred             ccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCC
Q 042149          478 LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVAL  557 (625)
Q Consensus       478 ~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~  557 (625)
                      .+.++|+|+|||++||||.|..||........+...+.             ..+.-+..++.+..+.+||.+.|.+||.+
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~-------------~~l~Fp~~~~vs~~akDLIr~LLvKdP~k  378 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG-------------QPLKFPEEPEVSSAAKDLIRKLLVKDPSK  378 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc-------------CCCcCCCCCcchhHHHHHHHHHhccChhh
Confidence            99999999999999999999999876655444332221             11211112366788999999999999999


Q ss_pred             CCC----HHHHHH--HHccccCCCCCCCCCCCcc
Q 042149          558 RPS----MAEVVH--MLNNIDYEIPPPKQPPFLN  585 (625)
Q Consensus       558 RPt----~~ev~~--~L~~~~~~l~~~~~~~~~~  585 (625)
                      |..    +.||.+  .+++++|.|-.-..||+.+
T Consensus       379 Rlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP  412 (459)
T KOG0610|consen  379 RLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIP  412 (459)
T ss_pred             hhccccchHHhhcCccccCCChhheeccCCCcCC
Confidence            997    888875  5688888765444454443

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-40  Score=335.70  Aligned_cols=245  Identities=22%  Similarity=0.261  Sum_probs=201.6

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ++|++.++||+|+||.||+|+.+ +++.||||++....   .+..+.+.+|+.++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46889999999999999999975 68999999986532   234567889999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++++|.+++....   .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            9999999999886543   3889999999999999999999775   999999999999999999999999998865432


Q ss_pred             CceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                      .    ....|++.|+|||++.+..++.++||||||+++|+|++|+.|+..... .    ..........          .
T Consensus       155 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-~----~~~~~i~~~~----------~  215 (291)
T cd05612         155 T----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-F----GIYEKILAGK----------L  215 (291)
T ss_pred             c----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-H----HHHHHHHhCC----------c
Confidence            2    234689999999999988899999999999999999999998753211 0    1111111111          1


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPS-----MAEVVHM  567 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~~  567 (625)
                      .++...+..+.+++.+||+.||.+||+     ++++++.
T Consensus       216 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         216 EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            223344667899999999999999995     8887754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=8.5e-39  Score=339.87  Aligned_cols=252  Identities=21%  Similarity=0.271  Sum_probs=196.8

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      .|+++++||+|+||+||+|++. +++.||||++...   .....+.+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999864 6889999999653   33456778999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+++|+|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+....
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            999999999886543   3888999999999999999999775   9999999999999999999999999975431100


Q ss_pred             c----------------------------------------------eeeecCCCCccccCccccccCcccccCcEEeeh
Q 042149          455 T----------------------------------------------HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFG  488 (625)
Q Consensus       455 ~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG  488 (625)
                      .                                              .......||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                              001235799999999999988999999999999


Q ss_pred             hhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhh--ccCCCCCCCCCHHHHHH
Q 042149          489 VLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLL--CTQAPVALRPSMAEVVH  566 (625)
Q Consensus       489 ~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~--cl~~~p~~RPt~~ev~~  566 (625)
                      |++|||++|+.|+.........    .......       ..+..+.....+.++.+++.+  |+..+|..||++.+++.
T Consensus       236 ~il~elltG~~Pf~~~~~~~~~----~~i~~~~-------~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTETQ----LKVINWE-------NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHHH----HHHHccc-------cccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            9999999999997543221110    0000000       001111112345667788877  55666777999999986


Q ss_pred             H
Q 042149          567 M  567 (625)
Q Consensus       567 ~  567 (625)
                      .
T Consensus       305 h  305 (381)
T cd05626         305 H  305 (381)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.9e-39  Score=326.92  Aligned_cols=255  Identities=27%  Similarity=0.382  Sum_probs=206.2

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      ..|++.++||+|+||.||+|..+ +++.||+|++... ......+.+|++++++++||||+++++++..++..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45788899999999999999965 5889999988644 334567899999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      ++++|.+++.... ...+++..++.++.|++++|+|||+.+   ++||||||+||++++++.+||+|||++.........
T Consensus        85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            9999999886543 234899999999999999999999775   999999999999999999999999999876543222


Q ss_pred             eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.....     ...+....         .......
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~~~~~~---------~~~~~~~  226 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELLE---------KGYRMER  226 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHH---------CCCCCCC
Confidence            2222334678999999988899999999999999999998 7777542211     11122111         1112223


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      +...+..+.+++.+||+.+|++||++.+++++|+.+
T Consensus       227 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         227 PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            445567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=8.7e-39  Score=333.56  Aligned_cols=252  Identities=23%  Similarity=0.279  Sum_probs=201.1

Q ss_pred             CccccccccccCceEEEEEEe----CCCCEEEEEEeecC----ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCee
Q 042149          299 FFDNSRKLGQGGAGSVFRGTL----PDGRNIAVKRLFFN----SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPES  369 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~  369 (625)
                      +|++.++||+|+||.||+++.    .+++.||+|++...    .....+.+.+|+.+++.+ +||||+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            488899999999999999985    35789999998643    233456788999999999 599999999999999999


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      ++||||+++++|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            99999999999999886543   3889999999999999999999775   99999999999999999999999999986


Q ss_pred             eCCCCceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          450 VAPDKTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      .............||+.|+|||++.+. .++.++||||||+++|||+||+.|+........ ..........      .+
T Consensus       155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~------~~  227 (332)
T cd05614         155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILK------CD  227 (332)
T ss_pred             ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhc------CC
Confidence            544333333346799999999999765 478899999999999999999999754322211 1111111111      11


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRP-----SMAEVVHM  567 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~  567 (625)
                          ...+...+..+.+++.+||+.||++||     +++++++.
T Consensus       228 ----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         228 ----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence                123444567789999999999999999     67777753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.8e-39  Score=334.33  Aligned_cols=244  Identities=25%  Similarity=0.320  Sum_probs=194.9

Q ss_pred             ccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHH---hcCCCCceeeeeeeeeeCCeeEEE
Q 042149          300 FDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLI---SGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l---~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      |++.+.||+|+||.||+|+++ +++.||||++...   .....+.+.+|++++   +.++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            677899999999999999965 6899999999753   233445677776655   567899999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+++++|...+..    ..+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            999999999887743    24899999999999999999999775   99999999999999999999999999875432


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      ... ......|++.|+|||++.+..++.++||||||+++|||++|+.|+......     ..........          
T Consensus       154 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-----~~~~~i~~~~----------  217 (324)
T cd05589         154 FGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-----EVFDSIVNDE----------  217 (324)
T ss_pred             CCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCC----------
Confidence            222 123467999999999999999999999999999999999999997533211     0111111111          


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRP-----SMAEVVH  566 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~  566 (625)
                      ...+...+..+.+++.+||+.+|++||     ++.++++
T Consensus       218 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         218 VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            112445567789999999999999999     5666665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.4e-39  Score=323.88  Aligned_cols=252  Identities=27%  Similarity=0.367  Sum_probs=202.8

Q ss_pred             cCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecC
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVP  377 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~  377 (625)
                      ++|.+.+.||+|+||.||+|+..++..+|||.+..... ..+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            45788899999999999999987777899998864432 24678999999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCcee
Q 042149          378 NRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV  457 (625)
Q Consensus       378 ~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  457 (625)
                      +++|.+++.....  .+++..++.++.+|+.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.........
T Consensus        83 ~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          83 NGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             CCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            9999998865332  4899999999999999999999775   9999999999999999999999999988765433222


Q ss_pred             eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCC
Q 042149          458 STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP  536 (625)
Q Consensus       458 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  536 (625)
                      .....++..|+|||.+.+..++.++||||||+++|+|++ |+.|+...... .    ........         .....+
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-~----~~~~~~~~---------~~~~~~  223 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-E----TVEKVSQG---------LRLYRP  223 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-H----HHHHHhcC---------CCCCCC
Confidence            223345678999999988889999999999999999999 88775422211 1    11111111         111112


Q ss_pred             hHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHc
Q 042149          537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLN  569 (625)
Q Consensus       537 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  569 (625)
                      ...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus       224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            334678899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-39  Score=338.52  Aligned_cols=252  Identities=23%  Similarity=0.260  Sum_probs=203.7

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ++|++.++||+|+||.||+|+.. +++.||||++...   .......+.+|+.++..++||||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46899999999999999999975 6899999998653   2244567889999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999998655   34899999999999999999999765   999999999999999999999999999866543


Q ss_pred             C----------------------------ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCC
Q 042149          454 K----------------------------THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSE  505 (625)
Q Consensus       454 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~  505 (625)
                      .                            ........||+.|+|||++.+..++.++|||||||++|||++|+.|+....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            3                            111223569999999999999999999999999999999999999975332


Q ss_pred             CCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 042149          506 GSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPS-MAEVVHM  567 (625)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~ev~~~  567 (625)
                      ..     ..+......      ......+.....+..+.+++.+|++ +|++||+ ++++++.
T Consensus       235 ~~-----~~~~~i~~~------~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 LQ-----ETYNKIINW------KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HH-----HHHHHHhcc------CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            11     111111110      0011111111246778899999997 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1e-38  Score=335.88  Aligned_cols=248  Identities=24%  Similarity=0.325  Sum_probs=195.7

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ++|+..++||+|+||.||+|++. +++.||||++.... ....+.+.+|+++++.++|+||+++++++.+++..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45667889999999999999965 68999999986553 34456789999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|....       ...+..+..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++.+.....
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            9999986532       2567788899999999999999775   99999999999999999999999999987643322


Q ss_pred             eeeecCCCCccccCcccccc-----CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVR-----GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                      . .....||..|+|||++..     ...+.++|||||||++|||++|+.|+....... . .........         .
T Consensus       224 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~-~~~~~~~~~---------~  291 (353)
T PLN00034        224 P-CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-W-ASLMCAICM---------S  291 (353)
T ss_pred             c-ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-H-HHHHHHHhc---------c
Confidence            1 223578999999998743     234568999999999999999999976322111 0 000000000         0


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      .....+...+.++.+++.+||+.+|++|||+.|+++.
T Consensus       292 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        292 QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1112234556789999999999999999999999864

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.9e-39  Score=327.60  Aligned_cols=257  Identities=27%  Similarity=0.409  Sum_probs=206.1

Q ss_pred             hcCccccccccccCceEEEEEEeCC------CCEEEEEEeecCChH-HHHHHHHHHHHHhcCCCCceeeeeeeeeeCCee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPD------GRNIAVKRLFFNSRQ-WVDQFFNEVNLISGIQHKNVVRLLGCSIEGPES  369 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  369 (625)
                      .++|.+.+.||+|+||.||+|.+.+      ++.||||.+...... ..+.+.+|+++++.++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3468888999999999999998632      478999998765433 567899999999999999999999999999999


Q ss_pred             EEEEEecCCCCcchhhhccCC-----------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCc
Q 042149          370 LLVYEYVPNRSLDQILFVKNT-----------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLT  438 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~  438 (625)
                      ++||||+++++|.+++...+.           ...+++..+..++.+++.+|.+||+.+   ++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            999999999999999865421           234788999999999999999999775   999999999999999999


Q ss_pred             eEEeecccceeeCCCCc-eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHH
Q 042149          439 PKIADFGLARHVAPDKT-HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWK  516 (625)
Q Consensus       439 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~  516 (625)
                      +||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |..|+..... ...    ..
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~-~~~----~~  235 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN-EEV----IE  235 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH-HHH----HH
Confidence            99999999976533222 11223346789999999999999999999999999999999 8887643221 111    11


Q ss_pred             hhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcc
Q 042149          517 HYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN  570 (625)
Q Consensus       517 ~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  570 (625)
                      ....         ......+...+..+.+++.+||+.+|++||++.||++.|++
T Consensus       236 ~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         236 CITQ---------GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             HHHc---------CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            1111         11112233456778999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-39  Score=324.13  Aligned_cols=255  Identities=27%  Similarity=0.433  Sum_probs=205.0

Q ss_pred             cCccccccccccCceEEEEEEeCC----CCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLPD----GRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      ++|++.+.||+|+||.||+|+++.    ...||||.+... .......+.+|+.++++++||||+++++.+.+....++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            578899999999999999998742    457899988654 344456789999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+++++|.+++....  ..+++..+..++.+++.||.|||+.+   |+||||||+||++++++.++|+|||+++....
T Consensus        84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            99999999999986533  24899999999999999999999764   99999999999999999999999999987752


Q ss_pred             CCce-eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          453 DKTH-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       453 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                      .... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..|+..... ..    .......         .
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-~~----~~~~~~~---------~  224 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QD----VIKAVED---------G  224 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-HH----HHHHHHc---------C
Confidence            2222 2222345678999999988899999999999999999998 8877532211 11    1111111         1


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      ...+.+...+..+.+++.+||+.+|++||++.||++.|.++
T Consensus       225 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         225 YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11122344567789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8.1e-39  Score=333.51  Aligned_cols=252  Identities=22%  Similarity=0.213  Sum_probs=202.3

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ++|++.++||+|+||.||+++.+ +++.||||++...   ..+..+.+.+|+.+++.++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46899999999999999999965 6899999999754   2334567889999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++++|.+++....  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            9999999999986542  24899999999999999999999775   999999999999999999999999999877554


Q ss_pred             CceeeecCCCCccccCccccc------cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccccccc
Q 042149          454 KTHVSTGIAGTLGYMAPEYLV------RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM  527 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  527 (625)
                      .........||+.|+|||++.      ...++.++||||||+++|||++|+.|+.......     .........  .  
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-----~~~~i~~~~--~--  226 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-----TYNNIMNFQ--R--  226 (330)
T ss_pred             CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-----HHHHHHcCC--C--
Confidence            443334457999999999986      4567899999999999999999999974322111     111111100  0  


Q ss_pred             CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       528 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                        .+.-+.....+..+.+++.+|++ +|++||++.++++
T Consensus       227 --~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         227 --FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             --ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence              00001122346678899999998 9999999999985

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6.3e-39  Score=333.80  Aligned_cols=242  Identities=23%  Similarity=0.266  Sum_probs=197.3

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCC
Q 042149          304 RKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNR  379 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~  379 (625)
                      +.||+|+||.||+++.+ +++.||||++...   .......+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999965 6899999999754   2345567889999999999999999999999999999999999999


Q ss_pred             CcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceeee
Q 042149          380 SLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVST  459 (625)
Q Consensus       380 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  459 (625)
                      +|.+.+....   .+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....... ...
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~  153 (328)
T cd05593          81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMK  153 (328)
T ss_pred             CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc-ccc
Confidence            9988875443   3899999999999999999999775   99999999999999999999999999875432221 123


Q ss_pred             cCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHH
Q 042149          460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENE  539 (625)
Q Consensus       460 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  539 (625)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.|+...... .    ........          ...++...
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-~----~~~~~~~~----------~~~~p~~~  218 (328)
T cd05593         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-K----LFELILME----------DIKFPRTL  218 (328)
T ss_pred             cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-H----HHHHhccC----------CccCCCCC
Confidence            457999999999999889999999999999999999999997432111 0    11111100          11234455


Q ss_pred             HHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042149          540 ASRVLQIGLLCTQAPVALRP-----SMAEVVHM  567 (625)
Q Consensus       540 ~~~l~~li~~cl~~~p~~RP-----t~~ev~~~  567 (625)
                      +..+.+++.+||+.+|++||     ++.|+++.
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         219 SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            67789999999999999997     88888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.9e-39  Score=351.67  Aligned_cols=251  Identities=20%  Similarity=0.288  Sum_probs=204.3

Q ss_pred             CccccccccccCceEEEEEEeC-C-CCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-D-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      .|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+|+.++|||||++++++..++..+|||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            3888899999999999999854 3 6778899876666666677889999999999999999999999999999999999


Q ss_pred             CCCCcchhhhcc-CCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          377 PNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       377 ~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      ++++|.+++... .....+++.++..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999887543 22335889999999999999999999775   99999999999999999999999999987654322


Q ss_pred             -eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          456 -HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       456 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.|+..... .    ..........         ..+
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-~----~~~~~~~~~~---------~~~  290 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-R----EIMQQVLYGK---------YDP  290 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-H----HHHHHHHhCC---------CCC
Confidence             123346799999999999999999999999999999999999998743211 0    1111111111         112


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .+...+..+.+++.+||+.+|++||++.+++.
T Consensus       291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            23455678999999999999999999999864

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-39  Score=328.16  Aligned_cols=249  Identities=33%  Similarity=0.514  Sum_probs=194.3

Q ss_pred             ccccccccCceEEEEEEeC-----CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          302 NSRKLGQGGAGSVFRGTLP-----DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       302 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      +.+.||.|.||.||+|.+.     .+..|+||.+... ..+..+.+.+|++++++++||||++++|++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999975     3567999999654 344578999999999999999999999999988889999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++|+|.++|.... ...+++..++.|+.||++||.|||+.+   ++|+||+++||++++++.+||+|||++........
T Consensus        83 ~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             cccccccccccccc-ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            99999999997662 234899999999999999999999875   99999999999999999999999999987633222


Q ss_pred             -eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          456 -HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       456 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                       ...........|+|||.+....++.++||||||+++|||++ |+.|+... ....    .........         ..
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~----~~~~~~~~~---------~~  224 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEE----IIEKLKQGQ---------RL  224 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHH----HHHHHHTTE---------ET
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccc-cccc----ccccccccc---------cc
Confidence             22223457789999999999999999999999999999999 56664322 1111    111111111         12


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPSMAEVVHML  568 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  568 (625)
                      +.+...+..+.+++.+||+.+|++|||+.+|++.|
T Consensus       225 ~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  225 PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            22445677899999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=6.5e-39  Score=341.03  Aligned_cols=260  Identities=25%  Similarity=0.352  Sum_probs=206.2

Q ss_pred             hcCccccccccccCceEEEEEEeC------CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCCe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEGPE  368 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~  368 (625)
                      .++|.+.++||+|+||.||+|++.      .+..||||++.... ....+.+.+|+++++++. ||||+++++++.+...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            567889999999999999999852      13469999996543 344567999999999996 9999999999999999


Q ss_pred             eEEEEEecCCCCcchhhhccCC----------------------------------------------------------
Q 042149          369 SLLVYEYVPNRSLDQILFVKNT----------------------------------------------------------  390 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~----------------------------------------------------------  390 (625)
                      .+|||||+++|+|.+++.....                                                          
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            9999999999999988764210                                                          


Q ss_pred             -----------------------------------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC
Q 042149          391 -----------------------------------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE  435 (625)
Q Consensus       391 -----------------------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~  435 (625)
                                                         ...+++..++.++.|+++||.|||+.+   |+||||||+|||++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence                                               123788889999999999999999775   999999999999999


Q ss_pred             CCceEEeecccceeeCCCCcee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhh
Q 042149          436 KLTPKIADFGLARHVAPDKTHV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHT  513 (625)
Q Consensus       436 ~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~  513 (625)
                      ++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.|+.........   
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~---  349 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF---  349 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH---
Confidence            9999999999998654332221 123356788999999998899999999999999999997 88776432211111   


Q ss_pred             HHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          514 VWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       514 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                       +.....         ......+...+..+.+++.+||+.+|++||++.+|.++|+.+.
T Consensus       350 -~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         350 -YNKIKS---------GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             -HHHHhc---------CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence             111111         1111224456778999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.9e-39  Score=333.05  Aligned_cols=255  Identities=23%  Similarity=0.350  Sum_probs=202.5

Q ss_pred             cCccccccccccCceEEEEEEeC-CCC----EEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGR----NIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      .+|++.+.||+|+||.||+|++. ++.    .||||++... .....+.+.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46899999999999999999864 333    3899998654 345567889999999999999999999998764 5789


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      |+||+++|+|.+++....  ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        86 v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            999999999999886543  34789999999999999999999775   9999999999999999999999999998765


Q ss_pred             CCCceee-ecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          452 PDKTHVS-TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       452 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      ....... ....++..|+|||++.+..++.++||||||+++|||++ |+.|+..... ..    .....         ..
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~-~~----~~~~~---------~~  226 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SE----ISSIL---------EK  226 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-HH----HHHHH---------hC
Confidence            4333222 22335678999999999999999999999999999998 8887642210 01    11111         11


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      ....+.+..++..+.+++.+||+.+|++||++.+++..|..+.
T Consensus       227 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         227 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1111223345667899999999999999999999999987764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.9e-38  Score=330.45  Aligned_cols=246  Identities=22%  Similarity=0.253  Sum_probs=196.8

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEEEEEecCC
Q 042149          304 RKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLLVYEYVPN  378 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~  378 (625)
                      ++||+|+||.||+|+++ +++.||||++...   .....+.+.+|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999975 6889999999753   334456788999999998 699999999999999999999999999


Q ss_pred             CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceee
Q 042149          379 RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS  458 (625)
Q Consensus       379 ~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  458 (625)
                      ++|.+++....   .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~  153 (329)
T cd05588          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TT  153 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC-cc
Confidence            99988875443   3899999999999999999999775   99999999999999999999999999875322221 12


Q ss_pred             ecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCc----cchhhHHHhhhccccccccCCCCCCC
Q 042149          459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSS----SVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       459 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.|+.......    .......+......          ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~----------~~  223 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ----------IR  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC----------CC
Confidence            34579999999999999999999999999999999999999985422111    11111112111111          12


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCCC------HHHHHH
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRPS------MAEVVH  566 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RPt------~~ev~~  566 (625)
                      .|...+..+.+++.+||+.+|++||+      +.++++
T Consensus       224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            24445677899999999999999997      677764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=7.4e-39  Score=322.00  Aligned_cols=254  Identities=29%  Similarity=0.428  Sum_probs=205.2

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      .+.|++.++||+|+||.||+|..++++.||+|.+..... ..+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            467899999999999999999988889999999865443 3467889999999999999999999864 56789999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      ++++|.+++.... ...+++.++..++.+++.+|+|||+.+   ++||||||+||+++.++.++|+|||++.........
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            9999999886543 335899999999999999999999765   999999999999999999999999999776533322


Q ss_pred             eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                      ......++..|+|||++....++.++||||||+++|||++ |+.|+..... ...    .....         .....+.
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~----~~~~~---------~~~~~~~  224 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-PEV----IQNLE---------RGYRMPR  224 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-HHH----HHHHH---------cCCCCCC
Confidence            2223456778999999988889999999999999999999 8887643221 111    11111         1111122


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcc
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN  570 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  570 (625)
                      +...+.++.+++.+||+.+|++||+++++++.|+.
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         225 PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            33446679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-39  Score=321.96  Aligned_cols=250  Identities=26%  Similarity=0.362  Sum_probs=200.8

Q ss_pred             CccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCC
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPN  378 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~  378 (625)
                      +|++.+.||+|+||.||+|.++++..+|+|.+..... ..+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            4778899999999999999987778899998864332 235688899999999999999999999999999999999999


Q ss_pred             CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceee
Q 042149          379 RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS  458 (625)
Q Consensus       379 ~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  458 (625)
                      ++|.+++.....  .+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||+++..........
T Consensus        84 ~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          84 GCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence            999998864432  4899999999999999999999775   99999999999999999999999999986543322222


Q ss_pred             ecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCCh
Q 042149          459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE  537 (625)
Q Consensus       459 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  537 (625)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ...    .....         .......+.
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~----~~~~~---------~~~~~~~~~  224 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-SEV----VESVS---------AGYRLYRPK  224 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH-HHH----HHHHH---------cCCcCCCCC
Confidence            22234568999999998899999999999999999999 6766542211 111    11111         111112234


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042149          538 NEASRVLQIGLLCTQAPVALRPSMAEVVHML  568 (625)
Q Consensus       538 ~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  568 (625)
                      ..+..+.+++.+||+.+|++|||+.|+++.|
T Consensus       225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            4577899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4e-39  Score=327.20  Aligned_cols=258  Identities=26%  Similarity=0.380  Sum_probs=202.8

Q ss_pred             HhcCccccccccccCceEEEEEEeC------CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCe
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPE  368 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  368 (625)
                      .+++|++.++||+|+||.||+|.++      .+..||||++... .......+.+|+.+++.++||||+++++++.++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4678999999999999999999753      2567999988643 23345678899999999999999999999999999


Q ss_pred             eEEEEEecCCCCcchhhhccCC-------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEE
Q 042149          369 SLLVYEYVPNRSLDQILFVKNT-------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKI  441 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl  441 (625)
                      .++||||+++++|.+++.....       ...+++..+..++.+++.||.|||+.+   ++||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999998864321       123678889999999999999999775   999999999999999999999


Q ss_pred             eecccceeeCCCCceee-ecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhh
Q 042149          442 ADFGLARHVAPDKTHVS-TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYK  519 (625)
Q Consensus       442 ~Dfgla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~  519 (625)
                      +|||+++.......... ....+++.|+|||++.++.++.++||||||+++|||++ |..|+.... ..    ...+...
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-~~----~~~~~~~  235 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-NE----QVLRFVM  235 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-HH----HHHHHHH
Confidence            99999876543322211 12345788999999998899999999999999999999 566653221 11    1111111


Q ss_pred             ccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcc
Q 042149          520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN  570 (625)
Q Consensus       520 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  570 (625)
                      ...         ....+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus       236 ~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         236 EGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             cCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            111         111234456678999999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.3e-38  Score=331.14  Aligned_cols=242  Identities=22%  Similarity=0.255  Sum_probs=196.3

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCC
Q 042149          304 RKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNR  379 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~  379 (625)
                      +.||+|+||.||+++.. +++.||+|++...   .......+.+|+++++.++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999964 6899999998653   2344567788999999999999999999999999999999999999


Q ss_pred             CcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhc-CCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceee
Q 042149          380 SLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG-GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS  458 (625)
Q Consensus       380 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  458 (625)
                      +|.+++....   .+++..+..++.||+.||.|||+ .   +|+||||||+|||++.++.+||+|||+++........ .
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~  153 (325)
T cd05594          81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-M  153 (325)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc-c
Confidence            9988875443   38999999999999999999996 4   4999999999999999999999999998754332222 2


Q ss_pred             ecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChH
Q 042149          459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPEN  538 (625)
Q Consensus       459 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  538 (625)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.|+..... .    ..........          ..++..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-~----~~~~~i~~~~----------~~~p~~  218 (325)
T cd05594         154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-E----KLFELILMEE----------IRFPRT  218 (325)
T ss_pred             ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-H----HHHHHHhcCC----------CCCCCC
Confidence            235699999999999999999999999999999999999998743211 0    1111111110          112344


Q ss_pred             HHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042149          539 EASRVLQIGLLCTQAPVALRP-----SMAEVVHM  567 (625)
Q Consensus       539 ~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~  567 (625)
                      .+..+.+++.+||+.||++|+     ++.++++.
T Consensus       219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            567789999999999999996     89998854

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-39  Score=300.00  Aligned_cols=262  Identities=22%  Similarity=0.283  Sum_probs=209.8

Q ss_pred             hcCccccccccccCceEEEEEE-eCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC-----eeE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP-----ESL  370 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~  370 (625)
                      .++|.+.++||+|||+-||+++ ..+++.+|+|++.....+..+..++|++..++++|||+++++++...+.     ..|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            4679999999999999999999 4578999999999888888999999999999999999999998876433     589


Q ss_pred             EEEEecCCCCcchhhhccC-CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          371 LVYEYVPNRSLDQILFVKN-TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      |+++|...|+|.+.+.... ++..+++.+++.|+.+|++||++||+.. .++.||||||.|||+.+.+.++|.|||.+..
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence            9999999999999886543 3336999999999999999999999874 4799999999999999999999999999865


Q ss_pred             eCCCCc---e-----eeecCCCCccccCcccccc---CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhh
Q 042149          450 VAPDKT---H-----VSTGIAGTLGYMAPEYLVR---GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHY  518 (625)
Q Consensus       450 ~~~~~~---~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~  518 (625)
                      ..-.-.   .     .......|..|.|||.+.-   ...++++|||||||++|+|+.|..||..-...           
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-----------  247 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-----------  247 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-----------
Confidence            421110   0     0113457899999999854   45789999999999999999999997532111           


Q ss_pred             hcccccccc-CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          519 KANRITQSM-DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       519 ~~~~~~~~i-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                       .+.+.-.+ ...+.-+.....++.+.+++.+|++.||.+||++.+++..++++
T Consensus       248 -GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  248 -GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             -CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence             11111111 11121111223688899999999999999999999999988765

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7.4e-39  Score=327.71  Aligned_cols=259  Identities=26%  Similarity=0.383  Sum_probs=208.8

Q ss_pred             cCccccccccccCceEEEEEEeC------CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      .+|.+.+.||+|+||.||+|+..      ++..+++|.+........+.+.+|+.++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45788899999999999999742      345689998876666666789999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCC-------------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCc
Q 042149          372 VYEYVPNRSLDQILFVKNT-------------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLT  438 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~  438 (625)
                      ||||+++++|.+++.....             ...+++..++.++.+|+.||+|||+++   ++||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            9999999999999865321             234889999999999999999999775   999999999999999999


Q ss_pred             eEEeecccceeeCCCCce-eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHH
Q 042149          439 PKIADFGLARHVAPDKTH-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWK  516 (625)
Q Consensus       439 ~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~  516 (625)
                      ++|+|||++......... ......+++.|+|||++.+..++.++||||||+++|||+| |+.|+..... .    ..+.
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-~----~~~~  236 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-T----EVIE  236 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-H----HHHH
Confidence            999999999765433221 1223456789999999998999999999999999999999 8877543211 1    1111


Q ss_pred             hhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccC
Q 042149          517 HYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY  573 (625)
Q Consensus       517 ~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  573 (625)
                      ......         ....+...+..+.+++.+||+.+|++||++.+|+++|+++..
T Consensus       237 ~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         237 CITQGR---------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHhCCC---------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            111111         111233456678999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6.1e-39  Score=335.14  Aligned_cols=246  Identities=23%  Similarity=0.269  Sum_probs=202.0

Q ss_pred             hcCccccccccccCceEEEEEEeCC--CCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPD--GRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      .++|++.+.||+|+||.||+|.++.  +..||+|++...   .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            4579999999999999999998543  368999988643   23445678899999999999999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||||+++++|.+++....   .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            999999999999886543   3889999999999999999999775   9999999999999999999999999998764


Q ss_pred             CCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      ...    ....||+.|+|||++.+..++.++|||||||++|||++|+.|+.....     ...........         
T Consensus       183 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~i~~~~---------  244 (340)
T PTZ00426        183 TRT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP-----LLIYQKILEGI---------  244 (340)
T ss_pred             CCc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-----HHHHHHHhcCC---------
Confidence            322    235799999999999988899999999999999999999999753211     01111111111         


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRP-----SMAEVVHM  567 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~  567 (625)
                       ..+|...+..+.+++.+||+.+|++|+     +++++++.
T Consensus       245 -~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        245 -IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             -CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence             112344556788999999999999995     88888764

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.1e-38  Score=325.07  Aligned_cols=256  Identities=23%  Similarity=0.379  Sum_probs=203.5

Q ss_pred             cCccccccccccCceEEEEEEe-----CCCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTL-----PDGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      +.|++.++||+|+||.||+|..     .+++.+++|.+... .......+.+|+.++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4688889999999999999984     24678999998643 34455778999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCC--------------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC
Q 042149          372 VYEYVPNRSLDQILFVKNT--------------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL  437 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~  437 (625)
                      ||||+++++|.+++.....              ...+++.....++.+++.||.|||+++   ++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            9999999999998853321              234788999999999999999999775   99999999999999999


Q ss_pred             ceEEeecccceeeCCCCc-eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHH
Q 042149          438 TPKIADFGLARHVAPDKT-HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVW  515 (625)
Q Consensus       438 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~  515 (625)
                      .+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..|+.... ....    .
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~-~~~~----~  236 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-NQEV----I  236 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-HHHH----H
Confidence            999999999986543322 11223446778999999988889999999999999999999 776653211 1111    1


Q ss_pred             HhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcc
Q 042149          516 KHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN  570 (625)
Q Consensus       516 ~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  570 (625)
                      +....         ......+...+..+.+++.+||+.+|++||++.+|.++|..
T Consensus       237 ~~~~~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         237 EMVRK---------RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHc---------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11111         11112234456778999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=7.7e-39  Score=327.07  Aligned_cols=260  Identities=27%  Similarity=0.407  Sum_probs=207.8

Q ss_pred             hcCccccccccccCceEEEEEEeC------CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  370 (625)
                      .++|.+.+.||+|+||.||++...      ++..+|+|.+........+.+.+|+.++++++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            357889999999999999999842      34568999887666666778999999999999999999999999999999


Q ss_pred             EEEEecCCCCcchhhhccC----------CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceE
Q 042149          371 LVYEYVPNRSLDQILFVKN----------TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPK  440 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~k  440 (625)
                      +||||+++++|.+++....          ....+++..++.++.|++.+|+|||+.+   ++||||||+||++++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence            9999999999999886432          1234899999999999999999999775   99999999999999999999


Q ss_pred             EeecccceeeCCCCce-eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhh
Q 042149          441 IADFGLARHVAPDKTH-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHY  518 (625)
Q Consensus       441 l~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~  518 (625)
                      |+|||+++........ ......+++.|+|||++.+..++.++||||||+++|+|++ |..|+..... ..    .....
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-~~----~~~~i  235 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-NE----VIECI  235 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HH----HHHHH
Confidence            9999999865433221 1122345778999999988899999999999999999999 7776532211 11    11111


Q ss_pred             hccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccC
Q 042149          519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY  573 (625)
Q Consensus       519 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  573 (625)
                      .....         ...+...+..+.+++.+||+.+|.+|||+.++++.|+++..
T Consensus       236 ~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         236 TQGRV---------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            11111         11123345678999999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.3e-40  Score=302.35  Aligned_cols=249  Identities=27%  Similarity=0.343  Sum_probs=209.4

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .++|++.+.||+|.||.||.|+.+ ++-.||+|++.+..   .....++.+|++|-+.|+||||+++|++|.++...||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            468999999999999999999964 67889999997652   23346789999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      +||..+|.|...|+... ...+++.....++.|+|.||.|+|.+   ++|||||||+|+|++..+.+||+|||.+.... 
T Consensus       101 lEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            99999999999886443 34488999999999999999999976   59999999999999999999999999987654 


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                        .......+||..|.|||...+...+..+|+|++|++.||++.|.+||......     ...+....-          .
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-----etYkrI~k~----------~  238 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-----ETYKRIRKV----------D  238 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-----HHHHHHHHc----------c
Confidence              22234579999999999999999999999999999999999999997643311     112222211          1


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      -.+|...+....++|.+|+..+|.+|.+..|+++.
T Consensus       239 ~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  239 LKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            22356777888999999999999999999999864

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.1e-38  Score=327.85  Aligned_cols=246  Identities=22%  Similarity=0.262  Sum_probs=196.2

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEEEEEecCC
Q 042149          304 RKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLLVYEYVPN  378 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~  378 (625)
                      +.||+|+||.||+|+.+ +++.+|+|++...   .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 6789999998753   344556788899998877 799999999999999999999999999


Q ss_pred             CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceee
Q 042149          379 RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS  458 (625)
Q Consensus       379 ~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  458 (625)
                      ++|..++....   .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++....... ..
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~  153 (329)
T cd05618          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TT  153 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cc
Confidence            99988875443   3899999999999999999999775   99999999999999999999999999875332221 12


Q ss_pred             ecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCC----ccchhhHHHhhhccccccccCCCCCCC
Q 042149          459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGS----SSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       459 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.|+......    .....+.+.......          ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~~  223 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------IR  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------CC
Confidence            2457999999999999999999999999999999999999998532211    111112222211111          12


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCCC------HHHHHH
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRPS------MAEVVH  566 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RPt------~~ev~~  566 (625)
                      .|...+..+.+++.+||+.||++||+      +.++++
T Consensus       224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence            34455677889999999999999998      466654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.3e-38  Score=327.83  Aligned_cols=242  Identities=26%  Similarity=0.332  Sum_probs=195.2

Q ss_pred             cccccccCceEEEEEEe----CCCCEEEEEEeecC----ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          303 SRKLGQGGAGSVFRGTL----PDGRNIAVKRLFFN----SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      +++||+|+||.||+++.    .+++.||||.+...    .......+.+|+.+|+.++||||+++++.+..++..++|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            36799999999999985    35789999998643    22334567889999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+++++|.+.+....   .+.+..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          81 YLSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            999999999886543   3788889999999999999999775   9999999999999999999999999987543322


Q ss_pred             ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          455 THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                      . ......||+.|+|||++.+..++.++||||||+++|||++|+.|+......     ..........          ..
T Consensus       155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~~~~~~~----------~~  218 (323)
T cd05584         155 T-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTIDKILKGK----------LN  218 (323)
T ss_pred             C-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHHHHHcCC----------CC
Confidence            2 123357999999999999888999999999999999999999987532211     1111111111          12


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRP-----SMAEVVH  566 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~  566 (625)
                      .+...+..+.+++.+||+.+|++||     ++.++++
T Consensus       219 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         219 LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            2444567789999999999999999     7888775

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.1e-38  Score=320.76  Aligned_cols=254  Identities=27%  Similarity=0.409  Sum_probs=203.6

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      .++|++.++||+|+||.||+|..+++..+|+|.+..... ..+.+.+|+.++++++||||+++++++. ....++||||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            457889999999999999999988888899999865433 2357899999999999999999999875 45689999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      ++++|.+++.... ...+++..+..++.+++.||.|||+.+   ++||||||+||++++++.++|+|||++.........
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          83 SKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            9999999886432 234899999999999999999999775   999999999999999999999999999876443322


Q ss_pred             eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                      ......++..|+|||++.+..++.++||||||+++|+|++ |..|+.... ..+..    ....         .....+.
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-~~~~~----~~~~---------~~~~~~~  224 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN-NREVL----EQVE---------RGYRMPC  224 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC-HHHHH----HHHH---------cCCCCCC
Confidence            2222345678999999988889999999999999999999 776654221 11111    1111         1111223


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcc
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN  570 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  570 (625)
                      +...+..+.+++.+||+.+|++|||+.++.+.|++
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            44556779999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-39  Score=345.10  Aligned_cols=257  Identities=23%  Similarity=0.290  Sum_probs=211.2

Q ss_pred             hcCccccccccccCceEEEEEEeCCC-CEEEEEEeecCChHHHHHHHHHHHHHhcCC-CCceeeeee-eeee------CC
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDG-RNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-HKNVVRLLG-CSIE------GP  367 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~-~~~~------~~  367 (625)
                      ..++.+.+.|.+|||+.||+|++..+ .++|+|++...++..++.+.+||.+|+.|+ |||||.+++ ....      .-
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            45677889999999999999998765 999999999889999999999999999997 999999999 3321      13


Q ss_pred             eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccc
Q 042149          368 ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA  447 (625)
Q Consensus       368 ~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla  447 (625)
                      +.+|.||||+||.|-+++..+.... |++.++++|+.++++|+.+||.. +.+|||||||-+||||..+|..||||||.+
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence            6789999999999999997665544 99999999999999999999987 678999999999999999999999999998


Q ss_pred             eeeCCCCceeee--------cCCCCccccCcccc---ccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHH
Q 042149          448 RHVAPDKTHVST--------GIAGTLGYMAPEYL---VRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWK  516 (625)
Q Consensus       448 ~~~~~~~~~~~~--------~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~  516 (625)
                      ............        ...-|+.|.|||++   .+..+++|+|||+|||+||-|+....||+....          
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------  263 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------  263 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence            643322211000        12358999999987   456889999999999999999999999753211          


Q ss_pred             hhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          517 HYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       517 ~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                             ..+++....-+..+..+..|.+||..||+.||++||++.+|++.+..+.
T Consensus       264 -------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~  312 (738)
T KOG1989|consen  264 -------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA  312 (738)
T ss_pred             -------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence                   1122222222234688999999999999999999999999998876653

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-39  Score=315.92  Aligned_cols=263  Identities=22%  Similarity=0.322  Sum_probs=205.4

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEee--cCChHHHHHHHHHHHHHhcCCCCceeeeeeeeee-----CCe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE-----GPE  368 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~  368 (625)
                      ...|...+.||+|+||.|..|..+ +|..||||++.  .......++..+|+++|+.++|+||+.+++.+..     -+.
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            445666789999999999999964 78999999997  6677778899999999999999999999998865     357


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      +|+|+|+| +.+|..++..+..   |+...+..++.|+++||+|+|+.   +++||||||+|+|++.+..+||+|||+|+
T Consensus       101 vYiV~elM-etDL~~iik~~~~---L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIKSQQD---LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             eEEehhHH-hhHHHHHHHcCcc---ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccccee
Confidence            89999999 7799998865543   89999999999999999999977   49999999999999999999999999999


Q ss_pred             eeCCC-CceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhh----------HHH
Q 042149          449 HVAPD-KTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT----------VWK  516 (625)
Q Consensus       449 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~----------~~~  516 (625)
                      ..... .....+..+.|..|.|||++.. ..|+.+.||||+|||+.||++|++-|+..+....+..-          ...
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence            87543 1222356788999999999865 68999999999999999999999877655433221100          111


Q ss_pred             hhhccccccccCCC-CCCCCC-----hHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          517 HYKANRITQSMDPG-LTGRFP-----ENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       517 ~~~~~~~~~~i~~~-~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ..........+... ..++.|     ++......+|+.+||..||.+|+|++|.++
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            11111111111110 001111     244566789999999999999999999885

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-38  Score=333.40  Aligned_cols=251  Identities=22%  Similarity=0.273  Sum_probs=199.0

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ++|++.++||+|+||.||+|+.. +++.||||++...   .......+.+|+.+++.++||||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999999975 6899999999653   2344567889999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++++|.+++....   .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            9999999999886543   3899999999999999999999775   999999999999999999999999998754321


Q ss_pred             Cce-------------------------------------eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh
Q 042149          454 KTH-------------------------------------VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS  496 (625)
Q Consensus       454 ~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt  496 (625)
                      ...                                     ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            110                                     0012469999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 042149          497 GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPS---MAEVVH  566 (625)
Q Consensus       497 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~ev~~  566 (625)
                      |..|+......    ..........       ..+..+.....+..+.+++.+|+. +|.+|++   +.|+++
T Consensus       235 G~~Pf~~~~~~----~~~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         235 GYPPFCSDNPQ----ETYRKIINWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCCCHH----HHHHHHHcCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            99997532211    1111110000       001101111335677889999996 8999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-38  Score=337.92  Aligned_cols=257  Identities=19%  Similarity=0.222  Sum_probs=196.4

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ..+|++.++||+|+||.||++.+. +++.||+|+..      ...+.+|++++++++||||+++++++..+...++|||+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            357999999999999999999964 68899999653      23567899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +. ++|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       165 ~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        165 YK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             CC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence            95 67877775433   3889999999999999999999775   99999999999999999999999999975433222


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCc------cchhhHHHhhhc---------
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSS------SVLHTVWKHYKA---------  520 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~------~~~~~~~~~~~~---------  520 (625)
                      .......||+.|+|||++.+..++.++||||||+++|||++|+.|+.......      ..+.........         
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence            22334679999999999999999999999999999999999998754322110      001111100000         


Q ss_pred             -ccccc---------ccCCCCCCC--CChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          521 -NRITQ---------SMDPGLTGR--FPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       521 -~~~~~---------~i~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                       ..+..         ...+.....  .....+..+.+++.+||+.||++|||++|+++
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence             00000         000000000  01134667899999999999999999999985

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.7e-38  Score=335.50  Aligned_cols=255  Identities=19%  Similarity=0.207  Sum_probs=200.4

Q ss_pred             HHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeE
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  370 (625)
                      ...++|++.++||+|+||.||+++++ +++.+|+|.+...   .......+.+|+.+++.++||||+++++.+.++...+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34578999999999999999999975 5889999998642   2334456889999999999999999999999999999


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      +||||+++|+|.+++...    .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       120 lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence            999999999999988532    3788999999999999999999775   999999999999999999999999999876


Q ss_pred             CCCCceeeecCCCCccccCccccccC----cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccc
Q 042149          451 APDKTHVSTGIAGTLGYMAPEYLVRG----QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS  526 (625)
Q Consensus       451 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (625)
                      ............||+.|+|||++.+.    .++.++||||||+++|||++|+.|+.....    .. .........    
T Consensus       193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~----~~-~~~~i~~~~----  263 (370)
T cd05621         193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL----VG-TYSKIMDHK----  263 (370)
T ss_pred             ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH----HH-HHHHHHhCC----
Confidence            54333333356799999999998754    378899999999999999999999753221    11 111111100    


Q ss_pred             cCCCCCCCCChHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 042149          527 MDPGLTGRFPENEASRVLQIGLLCTQAPVAL--RPSMAEVVHM  567 (625)
Q Consensus       527 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~  567 (625)
                        ..+.-+.....+..+.+++.+|++.++.+  ||++.|+++.
T Consensus       264 --~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         264 --NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             --cccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence              00111111234667888999999865544  8999999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.1e-38  Score=321.40  Aligned_cols=255  Identities=26%  Similarity=0.377  Sum_probs=203.0

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      .++|.+.++||+|+||.||+|+++++..||+|++..... ..+.+.+|+.++++++||||+++++.+. ....++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            356899999999999999999987777899999865332 2357899999999999999999999874 45689999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      ++++|.+++.... ...+++..+..++.+++.||.|||+.+   ++||||||+||++++++.++|+|||.+.........
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          83 SKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            9999999986432 234789999999999999999999775   999999999999999999999999999876543332


Q ss_pred             eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                      ......++..|+|||+..+..++.++||||||+++|||+| |+.|+..... ..    .......         ......
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~-~~----~~~~~~~---------~~~~~~  224 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-RE----VLDQVER---------GYRMPC  224 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh-HH----HHHHHhc---------CCCCCC
Confidence            2223456778999999988899999999999999999999 6666532211 11    1111111         111122


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      +...+..+.+++.+||+.+|++||++.++++.|+..
T Consensus       225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            345667789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.7e-38  Score=323.55  Aligned_cols=266  Identities=26%  Similarity=0.377  Sum_probs=205.0

Q ss_pred             ccccccccccCceEEEEEEe-----CCCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--CeeEE
Q 042149          300 FDNSRKLGQGGAGSVFRGTL-----PDGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG--PESLL  371 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~l  371 (625)
                      |++.+.||+|+||+||++..     .+++.||+|.+.... ......+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            38889999999999988652     357889999986543 33456788999999999999999999987653  46899


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||||+++++|.+++...    .+++.+++.++.|++.||.|||+++   |+||||||+|||+++++.++|+|||+++...
T Consensus        86 v~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            99999999999988542    3899999999999999999999775   9999999999999999999999999998664


Q ss_pred             CCCcee--eecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCC-ccchhhHHHhhhccccccccC
Q 042149          452 PDKTHV--STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGS-SSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       452 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      ......  .....++..|+|||.+....++.++||||||+++|||+||..|+...... ...............+.+.++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence            332211  11234567799999998888999999999999999999999886433211 111111110111112222223


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      .....+.+...+..+.+++.+||+.+|++|||+++|+++|+.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            33333335556788999999999999999999999999997653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.5e-38  Score=336.31  Aligned_cols=254  Identities=20%  Similarity=0.206  Sum_probs=202.1

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      ..++|++.++||+|+||.||+++.+ +++.||+|++...   .......+.+|+.+++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3567999999999999999999975 6889999998643   23344567899999999999999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||||+++|+|.+++...    .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            99999999999988532    3788889999999999999999775   9999999999999999999999999998765


Q ss_pred             CCCceeeecCCCCccccCccccccC----cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccccccc
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRG----QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM  527 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  527 (625)
                      ...........||+.|+|||++.+.    .++.++|||||||++|||++|+.|+......     ..+.......     
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~~i~~~~-----  263 (370)
T cd05596         194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-----GTYSKIMDHK-----  263 (370)
T ss_pred             CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-----HHHHHHHcCC-----
Confidence            4333233346799999999998653    4789999999999999999999997532211     1111111110     


Q ss_pred             CCCCCCCCChHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 042149          528 DPGLTGRFPENEASRVLQIGLLCTQAPVAL--RPSMAEVVHM  567 (625)
Q Consensus       528 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~  567 (625)
                       ..+.-+.....+..+.+++.+||+.+|++  ||+++|+++.
T Consensus       264 -~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         264 -NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             -CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence             00111111234678899999999999988  9999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.7e-38  Score=325.25  Aligned_cols=259  Identities=26%  Similarity=0.384  Sum_probs=206.2

Q ss_pred             HhcCccccccccccCceEEEEEEeC------CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCC
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGP  367 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  367 (625)
                      ..++|++.+.||+|+||.||++.+.      ....+|+|.+... ..+....+.+|+.+++++ +||||+++++++..+.
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            3567889999999999999999864      2367899988654 334556788999999999 7999999999999999


Q ss_pred             eeEEEEEecCCCCcchhhhcc-------------CCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEc
Q 042149          368 ESLLVYEYVPNRSLDQILFVK-------------NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD  434 (625)
Q Consensus       368 ~~~lV~e~~~~~sL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~  434 (625)
                      ..++||||+++++|.+++...             .....+++..++.++.|++.||.|||+.+   |+||||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence            999999999999999998643             22345899999999999999999999775   99999999999999


Q ss_pred             CCCceEEeecccceeeCCCCcee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchh
Q 042149          435 EKLTPKIADFGLARHVAPDKTHV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLH  512 (625)
Q Consensus       435 ~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~  512 (625)
                      .++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..|+.....     .
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~  241 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-----E  241 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH-----H
Confidence            99999999999998765433221 112335678999999988899999999999999999998 7777532111     1


Q ss_pred             hHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          513 TVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       513 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      .......         .......+...+..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus       242 ~~~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         242 ELFKLLK---------EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             HHHHHHH---------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            1111111         1111223445567889999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.6e-38  Score=334.67  Aligned_cols=252  Identities=21%  Similarity=0.249  Sum_probs=196.4

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      .+|++.++||+|+||.||+|+.. +++.||||++....   ......+.+|+++|++++||||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36899999999999999999965 68999999986432   233567889999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++++|.+++....   .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            9999999999986543   3788899999999999999999775   999999999999999999999999997532100


Q ss_pred             C------------------------------------------ceeeecCCCCccccCccccccCcccccCcEEeehhhh
Q 042149          454 K------------------------------------------THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLV  491 (625)
Q Consensus       454 ~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll  491 (625)
                      .                                          ........||+.|+|||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            0                                          0001135799999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCC---CHHHHHHH
Q 042149          492 IEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRP---SMAEVVHM  567 (625)
Q Consensus       492 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---t~~ev~~~  567 (625)
                      |||++|+.|+........    . ......      ......+.....+..+.+++.+|+ .+|++|+   ++.|+++.
T Consensus       235 yell~G~~Pf~~~~~~~~----~-~~i~~~------~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         235 YEMLVGQPPFLADTPAET----Q-LKVINW------ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             eehhhCCCCCCCCCHHHH----H-HHHhcc------CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            999999999754322111    0 000000      000111111234556777888866 5999999   88888864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.9e-38  Score=333.67  Aligned_cols=253  Identities=21%  Similarity=0.281  Sum_probs=194.9

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ++|++.++||+|+||+||+|+.. +++.||||++...   .......+.+|+.++.+++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47899999999999999999865 6899999998653   2334567889999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            9999999999986543   3899999999999999999999775   999999999999999999999999998754321


Q ss_pred             Cc----------------------------------eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCC
Q 042149          454 KT----------------------------------HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRR  499 (625)
Q Consensus       454 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~  499 (625)
                      ..                                  ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            10                                  00123579999999999999999999999999999999999999


Q ss_pred             CCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccC--CCCCCCCCHHHHHHH
Q 042149          500 NSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQ--APVALRPSMAEVVHM  567 (625)
Q Consensus       500 p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~--~~p~~RPt~~ev~~~  567 (625)
                      |+......     ..+........ ...   ...  ....+..+.+++.+++.  .++..||+++||++.
T Consensus       235 Pf~~~~~~-----~~~~~i~~~~~-~~~---~p~--~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         235 PFCSETPQ-----ETYKKVMNWKE-TLI---FPP--EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCCHH-----HHHHHHHcCcC-ccc---CCC--cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            97532211     11111111000 000   000  11234556677766443  344457999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.9e-38  Score=328.61  Aligned_cols=241  Identities=22%  Similarity=0.253  Sum_probs=189.7

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHH-HHhcCCCCceeeeeeeeeeCCeeEEEEEecCC
Q 042149          304 RKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVN-LISGIQHKNVVRLLGCSIEGPESLLVYEYVPN  378 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~  378 (625)
                      ++||+|+||.||+|+.. +|+.+|||++...   .......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999965 6899999998653   2233445555655 57789999999999999999999999999999


Q ss_pred             CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceee
Q 042149          379 RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS  458 (625)
Q Consensus       379 ~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  458 (625)
                      ++|...+....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~  153 (325)
T cd05604          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TT  153 (325)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Cc
Confidence            99988875433   3899999999999999999999775   99999999999999999999999999875322221 12


Q ss_pred             ecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChH
Q 042149          459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPEN  538 (625)
Q Consensus       459 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  538 (625)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.|+.....     ...........        +  ..++.
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~~~~~~--------~--~~~~~  218 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-----AEMYDNILHKP--------L--VLRPG  218 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-----HHHHHHHHcCC--------c--cCCCC
Confidence            345799999999999999999999999999999999999998753221     11111111111        0  11223


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          539 EASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       539 ~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .+..+.+++.+|++.+|++||++.+.++
T Consensus       219 ~~~~~~~ll~~ll~~~p~~R~~~~~~~~  246 (325)
T cd05604         219 ASLTAWSILEELLEKDRQRRLGAKEDFL  246 (325)
T ss_pred             CCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence            4567889999999999999998864443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.4e-38  Score=327.58  Aligned_cols=263  Identities=22%  Similarity=0.280  Sum_probs=196.9

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      .++|++.++||+|+||.||+|+.+ +++.||||++.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            478999999999999999999976 68899999986543 2223467789999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |++ ++|.+++....  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            996 56766664332  34788999999999999999999775   9999999999999999999999999987543222


Q ss_pred             ceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccc---------cc
Q 042149          455 THVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR---------IT  524 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---------~~  524 (625)
                      . ......+++.|+|||++.+ ..++.++|||||||++|||++|+.|+.........+...........         ..
T Consensus       158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd07869         158 H-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP  236 (303)
T ss_pred             c-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence            1 1223568999999999865 45788999999999999999999997643222111111111100000         00


Q ss_pred             cccCCCCCCCCCh---------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          525 QSMDPGLTGRFPE---------NEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       525 ~~i~~~~~~~~~~---------~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ...........+.         ..+..+.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0000000000010         12356789999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-38  Score=335.03  Aligned_cols=252  Identities=19%  Similarity=0.239  Sum_probs=196.5

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ++|.+.++||+|+||.||+++.+ +++.||||++...   .....+.+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46889999999999999999865 7899999998653   2344567889999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++++|.+++....   .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            9999999999886443   3888999999999999999999775   999999999999999999999999998643211


Q ss_pred             Cce----------------------------------------------eeecCCCCccccCccccccCcccccCcEEee
Q 042149          454 KTH----------------------------------------------VSTGIAGTLGYMAPEYLVRGQLTEKADVYAF  487 (625)
Q Consensus       454 ~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~Sl  487 (625)
                      ...                                              ......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000                                              0012469999999999999899999999999


Q ss_pred             hhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCC---CCHHHH
Q 042149          488 GVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALR---PSMAEV  564 (625)
Q Consensus       488 G~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~ev  564 (625)
                      ||++|||++|+.|+......     ..+.......  .    .+.-+.....+..+.+++.+|++ +|.+|   +++.|+
T Consensus       235 Gvil~elltG~~Pf~~~~~~-----~~~~~i~~~~--~----~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~  302 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSH-----ETYRKIINWR--E----TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI  302 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHH-----HHHHHHHccC--C----ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence            99999999999997532211     1111111000  0    00000011345678899999997 66665   699998


Q ss_pred             HHH
Q 042149          565 VHM  567 (625)
Q Consensus       565 ~~~  567 (625)
                      ++.
T Consensus       303 l~h  305 (377)
T cd05629         303 KSH  305 (377)
T ss_pred             hcC
Confidence            864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.8e-38  Score=329.20  Aligned_cols=238  Identities=25%  Similarity=0.271  Sum_probs=192.6

Q ss_pred             ccccccCceEEEEEEe----CCCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecC
Q 042149          304 RKLGQGGAGSVFRGTL----PDGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVP  377 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~  377 (625)
                      +.||+|+||.||+++.    .+++.||+|++....  ......+.+|++++++++||||+++++.+.+++..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999874    357899999997542  2234567789999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCcee
Q 042149          378 NRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV  457 (625)
Q Consensus       378 ~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  457 (625)
                      +++|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....... .
T Consensus        82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~  154 (318)
T cd05582          82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-K  154 (318)
T ss_pred             CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-c
Confidence            999999885443   3899999999999999999999775   99999999999999999999999999876543322 2


Q ss_pred             eecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCCh
Q 042149          458 STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE  537 (625)
Q Consensus       458 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  537 (625)
                      .....|++.|+|||++.+..++.++||||||+++|||++|+.|+...... .    .........          ...+.
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-~----~~~~i~~~~----------~~~p~  219 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-E----TMTMILKAK----------LGMPQ  219 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-H----HHHHHHcCC----------CCCCC
Confidence            23467999999999998888999999999999999999999987532110 0    111111100          11234


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHH
Q 042149          538 NEASRVLQIGLLCTQAPVALRPSMAE  563 (625)
Q Consensus       538 ~~~~~l~~li~~cl~~~p~~RPt~~e  563 (625)
                      ..+..+.+++.+||+.||++||++.+
T Consensus       220 ~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         220 FLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            45677899999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.4e-38  Score=330.12  Aligned_cols=260  Identities=22%  Similarity=0.326  Sum_probs=202.1

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      .++|++.++||+|+||.||++.++ ++..+|+|.+... .....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            468999999999999999999976 6788999988654 33445678999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+++++|.+++....   .+++..+..++.+++.||.|||+..  +++||||||+|||++.++.+||+|||++.......
T Consensus        84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  158 (333)
T cd06650          84 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (333)
T ss_pred             cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence            999999999986543   3788999999999999999999642  59999999999999999999999999987553221


Q ss_pred             ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcc-------------
Q 042149          455 THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN-------------  521 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~-------------  521 (625)
                         .....|++.|+|||++.+..++.++|||||||++|||++|+.|+.......  +..........             
T Consensus       159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  233 (333)
T cd06650         159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE--LELMFGCPVEGDPAESETSPRPRP  233 (333)
T ss_pred             ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhH--HHHHhcCcccCCccccccCcccCC
Confidence               123568999999999998889999999999999999999999875432110  00000000000             


Q ss_pred             -------------------ccccccCCCCCCCCC-hHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          522 -------------------RITQSMDPGLTGRFP-ENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       522 -------------------~~~~~i~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                                         .+.+.+........+ ...+.++.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                               000000000000011 123466899999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.3e-38  Score=317.92  Aligned_cols=246  Identities=26%  Similarity=0.387  Sum_probs=197.2

Q ss_pred             cccccCceEEEEEEe---CCCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCC
Q 042149          305 KLGQGGAGSVFRGTL---PDGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNR  379 (625)
Q Consensus       305 ~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~  379 (625)
                      +||+|+||.||+|.+   ++++.+|+|++....  ....+.+.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            699999999999974   357889999886442  345678899999999999999999999875 45678999999999


Q ss_pred             CcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceee-
Q 042149          380 SLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS-  458 (625)
Q Consensus       380 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-  458 (625)
                      +|.+++....   .+++..+..++.|++.||+|||+++   ++||||||+||++++++.+||+|||+++.......... 
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            9999885433   3889999999999999999999775   99999999999999999999999999987654433211 


Q ss_pred             -ecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCC
Q 042149          459 -TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP  536 (625)
Q Consensus       459 -~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  536 (625)
                       ....+++.|+|||.+....++.++||||||+++|||++ |+.|+..... ...    ...         +......+.+
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~----~~~---------i~~~~~~~~~  220 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-NEV----TQM---------IESGERMECP  220 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHH----HHH---------HHCCCCCCCC
Confidence             12234679999999988889999999999999999998 8888643211 111    111         1111122334


Q ss_pred             hHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       537 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      ...+..+.++|.+||+.+|++||++.+|++.|++.
T Consensus       221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            55677899999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.8e-38  Score=334.35  Aligned_cols=250  Identities=22%  Similarity=0.261  Sum_probs=194.6

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      .|+++++||+|+||.||+|+.. +++.||||++....   ......+.+|+.++++++||||+++++.+.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5889999999999999999965 68899999986532   3445678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+++|+|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            999999999886543   3788899999999999999999775   9999999999999999999999999975321000


Q ss_pred             ----------------------------------------------ceeeecCCCCccccCccccccCcccccCcEEeeh
Q 042149          455 ----------------------------------------------THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFG  488 (625)
Q Consensus       455 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG  488 (625)
                                                                    ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence                                                          0001134699999999999999999999999999


Q ss_pred             hhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCC---HHHHH
Q 042149          489 VLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPS---MAEVV  565 (625)
Q Consensus       489 ~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~ev~  565 (625)
                      |++|||++|+.|+........    .......       ......+.....+....+++.+++ .+|++|++   +.|++
T Consensus       236 vil~elltG~~Pf~~~~~~~~----~~~i~~~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~  303 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPLET----QMKVINW-------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK  303 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHHHH----HHHHHcc-------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence            999999999999753321110    1111000       001111111234556677777765 59999997   77776


Q ss_pred             H
Q 042149          566 H  566 (625)
Q Consensus       566 ~  566 (625)
                      +
T Consensus       304 ~  304 (382)
T cd05625         304 A  304 (382)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1e-38  Score=348.59  Aligned_cols=259  Identities=24%  Similarity=0.279  Sum_probs=207.4

Q ss_pred             HHHHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC-
Q 042149          292 ILERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP-  367 (625)
Q Consensus       292 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-  367 (625)
                      +.+...++|.+.++||+|+||+||+|+.. +++.||||++...  .......+.+|+.++..++|+||+++++.+.... 
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            34455679999999999999999999864 7899999998654  3455677889999999999999999988765432 


Q ss_pred             -------eeEEEEEecCCCCcchhhhccC-CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCce
Q 042149          368 -------ESLLVYEYVPNRSLDQILFVKN-TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP  439 (625)
Q Consensus       368 -------~~~lV~e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~  439 (625)
                             ..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence                   3689999999999999886432 2345889999999999999999999775   9999999999999999999


Q ss_pred             EEeecccceeeCCCCc-eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhh
Q 042149          440 KIADFGLARHVAPDKT-HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHY  518 (625)
Q Consensus       440 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~  518 (625)
                      ||+|||+++.+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.|+.....     .......
T Consensus       183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-----~~~~~~~  257 (496)
T PTZ00283        183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-----EEVMHKT  257 (496)
T ss_pred             EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHH
Confidence            9999999987643221 222346799999999999999999999999999999999999998743211     1111111


Q ss_pred             hccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       519 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      ...         .....+...+..+.+++.+||+.+|++||++.++++.
T Consensus       258 ~~~---------~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        258 LAG---------RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             hcC---------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            111         1122345567789999999999999999999999763

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.3e-38  Score=327.14  Aligned_cols=241  Identities=23%  Similarity=0.252  Sum_probs=194.6

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCC-ceeeeeeeeeeCCeeEEEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHK-NVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~~~~lV~  373 (625)
                      +|++.+.||+|+||.||+|+.+ +++.||||++...   .....+.+..|+.++..+.|+ +|+++++++.+.+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788999999999999999965 5789999998753   234566788899999999765 5888999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++++|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            9999999998886443   3889999999999999999999775   999999999999999999999999998754322


Q ss_pred             CceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                      .. ......||+.|+|||++.+..++.++||||||+++|||+||+.|+..... ..    ........          ..
T Consensus       155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-~~----~~~~i~~~----------~~  218 (324)
T cd05587         155 GK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DE----LFQSIMEH----------NV  218 (324)
T ss_pred             CC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-HH----HHHHHHcC----------CC
Confidence            22 12345799999999999999999999999999999999999998753221 11    11111111          11


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCCH
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPSM  561 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt~  561 (625)
                      .++...+..+.+++.+||+.+|++|++.
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         219 SYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            2234456678899999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.5e-38  Score=316.61  Aligned_cols=247  Identities=26%  Similarity=0.384  Sum_probs=196.0

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCCCc
Q 042149          304 RKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSL  381 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~sL  381 (625)
                      ++||+|+||.||+|+++ +++.+|+|.+... ..+....+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999975 7889999987543 344557799999999999999999999999999999999999999999


Q ss_pred             chhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceee-ec
Q 042149          382 DQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS-TG  460 (625)
Q Consensus       382 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~~  460 (625)
                      .+++....  ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........... ..
T Consensus        81 ~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            99885432  34889999999999999999999775   99999999999999999999999999875432211111 11


Q ss_pred             CCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHH
Q 042149          461 IAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENE  539 (625)
Q Consensus       461 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~  539 (625)
                      ...+..|+|||.+.++.++.++||||||+++|||++ |..|+..... ..             ....+........+...
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-~~-------------~~~~~~~~~~~~~~~~~  221 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-QQ-------------TREAIEQGVRLPCPELC  221 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-HH-------------HHHHHHcCCCCCCcccC
Confidence            123457999999998899999999999999999998 6666532111 00             01111111112234455


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHHHHHHHc
Q 042149          540 ASRVLQIGLLCTQAPVALRPSMAEVVHMLN  569 (625)
Q Consensus       540 ~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  569 (625)
                      +..+.+++.+||+.+|++|||+.+++++|.
T Consensus       222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            678899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.2e-38  Score=323.68  Aligned_cols=261  Identities=24%  Similarity=0.320  Sum_probs=198.4

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ++|++.++||+|+||.||+|+.+ +++.||+|++.... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56999999999999999999965 68899999886543 22345678999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++ +|.+++....  ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        85 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          85 LDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            975 8888775433  24788999999999999999999775   99999999999999999999999999976543222


Q ss_pred             eeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhH-----------HHhhhc-cc
Q 042149          456 HVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV-----------WKHYKA-NR  522 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~-----------~~~~~~-~~  522 (625)
                      . .....+++.|+|||++.+ ..++.++||||||+++|||+||+.|+......+. +...           |..... ..
T Consensus       159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         159 T-YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-LHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             c-ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhccccchh
Confidence            1 223468999999999865 5689999999999999999999988754322111 1111           111100 00


Q ss_pred             cccccCCCCCC----CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          523 ITQSMDPGLTG----RFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       523 ~~~~i~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ......+....    ........+..+++.+||+.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            01111111100    001123556789999999999999999999984

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.6e-38  Score=316.77  Aligned_cols=260  Identities=21%  Similarity=0.356  Sum_probs=208.1

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ++|++.++||+|+||.||+|+.. +++.||||++...   ..+....+.+|+++++.++||||+++++++...+..++||
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57899999999999999999965 7899999987542   3444567899999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccC-CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          374 EYVPNRSLDQILFVKN-TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      ||+++++|.+++.... ....+++..+..++.+++.||.|||+++   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998875422 2234788999999999999999999775   99999999999999999999999999887643


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      .... .....+++.|+|||.+.+..++.++|+||||+++|||++|+.|+......  ... ........        ...
T Consensus       159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~--~~~-~~~~~~~~--------~~~  226 (267)
T cd08228         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LFS-LCQKIEQC--------DYP  226 (267)
T ss_pred             hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc--HHH-HHHHHhcC--------CCC
Confidence            3221 12346889999999998888999999999999999999999986432211  111 11111110        011


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      ...+...+..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus       227 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         227 PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            1112345677999999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-37  Score=325.26  Aligned_cols=255  Identities=21%  Similarity=0.197  Sum_probs=196.5

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ++|++.+.||+|+||.||+++.+ +++.||||++...   .....+.+.+|+.++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47899999999999999999965 6899999998642   2334567889999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++++|.+++....  ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            9999999999885432  34889999999999999999999775   999999999999999999999999998766544


Q ss_pred             CceeeecCCCCccccCcccccc-----CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVR-----GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      .........||+.|+|||++..     +.++.++|||||||++|||++|+.|+.....    ...............   
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~----~~~~~~i~~~~~~~~---  228 (331)
T cd05597         156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYGKIMNHKEHFQ---  228 (331)
T ss_pred             CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH----HHHHHHHHcCCCccc---
Confidence            3332233469999999999863     4578899999999999999999999742211    111111111110000   


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCC--CCCCCCCHHHHHHH
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQA--PVALRPSMAEVVHM  567 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~--~p~~RPt~~ev~~~  567 (625)
                        . .......+..+.+++.+|+..  ++..||++.++++.
T Consensus       229 --~-~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         229 --F-PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             --C-CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence              0 111123456678888887754  33447899998865

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.8e-38  Score=323.34  Aligned_cols=256  Identities=23%  Similarity=0.371  Sum_probs=202.1

Q ss_pred             cCccccccccccCceEEEEEEeC------CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  370 (625)
                      ..|++.++||+|+||.||+|...      +++.||||++.... ....+.+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            34777889999999999999853      25789999987543 334567889999999999999999999999999999


Q ss_pred             EEEEecCCCCcchhhhccC-------------CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC
Q 042149          371 LVYEYVPNRSLDQILFVKN-------------TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL  437 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~  437 (625)
                      +++||+++++|.+++....             ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence            9999999999999885321             1234788899999999999999999775   99999999999999999


Q ss_pred             ceEEeecccceeeCCCCce-eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHH
Q 042149          438 TPKIADFGLARHVAPDKTH-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVW  515 (625)
Q Consensus       438 ~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~  515 (625)
                      .+||+|||+++........ ......+++.|+|||++.++.++.++||||||+++|||++ |..|+... ...    ...
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-~~~----~~~  236 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY-SNQ----DVI  236 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-CHH----HHH
Confidence            9999999998865433221 1223346789999999988899999999999999999998 66554321 111    111


Q ss_pred             HhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcc
Q 042149          516 KHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN  570 (625)
Q Consensus       516 ~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  570 (625)
                      ......         .....+...+..+.+++.+||+.+|++||++.+|+..|+.
T Consensus       237 ~~i~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 EMIRNR---------QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHcC---------CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            111111         1122345567778999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=333.38  Aligned_cols=262  Identities=26%  Similarity=0.362  Sum_probs=221.8

Q ss_pred             HHHHHHhcCccccccccccCceEEEEEEeCC-CCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCee
Q 042149          291 EILERATDFFDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPES  369 (625)
Q Consensus       291 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  369 (625)
                      +.++-...+...-++||.|.||.||.|+|+. .-.||||.++.+.. .+++|+.|+.+|+.++|||+|+++|+|..+..+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            4555445556677899999999999999874 67899999965544 478999999999999999999999999999999


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      |||.|||..|+|.++|...+. ..++....+.++.||..|++||..+   ++|||||...|.||.++..|||+|||++++
T Consensus       339 YIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRl  414 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRL  414 (1157)
T ss_pred             EEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhh
Confidence            999999999999999976654 3467777889999999999999966   599999999999999999999999999999


Q ss_pred             eCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCC-CCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          450 VAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR-RNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      +..+......+......|.|||-+.-..++.|+|||+|||+||||.|-. .|++              .+...++..++.
T Consensus       415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP--------------GidlSqVY~LLE  480 (1157)
T KOG4278|consen  415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP--------------GIDLSQVYGLLE  480 (1157)
T ss_pred             hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC--------------CccHHHHHHHHh
Confidence            8766555444556678999999999999999999999999999999844 4432              222223444555


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      .+.+.+.|..+++.+.+||+.||+.+|.+||++.|+.+.++.+
T Consensus       481 kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  481 KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence            6666677899999999999999999999999999999888765

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.6e-38  Score=314.18  Aligned_cols=247  Identities=27%  Similarity=0.374  Sum_probs=198.6

Q ss_pred             ccccccCceEEEEEEeCCCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCCCcc
Q 042149          304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLD  382 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~sL~  382 (625)
                      ++||+|+||.||+|..++++.+|+|.+.... ......+.+|+.++++++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            3699999999999998888999999886553 344457889999999999999999999999999999999999999999


Q ss_pred             hhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceeeecCC
Q 042149          383 QILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIA  462 (625)
Q Consensus       383 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  462 (625)
                      +++....  ..+++..+..++.+++.+|.|||+.+   ++||||||+||+++.++.+||+|||++...............
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (250)
T cd05085          81 SFLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ  155 (250)
T ss_pred             HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence            9885433  34789999999999999999999775   999999999999999999999999998764332222112223


Q ss_pred             CCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHH
Q 042149          463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEAS  541 (625)
Q Consensus       463 gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  541 (625)
                      +++.|+|||++.++.++.++||||||+++|+|++ |..|+......     ........         ......+...+.
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-----~~~~~~~~---------~~~~~~~~~~~~  221 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-----QAREQVEK---------GYRMSCPQKCPD  221 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-----HHHHHHHc---------CCCCCCCCCCCH
Confidence            4678999999988899999999999999999998 88776432111     11111111         111122344567


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHHHHc
Q 042149          542 RVLQIGLLCTQAPVALRPSMAEVVHMLN  569 (625)
Q Consensus       542 ~l~~li~~cl~~~p~~RPt~~ev~~~L~  569 (625)
                      .+.+++.+||+.+|++||++.|+++.|.
T Consensus       222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         222 DVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            8999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.7e-38  Score=325.59  Aligned_cols=241  Identities=22%  Similarity=0.273  Sum_probs=191.7

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEEEEEecCC
Q 042149          304 RKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLLVYEYVPN  378 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~  378 (625)
                      ++||+|+||.||+|+.. +++.||||.+...   .....+.+..|..++..+ +||||+++++.+..+...++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999965 5789999998653   223345566677777654 899999999999999999999999999


Q ss_pred             CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceee
Q 042149          379 RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS  458 (625)
Q Consensus       379 ~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  458 (625)
                      ++|.+++....   .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~  153 (316)
T cd05592          81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA  153 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence            99998886443   3889999999999999999999775   9999999999999999999999999998653322 222


Q ss_pred             ecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChH
Q 042149          459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPEN  538 (625)
Q Consensus       459 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  538 (625)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.|+..... .    .........          ....+..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-~----~~~~~i~~~----------~~~~~~~  218 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-D----ELFDSILND----------RPHFPRW  218 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-H----HHHHHHHcC----------CCCCCCC
Confidence            345799999999999988999999999999999999999998753221 1    111111110          1123444


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 042149          539 EASRVLQIGLLCTQAPVALRPSMA-EVVH  566 (625)
Q Consensus       539 ~~~~l~~li~~cl~~~p~~RPt~~-ev~~  566 (625)
                      .+..+.+++.+||+.+|++||++. ++++
T Consensus       219 ~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         219 ISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            566788999999999999999875 4543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-38  Score=317.69  Aligned_cols=255  Identities=25%  Similarity=0.414  Sum_probs=200.9

Q ss_pred             ccccccccccCceEEEEEEeCC----CCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCe-----
Q 042149          300 FDNSRKLGQGGAGSVFRGTLPD----GRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPE-----  368 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-----  368 (625)
                      |.+.+.||+|+||.||+|.+..    +..||||++...  .....+.+.+|+.+++.++||||+++++.+.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998642    367999998754  34556789999999999999999999998866554     


Q ss_pred             -eEEEEEecCCCCcchhhhccC---CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeec
Q 042149          369 -SLLVYEYVPNRSLDQILFVKN---TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADF  444 (625)
Q Consensus       369 -~~lV~e~~~~~sL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Df  444 (625)
                       .++||||+++++|..++....   ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             799999999999998885432   2235899999999999999999999775   999999999999999999999999


Q ss_pred             ccceeeCCCCceee-ecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccc
Q 042149          445 GLARHVAPDKTHVS-TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANR  522 (625)
Q Consensus       445 gla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  522 (625)
                      |+++.......... ....++..|+|||.+....++.++||||||+++|||++ |..|+.... .....    +....  
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~-~~~~~----~~~~~--  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE-NHEIY----DYLRH--  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-HHHHH----HHHHc--
Confidence            99987644332211 12235678999999988889999999999999999999 666653221 11111    11111  


Q ss_pred             cccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          523 ITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       523 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                             ......+...+..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus       231 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 -------GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             -------CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                   111122445667899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.4e-38  Score=316.46  Aligned_cols=253  Identities=26%  Similarity=0.400  Sum_probs=202.3

Q ss_pred             cCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecC
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVP  377 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~  377 (625)
                      ++|++.++||+|++|.||+|.++.+..+|+|++.... ...+.+.+|+.++++++|||++++++++. ....++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            5688899999999999999998777789999876543 23467889999999999999999999875 456899999999


Q ss_pred             CCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCcee
Q 042149          378 NRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV  457 (625)
Q Consensus       378 ~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  457 (625)
                      +++|.+++.... ...+++..+..++.+++.||.|||+.+   ++|+||||+||++++++.++|+|||++..........
T Consensus        84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05069          84 KGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence            999999886533 234789999999999999999999775   9999999999999999999999999998764433222


Q ss_pred             eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCC
Q 042149          458 STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP  536 (625)
Q Consensus       458 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  536 (625)
                      .....++..|+|||...+..++.++||||||+++|||+| |+.|+..... ..    .+.....         ......+
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~----~~~~~~~---------~~~~~~~  225 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-RE----VLEQVER---------GYRMPCP  225 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH-HH----HHHHHHc---------CCCCCCC
Confidence            223346778999999988889999999999999999999 7777542211 11    1111111         1111223


Q ss_pred             hHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcc
Q 042149          537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN  570 (625)
Q Consensus       537 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  570 (625)
                      ...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            4556789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.8e-38  Score=323.25  Aligned_cols=256  Identities=26%  Similarity=0.373  Sum_probs=203.0

Q ss_pred             CccccccccccCceEEEEEEeC------CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      +|++.+.||+|+||.||+|+..      ....+++|.+.... ....+.+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999853      23568888876543 3456789999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhhhccC---------------------CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCc
Q 042149          372 VYEYVPNRSLDQILFVKN---------------------TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSN  430 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~N  430 (625)
                      ||||+.+++|.+++....                     ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999875321                     1234789999999999999999999775   9999999999


Q ss_pred             EEEcCCCceEEeecccceeeCCCCcee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCc
Q 042149          431 ILLDEKLTPKIADFGLARHVAPDKTHV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSS  508 (625)
Q Consensus       431 Ill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~  508 (625)
                      ||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+....   
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---  234 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA---  234 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence            999999999999999997654332211 122345778999999988889999999999999999999 877753211   


Q ss_pred             cchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          509 SVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                        ....+....         .....+.+...+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus       235 --~~~~~~~~~---------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         235 --PERLFNLLK---------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             --HHHHHHHHh---------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence              111122111         1111222445567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-38  Score=319.16  Aligned_cols=252  Identities=24%  Similarity=0.289  Sum_probs=202.1

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      +|++.++||+|+||.||++... +++.||||++....   ......+.+|+.++++++||||+++++.+...+..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788999999999999999964 68999999986532   2233567889999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+++++|.+++..... ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            9999999988764332 34899999999999999999999775   9999999999999999999999999998754332


Q ss_pred             ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          455 THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                      .  .....|++.|+|||++.+..++.++||||||+++|||++|+.|+...... .........         +.. ....
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~~~~~---------~~~-~~~~  223 (285)
T cd05605         157 T--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREEVERR---------VKE-DQEE  223 (285)
T ss_pred             c--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHHHHHH---------hhh-cccc
Confidence            2  12346899999999999889999999999999999999999987532211 111111111         110 1112


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRP-----SMAEVVHM  567 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~  567 (625)
                      .+...+..+.+++.+||+.||++||     +++++++.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         224 YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            3445677789999999999999999     88888653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.1e-37  Score=322.85  Aligned_cols=255  Identities=20%  Similarity=0.182  Sum_probs=198.2

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ++|++.++||+|+||.||+++.+ +++.||+|.+...   .......+.+|+.++..++|+||+++++++.+++..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999975 6889999998642   2334456888999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||++||+|.+++....  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999999986532  24889999999999999999999775   999999999999999999999999999876554


Q ss_pred             CceeeecCCCCccccCcccccc-----CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVR-----GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      .........||+.|+|||++.+     +.++.++||||||+++|||++|+.|+......    . .......... .   
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----~-~~~~i~~~~~-~---  226 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV----E-TYGKIMNHEE-R---  226 (331)
T ss_pred             CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH----H-HHHHHHcCCC-c---
Confidence            4333334579999999999875     46789999999999999999999997432111    1 1111111000 0   


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVAL--RPSMAEVVHM  567 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~  567 (625)
                      ... +......+..+.+++.+|+...+++  |++++++++.
T Consensus       227 ~~~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         227 FQF-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             ccC-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            000 1111234567889999998865544  4688888754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1e-37  Score=324.17  Aligned_cols=237  Identities=23%  Similarity=0.259  Sum_probs=188.4

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHH-HHhcCCCCceeeeeeeeeeCCeeEEEEEecCC
Q 042149          304 RKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVN-LISGIQHKNVVRLLGCSIEGPESLLVYEYVPN  378 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~  378 (625)
                      +.||+|+||+||+|+++ +++.||||++....   ......+.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999975 68999999986532   223344555554 56889999999999999999999999999999


Q ss_pred             CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceee
Q 042149          379 RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS  458 (625)
Q Consensus       379 ~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  458 (625)
                      ++|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~  153 (323)
T cd05575          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TT  153 (323)
T ss_pred             CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-cc
Confidence            99998886543   3889999999999999999999775   99999999999999999999999999875432222 22


Q ss_pred             ecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChH
Q 042149          459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPEN  538 (625)
Q Consensus       459 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  538 (625)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.|+.....     ...........          ...+..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~----------~~~~~~  218 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AEMYDNILNKP----------LRLKPN  218 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HHHHHHHHcCC----------CCCCCC
Confidence            345799999999999999999999999999999999999998753211     11111111111          112334


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHH
Q 042149          539 EASRVLQIGLLCTQAPVALRPSMA  562 (625)
Q Consensus       539 ~~~~l~~li~~cl~~~p~~RPt~~  562 (625)
                      .+..+.+++.+||+.+|++||++.
T Consensus       219 ~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         219 ISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCHHHHHHHHHHhhcCHHhCCCCC
Confidence            467789999999999999999874

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4e-38  Score=329.29  Aligned_cols=260  Identities=21%  Similarity=0.276  Sum_probs=194.8

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC-----CeeE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG-----PESL  370 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~  370 (625)
                      +|++.++||+|+||.||+|+.+ +++.||||++...  .......+.+|+.++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4888999999999999999965 6899999998643  233445788999999999999999999987643     2479


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      +||||+. ++|.+++....   .+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 68888775433   3899999999999999999999775   999999999999999999999999999764


Q ss_pred             CCCCc--eeeecCCCCccccCcccccc--CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhH-----------H
Q 042149          451 APDKT--HVSTGIAGTLGYMAPEYLVR--GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV-----------W  515 (625)
Q Consensus       451 ~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~-----------~  515 (625)
                      .....  .......||+.|+|||++.+  ..++.++||||||+++|||+||+.|+....... .....           +
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLITDLLGTPSPETI  232 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCCHHHH
Confidence            32221  11234579999999999866  678999999999999999999998875432111 00000           0


Q ss_pred             Hhhhcccccc---ccCCCCCCCC---ChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          516 KHYKANRITQ---SMDPGLTGRF---PENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       516 ~~~~~~~~~~---~i~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ..+......+   .+........   .+..+..+.+++.+||+.+|++|||++|+++
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            1111110000   0000000000   0123456789999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=9.1e-38  Score=315.00  Aligned_cols=259  Identities=22%  Similarity=0.365  Sum_probs=209.2

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ++|++.++||+|+||.||+|... +++.||+|.+...   .....+.+.+|++++++++|+||+++++.+...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57899999999999999999976 7899999988532   2344668899999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhcc-CCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          374 EYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       374 e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      ||+++++|.+++... .....+++..+..++.+++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999988542 22344889999999999999999999775   99999999999999999999999999876543


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      .... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.|+......  . ........         ....
T Consensus       159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~-~~~~~~~~---------~~~~  225 (267)
T cd08224         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--L-YSLCKKIE---------KCDY  225 (267)
T ss_pred             CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc--H-HHHHhhhh---------cCCC
Confidence            3221 12346889999999998888999999999999999999999986432211  0 00111111         1111


Q ss_pred             CCCCh-HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          533 GRFPE-NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       533 ~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      .+.+. ..+..+.+++.+||+.+|++|||+.+|+++|+++.
T Consensus       226 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         226 PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            12222 55677899999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.7e-38  Score=330.18  Aligned_cols=259  Identities=29%  Similarity=0.410  Sum_probs=202.8

Q ss_pred             hcCccccccccccCceEEEEEEeC------CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeee-CC
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIE-GP  367 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~-~~  367 (625)
                      .++|++.+.||+|+||.||+|+..      +++.||+|++... .....+.+.+|+.+++++ +||||+++++++.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            457999999999999999999732      3578999988643 234456788999999999 79999999998764 45


Q ss_pred             eeEEEEEecCCCCcchhhhccCC---------------------------------------------------------
Q 042149          368 ESLLVYEYVPNRSLDQILFVKNT---------------------------------------------------------  390 (625)
Q Consensus       368 ~~~lV~e~~~~~sL~~~l~~~~~---------------------------------------------------------  390 (625)
                      ..+++|||+++++|.+++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            68899999999999988854221                                                         


Q ss_pred             -cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCcee-eecCCCCcccc
Q 042149          391 -IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV-STGIAGTLGYM  468 (625)
Q Consensus       391 -~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~  468 (625)
                       ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.++|+|||+++.+....... .....++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             125789999999999999999999775   9999999999999999999999999998764332222 12234677899


Q ss_pred             CccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHH
Q 042149          469 APEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIG  547 (625)
Q Consensus       469 aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  547 (625)
                      |||++.+..++.++|||||||++|||++ |..|+......+.    ........         .....+...+.++.+++
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~----~~~~~~~~---------~~~~~~~~~~~~~~~l~  309 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE----FCRRLKEG---------TRMRAPEYATPEIYSIM  309 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH----HHHHHhcc---------CCCCCCccCCHHHHHHH
Confidence            9999999999999999999999999998 8887643221111    11111111         11112334456789999


Q ss_pred             hhccCCCCCCCCCHHHHHHHHccc
Q 042149          548 LLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       548 ~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      .+||+.+|++||++.||+++|+.+
T Consensus       310 ~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         310 LDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=7e-38  Score=318.68  Aligned_cols=246  Identities=22%  Similarity=0.274  Sum_probs=196.3

Q ss_pred             ccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCCCc
Q 042149          306 LGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSL  381 (625)
Q Consensus       306 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~sL  381 (625)
                      ||+|+||+||++.++ +++.+|||++....   ....+.+..|+.+++.++||||+++.+++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999965 68899999986542   23345678899999999999999999999999999999999999999


Q ss_pred             chhhhcc-CCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceeeec
Q 042149          382 DQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG  460 (625)
Q Consensus       382 ~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  460 (625)
                      .+.+... .....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.++|+|||++......... ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence            8877532 22345899999999999999999999775   999999999999999999999999999866543322 234


Q ss_pred             CCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHH
Q 042149          461 IAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEA  540 (625)
Q Consensus       461 ~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  540 (625)
                      ..||+.|+|||++.+..++.++||||||+++|||++|+.|+.......... .....        ....  ....+...+
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~--------~~~~--~~~~~~~~~  225 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK-ELKQR--------ILND--SVTYPDKFS  225 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH-HHHHh--------hccc--CCCCcccCC
Confidence            578999999999999999999999999999999999999975432211100 00000        0111  112244566


Q ss_pred             HHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042149          541 SRVLQIGLLCTQAPVALRP-----SMAEVVH  566 (625)
Q Consensus       541 ~~l~~li~~cl~~~p~~RP-----t~~ev~~  566 (625)
                      ..+.+++.+||+.+|++||     +++++++
T Consensus       226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         226 PASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            7789999999999999999     6677775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.3e-38  Score=320.05  Aligned_cols=256  Identities=25%  Similarity=0.336  Sum_probs=199.9

Q ss_pred             cCccccccccccCceEEEEEEeC-CCC----EEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGR----NIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      +.|++.+.||+|+||+||+|++. +++    .+++|.+.... ......+.+|+.++++++||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            46888899999999999999964 444    47778775432 334567888999999999999999999875 456789


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ++||+++++|.+++....  ..+++..+..++.||+.||.|||+.+   ++||||||+||++++++.+||+|||+++...
T Consensus        86 i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            999999999999986433  34899999999999999999999775   9999999999999999999999999998764


Q ss_pred             CCCce-eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          452 PDKTH-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       452 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      ..... ......++..|+|||.+.++.++.++||||||+++|||++ |+.|+..... ..    .......         
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~----~~~~~~~---------  226 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-HE----VPDLLEK---------  226 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HH----HHHHHHC---------
Confidence            33322 1223457789999999998999999999999999999998 8877643211 00    1111111         


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccC
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY  573 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  573 (625)
                      ......+...+..+.+++.+||..+|++|||+.|+++.|..+..
T Consensus       227 ~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         227 GERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            11111122345567889999999999999999999999877653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=7.8e-38  Score=324.79  Aligned_cols=237  Identities=22%  Similarity=0.264  Sum_probs=187.3

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHH-HHhcCCCCceeeeeeeeeeCCeeEEEEEecCC
Q 042149          304 RKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVN-LISGIQHKNVVRLLGCSIEGPESLLVYEYVPN  378 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~  378 (625)
                      ++||+|+||.||+|++. +++.||+|++....   ......+.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 68899999986432   223344555554 67889999999999999999999999999999


Q ss_pred             CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceee
Q 042149          379 RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS  458 (625)
Q Consensus       379 ~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  458 (625)
                      ++|...+....   .+.+..+..++.||+.||.|||+.+   |+||||||+||+|+.++.+||+|||+++....... ..
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~  153 (321)
T cd05603          81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TT  153 (321)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-cc
Confidence            99988775433   3788899999999999999999775   99999999999999999999999999875322221 22


Q ss_pred             ecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChH
Q 042149          459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPEN  538 (625)
Q Consensus       459 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  538 (625)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.|+.....     ..........          ....+..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~----------~~~~~~~  218 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQMYDNILHK----------PLQLPGG  218 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HHHHHHHhcC----------CCCCCCC
Confidence            345789999999999988999999999999999999999998743211     1111111111          0122344


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHH
Q 042149          539 EASRVLQIGLLCTQAPVALRPSMA  562 (625)
Q Consensus       539 ~~~~l~~li~~cl~~~p~~RPt~~  562 (625)
                      .+..+.+++.+||+.+|++||+..
T Consensus       219 ~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         219 KTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCHHHHHHHHHHccCCHhhcCCCC
Confidence            567789999999999999999763

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.3e-38  Score=326.70  Aligned_cols=242  Identities=23%  Similarity=0.261  Sum_probs=195.1

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEEEEEecCC
Q 042149          304 RKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLLVYEYVPN  378 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~  378 (625)
                      ++||+|+||.||+|+.+ +++.||||++...   .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999975 5789999998653   234456678899999866 799999999999999999999999999


Q ss_pred             CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceee
Q 042149          379 RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS  458 (625)
Q Consensus       379 ~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  458 (625)
                      ++|...+....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......... .
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~  153 (321)
T cd05591          81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT-T  153 (321)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCcc-c
Confidence            99998886443   3889999999999999999999775   999999999999999999999999998764332222 2


Q ss_pred             ecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChH
Q 042149          459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPEN  538 (625)
Q Consensus       459 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  538 (625)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.|+......     ..........          ...|..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-----~~~~~i~~~~----------~~~p~~  218 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-----DLFESILHDD----------VLYPVW  218 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-----HHHHHHHcCC----------CCCCCC
Confidence            3457999999999999889999999999999999999999997533211     1111111111          112333


Q ss_pred             HHHHHHHHHhhccCCCCCCCC-------CHHHHHHH
Q 042149          539 EASRVLQIGLLCTQAPVALRP-------SMAEVVHM  567 (625)
Q Consensus       539 ~~~~l~~li~~cl~~~p~~RP-------t~~ev~~~  567 (625)
                      .+..+.+++.+||+.+|++||       ++.++++.
T Consensus       219 ~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         219 LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            456788999999999999999       77877753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.6e-38  Score=319.88  Aligned_cols=267  Identities=24%  Similarity=0.354  Sum_probs=204.6

Q ss_pred             cCccccccccccCceEEEEEEe-----CCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeee--CCeeE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTL-----PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE--GPESL  370 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~  370 (625)
                      .+|++.+.||+|+||.||++..     .+++.||||++........+.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4688899999999999999974     2578999999987777777889999999999999999999997653  34689


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      +||||+++++|.+++....  ..+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++...
T Consensus        84 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            9999999999999885432  24899999999999999999999775   999999999999999999999999999876


Q ss_pred             CCCCceee--ecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhh----ccccc
Q 042149          451 APDKTHVS--TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK----ANRIT  524 (625)
Q Consensus       451 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~----~~~~~  524 (625)
                      ........  ....++..|+|||++.+..++.++||||||+++|||++|..+......  ...........    ...+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA--EFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch--hhhhhcccccccccchHHHH
Confidence            44332211  122344569999999888899999999999999999998765422110  00000000000    00011


Q ss_pred             cccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          525 QSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       525 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      +.+......+.+...+..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            11111122223345567899999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.4e-38  Score=320.13  Aligned_cols=255  Identities=25%  Similarity=0.370  Sum_probs=203.3

Q ss_pred             cCccccccccccCceEEEEEEeC------CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      +++...++||+|+||.||++...      ++..+|+|.+........+.+.+|+++++.++||||+++++++.+....++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46778899999999999999732      356789998877666777889999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCC------------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCce
Q 042149          372 VYEYVPNRSLDQILFVKNT------------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP  439 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~  439 (625)
                      ||||+++++|.+++.....            ...+++..+..++.|++.||+|||+.+   ++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999998865432            134789999999999999999999775   9999999999999999999


Q ss_pred             EEeecccceeeCCCCcee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHh
Q 042149          440 KIADFGLARHVAPDKTHV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKH  517 (625)
Q Consensus       440 kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~  517 (625)
                      ||+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.|+..... ....    ..
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~----~~  236 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN-TEAI----EC  236 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH-HHHH----HH
Confidence            999999987654322211 112345788999999998999999999999999999998 7776532111 1110    00


Q ss_pred             hhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHc
Q 042149          518 YKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLN  569 (625)
Q Consensus       518 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  569 (625)
                               +........+...+..+.+++.+||+.+|++||++.||++.|+
T Consensus       237 ---------~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         237 ---------ITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             ---------HHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                     0011111223345667899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.8e-38  Score=318.06  Aligned_cols=255  Identities=24%  Similarity=0.320  Sum_probs=202.1

Q ss_pred             hcCccccccccccCceEEEEEEe-CCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      .++|++.++||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++.+..+...++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            45799999999999999999996 46889999999766555566788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+++....   .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++........
T Consensus        88 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          88 CGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            99999999886443   3789999999999999999999765   99999999999999999999999999987643221


Q ss_pred             eeeecCCCCccccCccccc---cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLV---RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      . .....+++.|+|||.+.   ...++.++||||||+++|||++|+.|+..........     ......   ...+.. 
T Consensus       162 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-----~~~~~~---~~~~~~-  231 (267)
T cd06646         162 K-RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-----LMSKSN---FQPPKL-  231 (267)
T ss_pred             c-cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-----eeecCC---CCCCCC-
Confidence            1 12346889999999884   3457889999999999999999998864221111000     000000   000000 


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHML  568 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  568 (625)
                       ......+..+.+++.+||+.+|++||+++++++.|
T Consensus       232 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         232 -KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             -ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence             11223457789999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.2e-38  Score=315.91  Aligned_cols=255  Identities=27%  Similarity=0.405  Sum_probs=204.8

Q ss_pred             HhcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ..++|++.++||+|+||.||+|....+..+|+|.+.... ...+.+.+|+.++++++|+||+++++.+.+ ...+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            356789999999999999999998777889999886543 345678999999999999999999999877 778999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+++.... ...+++..+..++.+++.||.|||+.+   ++||||||+||+++.++.+||+|||++........
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          82 MAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             CCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence            99999999986543 234788999999999999999999775   99999999999999999999999999976644332


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                      .......++..|+|||++..+.++.++|+||||+++|+++| |+.|+..... ..    ........         ...+
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-~~----~~~~~~~~---------~~~~  223 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-PE----VIRALERG---------YRMP  223 (260)
T ss_pred             ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH-HH----HHHHHhCC---------CCCC
Confidence            22223345678999999988889999999999999999999 7777542211 11    11111111         1111


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcc
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN  570 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  570 (625)
                      .+...+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            233456678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=7e-38  Score=313.78  Aligned_cols=250  Identities=25%  Similarity=0.374  Sum_probs=205.5

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      +|++.+.||+|++|.||+|+.+ +++.|++|.+...  .....+.+.+|++++++++||||+++++.+.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778889999999999999975 6899999988643  345567889999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+++.... ...+++..++.++.+++.||.|||+.+   ++|+||||+||++++++.++|+|||+++.......
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            99999999987542 345899999999999999999999775   99999999999999999999999999887654332


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                      . .....+++.|+|||+..+..++.++|+||||+++|+|++|+.|+.....     .........         ......
T Consensus       157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~---------~~~~~~  221 (256)
T cd08529         157 F-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----GALILKIIR---------GVFPPV  221 (256)
T ss_pred             h-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHc---------CCCCCC
Confidence            2 2234688999999999999999999999999999999999998753321     111111111         111222


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      +...+..+.+++.+||+.+|++||++.++++.
T Consensus       222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         222 SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            33556789999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-38  Score=317.65  Aligned_cols=256  Identities=29%  Similarity=0.416  Sum_probs=207.0

Q ss_pred             HhcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ..++|.+.++||+|+||.||+|.+++++.+|||.+..... ..+.+.+|+.++++++||||+++++++......++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            3578999999999999999999988888999998875433 346789999999999999999999999998999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+++.... ...+++..+..++.+++.||.|||+++   ++|+||||+||+++.++.+||+|||++........
T Consensus        83 ~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          83 MSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             cCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            99999999886543 234899999999999999999999775   99999999999999999999999999887654222


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                      .......++..|+|||.+.+..++.++||||||+++|+|++ |+.|+..... ...    ......         .....
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-~~~----~~~~~~---------~~~~~  224 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-REV----LEQVER---------GYRMP  224 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHH----HHHHHc---------CCCCC
Confidence            22222345678999999998889999999999999999999 8877632211 111    111111         11112


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcc
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN  570 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  570 (625)
                      .+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus       225 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         225 RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            233446778999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=328.40  Aligned_cols=246  Identities=29%  Similarity=0.370  Sum_probs=206.9

Q ss_pred             cccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCCCcch
Q 042149          305 KLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQ  383 (625)
Q Consensus       305 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~sL~~  383 (625)
                      +||+|.||+||.|++. +...+|||.+.....+..+.+.+||.+.++|+|.|||+++|.+.+++.+-|.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            5999999999999976 456789999988777888899999999999999999999999999999999999999999999


Q ss_pred             hhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEc-CCCceEEeecccceeeCCCCceeeecCC
Q 042149          384 ILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIA  462 (625)
Q Consensus       384 ~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~  462 (625)
                      +|..+=+.-.-.+..+-.+..||++||.|||++.   |||||||-+||||+ -.|.+||+|||-++.+..-+. ....+.
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TETFT  737 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTETFT  737 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCc-cccccc
Confidence            9976533322477888899999999999999875   99999999999997 478999999999987654333 234578


Q ss_pred             CCccccCccccccC--cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHH
Q 042149          463 GTLGYMAPEYLVRG--QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEA  540 (625)
Q Consensus       463 gt~~y~aPE~~~~~--~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  540 (625)
                      ||..|||||++..+  .|+.++|||||||++.||.||++||......+.-.            .++---...++.|.+.+
T Consensus       738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM------------FkVGmyKvHP~iPeels  805 (1226)
T KOG4279|consen  738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM------------FKVGMYKVHPPIPEELS  805 (1226)
T ss_pred             cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh------------hhhcceecCCCCcHHHH
Confidence            99999999999876  58899999999999999999999986544332211            11111122356688999


Q ss_pred             HHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          541 SRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       541 ~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .+...+|++|+.++|.+||++.++++
T Consensus       806 aeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  806 AEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHcCCCcccCccHHHhcc
Confidence            99999999999999999999999985

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7.6e-38  Score=314.28  Aligned_cols=247  Identities=22%  Similarity=0.373  Sum_probs=196.0

Q ss_pred             cccccCceEEEEEEeC---CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCCC
Q 042149          305 KLGQGGAGSVFRGTLP---DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRS  380 (625)
Q Consensus       305 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~s  380 (625)
                      .||+|+||.||+|++.   .+..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999753   35579999886553 344567999999999999999999999875 457899999999999


Q ss_pred             cchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceee--
Q 042149          381 LDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS--  458 (625)
Q Consensus       381 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~--  458 (625)
                      |.+++....  ..+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++...........  
T Consensus        81 L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            999885432  34899999999999999999999775   99999999999999999999999999986544332221  


Q ss_pred             ecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCCh
Q 042149          459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE  537 (625)
Q Consensus       459 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  537 (625)
                      ....+++.|+|||.+....++.++||||||+++|||++ |+.|+..... .    ......         ........+.
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~----~~~~~~---------~~~~~~~~~~  221 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-P----EVMSFI---------EQGKRLDCPA  221 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-H----HHHHHH---------HCCCCCCCCC
Confidence            12234678999999988889999999999999999996 8887642211 1    111111         1111222344


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          538 NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       538 ~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      ..+.++.+++.+||+.+|++||++.+|.+.|+.+
T Consensus       222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            5677899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5e-38  Score=319.58  Aligned_cols=260  Identities=28%  Similarity=0.369  Sum_probs=207.2

Q ss_pred             hcCccccccccccCceEEEEEEeCC-----CCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeee-CCee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPD-----GRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE-GPES  369 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~  369 (625)
                      .++|++.+.||+|+||.||+|.+.+     +..|++|++... .....+.+.+|+.++++++||||+++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            5688999999999999999999765     678899988654 34556778999999999999999999998766 5678


Q ss_pred             EEEEEecCCCCcchhhhccCCc-----CCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeec
Q 042149          370 LLVYEYVPNRSLDQILFVKNTI-----HILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADF  444 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Df  444 (625)
                      ++++||+++++|.+++......     ..+++..++.++.+++.||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999988654322     45899999999999999999999765   999999999999999999999999


Q ss_pred             ccceeeCCCCcee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccc
Q 042149          445 GLARHVAPDKTHV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANR  522 (625)
Q Consensus       445 gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  522 (625)
                      |+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.|+..... .+    ........ 
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~----~~~~~~~~-  235 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-FE----MAAYLKDG-  235 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-HH----HHHHHHcC-
Confidence            9998664433222 123346778999999988889999999999999999999 8887643211 11    11111111 


Q ss_pred             cccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccC
Q 042149          523 ITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY  573 (625)
Q Consensus       523 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  573 (625)
                              .....+...+..+.+++.+||+.+|++|||+.++++.|..+..
T Consensus       236 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         236 --------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             --------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                    1111123345678999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=4.5e-38  Score=321.63  Aligned_cols=261  Identities=24%  Similarity=0.299  Sum_probs=193.3

Q ss_pred             cCccccccccccCceEEEEEEeC--CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcC---CCCceeeeeeeee-----e
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP--DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGI---QHKNVVRLLGCSI-----E  365 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~-----~  365 (625)
                      ++|++.+.||+|+||.||+|++.  +++.||||++....  ......+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36889999999999999999863  46789999886432  22234556777777665   6999999999875     3


Q ss_pred             CCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecc
Q 042149          366 GPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFG  445 (625)
Q Consensus       366 ~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfg  445 (625)
                      ....++||||++ ++|.+++..... ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            456899999996 588888754332 34899999999999999999999775   9999999999999999999999999


Q ss_pred             cceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhc---cc
Q 042149          446 LARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKA---NR  522 (625)
Q Consensus       446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~---~~  522 (625)
                      +++......  ......|++.|+|||++.+..++.++||||||+++|||++|+.|+......+ .+.........   ..
T Consensus       156 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~~~~~  232 (290)
T cd07862         156 LARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEED  232 (290)
T ss_pred             ceEeccCCc--ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhh
Confidence            998754332  2234568999999999988899999999999999999999998875432211 11111110000   00


Q ss_pred             cc-------cccCCCCCC---CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          523 IT-------QSMDPGLTG---RFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       523 ~~-------~~i~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ..       .........   ...+..+..+.+++.+||+.+|++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00       000000000   011234566789999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=9.8e-38  Score=324.31  Aligned_cols=241  Identities=23%  Similarity=0.257  Sum_probs=194.9

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEEEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      +|++.+.||+|+||.||+|+.+ +++.||||++....   ....+.+..|..++..+ +||+|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788999999999999999975 57899999987542   33345677788888877 5899999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++++|.+.+....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            9999999998886443   3889999999999999999999775   999999999999999999999999999764322


Q ss_pred             CceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                      .. ......||+.|+|||++.+..++.++|||||||++|||+||+.|+..... ..+    ........          .
T Consensus       155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~----~~~i~~~~----------~  218 (323)
T cd05616         155 GV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DEL----FQSIMEHN----------V  218 (323)
T ss_pred             CC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-HHH----HHHHHhCC----------C
Confidence            22 22345799999999999999999999999999999999999999753221 111    11111111          1


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCCH
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPSM  561 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt~  561 (625)
                      .+|...+.++.+++.+|++.+|++|++.
T Consensus       219 ~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            2344556778999999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=313.87  Aligned_cols=251  Identities=25%  Similarity=0.361  Sum_probs=203.2

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-----hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-----RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      ++|++.+.||+|++|.||+|... +++.+|+|.+....     ......+.+|++++++++||||+++++++.++...++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57899999999999999999864 68999999886432     2234678899999999999999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||||+++++|.+++....   .+++..+..++.+++.||.|||+.+   ++||||+|+||++++++.++|+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            999999999999886543   3788999999999999999999775   9999999999999999999999999987654


Q ss_pred             CCCceee--ecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          452 PDKTHVS--TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       452 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      .......  ....++..|+|||++.+..++.++||||||+++|||++|+.|+......    ......         ...
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~---------~~~  222 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM----AAIFKI---------ATQ  222 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH----HHHHHH---------hcc
Confidence            3222111  2345788999999999988999999999999999999999886432111    111111         011


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      ......+...+..+.+++.+||+.+|++|||+.++++.
T Consensus       223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         223 PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            11122344566778999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.5e-38  Score=320.17  Aligned_cols=264  Identities=25%  Similarity=0.362  Sum_probs=202.2

Q ss_pred             hcCccccccccccCceEEEEEEeCC---------------CCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPD---------------GRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLL  360 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~  360 (625)
                      .++|++.++||+|+||.||+++...               ...||||++... .....+.+.+|++++++++||||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3578999999999999999987532               235899988654 344566799999999999999999999


Q ss_pred             eeeeeCCeeEEEEEecCCCCcchhhhccC---------CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcE
Q 042149          361 GCSIEGPESLLVYEYVPNRSLDQILFVKN---------TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNI  431 (625)
Q Consensus       361 ~~~~~~~~~~lV~e~~~~~sL~~~l~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NI  431 (625)
                      +++...+..++||||+++++|.+++....         ....+++..++.++.+++.||.|||+.+   ++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            99999999999999999999999885432         1123688999999999999999999775   99999999999


Q ss_pred             EEcCCCceEEeecccceeeCCCCcee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCC-cc
Q 042149          432 LLDEKLTPKIADFGLARHVAPDKTHV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGS-SS  509 (625)
Q Consensus       432 ll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~-~~  509 (625)
                      ++++++.+||+|||++.......... .....+++.|+|||++..+.++.++||||||+++|+|+++..+.++.... ..
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            99999999999999987654332211 12234577999999999899999999999999999999954433332211 11


Q ss_pred             chhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHc
Q 042149          510 VLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLN  569 (625)
Q Consensus       510 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  569 (625)
                      .+....+.+....      .......+...+..+.+|+.+||+.+|++||++.+|++.|.
T Consensus       241 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 VIENTGEFFRNQG------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHhhhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            1111111111100      01111123344678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.4e-37  Score=321.85  Aligned_cols=246  Identities=21%  Similarity=0.247  Sum_probs=196.6

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEEEEEecCC
Q 042149          304 RKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLLVYEYVPN  378 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~  378 (625)
                      ++||+|+||.||+|+.+ +++.||||++...   .....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999965 6789999999754   234456788999999888 699999999999999999999999999


Q ss_pred             CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceee
Q 042149          379 RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS  458 (625)
Q Consensus       379 ~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  458 (625)
                      ++|..++....   .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~  153 (327)
T cd05617          81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TT  153 (327)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ce
Confidence            99988875443   3899999999999999999999775   99999999999999999999999999875332222 12


Q ss_pred             ecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCc--cchhhHHHhhhccccccccCCCCCCCCC
Q 042149          459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSS--SVLHTVWKHYKANRITQSMDPGLTGRFP  536 (625)
Q Consensus       459 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~~~~~~~  536 (625)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.|+.......  ......+......          ....|
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------~~~~p  223 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK----------PIRIP  223 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC----------CCCCC
Confidence            34679999999999999999999999999999999999999985432211  1111222221111          11234


Q ss_pred             hHHHHHHHHHHhhccCCCCCCCCC------HHHHHH
Q 042149          537 ENEASRVLQIGLLCTQAPVALRPS------MAEVVH  566 (625)
Q Consensus       537 ~~~~~~l~~li~~cl~~~p~~RPt------~~ev~~  566 (625)
                      ...+..+.+++.+||+.||++||+      ++++++
T Consensus       224 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  259 (327)
T cd05617         224 RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKS  259 (327)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc
Confidence            445677889999999999999998      456654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.6e-38  Score=327.04  Aligned_cols=236  Identities=24%  Similarity=0.290  Sum_probs=191.4

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEEEEEecCC
Q 042149          304 RKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLLVYEYVPN  378 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~  378 (625)
                      ++||+|+||.||+|+++ +++.||||++...   .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 5889999998653   234456778899888876 699999999999999999999999999


Q ss_pred             CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceee
Q 042149          379 RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS  458 (625)
Q Consensus       379 ~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  458 (625)
                      ++|.+++....   .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~  153 (320)
T cd05590          81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TT  153 (320)
T ss_pred             chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-cc
Confidence            99998886443   3889999999999999999999775   99999999999999999999999999876432222 22


Q ss_pred             ecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChH
Q 042149          459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPEN  538 (625)
Q Consensus       459 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  538 (625)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.|+......     ..........          ...+..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~~~~----------~~~~~~  218 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-----DLFEAILNDE----------VVYPTW  218 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----HHHHHHhcCC----------CCCCCC
Confidence            3457999999999999889999999999999999999999997532211     1111111111          112334


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCH
Q 042149          539 EASRVLQIGLLCTQAPVALRPSM  561 (625)
Q Consensus       539 ~~~~l~~li~~cl~~~p~~RPt~  561 (625)
                      .+..+.+++.+||+.||++||++
T Consensus       219 ~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         219 LSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCHHHHHHHHHHcccCHHHCCCC
Confidence            56778999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-38  Score=318.92  Aligned_cols=256  Identities=28%  Similarity=0.405  Sum_probs=204.9

Q ss_pred             hcCccccccccccCceEEEEEEeC------CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPES  369 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  369 (625)
                      .++|.+.+.||+|+||.||+|..+      .+..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            467889999999999999999864      24689999986543 34456788999999999999999999999999999


Q ss_pred             EEEEEecCCCCcchhhhccCC-------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEe
Q 042149          370 LLVYEYVPNRSLDQILFVKNT-------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIA  442 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~  442 (625)
                      ++||||+++++|.+++.....       ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            999999999999999865332       223788999999999999999999765   9999999999999999999999


Q ss_pred             ecccceeeCCCCce-eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhc
Q 042149          443 DFGLARHVAPDKTH-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKA  520 (625)
Q Consensus       443 Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  520 (625)
                      |||+++........ ......++..|+|||.+.++.++.++||||||+++|||+| |+.|+..... .    ...+....
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-~----~~~~~~~~  236 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-E----EVLKFVID  236 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-H----HHHHHHhc
Confidence            99998765433221 1223456789999999988889999999999999999998 7777542211 1    11111111


Q ss_pred             cccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHc
Q 042149          521 NRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLN  569 (625)
Q Consensus       521 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  569 (625)
                      .         .....+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       237 ~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         237 G---------GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             C---------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            1         111224445778999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5.7e-38  Score=318.75  Aligned_cols=256  Identities=29%  Similarity=0.360  Sum_probs=201.5

Q ss_pred             hcCccccccccccCceEEEEEEeC------CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPES  369 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  369 (625)
                      .++|.+.+.||+|++|.||+|.+.      .+..||+|.+.... ......+.+|+.++++++||||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            467899999999999999999864      35678999876443 34456789999999999999999999999999999


Q ss_pred             EEEEEecCCCCcchhhhccCC----cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC---ceEEe
Q 042149          370 LLVYEYVPNRSLDQILFVKNT----IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL---TPKIA  442 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~---~~kl~  442 (625)
                      ++||||+++++|.+++.....    ...+++..++.++.||+.||+|||+.+   ++||||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence            999999999999998865432    124899999999999999999999775   99999999999998654   59999


Q ss_pred             ecccceeeCCCCcee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhc
Q 042149          443 DFGLARHVAPDKTHV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKA  520 (625)
Q Consensus       443 Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  520 (625)
                      |||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..|+..... ...    ...   
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-~~~----~~~---  233 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEV----MEF---  233 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHH----HHH---
Confidence            999998763322211 112234568999999999999999999999999999997 7777542211 111    111   


Q ss_pred             cccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHc
Q 042149          521 NRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLN  569 (625)
Q Consensus       521 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  569 (625)
                            +........+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus       234 ------~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         234 ------VTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             ------HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                  1111112224455678899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=9.8e-38  Score=314.98  Aligned_cols=259  Identities=22%  Similarity=0.362  Sum_probs=207.7

Q ss_pred             cCccccccccccCceEEEEEEe-CCCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ++|++.+.||+|+||.||+|+. .+++.+|||.+...   .......+.+|+.+++.++||||+++++++.+++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688889999999999999996 47899999987643   3344567889999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhcc-CCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          374 EYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       374 e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      ||+++++|.+++... .....+++..++.++.+++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999988642 22345899999999999999999999775   99999999999999999999999999876543


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      .... .....++..|+|||.+.+..++.++|+||||+++|+|++|..|+......   .....+...     ....+   
T Consensus       159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~-----~~~~~---  226 (267)
T cd08229         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLCKKIE-----QCDYP---  226 (267)
T ss_pred             CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHhhhhh-----cCCCC---
Confidence            3221 12346889999999998888999999999999999999999986432111   001111111     00011   


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      ...+...+..+.+++.+||+.+|++|||+.+|++++.++
T Consensus       227 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         227 PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            111234567899999999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.8e-38  Score=308.97  Aligned_cols=265  Identities=23%  Similarity=0.285  Sum_probs=201.3

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChH--HHHHHHHHHHHHhcCCCCc-eeeeeeeeeeCC-----
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKN-VVRLLGCSIEGP-----  367 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~-----  367 (625)
                      ...|+.+++||+|+||+||+|+.+ +|+.||+|++....++  .-....+|+.+|++|+|+| ||.+++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            345666778999999999999964 7899999999776442  3345689999999999999 999999998877     


Q ss_pred             -eeEEEEEecCCCCcchhhhccCCc-CCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecc
Q 042149          368 -ESLLVYEYVPNRSLDQILFVKNTI-HILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFG  445 (625)
Q Consensus       368 -~~~lV~e~~~~~sL~~~l~~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfg  445 (625)
                       .+++|+||+ .-+|..++...... ..++...+..++.||+.||+|||+++   |+||||||+||||+++|.+||+|||
T Consensus        90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence             889999999 56888888655432 33677889999999999999999775   9999999999999999999999999


Q ss_pred             cceeeCCCCceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcc---
Q 042149          446 LARHVAPDKTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN---  521 (625)
Q Consensus       446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~---  521 (625)
                      +|+.+.-... ..++.++|..|.|||++.+. .|+...||||+|||+.||++++.-|+.... .+.+...++.....   
T Consensus       166 lAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  166 LARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             hHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHHHcCCCCcc
Confidence            9996653222 23456789999999999886 799999999999999999998876544322 22222222222111   


Q ss_pred             cccccc-----CCCCCCCC-C-------hHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          522 RITQSM-----DPGLTGRF-P-------ENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       522 ~~~~~i-----~~~~~~~~-~-------~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      .+....     +....... +       +.......+++.+|++.+|.+|.|++.++++
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            111110     10111100 1       1112467899999999999999999999865

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.2e-37  Score=321.70  Aligned_cols=255  Identities=20%  Similarity=0.187  Sum_probs=197.5

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ++|++.++||+|+||.||+++++ +++.+|+|++...   .......+.+|+.++..++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47889999999999999999976 5788999998642   2333456888999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++|+|.+++....  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            9999999999986532  23889999999999999999999775   999999999999999999999999999765444


Q ss_pred             CceeeecCCCCccccCccccc-----cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLV-----RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      .........||+.|+|||++.     ...++.++|||||||++|||++|+.|+....    ...............    
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~----~~~~~~~i~~~~~~~----  227 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES----LVETYGKIMNHKERF----  227 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC----HHHHHHHHhCCCccc----
Confidence            333333457999999999986     3467899999999999999999999975321    111111111110000    


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVAL--RPSMAEVVHM  567 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~  567 (625)
                        .........+..+.+++.+|+..++++  |++++|+++.
T Consensus       228 --~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         228 --QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             --cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence              001112344667888999988654444  6899998865

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.7e-38  Score=318.25  Aligned_cols=269  Identities=22%  Similarity=0.374  Sum_probs=203.9

Q ss_pred             cCccccccccccCceEEEEEEe-----CCCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--Cee
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTL-----PDGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG--PES  369 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~  369 (625)
                      ..|++.++||+|+||.||++..     .+++.||+|.+... .......+.+|+.++++++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4578899999999999999973     35788999998654 344556899999999999999999999988775  568


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      ++||||+++++|.+++....  ..+++..+..++.+++.||.|||+.+   ++||||||+||+++.++.++|+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            99999999999999885432  24899999999999999999999775   99999999999999999999999999987


Q ss_pred             eCCCCce--eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCc-cchhhHHHhhhccccccc
Q 042149          450 VAPDKTH--VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSS-SVLHTVWKHYKANRITQS  526 (625)
Q Consensus       450 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~  526 (625)
                      .......  ......++..|+|||++.+..++.++||||||+++|||+|++.|........ ..................
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            6443221  1123456778999999988889999999999999999999876542211000 000000000000000001


Q ss_pred             cCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       527 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      +......+.+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            111111222344567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=7.1e-38  Score=316.91  Aligned_cols=255  Identities=24%  Similarity=0.388  Sum_probs=198.2

Q ss_pred             ccccccccccCceEEEEEEeCC-CC--EEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC------Ce
Q 042149          300 FDNSRKLGQGGAGSVFRGTLPD-GR--NIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG------PE  368 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~  368 (625)
                      |.+.++||+|+||.||+|++.+ +.  .+|+|.+...  .....+.+.+|+.+++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467889999999999999754 33  5899987653  355577889999999999999999999977532      25


Q ss_pred             eEEEEEecCCCCcchhhhcc---CCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecc
Q 042149          369 SLLVYEYVPNRSLDQILFVK---NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFG  445 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfg  445 (625)
                      .++||||+++++|.+++...   .....+++.....++.|++.||.|||+++   |+||||||+|||+++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            68999999999999877432   12334889999999999999999999775   9999999999999999999999999


Q ss_pred             cceeeCCCCceee-ecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhcccc
Q 042149          446 LARHVAPDKTHVS-TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRI  523 (625)
Q Consensus       446 la~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  523 (625)
                      +++.+........ ....+++.|+|||...+..++.++||||||+++|||++ |+.|+.... .    ...+....... 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~----~~~~~~~~~~~-  231 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE-N----SEIYDYLRQGN-  231 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC-H----HHHHHHHHcCC-
Confidence            9987654332111 12346778999999998899999999999999999999 676653221 1    11122222111 


Q ss_pred             ccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          524 TQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       524 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                              ....+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       232 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 --------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                    1112334566789999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.3e-38  Score=314.40  Aligned_cols=251  Identities=27%  Similarity=0.440  Sum_probs=205.0

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      .++|++.+.||+|+||.||+|... ++.||||.+..... ..+++.+|+.++++++|+||+++++++.+....++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            357888999999999999999875 78999999976544 5678999999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      ++++|.+++..... ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||.++....... 
T Consensus        83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          83 AKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            99999998865442 24899999999999999999999775   99999999999999999999999999987632222 


Q ss_pred             eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                         ....+..|+|||++..+.++.++||||||+++|||++ |..|+.... ...    .......         ......
T Consensus       158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~----~~~~~~~---------~~~~~~  220 (256)
T cd05039         158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKD----VVPHVEK---------GYRMEA  220 (256)
T ss_pred             ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC-HHH----HHHHHhc---------CCCCCC
Confidence               2345668999999988899999999999999999997 887753221 111    1111111         111112


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      +...+..+.+++.+||+.+|++||+++|++++|+++
T Consensus       221 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            334567789999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.3e-37  Score=316.20  Aligned_cols=250  Identities=23%  Similarity=0.239  Sum_probs=195.3

Q ss_pred             ccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCCCc
Q 042149          306 LGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSL  381 (625)
Q Consensus       306 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~sL  381 (625)
                      ||+|+||.||+++.+ +|+.||+|++....   ......+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999965 68999999986432   12234556799999999999999999999999999999999999999


Q ss_pred             chhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceeeecC
Q 042149          382 DQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGI  461 (625)
Q Consensus       382 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  461 (625)
                      .+++..... ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++........  ....
T Consensus        81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~  154 (277)
T cd05607          81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQR  154 (277)
T ss_pred             HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eecc
Confidence            988754432 33889999999999999999999775   99999999999999999999999999887654322  2335


Q ss_pred             CCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHH
Q 042149          462 AGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEAS  541 (625)
Q Consensus       462 ~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  541 (625)
                      .|++.|+|||++.+..++.++|||||||++|||++|+.|+........... ........        ... ......+.
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~-~~~~~~~~--------~~~-~~~~~~~~  224 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEE-LKRRTLED--------EVK-FEHQNFTE  224 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHH-HHHHhhcc--------ccc-cccccCCH
Confidence            689999999999988899999999999999999999998753322111111 11110000        000 01123456


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          542 RVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       542 ~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      ++.+++.+||+.+|++||++.|+++.+...
T Consensus       225 ~~~~li~~~L~~~P~~R~~~~~~~~~~~~h  254 (277)
T cd05607         225 ESKDICRLFLAKKPEDRLGSREKNDDPRKH  254 (277)
T ss_pred             HHHHHHHHHhccCHhhCCCCccchhhhhcC
Confidence            789999999999999999998776554443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=8.2e-38  Score=330.62  Aligned_cols=258  Identities=20%  Similarity=0.214  Sum_probs=202.0

Q ss_pred             HHHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCe
Q 042149          293 LERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPE  368 (625)
Q Consensus       293 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  368 (625)
                      ++...++|++.+.||+|+||.||+++++ +++.+|+|++...   .......+.+|+.+++.++||||+++++.+.+++.
T Consensus        38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~  117 (371)
T cd05622          38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  117 (371)
T ss_pred             cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            3445678999999999999999999976 6889999998642   23344567899999999999999999999999999


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      .++||||+++++|.+++...    .++...+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       118 ~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~  190 (371)
T cd05622         118 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (371)
T ss_pred             EEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence            99999999999999988532    3788889999999999999999775   9999999999999999999999999998


Q ss_pred             eeCCCCceeeecCCCCccccCccccccC----cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccc
Q 042149          449 HVAPDKTHVSTGIAGTLGYMAPEYLVRG----QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRIT  524 (625)
Q Consensus       449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  524 (625)
                      ..............||+.|+|||++...    .++.++|||||||++|||++|+.|+.....    .. .+.......  
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~-~~~~i~~~~--  263 (371)
T cd05622         191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VG-TYSKIMNHK--  263 (371)
T ss_pred             EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH----HH-HHHHHHcCC--
Confidence            7654433333356799999999998654    378999999999999999999999753211    11 111111100  


Q ss_pred             cccCCCCCCCCChHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHH
Q 042149          525 QSMDPGLTGRFPENEASRVLQIGLLCTQAPVAL--RPSMAEVVHML  568 (625)
Q Consensus       525 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~L  568 (625)
                          ..+.-+.....+..+.+++.+|++.++.+  ||+++|+++..
T Consensus       264 ----~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         264 ----NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             ----CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence                00111112345677889999999854443  78999988754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=7.8e-38  Score=323.94  Aligned_cols=240  Identities=23%  Similarity=0.274  Sum_probs=192.3

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEEEEEecCC
Q 042149          304 RKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLLVYEYVPN  378 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~  378 (625)
                      ++||+|+||.||+|+++ +++.||||.+....   ....+.+..|..++..+ +||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999976 68899999987542   23445667788888754 899999999999999999999999999


Q ss_pred             CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceee
Q 042149          379 RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS  458 (625)
Q Consensus       379 ~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  458 (625)
                      ++|.+++....   .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~  153 (316)
T cd05620          81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-RA  153 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-ce
Confidence            99998886543   3889999999999999999999775   99999999999999999999999999875322221 22


Q ss_pred             ecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChH
Q 042149          459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPEN  538 (625)
Q Consensus       459 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  538 (625)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.|+.....     ...++.....          ....+..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-----~~~~~~~~~~----------~~~~~~~  218 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-----DELFESIRVD----------TPHYPRW  218 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhC----------CCCCCCC
Confidence            346799999999999999999999999999999999999998743211     1111111111          1122334


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 042149          539 EASRVLQIGLLCTQAPVALRPSMA-EVV  565 (625)
Q Consensus       539 ~~~~l~~li~~cl~~~p~~RPt~~-ev~  565 (625)
                      .+.++.+++.+||+.||++||++. +++
T Consensus       219 ~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         219 ITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            566789999999999999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.1e-38  Score=322.52  Aligned_cols=258  Identities=28%  Similarity=0.353  Sum_probs=202.3

Q ss_pred             cCccccccccccCceEEEEEEeCC-C--CEEEEEEeecC-ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLPD-G--RNIAVKRLFFN-SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV  372 (625)
                      ++|++.+.||+|+||.||+|..++ +  ..+++|.+... .....+.+.+|+.++.++ +||||+++++++.+....++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578899999999999999998753 3  34688877642 344567789999999999 799999999999999999999


Q ss_pred             EEecCCCCcchhhhccC-------------CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCce
Q 042149          373 YEYVPNRSLDQILFVKN-------------TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP  439 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~  439 (625)
                      |||+++++|.+++....             ....+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999986432             1134889999999999999999999775   9999999999999999999


Q ss_pred             EEeecccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhh
Q 042149          440 KIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHY  518 (625)
Q Consensus       440 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~  518 (625)
                      ||+|||++.......  .......+..|+|||+.....++.++||||||+++|||++ |+.|+..... ..    .+.. 
T Consensus       159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-~~----~~~~-  230 (297)
T cd05089         159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-AE----LYEK-  230 (297)
T ss_pred             EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HH----HHHH-
Confidence            999999986432111  1111223567999999988889999999999999999998 8887642211 11    1111 


Q ss_pred             hccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCC
Q 042149          519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYE  574 (625)
Q Consensus       519 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  574 (625)
                              +........+...+..+.+++.+||+.+|.+||+++++++.|..+...
T Consensus       231 --------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~  278 (297)
T cd05089         231 --------LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA  278 (297)
T ss_pred             --------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                    111112223445567889999999999999999999999998776543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=8.7e-38  Score=315.59  Aligned_cols=255  Identities=26%  Similarity=0.404  Sum_probs=203.7

Q ss_pred             cCccccccccccCceEEEEEEeC-C---CCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-D---GRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      ++|++.+.||+|+||.||+|++. +   +..+|+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            56888999999999999999864 2   3368999886542 34456889999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+++++|.+++....  ..+++.++..++.|++.||.+||+.+   ++||||||+|||++.++.++|+|||++.....
T Consensus        84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            99999999999986443  34899999999999999999999775   99999999999999999999999999987654


Q ss_pred             CCceeee--cCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          453 DKTHVST--GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       453 ~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      .......  ...++..|+|||.+.+..++.++|+||||+++||+++ |..|+..... ...    .......        
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~-~~~----~~~~~~~--------  225 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-QDV----IKAIEEG--------  225 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH-HHH----HHHHhCC--------
Confidence            3332222  2234568999999998899999999999999999886 8888643211 111    1111111        


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                       ...+.+...+..+.+++.+||+.+|++||++.++++.|.++
T Consensus       226 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         226 -YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence             11122334567789999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1e-37  Score=323.38  Aligned_cols=241  Identities=24%  Similarity=0.279  Sum_probs=195.5

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEEEEEecCC
Q 042149          304 RKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLLVYEYVPN  378 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~  378 (625)
                      +.||+|+||.||+|+++ +++.||||++...   .....+.+.+|..+++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 5789999998754   234456778899999888 699999999999999999999999999


Q ss_pred             CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceee
Q 042149          379 RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS  458 (625)
Q Consensus       379 ~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  458 (625)
                      ++|.+.+....   .+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++........ .
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~  153 (318)
T cd05570          81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT-T  153 (318)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc-c
Confidence            99998886543   3899999999999999999999775   999999999999999999999999998753222221 2


Q ss_pred             ecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChH
Q 042149          459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPEN  538 (625)
Q Consensus       459 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  538 (625)
                      ....|++.|+|||++.+..++.++|||||||++|+|++|+.|+.....     ...........          ...+..
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-----~~~~~~i~~~~----------~~~~~~  218 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-----DELFQSILEDE----------VRYPRW  218 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-----HHHHHHHHcCC----------CCCCCc
Confidence            235689999999999999999999999999999999999998743221     11111111111          112344


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 042149          539 EASRVLQIGLLCTQAPVALRPSM-----AEVVH  566 (625)
Q Consensus       539 ~~~~l~~li~~cl~~~p~~RPt~-----~ev~~  566 (625)
                      .+..+.+++.+||+.+|++||++     .++++
T Consensus       219 ~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            56778999999999999999999     88775

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6e-38  Score=323.10  Aligned_cols=259  Identities=26%  Similarity=0.364  Sum_probs=205.3

Q ss_pred             hcCccccccccccCceEEEEEEeC--------CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeC
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP--------DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEG  366 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  366 (625)
                      .++|.+.+.||+|+||.||+|+..        ++..||+|.+... .......+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            567889999999999999999731        2457899988644 344567889999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCCcchhhhccCC-------------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE
Q 042149          367 PESLLVYEYVPNRSLDQILFVKNT-------------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL  433 (625)
Q Consensus       367 ~~~~lV~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll  433 (625)
                      ...++||||+++++|.+++.....             ...+++..+..++.||+.||.|||+++   ++||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence            999999999999999999865422             234788899999999999999999775   9999999999999


Q ss_pred             cCCCceEEeecccceeeCCCCcee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccch
Q 042149          434 DEKLTPKIADFGLARHVAPDKTHV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVL  511 (625)
Q Consensus       434 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~  511 (625)
                      +.++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|+|++ |..|+....     .
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~  245 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-----V  245 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-----H
Confidence            999999999999998765433222 122345678999999988889999999999999999998 666543211     1


Q ss_pred             hhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          512 HTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       512 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      ..........         .....+...+..+.+++.+||+.+|++||++.|+++.|.++.
T Consensus       246 ~~~~~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         246 EELFKLLKEG---------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             HHHHHHHHcC---------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence            1111111111         111223455678999999999999999999999999997764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1e-37  Score=315.18  Aligned_cols=256  Identities=30%  Similarity=0.471  Sum_probs=204.5

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCC---EEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGR---NIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      .++|+..++||+|+||.||+|+++ +++   .+|+|++... .....+.+.+|++++++++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            356888899999999999999975 333   6899988655 34446778999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||||+++++|.+++....  ..+++..+..++.+++.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            999999999999885432  34899999999999999999999775   9999999999999999999999999998664


Q ss_pred             CCCceeee--cCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          452 PDKTHVST--GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       452 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      ........  ....++.|+|||++....++.++||||||+++|||++ |+.|+..... .    ........        
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-~----~~~~~i~~--------  225 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-H----EVMKAIND--------  225 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-H----HHHHHHhc--------
Confidence            33222111  1223567999999988889999999999999999998 8888643221 1    11111111        


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                       ....+.+...+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       226 -~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         226 -GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             111122334567789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.1e-37  Score=316.26  Aligned_cols=264  Identities=26%  Similarity=0.362  Sum_probs=204.1

Q ss_pred             hcCccccccccccCceEEEEEEeCC-----------------CCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPD-----------------GRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVR  358 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~  358 (625)
                      ..+|++.++||+|+||.||+|.+..                 +..||+|++.... ....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578999999999999999998542                 2458999887553 445678899999999999999999


Q ss_pred             eeeeeeeCCeeEEEEEecCCCCcchhhhccC--------CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCc
Q 042149          359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKN--------TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSN  430 (625)
Q Consensus       359 l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~N  430 (625)
                      +++++..++..++||||+++++|.+++....        ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999886543        1124899999999999999999999775   9999999999


Q ss_pred             EEEcCCCceEEeecccceeeCCCCce-eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhC--CCCCCCCCCC
Q 042149          431 ILLDEKLTPKIADFGLARHVAPDKTH-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG--RRNSVFSEGS  507 (625)
Q Consensus       431 Ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG--~~p~~~~~~~  507 (625)
                      |+++.++.++|+|||+++........ ......+++.|+|||++.++.++.++||||||+++|||+++  ..|+... ..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~-~~  239 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL-TD  239 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc-Ch
Confidence            99999999999999998765433222 12234567899999999888999999999999999999984  4443211 11


Q ss_pred             ccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcc
Q 042149          508 SSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN  570 (625)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  570 (625)
                      ...+......+....      .......+...+.++.+++.+||+.+|++|||+.||++.|++
T Consensus       240 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         240 QQVIENAGHFFRDDG------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             HHHHHHHHhcccccc------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            111111111111111      111111233455789999999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.7e-37  Score=321.42  Aligned_cols=241  Identities=23%  Similarity=0.290  Sum_probs=192.2

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhc-CCCCceeeeeeeeeeCCeeEEEEEecCC
Q 042149          304 RKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISG-IQHKNVVRLLGCSIEGPESLLVYEYVPN  378 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~~lV~e~~~~  378 (625)
                      +.||+|+||.||+|++. +++.||||++....   ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999975 57899999987542   2334566778888876 4899999999999999999999999999


Q ss_pred             CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceee
Q 042149          379 RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS  458 (625)
Q Consensus       379 ~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  458 (625)
                      ++|.+++....   .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~  153 (316)
T cd05619          81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KT  153 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ce
Confidence            99999886433   3889999999999999999999775   99999999999999999999999999875432222 12


Q ss_pred             ecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChH
Q 042149          459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPEN  538 (625)
Q Consensus       459 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  538 (625)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.|+.....     ..........      .    ...+..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~i~~~------~----~~~~~~  218 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-----EELFQSIRMD------N----PCYPRW  218 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhC------C----CCCCcc
Confidence            345799999999999988999999999999999999999998743221     1111111111      0    112334


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 042149          539 EASRVLQIGLLCTQAPVALRPSMA-EVVH  566 (625)
Q Consensus       539 ~~~~l~~li~~cl~~~p~~RPt~~-ev~~  566 (625)
                      .+..+.+++.+||+.+|++||++. ++.+
T Consensus       219 ~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         219 LTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            556788999999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=5.5e-38  Score=323.82  Aligned_cols=259  Identities=27%  Similarity=0.366  Sum_probs=204.3

Q ss_pred             hcCccccccccccCceEEEEEEeC--------CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeC
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP--------DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEG  366 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  366 (625)
                      .++|.+.+.||+|+||.||+|+..        +...+|+|.+... .......+.+|+.+++.+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            367999999999999999999752        2356999988754 244556788999999999 799999999999999


Q ss_pred             CeeEEEEEecCCCCcchhhhccCC-------------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE
Q 042149          367 PESLLVYEYVPNRSLDQILFVKNT-------------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL  433 (625)
Q Consensus       367 ~~~~lV~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll  433 (625)
                      ...++||||+++++|.+++.....             ...+++.+++.++.|++.||+|||+.+   ++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            999999999999999999865432             134889999999999999999999765   9999999999999


Q ss_pred             cCCCceEEeecccceeeCCCCcee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccch
Q 042149          434 DEKLTPKIADFGLARHVAPDKTHV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVL  511 (625)
Q Consensus       434 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~  511 (625)
                      +.++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |+.|+.... .    
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~-~----  248 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-V----  248 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-H----
Confidence            999999999999987654322111 112234578999999988889999999999999999998 666653211 1    


Q ss_pred             hhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          512 HTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       512 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      .........         ....+.+...+..+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus       249 ~~~~~~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~  300 (307)
T cd05098         249 EELFKLLKE---------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  300 (307)
T ss_pred             HHHHHHHHc---------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence            111111111         1112234455678899999999999999999999999997753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=324.68  Aligned_cols=264  Identities=25%  Similarity=0.363  Sum_probs=212.2

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      .+...+.++||+|.||.|.++....+..||||+++... ......|.+|+++|.+|+|||||+++|+|..++.+++|+||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            44567788999999999999999888999999998774 44458899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      |++|+|.+++....... +.-.....|+.||+.||+||.   +.++|||||.+.|+|+++++++||+|||+++.+-.+..
T Consensus       617 mEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence            99999999997664433 455667789999999999999   45799999999999999999999999999996655444


Q ss_pred             ee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh--CCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          456 HV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS--GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       456 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      .. ....+-..+|||||.+.-++++.++|||+||+++||+++  ..+|+....+. ..+...-.....+      .....
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e-~vven~~~~~~~~------~~~~~  765 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE-QVVENAGEFFRDQ------GRQVV  765 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH-HHHHhhhhhcCCC------Cccee
Confidence            33 334566789999999999999999999999999999876  45554322111 1111111111111      11122


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      ...|+.++..+.+++++||..+-++||+++++...|.+.
T Consensus       766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            334778899999999999999999999999999888653

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.5e-37  Score=311.58  Aligned_cols=250  Identities=19%  Similarity=0.265  Sum_probs=203.4

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      +|++.++||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.+++.++||||+++++.+..++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4788899999999999999965 6889999988643 3445678889999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      ++++|.+++... ....+++..++.++.+++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            999999887543 2334789999999999999999999775   99999999999999999999999999876643322 


Q ss_pred             eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP  536 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  536 (625)
                      ......+++.|+|||++.+..++.++|+||||+++|+|++|+.|+.....    ..... ......         ....+
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~----~~~~~-~~~~~~---------~~~~~  221 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW----KNLIL-KVCQGS---------YKPLP  221 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH----HHHHH-HHhcCC---------CCCCC
Confidence            22235689999999999888899999999999999999999998642211    00011 111111         11223


Q ss_pred             hHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       537 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      ...+..+.+++.+||+.+|++||++.+++..
T Consensus       222 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         222 SHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            4456678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-37  Score=325.59  Aligned_cols=260  Identities=27%  Similarity=0.355  Sum_probs=204.5

Q ss_pred             hcCccccccccccCceEEEEEEeC--------CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeC
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP--------DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEG  366 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  366 (625)
                      ..+|.+.+.||+|+||.||+|+..        .+..||+|.+... .....+.+.+|+.+++++ +||||+++++++...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            346899999999999999999742        1236899987643 344567899999999999 799999999999999


Q ss_pred             CeeEEEEEecCCCCcchhhhccC-------------CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE
Q 042149          367 PESLLVYEYVPNRSLDQILFVKN-------------TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL  433 (625)
Q Consensus       367 ~~~~lV~e~~~~~sL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll  433 (625)
                      ...+++|||+++++|.+++....             ....+++..+..++.|++.||.|||+.+   ++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence            99999999999999999986532             2234788999999999999999999775   9999999999999


Q ss_pred             cCCCceEEeecccceeeCCCCcee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccch
Q 042149          434 DEKLTPKIADFGLARHVAPDKTHV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVL  511 (625)
Q Consensus       434 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~  511 (625)
                      +.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..|+.... .    
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~----  242 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP-V----  242 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC-H----
Confidence            999999999999998654332211 112234568999999999999999999999999999998 666653211 1    


Q ss_pred             hhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccC
Q 042149          512 HTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY  573 (625)
Q Consensus       512 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  573 (625)
                      .........         ....+.+...+..+.+++.+||+.+|++||++.|+++.|.++..
T Consensus       243 ~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         243 EELFKLLKE---------GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             HHHHHHHHc---------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            111111111         11112234456678999999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.5e-37  Score=323.21  Aligned_cols=243  Identities=20%  Similarity=0.225  Sum_probs=189.7

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHH-HHHhcCCCCceeeeeeeeeeCCeeEEEEEecCC
Q 042149          304 RKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEV-NLISGIQHKNVVRLLGCSIEGPESLLVYEYVPN  378 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~  378 (625)
                      +.||+|+||+||+|+++ +++.||+|++....   ......+..|. .+++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999976 57889999986532   22223444444 457889999999999999999999999999999


Q ss_pred             CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceee
Q 042149          379 RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS  458 (625)
Q Consensus       379 ~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  458 (625)
                      ++|.+++....   .+.+..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~  153 (325)
T cd05602          81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TT  153 (325)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cc
Confidence            99999886543   3778888899999999999999775   99999999999999999999999999875432222 22


Q ss_pred             ecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChH
Q 042149          459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPEN  538 (625)
Q Consensus       459 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  538 (625)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.|+......     ..+.......          ...++.
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~~~----------~~~~~~  218 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-----EMYDNILNKP----------LQLKPN  218 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH-----HHHHHHHhCC----------cCCCCC
Confidence            3457999999999999999999999999999999999999987532111     1111111111          112334


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042149          539 EASRVLQIGLLCTQAPVALRPSMAEVVHML  568 (625)
Q Consensus       539 ~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  568 (625)
                      .+..+.+++.+||+.+|.+||++.+.+..+
T Consensus       219 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~i  248 (325)
T cd05602         219 ITNSARHLLEGLLQKDRTKRLGAKDDFMEI  248 (325)
T ss_pred             CCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence            566789999999999999999887544333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=8.3e-38  Score=321.86  Aligned_cols=257  Identities=28%  Similarity=0.362  Sum_probs=200.5

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCC--EEEEEEeecC-ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGR--NIAVKRLFFN-SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l  371 (625)
                      .++|++.+.||+|+||.||+|+++ ++.  .+++|++... .......+.+|++++.++ +||||+++++++..++..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            357888999999999999999964 444  4577776543 344566888999999999 89999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCC-------------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCc
Q 042149          372 VYEYVPNRSLDQILFVKNT-------------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLT  438 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~  438 (625)
                      ||||+++++|.+++.....             ...+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence            9999999999998864421             234789999999999999999999775   999999999999999999


Q ss_pred             eEEeecccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHh
Q 042149          439 PKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKH  517 (625)
Q Consensus       439 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~  517 (625)
                      +||+|||++........  .....++..|+|||++.+..++.++||||||+++|||+| |..|+..... .+    ....
T Consensus       163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~----~~~~  235 (303)
T cd05088         163 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AE----LYEK  235 (303)
T ss_pred             EEeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-HH----HHHH
Confidence            99999999864221111  111234678999999988889999999999999999998 8877642211 11    1111


Q ss_pred             hhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          518 YKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       518 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      ..         .......+...+..+.+++.+||+.+|++||++.++++.|..+.
T Consensus       236 ~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~  281 (303)
T cd05088         236 LP---------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  281 (303)
T ss_pred             Hh---------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11         11111123334567899999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.6e-38  Score=320.73  Aligned_cols=260  Identities=27%  Similarity=0.381  Sum_probs=202.6

Q ss_pred             HHhcCccccccccccCceEEEEEEeC------CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP  367 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  367 (625)
                      ...++|++.++||+|+||.||+|..+      .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+..
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            34678999999999999999999743      24579999876443 333456889999999999999999999999999


Q ss_pred             eeEEEEEecCCCCcchhhhccCC-------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceE
Q 042149          368 ESLLVYEYVPNRSLDQILFVKNT-------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPK  440 (625)
Q Consensus       368 ~~~lV~e~~~~~sL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~k  440 (625)
                      ..++||||+++++|.+++.....       ...+++..+..++.|++.||.|||+++   |+||||||+||++++++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence            99999999999999999864321       234577888999999999999999775   99999999999999999999


Q ss_pred             EeecccceeeCCCCcee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhh
Q 042149          441 IADFGLARHVAPDKTHV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHY  518 (625)
Q Consensus       441 l~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~  518 (625)
                      |+|||+++......... .....++..|+|||.+.++.++.++||||||+++|||++ |..|+... ...+.    .+..
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~-~~~~~----~~~~  234 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL-SNEQV----LKFV  234 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC-CHHHH----HHHH
Confidence            99999987654322211 112245678999999998899999999999999999999 56554321 11111    1111


Q ss_pred             hccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       519 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      ...         .....+...+..+.+++.+||+.+|++|||+.++++.|.+.
T Consensus       235 ~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         235 MDG---------GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            111         01112334467899999999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.1e-37  Score=331.47  Aligned_cols=260  Identities=25%  Similarity=0.390  Sum_probs=205.3

Q ss_pred             HhcCccccccccccCceEEEEEEeC------CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCC
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEGP  367 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~  367 (625)
                      ..++|.+.++||+|+||.||+|++.      .++.||||++.... ....+.+.+|+++|.++. ||||+++++.+....
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3456888899999999999999853      34689999997542 333457889999999997 999999999999999


Q ss_pred             eeEEEEEecCCCCcchhhhccCC---------------------------------------------------------
Q 042149          368 ESLLVYEYVPNRSLDQILFVKNT---------------------------------------------------------  390 (625)
Q Consensus       368 ~~~lV~e~~~~~sL~~~l~~~~~---------------------------------------------------------  390 (625)
                      ..++||||+++|+|.++++....                                                         
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            99999999999999998864321                                                         


Q ss_pred             --------------------------------------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEE
Q 042149          391 --------------------------------------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNIL  432 (625)
Q Consensus       391 --------------------------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIl  432 (625)
                                                            ...+++...+.++.|++.||.|||+.+   ++||||||+|||
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence                                                  123677888999999999999999765   999999999999


Q ss_pred             EcCCCceEEeecccceeeCCCCce-eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccc
Q 042149          433 LDEKLTPKIADFGLARHVAPDKTH-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSV  510 (625)
Q Consensus       433 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~  510 (625)
                      +++++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+........ 
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-  350 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-  350 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence            999999999999999865432221 1123356789999999988889999999999999999998 7777643221111 


Q ss_pred             hhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          511 LHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       511 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                         .....         ........+...+..+.+++.+||+.+|++||++.||++.|+++
T Consensus       351 ---~~~~~---------~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         351 ---FYNAI---------KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             ---HHHHH---------HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence               11111         11111223445567899999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-37  Score=322.19  Aligned_cols=253  Identities=23%  Similarity=0.273  Sum_probs=212.2

Q ss_pred             HHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCCh---HHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCCee
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSR---QWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEGPES  369 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~  369 (625)
                      ...+.|++.+.||+|.||.||+++.+ +|+.+|+|.+.+...   ...+.+.+|+.+|+++. |||||.+++.++.....
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~  111 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV  111 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence            44567899999999999999999976 599999999976532   34578999999999998 99999999999999999


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC----CCceEEeecc
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE----KLTPKIADFG  445 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~----~~~~kl~Dfg  445 (625)
                      ++|||++.||.|.+.+...   + +++..+..++.|++.++.|||+.+   |+||||||+|+|+..    ++.+|++|||
T Consensus       112 ~lvmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            9999999999999988766   3 899999999999999999999765   999999999999963    3579999999


Q ss_pred             cceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccccc
Q 042149          446 LARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQ  525 (625)
Q Consensus       446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  525 (625)
                      ++.....  .......+||+.|+|||++....|+..+||||+|+++|.|++|..||..........     .....+.  
T Consensus       185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-----~i~~~~~--  255 (382)
T KOG0032|consen  185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-----AILRGDF--  255 (382)
T ss_pred             CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-----HHHcCCC--
Confidence            9998876  334456799999999999999999999999999999999999999976443322211     1111111  


Q ss_pred             ccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          526 SMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       526 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                          ....+.-+..+....+++..++..||.+|+|+.++++.
T Consensus       256 ----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  256 ----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             ----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                22233345668889999999999999999999999973

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.3e-37  Score=314.49  Aligned_cols=255  Identities=25%  Similarity=0.409  Sum_probs=201.8

Q ss_pred             cCccccccccccCceEEEEEEeCC-C---CEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLPD-G---RNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      ..|++.+.||+|+||.||+|.++. +   ..||||.+... .......|.+|+.++++++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            357889999999999999999653 3   36999998654 455567899999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+++++|.+++....  ..+++.+++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.....
T Consensus        84 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            99999999999886432  34899999999999999999999775   99999999999999999999999999876543


Q ss_pred             CCceee--ecCC--CCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhcccccccc
Q 042149          453 DKTHVS--TGIA--GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSM  527 (625)
Q Consensus       453 ~~~~~~--~~~~--gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  527 (625)
                      ......  ....  .+..|+|||++.+..++.++||||||+++|||++ |..|+..... ..    .......       
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-~~----~~~~i~~-------  226 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QD----VINAIEQ-------  226 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-HH----HHHHHHc-------
Confidence            222111  1111  2457999999998899999999999999999886 8887642211 11    1111110       


Q ss_pred             CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       528 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                        ....+.+...+..+.+++.+||+.+|++||++.+|+..|+++
T Consensus       227 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         227 --DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             --CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence              111112334566789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.7e-37  Score=311.45  Aligned_cols=249  Identities=25%  Similarity=0.396  Sum_probs=199.4

Q ss_pred             cCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeee-eCCeeEEEEEec
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI-EGPESLLVYEYV  376 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~lV~e~~  376 (625)
                      ++|++.+.||+|+||.||++..+ ++.+|+|.+....  ..+.+.+|+.++++++|||++++++++. +++..++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46888999999999999999864 7889999885433  3467899999999999999999999764 456789999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      ++++|.+++..... ..+++..++.++.+++.+|+|||+++   ++||||||+||++++++.+||+|||+++....... 
T Consensus        83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-  157 (256)
T cd05082          83 AKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-  157 (256)
T ss_pred             CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccCC-
Confidence            99999998865432 34889999999999999999999775   99999999999999999999999999876433221 


Q ss_pred             eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                         ...++..|+|||++.+..++.++||||||+++|||++ |+.|+..... ..    .......         ......
T Consensus       158 ---~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-~~----~~~~~~~---------~~~~~~  220 (256)
T cd05082         158 ---TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KD----VVPRVEK---------GYKMDA  220 (256)
T ss_pred             ---CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-HH----HHHHHhc---------CCCCCC
Confidence               2345678999999988889999999999999999998 8777542211 11    1111111         111122


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      +...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       221 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            344567889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.4e-37  Score=316.14  Aligned_cols=256  Identities=25%  Similarity=0.358  Sum_probs=201.7

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCC----EEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGR----NIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  370 (625)
                      .++|++.++||+|+||+||+|++. +++    .||+|.+... .......+.+|+.+++.+.||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            356888999999999999999853 444    4899988654 34445678899999999999999999998865 4578


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      ++|||+++|+|.+++....  ..+++..++.++.|++.||.|||+.+   ++||||||+|||+++++.+||+|||+++..
T Consensus        85 l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            9999999999999886432  34899999999999999999999775   999999999999999999999999999876


Q ss_pred             CCCCcee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          451 APDKTHV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       451 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      ....... .....+++.|+|||...+..++.++||||||+++|||++ |..|+..... ...    .....         
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~----~~~~~---------  225 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-REI----PDLLE---------  225 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHH----HHHHH---------
Confidence            5433221 112345678999999988899999999999999999998 7777532211 111    11111         


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      .....+.+...+..+.+++.+||+.+|++||++.++++.|..+.
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~  269 (279)
T cd05109         226 KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA  269 (279)
T ss_pred             CCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            11111223345667899999999999999999999999987764

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.3e-37  Score=322.18  Aligned_cols=260  Identities=27%  Similarity=0.361  Sum_probs=204.5

Q ss_pred             hcCccccccccccCceEEEEEEeC--------CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeC
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP--------DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEG  366 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  366 (625)
                      .++|.+.++||+|+||.||+|+..        ....+|+|.+... .......+.+|+.+++++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            357889999999999999999742        2456899988654 344566788999999999 699999999999999


Q ss_pred             CeeEEEEEecCCCCcchhhhccCC-------------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE
Q 042149          367 PESLLVYEYVPNRSLDQILFVKNT-------------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL  433 (625)
Q Consensus       367 ~~~~lV~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll  433 (625)
                      ...++||||+++++|.+++.....             ...+++.++..++.|++.||.|||+.+   ++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence            999999999999999999865321             234889999999999999999999775   9999999999999


Q ss_pred             cCCCceEEeecccceeeCCCCcee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccch
Q 042149          434 DEKLTPKIADFGLARHVAPDKTHV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVL  511 (625)
Q Consensus       434 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~  511 (625)
                      ++++.+||+|||+++......... .....++..|+|||++.++.++.++||||||+++|||++ |..|+.... ..   
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~-~~---  243 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP-VE---  243 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC-HH---
Confidence            999999999999998654322211 111234568999999988899999999999999999999 776653211 11   


Q ss_pred             hhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccC
Q 042149          512 HTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY  573 (625)
Q Consensus       512 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  573 (625)
                       .........         .....+...+..+.+++.+||+.+|++|||+.|+++.|.++..
T Consensus       244 -~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         244 -ELFKLLREG---------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             -HHHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence             111111111         1112244556788899999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.2e-37  Score=318.08  Aligned_cols=257  Identities=28%  Similarity=0.415  Sum_probs=203.5

Q ss_pred             hcCccccccccccCceEEEEEEeC------CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPES  369 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  369 (625)
                      .++|++.+.||+|+||.||+|.++      ++..||+|++.... ......+.+|+.++++++||||+++++++.++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467999999999999999999853      46789999886543 44456789999999999999999999999999999


Q ss_pred             EEEEEecCCCCcchhhhccC-------------------CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCc
Q 042149          370 LLVYEYVPNRSLDQILFVKN-------------------TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSN  430 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~N  430 (625)
                      ++||||+++++|.+++....                   ....+++..++.++.+++.||.|||..+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999986432                   1234788899999999999999999775   9999999999


Q ss_pred             EEEcCCCceEEeecccceeeCCCCce-eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCc
Q 042149          431 ILLDEKLTPKIADFGLARHVAPDKTH-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSS  508 (625)
Q Consensus       431 Ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~  508 (625)
                      |+++.++.++|+|||++......... .......+..|+|||.+.+..++.++||||||+++|||++ |..|+... ...
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~-~~~  239 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM-AHE  239 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-CHH
Confidence            99999999999999998765432211 1112335678999999988899999999999999999998 76665311 111


Q ss_pred             cchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcc
Q 042149          509 SVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN  570 (625)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  570 (625)
                      +    ..........         ...+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus       240 ~----~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 E----VIYYVRDGNV---------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             H----HHHHHhcCCC---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            1    1111111111         11233456789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.9e-37  Score=319.02  Aligned_cols=258  Identities=28%  Similarity=0.393  Sum_probs=205.0

Q ss_pred             hcCccccccccccCceEEEEEEeC------CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPE  368 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~  368 (625)
                      .++|++.+.||+|+||.||+|...      .+..+|||++... .....+.+.+|+.+++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            457999999999999999999741      3457999988654 344456789999999999 79999999999999999


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      .++||||+++++|.+++..... ..+++.++..++.+++.||.|||+++   ++|+||||+|||++.++.++|+|||+++
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence            9999999999999998864332 23899999999999999999999775   9999999999999999999999999998


Q ss_pred             eeCCCCcee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccc
Q 042149          449 HVAPDKTHV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQS  526 (625)
Q Consensus       449 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (625)
                      ......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.|+.........    .+...       
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~----~~~~~-------  258 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF----YKLIK-------  258 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH----HHHHH-------
Confidence            664433221 122346788999999999999999999999999999998 88775432211111    11111       


Q ss_pred             cCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       527 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                        .......+...+..+.+++.+||+.+|++|||+.|+++.|.+.
T Consensus       259 --~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         259 --EGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             --cCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence              1111112233456789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.1e-37  Score=312.57  Aligned_cols=253  Identities=23%  Similarity=0.327  Sum_probs=200.9

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      .++|++.++||+|+||.||+|+.. +++.||+|.+..........+.+|+.+++.++||||+++++.+...+..++||||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            357888889999999999999864 6889999998776655566788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+++....   .+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        88 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06645          88 CGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA  161 (267)
T ss_pred             cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence            99999999886543   3899999999999999999999775   99999999999999999999999999876543221


Q ss_pred             eeeecCCCCccccCccccc---cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLV---RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                       ......|++.|+|||++.   ...++.++||||||+++|+|++|+.|+.........    +.. .....   ..+...
T Consensus       162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~----~~~-~~~~~---~~~~~~  232 (267)
T cd06645         162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL----FLM-TKSNF---QPPKLK  232 (267)
T ss_pred             -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH----Hhh-hccCC---CCCccc
Confidence             122356899999999874   456889999999999999999999886432211111    100 00000   000000


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .  ....+..+.+++.+||+.+|++||++++|++
T Consensus       233 ~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         233 D--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             c--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            0  1123456889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-37  Score=309.98  Aligned_cols=248  Identities=26%  Similarity=0.382  Sum_probs=197.3

Q ss_pred             ccccccCceEEEEEEeC--C--CCEEEEEEeecCCh-HHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCC
Q 042149          304 RKLGQGGAGSVFRGTLP--D--GRNIAVKRLFFNSR-QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPN  378 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~  378 (625)
                      ++||+|+||.||+|+..  +  +..+|+|.+..... ...+.+.+|+.+++.+.||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999753  2  36899998875543 34567899999999999999999999875 4568999999999


Q ss_pred             CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceee
Q 042149          379 RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS  458 (625)
Q Consensus       379 ~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  458 (625)
                      ++|.+++....   .+++..+..++.|++.+|+|||..+   ++||||||+|||++.++.+||+|||+++..........
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            99999986544   4899999999999999999999775   99999999999999999999999999987654433222


Q ss_pred             e--cCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          459 T--GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       459 ~--~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                      .  ...++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ..    .........         ....
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-~~----~~~~~~~~~---------~~~~  219 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-AE----VIAMLESGE---------RLPR  219 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-HH----HHHHHHcCC---------cCCC
Confidence            1  1223568999999988899999999999999999998 8877643221 11    111111111         1122


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      +...+..+.+++.+||+.+|++||++.++++.|+++.
T Consensus       220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            3445678899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=5.5e-37  Score=314.64  Aligned_cols=263  Identities=24%  Similarity=0.344  Sum_probs=201.6

Q ss_pred             cCccccccccccCceEEEEEEeC-----------------CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeee
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-----------------DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRL  359 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l  359 (625)
                      ++|++.++||+|+||.||++...                 ++..+|+|++... .....+.+.+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56899999999999999998532                 2346899988754 34456789999999999999999999


Q ss_pred             eeeeeeCCeeEEEEEecCCCCcchhhhccCC--------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcE
Q 042149          360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNT--------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNI  431 (625)
Q Consensus       360 ~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NI  431 (625)
                      ++++...+..++||||+++++|.+++.....        ...+++..+..++.|++.||+|||+.+   ++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence            9999999999999999999999998865321        123778899999999999999999775   99999999999


Q ss_pred             EEcCCCceEEeecccceeeCCCCcee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh--CCCCCCCCCCCc
Q 042149          432 LLDEKLTPKIADFGLARHVAPDKTHV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS--GRRNSVFSEGSS  508 (625)
Q Consensus       432 ll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt--G~~p~~~~~~~~  508 (625)
                      |++.++.++|+|||+++.+....... .....+++.|++||....+.++.++||||||+++|||++  |..|+.... ..
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~-~~  240 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS-DE  240 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC-hH
Confidence            99999999999999998654332221 112334678999999888899999999999999999999  444543211 11


Q ss_pred             cchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcc
Q 042149          509 SVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN  570 (625)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  570 (625)
                      .........+....      .....+.+..++..+.+++.+||+.+|++||++.+|++.|++
T Consensus       241 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 QVIENTGEFFRDQG------RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHHHHHHHHhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            11111111111100      001111233456789999999999999999999999998853

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-39  Score=297.62  Aligned_cols=252  Identities=25%  Similarity=0.318  Sum_probs=205.7

Q ss_pred             HhcCccccccccccCceEEEEEEe-CCCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      +.+.|++-+.||+|.|+.||+..+ ++|+.+|+|++...  .....+.+.+|+.|-+.|+||||+++.+.+.++...++|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            456788888999999999999985 47999999987543  344678899999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEc---CCCceEEeeccccee
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADFGLARH  449 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~---~~~~~kl~Dfgla~~  449 (625)
                      +|+|.|++|-.-+-.+   ...++..+-..++||+++|.|+|.++   |||||+||+|+++-   ..--+||+|||+|..
T Consensus        89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence            9999999986544333   23677888899999999999999775   99999999999995   345699999999998


Q ss_pred             eCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          450 VAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      ..  ......+..|||+|||||++...+|+..+|||+-|||||-||.|..||....     .+..++....+..      
T Consensus       163 l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~-----~~rlye~I~~g~y------  229 (355)
T KOG0033|consen  163 VN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-----QHRLYEQIKAGAY------  229 (355)
T ss_pred             eC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc-----HHHHHHHHhcccc------
Confidence            87  3334456789999999999999999999999999999999999999975321     1223333333221      


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ...++.-+...+.-.+|+.+||..||.+|.|+.|.++
T Consensus       230 d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  230 DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            2233334566778899999999999999999987654

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-37  Score=310.04  Aligned_cols=249  Identities=32%  Similarity=0.463  Sum_probs=202.9

Q ss_pred             ccccccCceEEEEEEeCC----CCEEEEEEeecCChH-HHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCC
Q 042149          304 RKLGQGGAGSVFRGTLPD----GRNIAVKRLFFNSRQ-WVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPN  378 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~  378 (625)
                      +.||+|+||.||+|....    +..+++|.+...... ..+.+.+|+++++.++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999999653    788999998765433 367899999999999999999999999999999999999999


Q ss_pred             CCcchhhhccCC------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          379 RSLDQILFVKNT------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       379 ~sL~~~l~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      ++|.+++.....      ...+++..++.++.+++.||.|||+++   ++||||||+||+++.++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999876521      245899999999999999999999775   99999999999999999999999999987654


Q ss_pred             CCc-eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          453 DKT-HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       453 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                      ... .......+++.|+|||.+....++.++||||||+++|||++ |..|+.....     ...+.....         .
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~~~~---------~  223 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-----EEVLEYLRK---------G  223 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHHc---------C
Confidence            432 11224567889999999988889999999999999999999 4776543311     111111111         1


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHc
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLN  569 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  569 (625)
                      .....+...+.++.+++.+||+.+|++|||+.|+++.|+
T Consensus       224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            112234455778999999999999999999999998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.9e-37  Score=310.91  Aligned_cols=251  Identities=26%  Similarity=0.399  Sum_probs=200.8

Q ss_pred             cCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecC
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVP  377 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~  377 (625)
                      ..|++.+.||+|+||.||+|.+.+++.+|+|.+..... ....+.+|++++++++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            46788899999999999999987788999998864432 23578899999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCcee
Q 042149          378 NRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV  457 (625)
Q Consensus       378 ~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  457 (625)
                      +++|.+++....  ..+++..+..++.+++.+|++||+.+   ++|+||||+||+++.++.++|+|||++..........
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          83 HGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            999999886433  23789999999999999999999775   9999999999999999999999999987654332222


Q ss_pred             eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCC
Q 042149          458 STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP  536 (625)
Q Consensus       458 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  536 (625)
                      .....++..|+|||.+.++.++.++||||||+++|||++ |..|+..... ...    .......         .....+
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~----~~~~~~~---------~~~~~~  223 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-SEV----VETINAG---------FRLYKP  223 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-HHH----HHHHhCC---------CCCCCC
Confidence            223345678999999988899999999999999999998 7777532211 111    1111110         011112


Q ss_pred             hHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042149          537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHML  568 (625)
Q Consensus       537 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  568 (625)
                      ...+..+.+++.+||+.+|++|||+.++++.|
T Consensus       224 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            23457799999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.5e-37  Score=329.42  Aligned_cols=261  Identities=24%  Similarity=0.289  Sum_probs=197.6

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC-----eeE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP-----ESL  370 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~  370 (625)
                      +|++.++||+|+||.||++... +++.||||++...  .......+.+|+++++.++||||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788999999999999999964 7899999988543  3344567889999999999999999999998776     789


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      +||||+. ++|.+.+...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999996 5777766433   34899999999999999999999775   999999999999999999999999999875


Q ss_pred             CCCCceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccc-------
Q 042149          451 APDKTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR-------  522 (625)
Q Consensus       451 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-------  522 (625)
                      ............+++.|+|||++.+. .++.++|||||||++|||++|+.|+....... .+...........       
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHHHh
Confidence            44333333345689999999998774 57899999999999999999999875432111 1111100000000       


Q ss_pred             ---ccccc-CCCCC-------CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          523 ---ITQSM-DPGLT-------GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       523 ---~~~~i-~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                         ....+ .....       .......+..+.+++.+||+.||++|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence               00000 00000       01122335678899999999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=7.9e-38  Score=337.58  Aligned_cols=260  Identities=18%  Similarity=0.254  Sum_probs=192.2

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--------
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG--------  366 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--------  366 (625)
                      ..++|++.++||+|+||.||+|+.. +++.||||++....    ....+|+.+|+.++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3467999999999999999999975 68899999885443    2345799999999999999999876432        


Q ss_pred             CeeEEEEEecCCCCcchhhhc-cCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC-ceEEeec
Q 042149          367 PESLLVYEYVPNRSLDQILFV-KNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL-TPKIADF  444 (625)
Q Consensus       367 ~~~~lV~e~~~~~sL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-~~kl~Df  444 (625)
                      ..+++||||+++ +|.+++.. ......+++..+..++.||+.||.|||+.+   |+||||||+||||+.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence            246799999975 66665542 223345899999999999999999999775   99999999999999654 7999999


Q ss_pred             ccceeeCCCCceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcc--
Q 042149          445 GLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN--  521 (625)
Q Consensus       445 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~--  521 (625)
                      |+++.+......  ....||+.|+|||++.+. .++.++|||||||++|||++|.+|+........+ ..........  
T Consensus       216 Gla~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~-~~i~~~~~~p~~  292 (440)
T PTZ00036        216 GSAKNLLAGQRS--VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL-VRIIQVLGTPTE  292 (440)
T ss_pred             ccchhccCCCCc--ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCCH
Confidence            999876443322  235789999999998764 6899999999999999999999887533221111 1111111000  


Q ss_pred             -------------ccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          522 -------------RITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       522 -------------~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                                   .........+...+|...+.++.+|+.+||+.+|++|||+.|+++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence                         000000011111123344677899999999999999999999984

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3e-37  Score=316.60  Aligned_cols=249  Identities=24%  Similarity=0.395  Sum_probs=204.2

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      .+|++.+.||+|+||.||+|+.. +++.|++|.+........+.+.+|+.+++.+.||||+++++.+..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            57888999999999999999964 68999999998766556678899999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      ++++|.+++...    .+++.++..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++.........
T Consensus       100 ~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  172 (296)
T cd06654         100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (296)
T ss_pred             CCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence            999999988432    3789999999999999999999775   999999999999999999999999998765433221


Q ss_pred             eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP  536 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  536 (625)
                       .....+++.|+|||.+.+..++.++||||||+++|+|++|+.|+.........    .......        ......+
T Consensus       173 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~----~~~~~~~--------~~~~~~~  239 (296)
T cd06654         173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL----YLIATNG--------TPELQNP  239 (296)
T ss_pred             -cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH----HHHhcCC--------CCCCCCc
Confidence             22346889999999998888999999999999999999999997533221111    0100000        0011123


Q ss_pred             hHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          537 ENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       537 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ...+..+.+++.+||..+|++||++.++++
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             cccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            455677899999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-37  Score=311.88  Aligned_cols=249  Identities=29%  Similarity=0.385  Sum_probs=194.8

Q ss_pred             ccccccCceEEEEEEeCC-CC--EEEEEEeecC-ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEEEEEecCC
Q 042149          304 RKLGQGGAGSVFRGTLPD-GR--NIAVKRLFFN-SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLLVYEYVPN  378 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~~  378 (625)
                      +.||+|+||.||+|++++ +.  .+++|.+... .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            369999999999999753 43  4688887643 345567889999999999 799999999999999999999999999


Q ss_pred             CCcchhhhccC-------------CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecc
Q 042149          379 RSLDQILFVKN-------------TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFG  445 (625)
Q Consensus       379 ~sL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfg  445 (625)
                      ++|.+++....             ....+++..+..++.+++.||+|||+.+   ++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999886432             1234789999999999999999999775   9999999999999999999999999


Q ss_pred             cceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccc
Q 042149          446 LARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRIT  524 (625)
Q Consensus       446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  524 (625)
                      ++........  ......+..|+|||++....++.++||||||+++|||++ |+.|+..... .    ......      
T Consensus       158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~----~~~~~~------  224 (270)
T cd05047         158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-A----ELYEKL------  224 (270)
T ss_pred             Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-H----HHHHHH------
Confidence            9863221111  111234567999999988889999999999999999997 8887632211 1    111111      


Q ss_pred             cccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          525 QSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       525 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                         ......+.+...+..+.+++.+||+.+|.+|||+.++++.|.++
T Consensus       225 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         225 ---PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             ---hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence               11111122334556789999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-37  Score=307.82  Aligned_cols=247  Identities=27%  Similarity=0.408  Sum_probs=197.8

Q ss_pred             ccccccCceEEEEEEeCCCCEEEEEEeecCCh-HHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCCCcc
Q 042149          304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR-QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLD  382 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~sL~  382 (625)
                      ++||+|+||.||++.+++++.||+|++..... .....+.+|++++++++||||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            47999999999999987799999998865433 35678999999999999999999999999999999999999999999


Q ss_pred             hhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceee-ecC
Q 042149          383 QILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS-TGI  461 (625)
Q Consensus       383 ~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~~~  461 (625)
                      +++....  ..+++..+..++.+++.+|.|||+++   ++||||||+||+++.++.++|+|||++........... ...
T Consensus        81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            9885432  24788999999999999999999775   99999999999999999999999999876542222111 112


Q ss_pred             CCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHH
Q 042149          462 AGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEA  540 (625)
Q Consensus       462 ~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  540 (625)
                      .++..|+|||.+.++.++.++||||||+++|||+| |..|+..... ..    ....         +........+...+
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-~~----~~~~---------~~~~~~~~~~~~~~  221 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-QQ----TRER---------IESGYRMPAPQLCP  221 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-HH----HHHH---------HhcCCCCCCCccCC
Confidence            34567999999988899999999999999999999 6665432211 10    0111         11111112244556


Q ss_pred             HHHHHHHhhccCCCCCCCCCHHHHHHHHc
Q 042149          541 SRVLQIGLLCTQAPVALRPSMAEVVHMLN  569 (625)
Q Consensus       541 ~~l~~li~~cl~~~p~~RPt~~ev~~~L~  569 (625)
                      ..+.+++.+||+.+|++|||+.|+++.|+
T Consensus       222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            78999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.8e-37  Score=327.25  Aligned_cols=251  Identities=22%  Similarity=0.281  Sum_probs=195.7

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ++|++.+.||+|+||.||+++.+ +++.||||++...   ..+....+.+|+.++..++||||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46889999999999999999975 6899999998643   2344567889999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++++|.+++....   .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            9999999999886543   3889999999999999999999775   999999999999999999999999998754321


Q ss_pred             Cc----------------------------------eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCC
Q 042149          454 KT----------------------------------HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRR  499 (625)
Q Consensus       454 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~  499 (625)
                      ..                                  .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            10                                  00113479999999999999999999999999999999999999


Q ss_pred             CCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 042149          500 NSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPS---MAEVVH  566 (625)
Q Consensus       500 p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~ev~~  566 (625)
                      |+......     ..+.......      ..+.-+.....+..+.+++.+++. +|++|++   +.|+++
T Consensus       235 Pf~~~~~~-----~~~~~i~~~~------~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~  292 (360)
T cd05627         235 PFCSETPQ-----ETYRKVMNWK------ETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCCCHH-----HHHHHHHcCC------CceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence            87533211     1111111100      000000011235567888888764 9999985   566654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.4e-37  Score=312.88  Aligned_cols=256  Identities=23%  Similarity=0.315  Sum_probs=203.9

Q ss_pred             hcCccccccccccCceEEEEEEeCC----CCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPD----GRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      .++|.+.++||+|+||.||+|.+.+    ...|+||...... .+..+.+.+|+.++++++||||+++++++.+ ...++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            3568888999999999999998643    2468999886654 5566789999999999999999999998865 55789


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||||+++++|.+++....  ..+++..++.++.+++.||.|||+.+   ++||||||+||+++.++.++|+|||+++...
T Consensus        84 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          84 VMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence            999999999999986433  24899999999999999999999775   9999999999999999999999999998765


Q ss_pred             CCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                      ...........+++.|+|||.+....++.++||||||+++|||++ |..|+...... ..    ........        
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-~~----~~~~~~~~--------  225 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-DV----IGRIENGE--------  225 (270)
T ss_pred             cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-HH----HHHHHcCC--------
Confidence            443222223345678999999988889999999999999999996 88886432211 11    11111111        


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                       ....+...+..+.+++.+|+..+|++|||+.++++.|.++.
T Consensus       226 -~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         226 -RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             -cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence             11223455678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.5e-37  Score=346.82  Aligned_cols=259  Identities=22%  Similarity=0.298  Sum_probs=202.4

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ++|++.++||+|+||.||+|++. +++.||||++...   .....+++.+|++++++++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999999975 6899999998643   2344567999999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccC--------CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecc
Q 042149          374 EYVPNRSLDQILFVKN--------TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFG  445 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfg  445 (625)
                      ||++|++|.+++....        ....+++..++.++.||++||+|||+.+   |+||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999886321        1123567788999999999999999775   9999999999999999999999999


Q ss_pred             cceeeCCCCc-----------------eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCc
Q 042149          446 LARHVAPDKT-----------------HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSS  508 (625)
Q Consensus       446 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~  508 (625)
                      +++.......                 .......||+.|+|||++.+..++.++|||||||++|||+||+.|+.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9987621110                 00113469999999999999999999999999999999999999975322110


Q ss_pred             cchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHccc
Q 042149          509 SVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRP-SMAEVVHMLNNI  571 (625)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~ev~~~L~~~  571 (625)
                      .    ...    ..   ..++... ......+..+.+++.+|++.+|++|| +++++++.|+..
T Consensus       239 i----~~~----~~---i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        239 I----SYR----DV---ILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             h----hhh----hh---ccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            0    000    00   0011000 00124456788999999999999996 566677777654

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.7e-38  Score=310.01  Aligned_cols=257  Identities=24%  Similarity=0.305  Sum_probs=195.3

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC-----eeEEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP-----ESLLV  372 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~lV  372 (625)
                      .|...+++|.|.||.||+|... ++..||||+...+.+-    -.+|+++|+.++|||||++.-+|....     ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4677889999999999999964 5799999999766432    246999999999999999998886432     34689


Q ss_pred             EEecCCCCcchhhhcc-CCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCC-CceEEeecccceee
Q 042149          373 YEYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEK-LTPKIADFGLARHV  450 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~-~~~kl~Dfgla~~~  450 (625)
                      ||||+. +|.+.+... .....++...+.-+..||.+||.|||+.   +|+||||||+|||+|.+ |.+||+|||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999975 787777532 1223477788888999999999999976   49999999999999975 99999999999998


Q ss_pred             CCCCceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccc---cc--
Q 042149          451 APDKTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR---IT--  524 (625)
Q Consensus       451 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~--  524 (625)
                      ..++...+  ...|..|.|||.+.+ .+|+.+.||||.||++.||+-|++-|......+.+ ....+.+....   +.  
T Consensus       177 ~~~epniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL-~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  177 VKGEPNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQL-VEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             ccCCCcee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHH-HHHHHHhCCCCHHHHhhc
Confidence            77666543  467899999999987 58999999999999999999999876653332222 12212111110   00  


Q ss_pred             -----cccCCCCC-----CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          525 -----QSMDPGLT-----GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       525 -----~~i~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                           +.-.+.+.     .-.....+.+..+++.++++.+|.+|.++.|++.
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                 11111111     1133456778899999999999999999988874

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5e-37  Score=310.18  Aligned_cols=257  Identities=27%  Similarity=0.358  Sum_probs=203.8

Q ss_pred             HHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          294 ERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       294 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      +..++.+.....||+|+||.||+|++. ++..|++|.+........+.+.+|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            344666777789999999999999965 6788999998777666778899999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC-CCceEEeecccceeeC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE-KLTPKIADFGLARHVA  451 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~-~~~~kl~Dfgla~~~~  451 (625)
                      |||+++++|.+++.........++..+..++.||+.||.|||+.+   |+||||||+||+++. ++.++|+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            999999999999865432212378888999999999999999775   999999999999986 6799999999987654


Q ss_pred             CCCceeeecCCCCccccCccccccCc--ccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRGQ--LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      ..... .....+++.|+|||++....  ++.++||||||+++|+|++|+.|+........   ..+..   .      ..
T Consensus       161 ~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~---~------~~  227 (268)
T cd06624         161 GINPC-TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKV---G------MF  227 (268)
T ss_pred             cCCCc-cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhh---h------hh
Confidence            32221 22345889999999986643  78899999999999999999988643221111   00110   0      00


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ......+.....++.+++.+||+.+|++|||+.|+++
T Consensus       228 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         228 KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            1112234456678899999999999999999999985

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=6.1e-37  Score=311.57  Aligned_cols=249  Identities=21%  Similarity=0.311  Sum_probs=198.8

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ++|++.++||+|+||.||+|++. +++.||+|.+... .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            35788899999999999999864 6889999998655 344456789999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|..+.       .+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-  149 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-  149 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence            9999996542       2678888999999999999999775   9999999999999999999999999997654322 


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccch--hhHHHhhhccccccccCCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVL--HTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                        .....++..|+|||++.+..++.++||||||+++|+|++|+.|+..........  ...........     .+.+  
T Consensus       150 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~--  220 (279)
T cd06619         150 --AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVL--  220 (279)
T ss_pred             --ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCC--
Confidence              223578999999999998899999999999999999999999975432211110  00011111110     0111  


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                       .....+.++.+++.+||+.+|++||+++|+++.
T Consensus       221 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         221 -PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             -CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence             112345678999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.3e-37  Score=309.33  Aligned_cols=248  Identities=28%  Similarity=0.404  Sum_probs=199.2

Q ss_pred             ccccccCceEEEEEEeCC--C--CEEEEEEeecCCh-HHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCC
Q 042149          304 RKLGQGGAGSVFRGTLPD--G--RNIAVKRLFFNSR-QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPN  378 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~  378 (625)
                      ++||+|++|.||+|.+.+  +  ..||||.+..... ...+.+.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998643  3  3689999877655 667789999999999999999999999988 889999999999


Q ss_pred             CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCcee-
Q 042149          379 RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV-  457 (625)
Q Consensus       379 ~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-  457 (625)
                      ++|.+.+..... ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++......... 
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999866543 45899999999999999999999775   9999999999999999999999999998765432221 


Q ss_pred             -eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          458 -STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       458 -~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                       .....++..|+|||++.+..++.++||||||+++|||++ |+.|+..... .+.    .+.....        ......
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~----~~~~~~~--------~~~~~~  222 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-SQI----LKKIDKE--------GERLER  222 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH-HHH----HHHHHhc--------CCcCCC
Confidence             113457789999999988899999999999999999999 8888632211 111    1111100        001112


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHc
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLN  569 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  569 (625)
                      +...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            3345677899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-37  Score=308.19  Aligned_cols=254  Identities=24%  Similarity=0.323  Sum_probs=205.3

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      .++|++.+.||+|+||.||+|... +++.+++|.+........+.+.+|+.++++++||||+++++.+..+...+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            367899999999999999999975 5788999999877666678899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+++....  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        82 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  156 (262)
T cd06613          82 CGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA  156 (262)
T ss_pred             CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence            99999999886542  24889999999999999999999775   99999999999999999999999999876543221


Q ss_pred             eeeecCCCCccccCccccccC---cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRG---QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                       ......++..|+|||.+...   .++.++||||||+++|||+||+.|+.........    . ......   ....  .
T Consensus       157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~----~-~~~~~~---~~~~--~  225 (262)
T cd06613         157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL----F-LISKSN---FPPP--K  225 (262)
T ss_pred             -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH----H-HHHhcc---CCCc--c
Confidence             12235688899999998776   7889999999999999999999886432211110    0 000000   0000  1


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ...+...+..+.+++.+||+.+|.+|||+.+|+.
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1123455678999999999999999999999885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.4e-37  Score=324.02  Aligned_cols=260  Identities=28%  Similarity=0.388  Sum_probs=201.1

Q ss_pred             hcCccccccccccCceEEEEEEe------CCCCEEEEEEeecCC-hHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeC-C
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL------PDGRNIAVKRLFFNS-RQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEG-P  367 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-~  367 (625)
                      .++|++.++||+|+||.||+|++      .+++.||||++.... ......+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            46799999999999999999973      347889999997543 34456788999999999 689999999987654 5


Q ss_pred             eeEEEEEecCCCCcchhhhccCC---------------------------------------------------------
Q 042149          368 ESLLVYEYVPNRSLDQILFVKNT---------------------------------------------------------  390 (625)
Q Consensus       368 ~~~lV~e~~~~~sL~~~l~~~~~---------------------------------------------------------  390 (625)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999998864321                                                         


Q ss_pred             -------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCcee-eecCC
Q 042149          391 -------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV-STGIA  462 (625)
Q Consensus       391 -------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~  462 (625)
                             ...+++..+..++.|+++||+|||+++   |+||||||+||+++.++.+||+|||++.......... .....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   123678888999999999999999775   9999999999999999999999999987653322211 11234


Q ss_pred             CCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHH
Q 042149          463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEAS  541 (625)
Q Consensus       463 gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  541 (625)
                      +++.|+|||.+.+..++.++||||||+++|+|++ |..|+........    ........         .....+...+.
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----~~~~~~~~---------~~~~~~~~~~~  309 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----FCRRLKEG---------TRMRAPDYTTP  309 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH----HHHHHhcc---------CCCCCCCCCCH
Confidence            5678999999988899999999999999999997 7777643221111    11111111         11111223345


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          542 RVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       542 ~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      .+.+++.+||+.+|++|||+.||++.|+.+.
T Consensus       310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         310 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            7899999999999999999999999997653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6.7e-37  Score=311.66  Aligned_cols=252  Identities=24%  Similarity=0.330  Sum_probs=200.5

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      +.|++.++||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++||||+++++.+...+..++||||+
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            34678889999999999999976 57788999987766667788999999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      ++++|..++....  ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........ 
T Consensus        85 ~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-  158 (282)
T cd06643          85 AGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-  158 (282)
T ss_pred             CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence            9999988775422  34899999999999999999999775   99999999999999999999999999876533221 


Q ss_pred             eeecCCCCccccCccccc-----cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLV-----RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      ......+++.|+|||++.     +..++.++||||||+++|||++|+.|+.......    ..... ....     .+. 
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~----~~~~~-~~~~-----~~~-  227 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR----VLLKI-AKSE-----PPT-  227 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH----HHHHH-hhcC-----CCC-
Confidence            122356899999999984     3457889999999999999999998864321110    00110 0000     000 


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                       ...+...+..+.+++.+||+.+|++||++.++++.
T Consensus       228 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         228 -LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             -CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             11133446778999999999999999999998753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-37  Score=320.77  Aligned_cols=240  Identities=23%  Similarity=0.279  Sum_probs=186.7

Q ss_pred             ccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcC---CCCceeeeeeeeeeCCeeEEEEEecCC
Q 042149          306 LGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGI---QHKNVVRLLGCSIEGPESLLVYEYVPN  378 (625)
Q Consensus       306 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~~~lV~e~~~~  378 (625)
                      ||+|+||+||+|+.+ +++.||||++...   .......+..|..++..+   .||||+++++.+.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999965 6899999998643   222344556677777665   699999999999999999999999999


Q ss_pred             CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceee
Q 042149          379 RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS  458 (625)
Q Consensus       379 ~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  458 (625)
                      ++|.+++....   .+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++........ .
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~-~  153 (330)
T cd05586          81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT-T  153 (330)
T ss_pred             ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC-c
Confidence            99998886443   3899999999999999999999775   999999999999999999999999998754322221 2


Q ss_pred             ecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCCh
Q 042149          459 TGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE  537 (625)
Q Consensus       459 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  537 (625)
                      ....||+.|+|||++.+. .++.++|||||||++|||++|+.|+.....     ...+........      .+.   ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-----~~~~~~i~~~~~------~~~---~~  219 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-----QQMYRNIAFGKV------RFP---KN  219 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-----HHHHHHHHcCCC------CCC---Cc
Confidence            345799999999998764 478999999999999999999998743211     111121111110      010   11


Q ss_pred             HHHHHHHHHHhhccCCCCCCCC----CHHHHHH
Q 042149          538 NEASRVLQIGLLCTQAPVALRP----SMAEVVH  566 (625)
Q Consensus       538 ~~~~~l~~li~~cl~~~p~~RP----t~~ev~~  566 (625)
                      ..+..+.+++.+||+.+|++||    ++.++++
T Consensus       220 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         220 VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            2456788999999999999998    5666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=8.5e-37  Score=315.11  Aligned_cols=261  Identities=23%  Similarity=0.314  Sum_probs=201.5

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ++|++.++||+|+||.||++.+. ++..+|+|.+... ......++.+|++++++++||||+++++.+..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46899999999999999999965 6788899988654 344456788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+++....   .+++..+..++.|+++||.|||+..  +++||||||+|||++.++.+||+|||++....... 
T Consensus        81 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  154 (308)
T cd06615          81 MDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  154 (308)
T ss_pred             cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence            99999999986543   3889999999999999999999632  59999999999999999999999999987553321 


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHh---hhccc----------
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKH---YKANR----------  522 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~---~~~~~----------  522 (625)
                        .....+++.|+|||.+.+..++.++||||||+++|+|++|+.|+...... .........   .....          
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK-ELEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh-hHHHhhcCccccccccCCcccccCCCC
Confidence              22356899999999998888999999999999999999999987533211 110000000   00000          


Q ss_pred             -------cccccC---CCCCCCCC-hHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          523 -------ITQSMD---PGLTGRFP-ENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       523 -------~~~~i~---~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                             ..+..+   .......+ ...+..+.+++.+||+.+|++|||+.+|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   000000   00000111 1245678999999999999999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.7e-37  Score=309.82  Aligned_cols=250  Identities=28%  Similarity=0.396  Sum_probs=193.3

Q ss_pred             ccccccCceEEEEEEeC----CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeee-eCCeeEEEEEecC
Q 042149          304 RKLGQGGAGSVFRGTLP----DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSI-EGPESLLVYEYVP  377 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~lV~e~~~  377 (625)
                      +.||+|+||.||+|.+.    +...+|+|++... .....+.+.+|+.+++.++||||+++++++. .+...++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46999999999999853    2457899988543 4455678899999999999999999999765 4556899999999


Q ss_pred             CCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCcee
Q 042149          378 NRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV  457 (625)
Q Consensus       378 ~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  457 (625)
                      +++|.+++....  ..+.+..+..++.+++.||.|||+.+   ++||||||+|||+++++.+||+|||+++.........
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            999999986432  23678888999999999999999764   9999999999999999999999999997654322111


Q ss_pred             ---eecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          458 ---STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       458 ---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                         .....+++.|+|||.+.+..++.++||||||+++|||++|+.|+............    ....         ....
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~----~~~~---------~~~~  222 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY----LLQG---------RRLL  222 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HhcC---------CCCC
Confidence               11334677899999998889999999999999999999976553222111111111    1100         0111


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      .+...+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       223 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         223 QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            1233456789999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.9e-37  Score=320.69  Aligned_cols=241  Identities=22%  Similarity=0.259  Sum_probs=193.9

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCCeeEEEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~  373 (625)
                      +|+..+.||+|+||.||+|+.+ +++.||||++...   .....+.+..|+.+++.+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4778899999999999999965 6899999998753   2334566788999998886 577888999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++++|.+++....   .+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            9999999998885443   3899999999999999999999775   999999999999999999999999998754322


Q ss_pred             CceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                      .. ......||+.|+|||++.+..++.++||||||+++|||++|+.|+..... ...    ........          .
T Consensus       155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-~~~----~~~i~~~~----------~  218 (323)
T cd05615         155 GV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DEL----FQSIMEHN----------V  218 (323)
T ss_pred             Cc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-HHH----HHHHHhCC----------C
Confidence            22 12345699999999999988999999999999999999999998753221 111    11111111          1


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCCH
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPSM  561 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt~  561 (625)
                      ..|...+..+.+++.+||+.+|++|++.
T Consensus       219 ~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            2234456678899999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.7e-37  Score=313.41  Aligned_cols=251  Identities=25%  Similarity=0.296  Sum_probs=200.0

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      .|+..+.||+|+||.||++... +++.||||.+....   ......+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3677889999999999999965 68999999886542   2334567889999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+++++|.+++..... ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          81 LMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             ecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            9999999998854332 34889999999999999999999765   9999999999999999999999999987654322


Q ss_pred             ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          455 THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                      .  .....|++.|+|||++.+..++.++||||||+++|+|++|+.|+........  .........         .....
T Consensus       157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~--~~~~~~~~~---------~~~~~  223 (285)
T cd05630         157 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERLVK---------EVQEE  223 (285)
T ss_pred             c--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch--HHHHHhhhh---------hhhhh
Confidence            2  1234689999999999999999999999999999999999999753321110  000110000         00111


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRPS-----MAEVVH  566 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~  566 (625)
                      .+...+..+.+++.+||+.+|++|||     ++|+++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         224 YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            23344567889999999999999999     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4.6e-37  Score=311.57  Aligned_cols=257  Identities=26%  Similarity=0.373  Sum_probs=203.4

Q ss_pred             cCccccccccccCceEEEEEEeC------CCCEEEEEEeecCChH-HHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFNSRQ-WVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  370 (625)
                      ++|++.+.||+|+||.||+|+.+      +.+.+++|.+...... ..+.+.+|++++++++||||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57889999999999999999854      2467899988654433 5678999999999999999999999999999999


Q ss_pred             EEEEecCCCCcchhhhccCCc------CCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeec
Q 042149          371 LVYEYVPNRSLDQILFVKNTI------HILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADF  444 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Df  444 (625)
                      +||||+++++|.+++......      ..+++..+..++.|++.+|.|||+.+   |+||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999998655422      14899999999999999999999775   999999999999999999999999


Q ss_pred             ccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhcccc
Q 042149          445 GLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRI  523 (625)
Q Consensus       445 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  523 (625)
                      |++...............++..|+|||.+.+..++.++||||||+++|+|++ |..|+.... ...    ..........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~-~~~----~~~~~~~~~~  236 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS-DEE----VLNRLQAGKL  236 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc-hHH----HHHHHHcCCc
Confidence            9987543322222223456778999999988889999999999999999999 555643211 111    1111111111


Q ss_pred             ccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcc
Q 042149          524 TQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN  570 (625)
Q Consensus       524 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  570 (625)
                      .        ...+...+..+.+++.+||+.+|++||++.|++..|.+
T Consensus       237 ~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         237 E--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             C--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            1        11123445679999999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-37  Score=310.48  Aligned_cols=247  Identities=25%  Similarity=0.343  Sum_probs=202.6

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ++|++.+.||.|++|.||+|++. +++.||+|.+.... ......+.+|+.+++.++||||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            46888899999999999999965 68899999986553 44556788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+++...    .+++..+..++.|++.+|.|||+++   ++||||+|+||++++++.++|+|||+++.......
T Consensus        81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            9999999988543    4899999999999999999999775   99999999999999999999999999987754322


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                       ......+++.|+|||++.+..++.++||||||+++|+|+||+.|+...... ...    .....         ......
T Consensus       154 -~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-~~~----~~~~~---------~~~~~~  218 (274)
T cd06609         154 -KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-RVL----FLIPK---------NNPPSL  218 (274)
T ss_pred             -ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-HHH----HHhhh---------cCCCCC
Confidence             222356888999999999888999999999999999999999987432211 100    00000         011111


Q ss_pred             ChH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          536 PEN-EASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       536 ~~~-~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      +.. .+..+.+++.+||+.+|++|||++++++
T Consensus       219 ~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         219 EGNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             cccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            112 4667889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.3e-36  Score=311.36  Aligned_cols=251  Identities=24%  Similarity=0.320  Sum_probs=201.5

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      +.|++.++||+|+||.||+|++. +++.+++|.+........+.+.+|+.+++.++||||+++++.+..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56889999999999999999975 58899999998777777888999999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      ++++|..++....  ..+++..+..++.|++.+|.|||+.+   ++||||||+||+++.++.++|+|||++.........
T Consensus        92 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  166 (292)
T cd06644          92 PGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR  166 (292)
T ss_pred             CCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence            9999988775433  24899999999999999999999765   999999999999999999999999998754322211


Q ss_pred             eeecCCCCccccCccccc-----cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLV-----RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                       .....+++.|+|||++.     ...++.++||||||+++|||++|+.|+......    .. ........     .+. 
T Consensus       167 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~-~~~~~~~~-----~~~-  234 (292)
T cd06644         167 -RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM----RV-LLKIAKSE-----PPT-  234 (292)
T ss_pred             -cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH----HH-HHHHhcCC-----Ccc-
Confidence             12346889999999985     345678999999999999999999886432111    00 11111100     000 


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                       ...+...+..+.+++.+||+.+|++||+++++++
T Consensus       235 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         235 -LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             -CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence             1113345567899999999999999999999985

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.1e-36  Score=310.84  Aligned_cols=250  Identities=24%  Similarity=0.289  Sum_probs=198.5

Q ss_pred             ccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          300 FDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      |+..++||+|+||+||+|.+. +++.+|+|.+....   ......+.+|++++++++|+||+++++.+..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            677889999999999999964 68899999986542   23345678899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+++..... ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++........
T Consensus        82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          82 MNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             ccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            999999988864432 34899999999999999999999775   99999999999999999999999999876543222


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                        .....|++.|+|||++.+..++.++|+||||+++|||++|+.|+........ ...........          ....
T Consensus       158 --~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~~~~~~----------~~~~  224 (285)
T cd05632         158 --IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDRRVLET----------EEVY  224 (285)
T ss_pred             --ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhhcc----------cccc
Confidence              1235789999999999888999999999999999999999998753221110 00111100000          0112


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPS-----MAEVVH  566 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~  566 (625)
                      +...+..+.+|+.+||+.+|++||+     +.++++
T Consensus       225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         225 SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            3344566889999999999999999     667665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=8.3e-37  Score=306.19  Aligned_cols=251  Identities=21%  Similarity=0.273  Sum_probs=204.8

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      +|+..+.||+|+||.||.++.. +++.+++|++...  .......+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            5888999999999999999854 6889999988654  345567789999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+++.... ...+++..+..++.+++.+|.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999886543 345899999999999999999999775   99999999999999999999999999987644332


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                       ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+......    ... .......         ....
T Consensus       157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~----~~~-~~~~~~~---------~~~~  221 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL----NLV-VKIVQGN---------YTPV  221 (256)
T ss_pred             -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH----HHH-HHHHcCC---------CCCC
Confidence             223456899999999998888999999999999999999999886432111    111 1111111         1112


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHML  568 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  568 (625)
                      +...+..+.+++.+||+.+|++||++.++++.+
T Consensus       222 ~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         222 VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            244567789999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.8e-37  Score=311.56  Aligned_cols=253  Identities=23%  Similarity=0.331  Sum_probs=198.0

Q ss_pred             HHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeC------
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEG------  366 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~------  366 (625)
                      .+.+.|++.+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++++ +||||+++++.+...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35677888999999999999999965 68889999886543 2345788999999998 699999999998753      


Q ss_pred             CeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccc
Q 042149          367 PESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGL  446 (625)
Q Consensus       367 ~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgl  446 (625)
                      ...++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence            46899999999999999886532 234889999999999999999999775   99999999999999999999999999


Q ss_pred             ceeeCCCCceeeecCCCCccccCccccc-----cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcc
Q 042149          447 ARHVAPDKTHVSTGIAGTLGYMAPEYLV-----RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN  521 (625)
Q Consensus       447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  521 (625)
                      +........ ......|++.|+|||++.     ...++.++||||||+++|||++|+.|+.......    ....... .
T Consensus       158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~----~~~~~~~-~  231 (272)
T cd06637         158 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----ALFLIPR-N  231 (272)
T ss_pred             ceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH----HHHHHhc-C
Confidence            886543222 123356899999999986     3357889999999999999999999864221110    0000000 0


Q ss_pred             ccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          522 RITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       522 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                              ......+...+..+.+++.+||+.+|++|||+.++++
T Consensus       232 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         232 --------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             --------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence                    0011112234567899999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.6e-37  Score=312.12  Aligned_cols=269  Identities=24%  Similarity=0.357  Sum_probs=206.3

Q ss_pred             cCccccccccccCceEEEEEEeC-----CCCEEEEEEeecCChH-HHHHHHHHHHHHhcCCCCceeeeeeeeee--CCee
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-----DGRNIAVKRLFFNSRQ-WVDQFFNEVNLISGIQHKNVVRLLGCSIE--GPES  369 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~  369 (625)
                      +.|++.+.||+|+||.||+|++.     +++.+|||.+...... ..+.+.+|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45778899999999999999853     3688999998765443 56789999999999999999999999877  5678


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      ++||||+++++|.+++.....  .+++..+..++.+++.||.|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            999999999999999865432  4899999999999999999999775   99999999999999999999999999987


Q ss_pred             eCCCCceee--ecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccc-hhhHHHhhhccccccc
Q 042149          450 VAPDKTHVS--TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSV-LHTVWKHYKANRITQS  526 (625)
Q Consensus       450 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~  526 (625)
                      .........  ....++..|+|||.+.+..++.++||||||+++|||+||+.|+......... ............+.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            653322111  1234556799999998889999999999999999999999875432211100 0000000000111111


Q ss_pred             cCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       527 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      +........+..++.++.+++.+||+.+|++|||+.||+++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            111222222344567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.2e-36  Score=309.16  Aligned_cols=248  Identities=23%  Similarity=0.366  Sum_probs=204.0

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ..|+..++||+|+||.||+|.+. ++..||||.+.... ......+.+|+.+++++.||||+++++.+.++...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35777889999999999999975 58899999887543 45567899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+++..    ..+++.+...++.+++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            999999998853    23788999999999999999999765   99999999999999999999999999977644332


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                       ......++..|+|||++.+..++.++|+||||+++|||++|+.|+.......              ....+........
T Consensus       157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------------~~~~~~~~~~~~~  221 (277)
T cd06640         157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR--------------VLFLIPKNNPPTL  221 (277)
T ss_pred             -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--------------HhhhhhcCCCCCC
Confidence             1223467889999999988889999999999999999999998864322110              0011111122233


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      +...+..+.+++.+||+.+|++||++.+++..
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            55677889999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.3e-37  Score=308.66  Aligned_cols=252  Identities=27%  Similarity=0.404  Sum_probs=199.3

Q ss_pred             ccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHH--HHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          300 FDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVD--QFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      |++.+.||+|+||+||+++.+ +++.+|+|++.........  ...+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            678899999999999999976 5668999999877544332  3456999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      ++++|.+++...   ..+++..+..++.|+++||.+||+.+   ++|+||||+||++++++.++|+|||.+...... ..
T Consensus        81 ~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~~  153 (260)
T PF00069_consen   81 PGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-NE  153 (260)
T ss_dssp             TTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST-TS
T ss_pred             cccccccccccc---cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cc
Confidence            999999999732   34899999999999999999999875   999999999999999999999999999865222 22


Q ss_pred             eeecCCCCccccCccccc-cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLV-RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                      ......+++.|+|||++. +...+.++||||||+++|+|++|..|+...... +......+. ........   ..   .
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~-~~~~~~~~~-~~~~~~~~---~~---~  225 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD-DQLEIIEKI-LKRPLPSS---SQ---Q  225 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH-HHHHHHHHH-HHTHHHHH---TT---S
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccch-hhhhhhhhc-cccccccc---cc---c
Confidence            333567899999999998 788999999999999999999999887543100 111111111 00000000   00   0


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .......+.+++.+||+.+|++||++.++++
T Consensus       226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  226 SREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111378999999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=7e-38  Score=293.46  Aligned_cols=251  Identities=24%  Similarity=0.328  Sum_probs=205.9

Q ss_pred             HHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--------ChHHHHHHHHHHHHHhcC-CCCceeeeeeee
Q 042149          294 ERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--------SRQWVDQFFNEVNLISGI-QHKNVVRLLGCS  363 (625)
Q Consensus       294 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~  363 (625)
                      +..-..|+..+.||.|..++|-+..++ +|++.|+|++...        ..+..+.-.+|+.||+++ -||+|+++.+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            344567888889999999999998865 7899999988532        133455667899999999 599999999999


Q ss_pred             eeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEee
Q 042149          364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIAD  443 (625)
Q Consensus       364 ~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~D  443 (625)
                      +.+...++|+|.|+.|.|-|+|...-.   +++++..+|++|+.+|++|||..   +|+||||||+|||+|++.++||+|
T Consensus        93 es~sF~FlVFdl~prGELFDyLts~Vt---lSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTSKVT---LSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhhhee---ecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEec
Confidence            999999999999999999999965554   89999999999999999999966   599999999999999999999999


Q ss_pred             cccceeeCCCCceeeecCCCCccccCcccccc------CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHh
Q 042149          444 FGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR------GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKH  517 (625)
Q Consensus       444 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~  517 (625)
                      ||++..+..+...  ...+|||+|+|||.+..      ..|+..+|+|++|+|+|-||.|-+||.             ..
T Consensus       167 FGFa~~l~~GekL--relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw-------------HR  231 (411)
T KOG0599|consen  167 FGFACQLEPGEKL--RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW-------------HR  231 (411)
T ss_pred             cceeeccCCchhH--HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh-------------HH
Confidence            9999988765543  45799999999999853      357889999999999999999999863             11


Q ss_pred             hhccccccccCCC---CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          518 YKANRITQSMDPG---LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       518 ~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                       +..-+..+|-.+   ...+.-.+.+....+||.+||+.||.+|.|.+|++.
T Consensus       232 -kQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  232 -KQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             -HHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence             011111112111   122234567788999999999999999999999885

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5.7e-37  Score=316.59  Aligned_cols=262  Identities=24%  Similarity=0.328  Sum_probs=197.7

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ++|.+.++||+|+||.||+|+.+ +++.||+|++.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56899999999999999999975 67889999986543 22334677899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++ +|.+++....  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        86 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            975 7777765432  34788999999999999999999775   99999999999999999999999999876543222


Q ss_pred             eeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchh----------hHHHhhhccccc
Q 042149          456 HVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLH----------TVWKHYKANRIT  524 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~----------~~~~~~~~~~~~  524 (625)
                      . .....+++.|+|||++.+ ..++.++||||||+++|||+||+.|+......+....          ..|..+......
T Consensus       160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         160 T-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             c-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence            1 223467899999999865 4688999999999999999999988754332111100          011111110000


Q ss_pred             cccC-CCCCC----CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          525 QSMD-PGLTG----RFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       525 ~~i~-~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ...+ +....    ......+..+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000 00000    011234567889999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.7e-37  Score=308.86  Aligned_cols=248  Identities=29%  Similarity=0.456  Sum_probs=200.3

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---------hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCe
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---------RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPE  368 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  368 (625)
                      +|.+.+.||+|++|.||+|... +++.+|+|.+....         .+..+.+.+|+.++++++||||+++++++.++..
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4778889999999999999864 57899999886432         1234678899999999999999999999999999


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      .++||||+++++|.+++....   .+++..+..++.+++.||.|||+.+   ++||||+|+||++++++.++|+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            999999999999999986443   3788999999999999999999775   9999999999999999999999999988


Q ss_pred             eeCCCCce-----eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccc
Q 042149          449 HVAPDKTH-----VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRI  523 (625)
Q Consensus       449 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  523 (625)
                      ........     ......|+..|+|||.+.+..++.++||||||+++|+|++|+.|+.......    ....      +
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~------~  224 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ----AIFK------I  224 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH----HHHH------H
Confidence            76422111     1113458899999999988889999999999999999999999875322110    0110      0


Q ss_pred             ccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          524 TQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       524 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ..    ......+...+..+.+++.+||+.+|++||++.||++
T Consensus       225 ~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         225 GE----NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             hc----cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            00    1122234456678899999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.7e-37  Score=312.75  Aligned_cols=248  Identities=24%  Similarity=0.371  Sum_probs=200.9

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      +.|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+.++++++||||+++++.+..++..++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            34667788999999999999865 57889999886543 44567889999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+++..    ..+++..+..++.++++||.|||+.+   ++|+||+|+||++++++.++|+|||++........
T Consensus        84 ~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          84 LGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             cCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            999999988743    34889999999999999999999775   99999999999999999999999999876543322


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                      . .....++..|+|||++.+..++.++||||||+++|||++|+.|+....... ..             ..+........
T Consensus       157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~-------------~~~~~~~~~~~  221 (277)
T cd06642         157 K-RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-VL-------------FLIPKNSPPTL  221 (277)
T ss_pred             h-hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-HH-------------hhhhcCCCCCC
Confidence            1 123468889999999998889999999999999999999998864221110 00             00111111122


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      +...+..+.+++.+||+.+|++||++.++++.
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            33456778999999999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1e-36  Score=305.63  Aligned_cols=249  Identities=23%  Similarity=0.283  Sum_probs=201.2

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeee-CCeeEEEEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE-GPESLLVYE  374 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lV~e  374 (625)
                      .|++.+.||+|++|.||++..+ +++.+|+|++...  .....+.+.+|++++++++|||++++++.+.. +..+++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4888999999999999999965 5788999998653  33455678999999999999999999998764 446899999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+++++|.+++.... ...+++.++..++.+++.+|.+||+.+   ++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            999999999886532 334899999999999999999999775   9999999999999999999999999998764332


Q ss_pred             ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          455 THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                      . ......+++.|+|||++.+..++.++||||||+++++|++|+.|+...+..    . .........         ...
T Consensus       157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~----~-~~~~~~~~~---------~~~  221 (257)
T cd08223         157 D-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN----S-LVYRIIEGK---------LPP  221 (257)
T ss_pred             C-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH----H-HHHHHHhcC---------CCC
Confidence            2 223356899999999999999999999999999999999999886432211    1 111111111         112


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .+...+..+.+++.+||+.+|++||++.++++
T Consensus       222 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         222 MPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            24456678999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-38  Score=324.93  Aligned_cols=247  Identities=27%  Similarity=0.391  Sum_probs=213.9

Q ss_pred             ccccccccCceEEEEEEeC--CCC--EEEEEEeecCChH-HHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          302 NSRKLGQGGAGSVFRGTLP--DGR--NIAVKRLFFNSRQ-WVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       302 ~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      ..++||+|.||+|++|.|.  .|+  .||||.+...... ....|.+|+.+|-+|+|||++++||+..+ ....+|||++
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            3568999999999999986  344  5799999765433 67899999999999999999999999887 7889999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      +.|+|.+.|+. .....+-......++.|||.||.||..++   +|||||...||||-....|||+||||.+.+......
T Consensus       193 plGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~  268 (1039)
T KOG0199|consen  193 PLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM  268 (1039)
T ss_pred             ccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence            99999999987 44455888889999999999999999775   999999999999998889999999999988765544


Q ss_pred             eee--cCCCCccccCccccccCcccccCcEEeehhhhHHHHhCC-CCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          457 VST--GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR-RNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       457 ~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                      ...  ...-...|+|||.+...+++.++|||+|||++|||+|+. .|              |.......+.+.||.+-+.
T Consensus       269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEeP--------------W~G~~g~qIL~~iD~~erL  334 (1039)
T KOG0199|consen  269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEP--------------WVGCRGIQILKNIDAGERL  334 (1039)
T ss_pred             eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCC--------------CCCCCHHHHHHhccccccC
Confidence            322  334567899999999999999999999999999999965 34              6677777788888877777


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      +.|..+++++++++..||..+|++|||+..|.+.
T Consensus       335 pRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             CCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            7899999999999999999999999999999743

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=9.2e-37  Score=313.18  Aligned_cols=250  Identities=24%  Similarity=0.393  Sum_probs=204.6

Q ss_pred             hcCccccccccccCceEEEEEEe-CCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ..+|.+.++||+|+||.||+|+. .+++.||+|.+........+.+.+|+.+++.++||||+++++.+......++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            36789999999999999999996 47899999999776655567789999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+++..    ..+++.++..++.+++.+|.|||+.+   ++||||||+|||++.++.++|+|||++........
T Consensus        98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            999999998843    23788999999999999999999775   99999999999999999999999999876543322


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                      . .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.|+..........    ....        ........
T Consensus       171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~----~~~~--------~~~~~~~~  237 (297)
T cd06656         171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY----LIAT--------NGTPELQN  237 (297)
T ss_pred             C-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee----eecc--------CCCCCCCC
Confidence            2 223468899999999988889999999999999999999999874322111100    0000        00001112


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      +...+..+.+++.+||+.+|++||++.++++
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            3445667889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1e-36  Score=305.35  Aligned_cols=249  Identities=27%  Similarity=0.419  Sum_probs=203.3

Q ss_pred             cCccccccccccCceEEEEEEeCC-CCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      ++|++.++||+|+||.||+|.+.+ ++.+++|.+.....  .+.+.+|++++++++||||+++++.+.+....++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578899999999999999999764 78999999865433  678999999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      ++++|.+++....  ..+++..+..++.+++.||.|||+.+   ++||||+|+||++++++.++|+|||++........ 
T Consensus        81 ~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          81 GAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             CCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            9999999885433  34899999999999999999999775   99999999999999999999999999887654332 


Q ss_pred             eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP  536 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  536 (625)
                      ......++..|+|||++.+..++.++||||||+++|+|++|+.|+..........     ....       ........+
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-----~~~~-------~~~~~~~~~  222 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-----MIPN-------KPPPTLSDP  222 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-----hhcc-------CCCCCCCch
Confidence            1223457889999999988899999999999999999999999875332111100     0000       000011123


Q ss_pred             hHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          537 ENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       537 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ...+..+.+++.+||+.+|++|||+.||++
T Consensus       223 ~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         223 EKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             hhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            345677899999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1e-36  Score=307.31  Aligned_cols=250  Identities=26%  Similarity=0.412  Sum_probs=201.3

Q ss_pred             CccccccccccCceEEEEEEeCCCCEEEEEEeecCC------hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS------RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      +|.+.+.||+|+||.||+|...+++.+|||.+....      .+....+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477889999999999999998889999999886432      23346788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+++++|.+++....   .+++..+..++.|++.+|+|||+.+   |+|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999986543   3789999999999999999999775   99999999999999999999999999875432


Q ss_pred             CC-----ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccccccc
Q 042149          453 DK-----THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM  527 (625)
Q Consensus       453 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  527 (625)
                      ..     ........++..|+|||++.+..++.++||||||+++|+|++|+.|+.........     ......      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~-----~~~~~~------  223 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM-----FYIGAH------  223 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH-----HHhhhc------
Confidence            11     11122356899999999999888999999999999999999999987532211110     000000      


Q ss_pred             CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       528 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                       .......+...+..+.+++.+||+.+|++||++.++++
T Consensus       224 -~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         224 -RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             -cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             00111223445677899999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=7e-37  Score=306.51  Aligned_cols=247  Identities=28%  Similarity=0.409  Sum_probs=197.5

Q ss_pred             cCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecC
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVP  377 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~  377 (625)
                      ++|.+.+.||+|+||.||++.. +++.+|+|++....  ..+.+.+|+.++++++||||+++++++..+ ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4588899999999999999975 67889999886543  235788999999999999999999988654 5799999999


Q ss_pred             CCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCcee
Q 042149          378 NRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV  457 (625)
Q Consensus       378 ~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  457 (625)
                      +++|.+++..... ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......   
T Consensus        82 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          82 KGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            9999999865432 34889999999999999999999765   9999999999999999999999999987643221   


Q ss_pred             eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCC
Q 042149          458 STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP  536 (625)
Q Consensus       458 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  536 (625)
                       .....+..|+|||.+.++.++.++|+||||+++|||++ |+.|+..... .    .......         .......+
T Consensus       155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~----~~~~~~~---------~~~~~~~~  219 (254)
T cd05083         155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-K----EVKECVE---------KGYRMEPP  219 (254)
T ss_pred             -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-H----HHHHHHh---------CCCCCCCC
Confidence             12334678999999988899999999999999999998 7777542211 1    1111111         11111223


Q ss_pred             hHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcc
Q 042149          537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN  570 (625)
Q Consensus       537 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  570 (625)
                      ...+..+.+++.+||+.+|++||++.++++.|++
T Consensus       220 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            3456778999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-36  Score=309.65  Aligned_cols=255  Identities=23%  Similarity=0.356  Sum_probs=202.8

Q ss_pred             cCccccccccccCceEEEEEEeC-CCC----EEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGR----NIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      ++|++.+.||+|+||.||+|.++ +++    .+|+|.+.... ......+.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            56888999999999999999864 333    58999876553 4456788999999999999999999999887 78899


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||||+++++|.+++.....  .+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        86 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            9999999999998865432  3899999999999999999999765   9999999999999999999999999998765


Q ss_pred             CCCceee-ecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          452 PDKTHVS-TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       452 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      ....... ....++..|+|||.+....++.++|+||||+++|||++ |+.|+..... .+    .......         
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~----~~~~~~~---------  226 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-VE----IPDLLEK---------  226 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-HH----HHHHHhC---------
Confidence            4332221 12234578999999988889999999999999999999 8888643211 11    1111111         


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      ......+...+..+.+++.+||..+|++||++.++++.|.++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~  269 (279)
T cd05057         227 GERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA  269 (279)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            1111223344567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-36  Score=306.52  Aligned_cols=240  Identities=21%  Similarity=0.335  Sum_probs=187.2

Q ss_pred             ccccccCceEEEEEEeCC-------------CCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeE
Q 042149          304 RKLGQGGAGSVFRGTLPD-------------GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  370 (625)
                      +.||+|+||.||+|....             ...|++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532             2358889877666666678899999999999999999999999999999


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCc-------eEEee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLT-------PKIAD  443 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~-------~kl~D  443 (625)
                      +||||+++++|..++....  ..+++..++.++.||++||.|||+++   |+||||||+|||++.++.       ++++|
T Consensus        81 lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            9999999999988875432  24899999999999999999999775   999999999999986654       89999


Q ss_pred             cccceeeCCCCceeeecCCCCccccCccccc-cCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhcc
Q 042149          444 FGLARHVAPDKTHVSTGIAGTLGYMAPEYLV-RGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKAN  521 (625)
Q Consensus       444 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  521 (625)
                      ||++.......     ...++..|+|||.+. +..++.++||||||+++|||++ |..|+..... ..    . ......
T Consensus       156 ~g~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~~----~-~~~~~~  224 (262)
T cd05077         156 PGIPITVLSRQ-----ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL-AE----K-ERFYEG  224 (262)
T ss_pred             CCCCccccCcc-----cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch-hH----H-HHHHhc
Confidence            99986543221     245788999999886 4678999999999999999985 6655432111 00    0 000010


Q ss_pred             ccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHc
Q 042149          522 RITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLN  569 (625)
Q Consensus       522 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  569 (625)
                      .        ..  ........+.+|+.+||+.+|++||++.+|++.|+
T Consensus       225 ~--------~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         225 Q--------CM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             C--------cc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            0        00  01122457889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-36  Score=308.49  Aligned_cols=253  Identities=23%  Similarity=0.355  Sum_probs=202.2

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ++|++.+.||+|+||.||++.++ +++.||+|.+... .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            46888999999999999999976 7899999988654 344457889999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|..++........+++..+..++.+++.||.|||.+.  +++||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA  158 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc
Confidence            999999988865433345899999999999999999999632  599999999999999999999999999876532221


Q ss_pred             eeeecCCCCccccCccccccCc------ccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQ------LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                         ....+++.|+|||.+.+..      ++.++||||||+++|+|++|+.|+...... ..    .....     ...+ 
T Consensus       159 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~----~~~~~-----~~~~-  224 (286)
T cd06622         159 ---KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-NI----FAQLS-----AIVD-  224 (286)
T ss_pred             ---ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-hH----HHHHH-----HHhh-
Confidence               2345888999999985543      478999999999999999999987432111 10    11100     0001 


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ......+...+..+.+++.+||+.+|++||++.++++
T Consensus       225 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         225 GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            1112234456788899999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.2e-36  Score=304.99  Aligned_cols=251  Identities=31%  Similarity=0.473  Sum_probs=200.8

Q ss_pred             ccccccccccCceEEEEEEeCC-----CCEEEEEEeecCChH-HHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          300 FDNSRKLGQGGAGSVFRGTLPD-----GRNIAVKRLFFNSRQ-WVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      +++.+.||.|+||.||++++.+     +..||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567889999999999999753     378999999765433 5678999999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++++|.+++...... .+++..+..++.|++.+|.+||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            999999999988654322 2899999999999999999999775   999999999999999999999999999876544


Q ss_pred             CceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      .........+++.|+|||.+.+..++.++||||||+++++|++ |..|+... ....    .........         .
T Consensus       157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-~~~~----~~~~~~~~~---------~  222 (258)
T smart00219      157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-SNEE----VLEYLKKGY---------R  222 (258)
T ss_pred             cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-CHHH----HHHHHhcCC---------C
Confidence            3222222347789999999988889999999999999999999 55554321 1111    111111111         1


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHML  568 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  568 (625)
                      ...+...+.++.+++.+||..+|++|||+.|+++.|
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            122334577899999999999999999999999764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.7e-36  Score=306.37  Aligned_cols=254  Identities=22%  Similarity=0.337  Sum_probs=201.0

Q ss_pred             CccccccccccCceEEEEEEeCC--CCEEEEEEeecC----------ChHHHHHHHHHHHHHhc-CCCCceeeeeeeeee
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLPD--GRNIAVKRLFFN----------SRQWVDQFFNEVNLISG-IQHKNVVRLLGCSIE  365 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~  365 (625)
                      +|++.+.||+|+||.||+|.++.  ++.+|+|.+...          .......+.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788899999999999999764  688999987532          23345667889998875 799999999999999


Q ss_pred             CCeeEEEEEecCCCCcchhhhcc-CCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeec
Q 042149          366 GPESLLVYEYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADF  444 (625)
Q Consensus       366 ~~~~~lV~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Df  444 (625)
                      ++..++||||+++++|.+++... .....+++..++.++.|++.+|.|||...  +++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999887532 23345889999999999999999999632  5999999999999999999999999


Q ss_pred             ccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccc
Q 042149          445 GLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRIT  524 (625)
Q Consensus       445 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  524 (625)
                      |++.......  ......++..|+|||.+.++.++.++||||||+++|+|++|+.|+......    . .........  
T Consensus       159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~----~-~~~~~~~~~--  229 (269)
T cd08528         159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML----S-LATKIVEAV--  229 (269)
T ss_pred             cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH----H-HHHHHhhcc--
Confidence            9998765433  223456899999999999888999999999999999999999886422110    0 011111111  


Q ss_pred             cccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHc
Q 042149          525 QSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLN  569 (625)
Q Consensus       525 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  569 (625)
                            .........+..+.+++.+||+.||++||++.|+.+++.
T Consensus       230 ------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         230 ------YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ------CCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                  000011134567899999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=7e-37  Score=309.11  Aligned_cols=250  Identities=30%  Similarity=0.425  Sum_probs=197.1

Q ss_pred             ccccccCceEEEEEEeCC-------CCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          304 RKLGQGGAGSVFRGTLPD-------GRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      +.||+|+||.||+|+.++       ++.+|||.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            469999999999998642       2578999875543 34466788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccC----CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC-----ceEEeeccc
Q 042149          376 VPNRSLDQILFVKN----TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL-----TPKIADFGL  446 (625)
Q Consensus       376 ~~~~sL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-----~~kl~Dfgl  446 (625)
                      +++++|.+++....    ....+++..+..++.+++.||.|||+.+   ++|+||||+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999986432    2234788999999999999999999775   99999999999999877     899999999


Q ss_pred             ceeeCCCCcee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccc
Q 042149          447 ARHVAPDKTHV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRIT  524 (625)
Q Consensus       447 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  524 (625)
                      ++......... .....++..|+|||++.++.++.++||||||+++|||++ |+.|+...... +    .....      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-~----~~~~~------  226 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-E----VLQHV------  226 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-H----HHHHH------
Confidence            87654322211 112345788999999999999999999999999999998 88876432211 1    11111      


Q ss_pred             cccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcc
Q 042149          525 QSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN  570 (625)
Q Consensus       525 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  570 (625)
                         ........+...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus       227 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         227 ---TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             ---hcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence               1111112244567788999999999999999999999998853

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-39  Score=302.96  Aligned_cols=246  Identities=28%  Similarity=0.397  Sum_probs=205.6

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecC
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVP  377 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~  377 (625)
                      -|.++.+||+|.||.||+|.++ .|+.+|||++...  .+++.+.+|+.||++.+.|++|++||.+.....++||||||.
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            4678889999999999999976 6999999988654  356889999999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCcee
Q 042149          378 NRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV  457 (625)
Q Consensus       378 ~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  457 (625)
                      .|+..+++..+.  +.|++.++..++...+.||+|||.   ++=||||||..|||++.+|..||+|||.+..+...... 
T Consensus       112 AGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK-  185 (502)
T KOG0574|consen  112 AGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK-  185 (502)
T ss_pred             CCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh-
Confidence            999999996554  459999999999999999999994   45899999999999999999999999999766543322 


Q ss_pred             eecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccccccc--CCCCCCCC
Q 042149          458 STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM--DPGLTGRF  535 (625)
Q Consensus       458 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i--~~~~~~~~  535 (625)
                      ...+.|||.|||||++..-.|+.++||||||++..||..|++|+..-..-              +..-+|  ++...-..
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM--------------RAIFMIPT~PPPTF~K  251 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM--------------RAIFMIPTKPPPTFKK  251 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc--------------ceeEeccCCCCCCCCC
Confidence            23478999999999999999999999999999999999999986422111              111111  11111223


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      |+.-+.++.+++.+||-++|++|-|+.++++
T Consensus       252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            6777889999999999999999999877765

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1e-36  Score=312.68  Aligned_cols=249  Identities=25%  Similarity=0.438  Sum_probs=203.6

Q ss_pred             cCccccccccccCceEEEEEEe-CCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      .+|++.+.||.|++|.||+|+. .+++.|+||.+........+.+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4689999999999999999986 478999999997665555678899999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      ++++|.+++...    .+++.++..++.+++.+|.|||+.+   ++||||||+||+++.++.+||+|||++.........
T Consensus        99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  171 (296)
T cd06655          99 AGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK  171 (296)
T ss_pred             CCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence            999999988432    3899999999999999999999775   999999999999999999999999998765443221


Q ss_pred             eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP  536 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  536 (625)
                       .....+++.|+|||.+.+..++.++||||||+++|+|++|+.|+.........    .. ......     +.  ...+
T Consensus       172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~----~~-~~~~~~-----~~--~~~~  238 (296)
T cd06655         172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL----YL-IATNGT-----PE--LQNP  238 (296)
T ss_pred             -CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HH-HHhcCC-----cc--cCCc
Confidence             22346889999999998888999999999999999999999887433221110    00 000000     00  1123


Q ss_pred             hHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          537 ENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       537 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ...+..+.+++.+||+.+|++||++.+|++
T Consensus       239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            345667889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.3e-36  Score=310.42  Aligned_cols=260  Identities=23%  Similarity=0.286  Sum_probs=192.4

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcC---CCCceeeeeeeeee-----CC
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGI---QHKNVVRLLGCSIE-----GP  367 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~-----~~  367 (625)
                      +|++.+.||+|+||+||+|+++ +++.||+|.+....  ......+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4888999999999999999975 68899999886432  22223456677777665   69999999998764     34


Q ss_pred             eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccc
Q 042149          368 ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA  447 (625)
Q Consensus       368 ~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla  447 (625)
                      ..++||||+++ +|.+++.... ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            57999999975 7877775433 234899999999999999999999775   999999999999999999999999999


Q ss_pred             eeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhh---ccccc
Q 042149          448 RHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK---ANRIT  524 (625)
Q Consensus       448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~---~~~~~  524 (625)
                      +.......  .....+++.|+|||++.+..++.++|||||||++|||++|++|+....... ..........   ...+.
T Consensus       156 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         156 RIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             ccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhCCCChhhCc
Confidence            86643221  223568999999999998899999999999999999999998864332211 1111111100   00000


Q ss_pred             c-------ccCCCCC---CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          525 Q-------SMDPGLT---GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       525 ~-------~i~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .       ...+...   ....+..+..+.+++.+||+.||++|||+.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0       0000000   0111234567889999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.8e-36  Score=303.94  Aligned_cols=253  Identities=26%  Similarity=0.345  Sum_probs=191.0

Q ss_pred             ccccccCceEEEEEEeC---CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCC
Q 042149          304 RKLGQGGAGSVFRGTLP---DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNR  379 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~  379 (625)
                      +.||+|+||.||+|...   ++..+|+|++.... ......+.+|+.++++++||||+++++.+.+....++||||++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            46999999999999854   34678999886543 334457889999999999999999999999999999999999999


Q ss_pred             CcchhhhccCC--cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCcee
Q 042149          380 SLDQILFVKNT--IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV  457 (625)
Q Consensus       380 sL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  457 (625)
                      +|.+++.....  ....++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999865322  223667788899999999999999775   9999999999999999999999999987543332211


Q ss_pred             -eecCCCCccccCccccccC-------cccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          458 -STGIAGTLGYMAPEYLVRG-------QLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       458 -~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                       .....+++.|+|||++...       .++.++||||||+++|||++ |+.|+....... .    .............+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-~----~~~~~~~~~~~~~~  232 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ-V----LTYTVREQQLKLPK  232 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH-H----HHHHhhcccCCCCC
Confidence             1234578899999998542       35789999999999999996 988875332211 1    11101111111111


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHc
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLN  569 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  569 (625)
                      +..    ....+..+.+++.+|| .+|++|||++||+..|+
T Consensus       233 ~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         233 PRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             Ccc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            111    1223456788999999 58999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.3e-36  Score=309.89  Aligned_cols=263  Identities=22%  Similarity=0.313  Sum_probs=198.1

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      +|++.+.||+|++|.||+|+.+ ++..||||++...  .....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999999975 6899999988643  223346788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      ++ ++|.+++........+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 588887765444456899999999999999999999775   99999999999999999999999999876543221


Q ss_pred             eeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchh----------hHHHhhhccc-c
Q 042149          456 HVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLH----------TVWKHYKANR-I  523 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~----------~~~~~~~~~~-~  523 (625)
                       ......+++.|+|||++.+. .++.++||||||+++|+|+||+.|+...........          ..|....... .
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
T cd07861         157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY  235 (285)
T ss_pred             -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence             12234578899999988654 578899999999999999999988753321111100          0011000000 0


Q ss_pred             ccccCC---CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          524 TQSMDP---GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       524 ~~~i~~---~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ......   ..........+.++.+++.+||+.||++|||+.+|++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000000   0000111234667889999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.5e-36  Score=320.91  Aligned_cols=260  Identities=25%  Similarity=0.323  Sum_probs=195.8

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC------
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG------  366 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------  366 (625)
                      ..++|++.+.||+|+||.||++... .++.||||++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4578999999999999999999965 6889999998643  334456788999999999999999999987543      


Q ss_pred             CeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccc
Q 042149          367 PESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGL  446 (625)
Q Consensus       367 ~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgl  446 (625)
                      ...++||||+++ +|.+.+..     .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence            357999999965 66665532     2788899999999999999999775   99999999999999999999999999


Q ss_pred             ceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHH----------
Q 042149          447 ARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWK----------  516 (625)
Q Consensus       447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~----------  516 (625)
                      ++......  ......+|+.|+|||++.+..++.++|||||||++|||++|+.||........ ......          
T Consensus       173 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~  249 (364)
T cd07875         173 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFM  249 (364)
T ss_pred             ccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHH
Confidence            98654322  22345789999999999999999999999999999999999998754321111 000000          


Q ss_pred             -hhh-------ccc-------cccccCCCC---CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          517 -HYK-------ANR-------ITQSMDPGL---TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       517 -~~~-------~~~-------~~~~i~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                       ...       ...       ..+......   ...........+.+++.+||+.||++|||+.|+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence             000       000       000000000   001111234568899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.7e-36  Score=303.91  Aligned_cols=249  Identities=21%  Similarity=0.286  Sum_probs=202.6

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      +|++.++||+|+||.||++... +++.+|+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4888999999999999999864 6899999998643  334456889999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+.+.... ...+++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            99999999886432 234789999999999999999999775   99999999999999999999999999976543322


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                      . .....|++.|+|||++.++.++.++|+||||+++++|++|+.|+......    ... .....+         .....
T Consensus       157 ~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~----~~~-~~~~~~---------~~~~~  221 (256)
T cd08218         157 L-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK----NLV-LKIIRG---------SYPPV  221 (256)
T ss_pred             h-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH----HHH-HHHhcC---------CCCCC
Confidence            1 12345888999999998888999999999999999999999886432111    001 111111         11122


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      +...+..+.+++.+||+.+|++||++.+|++
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            4455677999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-36  Score=309.53  Aligned_cols=257  Identities=24%  Similarity=0.343  Sum_probs=203.0

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ++|++.++||+|+||+||+++.. +++.||+|++.... ....+.+.+|+++++.++||||+++++.+...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56888899999999999999965 68899999886543 44567889999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+++...+   .+++..+..++.+++.+|.|||+..  +++||||||+||++++++.++|+|||++........
T Consensus        85 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~  159 (284)
T cd06620          85 MDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA  159 (284)
T ss_pred             CCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc
Confidence            99999999875433   3899999999999999999999632  599999999999999999999999999865432211


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccc---hhhHHHhhhccccccccCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSV---LHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                         ....|+..|+|||++.++.++.++||||||+++|+|++|+.|+.........   .......     ....+.... 
T Consensus       160 ---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~-  230 (284)
T cd06620         160 ---DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL-----LQQIVQEPP-  230 (284)
T ss_pred             ---CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHH-----HHHHhhccC-
Confidence               2356899999999998889999999999999999999999997643221100   0000000     000111000 


Q ss_pred             CCCC-hHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042149          533 GRFP-ENEASRVLQIGLLCTQAPVALRPSMAEVVHML  568 (625)
Q Consensus       533 ~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  568 (625)
                      ...+ ...+..+.+++.+||+.+|++|||+.|++++.
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            1111 22556789999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-37  Score=316.79  Aligned_cols=253  Identities=25%  Similarity=0.393  Sum_probs=216.2

Q ss_pred             ccccccccccCceEEEEEEeC---CCC--EEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          300 FDNSRKLGQGGAGSVFRGTLP---DGR--NIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~---~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      -...++||+|.||.||+|+..   .|.  .||||..+.+ +.+..+.|..|..+|+.++|||||+++|+|.+ ...+|||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wivm  469 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVM  469 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEE
Confidence            345678999999999999842   333  4788988763 55668899999999999999999999999875 5689999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      |.++-|.|..+|+.+.  ..++......++.||+.+|.|||+.   ++|||||...||||.....|||+|||+++.+..+
T Consensus       470 EL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  470 ELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             ecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            9999999999996554  3488889999999999999999976   5999999999999999999999999999998776


Q ss_pred             CceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      .....+...-...|||||.+.-..++.++|||-|||.+||++. |.+||              ...++.++.-.+..+-+
T Consensus       545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPf--------------qgvkNsDVI~~iEnGeR  610 (974)
T KOG4257|consen  545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPF--------------QGVKNSDVIGHIENGER  610 (974)
T ss_pred             chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcc--------------ccccccceEEEecCCCC
Confidence            6555555556779999999999999999999999999999987 77774              44455555556667777


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      .+.|++++..|..|+.+||..+|.+||.+.|+...|.++.
T Consensus       611 lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~  650 (974)
T KOG4257|consen  611 LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL  650 (974)
T ss_pred             CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence            7889999999999999999999999999999988776653

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=309.57  Aligned_cols=253  Identities=25%  Similarity=0.322  Sum_probs=203.7

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      .++|++.++||+|+||.||+|.+. ++..+|+|.+........+.+.+|++++++++||||+++++.+......++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            457889999999999999999975 6889999999877777778899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+++....  ..+++..+..++.|++.+|.|||+.+   |+|+||||+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            99999999886533  24899999999999999999999775   99999999999999999999999998865433222


Q ss_pred             eeeecCCCCccccCcccccc-----CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVR-----GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                      . .....+++.|+|||.+..     ..++.++||||||+++|||++|+.|+........     ........     .+.
T Consensus       159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~-----~~~  227 (280)
T cd06611         159 K-RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV-----LLKILKSE-----PPT  227 (280)
T ss_pred             c-cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH-----HHHHhcCC-----CCC
Confidence            1 223468999999999753     3467899999999999999999988643221110     11111110     000


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                        ...+...+..+.+++.+||+.+|++||++.++++.
T Consensus       228 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         228 --LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             --cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence              11133455678899999999999999999999863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.4e-36  Score=320.49  Aligned_cols=260  Identities=25%  Similarity=0.323  Sum_probs=195.4

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC-----
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP-----  367 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----  367 (625)
                      ..++|++.+.||+|+||.||+++.. +++.||||++...  .......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999999965 6899999998643  3344567889999999999999999999886543     


Q ss_pred             -eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccc
Q 042149          368 -ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGL  446 (625)
Q Consensus       368 -~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgl  446 (625)
                       ..++||||+++ +|.+.+..     .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence             47999999975 45554421     2788889999999999999999775   99999999999999999999999999


Q ss_pred             ceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHh---------
Q 042149          447 ARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKH---------  517 (625)
Q Consensus       447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~---------  517 (625)
                      ++......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.|+...+.... .......         
T Consensus       170 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~  246 (359)
T cd07876         170 ARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ-WNKVIEQLGTPSAEFM  246 (359)
T ss_pred             ccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCcHHHH
Confidence            97643322  12335789999999999999999999999999999999999998754321110 0000000         


Q ss_pred             ---------hhccc-------cccccCCCC---CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          518 ---------YKANR-------ITQSMDPGL---TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       518 ---------~~~~~-------~~~~i~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                               +....       ..+......   ...........+.+++.+||+.||++|||+.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                     00000       000000000   000111234668899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.6e-36  Score=307.68  Aligned_cols=239  Identities=23%  Similarity=0.345  Sum_probs=186.3

Q ss_pred             cccccCceEEEEEEeCC-------------------------CCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeee
Q 042149          305 KLGQGGAGSVFRGTLPD-------------------------GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRL  359 (625)
Q Consensus       305 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l  359 (625)
                      +||+|+||.||+|.+..                         ...|++|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997421                         13578998876655556788999999999999999999


Q ss_pred             eeeeeeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC--
Q 042149          360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL--  437 (625)
Q Consensus       360 ~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~--  437 (625)
                      ++++.+.+..++||||+++++|..++....  ..+++..+..++.||++||+|||+++   |+||||||+|||++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            999999999999999999999998885432  34889999999999999999999775   99999999999997543  


Q ss_pred             -----ceEEeecccceeeCCCCceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHH-hCCCCCCCCCCCccc
Q 042149          438 -----TPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVA-SGRRNSVFSEGSSSV  510 (625)
Q Consensus       438 -----~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~ell-tG~~p~~~~~~~~~~  510 (625)
                           .+|++|||++.......     ...++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+..... ...
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~  230 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP-SEK  230 (274)
T ss_pred             cCccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh-HHH
Confidence                 48999999876432221     2357788999998865 56899999999999999995 67777543211 111


Q ss_pred             hhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHc
Q 042149          511 LHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLN  569 (625)
Q Consensus       511 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  569 (625)
                      .. .   ...         ..  ..+......+.+++.+||+.+|++|||+.+|++.|.
T Consensus       231 ~~-~---~~~---------~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 ER-F---YEK---------KH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HH-H---HHh---------cc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            00 0   000         00  011222356889999999999999999999998773

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.3e-36  Score=342.36  Aligned_cols=260  Identities=22%  Similarity=0.320  Sum_probs=201.3

Q ss_pred             HHHHHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeee--
Q 042149          291 EILERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE--  365 (625)
Q Consensus       291 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--  365 (625)
                      ...+...++|+++++||+|+||+||+|.+. ++..+|+|.+...  .......+..|+.+|++|+|||||+++++|.+  
T Consensus         6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA   85 (1021)
T ss_pred             cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence            334455678999999999999999999975 5778899988643  34456788999999999999999999998864  


Q ss_pred             CCeeEEEEEecCCCCcchhhhcc-CCcCCCCHHHHHHHHHHHHHHHHHhhcCCC----ceEEEeeeccCcEEEcC-----
Q 042149          366 GPESLLVYEYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGGSG----IKIIHRDIKTSNILLDE-----  435 (625)
Q Consensus       366 ~~~~~lV~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~----~~iiHrDlkp~NIll~~-----  435 (625)
                      ...++|||||+++++|.++|... .....+++..++.|+.||+.||.|||..+.    .+||||||||+||||+.     
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            35689999999999999988643 222358999999999999999999997431    35999999999999964     


Q ss_pred             ------------CCceEEeecccceeeCCCCceeeecCCCCccccCcccccc--CcccccCcEEeehhhhHHHHhCCCCC
Q 042149          436 ------------KLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR--GQLTEKADVYAFGVLVIEVASGRRNS  501 (625)
Q Consensus       436 ------------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~ll~elltG~~p~  501 (625)
                                  .+.+||+|||++..+.....  .....||+.|+|||++.+  ..++.++||||||||+|||+||+.||
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF  243 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF  243 (1021)
T ss_pred             ccccccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence                        34589999999986543222  233579999999999864  45889999999999999999999997


Q ss_pred             CCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          502 VFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .......    .........       +.+.   ....+..+.+||..||+.+|++||++.|++.
T Consensus       244 ~~~~~~~----qli~~lk~~-------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        244 HKANNFS----QLISELKRG-------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CcCCcHH----HHHHHHhcC-------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            5322111    111111111       0010   1223567899999999999999999999984

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.2e-37  Score=308.30  Aligned_cols=241  Identities=24%  Similarity=0.385  Sum_probs=190.6

Q ss_pred             ccccccCceEEEEEEeCC--------CCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          304 RKLGQGGAGSVFRGTLPD--------GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      +.||+|+||.||+|..+.        ...+++|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            369999999999998642        234888888666666677899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCc--------eEEeecccc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLT--------PKIADFGLA  447 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~--------~kl~Dfgla  447 (625)
                      +++++|.+++.....  .+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            999999999865432  4889999999999999999999775   999999999999987654        699999988


Q ss_pred             eeeCCCCceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccc
Q 042149          448 RHVAPDKTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS  526 (625)
Q Consensus       448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (625)
                      ......     ....+++.|+|||++.+. .++.++||||||+++|||++|..++.........     ......     
T Consensus       156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-----~~~~~~-----  220 (258)
T cd05078         156 ITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-----LQFYED-----  220 (258)
T ss_pred             cccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-----HHHHHc-----
Confidence            654322     124578899999999764 5789999999999999999996543221111100     000000     


Q ss_pred             cCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHc
Q 042149          527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLN  569 (625)
Q Consensus       527 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  569 (625)
                           ....+.....++.+++.+||+.+|++|||++++++.|+
T Consensus       221 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 -----RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -----cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                 11123334567899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.8e-36  Score=303.46  Aligned_cols=249  Identities=25%  Similarity=0.371  Sum_probs=195.8

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC-----ChHHHHHHHHHHHHHhcCCCCceeeeeeeeee--CCee
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN-----SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE--GPES  369 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~  369 (625)
                      .+|+..+.||+|+||.||+|... +++.|++|++...     ..+....+.+|+.++++++||||+++++++.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36888999999999999999965 6899999988643     23445678999999999999999999998875  3578


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      +++|||+++++|.+++....   .+++...+.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            89999999999999886543   3789999999999999999999765   99999999999999999999999999876


Q ss_pred             eCCCCc--eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccccccc
Q 042149          450 VAPDKT--HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM  527 (625)
Q Consensus       450 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  527 (625)
                      ......  .......++..|+|||.+.+..++.++||||||+++|||++|+.|+.......    ...         +..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~----~~~---------~~~  222 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA----AIF---------KIA  222 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH----HHH---------HHh
Confidence            532111  11123458899999999988889999999999999999999999864321110    000         011


Q ss_pred             CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       528 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ........+......+..++ +||..+|++||+++||++
T Consensus       223 ~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         223 TQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             cCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            11111223444556677777 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.2e-36  Score=313.28  Aligned_cols=196  Identities=25%  Similarity=0.365  Sum_probs=158.9

Q ss_pred             cccccccCceEEEEEEeC---CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeee--CCeeEEEEEecC
Q 042149          303 SRKLGQGGAGSVFRGTLP---DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE--GPESLLVYEYVP  377 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lV~e~~~  377 (625)
                      .++||+|+||+||+|+.+   +++.+|+|.+....  ....+.+|+.++++++||||+++++.+..  +...++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999864   46789999886442  23457789999999999999999998854  456899999985


Q ss_pred             CCCcchhhhccC------CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE----cCCCceEEeecccc
Q 042149          378 NRSLDQILFVKN------TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL----DEKLTPKIADFGLA  447 (625)
Q Consensus       378 ~~sL~~~l~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll----~~~~~~kl~Dfgla  447 (625)
                       ++|.+++....      ....+++..+..++.||+.||.|||+++   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             47777664221      1234889999999999999999999775   9999999999999    45678999999999


Q ss_pred             eeeCCCCce--eeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCC
Q 042149          448 RHVAPDKTH--VSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFS  504 (625)
Q Consensus       448 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~  504 (625)
                      +........  ......||+.|+|||++.+ ..++.++|||||||++|||++|++|+...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            876533221  1234578999999999877 45899999999999999999999987543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.4e-36  Score=314.44  Aligned_cols=256  Identities=17%  Similarity=0.223  Sum_probs=193.8

Q ss_pred             cccccccc--CceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          302 NSRKLGQG--GAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       302 ~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      ++++||+|  +|++||+++.+ +|+.||||++...  .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            46789999  78999999864 7899999998654  3445567888999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      ++++|.+++..... ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+++.||+...........
T Consensus        82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            99999998854322 23889999999999999999999775   999999999999999999999999865433211110


Q ss_pred             ------eeecCCCCccccCcccccc--CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccccccc-
Q 042149          457 ------VSTGIAGTLGYMAPEYLVR--GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM-  527 (625)
Q Consensus       457 ------~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i-  527 (625)
                            ......++..|+|||++.+  ..++.++|||||||++|||++|+.|+...........    . ....+...+ 
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~----~-~~~~~~~~~~  232 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE----K-LNGTVPCLLD  232 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHH----H-hcCCcccccc
Confidence                  0112346778999999876  4688999999999999999999999753221111000    0 000000000 


Q ss_pred             ------------------CC-----------------CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          528 ------------------DP-----------------GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       528 ------------------~~-----------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                                        +.                 ....+.....+..+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                              00                 0001112234567899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.2e-36  Score=304.07  Aligned_cols=254  Identities=24%  Similarity=0.364  Sum_probs=204.1

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeee--CCeeEEEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE--GPESLLVY  373 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lV~  373 (625)
                      +|++.+.||.|+||.||++... +++.+|+|.+...  .....+.+.+|+.++++++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788899999999999999864 6889999988653  34456678899999999999999999997764  45679999


Q ss_pred             EecCCCCcchhhhcc-CCcCCCCHHHHHHHHHHHHHHHHHhhcCC--CceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          374 EYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGGS--GIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       374 e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      ||+++++|.+++... .....+++..++.++.+++.||.|||..+  ..+++|+||||+||++++++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999988643 22345899999999999999999999332  335999999999999999999999999999876


Q ss_pred             CCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          451 APDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                      ...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.|+.....     ....+..         ...
T Consensus       161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~---------~~~  225 (265)
T cd08217         161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-----LQLASKI---------KEG  225 (265)
T ss_pred             cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-----HHHHHHH---------hcC
Confidence            544321 2235689999999999888899999999999999999999998753321     1111111         111


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      .....+...+..+.+++.+||+.+|++||++.+|++.
T Consensus       226 ~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         226 KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            2223455667889999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-36  Score=324.55  Aligned_cols=259  Identities=24%  Similarity=0.283  Sum_probs=194.4

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ...|.+.++||+|+||.||+|++. .++.||||....      ..+.+|+++|++++|||||++++++..+...++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457999999999999999999976 578899996432      3456899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +. ++|.+++....  ..+++..++.|+.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.......
T Consensus       242 ~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            95 67877774332  24899999999999999999999775   99999999999999999999999999987643322


Q ss_pred             e-eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCC---ccchhhHHHhhhcccc-----ccc
Q 042149          456 H-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGS---SSVLHTVWKHYKANRI-----TQS  526 (625)
Q Consensus       456 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~---~~~~~~~~~~~~~~~~-----~~~  526 (625)
                      . ......||+.|+|||++.+..++.++|||||||++|||++|..++......   ................     ...
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence            1 122457999999999999999999999999999999999988764321111   0000111111110000     000


Q ss_pred             c------------CCCCCCCCC-------hHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          527 M------------DPGLTGRFP-------ENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       527 i------------~~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      .            .........       ......+.+|+.+||+.||++|||+.|+++.
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0            000000000       0223468899999999999999999999864

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.1e-36  Score=316.11  Aligned_cols=194  Identities=24%  Similarity=0.307  Sum_probs=168.7

Q ss_pred             CccccccccccCceEEEEEEe-CCCCEEEEEEeecCChHHHHHHHHHHHHHhcCC-C-----CceeeeeeeeeeCCeeEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-H-----KNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----pniv~l~~~~~~~~~~~l  371 (625)
                      +|++.+.||+|.||.|-+|.+ ++++.||||+++ +.+....+...|+.+|..|+ |     -|+|+++++|...++++|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiK-N~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIK-NKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeec-cChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            789999999999999999995 479999999885 45566778889999999997 4     379999999999999999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC--CCceEEeeccccee
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE--KLTPKIADFGLARH  449 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~--~~~~kl~Dfgla~~  449 (625)
                      |+|.+ ..+|.++|..+.- ..++...+..++.||+.+|.+||+.+   |||+||||+||||.+  ...|||+|||.+..
T Consensus       266 VfELL-~~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eehhh-hhhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence            99998 6799999975544 44999999999999999999999765   999999999999964  34799999999987


Q ss_pred             eCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCC
Q 042149          450 VAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSV  502 (625)
Q Consensus       450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~  502 (625)
                      ....-.    ...-+..|.|||++.+.+|+.+.||||||||+.||++|.+.|+
T Consensus       341 ~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp  389 (586)
T KOG0667|consen  341 ESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP  389 (586)
T ss_pred             cCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence            543322    3567889999999999999999999999999999999976544

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-36  Score=323.86  Aligned_cols=259  Identities=23%  Similarity=0.279  Sum_probs=196.5

Q ss_pred             hcCccccccccccCceEEEEEEeC---CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP---DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ..+|++.++||+|+||.||++...   .++.||||.+...     ....+|+++|++++||||+++++.+......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999743   4678999987543     23468999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      |++. ++|.+++...   ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.++|+|||++......
T Consensus       166 e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9995 5777777332   34899999999999999999999775   999999999999999999999999999765443


Q ss_pred             Cce-eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCcc--chhhHHHhhhcccc-------
Q 042149          454 KTH-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSS--VLHTVWKHYKANRI-------  523 (625)
Q Consensus       454 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~-------  523 (625)
                      ... ......||+.|+|||++....++.++|||||||++|||++|+.|+........  .+....+.......       
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            222 12246799999999999999999999999999999999999999754332211  01111110000000       


Q ss_pred             ---c---cccCCCCCCCC--C-----hHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          524 ---T---QSMDPGLTGRF--P-----ENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       524 ---~---~~i~~~~~~~~--~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                         .   .........++  +     ...+.++.+++.+||+.+|++|||+.|++..
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence               0   00000001000  0     1224567889999999999999999999864

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.5e-36  Score=305.27  Aligned_cols=253  Identities=25%  Similarity=0.338  Sum_probs=188.7

Q ss_pred             ccccccCceEEEEEEeCC---CCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCC
Q 042149          304 RKLGQGGAGSVFRGTLPD---GRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNR  379 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~  379 (625)
                      ++||+|+||.||+|...+   ...+++|.+... .......+.+|+.+++.++||||+++++.+.+....++||||++++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999997543   456888877544 3344567889999999999999999999999999999999999999


Q ss_pred             CcchhhhccCC--cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCcee
Q 042149          380 SLDQILFVKNT--IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV  457 (625)
Q Consensus       380 sL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  457 (625)
                      +|.+++.....  ....++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999865432  223567888899999999999999775   9999999999999999999999999986543322211


Q ss_pred             -eecCCCCccccCcccccc-------CcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          458 -STGIAGTLGYMAPEYLVR-------GQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       458 -~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                       .....+++.|+|||++..       ..++.++||||||+++|||++ |..|+...... +.   ....... .......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~---~~~~~~~-~~~~~~~  232 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-QV---LKQVVRE-QDIKLPK  232 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-HH---HHHHhhc-cCccCCC
Confidence             122346778999998743       356789999999999999999 55564322111 11   1111111 1111111


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHc
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLN  569 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  569 (625)
                      +.    .+...+..+.+++..|| .+|++|||+++|++.|.
T Consensus       233 ~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         233 PQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             Cc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            11    22344566778888998 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.2e-36  Score=302.01  Aligned_cols=247  Identities=30%  Similarity=0.433  Sum_probs=201.9

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-----hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-----RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      +|+..+.||+|++|.||+|..+ +++.|++|.+....     ++..+.+.+|+.+++.++||||+++++++......++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999976 78999999886543     34567899999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+++++|.+++....   .+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            99999999999886443   3789999999999999999999775   99999999999999999999999999877544


Q ss_pred             CCceeeecCCCCccccCccccccCc-ccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQ-LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      ..  ......+++.|+|||.+.... ++.++|+||||+++|+|++|+.|+.....    ....+.......         
T Consensus       155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~---------  219 (258)
T cd06632         155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG----VAAVFKIGRSKE---------  219 (258)
T ss_pred             cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH----HHHHHHHHhccc---------
Confidence            33  123456899999999987766 89999999999999999999998643321    111111111001         


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ....+......+.+++.+||+.+|++||++.+++.
T Consensus       220 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         220 LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            11223445677899999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-37  Score=316.58  Aligned_cols=244  Identities=30%  Similarity=0.456  Sum_probs=198.4

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      .|+.++.||.|.||.||-|++. +...||||++...   ..+..+.+..|+..|++++|||+|.+.|++..+...|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            4777889999999999999964 6788999999754   34556778999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      ||- |+-.|++.-..  +++.+.++..|..+.+.||+|||+.   +.||||||..|||+.+.|.|||+|||.|....+.+
T Consensus       107 YCl-GSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn  180 (948)
T KOG0577|consen  107 YCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN  180 (948)
T ss_pred             HHh-ccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCchh
Confidence            995 46666664332  3488999999999999999999966   59999999999999999999999999998766544


Q ss_pred             ceeeecCCCCccccCccccc---cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          455 THVSTGIAGTLGYMAPEYLV---RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      .     ++|||.|||||++.   .++|+-++||||||++..||...++|...+..-+.+     .++..     .-.|.+
T Consensus       181 s-----FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL-----YHIAQ-----NesPtL  245 (948)
T KOG0577|consen  181 S-----FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-----YHIAQ-----NESPTL  245 (948)
T ss_pred             c-----ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH-----HHHHh-----cCCCCC
Confidence            3     68999999999985   478999999999999999999887764322211111     11111     112222


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .   ..+.+..+.+++..||++-|.+|||.++++.
T Consensus       246 q---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  246 Q---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             C---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            2   4567888999999999999999999987654

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=6.3e-36  Score=301.40  Aligned_cols=256  Identities=28%  Similarity=0.369  Sum_probs=205.2

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ++|++.+.||.|+||+||+|... ++..+++|++.... ......+.+|+++++.++||||+++++.+......++|||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47899999999999999999964 67889999986543 33567899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+++........+++..+..++.|++.||.+||+.+   ++||||+|+||++++++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999876544345899999999999999999999775   99999999999999999999999999876654332


Q ss_pred             e---eeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          456 H---VSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       456 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      .   ......++..|+|||++... .++.++|+||||+++|+|++|+.|+........    ..+.....      .+..
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~----~~~~~~~~------~~~~  227 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV----LMLTLQND------PPSL  227 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh----HHHHhcCC------CCCc
Confidence            2   12234689999999998877 789999999999999999999998743222111    11111110      0111


Q ss_pred             CCC-CChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          532 TGR-FPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       532 ~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ... .....+..+.+++.+||+.+|++||++.++++
T Consensus       228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            110 01245677899999999999999999999985

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.4e-36  Score=308.15  Aligned_cols=260  Identities=24%  Similarity=0.331  Sum_probs=200.6

Q ss_pred             HHHHHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcC-CCCceeeeeeeee----
Q 042149          291 EILERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGI-QHKNVVRLLGCSI----  364 (625)
Q Consensus       291 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~----  364 (625)
                      +.+....++|++.+.||+|+||.||++..+ +++.+|+|++.... ...+.+.+|+.+++.+ +||||+++++++.    
T Consensus        11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   89 (286)
T cd06638          11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV   89 (286)
T ss_pred             ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence            444566789999999999999999999865 68899999875432 2235678899999999 6999999999874    


Q ss_pred             -eCCeeEEEEEecCCCCcchhhhcc-CCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEe
Q 042149          365 -EGPESLLVYEYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIA  442 (625)
Q Consensus       365 -~~~~~~lV~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~  442 (625)
                       .++..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~  166 (286)
T cd06638          90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLV  166 (286)
T ss_pred             CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEc
Confidence             345689999999999999887532 22345888999999999999999999775   9999999999999999999999


Q ss_pred             ecccceeeCCCCceeeecCCCCccccCcccccc-----CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHh
Q 042149          443 DFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR-----GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKH  517 (625)
Q Consensus       443 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~  517 (625)
                      |||+++........ .....|++.|+|||++..     ..++.++||||||+++|||++|+.|+.........     ..
T Consensus       167 dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~-----~~  240 (286)
T cd06638         167 DFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL-----FK  240 (286)
T ss_pred             cCCceeecccCCCc-cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH-----hh
Confidence            99998876433221 223468999999998853     45788999999999999999999987533211110     00


Q ss_pred             hhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          518 YKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       518 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      .....     .+..  ..+...+..+.+++.+||+.+|++|||+.|+++.
T Consensus       241 ~~~~~-----~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         241 IPRNP-----PPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             ccccC-----CCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            00000     0000  1122335578999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.2e-36  Score=313.15  Aligned_cols=256  Identities=23%  Similarity=0.345  Sum_probs=199.3

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCC----EEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGR----NIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  370 (625)
                      .+.|+..+.||+|+||.||+|++. ++.    .+|+|.+.... ......+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            356788899999999999999864 444    47888886543 33345788999999999999999999988654 567


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      +++||+++|+|.+++....  ..+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++..
T Consensus        85 ~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence            9999999999999886432  24789999999999999999999775   999999999999999999999999999876


Q ss_pred             CCCCcee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          451 APDKTHV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       451 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      ....... .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ..    .......        
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-~~----~~~~~~~--------  226 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-RE----IPDLLEK--------  226 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-HH----HHHHHHC--------
Confidence            4333221 112345778999999988899999999999999999997 8877642210 11    1111111        


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                       ......+...+..+.+++.+||..+|++||++.++++.|..+.
T Consensus       227 -~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         227 -GERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             -CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence             1111122334567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.8e-37  Score=311.66  Aligned_cols=251  Identities=24%  Similarity=0.395  Sum_probs=200.6

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCCeeEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~  373 (625)
                      -..|+++++||+||.+.||++...+.+.+|+|++...  +.+.+.-|.+|+.+|.+|+ |.+||++++|-..++.+|+||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            4568889999999999999999877788999977543  5667889999999999996 999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||- ..+|..+|..+.... ..| .+..+..|++.++.++|+.+   |||.||||.|+|+-. |.+||+|||+|..+..+
T Consensus       440 E~G-d~DL~kiL~k~~~~~-~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKKSID-PDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD  512 (677)
T ss_pred             ecc-cccHHHHHHhccCCC-chH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence            986 579999886554432 334 67778899999999999876   999999999999864 58999999999998877


Q ss_pred             Cceee-ecCCCCccccCccccccC-----------cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcc
Q 042149          454 KTHVS-TGIAGTLGYMAPEYLVRG-----------QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN  521 (625)
Q Consensus       454 ~~~~~-~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  521 (625)
                      .+... ...+||+.||+||.+...           +.+.++||||||||||+|+.|+.||....       ..|     .
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------n~~-----a  580 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------NQI-----A  580 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------HHH-----H
Confidence            66544 367999999999998543           25678999999999999999999964211       111     1


Q ss_pred             ccccccCCCCCCCCChHH-HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          522 RITQSMDPGLTGRFPENE-ASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       522 ~~~~~i~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ++..+.++...-++|.-- ..++.+++..||..||++||+..|+++
T Consensus       581 Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  581 KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            233344554332333211 122899999999999999999999985

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-36  Score=310.59  Aligned_cols=252  Identities=23%  Similarity=0.251  Sum_probs=200.9

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ++|++.+.||+|++|.||+|... +++.+|+|.+....   ......+.+|+++++.++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            46889999999999999999975 58999999987643   235567899999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+.+++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            999999999988643 2345899999999999999999999775   999999999999999999999999998754322


Q ss_pred             Cce----------------------------eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCC
Q 042149          454 KTH----------------------------VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSE  505 (625)
Q Consensus       454 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~  505 (625)
                      ...                            ......|+..|+|||++.+..++.++||||||+++|+|++|+.|+....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            110                            0112467889999999998889999999999999999999999975332


Q ss_pred             CCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 042149          506 GSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPS----MAEVVH  566 (625)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt----~~ev~~  566 (625)
                      ....     +...        .............+..+.+++.+||+.+|++||+    +.|++.
T Consensus       237 ~~~~-----~~~~--------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         237 RDET-----FSNI--------LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hHHH-----HHHH--------hcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            2111     1111        1111111111225778999999999999999999    555554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.4e-36  Score=302.07  Aligned_cols=249  Identities=24%  Similarity=0.341  Sum_probs=197.9

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC-----ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--Cee
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN-----SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG--PES  369 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~  369 (625)
                      ++|++.++||+|+||.||+|... +++.||||.+...     .....+.+.+|+.++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46889999999999999999965 5899999988542     234467889999999999999999999988763  467


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      ++||||+++++|.+++....   .+++.....++.+++.+|.|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            89999999999999886443   3788899999999999999999775   99999999999999999999999999876


Q ss_pred             eCCCCc--eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccccccc
Q 042149          450 VAPDKT--HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM  527 (625)
Q Consensus       450 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  527 (625)
                      ......  .......++..|+|||++.+..++.++||||||+++|||++|+.|+.......    ....         ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----~~~~---------~~  222 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA----AIFK---------IA  222 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH----HHHH---------Hh
Confidence            532111  11123468899999999988889999999999999999999999864321110    0000         01


Q ss_pred             CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       528 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ........+......+.+++.+|+. +|++||+++||++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         223 TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            1111223355667788899999995 8999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-37  Score=307.47  Aligned_cols=249  Identities=22%  Similarity=0.307  Sum_probs=210.0

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ..-|.+.+.||+|.|.+|-+|++- +|..||||++.+..  .-....+.+|++.|+.++|||||++|++......+|||.
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            455788889999999999999965 89999999996653  333457899999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE-cCCCceEEeecccceeeCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL-DEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll-~~~~~~kl~Dfgla~~~~~  452 (625)
                      |+-++|+|.+++-....+  +.+..+.+++.||+.|+.|+|+-+   +|||||||+||.+ ..-|-|||.|||++..+.+
T Consensus        97 ELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            999999999998655433  899999999999999999999665   9999999999876 5678999999999988876


Q ss_pred             CCceeeecCCCCccccCccccccCccc-ccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLT-EKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      +...  +..+|+..|-|||++.+..|+ +++||||||||||-|++|+.||....+.             +.+..++|-..
T Consensus       172 G~kL--~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-------------ETLTmImDCKY  236 (864)
T KOG4717|consen  172 GKKL--TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-------------ETLTMIMDCKY  236 (864)
T ss_pred             cchh--hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-------------hhhhhhhcccc
Confidence            6543  346999999999999999886 7899999999999999999997432222             22223333332


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                        ..|...+.++.+||..||..||++|.+.+||...
T Consensus       237 --tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  237 --TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             --cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence              2377889999999999999999999999999854

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4e-36  Score=302.78  Aligned_cols=252  Identities=25%  Similarity=0.370  Sum_probs=202.8

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ++|+..+.||+|++|.||++.++ +++.+|+|++.... ......+.+|++++++++||||+++++.+......++|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35778889999999999999976 68899999887653 34556789999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhc-CCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG-GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      +++++|.+++....  ..+++..+..++.+++.+|.|||+ .   +++|+||||+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            99999999886542  348899999999999999999997 5   59999999999999999999999999987653322


Q ss_pred             ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          455 THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                      ..   ...++..|+|||.+.+..++.++||||||+++|+|++|+.|+..............+......         ...
T Consensus       156 ~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~  223 (265)
T cd06605         156 AK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP---------PPR  223 (265)
T ss_pred             hh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC---------CCC
Confidence            21   156889999999998889999999999999999999999987543221111111111111111         111


Q ss_pred             CChH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          535 FPEN-EASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       535 ~~~~-~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .+.. .+..+.++|.+||..+|++|||+.+++.
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            1222 5677899999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3e-36  Score=302.48  Aligned_cols=238  Identities=26%  Similarity=0.394  Sum_probs=187.1

Q ss_pred             ccccccCceEEEEEEeCCCC-----------EEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          304 RKLGQGGAGSVFRGTLPDGR-----------NIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      ++||+|+||.||+|.+.+..           .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999976432           4778876554433 6788999999999999999999999888 788999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC-------ceEEeecc
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL-------TPKIADFG  445 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-------~~kl~Dfg  445 (625)
                      |||+++++|.+++.....  .+++..+..++.||+.||.|||+++   |+||||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            999999999998865432  4899999999999999999999765   99999999999999887       79999999


Q ss_pred             cceeeCCCCceeeecCCCCccccCccccccC--cccccCcEEeehhhhHHHHhC-CCCCCCCCCCccchhhHHHhhhccc
Q 042149          446 LARHVAPDKTHVSTGIAGTLGYMAPEYLVRG--QLTEKADVYAFGVLVIEVASG-RRNSVFSEGSSSVLHTVWKHYKANR  522 (625)
Q Consensus       446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~ll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~  522 (625)
                      ++.....     .....++..|+|||++...  .++.++||||||+++|||++| ..|+.... ....    ...+....
T Consensus       154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~----~~~~~~~~  223 (259)
T cd05037         154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEK----ERFYQDQH  223 (259)
T ss_pred             ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhH----HHHHhcCC
Confidence            9886543     1123567789999999876  789999999999999999996 44432221 1110    01111000


Q ss_pred             cccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHc
Q 042149          523 ITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLN  569 (625)
Q Consensus       523 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  569 (625)
                                 ..+......+.+++.+||+.+|++|||+.+|++.|+
T Consensus       224 -----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         224 -----------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             -----------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                       001111267899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.7e-36  Score=319.22  Aligned_cols=262  Identities=25%  Similarity=0.311  Sum_probs=196.7

Q ss_pred             HHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC-----
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG-----  366 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----  366 (625)
                      ...++|++.+.||+|+||.||++... .++.||||++...  .......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            34678999999999999999999865 6889999998653  334456788999999999999999999988643     


Q ss_pred             -CeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecc
Q 042149          367 -PESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFG  445 (625)
Q Consensus       367 -~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfg  445 (625)
                       ...++||||+++ +|.+.+..     .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence             357999999975 55555531     2788899999999999999999775   9999999999999999999999999


Q ss_pred             cceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchh----------hHH
Q 042149          446 LARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLH----------TVW  515 (625)
Q Consensus       446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~----------~~~  515 (625)
                      +++......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.|+...........          ..+
T Consensus       165 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             ccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            998653322  22345789999999999988999999999999999999999998753321111000          000


Q ss_pred             Hh-------hhcc--ccc-----cccCCCC---CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          516 KH-------YKAN--RIT-----QSMDPGL---TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       516 ~~-------~~~~--~~~-----~~i~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      ..       +...  ...     .......   ....+......+.+++.+||+.||++|||+.|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            00       0000  000     0000000   001122235678899999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.9e-36  Score=301.07  Aligned_cols=248  Identities=23%  Similarity=0.359  Sum_probs=200.8

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      +|+..+.||+|+||.||++... +++.+|||.+...  .....+.+.+|++++++++||||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4788999999999999999864 6889999988654  334567899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCC-CceEEeecccceeeCCCC
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEK-LTPKIADFGLARHVAPDK  454 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~-~~~kl~Dfgla~~~~~~~  454 (625)
                      +++++|.+++.... ...+++..+..++.+++.+|.|||+++   ++|+||+|+||+++.+ +.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            99999999986543 234899999999999999999999775   9999999999999854 468999999998764432


Q ss_pred             ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          455 THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                      .  .....+++.|+|||.+.+..++.++||||||+++|+|++|+.|+.......    .. .....         .....
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~----~~-~~~~~---------~~~~~  220 (256)
T cd08220         157 K--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA----LV-LKIMS---------GTFAP  220 (256)
T ss_pred             c--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH----HH-HHHHh---------cCCCC
Confidence            2  123468899999999988889999999999999999999998864322111    01 00000         01112


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .+...+..+.+++.+||+.+|++|||+.|+++
T Consensus       221 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         221 ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            23345677899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.7e-36  Score=306.52  Aligned_cols=261  Identities=25%  Similarity=0.319  Sum_probs=199.2

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      ++|++.++||+|++|.||+|+++ +++.||+|++....  ....+.+.+|+.++++++||||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46889999999999999999976 68999999886442  2233567899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+++++|..++....   .+++..+..++.|++.+|.|||+.+   ++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            999998888764332   3899999999999999999999765   9999999999999999999999999998765433


Q ss_pred             ceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHh-----------hhccc
Q 042149          455 THVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKH-----------YKANR  522 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~-----------~~~~~  522 (625)
                      .. .....++..|+|||++.+ ..++.++||||||+++|||++|+.|+......+... .....           +....
T Consensus       155 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         155 DD-YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY-LIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             cc-ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCChHHhhhccccc
Confidence            21 223457889999999876 467899999999999999999998875432211110 00000           00000


Q ss_pred             cc-cccCCCCCCCCC-----hHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          523 IT-QSMDPGLTGRFP-----ENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       523 ~~-~~i~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .. ....+......+     ...+..+.+++.+||+.+|++||++.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            00 000000000000     123567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.8e-36  Score=300.45  Aligned_cols=252  Identities=25%  Similarity=0.406  Sum_probs=202.2

Q ss_pred             CccccccccccCceEEEEEEe-CCCCEEEEEEeecCC------hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNS------RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      +|+..+.||+|++|.||+|.. .+++.+|+|.+....      ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999985 478999999886432      2345788999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC-ceEEeecccceee
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL-TPKIADFGLARHV  450 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-~~kl~Dfgla~~~  450 (625)
                      ||||+++++|.+++....   .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++ .++|+|||++...
T Consensus        81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            999999999999886543   3889999999999999999999775   99999999999998765 5999999998766


Q ss_pred             CCCCce---eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccccccc
Q 042149          451 APDKTH---VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM  527 (625)
Q Consensus       451 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  527 (625)
                      ......   ......++..|+|||.+.+..++.++||||||+++++|++|+.|+........ .....         +..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~---------~~~  224 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-LALIF---------KIA  224 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-HHHHH---------HHh
Confidence            433211   11234688999999999888899999999999999999999988643221111 11000         000


Q ss_pred             CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       528 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ........+...+..+.+++.+||+.+|++||++.++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         225 SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            111122345566788999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.1e-36  Score=309.59  Aligned_cols=255  Identities=20%  Similarity=0.244  Sum_probs=201.2

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ++|++.+.||+|+||.||++.+. +++.|++|.+....   ....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46889999999999999999975 57899999886543   344567889999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||++|++|.+++....   .+++..+..++.+++.||.|||+.+   ++||||||+||+++.++.++|+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            9999999999986543   3889999999999999999999775   999999999999999999999999998642110


Q ss_pred             C--------------ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhh
Q 042149          454 K--------------THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK  519 (625)
Q Consensus       454 ~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~  519 (625)
                      .              ........++..|+|||.+.+..++.++|+||||+++|||++|+.|+..... .    .......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-~----~~~~~~~  229 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-E----ELFGQVI  229 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-H----HHHHHHH
Confidence            0              0011124578899999999888899999999999999999999998642211 1    1111111


Q ss_pred             ccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcc
Q 042149          520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN  570 (625)
Q Consensus       520 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  570 (625)
                      .....   .+    ......+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       230 ~~~~~---~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         230 SDDIE---WP----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             hcccC---CC----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            11100   00    0112346678999999999999999997777766655

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.6e-36  Score=309.37  Aligned_cols=261  Identities=25%  Similarity=0.358  Sum_probs=199.1

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      ++|++.++||+|+||.||+|.++ +++.||+|++....  ....+.+.+|+++++.++||||+++++++..+...++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46889999999999999999976 58999999875432  2235678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+++++|.++.....   .+++.++..++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            999999988764332   2899999999999999999999775   9999999999999999999999999988764433


Q ss_pred             ceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHh-----------hhccc
Q 042149          455 THVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKH-----------YKANR  522 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~-----------~~~~~  522 (625)
                      .. .....++..|+|||++.+ ..++.++||||||+++|||++|++|+....... ........           +....
T Consensus       155 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         155 EV-YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID-QLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             cc-cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHHhCCCchhhHHHhccch
Confidence            22 223567899999999875 457889999999999999999987764322111 10010000           00000


Q ss_pred             cc-cccCCCCCC-----CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          523 IT-QSMDPGLTG-----RFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       523 ~~-~~i~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      +. ....+....     ...+..+..+.+++.+||+.+|++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00 000000000     012244677999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.3e-36  Score=309.67  Aligned_cols=262  Identities=23%  Similarity=0.289  Sum_probs=197.6

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ++|++.++||+|+||.||+|+.+ +++.||+|.+.... ......+.+|+.+++.++||||+++++++..+...++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            57899999999999999999975 68899999986543 23345677899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      ++ ++|.+++....  ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++........
T Consensus        86 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          86 LD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            97 58888775432  24789999999999999999999775   99999999999999999999999999876433222


Q ss_pred             eeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccc----------hhhHHHhhhcccc-
Q 042149          456 HVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSV----------LHTVWKHYKANRI-  523 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~----------~~~~~~~~~~~~~-  523 (625)
                      . .....+++.|+|||++.+. .++.++||||||+++|||++|+.|+.........          ....|..+..... 
T Consensus       160 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         160 T-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             c-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence            1 1234578999999998654 5788999999999999999999887543211100          0011111111000 


Q ss_pred             ccccCCCCCC----CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          524 TQSMDPGLTG----RFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       524 ~~~i~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ...-.+....    ......+..+.+++.+||+.||.+|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0000000000    011234567889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=8.3e-36  Score=302.87  Aligned_cols=248  Identities=25%  Similarity=0.373  Sum_probs=200.9

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      +-|++.++||+|+||.||+|... +++.+|||.+.... ......+.+|+.++++++||||+++++.+..+...++||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            34778889999999999999864 68899999876443 34456788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+++..    ..+++..+..++.+++.++.+||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          84 LGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            999999988843    24889999999999999999999775   99999999999999999999999999876644322


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                      . .....++..|+|||.+.+..++.++|+||||+++|+|++|..|+...... .    .....         ........
T Consensus       157 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~----~~~~~---------~~~~~~~~  221 (277)
T cd06641         157 K-RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-K----VLFLI---------PKNNPPTL  221 (277)
T ss_pred             h-hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-H----HHHHH---------hcCCCCCC
Confidence            1 22346888999999998888899999999999999999999886422110 0    00000         11111122


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      +...+..+.+++.+||+.+|++||++.++++.
T Consensus       222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            33456778899999999999999999999974

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=6e-36  Score=304.97  Aligned_cols=262  Identities=24%  Similarity=0.315  Sum_probs=201.4

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      +|++.+.||+|++|.||+|.+. +++.||||++....  ....+.+.+|+.++++++||||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788999999999999999965 68999999987653  34456789999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      + +++|.+++....  ..+++.+++.++.||+.+|.|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999999885443  44899999999999999999999775   99999999999999999999999999987654432


Q ss_pred             eeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcc------------c
Q 042149          456 HVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN------------R  522 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~------------~  522 (625)
                      .......++..|+|||.+.+. .++.++||||||+++|||++|++|+.... ...............            .
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN-DIEQLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC-HHHHHHHHHHHcCCCChHHHhhccCcch
Confidence            223345689999999998654 46899999999999999999966553221 111111111111000            0


Q ss_pred             cccccCCCCC----CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          523 ITQSMDPGLT----GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       523 ~~~~i~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      ......+...    ....++.+..+.+++.+||+.+|++||+++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0000000000    00112345788999999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.4e-36  Score=313.95  Aligned_cols=261  Identities=22%  Similarity=0.304  Sum_probs=195.3

Q ss_pred             HHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC----
Q 042149          294 ERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG----  366 (625)
Q Consensus       294 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~----  366 (625)
                      ....++|++.+.||+|+||.||+|... +++.||||++....  ......+.+|+.++++++||||+++++++...    
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            345678999999999999999999964 68899999986542  23345678999999999999999999987543    


Q ss_pred             --CeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeec
Q 042149          367 --PESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADF  444 (625)
Q Consensus       367 --~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Df  444 (625)
                        ...+++||++ +++|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||+++++.+||+||
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCC
Confidence              3578999988 7888887642    23899999999999999999999775   999999999999999999999999


Q ss_pred             ccceeeCCCCceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHH-------
Q 042149          445 GLARHVAPDKTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWK-------  516 (625)
Q Consensus       445 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~-------  516 (625)
                      |+++.....    .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.|+........+ .....       
T Consensus       163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~  237 (343)
T cd07878         163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQL-KRIMEVVGTPSP  237 (343)
T ss_pred             ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH-HHHHHHhCCCCH
Confidence            999865432    223568999999999876 57899999999999999999999887543211110 00000       


Q ss_pred             ----hhhccccccccCC--CCCC----CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          517 ----HYKANRITQSMDP--GLTG----RFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       517 ----~~~~~~~~~~i~~--~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                          ..........+..  ....    .........+.+++.+||+.||++|||+.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                0000000000000  0000    0001123457899999999999999999999853

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6.9e-36  Score=309.52  Aligned_cols=258  Identities=21%  Similarity=0.300  Sum_probs=185.8

Q ss_pred             cccccccCceEEEEEEeC---CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeee--CCeeEEEEEecC
Q 042149          303 SRKLGQGGAGSVFRGTLP---DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE--GPESLLVYEYVP  377 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~lV~e~~~  377 (625)
                      .++||+|+||.||+|+.+   +++.||+|.+....  ....+.+|+.++++++||||+++++++..  +...++||||+.
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            468999999999999964   45789999886443  23467889999999999999999998853  567899999986


Q ss_pred             CCCcchhhhcc------CCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE----cCCCceEEeecccc
Q 042149          378 NRSLDQILFVK------NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL----DEKLTPKIADFGLA  447 (625)
Q Consensus       378 ~~sL~~~l~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll----~~~~~~kl~Dfgla  447 (625)
                      + +|.+++...      .....+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 666665321      12234888999999999999999999775   9999999999999    46679999999999


Q ss_pred             eeeCCCCce--eeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCcc----c----h-----
Q 042149          448 RHVAPDKTH--VSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSS----V----L-----  511 (625)
Q Consensus       448 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~----~----~-----  511 (625)
                      +........  ......+|+.|+|||++.+ ..++.++||||||+++|||+||+.|+........    .    .     
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS  239 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence            876543221  1224568999999999876 4578999999999999999999988754322100    0    0     


Q ss_pred             ------hhHHHhhhccc-cccccC---------CCC---CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          512 ------HTVWKHYKANR-ITQSMD---------PGL---TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       512 ------~~~~~~~~~~~-~~~~i~---------~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                            ...|+.+.... ......         ..+   ...........+.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence                  00111111000 000000         000   00001122345788999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.9e-36  Score=310.05  Aligned_cols=249  Identities=25%  Similarity=0.399  Sum_probs=199.6

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecC
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVP  377 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~  377 (625)
                      .|.....||+|+||.||++... ++..||||++........+.+.+|+.+++.++||||+++++.+...+..++||||++
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            3444567999999999999864 688999999876666667789999999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCcee
Q 042149          378 NRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV  457 (625)
Q Consensus       378 ~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  457 (625)
                      +++|.+++...    .+++.++..++.+|+.||.|||+.+   |+||||||+||++++++.++|+|||++......... 
T Consensus       103 ~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-  174 (292)
T cd06658         103 GGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-  174 (292)
T ss_pred             CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-
Confidence            99999987432    3889999999999999999999775   999999999999999999999999998765332221 


Q ss_pred             eecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCCh
Q 042149          458 STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE  537 (625)
Q Consensus       458 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  537 (625)
                      .....+++.|+|||.+.+..++.++||||||+++|||++|+.|+...... ..    .....     ..+.+...  ...
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~----~~~~~-----~~~~~~~~--~~~  242 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-QA----MRRIR-----DNLPPRVK--DSH  242 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HH----HHHHH-----hcCCCccc--ccc
Confidence            12346889999999998888999999999999999999999986432111 00    00100     11111111  112


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          538 NEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       538 ~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      ..+..+.+++.+||+.+|++|||++++++.
T Consensus       243 ~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         243 KVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            345578899999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.2e-36  Score=306.50  Aligned_cols=244  Identities=25%  Similarity=0.330  Sum_probs=200.9

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ++|++.+.||+|+||.||++.+. +++.+|+|.+...   ..+..+.+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46889999999999999999975 6899999988653   2344577899999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++++|.+++....   .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            9999999999886553   4899999999999999999999775   999999999999999999999999999876543


Q ss_pred             CceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                          .....+++.|+|||.+.+...+.++||||||+++|+|++|+.|+.....     ....+......          .
T Consensus       155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~----------~  215 (290)
T cd05580         155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-----IQIYEKILEGK----------V  215 (290)
T ss_pred             ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhcCC----------c
Confidence                2235689999999999888889999999999999999999988643221     11111111111          1


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRP-----SMAEVVH  566 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~  566 (625)
                      ..+...+..+.+++.+||+.+|++||     +++|+++
T Consensus       216 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         216 RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            22344467889999999999999999     6666653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=9.4e-36  Score=299.64  Aligned_cols=252  Identities=25%  Similarity=0.369  Sum_probs=206.4

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCCh-HHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSR-QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ++|++.+.||+|++|.||+|+.. +++.|+||++..... .....+.+|+.++++++||||+++++++......++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36888999999999999999976 589999999876644 4567899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhc-CCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG-GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      +++++|.+++...   ..+++..++.++.|++++|.|||+ .+   ++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            9999999998654   348999999999999999999997 64   9999999999999999999999999998765433


Q ss_pred             ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          455 THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                      ... ....++..|+|||.+.+..++.++|+||||+++|+|++|+.|+...... .. ..........         ....
T Consensus       155 ~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~-~~~~~~~~~~---------~~~~  222 (264)
T cd06623         155 DQC-NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-SF-FELMQAICDG---------PPPS  222 (264)
T ss_pred             Ccc-cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-CH-HHHHHHHhcC---------CCCC
Confidence            322 2345788999999998888999999999999999999999987544320 10 0111111111         1111


Q ss_pred             CChH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          535 FPEN-EASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       535 ~~~~-~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      .+.. .+..+.+++.+||+.+|++||++.++++.
T Consensus       223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            2233 56789999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=7.3e-36  Score=302.34  Aligned_cols=255  Identities=25%  Similarity=0.388  Sum_probs=197.7

Q ss_pred             ccccccccccCceEEEEEEeC----CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC------
Q 042149          300 FDNSRKLGQGGAGSVFRGTLP----DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP------  367 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------  367 (625)
                      |.+.+.||+|+||.||+|.+.    +++.+|||++...  .....+++.+|+.++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567789999999999999853    3688999988654  3445678899999999999999999999886532      


Q ss_pred             eeEEEEEecCCCCcchhhhccC---CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeec
Q 042149          368 ESLLVYEYVPNRSLDQILFVKN---TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADF  444 (625)
Q Consensus       368 ~~~lV~e~~~~~sL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Df  444 (625)
                      ..++++||+++++|.+++....   ....+++.....++.|++.||+|||+.+   |+||||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            3478999999999988775321   2234788999999999999999999775   999999999999999999999999


Q ss_pred             ccceeeCCCCcee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccc
Q 042149          445 GLARHVAPDKTHV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANR  522 (625)
Q Consensus       445 gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  522 (625)
                      |+++......... .....+++.|++||.+....++.++||||||+++|||++ |+.|+.... ...+    ........
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~-~~~~----~~~~~~~~  232 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE-NSEI----YNYLIKGN  232 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC-HHHH----HHHHHcCC
Confidence            9988654332211 112345678999999988889999999999999999999 666653221 1111    11111111


Q ss_pred             cccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          523 ITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       523 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                               ....+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       233 ---------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         233 ---------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                     0111234567899999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.7e-36  Score=304.25  Aligned_cols=258  Identities=23%  Similarity=0.339  Sum_probs=199.6

Q ss_pred             HHHHHHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcC-CCCceeeeeeeeee--
Q 042149          290 YEILERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIE--  365 (625)
Q Consensus       290 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~--  365 (625)
                      +..+....+.|++.++||+|+||.||+|++. +++.+|+|.+.... .....+..|+.+++++ +||||+++++++..  
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   86 (282)
T cd06636           8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS   86 (282)
T ss_pred             hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence            3344456678999999999999999999974 68899999886543 3346788999999998 69999999998853  


Q ss_pred             ----CCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEE
Q 042149          366 ----GPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKI  441 (625)
Q Consensus       366 ----~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl  441 (625)
                          ....+++|||+++++|.+++.... ...+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.++|
T Consensus        87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l  162 (282)
T cd06636          87 PPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL  162 (282)
T ss_pred             ccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence                457899999999999999886433 234788889999999999999999775   999999999999999999999


Q ss_pred             eecccceeeCCCCceeeecCCCCccccCccccc-----cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHH
Q 042149          442 ADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLV-----RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWK  516 (625)
Q Consensus       442 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~  516 (625)
                      +|||++........ ......|++.|+|||.+.     ...++.++||||||+++|||++|+.|+.........    ..
T Consensus       163 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~----~~  237 (282)
T cd06636         163 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL----FL  237 (282)
T ss_pred             eeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh----hh
Confidence            99999875532221 122356899999999875     345788999999999999999999886432111110    00


Q ss_pred             hhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          517 HYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       517 ~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                            +.....   ........+..+.+++.+||+.+|.+||++.|+++
T Consensus       238 ------~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         238 ------IPRNPP---PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             ------HhhCCC---CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                  000001   11112245667999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.4e-36  Score=307.76  Aligned_cols=261  Identities=22%  Similarity=0.285  Sum_probs=196.4

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      +|++.++||+|+||.||+|+.. +|+.+|+|++....  ......+.+|+.++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999975 68999999986532  22335678899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++ +|.+++....  ..+++..+..++.||++||.|||+.+   ++||||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          81 CDQ-DLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            974 7777664332  34899999999999999999999775   99999999999999999999999999886543222


Q ss_pred             eeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcc------ccccccC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN------RITQSMD  528 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~i~  528 (625)
                      . .....+++.|+|||++.+. .++.++||||||+++|||+||+.|+....................      .+.+..+
T Consensus       155 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         155 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             C-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence            1 1234578999999998765 468999999999999999999988643322211111111100000      0000001


Q ss_pred             CCCC---------CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          529 PGLT---------GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       529 ~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ....         ....+..+..+.+++.+||+.||.+|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0000         0111234577889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-36  Score=307.35  Aligned_cols=263  Identities=24%  Similarity=0.314  Sum_probs=202.1

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      ++|++.++||+|+||.||+|.++ +++.||||++...  .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36889999999999999999976 5889999988643  23445788999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |++++.+..+....   ..+++..+..++.+++.||.|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            99987776655332   23889999999999999999999775   9999999999999999999999999998765544


Q ss_pred             ceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhH----------HHhhhcccc
Q 042149          455 THVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV----------WKHYKANRI  523 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~----------~~~~~~~~~  523 (625)
                      ........++..|+|||++.+. .++.++||||||+++|+|++|+.|+......+.+....          +..+.....
T Consensus       155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07833         155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR  234 (288)
T ss_pred             cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence            3233345688999999999887 78999999999999999999998765332111110000          000000000


Q ss_pred             c---cccCCC----CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          524 T---QSMDPG----LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       524 ~---~~i~~~----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .   +..+..    ....++...+..+.+++.+||+.+|++||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0   000000    001122334778999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.1e-35  Score=299.13  Aligned_cols=249  Identities=27%  Similarity=0.435  Sum_probs=201.1

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCCh--HHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSR--QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      +|++.++||+|+||.||+|... +++.|++|.+.....  ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4788899999999999999965 689999999876543  4678899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+++....   .+++..+..++.+++.||.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            99999999886432   3788999999999999999999775   99999999999999999999999999887654332


Q ss_pred             eeee---cCCCCccccCccccccCc---ccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          456 HVST---GIAGTLGYMAPEYLVRGQ---LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       456 ~~~~---~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      ....   ...+++.|+|||++....   ++.++||||||+++|+|++|+.|+........   ..... ..         
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~---~~~~~-~~---------  221 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ---IMFHV-GA---------  221 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH---HHHHH-hc---------
Confidence            2211   346788999999998766   88999999999999999999998743221110   01100 00         


Q ss_pred             CCCCCCCh--HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          530 GLTGRFPE--NEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       530 ~~~~~~~~--~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ......+.  ..+..+.+++.+||+.+|++||++.+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         222 GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00111122  23667889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.4e-35  Score=299.66  Aligned_cols=253  Identities=23%  Similarity=0.338  Sum_probs=188.1

Q ss_pred             ccccccCceEEEEEEeCCC---CEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCC
Q 042149          304 RKLGQGGAGSVFRGTLPDG---RNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNR  379 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~  379 (625)
                      ++||+|+||.||+|+..++   ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||++++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999985433   345677765443 345678999999999999999999999999999999999999999


Q ss_pred             CcchhhhccCC-cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC-cee
Q 042149          380 SLDQILFVKNT-IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK-THV  457 (625)
Q Consensus       380 sL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~-~~~  457 (625)
                      +|.+++..... ....++..+..++.||+.||.|||+.+   ++||||||+|||++.++.++|+|||++....... ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99998865422 234677788899999999999999775   9999999999999999999999999976432111 111


Q ss_pred             eecCCCCccccCcccccc-------CcccccCcEEeehhhhHHHHhCCC-CCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          458 STGIAGTLGYMAPEYLVR-------GQLTEKADVYAFGVLVIEVASGRR-NSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       458 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~ll~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      .....++..|+|||++..       ..++.++||||||+++|||+++.. |+... ...+..    .....+......++
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-~~~~~~----~~~~~~~~~~~~~~  232 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL-SDREVL----NHVIKDQQVKLFKP  232 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC-CHHHHH----HHHHhhcccccCCC
Confidence            223567889999998753       245789999999999999998654 43211 111111    11111121222233


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHc
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLN  569 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  569 (625)
                      .+.    ......+.+++..|| .+|++||++++|++.|.
T Consensus       233 ~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         233 QLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             ccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            332    224566788999999 57999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.1e-35  Score=304.46  Aligned_cols=251  Identities=24%  Similarity=0.391  Sum_probs=203.8

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      .++|++.+.||+|+||.||++... +++.+|+|.+........+.+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            367889999999999999999864 6789999998765555567889999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+++...    .+++.++..++.+++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        98 ~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            9999999988532    3788999999999999999999775   99999999999999999999999999876544332


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                      . .....+++.|+|||.+....++.++||||||+++|++++|+.|+........+.    .....        .......
T Consensus       171 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~----~~~~~--------~~~~~~~  237 (293)
T cd06647         171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY----LIATN--------GTPELQN  237 (293)
T ss_pred             c-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee----ehhcC--------CCCCCCC
Confidence            2 223468899999999988889999999999999999999999875332211110    00000        0000111


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      +...+..+.+++.+||+.+|++||++.+++..
T Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            33456678899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1e-35  Score=305.45  Aligned_cols=261  Identities=21%  Similarity=0.282  Sum_probs=198.4

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCCh-----HHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSR-----QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      +|++.+.||+|++|.||+|... +++.||||++.....     .....+.+|++++++++||||+++++++.+++..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778889999999999999965 689999999865432     2345677899999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+ +++|.+++....  ..+++..+..++.||++||.|||+++   ++|+||||+||+++.++.++|+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 899999886543  24899999999999999999999775   99999999999999999999999999987654


Q ss_pred             CCceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcc---------c
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN---------R  522 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~---------~  522 (625)
                      .... .....+++.|+|||.+.+ ..++.++||||||+++|||++|..|+.... ...............         .
T Consensus       155 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  232 (298)
T cd07841         155 PNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS-DIDQLGKIFEALGTPTEENWPGVTS  232 (298)
T ss_pred             CCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc-cHHHHHHHHHHcCCCchhhhhhccc
Confidence            3322 122356889999998865 467899999999999999999966543222 111111111100000         0


Q ss_pred             cccccCCCCCC-----CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          523 ITQSMDPGLTG-----RFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       523 ~~~~i~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      ...........     ......+..+.+++.+||+.+|++|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00000000000     1113446778999999999999999999999973

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.7e-36  Score=307.92  Aligned_cols=249  Identities=25%  Similarity=0.387  Sum_probs=199.9

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecC
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVP  377 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~  377 (625)
                      .|+...+||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++.+..++..++||||++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            3455668999999999999965 689999999876555556778899999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCcee
Q 042149          378 NRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV  457 (625)
Q Consensus       378 ~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  457 (625)
                      +++|..++..    ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......... 
T Consensus       102 ~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-  173 (297)
T cd06659         102 GGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-  173 (297)
T ss_pred             CCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccccc-
Confidence            9999987743    23889999999999999999999775   999999999999999999999999998755433221 


Q ss_pred             eecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCCh
Q 042149          458 STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE  537 (625)
Q Consensus       458 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  537 (625)
                      .....+++.|+|||++.+..++.++||||||+++|||++|+.|+....... ..    .......     ..  ......
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~----~~~~~~~-----~~--~~~~~~  241 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-AM----KRLRDSP-----PP--KLKNAH  241 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HH----HHHhccC-----CC--CccccC
Confidence            223568999999999988889999999999999999999999875322111 00    1111100     00  001122


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          538 NEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       538 ~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      ..+..+.+++.+||+.+|++||+++++++.
T Consensus       242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         242 KISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            345668899999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.8e-37  Score=317.15  Aligned_cols=243  Identities=22%  Similarity=0.343  Sum_probs=196.5

Q ss_pred             cccccccCceEEEEEEeC-CCCEEEEEEee----cCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC--eeEEEEEe
Q 042149          303 SRKLGQGGAGSVFRGTLP-DGRNIAVKRLF----FNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP--ESLLVYEY  375 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~lV~e~  375 (625)
                      ..+||+|+|-+||+|.+. +|.+||--.+.    ....+..++|..|+.+|+.|+|||||++|+.+.+..  ...+|.|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            346999999999999975 57777643222    235566789999999999999999999999998655  48899999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC-CCceEEeecccceeeCCCC
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE-KLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~-~~~~kl~Dfgla~~~~~~~  454 (625)
                      +..|+|..++.....   ++.+.+..|++||++||.|||++ .++|||||||-+||||+. -|.|||+|+|||.......
T Consensus       125 ~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  125 FTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             ccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            999999999865544   88899999999999999999998 679999999999999985 5899999999998765332


Q ss_pred             ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          455 THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                         .+.+.|||.|||||+.. ..|++.+||||||+-++||+|+..|+..-.+...+...+..+.+...+..+        
T Consensus       201 ---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV--------  268 (632)
T KOG0584|consen  201 ---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKV--------  268 (632)
T ss_pred             ---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhcc--------
Confidence               23478999999999885 899999999999999999999999986555443333222222222221111        


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                          ...++.++|.+|+.. .++|||+.|+++
T Consensus       269 ----~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  269 ----KDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ----CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence                134678999999999 999999999985

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=301.37  Aligned_cols=247  Identities=25%  Similarity=0.412  Sum_probs=198.4

Q ss_pred             CccccccccccCceEEEEEEe-CCCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCC---CCceeeeeeeeeeCCeeEEEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQ---HKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lV~  373 (625)
                      .|+..++||+|+||.||+|.+ .+++.+|+|.+... .....+.+.+|+.++++++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477888999999999999996 46899999988654 3445667889999999996   999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++++|.+++...    .+++...+.++.+++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            999999999987532    4899999999999999999999775   999999999999999999999999999876544


Q ss_pred             CceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      ... .....|+..|+|||.+.++ .++.++|+||||+++|+|++|+.|+........    . .....     ...+.+.
T Consensus       155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~----~-~~~~~-----~~~~~~~  223 (277)
T cd06917         155 SSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA----M-MLIPK-----SKPPRLE  223 (277)
T ss_pred             ccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh----h-hcccc-----CCCCCCC
Confidence            322 2234689999999998754 568999999999999999999998743221100    0 00000     0011111


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                         ....+..+.+++.+||+.+|++||++.+++.
T Consensus       224 ---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         224 ---DNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             ---cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence               1124567899999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.2e-35  Score=350.18  Aligned_cols=262  Identities=25%  Similarity=0.437  Sum_probs=209.2

Q ss_pred             HHhcCccccccccccCceEEEEEEe-CCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      .....|...++||+|+||.||+|++ .+++.||||++.....    ...+|++++++++|||||++++++.+.+..++||
T Consensus       687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence            3345678889999999999999997 4789999998864332    1235688999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++|+|.+++.      .++|..+..++.|+++||+|||.....+|+||||||+||+++.++.+++. ||........
T Consensus       763 Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~  835 (968)
T PLN00113        763 EYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD  835 (968)
T ss_pred             eCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC
Confidence            9999999999984      28999999999999999999996555579999999999999998888775 6655433221


Q ss_pred             CceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCC-CccchhhHHHhhhccccccccCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEG-SSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                           ....+++.|+|||++.+..++.++|||||||++|||+||+.|+..... ......+....+........+++.+.
T Consensus       836 -----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  910 (968)
T PLN00113        836 -----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIR  910 (968)
T ss_pred             -----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcccc
Confidence                 123678999999999999999999999999999999999999743322 22333443333333344445555553


Q ss_pred             C--CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          533 G--RFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       533 ~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      .  ..+.+...++.+++.+||+.+|++||||.||+++|+++.
T Consensus       911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  952 (968)
T PLN00113        911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS  952 (968)
T ss_pred             CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence            3  234566778899999999999999999999999998764

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2e-35  Score=299.05  Aligned_cols=254  Identities=25%  Similarity=0.370  Sum_probs=198.5

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCC----------hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS----------RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP  367 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~  367 (625)
                      +|.+.+.||+|+||.||+|... +++.+|||.+....          ....+.+.+|+.+++.++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4677889999999999999864 68999999885321          122456888999999999999999999999999


Q ss_pred             eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccc
Q 042149          368 ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA  447 (625)
Q Consensus       368 ~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla  447 (625)
                      ..++||||+++++|.+++....   .+++..+..++.+++.+|.|||+.+   ++||||+|+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            9999999999999999886543   4889999999999999999999775   999999999999999999999999998


Q ss_pred             eeeCCCCce-eeecCCCCccccCccccccCc--ccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccc
Q 042149          448 RHVAPDKTH-VSTGIAGTLGYMAPEYLVRGQ--LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRIT  524 (625)
Q Consensus       448 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  524 (625)
                      +........ ......++..|+|||.+....  ++.++|+||||+++|++++|..|+.....    .....+.... .. 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~-~~-  229 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----IAAMFKLGNK-RS-  229 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----HHHHHHhhcc-cc-
Confidence            765432111 122346889999999987654  78999999999999999999988642211    1111111111 10 


Q ss_pred             cccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          525 QSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       525 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                         ............+..+.+++.+||+.+|++||++.+|++.
T Consensus       230 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         230 ---APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             ---CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence               0111111122446788999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.4e-35  Score=301.83  Aligned_cols=252  Identities=23%  Similarity=0.295  Sum_probs=193.1

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHH-HhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNL-ISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      ++|++.+.||+|+||.||+|+++ +|+.||+|++.... .+....+..|+.+ ++.++||||+++++++..++..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46889999999999999999975 68999999986542 2233455556665 666789999999999999999999999


Q ss_pred             ecCCCCcchhhhcc-CCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          375 YVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       375 ~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      |++ ++|.+++... .....+++..++.++.|++.||.|||++.  +++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            996 6787776542 23345899999999999999999999752  4999999999999999999999999998865432


Q ss_pred             CceeeecCCCCccccCcccccc----CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVR----GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      ..  .....++..|+|||.+.+    ..++.++|+||||+++|+|++|+.|+.......   ....... ..     ..+
T Consensus       158 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~-~~-----~~~  226 (283)
T cd06617         158 VA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF---QQLKQVV-EE-----PSP  226 (283)
T ss_pred             cc--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH---HHHHHHH-hc-----CCC
Confidence            21  122468889999998864    456889999999999999999999864321111   1111110 00     001


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ..   .....+..+.+++.+||..+|++||++.++++
T Consensus       227 ~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         227 QL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11   01234567899999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6.2e-36  Score=326.20  Aligned_cols=262  Identities=17%  Similarity=0.187  Sum_probs=189.8

Q ss_pred             HHHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCC------Cceeeeeeeeee
Q 042149          293 LERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQH------KNVVRLLGCSIE  365 (625)
Q Consensus       293 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------pniv~l~~~~~~  365 (625)
                      +....++|++.++||+|+||+||+|.+. +++.||||++.... .....+..|+.+++.++|      ++++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3445688999999999999999999965 57889999986432 223445667777776654      458899998875


Q ss_pred             C-CeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC-------
Q 042149          366 G-PESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL-------  437 (625)
Q Consensus       366 ~-~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-------  437 (625)
                      + ...++|||++ +++|.+++....   .+++..+..++.||+.||.|||.+  .+||||||||+|||++.++       
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~  276 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVT  276 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccccccc
Confidence            4 5788999988 778888775443   389999999999999999999963  1499999999999998665       


Q ss_pred             ---------ceEEeecccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCc
Q 042149          438 ---------TPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSS  508 (625)
Q Consensus       438 ---------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~  508 (625)
                               .+||+|||++.....    ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus       277 ~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~  352 (467)
T PTZ00284        277 NRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE  352 (467)
T ss_pred             ccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence                     499999998754221    2234679999999999999999999999999999999999999975433211


Q ss_pred             cchhhHHH-------hhhc----cccccccC------CCCC---------CC-C-ChHHHHHHHHHHhhccCCCCCCCCC
Q 042149          509 SVLHTVWK-------HYKA----NRITQSMD------PGLT---------GR-F-PENEASRVLQIGLLCTQAPVALRPS  560 (625)
Q Consensus       509 ~~~~~~~~-------~~~~----~~~~~~i~------~~~~---------~~-~-~~~~~~~l~~li~~cl~~~p~~RPt  560 (625)
                      . +....+       .|..    .....+.+      +...         .. . .......+.+||.+||+.||++|||
T Consensus       353 ~-~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t  431 (467)
T PTZ00284        353 H-LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN  431 (467)
T ss_pred             H-HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence            1 110000       0000    00000000      0000         00 0 0011345779999999999999999


Q ss_pred             HHHHHH
Q 042149          561 MAEVVH  566 (625)
Q Consensus       561 ~~ev~~  566 (625)
                      ++|+++
T Consensus       432 a~e~L~  437 (467)
T PTZ00284        432 ARQMTT  437 (467)
T ss_pred             HHHHhc
Confidence            999986

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.9e-35  Score=298.80  Aligned_cols=260  Identities=23%  Similarity=0.254  Sum_probs=200.4

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--CeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG--PESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lV~  373 (625)
                      ++|+..++||.|++|.||++.++ +++.+|+|.+.... ......+.+|++++++++||||+++++++.+.  +.+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46888999999999999999975 68889999887543 34457789999999999999999999988653  4689999


Q ss_pred             EecCCCCcchhhhcc-CCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          374 EYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       374 e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      ||+++++|.+++... .....+++..+..++.+++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999999877532 22344889999999999999999999775   99999999999999999999999999875533


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      ...   ....++..|+|||.+.+..++.++||||||+++|+|++|+.|+........................+ .... 
T Consensus       158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-  232 (287)
T cd06621         158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL-KDEP-  232 (287)
T ss_pred             ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhh-ccCC-
Confidence            221   13457889999999998999999999999999999999999876442210000011111111111110 0000 


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                       ......+..+.+++.+||+.+|++|||+.|+++
T Consensus       233 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         233 -GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             -CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence             001234567899999999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.3e-35  Score=303.55  Aligned_cols=261  Identities=27%  Similarity=0.348  Sum_probs=201.4

Q ss_pred             HHHHHHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeC-
Q 042149          290 YEILERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEG-  366 (625)
Q Consensus       290 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-  366 (625)
                      .+.+...+++|++.+.||+|+||.||++..+ +++.+|+|.+.... ...+.+.+|+.+++++ +|||++++++++... 
T Consensus        14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   92 (291)
T cd06639          14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD   92 (291)
T ss_pred             cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence            3445566889999999999999999999974 68899999885432 2345678899999999 799999999998754 


Q ss_pred             ----CeeEEEEEecCCCCcchhhhcc-CCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEE
Q 042149          367 ----PESLLVYEYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKI  441 (625)
Q Consensus       367 ----~~~~lV~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl  441 (625)
                          ...++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||
T Consensus        93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl  169 (291)
T cd06639          93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKL  169 (291)
T ss_pred             ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEE
Confidence                3589999999999999987532 22345899999999999999999999775   999999999999999999999


Q ss_pred             eecccceeeCCCCceeeecCCCCccccCccccccC-----cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHH
Q 042149          442 ADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG-----QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWK  516 (625)
Q Consensus       442 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~  516 (625)
                      +|||++......... .....++..|+|||.+...     .++.++||||||+++|||++|+.|+........    ..+
T Consensus       170 ~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~----~~~  244 (291)
T cd06639         170 VDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT----LFK  244 (291)
T ss_pred             eecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH----HHH
Confidence            999998765432221 1234688999999998654     368899999999999999999988643221111    111


Q ss_pred             hhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          517 HYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       517 ~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                       .......     .+  ..+......+.+++.+||+.+|++||++.|+++.
T Consensus       245 -~~~~~~~-----~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         245 -IPRNPPP-----TL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             -HhcCCCC-----CC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence             1111100     01  1123345678999999999999999999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.3e-36  Score=313.64  Aligned_cols=191  Identities=27%  Similarity=0.363  Sum_probs=163.0

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ..+|++.+.||+|+||.||+|+.. +++.||+|.....      ....|+.++++++||||+++++++......++|||+
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  138 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH  138 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence            457999999999999999999975 5778999975332      235699999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +. ++|.+++....  ..+++..+..|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus       139 ~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  211 (357)
T PHA03209        139 YS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-  211 (357)
T ss_pred             cC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence            95 57777775432  34899999999999999999999775   9999999999999999999999999987533221 


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNS  501 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~  501 (625)
                       ......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus       212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence             122356899999999999999999999999999999999976654

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=302.91  Aligned_cols=262  Identities=24%  Similarity=0.307  Sum_probs=195.3

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCCh-HHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSR-QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ++|++.+.||+|++|.||+|..+ +++.||||.+..... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            67899999999999999999975 689999999865432 2234567899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +.+ +|.+++.....  .+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++.......
T Consensus        85 ~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            975 88887754332  4889999999999999999999775   99999999999999999999999999875432211


Q ss_pred             eeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccc---cccc-----
Q 042149          456 HVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR---ITQS-----  526 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~-----  526 (625)
                      . .....+++.|+|||++.+ ..++.++||||||+++|+|++|+.|+.......+.....+.......   ....     
T Consensus       159 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         159 T-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             c-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence            1 122346889999999875 45789999999999999999999887543321111111111110000   0000     


Q ss_pred             -c--------CCCCCCCC-ChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          527 -M--------DPGLTGRF-PENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       527 -i--------~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                       .        ...+.... .......+.+++.+||+.+|++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence             0        00000000 0011266789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=7.5e-36  Score=299.71  Aligned_cols=247  Identities=26%  Similarity=0.316  Sum_probs=202.8

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      +|++.+.||+|+||.||+|... +++.+|+|.+....   ....+.+.+|++++++++||||+++++.+.++...++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5888999999999999999975 68999999986542   3456789999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+++++|.+++...   ..+++..+..++.+++++|.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999988654   34889999999999999999999775   9999999999999999999999999987664432


Q ss_pred             ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          455 THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                      .  .....|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+......  ...........          ....
T Consensus       155 ~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~----------~~~~  220 (258)
T cd05578         155 L--TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQET----------ADVL  220 (258)
T ss_pred             c--ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhcc----------cccc
Confidence            1  22356889999999998888999999999999999999999987543321  11111111100          1122


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCCCH--HHHH
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRPSM--AEVV  565 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RPt~--~ev~  565 (625)
                      .+...+..+.+++.+||+.+|.+||++  +|++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            344566889999999999999999999  6554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-37  Score=314.40  Aligned_cols=252  Identities=23%  Similarity=0.342  Sum_probs=205.1

Q ss_pred             hcCccccccccccCceEEEEEEeCCC-CEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDG-RNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      .+.|+++..||.|+||.||+|+.++. -..|.|.+.....+.++.+.-||+||...+||+||++++.|..++.++|+.||
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            45688999999999999999997753 34577888888888899999999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      |.||-.+.++..-+  +.|.+.++..++.+++.||.|||++   +|||||||..|||+.-+|.++|+|||.+...... .
T Consensus       111 C~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~  184 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-R  184 (1187)
T ss_pred             cCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH-H
Confidence            99999999886544  3499999999999999999999977   5999999999999999999999999987543221 1


Q ss_pred             eeeecCCCCccccCccccc-----cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLV-----RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                      .....+.|||.|||||++.     ..+|+.++||||||++|.||..+.+|.....    ....+.+ .....     .|.
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln----pMRVllK-iaKSe-----PPT  254 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN----PMRVLLK-IAKSE-----PPT  254 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc----hHHHHHH-HhhcC-----CCc
Confidence            2234689999999999875     4579999999999999999999998853211    1111111 11111     111


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      +.  .|...+..+.+++.+||.+||..||++.++++
T Consensus       255 Ll--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  255 LL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             cc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            11  25566778999999999999999999998875

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-35  Score=298.89  Aligned_cols=254  Identities=26%  Similarity=0.356  Sum_probs=200.0

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCC------
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGP------  367 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~------  367 (625)
                      .+++|++.+.||+|++|.||+|..+ +++.+++|++..... ..+.+.+|+.+++++ +||||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4688999999999999999999975 578899998876544 346789999999999 6999999999997654      


Q ss_pred             eeEEEEEecCCCCcchhhhccC-CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccc
Q 042149          368 ESLLVYEYVPNRSLDQILFVKN-TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGL  446 (625)
Q Consensus       368 ~~~lV~e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgl  446 (625)
                      ..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence            4899999999999999886432 2345899999999999999999999775   99999999999999999999999999


Q ss_pred             ceeeCCCCceeeecCCCCccccCcccccc-----CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcc
Q 042149          447 ARHVAPDKTHVSTGIAGTLGYMAPEYLVR-----GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN  521 (625)
Q Consensus       447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  521 (625)
                      +......... .....+++.|+|||++..     ..++.++||||||+++|+|++|+.|+.........     ......
T Consensus       160 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~  233 (275)
T cd06608         160 SAQLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL-----FKIPRN  233 (275)
T ss_pred             ceecccchhh-hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH-----HHhhcc
Confidence            8765433222 223568999999998754     34678999999999999999999987422111110     011110


Q ss_pred             ccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          522 RITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       522 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                           ..+..  ..+...+..+.+++.+||..||++|||+.++++
T Consensus       234 -----~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         234 -----PPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             -----CCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                 01111  112345678899999999999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.8e-35  Score=302.59  Aligned_cols=263  Identities=22%  Similarity=0.276  Sum_probs=194.4

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCCh-HHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSR-QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      +++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++|+||+++++++..+...++|||
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            578999999999999999999864 688999999865432 223467789999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+. ++|.+.+....  ..+.+..+..++.|++.||.|||..+   |+|+||||+||+++.++.++|+|||+++......
T Consensus        84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          84 YMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             ccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            996 56666554322  23788889999999999999999775   9999999999999999999999999987543322


Q ss_pred             ceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcc------------
Q 042149          455 THVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN------------  521 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~------------  521 (625)
                      .. .....+++.|+|||.+.+. .++.++||||||+++|||++|+.|+.......+.+...|......            
T Consensus       158 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         158 QT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             CC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence            11 1234578999999998754 578899999999999999999998753322211111111111000            


Q ss_pred             ccccccCCCC-CCCC-----ChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          522 RITQSMDPGL-TGRF-----PENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       522 ~~~~~i~~~~-~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .......... ....     .......+.+++.+|++.+|++|||+.|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            0000000000 0000     0012456789999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.2e-35  Score=293.00  Aligned_cols=249  Identities=29%  Similarity=0.467  Sum_probs=203.4

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecC
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVP  377 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~  377 (625)
                      .|+..+.||+|++|.||++... +++.+++|++..........+.+|++++++++||||+++++.+......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4778899999999999999975 688999999977665567789999999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCcee
Q 042149          378 NRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV  457 (625)
Q Consensus       378 ~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  457 (625)
                      +++|.+++....  ..+++..+..++.+++.+|.+||..+   ++||||+|+||++++++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            999999886542  34899999999999999999999764   99999999999999999999999999887654432  


Q ss_pred             eecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCCh
Q 042149          458 STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE  537 (625)
Q Consensus       458 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  537 (625)
                      .....++..|+|||.+.+..++.++||||||+++++|++|+.|+.........    .. .......     ..  ..+.
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~----~~-~~~~~~~-----~~--~~~~  221 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL----FK-IATNGPP-----GL--RNPE  221 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH----HH-HHhcCCC-----Cc--Cccc
Confidence            22356889999999998888999999999999999999999886432211110    00 0000000     00  0112


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          538 NEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       538 ~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ..+..+.+++.+||+.+|++|||+.|+++
T Consensus       222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            22567899999999999999999999885

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-36  Score=302.00  Aligned_cols=246  Identities=24%  Similarity=0.284  Sum_probs=204.6

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      +.|..-++||+||||.||-++.+ +|+.+|.|++.+.   .+....-..+|-.||.++..|.||.+--.|+..+.+++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            56889999999999999999865 7999999988543   2333345678999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ..|+||+|.-+|...+. ..+++..+..++.+|+.||++||..   +||.|||||+|||+|+.|+++|+|+|+|..+...
T Consensus       265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999999987665 4499999999999999999999966   5999999999999999999999999999988766


Q ss_pred             CceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                      ....  ..+||.+|||||++.++.|+...|+|||||++|||+.|+.||....          ...+.+++.+.+.. ...
T Consensus       341 ~~~~--~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K----------eKvk~eEvdrr~~~-~~~  407 (591)
T KOG0986|consen  341 KPIR--GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK----------EKVKREEVDRRTLE-DPE  407 (591)
T ss_pred             Cccc--cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh----------hhhhHHHHHHHHhc-chh
Confidence            5543  3489999999999999999999999999999999999999974321          11122222222111 123


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCC
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPS  560 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt  560 (625)
                      +++...+++..+|....|++||++|..
T Consensus       408 ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  408 EYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             hcccccCHHHHHHHHHHHccCHHHhcc
Confidence            456777888899999999999999953

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.2e-35  Score=302.25  Aligned_cols=261  Identities=24%  Similarity=0.355  Sum_probs=198.7

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--CeeEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG--PESLLV  372 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lV  372 (625)
                      ++|++.+.||+|+||.||+|..+ +++.+|+|.+....  ......+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57888999999999999999976 68899999986543  22334577899999999999999999998877  899999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+++ +|.+++.....  .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        85 ~e~~~~-~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999974 88888754332  4899999999999999999999775   99999999999999999999999999987654


Q ss_pred             CCceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhh-----------HHHhhhc
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT-----------VWKHYKA  520 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~-----------~~~~~~~  520 (625)
                      .... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.|+....... ....           .|..+..
T Consensus       159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         159 PLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             Cccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchHHHHHhhc
Confidence            3222 1234578899999998764 46899999999999999999998875432211 1111           1111110


Q ss_pred             ------cccccccCCCCCCCCChH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          521 ------NRITQSMDPGLTGRFPEN-EASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       521 ------~~~~~~i~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                            ..........+...++.. .+..+.+++.+||+.+|++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                  000000011111222222 4677899999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-35  Score=308.22  Aligned_cols=245  Identities=20%  Similarity=0.276  Sum_probs=206.8

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ...|.+.+.||+|.|++|.+|++. ++..||||.+.+.  +......+.+|+++|+.|.|||||+++.+.+....+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            567899999999999999999975 6999999988764  3444566899999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+.+|.+.+++...+.   ..+..+..++.|+.++++|||++.   |+|||||.+||||+.+.++||+|||++..+...
T Consensus       135 eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             EeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence            99999999999976554   556888899999999999999775   999999999999999999999999999988744


Q ss_pred             CceeeecCCCCccccCccccccCcc-cccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      .  .....+|++.|+|||++.+.++ ++++|+||+|+++|-|+.|..||....-                 ..+-++.+.
T Consensus       209 ~--~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-----------------k~Lr~rvl~  269 (596)
T KOG0586|consen  209 L--MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-----------------KELRPRVLR  269 (596)
T ss_pred             c--cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-----------------ccccchhee
Confidence            3  3345799999999999998876 5899999999999999999999753211                 111111111


Q ss_pred             C--CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          533 G--RFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       533 ~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .  ..|.-...++.+++.+++-.+|.+|+++++|.+
T Consensus       270 gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  270 GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             eeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            1  124456778899999999999999999999976

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.7e-35  Score=300.49  Aligned_cols=248  Identities=28%  Similarity=0.419  Sum_probs=200.3

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecC
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVP  377 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~  377 (625)
                      .|...++||+|++|.||++... +++.+++|++........+.+.+|+.+++.+.||||+++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            3555679999999999999964 688999999876665556778999999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCcee
Q 042149          378 NRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV  457 (625)
Q Consensus       378 ~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  457 (625)
                      +++|.+++..    ..+++..+..++.+++.+|++||+.+   ++||||+|+||+++.++.++|+|||++......... 
T Consensus       100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-  171 (285)
T cd06648         100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-  171 (285)
T ss_pred             CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-
Confidence            9999998854    23889999999999999999999775   999999999999999999999999988755432221 


Q ss_pred             eecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCCh
Q 042149          458 STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE  537 (625)
Q Consensus       458 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  537 (625)
                      .....|++.|+|||.+.+..++.++||||||+++|||++|+.|+...... ..    ........     .+..  ..+.
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-~~----~~~~~~~~-----~~~~--~~~~  239 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-QA----MKRIRDNL-----PPKL--KNLH  239 (285)
T ss_pred             cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-HH----HHHHHhcC-----CCCC--cccc
Confidence            22356899999999998888999999999999999999999886432110 00    11111110     0111  1122


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          538 NEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       538 ~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ..+..+.+++.+||+.+|++||++.++++
T Consensus       240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         240 KVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            35567999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.8e-35  Score=301.31  Aligned_cols=246  Identities=30%  Similarity=0.430  Sum_probs=194.9

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      +.|++.++||+|+||.||+|+.. +++.||+|++...   ..+....+.+|+++++.++||||+++++++.+....++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888899999999999999965 6899999988643   2344567889999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+. ++|.+++....  ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            9997 46666554322  24899999999999999999999775   999999999999999999999999998765432


Q ss_pred             CceeeecCCCCccccCccccc---cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLV---RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                      .     ...+++.|+|||++.   .+.++.++||||||+++|||+||+.|+......    ..... .....        
T Consensus       169 ~-----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~----~~~~~-~~~~~--------  230 (307)
T cd06607         169 N-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYH-IAQND--------  230 (307)
T ss_pred             C-----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH----HHHHH-HhcCC--------
Confidence            2     246788999999874   356889999999999999999999886422110    00000 00000        


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      .....+...+..+.+++.+||+.+|++||++.+|+..
T Consensus       231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         231 SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0011123456779999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.3e-35  Score=302.32  Aligned_cols=261  Identities=20%  Similarity=0.304  Sum_probs=196.3

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      +|++.+.||+|++|.||+|+.+ +++.||||++....  ......+.+|++++++++||||+++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788999999999999999975 68999999886442  22345788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +. ++|..++.... ...+++..+..++.+++.||+|||..+   ++||||+|+||+++.++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            96 57888775433 244899999999999999999999775   99999999999999999999999999876543222


Q ss_pred             eeeecCCCCccccCccccccCc-ccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhH----------HHhhhcc---
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQ-LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV----------WKHYKAN---  521 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~----------~~~~~~~---  521 (625)
                      . .....+++.|+|||++.+.. ++.++||||||+++|||+||+.|+.............          |......   
T Consensus       156 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         156 T-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             c-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence            1 12335688999999887644 5889999999999999999999875432211111100          0000000   


Q ss_pred             --ccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          522 --RITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       522 --~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                        ...+...... ....+..+..+.+++.+||+.||++|||++++++
T Consensus       235 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         235 KPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence              0000000000 0011223456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.6e-35  Score=299.53  Aligned_cols=253  Identities=26%  Similarity=0.426  Sum_probs=204.8

Q ss_pred             HHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ..++.|+..+.||+|++|.||+|.++ +++.+++|++..... ..+.+.+|+++++.++||||+++++.+......++|+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            34667888899999999999999976 688999999976654 4667889999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++++|.+++....  ..+++..+..++.+++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            9999999999997544  35899999999999999999999765   999999999999999999999999988655432


Q ss_pred             CceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                      .. ......+++.|+|||++.+..++.++|+||||+++|+|++|+.|+........    . .........     .  .
T Consensus       170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~----~-~~~~~~~~~-----~--~  236 (286)
T cd06614         170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA----L-FLITTKGIP-----P--L  236 (286)
T ss_pred             hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH----H-HHHHhcCCC-----C--C
Confidence            22 12234578899999999888899999999999999999999988643211110    0 001111100     0  0


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ..+...+..+.+++.+||+.+|.+||++.++++
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            112235677899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6.2e-36  Score=329.41  Aligned_cols=255  Identities=27%  Similarity=0.405  Sum_probs=193.4

Q ss_pred             HHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeee------
Q 042149          294 ERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE------  365 (625)
Q Consensus       294 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------  365 (625)
                      .+...+|++++.||+||||.||+++.+ ||+.||||++... ..+....+.+|+..|++|+|||||+++..+.+      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            456778999999999999999999977 8999999999765 44556678999999999999999998754321      


Q ss_pred             --------------------------------------------------------------------------------
Q 042149          366 --------------------------------------------------------------------------------  365 (625)
Q Consensus       366 --------------------------------------------------------------------------------  365 (625)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -------------------------C--------CeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHH
Q 042149          366 -------------------------G--------PESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH  412 (625)
Q Consensus       366 -------------------------~--------~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~  412 (625)
                                               +        ..+||-||||+..+|.+++..+...+  .....++++++|++||.|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence                                     0        12578899999988888886554321  467889999999999999


Q ss_pred             hhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC-----------------CCCceeeecCCCCccccCcccccc
Q 042149          413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-----------------PDKTHVSTGIAGTLGYMAPEYLVR  475 (625)
Q Consensus       413 LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~  475 (625)
                      +|++|   ||||||||.|||+++++.|||+|||+|....                 .......+..+||.-|+|||++.+
T Consensus       713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            99886   9999999999999999999999999997621                 011112346789999999999976


Q ss_pred             C---cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccC
Q 042149          476 G---QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQ  552 (625)
Q Consensus       476 ~---~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~  552 (625)
                      .   +|+.|+|+||||||++||+.   ||......    .......+.+.+..-      ..+..+....=.++|.++++
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER----a~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~  856 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER----ASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLS  856 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhc---cCCchHHH----HHHHHhcccCCCCCC------cccccccchHHHHHHHHHhc
Confidence            4   59999999999999999984   33221111    111222333332221      11122233334689999999


Q ss_pred             CCCCCCCCHHHHHH
Q 042149          553 APVALRPSMAEVVH  566 (625)
Q Consensus       553 ~~p~~RPt~~ev~~  566 (625)
                      .||.+|||+.|++.
T Consensus       857 hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  857 HDPSKRPTATELLN  870 (1351)
T ss_pred             CCCccCCCHHHHhh
Confidence            99999999999885

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.4e-35  Score=297.31  Aligned_cols=250  Identities=21%  Similarity=0.312  Sum_probs=200.3

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      +|++.+.||+|+||.||+|..+ ++..+|+|.+....  ....+.+.+|+.++++++||||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788899999999999999975 58899999986542  23456788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC-ceEEeecccceeeCCCC
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL-TPKIADFGLARHVAPDK  454 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-~~kl~Dfgla~~~~~~~  454 (625)
                      +++++|.+++.... ...+++..+..++.+++.||.|||+.+   ++|+||||+||++++++ .+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            99999999886433 234799999999999999999999775   99999999999999875 46999999987665332


Q ss_pred             ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          455 THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                      .. .....|++.|+|||++.+..++.++|+||||+++|||++|+.|+......    ..... .....         ..+
T Consensus       157 ~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~~~~---------~~~  221 (257)
T cd08225         157 EL-AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH----QLVLK-ICQGY---------FAP  221 (257)
T ss_pred             cc-ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH----HHHHH-Hhccc---------CCC
Confidence            22 22346899999999998888999999999999999999999886432111    11111 11111         111


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      .+...+..+.+++.+||+.+|++|||+.|+++.
T Consensus       222 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         222 ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            223445678999999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-35  Score=326.00  Aligned_cols=268  Identities=18%  Similarity=0.230  Sum_probs=190.1

Q ss_pred             HHhcCccccccccccCceEEEEEEeCC--CCEEEEE------------------EeecCChHHHHHHHHHHHHHhcCCCC
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLPD--GRNIAVK------------------RLFFNSRQWVDQFFNEVNLISGIQHK  354 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~hp  354 (625)
                      ...++|+++++||+|+||+||++.++.  +...++|                  ++ .........+.+|+.+|++++||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~-~~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRV-KAGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHh-hcchHHHHHHHHHHHHHHhCCCC
Confidence            446789999999999999999987532  2222222                  11 11233456788999999999999


Q ss_pred             ceeeeeeeeeeCCeeEEEEEecCCCCcchhhhccCC--cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEE
Q 042149          355 NVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNT--IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNIL  432 (625)
Q Consensus       355 niv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIl  432 (625)
                      ||+++++++...+..++|+|++. ++|.+++.....  .......++..++.||+.||.|||+++   |+||||||+|||
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL  299 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF  299 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence            99999999999999999999985 466555543211  112345677889999999999999775   999999999999


Q ss_pred             EcCCCceEEeecccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCcc--c
Q 042149          433 LDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSS--V  510 (625)
Q Consensus       433 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~--~  510 (625)
                      |+.++.+||+|||+++.+............||+.|+|||++.+..++.++|||||||++|||++|+.++........  .
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            99999999999999987755443333456799999999999999999999999999999999999865443222111  1


Q ss_pred             hhhHHHhhh--cc-------ccccccCCCCC----CCCC-----hHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          511 LHTVWKHYK--AN-------RITQSMDPGLT----GRFP-----ENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       511 ~~~~~~~~~--~~-------~~~~~i~~~~~----~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      +........  ..       .+.+.++....    ...+     ...+..+.+++.+||+.||++|||+.|++..
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            111111000  00       00001100000    0000     0123456788999999999999999999863

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-37  Score=338.42  Aligned_cols=256  Identities=26%  Similarity=0.367  Sum_probs=207.7

Q ss_pred             HHHHhcCccccccccccCceEEEEEEe-CCCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCee
Q 042149          293 LERATDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPES  369 (625)
Q Consensus       293 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  369 (625)
                      +...+-+|+-..+||.|.||.||.|.. .+|.-.|+|.+...  .........+|+.++..++|||+|+.+|+-.+.+..
T Consensus      1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred             hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence            344556788899999999999999995 46888899977654  345566788999999999999999999999999999


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      +|.||||++|+|.+++.....   .++....-+..|++.|+.|||++|   ||||||||.||+|+.+|.+|++|||.|..
T Consensus      1310 ~IFMEyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred             HHHHHHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence            999999999999999864432   566666677889999999999886   99999999999999999999999999998


Q ss_pred             eCCCCcee---eecCCCCccccCccccccCc---ccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccc
Q 042149          450 VAPDKTHV---STGIAGTLGYMAPEYLVRGQ---LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRI  523 (625)
Q Consensus       450 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  523 (625)
                      +.......   .....||+.|||||++.+.+   -..++||||||||+.||.||++|+...++.-.+.    .+...   
T Consensus      1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIM----y~V~~--- 1456 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIM----YHVAA--- 1456 (1509)
T ss_pred             ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHH----hHHhc---
Confidence            76553222   12567999999999997643   4568999999999999999999965443321110    11111   


Q ss_pred             ccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          524 TQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       524 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                            +-.+.+|...+.+-.+++.+||+.||++|.++.|+++.
T Consensus      1457 ------gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 ------GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ------cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                  22344577788888999999999999999999988864

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.5e-35  Score=295.17  Aligned_cols=248  Identities=24%  Similarity=0.358  Sum_probs=203.7

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      +|++.++||+|++|.||+++.+ +++.+++|.+...  .......+.+|+.+++.++||||+++++++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788999999999999999865 6889999998653  334456788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccC-CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          376 VPNRSLDQILFVKN-TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       376 ~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      +++++|.+++.... ....+++..++.++.+++.||.|||+.+   ++|+||+|+||++++++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999999886522 2345899999999999999999999775   999999999999999999999999999876544 


Q ss_pred             ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          455 THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                        ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.|+......     .....         +.......
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----~~~~~---------~~~~~~~~  220 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-----DLRYK---------VQRGKYPP  220 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH---------HhcCCCCC
Confidence              122345889999999999889999999999999999999999886432210     01111         11111222


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .+...+.++.+++.+||+.+|++||++.++++
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            34466788999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-36  Score=327.59  Aligned_cols=266  Identities=22%  Similarity=0.236  Sum_probs=215.8

Q ss_pred             HHHHHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC
Q 042149          291 EILERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG  366 (625)
Q Consensus       291 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  366 (625)
                      ..++--.++|+++++||+|+||.|..++++ +++.||+|++.+.   .+.....|..|-.+|..-+.+-|+.++-.|.++
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            344555688999999999999999999986 5888999999762   344567899999999999999999999999999


Q ss_pred             CeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccc
Q 042149          367 PESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGL  446 (625)
Q Consensus       367 ~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgl  446 (625)
                      ..+|+||||++||+|-.++....   .+++..+..++..|+.||..||+.|   +|||||||+|||||..|++||+|||.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence            99999999999999999996555   4899999999999999999999664   99999999999999999999999999


Q ss_pred             ceeeCCCCceeeecCCCCccccCcccccc-----CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcc
Q 042149          447 ARHVAPDKTHVSTGIAGTLGYMAPEYLVR-----GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN  521 (625)
Q Consensus       447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  521 (625)
                      +-.+..++.-.....+|||.|++||++..     +.|+...|+||+||++|||+.|..||...    .+....-+.....
T Consensus       222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad----slveTY~KIm~hk  297 (1317)
T KOG0612|consen  222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD----SLVETYGKIMNHK  297 (1317)
T ss_pred             HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH----HHHHHHHHHhchh
Confidence            98888887777777899999999999953     57899999999999999999999997532    2333332222221


Q ss_pred             ccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCC---HHHHHH--HHccccCC
Q 042149          522 RITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPS---MAEVVH--MLNNIDYE  574 (625)
Q Consensus       522 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~ev~~--~L~~~~~~  574 (625)
                      +...+       +....++....+||.+.+ .+|+.|..   ++++..  .+.++.|+
T Consensus       298 ~~l~F-------P~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~  347 (1317)
T KOG0612|consen  298 ESLSF-------PDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWD  347 (1317)
T ss_pred             hhcCC-------CcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChh
Confidence            11111       011346777888888876 46888887   888875  34666653

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-36  Score=313.83  Aligned_cols=255  Identities=25%  Similarity=0.386  Sum_probs=199.3

Q ss_pred             ccccccccccCceEEEEEEe-CCCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC------CeeEE
Q 042149          300 FDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG------PESLL  371 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~~~l  371 (625)
                      |...+.||+||||.||+|++ ++|+.||||.+... .....+...+|+++|++|+|||||+++++=++.      ....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            45567899999999999995 47999999988653 344567888999999999999999999876543      35789


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEc--CCC--ceEEeecccc
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD--EKL--TPKIADFGLA  447 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~--~~~--~~kl~Dfgla  447 (625)
                      |||||.||+|...|........|++.+.+.++.++..||.|||+++   |+||||||.||++-  ++|  .-||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999987777777999999999999999999999775   99999999999984  323  4799999999


Q ss_pred             eeeCCCCceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccc--cc
Q 042149          448 RHVAPDKTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR--IT  524 (625)
Q Consensus       448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--~~  524 (625)
                      +...++.  ....+.||+.|.+||.+.. +.|+..+|.|||||++|+..||..||..........+..|.......  +.
T Consensus       172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~  249 (732)
T KOG4250|consen  172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA  249 (732)
T ss_pred             ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence            9887655  3456899999999999984 88999999999999999999999999776665444444444332221  11


Q ss_pred             cccCCCCC--------CCCC----hHHHHHHHHHHhhccCCCCCCCC
Q 042149          525 QSMDPGLT--------GRFP----ENEASRVLQIGLLCTQAPVALRP  559 (625)
Q Consensus       525 ~~i~~~~~--------~~~~----~~~~~~l~~li~~cl~~~p~~RP  559 (625)
                      -...+...        -++|    ......+-..+..+|..+|++|-
T Consensus       250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence            11111111        1112    33444556677778888888887

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=284.69  Aligned_cols=255  Identities=22%  Similarity=0.263  Sum_probs=208.4

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .++|+.+++||+|.||.|.+++-+ +++.+|+|++++.   .++.+..-..|-++|+..+||.+..+.-.|...+.+++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            467889999999999999999955 7999999999765   355566777899999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||..||.|.-+|....   .+++.....+-..|+.||.|||++   +||.||||.+|+|+|.+|++||+|||+++.--.
T Consensus       247 MeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             EEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc
Confidence            99999999988886543   388888888999999999999976   499999999999999999999999999986443


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      .+.. ...++|||.|+|||++....|+.++|+|.+||++|||.+|+.||...+...     ++.......          
T Consensus       321 ~g~t-~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k-----LFeLIl~ed----------  384 (516)
T KOG0690|consen  321 YGDT-TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK-----LFELILMED----------  384 (516)
T ss_pred             ccce-eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH-----HHHHHHhhh----------
Confidence            3333 345899999999999999999999999999999999999999975433221     111111111          


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH--HHccccC
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRP-----SMAEVVH--MLNNIDY  573 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~--~L~~~~~  573 (625)
                      -++|...+++...|+...|.+||.+|.     .+.||.+  .+..+.|
T Consensus       385 ~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W  432 (516)
T KOG0690|consen  385 LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDW  432 (516)
T ss_pred             ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCH
Confidence            235777778888999999999999995     4566653  3444443

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1e-34  Score=290.49  Aligned_cols=250  Identities=28%  Similarity=0.386  Sum_probs=206.8

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--CeeEEEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG--PESLLVY  373 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lV~  373 (625)
                      +|...+.||+|++|.||+|..+ +++.|++|++....  ....+.+.+|+.++++++||||+++++.+...  ...++||
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999976 68999999986654  35678899999999999999999999999988  8999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++++|.+++....   .+++..+..++.+++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            9999999999986544   4899999999999999999999765   999999999999999999999999999876554


Q ss_pred             Cce-eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          454 KTH-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       454 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      ... ......++..|+|||.+.....+.++||||||+++++|++|+.|+....   ......+..         ......
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~---------~~~~~~  222 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG---NPMAALYKI---------GSSGEP  222 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---chHHHHHhc---------cccCCC
Confidence            321 1223568899999999988889999999999999999999999875433   111111111         111122


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ...+...+..+.+++.+|++.+|++||++.+++.
T Consensus       223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            2334555788999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.6e-35  Score=299.03  Aligned_cols=260  Identities=22%  Similarity=0.358  Sum_probs=198.9

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      +|++.++||+|++|.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++.+.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5888999999999999999975 68899999987653 223456788999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      ++ +|.+++........+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 88887765554455899999999999999999999775   99999999999999999999999999875533221 


Q ss_pred             eeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchh----------hHHHhhhcccccc
Q 042149          457 VSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLH----------TVWKHYKANRITQ  525 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~----------~~~~~~~~~~~~~  525 (625)
                      ......+++.|++||.+.+. .++.++||||||+++|+|++|+.|+...........          ..|+.+....  .
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  233 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP--E  233 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCc--h
Confidence            11234578899999988664 568899999999999999999988654322111100          0011111000  0


Q ss_pred             ccCCCCC-------CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          526 SMDPGLT-------GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       526 ~i~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                       ......       ....+..+..+.+++.+|++.+|++||++.++++
T Consensus       234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         234 -YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             -hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             000000       0011234567889999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-35  Score=304.37  Aligned_cols=264  Identities=22%  Similarity=0.291  Sum_probs=195.6

Q ss_pred             CccccccccccCceEEEEEEeC---CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--CeeE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP---DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG--PESL  370 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~  370 (625)
                      +|++.++||+|+||.||+|+..   +++.||||.+....   ....+.+.+|+.++++++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999964   47899999997633   44456778999999999999999999999988  7899


Q ss_pred             EEEEecCCCCcchhhhccC--CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC----CCceEEeec
Q 042149          371 LVYEYVPNRSLDQILFVKN--TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE----KLTPKIADF  444 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~----~~~~kl~Df  444 (625)
                      +||||+++ +|.+++....  ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 5665553221  1235889999999999999999999775   999999999999998    899999999


Q ss_pred             ccceeeCCCCc--eeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCcc--------chhh
Q 042149          445 GLARHVAPDKT--HVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSS--------VLHT  513 (625)
Q Consensus       445 gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~--------~~~~  513 (625)
                      |++........  .......+++.|+|||++.+. .++.++||||||+++++|++|+.|+........        .+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99886543322  112235678999999988764 578999999999999999999988764432210        0000


Q ss_pred             HHHhhh-----------c-cccccccCCCCCCCCC---------h--HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          514 VWKHYK-----------A-NRITQSMDPGLTGRFP---------E--NEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       514 ~~~~~~-----------~-~~~~~~i~~~~~~~~~---------~--~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ......           . .......+.......+         .  ....++.+++.+||+.+|++|||+.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000000           0 0000000000001111         0  33456889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.6e-35  Score=299.02  Aligned_cols=255  Identities=24%  Similarity=0.310  Sum_probs=195.1

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCCeeEEEEEe
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      +|+..++||+|+||.||++.+. +++.+|||++.... ......+.+|+.++.++. ||||+++++++..+...+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            5666788999999999999965 68999999986542 345567889999999996 99999999999999999999999


Q ss_pred             cCCCCcchhhhc--cCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          376 VPNRSLDQILFV--KNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       376 ~~~~sL~~~l~~--~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      +. ++|.++...  ......+++..+..++.+++.||+|||+..  +++||||||+||+++.++.++|+|||++......
T Consensus        85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            85 455544321  112244899999999999999999999642  5999999999999999999999999998765432


Q ss_pred             CceeeecCCCCccccCccccccC---cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRG---QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                      ...  ....|++.|+|||++.+.   .++.++||||||+++|||++|+.|+....   ......... .     ....+.
T Consensus       162 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~-~-----~~~~~~  230 (288)
T cd06616         162 IAK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---SVFDQLTQV-V-----KGDPPI  230 (288)
T ss_pred             Ccc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc---hHHHHHhhh-c-----CCCCCc
Confidence            221  223588999999998766   68899999999999999999999965322   111111100 0     001111


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      +....+...+..+.+++.+||+.+|++|||+.+|++.
T Consensus       231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            2222223467789999999999999999999999863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1e-34  Score=292.14  Aligned_cols=242  Identities=21%  Similarity=0.284  Sum_probs=196.3

Q ss_pred             ccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCCCc
Q 042149          306 LGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSL  381 (625)
Q Consensus       306 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~sL  381 (625)
                      ||.|++|.||+++.. +++.+|+|++....   ....+.+.+|+.+++.++||||+++++.+.++...++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999975 58999999986532   24456799999999999999999999999999999999999999999


Q ss_pred             chhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceeeecC
Q 042149          382 DQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGI  461 (625)
Q Consensus       382 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  461 (625)
                      .+++....   .+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........  ....
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~--~~~~  152 (262)
T cd05572          81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTF  152 (262)
T ss_pred             HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc--cccc
Confidence            99886543   3889999999999999999999775   99999999999999999999999999987654321  1234


Q ss_pred             CCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHH
Q 042149          462 AGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEAS  541 (625)
Q Consensus       462 ~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  541 (625)
                      .+++.|+|||.+....++.++|+||||+++|+|++|..|+.......   .......        .+.......|...+.
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~--------~~~~~~~~~~~~~~~  221 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYNDI--------LKGNGKLEFPNYIDK  221 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHHHHHH--------hccCCCCCCCcccCH
Confidence            68899999999988889999999999999999999999875443211   0111111        111112223444477


Q ss_pred             HHHHHHhhccCCCCCCCCC-----HHHHHH
Q 042149          542 RVLQIGLLCTQAPVALRPS-----MAEVVH  566 (625)
Q Consensus       542 ~l~~li~~cl~~~p~~RPt-----~~ev~~  566 (625)
                      .+.+++.+||+.+|++||+     ++|+++
T Consensus       222 ~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         222 AAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            8999999999999999999     677665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-35  Score=291.69  Aligned_cols=247  Identities=24%  Similarity=0.402  Sum_probs=204.0

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCCh--HHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSR--QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      +|++.+.||+|++|.||+++.+ +++.|++|.+.....  ...+.+.+|++++++++|||++++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4788899999999999999865 678999999876543  5667899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+++...   ..+++..+..++.+++.+|.+||+.+   ++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            9999999988654   34899999999999999999999775   99999999999999999999999999987654433


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                      . .....++..|+|||.+.+..++.++|||+||+++|+|++|+.|+.....    ....+....          ......
T Consensus       155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~~~----------~~~~~~  219 (254)
T cd06627         155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRIVQ----------DDHPPL  219 (254)
T ss_pred             c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHhc----------cCCCCC
Confidence            2 2234688999999999888889999999999999999999988643221    111111110          011123


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      +...+..+.+++.+||+.+|++||++.+++.
T Consensus       220 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         220 PEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            4455678899999999999999999999884

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=8.7e-35  Score=306.04  Aligned_cols=260  Identities=25%  Similarity=0.332  Sum_probs=197.5

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC------
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG------  366 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------  366 (625)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++...  .......+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999965 7899999988542  334456778899999999999999999987643      


Q ss_pred             CeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccc
Q 042149          367 PESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGL  446 (625)
Q Consensus       367 ~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgl  446 (625)
                      ...++||||+.+ +|.+.+...     ++...+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence            357999999964 777766321     788899999999999999999775   99999999999999999999999999


Q ss_pred             ceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHH-----------
Q 042149          447 ARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVW-----------  515 (625)
Q Consensus       447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~-----------  515 (625)
                      ++.......  .....+++.|+|||.+.+..++.++||||||+++|+|++|+.|+...+.... .....           
T Consensus       165 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~  241 (353)
T cd07850         165 ARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ-WNKIIEQLGTPSDEFM  241 (353)
T ss_pred             ceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCCHHHH
Confidence            987543322  2234678999999999999999999999999999999999988754321110 00000           


Q ss_pred             -------Hhhhccc-------cccccCCCC----CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          516 -------KHYKANR-------ITQSMDPGL----TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       516 -------~~~~~~~-------~~~~i~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                             ..+....       ..+......    ....+...+..+.+++.+||+.||++|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                   0000000       001111100    011122346678999999999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-34  Score=292.66  Aligned_cols=249  Identities=22%  Similarity=0.320  Sum_probs=198.8

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC-----ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--Cee
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN-----SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG--PES  369 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~  369 (625)
                      .+|++.+.||+|+||.||+|... +++.||+|.+...     ..+....+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46889999999999999999964 6899999987532     234556889999999999999999999988764  468


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      ++||||+++++|.+.+.....   +++.....++.+++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~---l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGA---LTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            899999999999998864432   788999999999999999999775   99999999999999999999999999976


Q ss_pred             eCCCCc--eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccccccc
Q 042149          450 VAPDKT--HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM  527 (625)
Q Consensus       450 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  527 (625)
                      ......  .......++..|+|||.+.+..++.++|+||||+++|+|++|+.|+.......    ..         .+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~---------~~~~  222 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA----AI---------FKIA  222 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH----HH---------HHHH
Confidence            532111  11123568999999999988889999999999999999999999864321110    01         1111


Q ss_pred             CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       528 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ........|......+.+++.+||+ +|..||+..+++.
T Consensus       223 ~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         223 TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            1112233456677889999999999 5799999998775

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7e-35  Score=291.80  Aligned_cols=250  Identities=20%  Similarity=0.300  Sum_probs=205.2

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      +|++.+.||.|+||.||++.+. +++.+++|++....  ......+.+|+++++.++|||++++++.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4788899999999999999975 68999999987653  35567889999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccC-CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          376 VPNRSLDQILFVKN-TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       376 ~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      +++++|.+++.... ....+++..+..++.+++.||.+||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999886542 1245899999999999999999999775   9999999999999999999999999998765443


Q ss_pred             ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          455 THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                      . ......+++.|+|||.+.+..++.++|+||+|+++++|++|+.|+......     .........         ....
T Consensus       158 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~~---------~~~~  222 (258)
T cd08215         158 D-LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-----ELALKILKG---------QYPP  222 (258)
T ss_pred             c-eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH-----HHHHHHhcC---------CCCC
Confidence            1 223346889999999998888999999999999999999999886433211     111111111         1122


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .+...+..+.+++.+||..+|++|||+.++++
T Consensus       223 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         223 IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            23455677899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.3e-34  Score=300.08  Aligned_cols=248  Identities=29%  Similarity=0.418  Sum_probs=196.3

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      .|+..+.||+|+||.||+|+.. ++..+|+|++...   ..+....+.+|++++++++|||++++++++.++...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            4778889999999999999965 6889999998643   23445678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+.+ +|.+.+...  ...+++.++..++.+++.||.|||+.+   ++||||+|+||+++.++.++|+|||++...... 
T Consensus       106 ~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-  178 (317)
T cd06635         106 YCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-  178 (317)
T ss_pred             CCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence            9975 676666432  234899999999999999999999775   999999999999999999999999998754322 


Q ss_pred             ceeeecCCCCccccCccccc---cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          455 THVSTGIAGTLGYMAPEYLV---RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                          ....+++.|+|||++.   .+.++.++||||||+++|||++|+.|+........     ........        .
T Consensus       179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-----~~~~~~~~--------~  241 (317)
T cd06635         179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQNE--------S  241 (317)
T ss_pred             ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-----HHHHHhcc--------C
Confidence                2246888999999974   45688999999999999999999988643211110     11111110        0


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcc
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN  570 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  570 (625)
                      ........+..+.+++.+||+.+|++||++.+|++.+..
T Consensus       242 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  280 (317)
T cd06635         242 PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV  280 (317)
T ss_pred             CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence            111123456678999999999999999999999976543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=7.8e-35  Score=298.40  Aligned_cols=259  Identities=17%  Similarity=0.190  Sum_probs=186.6

Q ss_pred             hcCccccccccccCceEEEEEEeCC----CCEEEEEEeecCChHHH-----------HHHHHHHHHHhcCCCCceeeeee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPD----GRNIAVKRLFFNSRQWV-----------DQFFNEVNLISGIQHKNVVRLLG  361 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpniv~l~~  361 (625)
                      .+.|++.++||+|+||.||+|.+.+    +..+|+|+.........           .....++..+..++|+||+++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            4679999999999999999999654    34566665433321110           11233445566778999999999


Q ss_pred             eeeeCC----eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC
Q 042149          362 CSIEGP----ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL  437 (625)
Q Consensus       362 ~~~~~~----~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~  437 (625)
                      ++....    ..++++|++. .++.+.+....   ..++..+..++.|++.||.|||+.+   |+||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence            766543    3467788764 35555553322   2567888999999999999999775   99999999999999999


Q ss_pred             ceEEeecccceeeCCCCce------eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccch
Q 042149          438 TPKIADFGLARHVAPDKTH------VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVL  511 (625)
Q Consensus       438 ~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~  511 (625)
                      .++|+|||+++.+......      ......||+.|+|||++.+..++.++||||||+++|||++|+.|+..........
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            9999999999876432211      1123469999999999999999999999999999999999999986543333322


Q ss_pred             hhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHc
Q 042149          512 HTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLN  569 (625)
Q Consensus       512 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  569 (625)
                      ......+..    ++......   ..+.+..+.+++..||+.+|++||++.++++.|+
T Consensus       244 ~~~~~~~~~----~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        244 HAAKCDFIK----RLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHhHHHHHH----Hhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            222111110    11111111   2234677899999999999999999999998763

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-35  Score=298.08  Aligned_cols=260  Identities=24%  Similarity=0.335  Sum_probs=197.3

Q ss_pred             ccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--CeeEEEEE
Q 042149          300 FDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG--PESLLVYE  374 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lV~e  374 (625)
                      |++.++||+|++|.||+|+.. +++.+|+|++....  ......+.+|+.++++++|||++++++++...  ...++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            677889999999999999976 58899999997653  34456788999999999999999999999888  89999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+++ +|.+++....  ..+++..++.++.++++||+|||..+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9975 8888775432  34899999999999999999999775   9999999999999999999999999998765443


Q ss_pred             ceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcc------cccc--
Q 042149          455 THVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN------RITQ--  525 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~------~~~~--  525 (625)
                      ........++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...... .............      ...+  
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchhhccccccch
Confidence            222233457889999998765 46789999999999999999999886533221 1111111100000      0000  


Q ss_pred             ---ccCC------CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          526 ---SMDP------GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       526 ---~i~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                         ...+      .+.......++..+.+++.+||+.+|++||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence               0000      0000011112667899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.2e-34  Score=294.23  Aligned_cols=244  Identities=25%  Similarity=0.300  Sum_probs=193.4

Q ss_pred             ccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCCCc
Q 042149          306 LGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSL  381 (625)
Q Consensus       306 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~sL  381 (625)
                      ||+|+||+||++..+ +++.+|+|.+....   ......+.+|+++++.++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999865 68999999886532   22345677899999999999999999999999999999999999999


Q ss_pred             chhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceeeecC
Q 042149          382 DQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGI  461 (625)
Q Consensus       382 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  461 (625)
                      .+++..... ..+++..+..++.|++.+|.|||+.+   ++||||+|+||++++++.++|+|||++........  ....
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~  154 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGR  154 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--cccc
Confidence            998865443 34899999999999999999999775   99999999999999999999999999876543211  2234


Q ss_pred             CCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHH
Q 042149          462 AGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEAS  541 (625)
Q Consensus       462 ~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  541 (625)
                      .++..|+|||.+.+..++.++||||||+++|+|++|+.|+........ .    ......     +. ......+...+.
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~----~~~~~~-----~~-~~~~~~~~~~~~  223 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-K----EELKRR-----TL-EMAVEYPDKFSP  223 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-H----HHHHhc-----cc-cccccCCccCCH
Confidence            678899999999888899999999999999999999998754332111 0    000000     00 011122344577


Q ss_pred             HHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042149          542 RVLQIGLLCTQAPVALRP-----SMAEVVH  566 (625)
Q Consensus       542 ~l~~li~~cl~~~p~~RP-----t~~ev~~  566 (625)
                      .+.+++.+||+.+|++||     ++.++++
T Consensus       224 ~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         224 EAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             HHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            889999999999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.1e-34  Score=296.42  Aligned_cols=256  Identities=23%  Similarity=0.281  Sum_probs=201.6

Q ss_pred             CccccccccccCceEEEEEEe----CCCCEEEEEEeecCC----hHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCee
Q 042149          299 FFDNSRKLGQGGAGSVFRGTL----PDGRNIAVKRLFFNS----RQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPES  369 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~  369 (625)
                      +|++.+.||+|++|.||+++.    .+++.||||.+....    ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            477889999999999999984    257889999886432    23346788999999999 599999999999999999


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      ++||||+++++|.+.+....   .+++..+..++.|++++|.|||+.+   ++||||||+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            99999999999999886433   3889999999999999999999765   99999999999999999999999999877


Q ss_pred             eCCCCceeeecCCCCccccCccccccCc--ccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccccccc
Q 042149          450 VAPDKTHVSTGIAGTLGYMAPEYLVRGQ--LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM  527 (625)
Q Consensus       450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  527 (625)
                      .............|++.|+|||.+.+..  .+.++||||||+++|||++|..|+........ .....+....       
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~~~~~~~-------  226 (288)
T cd05583         155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS-QSEISRRILK-------  226 (288)
T ss_pred             cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch-HHHHHHHHHc-------
Confidence            5543332223356899999999987655  78899999999999999999998753221111 1111111000       


Q ss_pred             CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       528 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                         ...+.+...+..+.+++.+||+.+|++|||+.++.+.|+..
T Consensus       227 ---~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         227 ---SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             ---cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence               01122344566789999999999999999999888877653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.4e-34  Score=295.93  Aligned_cols=251  Identities=24%  Similarity=0.266  Sum_probs=197.7

Q ss_pred             CccccccccccCceEEEEEEe----CCCCEEEEEEeecCC----hHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCee
Q 042149          299 FFDNSRKLGQGGAGSVFRGTL----PDGRNIAVKRLFFNS----RQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPES  369 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~  369 (625)
                      +|++.+.||+|+||.||+++.    .+|+.||+|++....    ....+.+.+|+.+++++ +||||+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478889999999999999985    368899999986532    23346788999999999 599999999999999999


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      ++||||+++++|.+++....   .+++..+..++.|++.||.|||+.+   ++||||+|+|||++.++.+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            99999999999999886543   3788999999999999999999775   99999999999999999999999999987


Q ss_pred             eCCCCceeeecCCCCccccCccccccC--cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccccccc
Q 042149          450 VAPDKTHVSTGIAGTLGYMAPEYLVRG--QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM  527 (625)
Q Consensus       450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  527 (625)
                      .............|+..|+|||.+...  .++.++||||||+++|+|++|+.|+.......... ........       
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-~~~~~~~~-------  226 (290)
T cd05613         155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA-EISRRILK-------  226 (290)
T ss_pred             cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHH-HHHHHhhc-------
Confidence            654333222345689999999998753  46789999999999999999999875432211111 11111000       


Q ss_pred             CCCCCCCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042149          528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRP-----SMAEVVH  566 (625)
Q Consensus       528 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~  566 (625)
                         ...+.+...+..+.+++.+||+.+|++||     +..+++.
T Consensus       227 ---~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         227 ---SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ---cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence               01122444567789999999999999997     6677664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-35  Score=297.83  Aligned_cols=261  Identities=23%  Similarity=0.304  Sum_probs=196.3

Q ss_pred             ccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          300 FDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      |++.++||.|++|.||+|.++ +|+.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            677889999999999999965 78999999986543  233456889999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      + ++|.+++..... ..+++..+..++.|++++|.|||+.+   ++||||+|+||+++.++.++|+|||++.........
T Consensus        81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            5 688888754432 34899999999999999999999764   999999999999999999999999998765432211


Q ss_pred             eeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhh----------HHHhhhcc-ccc
Q 042149          457 VSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT----------VWKHYKAN-RIT  524 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~----------~~~~~~~~-~~~  524 (625)
                       .....+++.|+|||++.+. .++.++||||||+++|+|++|+.|+............          .|...... ...
T Consensus       156 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         156 -YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             -cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence             1223568899999988664 5688999999999999999999887543221111110          00000000 000


Q ss_pred             ccc---CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          525 QSM---DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       525 ~~i---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ...   .........+..+..+.+++.+||+.+|++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            000   000001112334567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.4e-34  Score=294.30  Aligned_cols=242  Identities=23%  Similarity=0.274  Sum_probs=187.7

Q ss_pred             cccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHh---cCCCCceeeeeeeeeeCCeeEEEEEecC
Q 042149          305 KLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLIS---GIQHKNVVRLLGCSIEGPESLLVYEYVP  377 (625)
Q Consensus       305 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~---~l~hpniv~l~~~~~~~~~~~lV~e~~~  377 (625)
                      .||+|+||.||++... +++.+|+|.+....   ......+.+|..+++   ...||||+.+++.+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999975 68899999886432   222233445544433   4479999999999999999999999999


Q ss_pred             CCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCcee
Q 042149          378 NRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV  457 (625)
Q Consensus       378 ~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  457 (625)
                      +++|.+++....   .+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++........  
T Consensus        81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~--  152 (279)
T cd05633          81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--  152 (279)
T ss_pred             CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence            999998886443   3899999999999999999999775   99999999999999999999999999875533221  


Q ss_pred             eecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCC
Q 042149          458 STGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP  536 (625)
Q Consensus       458 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  536 (625)
                       ....|++.|+|||.+.+ ..++.++||||||+++|||++|+.|+........  .......          .......+
T Consensus       153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~----------~~~~~~~~  219 (279)
T cd05633         153 -HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMT----------LTVNVELP  219 (279)
T ss_pred             -cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--HHHHHHh----------hcCCcCCc
Confidence             23468999999999864 5688999999999999999999998754322111  1111100          01112234


Q ss_pred             hHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042149          537 ENEASRVLQIGLLCTQAPVALRP-----SMAEVVHM  567 (625)
Q Consensus       537 ~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~  567 (625)
                      ...+.++.+++.+||+.||++||     +++|+++.
T Consensus       220 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         220 DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            45677889999999999999999     59998874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.1e-34  Score=297.32  Aligned_cols=263  Identities=23%  Similarity=0.316  Sum_probs=194.6

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCCe-----
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEGPE-----  368 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~-----  368 (625)
                      ++|++.+.||+|+||.||+|.+. +++.||||++....  ......+.+|+.+++.+. ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46889999999999999999965 68999999876542  223457888999999995 6999999999887665     


Q ss_pred             eEEEEEecCCCCcchhhhccCC--cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC-CCceEEeecc
Q 042149          369 SLLVYEYVPNRSLDQILFVKNT--IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE-KLTPKIADFG  445 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~-~~~~kl~Dfg  445 (625)
                      .++||||+++ +|.+++.....  ...+++..++.++.||+.||.|||..+   |+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999986 78887754322  245899999999999999999999775   999999999999998 8899999999


Q ss_pred             cceeeCCCCceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccc--
Q 042149          446 LARHVAPDKTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR--  522 (625)
Q Consensus       446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--  522 (625)
                      +++.+...... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..|+........... .........  
T Consensus       157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~  234 (295)
T cd07837         157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH-IFKLLGTPTEQ  234 (295)
T ss_pred             cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHHHhCCCChh
Confidence            98765332211 122356889999998865 4578999999999999999999988754322111110 001000000  


Q ss_pred             ----cccccC----CCCC----CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          523 ----ITQSMD----PGLT----GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       523 ----~~~~i~----~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                          .....+    +...    ....+..+..+.++|.+||+.+|++||++.|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                000000    0000    0001235677899999999999999999999885

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-34  Score=302.87  Aligned_cols=262  Identities=22%  Similarity=0.297  Sum_probs=195.0

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC-----Cee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG-----PES  369 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~  369 (625)
                      .++|++.++||+|+||.||+|++. +++.||||++... .......+.+|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            578999999999999999999864 6899999998643 334456788999999999999999999876644     357


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      ++||||+.+ +|.+++..    ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            999999964 77666632    24899999999999999999999775   99999999999999999999999999876


Q ss_pred             eCCCCcee--eecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhh-------
Q 042149          450 VAPDKTHV--STGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK-------  519 (625)
Q Consensus       450 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~-------  519 (625)
                      ........  .....|++.|+|||.+.+ ..++.++||||||+++|+|++|+.|+....... ..........       
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-~~~~~~~~~~~~~~~~~  234 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-QLNLILGVLGTPSQEDL  234 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCCHHHH
Confidence            54322211  123568999999998755 468899999999999999999998875322111 0000000000       


Q ss_pred             ----ccccccc---cCCCCCCC---CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          520 ----ANRITQS---MDPGLTGR---FPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       520 ----~~~~~~~---i~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                          .......   ........   ..+..+..+.+++.+||+.+|++|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                0000000   00000000   012235678999999999999999999999975

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.6e-34  Score=296.72  Aligned_cols=263  Identities=25%  Similarity=0.292  Sum_probs=195.4

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--CeeEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG--PESLL  371 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~l  371 (625)
                      .++|++.+.||+|+||.||+|..+ +++.||+|++....  ......+.+|+.++++++||||+++++++.+.  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467999999999999999999975 68999999986543  22233567899999999999999999998765  56899


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||||+.+ +|.+++....  ..+++.++..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++....
T Consensus        86 v~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999964 7877775432  34899999999999999999999775   9999999999999999999999999998765


Q ss_pred             CCCceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhH-----------HHhhh
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV-----------WKHYK  519 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~-----------~~~~~  519 (625)
                      ..... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.|+....... .+...           |..+.
T Consensus       160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         160 LPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             CccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCChhhchhhh
Confidence            43221 122345788999999865 457899999999999999999998875332211 11111           11111


Q ss_pred             cccccccc--CCCCCCC---CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          520 ANRITQSM--DPGLTGR---FPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       520 ~~~~~~~i--~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      ........  .......   .....+..+.+++.+||+.||++|||++|++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00000000  0000000   001235667899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=8.1e-35  Score=297.95  Aligned_cols=244  Identities=26%  Similarity=0.390  Sum_probs=196.6

Q ss_pred             cccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCCCc
Q 042149          303 SRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSL  381 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~sL  381 (625)
                      ..+||+|+||.||++..+ +++.||||++........+.+.+|+.+++.++||||+++++.+...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            467999999999999874 6899999998665555667899999999999999999999999999999999999999999


Q ss_pred             chhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceeeecC
Q 042149          382 DQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGI  461 (625)
Q Consensus       382 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  461 (625)
                      .+++...    .+++..+..++.|++.+|+|||+.+   ++|+||+|+||++++++.++|+|||++........ .....
T Consensus       105 ~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~  176 (292)
T cd06657         105 TDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL  176 (292)
T ss_pred             HHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence            9877432    3789999999999999999999775   99999999999999999999999999876543322 12235


Q ss_pred             CCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHH
Q 042149          462 AGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEAS  541 (625)
Q Consensus       462 ~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  541 (625)
                      .+++.|+|||.+.+..++.++|+||||+++|+|++|+.|+...... ....    ....     .......  .....+.
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-~~~~----~~~~-----~~~~~~~--~~~~~~~  244 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAMK----MIRD-----NLPPKLK--NLHKVSP  244 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHH----HHHh-----hCCcccC--CcccCCH
Confidence            6889999999998888899999999999999999999986432111 1110    0000     0011110  1123456


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          542 RVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       542 ~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .+.+++.+||+.+|.+||++.++++
T Consensus       245 ~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         245 SLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHHHHHHhCCcccCcCHHHHhc
Confidence            6889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.1e-34  Score=301.14  Aligned_cols=263  Identities=24%  Similarity=0.342  Sum_probs=197.5

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeC--Cee
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEG--PES  369 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~--~~~  369 (625)
                      ..++|++.+.||+|+||.||+|.+. +++.+|||++...  .......+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4678899999999999999999975 6889999988542  334456678899999999 999999999988643  468


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      ++||||++ ++|..++...    .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 4888877433    4789999999999999999999775   99999999999999999999999999986


Q ss_pred             eCCCCce----eeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHH---------
Q 042149          450 VAPDKTH----VSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVW---------  515 (625)
Q Consensus       450 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~---------  515 (625)
                      .......    ......|++.|+|||++.+ ..++.++||||||+++|+|++|+.|+........ .....         
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~  235 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAE  235 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHH
Confidence            6433221    2224568999999998765 4578999999999999999999988753221111 10000         


Q ss_pred             --HhhhccccccccCC---CC---CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          516 --KHYKANRITQSMDP---GL---TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       516 --~~~~~~~~~~~i~~---~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                        ...........++.   ..   .....+..+..+.+++.+||+.+|++|||+.++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence              00000000011110   00   001112246778999999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.6e-34  Score=299.34  Aligned_cols=259  Identities=19%  Similarity=0.239  Sum_probs=192.6

Q ss_pred             cccccc--CceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCC
Q 042149          304 RKLGQG--GAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPN  378 (625)
Q Consensus       304 ~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~  378 (625)
                      ..||+|  +||+||++++. +++.||||++...  ..+..+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            457777  89999999975 7899999998653  344567889999999999999999999999999999999999999


Q ss_pred             CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCcee-
Q 042149          379 RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV-  457 (625)
Q Consensus       379 ~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~-  457 (625)
                      ++|.+++..... ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            999998865432 24889999999999999999999775   9999999999999999999999998653322111100 


Q ss_pred             -----eecCCCCccccCccccccC--cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHH--------------
Q 042149          458 -----STGIAGTLGYMAPEYLVRG--QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWK--------------  516 (625)
Q Consensus       458 -----~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~--------------  516 (625)
                           .....++..|+|||++.+.  .++.++||||||+++|||++|+.|+...............              
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence                 0012346679999999764  4789999999999999999999987533221111100000              


Q ss_pred             --h-------hh----ccc-----cccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          517 --H-------YK----ANR-----ITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       517 --~-------~~----~~~-----~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                        .       +.    ...     .....+..+....+...+..+.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence              0       00    000     00111111222223456778999999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=8.1e-35  Score=292.68  Aligned_cols=243  Identities=24%  Similarity=0.318  Sum_probs=195.7

Q ss_pred             ccccCceEEEEEEeC-CCCEEEEEEeecCCh---HHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCCCc
Q 042149          306 LGQGGAGSVFRGTLP-DGRNIAVKRLFFNSR---QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSL  381 (625)
Q Consensus       306 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~sL  381 (625)
                      ||+|+||.||++++. +++.+++|.+.....   ...+.+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999976 589999999865433   4567889999999999999999999999999999999999999999


Q ss_pred             chhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc------
Q 042149          382 DQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT------  455 (625)
Q Consensus       382 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~------  455 (625)
                      .+++....   .+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++........      
T Consensus        81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            99886543   4899999999999999999999775   99999999999999999999999999875433221      


Q ss_pred             -eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          456 -HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       456 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                       .......++..|+|||.......+.++||||||+++|+|++|+.|+......     ..........        .  .
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~~~--------~--~  219 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----EIFQNILNGK--------I--E  219 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcCC--------c--C
Confidence             1222356788999999998888999999999999999999999886432211     0111111111        0  1


Q ss_pred             CChH--HHHHHHHHHhhccCCCCCCCCCHHHHHHHHc
Q 042149          535 FPEN--EASRVLQIGLLCTQAPVALRPSMAEVVHMLN  569 (625)
Q Consensus       535 ~~~~--~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  569 (625)
                      .+..  .+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            1122  2677899999999999999999966666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.5e-34  Score=296.22  Aligned_cols=262  Identities=21%  Similarity=0.283  Sum_probs=194.9

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      ++|++.+.||+|++|.||+|+.+ +++.||+|++....  ....+.+.+|++++++++||||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57889999999999999999975 68899999886432  2334678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC-CCceEEeecccceeeCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE-KLTPKIADFGLARHVAPD  453 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~-~~~~kl~Dfgla~~~~~~  453 (625)
                      |++ ++|.+.+..... ..+++..+..++.||+.||+|||+++   ++||||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 477776643332 23678888899999999999999775   999999999999985 567999999999765432


Q ss_pred             CceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccc---------c
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR---------I  523 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---------~  523 (625)
                      .. ......+++.|+|||++.+. .++.++||||||+++|+|+||+.|+......+... ..........         +
T Consensus       157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        157 VR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF-KIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             cc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCChhhccccccc
Confidence            21 11234578899999988664 57899999999999999999998875432211111 1111000000         0


Q ss_pred             cccc--CCCCCC----CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          524 TQSM--DPGLTG----RFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       524 ~~~i--~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ....  .+....    ...+..+..+.+++.+|++.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000  000000    011234566889999999999999999999986

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.8e-34  Score=287.74  Aligned_cols=246  Identities=22%  Similarity=0.233  Sum_probs=190.9

Q ss_pred             HHHhcCccccccc--cccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCee
Q 042149          294 ERATDFFDNSRKL--GQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPES  369 (625)
Q Consensus       294 ~~~~~~y~~~~~l--G~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~  369 (625)
                      ....++|++.+.+  |+|+||.||+++.+ +++.+|+|.+........     |+.....+ +||||+++++.+...+..
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~   84 (267)
T PHA03390         10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGH   84 (267)
T ss_pred             HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence            3445677777777  99999999999965 688899998865422111     22222222 699999999999999999


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC-ceEEeecccce
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL-TPKIADFGLAR  448 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-~~kl~Dfgla~  448 (625)
                      ++||||+++++|.+++....   .+++.++..++.|+++||.|||+.+   ++||||||+||+++.++ .++|+|||++.
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~  158 (267)
T PHA03390         85 VLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK  158 (267)
T ss_pred             EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence            99999999999999986543   4899999999999999999999775   99999999999999888 99999999987


Q ss_pred             eeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          449 HVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      ......     ...+++.|+|||++.+..++.++||||||+++|||++|+.|+.......-......... .        
T Consensus       159 ~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~--------  224 (267)
T PHA03390        159 IIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-Q--------  224 (267)
T ss_pred             ecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-c--------
Confidence            654322     24688999999999988999999999999999999999998763322110011111110 0        


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPS-MAEVVH  566 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~ev~~  566 (625)
                      .  ....+...+..+.+++.+||+.+|.+||+ ++++++
T Consensus       225 ~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        225 K--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             c--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            0  11123356778899999999999999996 688874

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.6e-34  Score=301.71  Aligned_cols=264  Identities=19%  Similarity=0.286  Sum_probs=198.5

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeee----CCee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIE----GPES  369 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~  369 (625)
                      .++|++.+.||+|+||.||+|..+ +++.||+|++....  ......+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            478999999999999999999965 68999999986542  2345678889999999999999999998763    3468


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      ++||||+. ++|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999995 58888775433   3899999999999999999999775   99999999999999999999999999976


Q ss_pred             eCCCCce---eeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccch----------hhHH
Q 042149          450 VAPDKTH---VSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVL----------HTVW  515 (625)
Q Consensus       450 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~----------~~~~  515 (625)
                      .......   ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+..........          ...+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            5433221   1123568999999999865 468899999999999999999999875332111000          0000


Q ss_pred             HhhhccccccccCC-CCCCCC-----ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          516 KHYKANRITQSMDP-GLTGRF-----PENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       516 ~~~~~~~~~~~i~~-~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      .......+...++. ......     .+..+..+.+++.+||+.+|++||++++++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            00111111111110 000111     12346789999999999999999999998864

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.7e-34  Score=295.40  Aligned_cols=265  Identities=24%  Similarity=0.306  Sum_probs=197.4

Q ss_pred             HHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC---
Q 042149          294 ERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP---  367 (625)
Q Consensus       294 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~---  367 (625)
                      +...++|++.++||+|+||.||+|.++ +++.||||++....  ......+.+|+.++++++||||+++++++.+..   
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            345678999999999999999999975 58899999986543  223356778999999999999999999887654   


Q ss_pred             -------eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceE
Q 042149          368 -------ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPK  440 (625)
Q Consensus       368 -------~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~k  440 (625)
                             ..++|+||+++ +|...+...  ...+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.+|
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence                   78999999976 666655433  234899999999999999999999775   99999999999999999999


Q ss_pred             EeecccceeeCCCCceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhh
Q 042149          441 IADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK  519 (625)
Q Consensus       441 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~  519 (625)
                      |+|||++...............++..|+|||.+.+. .++.++||||||+++|||++|+.|+...... ..+....+...
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~~~~~~~~~~  235 (302)
T cd07864         157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQLELISRLCG  235 (302)
T ss_pred             eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhC
Confidence            999999987654332222223467889999988653 5788999999999999999999886532211 11111111110


Q ss_pred             ccc---cccc--------cCC------CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          520 ANR---ITQS--------MDP------GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       520 ~~~---~~~~--------i~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ...   ....        .+.      .... .....+..+.+++.+||+.+|++||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CCChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            000   0000        000      0000 01123667899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-34  Score=288.14  Aligned_cols=245  Identities=22%  Similarity=0.244  Sum_probs=190.0

Q ss_pred             ccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHH-HhcCCCCceeeeeeeeeeCCeeEEEEEecCC
Q 042149          304 RKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNL-ISGIQHKNVVRLLGCSIEGPESLLVYEYVPN  378 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~  378 (625)
                      +.||+|+||.||+|... +++.||||.+....   ......+..|..+ ....+||||+++++.+..++..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56999999999999964 68999999886542   2223344555554 4455899999999999999999999999999


Q ss_pred             CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceee
Q 042149          379 RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS  458 (625)
Q Consensus       379 ~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  458 (625)
                      ++|.+++....   .+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++.....     .
T Consensus        82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~  150 (260)
T cd05611          82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N  150 (260)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence            99999886543   3889999999999999999999775   99999999999999999999999999876433     1


Q ss_pred             ecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChH
Q 042149          459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPEN  538 (625)
Q Consensus       459 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  538 (625)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++|..|+.....     ...+.........      ........
T Consensus       151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~------~~~~~~~~  219 (260)
T cd05611         151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAVFDNILSRRIN------WPEEVKEF  219 (260)
T ss_pred             ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcccC------CCCccccc
Confidence            234688999999999888889999999999999999999998743221     1112221111110      01111234


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHHHcc
Q 042149          539 EASRVLQIGLLCTQAPVALRPSMAEVVHMLNN  570 (625)
Q Consensus       539 ~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  570 (625)
                      .+..+.+++.+||+.+|++||++.++.+.|..
T Consensus       220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         220 CSPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             CCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence            56778999999999999999987666555533

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.7e-34  Score=292.22  Aligned_cols=257  Identities=21%  Similarity=0.267  Sum_probs=191.0

Q ss_pred             ccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeC--CeeEEEEE
Q 042149          300 FDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEG--PESLLVYE  374 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~--~~~~lV~e  374 (625)
                      |++.++||+|+||.||+|+.+ +++.+|+|++.... ........+|+.+++++. ||||+++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            667889999999999999965 68899999886532 222234457899999885 99999999999887  88999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+++ +|.+.+....  ..+++..+..++.|++.||+|||+.+   ++||||||+||+++. +.+||+|||+++......
T Consensus        81 ~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMDM-NLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCCc-cHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            9975 7776664432  34899999999999999999999775   999999999999999 999999999998764332


Q ss_pred             ceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHH-----------hhhccc
Q 042149          455 THVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWK-----------HYKANR  522 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~-----------~~~~~~  522 (625)
                      ..  ....+++.|+|||++.. +.++.++||||||+++|||++|+.|+......+ .......           ......
T Consensus       154 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         154 PY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD-QIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             Cc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH-HHHHHHHHcCCCCHHHHHhhcccc
Confidence            22  23457899999997654 557889999999999999999998875432211 1111100           000000


Q ss_pred             cccccCCCCC----CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          523 ITQSMDPGLT----GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       523 ~~~~i~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ......+...    .......+..+.+++.+||+.+|++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0000000000    0011245788999999999999999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.1e-34  Score=294.37  Aligned_cols=248  Identities=24%  Similarity=0.296  Sum_probs=202.1

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCCeeEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV  372 (625)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++...   .......+.+|++++++++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46889999999999999999975 7899999988653   2344567889999999998 99999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+++++|.+++....   .+++..++.++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            99999999999886543   4899999999999999999999775   99999999999999999999999999876543


Q ss_pred             CCc-------------------eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhh
Q 042149          453 DKT-------------------HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT  513 (625)
Q Consensus       453 ~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~  513 (625)
                      ...                   .......++..|+|||.+....++.++||||||++++++++|+.|+......    ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~  230 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY----LT  230 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH----HH
Confidence            321                   1122346789999999998888999999999999999999999886533210    00


Q ss_pred             HHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCH----HHHHH
Q 042149          514 VWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSM----AEVVH  566 (625)
Q Consensus       514 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~----~ev~~  566 (625)
                       .....          ......+...+..+.+++.+||+.+|++||++    +++++
T Consensus       231 -~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         231 -FQKIL----------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             -HHHHH----------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence             01111          01112344557778999999999999999999    66654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.6e-34  Score=294.85  Aligned_cols=259  Identities=19%  Similarity=0.239  Sum_probs=190.9

Q ss_pred             cccccccCceEEEEEEeCCCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCCC
Q 042149          303 SRKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRS  380 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~s  380 (625)
                      .+.+|.|+++.|+++.. +++.||||++...  ..+..+.+.+|+++++.++||||+++++++.+....+++|||+++++
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            33444555555555544 6899999998754  45567789999999999999999999999999999999999999999


Q ss_pred             cchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce----
Q 042149          381 LDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH----  456 (625)
Q Consensus       381 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~----  456 (625)
                      |.+++..... ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||.+.........    
T Consensus        86 l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          86 CEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             HHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            9998865432 23788999999999999999999775   999999999999999999999999988755322211    


Q ss_pred             --eeecCCCCccccCcccccc--CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHh----hh-------cc
Q 042149          457 --VSTGIAGTLGYMAPEYLVR--GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKH----YK-------AN  521 (625)
Q Consensus       457 --~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~----~~-------~~  521 (625)
                        ......++..|+|||++..  ..++.++||||||+++|||++|+.|+................    +.       ..
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence              1123457788999999866  358899999999999999999999875432221111110000    00       00


Q ss_pred             cccc----ccCC----CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          522 RITQ----SMDP----GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       522 ~~~~----~i~~----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ...+    ..++    ......+.....++.+++.+||+.+|++|||++++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            0000    0000    0011123345677899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-35  Score=274.08  Aligned_cols=249  Identities=24%  Similarity=0.363  Sum_probs=197.0

Q ss_pred             ccccccccccCceEEEEEEeC-CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCCeeEEEEEec
Q 042149          300 FDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      .+.+..||.|..|.||+++.+ +|..+|||.+... +.+..+++...+.++.... .|.||+.+|+|..+...+|.||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            455677999999999999976 5889999999765 5666778888888876664 899999999999999999999998


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                       ...++.++....  +++++.-+-++...++.||.||.+++  +|||||+||+|||+|+.|++||+|||++-.+-....+
T Consensus       174 -s~C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh  248 (391)
T KOG0983|consen  174 -STCAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH  248 (391)
T ss_pred             -HHHHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence             446666664332  33788888889999999999999865  7999999999999999999999999999776544333


Q ss_pred             eeecCCCCccccCcccccc---CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLVR---GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                        +...|-+.|||||.+.-   .+|+.++||||||++++||.||+.|+.....+-+.+..+..    .+     .+.+..
T Consensus       249 --trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln----~e-----PP~L~~  317 (391)
T KOG0983|consen  249 --TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN----EE-----PPLLPG  317 (391)
T ss_pred             --ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh----cC-----CCCCCc
Confidence              23578999999999854   47889999999999999999999998765443333222211    11     011111


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                        ....+..+.+++..||++|+.+||...++++
T Consensus       318 --~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  318 --HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             --ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence              1225778899999999999999999999875

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4e-34  Score=299.04  Aligned_cols=262  Identities=21%  Similarity=0.280  Sum_probs=196.9

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC-----Ce
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG-----PE  368 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~  368 (625)
                      .++|.+.+.||+|+||+||+|+.. +++.||||++...  .......+.+|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457999999999999999999964 6899999988643  233455678899999999999999999987644     35


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      .++||||+. ++|.+++....   .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999995 67877775433   3899999999999999999999775   9999999999999999999999999998


Q ss_pred             eeCCCCceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHH-----------
Q 042149          449 HVAPDKTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWK-----------  516 (625)
Q Consensus       449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~-----------  516 (625)
                      ....... ......++..|+|||.+.. ..++.++||||||+++|+|++|+.|+....... .......           
T Consensus       157 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         157 TTSEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QLKLITELLGSPSEEDLG  234 (337)
T ss_pred             ccCCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCChHHhh
Confidence            7644322 1223467889999998865 468899999999999999999998875332110 0000000           


Q ss_pred             hhhcccccccc---CCCCC---CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          517 HYKANRITQSM---DPGLT---GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       517 ~~~~~~~~~~i---~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      ..........+   .....   ....+..+..+.+++.+||+.+|++|||++++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            00000000000   00000   00122456778999999999999999999999865

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=7e-34  Score=293.35  Aligned_cols=247  Identities=28%  Similarity=0.432  Sum_probs=194.8

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      +.|+..+.||+|+||.||+|+.. ++..+|+|.+...   .......+.+|+++++.++|||++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34777889999999999999975 5788999988642   3344567889999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+. ++|.+.+....  ..+++..+..++.+++.+|.|||+.+   ++||||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            9996 57777664332  34789999999999999999999775   999999999999999999999999998765432


Q ss_pred             CceeeecCCCCccccCccccc---cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLV---RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                      .     ...+++.|+|||.+.   .+.++.++||||||+++|+|++|+.|+.........     .......     .+ 
T Consensus       169 ~-----~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-----~~~~~~~-----~~-  232 (308)
T cd06634         169 N-----XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-----YHIAQNE-----SP-  232 (308)
T ss_pred             c-----cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH-----HHHhhcC-----CC-
Confidence            2     246889999999975   356788999999999999999999886432111100     0011100     00 


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHML  568 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  568 (625)
                        ...+...+..+.+++.+||+.+|++||++.++++..
T Consensus       233 --~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         233 --ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             --CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence              111234566789999999999999999999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-34  Score=291.08  Aligned_cols=259  Identities=21%  Similarity=0.296  Sum_probs=198.9

Q ss_pred             ccccccccccCceEEEEEEeC-CCCEEEEEEeecCCh--HHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          300 FDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSR--QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      |++.+.||+|++|.||+|... +++.+++|++.....  .....+.+|+.++++++||||+++++++..+...++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999975 688999998865432  34567889999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      ++ +|.+++....  ..+++..+..++.+++.||.|||+.+   ++|+||||+||+++.++.++|+|||.+........ 
T Consensus        81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-  153 (283)
T cd05118          81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-  153 (283)
T ss_pred             CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence            75 8877775533  34899999999999999999999775   99999999999999999999999999887654431 


Q ss_pred             eeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhc---cccccccC----
Q 042149          457 VSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKA---NRITQSMD----  528 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~i~----  528 (625)
                      ......++..|+|||.+.+. .++.++|+||||+++|+|+||+.|+........ ..........   .......+    
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-LFKIFRTLGTPDPEVWPKFTSLARN  232 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCchHhcccchhhhhh
Confidence            12234578899999998776 789999999999999999999987643322111 1010000000   00000000    


Q ss_pred             -------C--CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          529 -------P--GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       529 -------~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                             .  .......+..+.++.+++.+||+.+|.+||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                   0  0001112345778999999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.8e-34  Score=293.60  Aligned_cols=253  Identities=24%  Similarity=0.346  Sum_probs=193.6

Q ss_pred             hcCccccccccccCceEEEEEEeCC-CCEEEEEEeecCC-hHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCCeeEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~  373 (625)
                      .++|++.++||+|+||.||+|.+++ ++.||||++.... ......+..|+.++.+.. ||||+++++++.+....++||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            4678899999999999999999864 8999999987543 333456677887776664 999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+. ++|.+++....  ..+++..+..++.+++.||.|||+..  +|+||||+|+||++++++.+||+|||++..+...
T Consensus        94 e~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          94 ELMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             eccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            9985 46776664422  25899999999999999999999632  4999999999999999999999999998765433


Q ss_pred             CceeeecCCCCccccCccccccCc----ccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQ----LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      ...  ....+++.|+|||.+.+..    ++.++||||||+++|+|++|+.|+.........+   ...... ..     +
T Consensus       169 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~~-~~-----~  237 (296)
T cd06618         169 KAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL---TKILQE-EP-----P  237 (296)
T ss_pred             Ccc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHH---HHHhcC-CC-----C
Confidence            222  2235788999999986543    7889999999999999999999874322111111   111111 00     0


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      ..  +.....+.++.+++.+||+.+|++||++.++++.
T Consensus       238 ~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         238 SL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00  0111345678999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=7.6e-34  Score=292.99  Aligned_cols=263  Identities=22%  Similarity=0.298  Sum_probs=191.1

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC------
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP------  367 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------  367 (625)
                      .++|++.++||+|+||.||+|+.. +++.||||++....  ......+.+|+.++++++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            457999999999999999999975 68999999886432  222345678999999999999999999887654      


Q ss_pred             --eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecc
Q 042149          368 --ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFG  445 (625)
Q Consensus       368 --~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfg  445 (625)
                        ..++||||+.+ +|.+.+....  ..+++.++..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence              45999999964 7777664332  24899999999999999999999775   9999999999999999999999999


Q ss_pred             cceeeCCCCce---eeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHH-----
Q 042149          446 LARHVAPDKTH---VSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWK-----  516 (625)
Q Consensus       446 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~-----  516 (625)
                      ++.........   ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+....... .......     
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~-~~~~~~~~~~~~  243 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH-QLTLISQLCGSI  243 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence            99765432221   11234578899999988664 47889999999999999999998764332111 1000000     


Q ss_pred             ------hhhcccccccc-CCC-CCCCC-----ChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          517 ------HYKANRITQSM-DPG-LTGRF-----PENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       517 ------~~~~~~~~~~i-~~~-~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                            ..........+ .+. .....     +......+.+++.+||+.+|++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence                  00000000000 000 00000     0112345679999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-33  Score=286.90  Aligned_cols=259  Identities=24%  Similarity=0.285  Sum_probs=193.1

Q ss_pred             ccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcC---CCCceeeeeeeeeeCCe-----
Q 042149          300 FDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGI---QHKNVVRLLGCSIEGPE-----  368 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~~~~-----  368 (625)
                      |++.++||+|+||.||+|+++ +++.+|+|++....  ......+.+|+.+++++   +||||+++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            677889999999999999976 48999999986432  22234566788777666   59999999999988776     


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      .+++|||+.+ +|.+++..... ..+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999975 78887754332 24899999999999999999999775   9999999999999999999999999997


Q ss_pred             eeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcc---cc--
Q 042149          449 HVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN---RI--  523 (625)
Q Consensus       449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~--  523 (625)
                      ........  ....++..|+|||++.+..++.++||||||+++|||++|+.|+..... .+............   ..  
T Consensus       156 ~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         156 IYSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             eccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcCCCChHhcCC
Confidence            76433221  223578899999999988999999999999999999999877543221 11111111110000   00  


Q ss_pred             -----ccccCCCCC---CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          524 -----TQSMDPGLT---GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       524 -----~~~i~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                           .........   .......+..+.+++.+||+.+|++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                 000000000   0111244577889999999999999999999884

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-34  Score=284.67  Aligned_cols=256  Identities=25%  Similarity=0.318  Sum_probs=200.6

Q ss_pred             hcCccccccccccCceEEEEEEe-CCCCEEEEEEeecC--C-----hHHHHHHHHHHHHHhcCCCCceeeeeeeee-eCC
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFN--S-----RQWVDQFFNEVNLISGIQHKNVVRLLGCSI-EGP  367 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~  367 (625)
                      .++|-.+++||+|||+.||+|.+ ...+.||||+-..+  .     ....+...+|..|.+.|+||.||++|++|. +..
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            35688899999999999999985 46788999976543  1     223456788999999999999999999986 556


Q ss_pred             eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEc---CCCceEEeec
Q 042149          368 ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADF  444 (625)
Q Consensus       368 ~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~---~~~~~kl~Df  444 (625)
                      .++-|+|||+|.+|+-+|....   .++++++..|+.||+.||.||.+. ..+|||-||||.|||+.   ..|.+||.||
T Consensus       542 sFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence            7899999999999999986443   489999999999999999999988 67999999999999995   3488999999


Q ss_pred             ccceeeCCCCce------eeecCCCCccccCccccccC----cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhH
Q 042149          445 GLARHVAPDKTH------VSTGIAGTLGYMAPEYLVRG----QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV  514 (625)
Q Consensus       445 gla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~  514 (625)
                      |+++.+..+...      ......||.+|++||.+.-+    +.+.|+||||+|||+|+.+.|++||.-.....++++. 
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe-  696 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE-  696 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh-
Confidence            999988654332      23356899999999988644    5688999999999999999999998755444333322 


Q ss_pred             HHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042149          515 WKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVV  565 (625)
Q Consensus       515 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~  565 (625)
                            ..+........  +.-+..+.+...+|.+||+..-++|....++.
T Consensus       697 ------NTIlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  697 ------NTILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             ------hchhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence                  11111111111  11234566778999999999999997766654

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.2e-33  Score=287.19  Aligned_cols=241  Identities=24%  Similarity=0.291  Sum_probs=186.8

Q ss_pred             cccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHH---HHHhcCCCCceeeeeeeeeeCCeeEEEEEecC
Q 042149          305 KLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEV---NLISGIQHKNVVRLLGCSIEGPESLLVYEYVP  377 (625)
Q Consensus       305 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~---~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~  377 (625)
                      .||+|+||.||+|+.. +++.||+|.+....   ......+.+|.   .+++...||||+++++.+...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999864 68899999886532   11122233443   34455679999999999999999999999999


Q ss_pred             CCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCcee
Q 042149          378 NRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV  457 (625)
Q Consensus       378 ~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  457 (625)
                      |++|.+++....   .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++........  
T Consensus        81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~--  152 (278)
T cd05606          81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--  152 (278)
T ss_pred             CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence            999998885433   4899999999999999999999775   99999999999999999999999999876533221  


Q ss_pred             eecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCC
Q 042149          458 STGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP  536 (625)
Q Consensus       458 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  536 (625)
                       ....|+..|+|||.+.++ .++.++||||+|+++|||++|+.|+........  ........          ......+
T Consensus       153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~----------~~~~~~~  219 (278)
T cd05606         153 -HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTL----------TMAVELP  219 (278)
T ss_pred             -cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHHHHHhh----------ccCCCCC
Confidence             234689999999998754 689999999999999999999998754322111  01111100          0111223


Q ss_pred             hHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042149          537 ENEASRVLQIGLLCTQAPVALRP-----SMAEVVH  566 (625)
Q Consensus       537 ~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~  566 (625)
                      ...+..+.+++.+|++.+|++||     ++.++++
T Consensus       220 ~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         220 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            34567899999999999999999     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.5e-33  Score=291.54  Aligned_cols=244  Identities=30%  Similarity=0.444  Sum_probs=191.7

Q ss_pred             ccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          300 FDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      |...++||+|+||.||+|+.. +++.|++|++...   .......+.+|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            667788999999999999964 6889999998643   334456788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +. ++|.+++....  ..+++.++..++.|++.+|.|||+.+   ++|+||+|+||+++.++.+||+|||++......  
T Consensus       103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~--  174 (313)
T cd06633         103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA--  174 (313)
T ss_pred             CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCCC--
Confidence            96 46766664332  34899999999999999999999775   999999999999999999999999988643221  


Q ss_pred             eeeecCCCCccccCccccc---cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLV---RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                         ....|+..|+|||++.   .+.++.++||||||+++|+|++|..|+.........    ... .....     +.  
T Consensus       175 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~----~~~-~~~~~-----~~--  239 (313)
T cd06633         175 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----YHI-AQNDS-----PT--  239 (313)
T ss_pred             ---CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH----HHH-HhcCC-----CC--
Confidence               2346889999999984   456888999999999999999999886432211111    110 00000     00  


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                       ......+..+.+++.+||+.+|++||++.+++..
T Consensus       240 -~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         240 -LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             1112334568899999999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4.9e-34  Score=294.56  Aligned_cols=263  Identities=24%  Similarity=0.333  Sum_probs=191.9

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCCh--HHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC------
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSR--QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP------  367 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------  367 (625)
                      .++|++.++||+|+||.||+|+.+ +++.+|||++.....  .....+.+|+++++.++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            578999999999999999999965 689999998865432  22345678999999999999999999875433      


Q ss_pred             --eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecc
Q 042149          368 --ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFG  445 (625)
Q Consensus       368 --~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfg  445 (625)
                        ..++||||+.+ +|...+...  ...+++..+..++.|+++||.|||+.+   |+||||||+||++++++.++|+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              46999999965 566655432  234899999999999999999999775   9999999999999999999999999


Q ss_pred             cceeeCCCCce----------eeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhH
Q 042149          446 LARHVAPDKTH----------VSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV  514 (625)
Q Consensus       446 la~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~  514 (625)
                      ++.........          ..+...+++.|+|||.+.+. .++.++||||||+++|||++|+.|+...... ......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~~~~  239 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQLHLI  239 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Confidence            99765432211          11234578889999988654 5789999999999999999999886432211 111111


Q ss_pred             HHhhhcc---------ccccccCCCCCCCCC-------hHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          515 WKHYKAN---------RITQSMDPGLTGRFP-------ENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       515 ~~~~~~~---------~~~~~i~~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      +......         .+....+.......+       ......+.+++.+||+.+|++|||+.|++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            1111000         000000000000011       122356889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-34  Score=288.49  Aligned_cols=261  Identities=25%  Similarity=0.312  Sum_probs=194.9

Q ss_pred             ccccccccccCceEEEEEEeC-CCCEEEEEEeecCCh-HHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCCeeEEEEEec
Q 042149          300 FDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSR-QWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      |++.+.||+|++|+||+|+.. +++.|+||++..... .......+|+..+++++ ||||+++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            667889999999999999975 578899998865422 22234567999999999 999999999999999999999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                       +++|.+.+.... ...+++..+..++.|++.+|.|||+++   ++|+||+|+||+++.++.++|+|||++.........
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY  155 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence             788988776544 234899999999999999999999775   999999999999999999999999999866433221


Q ss_pred             eeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccch----------hhHHHhh--hcccc
Q 042149          457 VSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVL----------HTVWKHY--KANRI  523 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~----------~~~~~~~--~~~~~  523 (625)
                        ....++..|+|||++.. ..++.++|+||||++++||++|+.|+..........          ...|...  ....+
T Consensus       156 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07830         156 --TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL  233 (283)
T ss_pred             --CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence              23467889999998854 457899999999999999999998764432211100          0000000  00000


Q ss_pred             ccccCCCCC---CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          524 TQSMDPGLT---GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       524 ~~~i~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      ...+.....   .......+..+.+++.+||+.+|++|||++|++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            000000000   00111225678999999999999999999999853

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.5e-34  Score=297.62  Aligned_cols=262  Identities=22%  Similarity=0.356  Sum_probs=196.7

Q ss_pred             HHHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC--
Q 042149          293 LERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP--  367 (625)
Q Consensus       293 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--  367 (625)
                      +....++|++.+.||+|+||.||+|... +++.||||++...  .......+.+|+.++++++||||+++++++....  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            3446788999999999999999999854 7899999988543  2334457889999999999999999999887554  


Q ss_pred             ----eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEee
Q 042149          368 ----ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIAD  443 (625)
Q Consensus       368 ----~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~D  443 (625)
                          ..++||||+ +++|.+++..    ..+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.++|+|
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence                458999999 7788887742    24899999999999999999999775   99999999999999999999999


Q ss_pred             cccceeeCCCCceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchh----------
Q 042149          444 FGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLH----------  512 (625)
Q Consensus       444 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~----------  512 (625)
                      ||++.......    ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.|+...........          
T Consensus       162 fg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (343)
T cd07880         162 FGLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK  237 (343)
T ss_pred             cccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            99987654322    23467899999999876 4588999999999999999999998753321111000          


Q ss_pred             hHHHhhhccccccccC--CCCC----CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          513 TVWKHYKANRITQSMD--PGLT----GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       513 ~~~~~~~~~~~~~~i~--~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .++..+........+.  +...    .......+..+.+++.+|++.+|++|||+.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0000000000000000  0000    0011234556889999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4e-34  Score=298.15  Aligned_cols=261  Identities=21%  Similarity=0.292  Sum_probs=200.0

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC-----eeE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP-----ESL  370 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~  370 (625)
                      +|++.+.||+|++|.||+|+.. +++.+|||++....  ....+.+.+|+.+++.++||||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5888999999999999999975 58999999987543  445578899999999999999999999988775     789


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      +||||++ ++|.+++....   .+++..+..++.+++.||.+||+.+   |+||||||+|||++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999997 47888775433   4899999999999999999999775   999999999999999999999999999876


Q ss_pred             CCCCc--eeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHh----------
Q 042149          451 APDKT--HVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKH----------  517 (625)
Q Consensus       451 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~----------  517 (625)
                      .....  .......+++.|+|||++.+. .++.++|+||||+++|+|++|+.|+....... ........          
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~  232 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID-QLNLIVEVLGTPSEEDLK  232 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHhcCCCChhHhh
Confidence            54431  112334678899999999887 78999999999999999999998875332111 00000000          


Q ss_pred             -hhccccccccC---CCC---CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          518 -YKANRITQSMD---PGL---TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       518 -~~~~~~~~~i~---~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                       .........+.   ...   .....+..+..+.+++.+||+.+|++||++++++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             00000000000   000   000112346778999999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-34  Score=286.72  Aligned_cols=257  Identities=30%  Similarity=0.439  Sum_probs=194.4

Q ss_pred             ccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhc--CCCCceeeeeeeeeeCC----eeEEEE
Q 042149          300 FDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISG--IQHKNVVRLLGCSIEGP----ESLLVY  373 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~~~----~~~lV~  373 (625)
                      .+..+.||+|.||.||+|.+.+ +.||||++...   ..+.|.+|-+|.+.  ++|+||+++++.-....    +++||+
T Consensus       212 l~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             hhhHHHhhcCccceeehhhccC-ceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            3456689999999999999854 99999998544   34578888888764  58999999998766554    899999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcC------CCceEEEeeeccCcEEEcCCCceEEeecccc
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG------SGIKIIHRDIKTSNILLDEKLTPKIADFGLA  447 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla  447 (625)
                      ||.+.|+|.++|..    +.++|.+..+++..+++||+|||+.      .+++|+|||||..||||.++++..|+|||+|
T Consensus       288 ~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             eeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            99999999999953    3489999999999999999999964      2467999999999999999999999999999


Q ss_pred             eeeCCCCceee-ecCCCCccccCccccccC-ccc-----ccCcEEeehhhhHHHHhCCCCC------CCCC------CCc
Q 042149          448 RHVAPDKTHVS-TGIAGTLGYMAPEYLVRG-QLT-----EKADVYAFGVLVIEVASGRRNS------VFSE------GSS  508 (625)
Q Consensus       448 ~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~-~~~-----~~~Dv~SlG~ll~elltG~~p~------~~~~------~~~  508 (625)
                      ..+..+..... ...+||.+|||||++.+. ++.     .+.||||+|.|+|||++.-...      .+..      +..
T Consensus       364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h  443 (534)
T KOG3653|consen  364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH  443 (534)
T ss_pred             EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence            98875444322 257899999999999653 232     3689999999999999853221      1110      001


Q ss_pred             cchhhHHHhhhccccccccCCCCCCCCCh-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          509 SVLHTVWKHYKANRITQSMDPGLTGRFPE-----NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      ..+...+....        ....++.++.     ....-+.+.+..||+.||+.|.|+.=+-+++..+.
T Consensus       444 Pt~e~mq~~VV--------~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~  504 (534)
T KOG3653|consen  444 PTLEEMQELVV--------RKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM  504 (534)
T ss_pred             CCHHHHHHHHH--------hhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence            11111111111        1112222221     33566889999999999999999988888887765

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-35  Score=308.05  Aligned_cols=254  Identities=25%  Similarity=0.385  Sum_probs=212.2

Q ss_pred             ccccccccccCceEEEEEEe-CCC----CEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          300 FDNSRKLGQGGAGSVFRGTL-PDG----RNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ....++||+|+||+||+|.+ +.|    -+||||++... ..+....+.+|+-+|.+|+|||++++++++.... +-||.
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            34577899999999999985 344    46799988654 4555678999999999999999999999998766 88999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      +|++.|+|.++++..  +..+-.+..+.|..||++||.|||++.   ++||||...||||..-..+||.|||+++....+
T Consensus       777 q~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            999999999999653  344888999999999999999999774   999999999999999999999999999998776


Q ss_pred             Cceeee-cCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          454 KTHVST-GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       454 ~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      ...... ...-.+.|||-|.+....++.++|||||||++||++| |..|+.              .....++.+++....
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~--------------gi~~~eI~dlle~ge  917 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYD--------------GIPAEEIPDLLEKGE  917 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccC--------------CCCHHHhhHHHhccc
Confidence            665543 3344678999999999999999999999999999998 777743              223334444555555


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccC
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY  573 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  573 (625)
                      +...|+.++.++..++.+||..|++.||+++++...+.+...
T Consensus       918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            556688999999999999999999999999999887766543

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=5.2e-34  Score=286.68  Aligned_cols=249  Identities=26%  Similarity=0.302  Sum_probs=194.6

Q ss_pred             CccccccccccCceEEEEEEeCC-CCEEEEEEeecC-----ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFN-----SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      +|.+.++||+|+||.||++++.. +..+++|.+...     .......+..|+.++++++||||+++++.+.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47888999999999999998653 444555554321     223345677899999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhcc-CCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          373 YEYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      |||+++++|.+++... .....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++. +.++|+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999888642 23345899999999999999999999775   999999999999975 579999999987764


Q ss_pred             CCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      .... ......+++.|+|||...+..++.++|+||||+++|+|++|+.|+....    ..... .....         ..
T Consensus       157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~----~~~~~-~~~~~---------~~  221 (260)
T cd08222         157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN----FLSVV-LRIVE---------GP  221 (260)
T ss_pred             CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHH-HHHHc---------CC
Confidence            3322 2223568899999999988888999999999999999999998864221    11111 11110         11


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ....+...+..+.+++.+||+.+|++||++.|+++
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         222 TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            11224456678899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.1e-33  Score=292.30  Aligned_cols=261  Identities=23%  Similarity=0.319  Sum_probs=196.0

Q ss_pred             HHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeee-CCeeE
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE-GPESL  370 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~  370 (625)
                      .++++|++.+.||+|+||.||+|..+ +++.||||++...  .....+.+.+|+++++.++||||+++++++.. ....+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            35788999999999999999999865 7899999988543  23345678899999999999999999998865 56789


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      +||||+ +++|.+++..    ..+++.....++.|+++||.|||+.+   |+||||+|+||++++++.++|+|||++...
T Consensus        87 lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          87 FVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            999998 5688887742    23788888899999999999999775   999999999999999999999999998754


Q ss_pred             CCCCceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccch----------hhHHHhhh
Q 042149          451 APDKTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVL----------HTVWKHYK  519 (625)
Q Consensus       451 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~----------~~~~~~~~  519 (625)
                      ....    ....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.|+..........          ......+.
T Consensus       159 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd07856         159 DPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC  234 (328)
T ss_pred             CCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            3221    23457889999998766 568999999999999999999998875432210000          00000000


Q ss_pred             ccccccccCC-CCCCCCC-----hHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          520 ANRITQSMDP-GLTGRFP-----ENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       520 ~~~~~~~i~~-~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      .....+.+.. ......+     +..+..+.+++.+||+.+|++||++.+++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         235 SENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             chhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0110011000 0001111     1245778999999999999999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-33  Score=294.57  Aligned_cols=261  Identities=24%  Similarity=0.376  Sum_probs=193.1

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC------
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP------  367 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------  367 (625)
                      .++|.+.+.||+|+||.||+|+.. +++.||||++...  .......+.+|+.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            578999999999999999999964 6899999988643  2333456889999999999999999999887543      


Q ss_pred             eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccc
Q 042149          368 ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA  447 (625)
Q Consensus       368 ~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla  447 (625)
                      ..++|+||+.. +|..++     ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            46899999964 665544     123889999999999999999999775   999999999999999999999999998


Q ss_pred             eeeCCCCceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHH----------
Q 042149          448 RHVAPDKTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWK----------  516 (625)
Q Consensus       448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~----------  516 (625)
                      +......    ....+++.|+|||.+.+ ..++.++||||||+++|||++|+.|+....... .....+.          
T Consensus       165 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  239 (342)
T cd07879         165 RHADAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEFV  239 (342)
T ss_pred             cCCCCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHH
Confidence            7643221    23467889999999876 468899999999999999999999875332111 1111111          


Q ss_pred             -hhhccccccccC--CCC-CCC---CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hccc
Q 042149          517 -HYKANRITQSMD--PGL-TGR---FPENEASRVLQIGLLCTQAPVALRPSMAEVVHM--LNNI  571 (625)
Q Consensus       517 -~~~~~~~~~~i~--~~~-~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~--L~~~  571 (625)
                       .+........+.  +.. ...   ..+..+..+.+++.+||+.+|++||++.+++..  ++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence             000000000000  000 000   011234568899999999999999999999853  4444

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.3e-33  Score=294.89  Aligned_cols=262  Identities=23%  Similarity=0.275  Sum_probs=194.2

Q ss_pred             hcCccc-cccccccCceEEEEEEeC-CCCEEEEEEeecCChHH--------------HHHHHHHHHHHhcCCCCceeeee
Q 042149          297 TDFFDN-SRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQW--------------VDQFFNEVNLISGIQHKNVVRLL  360 (625)
Q Consensus       297 ~~~y~~-~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~hpniv~l~  360 (625)
                      .++|.. .+.||+|+||+||+|+.+ +++.||||++.......              ...+.+|+++++.++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            455654 567999999999999965 68999999886442211              12467899999999999999999


Q ss_pred             eeeeeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceE
Q 042149          361 GCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPK  440 (625)
Q Consensus       361 ~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~k  440 (625)
                      +++..++..++||||+. ++|.+++....   .+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence            99999999999999996 58888875432   3889999999999999999999775   99999999999999999999


Q ss_pred             EeecccceeeCCCC-------------ceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCC
Q 042149          441 IADFGLARHVAPDK-------------THVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEG  506 (625)
Q Consensus       441 l~Dfgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~  506 (625)
                      |+|||++.......             ........+++.|+|||.+.+. .++.++||||||+++|||++|+.|+.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999997654110             1111223568899999998764 468999999999999999999988754332


Q ss_pred             CccchhhHHHhhhccc---cccc--------cCCCCC---CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          507 SSSVLHTVWKHYKANR---ITQS--------MDPGLT---GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       507 ~~~~~~~~~~~~~~~~---~~~~--------i~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .. .............   +.+.        ......   .......+..+.+++.+||+.+|++||+++|++.
T Consensus       240 ~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        240 ID-QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HH-HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            11 1111111111000   0000        000000   0011233567889999999999999999999996

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-33  Score=294.42  Aligned_cols=265  Identities=23%  Similarity=0.306  Sum_probs=197.2

Q ss_pred             HHHHHHhcCccccccccccCceEEEEEEe-CCCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC-
Q 042149          291 EILERATDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG-  366 (625)
Q Consensus       291 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  366 (625)
                      ..+..+.++|++.+.||+|+||.||+|.. ++++.||+|++....  ....+.+.+|+.++++++||||+++++++... 
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            44556789999999999999999999985 478899999986542  23346788999999999999999999987643 


Q ss_pred             -----CeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEE
Q 042149          367 -----PESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKI  441 (625)
Q Consensus       367 -----~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl  441 (625)
                           ...+++++++ +++|.+++...    .+++..+..++.|+++||.|||+.+   |+||||||+||++++++.+||
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl  161 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI  161 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence                 3467888887 78888877432    3899999999999999999999775   999999999999999999999


Q ss_pred             eecccceeeCCCCceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchh--------
Q 042149          442 ADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLH--------  512 (625)
Q Consensus       442 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~--------  512 (625)
                      +|||++......    .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.|+...........        
T Consensus       162 ~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (345)
T cd07877         162 LDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP  237 (345)
T ss_pred             eccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999998764322    223467899999998866 5688999999999999999999988753322111100        


Q ss_pred             --hHHHhhhcccc---ccccCCCCC---CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          513 --TVWKHYKANRI---TQSMDPGLT---GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       513 --~~~~~~~~~~~---~~~i~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                        ..+..+.....   ...+.....   .......+..+.+++.+|++.+|++||++.+++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         238 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence              00000000000   000000000   00011235568899999999999999999998854

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=8.7e-35  Score=277.46  Aligned_cols=203  Identities=25%  Similarity=0.346  Sum_probs=167.9

Q ss_pred             hcCccccccccccCceEEEEEEeC---C--CCEEEEEEeecCCh--HHHHHHHHHHHHHhcCCCCceeeeeeeeee-CCe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP---D--GRNIAVKRLFFNSR--QWVDQFFNEVNLISGIQHKNVVRLLGCSIE-GPE  368 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~  368 (625)
                      ...|+...+||+|.||.||+|+-+   +  .+.+|||+++....  .......+|+.+++.++||||+.+..++.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            456899999999999999999632   2  34789999865422  223567899999999999999999998887 788


Q ss_pred             eEEEEEecCCCCcchhhhcc--CCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCC----CceEEe
Q 042149          369 SLLVYEYVPNRSLDQILFVK--NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEK----LTPKIA  442 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~----~~~kl~  442 (625)
                      +++++||.+. +|.++++..  ...+.++......|+.||+.|+.|||++-   |+||||||.||||..+    |.|||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence            9999999965 777776532  23356888999999999999999999886   9999999999999866    999999


Q ss_pred             ecccceeeCCCCcee--eecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCC
Q 042149          443 DFGLARHVAPDKTHV--STGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVF  503 (625)
Q Consensus       443 Dfgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~  503 (625)
                      |||+++.+...-...  ...++-|..|.|||.+.+. .|+.+.|||++|||+.||||-++-|..
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            999999886543332  2356779999999999885 799999999999999999998865543

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-34  Score=272.65  Aligned_cols=264  Identities=25%  Similarity=0.314  Sum_probs=205.1

Q ss_pred             cCccccHHHHHHHhcCccccccccccCceEEEEEE-eCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCC-CCceeeeee
Q 042149          284 SSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-HKNVVRLLG  361 (625)
Q Consensus       284 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~  361 (625)
                      ++...+++.+.+.+     .+.||+|+++.|..++ +.+|.++|||++.+.......++.+|++++.+.+ |+||+++++
T Consensus        69 ss~~g~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLie  143 (463)
T KOG0607|consen   69 SSLSGKFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIE  143 (463)
T ss_pred             ccccchHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHH
Confidence            33444566666665     3579999999999998 5689999999998887777889999999999996 999999999


Q ss_pred             eeeeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC---c
Q 042149          362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL---T  438 (625)
Q Consensus       362 ~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~---~  438 (625)
                      +|+++..+|||||-|.||+|..+++.+..   +++.++..++.+|+.||.+||.+|   |.||||||+|||-..-.   -
T Consensus       144 fFEdd~~FYLVfEKm~GGplLshI~~~~~---F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsP  217 (463)
T KOG0607|consen  144 FFEDDTRFYLVFEKMRGGPLLSHIQKRKH---FNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSP  217 (463)
T ss_pred             HhcccceEEEEEecccCchHHHHHHHhhh---ccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCc
Confidence            99999999999999999999998876554   899999999999999999999886   99999999999986443   4


Q ss_pred             eEEeecccceeeCCCCc------eeeecCCCCccccCccccc-----cCcccccCcEEeehhhhHHHHhCCCCCCCCCCC
Q 042149          439 PKIADFGLARHVAPDKT------HVSTGIAGTLGYMAPEYLV-----RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGS  507 (625)
Q Consensus       439 ~kl~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~  507 (625)
                      +||+||.+...+.....      ......+|+..|||||+..     ...|+.+.|.||||||+|-||+|-+||...=+.
T Consensus       218 vKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~  297 (463)
T KOG0607|consen  218 VKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA  297 (463)
T ss_pred             eeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCC
Confidence            89999998764432211      1122457899999999873     246889999999999999999999998543211


Q ss_pred             ccchhhHHHhhhccc--------cccccCCCCCCCCCh----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          508 SSVLHTVWKHYKANR--------ITQSMDPGLTGRFPE----NEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       508 ~~~~~~~~~~~~~~~--------~~~~i~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      +  .     +|..++        +.+.|..+.. ++|+    .++.+-.+++...+..++.+|.++.+++.
T Consensus       298 d--C-----GWdrGe~Cr~CQ~~LFesIQEGkY-eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  298 D--C-----GWDRGEVCRVCQNKLFESIQEGKY-EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             c--C-----CccCCCccHHHHHHHHHHHhccCC-cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            0  0     111111        1122222211 2333    44666788999999999999999988876

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-33  Score=280.27  Aligned_cols=274  Identities=24%  Similarity=0.332  Sum_probs=205.9

Q ss_pred             ccHHHHHHHhcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhc--CCCCceeeeeeeeee
Q 042149          288 FKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISG--IQHKNVVRLLGCSIE  365 (625)
Q Consensus       288 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~  365 (625)
                      ...-..+.+...-.+.+.||+|.||.||+|++ .|..||||++...++   ..+.+|.+|.+.  |+|+||+.+++.-..
T Consensus       201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~  276 (513)
T KOG2052|consen  201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNK  276 (513)
T ss_pred             chhHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence            34445566677888999999999999999999 478999999965443   466788888875  499999999986654


Q ss_pred             CC----eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhc-----CCCceEEEeeeccCcEEEcCC
Q 042149          366 GP----ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG-----GSGIKIIHRDIKTSNILLDEK  436 (625)
Q Consensus       366 ~~----~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-----~~~~~iiHrDlkp~NIll~~~  436 (625)
                      ++    .++||.+|.+.|||.|+|..    ..++....++++..+|.||+|||.     +|++.|.|||||..||||..+
T Consensus       277 ~~gs~TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn  352 (513)
T KOG2052|consen  277 DNGSWTQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN  352 (513)
T ss_pred             CCCceEEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence            43    68999999999999999964    238999999999999999999994     467789999999999999999


Q ss_pred             CceEEeecccceeeCCCCcee---eecCCCCccccCccccccC----ccc--ccCcEEeehhhhHHHHhC----C-----
Q 042149          437 LTPKIADFGLARHVAPDKTHV---STGIAGTLGYMAPEYLVRG----QLT--EKADVYAFGVLVIEVASG----R-----  498 (625)
Q Consensus       437 ~~~kl~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~----~~~--~~~Dv~SlG~ll~elltG----~-----  498 (625)
                      +...|+|+|||..........   ....+||-+|||||++...    .+.  ..+||||||.|+||+...    .     
T Consensus       353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey  432 (513)
T KOG2052|consen  353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY  432 (513)
T ss_pred             CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence            999999999998765543222   2256899999999999553    122  369999999999999752    1     


Q ss_pred             -CCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          499 -RNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       499 -~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                       .|+....+.+...+...+..-.+++.-.+++.   ....+....+.++|..||..+|.-|-|+-.|.+.|.++.
T Consensus       433 ~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnr---W~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  433 QLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNR---WKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             cCCcccCCCCCCCHHHHhcceeecccCCCCCcc---cccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence             24332222222222222222222211111111   123567788999999999999999999999998887765

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-34  Score=287.69  Aligned_cols=242  Identities=24%  Similarity=0.293  Sum_probs=192.3

Q ss_pred             cccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCC
Q 042149          303 SRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNR  379 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~  379 (625)
                      .+.||+|.||+||-|.++ +|+.||||++.+.  ..+...++.+|+.||+.+.||.||.+.-.|+..+..++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            578999999999999975 7999999988543  2233478999999999999999999999999999999999999776


Q ss_pred             CcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCC---CceEEeecccceeeCCCCce
Q 042149          380 SLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEK---LTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       380 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~---~~~kl~Dfgla~~~~~~~~~  456 (625)
                      -|+-+|....  .+|++.....++.||+.||.|||-+   +|+|+||||+|||+...   ..+||+|||+|+.+.+..  
T Consensus       649 MLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--  721 (888)
T KOG4236|consen  649 MLEMILSSEK--GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--  721 (888)
T ss_pred             HHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence            6665554332  3488888888999999999999966   59999999999999643   579999999999986543  


Q ss_pred             eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP  536 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  536 (625)
                      ....++|||.|+|||+++.+.|+..-|+||+|||+|--|+|..||-.+++..+.++       +..       -+.++.|
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQ-------NAa-------FMyPp~P  787 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQ-------NAA-------FMYPPNP  787 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhh-------ccc-------cccCCCc
Confidence            33457999999999999999999999999999999999999988754433222111       100       0111112


Q ss_pred             -hHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042149          537 -ENEASRVLQIGLLCTQAPVALRPSMAEVV  565 (625)
Q Consensus       537 -~~~~~~l~~li~~cl~~~p~~RPt~~ev~  565 (625)
                       .+.+...+++|...||..-++|-+..+-+
T Consensus       788 W~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  788 WSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             hhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence             34566678889999999888897765543

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-33  Score=295.17  Aligned_cols=260  Identities=24%  Similarity=0.337  Sum_probs=196.7

Q ss_pred             HHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCe---
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPE---  368 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~---  368 (625)
                      ...++|++.+.||+|++|.||+|+.. +++.||||++...  .....+.+.+|+.++++++||||+++++++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34678999999999999999999975 5789999988643  23345677889999999999999999998876554   


Q ss_pred             ---eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecc
Q 042149          369 ---SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFG  445 (625)
Q Consensus       369 ---~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfg  445 (625)
                         .++|+||+ +++|.+++..    ..+++..+..++.|+++||.|||+.+   |+||||||+||+++.++.++|+|||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence               89999998 6789888753    24899999999999999999999775   9999999999999999999999999


Q ss_pred             cceeeCCCCceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchh----------hH
Q 042149          446 LARHVAPDKTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLH----------TV  514 (625)
Q Consensus       446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~----------~~  514 (625)
                      ++......    .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.|+........+..          ..
T Consensus       164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  239 (343)
T cd07851         164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL  239 (343)
T ss_pred             cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence            98765432    223467889999999865 3678999999999999999999988754322111000          00


Q ss_pred             HHhhhccccccccC---CCCCCCC---ChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          515 WKHYKANRITQSMD---PGLTGRF---PENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       515 ~~~~~~~~~~~~i~---~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      +..+........+.   ......+   ....+..+.+++.+||+.+|++|||+.||++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            11111000000000   0000000   1123677899999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-33  Score=312.54  Aligned_cols=263  Identities=26%  Similarity=0.358  Sum_probs=211.3

Q ss_pred             HHHHhcCccccccccccCceEEEEEEeC----C----CCEEEEEEeecC-ChHHHHHHHHHHHHHhcC-CCCceeeeeee
Q 042149          293 LERATDFFDNSRKLGQGGAGSVFRGTLP----D----GRNIAVKRLFFN-SRQWVDQFFNEVNLISGI-QHKNVVRLLGC  362 (625)
Q Consensus       293 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~----~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~  362 (625)
                      ++...++..+.+.||+|.||.|++|...    .    ...||||.+... .....+.+..|+++|+.+ +||||+.++|.
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            3334455566779999999999999742    1    356899998754 345678899999999999 59999999999


Q ss_pred             eeeCCeeEEEEEecCCCCcchhhhccC-------C----c--CCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccC
Q 042149          363 SIEGPESLLVYEYVPNRSLDQILFVKN-------T----I--HILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTS  429 (625)
Q Consensus       363 ~~~~~~~~lV~e~~~~~sL~~~l~~~~-------~----~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~  429 (625)
                      +.+....++|+||+..|+|.++|....       .    .  ..++....+.++.||+.|++||++.   ++|||||...
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR  447 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR  447 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence            999999999999999999999997655       0    0  2388899999999999999999976   4999999999


Q ss_pred             cEEEcCCCceEEeecccceeeCCCCceeeecCCC--CccccCccccccCcccccCcEEeehhhhHHHHhC-CCCCCCCCC
Q 042149          430 NILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG--TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG-RRNSVFSEG  506 (625)
Q Consensus       430 NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG-~~p~~~~~~  506 (625)
                      ||||.++..+||+|||+++..........+.-.+  ...|||||.+....|+.++||||||+++|||+|. ..|++....
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~  527 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP  527 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence            9999999999999999999765554444332232  4469999999999999999999999999999994 445432111


Q ss_pred             CccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          507 SSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      ..++    ++         .+..+.+.+.|..+..++.++|..||+.+|++||++.++++.++.+
T Consensus       528 ~~~l----~~---------~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  528 TEEL----LE---------FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             HHHH----HH---------HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            1111    22         2333444556888899999999999999999999999999999874

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-34  Score=269.72  Aligned_cols=255  Identities=18%  Similarity=0.198  Sum_probs=197.9

Q ss_pred             HHhcCccc-cccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcC-CCCceeeeeeeeee----CC
Q 042149          295 RATDFFDN-SRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIE----GP  367 (625)
Q Consensus       295 ~~~~~y~~-~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~----~~  367 (625)
                      .++++|.+ .++||-|-.|.|-.+.++ ++..+|+|++.-.     ....+|+++.-.. .|||||.+++++++    ..
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk  132 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRK  132 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence            34666765 467999999999999976 6889999988432     3457888886555 69999999998864    45


Q ss_pred             eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEc---CCCceEEeec
Q 042149          368 ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADF  444 (625)
Q Consensus       368 ~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~---~~~~~kl~Df  444 (625)
                      .+.+|||.|+||.|...++.++. ..+++.++..|+.||..|+.|||+   ++|.||||||+|+|..   .+-.+||+||
T Consensus       133 cLLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDf  208 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDF  208 (400)
T ss_pred             eeEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEeccc
Confidence            78899999999999999877655 348999999999999999999994   5799999999999996   4567999999


Q ss_pred             ccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccc
Q 042149          445 GLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRIT  524 (625)
Q Consensus       445 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  524 (625)
                      |+|+........  ...+.||.|.|||++...+|+...|+||+||++|-||+|-+||....+ ..+..-.......+.. 
T Consensus       209 GFAK~t~~~~~L--~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-~aispgMk~rI~~gqy-  284 (400)
T KOG0604|consen  209 GFAKETQEPGDL--MTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAISPGMKRRIRTGQY-  284 (400)
T ss_pred             ccccccCCCccc--cCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-ccCChhHHhHhhccCc-
Confidence            999976543332  345789999999999999999999999999999999999998754432 2111111111111110 


Q ss_pred             cccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          525 QSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       525 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                           ....+--...++...++|+.+|..+|.+|.|++++++.
T Consensus       285 -----~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  285 -----EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             -----cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence                 00111123557778999999999999999999999863

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.4e-33  Score=292.59  Aligned_cols=261  Identities=24%  Similarity=0.320  Sum_probs=193.3

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC---------
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG---------  366 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~---------  366 (625)
                      ..+|.+.+.||.|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++.+...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            468999999999999999999964 6899999999776666677889999999999999999999876543         


Q ss_pred             -----CeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEc-CCCceE
Q 042149          367 -----PESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPK  440 (625)
Q Consensus       367 -----~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~-~~~~~k  440 (625)
                           ...++||||++ ++|.+++..    ..+++..+..++.||++||.|||+.+   ++||||||+||+++ .++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence                 35789999997 588777642    23889999999999999999999775   99999999999997 456789


Q ss_pred             EeecccceeeCCCCcee--eecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHh
Q 042149          441 IADFGLARHVAPDKTHV--STGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKH  517 (625)
Q Consensus       441 l~Dfgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~  517 (625)
                      |+|||++..........  .....++..|+|||.+.. ..++.++||||||+++|+|++|+.|+............. ..
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~-~~  234 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL-ES  234 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-Hh
Confidence            99999997654321111  122357889999998755 467889999999999999999999875332111110000 00


Q ss_pred             hh------ccc----cccccC-CCCCCC-----CChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          518 YK------ANR----ITQSMD-PGLTGR-----FPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       518 ~~------~~~----~~~~i~-~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ..      ...    ...... ......     .....+.++.+++.+||+.+|++|||+.|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            00      000    000000 000000     11234567889999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-33  Score=283.92  Aligned_cols=260  Identities=25%  Similarity=0.329  Sum_probs=197.4

Q ss_pred             ccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          300 FDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      |+..+.||+|++|.||+|+.. +++.+|+|++....  ....+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566788999999999999975 58999999987653  334567889999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      + ++|.+++....  ..+++..+..++.+++.+|.+||+.+   |+||||+|+||++++++.++|+|||++.........
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  154 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT  154 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence            7 58999886542  24899999999999999999999875   999999999999999999999999998876443321


Q ss_pred             eeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccch----------hhHHHhhhccc-cc
Q 042149          457 VSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVL----------HTVWKHYKANR-IT  524 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~----------~~~~~~~~~~~-~~  524 (625)
                       .....++..|+|||.+.+. .++.++||||||+++|||++|+.|+..........          ...|..+.... ..
T Consensus       155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         155 -YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             -cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence             2234567889999998776 78999999999999999999987764332111100          00111111000 00


Q ss_pred             ccc---CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          525 QSM---DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       525 ~~i---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ...   .........+..+..+.+++.+||+.+|++||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            000   000000001123667999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-33  Score=278.24  Aligned_cols=236  Identities=27%  Similarity=0.322  Sum_probs=193.1

Q ss_pred             ccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCCCc
Q 042149          306 LGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSL  381 (625)
Q Consensus       306 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~sL  381 (625)
                      ||+|+||.||++... +++.+|+|.+....   ......+.+|+.++++++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999975 58899999886542   23566889999999999999999999999999999999999999999


Q ss_pred             chhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceeeecC
Q 042149          382 DQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGI  461 (625)
Q Consensus       382 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  461 (625)
                      .+++....   .+++.....++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++........ .....
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~  153 (250)
T cd05123          81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTF  153 (250)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCC
Confidence            99886543   3899999999999999999999765   99999999999999999999999999887644321 12335


Q ss_pred             CCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHH
Q 042149          462 AGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEAS  541 (625)
Q Consensus       462 ~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  541 (625)
                      .++..|+|||...+...+.++|+||||+++|+|++|+.|+...+. .    ........          .....+...+.
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~----~~~~~~~~----------~~~~~~~~~~~  218 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-K----EIYEKILK----------DPLRFPEFLSP  218 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-H----HHHHHHhc----------CCCCCCCCCCH
Confidence            688999999999888889999999999999999999998743221 0    11111111          11123444477


Q ss_pred             HHHHHHhhccCCCCCCCCCHHH
Q 042149          542 RVLQIGLLCTQAPVALRPSMAE  563 (625)
Q Consensus       542 ~l~~li~~cl~~~p~~RPt~~e  563 (625)
                      .+.+++.+||..+|++||++.+
T Consensus       219 ~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         219 EARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHHHHHHHhcCCHhhCCCccc
Confidence            8899999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.2e-32  Score=287.20  Aligned_cols=260  Identities=22%  Similarity=0.264  Sum_probs=190.3

Q ss_pred             CccccccccccCceEEEEEEeC-C--CCEEEEEEeecC--ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeC----Ce
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-D--GRNIAVKRLFFN--SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEG----PE  368 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~----~~  368 (625)
                      +|++.+.||+|+||.||+++.. .  +..||||++...  .......+.+|+.+++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4788899999999999999964 4  778999988643  233356788899999999 599999999875432    45


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      .++++||+. ++|.+.+....   .+++..+..++.||+.||.|||..+   ++||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            788999985 68888775433   3889999999999999999999775   9999999999999999999999999998


Q ss_pred             eeCCCCce---eeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhh-----------
Q 042149          449 HVAPDKTH---VSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT-----------  513 (625)
Q Consensus       449 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~-----------  513 (625)
                      ........   ......|++.|+|||++.+ ..++.++||||||+++|+|++|+.|+...... .....           
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~  232 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLGTPDEE  232 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhCCCCHH
Confidence            65432221   1123568999999998765 46889999999999999999999886532211 00000           


Q ss_pred             HHHhhhcccccc---ccCCCCC---CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          514 VWKHYKANRITQ---SMDPGLT---GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       514 ~~~~~~~~~~~~---~i~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .+..+.......   .......   ....+..+..+.+++.+||+.+|++|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000000   0000000   0011223567899999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-34  Score=279.14  Aligned_cols=241  Identities=23%  Similarity=0.261  Sum_probs=198.2

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l  371 (625)
                      ..+|..+.+||+|.||.|.+|..+ +...+|||+++++   ...+++--..|-++|+.. +-|.+++++.+|..-+.+|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            357889999999999999999865 5678999988765   234456667788888877 57889999999999999999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||||+.||+|.-.+++-++   +.+..+..++.+|+-||-+||+++   ||.||||.+|||+|.+|++||+|||+++.--
T Consensus       428 VMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             EEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence            9999999999888876555   777888999999999999999886   9999999999999999999999999998543


Q ss_pred             CCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      -+.. ....++|||.|+|||++.-.+|+.++|+||+||+||||+.|++|+...+..     .++....+..         
T Consensus       502 ~~~~-TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~-----elF~aI~ehn---------  566 (683)
T KOG0696|consen  502 FDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-----ELFQAIMEHN---------  566 (683)
T ss_pred             cCCc-ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHHHHHcc---------
Confidence            3222 234689999999999999999999999999999999999999997543322     1222222221         


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCC
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRP  559 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RP  559 (625)
                       ..+|...+.+...+....+.+.|.+|.
T Consensus       567 -vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  567 -VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             -CcCcccccHHHHHHHHHHhhcCCcccc
Confidence             235677788888899999999999994

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-32  Score=293.23  Aligned_cols=259  Identities=25%  Similarity=0.362  Sum_probs=208.3

Q ss_pred             HHHHHHHhcCccccccccccCceEEEEEEe-CCCCEEEEEEeecCChHHHHHHHHHHHHHhcC-CCCceeeeeeeeee--
Q 042149          290 YEILERATDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIE--  365 (625)
Q Consensus       290 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~--  365 (625)
                      ++.+..-++.|++.+.||.|.+|.||+++. ++++.+|||++...... -+.++.|.+||+.+ .|||++.++|++..  
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            334444577899999999999999999995 47889999988765433 35677889999888 59999999998863  


Q ss_pred             ---CCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEe
Q 042149          366 ---GPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIA  442 (625)
Q Consensus       366 ---~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~  442 (625)
                         ++.+|||||||.+||..|++.... +..+.|..+..|++.++.||.+||.+   .+||||||-.|||++.++.|||+
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence               568999999999999999987655 56699999999999999999999966   49999999999999999999999


Q ss_pred             ecccceeeCCCCceeeecCCCCccccCccccccC-----cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHh
Q 042149          443 DFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG-----QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKH  517 (625)
Q Consensus       443 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~  517 (625)
                      |||++........... ...|||.|||||++...     .|+..+|+||||++..||--|.+|..-+....       ..
T Consensus       166 DFGvSaQldsT~grRn-T~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr-------aL  237 (953)
T KOG0587|consen  166 DFGVSAQLDSTVGRRN-TFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR-------AL  237 (953)
T ss_pred             eeeeeeeeeccccccc-CcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-------hh
Confidence            9999987765444333 46899999999998643     46789999999999999999998854322111       11


Q ss_pred             hhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          518 YKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       518 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      +.-.     -+|......|..-.+++.++|..||.+|.++||++.++++
T Consensus       238 F~Ip-----RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  238 FLIP-----RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ccCC-----CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            1100     1222223346778899999999999999999999988764

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.6e-32  Score=310.08  Aligned_cols=146  Identities=25%  Similarity=0.338  Sum_probs=131.2

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .++|.+.++||+|+||.||+|.+. +++.||||++...   .......+.+|+.+++.++||||+++++.+......+||
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            467999999999999999999976 6899999998643   344457889999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      |||+.+++|.+++....   .+++..++.++.||+.||.|||..+   |+||||||+||||+.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999886443   3788999999999999999999775   9999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=269.96  Aligned_cols=256  Identities=23%  Similarity=0.275  Sum_probs=192.1

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHh-cCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLIS-GIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      ++.+.+..||.|.||+|++-.++ .|+..|||++.... .....++..|.+... .-+.||||++||....+...||.||
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            44556778999999999999875 79999999997653 456678888888754 4479999999999999999999999


Q ss_pred             ecCCCCcchhhhc--cCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          375 YVPNRSLDQILFV--KNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       375 ~~~~~sL~~~l~~--~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      .| ..||+.+...  ......+++.-.-.|....+.||.||....  +|||||+||+||||+..|.+||+|||++-.+..
T Consensus       144 LM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  144 LM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             HH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            99 4577654321  112233778777888888999999998754  799999999999999999999999999876533


Q ss_pred             CCceeeecCCCCccccCcccccc--CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVR--GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                      .-  ..+.-.|-..|||||.+..  ..|+.+|||||||++|||+.||+.|+.-....   ...+ .....+....+..  
T Consensus       221 Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv---feql-~~Vv~gdpp~l~~--  292 (361)
T KOG1006|consen  221 SI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV---FEQL-CQVVIGDPPILLF--  292 (361)
T ss_pred             HH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH---HHHH-HHHHcCCCCeecC--
Confidence            22  2233468889999999864  34889999999999999999999996533211   0000 0011111111100  


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                        ..-..+.+..+..+|..|+-+|..+||...++.+
T Consensus       293 --~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  293 --DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             --cccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence              1112346778999999999999999999999875

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.98  E-value=2.1e-32  Score=271.28  Aligned_cols=219  Identities=20%  Similarity=0.123  Sum_probs=176.1

Q ss_pred             cCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCCCcchhhhc
Q 042149          309 GGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFV  387 (625)
Q Consensus       309 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~  387 (625)
                      |.+|.||+++++ +++.+|+|++....     .+.+|...+....||||+++++++.+....++||||+++++|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            889999999975 68999999986543     233455555666799999999999999999999999999999998865


Q ss_pred             cCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceeeecCCCCccc
Q 042149          388 KNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGY  467 (625)
Q Consensus       388 ~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y  467 (625)
                      ..   .+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.++|+|||.+.......    ....++..|
T Consensus        79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y  148 (237)
T cd05576          79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMY  148 (237)
T ss_pred             hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccc
Confidence            43   3899999999999999999999775   9999999999999999999999999876553321    223567789


Q ss_pred             cCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHH
Q 042149          468 MAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIG  547 (625)
Q Consensus       468 ~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  547 (625)
                      +|||......++.++||||+|+++|||++|+.|+......                   +........+...+..+.+++
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~li  209 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-------------------INTHTTLNIPEWVSEEARSLL  209 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-------------------cccccccCCcccCCHHHHHHH
Confidence            9999998888999999999999999999999764321100                   000001112344567789999


Q ss_pred             hhccCCCCCCCCCH
Q 042149          548 LLCTQAPVALRPSM  561 (625)
Q Consensus       548 ~~cl~~~p~~RPt~  561 (625)
                      .+|++.||++||++
T Consensus       210 ~~~l~~dp~~R~~~  223 (237)
T cd05576         210 QQLLQFNPTERLGA  223 (237)
T ss_pred             HHHccCCHHHhcCC
Confidence            99999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.98  E-value=5.3e-33  Score=290.30  Aligned_cols=241  Identities=23%  Similarity=0.264  Sum_probs=196.4

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEEEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      .++.|+....+|.|.|+.|-.+.+. +++..+||++....    ....+|+.++... +||||+++.+.+.+....++||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            4677888888999999999999864 68899999996552    2345678776666 6999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE-cCCCceEEeecccceeeCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL-DEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll-~~~~~~kl~Dfgla~~~~~  452 (625)
                      |.+.|+-|.+.+.....   .. .++..|+.+|+.++.|||++|   +|||||||+|||+ ++.++++|+|||.++....
T Consensus       396 e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             hhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            99999887776643332   23 788889999999999999886   9999999999999 5889999999999987655


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      .    ..+.+-|..|.|||++....|++++||||||++||+||+|+.|+.....+.++.    ..            ...
T Consensus       469 ~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~----~~------------i~~  528 (612)
T KOG0603|consen  469 S----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIH----TR------------IQM  528 (612)
T ss_pred             h----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHH----Hh------------hcC
Confidence            4    223467899999999999999999999999999999999999976554431111    11            111


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      +++....+....+|+.+||+.+|.+||++.++...
T Consensus       529 ~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  529 PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             CccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence            22336678888999999999999999999998753

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.98  E-value=2.6e-32  Score=241.22  Aligned_cols=261  Identities=23%  Similarity=0.309  Sum_probs=195.6

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      .|.-.++||+|.||+||+|+.+ ++..||+|++..++  +..-....+|+-+|+.++|.|||++++....++.+-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            3555678999999999999954 67889999987653  23345678999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      |. .+|..+...-+  ..++......++.|+++||.++|++   ++.||||||+|+||+.+|.+||+|||+++.+.-.-.
T Consensus        83 cd-qdlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 CD-QDLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             hh-HHHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            94 47777664333  2388888999999999999999966   599999999999999999999999999997764433


Q ss_pred             eeeecCCCCccccCccccccCc-ccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhh---c---cccccccC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQ-LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK---A---NRITQSMD  528 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~---~---~~~~~~i~  528 (625)
                      ..+ ..+-|..|.+|.++.+.+ |+...|+||-|||+.|+....+|.....+..+.+...+....   +   ..+.++-|
T Consensus       157 cys-aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd  235 (292)
T KOG0662|consen  157 CYS-AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD  235 (292)
T ss_pred             eee-ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence            322 245689999999998864 789999999999999999866664322222222222222211   1   12233333


Q ss_pred             CCCCCCCCh-----HHH----HHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          529 PGLTGRFPE-----NEA----SRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       529 ~~~~~~~~~-----~~~----~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      -...+-+|.     +..    ..=.+++.+.+..+|.+|.++++.++
T Consensus       236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            333333331     222    23367888889999999999988764

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-33  Score=283.64  Aligned_cols=268  Identities=22%  Similarity=0.303  Sum_probs=212.9

Q ss_pred             cCccccccccccCceEEEEEEeCCCC-EEEEEEeec---CChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLPDGR-NIAVKRLFF---NSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~---~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      .+++.+..||-||||.|=++..++.+ .+|+|.+++   .+.+..+.+..|-.||...+.|.||++|..|.++...|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            34566778999999999999876533 477776654   34556778899999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      |-|-||.|..+|..++.   ++......++..+++|++|||.++   ||+|||||+|++++.+|-+||.|||+|+.+..+
T Consensus       500 EaClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  500 EACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HhhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            99999999999977665   788888889999999999999775   999999999999999999999999999998766


Q ss_pred             CceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                      ...  -+++|||.|.|||++.+...+.++|.||||+++||||+|.+||...+.... .....+.         +|.   -
T Consensus       574 ~KT--wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt-Yn~ILkG---------id~---i  638 (732)
T KOG0614|consen  574 RKT--WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT-YNLILKG---------IDK---I  638 (732)
T ss_pred             Cce--eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH-HHHHHhh---------hhh---h
Confidence            554  347999999999999999999999999999999999999999865432211 1111111         111   1


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHHH--ccccC------CCCCCCCCCCccc
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPS-----MAEVVHML--NNIDY------EIPPPKQPPFLNA  586 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~~L--~~~~~------~l~~~~~~~~~~~  586 (625)
                      .+|......-.++|.+....+|..|..     +.+|.+.-  ++..+      .++||-.|+..+.
T Consensus       639 ~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~p  704 (732)
T KOG0614|consen  639 EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANP  704 (732)
T ss_pred             hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCc
Confidence            245666777789999999999999975     56665432  33333      4666666655543

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-32  Score=260.84  Aligned_cols=246  Identities=22%  Similarity=0.252  Sum_probs=201.4

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeec---CChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFF---NSRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l  371 (625)
                      .++|.++++||+|.|..|-+++++ +.+.+|+|++++   +..+.++..+.|-.+..+- +||.+|.++.+|..+..+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            467999999999999999999975 578889998864   3567788888888888766 69999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      |.||++||+|.-+++.+.+   +++..+..+..+|+.||.|||+.|   ||.||||.+|+|+|..|++||.|+|+++.--
T Consensus       329 vieyv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence            9999999999877765443   899999999999999999999776   9999999999999999999999999998643


Q ss_pred             CCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCC---CccchhhHHHhhhccccccccC
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEG---SSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      ..+.. ...++|||.|+|||++.+..|...+|+|+||++++||..|+.||..-..   ..+...++++...+..+     
T Consensus       403 ~~gd~-tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi-----  476 (593)
T KOG0695|consen  403 GPGDT-TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI-----  476 (593)
T ss_pred             CCCcc-cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-----
Confidence            33332 3458999999999999999999999999999999999999999864321   12222233333222221     


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCC
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRP  559 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  559 (625)
                           ..|...+.+...++..-|.+||..|.
T Consensus       477 -----riprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  477 -----RIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             -----cccceeehhhHHHHHHhhcCCcHHhc
Confidence                 23555666677888899999999984

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=3.1e-31  Score=285.22  Aligned_cols=259  Identities=22%  Similarity=0.251  Sum_probs=180.6

Q ss_pred             hcCccccccccccCceEEEEEEe-----------------CCCCEEEEEEeecCChHHHHHH--------------HHHH
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL-----------------PDGRNIAVKRLFFNSRQWVDQF--------------FNEV  345 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E~  345 (625)
                      .++|++.++||+|+||+||+|.+                 ..++.||||++........+.|              ..|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            67899999999999999999963                 2356899999875543333333              3466


Q ss_pred             HHHhcCCCCce-----eeeeeeeee--------CCeeEEEEEecCCCCcchhhhccCC---------------------c
Q 042149          346 NLISGIQHKNV-----VRLLGCSIE--------GPESLLVYEYVPNRSLDQILFVKNT---------------------I  391 (625)
Q Consensus       346 ~~l~~l~hpni-----v~l~~~~~~--------~~~~~lV~e~~~~~sL~~~l~~~~~---------------------~  391 (625)
                      .++.+++|.++     +++++++..        +...+|||||+++++|.++++....                     .
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            67777766554     667777653        3568999999999999998864211                     1


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceeeecCCCCccccCcc
Q 042149          392 HILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE  471 (625)
Q Consensus       392 ~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE  471 (625)
                      ..+++..+..++.|++.+|.|||+.+   |+||||||+|||++.++.+||+|||++...............+++.|+|||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence            23467788999999999999999775   999999999999999999999999999765433222222234589999999


Q ss_pred             ccccCc--------------------c--cccCcEEeehhhhHHHHhCCC-CCCCCCCCc------cchhhHHHhhhccc
Q 042149          472 YLVRGQ--------------------L--TEKADVYAFGVLVIEVASGRR-NSVFSEGSS------SVLHTVWKHYKANR  522 (625)
Q Consensus       472 ~~~~~~--------------------~--~~~~Dv~SlG~ll~elltG~~-p~~~~~~~~------~~~~~~~~~~~~~~  522 (625)
                      .+....                    +  ..+.||||+||++++|++|.. |+.......      ......|..+....
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~  460 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK  460 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence            885432                    1  134799999999999999875 332111000      00011122221111


Q ss_pred             cccccCCCCCCCCChHHHHHHHHHHhhccCCCC---CCCCCHHHHHH
Q 042149          523 ITQSMDPGLTGRFPENEASRVLQIGLLCTQAPV---ALRPSMAEVVH  566 (625)
Q Consensus       523 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p---~~RPt~~ev~~  566 (625)
                      .    +    -...........+++.++|..+|   .+|+|++|+++
T Consensus       461 ~----~----~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        461 Y----D----FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             C----C----cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            1    1    11123446678899999999765   68999999985

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.1e-31  Score=276.76  Aligned_cols=208  Identities=25%  Similarity=0.338  Sum_probs=175.2

Q ss_pred             HHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCee
Q 042149          294 ERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPES  369 (625)
Q Consensus       294 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  369 (625)
                      +-....|..++.||-|+||.|-+++.. +...||+|.+.+.+   +..+..++.|-.||..-+.+-||+||-.|.+++.+
T Consensus       625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL  704 (1034)
T KOG0608|consen  625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL  704 (1034)
T ss_pred             hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence            333456889999999999999999854 46778999886543   44456788899999999999999999999999999


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      |+||+|++||++..+|-..+-   +.+..+..++.++..|+++.|..   ++|||||||+|||||.+|++||.||||+.-
T Consensus       705 YFVMdYIPGGDmMSLLIrmgI---FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTG  778 (1034)
T KOG0608|consen  705 YFVMDYIPGGDMMSLLIRMGI---FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTG  778 (1034)
T ss_pred             EEEEeccCCccHHHHHHHhcc---CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccccc
Confidence            999999999999998865543   88888889999999999999966   499999999999999999999999999853


Q ss_pred             eC---------CCCce--------------------------------eeecCCCCccccCccccccCcccccCcEEeeh
Q 042149          450 VA---------PDKTH--------------------------------VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFG  488 (625)
Q Consensus       450 ~~---------~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG  488 (625)
                      +.         .+...                                ....++||+.|+|||++....++...|+||.|
T Consensus       779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~g  858 (1034)
T KOG0608|consen  779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVG  858 (1034)
T ss_pred             ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhh
Confidence            21         11100                                00136799999999999999999999999999


Q ss_pred             hhhHHHHhCCCCCCCCCCC
Q 042149          489 VLVIEVASGRRNSVFSEGS  507 (625)
Q Consensus       489 ~ll~elltG~~p~~~~~~~  507 (625)
                      ||||||+.|+.||......
T Consensus       859 vil~em~~g~~pf~~~tp~  877 (1034)
T KOG0608|consen  859 VILYEMLVGQPPFLADTPG  877 (1034)
T ss_pred             HHHHHHhhCCCCccCCCCC
Confidence            9999999999998665443

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=2.1e-31  Score=293.76  Aligned_cols=258  Identities=20%  Similarity=0.230  Sum_probs=169.3

Q ss_pred             HhcCccccccccccCceEEEEEEeC-C----CCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeee------ee
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-D----GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGC------SI  364 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~------~~  364 (625)
                      ..++|++.++||+|+||.||+|++. +    +..||||++......  +...+|  .+....+.++..++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            3578999999999999999999975 4    689999987543221  111111  1222222333222221      24


Q ss_pred             eCCeeEEEEEecCCCCcchhhhccCCc-----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeec
Q 042149          365 EGPESLLVYEYVPNRSLDQILFVKNTI-----------------HILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIK  427 (625)
Q Consensus       365 ~~~~~~lV~e~~~~~sL~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlk  427 (625)
                      .+...++||||+.+++|.+++......                 .......+..++.||+.||.|||+.+   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            566889999999999999988643211                 01123345679999999999999775   9999999


Q ss_pred             cCcEEEcC-CCceEEeecccceeeCCCCceeeecCCCCccccCccccccC----------------------cccccCcE
Q 042149          428 TSNILLDE-KLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG----------------------QLTEKADV  484 (625)
Q Consensus       428 p~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv  484 (625)
                      |+|||++. ++.+||+|||+++.+............+++.|+|||.+...                      .++.++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999985 57999999999987654444444456789999999966322                      23456799


Q ss_pred             EeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhc-----cccccccCCCCCCC------CChHHHHHHHHHHhhccCC
Q 042149          485 YAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKA-----NRITQSMDPGLTGR------FPENEASRVLQIGLLCTQA  553 (625)
Q Consensus       485 ~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~i~~~~~~~------~~~~~~~~l~~li~~cl~~  553 (625)
                      |||||++|||+++..+...     ... .....+..     ..+...+.+....+      ..........+|+.+||+.
T Consensus       363 wSlGviL~el~~~~~~~~~-----~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDS-----NLI-QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             HHHHHHHHHHHhCcCCCch-----HHH-HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence            9999999999997654221     111 01110000     00111111111000      0011123456899999999


Q ss_pred             CCCCCCCHHHHHH
Q 042149          554 PVALRPSMAEVVH  566 (625)
Q Consensus       554 ~p~~RPt~~ev~~  566 (625)
                      ||++|||+.|+++
T Consensus       437 dP~kR~ta~e~L~  449 (566)
T PLN03225        437 KGRQRISAKAALA  449 (566)
T ss_pred             CcccCCCHHHHhC
Confidence            9999999999986

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=2.5e-31  Score=263.00  Aligned_cols=238  Identities=26%  Similarity=0.328  Sum_probs=192.5

Q ss_pred             CceEEEEEEeC-CCCEEEEEEeecCChHH-HHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCCCcchhhhc
Q 042149          310 GAGSVFRGTLP-DGRNIAVKRLFFNSRQW-VDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFV  387 (625)
Q Consensus       310 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~  387 (625)
                      +||.||+|+.. +++.+|+|++....... .+.+.+|++.+++++|+||+++++.+......+++|||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999976 58999999997665433 67899999999999999999999999999999999999999999998865


Q ss_pred             cCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceeeecCCCCccc
Q 042149          388 KNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGY  467 (625)
Q Consensus       388 ~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y  467 (625)
                      ...   +++..++.++.+++.++.+||+.+   ++|+||+|+||++++++.++|+|||.+.......  ......++..|
T Consensus        81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~  152 (244)
T smart00220       81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY  152 (244)
T ss_pred             ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence            433   789999999999999999999775   9999999999999999999999999998765432  22345688999


Q ss_pred             cCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHH
Q 042149          468 MAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIG  547 (625)
Q Consensus       468 ~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  547 (625)
                      ++||.+....++.++||||||+++++|++|..|+.........    ..........       ........+.++.+++
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~----~~~~~~~~~~-------~~~~~~~~~~~~~~~i  221 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLEL----FKKIGKPKPP-------FPPPEWKISPEAKDLI  221 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH----HHHHhccCCC-------CccccccCCHHHHHHH
Confidence            9999998888999999999999999999999886432211111    1111111100       0000011567899999


Q ss_pred             hhccCCCCCCCCCHHHHHH
Q 042149          548 LLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       548 ~~cl~~~p~~RPt~~ev~~  566 (625)
                      .+||..+|++||++.++++
T Consensus       222 ~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      222 RKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHccCCchhccCHHHHhh
Confidence            9999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1e-31  Score=264.09  Aligned_cols=265  Identities=20%  Similarity=0.229  Sum_probs=199.5

Q ss_pred             HHHHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCC--CCc----eeeeeeeee
Q 042149          292 ILERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ--HKN----VVRLLGCSI  364 (625)
Q Consensus       292 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--hpn----iv~l~~~~~  364 (625)
                      .....+++|.+...+|+|.||.|-++.+. .+..||||++.. -....+...-|+++|+++.  .|+    +|++.++|.
T Consensus        83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd  161 (415)
T KOG0671|consen   83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD  161 (415)
T ss_pred             eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence            33445788999999999999999999864 578899998753 3344566777999999994  333    788889999


Q ss_pred             eCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEc----------
Q 042149          365 EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD----------  434 (625)
Q Consensus       365 ~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~----------  434 (625)
                      -.++.+||+|.+ |.|+.++|..++ ..+++...+..+..|+++++++||+.   +++|-||||+|||+.          
T Consensus       162 yrghiCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~  236 (415)
T KOG0671|consen  162 YRGHICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNP  236 (415)
T ss_pred             ccCceEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEecc
Confidence            999999999998 778999886543 44589999999999999999999966   499999999999982          


Q ss_pred             ----------CCCceEEeecccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCC
Q 042149          435 ----------EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFS  504 (625)
Q Consensus       435 ----------~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~  504 (625)
                                .+..++|+|||.|....+..    ..++.|..|.|||++.+-.++...||||+||||.||.||..-|...
T Consensus       237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH  312 (415)
T KOG0671|consen  237 KKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH  312 (415)
T ss_pred             CCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence                      12458999999998765444    3367899999999999999999999999999999999999876555


Q ss_pred             CCCccc--hhhHH--------------Hhhhcccc-----------ccccCCCC----CCCCChHHHHHHHHHHhhccCC
Q 042149          505 EGSSSV--LHTVW--------------KHYKANRI-----------TQSMDPGL----TGRFPENEASRVLQIGLLCTQA  553 (625)
Q Consensus       505 ~~~~~~--~~~~~--------------~~~~~~~~-----------~~~i~~~~----~~~~~~~~~~~l~~li~~cl~~  553 (625)
                      ++.+.+  .+.+.              +.+..+++           ....++-.    .......+...|.+|+.+||..
T Consensus       313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f  392 (415)
T KOG0671|consen  313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF  392 (415)
T ss_pred             CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence            433211  00000              00000000           00000000    0011234566799999999999


Q ss_pred             CCCCCCCHHHHHH
Q 042149          554 PVALRPSMAEVVH  566 (625)
Q Consensus       554 ~p~~RPt~~ev~~  566 (625)
                      ||.+|+|+.|++.
T Consensus       393 DP~~RiTl~EAL~  405 (415)
T KOG0671|consen  393 DPARRITLREALS  405 (415)
T ss_pred             CccccccHHHHhc
Confidence            9999999999885

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=4.4e-33  Score=258.56  Aligned_cols=263  Identities=23%  Similarity=0.347  Sum_probs=192.5

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeee--------CC
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIE--------GP  367 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--------~~  367 (625)
                      .|+-..+||+|.||.||+|+.+ +|+.||+|++..++  ...-....+|+.+|..|+|+|++.+++.|..        ..
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            3555668999999999999965 58889998775432  2223456899999999999999999987753        23


Q ss_pred             eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccc
Q 042149          368 ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA  447 (625)
Q Consensus       368 ~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla  447 (625)
                      .+++||.+|+. +|.-+|...  ...++..++.+++.++..||.|+|..   .|+|||+||.|+||+.+|.+||+|||++
T Consensus        98 t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence            58999999964 677766433  34488999999999999999999965   5999999999999999999999999999


Q ss_pred             eeeCCCCce---eeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccc----------hhh
Q 042149          448 RHVAPDKTH---VSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSV----------LHT  513 (625)
Q Consensus       448 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~----------~~~  513 (625)
                      +.+......   ..+..+-|..|.+||.+.+ .+++++.|||.-|||+.||+|+.+-+........+          -..
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            766433221   1233456999999999887 57999999999999999999998654333222111          112


Q ss_pred             HHHhhhccccccccCCC-CCCCC---ChHH------HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          514 VWKHYKANRITQSMDPG-LTGRF---PENE------ASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       514 ~~~~~~~~~~~~~i~~~-~~~~~---~~~~------~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      +|....+-.+.+.+... +....   -++.      .++-.+|+.+++..||.+|+++.+++..
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            34444333344433211 11100   0111      2256689999999999999999998753

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-31  Score=261.58  Aligned_cols=268  Identities=23%  Similarity=0.330  Sum_probs=214.3

Q ss_pred             cHHHHHHHhcCccccccccccCceEEEEEEeCC------CCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeee
Q 042149          289 KYEILERATDFFDNSRKLGQGGAGSVFRGTLPD------GRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLG  361 (625)
Q Consensus       289 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~  361 (625)
                      +..++....+++.....+-+|.||.||.|.+.+      .+.|-+|.++.. ++-.+..+..|.-++..+.|||+..+.+
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            445555666778888999999999999997542      345667776544 3445678899999999999999999999


Q ss_pred             eeee-CCeeEEEEEecCCCCcchhhh-----ccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC
Q 042149          362 CSIE-GPESLLVYEYVPNRSLDQILF-----VKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE  435 (625)
Q Consensus       362 ~~~~-~~~~~lV~e~~~~~sL~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~  435 (625)
                      ++.+ ...++.++.++.-|+|+.+|.     +....+.++..+...++.|++.|++|||..+   +||.||...|.+||+
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence            8765 457889999999999999997     3344455778888999999999999999765   999999999999999


Q ss_pred             CCceEEeecccceeeCCCCceee-ecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhh
Q 042149          436 KLTPKIADFGLARHVAPDKTHVS-TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHT  513 (625)
Q Consensus       436 ~~~~kl~Dfgla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~  513 (625)
                      ...+||+|-.+++...+...+.. ........||+||.+.+..|+.++||||||+++|||.| |+.|+..-         
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI---------  502 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI---------  502 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc---------
Confidence            99999999999987665444332 23345679999999999999999999999999999988 66664321         


Q ss_pred             HHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccC
Q 042149          514 VWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY  573 (625)
Q Consensus       514 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  573 (625)
                           ...++...+..+.+-..|.++++++..+|.-||...|++||++++++.-|.+...
T Consensus       503 -----DPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~  557 (563)
T KOG1024|consen  503 -----DPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT  557 (563)
T ss_pred             -----CHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence                 1122222333334444588999999999999999999999999999998876543

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=7.1e-31  Score=280.15  Aligned_cols=245  Identities=29%  Similarity=0.422  Sum_probs=185.0

Q ss_pred             ccccccccccCce-EEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEEEEEecC
Q 042149          300 FDNSRKLGQGGAG-SVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLLVYEYVP  377 (625)
Q Consensus       300 y~~~~~lG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~~~  377 (625)
                      |...+.+|.|..| .||+|.. +|+.||||++-...   .....+|+..|+.- +|||||++++.-.+....||..|.| 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            4556679999987 5799998 57899999985443   34667999999998 5999999999988999999999999 


Q ss_pred             CCCcchhhhccCC-cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC-----CCceEEeecccceeeC
Q 042149          378 NRSLDQILFVKNT-IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE-----KLTPKIADFGLARHVA  451 (625)
Q Consensus       378 ~~sL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~-----~~~~kl~Dfgla~~~~  451 (625)
                      ..+|++++..... .....-...+.++.|+++||++||+-   +||||||||+||||+.     ..+++|+|||+++...
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            5799999865311 11111134577889999999999965   5999999999999974     2579999999999887


Q ss_pred             CCCceee--ecCCCCccccCccccccCcccccCcEEeehhhhHHHHhC-CCCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          452 PDKTHVS--TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG-RRNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       452 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      .+.....  .+..||-+|+|||++.....+.++||||||||+|+.++| .+||.-.-..+.-+     ...+..+.++  
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI-----l~~~~~L~~L--  735 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI-----LTGNYTLVHL--  735 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhh-----hcCccceeee--
Confidence            6554433  367899999999999998888999999999999999998 66765321111000     0000011100  


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                          .+ ..++  +-.+||.+|++++|..||++.+|+.
T Consensus       736 ----~~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  736 ----EP-LPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             ----cc-CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence                00 1111  6679999999999999999999974

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-30  Score=235.27  Aligned_cols=205  Identities=26%  Similarity=0.316  Sum_probs=166.2

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC-ChHHHHHHHHHHHHHhc-CCCCceeeeeeeeeeCCeeEEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN-SRQWVDQFFNEVNLISG-IQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~-l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      ..+....+..||+|++|.|=+-++. +|...|+|++... ..+...+..+|+.+..+ ...|.+|.+||....+...+|.
T Consensus        44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc  123 (282)
T KOG0984|consen   44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC  123 (282)
T ss_pred             chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence            3455556778999999999999875 7899999998654 34456678888887654 4799999999999999999999


Q ss_pred             EEecCCCCcchhhhcc-CCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          373 YEYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||.| ..||+.+...- ..+..+++.-.-+|+..++.||.|||++  +.+||||+||+||||+.+|++|++|||++-.+.
T Consensus       124 ME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~  200 (282)
T KOG0984|consen  124 MELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLV  200 (282)
T ss_pred             HHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence            9999 46777654321 2334488888899999999999999985  479999999999999999999999999998764


Q ss_pred             CCCceeeecCCCCccccCcccccc----CcccccCcEEeehhhhHHHHhCCCCCCCCC
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVR----GQLTEKADVYAFGVLVIEVASGRRNSVFSE  505 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlG~ll~elltG~~p~~~~~  505 (625)
                      +.-..  +-..|--.|||||.+..    ..|+.++||||||+++.||.+++.|+....
T Consensus       201 dSiAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  201 DSIAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             hhhHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            33221  22357789999998854    368999999999999999999999976543

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=1.8e-30  Score=238.06  Aligned_cols=252  Identities=19%  Similarity=0.268  Sum_probs=194.0

Q ss_pred             hcCccccccccccCceEEEEEEe-CCCCEEEEEEeecCChHHHHHHHHHHHHHhcCC-CCceeeeeeeeee--CCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-HKNVVRLLGCSIE--GPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~--~~~~~lV  372 (625)
                      +++|++.+++|+|.++.||.|.. .+...++||++++...   ..+.+|+.||..|. ||||+++++...+  ...+.||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            57899999999999999999984 5678899999976543   47889999999997 9999999998875  4567899


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC-CCceEEeecccceeeC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE-KLTPKIADFGLARHVA  451 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~-~~~~kl~Dfgla~~~~  451 (625)
                      +||+++.+...+.      +.++...+..++.+++.||.|+|+.|   |+|||+||.|++||. ...++|+|+|+|.++.
T Consensus       114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence            9999998887755      22777888999999999999999776   999999999999995 5679999999999887


Q ss_pred             CCCceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhh-----------
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK-----------  519 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~-----------  519 (625)
                      .......  .+.+..|--||.+.. ..|+.+-|+|||||++..|+..+.||.-..+..+.+-..-+...           
T Consensus       185 p~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY  262 (338)
T KOG0668|consen  185 PGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY  262 (338)
T ss_pred             CCceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence            6655433  245677888999876 56899999999999999999999997554433221111111000           


Q ss_pred             ----------------ccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          520 ----------------ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       520 ----------------~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                                      ...+...+.+.-.    .-..++..+++.+.|..|-.+|||+.|.+.
T Consensus       263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~----hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  263 QIDLDPQFEDILGRHSRKPWSRFINSENQ----HLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             ccCCChhHhhHhhccccccHHHhCCcccc----ccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                            0111112221111    112356789999999999999999999874

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-30  Score=244.89  Aligned_cols=261  Identities=23%  Similarity=0.324  Sum_probs=190.3

Q ss_pred             ccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC-----CeeEE
Q 042149          300 FDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG-----PESLL  371 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~~l  371 (625)
                      .+-.+-||.|+||+||.+.++ +|+.||+|++...  +-...+++.+|+++|.-++|.|++..++...-.     .++|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            345678999999999999975 7999999988543  333456889999999999999999988765432     25678


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      |.|.| ..+|..++-..+   .++...+.-++.||++||+|||+.+   |.||||||.|+|++.+..+||+|||+++...
T Consensus       135 ~TELm-QSDLHKIIVSPQ---~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  135 LTELM-QSDLHKIIVSPQ---ALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHH-HhhhhheeccCC---CCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence            88888 457877774333   3888888899999999999999774   9999999999999999999999999999877


Q ss_pred             CCCceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhh-----------
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK-----------  519 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~-----------  519 (625)
                      .++....+..+-|-.|.|||++++. .|+.+.||||+|||+.|||-.+..|-.-...+ .++...+...           
T Consensus       208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Piq-QL~lItdLLGTPs~EaMr~AC  286 (449)
T KOG0664|consen  208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIE-QLQMIIDLLGTPSQEAMKYAC  286 (449)
T ss_pred             hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHH-HHHHHHHHhCCCcHHHHHHHh
Confidence            6666666666778899999999884 79999999999999999996654332211111 1111111111           


Q ss_pred             ccccccccCCCCCC---------CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042149          520 ANRITQSMDPGLTG---------RFPENEASRVLQIGLLCTQAPVALRPSMAEVVHML  568 (625)
Q Consensus       520 ~~~~~~~i~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  568 (625)
                      ++.-..++......         ..+.....+-..+..+++..+|++|.+.++.+..+
T Consensus       287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            11111111111110         01122233455777889999999999998887654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=3.6e-30  Score=267.97  Aligned_cols=255  Identities=24%  Similarity=0.337  Sum_probs=204.4

Q ss_pred             HHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      .-.++|+.+.++|.|.+|.||+++++ +++..|||.++........-+.+|+-+++..+|||||.++|.+...+.++|.|
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            34678999999999999999999965 68999999998887777788899999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      |||.||+|.++.+..+.   +++.++...+++.++||+|||+++   =+|||||-.|||+++.|.+|+.|||.+..+...
T Consensus        92 EycgggslQdiy~~Tgp---lselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHVTGP---LSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             EecCCCcccceeeeccc---chhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence            99999999998765554   899999999999999999999876   799999999999999999999999998766543


Q ss_pred             CceeeecCCCCccccCcccc---ccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYL---VRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                      -.. .+.+.||+.|||||+.   +.+.|...+|||++|+...|+-.-++|. |.-.....+...     ..   ...++.
T Consensus       166 i~K-rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl-fdlhpmr~l~Lm-----Tk---S~~qpp  235 (829)
T KOG0576|consen  166 IAK-RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL-FDLHPMRALFLM-----TK---SGFQPP  235 (829)
T ss_pred             hhh-hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc-cccchHHHHHHh-----hc---cCCCCC
Confidence            222 3357899999999987   4567999999999999999997766552 221111000000     00   001111


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      -. +-+..-.+.+.+++..++.++|++||+++.++.
T Consensus       236 ~l-kDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  236 TL-KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cc-cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            10 112344677899999999999999999876643

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=4.5e-28  Score=233.63  Aligned_cols=210  Identities=33%  Similarity=0.534  Sum_probs=183.0

Q ss_pred             ccccCceEEEEEEeCC-CCEEEEEEeecCChH-HHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCCCcch
Q 042149          306 LGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQ-WVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQ  383 (625)
Q Consensus       306 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~sL~~  383 (625)
                      ||+|.+|.||++...+ ++.+++|++...... ..+.+.+|+..++.++|++|+++++++......+++||++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999754 899999998765432 45689999999999999999999999999999999999999999999


Q ss_pred             hhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC-CCceEEeecccceeeCCCCceeeecCC
Q 042149          384 ILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE-KLTPKIADFGLARHVAPDKTHVSTGIA  462 (625)
Q Consensus       384 ~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~  462 (625)
                      ++....  ..+++..+..++.+++++|.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~  154 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV  154 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence            886542  24889999999999999999999775   999999999999999 89999999999987654331 122245


Q ss_pred             CCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHH
Q 042149          463 GTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEAS  541 (625)
Q Consensus       463 gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  541 (625)
                      +...|++||..... ..+.+.|+|++|+++++|                                              .
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------~  188 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------P  188 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------H
Confidence            78899999999877 888999999999999999                                              4


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          542 RVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       542 ~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      .+.+++.+|++.+|++||++.++++.
T Consensus       189 ~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         189 ELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             HHHHHHHHHhhCCcccCcCHHHHhhC
Confidence            57899999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=4e-29  Score=256.19  Aligned_cols=195  Identities=24%  Similarity=0.375  Sum_probs=165.4

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHH-----HHHHHHHHHHHhcCC---CCceeeeeeeeee
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQW-----VDQFFNEVNLISGIQ---HKNVVRLLGCSIE  365 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~-----~~~~~~E~~~l~~l~---hpniv~l~~~~~~  365 (625)
                      ..|...+.||+|+||.|++|.++ +...|+||.+.+..   ..+     +-.+--||.||+.|+   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            45889999999999999999986 46778889886542   111     223445999999997   9999999999999


Q ss_pred             CCeeEEEEEec-CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeec
Q 042149          366 GPESLLVYEYV-PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADF  444 (625)
Q Consensus       366 ~~~~~lV~e~~-~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Df  444 (625)
                      ++..||+||.. +|-+|-+++..+.   .+++.++..|+.|++.|+++||.++   |||||||-+|+.++.+|-+||+||
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence            99999999976 4567777775443   4899999999999999999999886   999999999999999999999999


Q ss_pred             ccceeeCCCCceeeecCCCCccccCccccccCcc-cccCcEEeehhhhHHHHhCCCCC
Q 042149          445 GLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGRRNS  501 (625)
Q Consensus       445 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~ll~elltG~~p~  501 (625)
                      |.+.....+.-.   .++||..|.|||++.+.+| +..-|||++|++||-++....|+
T Consensus       715 gsaa~~ksgpfd---~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  715 GSAAYTKSGPFD---VFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             cchhhhcCCCcc---eeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            999877655443   3689999999999998876 56789999999999999877775

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=1.1e-28  Score=249.99  Aligned_cols=271  Identities=18%  Similarity=0.203  Sum_probs=209.3

Q ss_pred             cccHHHHHHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCC------CCceeee
Q 042149          287 NFKYEILERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ------HKNVVRL  359 (625)
Q Consensus       287 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------hpniv~l  359 (625)
                      .+++.+.+..-.+|.+....|+|-|++|-.|.+. -|..||||++..+. .....=+.|++||++|.      .-|.+++
T Consensus       421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl  499 (752)
T KOG0670|consen  421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRL  499 (752)
T ss_pred             eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence            4677888888999999999999999999999965 47899999997553 22344568999999996      3489999


Q ss_pred             eeeeeeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCC-Cc
Q 042149          360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEK-LT  438 (625)
Q Consensus       360 ~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~-~~  438 (625)
                      +..|...+++|||+|-+ ..+|.++|...+..-.|....+..++.|+..||..|...   +|+|.||||+||||++. ..
T Consensus       500 ~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~i  575 (752)
T KOG0670|consen  500 FRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNI  575 (752)
T ss_pred             HHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcce
Confidence            99999999999999987 578999998777666688999999999999999999965   49999999999999864 57


Q ss_pred             eEEeecccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHH--
Q 042149          439 PKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWK--  516 (625)
Q Consensus       439 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~--  516 (625)
                      +||||||.|........   +++.-+..|.|||++.+-+|+...|+||+||.||||.||+.-|+...+.+-+ .....  
T Consensus       576 LKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML-rl~me~K  651 (752)
T KOG0670|consen  576 LKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML-RLFMELK  651 (752)
T ss_pred             eeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHH-HHHHHhc
Confidence            89999999987654433   3445677899999999999999999999999999999999766543332211 11100  


Q ss_pred             ----------------hhhc--------------c---ccccccCCC------C--CCCCC---hHHHHHHHHHHhhccC
Q 042149          517 ----------------HYKA--------------N---RITQSMDPG------L--TGRFP---ENEASRVLQIGLLCTQ  552 (625)
Q Consensus       517 ----------------~~~~--------------~---~~~~~i~~~------~--~~~~~---~~~~~~l~~li~~cl~  552 (625)
                                      ++..              .   .+...+.|.      +  ...+|   ......+.+|+.+|+.
T Consensus       652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~  731 (752)
T KOG0670|consen  652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI  731 (752)
T ss_pred             CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence                            0000              0   011111110      0  01122   3456778899999999


Q ss_pred             CCCCCCCCHHHHHH
Q 042149          553 APVALRPSMAEVVH  566 (625)
Q Consensus       553 ~~p~~RPt~~ev~~  566 (625)
                      .||++|.|..+.+.
T Consensus       732 LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  732 LDPEKRITVNQALK  745 (752)
T ss_pred             cChhhcCCHHHHhc
Confidence            99999999998874

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=5.1e-27  Score=229.70  Aligned_cols=198  Identities=31%  Similarity=0.435  Sum_probs=171.1

Q ss_pred             ccccccccccCceEEEEEEeCC-CCEEEEEEeecCChH-HHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecC
Q 042149          300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQ-WVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVP  377 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~  377 (625)
                      |.+.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++...+..++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5667889999999999999764 889999999766544 67889999999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCcee
Q 042149          378 NRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV  457 (625)
Q Consensus       378 ~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  457 (625)
                      +++|.+++......  +++.....++.+++.++.+||+.+   ++|+||+|+||+++.++.++|+|||.+..........
T Consensus        81 ~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~  155 (225)
T smart00221       81 GGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL  155 (225)
T ss_pred             CCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence            99999988644321  788999999999999999999775   9999999999999999999999999998775443112


Q ss_pred             eecCCCCccccCcccc-ccCcccccCcEEeehhhhHHHHhCCCCCC
Q 042149          458 STGIAGTLGYMAPEYL-VRGQLTEKADVYAFGVLVIEVASGRRNSV  502 (625)
Q Consensus       458 ~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlG~ll~elltG~~p~~  502 (625)
                      .....++..|++||.+ ....++.++|+|+||+++++|++|+.|+.
T Consensus       156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            2234678899999998 66677889999999999999999999874

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=5.4e-28  Score=232.60  Aligned_cols=258  Identities=26%  Similarity=0.327  Sum_probs=189.7

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC------Ce
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG------PE  368 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~  368 (625)
                      .+|..++.+|.|.- .|-.|.+. .++.||+|++...  ......+..+|...+..+.|+||++++.+|.-.      ..
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            45677788999988 66666543 6899999988543  333456788999999999999999999988633      46


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      .|+|||+| ..+|...++..     ++-..+..|+.|++.|++|||+.+   |+||||||+||++..+..+||.|||+++
T Consensus        96 ~y~v~e~m-~~nl~~vi~~e-----lDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVILME-----LDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhh-hhHHHHHHHHh-----cchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence            79999999 45787777522     566788899999999999999775   9999999999999999999999999998


Q ss_pred             eeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccc------hh----hHHHh-
Q 042149          449 HVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSV------LH----TVWKH-  517 (625)
Q Consensus       449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~------~~----~~~~~-  517 (625)
                      .-...  ...+..+.|..|.|||++.+..+.+.+||||+||++.||++|+.-+...+..+..      +.    .+... 
T Consensus       167 ~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL  244 (369)
T KOG0665|consen  167 TEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL  244 (369)
T ss_pred             ccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence            65433  4566788999999999999988999999999999999999998765422111100      00    00000 


Q ss_pred             -------------hhccccccccCCCC-C--CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          518 -------------YKANRITQSMDPGL-T--GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       518 -------------~~~~~~~~~i~~~~-~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                                   +..-...+.+...+ .  .+.++-......+++.+||-.+|++|.+..+++..
T Consensus       245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                         00000111111100 0  11122234456889999999999999999998853

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=4.3e-27  Score=234.74  Aligned_cols=264  Identities=23%  Similarity=0.342  Sum_probs=196.4

Q ss_pred             HHHHHhcCccccccccccCceEEEEEEeC----CCCEEEEEEeecCChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeC
Q 042149          292 ILERATDFFDNSRKLGQGGAGSVFRGTLP----DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEG  366 (625)
Q Consensus       292 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~  366 (625)
                      .+....+.|.++++||+|.|++||++.+.    ..+.||+|.+.....  ..++.+|+++|..+. +.||+++.+++..+
T Consensus        30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnn  107 (418)
T KOG1167|consen   30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNN  107 (418)
T ss_pred             hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence            34455677999999999999999999853    467899998865432  256889999999995 99999999999999


Q ss_pred             CeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC-CCceEEeecc
Q 042149          367 PESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE-KLTPKIADFG  445 (625)
Q Consensus       367 ~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~-~~~~kl~Dfg  445 (625)
                      +...+|+||++.....+++..      ++..++..+++.++.||.++|.+|   ||||||||+|+|.+. -++-.|+|||
T Consensus       108 d~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             CeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence            999999999999998887732      678899999999999999999886   999999999999984 4778999999


Q ss_pred             cceeeCC-------------CCc------------------------------eeeecCCCCccccCcccccc-Cccccc
Q 042149          446 LARHVAP-------------DKT------------------------------HVSTGIAGTLGYMAPEYLVR-GQLTEK  481 (625)
Q Consensus       446 la~~~~~-------------~~~------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~  481 (625)
                      +|.....             ...                              .......||++|.|||++.. +..+++
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            9862100             000                              00113469999999999876 567899


Q ss_pred             CcEEeehhhhHHHHhCCCCCCCCCCCcc-chhhHH----Hhh-----hccc--ccc---------------ccC-CCCC-
Q 042149          482 ADVYAFGVLVIEVASGRRNSVFSEGSSS-VLHTVW----KHY-----KANR--ITQ---------------SMD-PGLT-  532 (625)
Q Consensus       482 ~Dv~SlG~ll~elltG~~p~~~~~~~~~-~~~~~~----~~~-----~~~~--~~~---------------~i~-~~~~-  532 (625)
                      +||||.|+|+..+++++.||....++-. +.+.+.    ...     ..+.  +.+               .++ ..+. 
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~  338 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK  338 (418)
T ss_pred             cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence            9999999999999999999765433322 211110    000     0001  000               000 0000 


Q ss_pred             --------CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          533 --------GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       533 --------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                              .......+..+.+++.+|++.||.+|.|+++.++
T Consensus       339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence                    0111222446889999999999999999999885

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=9.4e-27  Score=235.00  Aligned_cols=131  Identities=27%  Similarity=0.371  Sum_probs=111.9

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCC-----C---Cceeeeeeeeee---
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-----H---KNVVRLLGCSIE---  365 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---pniv~l~~~~~~---  365 (625)
                      .+|.+.++||.|.|++||++.+. ..+.||+|+.+ ......+....||++|++++     |   .+||+|++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK-SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK-SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEe-hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            68999999999999999999965 56788999874 44556778899999999984     3   359999999974   


Q ss_pred             -CCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE
Q 042149          366 -GPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL  433 (625)
Q Consensus       366 -~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll  433 (625)
                       +.++++|+|++ |.+|..+|..... +-++...+..|+.||+.||.|||.+.  +|||-||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence             56899999999 7788887765543 34999999999999999999999876  89999999999998

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=7.6e-27  Score=219.48  Aligned_cols=253  Identities=17%  Similarity=0.263  Sum_probs=186.7

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcC-CCCceeeeeee-eeeCCeeEEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGI-QHKNVVRLLGC-SIEGPESLLV  372 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~-~~~~~~~~lV  372 (625)
                      ..+.|.+.+.||+|.||.+-+++++ +...+++|-+... ......|.+|...--.| .|.||+.-|+. |...+..+++
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            3567899999999999999999987 4667888876543 33457889998876666 49999998874 5667788899


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEc--CCCceEEeecccceee
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD--EKLTPKIADFGLARHV  450 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~--~~~~~kl~Dfgla~~~  450 (625)
                      |||++.|+|...+...+    +.+....+++.|+++|+.|+|++   ++||||||.+||||-  +..++||+|||+.+..
T Consensus       101 qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             eccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccccc
Confidence            99999999998875433    77888899999999999999976   599999999999993  3458999999998754


Q ss_pred             CCCCceeeecCCCCccccCcccccc---C--cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccccc
Q 042149          451 APDKTHVSTGIAGTLGYMAPEYLVR---G--QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQ  525 (625)
Q Consensus       451 ~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  525 (625)
                      +..-.    ...-+..|.+||....   +  ...+.+|||.||++++.++||+.|+- .....+-.-+.|..|.......
T Consensus       174 g~tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ-ka~~~d~~Y~~~~~w~~rk~~~  248 (378)
T KOG1345|consen  174 GTTVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ-KASIMDKPYWEWEQWLKRKNPA  248 (378)
T ss_pred             Cceeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch-hhhccCchHHHHHHHhcccCcc
Confidence            32221    2334668999998743   2  34688999999999999999999974 2111121223345555444331


Q ss_pred             ccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          526 SMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       526 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                           +...+ ...+.....+..+-+.+++++|--..++.++
T Consensus       249 -----~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  249 -----LPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             -----Cchhh-cccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence                 11111 1234567788889999999999555554443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=6.6e-26  Score=262.41  Aligned_cols=196  Identities=18%  Similarity=0.176  Sum_probs=137.3

Q ss_pred             hcCCC-Cceeeeeeee-------eeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCce
Q 042149          349 SGIQH-KNVVRLLGCS-------IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIK  420 (625)
Q Consensus       349 ~~l~h-pniv~l~~~~-------~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~  420 (625)
                      +.++| +||+++++.+       .+...++++||++ +++|.++|...  ...+++.+++.++.||++||.|||+++   
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---  100 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---  100 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence            34556 5788888877       2334677889987 66999998533  344899999999999999999999775   


Q ss_pred             EEEeeeccCcEEEcCC-------------------CceEEeecccceeeCCCCc---------------eeeecCCCCcc
Q 042149          421 IIHRDIKTSNILLDEK-------------------LTPKIADFGLARHVAPDKT---------------HVSTGIAGTLG  466 (625)
Q Consensus       421 iiHrDlkp~NIll~~~-------------------~~~kl~Dfgla~~~~~~~~---------------~~~~~~~gt~~  466 (625)
                      |+||||||+||||+..                   +.+||+|||+++.......               .......||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            9999999999999643                   4556666666653211000               00012357889


Q ss_pred             ccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHH
Q 042149          467 YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQI  546 (625)
Q Consensus       467 y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l  546 (625)
                      |+|||++.+..++.++|||||||++|||++|..|+....   .    ........    ...+.     ..........+
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~----~~~~~~~~----~~~~~-----~~~~~~~~~~~  244 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---R----TMSSLRHR----VLPPQ-----ILLNWPKEASF  244 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---H----HHHHHHHh----hcChh-----hhhcCHHHHHH
Confidence            999999999999999999999999999999877632110   0    01111100    01110     11123345688


Q ss_pred             HhhccCCCCCCCCCHHHHHH
Q 042149          547 GLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       547 i~~cl~~~p~~RPt~~ev~~  566 (625)
                      +.+||+++|.+||++.||++
T Consensus       245 ~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHhCCCChhhCcChHHHhh
Confidence            89999999999999999975

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=2.9e-24  Score=221.93  Aligned_cols=176  Identities=19%  Similarity=0.181  Sum_probs=135.1

Q ss_pred             HHHHhcCccccccccccCceEEEEEEeC--CCCEEEEEEeecC-----ChHHHHHHHHHHHHHhcCCCCceee-eeeeee
Q 042149          293 LERATDFFDNSRKLGQGGAGSVFRGTLP--DGRNIAVKRLFFN-----SRQWVDQFFNEVNLISGIQHKNVVR-LLGCSI  364 (625)
Q Consensus       293 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~-l~~~~~  364 (625)
                      .....+.|.+.+.||+|+||+||+|+++  +++.+|||++...     .....+.+.+|+++|++++|+|++. +++.  
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--   90 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--   90 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence            3455678999999999999999999864  5777899987533     2334567999999999999999985 4432  


Q ss_pred             eCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeee-ccCcEEEcCCCceEEee
Q 042149          365 EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDI-KTSNILLDEKLTPKIAD  443 (625)
Q Consensus       365 ~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDl-kp~NIll~~~~~~kl~D  443 (625)
                        ...++||||++|++|....    .   ..   ...++.+++++|.|||+.+   |+|||| ||+|||++.++.+||+|
T Consensus        91 --~~~~LVmE~~~G~~L~~~~----~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiD  155 (365)
T PRK09188         91 --GKDGLVRGWTEGVPLHLAR----P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVID  155 (365)
T ss_pred             --CCcEEEEEccCCCCHHHhC----c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEE
Confidence              4579999999999996321    1   11   1467889999999999775   999999 99999999999999999


Q ss_pred             cccceeeCCCCceee-------ecCCCCccccCccccccCc------ccccCcEE
Q 042149          444 FGLARHVAPDKTHVS-------TGIAGTLGYMAPEYLVRGQ------LTEKADVY  485 (625)
Q Consensus       444 fgla~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~------~~~~~Dv~  485 (625)
                      ||+++.+........       +...+++.|+|||.+...+      .+..+|-|
T Consensus       156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            999997654332111       3567888999999986432      23346666

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=7.9e-24  Score=219.22  Aligned_cols=262  Identities=18%  Similarity=0.198  Sum_probs=195.0

Q ss_pred             CccccccccccCceEEEEEEeCCC--CEEEEEEeecCChHHHHHHHHHHHHHhcCCC----Cceeeeeeee-eeCCeeEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLPDG--RNIAVKRLFFNSRQWVDQFFNEVNLISGIQH----KNVVRLLGCS-IEGPESLL  371 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----pniv~l~~~~-~~~~~~~l  371 (625)
                      +|.+.++||+|+||.||.+...+.  ..+|+|............+..|+.++..+.+    +++..+++.+ ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999997653  4788887765433322367889999988873    6899999999 57788999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCC-----CceEEeeccc
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEK-----LTPKIADFGL  446 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~-----~~~kl~Dfgl  446 (625)
                      ||+.+ |.+|.++..... ...++....+.++.|++.+|++||+.|   ++||||||+|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99988 899999775444 456999999999999999999999776   9999999999999754     4699999999


Q ss_pred             ce--eeCCCCce----e---eecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHh
Q 042149          447 AR--HVAPDKTH----V---STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKH  517 (625)
Q Consensus       447 a~--~~~~~~~~----~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~  517 (625)
                      ++  .+......    .   .....||..|+++....+...+.+.|+||++.++.|++.|..|+........ ....   
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~---  249 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKF---  249 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHH---
Confidence            98  33222111    1   1245699999999999999999999999999999999999988643332211 1111   


Q ss_pred             hhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCC
Q 042149          518 YKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEI  575 (625)
Q Consensus       518 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l  575 (625)
                       ...........     .....+..+.++...+-..+...+|....+...|.+.....
T Consensus       250 -~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  250 -EKDPRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             -HHHhhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence             11010011110     12223445556666666689999999999998876654443

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=2e-24  Score=203.60  Aligned_cols=167  Identities=22%  Similarity=0.237  Sum_probs=125.1

Q ss_pred             CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceee
Q 042149          379 RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS  458 (625)
Q Consensus       379 ~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  458 (625)
                      |+|.+++...+  ..+++..++.++.|++.||.|||+++         ||+|||++.++.+|+  ||+++......    
T Consensus         1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence            68888886432  34899999999999999999999763         999999999999999  99988764322    


Q ss_pred             ecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChH
Q 042149          459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPEN  538 (625)
Q Consensus       459 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  538 (625)
                        ..||+.|+|||++.+..++.++||||||+++|||+||+.|+....................      ++.. ...+..
T Consensus        64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------~~~~-~~~~~~  134 (176)
T smart00750       64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD------DPRD-RSNLES  134 (176)
T ss_pred             --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC------Cccc-cccHHH
Confidence              2589999999999999999999999999999999999998754322222111111111100      0000 011223


Q ss_pred             HHH--HHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          539 EAS--RVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       539 ~~~--~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      ...  .+.+++.+||+.+|++||++.|+++.+...
T Consensus       135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            333  689999999999999999999999887543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=8.8e-23  Score=197.40  Aligned_cols=195  Identities=22%  Similarity=0.294  Sum_probs=168.4

Q ss_pred             CccccccccccCceEEEEEE-eCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCCeeEEEEEec
Q 042149          299 FFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      +|.+.++||+|.||+.+.|+ +-++..||||.-..  +....++..|.+..+.|. .++|+.+|-+..++.+-.||||++
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            68999999999999999998 45789999995433  333567889999999885 799999999999999999999998


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC-----CCceEEeecccceeeC
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE-----KLTPKIADFGLARHVA  451 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~-----~~~~kl~Dfgla~~~~  451 (625)
                       |-||+|+....+.  .++.+..+.++.|++.-++++|++.   +|.|||||+|+||..     ...+.|+|||+|+.+.
T Consensus       107 -GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  107 -GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             -CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence             8999998865543  3899999999999999999999875   999999999999952     3468999999999876


Q ss_pred             CCCce------eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCC
Q 042149          452 PDKTH------VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNS  501 (625)
Q Consensus       452 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~  501 (625)
                      ...+.      ..+...||.+||+-....+.+.+.+.|+-|||.++.+.|-|..|+
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPW  236 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW  236 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcc
Confidence            54432      234678999999999999999999999999999999999999995

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=6.6e-24  Score=199.58  Aligned_cols=247  Identities=22%  Similarity=0.363  Sum_probs=194.2

Q ss_pred             cccccccccCceEEEEEEeCCCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCC
Q 042149          301 DNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPN  378 (625)
Q Consensus       301 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~  378 (625)
                      ...-+|.+...|..|+|++ +|..+++|++...  .......|..|.-.|+.+.||||..+++.|...+.+.++..||+.
T Consensus       193 nl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            3455789999999999998 5667888877543  334456789999999999999999999999999999999999999


Q ss_pred             CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEe-eeccCcEEEcCCCceEEeecccceeeCCCCcee
Q 042149          379 RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHR-DIKTSNILLDEKLTPKIADFGLARHVAPDKTHV  457 (625)
Q Consensus       379 ~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHr-Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  457 (625)
                      |+|...|+.... -..+-.++.+++.++++|++|||+-.  +++-| -|....++||++.+.+|. .+-+++....    
T Consensus       272 gslynvlhe~t~-vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltaris-mad~kfsfqe----  343 (448)
T KOG0195|consen  272 GSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQE----  343 (448)
T ss_pred             hHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhhee-cccceeeeec----
Confidence            999999976543 44677899999999999999999875  45544 588999999999888774 2222221111    


Q ss_pred             eecCCCCccccCccccccCccc---ccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccc-ccccCCCCCC
Q 042149          458 STGIAGTLGYMAPEYLVRGQLT---EKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRI-TQSMDPGLTG  533 (625)
Q Consensus       458 ~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~i~~~~~~  533 (625)
                       .+..-.|.||+||.++..+-+   .++|+|||++++|||.|...||.....              .+. .++.-++++.
T Consensus       344 -~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp--------------mecgmkialeglrv  408 (448)
T KOG0195|consen  344 -VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP--------------MECGMKIALEGLRV  408 (448)
T ss_pred             -cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc--------------hhhhhhhhhccccc
Confidence             122357899999999876543   579999999999999999998753221              111 1233446667


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      ..|+..+..+.+++.-|+..||.+||.+..|+-.|+++
T Consensus       409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            77889999999999999999999999999999888765

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=1.7e-21  Score=200.88  Aligned_cols=261  Identities=27%  Similarity=0.345  Sum_probs=196.5

Q ss_pred             ccccccccccCceEEEEEEeCCCCEEEEEEeecCCh---HHHHHHHHHHHHHhcCCCC-ceeeeeeeeeeCCeeEEEEEe
Q 042149          300 FDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR---QWVDQFFNEVNLISGIQHK-NVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hp-niv~l~~~~~~~~~~~lV~e~  375 (625)
                      |.+.+.||.|+||.||++...  ..+++|.+.....   .....+.+|+.+++.+.|+ +|+++++.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667888999999999999976  7889998865532   2467899999999999988 799999999777778999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC-ceEEeecccceeeCCCC
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL-TPKIADFGLARHVAPDK  454 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-~~kl~Dfgla~~~~~~~  454 (625)
                      +.++++.+++........+.......++.+++.++.++|..+   ++|||+||+||+++..+ .++++|||+++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999966643321124888999999999999999999876   99999999999999888 79999999998655433


Q ss_pred             ce-----eeecCCCCccccCcccccc---CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccc
Q 042149          455 TH-----VSTGIAGTLGYMAPEYLVR---GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS  526 (625)
Q Consensus       455 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (625)
                      ..     ......|+..|++||.+.+   ...+...|+||+|++++++++|..|+...... ......+......... .
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~-~  234 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-SATSQTLKIILELPTP-S  234 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-ccHHHHHHHHHhcCCc-c
Confidence            22     2345689999999999987   57889999999999999999999984433221 0011111111111100 0


Q ss_pred             cCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       527 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      ................+.+++..++..+|..|.+..+....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00000000012223567899999999999999998877653

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=4.4e-23  Score=191.13  Aligned_cols=276  Identities=15%  Similarity=0.202  Sum_probs=200.8

Q ss_pred             hcCccccccccccCceEEEEEE-eCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCC-CceeeeeeeeeeCCeeEEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQH-KNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lV~e  374 (625)
                      ...|.++++||.|.||.+|.|. ..+|..||||.-....+  ..++.-|..+...|++ ..|+.+..++.+...-.+||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            4679999999999999999998 46899999997644332  2567789999999975 678888888999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEc---CCCceEEeecccceeeC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADFGLARHVA  451 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~---~~~~~kl~Dfgla~~~~  451 (625)
                      .+ |-+|+++..-...  .++.+..+-++-|++.-++|+|.++   +|||||||+|+|..   ....+.|+|||+++.+.
T Consensus        92 LL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             cc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence            98 8999998854433  3888999999999999999999775   99999999999985   44679999999998765


Q ss_pred             CCCce------eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccccc
Q 042149          452 PDKTH------VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQ  525 (625)
Q Consensus       452 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  525 (625)
                      +..+.      ..+...||..|.+-....+...+.+.|+-|+|.++.+...|..|+-........  .-.+...+..+..
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~--QKyEkI~EkK~s~  243 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK--QKYEKISEKKMST  243 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH--HHHHHHHHhhcCC
Confidence            43222      123567999999998888888899999999999999999999995432211110  0011111111110


Q ss_pred             ccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCCCCCCCCCcccc
Q 042149          526 SMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNAS  587 (625)
Q Consensus       526 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~~~~~~~~~~~~  587 (625)
                      .+ ..+..    ..|.++...+.-|-..--++-|...-+.+.+.-+...+.....-.|.|..
T Consensus       244 ~i-e~LC~----G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~  300 (341)
T KOG1163|consen  244 PI-EVLCK----GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTM  300 (341)
T ss_pred             CH-HHHhC----CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHH
Confidence            00 01112    22455666777788888888888776666665555455444444444443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.87  E-value=3.5e-22  Score=192.11  Aligned_cols=173  Identities=12%  Similarity=0.129  Sum_probs=134.7

Q ss_pred             HHHhcCccccccccccCceEEEEEEeCCCCEEEEEEeecCC---hHHHHH------HHHHHHHHhcCCCCceeeeeeeee
Q 042149          294 ERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVDQ------FFNEVNLISGIQHKNVVRLLGCSI  364 (625)
Q Consensus       294 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~------~~~E~~~l~~l~hpniv~l~~~~~  364 (625)
                      +-..++|.+.+.||.|+||.||++.. +++.+|||.+....   +.....      +.+|+..+.++.||+|+.+.+++.
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            34567899999999999999999766 57789999996542   222233      689999999999999999998866


Q ss_pred             eC--------CeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCC
Q 042149          365 EG--------PESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEK  436 (625)
Q Consensus       365 ~~--------~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~  436 (625)
                      ..        ...+|||||++|.+|.++..       ++.    ....+++.+|..+|..+   ++|||+||+||+++++
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~  171 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKN  171 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCC
Confidence            43        35789999999999987631       222    24558899999999775   9999999999999998


Q ss_pred             CceEEeecccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHH
Q 042149          437 LTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVA  495 (625)
Q Consensus       437 ~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ell  495 (625)
                      | ++|+|||...........             ..+.....+..++|+|+||+++..+.
T Consensus       172 g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        172 G-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             C-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            8 999999987654321111             11445556778999999999988664

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=1.2e-22  Score=223.66  Aligned_cols=253  Identities=25%  Similarity=0.253  Sum_probs=187.6

Q ss_pred             cccccccccCceEEEEEEeC-CCCEEEEEEee----c-CC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          301 DNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLF----F-NS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       301 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----~-~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ...+.+|.|++|.|+..... ..+..+.|...    . .. ......+..|+.+-..+.|||++..+....+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45778999999988877643 33334444332    1 11 222223677888889999999999888887777766669


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++ +|..++....   .+...++..++.|++.|+.|+|..|   |.||||||+|+++..+|.+||+|||.+..+...
T Consensus       401 E~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 9988875442   3788889999999999999999776   999999999999999999999999999876543


Q ss_pred             Cc---eeeecCCCCccccCccccccCcccc-cCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          454 KT---HVSTGIAGTLGYMAPEYLVRGQLTE-KADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       454 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      ..   ....+++|+..|+|||++.+.+|.+ ..||||.|+++..|++|+.|+......+...      .......+.-..
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~~~~~~~~~~~  547 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KTNNYSDQRNIF  547 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch------hhhccccccccc
Confidence            33   4456789999999999999999986 5899999999999999999876543322211      000000000000


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .-........+.+...++.++|+.+|.+|.|+++|++
T Consensus       548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            0001122455777889999999999999999999986

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.86  E-value=8.6e-22  Score=168.35  Aligned_cols=100  Identities=29%  Similarity=0.618  Sum_probs=71.4

Q ss_pred             ccccC-C-CCcc-CCCchHHHHHHHHHHHHHHHhccC--ccCceeeeeecCCCCcEEEEEeccCCCChhhhHHHHHHHHH
Q 042149           39 LYKCG-P-PAKV-SDNRNFRQNFDAVMGNISEQIMDD--HHYHFALHYVVSPAPQVYAYMQCHEDLSQTDCESCFSALKQ  113 (625)
Q Consensus        39 ~~~~~-~-~~~~-~~~~~f~~~l~~ll~~l~~~a~~~--~~~~~~~~~~~~~~~~vygl~qC~~dl~~~~C~~Cl~~~~~  113 (625)
                      |+.|+ | .+++ +++++|+++|++||+.|...++..  .+|++  ...+.++++||||+||++|+++.+|..||+.+..
T Consensus         1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~--~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~   78 (106)
T PF01657_consen    1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFAT--GSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVA   78 (106)
T ss_dssp             ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEE--EE--ST---EEEEEEE-TTS-HHHHHHHHHHHHC
T ss_pred             CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEE--eecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHH
Confidence            45687 4 3455 577789999999999999998765  35555  4457888999999999999999999999998886


Q ss_pred             hhhh-cCCCCceEEEcceeEEEEecCCC
Q 042149          114 KANR-CLPSDSARIFLDGCFLRYDNYDF  140 (625)
Q Consensus       114 ~~~~-c~~~~~~~~~~~~C~~ry~~~~f  140 (625)
                      .+.. |++++||+||+++|+||||+++|
T Consensus        79 ~~~~~C~~~~g~~v~~~~C~lRY~~~~F  106 (106)
T PF01657_consen   79 NISSCCPGSRGGRVWYDSCFLRYENYPF  106 (106)
T ss_dssp             CHHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred             HHHHhCCCCceEEEECCCEEEEEECCCC
Confidence            6655 99999999999999999999998

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.85  E-value=2.5e-21  Score=184.17  Aligned_cols=139  Identities=14%  Similarity=0.102  Sum_probs=107.7

Q ss_pred             cccccccCceEEEEEEeCCCCEEEEEEeecCChH--H------------------------HHHHHHHHHHHhcCCCCce
Q 042149          303 SRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQ--W------------------------VDQFFNEVNLISGIQHKNV  356 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~hpni  356 (625)
                      ...||+|+||.||+|..++|+.||||++......  .                        .....+|++++.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999888999999998654211  0                        1123459999999988776


Q ss_pred             eeeeeeeeeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHh-hcCCCceEEEeeeccCcEEEcC
Q 042149          357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL-HGGSGIKIIHRDIKTSNILLDE  435 (625)
Q Consensus       357 v~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~iiHrDlkp~NIll~~  435 (625)
                      ........  ...+|||||++|+++.......   ..+++.....++.|++.+|.++ |..+   |+||||||+|||+++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~~  153 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYHD  153 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEEC
Confidence            44333222  2348999999998776543222   2378899999999999999999 6665   999999999999984


Q ss_pred             CCceEEeecccceee
Q 042149          436 KLTPKIADFGLARHV  450 (625)
Q Consensus       436 ~~~~kl~Dfgla~~~  450 (625)
                       +.++|+|||++...
T Consensus       154 -~~v~LiDFG~a~~~  167 (190)
T cd05147         154 -GKLYIIDVSQSVEH  167 (190)
T ss_pred             -CcEEEEEccccccC
Confidence             78999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.84  E-value=2.8e-20  Score=177.52  Aligned_cols=141  Identities=17%  Similarity=0.173  Sum_probs=110.7

Q ss_pred             cccccccCceEEEEEEeCCCCEEEEEEeecCChH--------------------------HHHHHHHHHHHHhcCCCCce
Q 042149          303 SRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQ--------------------------WVDQFFNEVNLISGIQHKNV  356 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~hpni  356 (625)
                      ...||+|++|.||+|++.+|+.||||++......                          ....+.+|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4679999999999999878999999998754210                          02234679999999999987


Q ss_pred             eeeeeeeeeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhc-CCCceEEEeeeccCcEEEcC
Q 042149          357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG-GSGIKIIHRDIKTSNILLDE  435 (625)
Q Consensus       357 v~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiHrDlkp~NIll~~  435 (625)
                      .....+...  ..+|||||++|+++.......   ..++..+...++.+++.+|.++|. .+   |+||||||+||+++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            544443332  248999999988654432222   236788899999999999999997 65   99999999999999 


Q ss_pred             CCceEEeecccceeeCC
Q 042149          436 KLTPKIADFGLARHVAP  452 (625)
Q Consensus       436 ~~~~kl~Dfgla~~~~~  452 (625)
                      ++.++|+|||++.....
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            78999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=1.3e-19  Score=170.60  Aligned_cols=185  Identities=17%  Similarity=0.078  Sum_probs=138.6

Q ss_pred             cccccccccCceEEEEEEeCCCCEEEEEEeecCCh----HHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCCeeEEEEEe
Q 042149          301 DNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       301 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      .+...|++|+||+||.+.. .+.+++.+.+.....    -....+.+|+++|++|. |+++++++++    ...+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4567899999999997766 567788777754322    11225789999999995 5889999886    457999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeee-ccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDI-KTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDl-kp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      +.|.+|.+.+..          ....++.+++++|.++|..|   |+|||| ||+|||++.++.++|+|||++.......
T Consensus        80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            999988654311          12357788999999999876   999999 7999999999999999999998655433


Q ss_pred             ce----e--------eecCCCCccccCccccccC-ccc-ccCcEEeehhhhHHHHhCCCCCCC
Q 042149          455 TH----V--------STGIAGTLGYMAPEYLVRG-QLT-EKADVYAFGVLVIEVASGRRNSVF  503 (625)
Q Consensus       455 ~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~SlG~ll~elltG~~p~~~  503 (625)
                      ..    .        ......++.|++|+...-- ..+ ...+.++.|.-+|.++|++.+...
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            21    0        0012357888888865332 333 567889999999999999987543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.79  E-value=2.6e-20  Score=195.58  Aligned_cols=225  Identities=23%  Similarity=0.209  Sum_probs=177.8

Q ss_pred             cccccCceEEEEEE----eCCCCEEEEEEeecCCh--HHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCCeeEEEEEecC
Q 042149          305 KLGQGGAGSVFRGT----LPDGRNIAVKRLFFNSR--QWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEGPESLLVYEYVP  377 (625)
Q Consensus       305 ~lG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~~~  377 (625)
                      .+|+|.||.|++++    .+.++.+|+|.+.+...  ........|..++..++ ||.+|++...+..+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999875    34577889888765421  11125567888999997 9999999999999999999999999


Q ss_pred             CCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCcee
Q 042149          378 NRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV  457 (625)
Q Consensus       378 ~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  457 (625)
                      ||.|-..+.....   ..+.........++-+++++|+.+   |+|||+|++||+++.+|++++.|||+++..-..... 
T Consensus        81 gg~lft~l~~~~~---f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-  153 (612)
T KOG0603|consen   81 GGDLFTRLSKEVM---FDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-  153 (612)
T ss_pred             cchhhhccccCCc---hHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence            9999877754433   566666677788999999999665   999999999999999999999999999876443332 


Q ss_pred             eecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCCh
Q 042149          458 STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE  537 (625)
Q Consensus       458 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  537 (625)
                          +||..|||||+..  .....+|.||||++++||+||-.|+..     +..            ..+..  .....|.
T Consensus       154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~------------~~Il~--~~~~~p~  208 (612)
T KOG0603|consen  154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTM------------KRILK--AELEMPR  208 (612)
T ss_pred             ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHH------------HHHhh--hccCCch
Confidence                8999999999997  567889999999999999999988643     110            01111  1123477


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCH
Q 042149          538 NEASRVLQIGLLCTQAPVALRPSM  561 (625)
Q Consensus       538 ~~~~~l~~li~~cl~~~p~~RPt~  561 (625)
                      +.......++..+...+|.+|--.
T Consensus       209 ~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  209 ELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             hhhHHHHHHHHHHHhhCHHHHhcc
Confidence            788888999999999999999754

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=6.7e-19  Score=169.02  Aligned_cols=136  Identities=14%  Similarity=0.182  Sum_probs=106.2

Q ss_pred             cccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcC-----CCCceeeeeeeeeeCC---e-eEE
Q 042149          301 DNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI-----QHKNVVRLLGCSIEGP---E-SLL  371 (625)
Q Consensus       301 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~l~~~~~~~~---~-~~l  371 (625)
                      ...+.||+|+||.||.  +++....+||++........+.+.+|+.+++.+     .||||++++|+++++.   . ..+
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3467899999999996  554444579988766555567899999999999     5799999999998874   3 337


Q ss_pred             EEEe--cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHH-HHhhcCCCceEEEeeeccCcEEEcC----CCceEEeec
Q 042149          372 VYEY--VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGL-AHLHGGSGIKIIHRDIKTSNILLDE----KLTPKIADF  444 (625)
Q Consensus       372 V~e~--~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~iiHrDlkp~NIll~~----~~~~kl~Df  444 (625)
                      ||||  +.+++|.+++...    .+++.  ..++.+++.++ +|||+++   |+||||||+|||++.    ++.++|+||
T Consensus        83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            8999  5579999999542    14544  35677888777 9999775   999999999999973    348999995


Q ss_pred             ccc
Q 042149          445 GLA  447 (625)
Q Consensus       445 gla  447 (625)
                      +.+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            433

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.79  E-value=3.8e-19  Score=176.24  Aligned_cols=232  Identities=20%  Similarity=0.228  Sum_probs=148.1

Q ss_pred             ccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCC----------Cceeeeeeee--
Q 042149          300 FDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQH----------KNVVRLLGCS--  363 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------pniv~l~~~~--  363 (625)
                      ....+.||.|+++.||.+++. +++++|||++....   ....+++++|......+.+          -.++..++..  
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            344667999999999999986 58999999886543   3456777777766555432          1122222211  


Q ss_pred             -------eeCC--------eeEEEEEecCCCCcchhhhc---cCC-cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEe
Q 042149          364 -------IEGP--------ESLLVYEYVPNRSLDQILFV---KNT-IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHR  424 (625)
Q Consensus       364 -------~~~~--------~~~lV~e~~~~~sL~~~l~~---~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHr  424 (625)
                             ....        ..+++|+-+ -++|.+++..   ... ...+....++.+..|+++.+++||..|   ++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence                   1111        235677777 5678776532   221 223455666778899999999999886   9999


Q ss_pred             eeccCcEEEcCCCceEEeecccceeeCCCCceeeecCCCCccccCccccccC--------cccccCcEEeehhhhHHHHh
Q 042149          425 DIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG--------QLTEKADVYAFGVLVIEVAS  496 (625)
Q Consensus       425 Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~Dv~SlG~ll~ellt  496 (625)
                      ||+|+|++++.+|.++|+||+.....+.   .... ...+..|.|||.....        .++.+.|.|+||+++|.|++
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~---~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGT---RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTE---EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCc---eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            9999999999999999999987765332   1111 2456789999977442        57889999999999999999


Q ss_pred             CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCC
Q 042149          497 GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALR  558 (625)
Q Consensus       497 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R  558 (625)
                      |..|+..........   |               ...... +.++.+..||..+|+.+|++|
T Consensus       246 ~~lPf~~~~~~~~~~---~---------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  246 GRLPFGLSSPEADPE---W---------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             SS-STCCCGGGSTSG---G---------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ccCCCCCCCcccccc---c---------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999976442211100   0               011123 678889999999999999988

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.78  E-value=8e-20  Score=200.73  Aligned_cols=248  Identities=19%  Similarity=0.208  Sum_probs=179.2

Q ss_pred             CccccccccccCceEEEEEEeCCCCEEEEEEeecCC-hHHHHHHHH---HHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS-RQWVDQFFN---EVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~---E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      .+...+.||++.|=+|.+|+++.|. |+||++.+.. .-.++.|.+   |++ ...++|||.+.+...-+.....|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5677888999999999999998876 9999987654 222333333   444 555689999999888888888899999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC--C
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA--P  452 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~--~  452 (625)
                      |..+ +|.|.|..   ++-+...+..-|+-|++.||..+|..+   |+|||||.+||||+.-+.+.|+||...+...  +
T Consensus       102 yvkh-nLyDRlST---RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  102 YVKH-NLYDRLST---RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHhh-hhhhhhcc---chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            9954 78777743   334777888889999999999999775   9999999999999999999999999876432  2


Q ss_pred             CCce----eeecCCCCccccCccccccC-----------cccccCcEEeehhhhHHHHhC-CCCCCCCCCCccchhhHHH
Q 042149          453 DKTH----VSTGIAGTLGYMAPEYLVRG-----------QLTEKADVYAFGVLVIEVASG-RRNSVFSEGSSSVLHTVWK  516 (625)
Q Consensus       453 ~~~~----~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~SlG~ll~elltG-~~p~~~~~~~~~~~~~~~~  516 (625)
                      ++..    ...+...-..|+|||.+...           ..+++.||||+||++.||++- +++|...+        .. 
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ--------L~-  245 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ--------LL-  245 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH--------HH-
Confidence            2221    11233445689999987541           157899999999999999986 44443211        11 


Q ss_pred             hhhccc--cccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          517 HYKANR--ITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       517 ~~~~~~--~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      .++.+.  ..+.+-+.+       +...+.+++..|++.||++|.++++.++.-.+.
T Consensus       246 aYr~~~~~~~e~~Le~I-------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  246 AYRSGNADDPEQLLEKI-------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             hHhccCccCHHHHHHhC-------cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence            111111  000000011       122578999999999999999999999875554

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.77  E-value=3.8e-19  Score=152.04  Aligned_cols=87  Identities=26%  Similarity=0.580  Sum_probs=70.5

Q ss_pred             HHHHHHHHHHHHHHHHhhccC--CcceeeeccCCcceEEEEecccccCCcccchhhHHHHHhhcccccCCCCC-eEEeee
Q 042149          166 KQFEEKVIEVITNVTIVTKSN--GRFGQVEGKGGIATVYALAQCLKFLDNKGCSQCLDEAALRLKGCSKSGEG-RAMFAG  242 (625)
Q Consensus       166 ~~f~~~~~~Ll~~~~~~a~~~--~~f~~~~~~~~~~~vy~laQC~~dLs~~~C~~CL~~~~~~~~~c~~~~~g-~~~~~~  242 (625)
                      ..|..++..||..|+..|+..  .+|++++...+.++|||||||++||++.||+.||..++..++.||+.+.| +|++++
T Consensus        17 ~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~~~C~~~~g~~v~~~~   96 (106)
T PF01657_consen   17 STFEQNLNSLLSSLVSNAASSSSKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVANISSCCPGSRGGRVWYDS   96 (106)
T ss_dssp             -THHHHHHHHHHHHHHHGGGTT-TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCCHHHHTTSBSSEEEEESS
T ss_pred             chHHHHHHHHHHHHHHHHhhccccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHHHHhCCCCceEEEECCC
Confidence            349999999999999998754  68999987778889999999999999999999999999999997766665 999999


Q ss_pred             eeeeccCccc
Q 042149          243 CYVRFSTERF  252 (625)
Q Consensus       243 C~~r~~~~~f  252 (625)
                      |+||||+++|
T Consensus        97 C~lRY~~~~F  106 (106)
T PF01657_consen   97 CFLRYENYPF  106 (106)
T ss_dssp             EEEEEESS--
T ss_pred             EEEEEECCCC
Confidence            9999999987

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.76  E-value=2.2e-18  Score=181.42  Aligned_cols=217  Identities=25%  Similarity=0.399  Sum_probs=160.6

Q ss_pred             HhcCCCCceeeeeeeeeeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeec
Q 042149          348 ISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIK  427 (625)
Q Consensus       348 l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlk  427 (625)
                      |+.+.|.|+.+++|.+.+++..++|.+||..|+|.|.+...  ...+++.-...++++|+.||.|||... .. .|+.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~-~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNSP-IG-YHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcCc-ce-eeeeec
Confidence            46789999999999999999999999999999999999653  334889999999999999999999763 22 999999


Q ss_pred             cCcEEEcCCCceEEeecccceeeCCC-CceeeecCCCCccccCccccccC-------cccccCcEEeehhhhHHHHhCCC
Q 042149          428 TSNILLDEKLTPKIADFGLARHVAPD-KTHVSTGIAGTLGYMAPEYLVRG-------QLTEKADVYAFGVLVIEVASGRR  499 (625)
Q Consensus       428 p~NIll~~~~~~kl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~SlG~ll~elltG~~  499 (625)
                      +.|.++|....+||.|||+....... .........-..-|.|||.+...       ..+.+.||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999998765321 01111122345689999998763       14678999999999999999999


Q ss_pred             CCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          500 NSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       500 p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      |+............+.. ... .....+.|.+...  .+....+..++..||..+|++||++++|...++.+.
T Consensus       157 ~~~~~~~~~~~~eii~~-~~~-~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILR-VKK-GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             ccccccccCChHHHHHH-HHh-cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            98754333221111111 111 0111111111110  133447899999999999999999999988876654

>smart00090 RIO RIO-like kinase

Probab=99.75  E-value=7.5e-18  Score=165.79  Aligned_cols=142  Identities=15%  Similarity=0.146  Sum_probs=110.7

Q ss_pred             CccccccccccCceEEEEEE--eCCCCEEEEEEeecCChH------------------------HHHHHHHHHHHHhcCC
Q 042149          299 FFDNSRKLGQGGAGSVFRGT--LPDGRNIAVKRLFFNSRQ------------------------WVDQFFNEVNLISGIQ  352 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  352 (625)
                      .|.+.+.||+|++|.||+|.  ..+|+.||||++......                        ....+.+|+.+++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48889999999999999998  568999999988653210                        1134678999999997


Q ss_pred             CC--ceeeeeeeeeeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCc
Q 042149          353 HK--NVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSN  430 (625)
Q Consensus       353 hp--niv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~N  430 (625)
                      +.  .++++++.    ...++||||++|.+|........   .+...+...++.+++.+|.+||..+  +++||||||+|
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N  179 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN  179 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence            53  34455543    23589999999988876542222   2556667889999999999999663  39999999999


Q ss_pred             EEEcCCCceEEeecccceee
Q 042149          431 ILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       431 Ill~~~~~~kl~Dfgla~~~  450 (625)
                      |+++ ++.++|+|||.+...
T Consensus       180 Ili~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EEEE-CCCEEEEEChhhhcc
Confidence            9999 789999999988753

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=3.4e-18  Score=191.87  Aligned_cols=197  Identities=22%  Similarity=0.262  Sum_probs=156.0

Q ss_pred             HHHhcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCC---CCceeeeeeeeeeCCeeE
Q 042149          294 ERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ---HKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       294 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~  370 (625)
                      +...+.|.+.+.||+|+||.||+|...+|+.||||+-.+...=   .|.=-.+++.+|+   -+.|..+.....-.+..+
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~  770 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV  770 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence            3445678999999999999999999888999999977654310   0111122333333   345666666667778899


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEc-------CCCceEEee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD-------EKLTPKIAD  443 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~-------~~~~~kl~D  443 (625)
                      ||+||.+.|+|.+++.   +.+.++|.....++.|++..+++||..+   |||+||||+|.||.       +...++|+|
T Consensus       771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence            9999999999999985   4455899999999999999999999775   99999999999994       334689999


Q ss_pred             cccceeeCCCCc-eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCC
Q 042149          444 FGLARHVAPDKT-HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRR  499 (625)
Q Consensus       444 fgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~  499 (625)
                      ||-+-.+..-.. ......++|-.+-.+|+..+..++..+|.|.|+.+++-||.|+.
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            998865432221 23345788999999999999999999999999999999999984

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=1.3e-17  Score=162.11  Aligned_cols=134  Identities=19%  Similarity=0.303  Sum_probs=112.4

Q ss_pred             ccccccCceEEEEEEeCCCCEEEEEEeecCC---h-----HHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---R-----QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      +.||+|++|.||+|++ ++..++||+.....   .     .....+.+|+.++..+.|++|+....++......++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 67789999765332   1     1124678899999999999988777777778889999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      ++|++|.+++...      .+ .+..++.+++.+|.++|..+   ++|||++|+|||++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999987432      12 78889999999999999775   99999999999999 78899999998764

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.74  E-value=4.5e-19  Score=182.89  Aligned_cols=241  Identities=23%  Similarity=0.251  Sum_probs=159.1

Q ss_pred             cccccccccCceEEEEEEeCCC----CEEEEEEeecCChHHHHHHHHHHHHHhcCC-CCceeeee------eeee-----
Q 042149          301 DNSRKLGQGGAGSVFRGTLPDG----RNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-HKNVVRLL------GCSI-----  364 (625)
Q Consensus       301 ~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~------~~~~-----  364 (625)
                      .+.+-.+..+++.+...+...+    ..+.-|....++........+++..+.-.. |++.+..-      ..+.     
T Consensus       247 ~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~  326 (516)
T KOG1033|consen  247 SISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVG  326 (516)
T ss_pred             cccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhccccccc
Confidence            3444566666666665553222    223444443333233334445555554444 44333221      1111     


Q ss_pred             eCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeec
Q 042149          365 EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADF  444 (625)
Q Consensus       365 ~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Df  444 (625)
                      ....++|.|++|...+|.++|..+......++...+.++.|++.+++|   ++   .+|||+||.||+...+..+||.||
T Consensus       327 ~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDF  400 (516)
T KOG1033|consen  327 KKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDF  400 (516)
T ss_pred             cccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhh
Confidence            123578999999999999999877777778899999999999999999   43   999999999999998889999999


Q ss_pred             ccceeeCCCC-----ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhh
Q 042149          445 GLARHVAPDK-----THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHY  518 (625)
Q Consensus       445 gla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~  518 (625)
                      |+........     ....+...||..||+||++.+..|+.++||||||+|++||++ -...+..        .......
T Consensus       401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er--------~~t~~d~  472 (516)
T KOG1033|consen  401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER--------IATLTDI  472 (516)
T ss_pred             hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH--------HHhhhhh
Confidence            9987765544     122345689999999999999999999999999999999997 2211100        0001111


Q ss_pred             hccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 042149          519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEV  564 (625)
Q Consensus       519 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev  564 (625)
                      +.+.+    ++....++|.+     ..++.+++++.|.+||++.++
T Consensus       473 r~g~i----p~~~~~d~p~e-----~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  473 RDGII----PPEFLQDYPEE-----YTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             hcCCC----ChHHhhcCcHH-----HHHHHHhcCCCcccCchHHHH
Confidence            11111    11111122222     478889999999999955443

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.73  E-value=3e-17  Score=157.81  Aligned_cols=139  Identities=18%  Similarity=0.196  Sum_probs=109.7

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCCh----------------------HHHHHHHHHHHHHhcCCCC
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----------------------QWVDQFFNEVNLISGIQHK  354 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~hp  354 (625)
                      ...|.+.+.||+|+||.||++..++|+.||||++.....                      .....+.+|+.++..+.|+
T Consensus        14 ~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   93 (198)
T cd05144          14 GVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEE   93 (198)
T ss_pred             CchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHc
Confidence            334888899999999999999988899999998754321                      0112367789999999887


Q ss_pred             c--eeeeeeeeeeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEE
Q 042149          355 N--VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNIL  432 (625)
Q Consensus       355 n--iv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIl  432 (625)
                      +  ++..++    ....++||||++|++|..+...         .....++.+++.++.++|..+   ++||||||+||+
T Consensus        94 ~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nil  157 (198)
T cd05144          94 GFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNIL  157 (198)
T ss_pred             CCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEE
Confidence            4  444444    2456899999999998775421         234568889999999999765   999999999999


Q ss_pred             EcCCCceEEeecccceeeC
Q 042149          433 LDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       433 l~~~~~~kl~Dfgla~~~~  451 (625)
                      +++++.++|+|||++....
T Consensus       158 l~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         158 VDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             EcCCCcEEEEECCccccCC
Confidence            9999999999999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.71  E-value=4.1e-17  Score=157.04  Aligned_cols=130  Identities=22%  Similarity=0.360  Sum_probs=105.9

Q ss_pred             cccccCceEEEEEEeCCCCEEEEEEeecCC--------hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNS--------RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       305 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      .||+|+||.||+|.+ +++.+++|+.....        .....++.+|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 57889999865321        112356789999999999887665555556677789999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      +|++|.+.+.....          .++.+++.+|.+||+.+   ++|+|++|+||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH----------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999987743210          78899999999999775   99999999999999 78999999998865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.71  E-value=2.8e-17  Score=162.86  Aligned_cols=196  Identities=24%  Similarity=0.327  Sum_probs=137.7

Q ss_pred             CCCceeeeeeeeee---------------------------CCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHH
Q 042149          352 QHKNVVRLLGCSIE---------------------------GPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIIC  404 (625)
Q Consensus       352 ~hpniv~l~~~~~~---------------------------~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~  404 (625)
                      +|||||++.++|.+                           ...+|+||.-. ..+|.+++..+.    .+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~----~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH----RSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC----CchHHHHHHHH
Confidence            59999999887754                           23578999876 358888886544    56677778899


Q ss_pred             HHHHHHHHhhcCCCceEEEeeeccCcEEEc--CC--CceEEeecccceeeCCCCce---e--eecCCCCccccCcccccc
Q 042149          405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLD--EK--LTPKIADFGLARHVAPDKTH---V--STGIAGTLGYMAPEYLVR  475 (625)
Q Consensus       405 ~i~~~L~~LH~~~~~~iiHrDlkp~NIll~--~~--~~~kl~Dfgla~~~~~~~~~---~--~~~~~gt~~y~aPE~~~~  475 (625)
                      |+++|+.|||+++   |.|||||.+||||.  ++  ..+.|+|||.+-.-...+-.   .  .....|.-.-||||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999775   99999999999993  33  46799999987432221111   1  112457788999999865


Q ss_pred             Cc--c----cccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhh
Q 042149          476 GQ--L----TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLL  549 (625)
Q Consensus       476 ~~--~----~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~  549 (625)
                      .+  .    -.|+|.|+.|.+.||+++...||.. .+ +..+.  ...+.+.+         .+..|..++..+.+++..
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~-rG-em~L~--~r~Yqe~q---------LPalp~~vpp~~rqlV~~  492 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK-RG-EMLLD--TRTYQESQ---------LPALPSRVPPVARQLVFD  492 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccc-cc-hheec--hhhhhhhh---------CCCCcccCChHHHHHHHH
Confidence            32  1    2589999999999999988888643 11 11111  11122222         223466677788999999


Q ss_pred             ccCCCCCCCCCHHHHHHHH
Q 042149          550 CTQAPVALRPSMAEVVHML  568 (625)
Q Consensus       550 cl~~~p~~RPt~~ev~~~L  568 (625)
                      .|+.||++||+..=....|
T Consensus       493 lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  493 LLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HhcCCccccCCccHHHhHH
Confidence            9999999999875444444

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.70  E-value=4e-17  Score=180.59  Aligned_cols=137  Identities=22%  Similarity=0.323  Sum_probs=111.4

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecC--------ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--------SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPE  368 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  368 (625)
                      ...|...++||+|+||+||+|.+.. +.+++|+....        .....+.+.+|+++++.++|++++....++.....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            4455678899999999999998754 34444443221        11223568899999999999999988877777778


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      .++||||++|++|.+++.           ....++.+++++|.+||+.+   ++||||||+|||+ .++.++|+|||+++
T Consensus       411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            899999999999998773           35678999999999999775   9999999999999 57799999999987


Q ss_pred             e
Q 042149          449 H  449 (625)
Q Consensus       449 ~  449 (625)
                      .
T Consensus       476 ~  476 (535)
T PRK09605        476 Y  476 (535)
T ss_pred             c
Confidence            5

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.65  E-value=1.1e-15  Score=139.37  Aligned_cols=135  Identities=23%  Similarity=0.222  Sum_probs=114.5

Q ss_pred             ccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCC--CceeeeeeeeeeCCeeEEEEEecCCC
Q 042149          302 NSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQH--KNVVRLLGCSIEGPESLLVYEYVPNR  379 (625)
Q Consensus       302 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lV~e~~~~~  379 (625)
                      +.+.||+|.++.||++...+ +.++||.......  ...+.+|+.+++.++|  +++++++.+....+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            46789999999999999855 7899998865443  4678899999999976  58999999888888899999999988


Q ss_pred             CcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          380 SLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       380 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      .+..+          +......++.+++++|..+|.....+++|+||+|+||++++.+.++++|||.+..
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77653          4456677889999999999976445799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.65  E-value=4.6e-17  Score=179.23  Aligned_cols=208  Identities=19%  Similarity=0.218  Sum_probs=139.2

Q ss_pred             hcCccccccccccCceEEEEEEeCC-CCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      -.+|+.++.|..|++|.||..+++. .+.+|+| +++++--    +.+   ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li----lRn---ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI----LRN---ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh----hhc---cccccCCccee------------------
Confidence            4679999999999999999999874 5567774 4322210    001   22222333333                  


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC-
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK-  454 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~-  454 (625)
                         |+=..++...++   ++..        ++.+++|||..+   |+|||+||+|.+|..-|++|+.|||+.+...... 
T Consensus       136 ---gDc~tllk~~g~---lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ---GDCATLLKNIGP---LPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ---chhhhhcccCCC---Ccch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence               232333322122   2222        267899999775   9999999999999999999999999986431100 


Q ss_pred             -------------ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcc
Q 042149          455 -------------THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN  521 (625)
Q Consensus       455 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  521 (625)
                                   ....+.++|||.|+|||++....|+..+|+|++|+|+||.+-|..|+..+. .+++...+.....  
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt-peelfg~visd~i--  275 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-PEELFGQVISDDI--  275 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC-HHHHHhhhhhhhc--
Confidence                         011235789999999999999999999999999999999999999874332 2222222221110  


Q ss_pred             ccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCC
Q 042149          522 RITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRP  559 (625)
Q Consensus       522 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  559 (625)
                      .         ..+-.+..+.+..+++.+.|+.+|..|-
T Consensus       276 ~---------wpE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  276 E---------WPEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             c---------ccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence            0         1111223355678889999999999995

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.64  E-value=1.1e-15  Score=145.40  Aligned_cols=137  Identities=18%  Similarity=0.189  Sum_probs=98.0

Q ss_pred             cccccccCceEEEEEEeCCCCEEEEEEeecCChH--HHHH----------------------HHHHHHHHhcCCCCc--e
Q 042149          303 SRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQ--WVDQ----------------------FFNEVNLISGIQHKN--V  356 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~hpn--i  356 (625)
                      .+.||+|+||.||+|.+.+++.||||++......  ....                      ...|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999888999999988653211  1111                      135666666664432  4


Q ss_pred             eeeeeeeeeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhc-CCCceEEEeeeccCcEEEcC
Q 042149          357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG-GSGIKIIHRDIKTSNILLDE  435 (625)
Q Consensus       357 v~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiHrDlkp~NIll~~  435 (625)
                      ++.++.    ...++||||++++.+.........   .. .+...++.+++.++.++|. .   +|+||||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence            444443    246899999999654322111110   11 5678899999999999997 5   599999999999999 


Q ss_pred             CCceEEeecccceeeC
Q 042149          436 KLTPKIADFGLARHVA  451 (625)
Q Consensus       436 ~~~~kl~Dfgla~~~~  451 (625)
                      ++.++|+|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            8899999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.59  E-value=7.2e-15  Score=144.91  Aligned_cols=135  Identities=21%  Similarity=0.266  Sum_probs=104.0

Q ss_pred             ccccc-ccCceEEEEEEeCCCCEEEEEEeecCC-------------hHHHHHHHHHHHHHhcCCCCce--eeeeeeeeeC
Q 042149          303 SRKLG-QGGAGSVFRGTLPDGRNIAVKRLFFNS-------------RQWVDQFFNEVNLISGIQHKNV--VRLLGCSIEG  366 (625)
Q Consensus       303 ~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~hpni--v~l~~~~~~~  366 (625)
                      ...|| .||.|+||.+... +..++||++....             .....++.+|++++.+|+|++|  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            45687 8999999999874 6789999875321             1223567889999999998875  6777765433


Q ss_pred             C----eeEEEEEecCC-CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEE
Q 042149          367 P----ESLLVYEYVPN-RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKI  441 (625)
Q Consensus       367 ~----~~~lV~e~~~~-~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl  441 (625)
                      .    ..++|||+++| .+|.+++...    .++..    .+.+++.+|.+||+.|   |+||||||+|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence            2    23599999997 6888877432    24433    3567899999999876   999999999999998889999


Q ss_pred             eeccccee
Q 042149          442 ADFGLARH  449 (625)
Q Consensus       442 ~Dfgla~~  449 (625)
                      +|||.+..
T Consensus       184 IDfg~~~~  191 (239)
T PRK01723        184 IDFDRGEL  191 (239)
T ss_pred             EECCCccc
Confidence            99998865

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.56  E-value=8e-16  Score=169.75  Aligned_cols=255  Identities=23%  Similarity=0.238  Sum_probs=189.6

Q ss_pred             hcCccccccccccCceEEEEEEeC--CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCCeeEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP--DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~l  371 (625)
                      ...|.+.+.||+|.|+.|-.....  ....+|+|.+....  ....+....|..+-+.+. |+|++++++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            345777788999999999988753  34556777664432  344455666888888887 9999999999999999999


Q ss_pred             EEEecCCCCcchhhh-ccCCcCCCCHHHHHHHHHHHHHHHHHhh-cCCCceEEEeeeccCcEEEcCCC-ceEEeecccce
Q 042149          372 VYEYVPNRSLDQILF-VKNTIHILSWQQRFTIICGTAEGLAHLH-GGSGIKIIHRDIKTSNILLDEKL-TPKIADFGLAR  448 (625)
Q Consensus       372 V~e~~~~~sL~~~l~-~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~iiHrDlkp~NIll~~~~-~~kl~Dfgla~  448 (625)
                      +.||..|+++.+-+. ....  ..+....-.++.|+..++.|+| ..+   +.||||||+|.+++..+ .+++.|||+|.
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             ccCcccccccccccccCCcc--CCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhc
Confidence            999999999988773 2221  2455566678899999999999 765   99999999999999999 99999999998


Q ss_pred             eeCC--CCceeeecCCC-CccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccc
Q 042149          449 HVAP--DKTHVSTGIAG-TLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRIT  524 (625)
Q Consensus       449 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  524 (625)
                      .+..  +........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+.+.......    ...|......
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~----~~~~~~~~~~  249 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR----YSSWKSNKGR  249 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc----ceeecccccc
Confidence            7765  23333345678 9999999999884 5568899999999999999999997765433211    1111111100


Q ss_pred             cccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          525 QSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       525 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                            ..............++..+++..+|+.|.+.+++..
T Consensus       250 ------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  250 ------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence                  000112233455678888899899999999888754

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.51  E-value=1.1e-13  Score=148.18  Aligned_cols=141  Identities=21%  Similarity=0.242  Sum_probs=98.4

Q ss_pred             cccccccCceEEEEEEeCCCCEEEEEEeecCChHHHH----------------------------------------HHH
Q 042149          303 SRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVD----------------------------------------QFF  342 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~  342 (625)
                      .+.||.|++|.||+|++++|+.||||+..+...+.+.                                        .|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            3679999999999999999999999998765321110                                        144


Q ss_pred             HHHHHHhcCC----CCceeeeeeee-eeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHH-HHHHhhcC
Q 042149          343 NEVNLISGIQ----HKNVVRLLGCS-IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAE-GLAHLHGG  416 (625)
Q Consensus       343 ~E~~~l~~l~----hpniv~l~~~~-~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~-~L~~LH~~  416 (625)
                      +|+..+.++.    |.+-+.+-..+ ......+|||||++|++|.++.......  .+   ...++..++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~~---~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--LD---RKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--CC---HHHHHHHHHHHHHHHHHhC
Confidence            4666555552    22222222222 2344579999999999999876432111  22   3345555555 46788866


Q ss_pred             CCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       417 ~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      +   ++|+|+||.||++++++.++|+|||++..+.
T Consensus       277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            5   9999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.39  E-value=4.9e-13  Score=144.86  Aligned_cols=147  Identities=17%  Similarity=0.196  Sum_probs=94.6

Q ss_pred             HHhcCccccccccccCceEEEEEEeCC-CCEEEEEEeecCChHH----------------------------------HH
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQW----------------------------------VD  339 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~  339 (625)
                      .....|+. +.||+|++|.||+|++++ |+.||||++.++-.+.                                  .+
T Consensus       117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~  195 (537)
T PRK04750        117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK  195 (537)
T ss_pred             HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence            34556776 789999999999999887 9999999997552111                                  11


Q ss_pred             H------HHHHHHHHhcCC----CCceeeeeeeee-eCCeeEEEEEecCCCCcchhhh--ccC-CcCCCCHHHHHHHHHH
Q 042149          340 Q------FFNEVNLISGIQ----HKNVVRLLGCSI-EGPESLLVYEYVPNRSLDQILF--VKN-TIHILSWQQRFTIICG  405 (625)
Q Consensus       340 ~------~~~E~~~l~~l~----hpniv~l~~~~~-~~~~~~lV~e~~~~~sL~~~l~--~~~-~~~~l~~~~~~~i~~~  405 (625)
                      .      +.+|+..+.+++    +.+.+.+-.++. -....+|||||++|+.+.++-.  ..+ ....+.......++.|
T Consensus       196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q  275 (537)
T PRK04750        196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ  275 (537)
T ss_pred             HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence            1      333444444442    333333323222 2456789999999999987422  111 1111223333333333


Q ss_pred             HHHHHHHhhcCCCceEEEeeeccCcEEEcCCC----ceEEeecccceeeCC
Q 042149          406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL----TPKIADFGLARHVAP  452 (625)
Q Consensus       406 i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~----~~kl~Dfgla~~~~~  452 (625)
                      +       +..   +++|+|+||+||+++.++    .++++|||++..+..
T Consensus       276 i-------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 V-------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             H-------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            3       333   599999999999999887    999999999987654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.38  E-value=4.5e-13  Score=141.53  Aligned_cols=248  Identities=22%  Similarity=0.273  Sum_probs=183.0

Q ss_pred             cCccccccccc--cCceEEEEEEe---CCCCEEEEEEeec--CChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCCee
Q 042149          298 DFFDNSRKLGQ--GGAGSVFRGTL---PDGRNIAVKRLFF--NSRQWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEGPES  369 (625)
Q Consensus       298 ~~y~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~  369 (625)
                      ..|.+.+.+|.  |.+|.||.+..   .++..+|+|+-..  ........=.+|+...++++ |+|.++.+..++..+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            45777888999  99999999986   3688899997432  22222233356777777774 99999999999999999


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHH----HHHHhhcCCCceEEEeeeccCcEEEcCC-CceEEeec
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAE----GLAHLHGGSGIKIIHRDIKTSNILLDEK-LTPKIADF  444 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~iiHrDlkp~NIll~~~-~~~kl~Df  444 (625)
                      ++-.|++. .+|..+.+...  ..++....+..+.+..+    ||.++|..   +++|-|+||.||+...+ ...+++||
T Consensus       194 fiqtE~~~-~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeeecccc-chhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence            99999984 67777664332  23677778888888888    99999976   49999999999999988 88999999


Q ss_pred             ccceeeCCCCceee----ecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhc
Q 042149          445 GLARHVAPDKTHVS----TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKA  520 (625)
Q Consensus       445 gla~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~  520 (625)
                      |+...+........    ....|...|++||.. .+-++..+|+|++|.++.+..+|...+...-..      .|...+.
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W~~~r~  340 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS------SWSQLRQ  340 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC------Ccccccc
Confidence            99988876553221    233578899999976 556788999999999999999988765433111      1332222


Q ss_pred             cccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          521 NRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       521 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ..        +..++-.....++..++..+++.+|..|++...+..
T Consensus       341 ~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  341 GY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            22        111222223445556889999999999999887654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.36  E-value=2.3e-12  Score=120.39  Aligned_cols=131  Identities=17%  Similarity=0.119  Sum_probs=96.9

Q ss_pred             cccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCce-eeeeeeeeeCCeeEEEEEecCCCCc
Q 042149          303 SRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNV-VRLLGCSIEGPESLLVYEYVPNRSL  381 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lV~e~~~~~sL  381 (625)
                      ++.|+.|.++.||+++.. ++.+++|........ ...+.+|+.+++.+.+.++ ++++...  ....++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~-~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL-LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCccc-ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            456899999999999875 678999987544321 2346789999998865544 4555543  3345899999999888


Q ss_pred             chhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCC--CceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          382 DQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS--GIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       382 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      .+..        .   ....++.+++++|..||..+  ...++|+|++|+||+++ ++.++++|||.+..
T Consensus        79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            6531        1   11235678899999999764  23469999999999999 56899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.30  E-value=2.2e-11  Score=129.88  Aligned_cols=167  Identities=16%  Similarity=0.201  Sum_probs=127.8

Q ss_pred             eCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHH
Q 042149          319 LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQ  398 (625)
Q Consensus       319 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~  398 (625)
                      ..++.+|.|........+..+...+-++.|+.++||||+++++.++.++..|||+|-+.  .|..++...      ....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------~~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------GKEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------HHHH
Confidence            34688898888877666666778888999999999999999999999999999999873  566666432      3455


Q ss_pred             HHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceeeecCCCCccccCccccccCcc
Q 042149          399 RFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL  478 (625)
Q Consensus       399 ~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  478 (625)
                      ....+.||+.||.|||..+  +++|++|.-+.|+|+..|..||++|.++........ ......---.|..|+.+.... 
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~-  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE-  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence            6677899999999999766  799999999999999999999999998764432221 111112223455666542222 


Q ss_pred             cccCcEEeehhhhHHHHhCC
Q 042149          479 TEKADVYAFGVLVIEVASGR  498 (625)
Q Consensus       479 ~~~~Dv~SlG~ll~elltG~  498 (625)
                       -..|.|.||++++|++.|.
T Consensus       182 -~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             -cchhhhhHHHHHHHHhCcc
Confidence             3569999999999999994

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.27  E-value=3.3e-12  Score=124.46  Aligned_cols=201  Identities=20%  Similarity=0.240  Sum_probs=138.3

Q ss_pred             HHhcCCCCceeeeeeeeeeC-----CeeEEEEEecCCCCcchhhhccC-CcCCCCHHHHHHHHHHHHHHHHHhhcCCCce
Q 042149          347 LISGIQHKNVVRLLGCSIEG-----PESLLVYEYVPNRSLDQILFVKN-TIHILSWQQRFTIICGTAEGLAHLHGGSGIK  420 (625)
Q Consensus       347 ~l~~l~hpniv~l~~~~~~~-----~~~~lV~e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~  420 (625)
                      -|-.+.|.|||+++.++.+.     ....++.|||..|+|..+|+... ....+......+|+.||+.||.|||+. ..+
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence            34456699999999988643     46789999999999999997542 233477788889999999999999987 678


Q ss_pred             EEEeeeccCcEEEcCCCceEEeecccceeeCC----CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh
Q 042149          421 IIHRDIKTSNILLDEKLTPKIADFGLARHVAP----DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS  496 (625)
Q Consensus       421 iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt  496 (625)
                      |+|+++..+-|++..+|-+||.- +.......    ..........+.++|.+||.-...+.+.++|||+||+-..||.-
T Consensus       199 iihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             cccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            99999999999999998888742 21111110    00111112346789999998777788899999999999999988


Q ss_pred             CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          497 GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       497 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      |..-..........      .....+....+...+           -..++.+|++..|..||+|.+++-
T Consensus       278 lEiq~tnseS~~~~------ee~ia~~i~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  278 LEIQSTNSESKVEV------EENIANVIIGLENGL-----------QRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             heeccCCCcceeeh------hhhhhhheeeccCcc-----------ccCcCcccccCCCCCCcchhhhhc
Confidence            76432222111000      000001111111111           135778899999999999987754

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.22  E-value=2.1e-10  Score=108.36  Aligned_cols=135  Identities=12%  Similarity=0.072  Sum_probs=97.0

Q ss_pred             ccccccCceEEEEEEeCC-------CCEEEEEEeecCC------h----------------HHHHH----HHHHHHHHhc
Q 042149          304 RKLGQGGAGSVFRGTLPD-------GRNIAVKRLFFNS------R----------------QWVDQ----FFNEVNLISG  350 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~------~----------------~~~~~----~~~E~~~l~~  350 (625)
                      ..||.|.-+.||.|...+       +..+|||+.....      .                .....    ..+|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998543       4799999774210      0                01122    3479999999


Q ss_pred             CCC--CceeeeeeeeeeCCeeEEEEEecCCCCcch-hhhccCCcCCCCHHHHHHHHHHHHHHHHHh-hcCCCceEEEeee
Q 042149          351 IQH--KNVVRLLGCSIEGPESLLVYEYVPNRSLDQ-ILFVKNTIHILSWQQRFTIICGTAEGLAHL-HGGSGIKIIHRDI  426 (625)
Q Consensus       351 l~h--pniv~l~~~~~~~~~~~lV~e~~~~~sL~~-~l~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~iiHrDl  426 (625)
                      +..  -++++++++    ...+|||||+.+..+.. .+..    ..++..+...+..+++.+|..| |..+   |||+||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            863  456677764    56789999997654422 1211    1244556677788999999998 7664   999999


Q ss_pred             ccCcEEEcCCCceEEeecccceee
Q 042149          427 KTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       427 kp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      ++.||++++ +.+.|+|||.+...
T Consensus       152 s~~NIL~~~-~~v~iIDF~qav~~  174 (197)
T cd05146         152 SEYNMLWHD-GKVWFIDVSQSVEP  174 (197)
T ss_pred             CHHHEEEEC-CcEEEEECCCceeC
Confidence            999999974 68999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.20  E-value=1.3e-10  Score=113.44  Aligned_cols=142  Identities=22%  Similarity=0.258  Sum_probs=108.2

Q ss_pred             ccccccCceEEEEEEeCCCCEEEEEEeecCCh-HHHHHHHHHHHHHhcCCC--CceeeeeeeeeeCC---eeEEEEEecC
Q 042149          304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR-QWVDQFFNEVNLISGIQH--KNVVRLLGCSIEGP---ESLLVYEYVP  377 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~---~~~lV~e~~~  377 (625)
                      +.|+.|..+.||+++..+|+.+++|....... .....+.+|+++++.+.+  .++++++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999987778999998754432 134578899999999975  34677777766542   5689999999


Q ss_pred             CCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCC----------------------------------------
Q 042149          378 NRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS----------------------------------------  417 (625)
Q Consensus       378 ~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------------  417 (625)
                      |.++.+.+..    ..++..+...++.++++.|..||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9988775521    12566677777778888888877421                                        


Q ss_pred             -------------CceEEEeeeccCcEEEcC--CCceEEeeccccee
Q 042149          418 -------------GIKIIHRDIKTSNILLDE--KLTPKIADFGLARH  449 (625)
Q Consensus       418 -------------~~~iiHrDlkp~NIll~~--~~~~kl~Dfgla~~  449 (625)
                                   ...++|+|++|.||++++  ++.+.|+||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         245899999999999998  66789999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.17  E-value=2.5e-11  Score=128.44  Aligned_cols=245  Identities=20%  Similarity=0.156  Sum_probs=174.9

Q ss_pred             HhcCccccccccccCceEEEEEEe--CCCCEEEEEEeecCChHHHH--HHHHHHHHHhcC-CCCceeeeeeeeeeCCeeE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTL--PDGRNIAVKRLFFNSRQWVD--QFFNEVNLISGI-QHKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~  370 (625)
                      .+.+|..+..||.|.|+.|+....  .++..|++|.+.........  .-..|+.+...+ .|.+++..+..+......+
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            356788999999999999998874  36788999987655322222  234577777777 4999999988888888888


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCC-CceEEeeccccee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEK-LTPKIADFGLARH  449 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~-~~~kl~Dfgla~~  449 (625)
                      |--||++++++...+...   ..++...++.+..+++.++.++|+..   ++|+|+||+||++..+ +.-++.|||....
T Consensus       343 ip~e~~~~~s~~l~~~~~---~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTS---QMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             CchhhhcCcchhhhhHHH---HhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence            999999999887766322   23777888999999999999999765   9999999999999875 7889999998764


Q ss_pred             eCCCCceeeecCCCCcccc--CccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccccccc
Q 042149          450 VAPDKTHVSTGIAGTLGYM--APEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM  527 (625)
Q Consensus       450 ~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  527 (625)
                      +.-..    ......-++.  +|+......+..+.|++|||..+.+.++|..-......        |.....       
T Consensus       417 ~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------~~~i~~-------  477 (524)
T KOG0601|consen  417 LAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------SLTIRS-------  477 (524)
T ss_pred             cceec----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc--------ceeeec-------
Confidence            21111    1112233333  45555556788999999999999999998754221110        111111       


Q ss_pred             CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 042149          528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHML  568 (625)
Q Consensus       528 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L  568 (625)
                        ..... .+.....+..+...++.+++..||.+.++..+.
T Consensus       478 --~~~p~-~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  478 --GDTPN-LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             --ccccC-CCchHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence              11111 223336677788889999999999998876543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.12  E-value=5.9e-10  Score=101.61  Aligned_cols=131  Identities=21%  Similarity=0.294  Sum_probs=99.6

Q ss_pred             ccccccCceEEEEEEeCCCCEEEEEEeecC---Ch-----HHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFN---SR-----QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~---~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ..+++|+-+.+|.+.+. |.++++|.-.+.   .+     -..++-.+|+.++.+++--.|...+=+..+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35889999999999764 445777743322   11     1234567899999998765655555556677888999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      ++|..|.+.+...          ...++..+-.-+.-||..+   |+|+||.++||++..++ +.++||||+..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999888433          2456777778888999776   99999999999998774 99999999874

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.06  E-value=1.7e-09  Score=112.07  Aligned_cols=170  Identities=21%  Similarity=0.316  Sum_probs=129.4

Q ss_pred             CceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeee----eCCeeEEEEEecCC-CCcch
Q 042149          310 GAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI----EGPESLLVYEYVPN-RSLDQ  383 (625)
Q Consensus       310 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~----~~~~~~lV~e~~~~-~sL~~  383 (625)
                      ...+.|++..+ +|..|++|+++............-+++++++.|+|+|++.+++.    .+..+++|++|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            34678999865 89999999996554333334455688899999999999998876    45578999999987 67776


Q ss_pred             hhhccC------------CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          384 ILFVKN------------TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       384 ~l~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      +.+...            .....++...|.++.|+..||.++|+.|   +.-+-|.|.+|+++.+.+++|...|....+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence            554322            1233678899999999999999999886   7779999999999999999999999877665


Q ss_pred             CCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCC
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRN  500 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p  500 (625)
                      .+...               -+..   -.+-|.=.||.++..|.||...
T Consensus       445 ~d~~~---------------~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDPTE---------------PLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCCc---------------chhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            44311               1111   1345666799999999999643

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.00  E-value=4.1e-09  Score=95.59  Aligned_cols=143  Identities=22%  Similarity=0.270  Sum_probs=104.6

Q ss_pred             ccccccccCceEEEEEEeCCCCEEEEEEeecC--------ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          302 NSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--------SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       302 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ....|-+|+-+.|+++.+ .|+..+||.-...        .+-...+..+|+++|.++.--.|.-..-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            566788999999999987 5677778744322        1122346788999999887555554444567777888999


Q ss_pred             EecCC-CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC---ceEEeeccccee
Q 042149          374 EYVPN-RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL---TPKIADFGLARH  449 (625)
Q Consensus       374 e~~~~-~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~---~~kl~Dfgla~~  449 (625)
                      ||++| .++.+++....... ........++..|-+.+.-||.++   |||+||..+||+|..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 57777776544322 222233678888899999999776   99999999999997543   458999999754

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.98  E-value=1.2e-08  Score=103.25  Aligned_cols=266  Identities=15%  Similarity=0.150  Sum_probs=162.6

Q ss_pred             ccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcC-CCCceeeeee------eeeeC-CeeEEEE
Q 042149          302 NSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI-QHKNVVRLLG------CSIEG-PESLLVY  373 (625)
Q Consensus       302 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~------~~~~~-~~~~lV~  373 (625)
                      ..+.||+|+-+.+|..-  .-+..+.|+.+........+.   ++.|... .||-+-.-+.      +.-+. ....+.|
T Consensus        15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecc--hhhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            35679999999999653  122345677765543322222   2233333 4654332111      11122 2367888


Q ss_pred             EecCCCC-cchhhh---ccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          374 EYVPNRS-LDQILF---VKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       374 e~~~~~s-L~~~l~---~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      ..+++.- ...++.   .++......|.-.++..+.++.+.+.||..|   .+-+|+.++|+|+.+++.+.|.|-..-..
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence            8887742 222222   2333455789999999999999999999886   89999999999999999999998765444


Q ss_pred             eCCCCceeeecCCCCccccCcccccc-----CcccccCcEEeehhhhHHHHhC-CCCCCCCCCCccchhhHHHhhhcccc
Q 042149          450 VAPDKTHVSTGIAGTLGYMAPEYLVR-----GQLTEKADVYAFGVLVIEVASG-RRNSVFSEGSSSVLHTVWKHYKANRI  523 (625)
Q Consensus       450 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~ll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~  523 (625)
                      ..  +.......+|.++|.+||...-     -.-+...|.|.||++++++|.| ++|+..-.....--.-....+..+..
T Consensus       167 ~~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f  244 (637)
T COG4248         167 NA--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF  244 (637)
T ss_pred             cc--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence            32  2222334578999999997652     2446789999999999999998 77765322111100000001111111


Q ss_pred             ccccCC--CCC---CCCC-hHHHHHHHHHHhhccCC--CCCCCCCHHHHHHHHccccCCCCC
Q 042149          524 TQSMDP--GLT---GRFP-ENEASRVLQIGLLCTQA--PVALRPSMAEVVHMLNNIDYEIPP  577 (625)
Q Consensus       524 ~~~i~~--~~~---~~~~-~~~~~~l~~li~~cl~~--~p~~RPt~~ev~~~L~~~~~~l~~  577 (625)
                      ...-+.  .+.   ...| .-.+..+..+..+|+..  ++.-|||.+-.+..|..+..+|.+
T Consensus       245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~  306 (637)
T COG4248         245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK  306 (637)
T ss_pred             eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence            111110  000   1112 23456677777888765  467899999999888777665543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.96  E-value=1.3e-10  Score=129.08  Aligned_cols=250  Identities=20%  Similarity=0.201  Sum_probs=169.9

Q ss_pred             HHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeE
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  370 (625)
                      ...+.+.+.+-+-+|.++.++.+.-. .|...++|......   ....+....+-.++-...+|-++...-.+......+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            34677888888999999999988633 34334444332211   111222333333333445677776666566778899


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      ||++|..+++|...|+....   .+.......+..+...+++||..   .++|||++|.|+++..++..++.|||.....
T Consensus       881 L~~~~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hhhHHhccCCchhhhhcCCC---cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence            99999999999988865542   45455556667788899999954   4899999999999999999999999843221


Q ss_pred             CC------------------------------CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCC
Q 042149          451 AP------------------------------DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRN  500 (625)
Q Consensus       451 ~~------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p  500 (625)
                      ..                              +.........+|+.|.+||...+......+|+|++|+.++|.++|..|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            10                              000011245699999999999999999999999999999999999988


Q ss_pred             CCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHH
Q 042149          501 SVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMA  562 (625)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~  562 (625)
                      +.......     .++......+       .....+........+++...+..+|.+|-.+.
T Consensus      1035 ~na~tpq~-----~f~ni~~~~~-------~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQ-----IFENILNRDI-------PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCcchhh-----hhhccccCCC-------CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            64332211     1111111110       01122445566778899999999999997765

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.95  E-value=5.8e-09  Score=98.20  Aligned_cols=125  Identities=25%  Similarity=0.317  Sum_probs=81.6

Q ss_pred             EEEEEEeCCCCEEEEEEeecCC--------------------------hHHHHHHHHHHHHHhcCCCC--ceeeeeeeee
Q 042149          313 SVFRGTLPDGRNIAVKRLFFNS--------------------------RQWVDQFFNEVNLISGIQHK--NVVRLLGCSI  364 (625)
Q Consensus       313 ~Vy~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~E~~~l~~l~hp--niv~l~~~~~  364 (625)
                      .||.|...+|..+|||......                          ........+|.+.|.++..-  ++++++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899999899999999774321                          01124567899999999755  567777543 


Q ss_pred             eCCeeEEEEEecC--CCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHH-hhcCCCceEEEeeeccCcEEEcCCCceEE
Q 042149          365 EGPESLLVYEYVP--NRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH-LHGGSGIKIIHRDIKTSNILLDEKLTPKI  441 (625)
Q Consensus       365 ~~~~~~lV~e~~~--~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~iiHrDlkp~NIll~~~~~~kl  441 (625)
                         ...|||||++  |..+..+....     ++......++.+++..+.. +|..+   |+|+||.+.||+++++ .+.|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence               4579999998  66665543221     1123345566667774444 57665   9999999999999988 9999


Q ss_pred             eecccceee
Q 042149          442 ADFGLARHV  450 (625)
Q Consensus       442 ~Dfgla~~~  450 (625)
                      +|||.+...
T Consensus       148 IDf~qav~~  156 (188)
T PF01163_consen  148 IDFGQAVDS  156 (188)
T ss_dssp             --GTTEEET
T ss_pred             EecCcceec
Confidence            999987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.88  E-value=2e-08  Score=100.28  Aligned_cols=133  Identities=18%  Similarity=0.117  Sum_probs=95.6

Q ss_pred             eEEEEEEeCCCCEEEEEEeecCCh-HHHH----------HHHHHHHHHhcCCCCce--eeeeeeeee-----CCeeEEEE
Q 042149          312 GSVFRGTLPDGRNIAVKRLFFNSR-QWVD----------QFFNEVNLISGIQHKNV--VRLLGCSIE-----GPESLLVY  373 (625)
Q Consensus       312 g~Vy~~~~~~~~~vavK~~~~~~~-~~~~----------~~~~E~~~l~~l~hpni--v~l~~~~~~-----~~~~~lV~  373 (625)
                      ..|.+..+ +|+.+.||+...... +..+          .+.+|+..+.++..-+|  +.++++++.     ....+||+
T Consensus        36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            34666655 678899997744331 1122          37789999988854443  334455543     23578999


Q ss_pred             EecCCC-CcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC-------CCceEEeecc
Q 042149          374 EYVPNR-SLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE-------KLTPKIADFG  445 (625)
Q Consensus       374 e~~~~~-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~-------~~~~kl~Dfg  445 (625)
                      |++++. +|.+++..... ...+......++.+++..+.-||..|   |+|+||+++|||++.       ++.+.|+||+
T Consensus       115 e~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~  190 (268)
T PRK15123        115 EDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLH  190 (268)
T ss_pred             eeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence            999986 89888743211 22456677889999999999999876   999999999999975       4689999999


Q ss_pred             ccee
Q 042149          446 LARH  449 (625)
Q Consensus       446 la~~  449 (625)
                      .+..
T Consensus       191 r~~~  194 (268)
T PRK15123        191 RAQI  194 (268)
T ss_pred             cccc
Confidence            8753

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.87  E-value=1.5e-08  Score=97.95  Aligned_cols=134  Identities=20%  Similarity=0.215  Sum_probs=94.6

Q ss_pred             ccccccccccCceEEEEEEeCCCCEEEEEEeecCC---------h---------H----HHHHHHHHHHHHhcCCCC--c
Q 042149          300 FDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---------R---------Q----WVDQFFNEVNLISGIQHK--N  355 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---------~---------~----~~~~~~~E~~~l~~l~hp--n  355 (625)
                      ..+..+||-|.-+.||.|..++|.++|||.-....         +         .    .....++|.++|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            45678999999999999999999999999442211         0         1    123467899999999755  6


Q ss_pred             eeeeeeeeeeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC
Q 042149          356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE  435 (625)
Q Consensus       356 iv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~  435 (625)
                      +++.+++    +...+|||+++|..|...-.     ..-...+++   ..|++-+..+-..   +|||+|+.+-||++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~-----~~en~~~il---~~il~~~~~~~~~---GiVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLRL-----DVENPDEIL---DKILEEVRKAYRR---GIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeecccC-----cccCHHHHH---HHHHHHHHHHHHc---CccccCCchheEEEec
Confidence            7777654    57789999999977755321     112233333   3333333333323   3999999999999999


Q ss_pred             CCceEEeecccce
Q 042149          436 KLTPKIADFGLAR  448 (625)
Q Consensus       436 ~~~~kl~Dfgla~  448 (625)
                      +|.+.++||--+.
T Consensus       238 dg~~~vIDwPQ~v  250 (304)
T COG0478         238 DGDIVVIDWPQAV  250 (304)
T ss_pred             CCCEEEEeCcccc
Confidence            9999999997543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.82  E-value=2.2e-08  Score=108.17  Aligned_cols=142  Identities=17%  Similarity=0.203  Sum_probs=93.1

Q ss_pred             ccccccCceEEEEEEeCCCCEEEEEEeecCChHHH------------------------------H----------HHHH
Q 042149          304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWV------------------------------D----------QFFN  343 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~~  343 (625)
                      +-|+.+.-|.||+|++++|+.||||+..++-++.+                              +          .+.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            57899999999999999999999999876532211                              1          1233


Q ss_pred             HHHHHhcCC-----CCceeeeeeeeeeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 042149          344 EVNLISGIQ-----HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG  418 (625)
Q Consensus       344 E~~~l~~l~-----hpniv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~  418 (625)
                      |+..+.+++     .|++.-..=+.+-...-.|+|||++|..+.+.......+  .+.+.......++.--.-+-|    
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--~d~k~ia~~~~~~f~~q~~~d----  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG--IDRKELAELLVRAFLRQLLRD----  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC--CCHHHHHHHHHHHHHHHHHhc----
Confidence            454444442     233222222233356778999999999998875333221  443333333332222222223    


Q ss_pred             ceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       419 ~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                       ++.|.|.+|.||+++.+|++.+.|||+...+.+
T Consensus       285 -gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 -GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             -CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence             599999999999999999999999999876653

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.77  E-value=3.9e-09  Score=113.41  Aligned_cols=152  Identities=21%  Similarity=0.338  Sum_probs=105.2

Q ss_pred             HHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCcee--------eecCCCCccccCccccc
Q 042149          403 ICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV--------STGIAGTLGYMAPEYLV  474 (625)
Q Consensus       403 ~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~--------~~~~~gt~~y~aPE~~~  474 (625)
                      +.+++.||.|+|...  ++||++|.|++|.++.++.+||+.|+.+..........        ..-..-...|.|||++.
T Consensus       105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            334569999999754  89999999999999999999999999876544311111        11123466899999999


Q ss_pred             cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCC
Q 042149          475 RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAP  554 (625)
Q Consensus       475 ~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~  554 (625)
                      +...+.++|+||+|+++|-+..|+.+.....+....          .......+..-...++.+.+.++.+=+.+++..+
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~----------~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~  252 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS----------YSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGD  252 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcch----------hhhhhcccccccccccccCcHHHHHHHHHHhcCC
Confidence            988899999999999999999665543221111000          0011111111112234567788888899999999


Q ss_pred             CCCCCCHHHHHH
Q 042149          555 VALRPSMAEVVH  566 (625)
Q Consensus       555 p~~RPt~~ev~~  566 (625)
                      +..||++.++..
T Consensus       253 ~~~rp~~~~l~~  264 (700)
T KOG2137|consen  253 SAVRPTLDLLLS  264 (700)
T ss_pred             cccCcchhhhhc
Confidence            999997766643

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.62  E-value=1.3e-07  Score=91.18  Aligned_cols=123  Identities=24%  Similarity=0.266  Sum_probs=90.0

Q ss_pred             CCCEEEEEEeecC-Ch------HHHHHHHHHHHHHhcCCCCc--eeeeeeeeeeCC----eeEEEEEecCC-CCcchhhh
Q 042149          321 DGRNIAVKRLFFN-SR------QWVDQFFNEVNLISGIQHKN--VVRLLGCSIEGP----ESLLVYEYVPN-RSLDQILF  386 (625)
Q Consensus       321 ~~~~vavK~~~~~-~~------~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~----~~~lV~e~~~~-~sL~~~l~  386 (625)
                      .++.+.+|..... ..      -...+..+|...+..|..-+  +++.+++.+...    ..+||+|++++ .+|.+++.
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~  110 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ  110 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence            3566666654321 11      12346788888888875433  455566655432    45899999998 48998886


Q ss_pred             ccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC---ceEEeeccccee
Q 042149          387 VKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL---TPKIADFGLARH  449 (625)
Q Consensus       387 ~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~---~~kl~Dfgla~~  449 (625)
                      ....   .+......++.+++..+.-||..|   |+|+|+++.|||++.++   .+.|+||+-++.
T Consensus       111 ~~~~---~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  111 QWEQ---LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             hhcc---cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            4332   556677889999999999999886   99999999999999876   899999998765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.59  E-value=4.5e-07  Score=85.91  Aligned_cols=139  Identities=17%  Similarity=0.131  Sum_probs=101.2

Q ss_pred             ccccCceEEEEEEeCCCCEEEEEEeecC-C-----hHHHHHHHHHHHHHhcCCCCc--eeeeeeeeeeC----CeeEEEE
Q 042149          306 LGQGGAGSVFRGTLPDGRNIAVKRLFFN-S-----RQWVDQFFNEVNLISGIQHKN--VVRLLGCSIEG----PESLLVY  373 (625)
Q Consensus       306 lG~G~~g~Vy~~~~~~~~~vavK~~~~~-~-----~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~----~~~~lV~  373 (625)
                      -|+||.+-|+.-... |+.+-+|+.... .     +-....|.+|+..|.+|..-+  ++++.......    -..+||+
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            366999999997764 457899977521 1     223467999999999986332  44544222221    2468999


Q ss_pred             EecCC-CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCc--eEEeeccccee
Q 042149          374 EYVPN-RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLT--PKIADFGLARH  449 (625)
Q Consensus       374 e~~~~-~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~--~kl~Dfgla~~  449 (625)
                      |-+.| .+|.+++.... ....+...+..++.+++..+.-||..+   +.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            98865 68888774432 223677788899999999999999775   999999999999986667  99999986653

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.55  E-value=7e-07  Score=87.35  Aligned_cols=138  Identities=15%  Similarity=0.151  Sum_probs=85.5

Q ss_pred             cccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCc--eeeeeeeeeeCCeeEEEEEecCCCC
Q 042149          303 SRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKN--VVRLLGCSIEGPESLLVYEYVPNRS  380 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~lV~e~~~~~s  380 (625)
                      ...||+|..+.||+.   .+..+++|.......  .....+|.++++.+..-+  +++++++....+...+|||+++|.+
T Consensus         6 ~~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~--~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         6 WTQTGEGGNGESYTH---KTGKWMLKLYNPGFD--KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             heeecCCCCcceeEe---cCCCEEEEeCCCCCC--HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            357899999999984   255678887765332  245688999999886433  4677888777778889999999964


Q ss_pred             -cchhh---------------------hccCCcCCCCHHHHHHHHH-----------HHHHH-HHHh--hcCCCceEEEe
Q 042149          381 -LDQIL---------------------FVKNTIHILSWQQRFTIIC-----------GTAEG-LAHL--HGGSGIKIIHR  424 (625)
Q Consensus       381 -L~~~l---------------------~~~~~~~~l~~~~~~~i~~-----------~i~~~-L~~L--H~~~~~~iiHr  424 (625)
                       +...+                     +.. ...............           .+.+. ..+|  +.. ...++|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~-~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~-~~~~~Hg  158 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHST-KCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD-TSTCLHG  158 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCC-CCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC-CCceEec
Confidence             21111                     100 000011111100000           00011 1111  222 3457999


Q ss_pred             eeccCcEEEcCCCceEEeecccce
Q 042149          425 DIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       425 Dlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      |++|.||++++++ +.|+||+.+.
T Consensus       159 D~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       159 DFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCCcEEEcCCC-cEEEechhcC
Confidence            9999999999887 9999999764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.50  E-value=5.7e-07  Score=96.87  Aligned_cols=139  Identities=17%  Similarity=0.190  Sum_probs=92.8

Q ss_pred             ccccccCceEEEEEEeCCCCEEEEEEeecCChHH-------------------------------HH------HHHHHHH
Q 042149          304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQW-------------------------------VD------QFFNEVN  346 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~~~E~~  346 (625)
                      +-||.-..|.||+|++++|+.||||+.++.-++.                               .+      .|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            5689999999999999999999999886542211                               01      1334444


Q ss_pred             HHhcC----CCCc------eeeeeeeeeeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcC
Q 042149          347 LISGI----QHKN------VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG  416 (625)
Q Consensus       347 ~l~~l----~hpn------iv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~  416 (625)
                      ...++    .|-+      |++++-  .-.....|+||||+|..+.++-.-...  .++...+..-+.++..-+-+-|  
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~~qIf~~--  320 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYLEQIFKT--  320 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHHHHHHhc--
Confidence            43333    3444      444432  223467899999999988886543322  2555555544444433333333  


Q ss_pred             CCceEEEeeeccCcEEEc----CCCceEEeecccceeeC
Q 042149          417 SGIKIIHRDIKTSNILLD----EKLTPKIADFGLARHVA  451 (625)
Q Consensus       417 ~~~~iiHrDlkp~NIll~----~~~~~kl~Dfgla~~~~  451 (625)
                         +++|.|-+|.||+++    .++.+.+.|||+...+.
T Consensus       321 ---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  321 ---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             ---CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence               599999999999998    36789999999987654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.46  E-value=1.3e-06  Score=83.00  Aligned_cols=138  Identities=17%  Similarity=0.144  Sum_probs=90.0

Q ss_pred             HhcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHH---------HHHHHHHhcCCC---Cceeeeeee-
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQF---------FNEVNLISGIQH---KNVVRLLGC-  362 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~h---pniv~l~~~-  362 (625)
                      ...+|.+.+++-......|.+-.. +|+.+++|............|         .+++..+.+++.   -.+..++-. 
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            345688888888877777777766 568899998865543222222         233443433322   222222222 


Q ss_pred             ----eeeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCc
Q 042149          363 ----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLT  438 (625)
Q Consensus       363 ----~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~  438 (625)
                          +.-....+++|||++|..|.+...       ++.    .+...+.+.+.-||..|   ++|+|++|+|++++++ .
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~  172 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-G  172 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-c
Confidence                222345679999999988877542       222    23455677899999776   9999999999999866 4


Q ss_pred             eEEeeccccee
Q 042149          439 PKIADFGLARH  449 (625)
Q Consensus       439 ~kl~Dfgla~~  449 (625)
                      ++++||+..+.
T Consensus       173 i~iID~~~k~~  183 (229)
T PF06176_consen  173 IRIIDTQGKRM  183 (229)
T ss_pred             EEEEECccccc
Confidence            99999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.42  E-value=2.2e-06  Score=84.11  Aligned_cols=144  Identities=24%  Similarity=0.225  Sum_probs=85.2

Q ss_pred             cccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCC--ceeeeeeeee---eCCeeEEEEEecC
Q 042149          303 SRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHK--NVVRLLGCSI---EGPESLLVYEYVP  377 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--niv~l~~~~~---~~~~~~lV~e~~~  377 (625)
                      ++.|+.|..+.||+....+ +.+++|.....  .....+.+|..+++.+...  .+++++....   .....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            4578999999999999877 69999987544  4566788899998888533  3566666433   3335789999999


Q ss_pred             CCCcch----------------hh---hcc-CCcCCCCHHH---------HHHH------------HHHHHH-HHHHhhc
Q 042149          378 NRSLDQ----------------IL---FVK-NTIHILSWQQ---------RFTI------------ICGTAE-GLAHLHG  415 (625)
Q Consensus       378 ~~sL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~i~~-~L~~LH~  415 (625)
                      |..+..                .+   +.. .......+..         ....            ...+.+ .+..++.
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            988777                11   111 0000011100         0000            111122 2233331


Q ss_pred             ----CCCceEEEeeeccCcEEEc-CCCceEEeeccccee
Q 042149          416 ----GSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARH  449 (625)
Q Consensus       416 ----~~~~~iiHrDlkp~NIll~-~~~~~kl~Dfgla~~  449 (625)
                          .....++|+|+.|+||+++ +++.+-|+||+.+..
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence                2355799999999999999 566668999997653

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.39  E-value=6e-06  Score=79.44  Aligned_cols=152  Identities=20%  Similarity=0.177  Sum_probs=99.2

Q ss_pred             ccHHHHHHHhcCccccccc---cccCceEEEEEEeCCCCEEEEEEeecCChH------------------------HHHH
Q 042149          288 FKYEILERATDFFDNSRKL---GQGGAGSVFRGTLPDGRNIAVKRLFFNSRQ------------------------WVDQ  340 (625)
Q Consensus       288 ~~~~~~~~~~~~y~~~~~l---G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------------~~~~  340 (625)
                      ...+.+....++..+....   +.|.-..||+|...++..+|||+.......                        ....
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            3566777777777666554   467778999999888999999988543211                        0122


Q ss_pred             HHHHHHHHhcCC--CCceeeeeeeeeeCCeeEEEEEecCCCCcc-hhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 042149          341 FFNEVNLISGIQ--HKNVVRLLGCSIEGPESLLVYEYVPNRSLD-QILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS  417 (625)
Q Consensus       341 ~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~lV~e~~~~~sL~-~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~  417 (625)
                      ..+|...|+++.  +=.+++.+++.    .-.|||||+....+- =.|.+    -.+...+...+..++++.+.-|-...
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~a  186 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKEA  186 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHhc
Confidence            455777777764  33444555443    347999999554111 01110    11222245566666777776665422


Q ss_pred             CceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       418 ~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                        ++||+||..-|||+. ++.+.|+|||-+...
T Consensus       187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             --CcccccchhhheEEE-CCeEEEEECcccccc
Confidence              599999999999999 779999999977654

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.31  E-value=5.1e-06  Score=82.54  Aligned_cols=139  Identities=13%  Similarity=0.109  Sum_probs=85.5

Q ss_pred             ccccCc-eEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCCeeEEEEEecCCCCcch
Q 042149          306 LGQGGA-GSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQ  383 (625)
Q Consensus       306 lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~~~~~sL~~  383 (625)
                      |..|.. ..||+.... +..++||+.....   ...+.+|+++++.+. +--+++++++....+..++|||+++|.+|..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            455555 789999765 4678888775433   345678999988884 4446678887776677899999999988764


Q ss_pred             hhh-------------------ccCC-cCCCC--HHHHHHH-----------------------HHHHHHHHHHhh-cCC
Q 042149          384 ILF-------------------VKNT-IHILS--WQQRFTI-----------------------ICGTAEGLAHLH-GGS  417 (625)
Q Consensus       384 ~l~-------------------~~~~-~~~l~--~~~~~~i-----------------------~~~i~~~L~~LH-~~~  417 (625)
                      ...                   .... .....  .......                       ...+...|.... ...
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            321                   0000 00000  0000100                       011111111111 111


Q ss_pred             CceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          418 GIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       418 ~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      ...++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            3469999999999999998778899999764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.25  E-value=2.9e-07  Score=98.14  Aligned_cols=188  Identities=19%  Similarity=0.131  Sum_probs=134.8

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCc-eeeeeeeeeeCCeeEEEEEe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKN-VVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lV~e~  375 (625)
                      +..+...+.+++|+.+.++|.+.-..+....+.+...     ....-++++|.+++||| .+..++-+..++..+++|++
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI  315 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence            3344555678999999999998543344445544322     23455889999999999 77777777788899999999


Q ss_pred             cCCC-CcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          376 VPNR-SLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       376 ~~~~-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      +.++ +-.......  .-.+...+...+.+.-.++|+++|+..   =+|||    ||+..+ +..+..||+....+....
T Consensus       316 ~s~~rs~~~~~~~s--e~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~  385 (829)
T KOG0576|consen  316 CSTGRSSALEMTVS--EIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM  385 (829)
T ss_pred             hcCCccccccCChh--hHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence            9876 222111100  011344455667777788999999652   48888    777766 578999999887665443


Q ss_pred             ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCC
Q 042149          455 THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNS  501 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~  501 (625)
                        ......+++.++|||+.....+....|+|++|.-..++--|-+|.
T Consensus       386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence              233567999999999999999999999999999877887776653

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.21  E-value=6.6e-06  Score=77.83  Aligned_cols=104  Identities=25%  Similarity=0.201  Sum_probs=82.9

Q ss_pred             HHHHHHHhcCCC-CceeeeeeeeeeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCce
Q 042149          342 FNEVNLISGIQH-KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIK  420 (625)
Q Consensus       342 ~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~  420 (625)
                      .+|..+|+.+++ +++++++|.|    ..++|.||...+++......-......+|..+.+|+.++++.+.+|+......
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            468899999976 6999999998    45789999987766432111111123689999999999999999999765456


Q ss_pred             EEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          421 IIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       421 iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      +.-.|++|+|+-+++++++|++|.+.+..
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcch
Confidence            88899999999999999999999987654

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.19  E-value=7.2e-06  Score=74.58  Aligned_cols=127  Identities=18%  Similarity=0.201  Sum_probs=87.8

Q ss_pred             ccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCce-eeeeeeeeeCCeeEEEEEecCCCC
Q 042149          302 NSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNV-VRLLGCSIEGPESLLVYEYVPNRS  380 (625)
Q Consensus       302 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lV~e~~~~~s  380 (625)
                      +.+.|++|++|.||++.+. |..+|+|+-..+++  ...+..|+++|..++-.++ ++++.+..    .++.|||+.|..
T Consensus        26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~   98 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcc
Confidence            4568999999999999985 45899998765544  3678899999999875554 45555443    345699999988


Q ss_pred             cchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeec-cCcEEEcCCCceEEeecccce
Q 042149          381 LDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIK-TSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       381 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlk-p~NIll~~~~~~kl~Dfgla~  448 (625)
                      |.+.-...      +.+    -+..+++.-.-|...   +|-|..|. |..++|-+++.+.|+||.-|.
T Consensus        99 L~~~~~~~------~rk----~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112          99 LGKLEIGG------DRK----HLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             hhhhhhcc------cHH----HHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchh
Confidence            87754211      112    233344554445433   48888886 555555555599999999886

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.11  E-value=3.7e-05  Score=73.07  Aligned_cols=132  Identities=20%  Similarity=0.263  Sum_probs=92.3

Q ss_pred             ccccccccCceEEEEEEeCCCCEEEEEEeecCC----------------hHHHHHHHHHHHHHhcCC------CCceeee
Q 042149          302 NSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS----------------RQWVDQFFNEVNLISGIQ------HKNVVRL  359 (625)
Q Consensus       302 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------hpniv~l  359 (625)
                      ....||+|+.-.||.  ++++....||+.....                .....+..+|+.-...+.      +.+|.++
T Consensus         5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            345799999999985  5666778888886655                122455666776665555      7889999


Q ss_pred             eeeeeeCCeeEEEEEecCC------CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE
Q 042149          360 LGCSIEGPESLLVYEYVPN------RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL  433 (625)
Q Consensus       360 ~~~~~~~~~~~lV~e~~~~------~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll  433 (625)
                      +|+.+.+-.+.+|+|.+.+      -+|.+++....    ++. +....+.++.+-|.-.|      |+.+||+|+||++
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~~~~~L~~f~~~l~~~~------Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-ELRQALDEFKRYLLDHH------IVIRDLNPHNIVV  151 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-HHHHHHHHHHHHHHHcC------CeecCCCcccEEE
Confidence            9999999999999998744      35667663322    454 55555555555444443      9999999999999


Q ss_pred             cCC--C--ceEEee-ccc
Q 042149          434 DEK--L--TPKIAD-FGL  446 (625)
Q Consensus       434 ~~~--~--~~kl~D-fgl  446 (625)
                      ...  +  .+.|+| ||-
T Consensus       152 ~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  152 QRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             EecCCCceEEEEEeCCCC
Confidence            532  2  577777 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.09  E-value=2e-05  Score=77.86  Aligned_cols=74  Identities=20%  Similarity=0.323  Sum_probs=47.4

Q ss_pred             ccccccCce-EEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCC---ceeeeeeeeeeC---CeeEEEEEec
Q 042149          304 RKLGQGGAG-SVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHK---NVVRLLGCSIEG---PESLLVYEYV  376 (625)
Q Consensus       304 ~~lG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~~~---~~~~lV~e~~  376 (625)
                      +.|+.||.. .||+.    +..+++|.....  .....+.+|.++++.+...   .++++++.....   ...+++||++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            457777776 58975    235777765432  2245788999999887532   344555544332   2458899999


Q ss_pred             CCCCcch
Q 042149          377 PNRSLDQ  383 (625)
Q Consensus       377 ~~~sL~~  383 (625)
                      +|.++.+
T Consensus        77 ~G~~l~~   83 (235)
T cd05155          77 EGETATA   83 (235)
T ss_pred             cCCCCCc
Confidence            9988753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PLN02876 acyl-CoA dehydrogenase

Probab=98.09  E-value=2.8e-05  Score=90.70  Aligned_cols=79  Identities=14%  Similarity=0.285  Sum_probs=57.9

Q ss_pred             cccccccCceEEEEEEeCCC---CEEEEEEeecCC-hHHHHHHHHHHHHHhcCC-CCce--eeeeeeeeeC---CeeEEE
Q 042149          303 SRKLGQGGAGSVFRGTLPDG---RNIAVKRLFFNS-RQWVDQFFNEVNLISGIQ-HKNV--VRLLGCSIEG---PESLLV  372 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-hpni--v~l~~~~~~~---~~~~lV  372 (625)
                      ++.|+.|.+..+|+....++   ..+++|+..... ......+.+|+++|+.+. |+++  ++++.++.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            56789999999999886543   467888764432 122356889999999995 6665  7778877654   467899


Q ss_pred             EEecCCCCc
Q 042149          373 YEYVPNRSL  381 (625)
Q Consensus       373 ~e~~~~~sL  381 (625)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998754

>PRK10593 hypothetical protein; Provisional

Probab=98.09  E-value=4.9e-05  Score=77.68  Aligned_cols=77  Identities=10%  Similarity=-0.038  Sum_probs=56.5

Q ss_pred             ccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCC---Cceeeeeeeeee---CCeeEEEEEe
Q 042149          302 NSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQH---KNVVRLLGCSIE---GPESLLVYEY  375 (625)
Q Consensus       302 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---pniv~l~~~~~~---~~~~~lV~e~  375 (625)
                      ..+.||+|..+.||.....+++ +++|......  ....+.+|.+.|+.|..   -.++++++.+..   .+..+||||+
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQGN-PMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeeecCCccceeEEEEEcCCCC-EEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            3556999999999999866654 6667643211  22578899999998853   367888887754   3568999999


Q ss_pred             cCCCCc
Q 042149          376 VPNRSL  381 (625)
Q Consensus       376 ~~~~sL  381 (625)
                      ++|.++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            998765

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.88  E-value=0.00011  Score=69.22  Aligned_cols=125  Identities=28%  Similarity=0.404  Sum_probs=89.4

Q ss_pred             cCccccccccccCc-eEEEEEEeCCCCEEEEEEeec---CC-----------h-------HHHHHHHHHHHHHhcCC---
Q 042149          298 DFFDNSRKLGQGGA-GSVFRGTLPDGRNIAVKRLFF---NS-----------R-------QWVDQFFNEVNLISGIQ---  352 (625)
Q Consensus       298 ~~y~~~~~lG~G~~-g~Vy~~~~~~~~~vavK~~~~---~~-----------~-------~~~~~~~~E~~~l~~l~---  352 (625)
                      ..++.++.||.|.- |.||+++. +|+.+|+|.+..   ..           .       .....|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67888999999999 99999998 567999998321   10           0       22346788998877775   


Q ss_pred             CCce--eeeeeeeeeC------------------CeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHH
Q 042149          353 HKNV--VRLLGCSIEG------------------PESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH  412 (625)
Q Consensus       353 hpni--v~l~~~~~~~------------------~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~  412 (625)
                      +.++  |+.+|+..-.                  ....||.||++...            .+..    .-+.+|.+-|..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence            4566  8999987422                  12357888776533            0222    234556677888


Q ss_pred             hhcCCCceEEEeeeccCcEEEcCCCceEEeecccc
Q 042149          413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA  447 (625)
Q Consensus       413 LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla  447 (625)
                      +|..|   |+-+|+++.|..     .-||+|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            99665   999999999987     4589999864

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.87  E-value=8.6e-05  Score=73.18  Aligned_cols=141  Identities=18%  Similarity=0.203  Sum_probs=82.6

Q ss_pred             cccccccCceEEEEEEeCC--CCEEEEEEeecCChHHHHHHHHHHHHHhcCCC-CceeeeeeeeeeCCeeEEEEEecCCC
Q 042149          303 SRKLGQGGAGSVFRGTLPD--GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQH-KNVVRLLGCSIEGPESLLVYEYVPNR  379 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lV~e~~~~~  379 (625)
                      ++.|..|-...+|+....+  ++.+++|+....... .....+|+.+++.+.. .-.+++++...    -.+||||++|.
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~   77 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR   77 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence            3467778888999998764  678899976543222 1233578888888853 33445554432    24899999998


Q ss_pred             Ccchh-----------------hhccCCc--------CCCC-HHHHHHHH-------------------------HHHHH
Q 042149          380 SLDQI-----------------LFVKNTI--------HILS-WQQRFTII-------------------------CGTAE  408 (625)
Q Consensus       380 sL~~~-----------------l~~~~~~--------~~l~-~~~~~~i~-------------------------~~i~~  408 (625)
                      ++...                 ++.....        .... +..+..+.                         .+.+.
T Consensus        78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  157 (235)
T cd05157          78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS  157 (235)
T ss_pred             cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence            76421                 0111110        0111 22211211                         11111


Q ss_pred             HHH-HhhcC-CCceEEEeeeccCcEEEcC-CCceEEeecccce
Q 042149          409 GLA-HLHGG-SGIKIIHRDIKTSNILLDE-KLTPKIADFGLAR  448 (625)
Q Consensus       409 ~L~-~LH~~-~~~~iiHrDlkp~NIll~~-~~~~kl~Dfgla~  448 (625)
                      .|. .+... ....++|+|+++.|||+++ ++.+.|+||..+.
T Consensus       158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            111 11111 2457999999999999997 5789999999775

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.84  E-value=8.3e-05  Score=74.40  Aligned_cols=138  Identities=12%  Similarity=0.084  Sum_probs=78.8

Q ss_pred             cccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCce-eeeeeeeeeCCeeEEEEEecCCCCcch
Q 042149          305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNV-VRLLGCSIEGPESLLVYEYVPNRSLDQ  383 (625)
Q Consensus       305 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lV~e~~~~~sL~~  383 (625)
                      .+..|-.+.+|+... +++.+++|..........-...+|.++++.+....+ ++++....    -++||||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            356677889998874 567888887644332221235778999988864323 34444332    369999999977653


Q ss_pred             h-----------------hhccC-CcCCCCHHHH-HHHHHHH---------HHHHHHhhcC-----CCceEEEeeeccCc
Q 042149          384 I-----------------LFVKN-TIHILSWQQR-FTIICGT---------AEGLAHLHGG-----SGIKIIHRDIKTSN  430 (625)
Q Consensus       384 ~-----------------l~~~~-~~~~l~~~~~-~~i~~~i---------~~~L~~LH~~-----~~~~iiHrDlkp~N  430 (625)
                      .                 ++... ....++.... ..+..++         ...+..+-..     ....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 11111 0111222111 1111111         1112212111     12358999999999


Q ss_pred             EEEcCCCceEEeecccce
Q 042149          431 ILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       431 Ill~~~~~~kl~Dfgla~  448 (625)
                      |++++++ +.|+||+.+.
T Consensus       158 il~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             EEEeCCC-CEEEeccccC
Confidence            9999876 7899999775

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.70  E-value=0.00025  Score=74.75  Aligned_cols=76  Identities=18%  Similarity=0.230  Sum_probs=55.6

Q ss_pred             cccccccCceEEEEEEeCCC-CEEEEEEeecCC-------hHHHHHHHHHHHHHhcCC---CCceeeeeeeeeeCCeeEE
Q 042149          303 SRKLGQGGAGSVFRGTLPDG-RNIAVKRLFFNS-------RQWVDQFFNEVNLISGIQ---HKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~l  371 (625)
                      .+.||.|.+..||++...+| +.++||.-.+..       .-..+++..|.+.|+.+.   ..++++++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            35799999999999998776 589999753211       223567778888888763   3467888876  3456789


Q ss_pred             EEEecCCCC
Q 042149          372 VYEYVPNRS  380 (625)
Q Consensus       372 V~e~~~~~s  380 (625)
                      |||++++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.68  E-value=0.00014  Score=83.20  Aligned_cols=200  Identities=20%  Similarity=0.155  Sum_probs=138.6

Q ss_pred             HHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeE----EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHH
Q 042149          337 WVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL----LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH  412 (625)
Q Consensus       337 ~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~----lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~  412 (625)
                      .+...+-|+..+.++.|+|++.++.+..+.....    +..|++...++...++..+.   ++....+.+..++.+||.+
T Consensus       225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~---i~~~~~r~~~~~~~~GL~~  301 (1351)
T KOG1035|consen  225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS---IPLETLRILHQKLLEGLAY  301 (1351)
T ss_pred             HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc---cCHHHHHHHHHHHhhhHHH
Confidence            3445566778888999999999999887665444    34577888888877755443   7788888899999999999


Q ss_pred             hhcCCCceEEEeeeccC---cEEEcCCCceEEe--ecccceeeCCCCceeeecCCCCccccCccccccCccc--ccCcEE
Q 042149          413 LHGGSGIKIIHRDIKTS---NILLDEKLTPKIA--DFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLT--EKADVY  485 (625)
Q Consensus       413 LH~~~~~~iiHrDlkp~---NIll~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~Dv~  485 (625)
                      +|...   ..|.-|..+   +--.+..+.+.+.  ||+..+.........  ...-+..+.+||........  ...|+|
T Consensus       302 ~h~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~  376 (1351)
T KOG1035|consen  302 LHSLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLW  376 (1351)
T ss_pred             HHHhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHH
Confidence            99763   666655555   4455666777777  888877654333221  22345677788877665544  457999


Q ss_pred             eehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042149          486 AFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVV  565 (625)
Q Consensus       486 SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~  565 (625)
                      .+|.+...+..|..+.........                +++        ......+.....+|+..++++|++..+++
T Consensus       377 ~lgll~~~~~~~~~i~~~~~~~~~----------------~l~--------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll  432 (1351)
T KOG1035|consen  377 CLGLLLLQLSQGEDISEKSAVPVS----------------LLD--------VLSTSELLDALPKCLDEDSEERLSALELL  432 (1351)
T ss_pred             HHHHHHhhhhhcCcccccccchhh----------------hhc--------cccchhhhhhhhhhcchhhhhccchhhhh
Confidence            999999999998865432211110                001        01111466778899999999999999988


Q ss_pred             HHH
Q 042149          566 HML  568 (625)
Q Consensus       566 ~~L  568 (625)
                      ...
T Consensus       433 ~~~  435 (1351)
T KOG1035|consen  433 THP  435 (1351)
T ss_pred             hch
Confidence            654

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.68  E-value=0.00031  Score=71.85  Aligned_cols=142  Identities=16%  Similarity=0.165  Sum_probs=84.7

Q ss_pred             cccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCc--eeeeeee------eeeCCeeEEEEE
Q 042149          303 SRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKN--VVRLLGC------SIEGPESLLVYE  374 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~------~~~~~~~~lV~e  374 (625)
                      .+.|..|....+|+....+ ..+++|+....   ..+.+..|++++..+.+.+  +++++..      ....+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            5567778888999987644 46888987542   2345677888888775332  4444432      123456789999


Q ss_pred             ecCCCCcchh--------------hhccC----C----cCCCCHHHHH----------HHHHHHHHHHHHhhc----CCC
Q 042149          375 YVPNRSLDQI--------------LFVKN----T----IHILSWQQRF----------TIICGTAEGLAHLHG----GSG  418 (625)
Q Consensus       375 ~~~~~sL~~~--------------l~~~~----~----~~~l~~~~~~----------~i~~~i~~~L~~LH~----~~~  418 (625)
                      |++|..+...              ++...    .    .....|....          .....+...+.++..    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            9999776430              01000    0    0111221111          011112233344432    113


Q ss_pred             ceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          419 IKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       419 ~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      ..++|+|++|.||++++++.+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            469999999999999988777899999764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.55  E-value=0.0013  Score=68.16  Aligned_cols=142  Identities=15%  Similarity=0.181  Sum_probs=77.0

Q ss_pred             cccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCc--eeeeee------eeeeCCeeEEEEE
Q 042149          303 SRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKN--VVRLLG------CSIEGPESLLVYE  374 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~------~~~~~~~~~lV~e  374 (625)
                      .+.|+.|....+|+....+| .+++|+......   +.+..|+.++..|...+  +++++.      +....+..++++|
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            35567777789999887655 688998752222   33344555555553211  333332      1223556789999


Q ss_pred             ecCCCCcchh--------------hhccCC--------cCCCCH-HHHHH------------HHHH-HHHHHHHhhcC--
Q 042149          375 YVPNRSLDQI--------------LFVKNT--------IHILSW-QQRFT------------IICG-TAEGLAHLHGG--  416 (625)
Q Consensus       375 ~~~~~sL~~~--------------l~~~~~--------~~~l~~-~~~~~------------i~~~-i~~~L~~LH~~--  416 (625)
                      |++|..+...              ++....        ...+.| .....            .+.+ +...+..+...  
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            9999755310              111000        001112 11111            1111 11112222210  


Q ss_pred             --CCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          417 --SGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       417 --~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                        -..++||+|++|.||+++++...-|+||+.+.
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence              23469999999999999976556899999774

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.51  E-value=0.00044  Score=70.96  Aligned_cols=140  Identities=22%  Similarity=0.287  Sum_probs=82.9

Q ss_pred             ccccccCceEEEEEEeCC-------CCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCc-eeeeeeeeeeCCeeEEEEEe
Q 042149          304 RKLGQGGAGSVFRGTLPD-------GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKN-VVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lV~e~  375 (625)
                      +.|..|-...||+....+       ++.+++|+...... ......+|.++++.+...+ .+++++.+..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            345667777999988654       57889998654432 2335578888888885322 3455555432    368999


Q ss_pred             cCCCCcchh-----------------hhccCCcC------CCC--HHHHHHH--------------------------HH
Q 042149          376 VPNRSLDQI-----------------LFVKNTIH------ILS--WQQRFTI--------------------------IC  404 (625)
Q Consensus       376 ~~~~sL~~~-----------------l~~~~~~~------~l~--~~~~~~i--------------------------~~  404 (625)
                      ++|..+...                 ++......      ..+  +.....+                          ..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            999877531                 11111100      000  1111111                          11


Q ss_pred             HHHHHHHHhhc------CCCceEEEeeeccCcEEEcCC----CceEEeecccce
Q 042149          405 GTAEGLAHLHG------GSGIKIIHRDIKTSNILLDEK----LTPKIADFGLAR  448 (625)
Q Consensus       405 ~i~~~L~~LH~------~~~~~iiHrDlkp~NIll~~~----~~~kl~Dfgla~  448 (625)
                      .+...+..|..      .....++|+|+.|.||+++++    +.+.|+||..+.
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            12222333331      135679999999999999974    789999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.51  E-value=0.00098  Score=67.84  Aligned_cols=140  Identities=19%  Similarity=0.202  Sum_probs=85.1

Q ss_pred             cccccccccCceEEEEEEeCCCCEEEEEEee-cCChHHHHHHHHHHHHHhcCCC--CceeeeeeeeeeCC--eeEEEEEe
Q 042149          301 DNSRKLGQGGAGSVFRGTLPDGRNIAVKRLF-FNSRQWVDQFFNEVNLISGIQH--KNVVRLLGCSIEGP--ESLLVYEY  375 (625)
Q Consensus       301 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~--~~~lV~e~  375 (625)
                      .+++.+..|..-.+|..... ++.+++.+.. ...........+|.++++.+.-  --+...++.+.++.  ..+.||+|
T Consensus        28 ~~v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~  106 (321)
T COG3173          28 LIVEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW  106 (321)
T ss_pred             ceeeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence            44455544554555655544 7778888221 1223344566778888887743  33455666676665  77999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHH-HHHHHHHHHhhc---------------------------------------
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTII-CGTAEGLAHLHG---------------------------------------  415 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~-~~i~~~L~~LH~---------------------------------------  415 (625)
                      ++|..+...+.....      .  ..++ ..+++.|..||+                                       
T Consensus       107 veGe~~~~~~~~~~~------~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p  178 (321)
T COG3173         107 VEGEVVWSALPPESL------G--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP  178 (321)
T ss_pred             ecceeccCcCCcccc------h--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence            998544332211100      0  0111 133333333332                                       


Q ss_pred             ----------------CCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          416 ----------------GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       416 ----------------~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                                      .+...++|+|+++.||++++++-+-|+||+++..
T Consensus       179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence                            2234699999999999999888899999999864

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.44  E-value=0.0017  Score=66.90  Aligned_cols=155  Identities=15%  Similarity=0.171  Sum_probs=86.8

Q ss_pred             HHHHHHhcCccc-----cccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCc--eeeeeee-
Q 042149          291 EILERATDFFDN-----SRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKN--VVRLLGC-  362 (625)
Q Consensus       291 ~~~~~~~~~y~~-----~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~-  362 (625)
                      +.+...-+.|.+     .+.++.|....+|+....++ .+++|+......  .+.+..|++++..|...+  +++++.. 
T Consensus        10 ~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~   86 (307)
T TIGR00938        10 EEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSR   86 (307)
T ss_pred             HHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCC
Confidence            444444445543     45677777789999876554 577887654321  234456677777664222  3444332 


Q ss_pred             -----eeeCCeeEEEEEecCCCCcchh--------------hhccCCc---------CCCCHHHHHH------------H
Q 042149          363 -----SIEGPESLLVYEYVPNRSLDQI--------------LFVKNTI---------HILSWQQRFT------------I  402 (625)
Q Consensus       363 -----~~~~~~~~lV~e~~~~~sL~~~--------------l~~~~~~---------~~l~~~~~~~------------i  402 (625)
                           ....+..++++||++|..+...              ++.....         ....|.....            .
T Consensus        87 ~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~  166 (307)
T TIGR00938        87 DGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHM  166 (307)
T ss_pred             CCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHH
Confidence                 1224567899999998654311              1110000         0011211110            0


Q ss_pred             HHHHHHHHHHhhc----CCCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          403 ICGTAEGLAHLHG----GSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       403 ~~~i~~~L~~LH~----~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      ...+...++++..    .....++|+|+++.||++++++.+.|+||+.+.
T Consensus       167 ~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       167 GAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            1112233444432    123579999999999999988777899999764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PLN02236 choline kinase

Probab=97.31  E-value=0.0014  Score=68.52  Aligned_cols=140  Identities=24%  Similarity=0.345  Sum_probs=82.1

Q ss_pred             cccccCceEEEEEEeCC-----CCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCce-eeeeeeeeeCCeeEEEEEecCC
Q 042149          305 KLGQGGAGSVFRGTLPD-----GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNV-VRLLGCSIEGPESLLVYEYVPN  378 (625)
Q Consensus       305 ~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lV~e~~~~  378 (625)
                      .|-.|-...+|+....+     ++.+++|+........+++ .+|..+++.+..-++ +++++.+...    .|.||+++
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g  117 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHA  117 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCC
Confidence            35456677888886432     3678889776554443443 679999888854333 3556655332    58999988


Q ss_pred             CCcchh-----------------hhccC-C--cCCCCHHHHHHHHHHH-----------------H---HHHH-Hhhc-C
Q 042149          379 RSLDQI-----------------LFVKN-T--IHILSWQQRFTIICGT-----------------A---EGLA-HLHG-G  416 (625)
Q Consensus       379 ~sL~~~-----------------l~~~~-~--~~~l~~~~~~~i~~~i-----------------~---~~L~-~LH~-~  416 (625)
                      .+|...                 ++... +  .....+.++.++..++                 .   ..|+ .+.. .
T Consensus       118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~  197 (344)
T PLN02236        118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD  197 (344)
T ss_pred             CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence            777521                 11111 0  0011233333333221                 1   1111 1221 2


Q ss_pred             CCceEEEeeeccCcEEEcC-CCceEEeeccccee
Q 042149          417 SGIKIIHRDIKTSNILLDE-KLTPKIADFGLARH  449 (625)
Q Consensus       417 ~~~~iiHrDlkp~NIll~~-~~~~kl~Dfgla~~  449 (625)
                      ....++|+|+++.||++++ ++.+.|+||..+..
T Consensus       198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            2457999999999999986 46899999998753

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.27  E-value=0.0021  Score=64.92  Aligned_cols=70  Identities=14%  Similarity=0.074  Sum_probs=41.1

Q ss_pred             ccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCC-C-C-ceeeeeeeeeeCCeeEEEEEecCCCCc
Q 042149          306 LGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-H-K-NVVRLLGCSIEGPESLLVYEYVPNRSL  381 (625)
Q Consensus       306 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-p-niv~l~~~~~~~~~~~lV~e~~~~~sL  381 (625)
                      .++|....|+.....+|+.+++|.-.  .......+.+|+++|+.+. + | -+++++.  .  ..-.++|++++|..+
T Consensus        19 ~~~g~~~~v~~i~~~~g~~~VlR~p~--~~~~~~~l~rE~~vL~~L~~~l~vpvP~~~~--~--~~~~~~y~~i~G~p~   91 (276)
T cd05152          19 NESGLDFQVVFAKDTDGVPWVLRIPR--RPDVSERAAAEKRVLALVRKHLPVQVPDWRV--H--TPELIAYPKLPGVPA   91 (276)
T ss_pred             cCCcceeEEEEEEcCCCCeEEEEecC--CHHHHHHHHHHHHHHHHHHhcCCCCCCceee--e--cCceEEEeccCCCcc
Confidence            34444455665555568899999764  3333466889999999885 2 2 1122221  1  123567777777554

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.21  E-value=0.0003  Score=70.09  Aligned_cols=133  Identities=17%  Similarity=0.259  Sum_probs=91.6

Q ss_pred             ccccccccccCceEEEEEEeCCCCEEEEEEeecC---------Ch---------HH--H--HHHHHHHHHHhcCCCC--c
Q 042149          300 FDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFN---------SR---------QW--V--DQFFNEVNLISGIQHK--N  355 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~---------~~---------~~--~--~~~~~E~~~l~~l~hp--n  355 (625)
                      +.+.+.||-|.-+.||.+...+|++.++|.-...         .+         .|  +  -...+|...|+.|...  -
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            6778999999999999999999999999843211         11         11  1  1245688888888532  2


Q ss_pred             eeeeeeeeeeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC
Q 042149          356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE  435 (625)
Q Consensus       356 iv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~  435 (625)
                      +++.++    .+..++|||++.|-.|...-+.      .+...+..-+..+   +--|-.+   ++||+|..--||+|++
T Consensus       174 VPkpiD----~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~---Iv~la~~---GlIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  174 VPKPID----HNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGL---IVRLANH---GLIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCCccc----ccceeeHHHhhcccceeeeeec------CChHHHHHHHHHH---HHHHHHc---CceecccchheeEEec
Confidence            445554    3567899999999888664322      2333433333333   3334433   5999999999999999


Q ss_pred             CCceEEeecccce
Q 042149          436 KLTPKIADFGLAR  448 (625)
Q Consensus       436 ~~~~kl~Dfgla~  448 (625)
                      ++.++++||--..
T Consensus       238 d~~i~vIDFPQmv  250 (465)
T KOG2268|consen  238 DDKIVVIDFPQMV  250 (465)
T ss_pred             CCCEEEeechHhh
Confidence            9999999997443

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.11  E-value=0.0043  Score=62.79  Aligned_cols=73  Identities=16%  Similarity=0.205  Sum_probs=48.6

Q ss_pred             cccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCC---CCceeeeeeeeeeCCeeEEEEEecCCC
Q 042149          303 SRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ---HKNVVRLLGCSIEGPESLLVYEYVPNR  379 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lV~e~~~~~  379 (625)
                      .+.|+.|....+|+.. .+++.+.||.-.   ......|..|.+-|+.|.   .-.+++++++....+..+|||||++.+
T Consensus        22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             eEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            5568889999999987 567889999775   223356788888888883   446888999888888889999999776

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.88  E-value=0.0095  Score=62.72  Aligned_cols=73  Identities=11%  Similarity=0.133  Sum_probs=51.3

Q ss_pred             cccccccCceEEEEEEeCCCCEEEEEEeecCC-------hHHHHHHHHHHHHHhcCC---CCceeeeeeeeeeCCeeEEE
Q 042149          303 SRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS-------RQWVDQFFNEVNLISGIQ---HKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lV  372 (625)
                      .+.||.|....||+.... ++.++||+-....       +...++-..|++.|+.+.   ..++++++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            557899999999998864 5679999765211       113445555677776653   357888888776  456889


Q ss_pred             EEecCC
Q 042149          373 YEYVPN  378 (625)
Q Consensus       373 ~e~~~~  378 (625)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.77  E-value=0.0077  Score=62.27  Aligned_cols=72  Identities=19%  Similarity=0.175  Sum_probs=49.3

Q ss_pred             cccccCceEEEEEEeCCC-CEEEEEEeec-------CChHHHHHHHHHHHHHhcCC--CC-ceeeeeeeeeeCCeeEEEE
Q 042149          305 KLGQGGAGSVFRGTLPDG-RNIAVKRLFF-------NSRQWVDQFFNEVNLISGIQ--HK-NVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       305 ~lG~G~~g~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--hp-niv~l~~~~~~~~~~~lV~  373 (625)
                      .||.|-...||++..++| +.|+||.-.+       ..+-..++..-|.+.|+...  -| .+++++.  .+.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            589999999999998654 6899996532       11333456667777777653  34 4666664  3455667999


Q ss_pred             EecCC
Q 042149          374 EYVPN  378 (625)
Q Consensus       374 e~~~~  378 (625)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99855

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.74  E-value=0.016  Score=59.67  Aligned_cols=32  Identities=22%  Similarity=0.294  Sum_probs=28.4

Q ss_pred             CceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       418 ~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      +.+++|+|+.++||++++++.+.|+||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            45799999999999999998999999997753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.72  E-value=0.0067  Score=63.05  Aligned_cols=141  Identities=16%  Similarity=0.234  Sum_probs=80.4

Q ss_pred             ccccccCceEEEEEEeCC----CCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCce-eeeeeeeeeCCeeEEEEEecCC
Q 042149          304 RKLGQGGAGSVFRGTLPD----GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNV-VRLLGCSIEGPESLLVYEYVPN  378 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lV~e~~~~  378 (625)
                      +.|..|-...+|+....+    +..|++|+........++ -.+|..+++.+..-++ +++++++.. .   +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~Id-R~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVID-RERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEec-hHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcC
Confidence            345556677888886432    347888877655443332 3678888888864444 455655532 2   58999988


Q ss_pred             CCcchh-----------------hhccC-Cc-C-CCCHHHHHHHHHHH-------------------------HHHHHHh
Q 042149          379 RSLDQI-----------------LFVKN-TI-H-ILSWQQRFTIICGT-------------------------AEGLAHL  413 (625)
Q Consensus       379 ~sL~~~-----------------l~~~~-~~-~-~l~~~~~~~i~~~i-------------------------~~~L~~L  413 (625)
                      .+|...                 ++... +. . ...|..+.++..++                         +..+..+
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            776321                 11111 00 0 11233332322221                         1111212


Q ss_pred             h-c-CCCceEEEeeeccCcEEEcC-CCceEEeeccccee
Q 042149          414 H-G-GSGIKIIHRDIKTSNILLDE-KLTPKIADFGLARH  449 (625)
Q Consensus       414 H-~-~~~~~iiHrDlkp~NIll~~-~~~~kl~Dfgla~~  449 (625)
                      . . ..+..++|.||.+.|||+++ ++.++++||..|..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            1 1 12346899999999999974 57899999998753

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.66  E-value=0.016  Score=59.19  Aligned_cols=139  Identities=16%  Similarity=0.129  Sum_probs=92.0

Q ss_pred             ccccccccCceEEEEEEeCCCCEEEEEEeecC-----C--------------------hHH-HHHHHHHHHHHhcCCCCc
Q 042149          302 NSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFN-----S--------------------RQW-VDQFFNEVNLISGIQHKN  355 (625)
Q Consensus       302 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-----~--------------------~~~-~~~~~~E~~~l~~l~hpn  355 (625)
                      +..-|..|.-..||.|...+|..+|||+.+-.     +                    +.. .-....|++.|++|....
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            44457889999999999999999999976311     1                    111 224567888888887555


Q ss_pred             eeeeeeeeeeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC
Q 042149          356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE  435 (625)
Q Consensus       356 iv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~  435 (625)
                      |+-.--+..  ....|||+|+.. +-  +-...-..-.++...+...-.+++.-+.-|-+.+  ++||.||.--|+|+-+
T Consensus       228 IP~PePIlL--k~hVLVM~FlGr-dg--w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd  300 (520)
T KOG2270|consen  228 IPCPEPILL--KNHVLVMEFLGR-DG--WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD  300 (520)
T ss_pred             CCCCCceee--ecceEeeeeccC-CC--CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC
Confidence            432211111  235799999943 21  1111122223666677777777777777776655  6999999999999864


Q ss_pred             CCceEEeecccce
Q 042149          436 KLTPKIADFGLAR  448 (625)
Q Consensus       436 ~~~~kl~Dfgla~  448 (625)
                       |.+.|+|-+-+.
T Consensus       301 -G~lyiIDVSQSV  312 (520)
T KOG2270|consen  301 -GKLYIIDVSQSV  312 (520)
T ss_pred             -CEEEEEEccccc
Confidence             589999987554

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.65  E-value=0.0038  Score=60.38  Aligned_cols=123  Identities=18%  Similarity=0.171  Sum_probs=60.4

Q ss_pred             CCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCce-eeeeeeeeeCCeeEEEEEecCCCCcchh-h--------------
Q 042149          322 GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNV-VRLLGCSIEGPESLLVYEYVPNRSLDQI-L--------------  385 (625)
Q Consensus       322 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lV~e~~~~~sL~~~-l--------------  385 (625)
                      ++.|+|++........ -.-.+|..+++.+..-++ +++++.+.+    ..|.||+++.+|... +              
T Consensus         2 ~~~~~~Ri~g~~t~~~-idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~   76 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENF-IDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA   76 (211)
T ss_dssp             TSEEEEEEEESCGCSH-HHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCcccc-cCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence            4678888876664333 345778888888864333 556665433    267799977665321 0              


Q ss_pred             --hcc----CCcCCCCHHHHHHH----------------------HHHHHHHHHHhh----c-CCCceEEEeeeccCcEE
Q 042149          386 --FVK----NTIHILSWQQRFTI----------------------ICGTAEGLAHLH----G-GSGIKIIHRDIKTSNIL  432 (625)
Q Consensus       386 --~~~----~~~~~l~~~~~~~i----------------------~~~i~~~L~~LH----~-~~~~~iiHrDlkp~NIl  432 (625)
                        +..    ......-|.....+                      +..+..-+..+.    . .....++|.||.|.|||
T Consensus        77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil  156 (211)
T PF01633_consen   77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL  156 (211)
T ss_dssp             HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred             HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence              000    00000112222222                      001111112111    1 11356899999999999


Q ss_pred             E-cCCCceEEeeccccee
Q 042149          433 L-DEKLTPKIADFGLARH  449 (625)
Q Consensus       433 l-~~~~~~kl~Dfgla~~  449 (625)
                      + +.++.++|+||..+..
T Consensus       157 ~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  157 INNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             ETSSSSCEEE--GTT-EE
T ss_pred             eccCCCeEEEecHHHHhh
Confidence            9 7888999999998753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.43  E-value=0.0072  Score=63.25  Aligned_cols=74  Identities=15%  Similarity=0.104  Sum_probs=51.2

Q ss_pred             cccccccCceEEEEEEeCC-CCEEEEEEeec------CChHHHHHHHHHHHHHhcCC--CC-ceeeeeeeeeeCCeeEEE
Q 042149          303 SRKLGQGGAGSVFRGTLPD-GRNIAVKRLFF------NSRQWVDQFFNEVNLISGIQ--HK-NVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~--hp-niv~l~~~~~~~~~~~lV  372 (625)
                      .+.||.|--..||++.+++ ++.|+||.-.+      ..+-..++..-|.+.|+.+.  -| .+++++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            4578999999999999753 57899996532      12333566677888887663  33 56667653  45566789


Q ss_pred             EEecCC
Q 042149          373 YEYVPN  378 (625)
Q Consensus       373 ~e~~~~  378 (625)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998854

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.42  E-value=0.0002  Score=83.77  Aligned_cols=160  Identities=12%  Similarity=-0.025  Sum_probs=111.6

Q ss_pred             HHHHHHHHhcCCCCceeeeeeeee--eCCeeEEEEEecCCCCcchhhhccCCc-CCCCHHHHHHHHHHHHHHHHHhhcC-
Q 042149          341 FFNEVNLISGIQHKNVVRLLGCSI--EGPESLLVYEYVPNRSLDQILFVKNTI-HILSWQQRFTIICGTAEGLAHLHGG-  416 (625)
Q Consensus       341 ~~~E~~~l~~l~hpniv~l~~~~~--~~~~~~lV~e~~~~~sL~~~l~~~~~~-~~l~~~~~~~i~~~i~~~L~~LH~~-  416 (625)
                      ...|..-++...|+++.....-..  +..+.+.+++|+.+|.+.+.+-..... ..+...-....-.+.+....-+|.. 
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            334555566678999887765443  345678999999999998887544222 2222222222222224444454432 


Q ss_pred             -CCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHH
Q 042149          417 -SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVA  495 (625)
Q Consensus       417 -~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ell  495 (625)
                       ...--+|++||+-|.+|..+.++|+.++|+.+.... .........+++-|+.|++...-+++.++|+|..|+.+|+.-
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence             233478999999999999999999999999983322 222223456888999999999999999999999999999998


Q ss_pred             hCCCCC
Q 042149          496 SGRRNS  501 (625)
Q Consensus       496 tG~~p~  501 (625)
                      -|..++
T Consensus      1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred             cccHHH
Confidence            887664

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.06  E-value=0.059  Score=55.59  Aligned_cols=140  Identities=24%  Similarity=0.339  Sum_probs=80.0

Q ss_pred             cccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCc------eeeeee----eeeeCCeeEEEEE
Q 042149          305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKN------VVRLLG----CSIEGPESLLVYE  374 (625)
Q Consensus       305 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~l~~----~~~~~~~~~lV~e  374 (625)
                      .|.+ .-..||+....+|+. ++|.....  ....++..|+..|..|.-..      +..+=|    ........+-+++
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~  108 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE  108 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence            3444 456789998877776 88887665  22345667777777774211      222222    1111247889999


Q ss_pred             ecCCCCcch-hh--------------hcc---------CCcCCCCHHH----H---------HHHHHHHHHHHHHhhcC-
Q 042149          375 YVPNRSLDQ-IL--------------FVK---------NTIHILSWQQ----R---------FTIICGTAEGLAHLHGG-  416 (625)
Q Consensus       375 ~~~~~sL~~-~l--------------~~~---------~~~~~l~~~~----~---------~~i~~~i~~~L~~LH~~-  416 (625)
                      |++|..+.. ..              +..         .......|..    .         .....++...+..+... 
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            999988872 11              100         0111233330    0         01112222333333221 


Q ss_pred             ---CC---ceEEEeeeccCcEEEcCCCc-eEEeecccce
Q 042149          417 ---SG---IKIIHRDIKTSNILLDEKLT-PKIADFGLAR  448 (625)
Q Consensus       417 ---~~---~~iiHrDlkp~NIll~~~~~-~kl~Dfgla~  448 (625)
                         -.   ..+||+|+.|.||+++.+.. +-++|||-+.
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence               11   12999999999999998874 8999999764

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.86  E-value=0.023  Score=57.92  Aligned_cols=74  Identities=19%  Similarity=0.203  Sum_probs=58.9

Q ss_pred             CCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecc
Q 042149          366 GPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFG  445 (625)
Q Consensus       366 ~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfg  445 (625)
                      ....|++|++. |++|.-.       ....+.+...++.+.+..+.-+..+-  +.-|||+.-.||||+ +|+|.|+||-
T Consensus       298 ~~y~yl~~kdh-gt~is~i-------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfk  366 (488)
T COG5072         298 TLYLYLHFKDH-GTPISII-------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFK  366 (488)
T ss_pred             ceEEEEEEecC-Cceeeee-------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEee
Confidence            33567888876 5555432       12578899999999988888887654  799999999999999 8999999999


Q ss_pred             cceee
Q 042149          446 LARHV  450 (625)
Q Consensus       446 la~~~  450 (625)
                      +++.-
T Consensus       367 lsRl~  371 (488)
T COG5072         367 LSRLS  371 (488)
T ss_pred             eeecc
Confidence            99853

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.86  E-value=0.14  Score=52.56  Aligned_cols=29  Identities=28%  Similarity=0.367  Sum_probs=25.3

Q ss_pred             ceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          419 IKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       419 ~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      .+++|+|+++.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            46999999999999987 578999999654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.73  E-value=0.035  Score=52.77  Aligned_cols=116  Identities=16%  Similarity=0.152  Sum_probs=72.4

Q ss_pred             cCceEEEEEEeCCCCEEEEEEeecCChH-HHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCCCcchhhhc
Q 042149          309 GGAGSVFRGTLPDGRNIAVKRLFFNSRQ-WVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFV  387 (625)
Q Consensus       309 G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~  387 (625)
                      |+..+.-.+..+- .+..+|++....-. -...|.++.++++++.  .|+++..-  +.-...++.|+|..-..      
T Consensus        73 ~gNsTl~~~kt~i-G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKI-GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------  141 (308)
T ss_pred             CCceEEEEecccc-chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence            4445555554433 34456666432211 2345678888888774  67777632  23345688998843111      


Q ss_pred             cCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccc
Q 042149          388 KNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGL  446 (625)
Q Consensus       388 ~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgl  446 (625)
                            ..    ..++..=+..|.-.|+. ..+.+|+|..|+||+-|..|.+||.|=+.
T Consensus       142 ------~~----~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  142 ------NF----SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             ------ch----hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhh
Confidence                  11    12222225678888954 34799999999999999999999999774

The function of this family is unknown.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.72  E-value=0.14  Score=53.14  Aligned_cols=72  Identities=15%  Similarity=0.078  Sum_probs=44.6

Q ss_pred             cCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCc--eee---eee--eeeeCCeeEEEEEecCCCCc
Q 042149          309 GGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKN--VVR---LLG--CSIEGPESLLVYEYVPNRSL  381 (625)
Q Consensus       309 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~---l~~--~~~~~~~~~lV~e~~~~~sL  381 (625)
                      +.-..||+...++++.+++|...... .....+..|++.+..|....  ++.   .-|  ....++..+.++++++|...
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            34467999988788889999775332 22345667777777664211  222   112  12234567889999988654

>PRK06148 hypothetical protein; Provisional

Probab=95.57  E-value=0.12  Score=61.79  Aligned_cols=141  Identities=19%  Similarity=0.225  Sum_probs=78.5

Q ss_pred             ccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCC-------CCceeeee-ee----eee-CC--e
Q 042149          304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-------HKNVVRLL-GC----SIE-GP--E  368 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-------hpniv~l~-~~----~~~-~~--~  368 (625)
                      +.|+ |..-.+|+....+|+.+++|+.......  .....|.+.|..|.       -|.+++.. |-    ... +.  .
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            4564 4567889998878889999998754322  23344555555442       23333322 11    111 12  4


Q ss_pred             eEEEEEecCCCCcchhh-----------------h----ccC---CcCCCCHHH-----------------HHHHHHHHH
Q 042149          369 SLLVYEYVPNRSLDQIL-----------------F----VKN---TIHILSWQQ-----------------RFTIICGTA  407 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l-----------------~----~~~---~~~~l~~~~-----------------~~~i~~~i~  407 (625)
                      .+-+++|++|..|.+..                 +    .-.   ....+.|..                 ...++.++.
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            67789999998775410                 0    000   011122321                 112222333


Q ss_pred             HHHH-----HhhcCCCceEEEeeeccCcEEEcCCC--ceE-Eeecccce
Q 042149          408 EGLA-----HLHGGSGIKIIHRDIKTSNILLDEKL--TPK-IADFGLAR  448 (625)
Q Consensus       408 ~~L~-----~LH~~~~~~iiHrDlkp~NIll~~~~--~~k-l~Dfgla~  448 (625)
                      +.+.     .+. .-+..+||.|+++.|||++.++  .+. |+|||.+.
T Consensus       188 ~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        188 ARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             HHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            3222     121 1134699999999999999775  555 99999775

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.56  E-value=0.12  Score=49.62  Aligned_cols=75  Identities=21%  Similarity=0.288  Sum_probs=53.3

Q ss_pred             ccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCC---CCceeeeeeeeeeCCeeEEEEEecCCCC
Q 042149          304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ---HKNVVRLLGCSIEGPESLLVYEYVPNRS  380 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lV~e~~~~~s  380 (625)
                      +++.-|.--..|...+ ...++-||+-   .++....|..|+.-|..|.   .-++++++.+.......|+||||++-+.
T Consensus        22 ~~v~gG~inea~~v~d-g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~   97 (286)
T COG3001          22 EEVSGGDINEAWRLRD-GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP   97 (286)
T ss_pred             cccCCccccceeEeec-CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence            3455555555555543 3467888853   4445567888887777664   4567888999999999999999999877


Q ss_pred             cc
Q 042149          381 LD  382 (625)
Q Consensus       381 L~  382 (625)
                      ++
T Consensus        98 ~d   99 (286)
T COG3001          98 LD   99 (286)
T ss_pred             CC
Confidence            76

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=95.41  E-value=0.015  Score=61.77  Aligned_cols=48  Identities=25%  Similarity=0.345  Sum_probs=37.3

Q ss_pred             HHHHHHHHHhcCCCCceeeeeeeeeeCC-eeEEEEEecCCCCcchhhhcc
Q 042149          340 QFFNEVNLISGIQHKNVVRLLGCSIEGP-ESLLVYEYVPNRSLDQILFVK  388 (625)
Q Consensus       340 ~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lV~e~~~~~sL~~~l~~~  388 (625)
                      ++.-...+++.++|+|+...+++..... ...+|||++ +.+|++.+..+
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~   76 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG   76 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence            4556678899999999999998776443 467899988 77999887543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	625
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-49
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		8e-49
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-41
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-40
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-35
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-34
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-34
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-32
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-25
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		9e-25
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-22
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-21
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-21
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-21
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-21
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-21
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-21
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-21
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-21
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-21
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-21
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-21
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-21
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		9e-21
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		9e-21
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-19
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-19
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-19
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-19
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-19
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-19
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-19
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-19
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-19
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-19
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-19
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-19
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-19
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-19
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-19
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-19
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-19
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-19
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-19
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-19
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-19
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-19
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-19
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-19
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-19
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-19
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-19
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-19
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-19
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-19
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-19
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-19
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-19
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-19
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-19
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		7e-19
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-19
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-19
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		8e-19
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		9e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		9e-19
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-18
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-18
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-18
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-18
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-18
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-18
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-18
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-18
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-18
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-18
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-18
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-18
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-18
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-18
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-18
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-18
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-18
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-18
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		6e-18
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		6e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-18
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		7e-18
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		7e-18
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		7e-18
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		7e-18
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		7e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-18
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		8e-18
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		8e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-18
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-18
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-18
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		9e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		9e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-17
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-17
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-17
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-17
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-17
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-17
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-17
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-17
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-17
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		7e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		8e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		8e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		9e-17
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-16
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-16
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-16
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-16
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-16
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-16
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-16
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-16
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-16
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-16
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-16
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		7e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-16
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		8e-16
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		8e-16
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		9e-16
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-16
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-15
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-15
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-15
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-15
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-15
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-15
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-15
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-15
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-15
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-15
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-15
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-15
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-15
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-15
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-15
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		7e-15
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		7e-15
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-15
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-15
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		8e-15
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-15
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		8e-15
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		8e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		9e-15
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		9e-15
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-14
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-14
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-14
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-14
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-14
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-14
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-14
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-14
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-14
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-14
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-14
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-14
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-14
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-14
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-14
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-14
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-14
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-14
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-14
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-14
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-14
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-14
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-14
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-14
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-14
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-14
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-14
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-14
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-14
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-14
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-14
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-14
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-14
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-14
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-14
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-14
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-14
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-14
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-14
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-14
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-14
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-14
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-14
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-14
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-14
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-14
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-14
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-14
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		7e-14
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		8e-14
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		9e-14
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		9e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-13
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-13
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-13
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-13
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-13
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-13
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-13
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-13
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-13
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-13
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-13
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-13
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-13
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-13
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-13
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		6e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		7e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		7e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-13
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		7e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-13
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		8e-13
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		8e-13
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		8e-13
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-13
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		9e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-13
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-12
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-12
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-12
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-12
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-12
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-12
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-12
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-12
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-12
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-12
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-12
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-12
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-12
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-12
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-12
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-12
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-12
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-12
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-12
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-12
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-12
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-12
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		5e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-12
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-12
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		6e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		7e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		8e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-12
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		8e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		9e-12
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		9e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-12
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		9e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		9e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-12
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-11
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-11
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-11
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-11
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-11
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-11
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-11
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-11
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-11
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		4e-11
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		5e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-11
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		6e-11
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		6e-11
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-11
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		7e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		7e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		7e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		8e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		8e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		8e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		8e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		8e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		9e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		9e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		9e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-10
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-10
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-10
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-10
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		6e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		7e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		7e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		7e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		7e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		7e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		7e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		7e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		8e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		8e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		8e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		8e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		8e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		9e-10
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		9e-10
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-09
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-09
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-09
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-09
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		6e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		7e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		7e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		7e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		8e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		9e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		9e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-08
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-08
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-08
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-08
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-08
3soa_A	444	Full-Length Human Camkii Length = 444		2e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-08
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-08
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		8e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		9e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		9e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		9e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		9e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-07
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-07
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-07
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-07
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-07
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-07
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-07
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-07
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-07
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-07
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-07
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-07
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-07
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		4e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-07
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		5e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-07
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-07
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		7e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		7e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		7e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		7e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		7e-07
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		7e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		8e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		8e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		8e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		9e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-06
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-06
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-06
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		4e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		6e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		8e-06
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		9e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-05
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-05
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-05
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		6e-05
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		6e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		7e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		9e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-04
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-04
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-04
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-04
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-04
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-04
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-04
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-04
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-04
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-04
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  194 bits (493), Expect = 1e-49,   Method: Compositional matrix adjust.
 Identities = 112/288 (38%), Positives = 166/288 (57%), Gaps = 6/288 (2%)
Query: 288 FKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVD-QFFNEVN 346
           F    L+ A+D F N   LG+GG G V++G L DG  +AVKRL     Q  + QF  EV 
Sbjct: 28  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVE 87
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVK-NTIHILSWQQRFTIICG 405
           +IS   H+N++RL G  +   E LLVY Y+ N S+   L  +  +   L W +R  I  G
Sbjct: 88  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 147
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTL 465
           +A GLA+LH     KIIHRD+K +NILLDE+    + DFGLA+ +     HV   + GT+
Sbjct: 148 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTI 207
Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRR----NSVFSEGSSSVLHTVWKHYKAN 521
           G++APEYL  G+ +EK DV+ +GV+++E+ +G+R      + ++    +L  V    K  
Sbjct: 208 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 267
Query: 522 RITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLN 569
           ++   +D  L G + + E  +++Q+ LLCTQ+    RP M+EVV ML 
Sbjct: 268 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  191 bits (486), Expect = 8e-49,   Method: Compositional matrix adjust.
 Identities = 111/288 (38%), Positives = 165/288 (57%), Gaps = 6/288 (2%)
Query: 288 FKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVD-QFFNEVN 346
           F    L+ A+D F N   LG+GG G V++G L DG  +AVKRL     Q  + QF  EV 
Sbjct: 20  FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVE 79
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVK-NTIHILSWQQRFTIICG 405
           +IS   H+N++RL G  +   E LLVY Y+ N S+   L  +  +   L W +R  I  G
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTL 465
           +A GLA+LH     KIIHRD+K +NILLDE+    + DFGLA+ +     HV   + G +
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXI 199
Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRR----NSVFSEGSSSVLHTVWKHYKAN 521
           G++APEYL  G+ +EK DV+ +GV+++E+ +G+R      + ++    +L  V    K  
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259
Query: 522 RITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLN 569
           ++   +D  L G + + E  +++Q+ LLCTQ+    RP M+EVV ML 
Sbjct: 260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  168 bits (425), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 103/280 (36%), Positives = 158/280 (56%), Gaps = 7/280 (2%)
Query: 293 LERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ 352
           LE AT+ FD+   +G G  G V++G L DG  +A+KR    S Q +++F  E+  +S  +
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI-LSWQQRFTIICGTAEGLA 411
           H ++V L+G   E  E +L+Y+Y+ N +L + L+  +   + +SW+QR  I  G A GL 
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH-VAPDKTHVSTGIAGTLGYMAP 470
           +LH  +   IIHRD+K+ NILLDE   PKI DFG+++     D+TH+   + GTLGY+ P
Sbjct: 154 YLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDP 210
Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVW--KHYKANRITQSMD 528
           EY ++G+LTEK+DVY+FGV++ EV   R   V S     V    W  + +   ++ Q +D
Sbjct: 211 EYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270
Query: 529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHML 568
           P L  +       +     + C       RPSM +V+  L
Sbjct: 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  164 bits (416), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 102/280 (36%), Positives = 157/280 (56%), Gaps = 7/280 (2%)
Query: 293 LERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ 352
           LE AT+ FD+   +G G  G V++G L DG  +A+KR    S Q +++F  E+  +S  +
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI-LSWQQRFTIICGTAEGLA 411
           H ++V L+G   E  E +L+Y+Y+ N +L + L+  +   + +SW+QR  I  G A GL 
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH-VAPDKTHVSTGIAGTLGYMAP 470
           +LH  +   IIHRD+K+ NILLDE   PKI DFG+++      +TH+   + GTLGY+ P
Sbjct: 154 YLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDP 210
Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVW--KHYKANRITQSMD 528
           EY ++G+LTEK+DVY+FGV++ EV   R   V S     V    W  + +   ++ Q +D
Sbjct: 211 EYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270
Query: 529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHML 568
           P L  +       +     + C       RPSM +V+  L
Sbjct: 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  145 bits (366), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 91/224 (40%), Positives = 132/224 (58%), Gaps = 20/224 (8%)
Query: 287 NFKYEILERATDFFDN------SRKLGQGGAGSVFRGTLPDGRNIAVKRLF----FNSRQ 336
           +F +  L+  T+ FD         K+G+GG G V++G + +   +AVK+L       + +
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 337 WVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSW 396
              QF  E+ +++  QH+N+V LLG S +G +  LVY Y+PN SL   L   +    LSW
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 397 QQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK-- 454
             R  I  G A G+  LH       IHRDIK++NILLDE  T KI+DFGLAR  A +K  
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR--ASEKFA 187
Query: 455 -THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
            T + + I GT  YMAPE L RG++T K+D+Y+FGV+++E+ +G
Sbjct: 188 QTVMXSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITG 230

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  144 bits (364), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 91/224 (40%), Positives = 131/224 (58%), Gaps = 20/224 (8%)
Query: 287 NFKYEILERATDFFDN------SRKLGQGGAGSVFRGTLPDGRNIAVKRLF----FNSRQ 336
           +F +  L+  T+ FD         K+G+GG G V++G + +   +AVK+L       + +
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 337 WVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSW 396
              QF  E+ +++  QH+N+V LLG S +G +  LVY Y+PN SL   L   +    LSW
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 397 QQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK-- 454
             R  I  G A G+  LH       IHRDIK++NILLDE  T KI+DFGLAR  A +K  
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR--ASEKFA 187
Query: 455 -THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
            T +   I GT  YMAPE L RG++T K+D+Y+FGV+++E+ +G
Sbjct: 188 QTVMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  142 bits (358), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 90/224 (40%), Positives = 130/224 (58%), Gaps = 20/224 (8%)
Query: 287 NFKYEILERATDFFDN------SRKLGQGGAGSVFRGTLPDGRNIAVKRLF----FNSRQ 336
           +F +  L+  T+ FD         K+G+GG G V++G + +   +AVK+L       + +
Sbjct: 8   SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 66
Query: 337 WVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSW 396
              QF  E+ +++  QH+N+V LLG S +G +  LVY Y+PN SL   L   +    LSW
Sbjct: 67  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 126
Query: 397 QQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK-- 454
             R  I  G A G+  LH       IHRDIK++NILLDE  T KI+DFGLAR  A +K  
Sbjct: 127 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR--ASEKFA 181
Query: 455 -THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
              +   I GT  YMAPE L RG++T K+D+Y+FGV+++E+ +G
Sbjct: 182 QXVMXXRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITG 224

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  136 bits (343), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 88/222 (39%), Positives = 123/222 (55%), Gaps = 16/222 (7%)
Query: 287 NFKYEILERATDFFDN------SRKLGQGGAGSVFRGTLPDGRNIAVKRLF----FNSRQ 336
           +F +  L+  T+ FD         K G+GG G V++G + +   +AVK+L       + +
Sbjct: 5   SFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 63
Query: 337 WVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSW 396
              QF  E+ + +  QH+N+V LLG S +G +  LVY Y PN SL   L   +    LSW
Sbjct: 64  LKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSW 123
Query: 397 QQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH 456
             R  I  G A G+  LH       IHRDIK++NILLDE  T KI+DFGLAR        
Sbjct: 124 HXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 457 VSTG-IAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           V    I GT  Y APE L RG++T K+D+Y+FGV+++E+ +G
Sbjct: 181 VXXSRIVGTTAYXAPEAL-RGEITPKSDIYSFGVVLLEIITG 221

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 86/283 (30%), Positives = 141/283 (49%), Gaps = 27/283 (9%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLF---FNSRQWVDQFFNEVNLISGIQHKNVVRLLG 361
           K+G G  G+V R     G ++AVK L    F++ + V++F  EV ++  ++H N+V  +G
Sbjct: 44  KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAER-VNEFLREVAIMKRLRHPNIVLFMG 101
Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
              + P   +V EY+   SL ++L        L  ++R ++    A+G+ +LH  +   I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PI 160
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEK 481
           +HRD+K+ N+L+D+K T K+ DFGL+R  A      S   AGT  +MAPE L      EK
Sbjct: 161 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKA-SXFLXSKXAAGTPEWMAPEVLRDEPSNEK 219
Query: 482 ADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR---FPEN 538
           +DVY+FGV++ E+A+              L   W +    ++  ++  G   +    P N
Sbjct: 220 SDVYSFGVILWELAT--------------LQQPWGNLNPAQVVAAV--GFKCKRLEIPRN 263
Query: 539 EASRVLQIGLLCTQAPVALRPSMAEVVHMLNN-IDYEIPPPKQ 580
              +V  I   C       RPS A ++ +L   I   +PPP +
Sbjct: 264 LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR 306

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  112 bits (279), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 144/284 (50%), Gaps = 29/284 (10%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLF---FNSRQWVDQFFNEVNLISGIQHKNVVRLLG 361
           K+G G  G+V R     G ++AVK L    F++ + V++F  EV ++  ++H N+V  +G
Sbjct: 44  KIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAER-VNEFLREVAIMKRLRHPNIVLFMG 101
Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
              + P   +V EY+   SL ++L        L  ++R ++    A+G+ +LH  +   I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PI 160
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVST-GIAGTLGYMAPEYLVRGQLTE 480
           +HR++K+ N+L+D+K T K+ DFGL+R  A   T +S+   AGT  +MAPE L      E
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKA--STFLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 481 KADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR---FPE 537
           K+DVY+FGV++ E+A+              L   W +    ++  ++  G   +    P 
Sbjct: 219 KSDVYSFGVILWELAT--------------LQQPWGNLNPAQVVAAV--GFKCKRLEIPR 262
Query: 538 NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN-IDYEIPPPKQ 580
           N   +V  I   C       RPS A ++ +L   I   +PPP +
Sbjct: 263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR 306

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 122/256 (47%), Gaps = 19/256 (7%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           +LG G AG V+ G       +AVK L   S    D F  E NL+  +QH+ +VRL     
Sbjct: 20  RLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHR 424
           + P   ++ EY+ N SL   L   + I  L+  +   +    AEG+A +   +    IHR
Sbjct: 79  QEP-IYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 425 DIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADV 484
           D++ +NIL+ + L+ KIADFGLAR +   +     G    + + APE +  G  T K+DV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 485 YAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVL 544
           ++FG+L+ E+ +  R       +  V+  + + Y+  R             P+N    + 
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-------------PDNCPEELY 240
Query: 545 QIGLLCTQAPVALRPS 560
           Q+  LC +     RP+
Sbjct: 241 QLMRLCWKERPEDRPT 256

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 122/256 (47%), Gaps = 19/256 (7%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           +LG G  G V+ G       +AVK L   S    D F  E NL+  +QH+ +VRL     
Sbjct: 29  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 87
Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHR 424
           + P   ++ EY+ N SL   L   + I  L+  +   +    AEG+A +   +    IHR
Sbjct: 88  QEP-IYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 142
Query: 425 DIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADV 484
           D++ +NIL+ + L+ KIADFGLAR +  ++     G    + + APE +  G  T K+DV
Sbjct: 143 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 202
Query: 485 YAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVL 544
           ++FG+L+ E+ +  R       +  V+  + + Y+  R             P+N    + 
Sbjct: 203 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-------------PDNCPEELY 249
Query: 545 QIGLLCTQAPVALRPS 560
           Q+  LC +     RP+
Sbjct: 250 QLMRLCWKERPEDRPT 265

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 122/256 (47%), Gaps = 19/256 (7%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           +LG G  G V+ G       +AVK L   S    D F  E NL+  +QH+ +VRL     
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHR 424
           + P   ++ EY+ N SL   L   + I  L+  +   +    AEG+A +   +    IHR
Sbjct: 85  QEP-IYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 139
Query: 425 DIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADV 484
           D++ +NIL+ + L+ KIADFGLAR +  ++     G    + + APE +  G  T K+DV
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 199
Query: 485 YAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVL 544
           ++FG+L+ E+ +  R       +  V+  + + Y+  R             P+N    + 
Sbjct: 200 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-------------PDNCPEELY 246
Query: 545 QIGLLCTQAPVALRPS 560
           Q+  LC +     RP+
Sbjct: 247 QLMRLCWKERPEDRPT 262

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 122/256 (47%), Gaps = 19/256 (7%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           +LG G  G V+ G       +AVK L   S    D F  E NL+  +QH+ +VRL     
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHR 424
           + P   ++ EY+ N SL   L   + I  L+  +   +    AEG+A +   +    IHR
Sbjct: 79  QEP-IYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 425 DIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADV 484
           D++ +NIL+ + L+ KIADFGLAR +  ++     G    + + APE +  G  T K+DV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 485 YAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVL 544
           ++FG+L+ E+ +  R       +  V+  + + Y+  R             P+N    + 
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-------------PDNCPEELY 240
Query: 545 QIGLLCTQAPVALRPS 560
           Q+  LC +     RP+
Sbjct: 241 QLMRLCWKERPEDRPT 256

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 122/256 (47%), Gaps = 19/256 (7%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           +LG G  G V+ G       +AVK L   S    D F  E NL+  +QH+ +VRL     
Sbjct: 21  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 79
Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHR 424
           + P   ++ EY+ N SL   L   + I  L+  +   +    AEG+A +   +    IHR
Sbjct: 80  QEP-IYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 134
Query: 425 DIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADV 484
           D++ +NIL+ + L+ KIADFGLAR +  ++     G    + + APE +  G  T K+DV
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 194
Query: 485 YAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVL 544
           ++FG+L+ E+ +  R       +  V+  + + Y+  R             P+N    + 
Sbjct: 195 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-------------PDNCPEELY 241
Query: 545 QIGLLCTQAPVALRPS 560
           Q+  LC +     RP+
Sbjct: 242 QLMRLCWKERPEDRPT 257

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 122/256 (47%), Gaps = 19/256 (7%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           +LG G  G V+ G       +AVK L   S    D F  E NL+  +QH+ +VRL     
Sbjct: 22  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 80
Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHR 424
           + P   ++ EY+ N SL   L   + I  L+  +   +    AEG+A +   +    IHR
Sbjct: 81  QEP-IYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 135
Query: 425 DIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADV 484
           D++ +NIL+ + L+ KIADFGLAR +  ++     G    + + APE +  G  T K+DV
Sbjct: 136 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 195
Query: 485 YAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVL 544
           ++FG+L+ E+ +  R       +  V+  + + Y+  R             P+N    + 
Sbjct: 196 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-------------PDNCPEELY 242
Query: 545 QIGLLCTQAPVALRPS 560
           Q+  LC +     RP+
Sbjct: 243 QLMRLCWKERPEDRPT 258

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 122/256 (47%), Gaps = 19/256 (7%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           +LG G  G V+ G       +AVK L   S    D F  E NL+  +QH+ +VRL     
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHR 424
           + P   ++ EY+ N SL   L   + I  L+  +   +    AEG+A +   +    IHR
Sbjct: 79  QEP-IYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 425 DIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADV 484
           D++ +NIL+ + L+ KIADFGLAR +  ++     G    + + APE +  G  T K+DV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 485 YAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVL 544
           ++FG+L+ E+ +  R       +  V+  + + Y+  R             P+N    + 
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-------------PDNCPEELY 240
Query: 545 QIGLLCTQAPVALRPS 560
           Q+  LC +     RP+
Sbjct: 241 QLMRLCWKERPEDRPT 256

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 122/256 (47%), Gaps = 19/256 (7%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           +LG G  G V+ G       +AVK L   S    D F  E NL+  +QH+ +VRL     
Sbjct: 28  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 86
Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHR 424
           + P   ++ EY+ N SL   L   + I  L+  +   +    AEG+A +   +    IHR
Sbjct: 87  QEP-IYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 141
Query: 425 DIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADV 484
           D++ +NIL+ + L+ KIADFGLAR +  ++     G    + + APE +  G  T K+DV
Sbjct: 142 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 201
Query: 485 YAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVL 544
           ++FG+L+ E+ +  R       +  V+  + + Y+  R             P+N    + 
Sbjct: 202 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-------------PDNCPEELY 248
Query: 545 QIGLLCTQAPVALRPS 560
           Q+  LC +     RP+
Sbjct: 249 QLMRLCWKERPEDRPT 264

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 122/256 (47%), Gaps = 19/256 (7%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           +LG G  G V+ G       +AVK L   S    D F  E NL+  +QH+ +VRL     
Sbjct: 30  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 88
Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHR 424
           + P   ++ EY+ N SL   L   + I  L+  +   +    AEG+A +   +    IHR
Sbjct: 89  QEP-IYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 143
Query: 425 DIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADV 484
           D++ +NIL+ + L+ KIADFGLAR +  ++     G    + + APE +  G  T K+DV
Sbjct: 144 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 203
Query: 485 YAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVL 544
           ++FG+L+ E+ +  R       +  V+  + + Y+  R             P+N    + 
Sbjct: 204 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-------------PDNCPEELY 250
Query: 545 QIGLLCTQAPVALRPS 560
           Q+  LC +     RP+
Sbjct: 251 QLMRLCWKERPEDRPT 266

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 122/256 (47%), Gaps = 19/256 (7%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           +LG G  G V+ G       +AVK L   S    D F  E NL+  +QH+ +VRL     
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHR 424
           + P   ++ EY+ N SL   L   + I  L+  +   +    AEG+A +   +    IHR
Sbjct: 79  QEP-IYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 425 DIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADV 484
           D++ +NIL+ + L+ KIADFGLAR +  ++     G    + + APE +  G  T K+DV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 485 YAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVL 544
           ++FG+L+ E+ +  R       +  V+  + + Y+  R             P+N    + 
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-------------PDNCPEELY 240
Query: 545 QIGLLCTQAPVALRPS 560
           Q+  LC +     RP+
Sbjct: 241 QLMRLCWKERPEDRPT 256

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 122/256 (47%), Gaps = 19/256 (7%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           +LG G  G V+ G       +AVK L   S    D F  E NL+  +QH+ +VRL     
Sbjct: 15  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 73
Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHR 424
           + P   ++ EY+ N SL   L   + I  L+  +   +    AEG+A +   +    IHR
Sbjct: 74  QEP-IYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 128
Query: 425 DIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADV 484
           D++ +NIL+ + L+ KIADFGLAR +  ++     G    + + APE +  G  T K+DV
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 188
Query: 485 YAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVL 544
           ++FG+L+ E+ +  R       +  V+  + + Y+  R             P+N    + 
Sbjct: 189 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-------------PDNCPEELY 235
Query: 545 QIGLLCTQAPVALRPS 560
           Q+  LC +     RP+
Sbjct: 236 QLMRLCWKERPEDRPT 251

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 122/256 (47%), Gaps = 19/256 (7%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           +LG G  G V+ G       +AVK L   S    D F  E NL+  +QH+ +VRL     
Sbjct: 25  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 83
Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHR 424
           + P   ++ EY+ N SL   L   + I  L+  +   +    AEG+A +   +    IHR
Sbjct: 84  QEP-IYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 138
Query: 425 DIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADV 484
           D++ +NIL+ + L+ KIADFGLAR +  ++     G    + + APE +  G  T K+DV
Sbjct: 139 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 198
Query: 485 YAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVL 544
           ++FG+L+ E+ +  R       +  V+  + + Y+  R             P+N    + 
Sbjct: 199 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-------------PDNCPEELY 245
Query: 545 QIGLLCTQAPVALRPS 560
           Q+  LC +     RP+
Sbjct: 246 QLMRLCWKERPEDRPT 261

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 122/256 (47%), Gaps = 19/256 (7%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           +LG G  G V+ G       +AVK L   S    D F  E NL+  +QH+ +VRL     
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHR 424
           + P   ++ EY+ N SL   L   + I  L+  +   +    AEG+A +   +    IHR
Sbjct: 85  QEP-IYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 139
Query: 425 DIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADV 484
           D++ +NIL+ + L+ KIADFGLAR +  ++     G    + + APE +  G  T K+DV
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 199
Query: 485 YAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVL 544
           ++FG+L+ E+ +  R       +  V+  + + Y+  R             P+N    + 
Sbjct: 200 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-------------PDNCPEELY 246
Query: 545 QIGLLCTQAPVALRPS 560
           Q+  LC +     RP+
Sbjct: 247 QLMRLCWKERPEDRPT 262

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 122/256 (47%), Gaps = 19/256 (7%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           +LG G  G V+ G       +AVK L   S    D F  E NL+  +QH+ +VRL     
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVT 74
Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHR 424
           + P   ++ EY+ N SL   L   + I  L+  +   +    AEG+A +   +    IHR
Sbjct: 75  QEP-IYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 129
Query: 425 DIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADV 484
           +++ +NIL+ + L+ KIADFGLAR +  ++     G    + + APE +  G  T K+DV
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 189
Query: 485 YAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVL 544
           ++FG+L+ E+ +  R       +  V+  + + Y+  R             P+N    + 
Sbjct: 190 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-------------PDNCPEELY 236
Query: 545 QIGLLCTQAPVALRPS 560
           Q+  LC +     RP+
Sbjct: 237 QLMRLCWKERPEDRPT 252

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 137/276 (49%), Gaps = 30/276 (10%)
Query: 306 LGQGGAGSVFRGTLPDGRN-----IAVKRL--FFNSRQWVDQFFNEVNLISGIQHKNVVR 358
           +G G  G V++G L          +A+K L   +  +Q VD F  E  ++    H N++R
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNIIR 110
Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
           L G   +    +++ EY+ N +LD+  F++      S  Q   ++ G A G+ +L   + 
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIAAGMKYL---AN 165
Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVA--PDKTHVSTGIAGTLGYMAPEYLVRG 476
           +  +HRD+   NIL++  L  K++DFGL+R +   P+ T+ ++G    + + APE +   
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 477 QLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF 535
           + T  +DV++FG+++ EV + G R               W+    + + ++++ G     
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGER-------------PYWE-LSNHEVMKAINDGFRLPT 271
Query: 536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           P +  S + Q+ + C Q   A RP  A++V +L+ +
Sbjct: 272 PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 122/267 (45%), Gaps = 18/267 (6%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           ++LG G  G V+ G   +   +AVK L   +   V  F  E NL+  +QH  +VRL    
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
                  ++ EY+   SL   L       +L   +        AEG+A++   +    IH
Sbjct: 78  TREEPIYIITEYMAKGSLLDFLKSDEGGKVLL-PKLIDFSAQIAEGMAYIERKN---YIH 133
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +N+L+ E L  KIADFGLAR +  ++     G    + + APE +  G  T K+D
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSD 193
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRV 543
           V++FG+L+ E+ +  +       ++ V+  + + Y+  R+             EN    +
Sbjct: 194 VWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRV-------------ENCPDEL 240
Query: 544 LQIGLLCTQAPVALRPSMAEVVHMLNN 570
             I  +C +     RP+   +  +L++
Sbjct: 241 YDIMKMCWKEKAEERPTFDYLQSVLDD 267

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 132/274 (48%), Gaps = 27/274 (9%)
Query: 306 LGQGGAGSVFRGTL--PDGRNIAVK----RLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +G G +G V  G L  P  R++ V     +  +  RQ  D F +E +++    H N++RL
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEASIMGQFDHPNIIRL 115
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G    G  +++V EY+ N SLD   F++      +  Q   ++ G   G+ +L   S +
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQFTIMQLVGMLRGVGAGMRYL---SDL 170
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVA--PDKTHVSTGIAGTLGYMAPEYLVRGQ 477
             +HRD+   N+L+D  L  K++DFGL+R +   PD  + +TG    + + APE +    
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 478 LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE 537
            +  +DV++FGV++ EV +      ++  +  V+ +V + Y+         P      P 
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL--------PA-----PM 277
Query: 538 NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
                + Q+ L C     A RP  +++V +L+ +
Sbjct: 278 GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 114/226 (50%), Gaps = 25/226 (11%)
Query: 299 FFDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLFFNSRQ----WVDQFFNEVNLISGI 351
            F + R++G G  G+V+     D RN   +A+K++ ++ +Q    W D    EV  +  +
Sbjct: 16  LFSDLREIGHGSFGAVYFAR--DVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKL 72
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N ++  GC +    + LV EY    + D +   K  +  +   +   +  G  +GLA
Sbjct: 73  RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV---EIAAVTHGALQGLA 129
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           +LH  +   +IHRD+K  NILL E    K+ DFG A  +AP     +    GT  +MAPE
Sbjct: 130 YLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANXFVGTPYWMAPE 181
Query: 472 YLV---RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV 514
            ++    GQ   K DV++ G+  IE+A  R+  +F+  + S L+ +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHI 226

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 8/216 (3%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           KLGQG  G V+ GT      +A+K L   +    + F  E  ++  I+H+ +V+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTI-HILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           E P   +V EY+   SL  + F+K  +   L   Q   +    A G+A++     +  +H
Sbjct: 84  EEP-IYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 137
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +NIL+ E L  K+ADFGLAR +  ++     G    + + APE  + G+ T K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
           V++FG+L+ E+ +  R       +  VL  V + Y+
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 233

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 114/226 (50%), Gaps = 25/226 (11%)
Query: 299 FFDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLFFNSRQ----WVDQFFNEVNLISGI 351
            F + R++G G  G+V+     D RN   +A+K++ ++ +Q    W D    EV  +  +
Sbjct: 55  LFSDLREIGHGSFGAVYFAR--DVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKL 111
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N ++  GC +    + LV EY    + D +   K  +  +   +   +  G  +GLA
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV---EIAAVTHGALQGLA 168
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           +LH  +   +IHRD+K  NILL E    K+ DFG A  +AP    V     GT  +MAPE
Sbjct: 169 YLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPE 220
Query: 472 YLV---RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV 514
            ++    GQ   K DV++ G+  IE+A  R+  +F+  + S L+ +
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSALYHI 265

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 8/216 (3%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           KLGQG  G V+ GT      +A+K L   +    + F  E  ++  ++H+ +V+L     
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 365 EGPESLLVYEYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           E P   +V EY+   SL  + F+K  T   L   Q   +    A G+A++     +  +H
Sbjct: 74  EEP-IXIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 127
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +NIL+ E L  K+ADFGLAR +  ++     G    + + APE  + G+ T K+D
Sbjct: 128 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 187
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
           V++FG+L+ E+ +  R       +  VL  V + Y+
Sbjct: 188 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 223

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/275 (30%), Positives = 131/275 (47%), Gaps = 27/275 (9%)
Query: 306 LGQGGAGSVFRGTL--PDGRNI--AVKRL-FFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
           +G+G  G V+ GTL   DG+ I  AVK L        V QF  E  ++    H NV+ LL
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 361 GCSIEGPES-LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
           G  +    S L+V  Y+ +  L    F++N  H  + +         A+G+  L   +  
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL---ASK 157
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAP---DKTHVSTGIAGTLGYMAPEYLVRG 476
           K +HRD+   N +LDEK T K+ADFGLAR +     D  H  TG    + +MA E L   
Sbjct: 158 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 217
Query: 477 QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP 536
           + T K+DV++FGVL+ E+ +  R +      ++   TV+   +  R+ Q          P
Sbjct: 218 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYL-LQGRRLLQ----------P 264
Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           E     + ++ L C      +RPS +E+V  ++ I
Sbjct: 265 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 299

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 8/216 (3%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           KLGQG  G V+ GT      +A+K L   +    + F  E  ++  ++H+ +V+L     
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 365 EGPESLLVYEYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           E P   +V EY+   SL  + F+K  T   L   Q   +    A G+A++     +  +H
Sbjct: 77  EEP-IYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 130
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +NIL+ E L  K+ADFGLAR +  ++     G    + + APE  + G+ T K+D
Sbjct: 131 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 190
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
           V++FG+L+ E+ +  R       +  VL  V + Y+
Sbjct: 191 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 226

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/275 (30%), Positives = 131/275 (47%), Gaps = 27/275 (9%)
Query: 306 LGQGGAGSVFRGTL--PDGRNI--AVKRL-FFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
           +G+G  G V+ GTL   DG+ I  AVK L        V QF  E  ++    H NV+ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 361 GCSIEGPES-LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
           G  +    S L+V  Y+ +  L    F++N  H  + +         A+G+  L   +  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL---ASK 150
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAP---DKTHVSTGIAGTLGYMAPEYLVRG 476
           K +HRD+   N +LDEK T K+ADFGLAR +     D  H  TG    + +MA E L   
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 210
Query: 477 QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP 536
           + T K+DV++FGVL+ E+ +  R +      ++   TV+   +  R+ Q          P
Sbjct: 211 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYL-LQGRRLLQ----------P 257
Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           E     + ++ L C      +RPS +E+V  ++ I
Sbjct: 258 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 110/216 (50%), Gaps = 8/216 (3%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           KLGQG  G V+ GT      +A+K L   +    + F  E  ++  ++H+ +V+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTI-HILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           E P   +V EY+   SL  + F+K  +   L   Q   +    A G+A++     +  +H
Sbjct: 84  EEP-IYIVIEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 137
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +NIL+ E L  K+ADFGLAR +  ++     G    + + APE  + G+ T K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
           V++FG+L+ E+ +  R       +  VL  V + Y+
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 233

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 110/216 (50%), Gaps = 8/216 (3%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           KLGQG  G V+ GT      +A+K L   +    + F  E  ++  ++H+ +V+L     
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTI-HILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           E P   +V EY+   SL  + F+K  +   L   Q   +    A G+A++     +  +H
Sbjct: 75  EEP-IYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 128
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +NIL+ E L  K+ADFGLAR +  ++     G    + + APE  + G+ T K+D
Sbjct: 129 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
           V++FG+L+ E+ +  R       +  VL  V + Y+
Sbjct: 189 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 224

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/275 (30%), Positives = 131/275 (47%), Gaps = 27/275 (9%)
Query: 306 LGQGGAGSVFRGTL--PDGRNI--AVKRL-FFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
           +G+G  G V+ GTL   DG+ I  AVK L        V QF  E  ++    H NV+ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 361 GCSIEGPES-LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
           G  +    S L+V  Y+ +  L    F++N  H  + +         A+G+  L   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL---ASK 152
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAP---DKTHVSTGIAGTLGYMAPEYLVRG 476
           K +HRD+   N +LDEK T K+ADFGLAR +     D  H  TG    + +MA E L   
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 477 QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP 536
           + T K+DV++FGVL+ E+ +  R +      ++   TV+   +  R+ Q          P
Sbjct: 213 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYL-LQGRRLLQ----------P 259
Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           E     + ++ L C      +RPS +E+V  ++ I
Sbjct: 260 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/275 (30%), Positives = 131/275 (47%), Gaps = 27/275 (9%)
Query: 306 LGQGGAGSVFRGTL--PDGRNI--AVKRL-FFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
           +G+G  G V+ GTL   DG+ I  AVK L        V QF  E  ++    H NV+ LL
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 361 GCSIEGPES-LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
           G  +    S L+V  Y+ +  L    F++N  H  + +         A+G+  L   +  
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL---ASK 211
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAP---DKTHVSTGIAGTLGYMAPEYLVRG 476
           K +HRD+   N +LDEK T K+ADFGLAR +     D  H  TG    + +MA E L   
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 271
Query: 477 QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP 536
           + T K+DV++FGVL+ E+ +  R +      ++   TV+   +  R+ Q          P
Sbjct: 272 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYL-LQGRRLLQ----------P 318
Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           E     + ++ L C      +RPS +E+V  ++ I
Sbjct: 319 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/275 (30%), Positives = 131/275 (47%), Gaps = 27/275 (9%)
Query: 306 LGQGGAGSVFRGTL--PDGRNI--AVKRL-FFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
           +G+G  G V+ GTL   DG+ I  AVK L        V QF  E  ++    H NV+ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 361 GCSIEGPES-LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
           G  +    S L+V  Y+ +  L    F++N  H  + +         A+G+  L   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL---ASK 152
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAP---DKTHVSTGIAGTLGYMAPEYLVRG 476
           K +HRD+   N +LDEK T K+ADFGLAR +     D  H  TG    + +MA E L   
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 212
Query: 477 QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP 536
           + T K+DV++FGVL+ E+ +  R +      ++   TV+   +  R+ Q          P
Sbjct: 213 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYL-LQGRRLLQ----------P 259
Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           E     + ++ L C      +RPS +E+V  ++ I
Sbjct: 260 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/275 (30%), Positives = 131/275 (47%), Gaps = 27/275 (9%)
Query: 306 LGQGGAGSVFRGTL--PDGRNI--AVKRL-FFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
           +G+G  G V+ GTL   DG+ I  AVK L        V QF  E  ++    H NV+ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 361 GCSIEGPES-LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
           G  +    S L+V  Y+ +  L    F++N  H  + +         A+G+  L   +  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL---ASK 153
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAP---DKTHVSTGIAGTLGYMAPEYLVRG 476
           K +HRD+   N +LDEK T K+ADFGLAR +     D  H  TG    + +MA E L   
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 477 QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP 536
           + T K+DV++FGVL+ E+ +  R +      ++   TV+   +  R+ Q          P
Sbjct: 214 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYL-LQGRRLLQ----------P 260
Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           E     + ++ L C      +RPS +E+V  ++ I
Sbjct: 261 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/275 (30%), Positives = 131/275 (47%), Gaps = 27/275 (9%)
Query: 306 LGQGGAGSVFRGTL--PDGRNI--AVKRL-FFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
           +G+G  G V+ GTL   DG+ I  AVK L        V QF  E  ++    H NV+ LL
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 361 GCSIEGPES-LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
           G  +    S L+V  Y+ +  L    F++N  H  + +         A+G+  L   +  
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL---ASK 153
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAP---DKTHVSTGIAGTLGYMAPEYLVRG 476
           K +HRD+   N +LDEK T K+ADFGLAR +     D  H  TG    + +MA E L   
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 477 QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP 536
           + T K+DV++FGVL+ E+ +  R +      ++   TV+   +  R+ Q          P
Sbjct: 214 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYL-LQGRRLLQ----------P 260
Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           E     + ++ L C      +RPS +E+V  ++ I
Sbjct: 261 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 130/274 (47%), Gaps = 27/274 (9%)
Query: 306 LGQGGAGSVFRGTL--PDGRNIAVK----RLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +G G +G V  G L  P  R++ V     +  +  RQ  D F +E +++    H N++RL
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEASIMGQFDHPNIIRL 115
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G    G  +++V EY+ N SLD   F++      +  Q   ++ G   G+ +L   S +
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQFTIMQLVGMLRGVGAGMRYL---SDL 170
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVA--PDKTHVSTGIAGTLGYMAPEYLVRGQ 477
             +HRD+   N+L+D  L  K++DFGL+R +   PD    +TG    + + APE +    
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRT 230
Query: 478 LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE 537
            +  +DV++FGV++ EV +      ++  +  V+ +V + Y+                P 
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP-------------APM 277
Query: 538 NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
                + Q+ L C     A RP  +++V +L+ +
Sbjct: 278 GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 110/216 (50%), Gaps = 8/216 (3%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           KLGQG  G V+ GT      +A+K L   +    + F  E  ++  ++H+ +V+L     
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTI-HILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           E P   +V EY+   SL  + F+K  +   L   Q   +    A G+A++     +  +H
Sbjct: 73  EEP-IYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 126
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +NIL+ E L  K+ADFGLAR +  ++     G    + + APE  + G+ T K+D
Sbjct: 127 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 186
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
           V++FG+L+ E+ +  R       +  VL  V + Y+
Sbjct: 187 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 222

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 110/216 (50%), Gaps = 8/216 (3%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           KLGQG  G V+ GT      +A+K L   +    + F  E  ++  ++H+ +V+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTI-HILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           E P   +V EY+   SL  + F+K  +   L   Q   +    A G+A++     +  +H
Sbjct: 84  EEP-IYIVIEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 137
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +NIL+ E L  K+ADFGLAR +  ++     G    + + APE  + G+ T K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
           V++FG+L+ E+ +  R       +  VL  V + Y+
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 233

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 110/216 (50%), Gaps = 8/216 (3%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           KLGQG  G V+ GT      +A+K L   +    + F  E  ++  ++H+ +V+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTI-HILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           E P   +V EY+   SL  + F+K  +   L   Q   +    A G+A++     +  +H
Sbjct: 84  EEP-IYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 137
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +NIL+ E L  K+ADFGLAR +  ++     G    + + APE  + G+ T K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
           V++FG+L+ E+ +  R       +  VL  V + Y+
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 233

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 132/275 (48%), Gaps = 27/275 (9%)
Query: 306 LGQGGAGSVFRGTL--PDGRNI--AVKRL-FFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
           +G+G  G V+ GTL   DG+ I  AVK L        V QF  E  ++    H NV+ LL
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 361 GCSIEGPES-LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
           G  +    S L+V  Y+ +  L    F++N  H  + +         A+G+ +L   +  
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL---ASK 147
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK---THVSTGIAGTLGYMAPEYLVRG 476
           K +HRD+   N +LDEK T K+ADFGLAR +   +    H  TG    + +MA E L   
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207
Query: 477 QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP 536
           + T K+DV++FGVL+ E+ +  R +      ++   TV+   +  R+ Q          P
Sbjct: 208 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYL-LQGRRLLQ----------P 254
Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           E     + ++ L C      +RPS +E+V  ++ I
Sbjct: 255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 132/275 (48%), Gaps = 27/275 (9%)
Query: 306 LGQGGAGSVFRGTL--PDGRNI--AVKRL-FFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
           +G+G  G V+ GTL   DG+ I  AVK L        V QF  E  ++    H NV+ LL
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 361 GCSIEGPES-LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
           G  +    S L+V  Y+ +  L    F++N  H  + +         A+G+ +L   +  
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL---ASK 144
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK---THVSTGIAGTLGYMAPEYLVRG 476
           K +HRD+   N +LDEK T K+ADFGLAR +   +    H  TG    + +MA E L   
Sbjct: 145 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 204
Query: 477 QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP 536
           + T K+DV++FGVL+ E+ +  R +      ++   TV+   +  R+ Q          P
Sbjct: 205 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYL-LQGRRLLQ----------P 251
Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           E     + ++ L C      +RPS +E+V  ++ I
Sbjct: 252 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 286

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 133/277 (48%), Gaps = 27/277 (9%)
Query: 303 SRKLGQGGAGSVFRG--TLPDGRNIAVK----RLFFNSRQWVDQFFNEVNLISGIQHKNV 356
            R +G G  G V  G   LP  R++AV     ++ +  +Q  D F  E +++    H NV
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRD-FLCEASIMGQFDHPNV 106
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           V L G    G   ++V E++ N +LD   F++      +  Q   ++ G A G+ +L   
Sbjct: 107 VHLEGVVTRGKPVMIVIEFMENGALDA--FLRKHDGQFTVIQLVGMLRGIAAGMRYL--- 161
Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA--PDKTHVSTGIAGTLGYMAPEYLV 474
           + +  +HRD+   NIL++  L  K++DFGL+R +   P+  + +TG    + + APE + 
Sbjct: 162 ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQ 221
Query: 475 RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR 534
             + T  +DV+++G+++ EV S      +   +  V+  + + Y   R+   MD      
Sbjct: 222 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGY---RLPAPMDC----- 273
Query: 535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
                 + + Q+ L C Q   A RP   ++V +L+ +
Sbjct: 274 -----PAGLHQLMLDCWQKERAERPKFEQIVGILDKM 305

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 132/275 (48%), Gaps = 27/275 (9%)
Query: 306 LGQGGAGSVFRGTL--PDGRNI--AVKRL-FFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
           +G+G  G V+ GTL   DG+ I  AVK L        V QF  E  ++    H NV+ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 361 GCSIEGPES-LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
           G  +    S L+V  Y+ +  L    F++N  H  + +         A+G+ +L   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL---ASK 152
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK---THVSTGIAGTLGYMAPEYLVRG 476
           K +HRD+   N +LDEK T K+ADFGLAR +   +    H  TG    + +MA E L   
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 212
Query: 477 QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP 536
           + T K+DV++FGVL+ E+ +  R +      ++   TV+   +  R+ Q          P
Sbjct: 213 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYL-LQGRRLLQ----------P 259
Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           E     + ++ L C      +RPS +E+V  ++ I
Sbjct: 260 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 132/275 (48%), Gaps = 27/275 (9%)
Query: 306 LGQGGAGSVFRGTL--PDGRNI--AVKRL-FFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
           +G+G  G V+ GTL   DG+ I  AVK L        V QF  E  ++    H NV+ LL
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 361 GCSIEGPES-LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
           G  +    S L+V  Y+ +  L    F++N  H  + +         A+G+ +L   +  
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL---ASK 149
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK---THVSTGIAGTLGYMAPEYLVRG 476
           K +HRD+   N +LDEK T K+ADFGLAR +   +    H  TG    + +MA E L   
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 209
Query: 477 QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP 536
           + T K+DV++FGVL+ E+ +  R +      ++   TV+   +  R+ Q          P
Sbjct: 210 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYL-LQGRRLLQ----------P 256
Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           E     + ++ L C      +RPS +E+V  ++ I
Sbjct: 257 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 132/275 (48%), Gaps = 27/275 (9%)
Query: 306 LGQGGAGSVFRGTL--PDGRNI--AVKRL-FFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
           +G+G  G V+ GTL   DG+ I  AVK L        V QF  E  ++    H NV+ LL
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 361 GCSIEGPES-LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
           G  +    S L+V  Y+ +  L    F++N  H  + +         A+G+ +L   +  
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL---ASK 170
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK---THVSTGIAGTLGYMAPEYLVRG 476
           K +HRD+   N +LDEK T K+ADFGLAR +   +    H  TG    + +MA E L   
Sbjct: 171 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 230
Query: 477 QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP 536
           + T K+DV++FGVL+ E+ +  R +      ++   TV+   +  R+ Q          P
Sbjct: 231 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYL-LQGRRLLQ----------P 277
Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           E     + ++ L C      +RPS +E+V  ++ I
Sbjct: 278 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 312

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 8/216 (3%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           KLGQG  G V+ GT      +A+K L   +    + F  E  ++  ++H+ +V+L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 365 EGPESLLVYEYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           E P   +V EY+   SL  + F+K  T   L   Q   +    A G+A++     +  +H
Sbjct: 250 EEP-IYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 303
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +NIL+ E L  K+ADFGLAR +  ++     G    + + APE  + G+ T K+D
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
           V++FG+L+ E+ +  R       +  VL  V + Y+
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 399

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 130/276 (47%), Gaps = 27/276 (9%)
Query: 304 RKLGQGGAGSVFRG--TLPDGRNIAVK----RLFFNSRQWVDQFFNEVNLISGIQHKNVV 357
           R +G G  G V  G   LP  R + V     ++ +  +Q  D F  E +++    H N++
Sbjct: 28  RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNII 86
Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
            L G   +    ++V EY+ N SLD   F+K      +  Q   ++ G + G+ +L   S
Sbjct: 87  HLEGVVTKSKPVMIVTEYMENGSLDT--FLKKNDGQFTVIQLVGMLRGISAGMKYL---S 141
Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA--PDKTHVSTGIAGTLGYMAPEYLVR 475
            +  +HRD+   NIL++  L  K++DFGL+R +   P+  + + G    + + APE +  
Sbjct: 142 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAF 201
Query: 476 GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF 535
            + T  +DV+++G+++ EV S      +   +  V+  V + Y   R+   MD       
Sbjct: 202 RKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGY---RLPSPMDC------ 252
Query: 536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
                + + Q+ L C Q     RP   E+V+ML+ +
Sbjct: 253 ----PAALYQLMLDCWQKERNSRPKFDEIVNMLDKL 284

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 132/275 (48%), Gaps = 27/275 (9%)
Query: 306 LGQGGAGSVFRGTL--PDGRNI--AVKRL-FFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
           +G+G  G V+ GTL   DG+ I  AVK L        V QF  E  ++    H NV+ LL
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 361 GCSIEGPES-LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
           G  +    S L+V  Y+ +  L    F++N  H  + +         A+G+ +L   +  
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL---ASK 150
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK---THVSTGIAGTLGYMAPEYLVRG 476
           K +HRD+   N +LDEK T K+ADFGLAR +   +    H  TG    + +MA E L   
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 210
Query: 477 QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP 536
           + T K+DV++FGVL+ E+ +  R +      ++   TV+   +  R+ Q          P
Sbjct: 211 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYL-LQGRRLLQ----------P 257
Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           E     + ++ L C      +RPS +E+V  ++ I
Sbjct: 258 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 132/275 (48%), Gaps = 27/275 (9%)
Query: 306 LGQGGAGSVFRGTL--PDGRNI--AVKRL-FFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
           +G+G  G V+ GTL   DG+ I  AVK L        V QF  E  ++    H NV+ LL
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 361 GCSIEGPES-LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
           G  +    S L+V  Y+ +  L    F++N  H  + +         A+G+ +L   +  
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL---ASK 152
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK---THVSTGIAGTLGYMAPEYLVRG 476
           K +HRD+   N +LDEK T K+ADFGLAR +   +    H  TG    + +MA E L   
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 212
Query: 477 QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP 536
           + T K+DV++FGVL+ E+ +  R +      ++   TV+   +  R+ Q          P
Sbjct: 213 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYL-LQGRRLLQ----------P 259
Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           E     + ++ L C      +RPS +E+V  ++ I
Sbjct: 260 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 8/216 (3%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           KLGQG  G V+ GT      +A+K L   +    + F  E  ++  ++H+ +V+L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 365 EGPESLLVYEYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           E P   +V EY+   SL  + F+K  T   L   Q   +    A G+A++     +  +H
Sbjct: 250 EEP-IYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 303
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +NIL+ E L  K+ADFGLAR +  ++     G    + + APE  + G+ T K+D
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
           V++FG+L+ E+ +  R       +  VL  V + Y+
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 399

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 132/275 (48%), Gaps = 27/275 (9%)
Query: 306 LGQGGAGSVFRGTL--PDGRNI--AVKRL-FFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
           +G+G  G V+ GTL   DG+ I  AVK L        V QF  E  ++    H NV+ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 361 GCSIEGPES-LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
           G  +    S L+V  Y+ +  L    F++N  H  + +         A+G+ +L   +  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL---ASK 151
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK---THVSTGIAGTLGYMAPEYLVRG 476
           K +HRD+   N +LDEK T K+ADFGLAR +   +    H  TG    + +MA E L   
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 211
Query: 477 QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP 536
           + T K+DV++FGVL+ E+ +  R +      ++   TV+   +  R+ Q          P
Sbjct: 212 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYL-LQGRRLLQ----------P 258
Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           E     + ++ L C      +RPS +E+V  ++ I
Sbjct: 259 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 132/275 (48%), Gaps = 27/275 (9%)
Query: 306 LGQGGAGSVFRGTL--PDGRNI--AVKRL-FFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
           +G+G  G V+ GTL   DG+ I  AVK L        V QF  E  ++    H NV+ LL
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 361 GCSIEGPES-LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
           G  +    S L+V  Y+ +  L    F++N  H  + +         A+G+ +L   +  
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL---ASK 171
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK---THVSTGIAGTLGYMAPEYLVRG 476
           K +HRD+   N +LDEK T K+ADFGLAR +   +    H  TG    + +MA E L   
Sbjct: 172 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 231
Query: 477 QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP 536
           + T K+DV++FGVL+ E+ +  R +      ++   TV+   +  R+ Q          P
Sbjct: 232 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYL-LQGRRLLQ----------P 278
Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           E     + ++ L C      +RPS +E+V  ++ I
Sbjct: 279 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 313

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 110/216 (50%), Gaps = 8/216 (3%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           KLGQG  G V+ GT      +A+K L   +    + F  E  ++  ++H+ +V+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTI-HILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           E P   +V EY+   SL  + F+K  +   L   Q   +    A G+A++     +  +H
Sbjct: 84  EEP-IYIVCEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 137
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +NIL+ E L  K+ADFGLAR +  ++     G    + + APE  + G+ T K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
           V++FG+L+ E+ +  R       +  VL  V + Y+
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 233

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 132/275 (48%), Gaps = 27/275 (9%)
Query: 306 LGQGGAGSVFRGTL--PDGRNI--AVKRL-FFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
           +G+G  G V+ GTL   DG+ I  AVK L        V QF  E  ++    H NV+ LL
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 361 GCSIEGPES-LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
           G  +    S L+V  Y+ +  L    F++N  H  + +         A+G+ +L   +  
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL---ASK 151
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK---THVSTGIAGTLGYMAPEYLVRG 476
           K +HRD+   N +LDEK T K+ADFGLAR +   +    H  TG    + +MA E L   
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQ 211
Query: 477 QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP 536
           + T K+DV++FGVL+ E+ +  R +      ++   TV+   +  R+ Q          P
Sbjct: 212 KFTTKSDVWSFGVLLWELMT--RGAPPYPDVNTFDITVYL-LQGRRLLQ----------P 258
Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           E     + ++ L C      +RPS +E+V  ++ I
Sbjct: 259 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 11/201 (5%)
Query: 299 FFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVV 357
           + DN  K+G+G  G V   T+   G+ +AVK++    +Q  +  FNEV ++   QH+NVV
Sbjct: 21  YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVV 80
Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIIC-GTAEGLAHLHGG 416
            +    + G E  +V E++   +L  I+      H    +++   +C    + L+ LH  
Sbjct: 81  EMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQALSVLHAQ 135
Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG 476
               +IHRDIK+ +ILL      K++DFG    V+ +       + GT  +MAPE + R 
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRL 191
Query: 477 QLTEKADVYAFGVLVIEVASG 497
               + D+++ G++VIE+  G
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDG 212

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 8/216 (3%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           KLGQG  G V+ GT      +A+K L   +    + F  E  ++  ++H+ +V+L     
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 365 EGPESLLVYEYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           E P   +V EY+   SL  + F+K  T   L   Q   +    A G+A++     +  +H
Sbjct: 81  EEP-IYIVTEYMNKGSL--LDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVH 134
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +NIL+ E L  K+ADFGLAR +  ++     G    + + APE  + G+ T K+D
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
           V++FG+L+ E+ +  R       +  VL  V + Y+
Sbjct: 195 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 230

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 11/201 (5%)
Query: 299 FFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVV 357
           + DN  K+G+G  G V   T+   G+ +AVK++    +Q  +  FNEV ++   QH+NVV
Sbjct: 30  YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVV 89
Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIIC-GTAEGLAHLHGG 416
            +    + G E  +V E++   +L  I+      H    +++   +C    + L+ LH  
Sbjct: 90  EMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQALSVLHAQ 144
Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG 476
               +IHRDIK+ +ILL      K++DFG    V+ +       + GT  +MAPE + R 
Sbjct: 145 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRL 200
Query: 477 QLTEKADVYAFGVLVIEVASG 497
               + D+++ G++VIE+  G
Sbjct: 201 PYGPEVDIWSLGIMVIEMVDG 221

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 8/216 (3%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           KLGQG  G V+ GT      +A+K L   +    + F  E  ++  ++H+ +V+L     
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 365 EGPESLLVYEYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           E P   +V EY+   SL  + F+K  T   L   Q   +    A G+A++     +  +H
Sbjct: 81  EEP-IYIVTEYMNKGSL--LDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVH 134
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +NIL+ E L  K+ADFGLAR +  ++     G    + + APE  + G+ T K+D
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
           V++FG+L+ E+ +  R       +  VL  V + Y+
Sbjct: 195 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 230

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 11/201 (5%)
Query: 299 FFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVV 357
           + DN  K+G+G  G V   T+   G+ +AVK++    +Q  +  FNEV ++   QH+NVV
Sbjct: 25  YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVV 84
Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIIC-GTAEGLAHLHGG 416
            +    + G E  +V E++   +L  I+      H    +++   +C    + L+ LH  
Sbjct: 85  EMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQALSVLHAQ 139
Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG 476
               +IHRDIK+ +ILL      K++DFG    V+ +       + GT  +MAPE + R 
Sbjct: 140 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRL 195
Query: 477 QLTEKADVYAFGVLVIEVASG 497
               + D+++ G++VIE+  G
Sbjct: 196 PYGPEVDIWSLGIMVIEMVDG 216

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 11/201 (5%)
Query: 299 FFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVV 357
           + DN  K+G+G  G V   T+   G+ +AVK++    +Q  +  FNEV ++   QH+NVV
Sbjct: 32  YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVV 91
Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIIC-GTAEGLAHLHGG 416
            +    + G E  +V E++   +L  I+      H    +++   +C    + L+ LH  
Sbjct: 92  EMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQALSVLHAQ 146
Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG 476
               +IHRDIK+ +ILL      K++DFG    V+ +       + GT  +MAPE + R 
Sbjct: 147 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRL 202
Query: 477 QLTEKADVYAFGVLVIEVASG 497
               + D+++ G++VIE+  G
Sbjct: 203 PYGPEVDIWSLGIMVIEMVDG 223

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 8/216 (3%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           KLGQG  G V+ GT      +A+K L   +    + F  E  ++  ++H+ +V+L     
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 365 EGPESLLVYEYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           E P   +V EY+   SL  + F+K  T   L   Q   +    A G+A++     +  +H
Sbjct: 333 EEP-IYIVTEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 386
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +NIL+ E L  K+ADFGLAR +  ++     G    + + APE  + G+ T K+D
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
           V++FG+L+ E+ +  R       +  VL  V + Y+
Sbjct: 447 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 482

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 132/291 (45%), Gaps = 35/291 (12%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQW-------VDQFFNEVNL 347
           A +  +  +++G+GG G V +G L  D   +A+K L     +          +F  EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 348 ISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTA 407
           +S + H N+V+L G     P   +V E+VP   L   L  K   H + W  +  ++   A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIA 132
Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILL---DEK--LTPKIADFGLARHVAPDKTHVSTGIA 462
            G+ ++       I+HRD+++ NI L   DE   +  K+ADFGL++       H  +G+ 
Sbjct: 133 LGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLL 187
Query: 463 GTLGYMAPEYLVRGQ--LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKA 520
           G   +MAPE +   +   TEKAD Y+F +++  + +G     F E         + + K 
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE--GPFDE---------YSYGKI 236
Query: 521 NRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
             I    + GL    PE+   R+  +  LC       RP  + +V  L+ +
Sbjct: 237 KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 8/216 (3%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           KLGQG  G V+ GT      +A+K L   +    + F  E  ++  ++H+ +V+L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 365 EGPESLLVYEYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           E P   +V EY+   SL  + F+K  T   L   Q   +    A G+A++     +  +H
Sbjct: 250 EEP-IYIVGEYMSKGSL--LDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 303
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +NIL+ E L  K+ADFGLAR +  ++     G    + + APE  + G+ T K+D
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
           V++FG+L+ E+ +  R       +  VL  V + Y+
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 399

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 123/267 (46%), Gaps = 18/267 (6%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           +KLG G  G V+ G   +   +AVK L   +   V  F  E NL+  +QH  +VRL    
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
            +     ++ E++   SL   L       +L   +        AEG+A++   +    IH
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFLKSDEGGKVLL-PKLIDFSAQIAEGMAYIERKN---YIH 132
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +N+L+ E L  KIADFGLAR +  ++     G    + + APE +  G  T K++
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSN 192
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRV 543
           V++FG+L+ E+ +  +       ++ V+  + + Y+  R+             EN    +
Sbjct: 193 VWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRM-------------ENCPDEL 239
Query: 544 LQIGLLCTQAPVALRPSMAEVVHMLNN 570
             I  +C +     RP+   +  +L++
Sbjct: 240 YDIMKMCWKEKAEERPTFDYLQSVLDD 266

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 129/289 (44%), Gaps = 25/289 (8%)
Query: 279 TVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQW 337
           T +  SS N+    +ER TD      KLG G  G V+ G        +AVK L  ++ + 
Sbjct: 1   TSMDPSSPNYDKWEMER-TDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME- 57
Query: 338 VDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKN--TIHILS 395
           V++F  E  ++  I+H N+V+LLG     P   ++ E++   +L   L   N   ++ + 
Sbjct: 58  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVV 117
Query: 396 WQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT 455
                T I    E L   +       IHRD+   N L+ E    K+ADFGL+R +  D  
Sbjct: 118 LLYMATQISSAMEYLEKKN------FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 171
Query: 456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVW 515
               G    + + APE L   + + K+DV+AFGVL+ E+A+   +       S V   + 
Sbjct: 172 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 231
Query: 516 KHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEV 564
           K Y+  R             PE    +V ++   C Q   + RPS AE+
Sbjct: 232 KDYRMER-------------PEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 109/216 (50%), Gaps = 8/216 (3%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           KLGQG  G V+ GT      +A+K L   +    + F  E  ++  ++H+ +V+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTI-HILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           E P   +V EY+   SL  + F+K  +   L   Q   +    A G+A++     +  +H
Sbjct: 84  EEP-IYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 137
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD+  +NIL+ E L  K+ADFGLAR +  ++     G    + + APE  + G+ T K+D
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
           V++FG+L+ E+ +  R       +  VL  V + Y+
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 233

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 129/289 (44%), Gaps = 25/289 (8%)
Query: 279 TVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQW 337
           T +  SS N+    +ER TD      KLG G  G V+ G        +AVK L  ++ + 
Sbjct: 1   TSMDPSSPNYDKWEMER-TDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME- 57
Query: 338 VDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKN--TIHILS 395
           V++F  E  ++  I+H N+V+LLG     P   ++ E++   +L   L   N   ++ + 
Sbjct: 58  VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV 117
Query: 396 WQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT 455
                T I    E L   +       IHRD+   N L+ E    K+ADFGL+R +  D  
Sbjct: 118 LLYMATQISSAMEYLEKKN------FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 171
Query: 456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVW 515
               G    + + APE L   + + K+DV+AFGVL+ E+A+   +       S V   + 
Sbjct: 172 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 231
Query: 516 KHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEV 564
           K Y+  R             PE    +V ++   C Q   + RPS AE+
Sbjct: 232 KDYRMER-------------PEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 11/201 (5%)
Query: 299 FFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVV 357
           + DN  K+G+G  G V   T+   G+ +AVK++    +Q  +  FNEV ++   QH+NVV
Sbjct: 75  YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVV 134
Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIIC-GTAEGLAHLHGG 416
            +    + G E  +V E++   +L  I+      H    +++   +C    + L+ LH  
Sbjct: 135 EMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQALSVLHAQ 189
Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG 476
               +IHRDIK+ +ILL      K++DFG    V+ +       + GT  +MAPE + R 
Sbjct: 190 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPYWMAPELISRL 245
Query: 477 QLTEKADVYAFGVLVIEVASG 497
               + D+++ G++VIE+  G
Sbjct: 246 PYGPEVDIWSLGIMVIEMVDG 266

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 11/201 (5%)
Query: 299 FFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVV 357
           + DN  K+G+G  G V   T+   G+ +AVK++    +Q  +  FNEV ++   QH+NVV
Sbjct: 152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVV 211
Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIIC-GTAEGLAHLHGG 416
            +    + G E  +V E++   +L  I+      H    +++   +C    + L+ LH  
Sbjct: 212 EMYNSYLVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLQALSVLHAQ 266
Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG 476
               +IHRDIK+ +ILL      K++DFG    V+  +      + GT  +MAPE + R 
Sbjct: 267 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKXLVGTPYWMAPELISRL 322
Query: 477 QLTEKADVYAFGVLVIEVASG 497
               + D+++ G++VIE+  G
Sbjct: 323 PYGPEVDIWSLGIMVIEMVDG 343

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 127/284 (44%), Gaps = 25/284 (8%)
Query: 284 SSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFF 342
           SS N+    +ER TD      KLG G  G V+ G        +AVK L  ++ + V++F 
Sbjct: 6   SSPNYDKWEMER-TDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFL 62
Query: 343 NEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKN--TIHILSWQQRF 400
            E  ++  I+H N+V+LLG     P   ++ E++   +L   L   N   ++ +      
Sbjct: 63  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 122
Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG 460
           T I    E L   +       IHRD+   N L+ E    K+ADFGL+R +  D      G
Sbjct: 123 TQISSAMEYLEKKN------FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAG 176
Query: 461 IAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKA 520
               + + APE L   + + K+DV+AFGVL+ E+A+   +       S V   + K Y+ 
Sbjct: 177 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 236
Query: 521 NRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEV 564
            R             PE    +V ++   C Q   + RPS AE+
Sbjct: 237 ER-------------PEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 109/216 (50%), Gaps = 8/216 (3%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           KLGQG  G V+ GT      +A+K L   +    + F  E  ++  ++H+ +V+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTI-HILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           E P   +V EY+    L  + F+K  +   L   Q   +    A G+A++     +  +H
Sbjct: 84  EEP-IYIVMEYMSKGCL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 137
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +NIL+ E L  K+ADFGLAR +  ++     G    + + APE  + G+ T K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
           V++FG+L+ E+ +  R       +  VL  V + Y+
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 233

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 118/261 (45%), Gaps = 19/261 (7%)
Query: 305 KLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           KLG G  G V+ G        +AVK L  ++ + V++F  E  ++  I+H N+V+LLG  
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
              P   ++ E++   +L   L   N   + S      +    +  + +L   +    IH
Sbjct: 77  TREPPFYIIIEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN---FIH 132
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD+   N L+ E    K+ADFGL+R +  D      G    + + APE L   + + K+D
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRV 543
           V+AFGVL+ E+A+   +       S V   + K Y+  R             PE    +V
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMER-------------PEGCPEKV 239
Query: 544 LQIGLLCTQAPVALRPSMAEV 564
            ++   C Q   + RPS AE+
Sbjct: 240 YELMRACWQWNPSDRPSFAEI 260

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 109/216 (50%), Gaps = 8/216 (3%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           KLGQG  G V+ GT      +A+K L   +    + F  E  ++  ++H+ +V+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTI-HILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           E P   +V EY+    L  + F+K  +   L   Q   +    A G+A++     +  +H
Sbjct: 84  EEP-IYIVTEYMSKGCL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 137
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +NIL+ E L  K+ADFGLAR +  ++     G    + + APE  + G+ T K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
           V++FG+L+ E+ +  R       +  VL  V + Y+
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 233

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 127/282 (45%), Gaps = 21/282 (7%)
Query: 284 SSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFF 342
           SS N+    +ER TD      KLG G  G V+ G        +AVK L  ++ + V++F 
Sbjct: 6   SSPNYDKWEMER-TDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFL 62
Query: 343 NEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI 402
            E  ++  I+H N+V+LLG     P   ++ E++   +L   L   N   + S      +
Sbjct: 63  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYM 121
Query: 403 ICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIA 462
               +  + +L   +    IHRD+   N L+ E    K+ADFGL+R +  D      G  
Sbjct: 122 ATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 178
Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR 522
             + + APE L   + + K+DV+AFGVL+ E+A+   +       S V   + K Y+  R
Sbjct: 179 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 238
Query: 523 ITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEV 564
                        PE    +V ++   C Q   + RPS AE+
Sbjct: 239 -------------PEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 127/277 (45%), Gaps = 22/277 (7%)
Query: 306 LGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE 365
           +G+G  G V +      +++A+K++   S +    F  E+  +S + H N+V+L G  + 
Sbjct: 17  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN 73
Query: 366 GPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRD 425
                LV EY    SL  +L     +   +     +     ++G+A+LH      +IHRD
Sbjct: 74  --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 131
Query: 426 IKTSNILLDEKLTP-KIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADV 484
           +K  N+LL    T  KI DFG A  +   +TH+ T   G+  +MAPE       +EK DV
Sbjct: 132 LKPPNLLLVAGGTVLKICDFGTACDI---QTHM-TNNKGSAAWMAPEVFEGSNYSEKCDV 187
Query: 485 YAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVL 544
           +++G+++ EV + R+   F E        +W  +   R      P L    P+   S + 
Sbjct: 188 FSWGIILWEVITRRKP--FDEIGGPAFRIMWAVHNGTR------PPLIKNLPKPIESLMT 239
Query: 545 QIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQP 581
           +    C     + RPSM E+V ++ ++    P   +P
Sbjct: 240 R----CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 272

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 127/277 (45%), Gaps = 22/277 (7%)
Query: 306 LGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE 365
           +G+G  G V +      +++A+K++   S +    F  E+  +S + H N+V+L G  + 
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 366 GPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRD 425
                LV EY    SL  +L     +   +     +     ++G+A+LH      +IHRD
Sbjct: 73  --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 426 IKTSNILLDEKLTP-KIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADV 484
           +K  N+LL    T  KI DFG A  +   +TH+ T   G+  +MAPE       +EK DV
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACDI---QTHM-TNNKGSAAWMAPEVFEGSNYSEKCDV 186
Query: 485 YAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVL 544
           +++G+++ EV + R+   F E        +W  +   R      P L    P+   S + 
Sbjct: 187 FSWGIILWEVITRRKP--FDEIGGPAFRIMWAVHNGTR------PPLIKNLPKPIESLMT 238
Query: 545 QIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQP 581
           +    C     + RPSM E+V ++ ++    P   +P
Sbjct: 239 R----CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 127/291 (43%), Gaps = 33/291 (11%)
Query: 303 SRKLGQGGAGSVFRGTL------PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNV 356
            R+LG+G  G VF           D   +AVK L   S      F  E  L++ +QH+++
Sbjct: 18  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 77
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVK----------NTIHILSWQQRFTIICGT 406
           V+  G  +EG   ++V+EY+ +  L++ L             N    L+  Q   I    
Sbjct: 78  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTL 465
           A G+ +L   +    +HRD+ T N L+ E L  KI DFG++R V + D   V       +
Sbjct: 138 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQ 525
            +M PE ++  + T ++DV++ GV++ E        +F+ G        W     N + +
Sbjct: 195 RWMPPESIMYRKFTTESDVWSLGVVLWE--------IFTYGKQP-----WYQLSNNEVIE 241
Query: 526 SMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIP 576
            +  G   + P      V ++ L C Q    +R ++  +  +L N+    P
Sbjct: 242 CITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 127/284 (44%), Gaps = 25/284 (8%)
Query: 284 SSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFF 342
           SS N+    +ER TD      KLG G  G V+ G        +AVK L  ++ + V++F 
Sbjct: 6   SSPNYDKWEMER-TDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFL 62
Query: 343 NEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKN--TIHILSWQQRF 400
            E  ++  I+H N+V+LLG     P   ++ E++   +L   L   N   ++ +      
Sbjct: 63  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 122
Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG 460
           T I    E L   +       IHRD+   N L+ E    K+ADFGL+R +  D      G
Sbjct: 123 TQISSAMEYLEKKN------FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 176
Query: 461 IAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKA 520
               + + APE L   + + K+DV+AFGVL+ E+A+   +       S V   + K Y+ 
Sbjct: 177 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 236
Query: 521 NRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEV 564
            R             PE    +V ++   C Q   + RPS AE+
Sbjct: 237 ER-------------PEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 118/261 (45%), Gaps = 19/261 (7%)
Query: 305 KLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           KLG G  G V+ G        +AVK L  ++ + V++F  E  ++  I+H N+V+LLG  
Sbjct: 18  KLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
              P   ++ E++   +L   L   N   + S      +    +  + +L   +    IH
Sbjct: 77  TREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN---FIH 132
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD+   N L+ E    K+ADFGL+R +  D      G    + + APE L   + + K+D
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRV 543
           V+AFGVL+ E+A+   +       S V   + K Y+  R             PE    +V
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMER-------------PEGCPEKV 239
Query: 544 LQIGLLCTQAPVALRPSMAEV 564
            ++   C Q   + RPS AE+
Sbjct: 240 YELMRACWQWNPSDRPSFAEI 260

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 118/263 (44%), Gaps = 23/263 (8%)
Query: 305 KLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           KLG G  G V+ G        +AVK L  ++ + V++F  E  ++  I+H N+V+LLG  
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKN--TIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
              P   ++ E++   +L   L   N   ++ +      T I    E L   +       
Sbjct: 80  TREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN------F 133
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEK 481
           IHRD+   N L+ E    K+ADFGL+R +  D      G    + + APE L   + + K
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIK 193
Query: 482 ADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEAS 541
           +DV+AFGVL+ E+A+   +       S V   + K Y+  R             PE    
Sbjct: 194 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-------------PEGCPE 240
Query: 542 RVLQIGLLCTQAPVALRPSMAEV 564
           +V ++   C Q   + RPS AE+
Sbjct: 241 KVYELMRACWQWNPSDRPSFAEI 263

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 118/263 (44%), Gaps = 23/263 (8%)
Query: 305 KLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           KLG G  G V+ G        +AVK L  ++ + V++F  E  ++  I+H N+V+LLG  
Sbjct: 24  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKN--TIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
              P   ++ E++   +L   L   N   ++ +      T I    E L   +       
Sbjct: 83  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN------F 136
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEK 481
           IHRD+   N L+ E    K+ADFGL+R +  D      G    + + APE L   + + K
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 196
Query: 482 ADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEAS 541
           +DV+AFGVL+ E+A+   +       S V   + K Y+  R             PE    
Sbjct: 197 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-------------PEGCPE 243
Query: 542 RVLQIGLLCTQAPVALRPSMAEV 564
           +V ++   C Q   + RPS AE+
Sbjct: 244 KVYELMRACWQWNPSDRPSFAEI 266

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 118/261 (45%), Gaps = 19/261 (7%)
Query: 305 KLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           KLG G  G V+ G        +AVK L  ++ + V++F  E  ++  I+H N+V+LLG  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
              P   ++ E++   +L   L   N   + S      +    +  + +L   +    IH
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN---FIH 134
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD+   N L+ E    K+ADFGL+R +  D      G    + + APE L   + + K+D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRV 543
           V+AFGVL+ E+A+   +       S V   + K Y+  R             PE    +V
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-------------PEGCPEKV 241
Query: 544 LQIGLLCTQAPVALRPSMAEV 564
            ++   C Q   + RPS AE+
Sbjct: 242 YELMRACWQWNPSDRPSFAEI 262

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 135/293 (46%), Gaps = 28/293 (9%)
Query: 278 GTVLCTSSLNF----KYEILERATDFFDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFF 332
           G  L T +L F    K+E +ER TD      KLG G  G V+ G        +AVK L  
Sbjct: 11  GVDLGTENLYFQSMDKWE-MER-TDI-TMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKE 67
Query: 333 NSRQWVDQFFNEVNLISGIQHKNVVRLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTI 391
           ++ + V++F  E  ++  I+H N+V+LLG C++E P   +V EY+P  +L   L   N  
Sbjct: 68  DTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTLE-PPFYIVTEYMPYGNLLDYLRECNRE 125
Query: 392 HILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA 451
            + +      +    +  + +L   +    IHRD+   N L+ E    K+ADFGL+R + 
Sbjct: 126 EVTA-VVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHVVKVADFGLSRLMT 181
Query: 452 PDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVL 511
            D      G    + + APE L     + K+DV+AFGVL+ E+A+   +       S V 
Sbjct: 182 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 241
Query: 512 HTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEV 564
             + K Y+  +             PE    +V ++   C +   A RPS AE 
Sbjct: 242 DLLEKGYRMEQ-------------PEGCPPKVYELMRACWKWSPADRPSFAET 281

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 109/216 (50%), Gaps = 8/216 (3%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           KLGQG  G V+ GT      +A+K L   +    + F  E  ++  ++H+ +V+L     
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTI-HILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           E P   +V EY+   SL  + F+K  +   L   Q   +    A G+A++     +  +H
Sbjct: 251 EEP-IYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVH 304
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +NIL+ E L  K+ADFGL R +  ++     G    + + APE  + G+ T K+D
Sbjct: 305 RDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 364
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
           V++FG+L+ E+ +  R       +  VL  V + Y+
Sbjct: 365 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR 400

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 118/263 (44%), Gaps = 23/263 (8%)
Query: 305 KLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           KLG G  G V+ G        +AVK L  ++ + V++F  E  ++  I+H N+V+LLG  
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKN--TIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
              P   ++ E++   +L   L   N   ++ +      T I    E L   +       
Sbjct: 80  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN------F 133
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEK 481
           IHRD+   N L+ E    K+ADFGL+R +  D      G    + + APE L   + + K
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIK 193
Query: 482 ADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEAS 541
           +DV+AFGVL+ E+A+   +       S V   + K Y+  R             PE    
Sbjct: 194 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-------------PEGCPE 240
Query: 542 RVLQIGLLCTQAPVALRPSMAEV 564
           +V ++   C Q   + RPS AE+
Sbjct: 241 KVYELMRACWQWNPSDRPSFAEI 263

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 118/261 (45%), Gaps = 19/261 (7%)
Query: 305 KLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           KLG G  G V+ G        +AVK L  ++ + V++F  E  ++  I+H N+V+LLG  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
              P   ++ E++   +L   L   N   + S      +    +  + +L   +    IH
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN---FIH 134
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD+   N L+ E    K+ADFGL+R +  D      G    + + APE L   + + K+D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRV 543
           V+AFGVL+ E+A+   +       S V   + K Y+  R             PE    +V
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-------------PEGCPEKV 241
Query: 544 LQIGLLCTQAPVALRPSMAEV 564
            ++   C Q   + RPS AE+
Sbjct: 242 YELMRACWQWNPSDRPSFAEI 262

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 118/261 (45%), Gaps = 19/261 (7%)
Query: 305 KLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           KLG G  G V+ G        +AVK L  ++ + V++F  E  ++  I+H N+V+LLG  
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
              P   ++ E++   +L   L   N   + S      +    +  + +L   +    IH
Sbjct: 77  TREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN---FIH 132
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD+   N L+ E    K+ADFGL+R +  D      G    + + APE L   + + K+D
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRV 543
           V+AFGVL+ E+A+   +       S V   + K Y+  R             PE    +V
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMER-------------PEGCPEKV 239
Query: 544 LQIGLLCTQAPVALRPSMAEV 564
            ++   C Q   + RPS AE+
Sbjct: 240 YELMRACWQWNPSDRPSFAEI 260

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 118/263 (44%), Gaps = 23/263 (8%)
Query: 305 KLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           KLG G  G V+ G        +AVK L  ++ + V++F  E  ++  I+H N+V+LLG  
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKN--TIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
              P   ++ E++   +L   L   N   ++ +      T I    E L   +       
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN------F 134
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEK 481
           IHRD+   N L+ E    K+ADFGL+R +  D      G    + + APE L   + + K
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIK 194
Query: 482 ADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEAS 541
           +DV+AFGVL+ E+A+   +       S V   + K Y+  R             PE    
Sbjct: 195 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-------------PEGCPE 241
Query: 542 RVLQIGLLCTQAPVALRPSMAEV 564
           +V ++   C Q   + RPS AE+
Sbjct: 242 KVYELMRACWQWNPSDRPSFAEI 264

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 133/284 (46%), Gaps = 35/284 (12%)
Query: 304 RKLGQGGAGSVFRGTLPD------GRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKN 355
           R+LGQG  G V+ G   D         +AVK +  ++  R+ + +F NE +++ G    +
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 81
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILF-----VKNTI--HILSWQQRFTIICGTAE 408
           VVRLLG   +G  +L+V E + +  L   L       +N       + Q+   +    A+
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG-- 466
           G+A+L+     K +HRD+   N ++    T KI DFG+ R +  +  +   G  G L   
Sbjct: 142 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY-ETAYYRKGGKGLLPVR 197
Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS 526
           +MAPE L  G  T  +D+++FGV++ E+ S          +  VL  V            
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV------------ 245
Query: 527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN 570
           MD G   + P+N   RV  +  +C Q    +RP+  E+V++L +
Sbjct: 246 MDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 288

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 118/263 (44%), Gaps = 23/263 (8%)
Query: 305 KLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           KLG G  G V+ G        +AVK L  ++ + V++F  E  ++  I+H N+V+LLG  
Sbjct: 33  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 91
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKN--TIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
              P   ++ E++   +L   L   N   ++ +      T I    E L   +       
Sbjct: 92  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN------F 145
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEK 481
           IHRD+   N L+ E    K+ADFGL+R +  D      G    + + APE L   + + K
Sbjct: 146 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 205
Query: 482 ADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEAS 541
           +DV+AFGVL+ E+A+   +       S V   + K Y+  R             PE    
Sbjct: 206 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-------------PEGCPE 252
Query: 542 RVLQIGLLCTQAPVALRPSMAEV 564
           +V ++   C Q   + RPS AE+
Sbjct: 253 KVYELMRACWQWNPSDRPSFAEI 275

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 131/291 (45%), Gaps = 35/291 (12%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQW-------VDQFFNEVNL 347
           A +  +  +++G+GG G V +G L  D   +A+K L     +          +F  EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 348 ISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTA 407
           +S + H N+V+L G     P   +V E+VP   L   L  K   H + W  +  ++   A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIA 132
Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILL---DEK--LTPKIADFGLARHVAPDKTHVSTGIA 462
            G+ ++       I+HRD+++ NI L   DE   +  K+ADFG ++       H  +G+ 
Sbjct: 133 LGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQ----SVHSVSGLL 187
Query: 463 GTLGYMAPEYLVRGQ--LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKA 520
           G   +MAPE +   +   TEKAD Y+F +++  + +G     F E         + + K 
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE--GPFDE---------YSYGKI 236
Query: 521 NRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
             I    + GL    PE+   R+  +  LC       RP  + +V  L+ +
Sbjct: 237 KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 99/200 (49%), Gaps = 9/200 (4%)
Query: 299 FFDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVV 357
             D+  K+G+G  G V        GR +AVK +    +Q  +  FNEV ++   QH NVV
Sbjct: 46  LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVV 105
Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
            +    + G E  ++ E++   +L  I+        L+ +Q  T+     + LA+LH   
Sbjct: 106 EMYKSYLVGEELWVLMEFLQGGALTDIVSQVR----LNEEQIATVCEAVLQALAYLHAQG 161
Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQ 477
              +IHRDIK+ +ILL      K++DFG    ++ D       + GT  +MAPE + R  
Sbjct: 162 ---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKXLVGTPYWMAPEVISRSL 217
Query: 478 LTEKADVYAFGVLVIEVASG 497
              + D+++ G++VIE+  G
Sbjct: 218 YATEVDIWSLGIMVIEMVDG 237

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 118/263 (44%), Gaps = 23/263 (8%)
Query: 305 KLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           KLG G  G V+ G        +AVK L  ++ + V++F  E  ++  I+H N+V+LLG  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKN--TIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
              P   ++ E++   +L   L   N   ++ +      T I    E L   +       
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN------F 132
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEK 481
           IHRD+   N L+ E    K+ADFGL+R +  D      G    + + APE L   + + K
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 482 ADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEAS 541
           +DV+AFGVL+ E+A+   +       S V   + K Y+  R             PE    
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-------------PEGCPE 239
Query: 542 RVLQIGLLCTQAPVALRPSMAEV 564
           +V ++   C Q   + RPS AE+
Sbjct: 240 KVYELMRACWQWNPSDRPSFAEI 262

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 141/302 (46%), Gaps = 40/302 (13%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFRGTL-------PDGRNIAVKRL--FFNSRQWVDQFFNE 344
           E A +    SR+LGQG  G V+ G         P+ R +A+K +    + R+ + +F NE
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERI-EFLNE 78
Query: 345 VNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPN-------RSLDQILFVKNTIHILSWQ 397
            +++      +VVRLLG   +G  +L++ E +         RSL   +     +   S  
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138
Query: 398 QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV 457
           +   +    A+G+A+L+     K +HRD+   N ++ E  T KI DFG+ R +  +  + 
Sbjct: 139 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-ETDYY 194
Query: 458 STGIAGTLG--YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVW 515
             G  G L   +M+PE L  G  T  +DV++FGV++ E+A+          +  VL  V 
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV- 253
Query: 516 KHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEI 575
                      M+ GL  + P+N    + ++  +C Q    +RPS  E++   ++I  E+
Sbjct: 254 -----------MEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEII---SSIKEEM 298
Query: 576 PP 577
            P
Sbjct: 299 EP 300

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 141/302 (46%), Gaps = 40/302 (13%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFRGTL-------PDGRNIAVKRL--FFNSRQWVDQFFNE 344
           E A +    SR+LGQG  G V+ G         P+ R +A+K +    + R+ + +F NE
Sbjct: 11  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERI-EFLNE 68
Query: 345 VNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPN-------RSLDQILFVKNTIHILSWQ 397
            +++      +VVRLLG   +G  +L++ E +         RSL   +     +   S  
Sbjct: 69  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 128
Query: 398 QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV 457
           +   +    A+G+A+L+     K +HRD+   N ++ E  T KI DFG+ R +  +  + 
Sbjct: 129 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-ETDYY 184
Query: 458 STGIAGTLG--YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVW 515
             G  G L   +M+PE L  G  T  +DV++FGV++ E+A+          +  VL  V 
Sbjct: 185 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV- 243
Query: 516 KHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEI 575
                      M+ GL  + P+N    + ++  +C Q    +RPS  E++   ++I  E+
Sbjct: 244 -----------MEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEII---SSIKEEM 288
Query: 576 PP 577
            P
Sbjct: 289 EP 290

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 133/284 (46%), Gaps = 35/284 (12%)
Query: 304 RKLGQGGAGSVFRGTLPD------GRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKN 355
           R+LGQG  G V+ G   D         +AVK +  ++  R+ + +F NE +++ G    +
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 81
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILF-----VKNTI--HILSWQQRFTIICGTAE 408
           VVRLLG   +G  +L+V E + +  L   L       +N       + Q+   +    A+
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG-- 466
           G+A+L+     K +HRD+   N ++    T KI DFG+ R +  +  +   G  G L   
Sbjct: 142 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY-ETDYYRKGGKGLLPVR 197
Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS 526
           +MAPE L  G  T  +D+++FGV++ E+ S          +  VL  V            
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV------------ 245
Query: 527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN 570
           MD G   + P+N   RV  +  +C Q    +RP+  E+V++L +
Sbjct: 246 MDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 288

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 118/261 (45%), Gaps = 19/261 (7%)
Query: 305 KLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           KLG G  G V+ G        +AVK L  ++ + V++F  E  ++  I+H N+V+LLG  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
              P   ++ E++   +L   L   N   + S      +    +  + +L   +    IH
Sbjct: 79  TREPPFYIIIEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN---FIH 134
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD+   N L+ E    K+ADFGL+R +  D      G    + + APE L   + + K+D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRV 543
           V+AFGVL+ E+A+   +       S V   + K Y+  R             PE    +V
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-------------PEGCPEKV 241
Query: 544 LQIGLLCTQAPVALRPSMAEV 564
            ++   C Q   + RPS AE+
Sbjct: 242 YELMRACWQWNPSDRPSFAEI 262

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 118/263 (44%), Gaps = 23/263 (8%)
Query: 305 KLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           KLG G  G V+ G        +AVK L  ++ + V++F  E  ++  I+H N+V+LLG  
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKN--TIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
              P   ++ E++   +L   L   N   ++ +      T I    E L   +       
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN------F 134
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEK 481
           IHRD+   N L+ E    K+ADFGL+R +  D      G    + + APE L   + + K
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 194
Query: 482 ADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEAS 541
           +DV+AFGVL+ E+A+   +       S V   + K Y+  R             PE    
Sbjct: 195 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-------------PEGCPE 241
Query: 542 RVLQIGLLCTQAPVALRPSMAEV 564
           +V ++   C Q   + RPS AE+
Sbjct: 242 KVYELMRACWQWNPSDRPSFAEI 264

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 118/263 (44%), Gaps = 23/263 (8%)
Query: 305 KLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           KLG G  G V+ G        +AVK L  ++ + V++F  E  ++  I+H N+V+LLG  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKN--TIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
              P   ++ E++   +L   L   N   ++ +      T I    E L   +       
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN------F 132
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEK 481
           IHRD+   N L+ E    K+ADFGL+R +  D      G    + + APE L   + + K
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 482 ADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEAS 541
           +DV+AFGVL+ E+A+   +       S V   + K Y+  R             PE    
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-------------PEGCPE 239
Query: 542 RVLQIGLLCTQAPVALRPSMAEV 564
           +V ++   C Q   + RPS AE+
Sbjct: 240 KVYELMRACWQWNPSDRPSFAEI 262

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 118/263 (44%), Gaps = 23/263 (8%)
Query: 305 KLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           KLG G  G V+ G        +AVK L  ++ + V++F  E  ++  I+H N+V+LLG  
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKN--TIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
              P   ++ E++   +L   L   N   ++ +      T I    E L   +       
Sbjct: 81  TREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN------F 134
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEK 481
           IHRD+   N L+ E    K+ADFGL+R +  D      G    + + APE L   + + K
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 194
Query: 482 ADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEAS 541
           +DV+AFGVL+ E+A+   +       S V   + K Y+  R             PE    
Sbjct: 195 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-------------PEGCPE 241
Query: 542 RVLQIGLLCTQAPVALRPSMAEV 564
           +V ++   C Q   + RPS AE+
Sbjct: 242 KVYELMRACWQWNPSDRPSFAEI 264

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 131/274 (47%), Gaps = 27/274 (9%)
Query: 306 LGQGGAGSVFRG--TLPDGRNIAVK----RLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +G G  G V  G   LP  + I+V     ++ +  +Q  D F  E +++    H N++RL
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRL 111
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G   +    ++V EY+ N SLD   F++      +  Q   ++ G A G+ +L   S +
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVA--PDKTHVSTGIAGTLGYMAPEYLVRGQ 477
             +HRD+   NIL++  L  K++DFGLAR +   P+  + + G    + + +PE +   +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 478 LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE 537
            T  +DV+++G+++ EV S      +   +  V+  V + Y+       + P      P 
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR-------LPP------PM 273
Query: 538 NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +  + + Q+ L C Q     RP   ++V +L+ +
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 118/261 (45%), Gaps = 19/261 (7%)
Query: 305 KLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           KLG G  G V+ G        +AVK L  ++ + V++F  E  ++  I+H N+V+LLG  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
              P   ++ E++   +L   L   N   + S      +    +  + +L   +    IH
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN---FIH 134
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD+   N L+ E    K+ADFGL+R +  D      G    + + APE L   + + K+D
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRV 543
           V+AFGVL+ E+A+   +       S V   + K Y+  R             PE    +V
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-------------PEGCPEKV 241
Query: 544 LQIGLLCTQAPVALRPSMAEV 564
            ++   C Q   + RPS AE+
Sbjct: 242 YELMRACWQWNPSDRPSFAEI 262

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 122/270 (45%), Gaps = 19/270 (7%)
Query: 303 SRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGC 362
            +KLG G  G V+  T      +AVK +   S   V+ F  E N++  +QH  +V+L   
Sbjct: 20  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV 78
Query: 363 SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
             + P  ++         LD +   + +   L     F+     AEG+A +   +    I
Sbjct: 79  VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS--AQIAEGMAFIEQRN---YI 133
Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKA 482
           HRD++ +NIL+   L  KIADFGLAR +  ++     G    + + APE +  G  T K+
Sbjct: 134 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 193
Query: 483 DVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASR 542
           DV++FG+L++E+ +  R       +  V+  + + Y+  R             PEN    
Sbjct: 194 DVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-------------PENCPEE 240
Query: 543 VLQIGLLCTQAPVALRPSMAEVVHMLNNID 572
           +  I + C +     RP+   +  +L++ +
Sbjct: 241 LYNIMMRCWKNRPEERPTFEYIQSVLDDFE 270

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 132/291 (45%), Gaps = 35/291 (12%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQW-------VDQFFNEVNL 347
           A +  +  +++G+GG G V +G L  D   +A+K L     +          +F  EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 348 ISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTA 407
           +S + H N+V+L G     P   +V E+VP   L   L  K   H + W  +  ++   A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIA 132
Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILL---DEK--LTPKIADFGLARHVAPDKTHVSTGIA 462
            G+ ++   +   I+HRD+++ NI L   DE   +  K+ADF L++       H  +G+ 
Sbjct: 133 LGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQ----SVHSVSGLL 187
Query: 463 GTLGYMAPEYLVRGQ--LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKA 520
           G   +MAPE +   +   TEKAD Y+F +++  + +G     F E         + + K 
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE--GPFDE---------YSYGKI 236
Query: 521 NRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
             I    + GL    PE+   R+  +  LC       RP  + +V  L+ +
Sbjct: 237 KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 100/196 (51%), Gaps = 9/196 (4%)
Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGC 362
            K+GQG +G+V+    +  G+ +A++++    +   +   NE+ ++   ++ N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 363 SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
            + G E  +V EY+   SL  ++    T   +   Q   +     + L  LH     ++I
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKA 482
           HRDIK+ NILL    + K+ DFG    + P+++  ST + GT  +MAPE + R     K 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKV 197
Query: 483 DVYAFGVLVIEVASGR 498
           D+++ G++ IE+  G 
Sbjct: 198 DIWSLGIMAIEMIEGE 213

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 113/202 (55%), Gaps = 16/202 (7%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLG 361
           +++G G  G+V++G      ++AVK L     + Q +  F NEV ++   +H N++  +G
Sbjct: 34  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 91
Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
            S + P+  +V ++    SL   L +  T       +   I   TA+G+ +LH  S   I
Sbjct: 92  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---I 145
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVSTGIAGTLGYMAPEYLVRGQ--- 477
           IHRD+K++NI L E LT KI DFGLA   +    +H    ++G++ +MAPE ++R Q   
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDKN 204
Query: 478 -LTEKADVYAFGVLVIEVASGR 498
             + ++DVYAFG+++ E+ +G+
Sbjct: 205 PYSFQSDVYAFGIVLYELMTGQ 226

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 133/284 (46%), Gaps = 35/284 (12%)
Query: 304 RKLGQGGAGSVFRGTLPD------GRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKN 355
           R+LGQG  G V+ G   D         +AVK +  ++  R+ + +F NE +++ G    +
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 80
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILF-----VKNTIH--ILSWQQRFTIICGTAE 408
           VVRLLG   +G  +L+V E + +  L   L       +N       + Q+   +    A+
Sbjct: 81  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 140
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG-- 466
           G+A+L+     K +HRD+   N ++    T KI DFG+ R +  +  +   G  G L   
Sbjct: 141 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIY-ETDYYRKGGKGLLPVR 196
Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS 526
           +MAPE L  G  T  +D+++FGV++ E+ S          +  VL  V            
Sbjct: 197 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV------------ 244
Query: 527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN 570
           MD G   + P+N   RV  +  +C Q    +RP+  E+V++L +
Sbjct: 245 MDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 287

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 141/302 (46%), Gaps = 40/302 (13%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFRGTL-------PDGRNIAVKRL--FFNSRQWVDQFFNE 344
           E A +    SR+LGQG  G V+ G         P+ R +A+K +    + R+ + +F NE
Sbjct: 6   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERI-EFLNE 63
Query: 345 VNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPN-------RSLDQILFVKNTIHILSWQ 397
            +++      +VVRLLG   +G  +L++ E +         RSL   +     +   S  
Sbjct: 64  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 123
Query: 398 QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV 457
           +   +    A+G+A+L+     K +HRD+   N ++ E  T KI DFG+ R +  +    
Sbjct: 124 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIX-ETDXX 179
Query: 458 STGIAGTLG--YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVW 515
             G  G L   +M+PE L  G  T  +DV++FGV++ E+A+          +  VL  V 
Sbjct: 180 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV- 238
Query: 516 KHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEI 575
                      M+ GL  + P+N    +L++  +C Q    +RPS  E++   ++I  E+
Sbjct: 239 -----------MEGGLLDK-PDNCPDMLLELMRMCWQYNPKMRPSFLEII---SSIKEEM 283
Query: 576 PP 577
            P
Sbjct: 284 EP 285

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 114/202 (56%), Gaps = 16/202 (7%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLG 361
           +++G G  G+V++G      ++AVK L     + Q +  F NEV ++   +H N++  +G
Sbjct: 14  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
            S + P+  +V ++    SL   L +  T   +   +   I   TA+G+ +LH  S   I
Sbjct: 72  YSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---I 125
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVSTGIAGTLGYMAPEYLVRGQ--- 477
           IHRD+K++NI L E LT KI DFGLA   +    +H    ++G++ +MAPE ++R Q   
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDKN 184
Query: 478 -LTEKADVYAFGVLVIEVASGR 498
             + ++DVYAFG+++ E+ +G+
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQ 206

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 131/274 (47%), Gaps = 27/274 (9%)
Query: 306 LGQGGAGSVFRG--TLPDGRNIAVK----RLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +G G  G V  G   LP  + I+V     ++ +  +Q  D F  E +++    H N++RL
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRL 111
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G   +    ++V EY+ N SLD   F++      +  Q   ++ G A G+ +L   S +
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVA--PDKTHVSTGIAGTLGYMAPEYLVRGQ 477
             +HRD+   NIL++  L  K++DFGL+R +   P+  + + G    + + +PE +   +
Sbjct: 167 GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 478 LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE 537
            T  +DV+++G+++ EV S      +   +  V+  V + Y+       + P      P 
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR-------LPP------PM 273
Query: 538 NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +  + + Q+ L C Q     RP   ++V +L+ +
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 113/202 (55%), Gaps = 16/202 (7%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLG 361
           +++G G  G+V++G      ++AVK L     + Q +  F NEV ++   +H N++  +G
Sbjct: 42  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
            S + P+  +V ++    SL   L +  T       +   I   TA+G+ +LH  S   I
Sbjct: 100 YSTK-PQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---I 153
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVSTGIAGTLGYMAPEYLVRGQ--- 477
           IHRD+K++NI L E LT KI DFGLA   +    +H    ++G++ +MAPE ++R Q   
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDKN 212
Query: 478 -LTEKADVYAFGVLVIEVASGR 498
             + ++DVYAFG+++ E+ +G+
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQ 234

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 132/284 (46%), Gaps = 35/284 (12%)
Query: 304 RKLGQGGAGSVFRGTLPD------GRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKN 355
           R+LGQG  G V+ G   D         +AVK +  ++  R+ + +F NE +++ G    +
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 81
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILF-----VKNTIH--ILSWQQRFTIICGTAE 408
           VVRLLG   +G  +L+V E + +  L   L       +N       + Q+   +    A+
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG-- 466
           G+A+L+     K +HRD+   N ++    T KI DFG+ R +  +      G  G L   
Sbjct: 142 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIX-ETDXXRKGGKGLLPVR 197
Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS 526
           +MAPE L  G  T  +D+++FGV++ E+ S          +  VL  V            
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV------------ 245
Query: 527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN 570
           MD G   + P+N   RV  +  +C Q    +RP+  E+V++L +
Sbjct: 246 MDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 288

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 132/284 (46%), Gaps = 35/284 (12%)
Query: 304 RKLGQGGAGSVFRGTLPD------GRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKN 355
           R+LGQG  G V+ G   D         +AVK +  ++  R+ + +F NE +++ G    +
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 78
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILF-----VKNTIH--ILSWQQRFTIICGTAE 408
           VVRLLG   +G  +L+V E + +  L   L       +N       + Q+   +    A+
Sbjct: 79  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 138
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG-- 466
           G+A+L+     K +HRD+   N ++    T KI DFG+ R +  +      G  G L   
Sbjct: 139 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIX-ETDXXRKGGKGLLPVR 194
Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS 526
           +MAPE L  G  T  +D+++FGV++ E+ S          +  VL  V            
Sbjct: 195 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV------------ 242
Query: 527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN 570
           MD G   + P+N   RV  +  +C Q    +RP+  E+V++L +
Sbjct: 243 MDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 285

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 141/302 (46%), Gaps = 40/302 (13%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFRGTL-------PDGRNIAVKRL--FFNSRQWVDQFFNE 344
           E A +    SR+LGQG  G V+ G         P+ R +A+K +    + R+ + +F NE
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERI-EFLNE 78
Query: 345 VNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPN-------RSLDQILFVKNTIHILSWQ 397
            +++      +VVRLLG   +G  +L++ E +         RSL   +     +   S  
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 138
Query: 398 QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV 457
           +   +    A+G+A+L+     K +HRD+   N ++ E  T KI DFG+ R +  +  + 
Sbjct: 139 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-ETDYY 194
Query: 458 STGIAGTLG--YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVW 515
             G  G L   +M+PE L  G  T  +DV++FGV++ E+A+          +  VL  V 
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV- 253
Query: 516 KHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEI 575
                      M+ GL  + P+N    + ++  +C Q    +RPS  E++   ++I  E+
Sbjct: 254 -----------MEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEII---SSIKEEM 298
Query: 576 PP 577
            P
Sbjct: 299 EP 300

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 141/302 (46%), Gaps = 40/302 (13%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFRGTL-------PDGRNIAVKRL--FFNSRQWVDQFFNE 344
           E A +    SR+LGQG  G V+ G         P+ R +A+K +    + R+ + +F NE
Sbjct: 12  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERI-EFLNE 69
Query: 345 VNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPN-------RSLDQILFVKNTIHILSWQ 397
            +++      +VVRLLG   +G  +L++ E +         RSL   +     +   S  
Sbjct: 70  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 129
Query: 398 QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV 457
           +   +    A+G+A+L+     K +HRD+   N ++ E  T KI DFG+ R +  +  + 
Sbjct: 130 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-ETDYY 185
Query: 458 STGIAGTLG--YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVW 515
             G  G L   +M+PE L  G  T  +DV++FGV++ E+A+          +  VL  V 
Sbjct: 186 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV- 244
Query: 516 KHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEI 575
                      M+ GL  + P+N    + ++  +C Q    +RPS  E++   ++I  E+
Sbjct: 245 -----------MEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEII---SSIKEEM 289
Query: 576 PP 577
            P
Sbjct: 290 EP 291

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 131/274 (47%), Gaps = 27/274 (9%)
Query: 306 LGQGGAGSVFRG--TLPDGRNIAVK----RLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +G G  G V  G   LP  + I+V     ++ +  +Q  D F  E +++    H N++RL
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRL 111
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G   +    ++V EY+ N SLD   F++      +  Q   ++ G A G+ +L   S +
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVA--PDKTHVSTGIAGTLGYMAPEYLVRGQ 477
             +HRD+   NIL++  L  K++DFGL+R +   P+  + + G    + + +PE +   +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 478 LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE 537
            T  +DV+++G+++ EV S      +   +  V+  V + Y+       + P      P 
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR-------LPP------PM 273
Query: 538 NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +  + + Q+ L C Q     RP   ++V +L+ +
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 131/274 (47%), Gaps = 27/274 (9%)
Query: 306 LGQGGAGSVFRG--TLPDGRNIAVK----RLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +G G  G V  G   LP  + I+V     ++ +  +Q  D F  E +++    H N++RL
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRL 111
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G   +    ++V EY+ N SLD   F++      +  Q   ++ G A G+ +L   S +
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVA--PDKTHVSTGIAGTLGYMAPEYLVRGQ 477
             +HRD+   NIL++  L  K++DFGL+R +   P+  + + G    + + +PE +   +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 478 LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE 537
            T  +DV+++G+++ EV S      +   +  V+  V + Y+       + P      P 
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR-------LPP------PM 273
Query: 538 NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +  + + Q+ L C Q     RP   ++V +L+ +
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 131/274 (47%), Gaps = 27/274 (9%)
Query: 306 LGQGGAGSVFRG--TLPDGRNIAVK----RLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +G G  G V  G   LP  + I+V     ++ +  +Q  D F  E +++    H N++RL
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRL 111
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G   +    ++V EY+ N SLD   F++      +  Q   ++ G A G+ +L   S +
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVA--PDKTHVSTGIAGTLGYMAPEYLVRGQ 477
             +HRD+   NIL++  L  K++DFGL+R +   P+  + + G    + + +PE +   +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 478 LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE 537
            T  +DV+++G+++ EV S      +   +  V+  V + Y+       + P      P 
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR-------LPP------PM 273
Query: 538 NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +  + + Q+ L C Q     RP   ++V +L+ +
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 110/208 (52%), Gaps = 9/208 (4%)
Query: 292 ILERATDFFDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISG 350
           + ++  + FD   KLG+G  GSV++    + G+ +A+K++   S   + +   E++++  
Sbjct: 23  LTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQ 80
Query: 351 IQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGL 410
               +VV+  G   +  +  +V EY    S+  I+ ++N    L+  +  TI+  T +GL
Sbjct: 81  CDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGL 138
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAP 470
            +LH    ++ IHRDIK  NILL+ +   K+ADFG+A  +  D       + GT  +MAP
Sbjct: 139 EYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT-DXMAKRNXVIGTPFWMAP 194
Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASGR 498
           E +        AD+++ G+  IE+A G+
Sbjct: 195 EVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 132/284 (46%), Gaps = 35/284 (12%)
Query: 304 RKLGQGGAGSVFRGTLPD------GRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKN 355
           R+LGQG  G V+ G   D         +AVK +  ++  R+ + +F NE +++ G    +
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 81
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILF-----VKNTI--HILSWQQRFTIICGTAE 408
           VVRLLG   +G  +L+V E + +  L   L       +N       + Q+   +    A+
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG-- 466
           G+A+L+     K +HRD+   N ++    T KI DFG+ R +  +      G  G L   
Sbjct: 142 GMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIX-ETDXXRKGGKGLLPVR 197
Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS 526
           +MAPE L  G  T  +D+++FGV++ E+ S          +  VL  V            
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV------------ 245
Query: 527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN 570
           MD G   + P+N   RV  +  +C Q    +RP+  E+V++L +
Sbjct: 246 MDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKD 288

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 141/302 (46%), Gaps = 40/302 (13%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFRGTL-------PDGRNIAVKRL--FFNSRQWVDQFFNE 344
           E A +    SR+LGQG  G V+ G         P+ R +A+K +    + R+ + +F NE
Sbjct: 43  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERI-EFLNE 100
Query: 345 VNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPN-------RSLDQILFVKNTIHILSWQ 397
            +++      +VVRLLG   +G  +L++ E +         RSL   +     +   S  
Sbjct: 101 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 160
Query: 398 QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV 457
           +   +    A+G+A+L+     K +HRD+   N ++ E  T KI DFG+ R +  +  + 
Sbjct: 161 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-ETDYY 216
Query: 458 STGIAGTLG--YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVW 515
             G  G L   +M+PE L  G  T  +DV++FGV++ E+A+          +  VL  V 
Sbjct: 217 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV- 275
Query: 516 KHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEI 575
                      M+ GL  + P+N    + ++  +C Q    +RPS  E++   ++I  E+
Sbjct: 276 -----------MEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEII---SSIKEEM 320
Query: 576 PP 577
            P
Sbjct: 321 EP 322

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 141/302 (46%), Gaps = 40/302 (13%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFRGTL-------PDGRNIAVKRL--FFNSRQWVDQFFNE 344
           E A +    SR+LGQG  G V+ G         P+ R +A+K +    + R+ + +F NE
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERI-EFLNE 71
Query: 345 VNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPN-------RSLDQILFVKNTIHILSWQ 397
            +++      +VVRLLG   +G  +L++ E +         RSL   +     +   S  
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 131
Query: 398 QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV 457
           +   +    A+G+A+L+     K +HRD+   N ++ E  T KI DFG+ R +  +  + 
Sbjct: 132 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-ETDYY 187
Query: 458 STGIAGTLG--YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVW 515
             G  G L   +M+PE L  G  T  +DV++FGV++ E+A+          +  VL  V 
Sbjct: 188 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV- 246
Query: 516 KHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEI 575
                      M+ GL  + P+N    + ++  +C Q    +RPS  E++   ++I  E+
Sbjct: 247 -----------MEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEII---SSIKEEM 291
Query: 576 PP 577
            P
Sbjct: 292 EP 293

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 141/302 (46%), Gaps = 40/302 (13%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFRGTL-------PDGRNIAVKRL--FFNSRQWVDQFFNE 344
           E A +    SR+LGQG  G V+ G         P+ R +A+K +    + R+ + +F NE
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERI-EFLNE 65
Query: 345 VNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPN-------RSLDQILFVKNTIHILSWQ 397
            +++      +VVRLLG   +G  +L++ E +         RSL   +     +   S  
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 398 QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV 457
           +   +    A+G+A+L+     K +HRD+   N  + E  T KI DFG+ R +  +  + 
Sbjct: 126 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIY-ETDYY 181
Query: 458 STGIAGTLG--YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVW 515
             G  G L   +M+PE L  G  T  +DV++FGV++ E+A+          +  VL  V 
Sbjct: 182 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV- 240
Query: 516 KHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEI 575
                      M+ GL  + P+N    +L++  +C Q    +RPS  E++   ++I  E+
Sbjct: 241 -----------MEGGLLDK-PDNCPDMLLELMRMCWQYNPKMRPSFLEII---SSIKEEM 285
Query: 576 PP 577
            P
Sbjct: 286 EP 287

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 141/302 (46%), Gaps = 40/302 (13%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFRGTL-------PDGRNIAVKRL--FFNSRQWVDQFFNE 344
           E A +    SR+LGQG  G V+ G         P+ R +A+K +    + R+ + +F NE
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERI-EFLNE 72
Query: 345 VNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPN-------RSLDQILFVKNTIHILSWQ 397
            +++      +VVRLLG   +G  +L++ E +         RSL   +     +   S  
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 132
Query: 398 QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV 457
           +   +    A+G+A+L+     K +HRD+   N ++ E  T KI DFG+ R +  +  + 
Sbjct: 133 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-ETDYY 188
Query: 458 STGIAGTLG--YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVW 515
             G  G L   +M+PE L  G  T  +DV++FGV++ E+A+          +  VL  V 
Sbjct: 189 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV- 247
Query: 516 KHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEI 575
                      M+ GL  + P+N    + ++  +C Q    +RPS  E++   ++I  E+
Sbjct: 248 -----------MEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEII---SSIKEEM 292
Query: 576 PP 577
            P
Sbjct: 293 EP 294

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 131/274 (47%), Gaps = 27/274 (9%)
Query: 306 LGQGGAGSVFRG--TLPDGRNIAVK----RLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +G G  G V  G   LP  + I+V     ++ +  +Q  D F  E +++    H N++RL
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRL 109
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G   +    ++V EY+ N SLD   F++      +  Q   ++ G A G+ +L   S +
Sbjct: 110 EGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 164
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVA--PDKTHVSTGIAGTLGYMAPEYLVRGQ 477
             +HRD+   NIL++  L  K++DFGL+R +   P+  + + G    + + +PE +   +
Sbjct: 165 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 224
Query: 478 LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE 537
            T  +DV+++G+++ EV S      +   +  V+  V + Y+       + P      P 
Sbjct: 225 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR-------LPP------PM 271
Query: 538 NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +  + + Q+ L C Q     RP   ++V +L+ +
Sbjct: 272 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 305

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 131/274 (47%), Gaps = 27/274 (9%)
Query: 306 LGQGGAGSVFRG--TLPDGRNIAVK----RLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +G G  G V  G   LP  + I+V     ++ +  +Q  D F  E +++    H N++RL
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRL 111
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G   +    ++V EY+ N SLD   F++      +  Q   ++ G A G+ +L   S +
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVA--PDKTHVSTGIAGTLGYMAPEYLVRGQ 477
             +HRD+   NIL++  L  K++DFGL+R +   P+  + + G    + + +PE +   +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 478 LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE 537
            T  +DV+++G+++ EV S      +   +  V+  V + Y+       + P      P 
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR-------LPP------PM 273
Query: 538 NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +  + + Q+ L C Q     RP   ++V +L+ +
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 141/302 (46%), Gaps = 40/302 (13%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFRGTL-------PDGRNIAVKRL--FFNSRQWVDQFFNE 344
           E A +    SR+LGQG  G V+ G         P+ R +A+K +    + R+ + +F NE
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERI-EFLNE 65
Query: 345 VNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPN-------RSLDQILFVKNTIHILSWQ 397
            +++      +VVRLLG   +G  +L++ E +         RSL   +     +   S  
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 398 QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV 457
           +   +    A+G+A+L+     K +HRD+   N ++ E  T KI DFG+ R +  +  + 
Sbjct: 126 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-ETDYY 181
Query: 458 STGIAGTLG--YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVW 515
             G  G L   +M+PE L  G  T  +DV++FGV++ E+A+          +  VL  V 
Sbjct: 182 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV- 240
Query: 516 KHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEI 575
                      M+ GL  + P+N    + ++  +C Q    +RPS  E++   ++I  E+
Sbjct: 241 -----------MEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEII---SSIKEEM 285
Query: 576 PP 577
            P
Sbjct: 286 EP 287

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 141/302 (46%), Gaps = 40/302 (13%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFRGTL-------PDGRNIAVKRL--FFNSRQWVDQFFNE 344
           E A +    SR+LGQG  G V+ G         P+ R +A+K +    + R+ + +F NE
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERI-EFLNE 71
Query: 345 VNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPN-------RSLDQILFVKNTIHILSWQ 397
            +++      +VVRLLG   +G  +L++ E +         RSL   +     +   S  
Sbjct: 72  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 131
Query: 398 QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV 457
           +   +    A+G+A+L+     K +HRD+   N ++ E  T KI DFG+ R +  +  + 
Sbjct: 132 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY-ETDYY 187
Query: 458 STGIAGTLG--YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVW 515
             G  G L   +M+PE L  G  T  +DV++FGV++ E+A+          +  VL  V 
Sbjct: 188 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV- 246
Query: 516 KHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEI 575
                      M+ GL  + P+N    + ++  +C Q    +RPS  E++   ++I  E+
Sbjct: 247 -----------MEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEII---SSIKEEM 291
Query: 576 PP 577
            P
Sbjct: 292 EP 293

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 131/274 (47%), Gaps = 27/274 (9%)
Query: 306 LGQGGAGSVFRG--TLPDGRNIAVK----RLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +G G  G V  G   LP  + I+V     ++ +  +Q  D F  E +++    H N++RL
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRL 82
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G   +    ++V EY+ N SLD   F++      +  Q   ++ G A G+ +L   S +
Sbjct: 83  EGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 137
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVA--PDKTHVSTGIAGTLGYMAPEYLVRGQ 477
             +HRD+   NIL++  L  K++DFGL+R +   P+  + + G    + + +PE +   +
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 197
Query: 478 LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE 537
            T  +DV+++G+++ EV S      +   +  V+  V + Y+       + P      P 
Sbjct: 198 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR-------LPP------PM 244
Query: 538 NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +  + + Q+ L C Q     RP   ++V +L+ +
Sbjct: 245 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 131/274 (47%), Gaps = 27/274 (9%)
Query: 306 LGQGGAGSVFRGTL--PDGRNI--AVKRL--FFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +G G  G V  G L  P  R I  A+K L   +  +Q  D F +E +++    H N++ L
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRD-FLSEASIMGQFDHPNIIHL 95
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G   +    +++ EY+ N SLD   F++      +  Q   ++ G   G+ +L   S +
Sbjct: 96  EGVVTKCKPVMIITEYMENGSLDA--FLRKNDGRFTVIQLVGMLRGIGSGMKYL---SDM 150
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVA--PDKTHVSTGIAGTLGYMAPEYLVRGQ 477
             +HRD+   NIL++  L  K++DFG++R +   P+  + + G    + + APE +   +
Sbjct: 151 SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 210
Query: 478 LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE 537
            T  +DV+++G+++ EV S      +   +  V+  + + Y   R+   MD  +      
Sbjct: 211 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGY---RLPPPMDCPIA----- 262
Query: 538 NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
                + Q+ L C Q   + RP   ++V+ML+ +
Sbjct: 263 -----LHQLMLDCWQKERSDRPKFGQIVNMLDKL 291

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 121/267 (45%), Gaps = 19/267 (7%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           +KLG G  G V+  T      +AVK +   S   V+ F  E N++  +QH  +V+L    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
            + P  ++         LD +   + +   L     F+     AEG+A +   +    IH
Sbjct: 253 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS--AQIAEGMAFIEQRN---YIH 307
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +NIL+   L  KIADFGLAR +  ++     G    + + APE +  G  T K+D
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRV 543
           V++FG+L++E+ +  R       +  V+  + + Y+  R             PEN    +
Sbjct: 368 VWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-------------PENCPEEL 414
Query: 544 LQIGLLCTQAPVALRPSMAEVVHMLNN 570
             I + C +     RP+   +  +L++
Sbjct: 415 YNIMMRCWKNRPEERPTFEYIQSVLDD 441

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 108/217 (49%), Gaps = 8/217 (3%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           ++LG G  G V+ GT      +A+K L   +    + F  E  ++  ++H  +V+L    
Sbjct: 15  KRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMS-PESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKN-TIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
            E P   +V EY+   SL  + F+K+     L       +    A G+A++     +  I
Sbjct: 74  SEEP-IYIVTEYMNKGSL--LDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYI 127
Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKA 482
           HRD++++NIL+   L  KIADFGLAR +  ++     G    + + APE  + G+ T K+
Sbjct: 128 HRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 483 DVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
           DV++FG+L+ E+ +  R       +  VL  V + Y+
Sbjct: 188 DVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR 224

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 131/274 (47%), Gaps = 27/274 (9%)
Query: 306 LGQGGAGSVFRG--TLPDGRNIAVK----RLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +G G  G V  G   LP  + I+V     ++ +  +Q  D F  E +++    H N++RL
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRL 99
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G   +    ++V EY+ N SLD   F++      +  Q   ++ G A G+ +L   S +
Sbjct: 100 EGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 154
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVA--PDKTHVSTGIAGTLGYMAPEYLVRGQ 477
             +HRD+   NIL++  L  K++DFGL+R +   P+  + + G    + + +PE +   +
Sbjct: 155 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 214
Query: 478 LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE 537
            T  +DV+++G+++ EV S      +   +  V+  V + Y+       + P      P 
Sbjct: 215 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR-------LPP------PM 261
Query: 538 NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +  + + Q+ L C Q     RP   ++V +L+ +
Sbjct: 262 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 295

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 130/274 (47%), Gaps = 27/274 (9%)
Query: 306 LGQGGAGSVFRG--TLPDGRNIAVK----RLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +G G  G V  G   LP  + I+V     ++ +  +Q  D F  E +++    H N++RL
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRL 111
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G   +    ++V EY+ N SLD   F++      +  Q   ++ G A G+ +L   S +
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVA--PDKTHVSTGIAGTLGYMAPEYLVRGQ 477
             +HRD+   NIL++  L  K++DFGL R +   P+  + + G    + + +PE +   +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 478 LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE 537
            T  +DV+++G+++ EV S      +   +  V+  V + Y+       + P      P 
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR-------LPP------PM 273
Query: 538 NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +  + + Q+ L C Q     RP   ++V +L+ +
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 140/302 (46%), Gaps = 40/302 (13%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFRGTL-------PDGRNIAVKRL--FFNSRQWVDQFFNE 344
           E A +    SR+LGQG  G V+ G         P+ R +A+K +    + R+ + +F NE
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAASMRERI-EFLNE 72
Query: 345 VNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPN-------RSLDQILFVKNTIHILSWQ 397
            +++      +VVRLLG   +G  +L++ E +         RSL   +     +   S  
Sbjct: 73  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 132
Query: 398 QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV 457
           +   +    A+G+A+L+     K +HRD+   N ++ E  T KI DFG+ R +  +    
Sbjct: 133 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIX-ETDXX 188
Query: 458 STGIAGTLG--YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVW 515
             G  G L   +M+PE L  G  T  +DV++FGV++ E+A+          +  VL  V 
Sbjct: 189 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV- 247
Query: 516 KHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEI 575
                      M+ GL  + P+N    + ++  +C Q    +RPS  E++   ++I  E+
Sbjct: 248 -----------MEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEII---SSIKEEM 292
Query: 576 PP 577
            P
Sbjct: 293 EP 294

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 131/274 (47%), Gaps = 27/274 (9%)
Query: 306 LGQGGAGSVFRGTL--PDGRNI--AVKRLF--FNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +G G  G V  G L  P  R I  A+K L   +  +Q  D F +E +++    H N++ L
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRD-FLSEASIMGQFDHPNIIHL 80
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G   +    +++ EY+ N SLD   F++      +  Q   ++ G   G+ +L   S +
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDA--FLRKNDGRFTVIQLVGMLRGIGSGMKYL---SDM 135
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVA--PDKTHVSTGIAGTLGYMAPEYLVRGQ 477
             +HRD+   NIL++  L  K++DFG++R +   P+  + + G    + + APE +   +
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 195
Query: 478 LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE 537
            T  +DV+++G+++ EV S      +   +  V+  + + Y   R+   MD  +      
Sbjct: 196 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGY---RLPPPMDCPIA----- 247
Query: 538 NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
                + Q+ L C Q   + RP   ++V+ML+ +
Sbjct: 248 -----LHQLMLDCWQKERSDRPKFGQIVNMLDKL 276

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 113/202 (55%), Gaps = 16/202 (7%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLG 361
           +++G G  G+V++G      ++AVK L     + Q +  F NEV ++   +H N++  +G
Sbjct: 16  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 73
Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
            S + P+  +V ++    SL   L +  T       +   I   TA+G+ +LH  S   I
Sbjct: 74  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---I 127
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVSTGIAGTLGYMAPEYLVRGQ--- 477
           IHRD+K++NI L E LT KI DFGLA   +    +H    ++G++ +MAPE ++R Q   
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-VIRMQDKN 186
Query: 478 -LTEKADVYAFGVLVIEVASGR 498
             + ++DVYAFG+++ E+ +G+
Sbjct: 187 PYSFQSDVYAFGIVLYELMTGQ 208

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 113/202 (55%), Gaps = 16/202 (7%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLG 361
           +++G G  G+V++G      ++AVK L     + Q +  F NEV ++   +H N++  +G
Sbjct: 19  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
            S + P+  +V ++    SL   L +  T       +   I   TA+G+ +LH  S   I
Sbjct: 77  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---I 130
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVSTGIAGTLGYMAPEYLVRGQ--- 477
           IHRD+K++NI L E LT KI DFGLA   +    +H    ++G++ +MAPE ++R Q   
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-VIRMQDKN 189
Query: 478 -LTEKADVYAFGVLVIEVASGR 498
             + ++DVYAFG+++ E+ +G+
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQ 211

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 114/202 (56%), Gaps = 16/202 (7%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLG 361
           +++G G  G+V++G      ++AVK L     + Q +  F NEV ++   +H N++  +G
Sbjct: 14  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
            S + P+  +V ++    SL   L +  T   +   +   I   TA+G+ +LH  S   I
Sbjct: 72  YSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---I 125
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVSTGIAGTLGYMAPEYLVRGQ--- 477
           IHRD+K++NI L E LT KI DFGLA   +    +H    ++G++ +MAPE ++R Q   
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-VIRMQDKN 184
Query: 478 -LTEKADVYAFGVLVIEVASGR 498
             + ++DVYAFG+++ E+ +G+
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 113/202 (55%), Gaps = 16/202 (7%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLG 361
           +++G G  G+V++G      ++AVK L     + Q +  F NEV ++   +H N++  +G
Sbjct: 42  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
            S + P+  +V ++    SL   L +  T       +   I   TA+G+ +LH  S   I
Sbjct: 100 YSTK-PQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---I 153
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVSTGIAGTLGYMAPEYLVRGQ--- 477
           IHRD+K++NI L E LT KI DFGLA   +    +H    ++G++ +MAPE ++R Q   
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-VIRMQDKN 212
Query: 478 -LTEKADVYAFGVLVIEVASGR 498
             + ++DVYAFG+++ E+ +G+
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 113/202 (55%), Gaps = 16/202 (7%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLG 361
           +++G G  G+V++G      ++AVK L     + Q +  F NEV ++   +H N++  +G
Sbjct: 41  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 98
Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
            S + P+  +V ++    SL   L +  T       +   I   TA+G+ +LH  S   I
Sbjct: 99  YSTK-PQLAIVTQWCEGSSLYHHLHIIETK--FEMIKLIDIARQTAQGMDYLHAKS---I 152
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVSTGIAGTLGYMAPEYLVRGQ--- 477
           IHRD+K++NI L E LT KI DFGLA   +    +H    ++G++ +MAPE ++R Q   
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-VIRMQDKN 211
Query: 478 -LTEKADVYAFGVLVIEVASGR 498
             + ++DVYAFG+++ E+ +G+
Sbjct: 212 PYSFQSDVYAFGIVLYELMTGQ 233

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/274 (25%), Positives = 131/274 (47%), Gaps = 27/274 (9%)
Query: 306 LGQGGAGSVFRGTL--PDGRNI--AVKRL--FFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +G G  G V  G L  P  R I  A+K L   +  +Q  D F +E +++    H N++ L
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRD-FLSEASIMGQFDHPNIIHL 74
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G   +    +++ EY+ N SLD   F++      +  Q   ++ G   G+ +L   S +
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDA--FLRKNDGRFTVIQLVGMLRGIGSGMKYL---SDM 129
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVA--PDKTHVSTGIAGTLGYMAPEYLVRGQ 477
             +HRD+   NIL++  L  K++DFG++R +   P+  + + G    + + APE +   +
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 189
Query: 478 LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE 537
            T  +DV+++G+++ EV S      +   +  V+  + + Y   R+   MD  +      
Sbjct: 190 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGY---RLPPPMDCPIA----- 241
Query: 538 NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
                + Q+ L C Q   + RP   ++V+ML+ +
Sbjct: 242 -----LHQLMLDCWQKERSDRPKFGQIVNMLDKL 270

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 114/202 (56%), Gaps = 16/202 (7%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLG 361
           +++G G  G+V++G      ++AVK L     + Q +  F NEV ++   +H N++  +G
Sbjct: 19  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
            S + P+  +V ++    SL   L +  T   +   +   I   TA+G+ +LH  S   I
Sbjct: 77  YSTK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---I 130
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVSTGIAGTLGYMAPEYLVRGQ--- 477
           IHRD+K++NI L E LT KI DFGLA   +    +H    ++G++ +MAPE ++R Q   
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-VIRMQDKN 189
Query: 478 -LTEKADVYAFGVLVIEVASGR 498
             + ++DVYAFG+++ E+ +G+
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 122/268 (45%), Gaps = 19/268 (7%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           +++G G  G V  G   +   +A+K +   S    D F  E  ++  + H  +V+L G  
Sbjct: 33  QEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMS-EDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           +E     LV+E++ +  L    +++    + + +    +     EG+A+L       +IH
Sbjct: 92  LEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 146
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD+   N L+ E    K++DFG+ R V  D+   STG    + + +PE     + + K+D
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 206
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRV 543
           V++FGVL+ E        VFSEG        +++   + + + +  G     P   ++ V
Sbjct: 207 VWSFGVLMWE--------VFSEGK-----IPYENRSNSEVVEDISTGFRLYKPRLASTHV 253
Query: 544 LQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            QI   C +     RP+ + ++  L  I
Sbjct: 254 YQIMNHCWKERPEDRPAFSRLLRQLAEI 281

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 113/202 (55%), Gaps = 16/202 (7%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLG 361
           +++G G  G+V++G      ++AVK L     + Q +  F NEV ++   +H N++  +G
Sbjct: 14  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
            S   P+  +V ++    SL   L +  T   +   +   I   TA+G+ +LH  S   I
Sbjct: 72  YST-APQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---I 125
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVSTGIAGTLGYMAPEYLVRGQ--- 477
           IHRD+K++NI L E LT KI DFGLA   +    +H    ++G++ +MAPE ++R Q   
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-VIRMQDKN 184
Query: 478 -LTEKADVYAFGVLVIEVASGR 498
             + ++DVYAFG+++ E+ +G+
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 133/284 (46%), Gaps = 35/284 (12%)
Query: 304 RKLGQGGAGSVFRGTLPD------GRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKN 355
           R+LGQG  G V+ G   D         +AVK +  ++  R+ + +F NE +++ G    +
Sbjct: 24  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 82
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILF-----VKNTI--HILSWQQRFTIICGTAE 408
           VVRLLG   +G  +L+V E + +  L   L       +N       + Q+   +    A+
Sbjct: 83  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 142
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG-- 466
           G+A+L+     K +HR++   N ++    T KI DFG+ R +  +  +   G  G L   
Sbjct: 143 GMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIY-ETDYYRKGGKGLLPVR 198
Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS 526
           +MAPE L  G  T  +D+++FGV++ E+ S          +  VL  V            
Sbjct: 199 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV------------ 246
Query: 527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN 570
           MD G   + P+N   RV  +  +C Q    +RP+  E+V++L +
Sbjct: 247 MDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKD 289

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 121/286 (42%), Gaps = 43/286 (15%)
Query: 306 LGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           LG+G  G   + T  + G  + +K L     +    F  EV ++  ++H NV++ +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 365 EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHR 424
           +      + EY+   +L  I  +K+      W QR +     A G+A+LH    + IIHR
Sbjct: 78  KDKRLNFITEYIKGGTLRGI--IKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 425 DIKTSNILLDEKLTPKIADFGLARHVAPDKTHVST-------------GIAGTLGYMAPE 471
           D+ + N L+ E     +ADFGLAR +  +KT                  + G   +MAPE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 472 YLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL 531
            +      EK DV++FG+++ E+  GR N+                   + + ++MD GL
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEII-GRVNA-----------------DPDYLPRTMDFGL 234
Query: 532 TGR------FPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
             R       P N       I + C       RPS  ++ H L  +
Sbjct: 235 NVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 111/202 (54%), Gaps = 16/202 (7%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLG 361
           +++G G  G+V++G      ++AVK L     + Q +  F NEV ++   +H N++  +G
Sbjct: 30  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
            S + P+  +V ++    SL   L    T      ++   I   TA G+ +LH  S   I
Sbjct: 88  YSTK-PQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVSTGIAGTLGYMAPEYLVRGQLTE 480
           IHRD+K++NI L E  T KI DFGLA   +    +H    ++G++ +MAPE ++R Q + 
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDSN 200
Query: 481 ----KADVYAFGVLVIEVASGR 498
               ++DVYAFG+++ E+ +G+
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQ 222

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 133/284 (46%), Gaps = 35/284 (12%)
Query: 304 RKLGQGGAGSVFRGTLPD------GRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKN 355
           R+LGQG  G V+ G   D         +AVK +  ++  R+ + +F NE +++ G    +
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNEASVMKGFTCHH 81
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILF-----VKNTI--HILSWQQRFTIICGTAE 408
           VVRLLG   +G  +L+V E + +  L   L       +N       + Q+   +    A+
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG-- 466
           G+A+L+     K +HR++   N ++    T KI DFG+ R +  +  +   G  G L   
Sbjct: 142 GMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIY-ETDYYRKGGKGLLPVR 197
Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS 526
           +MAPE L  G  T  +D+++FGV++ E+ S          +  VL  V            
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV------------ 245
Query: 527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN 570
           MD G   + P+N   RV  +  +C Q    +RP+  E+V++L +
Sbjct: 246 MDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKD 288

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 110/202 (54%), Gaps = 16/202 (7%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLG 361
           +++G G  G+V++G      ++AVK L     + Q +  F NEV ++   +H N++  +G
Sbjct: 30  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
            S   P+  +V ++    SL   L    T      ++   I   TA G+ +LH  S   I
Sbjct: 88  YST-APQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVSTGIAGTLGYMAPEYLVRGQLTE 480
           IHRD+K++NI L E  T KI DFGLA   +    +H    ++G++ +MAPE ++R Q + 
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDSN 200
Query: 481 ----KADVYAFGVLVIEVASGR 498
               ++DVYAFG+++ E+ +G+
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGC 362
            K+GQG +G+V+    +  G+ +A++++    +   +   NE+ ++   ++ N+V  L  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 363 SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
            + G E  +V EY+   SL  ++    T   +   Q   +     + L  LH     ++I
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 139
Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKA 482
           HRDIK+ NILL    + K+ DFG    + P+++  S  + GT  +MAPE + R     K 
Sbjct: 140 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX-MVGTPYWMAPEVVTRKAYGPKV 198
Query: 483 DVYAFGVLVIEVASGR 498
           D+++ G++ IE+  G 
Sbjct: 199 DIWSLGIMAIEMIEGE 214

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGC 362
            K+GQG +G+V+    +  G+ +A++++    +   +   NE+ ++   ++ N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 363 SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
            + G E  +V EY+   SL  ++    T   +   Q   +     + L  LH     ++I
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKA 482
           HRDIK+ NILL    + K+ DFG    + P+++  S  + GT  +MAPE + R     K 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX-MVGTPYWMAPEVVTRKAYGPKV 197
Query: 483 DVYAFGVLVIEVASGR 498
           D+++ G++ IE+  G 
Sbjct: 198 DIWSLGIMAIEMIEGE 213

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 9/201 (4%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNV 356
           ++  N  K+G+G  G V   T    G+ +AVK++    +Q  +  FNEV ++    H NV
Sbjct: 45  EYLANFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNV 104
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           V +    + G E  +V E++   +L  I+    T   ++ +Q  T+       L++LH  
Sbjct: 105 VDMYSSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLSVLRALSYLHNQ 160
Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG 476
               +IHRDIK+ +ILL      K++DFG    V+ +       + GT  +MAPE + R 
Sbjct: 161 G---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKXLVGTPYWMAPEVISRL 216
Query: 477 QLTEKADVYAFGVLVIEVASG 497
               + D+++ G++VIE+  G
Sbjct: 217 PYGTEVDIWSLGIMVIEMIDG 237

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 100/196 (51%), Gaps = 9/196 (4%)
Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGC 362
            K+GQG +G+V+    +  G+ +A++++    +   +   NE+ ++   ++ N+V  L  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 363 SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
            + G E  +V EY+   SL  ++    T   +   Q   +     + L  LH     ++I
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 139
Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKA 482
           HR+IK+ NILL    + K+ DFG    + P+++  ST + GT  +MAPE + R     K 
Sbjct: 140 HRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKV 198
Query: 483 DVYAFGVLVIEVASGR 498
           D+++ G++ IE+  G 
Sbjct: 199 DIWSLGIMAIEMIEGE 214

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGC 362
            K+GQG +G+V+    +  G+ +A++++    +   +   NE+ ++   ++ N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 363 SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
            + G E  +V EY+   SL  ++    T   +   Q   +     + L  LH     ++I
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKA 482
           HRDIK+ NILL    + K+ DFG    + P+++  S  + GT  +MAPE + R     K 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSE-MVGTPYWMAPEVVTRKAYGPKV 197
Query: 483 DVYAFGVLVIEVASGR 498
           D+++ G++ IE+  G 
Sbjct: 198 DIWSLGIMAIEMIEGE 213

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 123/268 (45%), Gaps = 19/268 (7%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           +++G G  G V  G   +   +A+K +   +    D F  E  ++  + H  +V+L G  
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLYGVC 71
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           +E     LV+E++ +  L    +++    + + +    +     EG+A+L   S   +IH
Sbjct: 72  LEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEAS---VIH 126
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD+   N L+ E    K++DFG+ R V  D+   STG    + + +PE     + + K+D
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRV 543
           V++FGVL+ E        VFSEG        +++   + + + +  G     P   ++ V
Sbjct: 187 VWSFGVLMWE--------VFSEGK-----IPYENRSNSEVVEDISTGFRLYKPRLASTHV 233
Query: 544 LQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            QI   C +     RP+ + ++  L  I
Sbjct: 234 YQIMNHCWKERPEDRPAFSRLLRQLAAI 261

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 97/194 (50%), Gaps = 8/194 (4%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLG-C 362
           ++LG G  G V  G      ++AVK +   S    D+FF E   +  + H  +V+  G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 363 SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
           S E P   +V EY+ N  L  + ++++    L   Q   +     EG+A L      + I
Sbjct: 73  SKEYP-IYIVTEYISNGCL--LNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFI 126
Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKA 482
           HRD+   N L+D  L  K++DFG+ R+V  D+   S G    + + APE     + + K+
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 483 DVYAFGVLVIEVAS 496
           DV+AFG+L+ EV S
Sbjct: 187 DVWAFGILMWEVFS 200

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 122/268 (45%), Gaps = 19/268 (7%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           +++G G  G V  G   +   +A+K +   +    D F  E  ++  + H  +V+L G  
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLYGVC 69
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           +E     LV+E++ +  L    +++    + + +    +     EG+A+L       +IH
Sbjct: 70  LEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 124
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD+   N L+ E    K++DFG+ R V  D+   STG    + + +PE     + + K+D
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 184
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRV 543
           V++FGVL+ E        VFSEG        +++   + + + +  G     P   ++ V
Sbjct: 185 VWSFGVLMWE--------VFSEGK-----IPYENRSNSEVVEDISTGFRLYKPRLASTHV 231
Query: 544 LQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            QI   C +     RP+ + ++  L  I
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 111/202 (54%), Gaps = 16/202 (7%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLG 361
           +++G G  G+V++G      ++AVK L     + Q +  F NEV ++   +H N++  +G
Sbjct: 18  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 75
Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
            S + P+  +V ++    SL   L    T      ++   I   TA G+ +LH  S   I
Sbjct: 76  YSTK-PQLAIVTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHAKS---I 129
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVSTGIAGTLGYMAPEYLVRGQLTE 480
           IHRD+K++NI L E  T KI DFGLA   +    +H    ++G++ +MAPE ++R Q + 
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-VIRMQDSN 188
Query: 481 ----KADVYAFGVLVIEVASGR 498
               ++DVYAFG+++ E+ +G+
Sbjct: 189 PYSFQSDVYAFGIVLYELMTGQ 210

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 122/268 (45%), Gaps = 19/268 (7%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           +++G G  G V  G   +   +A+K +   +    D F  E  ++  + H  +V+L G  
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLYGVC 71
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           +E     LV+E++ +  L    +++    + + +    +     EG+A+L       +IH
Sbjct: 72  LEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 126
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD+   N L+ E    K++DFG+ R V  D+   STG    + + +PE     + + K+D
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRV 543
           V++FGVL+ E        VFSEG        +++   + + + +  G     P   ++ V
Sbjct: 187 VWSFGVLMWE--------VFSEGK-----IPYENRSNSEVVEDISTGFRLYKPRLASTHV 233
Query: 544 LQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            QI   C +     RP+ + ++  L  I
Sbjct: 234 YQIMNHCWKERPEDRPAFSRLLRQLAEI 261

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 118/261 (45%), Gaps = 19/261 (7%)
Query: 305 KLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           KLG G  G V+ G        +AVK L  ++ + V++F  E  ++  I+H N+V+LLG  
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
              P   ++ E++   +L   L   N   + S      +    +  + +L   +    IH
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLLYMATQISSAMEYLEKKN---FIH 341
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           R++   N L+ E    K+ADFGL+R +  D      G    + + APE L   + + K+D
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRV 543
           V+AFGVL+ E+A+   +       S V   + K Y+  R             PE    +V
Sbjct: 402 VWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-------------PEGCPEKV 448
Query: 544 LQIGLLCTQAPVALRPSMAEV 564
            ++   C Q   + RPS AE+
Sbjct: 449 YELMRACWQWNPSDRPSFAEI 469

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 98/193 (50%), Gaps = 6/193 (3%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           ++LG G  G V  G      ++A+K +   S    D+F  E  ++  + H+ +V+L G  
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
            +     ++ EY+ N  L  + +++   H    QQ   +     E + +L      + +H
Sbjct: 73  TKQRPIFIITEYMANGCL--LNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLH 127
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD+   N L++++   K++DFGL+R+V  D+   S G    + +  PE L+  + + K+D
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 187
Query: 484 VYAFGVLVIEVAS 496
           ++AFGVL+ E+ S
Sbjct: 188 IWAFGVLMWEIYS 200

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 87/327 (26%), Positives = 139/327 (42%), Gaps = 41/327 (12%)
Query: 257 YQKKETRYKRLSEMRKGQVLLGTVLCTS----------------SLNFKYEILERATDFF 300
           Y   E+R+  L+E+      +   L T+                S N+    +ER TD  
Sbjct: 204 YVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMER-TDI- 261
Query: 301 DNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
               KLG G  G V+ G        +AVK L  ++ + V++F  E  ++  I+H N+V+L
Sbjct: 262 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQL 320
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKN--TIHILSWQQRFTIICGTAEGLAHLHGGS 417
           LG     P   ++ E++   +L   L   N   ++ +      T I    E L   +   
Sbjct: 321 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--- 377
Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQ 477
               IHR++   N L+ E    K+ADFGL+R +  D      G    + + APE L   +
Sbjct: 378 ---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 434
Query: 478 LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE 537
            + K+DV+AFGVL+ E+A+   +       S V   + K Y+  R             PE
Sbjct: 435 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-------------PE 481
Query: 538 NEASRVLQIGLLCTQAPVALRPSMAEV 564
               +V ++   C Q   + RPS AE+
Sbjct: 482 GCPEKVYELMRACWQWNPSDRPSFAEI 508

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 98/193 (50%), Gaps = 6/193 (3%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           ++LG G  G V  G      ++A+K +   S    D+F  E  ++  + H+ +V+L G  
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
            +     ++ EY+ N  L  + +++   H    QQ   +     E + +L      + +H
Sbjct: 69  TKQRPIFIITEYMANGCL--LNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLH 123
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD+   N L++++   K++DFGL+R+V  D+   S G    + +  PE L+  + + K+D
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 183
Query: 484 VYAFGVLVIEVAS 496
           ++AFGVL+ E+ S
Sbjct: 184 IWAFGVLMWEIYS 196

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 122/268 (45%), Gaps = 19/268 (7%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           +++G G  G V  G   +   +A+K +   +    D F  E  ++  + H  +V+L G  
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLYGVC 74
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           +E     LV+E++ +  L    +++    + + +    +     EG+A+L       +IH
Sbjct: 75  LEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 129
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD+   N L+ E    K++DFG+ R V  D+   STG    + + +PE     + + K+D
Sbjct: 130 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 189
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRV 543
           V++FGVL+ E        VFSEG        +++   + + + +  G     P   ++ V
Sbjct: 190 VWSFGVLMWE--------VFSEGK-----IPYENRSNSEVVEDISTGFRLYKPRLASTHV 236
Query: 544 LQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            QI   C +     RP+ + ++  L  I
Sbjct: 237 YQIMNHCWRERPEDRPAFSRLLRQLAEI 264

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 98/193 (50%), Gaps = 6/193 (3%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           ++LG G  G V  G      ++A+K +   S    D+F  E  ++  + H+ +V+L G  
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
            +     ++ EY+ N  L  + +++   H    QQ   +     E + +L      + +H
Sbjct: 74  TKQRPIFIITEYMANGCL--LNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLH 128
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD+   N L++++   K++DFGL+R+V  D+   S G    + +  PE L+  + + K+D
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 188
Query: 484 VYAFGVLVIEVAS 496
           ++AFGVL+ E+ S
Sbjct: 189 IWAFGVLMWEIYS 201

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 98/193 (50%), Gaps = 6/193 (3%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           ++LG G  G V  G      ++A+K +   S    D+F  E  ++  + H+ +V+L G  
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
            +     ++ EY+ N  L  + +++   H    QQ   +     E + +L      + +H
Sbjct: 89  TKQRPIFIITEYMANGCL--LNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLH 143
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD+   N L++++   K++DFGL+R+V  D+   S G    + +  PE L+  + + K+D
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSD 203
Query: 484 VYAFGVLVIEVAS 496
           ++AFGVL+ E+ S
Sbjct: 204 IWAFGVLMWEIYS 216

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 130/274 (47%), Gaps = 27/274 (9%)
Query: 306 LGQGGAGSVFRG--TLPDGRNIAVK----RLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +G G  G V  G   LP  + I+V     ++ +  +Q  D F  E +++    H N++RL
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRL 111
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G   +    ++V E + N SLD   F++      +  Q   ++ G A G+ +L   S +
Sbjct: 112 EGVVTKSKPVMIVTEXMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVA--PDKTHVSTGIAGTLGYMAPEYLVRGQ 477
             +HRD+   NIL++  L  K++DFGL+R +   P+  + + G    + + +PE +   +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 478 LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE 537
            T  +DV+++G+++ EV S      +   +  V+  V + Y+       + P      P 
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR-------LPP------PM 273
Query: 538 NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +  + + Q+ L C Q     RP   ++V +L+ +
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 130/274 (47%), Gaps = 27/274 (9%)
Query: 306 LGQGGAGSVFRG--TLPDGRNIAVK----RLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +G G  G V  G   LP  + I+V     ++ +  +Q  D F  E +++    H N++RL
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRL 111
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G   +    ++V E + N SLD   F++      +  Q   ++ G A G+ +L   S +
Sbjct: 112 EGVVTKSKPVMIVTEXMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 166
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVA--PDKTHVSTGIAGTLGYMAPEYLVRGQ 477
             +HRD+   NIL++  L  K++DFGL+R +   P+  + + G    + + +PE +   +
Sbjct: 167 GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 478 LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE 537
            T  +DV+++G+++ EV S      +   +  V+  V + Y+       + P      P 
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR-------LPP------PM 273
Query: 538 NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +  + + Q+ L C Q     RP   ++V +L+ +
Sbjct: 274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 98/193 (50%), Gaps = 6/193 (3%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           ++LG G  G V  G      ++A+K +   S    D+F  E  ++  + H+ +V+L G  
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
            +     ++ EY+ N  L  + +++   H    QQ   +     E + +L      + +H
Sbjct: 89  TKQRPIFIITEYMANGCL--LNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLH 143
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD+   N L++++   K++DFGL+R+V  D+   S G    + +  PE L+  + + K+D
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 203
Query: 484 VYAFGVLVIEVAS 496
           ++AFGVL+ E+ S
Sbjct: 204 IWAFGVLMWEIYS 216

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 130/274 (47%), Gaps = 27/274 (9%)
Query: 306 LGQGGAGSVFRG--TLPDGRNIAVK----RLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +G G  G V  G   LP  + I+V     ++ +  +Q  D F  E +++    H N++RL
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRL 82
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G   +    ++V E + N SLD   F++      +  Q   ++ G A G+ +L   S +
Sbjct: 83  EGVVTKSKPVMIVTEXMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---SDM 137
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVA--PDKTHVSTGIAGTLGYMAPEYLVRGQ 477
             +HRD+   NIL++  L  K++DFGL+R +   P+  + + G    + + +PE +   +
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 197
Query: 478 LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE 537
            T  +DV+++G+++ EV S      +   +  V+  V + Y+       + P      P 
Sbjct: 198 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR-------LPP------PM 244
Query: 538 NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +  + + Q+ L C Q     RP   ++V +L+ +
Sbjct: 245 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 133/276 (48%), Gaps = 29/276 (10%)
Query: 306 LGQGGAGSVFRG--TLPDGRNI--AVKRLF--FNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +G G  G V  G   LP  R I  A+K L   +  +Q  D F +E +++    H NV+ L
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFDHPNVIHL 99
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G   +    +++ E++ N SLD   F++      +  Q   ++ G A G+ +L   + +
Sbjct: 100 EGVVTKSTPVMIITEFMENGSLDS--FLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADM 154
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH--VSTGIAGTLG--YMAPEYLVR 475
             +HRD+   NIL++  L  K++DFGL+R +  D +    ++ + G +   + APE +  
Sbjct: 155 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 214
Query: 476 GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF 535
            + T  +DV+++G+++ EV S      +   +  V++ + + Y+       + P      
Sbjct: 215 RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR-------LPP------ 261
Query: 536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           P +  S + Q+ L C Q     RP   ++V+ L+ +
Sbjct: 262 PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 297

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 98/193 (50%), Gaps = 6/193 (3%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           ++LG G  G V  G      ++A+K +   S    D+F  E  ++  + H+ +V+L G  
Sbjct: 21  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
            +     ++ EY+ N  L  + +++   H    QQ   +     E + +L      + +H
Sbjct: 80  TKQRPIFIITEYMANGCL--LNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLH 134
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD+   N L++++   K++DFGL+R+V  D+   S G    + +  PE L+  + + K+D
Sbjct: 135 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 194
Query: 484 VYAFGVLVIEVAS 496
           ++AFGVL+ E+ S
Sbjct: 195 IWAFGVLMWEIYS 207

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 98/193 (50%), Gaps = 6/193 (3%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           ++LG G  G V  G      ++A+K +   S    D+F  E  ++  + H+ +V+L G  
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
            +     ++ EY+ N  L  + +++   H    QQ   +     E + +L      + +H
Sbjct: 74  TKQRPIFIITEYMANGCL--LNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLH 128
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD+   N L++++   K++DFGL+R+V  D+   S G    + +  PE L+  + + K+D
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSD 188
Query: 484 VYAFGVLVIEVAS 496
           ++AFGVL+ E+ S
Sbjct: 189 IWAFGVLMWEIYS 201

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 107/209 (51%), Gaps = 28/209 (13%)
Query: 306 LGQGGAGSVFRGTLPDGRNIAVKRLFFNS----RQWVDQFFNEVNLISGIQHKNVVRLLG 361
           +G GG G V+R     G  +AVK    +      Q ++    E  L + ++H N++ L G
Sbjct: 15  IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIH--ILSWQQRFTIICGTAEGLAHLHGGSGI 419
             ++ P   LV E+     L+++L  K      +++W  +       A G+ +LH  + +
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQI------ARGMNYLHDEAIV 127
Query: 420 KIIHRDIKTSNILLDEKLTP--------KIADFGLARHVAPDKTHVSTGI--AGTLGYMA 469
            IIHRD+K+SNIL+ +K+          KI DFGLAR     + H +T +  AG   +MA
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAAGAYAWMA 182
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           PE +     ++ +DV+++GVL+ E+ +G 
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 22/209 (10%)
Query: 305 KLGQGGAGSVF----RGTLP--DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVR 358
           +LG+G  G VF       LP  D   +AVK L   S      F  E  L++ +QH+++VR
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQIL--------FVKNTIHI----LSWQQRFTIICGT 406
             G   EG   L+V+EY+ +  L++ L         +     +    L   Q   +    
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTL 465
           A G+ +L   +G+  +HRD+ T N L+ + L  KI DFG++R + + D   V       +
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEV 494
            +M PE ++  + T ++DV++FGV++ E+
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEI 230

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   + + L     +     Q+  T I   A  L+
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL---QKLSKFDEQRTATYITELANALS 127
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     ++IHRDIK  N+LL      KIADFG + H    +    T + GTL Y+ PE
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPE 181
Query: 472 YLVRGQL-TEKADVYAFGVLVIEVASGR 498
            ++ G++  EK D+++ GVL  E   G+
Sbjct: 182 -MIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 305 KLGQGGAGSVF----RGTLP--DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVR 358
           +LG+G  G VF       LP  D   +AVK L   S      F  E  L++ +QH+++VR
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKN------------TIHILSWQQRFTIICGT 406
             G   EG   L+V+EY+ +  L++ L                    L   Q   +    
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTL 465
           A G+ +L   +G+  +HRD+ T N L+ + L  KI DFG++R + + D   V       +
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEV 494
            +M PE ++  + T ++DV++FGV++ E+
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEI 224

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/216 (33%), Positives = 110/216 (50%), Gaps = 35/216 (16%)
Query: 306 LGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNL--ISGIQHKNVVRLL--- 360
           +G+G  G+V++G+L D R +AVK   F +RQ    F NE N+  +  ++H N+ R +   
Sbjct: 21  IGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEHDNIARFIVGD 76
Query: 361 -GCSIEGP-ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG--- 415
              + +G  E LLV EY PN SL + L    ++H   W     +      GLA+LH    
Sbjct: 77  ERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRLAHSVTRGLAYLHTELP 132
Query: 416 -GSGIK--IIHRDIKTSNILLDEKLTPKIADFGLA------RHVAP-DKTHVSTGIAGTL 465
            G   K  I HRD+ + N+L+    T  I+DFGL+      R V P ++ + +    GT+
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTI 192
Query: 466 GYMAPEYL---VRGQLTEKA----DVYAFGVLVIEV 494
            YMAPE L   V  +  E A    D+YA G++  E+
Sbjct: 193 RYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 107/223 (47%), Gaps = 15/223 (6%)
Query: 281 LCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQW 337
           L +   N + +  + A + F+  R LG+G  G+V+       + I   ++ F +   +  
Sbjct: 17  LASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG 76
Query: 338 VD-QFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSW 396
           V+ Q   EV + S ++H N++RL G   +     L+ EY P   L  +      +     
Sbjct: 77  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDE 133
Query: 397 QQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH 456
           Q+  T I   A  L++ H     ++IHRDIK  N+LL      KIADFG + H    +  
Sbjct: 134 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 188
Query: 457 VSTGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGR 498
             T + GTL Y+ PE ++ G++  EK D+++ GVL  E   G+
Sbjct: 189 -RTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L+
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 139
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     ++IHRDIK  N+LL      KIADFG + H    +    T + GTL Y+ PE
Sbjct: 140 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPE 193
Query: 472 YLVRGQL-TEKADVYAFGVLVIEVASGR 498
            ++ G++  EK D+++ GVL  E   G+
Sbjct: 194 -MIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     ++IHRDIK  N+LL      KIADFG + H    +    T + GTL Y+ PE
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPE 179
Query: 472 YLVRGQL-TEKADVYAFGVLVIEVASGR 498
            ++ G++  EK D+++ GVL  E   G+
Sbjct: 180 -MIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     ++IHRDIK  N+LL      KIADFG + H    +    T + GTL Y+ PE
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLPPE 176
Query: 472 YLVRGQL-TEKADVYAFGVLVIEVASGR 498
            ++ G++  EK D+++ GVL  E   G+
Sbjct: 177 -MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L+
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     ++IHRDIK  N+LL      KIADFG + H    +    T + GTL Y+ PE
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLPPE 181
Query: 472 YLVRGQL-TEKADVYAFGVLVIEVASGR 498
            ++ G++  EK D+++ GVL  E   G+
Sbjct: 182 -MIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 22/209 (10%)
Query: 305 KLGQGGAGSVF----RGTLP--DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVR 358
           +LG+G  G VF       LP  D   +AVK L   S      F  E  L++ +QH+++VR
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKN------------TIHILSWQQRFTIICGT 406
             G   EG   L+V+EY+ +  L++ L                    L   Q   +    
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTL 465
           A G+ +L   +G+  +HRD+ T N L+ + L  KI DFG++R + + D   V       +
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEV 494
            +M PE ++  + T ++DV++FGV++ E+
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEI 253

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     ++IHRDIK  N+LL      KIADFG + H    +    T + GTL Y+ PE
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLPPE 176
Query: 472 YLVRGQL-TEKADVYAFGVLVIEVASGR 498
            ++ G++  EK D+++ GVL  E   G+
Sbjct: 177 -MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L+
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     ++IHRDIK  N+LL      KIADFG + H    +    T + GTL Y+ PE
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPE 181
Query: 472 YLVRGQL-TEKADVYAFGVLVIEVASGR 498
            ++ G++  EK D+++ GVL  E   G+
Sbjct: 182 -MIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L+
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     ++IHRDIK  N+LL      KIADFG + H    +    T + GTL Y+ PE
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTDLCGTLDYLPPE 177
Query: 472 YLVRGQL-TEKADVYAFGVLVIEVASGR 498
            ++ G++  EK D+++ GVL  E   G+
Sbjct: 178 -MIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L+
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     ++IHRDIK  N+LL      KIADFG + H    +    T ++GTL Y+ PE
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSR---RTTLSGTLDYLPPE 177
Query: 472 YLVRGQL-TEKADVYAFGVLVIEVASGR 498
            ++ G++  EK D+++ GVL  E   G+
Sbjct: 178 -MIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     ++IHRDIK  N+LL      KIADFG + H    +    T + GTL Y+ PE
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPE 176
Query: 472 YLVRGQL-TEKADVYAFGVLVIEVASGR 498
            ++ G++  EK D+++ GVL  E   G+
Sbjct: 177 -MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 134/276 (48%), Gaps = 29/276 (10%)
Query: 306 LGQGGAGSVFRGTL--PDGRN--IAVKRLF--FNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +G G  G V RG L  P  +   +A+K L   +  RQ   +F +E +++   +H N++RL
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ-RREFLSEASIMGQFEHPNIIRL 80
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G        +++ E++ N +LD  L + +    +   Q   ++ G A G+ +L   + +
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI--QLVGMLRGIASGMRYL---AEM 135
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHV---APDKTHVST-GIAGTLGYMAPEYLVR 475
             +HRD+   NIL++  L  K++DFGL+R +   + D T+ S+ G    + + APE +  
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAF 195
Query: 476 GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF 535
            + T  +D +++G+++ EV S      +   +  V++ + + Y+       + P      
Sbjct: 196 RKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYR-------LPP------ 242
Query: 536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           P +  + + Q+ L C Q     RP   +VV  L+ +
Sbjct: 243 PPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 278

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+     + + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L+
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     K+IHRDIK  N+LL      KIADFG + H    +      + GTL Y+ PE
Sbjct: 123 YCHSK---KVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCGTLDYLPPE 176
Query: 472 YLVRGQL-TEKADVYAFGVLVIEVASGR 498
            ++ G++  EK D+++ GVL  E   G+
Sbjct: 177 -MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L+
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     ++IHRDIK  N+LL      KIADFG + H    +    T + GTL Y+ PE
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPE 181
Query: 472 YLVRGQLTEKADVYAFGVLVIEVASGR 498
            +      EK D+++ GVL  E   G+
Sbjct: 182 XIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     ++IHRDIK  N+LL      KIADFG + H    +    T + GTL Y+ PE
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTELCGTLDYLPPE 176
Query: 472 YLVRGQL-TEKADVYAFGVLVIEVASGR 498
            ++ G++  EK D+++ GVL  E   G+
Sbjct: 177 -MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 114/251 (45%), Gaps = 36/251 (14%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGIQHKN 355
           FD  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S ++H N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           ++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L++ H 
Sbjct: 74  ILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++IHRDIK  N+LL      KIADFG + H    +    T + GTL Y+ PE ++ 
Sbjct: 131 K---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPE-MIE 183
Query: 476 GQL-TEKADVYAFGVLVIEVASG-------------RRNS--------VFSEGSSSVLHT 513
           G++  EK D+++ GVL  E   G             RR S          +EG+  ++  
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLISR 243
Query: 514 VWKHYKANRIT 524
           + KH  + R+T
Sbjct: 244 LLKHNASQRLT 254

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 121/268 (45%), Gaps = 19/268 (7%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           +++G G  G V  G   +   +A+K +   +    D F  E  ++  + H  +V+L G  
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLYGVC 72
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           +E     LV E++ +  L    +++    + + +    +     EG+A+L       +IH
Sbjct: 73  LEQAPICLVTEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD+   N L+ E    K++DFG+ R V  D+   STG    + + +PE     + + K+D
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRV 543
           V++FGVL+ E        VFSEG        +++   + + + +  G     P   ++ V
Sbjct: 188 VWSFGVLMWE--------VFSEGK-----IPYENRSNSEVVEDISTGFRLYKPRLASTHV 234
Query: 544 LQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            QI   C +     RP+ + ++  L  I
Sbjct: 235 YQIMNHCWRERPEDRPAFSRLLRQLAEI 262

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     ++IHRDIK  N+LL      KIADFG + H    +    T + GTL Y+ PE
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPE 179
Query: 472 YLVRGQL-TEKADVYAFGVLVIEVASGR 498
            ++ G++  EK D+++ GVL  E   G+
Sbjct: 180 -MIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L+
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     ++IHRDIK  N+LL      KIADFG + H    +    T + GTL Y+ PE
Sbjct: 122 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPE 175
Query: 472 YLVRGQL-TEKADVYAFGVLVIEVASGR 498
            ++ G++  EK D+++ GVL  E   G+
Sbjct: 176 -MIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L+
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 126
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     ++IHRDIK  N+LL      KIADFG + H    +    T + GTL Y+ PE
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPE 180
Query: 472 YLVRGQL-TEKADVYAFGVLVIEVASGR 498
            ++ G++  EK D+++ GVL  E   G+
Sbjct: 181 -MIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     ++IHRDIK  N+LL      KIADFG + H    +    T + GTL Y+ PE
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTXLCGTLDYLPPE 176
Query: 472 YLVRGQL-TEKADVYAFGVLVIEVASGR 498
            ++ G++  EK D+++ GVL  E   G+
Sbjct: 177 -MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 118/267 (44%), Gaps = 29/267 (10%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           +KLG G  G V+  T      +AVK +   S   V+ F  E N++  +QH  +V+L    
Sbjct: 188 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 246
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
            + P  ++         LD +   + +   L     F+     AEG+A +   +    IH
Sbjct: 247 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS--AQIAEGMAFIEQRN---YIH 301
Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +NIL+   L  KIADFGLAR           G    + + APE +  G  T K+D
Sbjct: 302 RDLRAANILVSASLVCKIADFGLAR----------VGAKFPIKWTAPEAINFGSFTIKSD 351
Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRV 543
           V++FG+L++E+ +  R       +  V+  + + Y+  R             PEN    +
Sbjct: 352 VWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-------------PENCPEEL 398
Query: 544 LQIGLLCTQAPVALRPSMAEVVHMLNN 570
             I + C +     RP+   +  +L++
Sbjct: 399 YNIMMRCWKNRPEERPTFEYIQSVLDD 425

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L+
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 119
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     ++IHRDIK  N+LL      KIADFG + H    +    T + GTL Y+ PE
Sbjct: 120 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTTLCGTLDYLPPE 173
Query: 472 YLVRGQL-TEKADVYAFGVLVIEVASGR 498
            ++ G++  EK D+++ GVL  E   G+
Sbjct: 174 -MIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 130/299 (43%), Gaps = 38/299 (12%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFRG------TLPDGRNIAVKRLFFNSRQWVDQ-FFNEVN 346
           E   D  +  + LG+G  G V              R +AVK L   +     +   +E+ 
Sbjct: 23  EFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELK 82
Query: 347 LISGI-QHKNVVRLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFT--- 401
           ++  I  H NVV LLG C+  G   +++ E+    +L   L  K     + ++  +    
Sbjct: 83  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN-EFVPYKDLYKDFL 141
Query: 402 ----IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV 457
               +IC + +    +   +  K IHRD+   NILL EK   KI DFGLAR +  D  +V
Sbjct: 142 TLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 201
Query: 458 STGIAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWK 516
             G A   L +MAPE +     T ++DV++FGVL+ E        +FS G+S        
Sbjct: 202 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE--------IFSLGASP------- 246
Query: 517 HYKANRITQS----MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            Y   +I +     +  G   R P+     + Q  L C     + RP+ +E+V  L N+
Sbjct: 247 -YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 304

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     ++IHRDIK  N+LL      KIADFG + H    +      + GTL Y+ PE
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCGTLDYLPPE 179
Query: 472 YLVRGQL-TEKADVYAFGVLVIEVASGR 498
            ++ G++  EK D+++ GVL  E   G+
Sbjct: 180 -MIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     ++IHRDIK  N+LL      KIADFG + H    +      + GTL Y+ PE
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RAALCGTLDYLPPE 176
Query: 472 YLVRGQL-TEKADVYAFGVLVIEVASGR 498
            ++ G++  EK D+++ GVL  E   G+
Sbjct: 177 -MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 133/276 (48%), Gaps = 29/276 (10%)
Query: 306 LGQGGAGSVFRGTL--PDGRN--IAVKRLF--FNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +G G  G V RG L  P  +   +A+K L   +  RQ   +F +E +++   +H N++RL
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ-RREFLSEASIMGQFEHPNIIRL 82
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G        +++ E++ N +LD  L + +    +   Q   ++ G A G+ +L   + +
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI--QLVGMLRGIASGMRYL---AEM 137
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHV---APDKTHVST-GIAGTLGYMAPEYLVR 475
             +HRD+   NIL++  L  K++DFGL+R +   + D T  S+ G    + + APE +  
Sbjct: 138 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAF 197
Query: 476 GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF 535
            + T  +D +++G+++ EV S      +   +  V++ + + Y+       + P      
Sbjct: 198 RKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYR-------LPP------ 244
Query: 536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           P +  + + Q+ L C Q     RP   +VV  L+ +
Sbjct: 245 PPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 280

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L+
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     ++IHRDIK  N+LL      KIA+FG + H    +    T + GTL Y+ PE
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR---RTTLCGTLDYLPPE 178
Query: 472 YLVRGQL-TEKADVYAFGVLVIEVASGR 498
            ++ G++  EK D+++ GVL  E   G+
Sbjct: 179 -MIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 106/223 (47%), Gaps = 15/223 (6%)
Query: 281 LCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQW 337
           L +   N + +  + A + F+  R LG+G  G+V+       + I   ++ F +   +  
Sbjct: 17  LASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG 76
Query: 338 VD-QFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSW 396
           V+ Q   EV + S ++H N++RL G   +     L+ EY P   L  +      +     
Sbjct: 77  VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDE 133
Query: 397 QQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH 456
           Q+  T I   A  L++ H     ++IHRDIK  N+LL      KIADFG + H    +  
Sbjct: 134 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 188
Query: 457 VSTGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGR 498
               + GTL Y+ PE ++ G++  EK D+++ GVL  E   G+
Sbjct: 189 -RDDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 114/227 (50%), Gaps = 24/227 (10%)
Query: 278 GTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVF--RGTLPDGRNIAVKRLFFNSR 335
           G+ +    +N +Y+I++          KLG GG  +V+    T+ + + +A+K +F   R
Sbjct: 1   GSHMIGKIINERYKIVD----------KLGGGGMSTVYLAEDTILNIK-VAIKAIFIPPR 49
Query: 336 Q---WVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIH 392
           +    + +F  EV+  S + H+N+V ++    E     LV EY+   +L + +       
Sbjct: 50  EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-- 107
Query: 393 ILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP 452
            LS            +G+ H H    ++I+HRDIK  NIL+D   T KI DFG+A+ ++ 
Sbjct: 108 -LSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163
Query: 453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEK-ADVYAFGVLVIEVASGR 498
                +  + GT+ Y +PE   +G+ T++  D+Y+ G+++ E+  G 
Sbjct: 164 TSLTQTNHVLGTVQYFSPEQ-AKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   + + L     +     Q+  T I   A  L+
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL---QKLSKFDEQRTATYITELANALS 127
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     ++IHRDIK  N+LL      KIADFG + H    +      + GTL Y+ PE
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLXGTLDYLPPE 181
Query: 472 YLVRGQL-TEKADVYAFGVLVIEVASGR 498
            ++ G++  EK D+++ GVL  E   G+
Sbjct: 182 -MIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 85/301 (28%), Positives = 129/301 (42%), Gaps = 42/301 (13%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFRG------TLPDGRNIAVKRLFFNSRQWVDQ-FFNEVN 346
           E   D  +  + LG+G  G V              R +AVK L   +     +   +E+ 
Sbjct: 23  EFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELK 82
Query: 347 LISGI-QHKNVVRLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---------LS 395
           ++  I  H NVV LLG C+  G   +++ E+    +L   L  K    +         L+
Sbjct: 83  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLT 142
Query: 396 WQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT 455
            +         A+G+  L   +  K IHRD+   NILL EK   KI DFGLAR +  D  
Sbjct: 143 LEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPD 199
Query: 456 HVSTGIAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV 514
           +V  G A   L +MAPE +     T ++DV++FGVL+ E        +FS G+S      
Sbjct: 200 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE--------IFSLGASP----- 246
Query: 515 WKHYKANRITQS----MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN 570
              Y   +I +     +  G   R P+     + Q  L C     + RP+ +E+V  L N
Sbjct: 247 ---YPGVKIDEEFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 303
Query: 571 I 571
           +
Sbjct: 304 L 304

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L+
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     ++IHRDIK  N+LL      KIADFG + H    +      + GTL Y+ PE
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT---LCGTLDYLPPE 177
Query: 472 YLVRGQL-TEKADVYAFGVLVIEVASGR 498
            ++ G++  EK D+++ GVL  E   G+
Sbjct: 178 -MIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L+
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     ++IHRDIK  N+LL      KIADFG + H    +      + GTL Y+ PE
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLCGTLDYLPPE 178
Query: 472 YLVRGQL-TEKADVYAFGVLVIEVASGR 498
            ++ G++  EK D+++ GVL  E   G+
Sbjct: 179 -MIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     ++IHRDIK  N+LL      KIA+FG + H    +    T + GTL Y+ PE
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSR---RTTLCGTLDYLPPE 179
Query: 472 YLVRGQL-TEKADVYAFGVLVIEVASGR 498
            ++ G++  EK D+++ GVL  E   G+
Sbjct: 180 -MIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 127/292 (43%), Gaps = 40/292 (13%)
Query: 304 RKLGQGGAGSVFRG------TLPDGRNIAVKRLFFNSRQWVDQ-FFNEVNLISGI-QHKN 355
           + LG+G  G V              R +AVK L   +     +   +E+ ++  I  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 356 VVRLLG-CSIEGPESLLVYEYVPNRSLDQIL------FVKNTIHILSWQQRFT----IIC 404
           VV LLG C+  G   +++ E+    +L   L      FV   +      + F     +IC
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG- 463
            + +    +   +  K IHRD+   NILL EK   KI DFGLAR +  D  +V  G A  
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 212
Query: 464 TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRI 523
            L +MAPE +     T ++DV++FGVL+ E        +FS G+S         Y   +I
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWE--------IFSLGASP--------YPGVKI 256
Query: 524 TQS----MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            +     +  G   R P+     + Q  L C     + RP+ +E+V  L N+
Sbjct: 257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/251 (28%), Positives = 113/251 (45%), Gaps = 36/251 (14%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGIQHKN 355
           FD  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S ++H N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           ++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L++ H 
Sbjct: 74  ILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYCHS 130
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++IHRDIK  N+LL      KIADFG + H    +      + GTL Y+ PE ++ 
Sbjct: 131 K---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT---LCGTLDYLPPE-MIE 183
Query: 476 GQL-TEKADVYAFGVLVIEVASG-------------RRNS--------VFSEGSSSVLHT 513
           G++  EK D+++ GVL  E   G             RR S          +EG+  ++  
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLISR 243
Query: 514 VWKHYKANRIT 524
           + KH  + R+T
Sbjct: 244 LLKHNASQRLT 254

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 92/310 (29%), Positives = 141/310 (45%), Gaps = 27/310 (8%)
Query: 278 GTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPD-GRNIAVKR-LFFNSR 335
           G  L T +L F+      + + ++N   +G+G  G V +    D GR +A+K+ L  +  
Sbjct: 11  GVDLGTENLYFQ------SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD 64
Query: 336 QWVDQF-FNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHIL 394
           + V +    E+ L+  ++H+N+V LL    +     LV+E+V +  LD +    N +   
Sbjct: 65  KMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQ 124
Query: 395 SWQQR-FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
             Q+  F II G   G  H H      IIHRDIK  NIL+ +    K+ DFG AR +A  
Sbjct: 125 VVQKYLFQIINGI--GFCHSHN-----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177
Query: 454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKA-DVYAFGVLVIEVASGRRNSVFSEGSSSVLH 512
                  +A T  Y APE LV      KA DV+A G LV E+  G    +F  G S +  
Sbjct: 178 GEVYDDEVA-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG--EPLFP-GDSDIDQ 233
Query: 513 TVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALR-PSMAEVVHMLNNI 571
                Y       ++ P     F +N     +++  +  + P+  R P ++EVV  L   
Sbjct: 234 L----YHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKK 289
Query: 572 DYEIPPPKQP 581
              I P K+P
Sbjct: 290 CLHIDPDKRP 299

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 132/276 (47%), Gaps = 29/276 (10%)
Query: 306 LGQGGAGSVFRG--TLPDGRNI--AVKRLF--FNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +G G  G V  G   LP  R I  A+K L   +  +Q  D F +E +++    H NV+ L
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFDHPNVIHL 73
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G   +    +++ E++ N SLD   F++      +  Q   ++ G A G+ +L   + +
Sbjct: 74  EGVVTKSTPVMIITEFMENGSLDS--FLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADM 128
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH--VSTGIAGTLG--YMAPEYLVR 475
             +HR +   NIL++  L  K++DFGL+R +  D +    ++ + G +   + APE +  
Sbjct: 129 NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 188
Query: 476 GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF 535
            + T  +DV+++G+++ EV S      +   +  V++ + + Y+       + P      
Sbjct: 189 RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR-------LPP------ 235
Query: 536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           P +  S + Q+ L C Q     RP   ++V+ L+ +
Sbjct: 236 PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 271

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 127/292 (43%), Gaps = 40/292 (13%)
Query: 304 RKLGQGGAGSVFRG------TLPDGRNIAVKRLFFNSRQWVDQ-FFNEVNLISGI-QHKN 355
           + LG+G  G V              R +AVK L   +     +   +E+ ++  I  H N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 356 VVRLLG-CSIEGPESLLVYEYVPNRSLDQIL------FVKNTIHILSWQQRFT----IIC 404
           VV LLG C+  G   +++ E+    +L   L      FV   +      + F     +IC
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG- 463
            + +    +   +  K IHRD+   NILL EK   KI DFGLAR +  D  +V  G A  
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 203
Query: 464 TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRI 523
            L +MAPE +     T ++DV++FGVL+ E        +FS G+S         Y   +I
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWE--------IFSLGASP--------YPGVKI 247
Query: 524 TQS----MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            +     +  G   R P+     + Q  L C     + RP+ +E+V  L N+
Sbjct: 248 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     ++IHRDIK  N+LL      KIADFG + H    +      + GTL Y+ PE
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLCGTLDYLPPE 179
Query: 472 YLVRGQL-TEKADVYAFGVLVIEVASGR 498
            ++ G++  EK D+++ GVL  E   G+
Sbjct: 180 -MIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     ++IHRDIK  N+LL      KIADFG + H    +      + GTL Y+ PE
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RXXLCGTLDYLPPE 176
Query: 472 YLVRGQL-TEKADVYAFGVLVIEVASGR 498
            ++ G++  EK D+++ GVL  E   G+
Sbjct: 177 -MIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 85/302 (28%), Positives = 129/302 (42%), Gaps = 40/302 (13%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFRG------TLPDGRNIAVKRLFFNSRQWVDQ-FFNEVN 346
           E   D     + LG+G  G V              R +AVK L   +     +   +E+ 
Sbjct: 60  EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 119
Query: 347 LISGI-QHKNVVRLLG-CSIEGPESLLVYEYVPNRSLDQIL------FVKNTIHILSWQQ 398
           ++  I  H NVV LLG C+  G   +++ E+    +L   L      FV   +      +
Sbjct: 120 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 179
Query: 399 RFT----IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK 454
            F     +IC + +    +   +  K IHRD+   NILL EK   KI DFGLAR +  D 
Sbjct: 180 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 239
Query: 455 THVSTGIAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT 513
            +V  G A   L +MAPE +     T ++DV++FGVL+ E        +FS G+S     
Sbjct: 240 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE--------IFSLGASP---- 287
Query: 514 VWKHYKANRITQS----MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLN 569
               Y   +I +     +  G   R P+     + Q  L C     + RP+ +E+V  L 
Sbjct: 288 ----YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 343
Query: 570 NI 571
           N+
Sbjct: 344 NL 345

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 127/292 (43%), Gaps = 40/292 (13%)
Query: 304 RKLGQGGAGSVFRG------TLPDGRNIAVKRLFFNSRQWVDQ-FFNEVNLISGI-QHKN 355
           + LG+G  G V              R +AVK L   +     +   +E+ ++  I  H N
Sbjct: 24  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 356 VVRLLG-CSIEGPESLLVYEYVPNRSLDQIL------FVKNTIHILSWQQRFT----IIC 404
           VV LLG C+  G   +++ E+    +L   L      FV   +      + F     +IC
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG- 463
            + +    +   +  K IHRD+   NILL EK   KI DFGLAR +  D  +V  G A  
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 203
Query: 464 TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRI 523
            L +MAPE +     T ++DV++FGVL+ E        +FS G+S         Y   +I
Sbjct: 204 PLKWMAPETIFDRVYTIQSDVWSFGVLLWE--------IFSLGASP--------YPGVKI 247
Query: 524 TQS----MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            +     +  G   R P+     + Q  L C     + RP+ +E+V  L N+
Sbjct: 248 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
           A + F+  R LG+G  G+V+       + I   ++ F +   +  V+ Q   EV + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++RL G   +     L+ EY P   L  +      +     Q+  T I   A  L+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     ++IHRDIK  N+LL      KIADFG + H    +      + GTL Y+ PE
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RDDLCGTLDYLPPE 179
Query: 472 YLVRGQL-TEKADVYAFGVLVIEVASGR 498
            ++ G++  EK D+++ GVL  E   G+
Sbjct: 180 -MIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 102/201 (50%), Gaps = 16/201 (7%)
Query: 304 RKLGQGGAGSVFR---GTLPD--GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVR 358
           R+LG+G  GSV       L D  G  +AVK+L  ++ + +  F  E+ ++  +QH N+V+
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 359 LLG-CSIEGPESL-LVYEYVPNRSLDQILFV-KNTIHILSWQQRFTIICGTAEGLAHLHG 415
             G C   G  +L L+ E++P  SL + L   K  I  +   Q  + IC   E L     
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLG---- 134
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT--LGYMAPEYL 473
               + IHRD+ T NIL++ +   KI DFGL + +  DK        G   + + APE L
Sbjct: 135 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 474 VRGQLTEKADVYAFGVLVIEV 494
              + +  +DV++FGV++ E+
Sbjct: 193 TESKFSVASDVWSFGVVLYEL 213

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR---GTLPD--GRNIAVKRLFFNSRQWVDQFFNEVNLI 348
           ER   F    ++LG+G  GSV       L D  G  +AVK+L  ++ + +  F  E+ ++
Sbjct: 9   ERHLKFL---QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 349 SGIQHKNVVRLLG-CSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICG 405
             +QH N+V+  G C   G  +L L+ EY+P  SL D +   K  I  +   Q  + IC 
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT- 464
             E L         + IHRD+ T NIL++ +   KI DFGL + +  DK        G  
Sbjct: 126 GMEYLG------TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 179
Query: 465 -LGYMAPEYLVRGQLTEKADVYAFGVLVIEV 494
            + + APE L   + +  +DV++FGV++ E+
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYEL 210

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 126/292 (43%), Gaps = 40/292 (13%)
Query: 304 RKLGQGGAGSVFRG------TLPDGRNIAVKRLFFNSRQWVDQ-FFNEVNLISGI-QHKN 355
           + LG+G  G V              R +AVK L   +     +   +E+ ++  I  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 356 VVRLLG-CSIEGPESLLVYEYVPNRSLDQIL------FVKNTIHILSWQQRFT----IIC 404
           VV LLG C+  G   +++ E+    +L   L      FV   +      + F     +IC
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG- 463
            + +    +   +  K IHRD+   NILL EK   KI DFGLAR +  D   V  G A  
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 464 TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRI 523
            L +MAPE +     T ++DV++FGVL+ E        +FS G+S         Y   +I
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWE--------IFSLGASP--------YPGVKI 256
Query: 524 TQS----MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            +     +  G   R P+     + Q  L C     + RP+ +E+V  L N+
Sbjct: 257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 109/222 (49%), Gaps = 26/222 (11%)
Query: 291 EILERATDFFDNSRK--LGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQWVDQFFNEVNL 347
           ++LE   ++ +N  +  LG+G  G V+ G  L +   IA+K +     ++      E+ L
Sbjct: 13  DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIAL 72
Query: 348 ISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVK--------NTIHILSWQQR 399
              ++HKN+V+ LG   E     +  E VP  SL  +L  K         TI   + Q  
Sbjct: 73  HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-- 130
Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE-KLTPKIADFGLARHVAPDKTHVS 458
                   EGL +LH     +I+HRDIK  N+L++      KI+DFG ++ +A       
Sbjct: 131 ------ILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE 181
Query: 459 TGIAGTLGYMAPEYLVRGQ--LTEKADVYAFGVLVIEVASGR 498
           T   GTL YMAPE + +G     + AD+++ G  +IE+A+G+
Sbjct: 182 T-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR---GTLPD--GRNIAVKRLFFNSRQWVDQFFNEVNLI 348
           ER   F    ++LG+G  GSV       L D  G  +AVK+L  ++ + +  F  E+ ++
Sbjct: 13  ERHLKFL---QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 69
Query: 349 SGIQHKNVVRLLG-CSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICG 405
             +QH N+V+  G C   G  +L L+ EY+P  SL D +   K  I  +   Q  + IC 
Sbjct: 70  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 129
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT- 464
             E L         + IHRD+ T NIL++ +   KI DFGL + +  DK        G  
Sbjct: 130 GMEYLG------TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 183
Query: 465 -LGYMAPEYLVRGQLTEKADVYAFGVLVIEV 494
            + + APE L   + +  +DV++FGV++ E+
Sbjct: 184 PIFWYAPESLTESKFSVASDVWSFGVVLYEL 214

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR---GTLPD--GRNIAVKRLFFNSRQWVDQFFNEVNLI 348
           ER   F    ++LG+G  GSV       L D  G  +AVK+L  ++ + +  F  E+ ++
Sbjct: 9   ERHLKFL---QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 349 SGIQHKNVVRLLG-CSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICG 405
             +QH N+V+  G C   G  +L L+ EY+P  SL D +   K  I  +   Q  + IC 
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT- 464
             E L         + IHRD+ T NIL++ +   KI DFGL + +  DK        G  
Sbjct: 126 GMEYLG------TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 179
Query: 465 -LGYMAPEYLVRGQLTEKADVYAFGVLVIEV 494
            + + APE L   + +  +DV++FGV++ E+
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYEL 210

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR---GTLPD--GRNIAVKRLFFNSRQWVDQFFNEVNLI 348
           ER   F    ++LG+G  GSV       L D  G  +AVK+L  ++ + +  F  E+ ++
Sbjct: 8   ERHLKFL---QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 64
Query: 349 SGIQHKNVVRLLG-CSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICG 405
             +QH N+V+  G C   G  +L L+ EY+P  SL D +   K  I  +   Q  + IC 
Sbjct: 65  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 124
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT- 464
             E L         + IHRD+ T NIL++ +   KI DFGL + +  DK        G  
Sbjct: 125 GMEYLG------TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 178
Query: 465 -LGYMAPEYLVRGQLTEKADVYAFGVLVIEV 494
            + + APE L   + +  +DV++FGV++ E+
Sbjct: 179 PIFWYAPESLTESKFSVASDVWSFGVVLYEL 209

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 102/201 (50%), Gaps = 16/201 (7%)
Query: 304 RKLGQGGAGSVFR---GTLPD--GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVR 358
           ++LG+G  GSV       L D  G  +AVK+L  ++ + +  F  E+ ++  +QH N+V+
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 359 LLG-CSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
             G C   G  +L L+ EY+P  SL D +   K  I  +   Q  + IC   E L     
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---- 136
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT--LGYMAPEYL 473
               + IHRD+ T NIL++ +   KI DFGL + +  DK        G   + + APE L
Sbjct: 137 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 194
Query: 474 VRGQLTEKADVYAFGVLVIEV 494
              + +  +DV++FGV++ E+
Sbjct: 195 TESKFSVASDVWSFGVVLYEL 215

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 102/201 (50%), Gaps = 16/201 (7%)
Query: 304 RKLGQGGAGSVFR---GTLPD--GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVR 358
           ++LG+G  GSV       L D  G  +AVK+L  ++ + +  F  E+ ++  +QH N+V+
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 359 LLG-CSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
             G C   G  +L L+ EY+P  SL D +   K  I  +   Q  + IC   E L     
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---- 137
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT--LGYMAPEYL 473
               + IHRD+ T NIL++ +   KI DFGL + +  DK        G   + + APE L
Sbjct: 138 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 195
Query: 474 VRGQLTEKADVYAFGVLVIEV 494
              + +  +DV++FGV++ E+
Sbjct: 196 TESKFSVASDVWSFGVVLYEL 216

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 85/304 (27%), Positives = 128/304 (42%), Gaps = 45/304 (14%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFRG------TLPDGRNIAVKRLFFNSRQWVDQ-FFNEVN 346
           E   D  +  + LG+G  G V              R +AVK L   +     +   +E+ 
Sbjct: 24  EFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 83
Query: 347 LISGI-QHKNVVRLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTIHI----------- 393
           ++  I  H NVV LLG C+  G   +++ E+    +L   L  K    +           
Sbjct: 84  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKD 143
Query: 394 -LSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP 452
            L+ +         A+G+  L   +  K IHRD+   NILL EK   KI DFGLAR +  
Sbjct: 144 FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXK 200
Query: 453 DKTHVSTGIAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVL 511
           D   V  G A   L +MAPE +     T ++DV++FGVL+ E        +FS G+S   
Sbjct: 201 DPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE--------IFSLGASP-- 250
Query: 512 HTVWKHYKANRITQS----MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM 567
                 Y   +I +     +  G   R P+     + Q  L C     + RP+ +E+V  
Sbjct: 251 ------YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304
Query: 568 LNNI 571
           L N+
Sbjct: 305 LGNL 308

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 102/201 (50%), Gaps = 16/201 (7%)
Query: 304 RKLGQGGAGSVFR---GTLPD--GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVR 358
           ++LG+G  GSV       L D  G  +AVK+L  ++ + +  F  E+ ++  +QH N+V+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 359 LLG-CSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
             G C   G  +L L+ EY+P  SL D +   K  I  +   Q  + IC   E L     
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---- 162
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT--LGYMAPEYL 473
               + IHRD+ T NIL++ +   KI DFGL + +  DK        G   + + APE L
Sbjct: 163 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 220
Query: 474 VRGQLTEKADVYAFGVLVIEV 494
              + +  +DV++FGV++ E+
Sbjct: 221 TESKFSVASDVWSFGVVLYEL 241

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 102/201 (50%), Gaps = 16/201 (7%)
Query: 304 RKLGQGGAGSVFR---GTLPD--GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVR 358
           ++LG+G  GSV       L D  G  +AVK+L  ++ + +  F  E+ ++  +QH N+V+
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 359 LLG-CSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
             G C   G  +L L+ EY+P  SL D +   K  I  +   Q  + IC   E L     
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---- 138
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT--LGYMAPEYL 473
               + IHRD+ T NIL++ +   KI DFGL + +  DK        G   + + APE L
Sbjct: 139 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 196
Query: 474 VRGQLTEKADVYAFGVLVIEV 494
              + +  +DV++FGV++ E+
Sbjct: 197 TESKFSVASDVWSFGVVLYEL 217

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR---GTLPD--GRNIAVKRLFFNSRQWVDQFFNEVNLI 348
           ER   F    ++LG+G  GSV       L D  G  +AVK+L  ++ + +  F  E+ ++
Sbjct: 12  ERHLKFL---QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 68
Query: 349 SGIQHKNVVRLLG-CSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICG 405
             +QH N+V+  G C   G  +L L+ EY+P  SL D +   K  I  +   Q  + IC 
Sbjct: 69  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 128
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT- 464
             E L         + IHRD+ T NIL++ +   KI DFGL + +  DK        G  
Sbjct: 129 GMEYLG------TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 182
Query: 465 -LGYMAPEYLVRGQLTEKADVYAFGVLVIEV 494
            + + APE L   + +  +DV++FGV++ E+
Sbjct: 183 PIFWYAPESLTESKFSVASDVWSFGVVLYEL 213

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR---GTLPD--GRNIAVKRLFFNSRQWVDQFFNEVNLI 348
           ER   F    ++LG+G  GSV       L D  G  +AVK+L  ++ + +  F  E+ ++
Sbjct: 7   ERHLKFL---QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 63
Query: 349 SGIQHKNVVRLLG-CSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICG 405
             +QH N+V+  G C   G  +L L+ EY+P  SL D +   K  I  +   Q  + IC 
Sbjct: 64  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 123
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT- 464
             E L         + IHRD+ T NIL++ +   KI DFGL + +  DK        G  
Sbjct: 124 GMEYLG------TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 177
Query: 465 -LGYMAPEYLVRGQLTEKADVYAFGVLVIEV 494
            + + APE L   + +  +DV++FGV++ E+
Sbjct: 178 PIFWYAPESLTESKFSVASDVWSFGVVLYEL 208

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR---GTLPD--GRNIAVKRLFFNSRQWVDQFFNEVNLI 348
           ER   F    ++LG+G  GSV       L D  G  +AVK+L  ++ + +  F  E+ ++
Sbjct: 27  ERHLKFL---QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 83
Query: 349 SGIQHKNVVRLLG-CSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICG 405
             +QH N+V+  G C   G  +L L+ EY+P  SL D +   K  I  +   Q  + IC 
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 143
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT- 464
             E L         + IHRD+ T NIL++ +   KI DFGL + +  DK        G  
Sbjct: 144 GMEYLG------TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 197
Query: 465 -LGYMAPEYLVRGQLTEKADVYAFGVLVIEV 494
            + + APE L   + +  +DV++FGV++ E+
Sbjct: 198 PIFWYAPESLTESKFSVASDVWSFGVVLYEL 228

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR---GTLPD--GRNIAVKRLFFNSRQWVDQFFNEVNLI 348
           ER   F    ++LG+G  GSV       L D  G  +AVK+L  ++ + +  F  E+ ++
Sbjct: 9   ERHLKFL---QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 349 SGIQHKNVVRLLG-CSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICG 405
             +QH N+V+  G C   G  +L L+ EY+P  SL D +   K  I  +   Q  + IC 
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT- 464
             E L         + IHRD+ T NIL++ +   KI DFGL + +  DK        G  
Sbjct: 126 GMEYLG------TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179
Query: 465 -LGYMAPEYLVRGQLTEKADVYAFGVLVIEV 494
            + + APE L   + +  +DV++FGV++ E+
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYEL 210

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 126/292 (43%), Gaps = 40/292 (13%)
Query: 304 RKLGQGGAGSVFRG------TLPDGRNIAVKRLFFNSRQWVDQ-FFNEVNLISGI-QHKN 355
           + LG+G  G V              R +AVK L   +     +   +E+ ++  I  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 356 VVRLLG-CSIEGPESLLVYEYVPNRSLDQIL------FVKNTIHILSWQQRFT----IIC 404
           VV LLG C+  G   +++ E+    +L   L      FV   +      + F     +IC
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG- 463
            + +    +   +  K IHRD+   NILL EK   KI DFGLAR +  D   V  G A  
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARL 212
Query: 464 TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRI 523
            L +MAPE +     T ++DV++FGVL+ E        +FS G+S         Y   +I
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWE--------IFSLGASP--------YPGVKI 256
Query: 524 TQS----MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            +     +  G   R P+     + Q  L C     + RP+ +E+V  L N+
Sbjct: 257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 127/298 (42%), Gaps = 40/298 (13%)
Query: 298 DFFDNSRKLGQGGAGSVFRG------TLPDGRNIAVKRLFFNSRQWVDQ-FFNEVNLISG 350
           D     + LG+G  G V              R +AVK L   +     +   +E+ ++  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 351 I-QHKNVVRLLG-CSIEGPESLLVYEYVPNRSLDQIL------FVKNTIHILSWQQRFT- 401
           I  H NVV LLG C+  G   +++ E+    +L   L      FV   +      + F  
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 402 ---IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS 458
              +IC + +    +   +  K IHRD+   NILL EK   KI DFGLAR +  D   V 
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 197
Query: 459 TGIAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKH 517
            G A   L +MAPE +     T ++DV++FGVL+ E        +FS G+S         
Sbjct: 198 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE--------IFSLGASP-------- 241
Query: 518 YKANRITQS----MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           Y   +I +     +  G   R P+     + Q  L C     + RP+ +E+V  L N+
Sbjct: 242 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 126/295 (42%), Gaps = 46/295 (15%)
Query: 304 RKLGQGGAGSVFRG------TLPDGRNIAVKRLFFNSRQWVDQ-FFNEVNLISGI-QHKN 355
           + LG+G  G V              R +AVK L   +     +   +E+ ++  I  H N
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 94
Query: 356 VVRLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTIHI-------------LSWQQRFT 401
           VV LLG C+  G   +++ E+    +L   L  K    +             L+ +    
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLIC 154
Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGI 461
                A+G+  L   +  K IHRD+   NILL EK   KI DFGLAR +  D  +V  G 
Sbjct: 155 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 211
Query: 462 AG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKA 520
           A   L +MAPE +     T ++DV++FGVL+ E        +FS G+S         Y  
Sbjct: 212 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE--------IFSLGASP--------YPG 255
Query: 521 NRITQS----MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            +I +     +  G   R P+     + Q  L C     + RP+ +E+V  L N+
Sbjct: 256 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 310

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR---GTLPD--GRNIAVKRLFFNSRQWVDQFFNEVNLI 348
           ER   F    ++LG+G  GSV       L D  G  +AVK+L  ++ + +  F  E+ ++
Sbjct: 27  ERHLKFL---QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 83
Query: 349 SGIQHKNVVRLLG-CSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICG 405
             +QH N+V+  G C   G  +L L+ EY+P  SL D +   K  I  +   Q  + IC 
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 143
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT- 464
             E L         + IHRD+ T NIL++ +   KI DFGL + +  DK        G  
Sbjct: 144 GMEYLG------TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 197
Query: 465 -LGYMAPEYLVRGQLTEKADVYAFGVLVIEV 494
            + + APE L   + +  +DV++FGV++ E+
Sbjct: 198 PIFWYAPESLTESKFSVASDVWSFGVVLYEL 228

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 84/298 (28%), Positives = 127/298 (42%), Gaps = 40/298 (13%)
Query: 298 DFFDNSRKLGQGGAGSVFRG------TLPDGRNIAVKRLFFNSRQWVDQ-FFNEVNLISG 350
           D     + LG+G  G V              R +AVK L   +     +   +E+ ++  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 351 I-QHKNVVRLLG-CSIEGPESLLVYEYVPNRSLDQIL------FVKNTIHILSWQQRFT- 401
           I  H NVV LLG C+  G   +++ E+    +L   L      FV   +      + F  
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 402 ---IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS 458
              +IC + +    +   +  K IHRD+   NILL EK   KI DFGLAR +  D   V 
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 197
Query: 459 TGIAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKH 517
            G A   L +MAPE +     T ++DV++FGVL+ E        +FS G+S         
Sbjct: 198 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE--------IFSLGASP-------- 241
Query: 518 YKANRITQS----MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           Y   +I +     +  G   R P+     + Q  L C     + RP+ +E+V  L N+
Sbjct: 242 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 125/293 (42%), Gaps = 44/293 (15%)
Query: 304 RKLGQGGAGSVFRG------TLPDGRNIAVKRLFFNSRQWVDQ-FFNEVNLISGI-QHKN 355
           + LG+G  G V              R +AVK L   +     +   +E+ ++  I  H N
Sbjct: 35  KPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 94
Query: 356 VVRLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTIHI-----------LSWQQRFTII 403
           VV LLG C+  G   +++ E+    +L   L  K    +           L+ +      
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYS 154
Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG 463
              A+G+  L   +  K IHRD+   NILL EK   KI DFGLAR +  D   V  G A 
Sbjct: 155 FQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 464 -TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR 522
             L +MAPE +     T ++DV++FGVL+ E        +FS G+S         Y   +
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWE--------IFSLGASP--------YPGVK 255
Query: 523 ITQS----MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           I +     +  G   R P+     + Q  L C     + RP+ +E+V  L N+
Sbjct: 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 106/211 (50%), Gaps = 19/211 (9%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR---GTLPD--GRNIAVKRLFFNSRQWVDQFFNEVNLI 348
           ER   F    ++LG+G  GSV       L D  G  +AVK+L  ++ + +  F  E+ ++
Sbjct: 10  ERHLKFL---QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 66
Query: 349 SGIQHKNVVRLLG-CSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICG 405
             +QH N+V+  G C   G  +L L+ EY+P  SL D +   K  I  +   Q  + IC 
Sbjct: 67  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 126
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT- 464
             E L         + IHR++ T NIL++ +   KI DFGL + +  DK +      G  
Sbjct: 127 GMEYLG------TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES 180
Query: 465 -LGYMAPEYLVRGQLTEKADVYAFGVLVIEV 494
            + + APE L   + +  +DV++FGV++ E+
Sbjct: 181 PIFWYAPESLTESKFSVASDVWSFGVVLYEL 211

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 90/184 (48%), Gaps = 10/184 (5%)
Query: 321 DGRNIAVKRLFFNSRQWVDQ--FFNEVNLISGIQHKNVVRLLGCSIEGPESLL--VYEYV 376
           DG+ +  K L + S    ++    +EVNL+  ++H N+VR     I+   + L  V EY 
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA----HLHGGSGIKIIHRDIKTSNIL 432
               L  ++  K T       + F +   T   LA    H     G  ++HRD+K +N+ 
Sbjct: 90  EGGDLASVI-TKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVF 148
Query: 433 LDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVI 492
           LD K   K+ DFGLAR +  D T  +    GT  YM+PE + R    EK+D+++ G L+ 
Sbjct: 149 LDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLY 207
Query: 493 EVAS 496
           E+ +
Sbjct: 208 ELCA 211

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 90/184 (48%), Gaps = 10/184 (5%)
Query: 321 DGRNIAVKRLFFNSRQWVDQ--FFNEVNLISGIQHKNVVRLLGCSIEGPESLL--VYEYV 376
           DG+ +  K L + S    ++    +EVNL+  ++H N+VR     I+   + L  V EY 
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA----HLHGGSGIKIIHRDIKTSNIL 432
               L  ++  K T       + F +   T   LA    H     G  ++HRD+K +N+ 
Sbjct: 90  EGGDLASVI-TKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVF 148
Query: 433 LDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVI 492
           LD K   K+ DFGLAR +  D +   T   GT  YM+PE + R    EK+D+++ G L+ 
Sbjct: 149 LDGKQNVKLGDFGLARILNHDTSFAKT-FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLY 207
Query: 493 EVAS 496
           E+ +
Sbjct: 208 ELCA 211

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 107/220 (48%), Gaps = 26/220 (11%)
Query: 293 LERATDFFDNSRK--LGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQWVDQFFNEVNLIS 349
           LE   ++ +N  +  LG+G  G V+ G  L +   IA+K +     ++      E+ L  
Sbjct: 1   LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHK 60
Query: 350 GIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVK--------NTIHILSWQQRFT 401
            ++HKN+V+ LG   E     +  E VP  SL  +L  K         TI   + Q    
Sbjct: 61  HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ---- 116
Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE-KLTPKIADFGLARHVAPDKTHVSTG 460
                 EGL +LH     +I+HRDIK  N+L++      KI+DFG ++ +A       T 
Sbjct: 117 ----ILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET- 168
Query: 461 IAGTLGYMAPEYLVRGQ--LTEKADVYAFGVLVIEVASGR 498
             GTL YMAPE + +G     + AD+++ G  +IE+A+G+
Sbjct: 169 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 104/226 (46%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 25  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 80
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 81  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 128
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH A +
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 186 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 101/201 (50%), Gaps = 16/201 (7%)
Query: 304 RKLGQGGAGSVFR---GTLPD--GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVR 358
           ++LG+G  GSV       L D  G  +AVK+L  ++ + +  F  E+ ++  +QH N+V+
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 359 LLG-CSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
             G C   G  +L L+ EY+P  SL D +      I  +   Q  + IC   E L     
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLG---- 134
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT--LGYMAPEYL 473
               + IHRD+ T NIL++ +   KI DFGL + +  DK        G   + + APE L
Sbjct: 135 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 474 VRGQLTEKADVYAFGVLVIEV 494
              + +  +DV++FGV++ E+
Sbjct: 193 TESKFSVASDVWSFGVVLYEL 213

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 104/226 (46%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 25  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 80
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 81  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 128
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH A +
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 186 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 104/226 (46%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 25  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 80
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 81  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 128
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH A +
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 186 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 70/294 (23%), Positives = 122/294 (41%), Gaps = 36/294 (12%)
Query: 303 SRKLGQGGAGSVFRGT------LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNV 356
            R+LG+G  G VF           D   +AVK L   +      F  E  L++ +QH+++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI-------------LSWQQRFTII 403
           V+  G   +G   ++V+EY+ +  L++ L       +             L   Q   I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIA 462
              A G+ +L   +    +HRD+ T N L+   L  KI DFG++R V + D   V     
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR 522
             + +M PE ++  + T ++DV++FGV++ E        +F+ G        W       
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWE--------IFTYGKQP-----WFQLSNTE 243
Query: 523 ITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIP 576
           + + +  G     P      V  + L C Q     R ++ E+  +L+ +    P
Sbjct: 244 VIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGKATP 297

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 15/219 (6%)
Query: 305 KLGQGGAGSVFRGTL--PDGRNIAV-----KRLFFNSRQWVDQFFNEVNLISGIQHKNVV 357
           KLG G  G V RG    P G+ ++V     K    +  + +D F  EVN +  + H+N++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
           RL G  +  P  + V E  P  SL   L       +L    R+ +    AEG+ +L    
Sbjct: 75  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 130
Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH--VSTGIAGTLGYMAPEYLVR 475
             + IHRD+   N+LL  +   KI DFGL R +  +  H  +         + APE L  
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 188
Query: 476 GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV 514
              +  +D + FGV + E+ +  +        S +LH +
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 15/219 (6%)
Query: 305 KLGQGGAGSVFRGTL--PDGRNIAV-----KRLFFNSRQWVDQFFNEVNLISGIQHKNVV 357
           KLG G  G V RG    P G+ ++V     K    +  + +D F  EVN +  + H+N++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
           RL G  +  P  + V E  P  SL   L       +L    R+ +    AEG+ +L    
Sbjct: 75  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 130
Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH--VSTGIAGTLGYMAPEYLVR 475
             + IHRD+   N+LL  +   KI DFGL R +  +  H  +         + APE L  
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 476 GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV 514
              +  +D + FGV + E+ +  +        S +LH +
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 15/219 (6%)
Query: 305 KLGQGGAGSVFRGTL--PDGRNIAV-----KRLFFNSRQWVDQFFNEVNLISGIQHKNVV 357
           KLG G  G V RG    P G+ ++V     K    +  + +D F  EVN +  + H+N++
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
           RL G  +  P  + V E  P  SL   L       +L    R+ +    AEG+ +L    
Sbjct: 75  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 130
Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH--VSTGIAGTLGYMAPEYLVR 475
             + IHRD+   N+LL  +   KI DFGL R +  +  H  +         + APE L  
Sbjct: 131 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 476 GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV 514
              +  +D + FGV + E+ +  +        S +LH +
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 15/219 (6%)
Query: 305 KLGQGGAGSVFRGTL--PDGRNIAV-----KRLFFNSRQWVDQFFNEVNLISGIQHKNVV 357
           KLG G  G V RG    P G+ ++V     K    +  + +D F  EVN +  + H+N++
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
           RL G  +  P  + V E  P  SL   L       +L    R+ +    AEG+ +L    
Sbjct: 85  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 140
Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH--VSTGIAGTLGYMAPEYLVR 475
             + IHRD+   N+LL  +   KI DFGL R +  +  H  +         + APE L  
Sbjct: 141 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198
Query: 476 GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV 514
              +  +D + FGV + E+ +  +        S +LH +
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 15/219 (6%)
Query: 305 KLGQGGAGSVFRGTL--PDGRNIAV-----KRLFFNSRQWVDQFFNEVNLISGIQHKNVV 357
           KLG G  G V RG    P G+ ++V     K    +  + +D F  EVN +  + H+N++
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
           RL G  +  P  + V E  P  SL   L       +L    R+ +    AEG+ +L    
Sbjct: 79  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 134
Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH--VSTGIAGTLGYMAPEYLVR 475
             + IHRD+   N+LL  +   KI DFGL R +  +  H  +         + APE L  
Sbjct: 135 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 476 GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV 514
              +  +D + FGV + E+ +  +        S +LH +
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 231

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 15/219 (6%)
Query: 305 KLGQGGAGSVFRGTL--PDGRNIAV-----KRLFFNSRQWVDQFFNEVNLISGIQHKNVV 357
           KLG G  G V RG    P G+ ++V     K    +  + +D F  EVN +  + H+N++
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
           RL G  +  P  + V E  P  SL   L       +L    R+ +    AEG+ +L    
Sbjct: 85  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 140
Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH--VSTGIAGTLGYMAPEYLVR 475
             + IHRD+   N+LL  +   KI DFGL R +  +  H  +         + APE L  
Sbjct: 141 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKT 198
Query: 476 GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV 514
              +  +D + FGV + E+ +  +        S +LH +
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 125/297 (42%), Gaps = 45/297 (15%)
Query: 304 RKLGQGGAGSVFR----GTLP--DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNV 356
           R +G+G  G VF+    G LP      +AVK L    S      F  E  L++   + N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---------------------LS 395
           V+LLG    G    L++EY+    L++ L   +   +                     LS
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 396 WQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDK 454
             ++  I    A G+A+L   S  K +HRD+ T N L+ E +  KIADFGL+R++ + D 
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 455 THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV 514
                  A  + +M PE +   + T ++DV+A+GV++ E+ S      +      V++ V
Sbjct: 230 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV 289
Query: 515 WKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
                          G     PEN    +  +  LC     A RPS   +  +L  +
Sbjct: 290 RD-------------GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 108/203 (53%), Gaps = 18/203 (8%)
Query: 303 SRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGC 362
           S ++G G  G+V++G       + + ++   + +    F NEV ++   +H N++  +G 
Sbjct: 41  STRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 363 SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
             +   ++ V ++    SL + L V+ T   +   Q   I   TA+G+ +LH  +   II
Sbjct: 101 MTKDNLAI-VTQWCEGSSLYKHLHVQETKFQMF--QLIDIARQTAQGMDYLHAKN---II 154
Query: 423 HRDIKTSNILLDEKLTPKIADFGLA----RHVAPDKTHVSTGIAGTLGYMAPEYLVRGQ- 477
           HRD+K++NI L E LT KI DFGLA    R     +    T   G++ +MAPE ++R Q 
Sbjct: 155 HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT---GSVLWMAPE-VIRMQD 210
Query: 478 ---LTEKADVYAFGVLVIEVASG 497
               + ++DVY++G+++ E+ +G
Sbjct: 211 NNPFSFQSDVYSYGIVLYELMTG 233

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 15/219 (6%)
Query: 305 KLGQGGAGSVFRGTL--PDGRNIAV-----KRLFFNSRQWVDQFFNEVNLISGIQHKNVV 357
           KLG G  G V RG    P G+ ++V     K    +  + +D F  EVN +  + H+N++
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
           RL G  +  P  + V E  P  SL   L       +L    R+ +    AEG+ +L    
Sbjct: 79  RLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK- 134
Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH--VSTGIAGTLGYMAPEYLVR 475
             + IHRD+   N+LL  +   KI DFGL R +  +  H  +         + APE L  
Sbjct: 135 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 192
Query: 476 GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV 514
              +  +D + FGV + E+ +  +        S +LH +
Sbjct: 193 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 231

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 18  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 179 M----TGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 18  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 179 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 307 GQGGAGSVFRGTLPDGRNIAVKRLFFNSRQ-WVDQFFNEVNLISGIQHKNVVRLLGCSIE 365
            +G  G V++  L +   +AVK      +Q W +++  EV  + G++H+N+++ +G    
Sbjct: 33  ARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIGAEKR 89
Query: 366 GP----ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH------- 414
           G     +  L+  +    SL   L      +++SW +   I    A GLA+LH       
Sbjct: 90  GTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPGLK 145
Query: 415 GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVST-GIAGTLGYMAPEYL 473
            G    I HRDIK+ N+LL   LT  IADFGLA      K+   T G  GT  YMAPE L
Sbjct: 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVL 205
Query: 474 VRGQLT------EKADVYAFGVLVIEVAS 496
             G +        + D+YA G+++ E+AS
Sbjct: 206 -EGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 24  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR 79
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 80  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 127
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 128 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 184
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 185 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/223 (32%), Positives = 105/223 (47%), Gaps = 17/223 (7%)
Query: 291 EILER--ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNE 344
           +IL R    D F+  R LG+G  G+V+         I   ++ F S   ++ V+ Q   E
Sbjct: 14  DILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRRE 73
Query: 345 VNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIIC 404
           + + + + H N++RL     +     L+ EY P   L + L    T      Q+  TI+ 
Sbjct: 74  IEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCT---FDEQRTATIME 130
Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT 464
             A+ L + HG    K+IHRDIK  N+LL  K   KIADFG + H AP     +  + GT
Sbjct: 131 ELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWSVH-APSLRRKT--MCGT 184
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGS 507
           L Y+ PE +      EK D++  GVL  E+  G  N  F   S
Sbjct: 185 LDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG--NPPFESAS 225

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 28  WEVPER----YQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR 83
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 84  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 131
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 132 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 188
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 189 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 38  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR 93
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 94  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 141
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 142 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 198
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 199 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 14  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR 69
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 70  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 117
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 175 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 23  WEVPER----YQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 78
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 79  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 126
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 127 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE 183
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 184 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 90/184 (48%), Gaps = 10/184 (5%)
Query: 321 DGRNIAVKRLFFNSRQWVDQ--FFNEVNLISGIQHKNVVRLLGCSIEGPESLL--VYEYV 376
           DG+ +  K L + S    ++    +EVNL+  ++H N+VR     I+   + L  V EY 
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA----HLHGGSGIKIIHRDIKTSNIL 432
               L  ++  K T       + F +   T   LA    H     G  ++HRD+K +N+ 
Sbjct: 90  EGGDLASVI-TKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVF 148
Query: 433 LDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVI 492
           LD K   K+ DFGLAR +  D+   +    GT  YM+PE + R    EK+D+++ G L+ 
Sbjct: 149 LDGKQNVKLGDFGLARILNHDED-FAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLY 207
Query: 493 EVAS 496
           E+ +
Sbjct: 208 ELCA 211

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 37  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR 92
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 93  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 140
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 141 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 197
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 198 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 310 GAGSVFRGTL--PDGRNIAVKRLFFNSRQW-VDQFFNEVNLISGIQHKNVVRLLGCSIEG 366
           GA +V +     P    +A+KR+     Q  +D+   E+  +S   H N+V      +  
Sbjct: 26  GATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK 85
Query: 367 PESLLVYEYVPNRSLDQIL--FVKNTIH---ILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
            E  LV + +   S+  I+   V    H   +L      TI+    EGL +LH    I  
Sbjct: 86  DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQI-- 143
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAP----DKTHVSTGIAGTLGYMAPEYL--VR 475
            HRD+K  NILL E  + +IADFG++  +A      +  V     GT  +MAPE +  VR
Sbjct: 144 -HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR 202
Query: 476 GQLTEKADVYAFGVLVIEVASG 497
           G    KAD+++FG+  IE+A+G
Sbjct: 203 G-YDFKADIWSFGITAIELATG 223

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 103/229 (44%), Gaps = 24/229 (10%)
Query: 287 NFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL---FFNSRQWVDQ-- 340
           N K+E       F    + LG G  G V   T    G+  AV ++      S    D+  
Sbjct: 38  NEKWEFPRNNLQF---GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE 94
Query: 341 -FFNEVNLISGI-QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQ 398
              +E+ ++S + QH+N+V LLG    G   L++ EY     L  + F++    +L    
Sbjct: 95  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL--LNFLRRKSRVLETDP 152
Query: 399 RFTIICGTAEGLAHLHGGSGI----------KIIHRDIKTSNILLDEKLTPKIADFGLAR 448
            F I   TA     LH  S +            IHRD+   N+LL      KI DFGLAR
Sbjct: 153 AFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
Query: 449 HVAPDKTHVSTGIAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
            +  D  ++  G A   + +MAPE +     T ++DV+++G+L+ E+ S
Sbjct: 213 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 24  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 79
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 80  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 127
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 128 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 184
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 185 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 23  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 78
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 79  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 126
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 127 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE 183
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 184 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 23  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 78
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 79  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 126
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 127 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 183
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 184 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 17  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 72
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 73  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 120
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 121 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 177
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 178 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 18  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 179 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 25  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 80
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 81  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 128
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 185
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 186 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 29  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 84
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 85  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 132
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 133 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE 189
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 190 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 18  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 179 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 20  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 75
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 76  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 123
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 124 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 180
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 181 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 18  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 179 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 310 GAGSVFRGTL--PDGRNIAVKRLFFNSRQW-VDQFFNEVNLISGIQHKNVVRLLGCSIEG 366
           GA +V +     P    +A+KR+     Q  +D+   E+  +S   H N+V      +  
Sbjct: 21  GATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK 80
Query: 367 PESLLVYEYVPNRSLDQIL--FVKNTIH---ILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
            E  LV + +   S+  I+   V    H   +L      TI+    EGL +LH    I  
Sbjct: 81  DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQI-- 138
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAP----DKTHVSTGIAGTLGYMAPEYL--VR 475
            HRD+K  NILL E  + +IADFG++  +A      +  V     GT  +MAPE +  VR
Sbjct: 139 -HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR 197
Query: 476 GQLTEKADVYAFGVLVIEVASG 497
           G    KAD+++FG+  IE+A+G
Sbjct: 198 G-YDFKADIWSFGITAIELATG 218

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 18  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQK 121
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE 178
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 179 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 18  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 179 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 24  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 79
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 80  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 127
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 128 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 184
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 185 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 18  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 179 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 20  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 75
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 76  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 123
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 124 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 180
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 181 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 23  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 78
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 79  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 126
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 127 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 183
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 184 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 18  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 179 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 18  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 179 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 30  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELR 85
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 86  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 133
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 134 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 190
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 191 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 30  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 85
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 86  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 133
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 134 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 190
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 191 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 15  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 70
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 71  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 118
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 119 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 175
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 176 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 30  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 85
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 86  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 133
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 134 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 190
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 191 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 18  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 179 M----TGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 20  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 75
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 76  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 123
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 124 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 180
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 181 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 18  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQK 121
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 179 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 100/226 (44%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 14  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR 69
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICG- 405
           L+  ++H+NV+ LL              + P RSL++   V    H++       + C  
Sbjct: 70  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCAK 117
Query: 406 ------------TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
                          GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 175 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 29  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 84
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 85  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 132
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 133 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 189
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 190 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 38  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 93
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 94  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 141
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 142 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 198
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 199 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 37  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 92
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 93  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 140
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 141 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 197
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 198 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 15  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 70
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 71  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 118
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 119 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 175
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 176 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 16  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 71
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 72  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 119
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 120 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 176
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 177 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 41  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 96
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 97  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 144
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 145 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 201
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 202 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 14  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 69
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 70  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 117
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 175 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 20  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 75
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 76  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 123
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 124 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDDE 180
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 181 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 24  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 79
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 80  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 127
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 128 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDDE 184
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 185 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 18  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                 G   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 179 M----AGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 18  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 178
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                 G   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 179 M----AGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 18  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI D+GLARH   +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLARHTDDE 178
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 179 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 76/157 (48%), Gaps = 21/157 (13%)
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG-TLGYMAPEYLVRGQL 478
           K IHRD+   NILL EK   KI DFGLAR +  D  +V  G A   L +MAPE +     
Sbjct: 211 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 270
Query: 479 TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS----MDPGLTGR 534
           T ++DV++FGVL+ E        +FS G+S         Y   +I +     +  G   R
Sbjct: 271 TIQSDVWSFGVLLWE--------IFSLGASP--------YPGVKIDEEFCRRLKEGTRMR 314
Query: 535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            P+     + Q  L C     + RP+ +E+V  L N+
Sbjct: 315 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 351

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 14  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR 69
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 70  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 117
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                 G   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 175 M----AGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 76/157 (48%), Gaps = 21/157 (13%)
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG-TLGYMAPEYLVRGQL 478
           K IHRD+   NILL EK   KI DFGLAR +  D  +V  G A   L +MAPE +     
Sbjct: 218 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 277
Query: 479 TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS----MDPGLTGR 534
           T ++DV++FGVL+ E        +FS G+S         Y   +I +     +  G   R
Sbjct: 278 TIQSDVWSFGVLLWE--------IFSLGASP--------YPGVKIDEEFCRRLKEGTRMR 321
Query: 535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            P+     + Q  L C     + RP+ +E+V  L N+
Sbjct: 322 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 358

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 76/157 (48%), Gaps = 21/157 (13%)
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG-TLGYMAPEYLVRGQL 478
           K IHRD+   NILL EK   KI DFGLAR +  D  +V  G A   L +MAPE +     
Sbjct: 213 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 272
Query: 479 TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS----MDPGLTGR 534
           T ++DV++FGVL+ E        +FS G+S         Y   +I +     +  G   R
Sbjct: 273 TIQSDVWSFGVLLWE--------IFSLGASP--------YPGVKIDEEFCRRLKEGTRMR 316
Query: 535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            P+     + Q  L C     + RP+ +E+V  L N+
Sbjct: 317 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 128/281 (45%), Gaps = 31/281 (11%)
Query: 302 NSRKLGQGGAGSVFRGTLPDGRN----IAVKRLF-FNSRQWVDQFFNEVNLISGIQHKNV 356
           + R +G+G  G V+ G   D        A+K L      Q V+ F  E  L+ G+ H NV
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 357 VRLLGCSIEGPESL--LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH 414
           + L+G  +  PE L  ++  Y+ +  L Q  F+++     + +   +     A G+ +L 
Sbjct: 85  LALIGIMLP-PEGLPHVLLPYMCHGDLLQ--FIRSPQRNPTVKDLISFGLQVARGMEYL- 140
Query: 415 GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG----IAGTLGYMAP 470
             +  K +HRD+   N +LDE  T K+ADFGLAR +  D+ + S          + + A 
Sbjct: 141 --AEQKFVHRDLAARNCMLDESFTVKVADFGLARDIL-DREYYSVQQHRHARLPVKWTAL 197
Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG 530
           E L   + T K+DV++FGVL+ E        + + G+       ++H     +T  +  G
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWE--------LLTRGAPP-----YRHIDPFDLTHFLAQG 244
Query: 531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
                PE     + Q+   C +A  A+RP+   +V  +  I
Sbjct: 245 RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 76/157 (48%), Gaps = 21/157 (13%)
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG-TLGYMAPEYLVRGQL 478
           K IHRD+   NILL EK   KI DFGLAR +  D  +V  G A   L +MAPE +     
Sbjct: 220 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 279
Query: 479 TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS----MDPGLTGR 534
           T ++DV++FGVL+ E        +FS G+S         Y   +I +     +  G   R
Sbjct: 280 TIQSDVWSFGVLLWE--------IFSLGASP--------YPGVKIDEEFCRRLKEGTRMR 323
Query: 535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            P+     + Q  L C     + RP+ +E+V  L N+
Sbjct: 324 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 360

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 97/203 (47%), Gaps = 11/203 (5%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL----FFNSRQWVDQFFNEVNLISGIQHK 354
           F   +K+G+G    V+R   L DG  +A+K++      +++   D    E++L+  + H 
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARAD-CIKEIDLLKQLNHP 92
Query: 355 NVVRLLGCSIEGPESLLVYEYVPNRSLDQIL-FVKNTIHILSWQQRFTIICGTAEGLAHL 413
           NV++     IE  E  +V E      L +++   K    ++  +  +         L H+
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H     +++HRDIK +N+ +      K+ D GL R  +  KT  +  + GT  YM+PE +
Sbjct: 153 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERI 208
Query: 474 VRGQLTEKADVYAFGVLVIEVAS 496
                  K+D+++ G L+ E+A+
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAA 231

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 121/271 (44%), Gaps = 29/271 (10%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           + +G+G  G V  G    G  +AVK +  ++      F  E ++++ ++H N+V+LLG  
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 364 IEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
           +E    L +V EY+   SL   L  +    +L             E + +L G +    +
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FV 139
Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTL--GYMAPEYLVRGQLTE 480
           HRD+   N+L+ E    K++DFGL +  +      ST   G L   + APE L   + + 
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREKKFST 193
Query: 481 KADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEA 540
           K+DV++FG+L+ E+ S  R          V+  V K YK       MD       P+   
Sbjct: 194 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-------MDA------PDGCP 240
Query: 541 SRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
             V ++   C     A+RPS  ++   L +I
Sbjct: 241 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 121/271 (44%), Gaps = 29/271 (10%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           + +G+G  G V  G    G  +AVK +  ++      F  E ++++ ++H N+V+LLG  
Sbjct: 12  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 364 IEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
           +E    L +V EY+   SL   L  +    +L             E + +L G +    +
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FV 124
Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTL--GYMAPEYLVRGQLTE 480
           HRD+   N+L+ E    K++DFGL +  +      ST   G L   + APE L   + + 
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREKKFST 178
Query: 481 KADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEA 540
           K+DV++FG+L+ E+ S  R          V+  V K YK       MD       P+   
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-------MDA------PDGCP 225
Query: 541 SRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
             V ++   C     A+RPS  ++   L +I
Sbjct: 226 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 256

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 38  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR 93
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 94  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 141
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 142 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 198
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                 G   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 199 M----XGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 102/229 (44%), Gaps = 24/229 (10%)
Query: 287 NFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL---FFNSRQWVDQ-- 340
           N K+E       F    + LG G  G V   T    G+  AV ++      S    D+  
Sbjct: 38  NEKWEFPRNNLQF---GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE 94
Query: 341 -FFNEVNLISGI-QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQ 398
              +E+ ++S + QH+N+V LLG    G   L++ EY     L  + F++    +L    
Sbjct: 95  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL--LNFLRRKSRVLETDP 152
Query: 399 RFTIICGTAEGLAHLHGGSGI----------KIIHRDIKTSNILLDEKLTPKIADFGLAR 448
            F I   T      LH  S +            IHRD+   N+LL      KI DFGLAR
Sbjct: 153 AFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
Query: 449 HVAPDKTHVSTGIAGT-LGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
            +  D  ++  G A   + +MAPE +     T ++DV+++G+L+ E+ S
Sbjct: 213 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 14/205 (6%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRL-FFNSRQWVDQFFNEVNLISGIQH 353
           + F    ++G+G  G VF+G   D R    +A+K +    +   ++    E+ ++S    
Sbjct: 23  ELFTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 80
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
             V +  G  ++G +  ++ EY+   S   +L            Q  T++    +GL +L
Sbjct: 81  SYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEF----QIATMLKEILKGLDYL 136
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H     K IHRDIK +N+LL E+   K+ADFG+A  +   +   +T   GT  +MAPE +
Sbjct: 137 HSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVI 192
Query: 474 VRGQLTEKADVYAFGVLVIEVASGR 498
            +     KAD+++ G+  IE+A G 
Sbjct: 193 QQSAYDSKADIWSLGITAIELAKGE 217

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 103/198 (52%), Gaps = 13/198 (6%)
Query: 306 LGQGGAGSVFRGT-LPDGRNI----AVKRLFFNSRQWVD-QFFNEVNLISGIQHKNVVRL 359
           LG G  G+V++G  +PDG N+    A+K L  N+    + +  +E  +++G+    V RL
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
           LG  +     L V + +P   L  +  V+     L  Q         A+G+++L     +
Sbjct: 85  LGICLTSTVQL-VTQLMPYGCL--LDHVRENRGRLGSQDLLNWCMQIAKGMSYLED---V 138
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV-STGIAGTLGYMAPEYLVRGQL 478
           +++HRD+   N+L+      KI DFGLAR +  D+T   + G    + +MA E ++R + 
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRF 198
Query: 479 TEKADVYAFGVLVIEVAS 496
           T ++DV+++GV V E+ +
Sbjct: 199 THQSDVWSYGVTVWELMT 216

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 120/271 (44%), Gaps = 29/271 (10%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           + +G+G  G V  G    G  +AVK +  ++      F  E ++++ ++H N+V+LLG  
Sbjct: 18  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 364 IEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
           +E    L +V EY+   SL   L  +    +L             E + +L G +    +
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FV 130
Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTL--GYMAPEYLVRGQLTE 480
           HRD+   N+L+ E    K++DFGL +  +      ST   G L   + APE L     + 
Sbjct: 131 HRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREAAFST 184
Query: 481 KADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEA 540
           K+DV++FG+L+ E+ S  R          V+  V K YK       MD       P+   
Sbjct: 185 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-------MDA------PDGCP 231
Query: 541 SRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
             V ++   C     A+RPS  ++   L +I
Sbjct: 232 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 262

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 107/225 (47%), Gaps = 17/225 (7%)
Query: 278 GTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRL-FFN 333
           G  L T +L F+    E   + F    K+G+G  G VF+G   D R    +A+K +    
Sbjct: 10  GVDLGTENLYFQSMDPE---ELFTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEE 64
Query: 334 SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI 393
           +   ++    E+ ++S      V +  G  ++  +  ++ EY+   S   +L        
Sbjct: 65  AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGP 120
Query: 394 LSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
           L   Q  TI+    +GL +LH     K IHRDIK +N+LL E    K+ADFG+A  +   
Sbjct: 121 LDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 177
Query: 454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           +   +T   GT  +MAPE + +     KAD+++ G+  IE+A G 
Sbjct: 178 QIKRNT-FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 221

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 41  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 96
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 97  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 144
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 145 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 201
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                 G   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 202 M----XGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
             D FD  R LG+G  G+V+       + I   ++ F S   ++ V+ Q   E+ + S +
Sbjct: 13  TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 72
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++R+     +     L+ E+ P   L + L           Q+  T +   A+ L 
Sbjct: 73  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALH 129
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     K+IHRDIK  N+L+  K   KIADFG + H AP  +     + GTL Y+ PE
Sbjct: 130 YCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVH-AP--SLRRRXMCGTLDYLPPE 183
Query: 472 YLVRGQLTEKADVYAFGVLVIEVASG 497
            +      EK D++  GVL  E   G
Sbjct: 184 MIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 14/205 (6%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRL-FFNSRQWVDQFFNEVNLISGIQH 353
           + F    K+G+G  G VF+G   D R    +A+K +    +   ++    E+ ++S    
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 64
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
             V +  G  ++  +  ++ EY+   S   +L        L   Q  TI+    +GL +L
Sbjct: 65  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYL 120
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H     K IHRDIK +N+LL E    K+ADFG+A  +   +   +T   GT  +MAPE +
Sbjct: 121 HSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVI 176
Query: 474 VRGQLTEKADVYAFGVLVIEVASGR 498
            +     KAD+++ G+  IE+A G 
Sbjct: 177 KQSAYDSKADIWSLGITAIELARGE 201

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 305 KLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVD-----QFFNEVNLISGIQHKNVVR 358
           ++G+G  G VF G L  D   +AVK    + R+ +      +F  E  ++    H N+VR
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
           L+G   +     +V E V  +  D + F++     L  +    ++   A G+ +L     
Sbjct: 177 LIGVCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC- 233
Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT-LGYMAPEYLVRGQ 477
              IHRD+   N L+ EK   KI+DFG++R  A      S G+    + + APE L  G+
Sbjct: 234 --CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGR 291
Query: 478 LTEKADVYAFGVLVIEVAS 496
            + ++DV++FG+L+ E  S
Sbjct: 292 YSSESDVWSFGILLWETFS 310

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 306 LGQGGAGSVFRGTLP--DGRN--IAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRL 359
           LG+G  GSV  G L   DG +  +AVK +  +  S++ +++F +E   +    H NV+RL
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 360 LGCSIEG-----PESLLVYEYVPNRSLDQILF---VKNTIHILSWQQRFTIICGTAEGLA 411
           LG  IE      P+ +++  ++    L   L    ++     +  Q     +   A G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT-LGYMAP 470
           +L   S    +HRD+   N +L + +T  +ADFGL++ +     +    IA   + ++A 
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 471 EYLVRGQLTEKADVYAFGVLVIEVAS 496
           E L     T K+DV+AFGV + E+A+
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 18  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DF LARH   +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLARHTDDE 178
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 179 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 107/233 (45%), Gaps = 41/233 (17%)
Query: 293 LERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI 351
           L  A+DF +    LGQG  G V +     D R  A+K++  ++ + +    +EV L++ +
Sbjct: 2   LRYASDF-EEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASL 59
Query: 352 QHKNVVRLLGC------------SIEGPESLLV-YEYVPNRSLDQILFVKNTIHILSWQQ 398
            H+ VVR                +++   +L +  EY  NR+L  ++  +N       QQ
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLN-----QQ 114
Query: 399 R---FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV----- 450
           R   + +     E L+++H      IIHRD+K  NI +DE    KI DFGLA++V     
Sbjct: 115 RDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 451 --------APDKTHVSTGIAGTLGYMAPEYLV-RGQLTEKADVYAFGVLVIEV 494
                    P  +   T   GT  Y+A E L   G   EK D+Y+ G++  E+
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 18  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQK 121
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGL RH   +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE 178
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 179 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       S+E  + + +   + + +L Q++ ++     L  ++   ++     G
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME-----LDHERMSYLLYQMLVG 138
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T    T  Y A
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG--TSFMMTPYVVTRYYRA 193
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASG 497
           PE ++     E  D+++ GV++ E+  G
Sbjct: 194 PEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 13/206 (6%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS---RQWVD-QFFNEVNLISGI 351
             D FD  R LG+G  G+V+       + I   ++ F S   ++ V+ Q   E+ + S +
Sbjct: 12  TIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N++R+     +     L+ E+ P   L + L           Q+  T +   A+ L 
Sbjct: 72  RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALH 128
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           + H     K+IHRDIK  N+L+  K   KIADFG + H AP        + GTL Y+ PE
Sbjct: 129 YCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVH-APSLR--RRXMCGTLDYLPPE 182
Query: 472 YLVRGQLTEKADVYAFGVLVIEVASG 497
            +      EK D++  GVL  E   G
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVVAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       S+E  + + +   + + +L Q++ ++     L  ++   ++     G
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME-----LDHERMSYLLYQMLVG 138
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T    T  Y A
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG--TSFMMTPYVVTRYYRA 193
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASG 497
           PE ++     E  D+++ GV++ E+  G
Sbjct: 194 PEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 305 KLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVD-----QFFNEVNLISGIQHKNVVR 358
           ++G+G  G VF G L  D   +AVK    + R+ +      +F  E  ++    H N+VR
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
           L+G   +     +V E V  +  D + F++     L  +    ++   A G+ +L     
Sbjct: 177 LIGVCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC- 233
Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT-LGYMAPEYLVRGQ 477
              IHRD+   N L+ EK   KI+DFG++R  A      S G+    + + APE L  G+
Sbjct: 234 --CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 478 LTEKADVYAFGVLVIEVAS 496
            + ++DV++FG+L+ E  S
Sbjct: 292 YSSESDVWSFGILLWETFS 310

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 126/295 (42%), Gaps = 51/295 (17%)
Query: 304 RKLGQGGAGSVFRGTL------PDGRNIAVKRL----FFNSRQWVDQFFNEVNLISGI-Q 352
           + LG G  G V   T            +AVK L        R+      +E+ ++S +  
Sbjct: 52  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE---ALMSELKVLSYLGN 108
Query: 353 HKNVVRLLG-CSIEGPESLLVYEYV--------PNRSLDQILFVKNTIHILSWQQRF--- 400
           H N+V LLG C+I GP +L++ EY           R  D  +  K +  I+   +     
Sbjct: 109 HMNIVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 401 ----TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH 456
               +     A+G+A L   +    IHRD+   NILL      KI DFGLARH+  D  +
Sbjct: 168 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNY 224
Query: 457 VSTGIAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSV--LHT 513
           V  G A   + +MAPE +     T ++DV+++G+ + E        +FS GSS    +  
Sbjct: 225 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE--------LFSLGSSPYPGMPV 276
Query: 514 VWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHML 568
             K YK       +  G     PE+  + +  I   C  A    RP+  ++V ++
Sbjct: 277 DSKFYKM------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 325

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 126/258 (48%), Gaps = 38/258 (14%)
Query: 300 FDNSRKLGQGGAGSVF---RGTLPD-GRNIAVKRLFFNSRQWVDQFFN--EVNLISGIQH 353
           F+  + LGQG  G VF   + T PD G   A+K L   + +  D+     E ++++ + H
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNH 89
Query: 354 KNVVRL-LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI-ICGTAEGLA 411
             VV+L      EG +  L+ +++  R  D  LF + +  ++  ++     +   A GL 
Sbjct: 90  PFVVKLHYAFQTEG-KLYLILDFL--RGGD--LFTRLSKEVMFTEEDVKFYLAELALGLD 144
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           HLH    + II+RD+K  NILLDE+   K+ DFGL++  A D    +    GT+ YMAPE
Sbjct: 145 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-AIDHEKKAYSFCGTVEYMAPE 200
Query: 472 YLVRGQLTEKADVYAFGVLVIEVASG--------RRNSV-------------FSEGSSSV 510
            + R   +  AD +++GVL+ E+ +G        R+ ++              S  + S+
Sbjct: 201 VVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFLSTEAQSL 260
Query: 511 LHTVWKHYKANRITQSMD 528
           L  ++K   ANR+    D
Sbjct: 261 LRALFKRNPANRLGSGPD 278

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 128/297 (43%), Gaps = 44/297 (14%)
Query: 299 FFDNSRKLGQGGAGSVF--------RGTLPDGRNIAVKRLFFNS-RQWVDQFFNEVNLIS 349
           +    R LG+G  G V          GT   G  +AVK L  ++  Q    +  E++++ 
Sbjct: 32  YLKKIRDLGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADAGPQHRSGWKQEIDILR 88
Query: 350 GIQHKNVVRLLGCSIE-GPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTA 407
            + H+++++  GC  + G  SL LV EYVP  SL   L      H +   Q         
Sbjct: 89  TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQIC 144
Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP--DKTHVSTGIAGTL 465
           EG+A+LH       IHRD+   N+LLD     KI DFGLA+ V    +   V       +
Sbjct: 145 EGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPV 201
Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSV-----------FSEGSSSVLHTV 514
            + APE L   +    +DV++FGV + E+ +   +S             ++G  +VL   
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL--- 258
Query: 515 WKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
                  R+T+ ++ G     P+   + V  +   C +   + RP+   ++ +L  +
Sbjct: 259 -------RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 18  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI  FGLARH   +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLARHTDDE 178
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 179 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 18  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI D GLARH   +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLARHTDDE 178
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 179 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/309 (23%), Positives = 132/309 (42%), Gaps = 57/309 (18%)
Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNL 347
           KY + +R    F     +G GG G VF+     DG+   ++R+ +N+    ++   EV  
Sbjct: 3   KYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN----EKAEREVKA 58
Query: 348 ISGIQHKNVVRLLGC-------SIEGPESLLVYEYVP------NRSLDQILFV------K 388
           ++ + H N+V   GC            +SL   +Y P      +RS  + LF+      K
Sbjct: 59  LAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDK 118
Query: 389 NTIHILSWQQR---------FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP 439
            T+     ++R           +     +G+ ++H     K+IHRD+K SNI L +    
Sbjct: 119 GTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQV 175
Query: 440 KIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRR 499
           KI DFGL   +  D     +   GTL YM+PE +      ++ D+YA G+++ E      
Sbjct: 176 KIGDFGLVTSLKNDGKRTRS--KGTLRYMSPEQISSQDYGKEVDLYALGLILAE------ 227
Query: 500 NSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRP 559
                     +LH     ++ ++    +  G+     + +   +LQ   L ++ P   RP
Sbjct: 228 ----------LLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQ--KLLSKKPED-RP 274
Query: 560 SMAEVVHML 568
           + +E++  L
Sbjct: 275 NTSEILRTL 283

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 10/215 (4%)
Query: 286 LNFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWV-DQFFN 343
           L  K ++ E   D F+   +LG G  G VF+ +  P G  +A K +    +  + +Q   
Sbjct: 56  LTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 115
Query: 344 EVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTII 403
           E+ ++       +V   G      E  +  E++   SLDQ+L     I     Q    + 
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI---PEQILGKVS 172
Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG 463
               +GL +L      KI+HRD+K SNIL++ +   K+ DFG++  +      ++    G
Sbjct: 173 IAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVG 227
Query: 464 TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           T  YM+PE L     + ++D+++ G+ ++E+A GR
Sbjct: 228 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 127/297 (42%), Gaps = 44/297 (14%)
Query: 299 FFDNSRKLGQGGAGSVF--------RGTLPDGRNIAVKRLFFN-SRQWVDQFFNEVNLIS 349
           +    R LG+G  G V          GT   G  +AVK L  +   Q    +  E++++ 
Sbjct: 15  YLKKIRDLGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADCGPQHRSGWKQEIDILR 71
Query: 350 GIQHKNVVRLLGC-SIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTA 407
            + H+++++  GC   +G +SL LV EYVP  SL   L      H +   Q         
Sbjct: 72  TLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQIC 127
Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG--TL 465
           EG+A+LH       IHR++   N+LLD     KI DFGLA+ V     +      G   +
Sbjct: 128 EGMAYLHAQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 184
Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSV-----------FSEGSSSVLHTV 514
            + APE L   +    +DV++FGV + E+ +   +S             ++G  +VL   
Sbjct: 185 FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL--- 241
Query: 515 WKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
                  R+T+ ++ G     P+     V  +   C +   + RP+   ++ +L  +
Sbjct: 242 -------RLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTV 291

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRL-FFNSRQWVDQFFNEVNLISGIQH 353
           + F    K+G+G  G VF+G   D R    +A+K +    +   ++    E+ ++S    
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 79
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
             V +  G  ++  +  ++ EY+   S   +L        L   Q  TI+    +GL +L
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYL 135
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H     K IHRDIK +N+LL E    K+ADFG+A  +  D         GT  +MAPE +
Sbjct: 136 HSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNXFVGTPFWMAPEVI 191
Query: 474 VRGQLTEKADVYAFGVLVIEVASGR 498
            +     KAD+++ G+  IE+A G 
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGE 216

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 22/208 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       S+E  + + +   + + +L Q++ ++     +S+   + ++CG    
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL-LYQMLCG---- 138
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T    T  Y A
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRA 193
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASG 497
           PE ++     E  D+++ G ++ E+  G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 101/226 (44%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    +     +G G  GSV     +  G  IAVK+L   F S     + + E+ 
Sbjct: 47  WEVPER----YQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELR 102
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P  SL++   V    H++          Q+
Sbjct: 103 LLKHMKHENVIGLLDV------------FTPATSLEEFNDVYLVTHLMGADLNNIVKCQK 150
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH   +
Sbjct: 151 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 207
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++         D+++ G ++ E+ +GR
Sbjct: 208 M----TGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 18  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI D GLARH   +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLARHTDDE 178
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 179 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 121/295 (41%), Gaps = 54/295 (18%)
Query: 304 RKLGQGGAGSVFRGTL------PDGRNIAVKRL--FFNSRQWVDQFFNEVNLISGIQHKN 355
           R LG G  G V+ G +      P    +AVK L   ++ +  +D F  E  +IS   H+N
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELD-FLMEALIISKFNHQN 109
Query: 356 VVRLLGCSIEGPESLLVYEYV-------------PNRSLDQILFVKNTIHILSWQQRFTI 402
           +VR +G S++     ++ E +             P  S    L + + +H+        I
Sbjct: 110 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR-----DI 164
Query: 403 ICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADFGLARHVAPDKTHVST 459
            CG  + L   H       IHRDI   N LL         KI DFG+AR +     +   
Sbjct: 165 ACG-CQYLEENH------FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 217
Query: 460 GIAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHY 518
           G A   + +M PE  + G  T K D ++FGVL+ E+ S       S+ +  VL  V    
Sbjct: 218 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 277
Query: 519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY 573
           +       MDP      P+N    V +I   C Q     RP+ A +   L  I+Y
Sbjct: 278 R-------MDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAII---LERIEY 316

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 127/297 (42%), Gaps = 44/297 (14%)
Query: 299 FFDNSRKLGQGGAGSVF--------RGTLPDGRNIAVKRLFFN-SRQWVDQFFNEVNLIS 349
           +    R LG+G  G V          GT   G  +AVK L  +   Q    +  E++++ 
Sbjct: 15  YLKKIRDLGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKADCGPQHRSGWKQEIDILR 71
Query: 350 GIQHKNVVRLLGC-SIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTA 407
            + H+++++  GC   +G +SL LV EYVP  SL   L      H +   Q         
Sbjct: 72  TLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQIC 127
Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG--TL 465
           EG+A+LH       IHR++   N+LLD     KI DFGLA+ V     +      G   +
Sbjct: 128 EGMAYLHSQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 184
Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSV-----------FSEGSSSVLHTV 514
            + APE L   +    +DV++FGV + E+ +   +S             ++G  +VL   
Sbjct: 185 FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL--- 241
Query: 515 WKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
                  R+T+ ++ G     P+     V  +   C +   + RP+   ++ +L  +
Sbjct: 242 -------RLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTV 291

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 10/215 (4%)
Query: 286 LNFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWV-DQFFN 343
           L  K ++ E   D F+   +LG G  G VF+ +  P G  +A K +    +  + +Q   
Sbjct: 21  LTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 80
Query: 344 EVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTII 403
           E+ ++       +V   G      E  +  E++   SLDQ+L     I     Q    + 
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI---PEQILGKVS 137
Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG 463
               +GL +L      KI+HRD+K SNIL++ +   K+ DFG++  +      ++    G
Sbjct: 138 IAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVG 192
Query: 464 TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           T  YM+PE L     + ++D+++ G+ ++E+A GR
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 22/208 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       S+E  + + +   + + +L Q++ ++     +S+   + ++CG    
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL-LYQMLCG---- 138
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T    T  Y A
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG--TSFMMTPYVVTRYYRA 193
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASG 497
           PE ++     E  D+++ G ++ E+  G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRL-FFNSRQWVDQFFNEVNLISGIQH 353
           + F    K+G+G  G VF+G   D R    +A+K +    +   ++    E+ ++S    
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 64
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
             V +  G  ++  +  ++ EY+   S   +L        L   Q  TI+    +GL +L
Sbjct: 65  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYL 120
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H     K IHRDIK +N+LL E    K+ADFG+A  +  D         GT  +MAPE +
Sbjct: 121 HSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQIKRNXFVGTPFWMAPEVI 176
Query: 474 VRGQLTEKADVYAFGVLVIEVASGR 498
            +     KAD+++ G+  IE+A G 
Sbjct: 177 KQSAYDSKADIWSLGITAIELARGE 201

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 22/208 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       S+E  + + +   + + +L Q++ ++     +S+   + ++CG    
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL-LYQMLCG---- 138
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T    T  Y A
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG--TSFMMTPYVVTRYYRA 193
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASG 497
           PE ++     E  D+++ G ++ E+  G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 77/167 (46%), Gaps = 16/167 (9%)
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG-T 464
            A G+  L   S  K IHRD+   NILL E    KI DFGLAR +  +  +V  G     
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRIT 524
           L +MAPE +     + K+DV+++GVL+ E        +FS G S            +R+ 
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWE--------IFSLGGSPYPGVQMDEDFCSRLR 316
Query: 525 QSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +    G+  R PE     + QI L C       RP  AE+V  L ++
Sbjct: 317 E----GMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKLGDL 359

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 119/271 (43%), Gaps = 29/271 (10%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           + +G+G  G V  G    G  +AVK +  ++      F  E ++++ ++H N+V+LLG  
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 364 IEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
           +E    L +V EY+   SL   L  +    +L             E + +L G +    +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FV 311
Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTL--GYMAPEYLVRGQLTE 480
           HRD+   N+L+ E    K++DFGL +  +      ST   G L   + APE L   + + 
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREKKFST 365
Query: 481 KADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEA 540
           K+DV++FG+L+ E+ S  R          V+  V K YK       MD       P+   
Sbjct: 366 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-------MDA------PDGCP 412
Query: 541 SRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
             V  +   C     A RP+  ++   L +I
Sbjct: 413 PAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 40/226 (17%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 18  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 73
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ-------QR 399
           L+  ++H+NV+ LL              + P RSL++   V    H++          Q+
Sbjct: 74  LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 121
Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            T      +I     GL ++H      IIHRD+K SN+ ++E    KI D GLARH   +
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLARHTDDE 178
Query: 454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
                TG   T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 179 M----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 119/294 (40%), Gaps = 52/294 (17%)
Query: 304 RKLGQGGAGSVFRGTL------PDGRNIAVKRLF-FNSRQWVDQFFNEVNLISGIQHKNV 356
           R LG G  G V+ G +      P    +AVK L    S Q    F  E  +IS + H+N+
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNI 110
Query: 357 VRLLGCSIEGPESLLVYEYV-------------PNRSLDQILFVKNTIHILSWQQRFTII 403
           VR +G S++     ++ E +             P  S    L + + +H+        I 
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR-----DIA 165
Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADFGLARHVAPDKTHVSTG 460
           CG  + L   H       IHRDI   N LL         KI DFG+AR +     +   G
Sbjct: 166 CG-CQYLEENH------FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 218
Query: 461 IAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
            A   + +M PE  + G  T K D ++FGVL+ E+ S       S+ +  VL  V    +
Sbjct: 219 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 278
Query: 520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY 573
                  MDP      P+N    V +I   C Q     RP+ A +   L  I+Y
Sbjct: 279 -------MDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAII---LERIEY 316

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 22/203 (10%)
Query: 306 LGQGGAGS-VFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLI-SGIQHKNVVRLLGCS 363
           LG G  G+ V+RG   D R++AVKR+      + D+   EV L+    +H NV+R   C+
Sbjct: 32  LGHGAEGTIVYRGMF-DNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVIRYF-CT 86
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
            +  +   +   +   +L + +  K+  H+    +  T++  T  GLAHLH    + I+H
Sbjct: 87  EKDRQFQYIAIELCAATLQEYVEQKDFAHL--GLEPITLLQQTTSGLAHLH---SLNIVH 141
Query: 424 RDIKTSNILLDE-----KLTPKIADFGLARHVAPDKTHVS--TGIAGTLGYMAPEYL--- 473
           RD+K  NIL+       K+   I+DFGL + +A  +   S  +G+ GT G++APE L   
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201
Query: 474 VRGQLTEKADVYAFGVLVIEVAS 496
            +   T   D+++ G +   V S
Sbjct: 202 CKENPTYTVDIFSAGCVFYYVIS 224

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 10/208 (4%)
Query: 293 LERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWV-DQFFNEVNLISG 350
           +E   D F+   +LG G  G VF+ +  P G  +A K +    +  + +Q   E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 351 IQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGL 410
                +V   G      E  +  E++   SLDQ+L     I     Q    +     +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI---PEQILGKVSIAVIKGL 117
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAP 470
            +L      KI+HRD+K SNIL++ +   K+ DFG++  +      ++    GT  YM+P
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSP 172
Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASGR 498
           E L     + ++D+++ G+ ++E+A GR
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 10/208 (4%)
Query: 293 LERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWV-DQFFNEVNLISG 350
           +E   D F+   +LG G  G VF+ +  P G  +A K +    +  + +Q   E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 351 IQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGL 410
                +V   G      E  +  E++   SLDQ+L     I     Q    +     +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI---PEQILGKVSIAVIKGL 117
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAP 470
            +L      KI+HRD+K SNIL++ +   K+ DFG++  +      ++    GT  YM+P
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSP 172
Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASGR 498
           E L     + ++D+++ G+ ++E+A GR
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 10/208 (4%)
Query: 293 LERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWV-DQFFNEVNLISG 350
           +E   D F+   +LG G  G VF+ +  P G  +A K +    +  + +Q   E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 351 IQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGL 410
                +V   G      E  +  E++   SLDQ+L     I     Q    +     +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI---PEQILGKVSIAVIKGL 117
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAP 470
            +L      KI+HRD+K SNIL++ +   K+ DFG++  +      ++    GT  YM+P
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSP 172
Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASGR 498
           E L     + ++D+++ G+ ++E+A GR
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 106/215 (49%), Gaps = 13/215 (6%)
Query: 303 SRKLGQGGAGSVFRGTLPDGR----NIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVV 357
           +R LG+G  G V+ G   + +    N+AVK    + +    ++F +E  ++  + H ++V
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFV-KNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +L+G   E P + ++ E  P   L   L   KN++ +L+       IC   + +A+L   
Sbjct: 73  KLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC---KAMAYLES- 127
Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG 476
             I  +HRDI   NIL+      K+ DFGL+R++  +  + ++     + +M+PE +   
Sbjct: 128 --INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 185
Query: 477 QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVL 511
           + T  +DV+ F V + E+ S  +   F   +  V+
Sbjct: 186 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 220

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 10/208 (4%)
Query: 293 LERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWV-DQFFNEVNLISG 350
           +E   D F+   +LG G  G VF+ +  P G  +A K +    +  + +Q   E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 351 IQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGL 410
                +V   G      E  +  E++   SLDQ+L     I     Q    +     +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI---PEQILGKVSIAVIKGL 117
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAP 470
            +L      KI+HRD+K SNIL++ +   K+ DFG++  +      ++    GT  YM+P
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSP 172
Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASGR 498
           E L     + ++D+++ G+ ++E+A GR
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 119/294 (40%), Gaps = 52/294 (17%)
Query: 304 RKLGQGGAGSVFRGTL------PDGRNIAVKRLF-FNSRQWVDQFFNEVNLISGIQHKNV 356
           R LG G  G V+ G +      P    +AVK L    S Q    F  E  +IS + H+N+
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNI 96
Query: 357 VRLLGCSIEGPESLLVYEYV-------------PNRSLDQILFVKNTIHILSWQQRFTII 403
           VR +G S++     ++ E +             P  S    L + + +H+        I 
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR-----DIA 151
Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADFGLARHVAPDKTHVSTG 460
           CG  + L   H       IHRDI   N LL         KI DFG+AR +     +   G
Sbjct: 152 CG-CQYLEENH------FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 204
Query: 461 IAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
            A   + +M PE  + G  T K D ++FGVL+ E+ S       S+ +  VL  V    +
Sbjct: 205 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 264
Query: 520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY 573
                  MDP      P+N    V +I   C Q     RP+ A +   L  I+Y
Sbjct: 265 -------MDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAII---LERIEY 302

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 83/166 (50%), Gaps = 26/166 (15%)
Query: 353 HKNVVRLLG-CSIEGPESLLVYEYV-------------PNRSLDQI-------LFVKNTI 391
           H+N+V LLG C++ GP   L++EY                 S D+I       L  +  +
Sbjct: 108 HENIVNLLGACTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 392 HILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA 451
           ++L+++         A+G+  L   S    +HRD+   N+L+      KI DFGLAR + 
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 452 PDKTHVSTGIAGT-LGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
            D  +V  G A   + +MAPE L  G  T K+DV+++G+L+ E+ S
Sbjct: 224 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 10/208 (4%)
Query: 293 LERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWV-DQFFNEVNLISG 350
           +E   D F+   +LG G  G VF+ +  P G  +A K +    +  + +Q   E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 351 IQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGL 410
                +V   G      E  +  E++   SLDQ+L     I     Q    +     +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI---PEQILGKVSIAVIKGL 117
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAP 470
            +L      KI+HRD+K SNIL++ +   K+ DFG++  +      ++    GT  YM+P
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSP 172
Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASGR 498
           E L     + ++D+++ G+ ++E+A GR
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 118/294 (40%), Gaps = 52/294 (17%)
Query: 304 RKLGQGGAGSVFRGTL------PDGRNIAVKRLF-FNSRQWVDQFFNEVNLISGIQHKNV 356
           R LG G  G V+ G +      P    +AVK L    S Q    F  E  +IS   H+N+
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 110
Query: 357 VRLLGCSIEGPESLLVYEYV-------------PNRSLDQILFVKNTIHILSWQQRFTII 403
           VR +G S++     ++ E +             P  S    L + + +H+        I 
Sbjct: 111 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR-----DIA 165
Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADFGLARHVAPDKTHVSTG 460
           CG  + L   H       IHRDI   N LL         KI DFG+AR +     +   G
Sbjct: 166 CG-CQYLEENH------FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 218
Query: 461 IAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
            A   + +M PE  + G  T K D ++FGVL+ E+ S       S+ +  VL  V    +
Sbjct: 219 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 278
Query: 520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY 573
                  MDP      P+N    V +I   C Q     RP+ A +   L  I+Y
Sbjct: 279 -------MDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAII---LERIEY 316

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 133/293 (45%), Gaps = 42/293 (14%)
Query: 304 RKLGQGGAGSVFR----GTLPDGRN----IAVKRLFFNSRQW-VDQFFNEVNLISGI-QH 353
           + LG+G  G V      G   D  N    +AVK L  ++ +  +    +E+ ++  I +H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 354 KNVVRLLG-CSIEGPESLLV--------YEYVPNRSLDQILFVKNTIH----ILSWQQRF 400
           KN++ LLG C+ +GP  ++V         EY+  R    + F  N  H     LS +   
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVST 459
           +     A G+ +L   +  K IHRD+   N+L+ E    KIADFGLAR +   D    +T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTT 210
Query: 460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT-VWKHY 518
                + +MAPE L     T ++DV++FGVL+ E        +F+ G S      V + +
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE--------IFTLGGSPYPGVPVEELF 262
Query: 519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           K  +    MD       P N  + +  +   C  A  + RP+  ++V  L+ I
Sbjct: 263 KLLKEGHRMDK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 106/215 (49%), Gaps = 13/215 (6%)
Query: 303 SRKLGQGGAGSVFRGTLPDGR----NIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVV 357
           +R LG+G  G V+ G   + +    N+AVK    + +    ++F +E  ++  + H ++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFV-KNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +L+G   E P + ++ E  P   L   L   KN++ +L+       IC   + +A+L   
Sbjct: 77  KLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC---KAMAYLES- 131
Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG 476
             I  +HRDI   NIL+      K+ DFGL+R++  +  + ++     + +M+PE +   
Sbjct: 132 --INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 189
Query: 477 QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVL 511
           + T  +DV+ F V + E+ S  +   F   +  V+
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 224

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 118/294 (40%), Gaps = 52/294 (17%)
Query: 304 RKLGQGGAGSVFRGTL------PDGRNIAVKRLF-FNSRQWVDQFFNEVNLISGIQHKNV 356
           R LG G  G V+ G +      P    +AVK L    S Q    F  E  +IS   H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 357 VRLLGCSIEGPESLLVYEYV-------------PNRSLDQILFVKNTIHILSWQQRFTII 403
           VR +G S++     ++ E +             P  S    L + + +H+        I 
Sbjct: 96  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR-----DIA 150
Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADFGLARHVAPDKTHVSTG 460
           CG  + L   H       IHRDI   N LL         KI DFG+AR +     +   G
Sbjct: 151 CG-CQYLEENH------FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 203
Query: 461 IAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
            A   + +M PE  + G  T K D ++FGVL+ E+ S       S+ +  VL  V    +
Sbjct: 204 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263
Query: 520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY 573
                  MDP      P+N    V +I   C Q     RP+ A +   L  I+Y
Sbjct: 264 -------MDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAII---LERIEY 301

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 118/294 (40%), Gaps = 52/294 (17%)
Query: 304 RKLGQGGAGSVFRGTL------PDGRNIAVKRLF-FNSRQWVDQFFNEVNLISGIQHKNV 356
           R LG G  G V+ G +      P    +AVK L    S Q    F  E  +IS   H+N+
Sbjct: 28  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 87
Query: 357 VRLLGCSIEGPESLLVYEYV-------------PNRSLDQILFVKNTIHILSWQQRFTII 403
           VR +G S++     ++ E +             P  S    L + + +H+        I 
Sbjct: 88  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR-----DIA 142
Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADFGLARHVAPDKTHVSTG 460
           CG  + L   H       IHRDI   N LL         KI DFG+AR +     +   G
Sbjct: 143 CG-CQYLEENH------FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 195
Query: 461 IAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
            A   + +M PE  + G  T K D ++FGVL+ E+ S       S+ +  VL  V    +
Sbjct: 196 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 255
Query: 520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY 573
                  MDP      P+N    V +I   C Q     RP+ A +   L  I+Y
Sbjct: 256 -------MDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAII---LERIEY 293

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 118/294 (40%), Gaps = 52/294 (17%)
Query: 304 RKLGQGGAGSVFRGTL------PDGRNIAVKRLF-FNSRQWVDQFFNEVNLISGIQHKNV 356
           R LG G  G V+ G +      P    +AVK L    S Q    F  E  +IS   H+N+
Sbjct: 43  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 102
Query: 357 VRLLGCSIEGPESLLVYEYV-------------PNRSLDQILFVKNTIHILSWQQRFTII 403
           VR +G S++     ++ E +             P  S    L + + +H+        I 
Sbjct: 103 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR-----DIA 157
Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADFGLARHVAPDKTHVSTG 460
           CG  + L   H       IHRDI   N LL         KI DFG+AR +     +   G
Sbjct: 158 CG-CQYLEENH------FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 210
Query: 461 IAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
            A   + +M PE  + G  T K D ++FGVL+ E+ S       S+ +  VL  V    +
Sbjct: 211 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 270
Query: 520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY 573
                  MDP      P+N    V +I   C Q     RP+ A +   L  I+Y
Sbjct: 271 -------MDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAII---LERIEY 308

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 103/207 (49%), Gaps = 13/207 (6%)
Query: 303 SRKLGQGGAGSVFRGTLPDGR----NIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVV 357
           +R LG+G  G V+ G   + +    N+AVK    + +    ++F +E  ++  + H ++V
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFV-KNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +L+G   E P + ++ E  P   L   L   KN++ +L+       IC   + +A+L   
Sbjct: 89  KLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC---KAMAYLES- 143
Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG 476
             I  +HRDI   NIL+      K+ DFGL+R++  +  + ++     + +M+PE +   
Sbjct: 144 --INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 201
Query: 477 QLTEKADVYAFGVLVIEVASGRRNSVF 503
           + T  +DV+ F V + E+ S  +   F
Sbjct: 202 RFTTASDVWMFAVCMWEILSFGKQPFF 228

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 22/208 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       S+E  + + +   + + +L Q++ ++     +S+   + ++CG    
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-LYQMLCG---- 138
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T    T  Y A
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRA 193
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASG 497
           PE ++     E  D+++ G ++ E+  G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 10/215 (4%)
Query: 286 LNFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWV-DQFFN 343
           L  K ++ E   D F+   +LG G  G VF+ +  P G  +A K +    +  + +Q   
Sbjct: 13  LTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 72
Query: 344 EVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTII 403
           E+ ++       +V   G      E  +  E++   SLDQ+L     I     Q    + 
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI---PEQILGKVS 129
Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG 463
               +GL +L      KI+HRD+K SNIL++ +   K+ DFG++  +      ++    G
Sbjct: 130 IAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVG 184
Query: 464 TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           T  YM+PE L     + ++D+++ G+ ++E+A GR
Sbjct: 185 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 118/294 (40%), Gaps = 52/294 (17%)
Query: 304 RKLGQGGAGSVFRGTL------PDGRNIAVKRLF-FNSRQWVDQFFNEVNLISGIQHKNV 356
           R LG G  G V+ G +      P    +AVK L    S Q    F  E  +IS   H+N+
Sbjct: 53  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 112
Query: 357 VRLLGCSIEGPESLLVYEYV-------------PNRSLDQILFVKNTIHILSWQQRFTII 403
           VR +G S++     ++ E +             P  S    L + + +H+        I 
Sbjct: 113 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR-----DIA 167
Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADFGLARHVAPDKTHVSTG 460
           CG  + L   H       IHRDI   N LL         KI DFG+AR +     +   G
Sbjct: 168 CG-CQYLEENH------FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 220
Query: 461 IAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
            A   + +M PE  + G  T K D ++FGVL+ E+ S       S+ +  VL  V    +
Sbjct: 221 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 280
Query: 520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY 573
                  MDP      P+N    V +I   C Q     RP+ A +   L  I+Y
Sbjct: 281 -------MDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAII---LERIEY 318

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 118/294 (40%), Gaps = 52/294 (17%)
Query: 304 RKLGQGGAGSVFRGTL------PDGRNIAVKRLF-FNSRQWVDQFFNEVNLISGIQHKNV 356
           R LG G  G V+ G +      P    +AVK L    S Q    F  E  +IS   H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 357 VRLLGCSIEGPESLLVYEYV-------------PNRSLDQILFVKNTIHILSWQQRFTII 403
           VR +G S++     ++ E +             P  S    L + + +H+        I 
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR-----DIA 150
Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADFGLARHVAPDKTHVSTG 460
           CG  + L   H       IHRDI   N LL         KI DFG+AR +     +   G
Sbjct: 151 CG-CQYLEENH------FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 203
Query: 461 IAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
            A   + +M PE  + G  T K D ++FGVL+ E+ S       S+ +  VL  V    +
Sbjct: 204 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263
Query: 520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY 573
                  MDP      P+N    V +I   C Q     RP+ A +   L  I+Y
Sbjct: 264 -------MDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAII---LERIEY 301

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 118/294 (40%), Gaps = 52/294 (17%)
Query: 304 RKLGQGGAGSVFRGTL------PDGRNIAVKRL-FFNSRQWVDQFFNEVNLISGIQHKNV 356
           R LG G  G V+ G +      P    +AVK L    S Q    F  E  +IS   H+N+
Sbjct: 63  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 122
Query: 357 VRLLGCSIEGPESLLVYEYV-------------PNRSLDQILFVKNTIHILSWQQRFTII 403
           VR +G S++     ++ E +             P  S    L + + +H+        I 
Sbjct: 123 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR-----DIA 177
Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADFGLARHVAPDKTHVSTG 460
           CG  + L   H       IHRDI   N LL         KI DFG+AR +     +   G
Sbjct: 178 CG-CQYLEENH------FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 230
Query: 461 IAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
            A   + +M PE  + G  T K D ++FGVL+ E+ S       S+ +  VL  V    +
Sbjct: 231 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 290
Query: 520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY 573
                  MDP      P+N    V +I   C Q     RP+ A +   L  I+Y
Sbjct: 291 -------MDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAII---LERIEY 328

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 118/294 (40%), Gaps = 52/294 (17%)
Query: 304 RKLGQGGAGSVFRGTL------PDGRNIAVKRLF-FNSRQWVDQFFNEVNLISGIQHKNV 356
           R LG G  G V+ G +      P    +AVK L    S Q    F  E  +IS   H+N+
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 96
Query: 357 VRLLGCSIEGPESLLVYEYV-------------PNRSLDQILFVKNTIHILSWQQRFTII 403
           VR +G S++     ++ E +             P  S    L + + +H+        I 
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR-----DIA 151
Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADFGLARHVAPDKTHVSTG 460
           CG  + L   H       IHRDI   N LL         KI DFG+AR +     +   G
Sbjct: 152 CG-CQYLEENH------FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG 204
Query: 461 IAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
            A   + +M PE  + G  T K D ++FGVL+ E+ S       S+ +  VL  V    +
Sbjct: 205 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 264
Query: 520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY 573
                  MDP      P+N    V +I   C Q     RP+ A +   L  I+Y
Sbjct: 265 -------MDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAII---LERIEY 302

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 22/208 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       S+E  + + +   + + +L Q++ ++     +S+   + ++CG    
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-LYQMLCG---- 139
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T    T  Y A
Sbjct: 140 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRA 194
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASG 497
           PE ++     E  D+++ G ++ E+  G
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 110/221 (49%), Gaps = 25/221 (11%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           +   + +G G  G V   F   L  G N+AVK+L   F ++    + + E+ L+  + HK
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 81
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       ++E  + + +   + + +L Q++ ++     +S+   + ++CG    
Sbjct: 82  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL-LYQMLCG---- 136
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR  + +   + T    T  Y A
Sbjct: 137 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTASTN--FMMTPYVVTRYYRA 191
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSV 510
           PE ++     E  D+++ G ++ E+  G   SV  +G+  +
Sbjct: 192 PEVILGMGYKENVDIWSVGCIMGELVKG---SVIFQGTDHI 229

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       S+E  + + +   + + +L Q++ ++     L  ++   ++     G
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME-----LDHERMSYLLYQMLVG 138
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T    T  Y A
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG--TSFMMTPYVVTRYYRA 193
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASG 497
           PE ++     E  D+++ G ++ E+  G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 22/208 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       S+E  + + +   + + +L Q++ ++     +S+   + ++CG    
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-LYQMLCG---- 138
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T    T  Y A
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRA 193
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASG 497
           PE ++     E  D+++ G ++ E+  G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 101/226 (44%), Gaps = 22/226 (9%)
Query: 287 NFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL---FFNSRQWVDQ-- 340
           N K+E       F    + LG G  G V   T    G+  AV ++      S    D+  
Sbjct: 30  NEKWEFPRNNLQF---GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE 86
Query: 341 -FFNEVNLISGI-QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI----- 393
              +E+ ++S + QH+N+V LLG    G   L++ EY     L   L  K    +     
Sbjct: 87  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDG 146
Query: 394 --LSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA 451
             L  +         A+G+A L   +    IHRD+   N+LL      KI DFGLAR + 
Sbjct: 147 RPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 203
Query: 452 PDKTHVSTGIAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
            D  ++  G A   + +MAPE +     T ++DV+++G+L+ E+ S
Sbjct: 204 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 101/226 (44%), Gaps = 22/226 (9%)
Query: 287 NFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL---FFNSRQWVDQ-- 340
           N K+E       F    + LG G  G V   T    G+  AV ++      S    D+  
Sbjct: 38  NEKWEFPRNNLQF---GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE 94
Query: 341 -FFNEVNLISGI-QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI----- 393
              +E+ ++S + QH+N+V LLG    G   L++ EY     L   L  K    +     
Sbjct: 95  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDG 154
Query: 394 --LSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA 451
             L  +         A+G+A L   +    IHRD+   N+LL      KI DFGLAR + 
Sbjct: 155 RPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 211
Query: 452 PDKTHVSTGIAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
            D  ++  G A   + +MAPE +     T ++DV+++G+L+ E+ S
Sbjct: 212 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 22/208 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       S+E  + + +   + + +L Q++ ++     +S+   + ++CG    
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-LYQMLCG---- 138
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T    T  Y A
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPEVVTRYYRA 193
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASG 497
           PE ++     E  D+++ G ++ E+  G
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 118/294 (40%), Gaps = 52/294 (17%)
Query: 304 RKLGQGGAGSVFRGTL------PDGRNIAVKRLF-FNSRQWVDQFFNEVNLISGIQHKNV 356
           R LG G  G V+ G +      P    +AVK L    S Q    F  E  +IS   H+N+
Sbjct: 54  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 113
Query: 357 VRLLGCSIEGPESLLVYEYV-------------PNRSLDQILFVKNTIHILSWQQRFTII 403
           VR +G S++     ++ E +             P  S    L + + +H+        I 
Sbjct: 114 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR-----DIA 168
Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADFGLARHVAPDKTHVSTG 460
           CG  + L   H       IHRDI   N LL         KI DFG+AR +     +   G
Sbjct: 169 CG-CQYLEENH------FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGG 221
Query: 461 IAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
            A   + +M PE  + G  T K D ++FGVL+ E+ S       S+ +  VL  V    +
Sbjct: 222 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 281
Query: 520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY 573
                  MDP      P+N    V +I   C Q     RP+ A +   L  I+Y
Sbjct: 282 -------MDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAII---LERIEY 319

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 118/294 (40%), Gaps = 52/294 (17%)
Query: 304 RKLGQGGAGSVFRGTL------PDGRNIAVKRLF-FNSRQWVDQFFNEVNLISGIQHKNV 356
           R LG G  G V+ G +      P    +AVK L    S Q    F  E  +IS   H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 357 VRLLGCSIEGPESLLVYEYV-------------PNRSLDQILFVKNTIHILSWQQRFTII 403
           VR +G S++     ++ E +             P  S    L + + +H+        I 
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR-----DIA 191
Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADFGLARHVAPDKTHVSTG 460
           CG  + L   H       IHRDI   N LL         KI DFG+AR +     +   G
Sbjct: 192 CG-CQYLEENH------FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGG 244
Query: 461 IAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
            A   + +M PE  + G  T K D ++FGVL+ E+ S       S+ +  VL  V    +
Sbjct: 245 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304
Query: 520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY 573
                  MDP      P+N    V +I   C Q     RP+ A +   L  I+Y
Sbjct: 305 -------MDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAII---LERIEY 342

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 133/293 (45%), Gaps = 42/293 (14%)
Query: 304 RKLGQGGAGSVFR----GTLPDGRN----IAVKRLFFNSRQW-VDQFFNEVNLISGI-QH 353
           + LG+G  G V      G   D  N    +AVK L  ++ +  +    +E+ ++  I +H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 354 KNVVRLLG-CSIEGPESLLV--------YEYVPNRSLDQILFVKNTIH----ILSWQQRF 400
           KN++ LLG C+ +GP  ++V         EY+  R    + +  N  H     LS +   
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVST 459
           +     A G+ +L   +  K IHRD+   N+L+ E    KIADFGLAR +   D    +T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT-VWKHY 518
                + +MAPE L     T ++DV++FGVL+ E        +F+ G S      V + +
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE--------IFTLGGSPYPGVPVEELF 262
Query: 519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           K  +    MD       P N  + +  +   C  A  + RP+  ++V  L+ I
Sbjct: 263 KLLKEGHRMDK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 133/293 (45%), Gaps = 42/293 (14%)
Query: 304 RKLGQGGAGSVFR----GTLPDGRN----IAVKRLFFNSRQW-VDQFFNEVNLISGI-QH 353
           + LG+G  G V      G   D  N    +AVK L  ++ +  +    +E+ ++  I +H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 354 KNVVRLLG-CSIEGPESLLV--------YEYVPNRSLDQILFVKNTIH----ILSWQQRF 400
           KN++ LLG C+ +GP  ++V         EY+  R    + +  N  H     LS +   
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVST 459
           +     A G+ +L   +  K IHRD+   N+L+ E    KIADFGLAR +   D    +T
Sbjct: 139 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT-VWKHY 518
                + +MAPE L     T ++DV++FGVL+ E        +F+ G S      V + +
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE--------IFTLGGSPYPGVPVEELF 247
Query: 519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           K  +    MD       P N  + +  +   C  A  + RP+  ++V  L+ I
Sbjct: 248 KLLKEGHRMDK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 104/232 (44%), Gaps = 41/232 (17%)
Query: 293 LERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI 351
           L  A+DF +    LGQG  G V +     D R  A+K++  ++ + +    +EV L++ +
Sbjct: 2   LRYASDF-EEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASL 59
Query: 352 QHKNVVRLLGCSIE-----GPES--------LLVYEYVPNRSLDQILFVKNTIHILSWQQ 398
            H+ VVR     +E      P +         +  EY  NR+L  ++  +N       QQ
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLN-----QQ 114
Query: 399 R---FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV----- 450
           R   + +     E L+++H      IIHR++K  NI +DE    KI DFGLA++V     
Sbjct: 115 RDEYWRLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 451 --------APDKTHVSTGIAGTLGYMAPEYLV-RGQLTEKADVYAFGVLVIE 493
                    P  +   T   GT  Y+A E L   G   EK D Y+ G++  E
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 16/211 (7%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVV 357
           ++   +LG GG G V R    D G  +A+K+     S +  +++  E+ ++  + H NVV
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 358 RLL----GCSIEGPESL--LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
                  G     P  L  L  EY     L + L        L      T++   +  L 
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 136
Query: 412 HLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           +LH     +IIHRD+K  NI+L    ++L  KI D G A+ +  D+  + T   GTL Y+
Sbjct: 137 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYL 191
Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGRR 499
           APE L + + T   D ++FG L  E  +G R
Sbjct: 192 APELLEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 97/211 (45%), Gaps = 16/211 (7%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVV 357
           ++   +LG GG G V R    D G  +A+K+     S +  +++  E+ ++  + H NVV
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 358 RLL----GCSIEGPESL--LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
                  G     P  L  L  EY     L + L        L      T++   +  L 
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 412 HLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           +LH     +IIHRD+K  NI+L    ++L  KI D G A+ +  D+  + T   GTL Y+
Sbjct: 136 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYL 190
Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGRR 499
           APE L + + T   D ++FG L  E  +G R
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 133/293 (45%), Gaps = 42/293 (14%)
Query: 304 RKLGQGGAGSVFR----GTLPDGRN----IAVKRLFFNSRQW-VDQFFNEVNLISGI-QH 353
           + LG+G  G V      G   D  N    +AVK L  ++ +  +    +E+ ++  I +H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 354 KNVVRLLG-CSIEGPESLLV--------YEYVPNRSLDQILFVKNTIH----ILSWQQRF 400
           KN++ LLG C+ +GP  ++V         EY+  R    + +  N  H     LS +   
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVST 459
           +     A G+ +L   +  K IHRD+   N+L+ E    KIADFGLAR +   D    +T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT-VWKHY 518
                + +MAPE L     T ++DV++FGVL+ E        +F+ G S      V + +
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE--------IFTLGGSPYPGVPVEELF 262
Query: 519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           K  +    MD       P N  + +  +   C  A  + RP+  ++V  L+ I
Sbjct: 263 KLLKEGHRMDK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       ++E  + + +   + + +L Q++ ++     L  ++   ++     G
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME-----LDHERMSYLLYQMLXG 138
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T    T  Y A
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG--TSFMMTPYVVTRYYRA 193
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           PE ++     E  D+++ G ++ E+   +
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 22/206 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       ++E  + + +   + + +L Q++ ++     +S+   + ++CG    
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL-LYQMLCG---- 138
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T    T  Y A
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG--TSFMMTPYVVTRYYRA 193
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVA 495
           PE ++     E  D+++ G ++ E+ 
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 102/232 (43%), Gaps = 28/232 (12%)
Query: 287 NFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL---FFNSRQWVDQ-- 340
           N K+E       F    + LG G  G V   T    G+  AV ++      S    D+  
Sbjct: 38  NEKWEFPRNNLQF---GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE 94
Query: 341 -FFNEVNLISGI-QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVK---------- 388
              +E+ ++S + QH+N+V LLG    G   L++ EY     L   L  K          
Sbjct: 95  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYN 154
Query: 389 ---NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFG 445
              N    LS +         A+G+A L   +    IHRD+   N+LL      KI DFG
Sbjct: 155 PSHNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFG 211
Query: 446 LARHVAPDKTHVSTGIAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
           LAR +  D  ++  G A   + +MAPE +     T ++DV+++G+L+ E+ S
Sbjct: 212 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 10/207 (4%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWV-DQFFNEVNLISGI 351
           E   D F+   +LG G  G VF+ +  P G  +A K +    +  + +Q   E+ ++   
Sbjct: 5   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 64
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
               +V   G      E  +  E++   SLDQ+L     I     Q    +     +GL 
Sbjct: 65  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI---PEQILGKVSIAVIKGLT 121
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           +L      KI+HRD+K SNIL++ +   K+ DFG++  +  +   ++    GT  YM+PE
Sbjct: 122 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE---MANEFVGTRSYMSPE 176
Query: 472 YLVRGQLTEKADVYAFGVLVIEVASGR 498
            L     + ++D+++ G+ ++E+A GR
Sbjct: 177 RLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 133/293 (45%), Gaps = 42/293 (14%)
Query: 304 RKLGQGGAGSVFR----GTLPDGRN----IAVKRLFFNSRQW-VDQFFNEVNLISGI-QH 353
           + LG+G  G V      G   D  N    +AVK L  ++ +  +    +E+ ++  I +H
Sbjct: 26  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 85
Query: 354 KNVVRLLG-CSIEGPESLLV--------YEYVPNRSLDQILFVKNTIH----ILSWQQRF 400
           KN++ LLG C+ +GP  ++V         EY+  R    + +  N  H     LS +   
Sbjct: 86  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVST 459
           +     A G+ +L   +  K IHRD+   N+L+ E    KIADFGLAR +   D    +T
Sbjct: 146 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 202
Query: 460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT-VWKHY 518
                + +MAPE L     T ++DV++FGVL+ E        +F+ G S      V + +
Sbjct: 203 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE--------IFTLGGSPYPGVPVEELF 254
Query: 519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           K  +    MD       P N  + +  +   C  A  + RP+  ++V  L+ I
Sbjct: 255 KLLKEGHRMDK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 301

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 133/293 (45%), Gaps = 42/293 (14%)
Query: 304 RKLGQGGAGSVFR----GTLPDGRN----IAVKRLFFNSRQW-VDQFFNEVNLISGI-QH 353
           + LG+G  G V      G   D  N    +AVK L  ++ +  +    +E+ ++  I +H
Sbjct: 23  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 82
Query: 354 KNVVRLLG-CSIEGPESLLV--------YEYVPNRSLDQILFVKNTIH----ILSWQQRF 400
           KN++ LLG C+ +GP  ++V         EY+  R    + +  N  H     LS +   
Sbjct: 83  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVST 459
           +     A G+ +L   +  K IHRD+   N+L+ E    KIADFGLAR +   D    +T
Sbjct: 143 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 199
Query: 460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT-VWKHY 518
                + +MAPE L     T ++DV++FGVL+ E        +F+ G S      V + +
Sbjct: 200 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE--------IFTLGGSPYPGVPVEELF 251
Query: 519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           K  +    MD       P N  + +  +   C  A  + RP+  ++V  L+ I
Sbjct: 252 KLLKEGHRMDK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 298

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 133/293 (45%), Gaps = 42/293 (14%)
Query: 304 RKLGQGGAGSVFR----GTLPDGRN----IAVKRLFFNSRQW-VDQFFNEVNLISGI-QH 353
           + LG+G  G V      G   D  N    +AVK L  ++ +  +    +E+ ++  I +H
Sbjct: 34  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 93
Query: 354 KNVVRLLG-CSIEGPESLLV--------YEYVPNRSLDQILFVKNTIH----ILSWQQRF 400
           KN++ LLG C+ +GP  ++V         EY+  R    + +  N  H     LS +   
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVST 459
           +     A G+ +L   +  K IHRD+   N+L+ E    KIADFGLAR +   D    +T
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT-VWKHY 518
                + +MAPE L     T ++DV++FGVL+ E        +F+ G S      V + +
Sbjct: 211 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE--------IFTLGGSPYPGVPVEELF 262
Query: 519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           K  +    MD       P N  + +  +   C  A  + RP+  ++V  L+ I
Sbjct: 263 KLLKEGHRMDK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 309

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       ++E  + + +   + + +L Q++ ++     L  ++   ++     G
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME-----LDHERMSYLLYQMLXG 138
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T    T  Y A
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG--TSFMMTPYVVTRYYRA 193
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           PE ++     E  D+++ G ++ E+   +
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 133/293 (45%), Gaps = 42/293 (14%)
Query: 304 RKLGQGGAGSVFR----GTLPDGRN----IAVKRLFFNSRQW-VDQFFNEVNLISGI-QH 353
           + LG+G  G V      G   D  N    +AVK L  ++ +  +    +E+ ++  I +H
Sbjct: 27  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 86
Query: 354 KNVVRLLG-CSIEGPESLLV--------YEYVPNRSLDQILFVKNTIH----ILSWQQRF 400
           KN++ LLG C+ +GP  ++V         EY+  R    + +  N  H     LS +   
Sbjct: 87  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVST 459
           +     A G+ +L   +  K IHRD+   N+L+ E    KIADFGLAR +   D    +T
Sbjct: 147 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 203
Query: 460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT-VWKHY 518
                + +MAPE L     T ++DV++FGVL+ E        +F+ G S      V + +
Sbjct: 204 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE--------IFTLGGSPYPGVPVEELF 255
Query: 519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           K  +    MD       P N  + +  +   C  A  + RP+  ++V  L+ I
Sbjct: 256 KLLKEGHRMDK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 302

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       ++E  + + +   + + +L Q++ ++     L  ++   ++     G
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME-----LDHERMSYLLYQMLXG 131
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T    T  Y A
Sbjct: 132 IKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG--TSFMMTPYVVTRYYRA 186
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           PE ++     E  D+++ G ++ E+   +
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 122/287 (42%), Gaps = 26/287 (9%)
Query: 299 FFDNSRKLGQGGAGSVF--------RGTLPDGRNIAVKRLFFN-SRQWVDQFFNEVNLIS 349
           +    R LG+G  G V          GT   G  +AVK L      Q    +  E+ ++ 
Sbjct: 9   YLKKIRDLGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKEGCGPQLRSGWQREIEILR 65
Query: 350 GIQHKNVVRLLGC-SIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTA 407
            + H+++V+  GC   +G +S+ LV EYVP  SL   L      H +   Q         
Sbjct: 66  TLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQIC 121
Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT--L 465
           EG+A+LH       IHR +   N+LLD     KI DFGLA+ V     +      G   +
Sbjct: 122 EGMAYLHAQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 178
Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEVAS--GRRNSVFSEGSSSVLHTVWKHYKANRI 523
            + APE L   +    +DV++FGV + E+ +      S  ++ +  + HT        R+
Sbjct: 179 FWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQ-GQMTVLRL 237
Query: 524 TQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN 570
           T+ ++ G     P+     +  +   C +   + RP+   +V +L  
Sbjct: 238 TELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQT 284

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 297 TDFFDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQ 352
           +D ++    LG GG   V     L D R++AVK L         +  +F  E    + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 353 HKNVVRLLGC----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAE 408
           H  +V +       +  GP   +V EYV   +L  I+  +     ++ ++   +I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 409 GL--AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV--STGIAGT 464
            L  +H +G     IIHRD+K +NIL+      K+ DFG+AR +A     V  +  + GT
Sbjct: 128 ALNFSHQNG-----IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGT 182
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y++PE      +  ++DVY+ G ++ EV +G
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 108/216 (50%), Gaps = 26/216 (12%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNE 344
           + +L+R    + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E
Sbjct: 58  FTVLKR----YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRE 111
Query: 345 VNLISGIQHKNVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQR 399
           + L+  + HKN++ LL       ++E  + + +   + + +L Q++ ++     +S+   
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL-L 170
Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVST 459
           + ++CG    + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T
Sbjct: 171 YQMLCG----IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMT 221
Query: 460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVA 495
               T  Y APE ++     E  D+++ G ++ E+ 
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 122/287 (42%), Gaps = 26/287 (9%)
Query: 299 FFDNSRKLGQGGAGSVF--------RGTLPDGRNIAVKRLFFN-SRQWVDQFFNEVNLIS 349
           +    R LG+G  G V          GT   G  +AVK L      Q    +  E+ ++ 
Sbjct: 10  YLKKIRDLGEGHFGKVSLYCYDPTNDGT---GEMVAVKALKEGCGPQLRSGWQREIEILR 66
Query: 350 GIQHKNVVRLLGC-SIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTA 407
            + H+++V+  GC   +G +S+ LV EYVP  SL   L      H +   Q         
Sbjct: 67  TLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQIC 122
Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT--L 465
           EG+A+LH       IHR +   N+LLD     KI DFGLA+ V     +      G   +
Sbjct: 123 EGMAYLHAQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 179
Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEVAS--GRRNSVFSEGSSSVLHTVWKHYKANRI 523
            + APE L   +    +DV++FGV + E+ +      S  ++ +  + HT        R+
Sbjct: 180 FWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQ-GQMTVLRL 238
Query: 524 TQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN 570
           T+ ++ G     P+     +  +   C +   + RP+   +V +L  
Sbjct: 239 TELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQT 285

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 106/233 (45%), Gaps = 41/233 (17%)
Query: 293 LERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI 351
           L  A+DF +    LGQG  G V +     D R  A+K++  ++ + +    +EV L++ +
Sbjct: 2   LRYASDF-EEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASL 59
Query: 352 QHKNVVRLLGC------------SIEGPESLLV-YEYVPNRSLDQILFVKNTIHILSWQQ 398
            H+ VVR                +++   +L +  EY  N +L  ++  +N       QQ
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN-----QQ 114
Query: 399 R---FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV----- 450
           R   + +     E L+++H      IIHRD+K  NI +DE    KI DFGLA++V     
Sbjct: 115 RDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 451 --------APDKTHVSTGIAGTLGYMAPEYLV-RGQLTEKADVYAFGVLVIEV 494
                    P  +   T   GT  Y+A E L   G   EK D+Y+ G++  E+
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 125/295 (42%), Gaps = 51/295 (17%)
Query: 304 RKLGQGGAGSVFRGTL------PDGRNIAVKRL----FFNSRQWVDQFFNEVNLISGI-Q 352
           + LG G  G V   T            +AVK L        R+      +E+ ++S +  
Sbjct: 47  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE---ALMSELKVLSYLGN 103
Query: 353 HKNVVRLLG-CSIEGPESLLVYEYV--------PNRSLDQILFVKNTIHILSWQQRF--- 400
           H N+V LLG C+I GP +L++ EY           R  D  +  K +  I+   +     
Sbjct: 104 HMNIVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 162
Query: 401 ----TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH 456
               +     A+G+A L   +    IHRD+   NILL      KI DFGLAR +  D  +
Sbjct: 163 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 219
Query: 457 VSTGIAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSV--LHT 513
           V  G A   + +MAPE +     T ++DV+++G+ + E        +FS GSS    +  
Sbjct: 220 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE--------LFSLGSSPYPGMPV 271
Query: 514 VWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHML 568
             K YK       +  G     PE+  + +  I   C  A    RP+  ++V ++
Sbjct: 272 DSKFYKM------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 320

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 133/293 (45%), Gaps = 42/293 (14%)
Query: 304 RKLGQGGAGSVFR----GTLPDGRN----IAVKRLFFNSRQW-VDQFFNEVNLISGI-QH 353
           + LG+G  G V      G   D  N    +AVK L  ++ +  +    +E+ ++  I +H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 354 KNVVRLLG-CSIEGPESLLV--------YEYVPNRSLDQILFVKNTIH----ILSWQQRF 400
           KN++ LLG C+ +GP  ++V         EY+  R    + +  N  H     LS +   
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVST 459
           +     A G+ +L   +  K IHRD+   N+L+ E    KIADFGLAR +   D    +T
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT-VWKHY 518
                + +MAPE L     T ++DV++FGVL+ E        +F+ G S      V + +
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE--------IFTLGGSPYPGVPVEELF 303
Query: 519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           K  +    MD       P N  + +  +   C  A  + RP+  ++V  L+ I
Sbjct: 304 KLLKEGHRMDK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 125/295 (42%), Gaps = 51/295 (17%)
Query: 304 RKLGQGGAGSVFRGTL------PDGRNIAVKRL----FFNSRQWVDQFFNEVNLISGI-Q 352
           + LG G  G V   T            +AVK L        R+      +E+ ++S +  
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE---ALMSELKVLSYLGN 85
Query: 353 HKNVVRLLG-CSIEGPESLLVYEYV--------PNRSLDQILFVKNTIHILSWQQRF--- 400
           H N+V LLG C+I GP +L++ EY           R  D  +  K +  I+   +     
Sbjct: 86  HMNIVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 401 ----TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH 456
               +     A+G+A L   +    IHRD+   NILL      KI DFGLAR +  D  +
Sbjct: 145 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 457 VSTGIAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSV--LHT 513
           V  G A   + +MAPE +     T ++DV+++G+ + E        +FS GSS    +  
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE--------LFSLGSSPYPGMPV 253
Query: 514 VWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHML 568
             K YK       +  G     PE+  + +  I   C  A    RP+  ++V ++
Sbjct: 254 DSKFYKM------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 85
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       S+E  + + +   + + +L Q++ ++     +S+   + ++CG    
Sbjct: 86  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-LYQMLCG---- 140
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + +      T  Y A
Sbjct: 141 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMVPFVVTRYYRA 195
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASG 497
           PE ++     E  D+++ G ++ E+  G
Sbjct: 196 PEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 109/219 (49%), Gaps = 26/219 (11%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNE 344
           + +L+R    + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E
Sbjct: 58  FTVLKR----YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRE 111
Query: 345 VNLISGIQHKNVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQR 399
           + L+  + HKN++ LL       ++E  + + +   + + +L Q++ ++     +S+   
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL-L 170
Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVST 459
           + ++CG    + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T
Sbjct: 171 YQMLCG----IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMT 221
Query: 460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
               T  Y APE ++     E  D+++ G ++ E+   +
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 125/295 (42%), Gaps = 51/295 (17%)
Query: 304 RKLGQGGAGSVFRGTL------PDGRNIAVKRL----FFNSRQWVDQFFNEVNLISGI-Q 352
           + LG G  G V   T            +AVK L        R+      +E+ ++S +  
Sbjct: 45  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE---ALMSELKVLSYLGN 101
Query: 353 HKNVVRLLG-CSIEGPESLLVYEYV--------PNRSLDQILFVKNTIHILSWQQRF--- 400
           H N+V LLG C+I GP +L++ EY           R  D  +  K +  I+   +     
Sbjct: 102 HMNIVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 160
Query: 401 ----TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH 456
               +     A+G+A L   +    IHRD+   NILL      KI DFGLAR +  D  +
Sbjct: 161 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 217
Query: 457 VSTGIAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSV--LHT 513
           V  G A   + +MAPE +     T ++DV+++G+ + E        +FS GSS    +  
Sbjct: 218 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE--------LFSLGSSPYPGMPV 269
Query: 514 VWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHML 568
             K YK       +  G     PE+  + +  I   C  A    RP+  ++V ++
Sbjct: 270 DSKFYKM------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 318

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 22/209 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       ++E  + + +   + + +L Q++ ++     +S+   + ++CG    
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL-LYQMLCG---- 138
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T    T  Y A
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG--TSFMMTPYVVTRYYRA 193
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           PE ++     E  D+++ G ++ E+   +
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 125/295 (42%), Gaps = 51/295 (17%)
Query: 304 RKLGQGGAGSVFRGTL------PDGRNIAVKRL----FFNSRQWVDQFFNEVNLISGI-Q 352
           + LG G  G V   T            +AVK L        R+      +E+ ++S +  
Sbjct: 52  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE---ALMSELKVLSYLGN 108
Query: 353 HKNVVRLLG-CSIEGPESLLVYEYV--------PNRSLDQILFVKNTIHILSWQQRF--- 400
           H N+V LLG C+I GP +L++ EY           R  D  +  K +  I+   +     
Sbjct: 109 HMNIVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 167
Query: 401 ----TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH 456
               +     A+G+A L   +    IHRD+   NILL      KI DFGLAR +  D  +
Sbjct: 168 EDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 224
Query: 457 VSTGIAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSV--LHT 513
           V  G A   + +MAPE +     T ++DV+++G+ + E        +FS GSS    +  
Sbjct: 225 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE--------LFSLGSSPYPGMPV 276
Query: 514 VWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHML 568
             K YK       +  G     PE+  + +  I   C  A    RP+  ++V ++
Sbjct: 277 DSKFYKM------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 325

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 22/209 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 82
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       ++E  + + +   + + +L Q++ ++     +S+   + ++CG    
Sbjct: 83  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL-LYQMLCG---- 137
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T    T  Y A
Sbjct: 138 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRA 192
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           PE ++     E  D+++ G ++ E+   +
Sbjct: 193 PEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 82/294 (27%), Positives = 118/294 (40%), Gaps = 52/294 (17%)
Query: 304 RKLGQGGAGSVFRGTL------PDGRNIAVKRLF-FNSRQWVDQFFNEVNLISGIQHKNV 356
           R LG G  G V+ G +      P    +AVK L    S Q    F  E  +IS   H+N+
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 96
Query: 357 VRLLGCSIEGPESLLVYEYV-------------PNRSLDQILFVKNTIHILSWQQRFTII 403
           VR +G S++     ++ E +             P  S    L + + +H+        I 
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR-----DIA 151
Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADFGLARHVAPDKTHVSTG 460
           CG  + L   H       IHRDI   N LL         KI DFG+A+ +     +   G
Sbjct: 152 CG-CQYLEENH------FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGG 204
Query: 461 IAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
            A   + +M PE  + G  T K D ++FGVL+ E+ S       S+ +  VL  V    +
Sbjct: 205 CAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 264
Query: 520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY 573
                  MDP      P+N    V +I   C Q     RP+ A +   L  I+Y
Sbjct: 265 -------MDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAII---LERIEY 302

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 22/209 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       ++E  + + +   + + +L Q++ ++     +S+   + ++CG    
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL-LYQMLCG---- 138
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T    T  Y A
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRA 193
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           PE ++     E  D+++ G ++ E+   +
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 22/209 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       ++E  + + +   + + +L Q++ ++     +S+   + ++CG    
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL-LYQMLCG---- 138
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T    T  Y A
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRA 193
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           PE ++     E  D+++ G ++ E+   +
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 22/209 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       ++E  + + +   + + +L Q++ ++     +S+   + ++CG    
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL-LYQMLCG---- 139
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T    T  Y A
Sbjct: 140 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRA 194
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           PE ++     E  D+++ G ++ E+   +
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 107/199 (53%), Gaps = 14/199 (7%)
Query: 305 KLGQGGAGSVFRGTLPDGRN-IAVKRLFFNSRQWVD-QFFNEVNLISGIQHKNVVRLLGC 362
           KLG+G   +V++G      N +A+K +     +        EV+L+  ++H N+V L   
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 363 SIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
            I   +SL LV+EY+ ++ L Q  ++ +  +I++       +     GLA+ H     K+
Sbjct: 69  -IHTEKSLTLVFEYL-DKDLKQ--YLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KV 121
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLV-RGQLT 479
           +HRD+K  N+L++E+   K+ADFGLAR  + P KT+ +  +  TL Y  P+ L+     +
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLGSTDYS 179
Query: 480 EKADVYAFGVLVIEVASGR 498
            + D++  G +  E+A+GR
Sbjct: 180 TQIDMWGVGCIFYEMATGR 198

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 22/209 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       ++E  + + +   + + +L Q++ ++     +S+   + ++CG    
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL-LYQMLCG---- 139
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T    T  Y A
Sbjct: 140 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRA 194
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           PE ++     E  D+++ G ++ E+   +
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 22/209 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       ++E  + + +   + + +L Q++ ++     +S+   + ++CG    
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL-LYQMLCG---- 132
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T    T  Y A
Sbjct: 133 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRA 187
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           PE ++     E  D+++ G ++ E+   +
Sbjct: 188 PEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 103/206 (50%), Gaps = 22/206 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 88
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       S+E  + + +   + + +L Q++ ++     +S+   + ++CG    
Sbjct: 89  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-LYQMLCG---- 143
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T    T  Y A
Sbjct: 144 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRA 198
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVA 495
           PE ++     E  D+++ G ++ E+ 
Sbjct: 199 PEVILGMGYKENVDLWSVGCIMGEMV 224

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 22/209 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       ++E  + + +   + + +L Q++ ++     +S+   + ++CG    
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL-LYQMLCG---- 131
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T    T  Y A
Sbjct: 132 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRA 186
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           PE ++     E  D+++ G ++ E+   +
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 297 TDFFDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQ 352
           +D ++    LG GG   V     L D R++AVK L         +  +F  E    + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 353 HKNVVRLLGC----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAE 408
           H  +V +       +  GP   +V EYV   +L  I+  +     ++ ++   +I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 409 GL--AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV--STGIAGT 464
            L  +H +G     IIHRD+K +NI++      K+ DFG+AR +A     V  +  + GT
Sbjct: 128 ALNFSHQNG-----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y++PE      +  ++DVY+ G ++ EV +G
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 103/206 (50%), Gaps = 22/206 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       S+E  + + +   + + +L Q++ ++     +S+   + ++CG    
Sbjct: 78  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-LYQMLCG---- 132
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T    T  Y A
Sbjct: 133 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRA 187
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVA 495
           PE ++     E  D+++ G ++ E+ 
Sbjct: 188 PEVILGMGYKENVDLWSVGCIMGEMV 213

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 297 TDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQ 352
           +D ++    LG GG   V     L D R++AVK L         +  +F  E    + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 353 HKNVVRLLGC----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAE 408
           H  +V +       +  GP   +V EYV   +L  I+  +     ++ ++   +I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 409 GL--AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV--STGIAGT 464
            L  +H +G     IIHRD+K +NI++      K+ DFG+AR +A     V  +  + GT
Sbjct: 128 ALNFSHQNG-----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y++PE      +  ++DVY+ G ++ EV +G
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 22/209 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       ++E  + + +   + + +L Q++ ++     +S+   + ++CG    
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL-LYQMLCG---- 132
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + + T    T  Y A
Sbjct: 133 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRYYRA 187
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           PE ++     E  D+++ G ++ E+   +
Sbjct: 188 PEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 125/279 (44%), Gaps = 37/279 (13%)
Query: 304 RKLGQGGAG-SVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLL 360
           +K+G+G  G ++   +  DGR   +K +  +  S +  ++   EV +++ ++H N+V+  
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 361 GCSIEGPESLLVYEYVPNRSLDQ-------ILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
               E     +V +Y     L +       +LF ++   IL W   F  IC     L H+
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQED--QILDW---FVQIC---LALKHV 141
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H     KI+HRDIK+ NI L +  T ++ DFG+AR V      ++    GT  Y++PE  
Sbjct: 142 HDR---KILHRDIKSQNIFLTKDGTVQLGDFGIAR-VLNSTVELARACIGTPYYLSPEIC 197
Query: 474 VRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGS---------SSVLHTVWKHYKANRIT 524
                  K+D++A G ++ E+ + +    F  GS         S     V  HY  +   
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKH--AFEAGSMKNLVLKIISGSFPPVSLHYSYD--L 253
Query: 525 QSMDPGLTGRFPENEAS--RVLQIGLLCTQAPVALRPSM 561
           +S+   L  R P +  S   +L+ G +  +    L P +
Sbjct: 254 RSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQL 292

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 131/293 (44%), Gaps = 42/293 (14%)
Query: 304 RKLGQGGAGSVF--------RGTLPDGRNIAVKRLFFNSRQW-VDQFFNEVNLISGI-QH 353
           + LG+G  G V         +    +   +AVK L  ++ +  +    +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 354 KNVVRLLG-CSIEGPESLLV--------YEYVPNRSLDQILFVKNTIHILSWQQRFTIIC 404
           KN++ LLG C+ +GP  ++V         EY+  R    + +  +   +   Q  F  + 
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 405 G----TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVST 459
                 A G+ +L   +  K IHRD+   N+L+ E    KIADFGLAR +   D    +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT-VWKHY 518
                + +MAPE L     T ++DV++FGVL+ E        +F+ G S      V + +
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE--------IFTLGGSPYPGIPVEELF 269
Query: 519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           K  +    MD       P N  + +  +   C  A  + RP+  ++V  L+ I
Sbjct: 270 KLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 37/220 (16%)
Query: 306 LGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLIS-GIQHKNVVRLLGCS 363
           LG G +G+V F+G+   GR +AVKR+  +   + D    E+ L++    H NV+R   CS
Sbjct: 23  LGYGSSGTVVFQGSF-QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYY-CS 77
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKN-TIHILSWQQRF---TIICGTAEGLAHLHGGSGI 419
                 L +   + N +L  ++  KN +   L  Q+ +   +++   A G+AHLH    +
Sbjct: 78  ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---L 134
Query: 420 KIIHRDIKTSNILLD-------------EKLTPKIADFGLARHVAPDKTHVSTGI---AG 463
           KIIHRD+K  NIL+              E L   I+DFGL + +   ++   T +   +G
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG 194
Query: 464 TLGYMAPEYL-------VRGQLTEKADVYAFGVLVIEVAS 496
           T G+ APE L        + +LT   D+++ G +   + S
Sbjct: 195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 111/233 (47%), Gaps = 21/233 (9%)
Query: 278 GTVLCTSSLNFK----YEILER---ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRL 330
           G  L T +L F+    YE + R     DF++   +LG G  G V++    +   +A  ++
Sbjct: 10  GVDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKV 69
Query: 331 F-FNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKN 389
               S + ++ +  E+++++   H N+V+LL          ++ E+    ++D ++    
Sbjct: 70  IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML--- 126
Query: 390 TIHILSWQQRFTIICG-TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR 448
            +     + +  ++C  T + L +LH     KIIHRD+K  NIL       K+ADFG++ 
Sbjct: 127 ELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA 183
Query: 449 HVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTE-----KADVYAFGVLVIEVAS 496
                     + I GT  +MAPE ++     +     KADV++ G+ +IE+A 
Sbjct: 184 KNTRXIQRRDSFI-GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE 235

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 111/233 (47%), Gaps = 21/233 (9%)
Query: 278 GTVLCTSSLNFK----YEILER---ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRL 330
           G  L T +L F+    YE + R     DF++   +LG G  G V++    +   +A  ++
Sbjct: 10  GVDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKV 69
Query: 331 F-FNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKN 389
               S + ++ +  E+++++   H N+V+LL          ++ E+    ++D ++    
Sbjct: 70  IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML--- 126
Query: 390 TIHILSWQQRFTIICG-TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR 448
            +     + +  ++C  T + L +LH     KIIHRD+K  NIL       K+ADFG++ 
Sbjct: 127 ELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA 183
Query: 449 HVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTE-----KADVYAFGVLVIEVAS 496
                     + I GT  +MAPE ++     +     KADV++ G+ +IE+A 
Sbjct: 184 KNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE 235

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 133/294 (45%), Gaps = 44/294 (14%)
Query: 304 RKLGQGGAGSVF--------RGTLPDGRNIAVKRLFFNSRQW-VDQFFNEVNLISGI-QH 353
           + LG+G  G V         +    +   +AVK L  ++ +  +    +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 354 KNVVRLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTIHI-------------LSWQQR 399
           KN++ LLG C+ +GP  ++V EY    +L + L  +    +             ++++  
Sbjct: 101 KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDL 159
Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVS 458
            +     A G+ +L   +  K IHRD+   N+L+ E    KIADFGLAR +   D    +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKT 216
Query: 459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT-VWKH 517
           T     + +MAPE L     T ++DV++FGVL+ E        +F+ G S      V + 
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE--------IFTLGGSPYPGIPVEEL 268
Query: 518 YKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +K  +    MD       P N  + +  +   C  A  + RP+  ++V  L+ I
Sbjct: 269 FKLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 126/286 (44%), Gaps = 58/286 (20%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           +G GG G VF+     DG+   +KR+ +N+    ++   EV  ++ + H N+V   GC  
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGC-W 73
Query: 365 EGPESLLVYEYVP-------NRSLDQILFV------KNTIHILSWQQR---------FTI 402
           +G      ++Y P       +RS  + LF+      K T+     ++R           +
Sbjct: 74  DG------FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 403 ICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIA 462
                +G+ ++H     K+I+RD+K SNI L +    KI DFGL   +  D     +   
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS--K 182
Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR 522
           GTL YM+PE +      ++ D+YA G+++ E                +LH     ++ ++
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAE----------------LLHVCDTAFETSK 226
Query: 523 ITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHML 568
               +  G+     + +   +LQ   L ++ P   RP+ +E++  L
Sbjct: 227 FFTDLRDGIISDIFDKKEKTLLQ--KLLSKKPED-RPNTSEILRTL 269

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 46/219 (21%)
Query: 306 LGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI--QHKNVVRLLGCS 363
           +G+G  G V+RG+   G N+AVK   F+SR     +F E  L + +  +H+N++  +   
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVK--IFSSRD-EKSWFRETELYNTVMLRHENILGFIASD 71
Query: 364 IEGPESLL-------------VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGL 410
           +    S               +Y+Y+   +LD +  ++             I+   A GL
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR-------------IVLSIASGL 118
Query: 411 AHLH----GGSGI-KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG---IA 462
           AHLH    G  G   I HRD+K+ NIL+ +     IAD GLA   +     +  G     
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 463 GTLGYMAPEYLVRGQLTE------KADVYAFGVLVIEVA 495
           GT  YMAPE L      +      + D++AFG+++ EVA
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 46/219 (21%)
Query: 306 LGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI--QHKNVVRLLGCS 363
           +G+G  G V+RG+   G N+AVK   F+SR     +F E  L + +  +H+N++  +   
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVK--IFSSRD-EKSWFRETELYNTVMLRHENILGFIASD 71
Query: 364 IEGPESLL-------------VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGL 410
           +    S               +Y+Y+   +LD +  ++             I+   A GL
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR-------------IVLSIASGL 118
Query: 411 AHLH----GGSGI-KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG---IA 462
           AHLH    G  G   I HRD+K+ NIL+ +     IAD GLA   +     +  G     
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 463 GTLGYMAPEYLVRGQLTE------KADVYAFGVLVIEVA 495
           GT  YMAPE L      +      + D++AFG+++ EVA
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/265 (24%), Positives = 115/265 (43%), Gaps = 39/265 (14%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQ-----FFNEVNLISGIQ 352
           D F+  R +G+G  G V      D + +   + + N ++ V++      F E+ ++ G++
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMK-YMNKQKCVERNEVRNVFKELQIMQGLE 73
Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSL-----DQILFVKNTIHILSWQQRFTIICGTA 407
           H  +V L     +  +  +V + +    L       + F + T+ +         IC   
Sbjct: 74  HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF--------ICELV 125
Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGY 467
             L +L      +IIHRD+K  NILLDE     I DF +A  + P +T ++T +AGT  Y
Sbjct: 126 MALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAA-MLPRETQITT-MAGTKPY 180
Query: 468 MAPEYLVRGQ---LTEKADVYAFGVLVIEVASGRRNSVFSEGSSS--VLHT--------- 513
           MAPE     +    +   D ++ GV   E+  GRR       +SS  ++HT         
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP 240
Query: 514 -VWKHYKANRITQSMDPGLTGRFPE 537
             W     + + + ++P    RF +
Sbjct: 241 SAWSQEMVSLLKKLLEPNPDQRFSQ 265

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 28/206 (13%)
Query: 304 RKLGQGGAGSVFRGTLPDGRN----IAVKRLFFNSRQWVD----------QFFNEVNLIS 349
           RKLG G  G V      +G +      +K+  F+  ++ D          + +NE++L+ 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 350 GIQHKNVVRLLGCSIEGPESLLVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICGTAE 408
            + H N+++L     +     LV E+     L +QI+      H         I+     
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII----NRHKFDECDAANIMKQILS 157
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEK---LTPKIADFGLARHVAPDKTHVSTGIAGTL 465
           G+ +LH  +   I+HRDIK  NILL+ K   L  KI DFGL+   + D  +      GT 
Sbjct: 158 GICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD--YKLRDRLGTA 212
Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLV 491
            Y+APE L + +  EK DV++ GV++
Sbjct: 213 YYIAPEVL-KKKYNEKCDVWSCGVIM 237

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 133/294 (45%), Gaps = 44/294 (14%)
Query: 304 RKLGQGGAGSVF--------RGTLPDGRNIAVKRLFFN-SRQWVDQFFNEVNLISGI-QH 353
           + LG+G  G V         +    +   +AVK L  + + + +    +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKH 100
Query: 354 KNVVRLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTIHI-------------LSWQQR 399
           KN++ LLG C+ +GP  ++V EY    +L + L  +    +             ++++  
Sbjct: 101 KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVS 458
            +     A G+ +L   +  K IHRD+   N+L+ E    KIADFGLAR +   D    +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT-VWKH 517
           T     + +MAPE L     T ++DV++FGVL+ E        +F+ G S      V + 
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE--------IFTLGGSPYPGIPVEEL 268
Query: 518 YKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +K  +    MD       P N  + +  +   C  A  + RP+  ++V  L+ I
Sbjct: 269 FKLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 34/223 (15%)
Query: 304 RKLGQGGAGSVFRGTL--PDGR----NIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNV 356
           + LG+G  G V + T     GR     +AVK L  N S   +    +E N++  + H +V
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 357 VRLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTI---------------------HIL 394
           ++L G CS +GP  LL+ EY    SL   L     +                       L
Sbjct: 89  IKLYGACSQDGP-LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 395 SWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK 454
           +     +     ++G+ +L   + +K++HRD+   NIL+ E    KI+DFGL+R V  + 
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 455 THVSTGIAGT-LGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
           ++V        + +MA E L     T ++DV++FGVL+ E+ +
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 110/233 (47%), Gaps = 21/233 (9%)
Query: 278 GTVLCTSSLNFK----YEILER---ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRL 330
           G  L T +L F+    YE + R     DF++   +LG G  G V++    +   +A  ++
Sbjct: 10  GVDLGTENLYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKV 69
Query: 331 F-FNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKN 389
               S + ++ +  E+++++   H N+V+LL          ++ E+    ++D ++    
Sbjct: 70  IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML--- 126
Query: 390 TIHILSWQQRFTIICG-TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR 448
            +     + +  ++C  T + L +LH     KIIHRD+K  NIL       K+ADFG++ 
Sbjct: 127 ELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA 183
Query: 449 HVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTE-----KADVYAFGVLVIEVAS 496
                       I GT  +MAPE ++     +     KADV++ G+ +IE+A 
Sbjct: 184 KNTRXIQRRDXFI-GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE 235

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 17/206 (8%)
Query: 300 FDNSRKLGQGGAGSVF---RGTLPDGRNI-AVKRLFFNSRQWVDQFFN--EVNLISGIQH 353
           F+  + LGQG  G VF   + +  D R + A+K L   + +  D+     E +++  + H
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 354 KNVVRL-LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI-ICGTAEGLA 411
             +V+L      EG +  L+ +++  R  D  LF + +  ++  ++     +   A  L 
Sbjct: 86  PFIVKLHYAFQTEG-KLYLILDFL--RGGD--LFTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           HLH    + II+RD+K  NILLDE+   K+ DFGL++  + D    +    GT+ YMAPE
Sbjct: 141 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPE 196
Query: 472 YLVRGQLTEKADVYAFGVLVIEVASG 497
            + R   T+ AD ++FGVL+ E+ +G
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 131/293 (44%), Gaps = 42/293 (14%)
Query: 304 RKLGQGGAGSVF--------RGTLPDGRNIAVKRLFFNSRQW-VDQFFNEVNLISGI-QH 353
           + LG+G  G V         +    +   +AVK L  ++ +  +    +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 354 KNVVRLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTIHI-------------LSWQQR 399
           KN++ LLG C+ +GP  ++V EY    +L + L  +    +             ++++  
Sbjct: 101 KNIIHLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVS 458
            +     A G+ +L   +  K IHRD+   N+L+ E    KIADFGLAR +   D    +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHY 518
           T     + +MAPE L     T ++DV++FGVL+ E        +F+ G S      +   
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE--------IFTLGGSP-----YPGI 263
Query: 519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
               + + +  G     P N  + +  +   C  A  + RP+  ++V  L+ I
Sbjct: 264 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 28/212 (13%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI--QHKNVVRLLG 361
           +++G+G  G V+ G    G  +AVK +FF + +    +F E  +   +  +H+N++  + 
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVK-VFFTTEE--ASWFRETEIYQTVLMRHENILGFIA 98
Query: 362 CSIEGPESL----LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG-- 415
             I+G  S     L+ +Y  N SL    ++K+T   L  +    +   +  GL HLH   
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYD--YLKSTT--LDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 416 ---GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS---TGIAGTLGYMA 469
                   I HRD+K+ NIL+ +  T  IAD GLA     D   V        GT  YM 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 470 PEYLVRG------QLTEKADVYAFGVLVIEVA 495
           PE L         Q    AD+Y+FG+++ EVA
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 97/204 (47%), Gaps = 14/204 (6%)
Query: 300 FDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWVD---QFFNEVNLISGIQHKN 355
           +D  + LG+G AG V           +AVK    + ++ VD       E+ +   + H+N
Sbjct: 8   WDLVQTLGEGAAGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           VV+  G   EG    L  EY     L   +     +     Q+ F  +     G+ +LHG
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG 122
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLV 474
              I I HRDIK  N+LLDE+   KI+DFGLA      ++  +   + GTL Y+APE L 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 475 RGQL-TEKADVYAFGVLVIEVASG 497
           R +   E  DV++ G+++  + +G
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 28/220 (12%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQWV-DQFFNEVNLISGIQHKNVV 357
           F+  + LG+GG G VF      D  N A+KR+   +R+   ++   EV  ++ ++H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 358 RLLGCSIEG-------PESLLVYEYVP-----NRSLDQILFVKNTIHILSWQQRFTIICG 405
           R     +E        P S  VY Y+        +L   +  + TI          I   
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS------- 458
            AE +  LH      ++HRD+K SNI        K+ DFGL   +  D+   +       
Sbjct: 127 IAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 459 ----TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEV 494
               TG  GT  YM+PE +     + K D+++ G+++ E+
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 306 LGQGGAGSVFRG-TLPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQHKNVVRLLG 361
           LG+G    V+R  ++  G  +A+K +          V +  NEV +   ++H +++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
              +     LV E   N  +++  ++KN +   S  +    +     G+ +LH      I
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNR--YLKNRVKPFSENEARHFMHQIITGMLYLHSHG---I 133
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLVRGQLTE 480
           +HRD+  SN+LL   +  KIADFGLA  +  P + H +  + GT  Y++PE   R     
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAHGL 191
Query: 481 KADVYAFGVLVIEVASGR 498
           ++DV++ G +   +  GR
Sbjct: 192 ESDVWSLGCMFYTLLIGR 209

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 131/293 (44%), Gaps = 42/293 (14%)
Query: 304 RKLGQGGAGSVF--------RGTLPDGRNIAVKRLFFNSRQW-VDQFFNEVNLISGI-QH 353
           + LG+G  G V         +    +   +AVK L  ++ +  +    +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 354 KNVVRLLG-CSIEGPESLLVY--------EYVPNRSLDQILFVKNTIHILSWQQRFTIIC 404
           KN++ LLG C+ +GP  ++V         EY+  R    + +  +   +   Q  F  + 
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 405 G----TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVST 459
                 A G+ +L   +  K IHRD+   N+L+ E    KIADFGLAR +   D    +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT-VWKHY 518
                + +MAPE L     T ++DV++FGVL+ E        +F+ G S      V + +
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE--------IFTLGGSPYPGIPVEELF 269
Query: 519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           K  +    MD       P N  + +  +   C  A  + RP+  ++V  L+ I
Sbjct: 270 KLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 14/217 (6%)
Query: 286 LNFKYEILERATDFFDNSRKLGQGGAGSVFR-GTLPDGRNIAVKRLFFNSRQWV-DQFFN 343
           L  K ++ E   D F+   +LG G  G V +    P G  +A K +    +  + +Q   
Sbjct: 4   LTQKAKVGELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIR 63
Query: 344 EVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI--HILSWQQRFT 401
           E+ ++       +V   G      E  +  E++   SLDQ+L     I   IL       
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----K 118
Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGI 461
           +      GLA+L      +I+HRD+K SNIL++ +   K+ DFG++  +      ++   
Sbjct: 119 VSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSF 173
Query: 462 AGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
            GT  YMAPE L     + ++D+++ G+ ++E+A GR
Sbjct: 174 VGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           +   + +G G  G V   F   L  G N+AVK+L   F ++    + + E+ L+  + HK
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHK 83
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       ++E  + + +   + + +L Q++ ++     +S+   + ++CG    
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL-LYQMLCG---- 138
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR    +   + T    T  Y A
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRYYRA 193
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASG 497
           PE ++        D+++ G ++ E+  G
Sbjct: 194 PEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNVV 357
           +    K+G+G  G V++     GR +A+KR+  ++           E++L+  + H N+V
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
            L+          LV+E++  + L ++L    T   L   Q    +     G+AH H   
Sbjct: 83  SLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTG--LQDSQIKIYLYQLLRGVAHCHQH- 138
Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLV-R 475
             +I+HRD+K  N+L++     K+ADFGLAR    P +++    +  TL Y AP+ L+  
Sbjct: 139 --RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLMGS 194
Query: 476 GQLTEKADVYAFGVLVIEVASGR 498
            + +   D+++ G +  E+ +G+
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGK 217

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 133/294 (45%), Gaps = 44/294 (14%)
Query: 304 RKLGQGGAGSVF--------RGTLPDGRNIAVKRLFFNSRQW-VDQFFNEVNLISGI-QH 353
           + LG+G  G V         +    +   +AVK L  ++ +  +    +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 354 KNVVRLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTIHI-------------LSWQQR 399
           KN++ LLG C+ +GP  ++V EY    +L + L  +    +             ++++  
Sbjct: 101 KNIITLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVS 458
            +     A G+ +L   +  K IHRD+   N+L+ E    KIADFGLAR +   D    +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT-VWKH 517
           T     + +MAPE L     T ++DV++FGVL+ E        +F+ G S      V + 
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE--------IFTLGGSPYPGIPVEEL 268
Query: 518 YKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +K  +    MD       P N  + +  +   C  A  + RP+  ++V  L+ I
Sbjct: 269 FKLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 133/294 (45%), Gaps = 44/294 (14%)
Query: 304 RKLGQGGAGSVF--------RGTLPDGRNIAVKRLFFNSRQW-VDQFFNEVNLISGI-QH 353
           + LG+G  G V         +    +   +AVK L  ++ +  +    +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 354 KNVVRLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTIHI-------------LSWQQR 399
           KN++ LLG C+ +GP  ++V EY    +L + L  +    +             ++++  
Sbjct: 101 KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVS 458
            +     A G+ +L   +  K IHRD+   N+L+ E    KIADFGLAR +   D    +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNT 216
Query: 459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT-VWKH 517
           T     + +MAPE L     T ++DV++FGVL+ E        +F+ G S      V + 
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE--------IFTLGGSPYPGIPVEEL 268
Query: 518 YKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +K  +    MD       P N  + +  +   C  A  + RP+  ++V  L+ I
Sbjct: 269 FKLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 106/213 (49%), Gaps = 24/213 (11%)
Query: 305 KLGQGGAGSVFRGTL------PDGRNIAVKRLFFNSRQWV-DQFFNEVNLISGIQHKNVV 357
           +LG+   G V++G L         + +A+K L   +   + ++F +E  L + +QH NVV
Sbjct: 33  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 92
Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKN------------TIHILSWQQRFT-IIC 404
            LLG   +     +++ Y  +  L + L +++            T+        F  ++ 
Sbjct: 93  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 152
Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAG 463
             A G+ +L   S   ++H+D+ T N+L+ +KL  KI+D GL R V A D   +      
Sbjct: 153 QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 209
Query: 464 TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
            + +MAPE ++ G+ +  +D++++GV++ EV S
Sbjct: 210 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 131/293 (44%), Gaps = 42/293 (14%)
Query: 304 RKLGQGGAGSVF--------RGTLPDGRNIAVKRLFFNSRQW-VDQFFNEVNLISGI-QH 353
           + LG+G  G V         +    +   +AVK L  ++ +  +    +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 354 KNVVRLLG-CSIEGPESLLV--------YEYVPNRSLDQILFVKNTIHILSWQQRFTIIC 404
           KN++ LLG C+ +GP  ++V         EY+  R    + +  +   +   Q  F  + 
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 405 G----TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVST 459
                 A G+ +L   +  K IHRD+   N+L+ E    KIADFGLAR +   D    +T
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT-VWKHY 518
                + +MAPE L     T ++DV++FGVL+ E        +F+ G S      V + +
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE--------IFTLGGSPYPGIPVEELF 269
Query: 519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           K  +    MD       P N  + +  +   C  A  + RP+  ++V  L+ I
Sbjct: 270 KLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 100/219 (45%), Gaps = 46/219 (21%)
Query: 306 LGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI--QHKNVVRLLGCS 363
           +G+G  G V+RG+   G N+AVK   F+SR     +F E  L + +  +H+N++  +   
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVK--IFSSRD-EKSWFRETELYNTVMLRHENILGFIASD 100
Query: 364 IEGPESLL-------------VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGL 410
           +    S               +Y+Y+   +LD +  ++             I+   A GL
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLR-------------IVLSIASGL 147
Query: 411 AHLH----GGSGI-KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG---IA 462
           AHLH    G  G   I HRD+K+ NIL+ +     IAD GLA   +     +  G     
Sbjct: 148 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 207
Query: 463 GTLGYMAPEYLVRGQLTE------KADVYAFGVLVIEVA 495
           GT  YMAPE L      +      + D++AFG+++ EVA
Sbjct: 208 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 246

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 17/206 (8%)
Query: 300 FDNSRKLGQGGAGSVF---RGTLPDGRNI-AVKRLFFNSRQWVDQFFN--EVNLISGIQH 353
           F+  + LGQG  G VF   + +  D R + A+K L   + +  D+     E +++  + H
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 86
Query: 354 KNVVRL-LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI-ICGTAEGLA 411
             +V+L      EG +  L+ +++  R  D  LF + +  ++  ++     +   A  L 
Sbjct: 87  PFIVKLHYAFQTEG-KLYLILDFL--RGGD--LFTRLSKEVMFTEEDVKFYLAELALALD 141
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           HLH    + II+RD+K  NILLDE+   K+ DFGL++  + D    +    GT+ YMAPE
Sbjct: 142 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPE 197
Query: 472 YLVRGQLTEKADVYAFGVLVIEVASG 497
            + R   T+ AD ++FGVL+ E+ +G
Sbjct: 198 VVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNVV 357
           +    K+G+G  G V++     GR +A+KR+  ++           E++L+  + H N+V
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
            L+          LV+E++  + L ++L    T   L   Q    +     G+AH H   
Sbjct: 83  SLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTG--LQDSQIKIYLYQLLRGVAHCHQH- 138
Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLV-R 475
             +I+HRD+K  N+L++     K+ADFGLAR    P +++    +  TL Y AP+ L+  
Sbjct: 139 --RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLMGS 194
Query: 476 GQLTEKADVYAFGVLVIEVASGR 498
            + +   D+++ G +  E+ +G+
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 106/213 (49%), Gaps = 24/213 (11%)
Query: 305 KLGQGGAGSVFRGTL------PDGRNIAVKRLFFNSRQWV-DQFFNEVNLISGIQHKNVV 357
           +LG+   G V++G L         + +A+K L   +   + ++F +E  L + +QH NVV
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKN------------TIHILSWQQRFT-IIC 404
            LLG   +     +++ Y  +  L + L +++            T+        F  ++ 
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAG 463
             A G+ +L   S   ++H+D+ T N+L+ +KL  KI+D GL R V A D   +      
Sbjct: 136 QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 192
Query: 464 TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
            + +MAPE ++ G+ +  +D++++GV++ EV S
Sbjct: 193 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 17/206 (8%)
Query: 300 FDNSRKLGQGGAGSVF---RGTLPDGRNI-AVKRLFFNSRQWVDQFFN--EVNLISGIQH 353
           F+  + LGQG  G VF   + +  D R + A+K L   + +  D+     E +++  + H
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 354 KNVVRL-LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI-ICGTAEGLA 411
             +V+L      EG +  L+ +++  R  D  LF + +  ++  ++     +   A  L 
Sbjct: 86  PFIVKLHYAFQTEG-KLYLILDFL--RGGD--LFTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           HLH    + II+RD+K  NILLDE+   K+ DFGL++  + D    +    GT+ YMAPE
Sbjct: 141 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPE 196
Query: 472 YLVRGQLTEKADVYAFGVLVIEVASG 497
            + R   T+ AD ++FGVL+ E+ +G
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 105/216 (48%), Gaps = 33/216 (15%)
Query: 306 LGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLIS-GIQHKNVVRLLGCS 363
           LG G +G+V F+G+   GR +AVKR+  +   + D    E+ L++    H NV+R   CS
Sbjct: 41  LGYGSSGTVVFQGSF-QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYY-CS 95
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKN-TIHILSWQQRF---TIICGTAEGLAHLHGGSGI 419
                 L +   + N +L  ++  KN +   L  Q+ +   +++   A G+AHLH    +
Sbjct: 96  ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---L 152
Query: 420 KIIHRDIKTSNILLD-------------EKLTPKIADFGLARHVAPDKTHVSTGI---AG 463
           KIIHRD+K  NIL+              E L   I+DFGL + +   +      +   +G
Sbjct: 153 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSG 212
Query: 464 TLGYMAPEYL---VRGQLTEKADVYAFGVLVIEVAS 496
           T G+ APE L    + +LT   D+++ G +   + S
Sbjct: 213 TSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 105/216 (48%), Gaps = 33/216 (15%)
Query: 306 LGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLIS-GIQHKNVVRLLGCS 363
           LG G +G+V F+G+   GR +AVKR+  +   + D    E+ L++    H NV+R   CS
Sbjct: 41  LGYGSSGTVVFQGSF-QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYY-CS 95
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKN-TIHILSWQQRF---TIICGTAEGLAHLHGGSGI 419
                 L +   + N +L  ++  KN +   L  Q+ +   +++   A G+AHLH    +
Sbjct: 96  ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---L 152
Query: 420 KIIHRDIKTSNILLD-------------EKLTPKIADFGLARHVAPDKTHVSTGI---AG 463
           KIIHRD+K  NIL+              E L   I+DFGL + +   +      +   +G
Sbjct: 153 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSG 212
Query: 464 TLGYMAPEYL---VRGQLTEKADVYAFGVLVIEVAS 496
           T G+ APE L    + +LT   D+++ G +   + S
Sbjct: 213 TSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 131/293 (44%), Gaps = 42/293 (14%)
Query: 304 RKLGQGGAGSVF--------RGTLPDGRNIAVKRLFFNSRQW-VDQFFNEVNLISGI-QH 353
           + LG+G  G V         +    +   +AVK L  ++ +  +    +E+ ++  I +H
Sbjct: 28  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 87
Query: 354 KNVVRLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTIHI-------------LSWQQR 399
           KN++ LLG C+ +GP  ++V EY    +L + L  +    +             ++++  
Sbjct: 88  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 146
Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVS 458
            +     A G+ +L   +  K IHRD+   N+L+ E    KIADFGLAR +   D    +
Sbjct: 147 VSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKT 203
Query: 459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHY 518
           T     + +MAPE L     T ++DV++FGVL+ E        +F+ G S      +   
Sbjct: 204 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE--------IFTLGGSP-----YPGI 250
Query: 519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
               + + +  G     P N  + +  +   C  A  + RP+  ++V  L+ I
Sbjct: 251 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 303

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 133/294 (45%), Gaps = 44/294 (14%)
Query: 304 RKLGQGGAGSVF--------RGTLPDGRNIAVKRLFFNSRQW-VDQFFNEVNLISGI-QH 353
           + LG+G  G V         +    +   +AVK L  ++ +  +    +E+ ++  I +H
Sbjct: 33  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 92
Query: 354 KNVVRLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTIHI-------------LSWQQR 399
           KN++ LLG C+ +GP  ++V EY    +L + L  +    +             ++++  
Sbjct: 93  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 151
Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVS 458
            +     A G+ +L   +  K IHRD+   N+L+ E    KIADFGLAR +   D    +
Sbjct: 152 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 208
Query: 459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT-VWKH 517
           T     + +MAPE L     T ++DV++FGVL+ E        +F+ G S      V + 
Sbjct: 209 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE--------IFTLGGSPYPGIPVEEL 260
Query: 518 YKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +K  +    MD       P N  + +  +   C  A  + RP+  ++V  L+ I
Sbjct: 261 FKLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 308

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 22/206 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       S+E  + + +   + + +L Q++ ++     +S+   + ++CG    
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-LYQMLCG---- 138
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + +      T  Y A
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMEPEVVTRYYRA 193
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVA 495
           PE ++     E  D+++ G ++ E+ 
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 133/294 (45%), Gaps = 44/294 (14%)
Query: 304 RKLGQGGAGSVF--------RGTLPDGRNIAVKRLFFNSRQW-VDQFFNEVNLISGI-QH 353
           + LG+G  G V         +    +   +AVK L  ++ +  +    +E+ ++  I +H
Sbjct: 30  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 89
Query: 354 KNVVRLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTIHI-------------LSWQQR 399
           KN++ LLG C+ +GP  ++V EY    +L + L  +    +             ++++  
Sbjct: 90  KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 148
Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVS 458
            +     A G+ +L   +  K IHRD+   N+L+ E    KIADFGLAR +   D    +
Sbjct: 149 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 205
Query: 459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT-VWKH 517
           T     + +MAPE L     T ++DV++FGVL+ E        +F+ G S      V + 
Sbjct: 206 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE--------IFTLGGSPYPGIPVEEL 257
Query: 518 YKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +K  +    MD       P N  + +  +   C  A  + RP+  ++V  L+ I
Sbjct: 258 FKLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 305

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 133/294 (45%), Gaps = 44/294 (14%)
Query: 304 RKLGQGGAGSVF--------RGTLPDGRNIAVKRLFFNSRQW-VDQFFNEVNLISGI-QH 353
           + LG+G  G V         +    +   +AVK L  ++ +  +    +E+ ++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 354 KNVVRLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTIHI-------------LSWQQR 399
           KN++ LLG C+ +GP  ++V EY    +L + L  +    +             ++++  
Sbjct: 101 KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVS 458
            +     A G+ +L   +  K IHRD+   N+L+ E    +IADFGLAR +   D    +
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKT 216
Query: 459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT-VWKH 517
           T     + +MAPE L     T ++DV++FGVL+ E        +F+ G S      V + 
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE--------IFTLGGSPYPGIPVEEL 268
Query: 518 YKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +K  +    MD       P N  + +  +   C  A  + RP+  ++V  L+ I
Sbjct: 269 FKLLKEGHRMDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 26/204 (12%)
Query: 304 RKLGQGGAGSV-FRGTLPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           R LG G  G V    +  +GR  A+K L        + V+   +E  ++S + H  ++R+
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICG---TAE---GLAHL 413
            G   +  +  ++ +Y+    L           +L   QRF         AE    L +L
Sbjct: 72  WGTFQDAQQIFMIMDYIEGGEL---------FSLLRKSQRFPNPVAKFYAAEVCLALEYL 122
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H      II+RD+K  NILLD+    KI DFG A++V PD T+    + GT  Y+APE +
Sbjct: 123 HSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVTYX---LCGTPDYIAPEVV 175
Query: 474 VRGQLTEKADVYAFGVLVIEVASG 497
                 +  D ++FG+L+ E+ +G
Sbjct: 176 STKPYNKSIDWWSFGILIYEMLAG 199

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 306 LGQGGAGSVFRGT-LPDGRNI----AVKRLFFNSRQWVD-QFFNEVNLISGIQHKNVVRL 359
           LG G  G+V++G  +P+G  +    A+K L   +    + +F +E  +++ + H ++VRL
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
           LG  +  P   LV + +P+  L  + +V      +  Q         A+G+ +L      
Sbjct: 83  LGVCL-SPTIQLVTQLMPHGCL--LEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER--- 136
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-KTHVSTGIAGTLGYMAPEYLVRGQL 478
           +++HRD+   N+L+      KI DFGLAR +  D K + + G    + +MA E +   + 
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 196
Query: 479 TEKADVYAFGVLVIEVAS 496
           T ++DV+++GV + E+ +
Sbjct: 197 THQSDVWSYGVTIWELMT 214

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 34/223 (15%)
Query: 304 RKLGQGGAGSVFRGTL--PDGR----NIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNV 356
           + LG+G  G V + T     GR     +AVK L  N S   +    +E N++  + H +V
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 357 VRLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTI---------------------HIL 394
           ++L G CS +GP  LL+ EY    SL   L     +                       L
Sbjct: 89  IKLYGACSQDGP-LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 395 SWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK 454
           +     +     ++G+ +L   + +K++HRD+   NIL+ E    KI+DFGL+R V  + 
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 455 THVSTGIAGT-LGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
           + V        + +MA E L     T ++DV++FGVL+ E+ +
Sbjct: 205 SXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 25/211 (11%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN--------IAVKRLFFNSRQWVDQFFNEVNLISGI 351
           F+  R LG+GG G VF+     G N        +  K +   + +       E N++  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSL-----DQILFVKNTIHILSWQQRFTIICGT 406
           +H  +V L+     G +  L+ EY+    L      + +F+++T            +   
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY--------LAEI 130
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG 466
           +  L HLH      II+RD+K  NI+L+ +   K+ DFGL +    D T V+    GT+ 
Sbjct: 131 SMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHXFCGTIE 186
Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           YMAPE L+R       D ++ G L+ ++ +G
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 129/286 (45%), Gaps = 30/286 (10%)
Query: 299 FFDNSRKLGQGGAGSVFRGTL-PDGRN----IAVKRLFFNSR-QWVDQFFNEVNLISGIQ 352
           F    R LG+G  G V      P+G N    +AVK L   S    +     E+ ++  + 
Sbjct: 10  FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 69
Query: 353 HKNVVRLLG-CSIEGPESL-LVYEYVPNRSLDQILFV-KNTIHILSWQQRFTIICGTAEG 409
           H+N+V+  G C+ +G   + L+ E++P+ SL + L   KN I++   +Q+        +G
Sbjct: 70  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL---KQQLKYAVQICKG 126
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH--VSTGIAGTLGY 467
           + +L  GS  + +HRD+   N+L++ +   KI DFGL + +  DK    V       + +
Sbjct: 127 MDYL--GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFW 183
Query: 468 MAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWK-------HYKA 520
            APE L++ +    +DV++FGV + E+ +      + +  SS +    K           
Sbjct: 184 YAPECLMQSKFYIASDVWSFGVTLHELLT------YCDSDSSPMALFLKMIGPTHGQMTV 237
Query: 521 NRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH 566
            R+  ++  G     P N    V Q+   C +   + R S   ++ 
Sbjct: 238 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 283

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 127/286 (44%), Gaps = 30/286 (10%)
Query: 299 FFDNSRKLGQGGAGSVFRGTL-PDGRN----IAVKRLFFNSR-QWVDQFFNEVNLISGIQ 352
           F    R LG+G  G V      P+G N    +AVK L   S    +     E+ ++  + 
Sbjct: 22  FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 81
Query: 353 HKNVVRLLG-CSIEGPESL-LVYEYVPNRSLDQILFV-KNTIHILSWQQRFTIICGTAEG 409
           H+N+V+  G C+ +G   + L+ E++P+ SL + L   KN I++   +Q+        +G
Sbjct: 82  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL---KQQLKYAVQICKG 138
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH--VSTGIAGTLGY 467
           + +L      + +HRD+   N+L++ +   KI DFGL + +  DK    V       + +
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFW 195
Query: 468 MAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWK-------HYKA 520
            APE L++ +    +DV++FGV + E+ +      + +  SS +    K           
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLT------YCDSDSSPMALFLKMIGPTHGQMTV 249
Query: 521 NRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH 566
            R+  ++  G     P N    V Q+   C +   + R S   ++ 
Sbjct: 250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 25/211 (11%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN--------IAVKRLFFNSRQWVDQFFNEVNLISGI 351
           F+  R LG+GG G VF+     G N        +  K +   + +       E N++  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSL-----DQILFVKNTIHILSWQQRFTIICGT 406
           +H  +V L+     G +  L+ EY+    L      + +F+++T            +   
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY--------LAEI 130
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG 466
           +  L HLH      II+RD+K  NI+L+ +   K+ DFGL +    D T V+    GT+ 
Sbjct: 131 SMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHTFCGTIE 186
Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           YMAPE L+R       D ++ G L+ ++ +G
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 27/211 (12%)
Query: 306 LGQGGAGSVFRGTLP-DG--RNIAVKRLF-FNSRQWVDQFFNEVNLISGI-QHKNVVRLL 360
           +G+G  G V +  +  DG   + A+KR+  + S+     F  E+ ++  +  H N++ LL
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 361 GCSIEGPESLLVYEYVPNRSLDQIL-------------FVKNTIHILSWQQRFTIICGTA 407
           G         L  EY P+ +L   L                +T   LS QQ        A
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR--HVAPDKTHVSTGIAGTL 465
            G+ +L   S  + IHRD+   NIL+ E    KIADFGL+R   V   KT     +    
Sbjct: 153 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR--- 206
Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
            +MA E L     T  +DV+++GVL+ E+ S
Sbjct: 207 -WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 31/207 (14%)
Query: 306 LGQGGAGSVFRGTLP-DGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHKNVVRLLGC 362
           +G G  GSV        G  +A+K+L   F S  +  + + E+ L+  +QH+NV+ LL  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL-- 89
Query: 363 SIEGPESLL-----VYEYVP--NRSLDQIL---FVKNTIHILSWQQRFTIICGTAEGLAH 412
            +  P S L      Y  +P     L +I+   F +  I  L +Q          +GL +
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQ--------MLKGLKY 141
Query: 413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEY 472
           +H      ++HRD+K  N+ ++E    KI DFGLARH   +     TG   T  Y APE 
Sbjct: 142 IHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEV 194
Query: 473 LVRG-QLTEKADVYAFGVLVIEVASGR 498
           ++      +  D+++ G ++ E+ +G+
Sbjct: 195 ILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 27/211 (12%)
Query: 306 LGQGGAGSVFRGTLP-DG--RNIAVKRLF-FNSRQWVDQFFNEVNLISGI-QHKNVVRLL 360
           +G+G  G V +  +  DG   + A+KR+  + S+     F  E+ ++  +  H N++ LL
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 361 GCSIEGPESLLVYEYVPNRSLDQIL-------------FVKNTIHILSWQQRFTIICGTA 407
           G         L  EY P+ +L   L                +T   LS QQ        A
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR--HVAPDKTHVSTGIAGTL 465
            G+ +L   S  + IHRD+   NIL+ E    KIADFGL+R   V   KT     +    
Sbjct: 143 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR--- 196
Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
            +MA E L     T  +DV+++GVL+ E+ S
Sbjct: 197 -WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFF--NEVNLISGIQHKN 355
           D++D   +LG G  G V R        + V + F N+   +D++   NE+++++ + H  
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAK-FINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           ++ L     +  E +L+ E++    L   +  ++  + +S  +    +    EGL H+H 
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHE 167
Query: 416 GSGIKIIHRDIKTSNILLDEKLTP--KIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
            S   I+H DIK  NI+ + K     KI DFGLA  + PD+  +      T  + APE +
Sbjct: 168 HS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIV 222
Query: 474 VRGQLTEKADVYAFGVLVIEVASG 497
            R  +    D++A GVL   + SG
Sbjct: 223 DREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 102/206 (49%), Gaps = 22/206 (10%)
Query: 300 FDNSRKLGQGGAGSV---FRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + N + +G G  G V   +   L   RN+A+K+L   F ++    + + E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 355 NVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           N++ LL       S+E  + + +   + + +L Q++ ++     +S+   + ++CG    
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-LYQMLCG---- 138
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
           + HLH      IIHRD+K SNI++    T KI DFGLAR      + +      T  Y A
Sbjct: 139 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMEPEVVTRYYRA 193
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVA 495
           PE ++     E  D+++ G ++ E+ 
Sbjct: 194 PEVILGMGYKENVDLWSVGCIMGEMV 219

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 94/202 (46%), Gaps = 10/202 (4%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRL--FFNSRQWVDQFFNEVNLISGIQHKN 355
           + F    ++G+G  G V++G     + +   ++     +   ++    E+ ++S      
Sbjct: 19  ELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 78
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           + R  G  ++  +  ++ EY+   S   +L        L      TI+    +GL +LH 
Sbjct: 79  ITRYFGSYLKSTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHS 134
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               + IHRDIK +N+LL E+   K+ADFG+A  +  D         GT  +MAPE + +
Sbjct: 135 E---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-DTQIKRNXFVGTPFWMAPEVIKQ 190
Query: 476 GQLTEKADVYAFGVLVIEVASG 497
                KAD+++ G+  IE+A G
Sbjct: 191 SAYDFKADIWSLGITAIELAKG 212

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 31/207 (14%)
Query: 306 LGQGGAGSVFRGTLP-DGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHKNVVRLLGC 362
           +G G  GSV        G  +A+K+L   F S  +  + + E+ L+  +QH+NV+ LL  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL-- 107
Query: 363 SIEGPESLL-----VYEYVP--NRSLDQIL---FVKNTIHILSWQQRFTIICGTAEGLAH 412
            +  P S L      Y  +P     L +I+   F +  I  L +Q          +GL +
Sbjct: 108 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQ--------MLKGLKY 159
Query: 413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEY 472
           +H      ++HRD+K  N+ ++E    KI DFGLARH   +     TG   T  Y APE 
Sbjct: 160 IHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEV 212
Query: 473 LVRG-QLTEKADVYAFGVLVIEVASGR 498
           ++      +  D+++ G ++ E+ +G+
Sbjct: 213 ILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 131/293 (44%), Gaps = 42/293 (14%)
Query: 304 RKLGQGGAGSVF--------RGTLPDGRNIAVKRLFFNSRQW-VDQFFNEVNLISGI-QH 353
           + LG+G  G V         +    +   +AVK L  ++ +  +    +E+ ++  I +H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 354 KNVVRLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTIHI-------------LSWQQR 399
           KN++ LLG C+ +GP  ++V EY    +L + L  +    +             ++++  
Sbjct: 147 KNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVS 458
            +     A G+ +L   +  K IHRD+   N+L+ E    KIADFGLAR +   D    +
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHY 518
           T     + +MAPE L     T ++DV++FGVL+ E        +F+ G S      +   
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE--------IFTLGGSP-----YPGI 309
Query: 519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
               + + +  G     P N  + +  +   C  A  + RP+  ++V  L+ I
Sbjct: 310 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLF-FNSRQWVDQFFNEVNLISGIQHKN 355
           + N   +G+G  G V      D  N   +A+K++  F  + +  +   E+ ++   +H+N
Sbjct: 27  YTNLSYIGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHEN 84
Query: 356 VVRL----LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           ++ +       +IE  + + + + +    L ++L  ++    LS       +     GL 
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLK 140
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS--TGIAGTLGYMA 469
           ++H  +   ++HRD+K SN+LL+     KI DFGLAR   PD  H    T    T  Y A
Sbjct: 141 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 470 PEYLVRGQ-LTEKADVYAFGVLVIEVASGR 498
           PE ++  +  T+  D+++ G ++ E+ S R
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 14/204 (6%)
Query: 300 FDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWVD---QFFNEVNLISGIQHKN 355
           +D  + LG+G  G V           +AVK    + ++ VD       E+ + + + H+N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINAMLNHEN 66
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           VV+  G   EG    L  EY     L   +     +     Q+ F  +     G+ +LHG
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG 123
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLV 474
              I I HRDIK  N+LLDE+   KI+DFGLA      ++  +   + GTL Y+APE L 
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 475 RGQL-TEKADVYAFGVLVIEVASG 497
           R +   E  DV++ G+++  + +G
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 304 RKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGC 362
           + LG GG G VF     D  + +A+K++     Q V     E+ +I  + H N+V++   
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVF-- 74
Query: 363 SIEGPE-SLLVYEYVPNRSLDQILFVKNTIH-----------ILSWQQRFTIICGTAEGL 410
            I GP  S L  +      L+ +  V+  +            +L    R   +     GL
Sbjct: 75  EILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL-FMYQLLRGL 133
Query: 411 AHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAP---DKTHVSTGIAGTLG 466
            ++H  +   ++HRD+K +N+ ++ E L  KI DFGLAR + P    K H+S G+  T  
Sbjct: 134 KYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKW 189
Query: 467 YMAPEYLVR-GQLTEKADVYAFGVLVIEVASGR 498
           Y +P  L+     T+  D++A G +  E+ +G+
Sbjct: 190 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 102/213 (47%), Gaps = 27/213 (12%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQWV-DQFFNEVNLISGIQHKNVV 357
           F    KLG G   +V++G     G  +A+K +  +S +        E++L+  ++H+N+V
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIV 66
Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVK-----------NTIHILSWQQRFTIICGT 406
           RL        +  LV+E++ N  L + +  +           N +    WQ         
Sbjct: 67  RLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQ--------L 117
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG 466
            +GLA  H     KI+HRD+K  N+L++++   K+ DFGLAR         S+ +  TL 
Sbjct: 118 LQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLW 173
Query: 467 YMAPEYLVRGQL-TEKADVYAFGVLVIEVASGR 498
           Y AP+ L+  +  +   D+++ G ++ E+ +G+
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 306 LGQGGAGSVFRGT-LPDGRNI----AVKRLFFNSRQWVD-QFFNEVNLISGIQHKNVVRL 359
           LG G  G+V++G  +P+G  +    A+K L   +    + +F +E  +++ + H ++VRL
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
           LG  +  P   LV + +P+  L  + +V      +  Q         A+G+ +L      
Sbjct: 106 LGVCL-SPTIQLVTQLMPHGCL--LEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER--- 159
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-KTHVSTGIAGTLGYMAPEYLVRGQL 478
           +++HRD+   N+L+      KI DFGLAR +  D K + + G    + +MA E +   + 
Sbjct: 160 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 219
Query: 479 TEKADVYAFGVLVIEVAS 496
           T ++DV+++GV + E+ +
Sbjct: 220 THQSDVWSYGVTIWELMT 237

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 306 LGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI--QHKNVVRLLGCS 363
           +G+G  G V+RG    G  +AVK   F+SR+    +F E  +   +  +H+N++  +   
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVK--IFSSRE-ERSWFREAEIYQTVMLRHENILGFIAAD 67
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH----GGSGI 419
            +   +      V +      LF     + ++ +    +   TA GLAHLH    G  G 
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 127
Query: 420 -KIIHRDIKTSNILLDEKLTPKIADFGLA-RH-VAPDKTHVSTG-IAGTLGYMAPEYLVR 475
             I HRD+K+ NIL+ +  T  IAD GLA RH  A D   ++     GT  YMAPE L  
Sbjct: 128 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 187
Query: 476 G------QLTEKADVYAFGVLVIEVASGRRNSV 502
                  +  ++AD+YA G++  E+A  RR S+
Sbjct: 188 SINMKHFESFKRADIYAMGLVFWEIA--RRCSI 218

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 76/158 (48%), Gaps = 12/158 (7%)
Query: 339 DQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSL---DQILFV--KNTIHI 393
           D F NE+ +I+ I+++  +   G      E  ++YEY+ N S+   D+  FV  KN    
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 394 LSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
           +  Q    II       +++H    I   HRD+K SNIL+D+    K++DFG + ++   
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNI--CHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
Query: 454 KTHVSTGIAGTLGYMAPEYLVRGQLTE--KADVYAFGV 489
           K     G  GT  +M PE+          K D+++ G+
Sbjct: 206 KIK---GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGI 240

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 101/239 (42%), Gaps = 35/239 (14%)
Query: 287 NFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL---FFNSRQWVDQ-- 340
           N K+E       F    + LG G  G V   T    G+  AV ++      S    D+  
Sbjct: 23  NEKWEFPRNNLQF---GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE 79
Query: 341 -FFNEVNLISGI-QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI----- 393
              +E+ ++S + QH+N+V LLG    G   L++ EY     L   L  K    +     
Sbjct: 80  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLA 139
Query: 394 ---------------LSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLT 438
                          L  +         A+G+A L   +    IHRD+   N+LL     
Sbjct: 140 PGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHV 196
Query: 439 PKIADFGLARHVAPDKTHVSTGIAG-TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
            KI DFGLAR +  D  ++  G A   + +MAPE +     T ++DV+++G+L+ E+ S
Sbjct: 197 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 105/220 (47%), Gaps = 37/220 (16%)
Query: 306 LGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLIS-GIQHKNVVRLLGCS 363
           LG G +G+V F+G+   GR +AVKR+  +   + D    E+ L++    H NV+R   CS
Sbjct: 23  LGYGSSGTVVFQGSF-QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYY-CS 77
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKN-TIHILSWQQRF---TIICGTAEGLAHLHGGSGI 419
                 L +   + N +L  ++  KN +   L  Q+ +   +++   A G+AHLH    +
Sbjct: 78  ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---L 134
Query: 420 KIIHRDIKTSNILLD-------------EKLTPKIADFGLARHVAPDKTHVSTGI---AG 463
           KIIHRD+K  NIL+              E L   I+DFGL + +   +      +   +G
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSG 194
Query: 464 TLGYMAPEYL-------VRGQLTEKADVYAFGVLVIEVAS 496
           T G+ APE L        + +LT   D+++ G +   + S
Sbjct: 195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 300 FDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWVD---QFFNEVNLISGIQHKN 355
           +D  + LG+G  G V           +AVK    + ++ VD       E+ +   + H+N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           VV+  G   EG    L  EY     L   +     +     Q+ F  +     G+ +LHG
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG 122
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLV 474
              I I HRDIK  N+LLDE+   KI+DFGLA      ++  +   + GTL Y+APE L 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 475 RGQL-TEKADVYAFGVLVIEVASG 497
           R +   E  DV++ G+++  + +G
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 106/243 (43%), Gaps = 30/243 (12%)
Query: 339 DQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVP----NRSLDQILFVKNTIHIL 394
           D+   E N++  + +  +VR++G   E    +LV E       N+ L Q   VK+   I 
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII- 114
Query: 395 SWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK 454
                  ++   + G+ +L   +    +HRD+   N+LL  +   KI+DFGL++ +  D+
Sbjct: 115 ------ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 165
Query: 455 THVSTGIAGT--LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLH 512
            +      G   + + APE +   + + K+DV++FGVL+ E         FS G      
Sbjct: 166 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE--------AFSYGQKP--- 214
Query: 513 TVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID 572
             ++  K + +T  ++ G     P      +  +  LC    V  RP  A V   L N  
Sbjct: 215 --YRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 272
Query: 573 YEI 575
           Y++
Sbjct: 273 YDV 275

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 106/243 (43%), Gaps = 30/243 (12%)
Query: 339 DQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVP----NRSLDQILFVKNTIHIL 394
           D+   E N++  + +  +VR++G   E    +LV E       N+ L Q   VK+     
Sbjct: 53  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD----- 106
Query: 395 SWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK 454
             +    ++   + G+ +L   +    +HRD+   N+LL  +   KI+DFGL++ +  D+
Sbjct: 107 --KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161
Query: 455 THVSTGIAGT--LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLH 512
            +      G   + + APE +   + + K+DV++FGVL+ E         FS G      
Sbjct: 162 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE--------AFSYGQKP--- 210
Query: 513 TVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID 572
             ++  K + +T  ++ G     P      +  +  LC    V  RP  A V   L N  
Sbjct: 211 --YRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268
Query: 573 YEI 575
           Y++
Sbjct: 269 YDV 271

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 300 FDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWVD---QFFNEVNLISGIQHKN 355
           +D  + LG+G  G V           +AVK    + ++ VD       E+ +   + H+N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEIXINKMLNHEN 66
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           VV+  G   EG    L  EY     L   +     +     Q+ F  +     G+ +LHG
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG 123
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLV 474
              I I HRDIK  N+LLDE+   KI+DFGLA      ++  +   + GTL Y+APE L 
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 180
Query: 475 RGQL-TEKADVYAFGVLVIEVASG 497
           R +   E  DV++ G+++  + +G
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 297 TDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQ 352
           +D ++    LG GG   V     L   R++AVK L         +  +F  E    + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 353 HKNVVRLLGC----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAE 408
           H  +V +       +  GP   +V EYV   +L  I+  +     ++ ++   +I    +
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 409 GL--AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV--STGIAGT 464
            L  +H +G     IIHRD+K +NI++      K+ DFG+AR +A     V  +  + GT
Sbjct: 128 ALNFSHQNG-----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y++PE      +  ++DVY+ G ++ EV +G
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 300 FDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWVD---QFFNEVNLISGIQHKN 355
           +D  + LG+G  G V           +AVK    + ++ VD       E+ +   + H+N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEIXINKMLNHEN 65
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           VV+  G   EG    L  EY     L   +     +     Q+ F  +     G+ +LHG
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG 122
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLV 474
              I I HRDIK  N+LLDE+   KI+DFGLA      ++  +   + GTL Y+APE L 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 475 RGQL-TEKADVYAFGVLVIEVASG 497
           R +   E  DV++ G+++  + +G
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 306 LGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI--QHKNVVRLLGCS 363
           +G+G  G V+RG    G  +AVK   F+SR+    +F E  +   +  +H+N++  +   
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVK--IFSSRE-ERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH----GGSGI 419
            +   +      V +      LF     + ++ +    +   TA GLAHLH    G  G 
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 420 -KIIHRDIKTSNILLDEKLTPKIADFGLA-RH-VAPDKTHVSTG-IAGTLGYMAPEYLVR 475
             I HRD+K+ NIL+ +  T  IAD GLA RH  A D   ++     GT  YMAPE L  
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 476 G------QLTEKADVYAFGVLVIEVASGRRNSV 502
                  +  ++AD+YA G++  E+A  RR S+
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIA--RRCSI 217

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 106/243 (43%), Gaps = 30/243 (12%)
Query: 339 DQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVP----NRSLDQILFVKNTIHIL 394
           D+   E N++  + +  +VR++G   E    +LV E       N+ L Q   VK+   I 
Sbjct: 51  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII- 108
Query: 395 SWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK 454
                  ++   + G+ +L   +    +HRD+   N+LL  +   KI+DFGL++ +  D+
Sbjct: 109 ------ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 159
Query: 455 THVSTGIAGT--LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLH 512
            +      G   + + APE +   + + K+DV++FGVL+ E         FS G      
Sbjct: 160 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE--------AFSYGQKP--- 208
Query: 513 TVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID 572
             ++  K + +T  ++ G     P      +  +  LC    V  RP  A V   L N  
Sbjct: 209 --YRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 266
Query: 573 YEI 575
           Y++
Sbjct: 267 YDV 269

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 106/243 (43%), Gaps = 30/243 (12%)
Query: 339 DQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVP----NRSLDQILFVKNTIHIL 394
           D+   E N++  + +  +VR++G   E    +LV E       N+ L Q   VK+   I 
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII- 130
Query: 395 SWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK 454
                  ++   + G+ +L   +    +HRD+   N+LL  +   KI+DFGL++ +  D+
Sbjct: 131 ------ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 181
Query: 455 THVSTGIAGT--LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLH 512
            +      G   + + APE +   + + K+DV++FGVL+ E         FS G      
Sbjct: 182 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE--------AFSYGQKP--- 230
Query: 513 TVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID 572
             ++  K + +T  ++ G     P      +  +  LC    V  RP  A V   L N  
Sbjct: 231 --YRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 288
Query: 573 YEI 575
           Y++
Sbjct: 289 YDV 291

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 106/243 (43%), Gaps = 30/243 (12%)
Query: 339 DQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVP----NRSLDQILFVKNTIHIL 394
           D+   E N++  + +  +VR++G   E    +LV E       N+ L Q   VK+   I 
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII- 130
Query: 395 SWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK 454
                  ++   + G+ +L   +    +HRD+   N+LL  +   KI+DFGL++ +  D+
Sbjct: 131 ------ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 181
Query: 455 THVSTGIAGT--LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLH 512
            +      G   + + APE +   + + K+DV++FGVL+ E         FS G      
Sbjct: 182 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE--------AFSYGQKP--- 230
Query: 513 TVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID 572
             ++  K + +T  ++ G     P      +  +  LC    V  RP  A V   L N  
Sbjct: 231 --YRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 288
Query: 573 YEI 575
           Y++
Sbjct: 289 YDV 291

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 300 FDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWVD---QFFNEVNLISGIQHKN 355
           +D  + LG+G  G V           +AVK    + ++ VD       E+ +   + H+N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           VV+  G   EG    L  EY     L   +     +     Q+ F  +     G+ +LHG
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG 123
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLV 474
              I I HRDIK  N+LLDE+   KI+DFGLA      ++  +   + GTL Y+APE L 
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 475 RGQL-TEKADVYAFGVLVIEVASG 497
           R +   E  DV++ G+++  + +G
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + LG G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L+         LD +   K+ I   ++L+W          AEG+
Sbjct: 74  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAEGM 127
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFGLA+ + A +K + + G    + +MA
Sbjct: 128 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 184
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 185 LESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 106/243 (43%), Gaps = 30/243 (12%)
Query: 339 DQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVP----NRSLDQILFVKNTIHIL 394
           D+   E N++  + +  +VR++G   E    +LV E       N+ L Q   VK+     
Sbjct: 71  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD----- 124
Query: 395 SWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK 454
             +    ++   + G+ +L   +    +HRD+   N+LL  +   KI+DFGL++ +  D+
Sbjct: 125 --KNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 179
Query: 455 THVSTGIAGT--LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLH 512
            +      G   + + APE +   + + K+DV++FGVL+ E         FS G      
Sbjct: 180 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE--------AFSYGQKP--- 228
Query: 513 TVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID 572
             ++  K + +T  ++ G     P      +  +  LC    V  RP  A V   L N  
Sbjct: 229 --YRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 286
Query: 573 YEI 575
           Y++
Sbjct: 287 YDV 289

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 306 LGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI--QHKNVVRLLGCS 363
           +G+G  G V+RG    G  +AVK   F+SR+    +F E  +   +  +H+N++  +   
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVK--IFSSRE-ERSWFREAEIYQTVMLRHENILGFIAAD 72
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH----GGSGI 419
            +   +      V +      LF     + ++ +    +   TA GLAHLH    G  G 
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 132
Query: 420 -KIIHRDIKTSNILLDEKLTPKIADFGLA-RH-VAPDKTHVSTG-IAGTLGYMAPEYLVR 475
             I HRD+K+ NIL+ +  T  IAD GLA RH  A D   ++     GT  YMAPE L  
Sbjct: 133 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 192
Query: 476 G------QLTEKADVYAFGVLVIEVASGRRNSV 502
                  +  ++AD+YA G++  E+A  RR S+
Sbjct: 193 SINMKHFESFKRADIYAMGLVFWEIA--RRCSI 223

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 300 FDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWVD---QFFNEVNLISGIQHKN 355
           +D  + LG+G  G V           +AVK    + ++ VD       E+ +   + H+N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           VV+  G   EG    L  EY     L   +     +     Q+ F  +     G+ +LHG
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG 122
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLV 474
              I I HRDIK  N+LLDE+   KI+DFGLA      ++  +   + GTL Y+APE L 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 475 RGQL-TEKADVYAFGVLVIEVASG 497
           R +   E  DV++ G+++  + +G
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 101/218 (46%), Gaps = 40/218 (18%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLF--FNSRQWVDQFFNEVNLISGIQHK 354
           + + + +G G  G+V      DGR    +A+K+L+  F S  +  + + E+ L+  ++H+
Sbjct: 27  YRDLQPVGSGAYGAVCSAV--DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84
Query: 355 NVVRLLGCSIEGPESLLVYEYVPNRSLDQIL-------FVKNTIHILSWQQRFT------ 401
           NV+ LL              + P+ +LD          F+   +  L   ++        
Sbjct: 85  NVIGLLDV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF 132
Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGI 461
           ++    +GL ++H      IIHRD+K  N+ ++E    KI DFGLAR    +      G 
Sbjct: 133 LVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MXGX 185
Query: 462 AGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
             T  Y APE ++   + T+  D+++ G ++ E+ +G+
Sbjct: 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 300 FDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWVD---QFFNEVNLISGIQHKN 355
           +D  + LG+G  G V           +AVK    + ++ VD       E+ +   + H+N
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           VV+  G   EG    L  EY     L   +     +     Q+ F  +     G+ +LHG
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG 121
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLV 474
              I I HRDIK  N+LLDE+   KI+DFGLA      ++  +   + GTL Y+APE L 
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 475 RGQL-TEKADVYAFGVLVIEVASG 497
           R +   E  DV++ G+++  + +G
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAG 202

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 306 LGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI--QHKNVVRLLGCS 363
           +G+G  G V+RG    G  +AVK   F+SR+    +F E  +   +  +H+N++  +   
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVK--IFSSRE-ERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH----GGSGI 419
            +   +      V +      LF     + ++ +    +   TA GLAHLH    G  G 
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 165
Query: 420 -KIIHRDIKTSNILLDEKLTPKIADFGLA-RH-VAPDKTHVSTG-IAGTLGYMAPEYLVR 475
             I HRD+K+ NIL+ +  T  IAD GLA RH  A D   ++     GT  YMAPE L  
Sbjct: 166 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225
Query: 476 G------QLTEKADVYAFGVLVIEVASGRRNSV 502
                  +  ++AD+YA G++  E+A  RR S+
Sbjct: 226 SINMKHFESFKRADIYAMGLVFWEIA--RRCSI 256

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 106/243 (43%), Gaps = 30/243 (12%)
Query: 339 DQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVP----NRSLDQILFVKNTIHIL 394
           D+   E N++  + +  +VR++G   E    +LV E       N+ L Q   VK+   I 
Sbjct: 63  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII- 120
Query: 395 SWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK 454
                  ++   + G+ +L   +    +HRD+   N+LL  +   KI+DFGL++ +  D+
Sbjct: 121 ------ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171
Query: 455 THVSTGIAGT--LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLH 512
            +      G   + + APE +   + + K+DV++FGVL+ E         FS G      
Sbjct: 172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE--------AFSYGQKP--- 220
Query: 513 TVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID 572
             ++  K + +T  ++ G     P      +  +  LC    V  RP  A V   L N  
Sbjct: 221 --YRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278
Query: 573 YEI 575
           Y++
Sbjct: 279 YDV 281

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLF-FNSRQWVDQFFNEVNLISGIQHKN 355
           + N   +G+G  G V      D  N   +A+K++  F  + +  +   E+ ++   +H+N
Sbjct: 27  YTNLSYIGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHEN 84
Query: 356 VVRL----LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           ++ +       +IE  + + + + +    L ++L  ++    LS       +     GL 
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLK 140
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS--TGIAGTLGYMA 469
           ++H  +   ++HRD+K SN+LL+     KI DFGLAR   PD  H    T    T  Y A
Sbjct: 141 YIHSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 470 PEYLVRGQ-LTEKADVYAFGVLVIEVASGR 498
           PE ++  +  T+  D+++ G ++ E+ S R
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 300 FDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWVD---QFFNEVNLISGIQHKN 355
           +D  + LG+G  G V           +AVK    + ++ VD       E+ +   + H+N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           VV+  G   EG    L  EY     L   +     +     Q+ F  +     G+ +LHG
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG 122
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLV 474
              I I HRDIK  N+LLDE+   KI+DFGLA      ++  +   + GTL Y+APE L 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 475 RGQL-TEKADVYAFGVLVIEVASG 497
           R +   E  DV++ G+++  + +G
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 300 FDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWVD---QFFNEVNLISGIQHKN 355
           +D  + LG+G  G V           +AVK    + ++ VD       E+ +   + H+N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           VV+  G   EG    L  EY     L   +     +     Q+ F  +     G+ +LHG
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG 123
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLV 474
              I I HRDIK  N+LLDE+   KI+DFGLA      ++  +   + GTL Y+APE L 
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 475 RGQL-TEKADVYAFGVLVIEVASG 497
           R +   E  DV++ G+++  + +G
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 306 LGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI--QHKNVVRLLGCS 363
           +G+G  G V+RG    G  +AVK   F+SR+    +F E  +   +  +H+N++  +   
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVK--IFSSRE-ERSWFREAEIYQTVMLRHENILGFIAAD 69
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH----GGSGI 419
            +   +      V +      LF     + ++ +    +   TA GLAHLH    G  G 
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 129
Query: 420 -KIIHRDIKTSNILLDEKLTPKIADFGLA-RH-VAPDKTHVSTG-IAGTLGYMAPEYLVR 475
             I HRD+K+ NIL+ +  T  IAD GLA RH  A D   ++     GT  YMAPE L  
Sbjct: 130 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 189
Query: 476 G------QLTEKADVYAFGVLVIEVASGRRNSV 502
                  +  ++AD+YA G++  E+A  RR S+
Sbjct: 190 SINMKHFESFKRADIYAMGLVFWEIA--RRCSI 220

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 300 FDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWVD---QFFNEVNLISGIQHKN 355
           +D  + LG+G  G V           +AVK    + ++ VD       E+ +   + H+N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           VV+  G   EG    L  EY     L   +     +     Q+ F  +     G+ +LHG
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG 122
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLV 474
              I I HRDIK  N+LLDE+   KI+DFGLA      ++  +   + GTL Y+APE L 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 475 RGQL-TEKADVYAFGVLVIEVASG 497
           R +   E  DV++ G+++  + +G
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 300 FDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWVD---QFFNEVNLISGIQHKN 355
           +D  + LG+G  G V           +AVK    + ++ VD       E+ +   + H+N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           VV+  G   EG    L  EY     L   +     +     Q+ F  +     G+ +LHG
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG 122
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLV 474
              I I HRDIK  N+LLDE+   KI+DFGLA      ++  +   + GTL Y+APE L 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 475 RGQL-TEKADVYAFGVLVIEVASG 497
           R +   E  DV++ G+++  + +G
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 109/218 (50%), Gaps = 19/218 (8%)
Query: 289 KYEILERATD---FFDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNE 344
           +YE + R  D    ++   +LG G  G V++    + G   A K +   S + ++ +  E
Sbjct: 7   EYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVE 66
Query: 345 VNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIIC 404
           + +++   H  +V+LLG      +  ++ E+ P  ++D I+   +       + +  ++C
Sbjct: 67  IEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVC 123
Query: 405 -GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGL-ARHVAPDKTHVSTGIA 462
               E L  LH     +IIHRD+K  N+L+  +   ++ADFG+ A+++   +   S    
Sbjct: 124 RQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FI 178
Query: 463 GTLGYMAPEYLVRGQLTE-----KADVYAFGVLVIEVA 495
           GT  +MAPE ++   + +     KAD+++ G+ +IE+A
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 216

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 300 FDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWVD---QFFNEVNLISGIQHKN 355
           +D  + LG+G  G V           +AVK    + ++ VD       E+ +   + H+N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           VV+  G   EG    L  EY     L   +     +     Q+ F  +     G+ +LHG
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG 122
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLV 474
              I I HRDIK  N+LLDE+   KI+DFGLA      ++  +   + GTL Y+APE L 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 475 RGQL-TEKADVYAFGVLVIEVASG 497
           R +   E  DV++ G+++  + +G
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 306 LGQGGAGSVFRGTLPDGRNIAVKRLFFNSR--QWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           LGQG   +VFRG      ++   ++F N    + VD    E  ++  + HKN+V+L    
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 364 IEGP--ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
            E      +L+ E+ P  SL  +L   +  + L   +   ++     G+ HL       I
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133
Query: 422 IHRDIKTSNILL----DEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQ 477
           +HR+IK  NI+     D +   K+ DFG AR +  D+  VS  + GT  Y+ P+   R  
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMYERAV 191
Query: 478 LTE--------KADVYAFGVLVIEVASG 497
           L +          D+++ GV     A+G
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLF-FNSRQWVDQFFNEVNLISGIQHKN 355
           + N   +G+G  G V      D  N   +A+K++  F  + +  +   E+ ++   +H+N
Sbjct: 23  YTNLSYIGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 80
Query: 356 VVRL----LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           ++ +       +IE  + + + + +    L ++L  ++    LS       +     GL 
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLK 136
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS--TGIAGTLGYMA 469
           ++H  +   ++HRD+K SN+LL+     KI DFGLAR   PD  H    T    T  Y A
Sbjct: 137 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 470 PEYLVRGQ-LTEKADVYAFGVLVIEVASGR 498
           PE ++  +  T+  D+++ G ++ E+ S R
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 300 FDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWVD---QFFNEVNLISGIQHKN 355
           +D  + LG+G  G V           +AVK    + ++ VD       E+ +   + H+N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           VV+  G   EG    L  EY     L   +     +     Q+ F  +     G+ +LHG
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG 123
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLV 474
              I I HRDIK  N+LLDE+   KI+DFGLA      ++  +   + GTL Y+APE L 
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 475 RGQL-TEKADVYAFGVLVIEVASG 497
           R +   E  DV++ G+++  + +G
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 300 FDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWVD---QFFNEVNLISGIQHKN 355
           +D  + LG+G  G V           +AVK    + ++ VD       E+ +   + H+N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           VV+  G   EG    L  EY     L   +     +     Q+ F  +     G+ +LHG
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG 123
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLV 474
              I I HRDIK  N+LLDE+   KI+DFGLA      ++  +   + GTL Y+APE L 
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 475 RGQL-TEKADVYAFGVLVIEVASG 497
           R +   E  DV++ G+++  + +G
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 300 FDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWVD---QFFNEVNLISGIQHKN 355
           +D  + LG+G  G V           +AVK    + ++ VD       E+ +   + H+N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           VV+  G   EG    L  EY     L   +     +     Q+ F  +     G+ +LHG
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG 123
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLV 474
              I I HRDIK  N+LLDE+   KI+DFGLA      ++  +   + GTL Y+APE L 
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 475 RGQL-TEKADVYAFGVLVIEVASG 497
           R +   E  DV++ G+++  + +G
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLF-FNSRQWVDQFFNEVNLISGIQHKN 355
           + N   +G+G  G V      D  N   +A+K++  F  + +  +   E+ ++   +H+N
Sbjct: 23  YTNLSYIGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 80
Query: 356 VVRL----LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           ++ +       +IE  + + + + +    L ++L  ++    LS       +     GL 
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLK 136
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS--TGIAGTLGYMA 469
           ++H  +   ++HRD+K SN+LL+     KI DFGLAR   PD  H    T    T  Y A
Sbjct: 137 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 193
Query: 470 PEYLVRGQ-LTEKADVYAFGVLVIEVASGR 498
           PE ++  +  T+  D+++ G ++ E+ S R
Sbjct: 194 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 306 LGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI--QHKNVVRLLGCS 363
           +G+G  G V+RG    G  +AVK   F+SR+    +F E  +   +  +H+N++  +   
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVK--IFSSRE-ERSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH----GGSGI 419
            +   +      V +      LF     + ++ +    +   TA GLAHLH    G  G 
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 152
Query: 420 -KIIHRDIKTSNILLDEKLTPKIADFGLA-RH-VAPDKTHVSTG-IAGTLGYMAPEYLVR 475
             I HRD+K+ NIL+ +  T  IAD GLA RH  A D   ++     GT  YMAPE L  
Sbjct: 153 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 212
Query: 476 G------QLTEKADVYAFGVLVIEVASGRRNSV 502
                  +  ++AD+YA G++  E+A  RR S+
Sbjct: 213 SINMKHFESFKRADIYAMGLVFWEIA--RRCSI 243

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLF-FNSRQWVDQFFNEVNLISGIQHKN 355
           + N   +G+G  G V      D  N   +A+K++  F  + +  +   E+ ++   +H+N
Sbjct: 25  YTNLSYIGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 356 VVRL----LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           ++ +       +IE  + + + + +    L ++L  ++    LS       +     GL 
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLK 138
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS--TGIAGTLGYMA 469
           ++H  +   ++HRD+K SN+LL+     KI DFGLAR   PD  H    T    T  Y A
Sbjct: 139 YIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 470 PEYLVRGQ-LTEKADVYAFGVLVIEVASGR 498
           PE ++  +  T+  D+++ G ++ E+ S R
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLF-FNSRQWVDQFFNEVNLISGIQHKN 355
           + N   +G+G  G V      D  N   +A+K++  F  + +  +   E+ ++   +H+N
Sbjct: 30  YTNLSYIGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 87
Query: 356 VVRL----LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           ++ +       +IE  + + + + +    L ++L  ++    LS       +     GL 
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLK 143
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS--TGIAGTLGYMA 469
           ++H  +   ++HRD+K SN+LL+     KI DFGLAR   PD  H    T    T  Y A
Sbjct: 144 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 200
Query: 470 PEYLVRGQ-LTEKADVYAFGVLVIEVASGR 498
           PE ++  +  T+  D+++ G ++ E+ S R
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLF-FNSRQWVDQFFNEVNLISGIQHKN 355
           + N   +G+G  G V      D  N   +A+K++  F  + +  +   E+ ++   +H+N
Sbjct: 31  YTNLSYIGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 88
Query: 356 VVRL----LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           ++ +       +IE  + + + + +    L ++L  ++    LS       +     GL 
Sbjct: 89  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLK 144
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS--TGIAGTLGYMA 469
           ++H  +   ++HRD+K SN+LL+     KI DFGLAR   PD  H    T    T  Y A
Sbjct: 145 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 201
Query: 470 PEYLVRGQ-LTEKADVYAFGVLVIEVASGR 498
           PE ++  +  T+  D+++ G ++ E+ S R
Sbjct: 202 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLF-FNSRQWVDQFFNEVNLISGIQHKN 355
           + N   +G+G  G V      D  N   +A+K++  F  + +  +   E+ ++   +H+N
Sbjct: 22  YTNLSYIGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 79
Query: 356 VVRL----LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           ++ +       +IE  + + + + +    L ++L  ++    LS       +     GL 
Sbjct: 80  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLK 135
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS--TGIAGTLGYMA 469
           ++H  +   ++HRD+K SN+LL+     KI DFGLAR   PD  H    T    T  Y A
Sbjct: 136 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 192
Query: 470 PEYLVRGQ-LTEKADVYAFGVLVIEVASGR 498
           PE ++  +  T+  D+++ G ++ E+ S R
Sbjct: 193 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLF-FNSRQWVDQFFNEVNLISGIQHKN 355
           + N   +G+G  G V      D  N   +A+K++  F  + +  +   E+ ++   +H+N
Sbjct: 29  YTNLSYIGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 356 VVRL----LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           ++ +       +IE  + + + + +    L ++L  ++    LS       +     GL 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLK 142
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS--TGIAGTLGYMA 469
           ++H  +   ++HRD+K SN+LL+     KI DFGLAR   PD  H    T    T  Y A
Sbjct: 143 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 470 PEYLVRGQ-LTEKADVYAFGVLVIEVASGR 498
           PE ++  +  T+  D+++ G ++ E+ S R
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRNIAVKRL--------FFNSRQWVD---QFFNEVNLI 348
           +D  + LG+G  G V          +AV R+          + ++ VD       E+ + 
Sbjct: 9   WDLVQTLGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN 59
Query: 349 SGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAE 408
             + H+NVV+  G   EG    L  EY     L   +     +     Q+ F  +     
Sbjct: 60  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--- 116
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGY 467
           G+ +LHG   I I HRDIK  N+LLDE+   KI+DFGLA      ++  +   + GTL Y
Sbjct: 117 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 468 MAPEYLVRGQL-TEKADVYAFGVLVIEVASG 497
           +APE L R +   E  DV++ G+++  + +G
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 297 TDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQ 352
           +D ++    LG GG   V     L   R++AVK L         +  +F  E    + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 353 HKNVVRLLGC----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAE 408
           H  +V +       +  GP   +V EYV   +L  I+  +     ++ ++   +I    +
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 127
Query: 409 GL--AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV--STGIAGT 464
            L  +H +G     IIHRD+K +NI++      K+ DFG+AR +A     V  +  + GT
Sbjct: 128 ALNFSHQNG-----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y++PE      +  ++DVY+ G ++ EV +G
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLF-FNSRQWVDQFFNEVNLISGIQHKN 355
           + N   +G+G  G V      D  N   +A+K++  F  + +  +   E+ ++   +H+N
Sbjct: 25  YTNLSYIGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 356 VVRL----LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           ++ +       +IE  + + + + +    L ++L  ++    LS       +     GL 
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLK 138
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS--TGIAGTLGYMA 469
           ++H  +   ++HRD+K SN+LL+     KI DFGLAR   PD  H    T    T  Y A
Sbjct: 139 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 470 PEYLVRGQ-LTEKADVYAFGVLVIEVASGR 498
           PE ++  +  T+  D+++ G ++ E+ S R
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLF-FNSRQWVDQFFNEVNLISGIQHKN 355
           + N   +G+G  G V      D  N   +A+K++  F  + +  +   E+ ++   +H+N
Sbjct: 29  YTNLSYIGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 356 VVRL----LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           ++ +       +IE  + + + + +    L ++L  ++    LS       +     GL 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQH----LSNDHICYFLYQILRGLK 142
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS--TGIAGTLGYMA 469
           ++H  +   ++HRD+K SN+LL+     KI DFGLAR   PD  H    T    T  Y A
Sbjct: 143 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 470 PEYLVRGQ-LTEKADVYAFGVLVIEVASGR 498
           PE ++  +  T+  D+++ G ++ E+ S R
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLF-FNSRQWVDQFFNEVNLISGIQHKN 355
           + N   +G+G  G V      D  N   +A+K++  F  + +  +   E+ ++   +H+N
Sbjct: 27  YTNLSYIGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 84
Query: 356 VVRL----LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           ++ +       +IE  + + + + +    L ++L  ++    LS       +     GL 
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLK 140
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS--TGIAGTLGYMA 469
           ++H  +   ++HRD+K SN+LL+     KI DFGLAR   PD  H    T    T  Y A
Sbjct: 141 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 197
Query: 470 PEYLVRGQ-LTEKADVYAFGVLVIEVASGR 498
           PE ++  +  T+  D+++ G ++ E+ S R
Sbjct: 198 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFN----EVNLISGIQ 352
           +D +D   +LG+G A SV R  +     +       N+++   + F     E  +   +Q
Sbjct: 5   SDNYDVKEELGKG-AFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63
Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
           H N+VRL     E     LV++ V    L + +  +      S       I    E +A+
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAY 120
Query: 413 LHGGSGIKIIHRDIKTSNILLDEKL---TPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
            H      I+HR++K  N+LL  K      K+ADFGLA  V  + +    G AGT GY++
Sbjct: 121 CHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAGTPGYLS 175
Query: 470 PEYLVRGQLTEKADVYAFGVLV 491
           PE L +   ++  D++A GV++
Sbjct: 176 PEVLKKDPYSKPVDIWACGVIL 197

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRNIAVKRL--------FFNSRQWVD---QFFNEVNLI 348
           +D  + LG+G  G V          +AV R+          + ++ VD       E+ + 
Sbjct: 8   WDLVQTLGEGAYGEV---------QLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN 58
Query: 349 SGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAE 408
             + H+NVV+  G   EG    L  EY     L   +     +     Q+ F  +     
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--- 115
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGY 467
           G+ +LHG   I I HRDIK  N+LLDE+   KI+DFGLA      ++  +   + GTL Y
Sbjct: 116 GVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 468 MAPEYLVRGQL-TEKADVYAFGVLVIEVASG 497
           +APE L R +   E  DV++ G+++  + +G
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLF-FNSRQWVDQFFNEVNLISGIQHKN 355
           + N   +G+G  G V      D  N   +A+K++  F  + +  +   E+ ++   +H+N
Sbjct: 29  YTNLSYIGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 356 VVRL----LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           ++ +       +IE  + + + + +    L ++L  ++    LS       +     GL 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLK 142
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS--TGIAGTLGYMA 469
           ++H  +   ++HRD+K SN+LL+     KI DFGLAR   PD  H    T    T  Y A
Sbjct: 143 YIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 470 PEYLVRGQ-LTEKADVYAFGVLVIEVASGR 498
           PE ++  +  T+  D+++ G ++ E+ S R
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFN----EVNLISGIQ 352
           +D +D   +LG+G A SV R  +     +       N+++   + F     E  +   +Q
Sbjct: 4   SDNYDVKEELGKG-AFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 62
Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
           H N+VRL     E     LV++ V    L + +  +      S       I    E +A+
Sbjct: 63  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAY 119
Query: 413 LHGGSGIKIIHRDIKTSNILLDEKL---TPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
            H      I+HR++K  N+LL  K      K+ADFGLA  V  + +    G AGT GY++
Sbjct: 120 CHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAGTPGYLS 174
Query: 470 PEYLVRGQLTEKADVYAFGVLV 491
           PE L +   ++  D++A GV++
Sbjct: 175 PEVLKKDPYSKPVDIWACGVIL 196

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 300 FDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWVD---QFFNEVNLISGIQHKN 355
           +D  + LG+G  G V           +AVK    + ++ VD       E+ +   + H+N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           VV+  G   EG    L  EY     L   +     +     Q+ F  +     G+ +LHG
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG 122
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLV 474
              I I HRDIK  N+LLDE+   KI+DFGLA      ++  +   + GTL Y+APE L 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 475 RGQL-TEKADVYAFGVLVIEVASG 497
           R +   E  DV++ G+++  + +G
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVD-----QFFNEVNLISGIQH 353
           F   + LG G  G+V++G  +P+G  + +       R+        +  +E  +++ + +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L+         LD +   K+ I   ++L+W          A+G+
Sbjct: 111 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 164
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFGLA+ + A +K + + G    + +MA
Sbjct: 165 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 221
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 222 LESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 300 FDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWVD---QFFNEVNLISGIQHKN 355
           +D  + LG+G  G V           +AVK    + ++ VD       E+ +   + H+N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           VV+  G   EG    L  EY     L   +     +     Q+ F  +     G+ +LHG
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG 122
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLV 474
              I I HRDIK  N+LLDE+   KI+DFGLA      ++  +   + GTL Y+APE L 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 475 RGQL-TEKADVYAFGVLVIEVASG 497
           R +   E  DV++ G+++  + +G
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + LG G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L++        LD +   K+ I   ++L+W          A+G+
Sbjct: 78  PHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKGM 131
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFGLA+ + A +K + + G    + +MA
Sbjct: 132 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 188
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 189 LESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 102/223 (45%), Gaps = 34/223 (15%)
Query: 304 RKLGQGGAGSVFRGTL--PDGR----NIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNV 356
           + LG+G  G V + T     GR     +AVK L  N S   +    +E N++  + H +V
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 357 VRLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTI---------------------HIL 394
           ++L G CS +GP  LL+ EY    SL   L     +                       L
Sbjct: 89  IKLYGACSQDGP-LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 395 SWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK 454
           +     +     ++G+ +L   + + ++HRD+   NIL+ E    KI+DFGL+R V  + 
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 455 THVSTGIAGT-LGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
           + V        + +MA E L     T ++DV++FGVL+ E+ +
Sbjct: 205 SXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLF-FNSRQWVDQFFNEVNLISGIQHKN 355
           + N   +G+G  G V      D  N   +A+K++  F  + +  +   E+ ++   +H+N
Sbjct: 29  YTNLSYIGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHEN 86
Query: 356 VVRL----LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           ++ +       +IE  + + + + +    L ++L  ++    LS       +     GL 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLK 142
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS--TGIAGTLGYMA 469
           ++H  +   ++HRD+K SN+LL+     KI DFGLAR   PD  H    T    T  Y A
Sbjct: 143 YIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 470 PEYLVRGQ-LTEKADVYAFGVLVIEVASGR 498
           PE ++  +  T+  D+++ G ++ E+ S R
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 101/199 (50%), Gaps = 16/199 (8%)
Query: 305 KLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           +LG G  G V++    + G   A K +   S + ++ +  E+ +++   H  +V+LLG  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIIC-GTAEGLAHLHGGSGIKII 422
               +  ++ E+ P  ++D I+   +       + +  ++C    E L  LH     +II
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEALNFLHSK---RII 131
Query: 423 HRDIKTSNILLDEKLTPKIADFGL-ARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTE- 480
           HRD+K  N+L+  +   ++ADFG+ A+++   +   S    GT  +MAPE ++   + + 
Sbjct: 132 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCETMKDT 189
Query: 481 ----KADVYAFGVLVIEVA 495
               KAD+++ G+ +IE+A
Sbjct: 190 PYDYKADIWSLGITLIEMA 208

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 73/142 (51%), Gaps = 14/142 (9%)
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           GL  LH     +I++RD+K  NILLD+    +I+D GLA HV   +T    G  GT+GYM
Sbjct: 298 GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYM 352
Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMD 528
           APE +   + T   D +A G L+ E+ +G+  S F +    +     K  +  R+ + + 
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQ--SPFQQRKKKI-----KREEVERLVKEVP 405
Query: 529 PGLTGRFPENEASRVLQIGLLC 550
              + RF  +  +R L   LLC
Sbjct: 406 EEYSERF--SPQARSLCSQLLC 425

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 304 RKLGQGGAGSVFRGTLPDGR---NIAVKRLF--FNSRQWVDQFFNEVNLISGIQHKNVVR 358
           R +G G  GSV      D R    +AVK+L   F S     + + E+ L+  ++H+NV+ 
Sbjct: 26  RPVGSGAYGSVCSAY--DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIG 83
Query: 359 LL-----GCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
           LL       SIE    + +   +    L+ I+        LS +    ++     GL ++
Sbjct: 84  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIV----KCQALSDEHVQFLVYQLLRGLKYI 139
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H      IIHRD+K SN+ ++E    +I DFGLAR    +     TG   T  Y APE +
Sbjct: 140 HSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADEEM----TGYVATRWYRAPEIM 192
Query: 474 VRG-QLTEKADVYAFGVLVIEVASGR 498
           +      +  D+++ G ++ E+  G+
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 297 TDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQ 352
           +D ++    LG GG   V     L   R++AVK L         +  +F  E    + + 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 353 HKNVVRLLGC----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAE 408
           H  +V +       +  GP   +V EYV   +L  I+  +     ++ ++   +I    +
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 144
Query: 409 GL--AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV--STGIAGT 464
            L  +H +G     IIHRD+K +NI++      K+ DFG+AR +A     V  +  + GT
Sbjct: 145 ALNFSHQNG-----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 199
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y++PE      +  ++DVY+ G ++ EV +G
Sbjct: 200 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLF-FNSRQWVDQFFNEVNLISGIQHKN 355
           + N   +G+G  G V      D  N   +A+K++  F  + +  +   E+ ++   +H+N
Sbjct: 25  YTNLSYIGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 356 VVRL----LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           ++ +       +IE  + + + + +    L ++L  ++    LS       +     GL 
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLK 138
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS--TGIAGTLGYMA 469
           ++H  +   ++HRD+K SN+LL+     KI DFGLAR   PD  H    T    T  Y A
Sbjct: 139 YIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 470 PEYLVRGQ-LTEKADVYAFGVLVIEVASGR 498
           PE ++  +  T+  D+++ G ++ E+ S R
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 14/204 (6%)
Query: 300 FDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWVD---QFFNEVNLISGIQHKN 355
           +D  + LG+G  G V           +AVK    + ++ VD       E+ +   + H+N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHEN 65
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           VV+  G   EG    L  EY     L   +     +     Q+ F  +     G+ +LHG
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA---GVVYLHG 122
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLV 474
              I I HRDIK  N+LLDE+   KI+DFGLA      ++  +   + GTL Y+APE L 
Sbjct: 123 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLK 179
Query: 475 RGQL-TEKADVYAFGVLVIEVASG 497
           R +   E  DV++ G+++  + +G
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFN----EVNLISGIQ 352
           +D +D   +LG+G A SV R  +     +       N+++   + F     E  +   +Q
Sbjct: 5   SDNYDVKEELGKG-AFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63
Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
           H N+VRL     E     LV++ V    L + +  +      S       I    E +A+
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAY 120
Query: 413 LHGGSGIKIIHRDIKTSNILLDEKL---TPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
            H      I+HR++K  N+LL  K      K+ADFGLA  V  + +    G AGT GY++
Sbjct: 121 CHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAGTPGYLS 175
Query: 470 PEYLVRGQLTEKADVYAFGVLV 491
           PE L +   ++  D++A GV++
Sbjct: 176 PEVLKKDPYSKPVDIWACGVIL 197

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 73/142 (51%), Gaps = 14/142 (9%)
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           GL  LH     +I++RD+K  NILLD+    +I+D GLA HV   +T    G  GT+GYM
Sbjct: 298 GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYM 352
Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMD 528
           APE +   + T   D +A G L+ E+ +G+  S F +    +     K  +  R+ + + 
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQ--SPFQQRKKKI-----KREEVERLVKEVP 405
Query: 529 PGLTGRFPENEASRVLQIGLLC 550
              + RF  +  +R L   LLC
Sbjct: 406 EEYSERF--SPQARSLCSQLLC 425

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLF-FNSRQWVDQFFNEVNLISGIQHKN 355
           + N   +G+G  G V      D  N   +A+K++  F  + +  +   E+ ++   +H+N
Sbjct: 33  YTNLSYIGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 90
Query: 356 VVRL----LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           ++ +       +IE  + + + + +    L ++L  ++    LS       +     GL 
Sbjct: 91  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLK 146
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS--TGIAGTLGYMA 469
           ++H  +   ++HRD+K SN+LL+     KI DFGLAR   PD  H    T    T  Y A
Sbjct: 147 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 203
Query: 470 PEYLVRGQ-LTEKADVYAFGVLVIEVASGR 498
           PE ++  +  T+  D+++ G ++ E+ S R
Sbjct: 204 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLF-FNSRQWVDQFFNEVNLISGIQHKN 355
           + N   +G+G  G V      D  N   +A+K++  F  + +  +   E+ ++   +H+N
Sbjct: 25  YTNLSYIGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 356 VVRL----LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           ++ +       +IE  + + + + +    L ++L  ++    LS       +     GL 
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLK 138
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS--TGIAGTLGYMA 469
           ++H  +   ++HRD+K SN+LL+     KI DFGLAR   PD  H    T    T  Y A
Sbjct: 139 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 470 PEYLVRGQ-LTEKADVYAFGVLVIEVASGR 498
           PE ++  +  T+  D+++ G ++ E+ S R
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 28/210 (13%)
Query: 307 GQGGAGSVFRGTLPDGRNIAVKRLFFNSRQ-WVDQFFNEVNLISGIQHKNVVRLLGCSIE 365
            +G  G V++  L +   +AVK      +Q W  Q   E+    G++H+N+++ +     
Sbjct: 24  ARGRFGCVWKAQLMND-FVAVKIFPLQDKQSW--QSEREIFSTPGMKHENLLQFIAAEKR 80
Query: 366 GP----ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG------ 415
           G     E  L+  +    SL   L      +I++W +   +    + GL++LH       
Sbjct: 81  GSNLEVELWLITAFHDKGSLTDYL----KGNIITWNELCHVAETMSRGLSYLHEDVPWCR 136
Query: 416 GSGIK--IIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVST-GIAGTLGYMAPEY 472
           G G K  I HRD K+ N+LL   LT  +ADFGLA    P K    T G  GT  YMAPE 
Sbjct: 137 GEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEV 196
Query: 473 LVRGQLT------EKADVYAFGVLVIEVAS 496
           L  G +        + D+YA G+++ E+ S
Sbjct: 197 L-EGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLF-FNSRQWVDQFFNEVNLISGIQHKN 355
           + N   +G+G  G V      D  N   +A+K++  F  + +  +   E+ ++   +H+N
Sbjct: 45  YTNLSYIGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 102
Query: 356 VVRL----LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           ++ +       +IE  + + + + +    L ++L  ++    LS       +     GL 
Sbjct: 103 IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLK 158
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS--TGIAGTLGYMA 469
           ++H  +   ++HRD+K SN+LL+     KI DFGLAR   PD  H    T    T  Y A
Sbjct: 159 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 470 PEYLVRGQ-LTEKADVYAFGVLVIEVASGR 498
           PE ++  +  T+  D+++ G ++ E+ S R
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLF-FNSRQWVDQFFNEVNLISGIQHKN 355
           + N   +G+G  G V      D  N   +A+K++  F  + +  +   E+ ++   +H+N
Sbjct: 25  YTNLSYIGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 356 VVRL----LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           ++ +       +IE  + + + + +    L ++L  ++    LS       +     GL 
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLK 138
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS--TGIAGTLGYMA 469
           ++H  +   ++HRD+K SN+LL+     KI DFGLAR   PD  H    T    T  Y A
Sbjct: 139 YIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRA 195
Query: 470 PEYLVRGQ-LTEKADVYAFGVLVIEVASGR 498
           PE ++  +  T+  D+++ G ++ E+ S R
Sbjct: 196 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 108/224 (48%), Gaps = 27/224 (12%)
Query: 305 KLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVD-----QFFNEVNLI-SGIQHKNVV 357
           ++G+G  GSV +    P G+ +AVKR+    R  VD     Q   +++++        +V
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRI----RSTVDEKEQKQLLMDLDVVMRSSDCPYIV 84
Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQIL-FVKNTIH-ILSWQQRFTIICGTAEGLAHLHG 415
           +  G      +  +  E + + S D+   +V + +  ++  +    I   T + L HL  
Sbjct: 85  QFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK- 142
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL-- 473
              +KIIHRDIK SNILLD     K+ DFG++  +    +   T  AG   YMAPE +  
Sbjct: 143 -ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAKTRDAGCRPYMAPERIDP 199
Query: 474 --VRGQLTEKADVYAFGVLVIEVASGR-----RNSVFSEGSSSV 510
              R     ++DV++ G+ + E+A+GR      NSVF + +  V
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV 243

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 27/211 (12%)
Query: 306 LGQGGAGSVFRGTLP-DG--RNIAVKRLF-FNSRQWVDQFFNEVNLISGI-QHKNVVRLL 360
           +G+G  G V +  +  DG   + A+KR+  + S+     F  E+ ++  +  H N++ LL
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 361 GCSIEGPESLLVYEYVPNRSLDQIL-------------FVKNTIHILSWQQRFTIICGTA 407
           G         L  EY P+ +L   L                +T   LS QQ        A
Sbjct: 90  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 149
Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR--HVAPDKTHVSTGIAGTL 465
            G+ +L   S  + IHR++   NIL+ E    KIADFGL+R   V   KT     +    
Sbjct: 150 RGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR--- 203
Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
            +MA E L     T  +DV+++GVL+ E+ S
Sbjct: 204 -WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 11/203 (5%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQHKN 355
           F   + LG+G   +V     L   R  A+K L          V     E +++S + H  
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
            V+L  C  +  +      Y  N  L     +K    I S+ +  T    TAE ++ L  
Sbjct: 99  FVKLYFCFQDDEKLYFGLSYAKNGEL-----LKYIRKIGSFDETCTRFY-TAEIVSALEY 152
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-KTHVSTGIAGTLGYMAPEYLV 474
             G  IIHRD+K  NILL+E +  +I DFG A+ ++P+ K   +    GT  Y++PE L 
Sbjct: 153 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLT 212
Query: 475 RGQLTEKADVYAFGVLVIEVASG 497
                + +D++A G ++ ++ +G
Sbjct: 213 EKSACKSSDLWALGCIIYQLVAG 235

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + LG G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L+         LD +   K+ I   ++L+W          A+G+
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKGM 130
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFGLA+ + A +K + + G    + +MA
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFN----EVNLISGIQ 352
           +D +D   +LG+G A SV R  +     +       N+++   + F     E  +   +Q
Sbjct: 28  SDNYDVKEELGKG-AFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 86
Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
           H N+VRL     E     LV++ V    L + +  +      S       I    E +A+
Sbjct: 87  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAY 143
Query: 413 LHGGSGIKIIHRDIKTSNILLDEKL---TPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
            H      I+HR++K  N+LL  K      K+ADFGLA  V  + +    G AGT GY++
Sbjct: 144 CHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAGTPGYLS 198
Query: 470 PEYLVRGQLTEKADVYAFGVLV 491
           PE L +   ++  D++A GV++
Sbjct: 199 PEVLKKDPYSKPVDIWACGVIL 220

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLF-FNSRQWVDQFFNEVNLISGIQHKN 355
           + N   +G+G  G V      D  N   +A+K++  F  + +  +   E+ ++   +H+N
Sbjct: 45  YTNLSYIGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 102
Query: 356 VVRL----LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           ++ +       +IE  + + +  ++    L ++L  ++    LS       +     GL 
Sbjct: 103 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----LSNDHICYFLYQILRGLK 158
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS--TGIAGTLGYMA 469
           ++H  +   ++HRD+K SN+LL+     KI DFGLAR   PD  H    T    T  Y A
Sbjct: 159 YIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 215
Query: 470 PEYLVRGQ-LTEKADVYAFGVLVIEVASGR 498
           PE ++  +  T+  D+++ G ++ E+ S R
Sbjct: 216 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 105/243 (43%), Gaps = 30/243 (12%)
Query: 339 DQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVP----NRSLDQILFVKNTIHIL 394
           D+   E N++  + +  +VR++G   E    +LV E       N+ L Q   VK+   I 
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII- 114
Query: 395 SWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK 454
                  ++   + G+ +L   +    +HRD+   N+LL  +   KI+DFGL++ +  D+
Sbjct: 115 ------ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 165
Query: 455 THVSTGIAGT--LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLH 512
                   G   + + APE +   + + K+DV++FGVL+ E         FS G      
Sbjct: 166 NXYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE--------AFSYGQKP--- 214
Query: 513 TVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID 572
             ++  K + +T  ++ G     P      +  +  LC    V  RP  A V   L N  
Sbjct: 215 --YRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 272
Query: 573 YEI 575
           Y++
Sbjct: 273 YDV 275

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 17/200 (8%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFF-----NSRQWVDQFFNEVNLISGIQHKNVVRL 359
           LG G  G+V +G  +P+G +I +          + RQ      + +  I  + H ++VRL
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL--HGGS 417
           LG    G    LV +Y+P  SL  +  V+     L  Q         A+G+ +L  HG  
Sbjct: 99  LGLC-PGSSLQLVTQYLPLGSL--LDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG-- 153
Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT-LGYMAPEYLVRG 476
              ++HR++   N+LL      ++ADFG+A  + PD   +    A T + +MA E +  G
Sbjct: 154 ---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 210
Query: 477 QLTEKADVYAFGVLVIEVAS 496
           + T ++DV+++GV V E+ +
Sbjct: 211 KYTHQSDVWSYGVTVWELMT 230

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRLFF-----NSRQWVDQFFNEVNLISGIQHKNVV 357
           + LG G  G+V +G  +P+G +I +          + RQ      + +  I  + H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL--HG 415
           RLLG    G    LV +Y+P  SL  +  V+     L  Q         A+G+ +L  HG
Sbjct: 79  RLLGLC-PGSSLQLVTQYLPLGSL--LDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT-LGYMAPEYLV 474
                ++HR++   N+LL      ++ADFG+A  + PD   +    A T + +MA E + 
Sbjct: 136 -----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 475 RGQLTEKADVYAFGVLVIEVAS 496
            G+ T ++DV+++GV V E+ +
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMT 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 305 KLGQGGAGSVFRGTL-PDGRN----IAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +LG+G  GSV      P G N    +AVK+L  +       F  E+ ++  +    +V+ 
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 360 LGCSI-EGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
            G S   G +SL LV EY+P+  L    F++     L   +         +G+ +L    
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQICKGMEYL---G 144
Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT--LGYMAPEYLVR 475
             + +HRD+   NIL++ +   KIADFGLA+ +  DK +      G   + + APE L  
Sbjct: 145 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 204
Query: 476 GQLTEKADVYAFGVLVIEV 494
              + ++DV++FGV++ E+
Sbjct: 205 NIFSRQSDVWSFGVVLYEL 223

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 305 KLGQGGAGSVFRGTL-PDGRN----IAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +LG+G  GSV      P G N    +AVK+L  +       F  E+ ++  +    +V+ 
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 76
Query: 360 LGCSI-EGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
            G S   G +SL LV EY+P+  L    F++     L   +         +G+ +L    
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQICKGMEYL---G 131
Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT--LGYMAPEYLVR 475
             + +HRD+   NIL++ +   KIADFGLA+ +  DK +      G   + + APE L  
Sbjct: 132 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 191
Query: 476 GQLTEKADVYAFGVLVIEV 494
              + ++DV++FGV++ E+
Sbjct: 192 NIFSRQSDVWSFGVVLYEL 210

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLF-FNSRQWVDQFFNEVNLISGIQHKN 355
           + N   +G+G  G V      D  N   +A++++  F  + +  +   E+ ++   +H+N
Sbjct: 29  YTNLSYIGEGAYGMVCSAY--DNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 356 VVRL----LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           ++ +       +IE  + + + + +    L ++L  ++    LS       +     GL 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLK 142
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS--TGIAGTLGYMA 469
           ++H  +   ++HRD+K SN+LL+     KI DFGLAR   PD  H    T    T  Y A
Sbjct: 143 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 470 PEYLVRGQ-LTEKADVYAFGVLVIEVASGR 498
           PE ++  +  T+  D+++ G ++ E+ S R
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + LG G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L++        LD +   K+ I   ++L+W          A+G+
Sbjct: 81  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 134
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFGLA+ + A +K + + G    + +MA
Sbjct: 135 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 191
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 192 LESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + LG G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L++        LD +   K+ I   ++L+W          A+G+
Sbjct: 77  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 130
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFGLA+ + A +K + + G    + +MA
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 106/243 (43%), Gaps = 30/243 (12%)
Query: 339 DQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVP----NRSLDQILFVKNTIHIL 394
           D+   E N++  + +  +VR++G   E    +LV E       N+ L Q   VK+   I 
Sbjct: 415 DELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNII- 472
Query: 395 SWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK 454
                  ++   + G+ +L   +    +HRD+   N+LL  +   KI+DFGL++ +  D+
Sbjct: 473 ------ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523
Query: 455 THVSTGIAGT--LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLH 512
            +      G   + + APE +   + + K+DV++FGVL+ E         FS G      
Sbjct: 524 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE--------AFSYGQKP--- 572
Query: 513 TVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID 572
             ++  K + +T  ++ G     P      +  +  LC    V  RP  A V   L N  
Sbjct: 573 --YRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630
Query: 573 YEI 575
           Y++
Sbjct: 631 YDV 633

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + LG G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L++        LD +   K+ I   ++L+W          A+G+
Sbjct: 80  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 133
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFGLA+ + A +K + + G    + +MA
Sbjct: 134 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 305 KLGQGGAGSVFRGTL-PDGRN----IAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +LG+G  GSV      P G N    +AVK+L  +       F  E+ ++  +    +V+ 
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 77
Query: 360 LGCSI-EGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
            G S   G +SL LV EY+P+  L    F++     L   +         +G+ +L    
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQICKGMEYL---G 132
Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG--TLGYMAPEYLVR 475
             + +HRD+   NIL++ +   KIADFGLA+ +  DK +      G   + + APE L  
Sbjct: 133 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 192
Query: 476 GQLTEKADVYAFGVLVIEV 494
              + ++DV++FGV++ E+
Sbjct: 193 NIFSRQSDVWSFGVVLYEL 211

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + LG G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L++        LD +   K+ I   ++L+W          A+G+
Sbjct: 78  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 131
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFGLA+ + A +K + + G    + +MA
Sbjct: 132 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 188
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 189 LESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 304 RKLGQGGAGSVFRGTLPDGR---NIAVKRLF--FNSRQWVDQFFNEVNLISGIQHKNVVR 358
           R +G G  GSV      D R    +AVK+L   F S     + + E+ L+  ++H+NV+ 
Sbjct: 34  RPVGSGAYGSVCSAY--DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIG 91
Query: 359 LL-----GCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
           LL       SIE    + +   +    L+ I  VK+    LS +    ++     GL ++
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLMGADLNNI--VKS--QALSDEHVQFLVYQLLRGLKYI 147
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H      IIHRD+K SN+ ++E    +I DFGLAR    +     TG   T  Y APE +
Sbjct: 148 HSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEM----TGYVATRWYRAPEIM 200
Query: 474 VRG-QLTEKADVYAFGVLVIEVASGR 498
           +      +  D+++ G ++ E+  G+
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + LG G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L++        LD +   K+ I   ++L+W          A+G+
Sbjct: 79  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 132
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFGLA+ + A +K + + G    + +MA
Sbjct: 133 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 304 RKLGQGGAGSVFRGTLPDGR---NIAVKRLF--FNSRQWVDQFFNEVNLISGIQHKNVVR 358
           R +G G  GSV      D R    +AVK+L   F S     + + E+ L+  ++H+NV+ 
Sbjct: 34  RPVGSGAYGSVCSAY--DARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIG 91
Query: 359 LL-----GCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
           LL       SIE    + +   +    L+ I+        LS +    ++     GL ++
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIV----KCQALSDEHVQFLVYQLLRGLKYI 147
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H      IIHRD+K SN+ ++E    +I DFGLAR    +     TG   T  Y APE +
Sbjct: 148 HSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEM----TGYVATRWYRAPEIM 200
Query: 474 VRG-QLTEKADVYAFGVLVIEVASGR 498
           +      +  D+++ G ++ E+  G+
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 306 LGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI-QHKNVVRLLGCSI 364
           +G G  G V++G       +A  ++   +    ++   E+N++     H+N+    G  I
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 365 E-GPESL-----LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIIC-GTAEGLAHLHGGS 417
           +  P  +     LV E+    S+  +  +KNT      ++    IC     GL+HLH   
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDL--IKNTKGNTLKEEWIAYICREILRGLSHLHQH- 148
Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQ 477
             K+IHRDIK  N+LL E    K+ DFG++  +       +T I GT  +MAPE +   +
Sbjct: 149 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDE 205
Query: 478 LTE-----KADVYAFGVLVIEVASG 497
             +     K+D+++ G+  IE+A G
Sbjct: 206 NPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + LG G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L+         LD +   K+ I   ++L+W          A+G+
Sbjct: 87  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 140
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFGLA+ + A +K + + G    + +MA
Sbjct: 141 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 197
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 198 LESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + LG G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L+         LD +   K+ I   ++L+W          A+G+
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 124
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFGLA+ + A +K + + G    + +MA
Sbjct: 125 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 14/199 (7%)
Query: 305 KLGQGGAGSVFRGTL-PDGRN----IAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           +LG+G  GSV      P G N    +AVK+L  +       F  E+ ++  +    +V+ 
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 73
Query: 360 LGCSIEG--PESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
            G S     PE  LV EY+P+  L    F++     L   +         +G+ +L    
Sbjct: 74  RGVSYGPGRPELRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQICKGMEYL---G 128
Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG--TLGYMAPEYLVR 475
             + +HRD+   NIL++ +   KIADFGLA+ +  DK        G   + + APE L  
Sbjct: 129 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSD 188
Query: 476 GQLTEKADVYAFGVLVIEV 494
              + ++DV++FGV++ E+
Sbjct: 189 NIFSRQSDVWSFGVVLYEL 207

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/243 (24%), Positives = 106/243 (43%), Gaps = 30/243 (12%)
Query: 339 DQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVP----NRSLDQILFVKNTIHIL 394
           D+   E N++  + +  +VR++G   E    +LV E       N+ L Q   VK+   I 
Sbjct: 416 DELLAEANVMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRHVKDKNII- 473
Query: 395 SWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK 454
                  ++   + G+ +L   +    +HRD+   N+LL  +   KI+DFGL++ +  D+
Sbjct: 474 ------ELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 524
Query: 455 THVSTGIAGT--LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLH 512
            +      G   + + APE +   + + K+DV++FGVL+ E         FS G      
Sbjct: 525 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE--------AFSYGQKP--- 573
Query: 513 TVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID 572
             ++  K + +T  ++ G     P      +  +  LC    V  RP  A V   L N  
Sbjct: 574 --YRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 631
Query: 573 YEI 575
           Y++
Sbjct: 632 YDV 634

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + LG G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L+         LD +   K+ I   ++L+W          A+G+
Sbjct: 80  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 133
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFGLA+ + A +K + + G    + +MA
Sbjct: 134 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + LG G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L+         LD +   K+ I   ++L+W          A+G+
Sbjct: 102 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 155
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFGLA+ + A +K + + G    + +MA
Sbjct: 156 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 212
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 213 LESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + LG G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L+         LD +   K+ I   ++L+W          A+G+
Sbjct: 83  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 136
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFGLA+ + A +K + + G    + +MA
Sbjct: 137 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 193
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 194 LESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + LG G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L+         LD +   K+ I   ++L+W          A+G+
Sbjct: 80  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 133
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFGLA+ + A +K + + G    + +MA
Sbjct: 134 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + LG G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L+         LD +   K+ I   ++L+W          A+G+
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 130
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFGLA+ + A +K + + G    + +MA
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + LG G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L+         LD +   K+ I   ++L+W          A+G+
Sbjct: 80  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 133
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFGLA+ + A +K + + G    + +MA
Sbjct: 134 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + LG G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L+         LD +   K+ I   ++L+W          A+G+
Sbjct: 79  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 132
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFGLA+ + A +K + + G    + +MA
Sbjct: 133 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + LG G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L+         LD +   K+ I   ++L+W          A+G+
Sbjct: 84  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 137
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFGLA+ + A +K + + G    + +MA
Sbjct: 138 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + LG G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L+         LD +   K+ I   ++L+W  +       A+G+
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGM 130
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFGLA+ + A +K + + G    + +MA
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 306 LGQGGAGSVFRGTLPDGRNIAVKRLFFNSR--QWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           LGQG   +VFRG      ++   ++F N    + VD    E  ++  + HKN+V+L    
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 364 IEGP--ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
            E      +L+ E+ P  SL  +L   +  + L   +   ++     G+ HL       I
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133
Query: 422 IHRDIKTSNILL----DEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQ 477
           +HR+IK  NI+     D +   K+ DFG AR +  D+  V   + GT  Y+ P+   R  
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVX--LYGTEEYLHPDMYERAV 191
Query: 478 LTE--------KADVYAFGVLVIEVASG 497
           L +          D+++ GV     A+G
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 56/93 (60%), Gaps = 1/93 (1%)
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-KTHVSTGIAGT 464
           TAE ++ L    G  IIHRD+K  NILL+E +  +I DFG A+ ++P+ K   +    GT
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y++PE L     ++ +D++A G ++ ++ +G
Sbjct: 198 AQYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 297 TDFFDNSRKLGQGGAGSVFR-GTLPDGRNIAVKRLFFNSRQWVDQ------FFNEVNLIS 349
           +D +   R LG+G  G V        G+  AVK +   S++ V Q         EV L+ 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI---SKRQVKQKTDKESLLREVQLLK 87
Query: 350 GIQHKNVVRLLGCSIEGPESLLVYE-YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAE 408
            + H N+++L     +     LV E Y      D+I+  K    + + +    II     
Sbjct: 88  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR----IIRQVLS 143
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEK---LTPKIADFGLARHVAPDKTHVSTGIAGTL 465
           G+ ++H     KI+HRD+K  N+LL+ K      +I DFGL+ H    K        GT 
Sbjct: 144 GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--IGTA 198
Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
            Y+APE L  G   EK DV++ GV++  + SG
Sbjct: 199 YYIAPEVL-HGTYDEKCDVWSTGVILYILLSG 229

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLF-FNSRQWVDQFFNEVNLISGIQHKN 355
           + N   +G+G  G V      D  N   +A+K++  F  + +  +   E+ ++   +H+N
Sbjct: 29  YTNLSYIGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 356 VVRL----LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           ++ +       +IE  + + + + +    L ++L  ++    LS       +     GL 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLK 142
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS--TGIAGTLGYMA 469
           ++H  +   ++HRD+K SN+LL+     KI DFGLAR   PD  H         T  Y A
Sbjct: 143 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 199
Query: 470 PEYLVRGQ-LTEKADVYAFGVLVIEVASGR 498
           PE ++  +  T+  D+++ G ++ E+ S R
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLF-FNSRQWVDQFFNEVNLISGIQHKN 355
           + N   +G+G  G V      D  N   +A+K++  F  + +  +   E+ ++   +H+N
Sbjct: 30  YTNLSYIGEGAYGMVCSAY--DNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 87
Query: 356 VVRL----LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           ++ +       +IE  + + + + +    L ++L  ++    LS       +     GL 
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH----LSNDHICYFLYQILRGLK 143
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS--TGIAGTLGYMA 469
           ++H  +   ++HRD+K SN+LL+     KI DFGLAR   PD  H         T  Y A
Sbjct: 144 YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRA 200
Query: 470 PEYLVRGQ-LTEKADVYAFGVLVIEVASGR 498
           PE ++  +  T+  D+++ G ++ E+ S R
Sbjct: 201 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 53/90 (58%), Gaps = 4/90 (4%)
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           GL HLH  +   II+RD+K  N+LLD+    +I+D GLA  +   +T  + G AGT G+M
Sbjct: 301 GLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFM 356
Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           APE L+  +     D +A GV + E+ + R
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 53/90 (58%), Gaps = 4/90 (4%)
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           GL HLH  +   II+RD+K  N+LLD+    +I+D GLA  +   +T  + G AGT G+M
Sbjct: 301 GLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFM 356
Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           APE L+  +     D +A GV + E+ + R
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 53/90 (58%), Gaps = 4/90 (4%)
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           GL HLH  +   II+RD+K  N+LLD+    +I+D GLA  +   +T  + G AGT G+M
Sbjct: 301 GLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFM 356
Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           APE L+  +     D +A GV + E+ + R
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 53/90 (58%), Gaps = 4/90 (4%)
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           GL HLH  +   II+RD+K  N+LLD+    +I+D GLA  +   +T  + G AGT G+M
Sbjct: 301 GLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFM 356
Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           APE L+  +     D +A GV + E+ + R
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 297 TDFFDNSRKLGQGGAGSVF--RGTLPDGRNIAVKRLFFNSRQWVDQ------FFNEVNLI 348
           +D +   R LG+G  G V   +  +  G+  AVK +   S++ V Q         EV L+
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVI---SKRQVKQKTDKESLLREVQLL 80
Query: 349 SGIQHKNVVRLLGCSIEGPESLLVYE-YVPNRSLDQILFVKNTIHILSWQQRFTIICGTA 407
             + H N+++L     +     LV E Y      D+I+  K    + + +    II    
Sbjct: 81  KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR----IIRQVL 136
Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP---KIADFGLARHVAPDKTHVSTGIAGT 464
            G+ ++H     KI+HRD+K  N+LL+ K      +I DFGL+ H    K        GT
Sbjct: 137 SGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--IGT 191
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y+APE L  G   EK DV++ GV++  + SG
Sbjct: 192 AYYIAPEVL-HGTYDEKCDVWSTGVILYILLSG 223

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 28/210 (13%)
Query: 306 LGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI--QHKNVVRLLGCS 363
           +G+G  G V+RG L  G ++AVK   F+SR     +F E  + + +  +H N++  +   
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVK--IFSSRD-EQSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 364 IEGPES----LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH----G 415
           +    S     L+  Y  + SL   L  +     L+ +   +  CG    LAHLH    G
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACG----LAHLHVEIFG 127
Query: 416 GSGI-KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG---IAGTLGYMAPE 471
             G   I HRD K+ N+L+   L   IAD GLA   +    ++  G     GT  YMAPE
Sbjct: 128 TQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPE 187
Query: 472 YL---VRGQLTEK---ADVYAFGVLVIEVA 495
            L   +R    E     D++AFG+++ E+A
Sbjct: 188 VLDEQIRTDCFESYKWTDIWAFGLVLWEIA 217

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 1/93 (1%)
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-KTHVSTGIAGT 464
           TAE ++ L    G  IIHRD+K  NILL+E +  +I DFG A+ ++P+ K   +    GT
Sbjct: 135 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y++PE L      + +D++A G ++ ++ +G
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 306 LGQGGAGSVFRGTLPDGRNI-AVKRLFFNSRQWVDQFFN-----EVNLISGIQHKNVVRL 359
           LG+G   +V++    +   I A+K++    R       N     E+ L+  + H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
           L          LV++++     D  + +K+   +L+       +  T +GL +LH     
Sbjct: 78  LDAFGHKSNISLVFDFM---ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 132
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMAPEYLVRGQL 478
            I+HRD+K +N+LLDE    K+ADFGLA+   +P++ +    +  T  Y APE L   ++
Sbjct: 133 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV--TRWYRAPELLFGARM 189
Query: 479 TE-KADVYAFGVLVIEV 494
                D++A G ++ E+
Sbjct: 190 YGVGVDMWAVGCILAEL 206

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 26/204 (12%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQ------FFNEVNLISGIQHKNVVR 358
           LG+G  G V   T     + +A+K   F SRQ + +         E++ +  ++H ++++
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALK---FISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRF--TIICGTAEGLAHLHGG 416
           L        + ++V EY      D I+  K         +RF   IIC       H H  
Sbjct: 74  LYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTE--DEGRRFFQQIICAIE--YCHRH-- 127
Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG 476
              KI+HRD+K  N+LLD+ L  KIADFGL+ ++  D   + T   G+  Y APE ++ G
Sbjct: 128 ---KIVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKTS-CGSPNYAAPE-VING 181
Query: 477 QLTE--KADVYAFGVLVIEVASGR 498
           +L    + DV++ G+++  +  GR
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 1/93 (1%)
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-KTHVSTGIAGT 464
           TAE ++ L    G  IIHRD+K  NILL+E +  +I DFG A+ ++P+ K   +    GT
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y++PE L      + +D++A G ++ ++ +G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 1/93 (1%)
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-KTHVSTGIAGT 464
           TAE ++ L    G  IIHRD+K  NILL+E +  +I DFG A+ ++P+ K   +    GT
Sbjct: 114 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y++PE L      + +D++A G ++ ++ +G
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 122/269 (45%), Gaps = 51/269 (18%)
Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQ-HKNVVRL 359
           +KLG+G  G V++      G  +AVK++F  F +     + F E+ +++ +  H+N+V L
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 360 LGC--SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
           L    +    +  LV++Y     ++  L      +IL    +  ++    + + +LH G 
Sbjct: 75  LNVLRADNDRDVYLVFDY-----METDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA--------------------PDKTHV 457
              ++HRD+K SNILL+ +   K+ADFGL+R                        D   +
Sbjct: 130 ---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 458 STGIAGTLGYMAPEYLV-RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWK 516
            T    T  Y APE L+   + T+  D+++ G ++ E+  G+   +F  GSS++      
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK--PIFP-GSSTM------ 237
Query: 517 HYKANRITQSMDPGLTGRFPENEASRVLQ 545
             +  RI   +D      FP NE    +Q
Sbjct: 238 -NQLERIIGVID------FPSNEDVESIQ 259

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 1/93 (1%)
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-KTHVSTGIAGT 464
           TAE ++ L    G  IIHRD+K  NILL+E +  +I DFG A+ ++P+ K   +    GT
Sbjct: 115 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y++PE L      + +D++A G ++ ++ +G
Sbjct: 175 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 1/93 (1%)
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-KTHVSTGIAGT 464
           TAE ++ L    G  IIHRD+K  NILL+E +  +I DFG A+ ++P+ K   +    GT
Sbjct: 113 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y++PE L      + +D++A G ++ ++ +G
Sbjct: 173 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 1/93 (1%)
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-KTHVSTGIAGT 464
           TAE ++ L    G  IIHRD+K  NILL+E +  +I DFG A+ ++P+ K   +    GT
Sbjct: 116 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y++PE L      + +D++A G ++ ++ +G
Sbjct: 176 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 81/160 (50%), Gaps = 13/160 (8%)
Query: 335 RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL--VYEYVPNRSLDQILFVKNTIH 392
           R  ++Q + E+ ++  + H NVV+L+    +  E  L  V+E V    + ++     T+ 
Sbjct: 77  RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV----PTLK 132
Query: 393 ILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP 452
            LS  Q         +G+ +LH     KIIHRDIK SN+L+ E    KIADFG++     
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 453 DKTHVSTGIAGTLGYMAPEYL--VRGQLTEKA-DVYAFGV 489
               +S  + GT  +MAPE L   R   + KA DV+A GV
Sbjct: 190 SDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGV 228

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 1/93 (1%)
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-KTHVSTGIAGT 464
           TAE ++ L    G  IIHRD+K  NILL+E +  +I DFG A+ ++P+ K   +    GT
Sbjct: 120 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y++PE L      + +D++A G ++ ++ +G
Sbjct: 180 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 1/93 (1%)
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-KTHVSTGIAGT 464
           TAE ++ L    G  IIHRD+K  NILL+E +  +I DFG A+ ++P+ K   +    GT
Sbjct: 135 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y++PE L      + +D++A G ++ ++ +G
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 1/93 (1%)
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-KTHVSTGIAGT 464
           TAE ++ L    G  IIHRD+K  NILL+E +  +I DFG A+ ++P+ K   +    GT
Sbjct: 139 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y++PE L      + +D++A G ++ ++ +G
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 297 TDFFDNSRKLGQGGAGSVF--RGTLPDGRNIAVKRLFFNSRQWVDQ------FFNEVNLI 348
           +D +   R LG+G  G V   +  +  G+  AVK +   S++ V Q         EV L+
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVI---SKRQVKQKTDKESLLREVQLL 103
Query: 349 SGIQHKNVVRLLGCSIEGPESLLVYE-YVPNRSLDQILFVKNTIHILSWQQRFTIICGTA 407
             + H N+++L     +     LV E Y      D+I+  K    + + +    II    
Sbjct: 104 KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR----IIRQVL 159
Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP---KIADFGLARHVAPDKTHVSTGIAGT 464
            G+ ++H     KI+HRD+K  N+LL+ K      +I DFGL+ H    K        GT
Sbjct: 160 SGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--IGT 214
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y+APE L  G   EK DV++ GV++  + SG
Sbjct: 215 AYYIAPEVL-HGTYDEKCDVWSTGVILYILLSG 246

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + LG G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L++        LD +   K+ I   ++L+W          A+G+
Sbjct: 81  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 134
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFG A+ + A +K + + G    + +MA
Sbjct: 135 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 191
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 192 LESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 297 TDFFDNSRKLGQGGAGSVF--RGTLPDGRNIAVKRLFFNSRQWVDQ------FFNEVNLI 348
           +D +   R LG+G  G V   +  +  G+  AVK +   S++ V Q         EV L+
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVI---SKRQVKQKTDKESLLREVQLL 104
Query: 349 SGIQHKNVVRLLGCSIEGPESLLVYE-YVPNRSLDQILFVKNTIHILSWQQRFTIICGTA 407
             + H N+++L     +     LV E Y      D+I+  K    + + +    II    
Sbjct: 105 KQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR----IIRQVL 160
Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP---KIADFGLARHVAPDKTHVSTGIAGT 464
            G+ ++H     KI+HRD+K  N+LL+ K      +I DFGL+ H    K        GT
Sbjct: 161 SGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--IGT 215
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y+APE L  G   EK DV++ GV++  + SG
Sbjct: 216 AYYIAPEVL-HGTYDEKCDVWSTGVILYILLSG 247

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 1/93 (1%)
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-KTHVSTGIAGT 464
           TAE ++ L    G  IIHRD+K  NILL+E +  +I DFG A+ ++P+ K   +    GT
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y++PE L      + +D++A G ++ ++ +G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 1/93 (1%)
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-KTHVSTGIAGT 464
           TAE ++ L    G  IIHRD+K  NILL+E +  +I DFG A+ ++P+ K   +    GT
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y++PE L      + +D++A G ++ ++ +G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 1/93 (1%)
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-KTHVSTGIAGT 464
           TAE ++ L    G  IIHRD+K  NILL+E +  +I DFG A+ ++P+ K   +    GT
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y++PE L      + +D++A G ++ ++ +G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + LG G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L++        LD +   K+ I   ++L+W          A+G+
Sbjct: 79  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 132
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFG A+ + A +K + + G    + +MA
Sbjct: 133 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 21/207 (10%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQ--FFNEVNLISGIQHKNV 356
           ++   K+G+G  G VF+    D G+ +A+K+   +    V +     E+ ++  ++H N+
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQIL-----FVKNTIHILSWQQRFTIICGTAEGLA 411
           V LL          LV+EY  +  L ++        ++ +  ++WQ         A    
Sbjct: 65  VNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTL------QAVNFC 118
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           H H       IHRD+K  NIL+ +    K+ DFG AR +     +    +A T  Y +PE
Sbjct: 119 HKHN-----CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPE 172
Query: 472 YLV-RGQLTEKADVYAFGVLVIEVASG 497
            LV   Q     DV+A G +  E+ SG
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 1/93 (1%)
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-KTHVSTGIAGT 464
           TAE ++ L    G  IIHRD+K  NILL+E +  +I DFG A+ ++P+ K   +    GT
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y++PE L      + +D++A G ++ ++ +G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + LG G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L++        LD +   K+ I   ++L+W          A+G+
Sbjct: 79  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 132
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFG A+ + A +K + + G    + +MA
Sbjct: 133 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLF-FNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           LG+G  G V   T  P G  +A+K++  F+   +  +   E+ ++   +H+N++ +   +
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIF--N 76
Query: 364 IEGPESLLVYE--YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
           I+ P+S   +   Y+    +   L    +  +LS       I  T   +  LHG +   +
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSN---V 133
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHV---APDKTHVS------TGIAGTLGYMAPE- 471
           IHRD+K SN+L++     K+ DFGLAR +   A D +  +      T    T  Y APE 
Sbjct: 134 IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEV 193
Query: 472 YLVRGQLTEKADVYAFGVLVIEV 494
            L   + +   DV++ G ++ E+
Sbjct: 194 MLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 103/207 (49%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + L  G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L++        LD +   K+ I   ++L+W          A+G+
Sbjct: 84  PHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 137
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFGLA+ + A +K + + G    + +MA
Sbjct: 138 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 1/93 (1%)
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-KTHVSTGIAGT 464
           TAE ++ L    G  IIHRD+K  NILL+E +  +I DFG A+ ++P+ K   +    GT
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y++PE L      + +D++A G ++ ++ +G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLF-FNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           LG+G  G V   T  P G  +A+K++  F+   +  +   E+ ++   +H+N++ +   +
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIF--N 76
Query: 364 IEGPESLLVYE--YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
           I+ P+S   +   Y+    +   L    +  +LS       I  T   +  LHG +   +
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSN---V 133
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHV---APDKTHVS------TGIAGTLGYMAPE- 471
           IHRD+K SN+L++     K+ DFGLAR +   A D +  +      T    T  Y APE 
Sbjct: 134 IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEV 193
Query: 472 YLVRGQLTEKADVYAFGVLVIEV 494
            L   + +   DV++ G ++ E+
Sbjct: 194 MLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + L  G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L+         LD +   K+ I   ++L+W          A+G+
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 130
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFGLA+ + A +K + + G    + +MA
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 1/93 (1%)
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-KTHVSTGIAGT 464
           TAE ++ L    G  IIHRD+K  NILL+E +  +I DFG A+ ++P+ K   +    GT
Sbjct: 139 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y++PE L      + +D++A G ++ ++ +G
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 1/93 (1%)
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-KTHVSTGIAGT 464
           TAE ++ L    G  IIHRD+K  NILL+E +  +I DFG A+ ++P+ K   +    GT
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y++PE L      + +D++A G ++ ++ +G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 1/93 (1%)
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-KTHVSTGIAGT 464
           TAE ++ L    G  IIHRD+K  NILL+E +  +I DFG A+ ++P+ K   +    GT
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y++PE L      + +D++A G ++ ++ +G
Sbjct: 198 AQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + L  G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L+         LD +   K+ I   ++L+W          A+G+
Sbjct: 84  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 137
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFGLA+ + A +K + + G    + +MA
Sbjct: 138 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + LG G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L+         LD +   K+ I   ++L+W          A+G+
Sbjct: 77  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 130
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFG A+ + A +K + + G    + +MA
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 1/93 (1%)
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-KTHVSTGIAGT 464
           TAE ++ L    G  IIHRD+K  NILL+E +  +I DFG A+ ++P+ K   +    GT
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y++PE L      + +D++A G ++ ++ +G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + LG G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L+         LD +   K+ I   ++L+W          A+G+
Sbjct: 79  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 132
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFG A+ + A +K + + G    + +MA
Sbjct: 133 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 1/93 (1%)
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-KTHVSTGIAGT 464
           TAE ++ L    G  IIHRD+K  NILL+E +  +I DFG A+ ++P+ K   +    GT
Sbjct: 141 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y++PE L      + +D++A G ++ ++ +G
Sbjct: 201 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 102/235 (43%), Gaps = 27/235 (11%)
Query: 285 SLNFKYEILERATDF------FDNSRKLGQGGAGSVFRGTLP--DGR--NIAVKRLFFN- 333
           SL    E+ E+  D       F   R LG+G  GSV    L   DG    +AVK L  + 
Sbjct: 4   SLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADI 63
Query: 334 -SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG------PESLLVYEYVPNRSLDQILF 386
            +   +++F  E   +    H +V +L+G S+        P  +++  ++ +  L   L 
Sbjct: 64  IASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL 123
Query: 387 ---VKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIAD 443
              +      L  Q     +   A G+ +L   S    IHRD+   N +L E +T  +AD
Sbjct: 124 ASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVAD 180
Query: 444 FGLARHVAPDKTHVSTGIAGTL--GYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
           FGL+R +     +   G A  L   ++A E L     T  +DV+AFGV + E+ +
Sbjct: 181 FGLSRKIY-SGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E+V ++ L + +       I   L     F ++ G A    H 
Sbjct: 68  VKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 124
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 125 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 177
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHG 415
           V+LL       +  LV+E++   S+D   F+  + +  +      + +    +GLA  H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMAPEYLV 474
               +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE L+
Sbjct: 123 H---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 177
Query: 475 RGQLTEKA-DVYAFGVLVIEVASGR 498
             +    A D+++ G +  E+ + R
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNI----AVKRLF-FNSRQWVDQFFNEVNLISGIQH 353
           F   + LG G  G+V++G  +P+G  +    A+K L    S +   +  +E  +++ + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGTAEGL 410
            +V RLLG  +     L+         LD +   K+ I   ++L+W          A+G+
Sbjct: 84  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 137
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMA 469
            +L      +++HRD+   N+L+      KI DFG A+ + A +K + + G    + +MA
Sbjct: 138 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
            E ++    T ++DV+++GV V E+ +
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHG 415
           V+LL       +  LV+E++   S+D   F+  + +  +      + +    +GLA  H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMAPEYLV 474
               +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE L+
Sbjct: 125 H---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 179
Query: 475 RGQLTEKA-DVYAFGVLVIEVASGR 498
             +    A D+++ G +  E+ + R
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/143 (34%), Positives = 73/143 (51%), Gaps = 19/143 (13%)
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           GL H+H      +++RD+K +NILLDE    +I+D GLA   +  K H S    GT GYM
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 357
Query: 469 APEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM 527
           APE L +G      AD ++ G ++ ++  G  +S F +  +   H +      +R+T +M
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRG--HSPFRQHKTKDKHEI------DRMTLTM 409
Query: 528 DPGLTGRF-PENEASRVLQIGLL 549
              L   F PE    R L  GLL
Sbjct: 410 AVELPDSFSPE---LRSLLEGLL 429

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/143 (34%), Positives = 73/143 (51%), Gaps = 19/143 (13%)
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           GL H+H      +++RD+K +NILLDE    +I+D GLA   +  K H S    GT GYM
Sbjct: 303 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 356
Query: 469 APEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM 527
           APE L +G      AD ++ G ++ ++  G  +S F +  +   H +      +R+T +M
Sbjct: 357 APEVLQKGVAYDSSADWFSLGCMLFKLLRG--HSPFRQHKTKDKHEI------DRMTLTM 408
Query: 528 DPGLTGRF-PENEASRVLQIGLL 549
              L   F PE    R L  GLL
Sbjct: 409 AVELPDSFSPE---LRSLLEGLL 428

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLF-FNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           LG+G  G V   T  P G  +A+K++  F+   +  +   E+ ++   +H+N++ +   +
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIF--N 76
Query: 364 IEGPESLLVYE--YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
           I+ P+S   +   Y+    +   L    +  +LS       I  T   +  LHG +   +
Sbjct: 77  IQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSN---V 133
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHV---APDKTHVSTGIAG------TLGYMAPE- 471
           IHRD+K SN+L++     K+ DFGLAR +   A D +  +   +G      T  Y APE 
Sbjct: 134 IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEV 193
Query: 472 YLVRGQLTEKADVYAFGVLVIEV 494
            L   + +   DV++ G ++ E+
Sbjct: 194 MLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR-----GTLPDGRNIAVKRLFFNSRQWV--DQFFNEVN 346
           E   D++D   +LG G    V +       L        KR   +SR+ V  +    EV+
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGT 406
           ++  IQH NV+ L        + +L+ E V    L   L  K +   L+ ++    +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPK----IADFGLARHVAPDKTHVSTGIA 462
             G+ +LH    ++I H D+K  NI+L ++  PK    I DFGLA  +  D  +    I 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178
Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           GT  ++APE +    L  +AD+++ GV+   + SG
Sbjct: 179 GTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/143 (34%), Positives = 73/143 (51%), Gaps = 19/143 (13%)
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           GL H+H      +++RD+K +NILLDE    +I+D GLA   +  K H S    GT GYM
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 357
Query: 469 APEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM 527
           APE L +G      AD ++ G ++ ++  G  +S F +  +   H +      +R+T +M
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRG--HSPFRQHKTKDKHEI------DRMTLTM 409
Query: 528 DPGLTGRF-PENEASRVLQIGLL 549
              L   F PE    R L  GLL
Sbjct: 410 AVELPDSFSPE---LRSLLEGLL 429

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/143 (34%), Positives = 73/143 (51%), Gaps = 19/143 (13%)
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           GL H+H      +++RD+K +NILLDE    +I+D GLA   +  K H S    GT GYM
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 357
Query: 469 APEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM 527
           APE L +G      AD ++ G ++ ++  G  +S F +  +   H +      +R+T +M
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRG--HSPFRQHKTKDKHEI------DRMTLTM 409
Query: 528 DPGLTGRF-PENEASRVLQIGLL 549
              L   F PE    R L  GLL
Sbjct: 410 AVELPDSFSPE---LRSLLEGLL 429

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L + +       I   L     F ++ G A    H 
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 128
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 129 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEI 181
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 182 LLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHG 415
           V+LL       +  LV+E++   S+D   F+  + +  +      + +    +GLA  H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMAPEYLV 474
               +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE L+
Sbjct: 125 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 179
Query: 475 RGQLTEKA-DVYAFGVLVIEVASGR 498
             +    A D+++ G +  E+ + R
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 33/83 (39%), Positives = 52/83 (62%), Gaps = 7/83 (8%)
Query: 421 IIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTE 480
           +IHRD+K SNILLDE+   K+ DFG++  +  DK    +  AG   YMAPE +     T+
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS--AGCAAYMAPERIDPPDPTK 203
Query: 481 -----KADVYAFGVLVIEVASGR 498
                +ADV++ G+ ++E+A+G+
Sbjct: 204 PDYDIRADVWSLGISLVELATGQ 226

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L + +       I   L     F ++ G A    H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 121
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 122 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEI 174
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 175 LLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 95/194 (48%), Gaps = 16/194 (8%)
Query: 304 RKLGQGGAGSV-FRGTLPDGRNIAVK---RLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           + LG+G  G V        G+ +A+K   +          +   E++ +  ++H ++++L
Sbjct: 20  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 79
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
                   E ++V EY  N   D I+  ++ +     ++ F  I    E   H H     
Sbjct: 80  YDVIKSKDEIIMVIEYAGNELFDYIV-QRDKMSEQEARRFFQQIISAVE-YCHRH----- 132
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLT 479
           KI+HRD+K  N+LLDE L  KIADFGL+ ++  D   + T   G+  Y APE ++ G+L 
Sbjct: 133 KIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTS-CGSPNYAAPE-VISGKLY 189
Query: 480 E--KADVYAFGVLV 491
              + DV++ GV++
Sbjct: 190 AGPEVDVWSCGVIL 203

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHG 415
           V+LL       +  LV+E++   S+D   F+  + +  +      + +    +GLA  H 
Sbjct: 67  VKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMAPEYLV 474
               +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE L+
Sbjct: 124 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILL 178
Query: 475 RGQLTEKA-DVYAFGVLVIEVASGR 498
             +    A D+++ G +  E+ + R
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 297 TDFFDNSRKLGQGGAGSVFR-GTLPDGRNIAVKRLFFNSRQWV----DQFFNEVNLISGI 351
           TD +    +LG+G    V R   +P G+  A K    N+++       +   E  +   +
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAK--IINTKKLSARDHQKLEREARICRLL 60
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N+VRL     E     LV++ V    L + +  +      S       I    E + 
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE---YYSEADASHCIQQILESVN 117
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEK---LTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           H H      I+HRD+K  N+LL  K      K+ADFGLA  V  D+     G AGT GY+
Sbjct: 118 HCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFGFAGTPGYL 173
Query: 469 APEYLVRGQLTEKADVYAFGVLV 491
           +PE L +    +  D++A GV++
Sbjct: 174 SPEVLRKDPYGKPVDMWACGVIL 196

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 13/198 (6%)
Query: 306 LGQGGAGSVFRGTLPDGR-----NIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
           LG+GG    F  +  D +      I  K L     Q  ++   E+++   + H++VV   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVGFH 83
Query: 361 GCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIK 420
           G   +     +V E    RSL   L +      L+  +    +     G  +LH     +
Sbjct: 84  GFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLHRN---R 137
Query: 421 IIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTE 480
           +IHRD+K  N+ L+E L  KI DFGLA  V  D     T + GT  Y+APE L +   + 
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHSF 196
Query: 481 KADVYAFGVLVIEVASGR 498
           + DV++ G ++  +  G+
Sbjct: 197 EVDVWSIGCIMYTLLVGK 214

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 13/198 (6%)
Query: 306 LGQGGAGSVFRGTLPDGR-----NIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
           LG+GG    F  +  D +      I  K L     Q  ++   E+++   + H++VV   
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVGFH 83
Query: 361 GCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIK 420
           G   +     +V E    RSL   L +      L+  +    +     G  +LH     +
Sbjct: 84  GFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLHRN---R 137
Query: 421 IIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTE 480
           +IHRD+K  N+ L+E L  KI DFGLA  V  D     T + GT  Y+APE L +   + 
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHSF 196
Query: 481 KADVYAFGVLVIEVASGR 498
           + DV++ G ++  +  G+
Sbjct: 197 EVDVWSIGCIMYTLLVGK 214

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 95/194 (48%), Gaps = 16/194 (8%)
Query: 304 RKLGQGGAGSV-FRGTLPDGRNIAVK---RLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           + LG+G  G V        G+ +A+K   +          +   E++ +  ++H ++++L
Sbjct: 19  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 78
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
                   E ++V EY  N   D I+  ++ +     ++ F  I    E   H H     
Sbjct: 79  YDVIKSKDEIIMVIEYAGNELFDYIV-QRDKMSEQEARRFFQQIISAVE-YCHRH----- 131
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLT 479
           KI+HRD+K  N+LLDE L  KIADFGL+ ++  D   + T   G+  Y APE ++ G+L 
Sbjct: 132 KIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTS-CGSPNYAAPE-VISGKLY 188
Query: 480 E--KADVYAFGVLV 491
              + DV++ GV++
Sbjct: 189 AGPEVDVWSCGVIL 202

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L + +       I   L     F ++ G A    H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 121
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 122 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEI 174
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L + +       I   L     F ++ G A    H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 120
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 121 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEI 173
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 95/194 (48%), Gaps = 16/194 (8%)
Query: 304 RKLGQGGAGSV-FRGTLPDGRNIAVK---RLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           + LG+G  G V        G+ +A+K   +          +   E++ +  ++H ++++L
Sbjct: 10  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 69
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
                   E ++V EY  N   D I+  ++ +     ++ F  I    E   H H     
Sbjct: 70  YDVIKSKDEIIMVIEYAGNELFDYIV-QRDKMSEQEARRFFQQIISAVE-YCHRH----- 122
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLT 479
           KI+HRD+K  N+LLDE L  KIADFGL+ ++  D   + T   G+  Y APE ++ G+L 
Sbjct: 123 KIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTS-CGSPNYAAPE-VISGKLY 179
Query: 480 E--KADVYAFGVLV 491
              + DV++ GV++
Sbjct: 180 AGPEVDVWSCGVIL 193

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L + +       I   L     F ++ G A    H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 120
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 121 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEI 173
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L + +       I   L     F ++ G A    H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 122
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 123 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEI 175
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR-----GTLPDGRNIAVKRLFFNSRQWV--DQFFNEVN 346
           E   D++D   +LG G    V +       L        KR   +SR+ V  +    EV+
Sbjct: 7   ENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGT 406
           ++  IQH NV+ L        + +L+ E V    L   L  K +   L+ ++    +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP----KIADFGLARHVAPDKTHVSTGIA 462
             G+ +LH    ++I H D+K  NI+L ++  P    KI DFGLA  +  D  +    I 
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178
Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           GT  ++APE +    L  +AD+++ GV+   + SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 13/198 (6%)
Query: 306 LGQGGAGSVFRGTLPDGR-----NIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
           LG+GG    F  +  D +      I  K L     Q  ++   E+++   + H++VV   
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVGFH 87
Query: 361 GCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIK 420
           G   +     +V E    RSL   L +      L+  +    +     G  +LH     +
Sbjct: 88  GFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLHRN---R 141
Query: 421 IIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTE 480
           +IHRD+K  N+ L+E L  KI DFGLA  V  D     T + GT  Y+APE L +   + 
Sbjct: 142 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHSF 200
Query: 481 KADVYAFGVLVIEVASGR 498
           + DV++ G ++  +  G+
Sbjct: 201 EVDVWSIGCIMYTLLVGK 218

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L + +       I   L     F ++ G A    H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 121
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 122 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEI 174
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L + +       I   L     F ++ G A    H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 121
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 122 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 174
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 297 TDFFDNSRKLGQGGAGSVFR-GTLPDGRNIAVKRLFFNSRQWV----DQFFNEVNLISGI 351
           TD +    +LG+G    V R   +P G+  A K    N+++       +   E  +   +
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAK--IINTKKLSARDHQKLEREARICRLL 60
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           +H N+VRL     E     LV++ V    L + +  +      S       I    E + 
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE---YYSEADASHCIQQILESVN 117
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEK---LTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           H H      I+HRD+K  N+LL  K      K+ADFGLA  V  D+     G AGT GY+
Sbjct: 118 HCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQ-QAWFGFAGTPGYL 173
Query: 469 APEYLVRGQLTEKADVYAFGVLV 491
           +PE L +    +  D++A GV++
Sbjct: 174 SPEVLRKDPYGKPVDMWACGVIL 196

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E+V ++ L   +       I   L     F ++ G A    H 
Sbjct: 64  VKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 120
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 121 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEI 173
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L + +       I   L     F ++ G A    H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 121
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 122 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 174
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L + +       I   L     F ++ G A    H 
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 125
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 126 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEI 178
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 179 LLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L + +       I   L     F ++ G A    H 
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 128
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 129 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEI 181
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 182 LLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L + +       I   L     F ++ G A    H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 122
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 123 H-----RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 175
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L + +       I   L     F ++ G A    H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 121
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 122 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 174
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L + +       I   L     F ++ G A    H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 121
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 122 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 174
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L + +       I   L     F ++ G A    H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 122
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 123 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 175
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR-----GTLPDGRNIAVKRLFFNSRQWV--DQFFNEVN 346
           E   D++D   +LG G    V +       L        KR   +SR+ V  +    EV+
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGT 406
           ++  IQH NV+ L        + +L+ E V    L   L  K +   L+ ++    +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP----KIADFGLARHVAPDKTHVSTGIA 462
             G+ +LH    ++I H D+K  NI+L ++  P    KI DFGLA  +  D  +    I 
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178
Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           GT  ++APE +    L  +AD+++ GV+   + SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L + +       I   L     F ++ G A    H 
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 123
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 124 H-----RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 176
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L + +       I   L     F ++ G A    H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 120
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 121 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 173
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L + +       I   L     F ++ G A    H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 120
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 121 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 173
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR-----GTLPDGRNIAVKRLFFNSRQWV--DQFFNEVN 346
           E   D++D   +LG G    V +       L        KR   +SR+ V  +    EV+
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGT 406
           ++  IQH NV+ L        + +L+ E V    L   L  K +   L+ ++    +   
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 122
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP----KIADFGLARHVAPDKTHVSTGIA 462
             G+ +LH    ++I H D+K  NI+L ++  P    KI DFGLA  +  D  +    I 
Sbjct: 123 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 177
Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           GT  ++APE +    L  +AD+++ GV+   + SG
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L + +       I   L     F ++ G A    H 
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 123
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 124 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 176
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 97/213 (45%), Gaps = 26/213 (12%)
Query: 297 TDFFDNSRKLGQGGAGSVF--RGTLPDGRNIAVKRLFFNSRQWVDQ------FFNEVNLI 348
           +D +   R LG+G  G V   +  +  G+  AVK +   S++ V Q         EV L+
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVI---SKRQVKQKTDKESLLREVQLL 80
Query: 349 SGIQHKNVVRLLGCSIEGPESLLVYE-YVPNRSLDQILFVKNTIHILSWQQRFTIICGTA 407
             + H N+ +L     +     LV E Y      D+I+  K    + + +    II    
Sbjct: 81  KQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR----IIRQVL 136
Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP---KIADFGLARHVAPDKTHVSTGIAGT 464
            G+ + H     KI+HRD+K  N+LL+ K      +I DFGL+ H    K        GT
Sbjct: 137 SGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK--IGT 191
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
             Y+APE L  G   EK DV++ GV++  + SG
Sbjct: 192 AYYIAPEVL-HGTYDEKCDVWSTGVILYILLSG 223

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR-----GTLPDGRNIAVKRLFFNSRQWV--DQFFNEVN 346
           E   D++D   +LG G    V +       L        KR   +SR+ V  +    EV+
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGT 406
           ++  IQH NV+ L        + +L+ E V    L   L  K +   L+ ++    +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP----KIADFGLARHVAPDKTHVSTGIA 462
             G+ +LH    ++I H D+K  NI+L ++  P    KI DFGLA  +  D  +    I 
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178
Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           GT  ++APE +    L  +AD+++ GV+   + SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 95/194 (48%), Gaps = 16/194 (8%)
Query: 304 RKLGQGGAGSV-FRGTLPDGRNIAVK---RLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           + LG+G  G V        G+ +A+K   +          +   E++ +  ++H ++++L
Sbjct: 14  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 73
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
                   E ++V EY  N   D I+  ++ +     ++ F  I    E   H H     
Sbjct: 74  YDVIKSKDEIIMVIEYAGNELFDYIV-QRDKMSEQEARRFFQQIISAVE-YCHRH----- 126
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLT 479
           KI+HRD+K  N+LLDE L  KIADFGL+ ++  D   + T   G+  Y APE ++ G+L 
Sbjct: 127 KIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTS-CGSPNYAAPE-VISGKLY 183
Query: 480 E--KADVYAFGVLV 491
              + DV++ GV++
Sbjct: 184 AGPEVDVWSCGVIL 197

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFN-----SRQWVDQFFNEVNLISGIQ 352
           D F   RKLG G  G V    L + R+  ++R+        S+  ++Q   E+ ++  + 
Sbjct: 22  DLFIFKRKLGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD 78
Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPN-RSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           H N++++     +     +V E       L++I+  +     LS      ++      LA
Sbjct: 79  HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTP----KIADFGLARHVAPDKTHVSTGIAGTLGY 467
           + H      ++H+D+K  NIL  +  +P    KI DFGLA     D+   ST  AGT  Y
Sbjct: 139 YFHSQH---VVHKDLKPENILFQDT-SPHSPIKIIDFGLAELFKSDEH--STNAAGTALY 192
Query: 468 MAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           MAPE   R  +T K D+++ GV++  + +G
Sbjct: 193 MAPEVFKR-DVTFKCDIWSAGVVMYFLLTG 221

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L + +       I   L     F ++ G A    H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 124
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 125 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 177
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L + +       I   L     F ++ G A    H 
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 123
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 124 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 176
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR-----GTLPDGRNIAVKRLFFNSRQWV--DQFFNEVN 346
           E   D++D   +LG G    V +       L        KR   +SR+ V  +    EV+
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGT 406
           ++  IQH NV+ L        + +L+ E V    L   L  K +   L+ ++    +   
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 122
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP----KIADFGLARHVAPDKTHVSTGIA 462
             G+ +LH    ++I H D+K  NI+L ++  P    KI DFGLA  +  D  +    I 
Sbjct: 123 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 177
Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           GT  ++APE +    L  +AD+++ GV+   + SG
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L + +       I   L     F ++ G A    H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 122
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 123 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 175
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L + +       I   L     F ++ G A    H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 124
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 125 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 177
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR-----GTLPDGRNIAVKRLFFNSRQWV--DQFFNEVN 346
           E   D++D   +LG G    V +       L        KR   +SR+ V  +    EV+
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGT 406
           ++  IQH NV+ L        + +L+ E V    L   L  K +   L+ ++    +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP----KIADFGLARHVAPDKTHVSTGIA 462
             G+ +LH    ++I H D+K  NI+L ++  P    KI DFGLA  +  D  +    I 
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178
Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           GT  ++APE +    L  +AD+++ GV+   + SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L + +       I   L     F ++ G A    H 
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 125
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 126 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 178
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 179 LLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 107/234 (45%), Gaps = 34/234 (14%)
Query: 295 RATDFFDNSRKLGQGGAGSVF--RGTLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISG 350
           RA   ++   ++G+G  G VF  R     GR +A+KR+   + +         EV ++  
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 351 IQ---HKNVVRLLG-CSIEGPES----LLVYEYVP---NRSLDQIL---FVKNTIHILSW 396
           ++   H NVVRL   C++   +      LV+E+V       LD++        TI  + +
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 397 QQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH 456
           Q           GL  LH     +++HRD+K  NIL+      K+ADFGLAR  +     
Sbjct: 128 Q--------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQM 174
Query: 457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSV 510
             T +  TL Y APE L++       D+++ G +  E+   RR  +F  GSS V
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF--RRKPLF-RGSSDV 225

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR-----GTLPDGRNIAVKRLFFNSRQWV--DQFFNEVN 346
           E   D++D   +LG G    V +       L        KR   +SR+ V  +    EV+
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGT 406
           ++  IQH NV+ L        + +L+ E V    L   L  K +   L+ ++    +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP----KIADFGLARHVAPDKTHVSTGIA 462
             G+ +LH    ++I H D+K  NI+L ++  P    KI DFGLA  +  D  +    I 
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178
Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           GT  ++APE +    L  +AD+++ GV+   + SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR-----GTLPDGRNIAVKRLFFNSRQWV--DQFFNEVN 346
           E   D++D   +LG G    V +       L        KR   +SR+ V  +    EV+
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGT 406
           ++  IQH NV+ L        + +L+ E V    L   L  K +   L+ ++    +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP----KIADFGLARHVAPDKTHVSTGIA 462
             G+ +LH    ++I H D+K  NI+L ++  P    KI DFGLA  +  D  +    I 
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178
Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           GT  ++APE +    L  +AD+++ GV+   + SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR-----GTLPDGRNIAVKRLFFNSRQWV--DQFFNEVN 346
           E   D++D   +LG G    V +       L        KR   +SR+ V  +    EV+
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGT 406
           ++  IQH NV+ L        + +L+ E V    L   L  K +   L+ ++    +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP----KIADFGLARHVAPDKTHVSTGIA 462
             G+ +LH    ++I H D+K  NI+L ++  P    KI DFGLA  +  D  +    I 
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178
Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           GT  ++APE +    L  +AD+++ GV+   + SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 88/182 (48%), Gaps = 15/182 (8%)
Query: 325 IAVKRLF-FNSRQWVDQFFNEVNLISGIQHKNVVR----LLGCSIEGPESLLVYEYVPNR 379
           +A+K++  F  + +  +   E+ ++   +H+NV+     L   ++E    + + + +   
Sbjct: 71  VAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMET 130
Query: 380 SLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP 439
            L ++L  +     LS       +     GL ++H  +   ++HRD+K SN+L++     
Sbjct: 131 DLYKLLKSQQ----LSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLINTTCDL 183
Query: 440 KIADFGLARHVAPDKTHVS--TGIAGTLGYMAPEYLVRGQ-LTEKADVYAFGVLVIEVAS 496
           KI DFGLAR   P+  H    T    T  Y APE ++  +  T+  D+++ G ++ E+ S
Sbjct: 184 KICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 243
Query: 497 GR 498
            R
Sbjct: 244 NR 245

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR-----GTLPDGRNIAVKRLFFNSRQWV--DQFFNEVN 346
           E   D++D   +LG G    V +       L        KR   +SR+ V  +    EV+
Sbjct: 7   ENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGT 406
           ++  IQH NV+ L        + +L+ E V    L   L  K +   L+ ++    +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP----KIADFGLARHVAPDKTHVSTGIA 462
             G+ +LH    ++I H D+K  NI+L ++  P    KI DFGLA  +  D  +    I 
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178
Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           GT  ++APE +    L  +AD+++ GV+   + SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 107/234 (45%), Gaps = 34/234 (14%)
Query: 295 RATDFFDNSRKLGQGGAGSVF--RGTLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISG 350
           RA   ++   ++G+G  G VF  R     GR +A+KR+   + +         EV ++  
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 351 IQ---HKNVVRLLG-CSIEGPES----LLVYEYVP---NRSLDQIL---FVKNTIHILSW 396
           ++   H NVVRL   C++   +      LV+E+V       LD++        TI  + +
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 397 QQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH 456
           Q           GL  LH     +++HRD+K  NIL+      K+ADFGLAR  +     
Sbjct: 128 Q--------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQM 174
Query: 457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSV 510
             T +  TL Y APE L++       D+++ G +  E+   RR  +F  GSS V
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF--RRKPLF-RGSSDV 225

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR-----GTLPDGRNIAVKRLFFNSRQWV--DQFFNEVN 346
           E   D++D   +LG G    V +       L        KR   +SR+ V  +    EV+
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGT 406
           ++  IQH NV+ L        + +L+ E V    L   L  K +   L+ ++    +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP----KIADFGLARHVAPDKTHVSTGIA 462
             G+ +LH    ++I H D+K  NI+L ++  P    KI DFGLA  +  D  +    I 
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178
Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           GT  ++APE +    L  +AD+++ GV+   + SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L   +       I   L     F ++ G A    H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 121
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 122 H-----RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 174
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 118/275 (42%), Gaps = 26/275 (9%)
Query: 295 RATDFFDNSRKLGQGGAGSVFRGTLPDGRNI----AVKRLFFNSRQWVDQFFNEVNLISG 350
           R    +   R LG+GG    +  T  D + +     V +         ++   E+ +   
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 351 IQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGL 410
           + + +VV   G   +     +V E    RSL ++   K    +   + R+  +  T +G+
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELH--KRRKAVTEPEARY-FMRQTIQGV 155
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAP 470
            +LH     ++IHRD+K  N+ L++ +  KI DFGLA  +  D     T + GT  Y+AP
Sbjct: 156 QYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LCGTPNYIAP 211
Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG 530
           E L +   + + D+++ G ++  +  G+         +S L   +   K N  +      
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGK-----PPFETSCLKETYIRIKKNEYS------ 260
Query: 531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVV 565
              R     AS +++  L    A   LRPS+AE++
Sbjct: 261 -VPRHINPVASALIRRML---HADPTLRPSVAELL 291

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 101/225 (44%), Gaps = 22/225 (9%)
Query: 278 GTVLCTSSLNFK-YEILERATDFFDNSRKLGQGGAGSVFRGTLPD-------GRNIAVKR 329
           G  L T +L F+      R TD +    +LG+G A SV R  +          + I  K+
Sbjct: 10  GVDLGTENLYFQXMATCTRFTDDYQLFEELGKG-AFSVVRRCVKKTPTQEYAAKIINTKK 68
Query: 330 LFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKN 389
           L     Q +++   E  +   ++H N+VRL     E     LV++ V    L + +  + 
Sbjct: 69  LSARDHQKLER---EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE 125
Query: 390 TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL---TPKIADFGL 446
                S       I    E + H+H      I+HRD+K  N+LL  K      K+ADFGL
Sbjct: 126 ---YYSEADASHCIHQILESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGL 179
Query: 447 ARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLV 491
           A  V  ++     G AGT GY++PE L +    +  D++A GV++
Sbjct: 180 AIEVQGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVIL 223

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 107/234 (45%), Gaps = 34/234 (14%)
Query: 295 RATDFFDNSRKLGQGGAGSVF--RGTLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISG 350
           RA   ++   ++G+G  G VF  R     GR +A+KR+   + +         EV ++  
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 351 IQ---HKNVVRLLG-CSIEGPES----LLVYEYVP---NRSLDQIL---FVKNTIHILSW 396
           ++   H NVVRL   C++   +      LV+E+V       LD++        TI  + +
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 397 QQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH 456
           Q           GL  LH     +++HRD+K  NIL+      K+ADFGLAR  +     
Sbjct: 128 Q--------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQM 174
Query: 457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSV 510
             T +  TL Y APE L++       D+++ G +  E+   RR  +F  GSS V
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF--RRKPLF-RGSSDV 225

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L + +       I   L     F ++ G +    H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLS--FCHS 121
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 122 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEI 174
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+K++  ++           E++L+  + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L   +       I   L     F ++ G A    H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 124
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 125 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 177
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR-----GTLPDGRNIAVKRLFFNSRQWV--DQFFNEVN 346
           E   D++D   +LG G    V +       L        KR   +SR+ V  +    EV+
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGT 406
           ++  IQH NV+ L        + +L+ E V    L   L  K +   L+ ++    +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP----KIADFGLARHVAPDKTHVSTGIA 462
             G+ +LH    ++I H D+K  NI+L ++  P    KI DFGLA  +  D  +    I 
Sbjct: 124 LNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178
Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           GT  ++APE +    L  +AD+++ GV+   + SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR-----GTLPDGRNIAVKRLFFNSRQWV--DQFFNEVN 346
           E   D++D   +LG G    V +       L        KR   +SR+ V  +    EV+
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGT 406
           ++  IQH NV+ L        + +L+ E V    L   L  K +   L+ ++    +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES---LTEEEATEFLKQI 123
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPK----IADFGLARHVAPDKTHVSTGIA 462
             G+ +LH    ++I H D+K  NI+L ++  PK    I DFGLA  +  D  +    I 
Sbjct: 124 LNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 178
Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           GT  ++APE +    L  +AD+++ GV+   + SG
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 13/198 (6%)
Query: 306 LGQGGAGSVFRGTLPDGR-----NIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
           LG+GG    F  +  D +      I  K L     Q  ++   E+++   + H++VV   
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVGFH 81
Query: 361 GCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIK 420
           G   +     +V E    RSL   L +      L+  +    +     G  +LH     +
Sbjct: 82  GFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLHRN---R 135
Query: 421 IIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTE 480
           +IHRD+K  N+ L+E L  KI DFGLA  V  D       + GT  Y+APE L +   + 
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 194
Query: 481 KADVYAFGVLVIEVASGR 498
           + DV++ G ++  +  G+
Sbjct: 195 EVDVWSIGCIMYTLLVGK 212

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 114/275 (41%), Gaps = 28/275 (10%)
Query: 304 RKLGQGGAGSVFRGTLPDGRN----IAVKRLFFNSRQWV-DQFFNEVNLISGIQHKNVVR 358
           R +G+G  G V +G      N    +A+K     +   V ++F  E   +    H ++V+
Sbjct: 19  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
           L+G   E P   ++ E      L   L V+     L+    +     TA  LA+L     
Sbjct: 79  LIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLESK-- 133
Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL 478
            + +HRDI   N+L+      K+ DFGL+R++     + ++     + +MAPE +   + 
Sbjct: 134 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 192
Query: 479 TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV--WKHYKANRITQSMDPGLTGRFP 536
           T  +DV+ FGV + E+               ++H V  ++  K N +   ++ G     P
Sbjct: 193 TSASDVWMFGVCMWEI---------------LMHGVKPFQGVKNNDVIGRIENGERLPMP 237
Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            N    +  +   C     + RP   E+   L+ I
Sbjct: 238 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 272

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 89/196 (45%), Gaps = 11/196 (5%)
Query: 304 RKLGQGGAGSVFRGTLPDGRN----IAVKRLFFNSRQWV-DQFFNEVNLISGIQHKNVVR 358
           R +G+G  G V +G      N    +A+K     +   V ++F  E   +    H ++V+
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
           L+G   E P   ++ E      L   L V+     L+    +     TA  LA+L     
Sbjct: 76  LIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLESK-- 130
Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL 478
            + +HRDI   N+L+      K+ DFGL+R++     + ++     + +MAPE +   + 
Sbjct: 131 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 479 TEKADVYAFGVLVIEV 494
           T  +DV+ FGV + E+
Sbjct: 190 TSASDVWMFGVCMWEI 205

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 114/275 (41%), Gaps = 28/275 (10%)
Query: 304 RKLGQGGAGSVFRGTLPDGRN----IAVKRLFFNSRQWV-DQFFNEVNLISGIQHKNVVR 358
           R +G+G  G V +G      N    +A+K     +   V ++F  E   +    H ++V+
Sbjct: 44  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
           L+G   E P   ++ E      L   L V+     L+    +     TA  LA+L     
Sbjct: 104 LIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLESK-- 158
Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL 478
            + +HRDI   N+L+      K+ DFGL+R++     + ++     + +MAPE +   + 
Sbjct: 159 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 217
Query: 479 TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV--WKHYKANRITQSMDPGLTGRFP 536
           T  +DV+ FGV + E+               ++H V  ++  K N +   ++ G     P
Sbjct: 218 TSASDVWMFGVCMWEI---------------LMHGVKPFQGVKNNDVIGRIENGERLPMP 262
Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            N    +  +   C     + RP   E+   L+ I
Sbjct: 263 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 297

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 86/196 (43%), Gaps = 11/196 (5%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWV-----DQFFNEVNLISGIQHKNVVR 358
           R +G+G  G V +G      N A+       +        ++F  E   +    H ++V+
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
           L+G   E P   ++ E      L   L V+     L+    +     TA  LA+L     
Sbjct: 73  LIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLESK-- 127
Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL 478
            + +HRDI   N+L+      K+ DFGL+R++     + ++     + +MAPE +   + 
Sbjct: 128 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 479 TEKADVYAFGVLVIEV 494
           T  +DV+ FGV + E+
Sbjct: 187 TSASDVWMFGVCMWEI 202

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 86/196 (43%), Gaps = 11/196 (5%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWV-----DQFFNEVNLISGIQHKNVVR 358
           R +G+G  G V +G      N A+       +        ++F  E   +    H ++V+
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
           L+G   E P   ++ E      L   L V+     L+    +     TA  LA+L     
Sbjct: 76  LIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLESK-- 130
Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL 478
            + +HRDI   N+L+      K+ DFGL+R++     + ++     + +MAPE +   + 
Sbjct: 131 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 479 TEKADVYAFGVLVIEV 494
           T  +DV+ FGV + E+
Sbjct: 190 TSASDVWMFGVCMWEI 205

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 114/275 (41%), Gaps = 28/275 (10%)
Query: 304 RKLGQGGAGSVFRGTLPDGRN----IAVKRLFFNSRQWV-DQFFNEVNLISGIQHKNVVR 358
           R +G+G  G V +G      N    +A+K     +   V ++F  E   +    H ++V+
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
           L+G   E P   ++ E      L   L V+     L+    +     TA  LA+L     
Sbjct: 81  LIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLESK-- 135
Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL 478
            + +HRDI   N+L+      K+ DFGL+R++     + ++     + +MAPE +   + 
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 479 TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV--WKHYKANRITQSMDPGLTGRFP 536
           T  +DV+ FGV + E+               ++H V  ++  K N +   ++ G     P
Sbjct: 195 TSASDVWMFGVCMWEI---------------LMHGVKPFQGVKNNDVIGRIENGERLPMP 239
Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            N    +  +   C     + RP   E+   L+ I
Sbjct: 240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 114/275 (41%), Gaps = 28/275 (10%)
Query: 304 RKLGQGGAGSVFRGTLPDGRN----IAVKRLFFNSRQWV-DQFFNEVNLISGIQHKNVVR 358
           R +G+G  G V +G      N    +A+K     +   V ++F  E   +    H ++V+
Sbjct: 18  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
           L+G   E P   ++ E      L   L V+     L+    +     TA  LA+L     
Sbjct: 78  LIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYLESK-- 132
Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL 478
            + +HRDI   N+L+      K+ DFGL+R++     + ++     + +MAPE +   + 
Sbjct: 133 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 191
Query: 479 TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV--WKHYKANRITQSMDPGLTGRFP 536
           T  +DV+ FGV + E+               ++H V  ++  K N +   ++ G     P
Sbjct: 192 TSASDVWMFGVCMWEI---------------LMHGVKPFQGVKNNDVIGRIENGERLPMP 236
Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            N    +  +   C     + RP   E+   L+ I
Sbjct: 237 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 271

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 13/198 (6%)
Query: 306 LGQGGAGSVFRGTLPDGR-----NIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
           LG+GG    F  +  D +      I  K L     Q  ++   E+++   + H++VV   
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVGFH 105
Query: 361 GCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIK 420
           G   +     +V E    RSL   L +      L+  +    +     G  +LH     +
Sbjct: 106 GFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLHRN---R 159
Query: 421 IIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTE 480
           +IHRD+K  N+ L+E L  KI DFGLA  V  D       + GT  Y+APE L +   + 
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 218
Query: 481 KADVYAFGVLVIEVASGR 498
           + DV++ G ++  +  G+
Sbjct: 219 EVDVWSIGCIMYTLLVGK 236

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 297 TDFFDNSRKLGQGGAGSVFR------GTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISG 350
           TD +     +G+G    V R      G     + I  K+L     Q +++   E  +   
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLER---EARICRL 59
Query: 351 IQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGL 410
           ++H N+VRL     E     LV++ V    L + +  +      S       I    E +
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAV 116
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKL---TPKIADFGLARHVAPDKTHVSTGIAGTLGY 467
            H H    + ++HRD+K  N+LL  K      K+ADFGLA  V  D+     G AGT GY
Sbjct: 117 LHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQ-QAWFGFAGTPGY 172
Query: 468 MAPEYLVRGQLTEKADVYAFGVLV 491
           ++PE L +    +  D++A GV++
Sbjct: 173 LSPEVLRKEAYGKPVDIWACGVIL 196

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/113 (38%), Positives = 62/113 (54%), Gaps = 13/113 (11%)
Query: 394 LSWQQRFT-----IICG-TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA 447
           LS ++RFT     I  G     L HLH    + II+RDIK  NILLD      + DFGL+
Sbjct: 150 LSQRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 206
Query: 448 RHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLT---EKADVYAFGVLVIEVASG 497
           +    D+T  +    GT+ YMAP+ +VRG  +   +  D ++ GVL+ E+ +G
Sbjct: 207 KEFVADETERAYDFCGTIEYMAPD-IVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 306 LGQGGAGSVFR-GTLPDGRNIAVKRLFFNSRQWVDQ--FFNEVNLISGIQHKNVVRLLGC 362
           LG+G  G V +       +  AVK +   S +  D      EV L+  + H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 363 SIEGPESLLVYE-YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
             +     +V E Y      D+I+  K      S      II     G+ ++H  +   I
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKR----FSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 422 IHRDIKTSNILLDEKLTP---KIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL 478
           +HRD+K  NILL+ K      KI DFGL+     + T +   I GT  Y+APE L RG  
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPEVL-RGTY 199
Query: 479 TEKADVYAFGVLVIEVASG 497
            EK DV++ GV++  + SG
Sbjct: 200 DEKCDVWSAGVILYILLSG 218

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 306 LGQGGAGSVFR-GTLPDGRNIAVKRLFFNSRQWVDQ--FFNEVNLISGIQHKNVVRLLGC 362
           LG+G  G V +       +  AVK +   S +  D      EV L+  + H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 363 SIEGPESLLVYE-YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
             +     +V E Y      D+I+  K      S      II     G+ ++H  +   I
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKR----FSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 422 IHRDIKTSNILLDEKLTP---KIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL 478
           +HRD+K  NILL+ K      KI DFGL+     + T +   I GT  Y+APE L RG  
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPEVL-RGTY 199
Query: 479 TEKADVYAFGVLVIEVASG 497
            EK DV++ GV++  + SG
Sbjct: 200 DEKCDVWSAGVILYILLSG 218

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 117/275 (42%), Gaps = 26/275 (9%)
Query: 295 RATDFFDNSRKLGQGGAGSVFRGTLPDGRNI----AVKRLFFNSRQWVDQFFNEVNLISG 350
           R    +   R LG+GG    +  T  D + +     V +         ++   E+ +   
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 351 IQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGL 410
           + + +VV   G   +     +V E    RSL ++   K    +   + R+  +  T +G+
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELH--KRRKAVTEPEARY-FMRQTIQGV 139
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAP 470
            +LH     ++IHRD+K  N+ L++ +  KI DFGLA  +  D       + GT  Y+AP
Sbjct: 140 QYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKDLCGTPNYIAP 195
Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG 530
           E L +   + + D+++ G ++  +  G+         +S L   +   K N  +      
Sbjct: 196 EVLCKKGHSFEVDIWSLGCILYTLLVGK-----PPFETSCLKETYIRIKKNEYS------ 244
Query: 531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVV 565
              R     AS +++  L    A   LRPS+AE++
Sbjct: 245 -VPRHINPVASALIRRML---HADPTLRPSVAELL 275

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 13/198 (6%)
Query: 306 LGQGGAGSVFRGTLPDGR-----NIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
           LG+GG    F  +  D +      I  K L     Q  ++   E+++   + H++VV   
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVGFH 107
Query: 361 GCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIK 420
           G   +     +V E    RSL   L +      L+  +    +     G  +LH     +
Sbjct: 108 GFFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLHRN---R 161
Query: 421 IIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTE 480
           +IHRD+K  N+ L+E L  KI DFGLA  V  D       + GT  Y+APE L +   + 
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 220
Query: 481 KADVYAFGVLVIEVASGR 498
           + DV++ G ++  +  G+
Sbjct: 221 EVDVWSIGCIMYTLLVGK 238

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 31/225 (13%)
Query: 278 GTVLCTSSLNFK--YEILERATDFFDNSRKLGQGGAGSVFR------GTLPDGRNIAVKR 329
           G  L T +L F+  Y++ E          +LG+G    V R      G     + I  K+
Sbjct: 10  GVDLGTENLYFQSMYQLFE----------ELGKGAFSVVRRCVKVLAGQEYAAKIINTKK 59
Query: 330 LFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKN 389
           L     Q +++   E  +   ++H N+VRL     E     L+++ V    L + +  + 
Sbjct: 60  LSARDHQKLER---EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE 116
Query: 390 TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL---TPKIADFGL 446
                S       I    E + H H    + ++HRD+K  N+LL  KL     K+ADFGL
Sbjct: 117 ---YYSEADASHCIQQILEAVLHCHQ---MGVVHRDLKPENLLLASKLKGAAVKLADFGL 170
Query: 447 ARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLV 491
           A  V  ++     G AGT GY++PE L +    +  D++A GV++
Sbjct: 171 AIEVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 214

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 10/203 (4%)
Query: 298 DFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNV 356
           D +D   +LG G  G V R T    G N A K +        +    E+  +S ++H  +
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           V L     +  E +++YE++    L +   V +  + +S  +    +    +GL H+H  
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEK--VADEHNKMSEDEAVEYMRQVCKGLCHMHEN 168
Query: 417 SGIKIIHRDIKTSNILLDEKLTP--KIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLV 474
           +    +H D+K  NI+   K +   K+ DFGL  H+ P ++   T   GT  + APE   
Sbjct: 169 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAE 223
Query: 475 RGQLTEKADVYAFGVLVIEVASG 497
              +    D+++ GVL   + SG
Sbjct: 224 GKPVGYYTDMWSVGVLSYILLSG 246

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 306 LGQGGAGSVFR-GTLPDGRNIAVKRLFFNSRQWVDQ--FFNEVNLISGIQHKNVVRLLGC 362
           LG+G  G V +       +  AVK +   S +  D      EV L+  + H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 363 SIEGPESLLVYE-YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
             +     +V E Y      D+I+  K      S      II     G+ ++H  +   I
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKR----FSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 422 IHRDIKTSNILLDEKLTP---KIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL 478
           +HRD+K  NILL+ K      KI DFGL+     + T +   I GT  Y+APE L RG  
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPEVL-RGTY 199
Query: 479 TEKADVYAFGVLVIEVASG 497
            EK DV++ GV++  + SG
Sbjct: 200 DEKCDVWSAGVILYILLSG 218

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+ ++  ++           E++L+  + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L + +       I   L     F ++ G A    H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 121
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 122 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEI 174
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           F    K+G+G  G V++      G  +A+ ++  ++           E++L+  + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI---LSWQQRFTIICGTAEGLAHL 413
           V+LL       +  LV+E++ ++ L + +       I   L     F ++ G A    H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA--FCHS 120
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTLGYMAPEY 472
           H     +++HRD+K  N+L++ +   K+ADFGLAR    P +T+    +  TL Y APE 
Sbjct: 121 H-----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEI 173
Query: 473 LVRGQLTEKA-DVYAFGVLVIEVASGR 498
           L+  +    A D+++ G +  E+ + R
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 101/198 (51%), Gaps = 14/198 (7%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNVVRLLGC 362
           K+G+G  G V++     G   A+K++               E++++  ++H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 363 SIEGPESLLVYEYVPNRSLDQILFV-KNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
                  +LV+E++ ++ L ++L V +  +  ++ +   + +     G+A+ H     ++
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAK---SFLLQLLNGIAYCHDR---RV 121
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLV-RGQLT 479
           +HRD+K  N+L++ +   KIADFGLAR    P + +    +  TL Y AP+ L+   + +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYRAPDVLMGSKKYS 179
Query: 480 EKADVYAFGVLVIEVASG 497
              D+++ G +  E+ +G
Sbjct: 180 TTIDIWSVGCIFAEMVNG 197

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 89/196 (45%), Gaps = 11/196 (5%)
Query: 304 RKLGQGGAGSVFRGTLPDGRN----IAVKRLFFNSRQWV-DQFFNEVNLISGIQHKNVVR 358
           R +G+G  G V +G      N    +A+K     +   V ++F  E   +    H ++V+
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
           L+G   E P   ++ E      L   L V+     L+    +     TA  LA+L     
Sbjct: 76  LIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA--LAYLESK-- 130
Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL 478
            + +HRDI   N+L+      K+ DFGL+R++     + ++     + +MAPE +   + 
Sbjct: 131 -RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 479 TEKADVYAFGVLVIEV 494
           T  +DV+ FGV + E+
Sbjct: 190 TSASDVWMFGVCMWEI 205

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR-----GTLPDGRNIAVKRLFFNSRQWV--DQFFNEVN 346
           ++  DF+D   +LG G    V +       L        KR    SR+ V  ++   EV+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGT 406
           ++  + H NV+ L        + +L+ E V    L   L  K +   LS ++  + I   
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQI 124
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP----KIADFGLARHVAPDKTHVSTGIA 462
            +G+ +LH     KI H D+K  NI+L +K  P    K+ DFGLA H   D       I 
Sbjct: 125 LDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-HEIEDGVEFK-NIF 179
Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           GT  ++APE +    L  +AD+++ GV+   + SG
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR-----GTLPDGRNIAVKRLFFNSRQWV--DQFFNEVN 346
           ++  DF+D   +LG G    V +       L        KR    SR+ V  ++   EV+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGT 406
           ++  + H NV+ L        + +L+ E V    L   L  K +   LS ++  + I   
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQI 124
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP----KIADFGLARHVAPDKTHVSTGIA 462
            +G+ +LH     KI H D+K  NI+L +K  P    K+ DFGLA H   D       I 
Sbjct: 125 LDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-HEIEDGVEFK-NIF 179
Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           GT  ++APE +    L  +AD+++ GV+   + SG
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR-----GTLPDGRNIAVKRLFFNSRQWV--DQFFNEVN 346
           ++  DF+D   +LG G    V +       L        KR    SR+ V  ++   EV+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGT 406
           ++  + H NV+ L        + +L+ E V    L   L  K +   LS ++  + I   
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQI 124
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP----KIADFGLARHVAPDKTHVSTGIA 462
            +G+ +LH     KI H D+K  NI+L +K  P    K+ DFGLA H   D       I 
Sbjct: 125 LDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-HEIEDGVEFK-NIF 179
Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           GT  ++APE +    L  +AD+++ GV+   + SG
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 117/275 (42%), Gaps = 26/275 (9%)
Query: 295 RATDFFDNSRKLGQGGAGSVFRGTLPDGRNI----AVKRLFFNSRQWVDQFFNEVNLISG 350
           R    +   R LG+GG    +  T  D + +     V +         ++   E+ +   
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 351 IQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGL 410
           + + +VV   G   +     +V E    RSL ++   K    +   + R+  +  T +G+
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELH--KRRKAVTEPEARY-FMRQTIQGV 155
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAP 470
            +LH     ++IHRD+K  N+ L++ +  KI DFGLA  +  D       + GT  Y+AP
Sbjct: 156 QYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKDLCGTPNYIAP 211
Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG 530
           E L +   + + D+++ G ++  +  G+         +S L   +   K N  +      
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGK-----PPFETSCLKETYIRIKKNEYS------ 260
Query: 531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVV 565
              R     AS +++  L    A   LRPS+AE++
Sbjct: 261 -VPRHINPVASALIRRML---HADPTLRPSVAELL 291

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 101/198 (51%), Gaps = 14/198 (7%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVK--RLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGC 362
           K+G+G  G V++     G   A+K  RL             E++++  ++H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 363 SIEGPESLLVYEYVPNRSLDQILFV-KNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
                  +LV+E++ ++ L ++L V +  +  ++ +   + +     G+A+ H     ++
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAK---SFLLQLLNGIAYCHDR---RV 121
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLV-RGQLT 479
           +HRD+K  N+L++ +   KIADFGLAR    P + +    +  TL Y AP+ L+   + +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYRAPDVLMGSKKYS 179
Query: 480 EKADVYAFGVLVIEVASG 497
              D+++ G +  E+ +G
Sbjct: 180 TTIDIWSVGCIFAEMVNG 197

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 10/203 (4%)
Query: 298 DFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNV 356
           D +D   +LG G  G V R T    G N A K +        +    E+  +S ++H  +
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           V L     +  E +++YE++    L +   V +  + +S  +    +    +GL H+H  
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEK--VADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 417 SGIKIIHRDIKTSNILLDEKLTP--KIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLV 474
           +    +H D+K  NI+   K +   K+ DFGL  H+ P ++   T   GT  + APE   
Sbjct: 275 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAE 329
Query: 475 RGQLTEKADVYAFGVLVIEVASG 497
              +    D+++ GVL   + SG
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSG 352

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR-----GTLPDGRNIAVKRLFFNSRQWV--DQFFNEVN 346
           ++  DF+D   +LG G    V +       L        KR    SR+ V  ++   EV+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGT 406
           ++  + H NV+ L        + +L+ E V    L   L  K +   LS ++  + I   
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQI 124
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP----KIADFGLARHVAPDKTHVSTGIA 462
            +G+ +LH     KI H D+K  NI+L +K  P    K+ DFGLA H   D       I 
Sbjct: 125 LDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-HEIEDGVEFK-NIF 179
Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           GT  ++APE +    L  +AD+++ GV+   + SG
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNVVRLLGC 362
           K+G+G  G V++     G   A+K++               E++++  ++H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 363 SIEGPESLLVYEYVPNRSLDQILFV-KNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
                  +LV+E++ ++ L ++L V +  +  ++ +   + +     G+A+ H     ++
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAK---SFLLQLLNGIAYCHDR---RV 121
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLV-RGQLTE 480
           +HRD+K  N+L++ +   KIADFGLAR         +  I  TL Y AP+ L+   + + 
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYST 180
Query: 481 KADVYAFGVLVIEVASG 497
             D+++ G +  E+ +G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR-----GTLPDGRNIAVKRLFFNSRQWV--DQFFNEVN 346
           ++  DF+D   +LG G    V +       L        KR    SR+ V  ++   EV+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGT 406
           ++  + H NV+ L        + +L+ E V    L   L  K +   LS ++  + I   
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQI 124
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP----KIADFGLARHVAPDKTHVSTGIA 462
            +G+ +LH     KI H D+K  NI+L +K  P    K+ DFGLA H   D       I 
Sbjct: 125 LDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-HEIEDGVEFK-NIF 179
Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           GT  ++APE +    L  +AD+++ GV+   + SG
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 27/218 (12%)
Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNI-AVKRLFFNSRQ--WVDQFFNEV 345
           KYE LE          K+G+G  G+VF+    +   I A+KR+  +            E+
Sbjct: 3   KYEKLE----------KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI 52
Query: 346 NLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQIL--FVKNTIHILSWQQRFTII 403
            L+  ++HKN+VRL        +  LV+E+      DQ L  +  +    L  +   + +
Sbjct: 53  CLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-----DQDLKKYFDSCNGDLDPEIVKSFL 107
Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIA 462
               +GL   H  +   ++HRD+K  N+L++     K+ADFGLAR    P + + +  + 
Sbjct: 108 FQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV- 163
Query: 463 GTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGRR 499
            TL Y  P+ L   +L +   D+++ G +  E+A+  R
Sbjct: 164 -TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAAR 200

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 294 ERATDFFDNSRKLGQGGAGSVFR-----GTLPDGRNIAVKRLFFNSRQWV--DQFFNEVN 346
           ++  DF+D   +LG G    V +       L        KR    SR+ V  ++   EV+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGT 406
           ++  + H N++ L        + +L+ E V    L   L  K +   LS ++  + I   
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQI 124
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP----KIADFGLARHVAPDKTHVSTGIA 462
            +G+ +LH     KI H D+K  NI+L +K  P    K+ DFGLA H   D       I 
Sbjct: 125 LDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA-HEIEDGVEFK-NIF 179
Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           GT  ++APE +    L  +AD+++ GV+   + SG
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 114/275 (41%), Gaps = 28/275 (10%)
Query: 304 RKLGQGGAGSVFRGTLPDGRN----IAVKRLFFNSRQWV-DQFFNEVNLISGIQHKNVVR 358
           R +G+G  G V +G      N    +A+K     +   V ++F  E   +    H ++V+
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
           L+G   E P   ++ E      L   L V+     L+    +     TA  LA+L     
Sbjct: 456 LIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA--LAYLESK-- 510
Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL 478
            + +HRDI   N+L+      K+ DFGL+R++     + ++     + +MAPE +   + 
Sbjct: 511 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 479 TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV--WKHYKANRITQSMDPGLTGRFP 536
           T  +DV+ FGV + E+               ++H V  ++  K N +   ++ G     P
Sbjct: 570 TSASDVWMFGVCMWEI---------------LMHGVKPFQGVKNNDVIGRIENGERLPMP 614
Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            N    +  +   C     + RP   E+   L+ I
Sbjct: 615 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 88/196 (44%), Gaps = 11/196 (5%)
Query: 304 RKLGQGGAGSVFRGTLPDGRN----IAVKRLFFNSRQWV-DQFFNEVNLISGIQHKNVVR 358
           R +G+G  G V +G      N    +A+K     +   V ++F  E   +    H ++V+
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
           L+G   E P   ++ E      L   L V+     L+    +     TA  LA+L     
Sbjct: 76  LIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA--LAYLESK-- 130
Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL 478
            + +HRDI   N+L+      K+ DFGL+R++       ++     + +MAPE +   + 
Sbjct: 131 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRF 189
Query: 479 TEKADVYAFGVLVIEV 494
           T  +DV+ FGV + E+
Sbjct: 190 TSASDVWMFGVCMWEI 205

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 117/275 (42%), Gaps = 26/275 (9%)
Query: 295 RATDFFDNSRKLGQGGAGSVFRGTLPDGRNI----AVKRLFFNSRQWVDQFFNEVNLISG 350
           R    +   R LG+GG    +  T  D + +     V +         ++   E+ +   
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 351 IQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGL 410
           + + +VV   G   +     +V E    RSL ++   K    +   + R+  +  T +G+
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELH--KRRKAVTEPEARY-FMRQTIQGV 155
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAP 470
            +LH     ++IHRD+K  N+ L++ +  KI DFGLA  +  D       + GT  Y+AP
Sbjct: 156 QYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-KKXLCGTPNYIAP 211
Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG 530
           E L +   + + D+++ G ++  +  G+         +S L   +   K N  +      
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGK-----PPFETSCLKETYIRIKKNEYS------ 260
Query: 531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVV 565
              R     AS +++  L    A   LRPS+AE++
Sbjct: 261 -VPRHINPVASALIRRML---HADPTLRPSVAELL 291

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 297 TDFFDNSRKLGQGGAGSVF--RGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQH 353
           ++ +   +KLG G  G V   R  +    R I + R    S     +   EV ++  + H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 354 KNVVRLLGCSIEGPESLLVYE-YVPNRSLDQILFVKNTIHILSWQQ--RFTIICGTAEGL 410
            N+++L     +     LV E Y      D+I      IH + + +     II     G+
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEI------IHRMKFNEVDAAVIIKQVLSGV 149
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTP---KIADFGLARHVAPDKTHVSTGIAGTLGY 467
            +LH  +   I+HRD+K  N+LL+ K      KI DFGL+  V  ++  +   + GT  Y
Sbjct: 150 TYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSA-VFENQKKMKERL-GTAYY 204
Query: 468 MAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           +APE L R +  EK DV++ GV++  + +G
Sbjct: 205 IAPEVL-RKKYDEKCDVWSIGVILFILLAG 233

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 89/196 (45%), Gaps = 11/196 (5%)
Query: 304 RKLGQGGAGSVFRGTLPDGRN----IAVKRLFFNSRQWV-DQFFNEVNLISGIQHKNVVR 358
           R +G+G  G V +G      N    +A+K     +   V ++F  E   +    H ++V+
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
           L+G   E P   ++ E      L   L V+     L+    +     TA  LA+L     
Sbjct: 456 LIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA--LAYLESK-- 510
Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL 478
            + +HRDI   N+L+      K+ DFGL+R++     + ++     + +MAPE +   + 
Sbjct: 511 -RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 479 TEKADVYAFGVLVIEV 494
           T  +DV+ FGV + E+
Sbjct: 570 TSASDVWMFGVCMWEI 585

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 104/252 (41%), Gaps = 28/252 (11%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRNI----AVKRLFFNSRQWVDQFFNEVNLISGIQHKN 355
           F+  + LG+G  G VF              A+K+        V+    E  ++S      
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 79
Query: 356 VVRLLGCSIEGPESLL-VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH 414
            +  + C+ +  E+L  V EY+    L   ++   + H     +          GL  LH
Sbjct: 80  FLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQFLH 136
Query: 415 GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH--VAPDKTHVSTGIAGTLGYMAPEY 472
                 I++RD+K  NILLD+    KIADFG+ +   +   KT+      GT  Y+APE 
Sbjct: 137 SKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN---EFCGTPDYIAPEI 190
Query: 473 LVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT 532
           L+  +     D ++FGVL+ E+  G ++    +    + H++            MD    
Sbjct: 191 LLGQKYNHSVDWWSFGVLLYEMLIG-QSPFHGQDEEELFHSI-----------RMDNPFY 238
Query: 533 GRFPENEASRVL 544
            R+ E EA  +L
Sbjct: 239 PRWLEKEAKDLL 250

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 16/205 (7%)
Query: 298 DFFDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRL----FFNSRQWVDQFFNEVNLISGIQ 352
           D F+  + +G G  G V     +  G + A+K L        +Q ++   NE  ++  + 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
              +V+L     +     +V EYVP   +   L     I   S                +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEY 156
Query: 413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEY 472
           LH    + +I+RD+K  N+L+D++   K+ADFG A+ V       +  + GT  Y+APE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEI 209
Query: 473 LVRGQLTEKADVYAFGVLVIEVASG 497
           ++     +  D +A GVL+ E+A+G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 66/138 (47%), Gaps = 20/138 (14%)
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH--VAPDKTHVSTGIAGTLG 466
           GL  LH      I++RD+K  NILLD+    KIADFG+ +   +   KT+      GT  
Sbjct: 130 GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNX---FCGTPD 183
Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS 526
           Y+APE L+  +     D ++FGVL+ E+  G ++    +    + H++            
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIG-QSPFHGQDEEELFHSI-----------R 231
Query: 527 MDPGLTGRFPENEASRVL 544
           MD     R+ E EA  +L
Sbjct: 232 MDNPFYPRWLEKEAKDLL 249

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 105/227 (46%), Gaps = 22/227 (9%)
Query: 304 RKLGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGC 362
           +KLG+GG   V     L DG   A+KR+  + +Q  ++   E ++     H N++RL+  
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 363 SIE----GPESLLVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
            +       E+ L+  +    +L ++I  +K+  + L+  Q   ++ G   GL  +H   
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG 154
Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLAR----HVAPDKTHVS----TGIAGTLGYMA 469
                HRD+K +NILL ++  P + D G       HV   +  ++         T+ Y A
Sbjct: 155 ---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 470 PE-YLVRGQ--LTEKADVYAFGVLVIEV--ASGRRNSVFSEGSSSVL 511
           PE + V+    + E+ DV++ G ++  +    G  + VF +G S  L
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 298 DFFDNSRKLGQGGAGSVFR-GTLPDGRNIAVKRL----FFNSRQWVDQFFNEVNLISGIQ 352
           D F+  + +G G  G V     +  G + A+K L        +Q ++   NE  ++  + 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI--ICGTAEGL 410
              +V+L     +     +V EY+P    D    ++          RF    I  T E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGG--DMFSHLRRIGRFSEPHARFYAAQIVLTFE-- 155
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAP 470
            +LH    + +I+RD+K  N+L+D++   K+ADFG A+ V       +  + GT  Y+AP
Sbjct: 156 -YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAP 207
Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASG 497
           E ++     +  D +A GVL+ E+A+G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 104/244 (42%), Gaps = 20/244 (8%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNI----AVKRLFFNSRQWVDQFFNEVNLISGI 351
             D F+  R LG+G  G V    + +  ++     +K+        V+    E  ++S  
Sbjct: 21  GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 352 QHKNVVRLLGCSIEGPESLL-VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGL 410
           ++   +  L C  + P+ L  V E+V     D +  ++ +      + RF      AE +
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFV--NGGDLMFHIQKSRRFDEARARFY----AAEII 134
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAP 470
           + L       II+RD+K  N+LLD +   K+ADFG+ +    +    +T   GT  Y+AP
Sbjct: 135 SALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDYIAP 193
Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASGR-------RNSVFSE-GSSSVLHTVWKHYKANR 522
           E L         D +A GVL+ E+  G         + +F    +  V++  W H  A  
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATG 253
Query: 523 ITQS 526
           I +S
Sbjct: 254 ILKS 257

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 61/110 (55%), Gaps = 11/110 (10%)
Query: 394 LSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
           LS ++  +I+    E ++ LH  +   I+HRD+K  NILLD+ +  +++DFG + H+ P 
Sbjct: 197 LSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253
Query: 454 KTHVSTGIAGTLGYMAPEYL------VRGQLTEKADVYAFGVLVIEVASG 497
           +      + GT GY+APE L            ++ D++A GV++  + +G
Sbjct: 254 EK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 298 DFFDNSRKLGQGGAGSVFR-GTLPDGRNIAVKRL----FFNSRQWVDQFFNEVNLISGIQ 352
           D F+  + +G G  G V     +  G + A+K L        +Q ++   NE  ++  + 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI--ICGTAEGL 410
              +V+L     +     +V EY+P    D    ++          RF    I  T E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGG--DMFSHLRRIGRFSEPHARFYAAQIVLTFE-- 155
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAP 470
            +LH    + +I+RD+K  N+L+D++   K+ADFG A+ V       +  + GT  Y+AP
Sbjct: 156 -YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAP 207
Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASG 497
           E ++     +  D +A GVL+ E+A+G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 93/220 (42%), Gaps = 39/220 (17%)
Query: 295 RATDFFDNS----RKLGQGGAGSVFR-GTLPDGRNIAVKRLFFNSRQWVDQF--FNEVNL 347
           R   FF  S     +LG G  G VF+  +  DGR  AVKR     R   D+     EV  
Sbjct: 50  RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGS 109
Query: 348 ISGI-QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSW------QQRF 400
              + QH   VRL     EG    L  E     SL Q        H  +W       Q +
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQ--------HCEAWGASLPEAQVW 160
Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG 460
             +  T   LAHLH      ++H D+K +NI L  +   K+ DFGL          + T 
Sbjct: 161 GYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLL-------VELGTA 210
Query: 461 IAGTLG-----YMAPEYLVRGQLTEKADVYAFGVLVIEVA 495
            AG +      YMAPE L++G     ADV++ G+ ++EVA
Sbjct: 211 GAGEVQEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVA 249

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 20/219 (9%)
Query: 277 LGTVLCTSSLNFKYEILER-ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR 335
           + T+ CT     +Y++ E      F   R+  +  AG  +   +     I  K+L     
Sbjct: 1   MATITCTR-FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMI-----INTKKLSARDH 54
Query: 336 QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILS 395
           Q +++   E  +   ++H N+VRL     E     L+++ V    L + +  +      S
Sbjct: 55  QKLER---EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE---YYS 108
Query: 396 WQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL---TPKIADFGLARHVAP 452
                  I    E + H H    + ++HR++K  N+LL  KL     K+ADFGLA  V  
Sbjct: 109 EADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165
Query: 453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLV 491
           ++     G AGT GY++PE L +    +  D++A GV++
Sbjct: 166 EQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 325 IAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQI 384
           I  KR+  N+++ +      + L  G  H N+V+L     +   + LV E +    L + 
Sbjct: 43  IISKRMEANTQKEI----TALKLCEG--HPNIVKLHEVFHDQLHTFLVMELLNGGELFE- 95
Query: 385 LFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL---DEKLTPKI 441
             +K   H    +  + I+      ++H+H    + ++HRD+K  N+L    ++ L  KI
Sbjct: 96  -RIKKKKHFSETEASY-IMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKI 150
Query: 442 ADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
            DFG AR   PD   + T    TL Y APE L +    E  D+++ GV++  + SG+
Sbjct: 151 IDFGFARLKPPDNQPLKTP-CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 305 KLGQGGAGSVFRGTLPDGR---NIAVKRLFFNSRQW-VDQFFNEVNLISGIQHKNVVRLL 360
           +LG G  GSV +G     +   ++A+K L   + +   ++   E  ++  + +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 361 G-CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
           G C  E    +LV E      L + L  K     +S      ++   + G+ +L   +  
Sbjct: 77  GVCQAEA--LMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYLEEKN-- 130
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT--LGYMAPEYLVRGQ 477
             +HRD+   N+LL  +   KI+DFGL++ +  D ++ +   AG   L + APE +   +
Sbjct: 131 -FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 478 LTEKADVYAFGVLVIEVAS 496
            + ++DV+++GV + E  S
Sbjct: 190 FSSRSDVWSYGVTMWEALS 208

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 101/231 (43%), Gaps = 29/231 (12%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFF-----NEVNLI- 348
           AT  ++   ++G G  G+V++   P  G  +A+K +   +              EV L+ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 349 --SGIQHKNVVRLLG-CSIEGPES----LLVYEYVPNRSLDQIL---FVKNTIHILSWQQ 398
                +H NVVRL+  C+    +      LV+E+V     DQ L     K     L  + 
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-----DQDLRTYLDKAPPPGLPAET 121
Query: 399 RFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS 458
              ++     GL  LH      I+HRD+K  NIL+    T K+ADFGLAR  +       
Sbjct: 122 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS--YQMAL 176
Query: 459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSS 509
           T +  TL Y APE L++       D+++ G +  E+   RR  +F   S +
Sbjct: 177 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNSEA 225

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 19/217 (8%)
Query: 293 LERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL--FFNSRQWVDQFFNEVNLIS 349
           +E   D  +   +LG+G  G V +   +P G+ +AVKR+    NS++      +    + 
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 350 GIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI---HILSWQQRFTIICGT 406
            +     V   G      +  +  E + + SLD+  F K  I     +       I    
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELM-DTSLDK--FYKQVIDKGQTIPEDILGKIAVSI 118
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGI-AGTL 465
            + L HLH  S + +IHRD+K SN+L++     K+ DFG++ ++  D   V+  I AG  
Sbjct: 119 VKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGCK 173
Query: 466 GYMAPEY----LVRGQLTEKADVYAFGVLVIEVASGR 498
            YMAPE     L +   + K+D+++ G+ +IE+A  R
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 102/232 (43%), Gaps = 34/232 (14%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVK--RLFFNSRQWVDQFFNEVNLI---S 349
           AT  ++   ++G G  G+V++   P  G  +A+K  R+             EV L+    
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 350 GIQHKNVVRLLG-CSIEGPES----LLVYEYVPNRSLDQIL---FVKNTIHILSWQQRFT 401
             +H NVVRL+  C+    +      LV+E+V     DQ L     K     L  +    
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-----DQDLRTYLDKAPPPGLPAETIKD 116
Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR----HVAPDKTHV 457
           ++     GL  LH      I+HRD+K  NIL+    T K+ADFGLAR     +A D   V
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVV 173
Query: 458 STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSS 509
                 TL Y APE L++       D+++ G +  E+   RR  +F   S +
Sbjct: 174 ------TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNSEA 217

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 105/229 (45%), Gaps = 20/229 (8%)
Query: 277 LGTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL--FFN 333
           L +  C S  N  +E+     D  +   +LG+G  G V +   +P G+ +AVKR+    N
Sbjct: 33  LDSKACISIGNQNFEV---KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN 89
Query: 334 SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI-- 391
           S++      +    +  +     V   G      +  +  E + + SLD+  F K  I  
Sbjct: 90  SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDK--FYKQVIDK 146
Query: 392 -HILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV 450
              +       I     + L HLH  S + +IHRD+K SN+L++     K+ DFG++ ++
Sbjct: 147 GQTIPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 204
Query: 451 APDKTHVSTGIAGTLGYMAPEY----LVRGQLTEKADVYAFGVLVIEVA 495
               +   T  AG   YMAPE     L +   + K+D+++ G+ +IE+A
Sbjct: 205 V--DSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELA 251

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 26/228 (11%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVK--RLFFNSRQWVDQFFNEVNLI---S 349
           AT  ++   ++G G  G+V++   P  G  +A+K  R+             EV L+    
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 350 GIQHKNVVRLLG-CSIEGPES----LLVYEYVPNRSLDQIL---FVKNTIHILSWQQRFT 401
             +H NVVRL+  C+    +      LV+E+V     DQ L     K     L  +    
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-----DQDLRTYLDKAPPPGLPAETIKD 116
Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGI 461
           ++     GL  LH      I+HRD+K  NIL+    T K+ADFGLAR  +         +
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYS--YQMALAPV 171
Query: 462 AGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSS 509
             TL Y APE L++       D+++ G +  E+   RR  +F   S +
Sbjct: 172 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNSEA 217

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 48/79 (60%), Gaps = 4/79 (5%)
Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL 478
           + +I+RD+K  N+L+D++   K+ADFG A+ V       +  + GT  Y+APE ++    
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGY 216
Query: 479 TEKADVYAFGVLVIEVASG 497
            +  D +A GVL+ E+A+G
Sbjct: 217 NKAVDWWALGVLIYEMAAG 235

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 91/198 (45%), Gaps = 16/198 (8%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           RK  Q G G  +       R ++  R    SR+ +++   EVN++  I+H N++ L    
Sbjct: 29  RKCRQKGTGKEYAAKFIKKRRLSSSRRGV-SREEIER---EVNILREIRHPNIITLHDIF 84
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
               + +L+ E V    L   L  K +   L+  +    +    +G+ +LH     +I H
Sbjct: 85  ENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGVHYLHSK---RIAH 138
Query: 424 RDIKTSNILLDEKLTP----KIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLT 479
            D+K  NI+L +K  P    K+ DFG+A  +          I GT  ++APE +    L 
Sbjct: 139 FDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEIVNYEPLG 196
Query: 480 EKADVYAFGVLVIEVASG 497
            +AD+++ GV+   + SG
Sbjct: 197 LEADMWSIGVITYILLSG 214

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 30/207 (14%)
Query: 305 KLGQGGAGSVFRGTLPDGRNIAV-------KRLFFNSRQWVDQFFNEVNLISGIQHKNVV 357
           ++G+G   +V++G L     + V       ++L  + RQ   +F  E   + G+QH N+V
Sbjct: 33  EIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNIV 88
Query: 358 RLLG---CSIEGPESL-LVYEYVPNRSLDQIL--FVKNTIHIL-SWQQRFTIICGTAEGL 410
           R       +++G + + LV E   + +L   L  F    I +L SW ++        +GL
Sbjct: 89  RFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI------LKGL 142
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKL-TPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
             LH  +   IIHRD+K  NI +     + KI D GLA      +   +  + GT  + A
Sbjct: 143 QFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKAVIGTPEFXA 198
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVAS 496
           PE     +  E  DVYAFG   +E A+
Sbjct: 199 PEXY-EEKYDESVDVYAFGXCXLEXAT 224

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 24/202 (11%)
Query: 306 LGQGGAGSVFR-GTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           LG G  G V +      G  +A K +     +  ++  NE+++++ + H N+++L     
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 365 EGPESLLVYEYVP-----NRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
              + +LV EYV      +R +D+   +     IL  +Q    IC   EG+ H+H    +
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQ----IC---EGIRHMH---QM 206
Query: 420 KIIHRDIKTSNILL---DEKLTPKIADFGLARHVAP-DKTHVSTGIAGTLGYMAPEYLVR 475
            I+H D+K  NIL    D K   KI DFGLAR   P +K  V+    GT  ++APE +  
Sbjct: 207 YILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKVNF---GTPEFLAPEVVNY 262
Query: 476 GQLTEKADVYAFGVLVIEVASG 497
             ++   D+++ GV+   + SG
Sbjct: 263 DFVSFPTDMWSVGVIAYMLLSG 284

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 16/205 (7%)
Query: 298 DFFDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRL----FFNSRQWVDQFFNEVNLISGIQ 352
           D F+  + LG G  G V     +  G + A+K L        +Q ++   NE  ++  + 
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 85
Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
              +V+L     +     +V EYVP   +   L     I   S                +
Sbjct: 86  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEY 142
Query: 413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEY 472
           LH    + +I+RD+K  N+L+D++   ++ DFG A+ V   K    T + GT  Y+APE 
Sbjct: 143 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---KGRTWT-LCGTPEYLAPEI 195
Query: 473 LVRGQLTEKADVYAFGVLVIEVASG 497
           ++     +  D +A GVL+ E+A+G
Sbjct: 196 ILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 298 DFFDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRL----FFNSRQWVDQFFNEVNLISGIQ 352
           D F+  + LG G  G V     +  G + A+K L        +Q ++   NE  ++  + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI--ICGTAEGL 410
              +V+L     +     +V EYVP   +     ++          RF    I  T E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFXEPHARFYAAQIVLTFE-- 155
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAP 470
            +LH    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+AP
Sbjct: 156 -YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAP 207
Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASG 497
           E ++     +  D +A GVL+ E+A+G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 298 DFFDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRL----FFNSRQWVDQFFNEVNLISGIQ 352
           D F+  + LG G  G V     +  G + A+K L        +Q ++   NE  ++  + 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 100
Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI--ICGTAEGL 410
              +V+L     +     +V EYVP   +   L  +          RF    I  T E  
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFE-- 156
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAP 470
            +LH    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+AP
Sbjct: 157 -YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAP 208
Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASG 497
           E ++     +  D +A GVL+ E+A+G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 298 DFFDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRL----FFNSRQWVDQFFNEVNLISGIQ 352
           D F+  + LG G  G V     +  G + A+K L        +Q ++   NE  ++  + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI--ICGTAEGL 410
              +V+L     +     +V EYVP   +     ++          RF    I  T E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFXEPHARFYAAQIVLTFE-- 155
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAP 470
            +LH    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+AP
Sbjct: 156 -YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAP 207
Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASG 497
           E ++     +  D +A GVL+ E+A+G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 91/198 (45%), Gaps = 16/198 (8%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           RK  Q G G  +       R ++  R    SR+ +++   EVN++  I+H N++ L    
Sbjct: 22  RKCRQKGTGKEYAAKFIKKRRLSSSRRGV-SREEIER---EVNILREIRHPNIITLHDIF 77
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
               + +L+ E V    L   L  K +   L+  +    +    +G+ +LH     +I H
Sbjct: 78  ENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGVHYLHSK---RIAH 131
Query: 424 RDIKTSNILLDEKLTP----KIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLT 479
            D+K  NI+L +K  P    K+ DFG+A  +          I GT  ++APE +    L 
Sbjct: 132 FDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEIVNYEPLG 189
Query: 480 EKADVYAFGVLVIEVASG 497
            +AD+++ GV+   + SG
Sbjct: 190 LEADMWSIGVITYILLSG 207

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 16/205 (7%)
Query: 298 DFFDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRL----FFNSRQWVDQFFNEVNLISGIQ 352
           D F+  + LG G  G V     +  G + A+K L        +Q ++   NE  ++  + 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 100
Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
              +V+L     +     +V EYVP   +   L     I   S                +
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEY 157
Query: 413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEY 472
           LH    + +I+RD+K  N+L+D++   ++ DFG A+ V   K    T + GT  Y+APE 
Sbjct: 158 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---KGRTWT-LCGTPEYLAPEI 210
Query: 473 LVRGQLTEKADVYAFGVLVIEVASG 497
           ++     +  D +A GVL+ E+A+G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 16/205 (7%)
Query: 298 DFFDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRL----FFNSRQWVDQFFNEVNLISGIQ 352
           D F+  + LG G  G V     +  G + A+K L        +Q ++   NE  ++  + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
              +V+L     +     +V EYVP   +   L     I   S                +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEY 156
Query: 413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEY 472
           LH    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEI 209
Query: 473 LVRGQLTEKADVYAFGVLVIEVASG 497
           ++     +  D +A GVL+ E+A+G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 27/218 (12%)
Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNI-AVKRLFFNSRQ--WVDQFFNEV 345
           KYE LE          K+G+G  G+VF+    +   I A+KR+  +            E+
Sbjct: 3   KYEKLE----------KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI 52
Query: 346 NLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQIL--FVKNTIHILSWQQRFTII 403
            L+  ++HKN+VRL        +  LV+E+      DQ L  +  +    L  +   + +
Sbjct: 53  CLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-----DQDLKKYFDSCNGDLDPEIVKSFL 107
Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIA 462
               +GL   H  +   ++HRD+K  N+L++     K+A+FGLAR    P + + +  + 
Sbjct: 108 FQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV- 163
Query: 463 GTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGRR 499
            TL Y  P+ L   +L +   D+++ G +  E+A+  R
Sbjct: 164 -TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 72/151 (47%), Gaps = 11/151 (7%)
Query: 343 NEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI 402
           NE+ ++  I+H N+V L      G    L+ + V    L   +  K      + +    +
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRL 121
Query: 403 ICGTAEGLAHLHGGSGIKIIHRDIKTSNIL---LDEKLTPKIADFGLARHVAPDKTHVST 459
           I    + + +LH    + I+HRD+K  N+L   LDE     I+DFGL++    D   V +
Sbjct: 122 IFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLS 176
Query: 460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVL 490
              GT GY+APE L +   ++  D ++ GV+
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 16/205 (7%)
Query: 298 DFFDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRL----FFNSRQWVDQFFNEVNLISGIQ 352
           D F+  + LG G  G V     +  G + A+K L        +Q ++   NE  ++  + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
              +V+L     +     +V EYVP   +   L     I   S                +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEY 156
Query: 413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEY 472
           LH    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEI 209
Query: 473 LVRGQLTEKADVYAFGVLVIEVASG 497
           ++     +  D +A GVL+ E+A+G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 72/151 (47%), Gaps = 11/151 (7%)
Query: 343 NEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI 402
           NE+ ++  I+H N+V L      G    L+ + V    L   +  K      + +    +
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRL 121
Query: 403 ICGTAEGLAHLHGGSGIKIIHRDIKTSNIL---LDEKLTPKIADFGLARHVAPDKTHVST 459
           I    + + +LH    + I+HRD+K  N+L   LDE     I+DFGL++    D   V +
Sbjct: 122 IFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLS 176
Query: 460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVL 490
              GT GY+APE L +   ++  D ++ GV+
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 72/152 (47%), Gaps = 11/152 (7%)
Query: 343 NEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI 402
           NE+ ++  I+H N+V L      G    L+ + V    L   +  K      + +    +
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRL 121
Query: 403 ICGTAEGLAHLHGGSGIKIIHRDIKTSNIL---LDEKLTPKIADFGLARHVAPDKTHVST 459
           I    + + +LH    + I+HRD+K  N+L   LDE     I+DFGL++    D   V +
Sbjct: 122 IFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLS 176
Query: 460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLV 491
              GT GY+APE L +   ++  D ++ GV+ 
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA 208

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 16/205 (7%)
Query: 298 DFFDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRL----FFNSRQWVDQFFNEVNLISGIQ 352
           D F+  + LG G  G V     +  G + A+K L        +Q ++   NE  ++  + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
              +V+L     +     +V EYVP   +   L     I   S                +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEY 156
Query: 413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEY 472
           LH    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEI 209
Query: 473 LVRGQLTEKADVYAFGVLVIEVASG 497
           ++     +  D +A GVL+ E+A+G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 16/205 (7%)
Query: 298 DFFDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRL----FFNSRQWVDQFFNEVNLISGIQ 352
           D F+  + LG G  G V     +  G + A+K L        +Q ++   NE  ++  + 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 100
Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
              +V+L     +     +V EYVP   +   L     I   S                +
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEY 157
Query: 413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEY 472
           LH    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE 
Sbjct: 158 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEI 210
Query: 473 LVRGQLTEKADVYAFGVLVIEVASG 497
           ++     +  D +A GVL+ E+A+G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 100/228 (43%), Gaps = 26/228 (11%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVK--RLFFNSRQWVDQFFNEVNLI---S 349
           AT  ++   ++G G  G+V++   P  G  +A+K  R+             EV L+    
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 350 GIQHKNVVRLLG-CSIEGPES----LLVYEYVPNRSLDQIL---FVKNTIHILSWQQRFT 401
             +H NVVRL+  C+    +      LV+E+V     DQ L     K     L  +    
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-----DQDLRTYLDKAPPPGLPAETIKD 116
Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGI 461
           ++     GL  LH      I+HRD+K  NIL+    T K+ADFGLAR  +         +
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV 173
Query: 462 AGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSS 509
             TL Y APE L++       D+++ G +  E+   RR  +F   S +
Sbjct: 174 --TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNSEA 217

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 103/231 (44%), Gaps = 23/231 (9%)
Query: 278 GTVLCTSSLNFK------YEILER-ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRL 330
           G  L T +L F+      YE+ E   +  F   RK  Q G G  +       R +   R 
Sbjct: 10  GVDLGTENLYFQSMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRR 69
Query: 331 FFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNT 390
              SR+ +++   EVN++  I+H N++ L        + +L+ E V    L   L  K +
Sbjct: 70  GV-SREEIER---EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES 125
Query: 391 IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP----KIADFGL 446
              L+  +    +    +G+ +LH     +I H D+K  NI+L +K  P    K+ DFG+
Sbjct: 126 ---LTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 179
Query: 447 ARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           A  +          I GT  ++APE +    L  +AD+++ GV+   + SG
Sbjct: 180 AHKIEAGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 87/204 (42%), Gaps = 14/204 (6%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQH 353
           D FD  + LG G  G V      +  N    ++    +    + ++   NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
             +V+L     +     +V EYV    +   L     I   S                +L
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  +AGT  Y+APE +
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLAGTPEYLAPEII 210
Query: 474 VRGQLTEKADVYAFGVLVIEVASG 497
           +     +  D +A GVL+ E+A+G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 13/153 (8%)
Query: 343 NEVNLISGIQHKNVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFT 401
           NE+ ++  I+H+N+V L     E P  L LV + V    L   +  K      + +   T
Sbjct: 69  NEIAVLRKIKHENIVALEDI-YESPNHLYLVMQLVSGGELFDRIVEKG---FYTEKDAST 124
Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILL---DEKLTPKIADFGLARHVAPDKTHVS 458
           +I    + + +LH    + I+HRD+K  N+L    DE+    I+DFGL++     K  V 
Sbjct: 125 LIRQVLDAVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSK--MEGKGDVM 179
Query: 459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLV 491
           +   GT GY+APE L +   ++  D ++ GV+ 
Sbjct: 180 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIA 212

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 298 DFFDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWV------DQFFNEVNLISG 350
           D F+  + LG G  G V     +  G + A+K L    +Q V      +   NE  ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL---DKQKVVKLKEIEHTLNEKRILQA 97
Query: 351 IQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGL 410
           +    +V+L     +     +V EY P   +   L     I   S               
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTF 154
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAP 470
            +LH    + +I+RD+K  N+++D++   K+ DFGLA+ V       +  + GT  Y+AP
Sbjct: 155 EYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGR----TWXLCGTPEYLAP 207
Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASG 497
           E ++     +  D +A GVL+ E+A+G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 18/206 (8%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQH 353
           D F+  + LG G  G V      +  N    ++    +    + ++   NE  ++  +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI--ICGTAEGLA 411
             +V+L     +     +V EYVP   +   L  +          RF    I  T E   
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL--RRIGRFXEPHARFYAAQIVLTFE--- 148
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           +LH    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE
Sbjct: 149 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 201
Query: 472 YLVRGQLTEKADVYAFGVLVIEVASG 497
            ++     +  D +A GVL+ E+A+G
Sbjct: 202 IILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 72/151 (47%), Gaps = 11/151 (7%)
Query: 343 NEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI 402
           NE+ ++  I+H N+V L      G    L+ + V    L   +  K      + +    +
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRL 121
Query: 403 ICGTAEGLAHLHGGSGIKIIHRDIKTSNIL---LDEKLTPKIADFGLARHVAPDKTHVST 459
           I    + + +LH    + I+HRD+K  N+L   LDE     I+DFGL++    D   V +
Sbjct: 122 IFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLS 176
Query: 460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVL 490
              GT GY+APE L +   ++  D ++ GV+
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 87/204 (42%), Gaps = 14/204 (6%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQH 353
           D F+  + LG G  G V      +  N    ++    +    + ++   NE  ++  +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
             +V+L     +     +V EYVP   +   L     I   S                +L
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 150
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE +
Sbjct: 151 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 203
Query: 474 VRGQLTEKADVYAFGVLVIEVASG 497
           +     +  D +A GVL+ E+A+G
Sbjct: 204 LSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 49/204 (24%), Positives = 86/204 (42%), Gaps = 14/204 (6%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQH 353
           D FD  + LG G  G V      +  N    ++    +    + ++   NE  ++  +  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
             +V+L     +     +V EYV    +   L     I   S                +L
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 144
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H    + +I+RD+K  N+L+DE+   ++ DFG A+ V       +  + GT  Y+APE +
Sbjct: 145 HS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 197
Query: 474 VRGQLTEKADVYAFGVLVIEVASG 497
           +     +  D +A GVL+ E+A+G
Sbjct: 198 LSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 87/204 (42%), Gaps = 14/204 (6%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQH 353
           D F+  + LG G  G V      +  N    ++    +    + ++   NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
             +V+L     +     +V EYVP   +   L     I   S                +L
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE +
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 211
Query: 474 VRGQLTEKADVYAFGVLVIEVASG 497
           +     +  D +A GVL+ E+A+G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 87/204 (42%), Gaps = 14/204 (6%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQH 353
           D F+  + LG G  G V      +  N    ++    +    + ++   NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
             +V+L     +     +V EYVP   +   L     I   S                +L
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE +
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 211
Query: 474 VRGQLTEKADVYAFGVLVIEVASG 497
           +     +  D +A GVL+ E+A+G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 87/204 (42%), Gaps = 14/204 (6%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQH 353
           D F+  + LG G  G V      +  N    ++    +    + ++   NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
             +V+L     +     +V EYVP   +   L     I   S                +L
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE +
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 211
Query: 474 VRGQLTEKADVYAFGVLVIEVASG 497
           +     +  D +A GVL+ E+A+G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 16/205 (7%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRL----FFNSRQWVDQFFNEVNLISGIQ 352
           D F+  + LG G  G V      + G + A+K L        +Q ++   NE  ++  + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
              +V+L     +     +V EYVP   +   L     I   S                +
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEY 156
Query: 413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEY 472
           LH    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEI 209
Query: 473 LVRGQLTEKADVYAFGVLVIEVASG 497
           ++     +  D +A GVL+ E+A+G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 20/207 (9%)
Query: 298 DFFDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRL----FFNSRQWVDQFFNEVNLISGIQ 352
           D F+  + LG G  G V     +  G + A+K L        +Q ++   NE  ++  + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI--ICGTAEGL 410
              +V+L     +     +V EY P   +     ++          RF    I  T E  
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFXEPHARFYAAQIVLTFE-- 155
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAP 470
            +LH    + +I+RD+K  N+++D++   K+ DFG A+ V       +  + GT  Y+AP
Sbjct: 156 -YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAP 207
Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASG 497
           E ++     +  D +A GVL+ E+A+G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 16/205 (7%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRL----FFNSRQWVDQFFNEVNLISGIQ 352
           D F+  + LG G  G V      + G + A+K L        +Q ++   NE  ++  + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
              +V+L     +     +V EYVP   +   L     I   S                +
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEY 156
Query: 413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEY 472
           LH    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEI 209
Query: 473 LVRGQLTEKADVYAFGVLVIEVASG 497
           ++     +  D +A GVL+ E+A+G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 23/207 (11%)
Query: 302 NSRKLGQGGAGSVFRGTLP----DGRNIAVKRLFFNSRQW----VDQFFNEVNLISGIQH 353
           N R L   G G+  +  L      GR +A+K    +  Q     + + F EV ++  + H
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIK--IIDKTQLNPTSLQKLFREVRIMKILNH 73
Query: 354 KNVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
            N+V+L    IE  ++L L+ EY     +   L     +     + +F  I    +   +
Sbjct: 74  PNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---Y 129
Query: 413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEY 472
            H     +I+HRD+K  N+LLD  +  KIADFG +               G   Y APE 
Sbjct: 130 CHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LDAFCGAPPYAAPE- 183
Query: 473 LVRGQLTE--KADVYAFGVLVIEVASG 497
           L +G+  +  + DV++ GV++  + SG
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 87/204 (42%), Gaps = 14/204 (6%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQH 353
           D F+  + LG G  G V      +  N    ++    +    + ++   NE  ++  +  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
             +V+L     +     +V EYVP   +   L     I   S                +L
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 178
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE +
Sbjct: 179 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 231
Query: 474 VRGQLTEKADVYAFGVLVIEVASG 497
           +     +  D +A GVL+ E+A+G
Sbjct: 232 LSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 305 KLGQGGAGSVFRGTLPDGR---NIAVKRLFFNSRQW-VDQFFNEVNLISGIQHKNVVRLL 360
           +LG G  GSV +G     +   ++A+K L   + +   ++   E  ++  + +  +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 361 G-CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
           G C  E    +LV E      L + L  K     +S      ++   + G+ +L   +  
Sbjct: 403 GVCQAEA--LMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYLEEKN-- 456
Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT--LGYMAPEYLVRGQ 477
             +HR++   N+LL  +   KI+DFGL++ +  D ++ +   AG   L + APE +   +
Sbjct: 457 -FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 478 LTEKADVYAFGVLVIEVAS 496
            + ++DV+++GV + E  S
Sbjct: 516 FSSRSDVWSYGVTMWEALS 534

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/78 (37%), Positives = 45/78 (57%), Gaps = 1/78 (1%)
Query: 421 IIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTE 480
           II+RD+K  N++LD +   KIADFG+ +    D    +    GT  Y+APE +      +
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-TTKXFCGTPDYIAPEIIAYQPYGK 521
Query: 481 KADVYAFGVLVIEVASGR 498
             D +AFGVL+ E+ +G+
Sbjct: 522 SVDWWAFGVLLYEMLAGQ 539

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 302 NSRKLGQGGAGSVFRGTLP----DGRNIAVK---RLFFNSRQWVDQFFNEVNLISGIQHK 354
           N R L   G G+  +  L      G+ +AVK   +   NS   + + F EV ++  + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSS-LQKLFREVRIMKVLNHP 73
Query: 355 NVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
           N+V+L    IE  ++L LV EY     +   L     +     + +F  I    +   + 
Sbjct: 74  NIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YC 129
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H      I+HRD+K  N+LLD  +  KIADFG +               G   Y APE L
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDAFCGAPPYAAPE-L 183
Query: 474 VRGQLTE--KADVYAFGVLVIEVASG 497
            +G+  +  + DV++ GV++  + SG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 16/205 (7%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRL----FFNSRQWVDQFFNEVNLISGIQ 352
           D F+  + LG G  G V      + G + A+K L        +Q ++   NE  ++  + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
              +V+L     +     +V EYVP   +   L     I   S                +
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEY 156
Query: 413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEY 472
           LH    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE 
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEI 209
Query: 473 LVRGQLTEKADVYAFGVLVIEVASG 497
           ++     +  D +A GVL+ E+A+G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 21/206 (10%)
Query: 302 NSRKLGQGGAGSVFRGTLP----DGRNIAVK---RLFFNSRQWVDQFFNEVNLISGIQHK 354
           N R L   G G+  +  L      G+ +AVK   +   NS   + + F EV ++  + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSS-LQKLFREVRIMKVLNHP 73
Query: 355 NVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
           N+V+L    IE  ++L LV EY     +   L     +     + +F  I    +   + 
Sbjct: 74  NIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YC 129
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H      I+HRD+K  N+LLD  +  KIADFG +          +    G+  Y APE L
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPE-L 183
Query: 474 VRGQLTE--KADVYAFGVLVIEVASG 497
            +G+  +  + DV++ GV++  + SG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 16/205 (7%)
Query: 298 DFFDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRL----FFNSRQWVDQFFNEVNLISGIQ 352
           D F+  + LG G  G V     +  G + A+K L        +Q ++   NE  ++  + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
              +V+L     +     +V EY P   +   L     I   S                +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEY 156
Query: 413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEY 472
           LH    + +I+RD+K  N+++D++   K+ DFG A+ V       +  + GT  Y+APE 
Sbjct: 157 LHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEI 209
Query: 473 LVRGQLTEKADVYAFGVLVIEVASG 497
           ++     +  D +A GVL+ E+A+G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 21/206 (10%)
Query: 302 NSRKLGQGGAGSVFRGTLP----DGRNIAVK---RLFFNSRQWVDQFFNEVNLISGIQHK 354
           N R L   G G+  +  L      G+ +AVK   +   NS   + + F EV ++  + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSS-LQKLFREVRIMKVLNHP 73
Query: 355 NVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
           N+V+L    IE  ++L LV EY     +   L     +     + +F  I    +   + 
Sbjct: 74  NIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YC 129
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H      I+HRD+K  N+LLD  +  KIADFG +          +    G+  Y APE L
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPE-L 183
Query: 474 VRGQLTE--KADVYAFGVLVIEVASG 497
            +G+  +  + DV++ GV++  + SG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 84/183 (45%), Gaps = 19/183 (10%)
Query: 322 GRNIAVKRLFFNSRQW----VDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL-LVYEYV 376
           GR +AVK    +  Q     + + F EV ++  + H N+V+L    IE  ++L LV EY 
Sbjct: 40  GREVAVK--IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV-IETEKTLYLVMEYA 96
Query: 377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEK 436
               +   L     +     + +F  I    +     +      I+HRD+K  N+LLD  
Sbjct: 97  SGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKY------IVHRDLKAENLLLDGD 150
Query: 437 LTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTE--KADVYAFGVLVIEV 494
           +  KIADFG +          +    G+  Y APE L +G+  +  + DV++ GV++  +
Sbjct: 151 MNIKIADFGFSNEFTVGNKLDT--FCGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTL 207
Query: 495 ASG 497
            SG
Sbjct: 208 VSG 210

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 302 NSRKLGQGGAGSVFRGTLP----DGRNIAVKRLFFNSRQW----VDQFFNEVNLISGIQH 353
           N R L   G G+  +  L      GR +A+K    +  Q     + + F EV ++  + H
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIK--IIDKTQLNPTSLQKLFREVRIMKILNH 70
Query: 354 KNVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
            N+V+L    IE  ++L L+ EY     +   L     +     + +F  I    +   +
Sbjct: 71  PNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---Y 126
Query: 413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEY 472
            H     +I+HRD+K  N+LLD  +  KIADFG +          +    G+  Y APE 
Sbjct: 127 CHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT--FCGSPPYAAPE- 180
Query: 473 LVRGQLTE--KADVYAFGVLVIEVASG 497
           L +G+  +  + DV++ GV++  + SG
Sbjct: 181 LFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 21/206 (10%)
Query: 302 NSRKLGQGGAGSVFRGTLP----DGRNIAVK---RLFFNSRQWVDQFFNEVNLISGIQHK 354
           N R L   G G+  +  L      G+ +AVK   +   NS   + + F EV ++  + H 
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSS-LQKLFREVRIMKVLNHP 66
Query: 355 NVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
           N+V+L    IE  ++L LV EY     +   L     +     + +F  I    +   + 
Sbjct: 67  NIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQ---YC 122
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H      I+HRD+K  N+LLD  +  KIADFG +          +    G+  Y APE L
Sbjct: 123 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPE-L 176
Query: 474 VRGQLTE--KADVYAFGVLVIEVASG 497
            +G+  +  + DV++ GV++  + SG
Sbjct: 177 FQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/265 (21%), Positives = 98/265 (36%), Gaps = 73/265 (27%)
Query: 300 FDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQWV-DQFFNEVNLISGIQHKNVV 357
           F+  + +G+GG G VF      D  N A+KR+   +R+   ++   EV  ++ ++H  +V
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 358 RLLGCSIEGPESLLVYE----YVPNRSLDQILF-------------------VKNTI--- 391
           R     +E P      E    ++ + S D  L                     KNT+   
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 392 -------------------HILSWQQR------------FTIICGTAEGLAHLHGGSGIK 420
                              ++  W  R              I    AE +  LH      
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--- 184
Query: 421 IIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVST-----------GIAGTLGYMA 469
           ++HRD+K SNI        K+ DFGL   +  D+   +            G  GT  YM+
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMS 244
Query: 470 PEYLVRGQLTEKADVYAFGVLVIEV 494
           PE +     + K D+++ G+++ E+
Sbjct: 245 PEQIHGNNYSHKVDIFSLGLILFEL 269

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 51/97 (52%), Gaps = 2/97 (2%)
Query: 421 IIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTE 480
           II+RD+K  N++LD +   KIADFG+ +    D    +    GT  Y+APE +      +
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-TTKXFCGTPDYIAPEIIAYQPYGK 200
Query: 481 KADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKH 517
             D +AFGVL+ E+ +G+      E    +  ++ +H
Sbjct: 201 SVDWWAFGVLLYEMLAGQA-PFEGEDEDELFQSIMEH 236

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 14/204 (6%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQH 353
           D FD  + LG G  G V      +  N    ++    +    + ++   NE  ++  +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
             +V+L     +     +V EYV    +   L     I   S                +L
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 178
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE +
Sbjct: 179 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGATWTLCGTPEYLAPEII 231
Query: 474 VRGQLTEKADVYAFGVLVIEVASG 497
           +     +  D +A GVL+ E+A+G
Sbjct: 232 LSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 25/211 (11%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFN-EVNLISGIQHKNVVR 358
           + N + +G G  G VF+  L +   +A+K++  + R     F N E+ ++  ++H NVV 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVD 96
Query: 359 LLGCSIEGPESL------LVYEYVPN---RSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
           L        +        LV EYVP    R+      +K T+ +L  +     +      
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIK---LYMYQLLRS 153
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKL-TPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           LA++H    I I HRDIK  N+LLD      K+ DFG A+ +   + +VS     +  Y 
Sbjct: 154 LAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX--ICSRYYR 208
Query: 469 APEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
           APE +      T   D+++ G ++ E+  G+
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQH 353
           D FD  + LG G  G V      +  N    ++    +    + ++   NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI--ICGTAEGLA 411
             +V+L     +     +V EYV    +     ++          RF    I  T E   
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFXEPHARFYAAQIVLTFE--- 155
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           +LH    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 472 YLVRGQLTEKADVYAFGVLVIEVASG 497
            ++     +  D +A GVL+ E+A+G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 86/204 (42%), Gaps = 14/204 (6%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQH 353
           D F+  + LG G  G V      +  N    ++    +    + ++   NE  ++  +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
             +V+L     +     +V EY P   +   L     I   S                +L
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H    + +I+RD+K  N+++D++   K+ DFG A+ V       +  + GT  Y+APE +
Sbjct: 159 HS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 211
Query: 474 VRGQLTEKADVYAFGVLVIEVASG 497
           +     +  D +A GVL+ E+A+G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 18/203 (8%)
Query: 297 TDFFDNSRKLGQGGAGSVF----RGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ 352
           +D +   +KLG G  G V     + T  +     +K+    +        +EV ++  + 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 353 HKNVVRLLGCSIEGPESLLVYE-YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLA 411
           H N+++L     +     LV E Y      D+I+  +      S      I+     G  
Sbjct: 80  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQK----FSEVDAAVIMKQVLSGTT 135
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTP---KIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           +LH  +   I+HRD+K  N+LL+ K      KI DFGL+ H             GT  Y+
Sbjct: 136 YLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER--LGTAYYI 190
Query: 469 APEYLVRGQLTEKADVYAFGVLV 491
           APE L R +  EK DV++ GV++
Sbjct: 191 APEVL-RKKYDEKCDVWSCGVIL 212

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 20/207 (9%)
Query: 298 DFFDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRLFFNSRQWV------DQFFNEVNLISG 350
           D F+  + LG G  G V     +  G + A+K L    +Q V      +   NE  ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKIL---DKQKVVKLKEIEHTLNEKRILQA 97
Query: 351 IQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGL 410
           +    +V+L     +     +V EY P   +   L     I   S               
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTF 154
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAP 470
            +LH    + +I+RD+K  N+++D++   ++ DFGLA+ V       +  + GT  Y+AP
Sbjct: 155 EYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGR----TWXLCGTPEYLAP 207
Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASG 497
           E ++     +  D +A GVL+ E+A+G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQH 353
           D FD  + LG G  G V      +  N    ++    +    + ++   NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI--ICGTAEGLA 411
             +V+L     +     +V EYV    +     ++          RF    I  T E   
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFXEPHARFYAAQIVLTFE--- 155
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           +LH    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 472 YLVRGQLTEKADVYAFGVLVIEVASG 497
            ++     +  D +A GVL+ E+A+G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 47/79 (59%), Gaps = 4/79 (5%)
Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL 478
           + +I+RD+K  N+++D++   K+ DFG A+ V       +  + GT  Y+APE ++    
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGY 216
Query: 479 TEKADVYAFGVLVIEVASG 497
            +  D +A GVL+ E+A+G
Sbjct: 217 NKAVDWWALGVLIYEMAAG 235

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQH 353
           D FD  + LG G  G V      +  N    ++    +    + ++   NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI--ICGTAEGLA 411
             +V+L     +     +V EYV    +     ++          RF    I  T E   
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFXEPHARFYAAQIVLTFE--- 155
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           +LH    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 472 YLVRGQLTEKADVYAFGVLVIEVASG 497
            ++     +  D +A GVL+ E+A+G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQH 353
           D FD  + LG G  G V      +  N    ++    +    + ++   NE  ++  +  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI--ICGTAEGLA 411
             +V+L     +     +V EYV    +     ++          RF    I  T E   
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFXEPHARFYAAQIVLTFE--- 150
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           +LH    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE
Sbjct: 151 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 203
Query: 472 YLVRGQLTEKADVYAFGVLVIEVASG 497
            ++     +  D +A GVL+ E+A+G
Sbjct: 204 IILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQH 353
           D FD  + LG G  G V      +  N    ++    +    + ++   NE  ++  +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI--ICGTAEGLA 411
             +V+L     +     +V EYV    +     ++          RF    I  T E   
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFXEPHARFYAAQIVLTFE--- 176
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           +LH    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 229
Query: 472 YLVRGQLTEKADVYAFGVLVIEVASG 497
            ++     +  D +A GVL+ E+A+G
Sbjct: 230 IILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQH 353
           D FD  + LG G  G V      +  N    ++    +    + ++   NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI--ICGTAEGLA 411
             +V+L     +     +V EYV    +     ++          RF    I  T E   
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFAEPHARFYAAQIVLTFE--- 155
Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           +LH    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPE 208
Query: 472 YLVRGQLTEKADVYAFGVLVIEVASG 497
            ++     +  D +A GVL+ E+A+G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 47/79 (59%), Gaps = 4/79 (5%)
Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL 478
           + +I+RD+K  N+++D++   K+ DFG A+ V       +  + GT  Y+APE ++    
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGY 216
Query: 479 TEKADVYAFGVLVIEVASG 497
            +  D +A GVL+ E+A+G
Sbjct: 217 NKAVDWWALGVLIYEMAAG 235

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 47/79 (59%), Gaps = 4/79 (5%)
Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL 478
           + +I+RD+K  N+++D++   K+ DFG A+ V       +  + GT  Y+APE ++    
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGY 216
Query: 479 TEKADVYAFGVLVIEVASG 497
            +  D +A GVL+ E+A+G
Sbjct: 217 NKAVDWWALGVLIYEMAAG 235

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 14/204 (6%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQH 353
           D FD  + LG G  G V      +  N    ++    +    + ++   NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
             +V+L     +     +V EYV    +   L     I   S                +L
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE +
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 474 VRGQLTEKADVYAFGVLVIEVASG 497
           +     +  D +A GVL+ E+A+G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 14/204 (6%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQH 353
           D FD  + LG G  G V      +  N    ++    +    + ++   NE  ++  +  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
             +V+L     +     +V EYV    +   L     I   S                +L
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE +
Sbjct: 159 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 211
Query: 474 VRGQLTEKADVYAFGVLVIEVASG 497
           +     +  D +A GVL+ E+A+G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 23/227 (10%)
Query: 280 VLCTSSLN-FKYEILERATDFFDNSRKLGQGGAGSVFRGTLPD---GRNIAVKRLFFNSR 335
           VL T  L    YE  E    +  +  +LG+G  G V R  + D   G   AVK++     
Sbjct: 54  VLLTEKLKPVDYEYREE-VHWMTHQPRLGRGSFGEVHR--MKDKQTGFQCAVKKVRLEVF 110
Query: 336 QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILS 395
           +       E+   +G+    +V L G   EGP   +  E +   SL Q++     +  L 
Sbjct: 111 R-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLP 162
Query: 396 WQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLT-PKIADFGLARHVAPDK 454
             +    +    EGL +LH     +I+H D+K  N+LL    +   + DFG A  + PD 
Sbjct: 163 EDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 219
Query: 455 THVS--TG--IAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
              S  TG  I GT  +MAPE ++      K D+++   +++ + +G
Sbjct: 220 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 14/204 (6%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQH 353
           D FD  + LG G  G V      +  N    ++    +    + ++   NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
             +V+L     +     +V EYV    +   L     I   S                +L
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE +
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 474 VRGQLTEKADVYAFGVLVIEVASG 497
           +     +  D +A GVL+ E+A+G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 14/204 (6%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQH 353
           D FD  + LG G  G V      +  N    ++    +    + ++   NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
             +V+L     +     +V EYV    +   L     I   S                +L
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE +
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLXGTPEYLAPEII 210
Query: 474 VRGQLTEKADVYAFGVLVIEVASG 497
           +     +  D +A GVL+ E+A+G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 14/204 (6%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQH 353
           D FD  + LG G  G V      +  N    ++    +    + ++   NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
             +V+L     +     +V EYV    +   L     I   S                +L
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE +
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 474 VRGQLTEKADVYAFGVLVIEVASG 497
           +     +  D +A GVL+ E+A+G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 105/240 (43%), Gaps = 38/240 (15%)
Query: 295 RATDFFDNSRKLGQGGAGSVFRGTLPDG-RNIAVKRLFFNSRQWVD--QFFNEVNLISGI 351
           +  D ++    +G+G  G V+     +  +N+A+K++       +D  +   E+ +++ +
Sbjct: 25  KVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRL 84
Query: 352 QHKNVVRLLGCSIEGPESLLVYE--YVPNRSLDQIL--FVKNTIHILSWQQRFTIICGTA 407
           +   ++RL    I  PE LL ++  Y+     D  L    K  I  L+ Q   TI+    
Sbjct: 85  KSDYIIRLHDLII--PEDLLKFDELYIVLEIADSDLKKLFKTPI-FLTEQHVKTILYNLL 141
Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK-THVSTGIAG--- 463
            G   +H      IIHRD+K +N LL++  + KI DFGLAR +  DK  H+   +     
Sbjct: 142 LGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEE 198
Query: 464 --------------------TLGYMAPEY-LVRGQLTEKADVYAFGVLVIEVASGRRNSV 502
                               T  Y APE  L++   T   D+++ G +  E+ +  ++ +
Sbjct: 199 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHI 258

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 14/204 (6%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQH 353
           D FD  + LG G  G V      +  N    ++    +    + ++   NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
             +V+L     +     +V EYV    +   L     I   S                +L
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE +
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 474 VRGQLTEKADVYAFGVLVIEVASG 497
           +     +  D +A GVL+ E+A+G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 21/206 (10%)
Query: 302 NSRKLGQGGAGSVFRGTLP----DGRNIAVK---RLFFNSRQWVDQFFNEVNLISGIQHK 354
           N R L   G G+  +  L      G+ +AV+   +   NS   + + F EV ++  + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSS-LQKLFREVRIMKVLNHP 73
Query: 355 NVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
           N+V+L    IE  ++L LV EY     +   L     +     + +F  I    +   + 
Sbjct: 74  NIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YC 129
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H      I+HRD+K  N+LLD  +  KIADFG +          +    G+  Y APE L
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPE-L 183
Query: 474 VRGQLTE--KADVYAFGVLVIEVASG 497
            +G+  +  + DV++ GV++  + SG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 57/114 (50%), Gaps = 15/114 (13%)
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIA-----G 463
           GL  LH      II+RD+K  N++LD +   KIADFG+       K H+  G+      G
Sbjct: 132 GLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMC------KEHMMDGVTTREFCG 182
Query: 464 TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKH 517
           T  Y+APE +      +  D +A+GVL+ E+ +G +     E    +  ++ +H
Sbjct: 183 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG-QPPFDGEDEDELFQSIMEH 235

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 14/204 (6%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQH 353
           D FD  + LG G  G V      +  N    ++    +    + ++   NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
             +V+L     +     +V EYV    +   L     I   S                +L
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE +
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 474 VRGQLTEKADVYAFGVLVIEVASG 497
           +     +  D +A GVL+ E+A+G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 102/228 (44%), Gaps = 25/228 (10%)
Query: 280 VLCTSSLN-FKYEILERATDFFDNSRKLGQGGAGSVFRGTLPD---GRNIAVKRLFFNSR 335
           VL T  L    YE  E    +  +  +LG+G  G V R  + D   G   AVK++     
Sbjct: 75  VLLTEKLKPVDYEYREE-VHWATHQLRLGRGSFGEVHR--MEDKQTGFQCAVKKVRLEVF 131
Query: 336 QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILS 395
           +       E+   +G+    +V L G   EGP   +  E +   SL Q++  +  +    
Sbjct: 132 R-----AEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLP--- 183
Query: 396 WQQRFTIICGTA-EGLAHLHGGSGIKIIHRDIKTSNILLDEKLT-PKIADFGLARHVAPD 453
            + R     G A EGL +LH     +I+H D+K  N+LL    +   + DFG A  + PD
Sbjct: 184 -EDRALYYLGQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPD 239
Query: 454 KTHVS--TG--IAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
               S  TG  I GT  +MAPE ++      K DV++   +++ + +G
Sbjct: 240 GLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 21/206 (10%)
Query: 302 NSRKLGQGGAGSVFRGTLP----DGRNIAVK---RLFFNSRQWVDQFFNEVNLISGIQHK 354
           N R L   G G+  +  L      G+ +AV+   +   NS   + + F EV ++  + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSS-LQKLFREVRIMKVLNHP 73
Query: 355 NVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
           N+V+L    IE  ++L LV EY     +   L     +     + +F  I    +   + 
Sbjct: 74  NIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YC 129
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H      I+HRD+K  N+LLD  +  KIADFG +               G+  Y APE L
Sbjct: 130 HQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDEFCGSPPYAAPE-L 183
Query: 474 VRGQLTE--KADVYAFGVLVIEVASG 497
            +G+  +  + DV++ GV++  + SG
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 86/204 (42%), Gaps = 14/204 (6%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQH 353
           D FD  + LG G  G V      +  N    ++    +    + ++   NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
             +V+L     +     +V EYV    +   L     I   S                +L
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H    + +I+RD+K  N+++D++   ++ DFG A+ V       +  + GT  Y+APE +
Sbjct: 158 HS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 474 VRGQLTEKADVYAFGVLVIEVASG 497
           +     +  D +A GVL+ E+A+G
Sbjct: 211 ISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 87/189 (46%), Gaps = 20/189 (10%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           ++   K+GQG  G VF+      G+ +A+K++   + +  +      E+ ++  ++H+NV
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 78
Query: 357 VRLLG-CSIEGP-------ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAE 408
           V L+  C  +            LV+++  +   D    + N +   +  +   ++     
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFCEH---DLAGLLSNVLVKFTLSEIKRVMQMLLN 135
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG---TL 465
           GL ++H     KI+HRD+K +N+L+      K+ADFGLAR  +  K            TL
Sbjct: 136 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 192
Query: 466 GYMAPEYLV 474
            Y  PE L+
Sbjct: 193 WYRPPELLL 201

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 30/209 (14%)
Query: 297 TDFFDNSRKLGQGGAGSVF----RGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ 352
           +D +   +KLG G  G V     + T  +     +K+    +        +EV ++  + 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 353 HKNVVRLLGCSIEGPESLLVYE-YVPNRSLDQILFVKNTIHILSWQQRFT------IICG 405
           H N+++L     +     LV E Y      D+I+           +Q+F+      I+  
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIIL----------RQKFSEVDAAVIMKQ 112
Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP---KIADFGLARHVAPDKTHVSTGIA 462
              G  +LH  +   I+HRD+K  N+LL+ K      KI DFGL+ H             
Sbjct: 113 VLSGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER--L 167
Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLV 491
           GT  Y+APE L R +  EK DV++ GV++
Sbjct: 168 GTAYYIAPEVL-RKKYDEKCDVWSCGVIL 195

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 16/205 (7%)
Query: 298 DFFDNSRKLGQGGAGSV-FRGTLPDGRNIAVKRL----FFNSRQWVDQFFNEVNLISGIQ 352
           D F+  + LG G  G V     +  G + A+K L        +Q ++   NE  ++  + 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVN 99
Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
              +V+L     +     +V EY P   +   L     I   S                +
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEY 156
Query: 413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEY 472
           LH    + +I+RD+K  N+++D++   ++ DFG A+ V       +  + GT  Y+APE 
Sbjct: 157 LHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEI 209
Query: 473 LVRGQLTEKADVYAFGVLVIEVASG 497
           ++     +  D +A GVL+ E+A+G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 84/180 (46%), Gaps = 15/180 (8%)
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYV-PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGL 410
           QH N++ L     +G    LV E +     LD+IL  K      S ++   ++    + +
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK----FFSEREASFVLHTIGKTV 134
Query: 411 AHLHGGSGIKIIHRDIKTSNIL-LDEKLTP---KIADFGLARHVAPDKTHVSTGIAGTLG 466
            +LH      ++HRD+K SNIL +DE   P   +I DFG A+ +  +   + T    T  
Sbjct: 135 EYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TAN 190
Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS 526
           ++APE L R    E  D+++ G+L+  + +G   + F+ G S     +     + + T S
Sbjct: 191 FVAPEVLKRQGYDEGCDIWSLGILLYTMLAGY--TPFANGPSDTPEEILTRIGSGKFTLS 248

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 47/79 (59%), Gaps = 4/79 (5%)
Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL 478
           + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE ++    
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEIILSKGY 215
Query: 479 TEKADVYAFGVLVIEVASG 497
            +  D +A GVL+ E+A+G
Sbjct: 216 NKAVDWWALGVLIYEMAAG 234

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 87/189 (46%), Gaps = 20/189 (10%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           ++   K+GQG  G VF+      G+ +A+K++   + +  +      E+ ++  ++H+NV
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 357 VRLLG-CSIEG-------PESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAE 408
           V L+  C  +            LV+++  +   D    + N +   +  +   ++     
Sbjct: 80  VNLIEICRTKASPYNRCKASIYLVFDFCEH---DLAGLLSNVLVKFTLSEIKRVMQMLLN 136
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG---TL 465
           GL ++H     KI+HRD+K +N+L+      K+ADFGLAR  +  K            TL
Sbjct: 137 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 466 GYMAPEYLV 474
            Y  PE L+
Sbjct: 194 WYRPPELLL 202

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 87/189 (46%), Gaps = 20/189 (10%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           ++   K+GQG  G VF+      G+ +A+K++   + +  +      E+ ++  ++H+NV
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 357 VRLLG-CSIEGP-------ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAE 408
           V L+  C  +            LV+++  +   D    + N +   +  +   ++     
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFCEH---DLAGLLSNVLVKFTLSEIKRVMQMLLN 136
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG---TL 465
           GL ++H     KI+HRD+K +N+L+      K+ADFGLAR  +  K            TL
Sbjct: 137 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 466 GYMAPEYLV 474
            Y  PE L+
Sbjct: 194 WYRPPELLL 202

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 82/174 (47%), Gaps = 15/174 (8%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKN--VVRL 359
           +++G GG+  VF+      +  A+K +       Q +D + NE+  ++ +Q  +  ++RL
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQR-FTIICGTAEGLAHLHGGSG 418
               I      +V E   N  L+  L  K +I    W+++ +      A    H HG   
Sbjct: 94  YDYEITDQYIYMVME-CGNIDLNSWLKKKKSID--PWERKSYWKNMLEAVHTIHQHG--- 147
Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH-VSTGIAGTLGYMAPE 471
             I+H D+K +N L+ + +  K+ DFG+A  + PD T  V     GT+ YM PE
Sbjct: 148 --IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 86/205 (41%), Gaps = 14/205 (6%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRNI----AVKRLFFNSRQWVDQFFNEVNLIS-GIQHK 354
           FD  R +G+G    V    L     I     VK+   N  + +D    E ++      H 
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 81
Query: 355 NVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH 414
            +V L  C         V EYV    L  +  ++    +     RF      +  L +LH
Sbjct: 82  FLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARF-YSAEISLALNYLH 138
Query: 415 GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH-VAPDKTHVSTGIAGTLGYMAPEYL 473
                 II+RD+K  N+LLD +   K+ D+G+ +  + P  T  ++   GT  Y+APE L
Sbjct: 139 ERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEIL 193
Query: 474 VRGQLTEKADVYAFGVLVIEVASGR 498
                    D +A GVL+ E+ +GR
Sbjct: 194 RGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 15/198 (7%)
Query: 306 LGQGGAGSVFRGTLP-DGRNIAVK---RLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLG 361
           LG G  G V  G     G  +AVK   R    S   V +   E+  +   +H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
                 +  +V EYV    L   +     +  +  ++ F  I  +A    H H      +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL-SAVDYCHRH-----MV 132
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTE- 480
           +HRD+K  N+LLD  +  KIADFGL+  ++ D   + T   G+  Y APE ++ G+L   
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTS-CGSPNYAAPE-VISGRLYAG 189
Query: 481 -KADVYAFGVLVIEVASG 497
            + D+++ GV++  +  G
Sbjct: 190 PEVDIWSCGVILYALLCG 207

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 87/189 (46%), Gaps = 20/189 (10%)
Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQHKNV 356
           ++   K+GQG  G VF+      G+ +A+K++   + +  +      E+ ++  ++H+NV
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 357 VRLLG-CSIEGP-------ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAE 408
           V L+  C  +            LV+++  +   D    + N +   +  +   ++     
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFCEH---DLAGLLSNVLVKFTLSEIKRVMQMLLN 136
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG---TL 465
           GL ++H     KI+HRD+K +N+L+      K+ADFGLAR  +  K            TL
Sbjct: 137 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 466 GYMAPEYLV 474
            Y  PE L+
Sbjct: 194 WYRPPELLL 202

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 84/180 (46%), Gaps = 15/180 (8%)
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICGTAEGL 410
           QH N++ L     +G    LV E +    L D+IL  K      S ++   ++    + +
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK----FFSEREASFVLHTIGKTV 134
Query: 411 AHLHGGSGIKIIHRDIKTSNIL-LDEKLTP---KIADFGLARHVAPDKTHVSTGIAGTLG 466
            +LH      ++HRD+K SNIL +DE   P   +I DFG A+ +  +   + T    T  
Sbjct: 135 EYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TAN 190
Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS 526
           ++APE L R    E  D+++ G+L+  + +G   + F+ G S     +     + + T S
Sbjct: 191 FVAPEVLKRQGYDEGCDIWSLGILLYTMLAGY--TPFANGPSDTPEEILTRIGSGKFTLS 248

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 30/206 (14%)
Query: 297 TDFFDNSRKLGQGGAGSVFR----GTLPDGRNIAVKRLFFNSRQWVDQFF--NEVNLISG 350
           +DFF+   +LG+G    V+R    GT    +  A+K L    ++ VD+     E+ ++  
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGT---QKPYALKVL----KKTVDKKIVRTEIGVLLR 104
Query: 351 IQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGL 410
           + H N+++L        E  LV E V    L   +  K      S +     +    E +
Sbjct: 105 LSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG---YYSERDAADAVKQILEAV 161
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTP------KIADFGLARHVAPDKTHVSTGIAGT 464
           A+LH      I+HRD+K  N+L     TP      KIADFGL++ V  +   +   + GT
Sbjct: 162 AYLHENG---IVHRDLKPENLLY---ATPAPDAPLKIADFGLSKIV--EHQVLMKTVCGT 213
Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVL 490
            GY APE L       + D+++ G++
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGII 239

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 82/174 (47%), Gaps = 15/174 (8%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKN--VVRL 359
           +++G GG+  VF+      +  A+K +       Q +D + NE+  ++ +Q  +  ++RL
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQR-FTIICGTAEGLAHLHGGSG 418
               I      +V E   N  L+  L  K +I    W+++ +      A    H HG   
Sbjct: 122 YDYEITDQYIYMVME-CGNIDLNSWLKKKKSID--PWERKSYWKNMLEAVHTIHQHG--- 175
Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH-VSTGIAGTLGYMAPE 471
             I+H D+K +N L+ + +  K+ DFG+A  + PD T  V     GT+ YM PE
Sbjct: 176 --IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 226

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 82/174 (47%), Gaps = 15/174 (8%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKN--VVRL 359
           +++G GG+  VF+      +  A+K +       Q +D + NE+  ++ +Q  +  ++RL
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQR-FTIICGTAEGLAHLHGGSG 418
               I      +V E   N  L+  L  K +I    W+++ +      A    H HG   
Sbjct: 75  YDYEITDQYIYMVME-CGNIDLNSWLKKKKSID--PWERKSYWKNMLEAVHTIHQHG--- 128
Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH-VSTGIAGTLGYMAPE 471
             I+H D+K +N L+ + +  K+ DFG+A  + PD T  V     GT+ YM PE
Sbjct: 129 --IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 86/205 (41%), Gaps = 14/205 (6%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRNI----AVKRLFFNSRQWVDQFFNEVNLIS-GIQHK 354
           FD  R +G+G    V    L     I     VK+   N  + +D    E ++      H 
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 355 NVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH 414
            +V L  C         V EYV    L  +  ++    +     RF      +  L +LH
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARF-YSAEISLALNYLH 170
Query: 415 GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH-VAPDKTHVSTGIAGTLGYMAPEYL 473
                 II+RD+K  N+LLD +   K+ D+G+ +  + P  T  ++   GT  Y+APE L
Sbjct: 171 ERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEIL 225
Query: 474 VRGQLTEKADVYAFGVLVIEVASGR 498
                    D +A GVL+ E+ +GR
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 25/228 (10%)
Query: 280 VLCTSSLN-FKYEILERATDFFDNSRKLGQGGAGSVFRGTLPD---GRNIAVKRLFFNSR 335
           VL T  L    YE  E    +  +  +LG+G  G V R  + D   G   AVK++     
Sbjct: 56  VLLTEKLKPVDYEYREE-VHWATHQLRLGRGSFGEVHR--MEDKQTGFQCAVKKVRLEVF 112
Query: 336 QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILS 395
           +       E+   +G+    +V L G   EGP   +  E +   SL Q++  +  +    
Sbjct: 113 R-----AEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLP--- 164
Query: 396 WQQRFTIICGTA-EGLAHLHGGSGIKIIHRDIKTSNILLDEKLT-PKIADFGLARHVAPD 453
            + R     G A EGL +LH     +I+H D+K  N+LL    +   + DFG A  + PD
Sbjct: 165 -EDRALYYLGQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPD 220
Query: 454 K--THVSTG--IAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
                + TG  I GT  +MAPE ++      K DV++   +++ + +G
Sbjct: 221 GLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 86/205 (41%), Gaps = 14/205 (6%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRNI----AVKRLFFNSRQWVDQFFNEVNLIS-GIQHK 354
           FD  R +G+G    V    L     I     VK+   N  + +D    E ++      H 
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 66
Query: 355 NVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH 414
            +V L  C         V EYV    L  +  ++    +     RF      +  L +LH
Sbjct: 67  FLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARF-YSAEISLALNYLH 123
Query: 415 GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH-VAPDKTHVSTGIAGTLGYMAPEYL 473
                 II+RD+K  N+LLD +   K+ D+G+ +  + P  T  ++   GT  Y+APE L
Sbjct: 124 ERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEIL 178
Query: 474 VRGQLTEKADVYAFGVLVIEVASGR 498
                    D +A GVL+ E+ +GR
Sbjct: 179 RGEDYGFSVDWWALGVLMFEMMAGR 203

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 82/174 (47%), Gaps = 15/174 (8%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKN--VVRL 359
           +++G GG+  VF+      +  A+K +       Q +D + NE+  ++ +Q  +  ++RL
Sbjct: 18  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 77
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQR-FTIICGTAEGLAHLHGGSG 418
               I      +V E   N  L+  L  K +I    W+++ +      A    H HG   
Sbjct: 78  YDYEITDQYIYMVME-CGNIDLNSWLKKKKSID--PWERKSYWKNMLEAVHTIHQHG--- 131
Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH-VSTGIAGTLGYMAPE 471
             I+H D+K +N L+ + +  K+ DFG+A  + PD T  V     GT+ YM PE
Sbjct: 132 --IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 182

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 86/205 (41%), Gaps = 14/205 (6%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRNI----AVKRLFFNSRQWVDQFFNEVNLIS-GIQHK 354
           FD  R +G+G    V    L     I     VK+   N  + +D    E ++      H 
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 355 NVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH 414
            +V L  C         V EYV    L  +  ++    +     RF      +  L +LH
Sbjct: 71  FLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARF-YSAEISLALNYLH 127
Query: 415 GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH-VAPDKTHVSTGIAGTLGYMAPEYL 473
                 II+RD+K  N+LLD +   K+ D+G+ +  + P  T  ++   GT  Y+APE L
Sbjct: 128 ERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEIL 182
Query: 474 VRGQLTEKADVYAFGVLVIEVASGR 498
                    D +A GVL+ E+ +GR
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGR 207

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 85/175 (48%), Gaps = 17/175 (9%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNI-AVKRLFFNS--RQWVDQFFNEVNLISGIQHKN--VVR 358
           +++G GG+  VF+  L + + I A+K +       Q +D + NE+  ++ +Q  +  ++R
Sbjct: 62  KQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQR-FTIICGTAEGLAHLHGGS 417
           L    I      +V E   N  L+  L  K +I    W+++ +      A    H HG  
Sbjct: 121 LYDYEITDQYIYMVME-CGNIDLNSWLKKKKSID--PWERKSYWKNMLEAVHTIHQHG-- 175
Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH-VSTGIAGTLGYMAPE 471
              I+H D+K +N L+ + +  K+ DFG+A  + PD T  V     GT+ YM PE
Sbjct: 176 ---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 226

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 23/227 (10%)
Query: 280 VLCTSSLN-FKYEILERATDFFDNSRKLGQGGAGSVFRGTLPD---GRNIAVKRLFFNSR 335
           VL T  L    YE  E    +  +  ++G+G  G V R  + D   G   AVK++     
Sbjct: 40  VLLTEKLKPVDYEYREE-VHWMTHQPRVGRGSFGEVHR--MKDKQTGFQCAVKKVRLEVF 96
Query: 336 QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILS 395
           +       E+   +G+    +V L G   EGP   +  E +   SL Q++     +  L 
Sbjct: 97  R-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLP 148
Query: 396 WQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLT-PKIADFGLARHVAPDK 454
             +    +    EGL +LH     +I+H D+K  N+LL    +   + DFG A  + PD 
Sbjct: 149 EDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205
Query: 455 THVS--TG--IAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
              S  TG  I GT  +MAPE ++      K D+++   +++ + +G
Sbjct: 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 86/204 (42%), Gaps = 14/204 (6%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQH 353
           D FD  + LG G  G V      +  N    ++    +    + ++   NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
             +V+L     +     +V EYV    +   L     I   S                +L
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+APE +
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPEII 210
Query: 474 VRGQLTEKADVYAFGVLVIEVASG 497
           +     +  D +A GVL+ ++A+G
Sbjct: 211 LSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 23/227 (10%)
Query: 280 VLCTSSLN-FKYEILERATDFFDNSRKLGQGGAGSVFRGTLPD---GRNIAVKRLFFNSR 335
           VL T  L    YE  E    +  +  ++G+G  G V R  + D   G   AVK++     
Sbjct: 56  VLLTEKLKPVDYEYREE-VHWMTHQPRVGRGSFGEVHR--MKDKQTGFQCAVKKVRLEVF 112
Query: 336 QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILS 395
           +       E+   +G+    +V L G   EGP   +  E +   SL Q++     +  L 
Sbjct: 113 R-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLP 164
Query: 396 WQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLT-PKIADFGLARHVAPDK 454
             +    +    EGL +LH     +I+H D+K  N+LL    +   + DFG A  + PD 
Sbjct: 165 EDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 221
Query: 455 THVS--TG--IAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
              S  TG  I GT  +MAPE ++      K D+++   +++ + +G
Sbjct: 222 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 82/174 (47%), Gaps = 15/174 (8%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKN--VVRL 359
           +++G GG+  VF+      +  A+K +       Q +D + NE+  ++ +Q  +  ++RL
Sbjct: 14  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 73
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQR-FTIICGTAEGLAHLHGGSG 418
               I      +V E   N  L+  L  K +I    W+++ +      A    H HG   
Sbjct: 74  YDYEITDQYIYMVME-CGNIDLNSWLKKKKSID--PWERKSYWKNMLEAVHTIHQHG--- 127
Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH-VSTGIAGTLGYMAPE 471
             I+H D+K +N L+ + +  K+ DFG+A  + PD T  V     GT+ YM PE
Sbjct: 128 --IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 178

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 74/156 (47%), Gaps = 20/156 (12%)
Query: 343 NEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSL-DQILFVKNTIHILSWQQRFT 401
           NE+ ++  I+H+N+V L           LV + V    L D+IL       + + +    
Sbjct: 55  NEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL----ERGVYTEKDASL 110
Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPK------IADFGLARHVAPDKT 455
           +I      + +LH      I+HRD+K  N+L    LTP+      I DFGL++    ++ 
Sbjct: 111 VIQQVLSAVKYLHENG---IVHRDLKPENLLY---LTPEENSKIMITDFGLSKM---EQN 161
Query: 456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLV 491
            + +   GT GY+APE L +   ++  D ++ GV+ 
Sbjct: 162 GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFN-EVNLISGIQHKNVV 357
           + +++ +G G  G V++  L D G  +A+K++  + R     F N E+ ++  + H N+V
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 95
Query: 358 RL---LGCSIEGPESL---LVYEYVPN---RSLDQILFVKNTIHI----LSWQQRFTIIC 404
           RL      S E  + +   LV +YVP    R        K T+ +    L   Q F    
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF---- 151
Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAG 463
                LA++H      I HRDIK  N+LLD +    K+ DFG A+ +   + +VS     
Sbjct: 152 ---RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--IC 203
Query: 464 TLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
           +  Y APE +      T   DV++ G ++ E+  G+
Sbjct: 204 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFN-EVNLISGIQHKNVV 357
           + +++ +G G  G V++  L D G  +A+K++  + R     F N E+ ++  + H N+V
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 104
Query: 358 RL---LGCSIEGPESL---LVYEYVPN---RSLDQILFVKNTIHI----LSWQQRFTIIC 404
           RL      S E  + +   LV +YVP    R        K T+ +    L   Q F    
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF---- 160
Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAG 463
                LA++H      I HRDIK  N+LLD +    K+ DFG A+ +   + +VS     
Sbjct: 161 ---RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YIC 212
Query: 464 TLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
           +  Y APE +      T   DV++ G ++ E+  G+
Sbjct: 213 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFN-EVNLISGIQHKNVV 357
           + +++ +G G  G V++  L D G  +A+K++  + R     F N E+ ++  + H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 76
Query: 358 RL---LGCSIEGPESL---LVYEYVPN---RSLDQILFVKNTIHILSWQQRFTIICGTAE 408
           RL      S E  + +   LV +YVP    R        K T+ ++  +     +     
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK---LYMYQLFR 133
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGY 467
            LA++H      I HRDIK  N+LLD +    K+ DFG A+ +   + +VS     +  Y
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYY 188
Query: 468 MAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
            APE +      T   DV++ G ++ E+  G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFN-EVNLISGIQHKNVV 357
           + +++ +G G  G V++  L D G  +A+K++  + R     F N E+ ++  + H N+V
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 84
Query: 358 RL---LGCSIEGPESL---LVYEYVPN---RSLDQILFVKNTIHI----LSWQQRFTIIC 404
           RL      S E  + +   LV +YVP    R        K T+ +    L   Q F    
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF---- 140
Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAG 463
                LA++H      I HRDIK  N+LLD +    K+ DFG A+ +   + +VS     
Sbjct: 141 ---RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--IC 192
Query: 464 TLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
           +  Y APE +      T   DV++ G ++ E+  G+
Sbjct: 193 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFN-EVNLISGIQHKNVV 357
           + +++ +G G  G V++  L D G  +A+K++  + R     F N E+ ++  + H N+V
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 80
Query: 358 RL---LGCSIEGPESL---LVYEYVPN---RSLDQILFVKNTIHILSWQQRFTIICGTAE 408
           RL      S E  + +   LV +YVP    R        K T+ ++  +     +     
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK---LYMYQLFR 137
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGY 467
            LA++H      I HRDIK  N+LLD +    K+ DFG A+ +   + +VS     +  Y
Sbjct: 138 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYY 192
Query: 468 MAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
            APE +      T   DV++ G ++ E+  G+
Sbjct: 193 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFN-EVNLISGIQHKNVV 357
           + +++ +G G  G V++  L D G  +A+K++  + R     F N E+ ++  + H N+V
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 88
Query: 358 RL---LGCSIEGPESL---LVYEYVPN---RSLDQILFVKNTIHI----LSWQQRFTIIC 404
           RL      S E  + +   LV +YVP    R        K T+ +    L   Q F    
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF---- 144
Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAG 463
                LA++H      I HRDIK  N+LLD +    K+ DFG A+ +   + +VS     
Sbjct: 145 ---RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--IC 196
Query: 464 TLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
           +  Y APE +      T   DV++ G ++ E+  G+
Sbjct: 197 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFN-EVNLISGIQHKNVV 357
           + +++ +G G  G V++  L D G  +A+K++  + R     F N E+ ++  + H N+V
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 88
Query: 358 RL---LGCSIEGPESL---LVYEYVPN---RSLDQILFVKNTIHI----LSWQQRFTIIC 404
           RL      S E  + +   LV +YVP    R        K T+ +    L   Q F    
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF---- 144
Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAG 463
                LA++H      I HRDIK  N+LLD +    K+ DFG A+ +   + +VS     
Sbjct: 145 ---RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--IC 196
Query: 464 TLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
           +  Y APE +      T   DV++ G ++ E+  G+
Sbjct: 197 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFN-EVNLISGIQHKNVV 357
           + +++ +G G  G V++  L D G  +A+K++  + R     F N E+ ++  + H N+V
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 77
Query: 358 RL---LGCSIEGPESL---LVYEYVPN---RSLDQILFVKNTIHILSWQQRFTIICGTAE 408
           RL      S E  + +   LV +YVP    R        K T+ ++  +     +     
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK---LYMYQLFR 134
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGY 467
            LA++H      I HRDIK  N+LLD +    K+ DFG A+ +   + +VS     +  Y
Sbjct: 135 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYY 189
Query: 468 MAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
            APE +      T   DV++ G ++ E+  G+
Sbjct: 190 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFN-EVNLISGIQHKNVV 357
           + +++ +G G  G V++  L D G  +A+K++  + R     F N E+ ++  + H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 110
Query: 358 RL---LGCSIEGPESL---LVYEYVPN---RSLDQILFVKNTIHI----LSWQQRFTIIC 404
           RL      S E  + +   LV +YVP    R        K T+ +    L   Q F    
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF---- 166
Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAG 463
                LA++H      I HRDIK  N+LLD +    K+ DFG A+ +   + +VS     
Sbjct: 167 ---RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--IC 218
Query: 464 TLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
           +  Y APE +      T   DV++ G ++ E+  G+
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFN-EVNLISGIQHKNVV 357
           + +++ +G G  G V++  L D G  +A+K++  + R     F N E+ ++  + H N+V
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 89
Query: 358 RL---LGCSIEGPESL---LVYEYVPN---RSLDQILFVKNTIHI----LSWQQRFTIIC 404
           RL      S E  + +   LV +YVP    R        K T+ +    L   Q F    
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF---- 145
Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAG 463
                LA++H      I HRDIK  N+LLD +    K+ DFG A+ +   + +VS     
Sbjct: 146 ---RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YIC 197
Query: 464 TLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
           +  Y APE +      T   DV++ G ++ E+  G+
Sbjct: 198 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFN-EVNLISGIQHKNVV 357
           + +++ +G G  G V++  L D G  +A+K++  + R     F N E+ ++  + H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 76
Query: 358 RL---LGCSIEGPESL---LVYEYVPN---RSLDQILFVKNTIHILSWQQRFTIICGTAE 408
           RL      S E  + +   LV +YVP    R        K T+ ++  +     +     
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK---LYMYQLFR 133
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGY 467
            LA++H      I HRDIK  N+LLD +    K+ DFG A+ +   + +VS     +  Y
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYY 188
Query: 468 MAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
            APE +      T   DV++ G ++ E+  G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 80/164 (48%), Gaps = 17/164 (10%)
Query: 342 FNEVNLISGIQ-HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRF 400
             EV+++  +  H N+++L           LV++ +    L   L  K T   LS ++  
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETR 127
Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG 460
            I+    E +  LH    + I+HRD+K  NILLD+ +  K+ DFG +  + P +   S  
Sbjct: 128 KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS-- 182
Query: 461 IAGTLGYMAPEYLVRGQLTE-------KADVYAFGVLVIEVASG 497
           + GT  Y+APE ++   + +       + D+++ GV++  + +G
Sbjct: 183 VCGTPSYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFN-EVNLISGIQHKNVV 357
           + +++ +G G  G V++  L D G  +A+K++  + R     F N E+ ++  + H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 110
Query: 358 RL---LGCSIEGPESL---LVYEYVPN---RSLDQILFVKNTIHI----LSWQQRFTIIC 404
           RL      S E  + +   LV +YVP    R        K T+ +    L   Q F    
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF---- 166
Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAG 463
                LA++H      I HRDIK  N+LLD +    K+ DFG A+ +   + +VS     
Sbjct: 167 ---RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YIC 218
Query: 464 TLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
           +  Y APE +      T   DV++ G ++ E+  G+
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 80/165 (48%), Gaps = 19/165 (11%)
Query: 341 FFNEVNLISGIQHKNVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQR 399
           F+ E ++++      VV+L  C+ +  + L +V EY+P   L  +  + N      W + 
Sbjct: 122 FWEERDIMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDL--VNLMSNYDVPEKWAKF 178
Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT---H 456
           +T     AE +  L     + +IHRD+K  N+LLD+    K+ADFG    +  D+T   H
Sbjct: 179 YT-----AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVH 231
Query: 457 VSTGIAGTLGYMAPEYLVR----GQLTEKADVYAFGVLVIEVASG 497
             T + GT  Y++PE L      G    + D ++ GV + E+  G
Sbjct: 232 CDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFN-EVNLISGIQHKNVV 357
           + +++ +G G  G V++  L D G  +A+K++  + R     F N E+ ++  + H N+V
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 112
Query: 358 RL---LGCSIEGPESL---LVYEYVPN---RSLDQILFVKNTIHI----LSWQQRFTIIC 404
           RL      S E  + +   LV +YVP    R        K T+ +    L   Q F    
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF---- 168
Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAG 463
                LA++H      I HRDIK  N+LLD +    K+ DFG A+ +   + +VS     
Sbjct: 169 ---RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YIC 220
Query: 464 TLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
           +  Y APE +      T   DV++ G ++ E+  G+
Sbjct: 221 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFN-EVNLISGIQHKNVV 357
           + +++ +G G  G V++  L D G  +A+K++  + R     F N E+ ++  + H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 76
Query: 358 RL---LGCSIEGPESL---LVYEYVPN---RSLDQILFVKNTIHILSWQQRFTIICGTAE 408
           RL      S E  + +   LV +YVP    R        K T+ ++  +     +     
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK---LYMYQLFR 133
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGY 467
            LA++H      I HRDIK  N+LLD +    K+ DFG A+ +   + +VS     +  Y
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YICSRYY 188
Query: 468 MAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
            APE +      T   DV++ G ++ E+  G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFN-EVNLISGIQHKNVV 357
           + +++ +G G  G V++  L D G  +A+K++  + R     F N E+ ++  + H N+V
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 81
Query: 358 RL---LGCSIEGPESL---LVYEYVPN---RSLDQILFVKNTIHI----LSWQQRFTIIC 404
           RL      S E  + +   LV +YVP    R        K T+ +    L   Q F    
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF---- 137
Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAG 463
                LA++H      I HRDIK  N+LLD +    K+ DFG A+ +   + +VS     
Sbjct: 138 ---RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YIC 189
Query: 464 TLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
           +  Y APE +      T   DV++ G ++ E+  G+
Sbjct: 190 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 3/90 (3%)
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
            L +LH  S   +++RD+K  N++LD+    KI DFGL +    D   + T   GT  Y+
Sbjct: 260 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYL 316
Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           APE L         D +  GV++ E+  GR
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFN-EVNLISGIQHKNVV 357
           + +++ +G G  G V++  L D G  +A+K++  + R     F N E+ ++  + H N+V
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 114
Query: 358 RL---LGCSIEGPESL---LVYEYVPN---RSLDQILFVKNTIHI----LSWQQRFTIIC 404
           RL      S E  + +   LV +YVP    R        K T+ +    L   Q F    
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF---- 170
Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAG 463
                LA++H      I HRDIK  N+LLD +    K+ DFG A+ +   + +VS     
Sbjct: 171 ---RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YIC 222
Query: 464 TLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
           +  Y APE +      T   DV++ G ++ E+  G+
Sbjct: 223 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 3/90 (3%)
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
            L +LH  S   +++RD+K  N++LD+    KI DFGL +    D   + T   GT  Y+
Sbjct: 263 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYL 319
Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           APE L         D +  GV++ E+  GR
Sbjct: 320 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 34/216 (15%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFN-EVNLISGIQHKNVV 357
           + +++ +G G  G V++  L D G  +A+K++  + R     F N E+ ++  + H N+V
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 155
Query: 358 RL---LGCSIEGPESL---LVYEYVPN---RSLDQILFVKNTIHI----LSWQQRFTIIC 404
           RL      S E  + +   LV +YVP    R        K T+ +    L   Q F    
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF---- 211
Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAG 463
                LA++H      I HRDIK  N+LLD +    K+ DFG A+ +   + +VS     
Sbjct: 212 ---RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--YIC 263
Query: 464 TLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
           +  Y APE +      T   DV++ G ++ E+  G+
Sbjct: 264 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFN-EVNLISGIQHKNVV 357
           + +++ +G G  G V++  L D G  +A+K++  + R     F N E+ ++  + H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 76
Query: 358 RL---LGCSIEGPESL---LVYEYVPN---RSLDQILFVKNTIHILSWQQRFTIICGTAE 408
           RL      S E  + +   LV +YVP    R        K T+ ++  +     +     
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK---LYMYQLFR 133
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGY 467
            LA++H      I HRDIK  N+LLD +    K+ DFG A+ +   + +VS     +  Y
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX--ICSRYY 188
Query: 468 MAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
            APE +      T   DV++ G ++ E+  G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 303 SRKLGQGGAGSVFRGTLPD--------GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHK 354
           +  LGQG    +F+G   +           + +K L    R + + FF   +++S + HK
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 355 NVVRLLGCSIEGPESLLVYEYVPNRSLDQILFV-KNTIHILSWQQRFTIICGTAEGLAHL 413
           ++V   G  + G E++LV E+V   SLD  L   KN I+IL W+          +  A +
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINIL-WKLEV-----AKQLAAAM 126
Query: 414 HGGSGIKIIHRDIKTSNILL----DEKL-TP---KIADFGLARHVAPDKTHVSTGIAGTL 465
           H      +IH ++   NILL    D K   P   K++D G++  V P        +   +
Sbjct: 127 HFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI-----LQERI 181
Query: 466 GYMAPEYLVRGQ-LTEKADVYAFGVLVIEVASG 497
            ++ PE +   + L    D ++FG  + E+ SG
Sbjct: 182 PWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 15/198 (7%)
Query: 306 LGQGGAGSVFRGTLP-DGRNIAVK---RLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLG 361
           LG G  G V  G     G  +AVK   R    S   V +   E+  +   +H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
                 +  +V EYV    L   +     +  +  ++ F  I  +A    H H      +
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL-SAVDYCHRH-----MV 132
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTE- 480
           +HRD+K  N+LLD  +  KIADFGL+  ++  +    +   G+  Y APE ++ G+L   
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS--CGSPNYAAPE-VISGRLYAG 189
Query: 481 -KADVYAFGVLVIEVASG 497
            + D+++ GV++  +  G
Sbjct: 190 PEVDIWSCGVILYALLCG 207

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 45/90 (50%), Gaps = 4/90 (4%)
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
            L +LH      +++RDIK  N++LD+    KI DFGL +    D   + T   GT  Y+
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYL 172
Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           APE L         D +  GV++ E+  GR
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 45/90 (50%), Gaps = 4/90 (4%)
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
            L +LH      +++RDIK  N++LD+    KI DFGL +    D   + T   GT  Y+
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYL 172
Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           APE L         D +  GV++ E+  GR
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 85/204 (41%), Gaps = 14/204 (6%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQH 353
           D FD  + LG G  G V      +  N    ++    +    + ++   NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
             +V+L     +     +V EYV    +   L     I   S                +L
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT  Y+AP  +
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEYLAPAII 210
Query: 474 VRGQLTEKADVYAFGVLVIEVASG 497
           +     +  D +A GVL+ E+A+G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 45/90 (50%), Gaps = 4/90 (4%)
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
            L +LH      +++RDIK  N++LD+    KI DFGL +    D   + T   GT  Y+
Sbjct: 120 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYL 175
Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           APE L         D +  GV++ E+  GR
Sbjct: 176 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 107/231 (46%), Gaps = 30/231 (12%)
Query: 282 CTSSLNFKYEILERATDFFDNSRKLGQGGAGSV--FRGTLPDGRNIAVKRL--FFNSRQW 337
            T  +  +YEI+E           +G G  G V   R  L  G+ +A+K++   F+    
Sbjct: 48  VTFDVGDEYEIIE----------TIGNGAYGVVSSARRRL-TGQQVAIKKIPNAFDVVTN 96
Query: 338 VDQFFNEVNLISGIQHKNVVRL---LGCSIEGPE--SLLVYEYVPNRSLDQILFVKNTIH 392
             +   E+ ++   +H N++ +   L  ++   E  S+ V   +    L QI+   ++  
Sbjct: 97  AKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQII---HSSQ 153
Query: 393 ILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-- 450
            L+ +     +     GL ++H     ++IHRD+K SN+L++E    KI DFG+AR +  
Sbjct: 154 PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210
Query: 451 -APDKTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRR 499
              +  +  T    T  Y APE ++   + T+  D+++ G +  E+ + R+
Sbjct: 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 105/224 (46%), Gaps = 30/224 (13%)
Query: 289 KYEILERATDFFDNSRKLGQGGAGSV--FRGTLPDGRNIAVKRL--FFNSRQWVDQFFNE 344
           +YEI+E           +G G  G V   R  L  G+ +A+K++   F+      +   E
Sbjct: 56  EYEIIE----------TIGNGAYGVVSSARRRL-TGQQVAIKKIPNAFDVVTNAKRTLRE 104
Query: 345 VNLISGIQHKNVVRL---LGCSIEGPE--SLLVYEYVPNRSLDQILFVKNTIHILSWQQR 399
           + ++   +H N++ +   L  ++   E  S+ V   +    L QI+   ++   L+ +  
Sbjct: 105 LKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQII---HSSQPLTLEHV 161
Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV---APDKTH 456
              +     GL ++H     ++IHRD+K SN+L++E    KI DFG+AR +     +  +
Sbjct: 162 RYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQY 218
Query: 457 VSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRR 499
             T    T  Y APE ++   + T+  D+++ G +  E+ + R+
Sbjct: 219 FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 81/182 (44%), Gaps = 17/182 (9%)
Query: 322 GRNIAVK---RLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL-LVYEYVP 377
           G+ +AVK   +   NS   + + F EV +   + H N+V+L    IE  ++L LV EY  
Sbjct: 39  GKEVAVKIIDKTQLNSSS-LQKLFREVRIXKVLNHPNIVKLFEV-IETEKTLYLVXEYAS 96
Query: 378 NRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL 437
              +   L           + +F  I    +   + H      I+HRD+K  N+LLD   
Sbjct: 97  GGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ---YCHQKF---IVHRDLKAENLLLDADX 150
Query: 438 TPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTE--KADVYAFGVLVIEVA 495
             KIADFG +               G   Y APE L +G+  +  + DV++ GV++  + 
Sbjct: 151 NIKIADFGFSNEFTFGNK--LDAFCGAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLV 207
Query: 496 SG 497
           SG
Sbjct: 208 SG 209

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 15/174 (8%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKN--VVRL 359
           +++G GG+  VF+      +  A+K +       Q +D + NE+  ++ +Q  +  ++RL
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQR-FTIICGTAEGLAHLHGGSG 418
               I      +V E   N  L+  L  K +I    W+++ +      A    H HG   
Sbjct: 94  YDYEITDQYIYMVME-CGNIDLNSWLKKKKSID--PWERKSYWKNMLEAVHTIHQHG--- 147
Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH-VSTGIAGTLGYMAPE 471
             I+H D+K +N L+ + +  K+ DFG+A  + PD    V     GT+ YM PE
Sbjct: 148 --IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPE 198

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 79/164 (48%), Gaps = 17/164 (10%)
Query: 342 FNEVNLISGIQ-HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRF 400
             EV+++  +  H N+++L           LV++ +    L   L  K T   LS ++  
Sbjct: 58  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETR 114
Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG 460
            I+    E +  LH    + I+HRD+K  NILLD+ +  K+ DFG +  + P +      
Sbjct: 115 KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LRE 169
Query: 461 IAGTLGYMAPEYLVRGQLTE-------KADVYAFGVLVIEVASG 497
           + GT  Y+APE ++   + +       + D+++ GV++  + +G
Sbjct: 170 VCGTPSYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 117/258 (45%), Gaps = 33/258 (12%)
Query: 278 GTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQ 336
           G+++  ++     E   +  D F   R  GQG  G+V  G     G ++A+K++  + R 
Sbjct: 3   GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR- 61
Query: 337 WVDQFFNEVNLISGIQHKNVVRL------LGCSIEGPESL-LVYEYVP--------NRSL 381
           + ++    +  ++ + H N+V+L      LG        L +V EYVP        N   
Sbjct: 62  FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYR 121
Query: 382 DQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL-TPK 440
            Q+      I +  +Q   +I C        LH  S + + HRDIK  N+L++E   T K
Sbjct: 122 RQVAPPPILIKVFLFQLIRSIGC--------LHLPS-VNVCHRDIKPHNVLVNEADGTLK 172
Query: 441 IADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQ-LTEKADVYAFGVLVIEVASGRR 499
           + DFG A+ ++P + +V+     +  Y APE +   Q  T   D+++ G +  E+  G  
Sbjct: 173 LCDFGSAKKLSPSEPNVA--YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-- 228
Query: 500 NSVF-SEGSSSVLHTVWK 516
             +F  + S+  LH + +
Sbjct: 229 EPIFRGDNSAGQLHEIVR 246

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 84/175 (48%), Gaps = 17/175 (9%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNI-AVKRLFFNS--RQWVDQFFNEVNLISGIQHKN--VVR 358
           +++G GG+  VF+  L + + I A+K +       Q +D + NE+  ++ +Q  +  ++R
Sbjct: 62  KQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQR-FTIICGTAEGLAHLHGGS 417
           L    I      +V E   N  L+  L  K +I    W+++ +      A    H HG  
Sbjct: 121 LYDYEITDQYIYMVME-CGNIDLNSWLKKKKSID--PWERKSYWKNMLEAVHTIHQHG-- 175
Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH-VSTGIAGTLGYMAPE 471
              I+H D+K +N L+ + +  K+ DFG+A  + PD T  V     G + YM PE
Sbjct: 176 ---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 79/164 (48%), Gaps = 17/164 (10%)
Query: 342 FNEVNLISGIQ-HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRF 400
             EV+++  +  H N+++L           LV++ +    L   L  K T   LS ++  
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETR 127
Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG 460
            I+    E +  LH    + I+HRD+K  NILLD+ +  K+ DFG +  + P +      
Sbjct: 128 KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LRE 182
Query: 461 IAGTLGYMAPEYLVRGQLTE-------KADVYAFGVLVIEVASG 497
           + GT  Y+APE ++   + +       + D+++ GV++  + +G
Sbjct: 183 VCGTPSYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 85/204 (41%), Gaps = 14/204 (6%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR----QWVDQFFNEVNLISGIQH 353
           D FD  + LG G  G V      +  N    ++    +    + ++   NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
             +V+L     +     +V EYV    +   L     I   S                +L
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H    + +I+RD+K  N+L+D++   ++ DFG A+ V       +  + GT   +APE +
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWXLCGTPEALAPEII 210
Query: 474 VRGQLTEKADVYAFGVLVIEVASG 497
           +     +  D +A GVL+ E+A+G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 106/231 (45%), Gaps = 27/231 (11%)
Query: 283 TSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQWVDQF 341
           T SL  K+E + + T     S  LG+G    V    +L +G+  AVK +   +     + 
Sbjct: 3   TDSLPGKFEDMYKLT-----SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRV 57
Query: 342 FNEVNLISGIQ-HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRF 400
           F EV  +   Q +KN++ L+    +     LV+E +   S+  +  ++   H  + ++  
Sbjct: 58  FREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSI--LAHIQKQKH-FNEREAS 114
Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD--EKLTP-KIADFGLARHV------A 451
            ++   A  L  LH      I HRD+K  NIL +  EK++P KI DF L   +       
Sbjct: 115 RVVRDVAAALDFLHTKG---IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCT 171
Query: 452 PDKTHVSTGIAGTLGYMAPEY--LVRGQLT---EKADVYAFGVLVIEVASG 497
           P  T   T   G+  YMAPE   +   Q T   ++ D+++ GV++  + SG
Sbjct: 172 PITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 13/151 (8%)
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICGTAEGL 410
           QH N++ L     +G    +V E +    L D+IL  K      S ++   ++    + +
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK----FFSEREASAVLFTITKTV 129
Query: 411 AHLHGGSGIKIIHRDIKTSNIL-LDEKLTP---KIADFGLARHVAPDKTHVSTGIAGTLG 466
            +LH      ++HRD+K SNIL +DE   P   +I DFG A+ +  +   + T    T  
Sbjct: 130 EYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY-TAN 185
Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           ++APE L R       D+++ GVL+  + +G
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 31/214 (14%)
Query: 303 SRKLGQGGAGSVFRGTLPD--------GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHK 354
           +  LGQG    +F+G   +           + +K L    R + + FF   +++S + HK
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 355 NVVRLLGCSIEGPESLLVYEYVPNRSLDQILFV-KNTIHILSWQQRFTIICGTAEGLAH- 412
           ++V   G    G E++LV E+V   SLD  L   KN I+IL W+         A+ LA  
Sbjct: 73  HLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINIL-WKLE------VAKQLAWA 125
Query: 413 LHGGSGIKIIHRDIKTSNILL----DEKL-TP---KIADFGLARHVAPDKTHVSTGIAGT 464
           +H      +IH ++   NILL    D K   P   K++D G++  V P        +   
Sbjct: 126 MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI-----LQER 180
Query: 465 LGYMAPEYLVRGQ-LTEKADVYAFGVLVIEVASG 497
           + ++ PE +   + L    D ++FG  + E+ SG
Sbjct: 181 IPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 10/102 (9%)
Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGI 461
           I     + L HLH  S + +IHRD+K SN+L++     K  DFG++ ++  D   V+  I
Sbjct: 141 IAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDD---VAKDI 195
Query: 462 -AGTLGYMAPEY----LVRGQLTEKADVYAFGVLVIEVASGR 498
            AG   Y APE     L +   + K+D+++ G+  IE+A  R
Sbjct: 196 DAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILR 237

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 15/198 (7%)
Query: 306 LGQGGAGSVFRGTLP-DGRNIAVK---RLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLG 361
           LG G  G V  G     G  +AVK   R    S   V +   E+  +   +H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
                 +  +V EYV    L   +     +     ++ F  I    +   H H      +
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD-YCHRH-----MV 137
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTE- 480
           +HRD+K  N+LLD  +  KIADFGL+  ++ D   +     G+  Y APE ++ G+L   
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRXS-CGSPNYAAPE-VISGRLYAG 194
Query: 481 -KADVYAFGVLVIEVASG 497
            + D+++ GV++  +  G
Sbjct: 195 PEVDIWSSGVILYALLCG 212

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 44/90 (48%), Gaps = 4/90 (4%)
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
            L +LH      +++RDIK  N++LD+    KI DFGL +    D   +     GT  Y+
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-FCGTPEYL 172
Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           APE L         D +  GV++ E+  GR
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 44/90 (48%), Gaps = 4/90 (4%)
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
            L +LH      +++RDIK  N++LD+    KI DFGL +    D   +     GT  Y+
Sbjct: 122 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-FCGTPEYL 177
Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           APE L         D +  GV++ E+  GR
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 3/90 (3%)
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
            L +LH  S   +++RD+K  N++LD+    KI DFGL +    D   +     GT  Y+
Sbjct: 121 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX-FCGTPEYL 177
Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           APE L         D +  GV++ E+  GR
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 3/90 (3%)
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
            L +LH  S   +++RD+K  N++LD+    KI DFGL +    D   +     GT  Y+
Sbjct: 122 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX-FCGTPEYL 178
Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           APE L         D +  GV++ E+  GR
Sbjct: 179 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 40/219 (18%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLF----FNSRQWVDQFFNEVNLISGIQHK 354
           + +++ +G G  G V++  L D G  +A+K++     F +R        E+ ++  + H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR--------ELQIMRKLDHC 73
Query: 355 NVVRL---LGCSIEGPESL---LVYEYVPN---RSLDQILFVKNTIHI----LSWQQRFT 401
           N+VRL      S E  + +   LV +YVP    R        K T+ +    L   Q F 
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF- 132
Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTG 460
                   LA++H      I HRDIK  N+LLD +    K+ DFG A+ +   + +VS  
Sbjct: 133 ------RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-- 181
Query: 461 IAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
              +  Y APE +      T   DV++ G ++ E+  G+
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 3/90 (3%)
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
            L +LH  S   +++RD+K  N++LD+    KI DFGL +    D   +     GT  Y+
Sbjct: 120 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX-FCGTPEYL 176
Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           APE L         D +  GV++ E+  GR
Sbjct: 177 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 44/90 (48%), Gaps = 4/90 (4%)
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
            L +LH      +++RDIK  N++LD+    KI DFGL +    D   +     GT  Y+
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-FCGTPEYL 172
Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           APE L         D +  GV++ E+  GR
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 44/90 (48%), Gaps = 4/90 (4%)
Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
            L +LH      +++RDIK  N++LD+    KI DFGL +    D   +     GT  Y+
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-FCGTPEYL 172
Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           APE L         D +  GV++ E+  GR
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 11/161 (6%)
Query: 341 FFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRF 400
           F+ E ++++      VV+L     +     +V EY+P   L  +  + N      W + +
Sbjct: 116 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL--VNLMSNYDVPEKWARFY 173
Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG 460
           T     AE +  L     +  IHRD+K  N+LLD+    K+ADFG    +  +       
Sbjct: 174 T-----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 228
Query: 461 IAGTLGYMAPEYLVR----GQLTEKADVYAFGVLVIEVASG 497
             GT  Y++PE L      G    + D ++ GV + E+  G
Sbjct: 229 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 40/219 (18%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLF----FNSRQWVDQFFNEVNLISGIQHK 354
           + +++ +G G  G V++  L D G  +A+K++     F +R        E+ ++  + H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR--------ELQIMRKLDHC 73
Query: 355 NVVRL---LGCSIEGPESL---LVYEYVPN---RSLDQILFVKNTIHI----LSWQQRFT 401
           N+VRL      S E  + +   LV +YVP    R        K T+ +    L   Q F 
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF- 132
Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTG 460
                   LA++H      I HRDIK  N+LLD +    K+ DFG A+ +   + +VS  
Sbjct: 133 ------RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-- 181
Query: 461 IAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
              +  Y APE +      T   DV++ G ++ E+  G+
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 87/212 (41%), Gaps = 26/212 (12%)
Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-HKNVVRLLG 361
           R L +GG   V+    +  GR  A+KRL  N  +       EV  +  +  H N+V+   
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 362 CSIEGPES--------LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
            +  G E         LL+ E    + L + L    +   LS      I   T   + H+
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQ-LVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA--PDKTHVSTGIA--------- 462
           H      IIHRD+K  N+LL  + T K+ DFG A  ++  PD +  +   A         
Sbjct: 153 HRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 463 GTLGYMAPEYL---VRGQLTEKADVYAFGVLV 491
            T  Y  PE +       + EK D++A G ++
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 99/219 (45%), Gaps = 40/219 (18%)
Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLF----FNSRQWVDQFFNEVNLISGIQHK 354
           + +++ +G G  G V++  L D G  +A+K++     F +R        E+ ++  + H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR--------ELQIMRKLDHC 73
Query: 355 NVVRL---LGCSIEGPESL---LVYEYVPN---RSLDQILFVKNTIHI----LSWQQRFT 401
           N+VRL      S E  + +   LV +YVP    R        K T+ +    L   Q F 
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLF- 132
Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTG 460
                   LA++H      I HRDIK  N+LLD +    K+ DFG A+ +   + +VS  
Sbjct: 133 ------RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX- 182
Query: 461 IAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGR 498
              +  Y APE +      T   DV++ G ++ E+  G+
Sbjct: 183 -ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 71/151 (47%), Gaps = 13/151 (8%)
Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICGTAEGL 410
           QH N++ L     +G    +V E      L D+IL  K      S ++   ++    + +
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQK----FFSEREASAVLFTITKTV 129
Query: 411 AHLHGGSGIKIIHRDIKTSNIL-LDEKLTP---KIADFGLARHVAPDKTHVSTGIAGTLG 466
            +LH      ++HRD+K SNIL +DE   P   +I DFG A+ +  +   + T    T  
Sbjct: 130 EYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY-TAN 185
Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           ++APE L R       D+++ GVL+    +G
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 11/161 (6%)
Query: 341 FFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRF 400
           F+ E ++++      VV+L     +     +V EY+P   L  +  + N      W + +
Sbjct: 121 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL--VNLMSNYDVPEKWARFY 178
Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG 460
           T     AE +  L     +  IHRD+K  N+LLD+    K+ADFG    +  +       
Sbjct: 179 T-----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 233
Query: 461 IAGTLGYMAPEYLVR----GQLTEKADVYAFGVLVIEVASG 497
             GT  Y++PE L      G    + D ++ GV + E+  G
Sbjct: 234 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 11/161 (6%)
Query: 341 FFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRF 400
           F+ E ++++      VV+L     +     +V EY+P   L  +  + N      W + +
Sbjct: 121 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL--VNLMSNYDVPEKWARFY 178
Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG 460
           T     AE +  L     +  IHRD+K  N+LLD+    K+ADFG    +  +       
Sbjct: 179 T-----AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 233
Query: 461 IAGTLGYMAPEYLVR----GQLTEKADVYAFGVLVIEVASG 497
             GT  Y++PE L      G    + D ++ GV + E+  G
Sbjct: 234 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 25/203 (12%)
Query: 297 TDFFDNSRKLGQG--GAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFN-EVNLISGIQH 353
           +D +D  + +G G  G   + R  L     +AVK  +      +D+    E+     ++H
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKL-TKELVAVK--YIERGAAIDENVQREIINHRSLRH 75
Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
            N+VR     +      ++ EY     L +   + N       + RF        G+++ 
Sbjct: 76  PNIVRFKEVILTPTHLAIIMEYASGGELYE--RICNAGRFSEDEARF-FFQQLLSGVSYC 132
Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTP--KIADFGLAR----HVAPDKTHVSTGIAGTLGY 467
           H    ++I HRD+K  N LLD    P  KI DFG ++    H  P  T       GT  Y
Sbjct: 133 HS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VGTPAY 183
Query: 468 MAPEYLVRGQLTEK-ADVYAFGV 489
           +APE L+R +   K ADV++ GV
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGV 206

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 61/282 (21%), Positives = 113/282 (40%), Gaps = 38/282 (13%)
Query: 306 LGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE 365
           +G+G  G V+ G       I +  +  ++   +  F  EV      +H+NVV  +G  + 
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 366 GPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRD 425
            P   ++      R+L  +  V++   +L   +   I     +G+ +LH      I+H+D
Sbjct: 101 PPHLAIITSLCKGRTLYSV--VRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 426 IKTSNILLDEKLTPKIADFG-------LARHVAPDKTHVSTGIAGTLGYMAPEYLV---- 474
           +K+ N+  D      I DFG       L      DK  +     G L ++APE +     
Sbjct: 156 LKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQN---GWLCHLAPEIIRQLSP 211
Query: 475 -----RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP 529
                +   ++ +DV+A G +  E+ +  R   F    +  +  +W+      +   M P
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHA--REWPFKTQPAEAI--IWQ------MGTGMKP 261
Query: 530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            L+      E S +L   L C       RP+  +++ ML  +
Sbjct: 262 NLSQIGMGKEISDIL---LFCWAFEQEERPTFTKLMDMLEKL 300

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 8/158 (5%)
Query: 344 EVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSL-DQILFVKNTIHILSWQQRFTI 402
           E ++   ++H ++V LL          +V+E++    L  +I+   +   + S       
Sbjct: 76  EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135
Query: 403 ICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP---KIADFGLARHVAPDKTHVST 459
           +    E L + H  +   IIHRD+K  N+LL  K      K+ DFG+A  +  +   V+ 
Sbjct: 136 MRQILEALRYCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG-ESGLVAG 191
Query: 460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           G  GT  +MAPE + R    +  DV+  GV++  + SG
Sbjct: 192 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 4/91 (4%)
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG 466
           A  L +LH    + I++RD+K  NILLD +    + DFGL +      +  ST   GT  
Sbjct: 149 ASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPE 204
Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
           Y+APE L +       D +  G ++ E+  G
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/239 (21%), Positives = 106/239 (44%), Gaps = 40/239 (16%)
Query: 298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVD--QFFNEVNLISGIQHK 354
           D ++    +G G  G V       + R +A+K++       +D  +   E+ +++ + H 
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 355 NVVRLLGC----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGL 410
           +VV++L       +E  + L V   + +    ++   +  +++     + T++     G+
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLF--RTPVYLTELHIK-TLLYNLLVGV 169
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV------------APDKTHVS 458
            ++H      I+HRD+K +N L+++  + K+ DFGLAR V            +P +  ++
Sbjct: 170 KYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 459 --------------TGIAGTLGYMAPEY-LVRGQLTEKADVYAFGVLVIEVASGRRNSV 502
                         TG   T  Y APE  L++   TE  DV++ G +  E+ +  + +V
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 48/97 (49%), Gaps = 5/97 (5%)
Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG 466
           AE +  +     +  +HRDIK  NIL+D     ++ADFG    +  D T  S+   GT  
Sbjct: 182 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 241
Query: 467 YMAPEYLV-----RGQLTEKADVYAFGVLVIEVASGR 498
           Y++PE L      +G+   + D ++ GV + E+  G 
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 100/220 (45%), Gaps = 35/220 (15%)
Query: 306 LGQGGAGSVFRGTLPDG-RNIAVKRLFFNSRQWVD--QFFNEVNLISGIQHKNVVRLLGC 362
           +G+G  G V+     +  +N+A+K++       +D  +   E+ +++ ++   ++RL   
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL 93
Query: 363 SIEGPESLLVYE--YVPNRSLDQIL--FVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
            I  P+ LL ++  Y+     D  L    K  I  L+ +   TI+     G   +H    
Sbjct: 94  II--PDDLLKFDELYIVLEIADSDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIHESG- 149
Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK-THVSTGIAG-------------- 463
             IIHRD+K +N LL++  + K+ DFGLAR +  +K T++   +                
Sbjct: 150 --IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQ 207
Query: 464 ------TLGYMAPEY-LVRGQLTEKADVYAFGVLVIEVAS 496
                 T  Y APE  L++   T+  D+++ G +  E+ +
Sbjct: 208 LTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 95/230 (41%), Gaps = 26/230 (11%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLF-----------FNSRQWVDQFFNEVNLISGIQ 352
           R +  G  G+V  G   +G  +A+KR+F            +      +   E+ L++   
Sbjct: 28  RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 353 HKNVV--RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGL 410
           H N++  R +    E P    +Y        D    + +   ++S Q     +     GL
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD--KTHVSTGIAGTLGYM 468
             LH      ++HRD+   NILL +     I DF LAR    D  KTH  T       Y 
Sbjct: 148 HVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH----RWYR 200
Query: 469 APEYLVRGQ-LTEKADVYAFGVLVIEVASGR---RNSVFSEGSSSVLHTV 514
           APE +++ +  T+  D+++ G ++ E+ + +   R S F    + ++  V
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/230 (23%), Positives = 95/230 (41%), Gaps = 26/230 (11%)
Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLF-----------FNSRQWVDQFFNEVNLISGIQ 352
           R +  G  G+V  G   +G  +A+KR+F            +      +   E+ L++   
Sbjct: 28  RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 353 HKNVV--RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGL 410
           H N++  R +    E P    +Y        D    + +   ++S Q     +     GL
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD--KTHVSTGIAGTLGYM 468
             LH      ++HRD+   NILL +     I DF LAR    D  KTH  T       Y 
Sbjct: 148 HVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH----RWYR 200
Query: 469 APEYLVRGQ-LTEKADVYAFGVLVIEVASGR---RNSVFSEGSSSVLHTV 514
           APE +++ +  T+  D+++ G ++ E+ + +   R S F    + ++  V
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 296 ATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQ--WVDQFFNEVNLISGIQ 352
           + D +    KLG+G  G V++         +A+KR+     +         EV+L+  +Q
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ 91
Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
           H+N++ L           L++EY  N   D   ++     + S +   + +     G+  
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEYAEN---DLKKYMDKNPDV-SMRVIKSFLYQLINGVNF 147
Query: 413 LHGGSGIKIIHRDIKTSNILL---DEKLTP--KIADFGLARHVAPDKTHVSTGIAGTLGY 467
            H     + +HRD+K  N+LL   D   TP  KI DFGLAR         +  I  TL Y
Sbjct: 148 CHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWY 203
Query: 468 MAPEYLVRGQ-LTEKADVYAFGVLVIEV 494
             PE L+  +  +   D+++   +  E+
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEM 231

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 101/243 (41%), Gaps = 45/243 (18%)
Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRGTL-----PDGRNIAVKRLFFNSRQWVDQFFNE 344
           YE + + ++ F    K+G+G   SV+  T      P+ + IA+K L   S         +
Sbjct: 13  YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEK-IALKHLIPTSHPIRIAAELQ 71
Query: 345 VNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIIC 404
              ++G Q  NV+ +  C  +    ++   Y+ + S   IL      + LS+Q+    + 
Sbjct: 72  CLTVAGGQ-DNVMGVKYCFRKNDHVVIAMPYLEHESFLDIL------NSLSFQEVREYML 124
Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP-KIADFGLARHVAPDKTHVSTGI-- 461
              + L  +H      I+HRD+K SN L + +L    + DFGLA+     K  +   +  
Sbjct: 125 NLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQS 181
Query: 462 -------------------------AGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVA 495
                                    AGT G+ APE L +    T   D+++ GV+ + + 
Sbjct: 182 EAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241
Query: 496 SGR 498
           SGR
Sbjct: 242 SGR 244

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 15/204 (7%)
Query: 299 FFDNSRKLGQGGAGSVFRGTLPDGRNI--AVKRLFFNSRQWVDQFFNEVNLISGIQHKNV 356
           ++     +G+G  G V +  +  G  I  A K++     + VD+F  E+ ++  + H N+
Sbjct: 27  YYTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNI 85
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RL     +  +  LV E      L + +  K    +        I+      +A+ H  
Sbjct: 86  IRLYETFEDNTDIYLVMELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCH-- 140
Query: 417 SGIKIIHRDIKTSNILL--DEKLTP-KIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
             + + HRD+K  N L   D   +P K+ DFGLA    P K   +    GT  Y++P+ L
Sbjct: 141 -KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK--VGTPYYVSPQVL 197
Query: 474 VRGQLTEKADVYAFGVLVIEVASG 497
             G    + D ++ GV++  +  G
Sbjct: 198 -EGLYGPECDEWSAGVMMYVLLCG 220

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 15/204 (7%)
Query: 299 FFDNSRKLGQGGAGSVFRGTLPDGRNI--AVKRLFFNSRQWVDQFFNEVNLISGIQHKNV 356
           ++     +G+G  G V +  +  G  I  A K++     + VD+F  E+ ++  + H N+
Sbjct: 10  YYTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNI 68
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RL     +  +  LV E      L + +  K    +        I+      +A+ H  
Sbjct: 69  IRLYETFEDNTDIYLVMELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCH-- 123
Query: 417 SGIKIIHRDIKTSNILL--DEKLTP-KIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
             + + HRD+K  N L   D   +P K+ DFGLA    P K   +    GT  Y++P+ L
Sbjct: 124 -KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK--VGTPYYVSPQVL 180
Query: 474 VRGQLTEKADVYAFGVLVIEVASG 497
             G    + D ++ GV++  +  G
Sbjct: 181 -EGLYGPECDEWSAGVMMYVLLCG 203

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 36/75 (48%)
Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKA 482
           HRD+K  NIL+       + DFG+A     +K        GTL Y APE       T +A
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRA 216
Query: 483 DVYAFGVLVIEVASG 497
           D+YA   ++ E  +G
Sbjct: 217 DIYALTCVLYECLTG 231

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 63/136 (46%), Gaps = 15/136 (11%)
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL-------V 474
           +HRDIK  NILLD     ++ADFG    +  D T  S    GT  Y++PE L        
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPG 243
Query: 475 RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR 534
            G    + D +A GV   E+  G+  + F   S++  +    HYK +     +D G+   
Sbjct: 244 TGSYGPECDWWALGVFAYEMFYGQ--TPFYADSTAETYGKIVHYKEHLSLPLVDEGV--- 298
Query: 535 FPENEASRVLQIGLLC 550
            PE EA   +Q  LLC
Sbjct: 299 -PE-EARDFIQ-RLLC 311

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/125 (29%), Positives = 59/125 (47%), Gaps = 11/125 (8%)
Query: 421 IIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLV----RG 476
           IIHRDIK  NI++ E  T K+ DFG A ++   K   +    GT+ Y APE L+    RG
Sbjct: 151 IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT--FCGTIEYCAPEVLMGNPYRG 208
Query: 477 QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP 536
               + ++++ GV +  +      + F E   +V   +   Y  ++   S+  GL    P
Sbjct: 209 P---ELEMWSLGVTLYTLVF--EENPFCELEETVEAAIHPPYLVSKELMSLVSGLLQPVP 263
Query: 537 ENEAS 541
           E   +
Sbjct: 264 ERRTT 268

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 86/201 (42%), Gaps = 21/201 (10%)
Query: 297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFN-EVNLISGIQHKN 355
           +D ++  + +G G  G V R       N  V   +    + +D+    E+     ++H N
Sbjct: 17  SDRYELVKDIGSGNFG-VARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPN 75
Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           +VR     +      +V EY     L +   + N       + RF        G+++ H 
Sbjct: 76  IVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARF-FFQQLISGVSYCHA 132
Query: 416 GSGIKIIHRDIKTSNILLDEKLTP--KIADFGLAR----HVAPDKTHVSTGIAGTLGYMA 469
              +++ HRD+K  N LLD    P  KI DFG ++    H  P  T       GT  Y+A
Sbjct: 133 ---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VGTPAYIA 183
Query: 470 PEYLVRGQLTEK-ADVYAFGV 489
           PE L++ +   K ADV++ GV
Sbjct: 184 PEVLLKKEYDGKVADVWSCGV 204

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 66/147 (44%), Gaps = 19/147 (12%)
Query: 350 GIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
            ++H N+VR     +      +V EY     L +   + N       + RF        G
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARF-FFQQLISG 127
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTP--KIADFGLAR----HVAPDKTHVSTGIAG 463
           +++ H    +++ HRD+K  N LLD    P  KIADFG ++    H  P          G
Sbjct: 128 VSYAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSA------VG 178
Query: 464 TLGYMAPEYLVRGQLTEK-ADVYAFGV 489
           T  Y+APE L++ +   K ADV++ GV
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGV 205

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 66/147 (44%), Gaps = 19/147 (12%)
Query: 350 GIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
            ++H N+VR     +      +V EY     L +   + N       + RF        G
Sbjct: 71  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARF-FFQQLISG 127
Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTP--KIADFGLAR----HVAPDKTHVSTGIAG 463
           +++ H    +++ HRD+K  N LLD    P  KI DFG ++    H  P  T       G
Sbjct: 128 VSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VG 178
Query: 464 TLGYMAPEYLVRGQLTEK-ADVYAFGV 489
           T  Y+APE L++ +   K ADV++ GV
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGV 205

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/82 (34%), Positives = 42/82 (51%), Gaps = 5/82 (6%)
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLV-----RG 476
           +HRDIK  N+LLD     ++ADFG    +  D T  S+   GT  Y++PE L       G
Sbjct: 213 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 272
Query: 477 QLTEKADVYAFGVLVIEVASGR 498
           +   + D ++ GV + E+  G 
Sbjct: 273 KYGPECDWWSLGVCMYEMLYGE 294

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/82 (34%), Positives = 42/82 (51%), Gaps = 5/82 (6%)
Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLV-----RG 476
           +HRDIK  N+LLD     ++ADFG    +  D T  S+   GT  Y++PE L       G
Sbjct: 197 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 256
Query: 477 QLTEKADVYAFGVLVIEVASGR 498
           +   + D ++ GV + E+  G 
Sbjct: 257 KYGPECDWWSLGVCMYEMLYGE 278

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 21/205 (10%)
Query: 306 LGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQWVDQFFN------EVNLI----SGIQHK 354
           LG+GG G+VF G  L D   +A+K +  N         +      EV L+    +G  H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 355 NVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH 414
            V+RLL    E  E  ++    P  + D   ++     +     R    C   + +A + 
Sbjct: 99  GVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSR----CFFGQVVAAIQ 153
Query: 415 GGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
                 ++HRDIK  NIL+D  +   K+ DFG +  +  D+ +  T   GT  Y  PE++
Sbjct: 154 HCHSRGVVHRDIKDENILIDLRRGCAKLIDFG-SGALLHDEPY--TDFDGTRVYSPPEWI 210
Query: 474 VRGQLTE-KADVYAFGVLVIEVASG 497
            R Q     A V++ G+L+ ++  G
Sbjct: 211 SRHQYHALPATVWSLGILLYDMVCG 235

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN------EVNLISGIQH--KNV 356
           LG GG GSV+ G  + D   +A+K +  +      +  N      EV L+  +      V
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RLL    E P+S ++    P    D   F+     +     R +      E + H H  
Sbjct: 91  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHN- 147
Query: 417 SGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++HRDIK  NIL+D  +   K+ DFG     A  K  V T   GT  Y  PE++  
Sbjct: 148 --CGVLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 202
Query: 476 GQLTEK-ADVYAFGVLVIEVASG 497
            +   + A V++ G+L+ ++  G
Sbjct: 203 HRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN------EVNLISGIQH--KNV 356
           LG GG GSV+ G  + D   +A+K +  +      +  N      EV L+  +      V
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RLL    E P+S ++    P    D   F+     +     R +      E + H H  
Sbjct: 77  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHN- 133
Query: 417 SGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++HRDIK  NIL+D  +   K+ DFG     A  K  V T   GT  Y  PE++  
Sbjct: 134 --CGVLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 188
Query: 476 GQLTEK-ADVYAFGVLVIEVASG 497
            +   + A V++ G+L+ ++  G
Sbjct: 189 HRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN------EVNLISGIQH--KNV 356
           LG GG GSV+ G  + D   +A+K +  +      +  N      EV L+  +      V
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RLL    E P+S ++    P    D   F+     +     R +      E + H H  
Sbjct: 91  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHN- 147
Query: 417 SGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++HRDIK  NIL+D  +   K+ DFG     A  K  V T   GT  Y  PE++  
Sbjct: 148 --CGVLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 202
Query: 476 GQLTEK-ADVYAFGVLVIEVASG 497
            +   + A V++ G+L+ ++  G
Sbjct: 203 HRYHGRSAAVWSLGILLYDMVCG 225

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN------EVNLISGIQH--KNV 356
           LG GG GSV+ G  + D   +A+K +  +      +  N      EV L+  +      V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RLL    E P+S ++    P    D   F+     +     R +      E + H H  
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHN- 160
Query: 417 SGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++HRDIK  NIL+D  +   K+ DFG     A  K  V T   GT  Y  PE++  
Sbjct: 161 --CGVLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 215
Query: 476 GQLTEK-ADVYAFGVLVIEVASG 497
            +   + A V++ G+L+ ++  G
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCG 238

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN------EVNLISGIQH--KNV 356
           LG GG GSV+ G  + D   +A+K +  +      +  N      EV L+  +      V
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RLL    E P+S ++    P    D   F+     +     R +      E + H H  
Sbjct: 119 IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHN- 175
Query: 417 SGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++HRDIK  NIL+D  +   K+ DFG     A  K  V T   GT  Y  PE++  
Sbjct: 176 --CGVLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 230
Query: 476 GQLTEK-ADVYAFGVLVIEVASG 497
            +   + A V++ G+L+ ++  G
Sbjct: 231 HRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN------EVNLISGIQH--KNV 356
           LG GG GSV+ G  + D   +A+K +  +      +  N      EV L+  +      V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RLL    E P+S ++    P    D   F+     +     R +      E + H H  
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHN- 161
Query: 417 SGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++HRDIK  NIL+D  +   K+ DFG     A  K  V T   GT  Y  PE++  
Sbjct: 162 --CGVLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 216
Query: 476 GQLTEK-ADVYAFGVLVIEVASG 497
            +   + A V++ G+L+ ++  G
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN------EVNLISGIQH--KNV 356
           LG GG GSV+ G  + D   +A+K +  +      +  N      EV L+  +      V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RLL    E P+S ++    P    D   F+     +     R +      E + H H  
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHN- 160
Query: 417 SGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++HRDIK  NIL+D  +   K+ DFG     A  K  V T   GT  Y  PE++  
Sbjct: 161 --CGVLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 215
Query: 476 GQLTEK-ADVYAFGVLVIEVASG 497
            +   + A V++ G+L+ ++  G
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN------EVNLISGIQH--KNV 356
           LG GG GSV+ G  + D   +A+K +  +      +  N      EV L+  +      V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RLL    E P+S ++    P    D   F+     +     R +      E + H H  
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHN- 161
Query: 417 SGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++HRDIK  NIL+D  +   K+ DFG     A  K  V T   GT  Y  PE++  
Sbjct: 162 --CGVLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 216
Query: 476 GQLTEK-ADVYAFGVLVIEVASG 497
            +   + A V++ G+L+ ++  G
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN------EVNLISGIQH--KNV 356
           LG GG GSV+ G  + D   +A+K +  +      +  N      EV L+  +      V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RLL    E P+S ++    P    D   F+     +     R +      E + H H  
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHN- 160
Query: 417 SGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++HRDIK  NIL+D  +   K+ DFG     A  K  V T   GT  Y  PE++  
Sbjct: 161 --CGVLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 215
Query: 476 GQLTEK-ADVYAFGVLVIEVASG 497
            +   + A V++ G+L+ ++  G
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN------EVNLISGIQH--KNV 356
           LG GG GSV+ G  + D   +A+K +  +      +  N      EV L+  +      V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RLL    E P+S ++    P    D   F+     +     R +      E + H H  
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHN- 161
Query: 417 SGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++HRDIK  NIL+D  +   K+ DFG     A  K  V T   GT  Y  PE++  
Sbjct: 162 --CGVLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 216
Query: 476 GQLTEK-ADVYAFGVLVIEVASG 497
            +   + A V++ G+L+ ++  G
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCG 239

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN------EVNLISGIQH--KNV 356
           LG GG GSV+ G  + D   +A+K +  +      +  N      EV L+  +      V
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RLL    E P+S ++    P    D   F+     +     R +      E + H H  
Sbjct: 76  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 133
Query: 417 SGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++HRDIK  NIL+D  +   K+ DFG     A  K  V T   GT  Y  PE++  
Sbjct: 134 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 187
Query: 476 GQLTEK-ADVYAFGVLVIEVASG 497
            +   + A V++ G+L+ ++  G
Sbjct: 188 HRYHGRSAAVWSLGILLYDMVCG 210

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN------EVNLISGIQH--KNV 356
           LG GG GSV+ G  + D   +A+K +  +      +  N      EV L+  +      V
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RLL    E P+S ++    P    D   F+     +     R +      E + H H  
Sbjct: 72  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNX 129
Query: 417 SGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++HRDIK  NIL+D  +   K+ DFG     A  K  V T   GT  Y  PE++  
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 183
Query: 476 GQLTEK-ADVYAFGVLVIEVASG 497
            +   + A V++ G+L+ ++  G
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCG 206

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN------EVNLISGIQH--KNV 356
           LG GG GSV+ G  + D   +A+K +  +      +  N      EV L+  +      V
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RLL    E P+S ++    P    D   F+     +     R +      E + H H  
Sbjct: 92  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHN- 148
Query: 417 SGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++HRDIK  NIL+D  +   K+ DFG     A  K  V T   GT  Y  PE++  
Sbjct: 149 --CGVLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 203
Query: 476 GQLTEK-ADVYAFGVLVIEVASG 497
            +   + A V++ G+L+ ++  G
Sbjct: 204 HRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN------EVNLISGIQH--KNV 356
           LG GG GSV+ G  + D   +A+K +  +      +  N      EV L+  +      V
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RLL    E P+S ++    P    D   F+     +     R +      E + H H  
Sbjct: 77  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 134
Query: 417 SGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++HRDIK  NIL+D  +   K+ DFG     A  K  V T   GT  Y  PE++  
Sbjct: 135 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 188
Query: 476 GQLTEK-ADVYAFGVLVIEVASG 497
            +   + A V++ G+L+ ++  G
Sbjct: 189 HRYHGRSAAVWSLGILLYDMVCG 211

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN------EVNLISGIQH--KNV 356
           LG GG GSV+ G  + D   +A+K +  +      +  N      EV L+  +      V
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RLL    E P+S ++    P    D   F+     +     R +      E + H H  
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHN- 161
Query: 417 SGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++HRDIK  NIL+D  +   K+ DFG     A  K  V T   GT  Y  PE++  
Sbjct: 162 --CGVLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 216
Query: 476 GQLTEK-ADVYAFGVLVIEVASG 497
            +   + A V++ G+L+ ++  G
Sbjct: 217 HRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN------EVNLISGIQH--KNV 356
           LG GG GSV+ G  + D   +A+K +  +      +  N      EV L+  +      V
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RLL    E P+S ++    P    D   F+     +     R +      E + H H  
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHN- 160
Query: 417 SGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++HRDIK  NIL+D  +   K+ DFG     A  K  V T   GT  Y  PE++  
Sbjct: 161 --CGVLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 215
Query: 476 GQLTEK-ADVYAFGVLVIEVASG 497
            +   + A V++ G+L+ ++  G
Sbjct: 216 HRYHGRSAAVWSLGILLYDMVCG 238

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN------EVNLISGIQH--KNV 356
           LG GG GSV+ G  + D   +A+K +  +      +  N      EV L+  +      V
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RLL    E P+S ++    P    D   F+     +     R +      E + H H  
Sbjct: 75  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 132
Query: 417 SGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++HRDIK  NIL+D  +   K+ DFG     A  K  V T   GT  Y  PE++  
Sbjct: 133 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 186
Query: 476 GQLTEK-ADVYAFGVLVIEVASG 497
            +   + A V++ G+L+ ++  G
Sbjct: 187 HRYHGRSAAVWSLGILLYDMVCG 209

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN------EVNLISGIQH--KNV 356
           LG GG GSV+ G  + D   +A+K +  +      +  N      EV L+  +      V
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RLL    E P+S ++    P    D   F+     +     R +      E + H H  
Sbjct: 119 IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 176
Query: 417 SGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++HRDIK  NIL+D  +   K+ DFG     A  K  V T   GT  Y  PE++  
Sbjct: 177 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 230
Query: 476 GQLTEK-ADVYAFGVLVIEVASG 497
            +   + A V++ G+L+ ++  G
Sbjct: 231 HRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN------EVNLISGIQH--KNV 356
           LG GG GSV+ G  + D   +A+K +  +      +  N      EV L+  +      V
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RLL    E P+S ++    P    D   F+     +     R +      E + H H  
Sbjct: 77  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 134
Query: 417 SGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++HRDIK  NIL+D  +   K+ DFG     A  K  V T   GT  Y  PE++  
Sbjct: 135 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 188
Query: 476 GQLTEK-ADVYAFGVLVIEVASG 497
            +   + A V++ G+L+ ++  G
Sbjct: 189 HRYHGRSAAVWSLGILLYDMVCG 211

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN------EVNLISGIQH--KNV 356
           LG GG GSV+ G  + D   +A+K +  +      +  N      EV L+  +      V
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RLL    E P+S ++    P    D   F+     +     R +      E + H H  
Sbjct: 92  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHN- 148
Query: 417 SGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++HRDIK  NIL+D  +   K+ DFG     A  K  V T   GT  Y  PE++  
Sbjct: 149 --CGVLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 203
Query: 476 GQLTEK-ADVYAFGVLVIEVASG 497
            +   + A V++ G+L+ ++  G
Sbjct: 204 HRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN------EVNLISGIQH--KNV 356
           LG GG GSV+ G  + D   +A+K +  +      +  N      EV L+  +      V
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RLL    E P+S ++    P    D   F+     +     R +      E + H H  
Sbjct: 92  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHN- 148
Query: 417 SGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++HRDIK  NIL+D  +   K+ DFG     A  K  V T   GT  Y  PE++  
Sbjct: 149 --CGVLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 203
Query: 476 GQLTEK-ADVYAFGVLVIEVASG 497
            +   + A V++ G+L+ ++  G
Sbjct: 204 HRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN------EVNLISGIQH--KNV 356
           LG GG GSV+ G  + D   +A+K +  +      +  N      EV L+  +      V
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RLL    E P+S ++    P    D   F+     +     R +      E + H H  
Sbjct: 111 IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHN- 167
Query: 417 SGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++HRDIK  NIL+D  +   K+ DFG     A  K  V T   GT  Y  PE++  
Sbjct: 168 --CGVLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 222
Query: 476 GQLTEK-ADVYAFGVLVIEVASG 497
            +   + A V++ G+L+ ++  G
Sbjct: 223 HRYHGRSAAVWSLGILLYDMVCG 245

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN------EVNLISGIQH--KNV 356
           LG GG GSV+ G  + D   +A+K +  +      +  N      EV L+  +      V
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RLL    E P+S ++    P    D   F+     +     R +      E + H H  
Sbjct: 72  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC 129
Query: 417 SGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++HRDIK  NIL+D  +   K+ DFG     A  K  V T   GT  Y  PE++  
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 183
Query: 476 GQLTEK-ADVYAFGVLVIEVASG 497
            +   + A V++ G+L+ ++  G
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCG 206

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN------EVNLISGIQH--KNV 356
           LG GG GSV+ G  + D   +A+K +  +      +  N      EV L+  +      V
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RLL    E P+S ++    P    D   F+     +     R +      E + H H  
Sbjct: 72  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHN- 128
Query: 417 SGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++HRDIK  NIL+D  +   K+ DFG     A  K  V T   GT  Y  PE++  
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 183
Query: 476 GQLTEK-ADVYAFGVLVIEVASG 497
            +   + A V++ G+L+ ++  G
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCG 206

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN------EVNLISGIQH--KNV 356
           LG GG GSV+ G  + D   +A+K +  +      +  N      EV L+  +      V
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RLL    E P+S ++    P    D   F+     +     R +      E + H H  
Sbjct: 124 IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHN- 180
Query: 417 SGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++HRDIK  NIL+D  +   K+ DFG     A  K  V T   GT  Y  PE++  
Sbjct: 181 --CGVLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 235
Query: 476 GQLTEK-ADVYAFGVLVIEVASG 497
            +   + A V++ G+L+ ++  G
Sbjct: 236 HRYHGRSAAVWSLGILLYDMVCG 258

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 48/95 (50%), Gaps = 14/95 (14%)
Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP----KIADFGLARHVAPDKTHV 457
           +I    EG+ +LH  +   I+H D+K  NILL   + P    KI DFG++R +     H 
Sbjct: 136 LIKQILEGVYYLHQNN---IVHLDLKPQNILLS-SIYPLGDIKIVDFGMSRKIG----HA 187
Query: 458 ST--GIAGTLGYMAPEYLVRGQLTEKADVYAFGVL 490
                I GT  Y+APE L    +T   D++  G++
Sbjct: 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGII 222

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 19/203 (9%)
Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN------EVNLISGIQH--KNV 356
           LG GG GSV+ G  + D   +A+K +  +      +  N      EV L+  +      V
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RLL    E P+S ++    P    D   F+     +     R +      E + H H  
Sbjct: 99  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCHN- 155
Query: 417 SGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++HRDIK  NIL+D  +   K+ DFG     A  K  V T   GT  Y  PE++  
Sbjct: 156 --CGVLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRY 210
Query: 476 GQLTEK-ADVYAFGVLVIEVASG 497
            +   + A V++ G+L+ ++  G
Sbjct: 211 HRYHGRSAAVWSLGILLYDMVCG 233

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 43/83 (51%), Gaps = 8/83 (9%)
Query: 421 IIHRDIKTSNILL---DEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR-- 475
           IIHRD+K  N+LL   +E    KI DFG ++ +   +T +   + GT  Y+APE LV   
Sbjct: 274 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVG 331
Query: 476 -GQLTEKADVYAFGVLVIEVASG 497
                   D ++ GV++    SG
Sbjct: 332 TAGYNRAVDCWSLGVILFICLSG 354

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 43/83 (51%), Gaps = 8/83 (9%)
Query: 421 IIHRDIKTSNILL---DEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR-- 475
           IIHRD+K  N+LL   +E    KI DFG ++ +   +T +   + GT  Y+APE LV   
Sbjct: 260 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLVSVG 317
Query: 476 -GQLTEKADVYAFGVLVIEVASG 497
                   D ++ GV++    SG
Sbjct: 318 TAGYNRAVDCWSLGVILFICLSG 340

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/218 (22%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 306 LGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFF--NEVNLISGIQHKNVVRLLGCS 363
           LG+G  G V R      +   + +  F   +  DQ     E+++++  +H+N++ L    
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAK--FVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
               E ++++E++    LD    +  +   L+ ++  + +    E L  LH  +   I H
Sbjct: 71  ESMEELVMIFEFISG--LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGH 125
Query: 424 RDIKTSNILLDEKL--TPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLV-----RG 476
            DI+  NI+   +   T KI +FG AR + P       G    L + APEY         
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKP-------GDNFRLLFTAPEYYAPEVHQHD 178
Query: 477 QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV 514
            ++   D+++ G LV  + SG  N   +E +  ++  +
Sbjct: 179 VVSTATDMWSLGTLVYVLLSG-INPFLAETNQQIIENI 215

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 28/169 (16%)
Query: 343 NEVNLISGIQHKNVVRLLGC--SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRF 400
            E+ L+  ++HKNV++L+    + E  +  +V EY      + +  V         ++RF
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP--------EKRF 106
Query: 401 TI------ICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-- 452
            +       C   +GL +LH      I+H+DIK  N+LL    T KI+  G+A  + P  
Sbjct: 107 PVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163
Query: 453 -DKTHVSTGIAGTLGYMAPEYLVRGQLT---EKADVYAFGVLVIEVASG 497
            D T  ++   G+  +  PE +  G  T    K D+++ GV +  + +G
Sbjct: 164 ADDTCRTS--QGSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTG 209
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	625
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-134
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-119
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-119
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-82
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-64
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-60
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-60
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-57
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-52
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-52
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-51
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-49
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-49
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-49
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-48
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-47
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-46
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-45
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-38
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-36
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-36
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-36
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-35
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-35
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-35
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-35
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-35
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-35
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-34
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-34
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-34
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-34
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-34
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-34
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-34
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	8e-34
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	9e-34
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-33
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-33
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-33
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-33
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-33
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-33
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-33
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-33
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-33
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-33
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	9e-33
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	9e-33
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-32
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-32
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-32
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-32
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-32
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-32
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-32
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-32
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-32
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-32
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-32
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-32
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	8e-32
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-31
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-31
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-31
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-31
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-31
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-31
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-31
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-31
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-31
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-31
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-31
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-31
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-31
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-31
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-31
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	8e-31
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-31
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-30
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-30
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-30
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-30
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-30
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-30
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-30
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	7e-30
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-29
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-29
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-29
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-29
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-29
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-29
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-29
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-29
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-28
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-28
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-28
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	8e-28
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-27
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-27
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-27
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	7e-27
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-26
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-26
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-26
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-26
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-25
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-25
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-25
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-25
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-25
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-25
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-25
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-25
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	9e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-24
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-24
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-24
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-24
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-24
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-24
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-24
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	8e-24
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-23
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-23
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-23
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-23
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-23
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-23
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	9e-23
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-22
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-22
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-22
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-22
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-22
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-22
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-22
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-22
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-22
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	5e-22
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	3e-11
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-21
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-21
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-21
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-20
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-20
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-20
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-20
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-20
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	9e-20
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-19
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-19
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-19
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-19
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-19
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-19
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-19
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	8e-19
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-19
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-18
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-18
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-18
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-18
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-18
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-18
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-18
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-18
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-18
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-18
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	9e-18
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-07
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-17
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-17
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	7e-17
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	8e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	9e-17
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-16
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-16
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-15
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-15
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-15
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-15
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-14
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-14
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-14
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-14
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-14
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-14
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-14
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-13
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-13
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-13
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-13
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-12
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-12
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-12
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-11
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-11
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-11
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-10
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-06
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-06
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	4e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  396 bits (1019), Expect = e-134
 Identities = 114/287 (39%), Positives = 167/287 (58%), Gaps = 6/287 (2%)

Query: 288 FKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVD-QFFNEVN 346
           F    L+ A+D F N   LG+GG G V++G L DG  +AVKRL     Q  + QF  EV 
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI-LSWQQRFTIICG 405
           +IS   H+N++RL G  +   E LLVY Y+ N S+   L  +      L W +R  I  G
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139

Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTL 465
           +A GLA+LH     KIIHRD+K +NILLDE+    + DFGLA+ +    THV+T + GT+
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199

Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFS----EGSSSVLHTVWKHYKAN 521
           G++APEYL  G+ +EK DV+ +GV+++E+ +G+R    +    +    +L  V    K  
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259

Query: 522 RITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHML 568
           ++   +D  L G + + E  +++Q+ LLCTQ+    RP M+EVV ML
Sbjct: 260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  357 bits (918), Expect = e-119
 Identities = 105/315 (33%), Positives = 169/315 (53%), Gaps = 9/315 (2%)

Query: 262 TRYKRLSEMRKGQVLLGTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPD 321
           ++Y + +      +    ++   S       LE AT+ FD+   +G G  G V++G L D
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62

Query: 322 GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSL 381
           G  +A+KR    S Q +++F  E+  +S  +H ++V L+G   E  E +L+Y+Y+ N +L
Sbjct: 63  GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122

Query: 382 DQILFVKNTIHI-LSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPK 440
            + L+  +   + +SW+QR  I  G A GL +LH  +   IIHRD+K+ NILLDE   PK
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179

Query: 441 IADFGLARHVAP--DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           I DFG+++      D+TH+ST + GTLGY+ PEY ++G+LTEK+DVY+FGV++ EV   R
Sbjct: 180 ITDFGISK-KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

Query: 499 RNSVFS--EGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVA 556
              V S      ++     + +   ++ Q +DP L  +       +     + C      
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298

Query: 557 LRPSMAEVVHMLNNI 571
            RPSM +V+  L   
Sbjct: 299 DRPSMGDVLWKLEYA 313

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  356 bits (917), Expect = e-119
 Identities = 97/297 (32%), Positives = 150/297 (50%), Gaps = 20/297 (6%)

Query: 288 FKYEILERATDFFD------NSRKLGQGGAGSVFRGTLPDGRNIAVKRL----FFNSRQW 337
           F +  L+  T+ FD         K+G+GG G V++G + +   +AVK+L       + + 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73

Query: 338 VDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQ 397
             QF  E+ +++  QH+N+V LLG S +G +  LVY Y+PN SL   L   +    LSW 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133

Query: 398 QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP--DKT 455
            R  I  G A G+  LH       IHRDIK++NILLDE  T KI+DFGLAR  +    +T
Sbjct: 134 MRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR-ASEKFAQT 189

Query: 456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVW 515
            +++ I GT  YMAPE L RG++T K+D+Y+FGV+++E+ +G            +L    
Sbjct: 190 VMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE 248

Query: 516 KHYKANR-ITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +     + I   +D  +           +  +   C       RP + +V  +L  +
Sbjct: 249 EIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  261 bits (669), Expect = 1e-82
 Identities = 77/316 (24%), Positives = 125/316 (39%), Gaps = 33/316 (10%)

Query: 282 CTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQ-WVDQ 340
            +S ++   E L   +          +G  G V++        +AVK      +Q W  Q
Sbjct: 8   HSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSW--Q 64

Query: 341 FFNEVNLISGIQHKNVVRLLGCSIEGP----ESLLVYEYVPNRSLDQILFVKNTIHILSW 396
              EV  + G++H+N+++ +G    G     +  L+  +    SL   L      +++SW
Sbjct: 65  NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA----NVVSW 120

Query: 397 QQRFTIICGTAEGLAHLH-------GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH 449
            +   I    A GLA+LH        G    I HRDIK+ N+LL   LT  IADFGLA  
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180

Query: 450 VAPDKTHV-STGIAGTLGYMAPEYL-----VRGQLTEKADVYAFGVLVIEVASGRR--NS 501
               K+   + G  GT  YMAPE L      +     + D+YA G+++ E+AS     + 
Sbjct: 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240

Query: 502 VFSEGSSSVLHTVWKHYKANRI-----TQSMDPGLTGRFPENEASRVL-QIGLLCTQAPV 555
              E        + +H     +      +   P L   + ++    +L +    C     
Sbjct: 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300

Query: 556 ALRPSMAEVVHMLNNI 571
             R S   V   +  +
Sbjct: 301 EARLSAGCVGERITQM 316

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  213 bits (543), Expect = 6e-64
 Identities = 73/335 (21%), Positives = 118/335 (35%), Gaps = 46/335 (13%)

Query: 286 LNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEV 345
           +           D       +G+G  G+V++G+L D R +AVK   F +RQ    F NE 
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEK 56

Query: 346 N--LISGIQHKNVVRLLGCSIEGPES-----LLVYEYVPNRSLDQILFVKNTIHILSWQQ 398
           N   +  ++H N+ R +              LLV EY PN SL + L +    H   W  
Sbjct: 57  NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL----HTSDWVS 112

Query: 399 RFTIICGTAEGLAHLH------GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP 452
              +      GLA+LH            I HRD+ + N+L+    T  I+DFGL+  +  
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172

Query: 453 DK-------THVSTGIAGTLGYMAPEYL-------VRGQLTEKADVYAFGVLVIEVASGR 498
           ++        + +    GT+ YMAPE L             ++ D+YA G++  E+    
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232

Query: 499 RNSVFSEGSSSVL----HTVWKHYKANRI-----TQSMDPGLTGRFPENEASRVLQIGLL 549
            +    E            V  H     +      +   P     + EN  +       +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292

Query: 550 --CTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPP 582
             C       R +       +  +       K   
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  201 bits (514), Expect = 5e-60
 Identities = 74/316 (23%), Positives = 133/316 (42%), Gaps = 28/316 (8%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
             +G+G  G V +      +++A+K++   S      F  E+  +S + H N+V+L G  
Sbjct: 14  EVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKLYGAC 70

Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           +      LV EY    SL  +L     +   +     +     ++G+A+LH      +IH
Sbjct: 71  LNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128

Query: 424 RDIKTSNILLDEKLT-PKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKA 482
           RD+K  N+LL    T  KI DFG A     D     T   G+  +MAPE       +EK 
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKC 184

Query: 483 DVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR--ITQSMDPGLTGRFPENEA 540
           DV+++G+++ EV + R+   F E        +W  +   R  + +++   +         
Sbjct: 185 DVFSWGIILWEVITRRK--PFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI--------- 233

Query: 541 SRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQP-PFLNASVISPSDNSKDSM 599
             ++     C     + RPSM E+V ++ ++    P   +P  +     + P ++ +   
Sbjct: 234 ESLMT---RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEP 290

Query: 600 MSSFKSFVAESPEIDH 615
              F  F      +DH
Sbjct: 291 YVDFAEFYRLW-SVDH 305

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  201 bits (514), Expect = 6e-60
 Identities = 79/280 (28%), Positives = 132/280 (47%), Gaps = 20/280 (7%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLG 361
            K+G G  G+V R     G ++AVK L       + V++F  EV ++  ++H N+V  +G
Sbjct: 43  EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
              + P   +V EY+   SL ++L        L  ++R ++    A+G+ +LH      I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPI 160

Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEK 481
           +HR++K+ N+L+D+K T K+ DFGL+R +       S   AGT  +MAPE L      EK
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEK 219

Query: 482 ADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM-DPGLTGRFPENEA 540
           +DVY+FGV++ E+A+ +                W +    ++  ++         P N  
Sbjct: 220 SDVYSFGVILWELATLQ--------------QPWGNLNPAQVVAAVGFKCKRLEIPRNLN 265

Query: 541 SRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQ 580
            +V  I   C       RPS A ++ +L  +     PP  
Sbjct: 266 PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  192 bits (490), Expect = 8e-57
 Identities = 70/286 (24%), Positives = 123/286 (43%), Gaps = 41/286 (14%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRLFF-------NSRQWVDQFFNEVNLISGIQHKN 355
           +++G+GG G V +G  + D   +A+K L            +   +F  EV ++S + H N
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           +V+L G     P   +V E+VP   L   L   +  H + W  +  ++   A G+ ++  
Sbjct: 85  IVKLYGLMHNPP--RMVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGIEYMQN 140

Query: 416 GSGIKIIHRDIKTSNILLDEK-----LTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAP 470
                I+HRD+++ NI L        +  K+ADFGL++       H  +G+ G   +MAP
Sbjct: 141 -QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMAP 195

Query: 471 EYLVRGQL--TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMD 528
           E +   +   TEKAD Y+F +++  + +G                 +  Y   +I     
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEG--------------PFDEYSYGKIKFINM 241

Query: 529 PGLTGR---FPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
               G     PE+   R+  +  LC       RP  + +V  L+ +
Sbjct: 242 IREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  180 bits (460), Expect = 1e-52
 Identities = 59/279 (21%), Positives = 112/279 (40%), Gaps = 37/279 (13%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLG 361
            KL +  +G +++G    G +I VK L     S +    F  E   +    H NV+ +LG
Sbjct: 16  TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 362 CSIEGPESLL--VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
                P      +  ++P  SL  +L  + T  ++   Q        A G+A LH     
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMARGMAFLHT-LEP 132

Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQ-- 477
            I    + + ++++DE +T +I+   +        +  S G      ++APE L + +  
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEAL-QKKPE 185

Query: 478 --LTEKADVYAFGVLVIEVASGRRNSVFSE-GSSSVLHTVWKHYKANR--ITQSMDPGLT 532
                 AD+++F VL+ E+ +      F++  +  +   V    +  R  I   + P + 
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREV--PFADLSNMEIGMKV--ALEGLRPTIPPGISPHV- 240

Query: 533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
                   S++++I   C     A RP    +V +L  +
Sbjct: 241 --------SKLMKI---CMNEDPAKRPKFDMIVPILEKM 268

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  180 bits (460), Expect = 1e-52
 Identities = 68/281 (24%), Positives = 114/281 (40%), Gaps = 35/281 (12%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRL----FFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
             +G GG G V+R     G  +AVK        +  Q ++    E  L + ++H N++ L
Sbjct: 13  EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G  ++ P   LV E+     L+++L  K     +            A G+ +LH  + +
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 420 KIIHRDIKTSNILLDEKLTP--------KIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
            IIHRD+K+SNIL+ +K+          KI DFGLAR             AG   +MAPE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAPE 184

Query: 472 YLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM-DPG 530
            +     ++ +DV+++GVL+ E+ +G                 ++      +   +    
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGE--------------VPFRGIDGLAVAYGVAMNK 230

Query: 531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           L    P        ++   C       RPS   ++  L  I
Sbjct: 231 LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  177 bits (451), Expect = 7e-51
 Identities = 68/295 (23%), Positives = 112/295 (37%), Gaps = 35/295 (11%)

Query: 304 RKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGC 362
             LG+G  G   + T    G  + +K L     +    F  EV ++  ++H NV++ +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 363 SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
             +      + EY+   +L  I+  K+      W QR +     A G+A+LH    + II
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNII 130

Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH-------------VSTGIAGTLGYMA 469
           HRD+ + N L+ E     +ADFGLAR +  +KT                  + G   +MA
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 470 PEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR--ITQSM 527
           PE +      EK DV++FG+++ E+                       Y         ++
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVN--------------ADPDYLPRTMDFGLNV 236

Query: 528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPP 582
              L    P N       I + C       RPS  ++ H L  +   +       
Sbjct: 237 RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  174 bits (444), Expect = 1e-49
 Identities = 71/299 (23%), Positives = 112/299 (37%), Gaps = 37/299 (12%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNE--VNLISGIQHKNVVRLLG 361
           +++G+G  G V+ G    G  +AVK            +F E  +     ++H+N++  + 
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIA 98

Query: 362 CSIEGPES----LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH--- 414
             I+G  S     L+ +Y  N SL   L        L  +    +   +  GL HLH   
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 415 --GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV---STGIAGTLGYMA 469
                   I HRD+K+ NIL+ +  T  IAD GLA     D   V        GT  YM 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214

Query: 470 PE------YLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEG------SSSVLHTVWKH 517
           PE           Q    AD+Y+FG+++ EVA    +    E               ++ 
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274

Query: 518 YKANRITQSMDPGLTGRFPENEASRVLQIGLL--CTQAPVALRPSMAEVVHMLNNIDYE 574
            +     + + P    R+  +E  R +   L+  C     A R +   V   L  +   
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQM-GKLMTECWAHNPASRLTALRVKKTLAKMSES 332

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  171 bits (435), Expect = 9e-49
 Identities = 73/302 (24%), Positives = 117/302 (38%), Gaps = 47/302 (15%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNE--VNLISGIQHKNVVRLLG 361
             +G+G  G V+RG+   G N+AVK     S +    +F E  +     ++H+N++  + 
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 362 CSIEGPES----LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH--- 414
             +    S     L+  Y    SL   L     +  L       I+   A GLAHLH   
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 415 --GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV---STGIAGTLGYMA 469
                   I HRD+K+ NIL+ +     IAD GLA   +     +   +    GT  YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185

Query: 470 PEYLVRGQL-------TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR 522
           PE L    +        ++ D++AFG+++ EVA      + S G        +     N 
Sbjct: 186 PEVL-DETIQVDCFDSYKRVDIWAFGLVLWEVARR----MVSNGIVEDYKPPFYDVVPND 240

Query: 523 IT-QSMD---------PGLTGRFPENEASRVLQIGLL--CTQAPVALRPSMAEVVHMLNN 570
            + + M          P +  R+  +     L   L+  C     + R +   +   L  
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSL-AKLMKECWYQNPSARLTALRIKKTLTK 299

Query: 571 ID 572
           ID
Sbjct: 300 ID 301

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  167 bits (424), Expect = 3e-47
 Identities = 71/280 (25%), Positives = 132/280 (47%), Gaps = 35/280 (12%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLG 361
           +++G G  G+V++G      ++AVK L     + Q +  F NEV ++   +H N++  +G
Sbjct: 30  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
            S     ++ V ++    SL   L    T      ++   I   TA G+ +LH      I
Sbjct: 88  YSTAPQLAI-VTQWCEGSSLYHHLHASETK--FEMKKLIDIARQTARGMDYLHA---KSI 141

Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVSTGIAGTLGYMAPEYLVRGQL-- 478
           IHRD+K++NI L E  T KI DFGLA   +    +H    ++G++ +MAPE ++R Q   
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDSN 200

Query: 479 --TEKADVYAFGVLVIEVASGRR-----NSVFSEGSSSVLHTVWKHYKANRITQSMDPGL 531
             + ++DVYAFG+++ E+ +G+      N+        ++  V +   +  +++      
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNR-----DQIIEMVGRGSLSPDLSK------ 249

Query: 532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
                 N   R+ ++   C +     RPS   ++  +  +
Sbjct: 250 ---VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  164 bits (418), Expect = 3e-46
 Identities = 58/300 (19%), Positives = 110/300 (36%), Gaps = 38/300 (12%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFF--NSRQWVDQFFNEVNLISGIQHKNVVRLLG 361
             +G+G  G V+ G    G  +A++ +    ++   +  F  EV      +H+NVV  +G
Sbjct: 39  ELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
             +  P   ++      R+L  ++       +L   +   I     +G+ +LH      I
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLH---AKGI 151

Query: 422 IHRDIKTSNILLDEKLTPKIADFGLAR----HVAPDKTHVSTGIAGTLGYMAPEYLVRGQ 477
           +H+D+K+ N+  D      I DFGL        A  +        G L ++APE + +  
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 478 L---------TEKADVYAFGVLVIEVASGRRNSVFSEGSSS-VLHTVWKHYKANRITQSM 527
                     ++ +DV+A G +  E+ +      F    +  ++  +    K N     M
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWP--FKTQPAEAIIWQMGTGMKPNLSQIGM 268

Query: 528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNAS 587
              ++             I L C       RP+  +++ ML  +         P     S
Sbjct: 269 GKEIS------------DILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKS 316

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  164 bits (416), Expect = 1e-45
 Identities = 72/297 (24%), Positives = 117/297 (39%), Gaps = 39/297 (13%)

Query: 305 KLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNE--VNLISGIQHKNVVRLLGC 362
            +G+G  G V+RG    G  +AVK     S +    +F E  +     ++H+N++  +  
Sbjct: 49  SIGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 363 SI----EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH---- 414
                    +  LV +Y  + SL   L      + ++ +    +   TA GLAHLH    
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 160

Query: 415 -GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV---STGIAGTLGYMAP 470
                  I HRD+K+ NIL+ +  T  IAD GLA         +        GT  YMAP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

Query: 471 EYLVRGQL-------TEKADVYAFGVLVIEVASGRRNSVFSE------GSSSVLHTVWKH 517
           E L    +        ++AD+YA G++  E+A         E                + 
Sbjct: 221 EVL-DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 279

Query: 518 YKANRITQSMDPGLTGRFPENEASRVLQIGLL--CTQAPVALRPSMAEVVHMLNNID 572
            +     Q + P +  R+   EA RV+   ++  C  A  A R +   +   L+ + 
Sbjct: 280 MRKVVCEQKLRPNIPNRWQSCEALRVM-AKIMRECWYANGAARLTALRIKKTLSQLS 335

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  143 bits (364), Expect = 5e-38
 Identities = 69/280 (24%), Positives = 112/280 (40%), Gaps = 39/280 (13%)

Query: 304 RKLGQGGAGSVFRGTL-PDGRNIAVKRL-FFNSRQWVDQFFNEVNLISGIQHKNVVRLLG 361
            ++G+G  G VF G L  D   +AVK            +F  E  ++    H N+VRL+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179

Query: 362 -CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIK 420
            C+ + P   +V E V         F++     L  +    ++   A G+ +L       
Sbjct: 180 VCTQKQP-IYIVMELVQGGDFLT--FLRTEGARLRVKTLLQMVGDAAAGMEYLES---KC 233

Query: 421 IIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGY--MAPEYLVRGQL 478
            IHRD+   N L+ EK   KI+DFG++R    D  + ++G    +     APE L  G+ 
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREE-ADGVYAASGGLRQVPVKWTAPEALNYGRY 292

Query: 479 TEKADVYAFGVLVIEVAS-------GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL 531
           + ++DV++FG+L+ E  S          N             V K  +       +    
Sbjct: 293 SSESDVWSFGILLWETFSLGASPYPNLSN-------QQTREFVEKGGR-------LPC-- 336

Query: 532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
               PE     V ++   C       RPS + +   L +I
Sbjct: 337 ----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  140 bits (355), Expect = 3e-36
 Identities = 74/279 (26%), Positives = 122/279 (43%), Gaps = 19/279 (6%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
            KLGQG  G V+ GT      +A+K L   +    + F  E  ++  ++H+ +V+L    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
            E P   +V EY+   SL   L    T   L   Q   +    A G+A++     +  +H
Sbjct: 249 SEEP-IYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 303

Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +NIL+ E L  K+ADFGLAR +  ++     G    + + APE  + G+ T K+D
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363

Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRV 543
           V++FG+L+ E+ +  R       +  VL  V + Y+       M        P      +
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-------MPC------PPECPESL 410

Query: 544 LQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPP 582
             +   C +     RP+   +   L +      P  QP 
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 449

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  136 bits (344), Expect = 4e-36
 Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 16/202 (7%)

Query: 305 KLGQGGAGSVFRGT-LPDGRNIAVK--RLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLG 361
           ++G+G   +V++G        +A    +    ++    +F  E  ++ G+QH N+VR   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 362 C---SIEGPESLLVY-EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
               +++G + +++  E + + +L   L       ++  +   +      +GL  LH   
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT-R 148

Query: 418 GIKIIHRDIKTSNILLDEKL-TPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG 476
              IIHRD+K  NI +     + KI D GLA             + GT  +MAPE     
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEM-YEE 204

Query: 477 QLTEKADVYAFGVLVIEVASGR 498
           +  E  DVYAFG+ ++E+A+  
Sbjct: 205 KYDESVDVYAFGMCMLEMATSE 226

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  135 bits (343), Expect = 9e-36
 Identities = 53/230 (23%), Positives = 95/230 (41%), Gaps = 32/230 (13%)

Query: 287 NFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEV 345
           N  Y  +          +KLG+GG   V     L DG   A+KR+  + +Q  ++   E 
Sbjct: 28  NKHYLFI----------QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREA 77

Query: 346 NLISGIQHKNVVRLLGCSIEGPES----LLVYEYVPNRSL-DQILFVKNTIHILSWQQRF 400
           ++     H N++RL+   +    +     L+  +    +L ++I  +K+  + L+  Q  
Sbjct: 78  DMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137

Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG 460
            ++ G   GL  +H        HRD+K +NILL ++  P + D G               
Sbjct: 138 WLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194

Query: 461 IA--------GTLGYMAPEYLVRGQ----LTEKADVYAFGVLVIEVASGR 498
           +          T+ Y APE L   Q    + E+ DV++ G ++  +  G 
Sbjct: 195 LTLQDWAAQRCTISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  140 bits (353), Expect = 1e-35
 Identities = 74/279 (26%), Positives = 122/279 (43%), Gaps = 19/279 (6%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
            KLGQG  G V+ GT      +A+K L   +    + F  E  ++  ++H+ +V+L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
            E P   +V EY+   SL   L    T   L   Q   +    A G+A++     +  +H
Sbjct: 332 SEEP-IYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVH 386

Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +NIL+ E L  K+ADFGLAR +  ++     G    + + APE  + G+ T K+D
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446

Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRV 543
           V++FG+L+ E+ +  R       +  VL  V + Y+       M        P      +
Sbjct: 447 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-------MPC------PPECPESL 493

Query: 544 LQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPP 582
             +   C +     RP+   +   L +      P  QP 
Sbjct: 494 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 532

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  139 bits (351), Expect = 2e-35
 Identities = 71/269 (26%), Positives = 119/269 (44%), Gaps = 19/269 (7%)

Query: 304 RKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGC 362
            KLG G  G V+ G        +AVK L  ++ + V++F  E  ++  I+H N+V+LLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 363 SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
               P   ++ E++   +L   L  +     +S      +    +  + +L        I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 340

Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKA 482
           HR++   N L+ E    K+ADFGL+R +  D      G    + + APE L   + + K+
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400

Query: 483 DVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASR 542
           DV+AFGVL+ E+A+   +       S V   + K Y+       M+       PE    +
Sbjct: 401 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-------MER------PEGCPEK 447

Query: 543 VLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           V ++   C Q   + RPS AE+      +
Sbjct: 448 VYELMRACWQWNPSDRPSFAEIHQAFETM 476

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  135 bits (341), Expect = 2e-35
 Identities = 53/223 (23%), Positives = 97/223 (43%), Gaps = 33/223 (14%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFN---SRQWVDQFFNE 344
            + I +          K+G+G    V+R   L DG  +A+K++        +       E
Sbjct: 33  NFRIEK----------KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKE 82

Query: 345 VNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQIL--FVKNTIH-----ILSWQ 397
           ++L+  + H NV++     IE  E  +V E      L +++  F K         +  + 
Sbjct: 83  IDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY- 141

Query: 398 QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV 457
             F  +C     L H+H     +++HRDIK +N+ +      K+ D GL R  +   T  
Sbjct: 142 --FVQLC---SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 193

Query: 458 STGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGRR 499
            + + GT  YM+PE  +       K+D+++ G L+ E+A+ + 
Sbjct: 194 HS-LVGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQS 234

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  133 bits (338), Expect = 3e-35
 Identities = 70/284 (24%), Positives = 118/284 (41%), Gaps = 41/284 (14%)

Query: 304 RKLGQGGAGSVFRGTLPDGRN----IAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVR 358
           R +G+G  G V+ G   D        A+K L      Q V+ F  E  L+ G+ H NV+ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 359 LLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
           L+G          ++  Y+ +  L Q  F+++     + +   +     A G+ +L   +
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQ--FIRSPQRNPTVKDLISFGLQVARGMEYL---A 141

Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTL--GYMAPEYLV 474
             K +HRD+   N +LDE  T K+ADFGLAR +   +   V       L   + A E L 
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201

Query: 475 RGQLTEKADVYAFGVLVIEVAS-------GRRNSVFSEGSSSVLHTVWKHYKANRITQSM 527
             + T K+DV++FGVL+ E+ +                    + H + +  +       +
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-------DLTHFLAQGRR-------L 247

Query: 528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
                   PE     + Q+   C +A  A+RP+   +V  +  I
Sbjct: 248 PQ------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  133 bits (337), Expect = 4e-35
 Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 36/212 (16%)

Query: 306 LGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI 364
           LG+G  G V+ G  L +   IA+K +     ++      E+ L   ++HKN+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 365 EGPESLLVYEYVPNRSLDQILFVKN-------------TIHILSWQQRFTIICGTAEGLA 411
           E     +  E VP  SL  +L  K              T  IL             EGL 
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-------------EGLK 136

Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKL-TPKIADFGLARHVAPDKTHVSTGIAGTLGYMAP 470
           +LH     +I+HRDIK  N+L++      KI+DFG ++ +A       T   GTL YMAP
Sbjct: 137 YLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAP 192

Query: 471 EYLVRGQL---TEKADVYAFGVLVIEVASGRR 499
           E ++        + AD+++ G  +IE+A+G+ 
Sbjct: 193 E-IIDKGPRGYGKAADIWSLGCTIIEMATGKP 223

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  133 bits (337), Expect = 5e-35
 Identities = 73/285 (25%), Positives = 120/285 (42%), Gaps = 43/285 (15%)

Query: 304 RKLGQGGAGSVFRGTLPDGRN----IAVKRL--FFNSRQWVDQFFNEVNLISGIQHKNVV 357
             +G+G  G V+ GTL D        AVK L    +  +    F  E  ++    H NV+
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNVL 89

Query: 358 RLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
            LLG C       L+V  Y+ +  L    F++N  H  + +         A+G+ +L   
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL--- 144

Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTL---GYMAPEYL 473
           +  K +HRD+   N +LDEK T K+ADFGLAR +   + +      G      +MA E L
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204

Query: 474 VRGQLTEKADVYAFGVLVIEVAS-------GRRNSVFSEGSSSVLHTVWKHYKANRITQS 526
              + T K+DV++FGVL+ E+ +                    +   + +  +       
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQGRR------- 250

Query: 527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +        PE     + ++ L C      +RPS +E+V  ++ I
Sbjct: 251 LLQ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  134 bits (340), Expect = 5e-35
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 30/220 (13%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFN--SRQWVDQFFNEV 345
           KY  L          +K+G+G  G         DGR   +K +  +  S +  ++   EV
Sbjct: 25  KYVRL----------QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREV 74

Query: 346 NLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIH-----ILSWQQRF 400
            +++ ++H N+V+      E     +V +Y     L + +  +  +      IL W   F
Sbjct: 75  AVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW---F 131

Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG 460
             IC     L H+H     KI+HRDIK+ NI L +  T ++ DFG+AR +          
Sbjct: 132 VQIC---LALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA- 184

Query: 461 IAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGRR 499
             GT  Y++PE +   +    K+D++A G ++ E+ + + 
Sbjct: 185 CIGTPYYLSPE-ICENKPYNNKSDIWALGCVLYELCTLKH 223

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  131 bits (333), Expect = 1e-34
 Identities = 62/276 (22%), Positives = 120/276 (43%), Gaps = 35/276 (12%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLG-C 362
           ++LG G  G V  G      ++A+K +   S    D+F  E  ++  + H+ +V+L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 363 SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
           + + P   ++ EY+ N  L    +++   H    QQ   +     E + +L      + +
Sbjct: 89  TKQRP-IFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFL 142

Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKA 482
           HRD+   N L++++   K++DFGL+R+V  D+   S G    + +  PE L+  + + K+
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202

Query: 483 DVYAFGVLVIEVAS-------GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF 535
           D++AFGVL+ E+ S          N       S     + +  +       +        
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTN-------SETAEHIAQGLR-------LYR------ 242

Query: 536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           P   + +V  I   C       RP+   ++  + ++
Sbjct: 243 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  132 bits (335), Expect = 1e-34
 Identities = 72/281 (25%), Positives = 118/281 (41%), Gaps = 22/281 (7%)

Query: 304 RKLGQGGAGSVFRGTL---PDGRNI--AVKRL-FFNSRQWVDQFFNEVNLISGIQHKNVV 357
           R LG+G  G V         DG     AVK L      Q    +  E++++  + H++++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 358 RLLG-CSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           +  G C   G  SL LV EYVP  SL    ++    H +   Q         EG+A+LH 
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRD--YLPR--HSIGLAQLLLFAQQICEGMAYLHA 152

Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTL--GYMAPEYL 473
                 IHRD+   N+LLD     KI DFGLA+ V     +      G     + APE L
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209

Query: 474 VRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT 532
              +    +DV++FGV + E+ +    +         ++          R+T+ ++ G  
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG-- 267

Query: 533 GRF--PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            R   P+   + V  +   C +   + RP+   ++ +L  +
Sbjct: 268 ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  131 bits (332), Expect = 2e-34
 Identities = 53/224 (23%), Positives = 88/224 (39%), Gaps = 28/224 (12%)

Query: 295 RATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQW-VDQFFNEVNLISGIQ 352
           R    F+  + LG+GG G VF      D  N A+KR+   +R+   ++   EV  ++ ++
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61

Query: 353 HKNVVRLLGCSIEGPESL------------LVYEYVPNRSLDQILFVKNTIHILSWQQRF 400
           H  +VR     +E   +             +  +     +L   +  + TI         
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR-----------H 449
            I    AE +  LH      ++HRD+K SNI        K+ DFGL              
Sbjct: 122 HIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 450 VAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIE 493
                    TG  GT  YM+PE +     + K D+++ G+++ E
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  129 bits (326), Expect = 6e-34
 Identities = 65/276 (23%), Positives = 120/276 (43%), Gaps = 35/276 (12%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLG-C 362
           +++G G  G V  G   +   +A+K +   +    + F  E  ++  + H  +V+L G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 363 SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
             + P   LV E++ +  L    +++    + + +    +     EG+A+L       +I
Sbjct: 73  LEQAP-ICLVTEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVI 126

Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKA 482
           HRD+   N L+ E    K++DFG+ R V  D+   STG    + + +PE     + + K+
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186

Query: 483 DVYAFGVLVIEVAS-------GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF 535
           DV++FGVL+ EV S        R N       S V+  +   ++       +        
Sbjct: 187 DVWSFGVLMWEVFSEGKIPYENRSN-------SEVVEDISTGFR-------LYK------ 226

Query: 536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           P   ++ V QI   C +     RP+ + ++  L  I
Sbjct: 227 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  133 bits (336), Expect = 6e-34
 Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 22/210 (10%)

Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI-QHKNVVR 358
           F     LG G  G++    + D R++AVKR+     +       EV L+    +H NV+R
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVIR 82

Query: 359 LLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
              C+ +  +   +  E     +L +   V+         +  T++  T  GLAHLH   
Sbjct: 83  YF-CTEKDRQFQYIAIELCAA-TLQEY--VEQKDFAHLGLEPITLLQQTTSGLAHLHS-- 136

Query: 418 GIKIIHRDIKTSNILLDEK-----LTPKIADFGLARHVAPDK--THVSTGIAGTLGYMAP 470
            + I+HRD+K  NIL+        +   I+DFGL + +A  +      +G+ GT G++AP
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 471 EYL---VRGQLTEKADVYAFGVLVIEVASG 497
           E L    +   T   D+++ G +   V S 
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  129 bits (326), Expect = 7e-34
 Identities = 73/276 (26%), Positives = 121/276 (43%), Gaps = 35/276 (12%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLG-C 362
           ++LG G  G V  G      ++AVK +   S    D+FF E   +  + H  +V+  G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 363 SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
           S E P   +V EY+ N  L    ++++    L   Q   +     EG+A L      + I
Sbjct: 73  SKEYP-IYIVTEYISNGCLLN--YLRSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFI 126

Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKA 482
           HRD+   N L+D  L  K++DFG+ R+V  D+   S G    + + APE     + + K+
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186

Query: 483 DVYAFGVLVIEVAS-GRR------NSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF 535
           DV+AFG+L+ EV S G+       N       S V+  V + ++       +        
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTN-------SEVVLKVSQGHR-------LYR------ 226

Query: 536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           P   +  + QI   C       RP+  +++  +  +
Sbjct: 227 PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  130 bits (329), Expect = 8e-34
 Identities = 65/302 (21%), Positives = 109/302 (36%), Gaps = 48/302 (15%)

Query: 304 RKLGQGGAGSVFRGTLPDGRN----IAVKRL--FFNSRQWVDQFFNEVNLISGIQHKNVV 357
           R LG+G  GSV    L         +AVK L     +   +++F  E   +    H +V 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 358 RLLG-CSIEGPES-----LLVYEYVPNRSLDQIL---FVKNTIHILSWQQRFTIICGTAE 408
           +L+G       +      +++  ++ +  L   L    +      L  Q     +   A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTL--G 466
           G+ +L   S    IHRD+   N +L E +T  +ADFGL+R +     +     A  L   
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGC-ASKLPVK 204

Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVAS-------GRRNSVFSEGSSSVLHTVWKHYK 519
           ++A E L     T  +DV+AFGV + E+ +       G  N       + + + +    +
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-------AEIYNYLIGGNR 257

Query: 520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPK 579
                  +        P      V  +   C  A    RPS   +   L NI   +    
Sbjct: 258 -------LKQ------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304

Query: 580 QP 581
             
Sbjct: 305 TS 306

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  133 bits (337), Expect = 8e-34
 Identities = 72/275 (26%), Positives = 121/275 (44%), Gaps = 33/275 (12%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           +KLG G  G V+  T      +AVK +   S   V+ F  E N++  +QH  +V+L    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
            + P   ++ E++   SL   L   +        +        AEG+A +        IH
Sbjct: 253 TKEP-IYIITEFMAKGSLLDFLK-SDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYIH 307

Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +NIL+   L  KIADFGLAR +  ++     G    + + APE +  G  T K+D
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367

Query: 484 VYAFGVLVIEVAS-GRR------NSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP 536
           V++FG+L++E+ + GR       N         V+  + + Y+       M        P
Sbjct: 368 VWSFGILLMEIVTYGRIPYPGMSN-------PEVIRALERGYR-------MPR------P 407

Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           EN    +  I + C +     RP+   +  +L++ 
Sbjct: 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  131 bits (332), Expect = 9e-34
 Identities = 74/285 (25%), Positives = 119/285 (41%), Gaps = 43/285 (15%)

Query: 304 RKLGQGGAGSVFRGTLPDGRN----IAVKRL--FFNSRQWVDQFFNEVNLISGIQHKNVV 357
             +G+G  G V+ GTL D        AVK L    +  +    F  E  ++    H NV+
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNVL 153

Query: 358 RLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
            LLG C       L+V  Y+ +  L    F++N  H  + +         A+G+  L   
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL--- 208

Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV-APDKTHVSTGIAGTL--GYMAPEYL 473
           +  K +HRD+   N +LDEK T K+ADFGLAR +   +   V       L   +MA E L
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268

Query: 474 VRGQLTEKADVYAFGVLVIEVAS-------GRRNSVFSEGSSSVLHTVWKHYKANRITQS 526
              + T K+DV++FGVL+ E+ +                    +   + +  +       
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQGRR------- 314

Query: 527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +        PE     + ++ L C      +RPS +E+V  ++ I
Sbjct: 315 LLQ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  129 bits (326), Expect = 1e-33
 Identities = 62/281 (22%), Positives = 125/281 (44%), Gaps = 20/281 (7%)

Query: 304 RKLGQGGAGSVFRGTL-PDGRN----IAVKRL-FFNSRQWVDQFFNEVNLISGIQHKNVV 357
           R LG+G  G V      P+G N    +AVK L   +    +     E+ ++  + H+N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 358 RLLG-CSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           +  G C+ +G   + L+ E++P+ SL +  ++    + ++ +Q+        +G+ +L  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKE--YLPKNKNKINLKQQLKYAVQICKGMDYL-- 142

Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTL--GYMAPEYL 473
               + +HRD+   N+L++ +   KI DFGL + +  DK + +          + APE L
Sbjct: 143 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201

Query: 474 VRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT 532
           ++ +    +DV++FGV + E+ +    +S        ++          R+  ++  G  
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG-- 259

Query: 533 GRF--PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            R   P N    V Q+   C +   + R S   ++     +
Sbjct: 260 KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  128 bits (324), Expect = 2e-33
 Identities = 60/236 (25%), Positives = 107/236 (45%), Gaps = 35/236 (14%)

Query: 273 GQVLLGTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPD---GRNIAVKR 329
           G  ++G ++     N +Y+I+++          LG GG  +V+     D      +A+K 
Sbjct: 1   GSHMIGKII-----NERYKIVDK----------LGGGGMSTVYLAE--DTILNIKVAIKA 43

Query: 330 L---FFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILF 386
           +        + + +F  EV+  S + H+N+V ++    E     LV EY+   +L + + 
Sbjct: 44  IFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI- 102

Query: 387 VKNTIHILSWQQRFTIICGTAEGL--AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADF 444
              +   LS            +G+  AH        I+HRDIK  NIL+D   T KI DF
Sbjct: 103 --ESHGPLSVDTAINFTNQILDGIKHAHDMR-----IVHRDIKPQNILIDSNKTLKIFDF 155

Query: 445 GLARHVAPDKTHVSTG-IAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRR 499
           G+A+ ++ + +   T  + GT+ Y +PE        E  D+Y+ G+++ E+  G  
Sbjct: 156 GIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  128 bits (325), Expect = 2e-33
 Identities = 68/303 (22%), Positives = 123/303 (40%), Gaps = 55/303 (18%)

Query: 304 RKLGQGGAGSVFRGTLPDGRN------IAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVV 357
           R+LG+G  G VF     +         +AVK L   +      F  E  L++ +QH+++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 358 RLLG-CSIEGPESLLVYEYVPNRSLDQIL-------------FVKNTIHILSWQQRFTII 403
           +  G C    P  ++V+EY+ +  L++ L               +     L   Q   I 
Sbjct: 81  KFYGVCGDGDP-LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG 463
              A G+ +L   +    +HRD+ T N L+   L  KI DFG++R V     +   G   
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG-HT 195

Query: 464 TL--GYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-------GRRNSVFSEGSSSVLHTV 514
            L   +M PE ++  + T ++DV++FGV++ E+ +          N+        V+  +
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-------EVIECI 248

Query: 515 WKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYE 574
            +          ++       P      V  + L C Q     R ++ E+  +L+ +  +
Sbjct: 249 TQGRV-------LER------PRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHAL-GK 294

Query: 575 IPP 577
             P
Sbjct: 295 ATP 297

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  129 bits (326), Expect = 3e-33
 Identities = 49/204 (24%), Positives = 97/204 (47%), Gaps = 14/204 (6%)

Query: 304 RKLGQGGAGSVFRGTL-PDGRN----IAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVV 357
           + LG G  G+V++G   P+G      +A+K L    S +   +  +E  +++ + + +V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
           RLLG  +      L+ + +P   L    +V+     +  Q         A+G+ +L    
Sbjct: 81  RLLGICLTST-VQLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL---E 134

Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT-LGYMAPEYLVRG 476
             +++HRD+   N+L+      KI DFGLA+ +  ++           + +MA E ++  
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194

Query: 477 QLTEKADVYAFGVLVIEVAS-GRR 499
             T ++DV+++GV V E+ + G +
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSK 218

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  127 bits (322), Expect = 3e-33
 Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 37/222 (16%)

Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVR 358
           F     +G GG G VF+     DG+   +KR+ +N+    ++   EV  ++ + H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVH 68

Query: 359 LLGCSIEGPESL----------------LVYEYVPNRSLDQILFVKNTIH-----ILSWQ 397
             GC                        +  E+    +L+Q +  +          L   
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL- 127

Query: 398 QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV 457
             F  I    +G+ ++H     K+I+RD+K SNI L +    KI DFGL   +  D    
Sbjct: 128 --FEQIT---KGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 179

Query: 458 STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRR 499
            +   GTL YM+PE +      ++ D+YA G+++ E+     
Sbjct: 180 RS--KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  128 bits (323), Expect = 3e-33
 Identities = 69/281 (24%), Positives = 124/281 (44%), Gaps = 20/281 (7%)

Query: 304 RKLGQGGAGSVFRGT---LPDGRNI--AVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVR 358
           ++LG+G  GSV       L D      AVK+L  ++ + +  F  E+ ++  +QH N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 359 LLG-CSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
             G C   G  +L L+ EY+P  SL    +++     +   +         +G+ +L   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYL--- 130

Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTL--GYMAPEYLV 474
              + IHRD+ T NIL++ +   KI DFGL + +  DK        G     + APE L 
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190

Query: 475 RGQLTEKADVYAFGVLVIEVAS--GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT 532
             + +  +DV++FGV++ E+ +   +  S  +E    + +          + + +     
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN-- 248

Query: 533 GRF--PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           GR   P+     +  I   C    V  RPS  ++   ++ I
Sbjct: 249 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  127 bits (322), Expect = 4e-33
 Identities = 55/202 (27%), Positives = 101/202 (50%), Gaps = 9/202 (4%)

Query: 297 TDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKN 355
              +    K+GQG +G+V+    +  G+ +A++++    +   +   NE+ ++   ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           +V  L   + G E  +V EY+   SL  ++    T   +   Q   +     + L  LH 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLHS 134

Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               ++IHRDIK+ NILL    + K+ DFG    + P+++  ST + GT  +MAPE + R
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTR 190

Query: 476 GQLTEKADVYAFGVLVIEVASG 497
                K D+++ G++ IE+  G
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEG 212

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  131 bits (331), Expect = 5e-33
 Identities = 68/269 (25%), Positives = 114/269 (42%), Gaps = 25/269 (9%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLG-C 362
           + +G+G  G V  G    G  +AVK +  ++      F  E ++++ ++H N+V+LLG  
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 363 SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
             E     +V EY+   SL   L       +L             E + +L    G   +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFV 311

Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKA 482
           HRD+   N+L+ E    K++DFGL +      T  +  +   + + APE L   + + K+
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEA--SSTQDTGKLP--VKWTAPEALREKKFSTKS 367

Query: 483 DVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASR 542
           DV++FG+L+ E+ S  R          V+  V K YK       MD       P+     
Sbjct: 368 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-------MDA------PDGCPPA 414

Query: 543 VLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           V  +   C     A RP+  ++   L +I
Sbjct: 415 VYDVMKNCWHLDAATRPTFLQLREQLEHI 443

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  128 bits (323), Expect = 5e-33
 Identities = 62/292 (21%), Positives = 116/292 (39%), Gaps = 49/292 (16%)

Query: 304 RKLGQGGAGSVFRGTLPDGRN----IAVKRL---FFNSRQWVDQFFNEVNLISGIQHKNV 356
           + LG+G  GSV  G L         +AVK +     + R+  + F +E   +    H NV
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEE-FLSEAACMKDFSHPNV 98

Query: 357 VRLLG-CSIEGPES----LLVYEYVPNRSLDQIL---FVKNTIHILSWQQRFTIICGTAE 408
           +RLLG C     +     +++  ++    L   L    ++     +  Q     +   A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTL--G 466
           G+ +L   S    +HRD+   N +L + +T  +ADFGL++ +     +        +   
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGR-IAKMPVK 214

Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVAS-------GRRNSVFSEGSSSVLHTVWKHYK 519
           ++A E L     T K+DV+AFGV + E+A+       G +N         +   +   ++
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-------HEMYDYLLHGHR 267

Query: 520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
                  +        PE+    + +I   C +     RP+ + +   L  +
Sbjct: 268 -------LKQ------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  126 bits (320), Expect = 5e-33
 Identities = 77/275 (28%), Positives = 125/275 (45%), Gaps = 33/275 (12%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
            +LG G  G V+ G       +AVK L   S    D F  E NL+  +QH+ +VRL    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
            + P   ++ EY+ N SL   L    +   L+  +   +    AEG+A +        IH
Sbjct: 78  TQEP-IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFI---EERNYIH 132

Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +NIL+ + L+ KIADFGLAR +  ++     G    + + APE +  G  T K+D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192

Query: 484 VYAFGVLVIEVAS-GRR------NSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP 536
           V++FG+L+ E+ + GR       N         V+  + + Y+       M        P
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTN-------PEVIQNLERGYR-------MVR------P 232

Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +N    + Q+  LC +     RP+   +  +L + 
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  128 bits (323), Expect = 6e-33
 Identities = 69/281 (24%), Positives = 125/281 (44%), Gaps = 20/281 (7%)

Query: 304 RKLGQGGAGSVFRGT---LPDGRNI--AVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVR 358
           ++LG+G  GSV       L D      AVK+L  ++ + +  F  E+ ++  +QH N+V+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 359 LLG-CSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
             G C   G  +L L+ EY+P  SL    +++     +   +         +G+ +L   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYL--- 161

Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTL--GYMAPEYLV 474
              + IHRD+ T NIL++ +   KI DFGL + +  DK +      G     + APE L 
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221

Query: 475 RGQLTEKADVYAFGVLVIEVAS--GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT 532
             + +  +DV++FGV++ E+ +   +  S  +E    + +          + + +     
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN-- 279

Query: 533 GRF--PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           GR   P+     +  I   C    V  RPS  ++   ++ I
Sbjct: 280 GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  127 bits (322), Expect = 9e-33
 Identities = 51/206 (24%), Positives = 86/206 (41%), Gaps = 27/206 (13%)

Query: 305 KLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           ++G+G  G V R      G   AVK++     +       E+   +G+    +V L G  
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAV 119

Query: 364 IEGPESLLVYEYVPNRSLDQIL-----FVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
            EGP   +  E +   SL Q++       ++       Q          EGL +LH    
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQ--------ALEGLEYLH---T 168

Query: 419 IKIIHRDIKTSNILLDEKLTP-KIADFGLARHVAPDKTHVSTG----IAGTLGYMAPEYL 473
            +I+H D+K  N+LL    +   + DFG A  + PD    S      I GT  +MAPE +
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228

Query: 474 VRGQLTEKADVYAFGVLVIEVASGRR 499
           +      K D+++   +++ + +G  
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCH 254

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  126 bits (318), Expect = 9e-33
 Identities = 59/226 (26%), Positives = 95/226 (42%), Gaps = 33/226 (14%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFN--SRQWVDQFFNEV 345
            YE+L            +G G  G   +     DG+ +  K L +   +        +EV
Sbjct: 7   DYEVL----------YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEV 56

Query: 346 NLISGIQHKNVVRLLGCSIEGPESLL--VYEYVPNRSLDQIL--FVKNTIH-----ILSW 396
           NL+  ++H N+VR     I+   + L  V EY     L  ++    K   +     +L  
Sbjct: 57  NLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV 116

Query: 397 QQRFTIICGTAEGLAHLH--GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK 454
               T +      L   H     G  ++HRD+K +N+ LD K   K+ DFGLAR +  D 
Sbjct: 117 ---MTQLT---LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 170

Query: 455 THVSTGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGRR 499
           +   T   GT  YM+PE  +      EK+D+++ G L+ E+ +   
Sbjct: 171 SFAKT-FVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMP 214

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  128 bits (324), Expect = 1e-32
 Identities = 80/331 (24%), Positives = 146/331 (44%), Gaps = 45/331 (13%)

Query: 304 RKLGQGGAGSVFRGTL--PDGRNI--AVKRL--FFNSRQWVDQFFNEVNLISGIQHKNVV 357
           + +G G  G V  G L  P  + I  A+K L   +  +Q  D F  E +++    H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNII 109

Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
           RL G   +    ++V EY+ N SLD   F++      +  Q   ++ G A G+ +L   S
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---S 164

Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA--PDKTHVSTGIAGTLGYMAPEYLVR 475
            +  +HRD+   NIL++  L  K++DFGL R +   P+  + + G    + + +PE +  
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224

Query: 476 GQLTEKADVYAFGVLVIEVAS-GRR------NSVFSEGSSSVLHTVWKHYKANRITQSMD 528
            + T  +DV+++G+++ EV S G R      N         V+  V + Y+       + 
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-------DVIKAVDEGYR-------LP 270

Query: 529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNASV 588
           P      P +  + + Q+ L C Q     RP   ++V +L+ +   I  P     + ++ 
Sbjct: 271 P------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL---IRNPGSLKIITSAA 321

Query: 589 ISPSDNSKDSMMSSFKSFVAESPEIDHSLKM 619
             PS+   D       +F     +  + +  
Sbjct: 322 ARPSNLLLDQSNVDITTFRTT-GDWLNGVWT 351

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  127 bits (321), Expect = 1e-32
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 9/202 (4%)

Query: 297 TDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKN 355
               D+  K+G+G  G V        GR +AVK +    +Q  +  FNEV ++   QH N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           VV +    + G E  ++ E++   +L  I+    +   L+ +Q  T+     + LA+LH 
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLHA 159

Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
                +IHRDIK+ +ILL      K++DFG    ++ D     + + GT  +MAPE + R
Sbjct: 160 Q---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-LVGTPYWMAPEVISR 215

Query: 476 GQLTEKADVYAFGVLVIEVASG 497
                + D+++ G++VIE+  G
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDG 237

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  126 bits (319), Expect = 2e-32
 Identities = 68/256 (26%), Positives = 95/256 (37%), Gaps = 23/256 (8%)

Query: 248 STERFFNPNYQKKETRYKRLSEMRKGQVLLGTVLCTSSLNFKYEILERATDFFDNSRKLG 307
           +   +F   +Q +  R     E  +           S               F    +LG
Sbjct: 15  TENLYFQSMHQLQPRRVSFRGEASE--------TLQSPGYDPSRPESFFQQSFQRLSRLG 66

Query: 308 QGGAGSVFRGT-LPDGRNIAVK--RLFFNSRQWVDQFFNEVNLISGI-QHKNVVRLLGCS 363
            G  G VF+     DGR  AVK     F   +   +   EV     + QH   VRL    
Sbjct: 67  HGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW 126

Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
            EG    L  E     SL Q    +     L   Q +  +  T   LAHLH      ++H
Sbjct: 127 EEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVH 180

Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVA-PDKTHVSTGIAGTLGYMAPEYLVRGQLTEKA 482
            D+K +NI L  +   K+ DFGL   +       V     G   YMAPE L++G     A
Sbjct: 181 LDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAPE-LLQGSYGTAA 236

Query: 483 DVYAFGVLVIEVASGR 498
           DV++ G+ ++EVA   
Sbjct: 237 DVFSLGLTILEVACNM 252

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  132 bits (333), Expect = 2e-32
 Identities = 50/246 (20%), Positives = 93/246 (37%), Gaps = 43/246 (17%)

Query: 262 TRYKRLSEMRKGQVLLGTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRG--TL 319
           + Y  L ++  G ++ G          +YE+             +  GG G ++      
Sbjct: 64  SPYSFLPQLNPGDIVAG----------QYEVKGC----------IAHGGLGWIYLALDRN 103

Query: 320 PDGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLL-----GCSIEGPESLLVY 373
            +GR + +K L  +   +       E   ++ + H ++V++            P   +V 
Sbjct: 104 VNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVM 163

Query: 374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL 433
           EYV  +SL +    K     L   +    +      L++LH    I +++ D+K  NI+L
Sbjct: 164 EYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIML 215

Query: 434 DEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIE 493
            E+   K+ D G    +          + GT G+ APE +VR   T   D+Y  G  +  
Sbjct: 216 TEE-QLKLIDLGAVSRI----NSFGY-LYGTPGFQAPE-IVRTGPTVATDIYTVGRTLAA 268

Query: 494 VASGRR 499
           +     
Sbjct: 269 LTLDLP 274

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  126 bits (319), Expect = 2e-32
 Identities = 63/246 (25%), Positives = 103/246 (41%), Gaps = 44/246 (17%)

Query: 268 SEMRKGQVLLGTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPD---GRN 324
           S M     L            +YE+ E           LG GG   V      D    R+
Sbjct: 2   SHMTTPSHLSD----------RYELGEI----------LGFGGMSEVHLAR--DLRDHRD 39

Query: 325 IAVKRL---FFNSRQWVDQFFNEVNLISGIQHKNVVRLL--GCSIEGPESL--LVYEYVP 377
           +AVK L         +  +F  E    + + H  +V +   G +      L  +V EYV 
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99

Query: 378 NRSLDQILFVKNTIHILSWQQRFTIICGTAEGL--AHLHGGSGIKIIHRDIKTSNILLDE 435
             +L  I+   +T   ++ ++   +I    + L  +H +G     IIHRD+K +NI++  
Sbjct: 100 GVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSHQNG-----IIHRDVKPANIMISA 151

Query: 436 KLTPKIADFGLARHVAPDKTHV-STG-IAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIE 493
               K+ DFG+AR +A     V  T  + GT  Y++PE      +  ++DVY+ G ++ E
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211

Query: 494 VASGRR 499
           V +G  
Sbjct: 212 VLTGEP 217

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  126 bits (318), Expect = 2e-32
 Identities = 50/219 (22%), Positives = 80/219 (36%), Gaps = 30/219 (13%)

Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRGTLPD---GRNIAVKRL---FFNSRQWVDQFFN 343
           Y +             +G+GG G V+     D    R +A+K +     +   +  +   
Sbjct: 36  YRLRRL----------VGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQR 83

Query: 344 EVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTII 403
           E      +Q  +VV +        +  +    +    L  +L        L+  +   I+
Sbjct: 84  EARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIV 140

Query: 404 CGTAEGL--AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGI 461
                 L  AH  G       HRD+K  NIL+       + DFG+A     D+     G 
Sbjct: 141 RQIGSALDAAHAAG-----ATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGN 194

Query: 462 A-GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRR 499
             GTL YMAPE       T +AD+YA   ++ E  +G  
Sbjct: 195 TVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSP 233

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  125 bits (316), Expect = 2e-32
 Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 16/206 (7%)

Query: 304 RKLGQGGAGSVFRGTL--PDGRNI--AVKRL---FFNSRQWVDQFFNEVNLISGIQHKNV 356
            KLG G  G V RG    P G+ +  AVK L     +  + +D F  EVN +  + H+N+
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83

Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RL G  +  P   +V E  P  SL     ++                  AEG+ +L   
Sbjct: 84  IRLYGVVLTPP-MKMVTELAPLGSLLD--RLRKHQGHFLLGTLSRYAVQVAEGMGYL--- 137

Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGY--MAPEYLV 474
              + IHRD+   N+LL  +   KI DFGL R +  +  H        + +   APE L 
Sbjct: 138 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197

Query: 475 RGQLTEKADVYAFGVLVIEVAS-GRR 499
               +  +D + FGV + E+ + G+ 
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQE 223

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  126 bits (318), Expect = 3e-32
 Identities = 72/292 (24%), Positives = 126/292 (43%), Gaps = 49/292 (16%)

Query: 304 RKLGQGGAGSVFRGTLPDGRN------IAVKRL--FFNSRQWVDQFFNEVNLISGIQHKN 355
           R+LGQG  G V+ G             +A+K +    + R+ ++ F NE +++      +
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHH 89

Query: 356 VVRLLGCSIEGPESLLVYEYVPN-------RSLDQILFVKNTIHILSWQQRFTIICGTAE 408
           VVRLLG   +G  +L++ E +         RSL   +     +   S  +   +    A+
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTL--G 466
           G+A+L   +  K +HRD+   N ++ E  T KI DFG+ R +     +   G  G L   
Sbjct: 150 GMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG-KGLLPVR 205

Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVAS-------GRRNSVFSEGSSSVLHTVWKHYK 519
           +M+PE L  G  T  +DV++FGV++ E+A+       G  N             V +   
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----------EQVLRFVM 254

Query: 520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
              +   +D       P+N    + ++  +C Q    +RPS  E++  +   
Sbjct: 255 EGGL---LDK------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  126 bits (318), Expect = 3e-32
 Identities = 68/296 (22%), Positives = 120/296 (40%), Gaps = 53/296 (17%)

Query: 304 RKLGQGGAGSVFRGTLPDGRN------IAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVV 357
            +LG+G  G VF     +         +AVK L   S      F  E  L++ +QH+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 358 RLLG-CSIEGPESLLVYEYVPNRSLDQIL------------FVKNTIHILSWQQRFTIIC 404
           R  G C+   P  L+V+EY+ +  L++ L                    L   Q   +  
Sbjct: 107 RFFGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT 464
             A G+ +L   +G+  +HRD+ T N L+ + L  KI DFG++R +     +   G    
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG-RTM 221

Query: 465 L--GYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-------GRRNSVFSEGSSSVLHTVW 515
           L   +M PE ++  + T ++DV++FGV++ E+ +          N+         +  + 
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-------EAIDCIT 274

Query: 516 KHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +  +       ++       P      V  I   C Q     R S+ +V   L  +
Sbjct: 275 QGRE-------LER------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  124 bits (314), Expect = 4e-32
 Identities = 70/279 (25%), Positives = 116/279 (41%), Gaps = 45/279 (16%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLG-C 362
           + +G+G  G V  G    G  +AVK +  ++      F  E ++++ ++H N+V+LLG  
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 363 SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
             E     +V EY+   SL   L       +L             E + +L    G   +
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFV 139

Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGY--MAPEYLVRGQLTE 480
           HRD+   N+L+ E    K++DFGL +    + +       G L     APE L   + + 
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDT--GKLPVKWTAPEALREKKFST 193

Query: 481 KADVYAFGVLVIEVASGRRNSVFSEGSS--------SVLHTVWKHYKANRITQSMDPGLT 532
           K+DV++FG+L+ E        ++S G           V+  V K YK       MD    
Sbjct: 194 KSDVWSFGILLWE--------IYSFGRVPYPRIPLKDVVPRVEKGYK-------MDA--- 235

Query: 533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
              P+     V ++   C     A+RPS  ++   L +I
Sbjct: 236 ---PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  124 bits (314), Expect = 6e-32
 Identities = 61/231 (26%), Positives = 93/231 (40%), Gaps = 42/231 (18%)

Query: 295 RATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQH 353
           R    F+    LGQG  G V +     D R  A+K++     + +    +EV L++ + H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNH 61

Query: 354 KNVVRLLGCSIEGPESL-------------LVYEYVPNRSLDQIL----FVKNTIHILSW 396
           + VVR     +E    +             +  EY  N +L  ++      +        
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121

Query: 397 QQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH 456
              F  I    E L+++H      IIHRD+K  NI +DE    KI DFGLA++V      
Sbjct: 122 ---FRQIL---EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172

Query: 457 VS-------------TGIAGTLGYMAPEYLV-RGQLTEKADVYAFGVLVIE 493
           +              T   GT  Y+A E L   G   EK D+Y+ G++  E
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  125 bits (316), Expect = 6e-32
 Identities = 79/310 (25%), Positives = 117/310 (37%), Gaps = 56/310 (18%)

Query: 304 RKLGQGGAGSVFRGTLPDGRN------IAVKRL--FFNSRQWVDQFFNEVNLISGIQHKN 355
           R LG G  G V+ G +    N      +AVK L    + +  +D F  E  +IS   H+N
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQN 94

Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQIL----FVKNTIHILSWQQRFTIICGTAEGLA 411
           +VR +G S++     ++ E +    L   L       +    L+      +    A G  
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 412 HLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADFGLARHVAPDKTHVSTGIAGTLG-- 466
           +L        IHRDI   N LL         KI DFG+AR +     +   G    L   
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG-CAMLPVK 210

Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVAS-------GRRNSVFSEGSSSVLHTVWKHYK 519
           +M PE  + G  T K D ++FGVL+ E+ S        + N         VL  V    +
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGR 263

Query: 520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN-------ID 572
                  MDP      P+N    V +I   C Q     RP+ A ++  +         I+
Sbjct: 264 -------MDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVIN 310

Query: 573 YEIPPPKQPP 582
             +P    P 
Sbjct: 311 TALPIEYGPL 320

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  124 bits (313), Expect = 6e-32
 Identities = 61/284 (21%), Positives = 115/284 (40%), Gaps = 46/284 (16%)

Query: 304 RKLGQGGAGSVFRGTL--PDGRNI--AVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVR 358
           R LG+G  G V+ G      G  I  AVK    + +    ++F +E  ++  + H ++V+
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77

Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
           L+G   E P + ++ E  P   L    +++   + L             + +A+L     
Sbjct: 78  LIGIIEEEP-TWIIMELYPYGELGH--YLERNKNSLKVLTLVLYSLQICKAMAYL---ES 131

Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG----IAGTLGYMAPEYLV 474
           I  +HRDI   NIL+      K+ DFGL+R++  +  + ++     I     +M+PE + 
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK----WMSPESIN 187

Query: 475 RGQLTEKADVYAFGVLVIEVAS-------GRRNSVFSEGSSSVLHTVWKHYKANRITQSM 527
             + T  +DV+ F V + E+ S          N         V+  + K  +       +
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-------DVIGVLEKGDR-------L 233

Query: 528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
                   P+     +  +   C     + RP   E+V  L+++
Sbjct: 234 PK------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  124 bits (314), Expect = 7e-32
 Identities = 61/202 (30%), Positives = 103/202 (50%), Gaps = 9/202 (4%)

Query: 297 TDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKN 355
            + FD   KLG+G  GSV++      G+ +A+K++   S   + +   E++++      +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPH 85

Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           VV+  G   +  +  +V EY    S+  I  ++     L+  +  TI+  T +GL +LH 
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDI--IRLRNKTLTEDEIATILQSTLKGLEYLHF 143

Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               + IHRDIK  NILL+ +   K+ADFG+A  +       +T I GT  +MAPE +  
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQE 199

Query: 476 GQLTEKADVYAFGVLVIEVASG 497
                 AD+++ G+  IE+A G
Sbjct: 200 IGYNCVADIWSLGITAIEMAEG 221

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  125 bits (315), Expect = 8e-32
 Identities = 61/330 (18%), Positives = 126/330 (38%), Gaps = 46/330 (13%)

Query: 304 RKLGQGGAGSVFRGTL-PDGRNI----AVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVV 357
           + LG G  G+V++G   P+G  +    A+K L   +  +   +  +E  +++ + + +V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
           RLLG  +      L+ + +P   L    +V+     +  Q         A+G+ +L    
Sbjct: 81  RLLGICLTST-VQLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL---E 134

Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT-LGYMAPEYLVRG 476
             +++HRD+   N+L+      KI DFGLA+ +  ++           + +MA E ++  
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194

Query: 477 QLTEKADVYAFGVLVIEVAS-------GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP 529
             T ++DV+++GV V E+ +       G          S +   + K  +       +  
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-------SEISSILEKGER-------LPQ 240

Query: 530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNASVI 589
                 P      V  I + C       RP   E++   + +       + P        
Sbjct: 241 ------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM------ARDPQRYLVIQG 288

Query: 590 SPSDNSKDSMMSSFKSFVAESPEIDHSLKM 619
               +      S+F   + +  ++D  +  
Sbjct: 289 DERMHLPSPTDSNFYRALMDEEDMDDVVDA 318

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  123 bits (312), Expect = 1e-31
 Identities = 51/207 (24%), Positives = 98/207 (47%), Gaps = 12/207 (5%)

Query: 297 TDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKN 355
            + ++   +LG G  G V++      G   A K +   S + ++ +  E+ +++   H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           +V+LLG      +  ++ E+ P  ++D I  +      L+  Q   +     E L  LH 
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAI--MLELDRGLTEPQIQVVCRQMLEALNFLHS 135

Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
               +IIHRD+K  N+L+  +   ++ADFG++           + I GT  +MAPE ++ 
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMC 191

Query: 476 GQLTE-----KADVYAFGVLVIEVASG 497
             + +     KAD+++ G+ +IE+A  
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQI 218

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  123 bits (311), Expect = 1e-31
 Identities = 66/298 (22%), Positives = 120/298 (40%), Gaps = 57/298 (19%)

Query: 304 RKLGQGGAGSVFRGTL----PDGRNI--AVKRL--FFNSRQWVDQFFNEVNLISGIQHKN 355
            +LG+   G V++G L    P  +    A+K L          + F +E  L + +QH N
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE-FRHEAMLRARLQHPN 73

Query: 356 VVRLLG-CSIEGPESLLVYEYVPNRSLDQIL-------------FVKNTIHILSWQQRFT 401
           VV LLG  + + P   +++ Y  +  L + L               +     L       
Sbjct: 74  VVCLLGVVTKDQP-LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132

Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGI 461
           ++   A G+ +L   S   ++H+D+ T N+L+ +KL  KI+D GL R V     +   G 
Sbjct: 133 LVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG- 188

Query: 462 AGTL--GYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-------GRRNSVFSEGSSSVLH 512
              L   +MAPE ++ G+ +  +D++++GV++ EV S       G  N         V+ 
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-------DVVE 241

Query: 513 TVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN 570
            +            +        P++  + V  + + C     + RP   ++   L  
Sbjct: 242 MIRNRQV-------LPC------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 286

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  124 bits (314), Expect = 1e-31
 Identities = 69/292 (23%), Positives = 124/292 (42%), Gaps = 19/292 (6%)

Query: 304 RKLGQGGAGSVFRGT---LPDGRNI--AVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVR 358
            +LG+G  GSV       L D      AVK+L  +       F  E+ ++  +    +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 359 LLG-CSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
             G     G +SL LV EY+P+  L    F++     L   +         +G+ +L   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQICKGMEYL--- 143

Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTL--GYMAPEYLV 474
              + +HRD+   NIL++ +   KIADFGLA+ +  DK +      G     + APE L 
Sbjct: 144 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203

Query: 475 RGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG 533
               + ++DV++FGV++ E+ +   ++   S     ++         +R+ + ++ G   
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG--Q 261

Query: 534 RF--PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPF 583
           R   P    + V ++  LC       RPS + +   L+ +       +   F
Sbjct: 262 RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAF 313

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  124 bits (313), Expect = 1e-31
 Identities = 63/206 (30%), Positives = 108/206 (52%), Gaps = 17/206 (8%)

Query: 304 RKLGQGGAGSVFRGTL--PDGRNI--AVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVV 357
           + +G G +G V  G L  P  R++  A+K L      RQ  D F +E +++    H N++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEASIMGQFDHPNII 113

Query: 358 RLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           RL G  +     +++V EY+ N SLD   F++      +  Q   ++ G   G+ +L   
Sbjct: 114 RLEGVVTRGRL-AMIVTEYMENGSLDT--FLRTHDGQFTIMQLVGMLRGVGAGMRYL--- 167

Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA--PDKTHVSTGIAGTLGYMAPEYLV 474
           S +  +HRD+   N+L+D  L  K++DFGL+R +   PD  + +TG    + + APE + 
Sbjct: 168 SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227

Query: 475 RGQLTEKADVYAFGVLVIEVAS-GRR 499
               +  +DV++FGV++ EV + G R
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGER 253

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  123 bits (310), Expect = 1e-31
 Identities = 58/281 (20%), Positives = 107/281 (38%), Gaps = 40/281 (14%)

Query: 304 RKLGQGGAGSVFRGTL--PDGRNI--AVKRL--FFNSRQWVDQFFNEVNLISGIQHKNVV 357
           R +G+G  G V +G    P+   +  A+K      +       F  E   +    H ++V
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIV 79

Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
           +L+G   E P   ++ E      L    F++   + L            +  LA+L    
Sbjct: 80  KLIGVITENP-VWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYL---E 133

Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQ 477
             + +HRDI   N+L+      K+ DFGL+R++     + ++     + +MAPE +   +
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 193

Query: 478 LTEKADVYAFGVLVIEVAS-------GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG 530
            T  +DV+ FGV + E+         G +N       + V+  +    +       +   
Sbjct: 194 FTSASDVWMFGVCMWEILMHGVKPFQGVKN-------NDVIGRIENGER-------LPM- 238

Query: 531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
                P N    +  +   C     + RP   E+   L+ I
Sbjct: 239 -----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  122 bits (309), Expect = 2e-31
 Identities = 74/270 (27%), Positives = 122/270 (45%), Gaps = 21/270 (7%)

Query: 304 RKLGQGGAGSVFRGTLPDGR-NIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLG- 361
            KLG G  G V+ G        +AVK L  ++ + V++F  E  ++  I+H N+V+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKI 421
           C+ E P   ++ E++   +L   L  +     +S      +    +  + +L        
Sbjct: 78  CTREPP-FYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL---EKKNF 132

Query: 422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEK 481
           IHRD+   N L+ E    K+ADFGL+R +  D      G    + + APE L   + + K
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192

Query: 482 ADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEAS 541
           +DV+AFGVL+ E+A+   +       S V   + K Y+       M+       PE    
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR-------MER------PEGCPE 239

Query: 542 RVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +V ++   C Q   + RPS AE+      +
Sbjct: 240 KVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  123 bits (311), Expect = 2e-31
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 14/204 (6%)

Query: 304 RKLGQGGAGSVFRGTL-PDGRNI----AVKRL-FFNSRQWVDQFFNEVNLISGIQHKNVV 357
           + LG G  G+V +G   P+G +I     +K +   + RQ      + +  I  + H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
           RLLG         LV +Y+P  SL     V+     L  Q         A+G+ +L    
Sbjct: 79  RLLGLCPGSS-LQLVTQYLPLGSLLD--HVRQHRGALGPQLLLNWGVQIAKGMYYL---E 132

Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT-LGYMAPEYLVRG 476
              ++HR++   N+LL      ++ADFG+A  + PD   +    A T + +MA E +  G
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192

Query: 477 QLTEKADVYAFGVLVIEVAS-GRR 499
           + T ++DV+++GV V E+ + G  
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAE 216

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  124 bits (314), Expect = 2e-31
 Identities = 79/310 (25%), Positives = 117/310 (37%), Gaps = 56/310 (18%)

Query: 304 RKLGQGGAGSVFRGTLPDGRN------IAVKRL--FFNSRQWVDQFFNEVNLISGIQHKN 355
           R LG G  G V+ G +    N      +AVK L    + +  +D F  E  +IS   H+N
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQN 135

Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQIL----FVKNTIHILSWQQRFTIICGTAEGLA 411
           +VR +G S++     ++ E +    L   L       +    L+      +    A G  
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 412 HLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADFGLARHVAPDKTHVSTGIAGTLG-- 466
           +L        IHRDI   N LL         KI DFG+AR +     +   G    L   
Sbjct: 196 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGG-CAMLPVK 251

Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVAS-------GRRNSVFSEGSSSVLHTVWKHYK 519
           +M PE  + G  T K D ++FGVL+ E+ S        + N         VL  V    +
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGR 304

Query: 520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN-------ID 572
                  MDP      P+N    V +I   C Q     RP+ A ++  +         I+
Sbjct: 305 -------MDP------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVIN 351

Query: 573 YEIPPPKQPP 582
             +P    P 
Sbjct: 352 TALPIEYGPL 361

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  122 bits (308), Expect = 3e-31
 Identities = 56/298 (18%), Positives = 107/298 (35%), Gaps = 68/298 (22%)

Query: 304 RKLGQGGAGSVFRGTLPDGRN--------IAVKRLFFNSRQWVDQFFNEVNLISGIQHKN 355
             LGQG    +F+G   +  +        + +K L    R + + FF   +++S + HK+
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73

Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           +V   G  + G E++LV E+V   SLD   ++K   + ++   +  +    A  +  L  
Sbjct: 74  LVLNYGVCVCGDENILVQEFVKFGSLDT--YLKKNKNCINILWKLEVAKQLAAAMHFL-- 129

Query: 416 GSGIKIIHRDIKTSNILLDEKLTP--------KIADFGLARHVAPDKTHVSTGIAGTLGY 467
                +IH ++   NILL  +           K++D G++  V P               
Sbjct: 130 -EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----------IL 177

Query: 468 ------MAPEYLV-RGQLTEKADVYAFGVLVIEVAS-------GRRNSVFSEGSSSVLHT 513
                 + PE +     L    D ++FG  + E+ S          +          L  
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-------QRKLQF 230

Query: 514 VWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
               +               + P  +A+ +  +   C       RPS   ++  LN++
Sbjct: 231 YEDRH---------------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  122 bits (308), Expect = 3e-31
 Identities = 69/300 (23%), Positives = 126/300 (42%), Gaps = 35/300 (11%)

Query: 287 NFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGR---NIAVKRL--FFNSRQWVDQF 341
             +  +           ++LG G  G+V +G     +    +AVK L    N     D+ 
Sbjct: 8   PKEVYL--DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDEL 65

Query: 342 FNEVNLISGIQHKNVVRLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRF 400
             E N++  + +  +VR++G C  E    +LV E      L++  +++   H +  +   
Sbjct: 66  LAEANVMQQLDNPYIVRMIGICEAESW--MLVMEMAELGPLNK--YLQQNRH-VKDKNII 120

Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG 460
            ++   + G+ +L        +HRD+   N+LL  +   KI+DFGL++ +  D+ +    
Sbjct: 121 ELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 177

Query: 461 IAGTL--GYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHY 518
             G     + APE +   + + K+DV++FGVL+ E         FS G        ++  
Sbjct: 178 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEA--------FSYG-----QKPYRGM 224

Query: 519 KANRITQSMDPGLTGRF--PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIP 576
           K + +T  ++ G   R   P      +  +  LC    V  RP  A V   L N  Y++ 
Sbjct: 225 KGSEVTAMLEKG--ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  121 bits (307), Expect = 4e-31
 Identities = 58/300 (19%), Positives = 113/300 (37%), Gaps = 31/300 (10%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRN---IAVKRLFFN-SRQWVDQFFNE 344
           K  +     +      +LG G  GSV +G     +    +A+K L     +   ++   E
Sbjct: 3   KLFLKR--DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMRE 60

Query: 345 VNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIIC 404
             ++  + +  +VRL+G        +LV E      L +  F+      +       ++ 
Sbjct: 61  AQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHK--FLVGKREEIPVSNVAELLH 117

Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT 464
             + G+ +L        +HRD+   N+LL  +   KI+DFGL++ +  D ++ +   AG 
Sbjct: 118 QVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174

Query: 465 L--GYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR 522
               + APE +   + + ++DV+++GV + E          S G        +K  K   
Sbjct: 175 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEA--------LSYG-----QKPYKKMKGPE 221

Query: 523 ITQSMDPGLTGRF--PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQ 580
           +   ++ G   R   P      +  +   C       RP    V   +    Y +    +
Sbjct: 222 VMAFIEQG--KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  122 bits (308), Expect = 5e-31
 Identities = 58/218 (26%), Positives = 91/218 (41%), Gaps = 23/218 (10%)

Query: 298 DFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLF-FNSRQWVDQFFNEVNLISGIQHKN 355
             +  S  LGQG   +VFRG     G   A+K     +  + VD    E  ++  + HKN
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 356 VVRLLGCSIEGPESLLVY---EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
           +V+L     E   +       E+ P  SL  +L   +  + L   +   ++     G+ H
Sbjct: 69  IVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 413 LHGGSGIKIIHRDIKTSNILL----DEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           L       I+HR+IK  NI+     D +   K+ DFG AR +  D+  VS  + GT  Y+
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYL 182

Query: 469 APEYLVRGQL--------TEKADVYAFGVLVIEVASGR 498
            P+   R  L            D+++ GV     A+G 
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  122 bits (308), Expect = 5e-31
 Identities = 79/298 (26%), Positives = 119/298 (39%), Gaps = 52/298 (17%)

Query: 304 RKLGQGGAGSVFRGTL------PDGRNIAVKRL--FFNSRQWVDQFFNEVNLISGI-QHK 354
           + LG+G  G V              R +AVK L       +      +E+ ++  I  H 
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA-LMSELKILIHIGHHL 91

Query: 355 NVVRLLG-CSIEGPESLLVYEYVPNRSLDQIL-------------FVKNTIHILSWQQRF 400
           NVV LLG C+  G   +++ E+    +L   L                     L+ +   
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG 460
                 A+G+  L   +  K IHRD+   NILL EK   KI DFGLAR +  D  +V  G
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208

Query: 461 IAGTL--GYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSS-----SVLHT 513
               L   +MAPE +     T ++DV++FGVL+ E+        FS G+S      +   
Sbjct: 209 -DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI--------FSLGASPYPGVKIDEE 259

Query: 514 VWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
             +  K       M        P+     + Q  L C     + RP+ +E+V  L N+
Sbjct: 260 FCRRLKEGTR---MRA------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  122 bits (309), Expect = 5e-31
 Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 29/214 (13%)

Query: 304 RKLGQGGAGSVFRGTL-PDGRNI--AVKRL--FFNSRQWVDQFFNEVNLISGI-QHKNVV 357
             +G+G  G V +  +  DG  +  A+KR+  + +     D F  E+ ++  +  H N++
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNII 89

Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQIL-------------FVKNTIHILSWQQRFTIIC 404
            LLG         L  EY P+ +L   L                +T   LS QQ      
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT 464
             A G+ +L   S  + IHRD+   NIL+ E    KIADFGL+R     +        G 
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGR 202

Query: 465 L--GYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
           L   +MA E L     T  +DV+++GVL+ E+ S
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  121 bits (307), Expect = 7e-31
 Identities = 78/300 (26%), Positives = 122/300 (40%), Gaps = 55/300 (18%)

Query: 304 RKLGQGGAGSVFRGTLPDGRN------IAVKRL--FFNSRQWVDQFFNEVNLISGI-QHK 354
           + LG G  G V   T            +AVK L    +  +      +E+ ++S +  H 
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA-LMSELKVLSYLGNHM 87

Query: 355 NVVRLLG-CSIEGPESLLVYEYVPNRSLDQIL---------------FVKNTIHILSWQQ 398
           N+V LLG C+I GP +L++ EY     L   L                +++    L  + 
Sbjct: 88  NIVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 399 RFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS 458
             +     A+G+A L   +    IHRD+   NILL      KI DFGLAR +  D  +V 
Sbjct: 147 LLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 459 TGIAGTL--GYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSS-----SVL 511
            G    L   +MAPE +     T ++DV+++G+ + E        +FS GSS      V 
Sbjct: 204 KG-NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE--------LFSLGSSPYPGMPVD 254

Query: 512 HTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
              +K  K       M        PE+  + +  I   C  A    RP+  ++V ++   
Sbjct: 255 SKFYKMIKEGFR---MLS------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  122 bits (308), Expect = 8e-31
 Identities = 75/285 (26%), Positives = 138/285 (48%), Gaps = 44/285 (15%)

Query: 304 RKLGQGGAGSVFRGTL--PDGRN---IAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNV 356
           + +G G  G V++G L    G+    +A+K L      +Q VD F  E  ++    H N+
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNI 108

Query: 357 VRLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           +RL G  S   P  +++ EY+ N +LD+  F++      S  Q   ++ G A G+ +L  
Sbjct: 109 IRLEGVISKYKP-MMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIAAGMKYL-- 163

Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA--PDKTHVSTGIAGTLGYMAPEYL 473
            + +  +HRD+   NIL++  L  K++DFGL+R +   P+ T+ ++G    + + APE +
Sbjct: 164 -ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222

Query: 474 VRGQLTEKADVYAFGVLVIEVAS-GRR------NSVFSEGSSSVLHTVWKHYKANRITQS 526
              + T  +DV++FG+++ EV + G R      N         V+  +   ++       
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAINDGFR------- 268

Query: 527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +        P +  S + Q+ + C Q   A RP  A++V +L+ +
Sbjct: 269 LPT------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  121 bits (306), Expect = 9e-31
 Identities = 66/306 (21%), Positives = 124/306 (40%), Gaps = 63/306 (20%)

Query: 304 RKLGQGGAGSVFRGTLPDGRN------IAVKRL--FFNSRQWVDQFFNEVNLISGIQHKN 355
           + LG+G  G V + T    +       +AVK L    +  +  D   +E N++  + H +
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD-LLSEFNVLKQVNHPH 87

Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSL---------------------DQILFVKNTIHIL 394
           V++L G   +    LL+ EY    SL                     +           L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 395 SWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK 454
           +     +     ++G+ +L   + +K++HRD+   NIL+ E    KI+DFGL+R V  + 
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 455 THVSTGIAGTL--GYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-------GRRNSVFSE 505
           ++V     G +   +MA E L     T ++DV++FGVL+ E+ +       G        
Sbjct: 205 SYVKRS-QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP----- 258

Query: 506 GSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVV 565
               + + +   ++       M+       P+N +  + ++ L C +     RP  A++ 
Sbjct: 259 --ERLFNLLKTGHR-------MER------PDNCSEEMYRLMLQCWKQEPDKRPVFADIS 303

Query: 566 HMLNNI 571
             L  +
Sbjct: 304 KDLEKM 309

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  122 bits (307), Expect = 1e-30
 Identities = 75/306 (24%), Positives = 124/306 (40%), Gaps = 63/306 (20%)

Query: 304 RKLGQGGAGSVFRGTLPDGRN------IAVKRL--FFNSRQWVDQFFNEVNLISGIQHKN 355
           R +G+G  G VF+   P          +AVK L    ++    D F  E  L++   + N
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEFDNPN 111

Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQIL---------------------FVKNTIHIL 394
           +V+LLG    G    L++EY+    L++ L                             L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 395 SWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK 454
           S  ++  I    A G+A+L   S  K +HRD+ T N L+ E +  KIADFGL+R++    
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 455 THVSTGIAGTL--GYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-------GRRNSVFSE 505
            + + G    +   +M PE +   + T ++DV+A+GV++ E+ S       G  +     
Sbjct: 229 YYKADG-NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH----- 282

Query: 506 GSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVV 565
                   V  + +   I   +        PEN    +  +  LC     A RPS   + 
Sbjct: 283 ------EEVIYYVRDGNI---LAC------PENCPLELYNLMRLCWSKLPADRPSFCSIH 327

Query: 566 HMLNNI 571
            +L  +
Sbjct: 328 RILQRM 333

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  126 bits (318), Expect = 1e-30
 Identities = 58/281 (20%), Positives = 106/281 (37%), Gaps = 40/281 (14%)

Query: 304 RKLGQGGAGSVFRGTL--PDGRNI--AVKRL--FFNSRQWVDQFFNEVNLISGIQHKNVV 357
           R +G+G  G V +G    P+   +  A+K      +       F  E   +    H ++V
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIV 454

Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
           +L+G   E P   ++ E      L    F++     L            +  LA+L    
Sbjct: 455 KLIGVITENP-VWIIMELCTLGELRS--FLQVRKFSLDLASLILYAYQLSTALAYL---E 508

Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQ 477
             + +HRDI   N+L+      K+ DFGL+R++     + ++     + +MAPE +   +
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 568

Query: 478 LTEKADVYAFGVLVIEVAS-------GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG 530
            T  +DV+ FGV + E+         G +N       + V+  +    +       +   
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKPFQGVKN-------NDVIGRIENGER-------LPM- 613

Query: 531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
                P N    +  +   C     + RP   E+   L+ I
Sbjct: 614 -----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  123 bits (311), Expect = 2e-30
 Identities = 57/229 (24%), Positives = 94/229 (41%), Gaps = 37/229 (16%)

Query: 298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVN-LISGIQHKNV 356
           +   + + LG G +G+V       GR +AVKR+      + D    E+  L     H NV
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM---LIDFCDIALMEIKLLTESDDHPNV 71

Query: 357 VRLLGCSIEGPESL-LVYEYVPNRSLDQIL----FVKNTIHILSWQQRFTIICGTAEGLA 411
           +R   CS      L +  E     +L  ++         + +       +++   A G+A
Sbjct: 72  IRYY-CSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTP-------------KIADFGLARHVAPDKTHVS 458
           HLH    +KIIHRD+K  NIL+                    I+DFGL + +   ++   
Sbjct: 130 HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 459 T---GIAGTLGYMAPEYL-------VRGQLTEKADVYAFGVLVIEVASG 497
           T     +GT G+ APE L        + +LT   D+++ G +   + S 
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  120 bits (304), Expect = 2e-30
 Identities = 72/317 (22%), Positives = 126/317 (39%), Gaps = 61/317 (19%)

Query: 304 RKLGQGGAGSVFRGTLPDGRN--------IAVKRL--FFNSRQWVDQFFNEVNLISGI-Q 352
           + LG+G  G V                  +AVK L      +   D   +E+ ++  I +
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGK 99

Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQIL-------------FVKNTIHILSWQQR 399
           HKN++ LLG   +     ++ EY    +L + L               +     ++++  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVST 459
            +     A G+ +L   +  K IHRD+   N+L+ E    KIADFGLAR +     +  T
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216

Query: 460 GIAGTL--GYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-------GRRNSVFSEGSSSV 510
              G L   +MAPE L     T ++DV++FGVL+ E+ +       G            +
Sbjct: 217 T-NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-------EEL 268

Query: 511 LHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN 570
              + + ++       MD       P N  + +  +   C  A  + RP+  ++V  L+ 
Sbjct: 269 FKLLKEGHR-------MDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 315

Query: 571 IDYEIPPPKQPPFLNAS 587
           I   +       +L+ S
Sbjct: 316 I---LTLTTNEEYLDLS 329

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  120 bits (304), Expect = 3e-30
 Identities = 52/229 (22%), Positives = 100/229 (43%), Gaps = 36/229 (15%)

Query: 287 NFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR--QWVDQFFNE 344
              Y IL+          ++G GG+  VF+      +  A+K +       Q +D + NE
Sbjct: 8   GRIYSILK----------QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNE 57

Query: 345 VNLISGIQHKN--VVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFT 401
           +  ++ +Q  +  ++RL        + + +V E   N  L+  L  K +   +   +R +
Sbjct: 58  IAYLNKLQQHSDKIIRLYD-YEITDQYIYMVMECG-NIDLNSWLKKKKS---IDPWERKS 112

Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS-TG 460
                 E +  +H      I+H D+K +N L+ +    K+ DFG+A  + PD T V    
Sbjct: 113 YWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDS 168

Query: 461 IAGTLGYMAPEYLV-----------RGQLTEKADVYAFGVLVIEVASGR 498
             GT+ YM PE +            + +++ K+DV++ G ++  +  G+
Sbjct: 169 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  120 bits (304), Expect = 5e-30
 Identities = 69/304 (22%), Positives = 120/304 (39%), Gaps = 64/304 (21%)

Query: 304 RKLGQGGAGSVFRGTLPDGRN--------IAVKRL--FFNSRQWVDQFFNEVNLISGI-Q 352
           + LG+G  G V                  +AVK L      +   D   +E+ ++  I +
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD-LVSEMEMMKMIGK 145

Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQIL-------------FVKNTIHILSWQQR 399
           HKN++ LLG   +     ++ EY    +L + L               +     ++++  
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVST 459
            +     A G+ +L   +  K IHRD+   N+L+ E    KIADFGLAR +     +   
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK-- 260

Query: 460 GIAGTLG-----YMAPEYLVRGQLTEKADVYAFGVLVIEVAS-------GRRNSVFSEGS 507
               T G     +MAPE L     T ++DV++FGVL+ E+ +       G          
Sbjct: 261 --KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV------- 311

Query: 508 SSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM 567
             +   + + ++       MD       P N  + +  +   C  A  + RP+  ++V  
Sbjct: 312 EELFKLLKEGHR-------MDK------PANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358

Query: 568 LNNI 571
           L+ I
Sbjct: 359 LDRI 362

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  118 bits (299), Expect = 7e-30
 Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 10/203 (4%)

Query: 297 TDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQ-WVDQFFNEVNLISGIQHK 354
            + F    K+G+G  G VF+G      + +A+K +     +  ++    E+ ++S     
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 355 NVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH 414
            V +  G  ++  +  ++ EY+   S   +L        L   Q  TI+    +GL +LH
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLH 136

Query: 415 GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLV 474
                K IHRDIK +N+LL E    K+ADFG+A  +   +   +T + GT  +MAPE + 
Sbjct: 137 S---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIK 192

Query: 475 RGQLTEKADVYAFGVLVIEVASG 497
           +     KAD+++ G+  IE+A G
Sbjct: 193 QSAYDSKADIWSLGITAIELARG 215

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  119 bits (301), Expect = 7e-30
 Identities = 70/304 (23%), Positives = 108/304 (35%), Gaps = 58/304 (19%)

Query: 304 RKLGQGGAGSVFRGTLPDGRN------IAVKRL--FFNSRQWVDQFFNEVNLISGI-QHK 354
           + LG G  G V   T            +AVK L    +S +      +E+ +++ +  H+
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA-LMSELKMMTQLGSHE 109

Query: 355 NVVRLLGCSIEGPESLLVYEYVPN-------RSLDQILFVKNTIHILSWQQRFTIICGT- 406
           N+V LLG         L++EY          RS  +        +    +          
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 407 ------------AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK 454
                       A+G+  L        +HRD+   N+L+      KI DFGLAR +  D 
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226

Query: 455 THVSTGIAGTL--GYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSS---- 508
            +V  G    L   +MAPE L  G  T K+DV+++G+L+ E        +FS G +    
Sbjct: 227 NYVVRG-NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE--------IFSLGVNPYPG 277

Query: 509 -SVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM 567
             V    +K  +       MD       P      +  I   C       RPS   +   
Sbjct: 278 IPVDANFYKLIQNGFK---MDQ------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328

Query: 568 LNNI 571
           L   
Sbjct: 329 LGCQ 332

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  120 bits (302), Expect = 1e-29
 Identities = 58/218 (26%), Positives = 91/218 (41%), Gaps = 23/218 (10%)

Query: 298 DFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLF-FNSRQWVDQFFNEVNLISGIQHKN 355
             +  S  LGQG   +VFRG     G   A+K     +  + VD    E  ++  + HKN
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 356 VVRLLGCSIEGPESLLVY---EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
           +V+L     E   +       E+ P  SL  +L   +  + L   +   ++     G+ H
Sbjct: 69  IVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 413 LHGGSGIKIIHRDIKTSNILL----DEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           L       I+HR+IK  NI+     D +   K+ DFG AR +  D+  VS  + GT  Y+
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYL 182

Query: 469 APEYLVRGQL--------TEKADVYAFGVLVIEVASGR 498
            P+   R  L            D+++ GV     A+G 
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  123 bits (309), Expect = 1e-29
 Identities = 57/285 (20%), Positives = 109/285 (38%), Gaps = 29/285 (10%)

Query: 305 KLGQGGAGSVFRGTL-PDGRNI--AVKRL-FFNSRQWVDQFFNEVNLISGIQHKNVVRLL 360
           +LG G  GSV +G      + I  A+K L     +   ++   E  ++  + +  +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 361 GCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIK 420
           G        +LV E      L +  F+      +       ++   + G+ +L       
Sbjct: 403 GVCQAEA-LMLVMEMAGGGPLHK--FLVGKREEIPVSNVAELLHQVSMGMKYL---EEKN 456

Query: 421 IIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGY--MAPEYLVRGQL 478
            +HR++   N+LL  +   KI+DFGL++ +  D ++ +   AG       APE +   + 
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516

Query: 479 TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF--P 536
           + ++DV+++GV + E          S G        +K  K   +   ++ G   R   P
Sbjct: 517 SSRSDVWSYGVTMWE--------ALSYG-----QKPYKKMKGPEVMAFIEQG--KRMECP 561

Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQP 581
                 +  +   C       RP    V   +    Y +    + 
Sbjct: 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 606

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  119 bits (299), Expect = 1e-29
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 18/208 (8%)

Query: 297 TDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFF---NEVNLISGIQ 352
              F + R++G G  G+V+    + +   +A+K++ ++ +Q  +++     EV  +  ++
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
           H N ++  GC +    + LV EY    + D    ++     L   +   +  G  +GLA+
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASD---LLEVHKKPLQEVEIAAVTHGALQGLAY 169

Query: 413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE- 471
           LH      +IHRD+K  NILL E    K+ DFG A  +AP  + V     GT  +MAPE 
Sbjct: 170 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEV 221

Query: 472 --YLVRGQLTEKADVYAFGVLVIEVASG 497
              +  GQ   K DV++ G+  IE+A  
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAER 249

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  118 bits (298), Expect = 1e-29
 Identities = 73/296 (24%), Positives = 114/296 (38%), Gaps = 51/296 (17%)

Query: 304 RKLGQGGAGSVFRGTLPDGRN------IAVKRL--FFNSRQWVDQFFNEVNLISGI-QHK 354
           + LG G  G V   T            +AVK L    ++ +      +E+ ++S + QH+
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LMSELKIMSHLGQHE 110

Query: 355 NVVRLLG-CSIEGPESLLVYEYVPN-----------RSLDQILFVKNTIHILSWQQRFTI 402
           N+V LLG C+  GP  L++ EY              R L+            S +     
Sbjct: 111 NIVNLLGACTHGGP-VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 403 ICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIA 462
               A+G+A L   +    IHRD+   N+LL      KI DFGLAR +  D  ++  G  
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG-N 225

Query: 463 GTL--GYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSS-----SVLHTVW 515
             L   +MAPE +     T ++DV+++G+L+ E+        FS G +      V    +
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI--------FSLGLNPYPGILVNSKFY 277

Query: 516 KHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           K  K       M        P      +  I   C       RP+  ++   L   
Sbjct: 278 KLVKDGYQ---MAQ------PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  118 bits (297), Expect = 1e-29
 Identities = 51/229 (22%), Positives = 99/229 (43%), Gaps = 36/229 (15%)

Query: 287 NFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQW--VDQFFNE 344
              Y IL+          ++G GG+  VF+      +  A+K +         +D + NE
Sbjct: 27  GRIYSILK----------QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNE 76

Query: 345 VNLISGIQHKN--VVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFT 401
           +  ++ +Q  +  ++RL        + + +V E   N  L+  L  K +   +   +R +
Sbjct: 77  IAYLNKLQQHSDKIIRLYDY-EITDQYIYMVMECG-NIDLNSWLKKKKS---IDPWERKS 131

Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS-TG 460
                 E +  +H      I+H D+K +N L+ +    K+ DFG+A  + PD T V    
Sbjct: 132 YWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDS 187

Query: 461 IAGTLGYMAPEYLV-----------RGQLTEKADVYAFGVLVIEVASGR 498
             GT+ YM PE +            + +++ K+DV++ G ++  +  G+
Sbjct: 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  116 bits (293), Expect = 3e-29
 Identities = 52/225 (23%), Positives = 82/225 (36%), Gaps = 35/225 (15%)

Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNIAVKR--LFFNSRQWVDQFFNEVNLISGI-QHKN 355
           F    K+G G  GSVF+     DG   A+KR                EV   + + QH +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICGTAEGLAHLH 414
           VVR      E    L+  EY    SL D I      +      +   ++     GL ++H
Sbjct: 73  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132

Query: 415 GGSGIKIIHRDIKTSNILLDE-------------------KLTPKIADFGLARHVAPDKT 455
               + ++H DIK SNI +                     K+  KI D G    ++  + 
Sbjct: 133 S---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189

Query: 456 HVSTGIAGTLGYMAPEYLVRGQL--TEKADVYAFGVLVIEVASGR 498
                  G   ++A E +++       KAD++A  + V+  A   
Sbjct: 190 EE-----GDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAE 228

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  117 bits (295), Expect = 4e-29
 Identities = 56/227 (24%), Positives = 84/227 (37%), Gaps = 34/227 (14%)

Query: 287 NFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEV 345
             +  +           R L +GG   V+    +  GR  A+KRL  N  +       EV
Sbjct: 27  ELRLRVR----------RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEV 76

Query: 346 NLISGIQ-HKNVVRLLGCSIEGPES-------LLVYEYVPNRSLDQILFVKNTIHILSWQ 397
             +  +  H N+V+    +  G E         L+   +    L + L    +   LS  
Sbjct: 77  CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCD 136

Query: 398 QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR--HVAPDKT 455
               I   T   + H+H      IIHRD+K  N+LL  + T K+ DFG A      PD +
Sbjct: 137 TVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS 195

Query: 456 HVSTGIA---------GTLGYMAPE--YLVRGQ-LTEKADVYAFGVL 490
             +   A          T  Y  PE   L     + EK D++A G +
Sbjct: 196 WSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI 242

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  118 bits (296), Expect = 4e-29
 Identities = 60/222 (27%), Positives = 104/222 (46%), Gaps = 18/222 (8%)

Query: 283 TSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWV-DQ 340
            + L  K ++ E   D F+   +LG G  G VF+ +  P G  +A K +    +  + +Q
Sbjct: 18  EAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ 77

Query: 341 FFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI--HILSWQQ 398
              E+ ++       +V   G      E  +  E++   SLDQ+L     I   IL    
Sbjct: 78  IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG--- 134

Query: 399 RFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD--KTH 456
              +     +GL +L      KI+HRD+K SNIL++ +   K+ DFG++  +      + 
Sbjct: 135 --KVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 190

Query: 457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           V     GT  YM+PE L     + ++D+++ G+ ++E+A GR
Sbjct: 191 V-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  117 bits (295), Expect = 1e-28
 Identities = 55/266 (20%), Positives = 106/266 (39%), Gaps = 44/266 (16%)

Query: 254 NPNYQKKETRYKRLSEMRKGQVLLGTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGS 313
              ++++      L      +       C S     Y IL+          ++G GG+  
Sbjct: 22  AAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILK----------QIGSGGSSK 71

Query: 314 VFRGTLPDGRNIAVKRLFFNSR--QWVDQFFNEVNLISGIQHKN--VVRLLGCSIEGPES 369
           VF+      +  A+K +       Q +D + NE+  ++ +Q  +  ++RL        + 
Sbjct: 72  VFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD-YEITDQY 130

Query: 370 L-LVYEYVPNRSLDQILFVKNTIHILS----WQQRFTIICGTAEGLAHLHGGSGIKIIHR 424
           + +V E   N  L+  L  K +I        W+          E +  +H      I+H 
Sbjct: 131 IYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKN-------MLEAVHTIHQ---HGIVHS 179

Query: 425 DIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS-TGIAGTLGYMAPEYLV--------- 474
           D+K +N L+ +    K+ DFG+A  + PD T V      G + YM PE +          
Sbjct: 180 DLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENG 238

Query: 475 --RGQLTEKADVYAFGVLVIEVASGR 498
             + +++ K+DV++ G ++  +  G+
Sbjct: 239 KSKSKISPKSDVWSLGCILYYMTYGK 264

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  116 bits (293), Expect = 2e-28
 Identities = 73/301 (24%), Positives = 120/301 (39%), Gaps = 58/301 (19%)

Query: 304 RKLGQGGAGSVFRGTLPDGRN--------IAVKRL--FFNSRQWVDQFFNEVNLISGI-Q 352
           + LG+G  G V                  +AVK L      +   D   +E+ ++  I +
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEMEMMKMIGK 133

Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQIL-------------FVKNTIHILSWQQR 399
           HKN++ LLG   +     ++ EY    +L + L                N    LS +  
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVST 459
            +     A G+ +L   +  K IHRD+   N+L+ E    KIADFGLAR +     +  T
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250

Query: 460 GIAGTL--GYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-------GRRNSVFSEGSSSV 510
              G L   +MAPE L     T ++DV++FGVL+ E+ +       G            +
Sbjct: 251 T-NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-------EL 302

Query: 511 LHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN 570
              + + ++       MD       P N  + +  +   C  A  + RP+  ++V  L+ 
Sbjct: 303 FKLLKEGHR-------MDK------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 349

Query: 571 I 571
           I
Sbjct: 350 I 350

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  115 bits (289), Expect = 6e-28
 Identities = 39/216 (18%), Positives = 80/216 (37%), Gaps = 19/216 (8%)

Query: 297 TDFFDNSRKLGQGGA--GSVFRGT-LPDGRNIAVKR--LFFNSRQWVDQFFNEVNLISGI 351
              ++    +G+G     +V      P G  + V+R  L   S + V     E+++    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 352 QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI-HILSWQQRFTIICGTAEGL 410
            H N+V      I   E  +V  ++   S   ++         ++      I+ G  + L
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI--CTHFMDGMNELAIAYILQGVLKAL 141

Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVST------GIAGT 464
            ++H    +  +HR +K S+IL+       ++       +                    
Sbjct: 142 DYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198

Query: 465 LGYMAPEYLVRGQL--TEKADVYAFGVLVIEVASGR 498
           L +++PE L +       K+D+Y+ G+   E+A+G 
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  112 bits (283), Expect = 8e-28
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 15/213 (7%)

Query: 298 DFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL-FFNSRQWVDQFFNEVNLISGIQHKN 355
           D ++    +G G    V      P    +A+KR+     +  +D+   E+  +S   H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQIL-----FVKNTIHILSWQQRFTIICGTAEGL 410
           +V      +   E  LV + +   S+  I+       ++   +L      TI+    EGL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFG----LARHVAPDKTHVSTGIAGTLG 466
            +LH       IHRD+K  NILL E  + +IADFG    LA      +  V     GT  
Sbjct: 135 EYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 467 YMAPEYLVRGQL-TEKADVYAFGVLVIEVASGR 498
           +MAPE + + +    KAD+++FG+  IE+A+G 
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  110 bits (278), Expect = 4e-27
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 27/207 (13%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRLF----FNSRQWVDQFFNEVNLISGIQHKNVVR 358
           R LG+GG    F  +        A K +         Q  ++   E+++   + H++VV 
Sbjct: 21  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ-REKMSMEISIHRSLAHQHVVG 79

Query: 359 LLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFT------IICGTAEGLA 411
             G   E  + + +V E    RSL         + +   ++  T       +     G  
Sbjct: 80  FHGF-FEDNDFVFVVLELCRRRSL---------LELHKRRKALTEPEARYYLRQIVLGCQ 129

Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           +LH     ++IHRD+K  N+ L+E L  KI DFGLA  V  D       + GT  Y+APE
Sbjct: 130 YLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE 185

Query: 472 YLVRGQLTEKADVYAFGVLVIEVASGR 498
            L +   + + DV++ G ++  +  G+
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  109 bits (275), Expect = 6e-27
 Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 29/211 (13%)

Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLF----FNSRQWVDQFFNEVNLISGIQHK 354
           F+  R LG+G  G+V+          +A+K LF      +     Q   EV + S ++H 
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLRHP 69

Query: 355 NVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRF------TIICGTA 407
           N++RL G        + L+ EY P  ++    + +     L    +F      T I   A
Sbjct: 70  NILRLYGY-FHDATRVYLILEYAPLGTV----YRE-----LQKLSKFDEQRTATYITELA 119

Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGY 467
             L++ H     ++IHRDIK  N+LL      KIADFG + H AP          GTL Y
Sbjct: 120 NALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTDL--CGTLDY 173

Query: 468 MAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           + PE +      EK D+++ GVL  E   G+
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  109 bits (275), Expect = 7e-27
 Identities = 50/193 (25%), Positives = 87/193 (45%), Gaps = 14/193 (7%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRLF----FNSRQWVDQFFNEVNLISGIQHKNVVR 358
             LG+G    V+R   +  G  +A+K +     + +   V +  NEV +   ++H +++ 
Sbjct: 17  NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGM-VQRVQNEVKIHCQLKHPSILE 75

Query: 359 LLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
           L     E    + LV E   N  +++ L  +      S  +    +     G+ +LH   
Sbjct: 76  LYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHS-- 130

Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQ 477
              I+HRD+  SN+LL   +  KIADFGLA  +        T + GT  Y++PE   R  
Sbjct: 131 -HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSA 188

Query: 478 LTEKADVYAFGVL 490
              ++DV++ G +
Sbjct: 189 HGLESDVWSLGCM 201

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  110 bits (278), Expect = 7e-27
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 27/207 (13%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRLF----FNSRQWVDQFFNEVNLISGIQHKNVVR 358
           R LG+GG    F  +        A K +         Q  ++   E+++   + H++VV 
Sbjct: 47  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ-REKMSMEISIHRSLAHQHVVG 105

Query: 359 LLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFT------IICGTAEGLA 411
             G   E  + + +V E    RSL         + +   ++  T       +     G  
Sbjct: 106 FHGF-FEDNDFVFVVLELCRRRSL---------LELHKRRKALTEPEARYYLRQIVLGCQ 155

Query: 412 HLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           +LH     ++IHRD+K  N+ L+E L  KI DFGLA  V  D       + GT  Y+APE
Sbjct: 156 YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE 211

Query: 472 YLVRGQLTEKADVYAFGVLVIEVASGR 498
            L +   + + DV++ G ++  +  G+
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  114 bits (285), Expect = 2e-26
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 22/220 (10%)

Query: 294 ERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQW---VDQFFNEVNLIS 349
            +    ++   +LG GG G V R      G  +A+K             +++  E+ ++ 
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIK--QCRQELSPKNRERWCLEIQIMK 67

Query: 350 GIQHKNVVRLLGCSIEGPESL-------LVYEYVPNRSLDQILFVKNTIHILSWQQRFTI 402
            + H NVV       +G + L       L  EY     L + L        L      T+
Sbjct: 68  KLNHPNVVSAREV-PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126

Query: 403 ICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADFGLARHVAPDKTHVST 459
           +   +  L +LH     +IIHRD+K  NI+L    ++L  KI D G A+ +      + T
Sbjct: 127 LSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCT 181

Query: 460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRR 499
              GTL Y+APE L + + T   D ++FG L  E  +G R
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  107 bits (270), Expect = 3e-26
 Identities = 64/243 (26%), Positives = 101/243 (41%), Gaps = 47/243 (19%)

Query: 267 LSEMRKGQVLLGTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNI 325
           L+EM K +  +            ++I           R LG+G  G+V+      +   +
Sbjct: 3   LAEMPKRKFTID----------DFDIG----------RPLGKGKFGNVYLAREKQNKFIM 42

Query: 326 AVKRLF---FNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL-LVYEYVPNRSL 381
           A+K LF           Q   E+ + S ++H N++R+        + + L+ E+ P   L
Sbjct: 43  ALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN-YFHDRKRIYLMLEFAPRGEL 101

Query: 382 DQILFVKNTIHILSWQQRF------TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE 435
               + +     L    RF      T +   A+ L + H     K+IHRDIK  N+L+  
Sbjct: 102 ----YKE-----LQKHGRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGY 149

Query: 436 KLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVA 495
           K   KIADFG + H    +    T + GTL Y+ PE +      EK D++  GVL  E  
Sbjct: 150 KGELKIADFGWSVHAPSLRRR--T-MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFL 206

Query: 496 SGR 498
            G 
Sbjct: 207 VGM 209

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  107 bits (270), Expect = 4e-26
 Identities = 54/200 (27%), Positives = 87/200 (43%), Gaps = 14/200 (7%)

Query: 297 TDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLF-FNSRQWVDQFFNEVNLISGIQHK 354
            D F   RKLG G  G V        G    +K +    S+  ++Q   E+ ++  + H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 355 NVVRLLGCSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
           N++++     E   ++ +V E      L ++I+  +     LS      ++      LA+
Sbjct: 81  NIIKIFEV-FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139

Query: 413 LHGGSGIKIIHRDIKTSNILL---DEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMA 469
            H      ++H+D+K  NIL          KI DFGLA     D+    T  AGT  YMA
Sbjct: 140 FHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--TNAAGTALYMA 194

Query: 470 PEYLVRGQLTEKADVYAFGV 489
           PE   +  +T K D+++ GV
Sbjct: 195 PEVF-KRDVTFKCDIWSAGV 213

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  108 bits (272), Expect = 6e-26
 Identities = 33/297 (11%), Positives = 71/297 (23%), Gaps = 48/297 (16%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRLF---FNSRQWVDQFFNEVNLISGIQHKNVVRL 359
             L  G    VF    +    + A+K       NSR  +++        + +  ++    
Sbjct: 68  EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127

Query: 360 LG----------CSIEG----------------PESLLVYEYVP---NRSLDQILFVKNT 390
                        +++                    LL+              + FV   
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187

Query: 391 IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV 450
                      +        A+L       ++H      N+ +       + D      V
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244

Query: 451 APDKTHVSTGIAGTLGYMAPEYLVRG--QLTEKADVYAFGVLVIEVASGRRNSVFSEGSS 508
                      +  + Y   E+L       T   + +  G+ +  V        F   + 
Sbjct: 245 ----GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL--PFGLVTP 298

Query: 509 SVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVV 565
            +  +  +       T S+  G     P+     ++    L        R    E +
Sbjct: 299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPD-FVKTLIG-RFLNFD--RRRRLLPLEAM 351

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  106 bits (268), Expect = 1e-25
 Identities = 52/208 (25%), Positives = 82/208 (39%), Gaps = 29/208 (13%)

Query: 294 ERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ 352
                 F     LG G    VF       G+  A+K +  +         NE+ ++  I+
Sbjct: 5   TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK 64

Query: 353 HKNVVRLLGCSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFT------IIC 404
           H+N+V L     E      LV + V    L D+IL           +  +T      +I 
Sbjct: 65  HENIVTLED-IYESTTHYYLVMQLVSGGELFDRILE----------RGVYTEKDASLVIQ 113

Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILL---DEKLTPKIADFGLARHVAPDKTHVSTGI 461
                + +LH      I+HRD+K  N+L    +E     I DFGL++          +  
Sbjct: 114 QVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STA 167

Query: 462 AGTLGYMAPEYLVRGQLTEKADVYAFGV 489
            GT GY+APE L +   ++  D ++ GV
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDCWSIGV 195

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  109 bits (275), Expect = 1e-25
 Identities = 60/203 (29%), Positives = 87/203 (42%), Gaps = 20/203 (9%)

Query: 297 TDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQ 352
           +D +   R LG+G  G V        G+  AVK +       +   +    EV L+  + 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 353 HKNVVRLLGCSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICGTAEGL 410
           H N+++L     E      LV E      L D+I+  K      S      II     G+
Sbjct: 85  HPNIMKLYE-FFEDKGYFYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGI 139

Query: 411 AHLHGGSGIKIIHRDIKTSNILL---DEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGY 467
            ++H     KI+HRD+K  N+LL    +    +I DFGL+ H    K        GT  Y
Sbjct: 140 TYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGTAYY 194

Query: 468 MAPEYLVRGQLTEKADVYAFGVL 490
           +APE L  G   EK DV++ GV+
Sbjct: 195 IAPEVL-HGTYDEKCDVWSTGVI 216

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  107 bits (268), Expect = 2e-25
 Identities = 48/205 (23%), Positives = 85/205 (41%), Gaps = 16/205 (7%)

Query: 297 TDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVK-----RLFFNSRQWVDQFFNEVNLISG 350
            D ++    +G+G    V R      G+  AVK     +   +     +    E ++   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 351 IQHKNVVRLLGCSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICGTAE 408
           ++H ++V LL  +      L +V+E++    L  +I+   +   + S       +    E
Sbjct: 83  LKHPHIVELLE-TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILL---DEKLTPKIADFGLARHVAPDKTHVSTGIAGTL 465
            L + H      IIHRD+K   +LL   +     K+  FG+A  +      V+ G  GT 
Sbjct: 142 ALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL-VAGGRVGTP 197

Query: 466 GYMAPEYLVRGQLTEKADVYAFGVL 490
            +MAPE + R    +  DV+  GV+
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVI 222

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  106 bits (266), Expect = 3e-25
 Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 19/214 (8%)

Query: 297 TDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI-QHK 354
              F+    +G G  G V++G  +  G+  A+K +     +  +    E+N++     H+
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE-IKQEINMLKKYSHHR 81

Query: 355 NVVRLLGCSIEGPESL------LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAE 408
           N+    G  I+           LV E+    S+  ++      + L  +    I      
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILR 140

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           GL+HLH     K+IHRDIK  N+LL E    K+ DFG++  +       +T I GT  +M
Sbjct: 141 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWM 196

Query: 469 APEYLVRGQLTE-----KADVYAFGVLVIEVASG 497
           APE +   +  +     K+D+++ G+  IE+A G
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  109 bits (273), Expect = 3e-25
 Identities = 59/256 (23%), Positives = 97/256 (37%), Gaps = 41/256 (16%)

Query: 254 NPNYQKKETRYKRLSEMRKGQVLLGTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGS 313
           + ++            +       G  +                + +   RKLG G  G 
Sbjct: 3   HHHHHSSGRENLYFQGIAINP---GMYVRKKEGKIG--------ESYFKVRKLGSGAYGE 51

Query: 314 VFRGT-LPDGRNIAVKRL-------------FFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           V            A+K +               N  ++ ++ +NE++L+  + H N+++L
Sbjct: 52  VLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111

Query: 360 LGCSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
                E  +   LV E+     L +QI+                I+     G+ +LH   
Sbjct: 112 FD-VFEDKKYFYLVTEFYEGGELFEQIINRHK----FDECDAANIMKQILSGICYLHK-- 164

Query: 418 GIKIIHRDIKTSNILL---DEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLV 474
              I+HRDIK  NILL   +  L  KI DFGL+   + D         GT  Y+APE L 
Sbjct: 165 -HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVL- 220

Query: 475 RGQLTEKADVYAFGVL 490
           + +  EK DV++ GV+
Sbjct: 221 KKKYNEKCDVWSCGVI 236

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  106 bits (266), Expect = 3e-25
 Identities = 47/214 (21%), Positives = 89/214 (41%), Gaps = 36/214 (16%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLF-----------------FNSRQWVDQFFNEVN 346
           R L QG    +      D +  A+K+                    + +   D F NE+ 
Sbjct: 37  RTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95

Query: 347 LISGIQHKNVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFT---- 401
           +I+ I+++  +   G  I   + + ++YEY+ N S+ +       +   ++         
Sbjct: 96  IITDIKNEYCLTCEG-IITNYDEVYIIYEYMENDSILKFD-EYFFVLDKNYTCFIPIQVI 153

Query: 402 --IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVST 459
             II       +++H  +   I HRD+K SNIL+D+    K++DFG + ++   K   S 
Sbjct: 154 KCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS- 210

Query: 460 GIAGTLGYMAPEYLVRGQLT---EKADVYAFGVL 490
              GT  +M PE     + +    K D+++ G+ 
Sbjct: 211 --RGTYEFMPPE-FFSNESSYNGAKVDIWSLGIC 241

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  104 bits (262), Expect = 4e-25
 Identities = 52/207 (25%), Positives = 94/207 (45%), Gaps = 13/207 (6%)

Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNS-RQWVDQFFNEVN-LISGIQHKNV 356
            +   +LG+G  G V +   +P G+ +AVKR+      Q   +   +++  +  +     
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68

Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQIL-FVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           V   G      +  +  E + + SLD+    V +    +       I     + L HLH 
Sbjct: 69  VTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH- 126

Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE---- 471
            S + +IHRD+K SN+L++     K+ DFG++ ++           AG   YMAPE    
Sbjct: 127 -SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPYMAPERINP 183

Query: 472 YLVRGQLTEKADVYAFGVLVIEVASGR 498
            L +   + K+D+++ G+ +IE+A  R
Sbjct: 184 ELNQKGYSVKSDIWSLGITMIELAILR 210

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  105 bits (265), Expect = 4e-25
 Identities = 57/223 (25%), Positives = 91/223 (40%), Gaps = 34/223 (15%)

Query: 283 TSSLNFKYEILERAT----DFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQW 337
           T+SL   Y I         DFF+   +LG+G    V+R       +  A+K         
Sbjct: 34  TASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALK--VLKKTVD 91

Query: 338 VDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILS 395
                 E+ ++  + H N+++L     E P  + LV E V    L D+I+          
Sbjct: 92  KKIVRTEIGVLLRLSHPNIIKLKE-IFETPTEISLVLELVTGGELFDRIVE--------- 141

Query: 396 WQQRFT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILL---DEKLTPKIADFGL 446
            +  ++       +    E +A+LH      I+HRD+K  N+L          KIADFGL
Sbjct: 142 -KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGL 197

Query: 447 ARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGV 489
           ++ V          + GT GY APE L       + D+++ G+
Sbjct: 198 SKIVEHQVLM--KTVCGTPGYCAPEILRGCAYGPEVDMWSVGI 238

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  105 bits (263), Expect = 5e-25
 Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 22/221 (9%)

Query: 291 EILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNS-RQWVDQFFNEVN-L 347
           +  +   +   +  ++G+G  GSV +    P G+ +AVKR+      +   Q   +++ +
Sbjct: 15  QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74

Query: 348 ISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFT-----I 402
           +       +V+  G      +  +  E + + S D+    K    +L             
Sbjct: 75  MRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFY--KYVYSVL--DDVIPEEILGK 129

Query: 403 IC-GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGI 461
           I   T + L HL     +KIIHRDIK SNILLD     K+ DFG++  +    +   T  
Sbjct: 130 ITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRD 185

Query: 462 AGTLGYMAPEYLVRGQL----TEKADVYAFGVLVIEVASGR 498
           AG   YMAPE +           ++DV++ G+ + E+A+GR
Sbjct: 186 AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  104 bits (262), Expect = 6e-25
 Identities = 50/211 (23%), Positives = 96/211 (45%), Gaps = 19/211 (9%)

Query: 298 DFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNS-RQWVDQFFNEVN-LISGIQHK 354
           +  +N  ++G G  G V++      G  IAVK++  +  ++   +   +++ ++      
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84

Query: 355 NVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTI--HILSWQQRFTIICGTAEGLAH 412
            +V+  G  I   +  +  E +   +      ++  I   IL       +     + L +
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAIVKALYY 139

Query: 413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEY 472
           L       +IHRD+K SNILLDE+   K+ DFG++  +           AG   YMAPE 
Sbjct: 140 LK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAAYMAPER 195

Query: 473 LVRGQLTE-----KADVYAFGVLVIEVASGR 498
           +     T+     +ADV++ G+ ++E+A+G+
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  105 bits (264), Expect = 7e-25
 Identities = 37/247 (14%), Positives = 72/247 (29%), Gaps = 23/247 (9%)

Query: 293 LERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLF-----FNSRQW-VDQFFNEVN 346
            +  +        LG+G    V+  T  D  +   K+ F       +  W        + 
Sbjct: 60  FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLME 119

Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQIL--FVKNTIHILSWQQRFTIIC 404
            +        ++     +    S+LV E     +L   +  +      ++      +   
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179

Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP-----------KIADFGLARHV-AP 452
                +  +H     +IIH DIK  N +L                  + D G +  +   
Sbjct: 180 RMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF 236

Query: 453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLH 512
            K  + T    T G+   E L       + D +     V  +  G    V +EG      
Sbjct: 237 PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE 296

Query: 513 TVWKHYK 519
            +++   
Sbjct: 297 GLFRRLP 303

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  107 bits (268), Expect = 9e-25
 Identities = 57/236 (24%), Positives = 91/236 (38%), Gaps = 19/236 (8%)

Query: 263 RYKRLSEMRKGQVLLGTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPD 321
            +       +  +     L  +   F        ++ +   +KLG G  G V        
Sbjct: 2   HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61

Query: 322 GRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL-LVYEYVPN 378
               A+K +     S     +   EV ++  + H N+++L     E   +  LV E    
Sbjct: 62  HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD-FFEDKRNYYLVMECYKG 120

Query: 379 RSL-DQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL---D 434
             L D+I+         +      II     G+ +LH      I+HRD+K  N+LL   +
Sbjct: 121 GELFDEIIHRMK----FNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKE 173

Query: 435 EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVL 490
           +    KI DFGL+      K        GT  Y+APE L R +  EK DV++ GV+
Sbjct: 174 KDALIKIVDFGLSAVFENQKKM--KERLGTAYYIAPEVL-RKKYDEKCDVWSIGVI 226

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  103 bits (260), Expect = 1e-24
 Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 33/212 (15%)

Query: 297 TDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVK----RLFFNSRQWVD--QFFNEVNLIS 349
            DF+D   +LG G    V +      G   A K    R    SR+ V   +   EV+++ 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 350 GIQHKNVVRLLGCSIEGPESL-LVYEYVPNRSL-DQILFV-----KNTIHILSWQQRFTI 402
            + H NV+ L     E    + L+ E V    L D +        +     +  +Q    
Sbjct: 71  QVLHHNVITLHD-VYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI--KQ---- 123

Query: 403 ICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP----KIADFGLARHVAPDKTHVS 458
           I    +G+ +LH     KI H D+K  NI+L +K  P    K+ DFGLA  +        
Sbjct: 124 IL---DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF-- 175

Query: 459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVL 490
             I GT  ++APE +    L  +AD+++ GV+
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  104 bits (262), Expect = 2e-24
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 33/215 (15%)

Query: 294 ERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVK----RLFFNSRQWVDQ--FFNEVN 346
           ++  DF+D   +LG G    V +      G   A K    R    SR+ V +     EV+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67

Query: 347 LISGIQHKNVVRLLGCSIEGPESL-LVYEYVPNRSL-DQILFV-----KNTIHILSWQQR 399
           ++  + H N++ L     E    + L+ E V    L D +        +     +  +Q 
Sbjct: 68  ILRQVLHPNIITLHD-VYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI--KQ- 123

Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP----KIADFGLARHVAPDKT 455
              I    +G+ +LH     KI H D+K  NI+L +K  P    K+ DFGLA  +     
Sbjct: 124 ---IL---DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174

Query: 456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVL 490
                I GT  ++APE +    L  +AD+++ GV+
Sbjct: 175 F--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  105 bits (264), Expect = 3e-24
 Identities = 58/216 (26%), Positives = 90/216 (41%), Gaps = 21/216 (9%)

Query: 282 CTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL--FFNSRQWV 338
            +   N  ++      + ++    LG+G  G V +       +  AVK +       +  
Sbjct: 8   SSGRENLYFQ--GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65

Query: 339 DQFFNEVNLISGIQHKNVVRLLGCSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSW 396
                EV L+  + H N+++L    +E   S  +V E      L D+I+  K      S 
Sbjct: 66  STILREVELLKKLDHPNIMKLFE-ILEDSSSFYIVGELYTGGELFDEIIKRKR----FSE 120

Query: 397 QQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL---DEKLTPKIADFGLARHVAPD 453
                II     G+ ++H      I+HRD+K  NILL   ++    KI DFGL+     +
Sbjct: 121 HDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

Query: 454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGV 489
                    GT  Y+APE L RG   EK DV++ GV
Sbjct: 178 TKM--KDRIGTAYYIAPEVL-RGTYDEKCDVWSAGV 210

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  101 bits (255), Expect = 3e-24
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 32/211 (15%)

Query: 294 ERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL---FFNSRQWVDQFFNEVNLIS 349
            + +D +D   +LG+G    V R      G   A K +     ++R    +   E  +  
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD-FQKLEREARICR 60

Query: 350 GIQHKNVVRLLGCSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFT------ 401
            +QH N+VRL   SI+      LV++ V    L + I+           ++ ++      
Sbjct: 61  KLQHPNIVRLHD-SIQEESFHYLVFDLVTGGELFEDIVA----------REFYSEADASH 109

Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILL---DEKLTPKIADFGLARHVAPDKTHVS 458
            I    E +A+ H      I+HR++K  N+LL    +    K+ADFGLA  V        
Sbjct: 110 CIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAW 164

Query: 459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGV 489
            G AGT GY++PE L +   ++  D++A GV
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 195

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  101 bits (255), Expect = 4e-24
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 33/208 (15%)

Query: 297 TDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQ 352
            + ++    LG+G  G V +       +  AVK +      ++        EV L+  + 
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKLD 79

Query: 353 HKNVVRLLGCSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFT------IIC 404
           H N+++L    +E   S  +V E      L D+I+           ++RF+      II 
Sbjct: 80  HPNIMKLFE-ILEDSSSFYIVGELYTGGELFDEIIK----------RKRFSEHDAARIIK 128

Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILL---DEKLTPKIADFGLARHVAPDKTHVSTGI 461
               G+ ++H      I+HRD+K  NILL   ++    KI DFGL+     +        
Sbjct: 129 QVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDR 183

Query: 462 AGTLGYMAPEYLVRGQLTEKADVYAFGV 489
            GT  Y+APE L RG   EK DV++ GV
Sbjct: 184 IGTAYYIAPEVL-RGTYDEKCDVWSAGV 210

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  101 bits (253), Expect = 5e-24
 Identities = 46/205 (22%), Positives = 81/205 (39%), Gaps = 29/205 (14%)

Query: 297 TDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKN 355
             ++     +G+G  G V            A K++     + VD+F  E+ ++  + H N
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67

Query: 356 VVRLLGCSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFT------IICGTA 407
           ++RL   + E    + LV E      L ++++           ++ F       I+    
Sbjct: 68  IIRLYE-TFEDNTDIYLVMELCTGGELFERVVH----------KRVFRESDAARIMKDVL 116

Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILL---DEKLTPKIADFGLARHVAPDKTHVSTGIAGT 464
             +A+ H    + + HRD+K  N L          K+ DFGLA    P K        GT
Sbjct: 117 SAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGT 171

Query: 465 LGYMAPEYLVRGQLTEKADVYAFGV 489
             Y++P+ L  G    + D ++ GV
Sbjct: 172 PYYVSPQVL-EGLYGPECDEWSAGV 195

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  103 bits (258), Expect = 6e-24
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 18/204 (8%)

Query: 294 ERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQ--FFNEVNLISG 350
               D++D   +LG G  G V R      GR    K  F N+   +D+    NE+++++ 
Sbjct: 47  GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK--FINTPYPLDKYTVKNEISIMNQ 104

Query: 351 IQHKNVVRLLGCSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICGTAE 408
           + H  ++ L   + E    + L+ E++    L D+I       + +S  +    +    E
Sbjct: 105 LHHPKLINLHD-AFEDKYEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACE 160

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTP--KIADFGLARHVAPDKTHVSTGIAGTLG 466
           GL H+H      I+H DIK  NI+ + K     KI DFGLA  + PD+  +      T  
Sbjct: 161 GLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAE 215

Query: 467 YMAPEYLVRGQLTEKADVYAFGVL 490
           + APE + R  +    D++A GVL
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGVL 239

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  101 bits (253), Expect = 6e-24
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 33/212 (15%)

Query: 297 TDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVK----RLFFNSRQWVD--QFFNEVNLIS 349
            D ++   +LG G    V +      G+  A K    R   +SR+ V   +   EVN++ 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 350 GIQHKNVVRLLGCSIEGPESL-LVYEYVPNRSL-DQILFV-----KNTIHILSWQQRFTI 402
            I+H N++ L     E    + L+ E V    L D +              L  +Q    
Sbjct: 64  EIRHPNIITLHD-IFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFL--KQ---- 116

Query: 403 ICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP----KIADFGLARHVAPDKTHVS 458
           I    +G+ +LH     +I H D+K  NI+L +K  P    K+ DFG+A  +        
Sbjct: 117 IL---DGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF-- 168

Query: 459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVL 490
             I GT  ++APE +    L  +AD+++ GV+
Sbjct: 169 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 200

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  101 bits (254), Expect = 8e-24
 Identities = 60/232 (25%), Positives = 96/232 (41%), Gaps = 45/232 (19%)

Query: 278 GTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVK----RLFF 332
           GTV    +++  Y+  E          +LG G    V +      G   A K    R   
Sbjct: 1   GTVFRQENVDDYYDTGE----------ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTK 50

Query: 333 NSRQWVDQ--FFNEVNLISGIQHKNVVRLLGCSIEGPESL-LVYEYVPNRSL-DQILFVK 388
           +SR+ V +     EV+++  IQH NV+ L     E    + L+ E V    L D +    
Sbjct: 51  SSRRGVSREDIEREVSILKEIQHPNVITLHE-VYENKTDVILILELVAGGELFDFLAE-- 107

Query: 389 NTIHILSWQQRFT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP--- 439
                   ++  T       +     G+ +LH    ++I H D+K  NI+L ++  P   
Sbjct: 108 --------KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPR 156

Query: 440 -KIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVL 490
            KI DFGLA  +          I GT  ++APE +    L  +AD+++ GV+
Sbjct: 157 IKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  102 bits (255), Expect = 1e-23
 Identities = 36/240 (15%), Positives = 68/240 (28%), Gaps = 53/240 (22%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSR--------------------------- 335
             LGQ    +    T    G +  V   +F  R                           
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 336 -QWVDQFFNEVNLISGIQHKNVVRLLGC-SIEGPESLLVYEYVPNRSLDQI---LFVKNT 390
            +   +F    +L+   Q K ++R+          S          +L      L   ++
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 391 IH-ILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH 449
            H  L    R  +       LA LH      ++H  ++  +I+LD++    +  F     
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255

Query: 450 VAPDKTHVSTGIAGTLGYMAPEYLV-----------RGQLTEKADVYAFGVLVIEVASGR 498
                       + + G+  PE              R  +T   D +A G+++  +    
Sbjct: 256 DGARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  103 bits (258), Expect = 1e-23
 Identities = 52/207 (25%), Positives = 91/207 (43%), Gaps = 29/207 (14%)

Query: 297 TDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL--FFNSRQWVDQFFNEVNLISGIQH 353
           T+ +    +LG+G    V R   +  G+  A   +     S +   +   E  +   ++H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 354 KNVVRLLGCSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFT------IICG 405
            N+VRL   SI       L+++ V    L + I+           ++ ++       I  
Sbjct: 70  PNIVRLHD-SISEEGHHYLIFDLVTGGELFEDIVA----------REYYSEADASHCIQQ 118

Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILL---DEKLTPKIADFGLARHVAPDKTHVSTGIA 462
             E + H H    + ++HR++K  N+LL    +    K+ADFGLA  V  ++     G A
Sbjct: 119 ILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-QAWFGFA 174

Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGV 489
           GT GY++PE L +    +  D++A GV
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGV 201

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  101 bits (254), Expect = 2e-23
 Identities = 59/225 (26%), Positives = 95/225 (42%), Gaps = 36/225 (16%)

Query: 282 CTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVK-----RLFFNSR 335
                 F      + +D +D   +LG+G    V R      G   A K     +L   S 
Sbjct: 13  MGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SA 69

Query: 336 QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHI 393
           +   +   E  +   +QH N+VRL   SI+      LV++ V    L + I+        
Sbjct: 70  RDFQKLEREARICRKLQHPNIVRLHD-SIQEESFHYLVFDLVTGGELFEDIVA------- 121

Query: 394 LSWQQRFT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILL---DEKLTPKIADF 444
              ++ ++       I    E +A+ H      I+HR++K  N+LL    +    K+ADF
Sbjct: 122 ---REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADF 175

Query: 445 GLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGV 489
           GLA  V   +     G AGT GY++PE L +   ++  D++A GV
Sbjct: 176 GLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  103 bits (259), Expect = 2e-23
 Identities = 50/200 (25%), Positives = 85/200 (42%), Gaps = 14/200 (7%)

Query: 297 TDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKN 355
            D +D   +LG G  G V R T    G N A K +        +    E+  +S ++H  
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215

Query: 356 VVRLLGCSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
           +V L   + E    + ++YE++    L +++    N    +S  +    +    +GL H+
Sbjct: 216 LVNLHD-AFEDDNEMVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHM 271

Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTP--KIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           H       +H D+K  NI+   K +   K+ DFGL  H+ P +        GT  + APE
Sbjct: 272 HE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--SVKVTTGTAEFAAPE 326

Query: 472 YLVRGQLTEKADVYAFGVLV 491
                 +    D+++ GVL 
Sbjct: 327 VAEGKPVGYYTDMWSVGVLS 346

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  100 bits (251), Expect = 6e-23
 Identities = 48/217 (22%), Positives = 87/217 (40%), Gaps = 38/217 (17%)

Query: 297 TDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVK-----RLFFNSRQWVD---QFFNEVNL 347
            D +  S+ LG G  G V         + +A++     +    S +  D       E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 348 ISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSL-DQILFVKNTIHILSWQQRFT----- 401
           +  + H  ++++     +  +  +V E +    L D++  V N        +R       
Sbjct: 194 LKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKV--VGN--------KRLKEATCK 242

Query: 402 -IICGTAEGLAHLHGGSGIKIIHRDIKTSNILL---DEKLTPKIADFGLARHVAPDKTHV 457
                    + +LH      IIHRD+K  N+LL   +E    KI DFG ++ +   +T +
Sbjct: 243 LYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL 297

Query: 458 STGIAGTLGYMAPEYLVRGQL---TEKADVYAFGVLV 491
              + GT  Y+APE LV           D ++ GV++
Sbjct: 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 99.2 bits (247), Expect = 6e-23
 Identities = 35/165 (21%), Positives = 59/165 (35%), Gaps = 14/165 (8%)

Query: 340 QFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQR 399
               ++  +     KN V  L  S       +  +     +L   +  + ++        
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166

Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR----------- 448
             I    AE +  LH      ++HRD+K SNI        K+ DFGL             
Sbjct: 167 LHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223

Query: 449 HVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIE 493
                     TG  GT  YM+PE +     + K D+++ G+++ E
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 98.5 bits (246), Expect = 9e-23
 Identities = 46/215 (21%), Positives = 80/215 (37%), Gaps = 38/215 (17%)

Query: 297 TDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL--------FFNSRQWVDQFFNEVNL 347
            D +  S+ LG G  G V         + +A+K +                     E+ +
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 348 ISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSL-DQILFVKNTIHILSWQQRFT----- 401
           +  + H  ++++     +  +  +V E +    L D++  V N        +R       
Sbjct: 69  LKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKV--VGN--------KRLKEATCK 117

Query: 402 -IICGTAEGLAHLHGGSGIKIIHRDIKTSNILL---DEKLTPKIADFGLARHVAPDKTHV 457
                    + +LH      IIHRD+K  N+LL   +E    KI DFG ++ +      +
Sbjct: 118 LYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SL 172

Query: 458 STGIAGTLGYMAPEYLV---RGQLTEKADVYAFGV 489
              + GT  Y+APE LV           D ++ GV
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 44/209 (21%), Positives = 83/209 (39%), Gaps = 29/209 (13%)

Query: 294 ERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQW-VDQFFNEVNLISGI 351
           +   + +  +  LG+G  G V R       +    K  F   +         E+++++  
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAK--FVKVKGTDQVLVKKEISILNIA 58

Query: 352 QHKNVVRLLGCSIEGPESL-LVYEYVPNRSL-DQILFVKNT------IHILSWQQRFTII 403
           +H+N++ L   S E  E L +++E++    + ++I            +  +   Q    +
Sbjct: 59  RHRNILHLHE-SFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYV--HQ----V 111

Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP--KIADFGLARHVAPDKTHVSTGI 461
           C   E L  LH      I H DI+  NI+   + +   KI +FG AR + P        +
Sbjct: 112 C---EALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLL 163

Query: 462 AGTLGYMAPEYLVRGQLTEKADVYAFGVL 490
                Y APE      ++   D+++ G L
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTL 192

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 98.0 bits (244), Expect = 2e-22
 Identities = 54/258 (20%), Positives = 85/258 (32%), Gaps = 55/258 (21%)

Query: 283 TSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVK-----RLFFNSRQ 336
             +L F+   L      +     +GQG  G V            A+K     ++   + +
Sbjct: 11  RENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPK 70

Query: 337 WVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL-LVYEYVPNRSL-DQI---------- 384
            V++   EV L+  + H N+ RL     E  + + LV E      L D++          
Sbjct: 71  DVERIKTEVRLMKKLHHPNIARLYEV-YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGK 129

Query: 385 --------------------LFVKNTIHILSWQQRFT------IICGTAEGLAHLHGGSG 418
                               +         S            I+      L +LH    
Sbjct: 130 CAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN--- 186

Query: 419 IKIIHRDIKTSNILL--DEKLTPKIADFGLARHVAPDKT---HVSTGIAGTLGYMAPEYL 473
             I HRDIK  N L   ++    K+ DFGL++          +  T  AGT  ++APE L
Sbjct: 187 QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL 246

Query: 474 VRGQL--TEKADVYAFGV 489
                    K D ++ GV
Sbjct: 247 NTTNESYGPKCDAWSAGV 264

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 99.4 bits (247), Expect = 2e-22
 Identities = 32/234 (13%), Positives = 63/234 (26%), Gaps = 42/234 (17%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSR--------------------------- 335
             LGQ    +    T    G +  V   +F  R                           
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 336 -QWVDQFFNEVNLISGIQHKNVVRLLGCSIEG--PESLLVYEYVPNRSLDQILFVKNTIH 392
            +   +F    +L+   Q K ++R+     +        +Y  + +        + +   
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 393 I---LSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH 449
               L    R  +       LA LH      ++H  ++  +I+LD++    +  F     
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 450 VAPDKTHVSTGIAGTLGYMAPEYLVRGQ-----LTEKADVYAFGVLVIEVASGR 498
                              A   L  GQ     +T   D +  G+ +  +    
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 47/218 (21%), Positives = 88/218 (40%), Gaps = 41/218 (18%)

Query: 297 TDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVK---------RLFFNSRQWVDQFFNEVN 346
            + ++    LG+G +  V R    P  +  AVK               ++  +    EV+
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 347 LISGI-QHKNVVRLLGCSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFT-- 401
           ++  +  H N+++L   + E      LV++ +    L D +            +   +  
Sbjct: 76  ILRKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGELFDYLTE----------KVTLSEK 124

Query: 402 ----IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV 457
               I+    E +  LH    + I+HRD+K  NILLD+ +  K+ DFG +  + P     
Sbjct: 125 ETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EK 179

Query: 458 STGIAGTLGYMAPEYLVRGQL------TEKADVYAFGV 489
              + GT  Y+APE +            ++ D+++ GV
Sbjct: 180 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 97.6 bits (244), Expect = 3e-22
 Identities = 52/201 (25%), Positives = 86/201 (42%), Gaps = 43/201 (21%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN---- 343
           +YE L+           LG+G   +V++       + +A+K++    R       N    
Sbjct: 11  RYEKLD----------FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL 60

Query: 344 -EVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPN---RSLD--QILFVKNTIHILSWQ 397
            E+ L+  + H N++ LL          LV++++       +    ++   + I      
Sbjct: 61  REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM 120

Query: 398 QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDK-- 454
                   T +GL +LH      I+HRD+K +N+LLDE    K+ADFGLA+    P++  
Sbjct: 121 --------TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 169

Query: 455 TH--VSTGIAGTLGYMAPEYL 473
           TH  V      T  Y APE L
Sbjct: 170 THQVV------TRWYRAPELL 184

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 96.5 bits (241), Expect = 3e-22
 Identities = 55/199 (27%), Positives = 79/199 (39%), Gaps = 33/199 (16%)

Query: 295 RATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN-----EVNL- 347
            AT  ++   ++G G  G+V++      G  +A+K +   +              EV L 
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 348 --ISGIQHKNVVRLL----GCSIEGPESL-LVYEYVPN------RSLDQILFVKNTIHIL 394
             +   +H NVVRL+        +    + LV+E+V                   TI  L
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDL 125

Query: 395 SWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK 454
             Q           GL  LH      I+HRD+K  NIL+    T K+ADFGLAR  +   
Sbjct: 126 MRQ--------FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM 174

Query: 455 THVSTGIAGTLGYMAPEYL 473
               T +  TL Y APE L
Sbjct: 175 AL--TPVVVTLWYRAPEVL 191

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 97.0 bits (242), Expect = 3e-22
 Identities = 50/206 (24%), Positives = 85/206 (41%), Gaps = 31/206 (15%)

Query: 298 DFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-HKN 355
           D     + LG+G      +       +  AVK +   S++       E+  +   + H N
Sbjct: 11  DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII---SKRMEANTQKEITALKLCEGHPN 67

Query: 356 VVRLLGCSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFT------IICGTA 407
           +V+L            LV E +    L ++I            ++ F+      I+    
Sbjct: 68  IVKLHE-VFHDQLHTFLVMELLNGGELFERIKK----------KKHFSETEASYIMRKLV 116

Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILL---DEKLTPKIADFGLARHVAPDKTHVSTGIAGT 464
             ++H+H    + ++HRD+K  N+L    ++ L  KI DFG AR   PD   + T    T
Sbjct: 117 SAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFT 172

Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVL 490
           L Y APE L +    E  D+++ GV+
Sbjct: 173 LHYAAPELLNQNGYDESCDLWSLGVI 198

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 97.5 bits (243), Expect = 4e-22
 Identities = 53/213 (24%), Positives = 95/213 (44%), Gaps = 22/213 (10%)

Query: 283 TSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQF 341
             ++N  Y +          +  LG G  G V +      G  +A K +     +  ++ 
Sbjct: 82  QGAVNSFYTV--------SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEV 133

Query: 342 FNEVNLISGIQHKNVVRLLGCSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQR 399
            NE+++++ + H N+++L   + E    + LV EYV    L D+I+      + L+    
Sbjct: 134 KNEISVMNQLDHANLIQLYD-AFESKNDIVLVMEYVDGGELFDRIIDES---YNLTELDT 189

Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP--KIADFGLARHVAPDKTHV 457
              +    EG+ H+H    + I+H D+K  NIL   +     KI DFGLAR   P +   
Sbjct: 190 ILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL- 245

Query: 458 STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVL 490
                GT  ++APE +    ++   D+++ GV+
Sbjct: 246 -KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVI 277

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 97.5 bits (243), Expect = 4e-22
 Identities = 49/217 (22%), Positives = 89/217 (41%), Gaps = 40/217 (18%)

Query: 297 TDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL--------FFNSRQWVDQFFNEVNL 347
              +D    +G+G +  V R      G   AVK +             +  +    E ++
Sbjct: 93  YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152

Query: 348 ISGI-QHKNVVRLLGCSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFT--- 401
           +  +  H +++ L+  S E    + LV++ +    L D +            +   +   
Sbjct: 153 LRQVAGHPHIITLID-SYESSSFMFLVFDLMRKGELFDYLTE----------KVALSEKE 201

Query: 402 ---IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS 458
              I+    E ++ LH      I+HRD+K  NILLD+ +  +++DFG + H+ P      
Sbjct: 202 TRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKL 256

Query: 459 TGIAGTLGYMAPEYLVRGQL------TEKADVYAFGV 489
             + GT GY+APE L            ++ D++A GV
Sbjct: 257 RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 93.4 bits (233), Expect = 4e-21
 Identities = 52/203 (25%), Positives = 88/203 (43%), Gaps = 49/203 (24%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN---- 343
            ++ +E          K+G+G  G V++      G  +A+K++  ++     +       
Sbjct: 4   NFQKVE----------KIGEGTYGVVYKARNKLTGEVVALKKIRLDTE---TEGVPSTAI 50

Query: 344 -EVNLISGIQHKNVVRLLGCSIEGPESL-LVYEYVPN------RSLDQILFVKNTIHILS 395
            E++L+  + H N+V+LL   I     L LV+E++         +          I    
Sbjct: 51  REISLLKELNHPNIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109

Query: 396 WQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDK 454
           +Q          +GLA  H     +++HRD+K  N+L++ +   K+ADFGLAR    P +
Sbjct: 110 FQ--------LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 158

Query: 455 --TH--VSTGIAGTLGYMAPEYL 473
             TH  V      TL Y APE L
Sbjct: 159 TYTHEVV------TLWYRAPEIL 175

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 93.5 bits (233), Expect = 5e-21
 Identities = 49/206 (23%), Positives = 84/206 (40%), Gaps = 22/206 (10%)

Query: 297 TDFFD-NSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQ----WVDQFFNEVNLISG 350
            +F+   S++LG+G    V +      G+  A K  F   R+       +  +E+ ++  
Sbjct: 27  NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAK--FLKKRRRGQDCRAEILHEIAVLEL 84

Query: 351 IQH-KNVVRLLGCSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFTIICGTA 407
            +    V+ L     E    + L+ EY     +      +     ++S      +I    
Sbjct: 85  AKSCPRVINLHE-VYENTSEIILILEYAAGGEIFSLC--LPELAEMVSENDVIRLIKQIL 141

Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILL---DEKLTPKIADFGLARHVAPDKTHVSTGIAGT 464
           EG+ +LH      I+H D+K  NILL         KI DFG++R +          I GT
Sbjct: 142 EGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACEL--REIMGT 196

Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVL 490
             Y+APE L    +T   D++  G++
Sbjct: 197 PEYLAPEILNYDPITTATDMWNIGII 222

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 93.0 bits (232), Expect = 6e-21
 Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 47/201 (23%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFN----- 343
           KY+ LE          K+G+G  G V++     GR +A+KR+  ++    D+        
Sbjct: 22  KYQKLE----------KVGEGTYGVVYKAKDSQGRIVALKRIRLDAE---DEGIPSTAIR 68

Query: 344 EVNLISGIQHKNVVRLLGCSIEGPESL-LVYEYVPN---RSLDQ--ILFVKNTIHILSWQ 397
           E++L+  + H N+V L+   I     L LV+E++     + LD+       + I I  +Q
Sbjct: 69  EISLLKELHHPNIVSLIDV-IHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ 127

Query: 398 QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDK-- 454
                      G+AH H     +I+HRD+K  N+L++     K+ADFGLAR    P +  
Sbjct: 128 --------LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY 176

Query: 455 TH--VSTGIAGTLGYMAPEYL 473
           TH  V      TL Y AP+ L
Sbjct: 177 THEVV------TLWYRAPDVL 191

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 91.4 bits (228), Expect = 1e-20
 Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 47/201 (23%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFN----- 343
           KY  LE          K+G+G  G V++     G   A+K++        D+        
Sbjct: 3   KYHGLE----------KIGEGTYGVVYKAQNNYGETFALKKIRLEKE---DEGIPSTTIR 49

Query: 344 EVNLISGIQHKNVVRLLGCSIEGPESL-LVYEYVPN---RSLDQ--ILFVKNTIHILSWQ 397
           E++++  ++H N+V+L    I   + L LV+E++     + LD         T      Q
Sbjct: 50  EISILKELKHSNIVKLYDV-IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ 108

Query: 398 QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDK-- 454
                      G+A+ H     +++HRD+K  N+L++ +   KIADFGLAR    P +  
Sbjct: 109 --------LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157

Query: 455 TH--VSTGIAGTLGYMAPEYL 473
           TH  V      TL Y AP+ L
Sbjct: 158 THEIV------TLWYRAPDVL 172

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 50/207 (24%), Positives = 83/207 (40%), Gaps = 31/207 (14%)

Query: 297 TDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVN-LISGIQHK 354
           TD ++    +G G      R          AVK +    +   D    E+  L+   QH 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII---DKSKRDPT-EEIEILLRYGQHP 76

Query: 355 NVVRLLGCSIEGPESLLVYEYVPNRSL-DQILFVKNTIHILSWQQRFT------IICGTA 407
           N++ L     +G    +V E +    L D+IL           Q+ F+      ++    
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGELLDKILR----------QKFFSEREASAVLFTIT 126

Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILL---DEKLTP-KIADFGLARHVAPDKTHVSTGIAG 463
           + + +LH      ++HRD+K SNIL           +I DFG A+ +  +   + T    
Sbjct: 127 KTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-PCY 182

Query: 464 TLGYMAPEYLVRGQLTEKADVYAFGVL 490
           T  ++APE L R       D+++ GVL
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVL 209

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 91.0 bits (227), Expect = 2e-20
 Identities = 52/202 (25%), Positives = 85/202 (42%), Gaps = 48/202 (23%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN---- 343
           KYE LE          K+G+G  G+VF+         +A+KR+  +     D+       
Sbjct: 3   KYEKLE----------KIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSAL 49

Query: 344 -EVNLISGIQHKNVVRLLGCSIEGPESL-LVYEYVPN---RSLDQ--ILFVKNTIHILSW 396
            E+ L+  ++HKN+VRL    +   + L LV+E+      +  D          +    +
Sbjct: 50  REICLLKELKHKNIVRLHDV-LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLF 108

Query: 397 QQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDK- 454
           Q          +GL   H      ++HRD+K  N+L++     K+A+FGLAR    P + 
Sbjct: 109 Q--------LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157

Query: 455 -TH--VSTGIAGTLGYMAPEYL 473
            +   V      TL Y  P+ L
Sbjct: 158 YSAEVV------TLWYRPPDVL 173

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 91.1 bits (227), Expect = 3e-20
 Identities = 53/189 (28%), Positives = 89/189 (47%), Gaps = 31/189 (16%)

Query: 298 DFFDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVD-QFFNEVNLISGIQHKN 355
           + +    KLG+G   +V++G        +A+K +     +        EV+L+  ++H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 356 VVRLLGCSIEGPESL-LVYEYVPN---RSLDQ--ILFVKNTIHILSWQQRFTIICGTAEG 409
           +V L    I   +SL LV+EY+     + LD    +   + + +  +Q           G
Sbjct: 62  IVTLHDI-IHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ--------LLRG 112

Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDK--TH--VSTGIAGT 464
           LA+ H     K++HRD+K  N+L++E+   K+ADFGLAR  + P K   +  V      T
Sbjct: 113 LAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV------T 163

Query: 465 LGYMAPEYL 473
           L Y  P+ L
Sbjct: 164 LWYRPPDIL 172

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 91.2 bits (227), Expect = 5e-20
 Identities = 59/233 (25%), Positives = 99/233 (42%), Gaps = 42/233 (18%)

Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFN----E 344
            E   +  D F   R  GQG  G+V  G     G ++A+K++  + R     F N     
Sbjct: 15  DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-----FRNRELQI 69

Query: 345 VNLISGIQHKNVVRLLGC----SIEGPESL---LVYEYVP---NRSLDQILFVKNTI--- 391
           +  ++ + H N+V+L              +   +V EYVP   +R        +      
Sbjct: 70  MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPI 129

Query: 392 HILSWQQRFT--IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE---KLTPKIADFGL 446
            I    + F   +I      +  LH  S + + HRDIK  N+L++E    L  K+ DFG 
Sbjct: 130 LI----KVFLFQLIRS----IGCLHLPS-VNVCHRDIKPHNVLVNEADGTL--KLCDFGS 178

Query: 447 ARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGR 498
           A+ ++P + +V+  I  +  Y APE +   Q  T   D+++ G +  E+  G 
Sbjct: 179 AKKLSPSEPNVAY-IC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 91.6 bits (228), Expect = 6e-20
 Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 41/228 (17%)

Query: 291 EILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLF----FNSRQWVDQFFNEVN 346
           +  E+    + N + +G G  G VF+  L +   +A+K++     F +R        E+ 
Sbjct: 33  KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR--------ELQ 84

Query: 347 LISGIQHKNVVRLLGCSIEGPESL------LVYEYVP---NRSLDQILFVKNTIHIL--- 394
           ++  ++H NVV L        +        LV EYVP    R+      +K T+ +L   
Sbjct: 85  IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIK 144

Query: 395 --SWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVA 451
              +Q            LA++H    I I HRDIK  N+LLD      K+ DFG A+ + 
Sbjct: 145 LYMYQ--------LLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193

Query: 452 PDKTHVSTGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGR 498
             + +VS  I  +  Y APE +      T   D+++ G ++ E+  G+
Sbjct: 194 AGEPNVSY-IC-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 89.6 bits (223), Expect = 9e-20
 Identities = 55/211 (26%), Positives = 87/211 (41%), Gaps = 62/211 (29%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNS---------RQWV 338
           +++ LE          KLG G   +V++G     G  +A+K +  +S         R   
Sbjct: 6   QFKQLE----------KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR--- 52

Query: 339 DQFFNEVNLISGIQHKNVVRLLGCSIEGPESL-LVYEYV----------PNRSLDQILFV 387
                E++L+  ++H+N+VRL    I     L LV+E++                     
Sbjct: 53  -----EISLMKELKHENIVRLYDV-IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLE 106

Query: 388 KNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA 447
            N +    WQ          +GLA  H     KI+HRD+K  N+L++++   K+ DFGLA
Sbjct: 107 LNLVKYFQWQ--------LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLA 155

Query: 448 RHVA-PDK--TH--VSTGIAGTLGYMAPEYL 473
           R    P    +   V      TL Y AP+ L
Sbjct: 156 RAFGIPVNTFSSEVV------TLWYRAPDVL 180

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 41/224 (18%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNS-RQWVDQF-FNEV 345
           KYE +           K+G+G  G VF+      G+ +A+K+   +     + +    E+
Sbjct: 4   KYEKIG----------KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREI 53

Query: 346 NLISGIQHKNVVRLLGCSIEGPESL-LVYEYVPN---RSLDQ--ILFVKNTIHILSWQQR 399
            ++  ++H N+V LL         L LV+EY  +     LD+      ++ +  ++WQ  
Sbjct: 54  RMLKQLKHPNLVNLLEV-FRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ-- 110

Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDK--TH 456
                 T + +   H       IHRD+K  NIL+ +    K+ DFG AR +  P      
Sbjct: 111 ------TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD 161

Query: 457 -VSTGIAGTLGYMAPEYLVRGQLTEKA-DVYAFGVLVIEVASGR 498
            V+     T  Y +PE LV         DV+A G +  E+ SG 
Sbjct: 162 EVA-----TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 90.9 bits (226), Expect = 1e-19
 Identities = 61/239 (25%), Positives = 100/239 (41%), Gaps = 40/239 (16%)

Query: 278 GTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQ 336
            TV+ T                + +++ +G G  G V++  L   G  +A+K++  + R 
Sbjct: 38  TTVVATPGQGPDRPQEVS----YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR- 92

Query: 337 WVDQFFN-EVNLISGIQHKNVVRLLGCSIEGPESL------LVYEYVP---NRSLDQILF 386
               F N E+ ++  + H N+VRL        E        LV +YVP    R       
Sbjct: 93  ----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148

Query: 387 VKNTI---HI--LSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP-K 440
            K T+   ++    +Q            LA++H      I HRDIK  N+LLD      K
Sbjct: 149 AKQTLPVIYVKLYMYQ--------LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLK 197

Query: 441 IADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGR 498
           + DFG A+ +   + +VS  I  +  Y APE +      T   DV++ G ++ E+  G+
Sbjct: 198 LCDFGSAKQLVRGEPNVSY-IC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 88.3 bits (219), Expect = 2e-19
 Identities = 26/216 (12%), Positives = 52/216 (24%), Gaps = 54/216 (25%)

Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRGTLPD---GRNIAVKRL---FFNSRQWVDQFFN 343
           Y +L             G       ++    D    R +A+  +          + +  +
Sbjct: 33  YRLLIF----------HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLS 80

Query: 344 EVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTII 403
               +S I    V R+L         L+V E++   SL ++          S       +
Sbjct: 81  RTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAM 135

Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG 463
              A      H  +G+         S + +       +A                     
Sbjct: 136 QSLAAAADAAHR-AGV--ALSIDHPSRVRVSIDGDVVLAYP------------------- 173

Query: 464 TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRR 499
               M            + D+   G  +  +   R 
Sbjct: 174 --ATMPDA-------NPQDDIRGIGASLYALLVNRW 200

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 88.8 bits (221), Expect = 2e-19
 Identities = 60/234 (25%), Positives = 95/234 (40%), Gaps = 55/234 (23%)

Query: 295 RATDFFDNSRKLGQGGAGSVFRG--TLPDGRNIAVKRLFFNS----------RQWVDQFF 342
           RA   ++   ++G+G  G VF+       GR +A+KR+   +          R       
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR------- 60

Query: 343 NEVNL---ISGIQHKNVVRLL----GCSIEGPESL-LVYEYVPN------RSLDQILFVK 388
            EV +   +   +H NVVRL         +    L LV+E+V          + +     
Sbjct: 61  -EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPT 119

Query: 389 NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR 448
            TI  + +Q           GL  LH     +++HRD+K  NIL+      K+ADFGLAR
Sbjct: 120 ETIKDMMFQ--------LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168

Query: 449 HVAPDK--TH--VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
             +     T   V      TL Y APE L++       D+++ G +  E+   +
Sbjct: 169 IYSFQMALTSVVV------TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 88.4 bits (220), Expect = 4e-19
 Identities = 54/211 (25%), Positives = 85/211 (40%), Gaps = 54/211 (25%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNS----------RQW 337
           KYE L           K+GQG  G VF+      G+ +A+K++   +          R  
Sbjct: 18  KYEKLA----------KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-- 65

Query: 338 VDQFFNEVNLISGIQHKNVVRLLG-------CSIEGPESL-LVYEYVPN---RSLDQILF 386
                 E+ ++  ++H+NVV L+               S+ LV+++  +     L  +L 
Sbjct: 66  ------EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV 119

Query: 387 VKNTIHILSW-QQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFG 445
                 I    Q           GL ++H     KI+HRD+K +N+L+      K+ADFG
Sbjct: 120 KFTLSEIKRVMQMLL-------NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169

Query: 446 LARHV-APDKTHVS--TGIAGTLGYMAPEYL 473
           LAR       +  +  T    TL Y  PE L
Sbjct: 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELL 200

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 88.0 bits (219), Expect = 4e-19
 Identities = 64/228 (28%), Positives = 96/228 (42%), Gaps = 49/228 (21%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN---- 343
           KYE L            +G+G  G V +      GR +A+K+   +     D+       
Sbjct: 26  KYENLG----------LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD---DKMVKKIAM 72

Query: 344 -EVNLISGIQHKNVVRLLGCSIEGPESL-LVYEYVPNRSLDQIL------FVKNTIHILS 395
            E+ L+  ++H+N+V LL    +  +   LV+E+V + ++   L           +    
Sbjct: 73  REIKLLKQLRHENLVNLLEV-CKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYL 130

Query: 396 WQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA-PDK 454
           +Q           G+   H      IIHRDIK  NIL+ +    K+ DFG AR +A P +
Sbjct: 131 FQ--------IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179

Query: 455 --TH-VSTGIAGTLGYMAPEYLVRGQLTEKA-DVYAFGVLVIEVASGR 498
                V+     T  Y APE LV      KA DV+A G LV E+  G 
Sbjct: 180 VYDDEVA-----TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 87.7 bits (218), Expect = 4e-19
 Identities = 51/201 (25%), Positives = 79/201 (39%), Gaps = 44/201 (21%)

Query: 295 RATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN-----EVNLI 348
            + D +    KLG+G  G V++         +A+KR+        ++        EV+L+
Sbjct: 31  TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE---EEGVPGTAIREVSLL 87

Query: 349 SGIQHKNVVRLLGCSIEGPESL-LVYEYVPNRSLDQIL-----FVKNTIHILSWQQRFTI 402
             +QH+N++ L    I     L L++EY     L + +          I    +Q     
Sbjct: 88  KELQHRNIIELKSV-IHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQ----- 140

Query: 403 ICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP-----KIADFGLARHVA-PDK-- 454
                 G+   H     + +HRD+K  N+LL           KI DFGLAR    P +  
Sbjct: 141 ---LINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF 194

Query: 455 TH--VSTGIAGTLGYMAPEYL 473
           TH  +      TL Y  PE L
Sbjct: 195 THEII------TLWYRPPEIL 209

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 87.8 bits (218), Expect = 8e-19
 Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 30/221 (13%)

Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           + +L+R    + N + +G G  G V         RN+A+K+L   F ++    + + E+ 
Sbjct: 21  FTVLKR----YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV 76

Query: 347 LISGIQHKNVVRLL-----GCSIEGPESL-LVYEYVPNRSLDQILFVKNT-IHI--LSWQ 397
           L+  + HKN++ LL       S+E  + + +V E +   +L Q++ ++     +  L +Q
Sbjct: 77  LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQ 135

Query: 398 QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV 457
               ++CG    + HLH      IIHRD+K SNI++    T KI DFGLAR        +
Sbjct: 136 ----MLCG----IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FM 182

Query: 458 STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
            T    T  Y APE ++     E  D+++ G ++ E+  G 
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 87.0 bits (216), Expect = 8e-19
 Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 40/205 (19%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVK-----RLFFNSRQWVDQFFNEVNLISGIQHKNVV 357
           + +G+G    V     +  GR +A+K     +L   +   + + F EV ++  + H N+V
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQL---NPTSLQKLFREVRIMKILNHPNIV 77

Query: 358 RLLGCSIEGPESL-LVYEYVPNRSL-DQI-----LFVKNTIHILSWQQRFTIICGTAEGL 410
           +L    IE  ++L L+ EY     + D +     +  K        +Q   I+      +
Sbjct: 78  KLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF--RQ---IVSA----V 127

Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD---KTHVSTGIAGTLGY 467
            + H     +I+HRD+K  N+LLD  +  KIADFG +                  G   Y
Sbjct: 128 QYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC-----GAPPY 179

Query: 468 MAPEYLVRGQLTE--KADVYAFGVL 490
            APE L +G+  +  + DV++ GV+
Sbjct: 180 AAPE-LFQGKKYDGPEVDVWSLGVI 203

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 87.9 bits (218), Expect = 8e-19
 Identities = 53/239 (22%), Positives = 89/239 (37%), Gaps = 43/239 (17%)

Query: 268 SEMRKGQVLLGTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIA 326
            +  +  V  G  +  +++   Y++  +          LG G  G V +          A
Sbjct: 41  QQFPQFHVKSGLQIKKNAIIDDYKVTSQ---------VLGLGINGKVLQIFNKRTQEKFA 91

Query: 327 VKRLFFNSRQWVDQFFNEVN-LISGIQHKNVVRLLGC---SIEGPESL-LVYEYVPNRSL 381
           +K L     Q   +   EV       Q  ++VR++        G + L +V E +    L
Sbjct: 92  LKML-----QDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL 146

Query: 382 -DQILFVKNTIHILSWQQRFT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILL- 433
             +I    +        Q FT      I+    E + +LH    I I HRD+K  N+L  
Sbjct: 147 FSRIQDRGD--------QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYT 195

Query: 434 --DEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVL 490
                   K+ DFG A+      +   T    T  Y+APE L   +  +  D+++ GV+
Sbjct: 196 SKRPNAILKLTDFGFAKETTSHNSL--TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 252

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 87.2 bits (216), Expect = 1e-18
 Identities = 48/206 (23%), Positives = 85/206 (41%), Gaps = 40/206 (19%)

Query: 294 ERATDFFDNSR-KLGQGGAGSVFRG---TLPDGRNIAVKRLFFNSRQWVDQFFNEVNLIS 349
           ER  D F+    K+G+G  G V++       D ++ A+K++             E+ L+ 
Sbjct: 16  ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLR 73

Query: 350 GIQHKNVVRLLGCSIE-GPESL-LVYEYV-------------PNRSLDQILFVKNTIHIL 394
            ++H NV+ L    +      + L+++Y                 +   +   +  +  L
Sbjct: 74  ELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133

Query: 395 SWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP----KIADFGLARHV 450
            +Q     I    +G+ +LH      ++HRD+K +NIL+  +       KIAD G AR  
Sbjct: 134 LYQ-----IL---DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182

Query: 451 -APDK--THVSTGIAGTLGYMAPEYL 473
            +P K    +   +  T  Y APE L
Sbjct: 183 NSPLKPLADLDPVVV-TFWYRAPELL 207

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 86.6 bits (215), Expect = 2e-18
 Identities = 54/234 (23%), Positives = 93/234 (39%), Gaps = 45/234 (19%)

Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLF--FNSRQWVDQFFN---- 343
           + +       +   R +  G  G+V  G   +G  +A+KR+F   +  + V+   +    
Sbjct: 18  HAMQSP----YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73

Query: 344 -----EVNLISGIQHKNVVRLLGCSIEGPESL-------LVYEYVPNRSLDQILFVKNTI 391
                E+ L++   H N++ L    I             LV E +    L Q++  +  +
Sbjct: 74  KRVLREIRLLNHFHHPNILGLR--DIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIV 130

Query: 392 ----HILSWQQRFT--IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFG 445
               HI    Q F   I+ G    L  LH      ++HRD+   NILL +     I DF 
Sbjct: 131 ISPQHI----QYFMYHILLG----LHVLHEAG---VVHRDLHPGNILLADNNDITICDFN 179

Query: 446 LARHVAPDKTHVSTGIAGTLGYMAPEYLV-RGQLTEKADVYAFGVLVIEVASGR 498
           LAR    D     T       Y APE ++     T+  D+++ G ++ E+ + +
Sbjct: 180 LAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 51/231 (22%), Positives = 83/231 (35%), Gaps = 45/231 (19%)

Query: 283 TSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQF 341
           +      Y++ E           LG+G    V     L   +  AVK +         + 
Sbjct: 7   SGRFEDVYQLQEDV---------LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV 57

Query: 342 FNEVNLISGIQ-HKNVVRLLGCSIEGPESLLVYEYVPNRSL-DQILFVKNTIHILSWQQR 399
           F EV ++   Q H+NV+ L+    E     LV+E +   S+   I            ++ 
Sbjct: 58  FREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK----------RRH 107

Query: 400 FT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILL---DEKLTPKIADFGLARHV 450
           F       ++   A  L  LH      I HRD+K  NIL    ++    KI DF L   +
Sbjct: 108 FNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164

Query: 451 APDKTHVS------TGIAGTLGYMAPEYLVRGQLT-----EKADVYAFGVL 490
             +               G+  YMAPE +           ++ D+++ GV+
Sbjct: 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 87.6 bits (217), Expect = 2e-18
 Identities = 61/221 (27%), Positives = 105/221 (47%), Gaps = 30/221 (13%)

Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           + +L+R    + N + +G G  G V         RN+A+K+L   F ++    + + E+ 
Sbjct: 58  FTVLKR----YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV 113

Query: 347 LISGIQHKNVVRLL-----GCSIEGPESL-LVYEYVPNRSLDQIL---FVKNTIHILSWQ 397
           L+  + HKN++ LL       ++E  + + LV E +   +L Q++        +  L +Q
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQ 172

Query: 398 QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV 457
               ++CG    + HLH      IIHRD+K SNI++    T KI DFGLAR        +
Sbjct: 173 ----MLCG----IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FM 219

Query: 458 STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
            T    T  Y APE ++     E  D+++ G ++ E+   +
Sbjct: 220 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 45/224 (20%), Positives = 80/224 (35%), Gaps = 44/224 (19%)

Query: 283 TSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQF 341
             ++   Y++ ++          LG G  G V        G+  A+K L+ + +      
Sbjct: 23  KYAVTDDYQLSKQ---------VLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-----A 68

Query: 342 FNEVN-LISGIQHKNVVRLLG----CSIEGPESLLVYEYVPNRSL-DQILFVKNTIHILS 395
             EV+         ++V +L             L++ E +    L  +I           
Sbjct: 69  RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRI--------QER 120

Query: 396 WQQRFT------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILL---DEKLTPKIADFGL 446
             Q FT      I+      +  LH      I HRD+K  N+L    ++    K+ DFG 
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177

Query: 447 ARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVL 490
           A+    +          T  Y+APE L   +  +  D+++ GV+
Sbjct: 178 AKETTQNAL---QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 88.0 bits (218), Expect = 3e-18
 Identities = 60/221 (27%), Positives = 92/221 (41%), Gaps = 45/221 (20%)

Query: 300 FDNSRKLGQGGAGSVF----RGTLPDGRNIAVKRL---FFNSRQWVDQFFNEVN---LIS 349
           F   R +G+GG G V+      T   G+  A+K L       +Q      NE     L+S
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADT---GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247

Query: 350 GIQHKNVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFT------- 401
                 +V +   +   P+ L  + + +    L          + LS    F+       
Sbjct: 248 TGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDL---------HYHLSQHGVFSEADMRFY 297

Query: 402 ---IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS 458
              II G    L H+H      +++RD+K +NILLDE    +I+D GLA   +  K H  
Sbjct: 298 AAEIILG----LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH-- 348

Query: 459 TGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGR 498
               GT GYMAPE L +G      AD ++ G ++ ++  G 
Sbjct: 349 -ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 84.6 bits (210), Expect = 4e-18
 Identities = 57/238 (23%), Positives = 104/238 (43%), Gaps = 40/238 (16%)

Query: 285 SLN-FKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFF 342
           S+N   +++  R    + + + LG GG G VF        + +A+K++     Q V    
Sbjct: 1   SMNIHGFDLGSR----YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL 56

Query: 343 NEVNLISGIQHKNVVRLL----------GCSIEGPESL----LVYEYVPNRSLDQILFVK 388
            E+ +I  + H N+V++              +     L    +V EY+    L  +L   
Sbjct: 57  REIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQG 115

Query: 389 N--TIHILSWQQRFT--IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIAD 443
                H     + F   ++     GL ++H  +   ++HRD+K +N+ ++ E L  KI D
Sbjct: 116 PLLEEHA----RLFMYQLLR----GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGD 164

Query: 444 FGLARHVAPDKTHVS--TGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGR 498
           FGLAR + P  +H    +    T  Y +P  L+     T+  D++A G +  E+ +G+
Sbjct: 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 84.6 bits (210), Expect = 4e-18
 Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 27/212 (12%)

Query: 300 FDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQHKN 355
           F   + LG+G   +V         R  A+K L          V     E +++S + H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91

Query: 356 VVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICG---TAE--- 408
            V+L   + +  E L     Y  N  L            +     F   C    TAE   
Sbjct: 92  FVKLY-FTFQDDEKLYFGLSYAKNGEL----L-----KYIRKIGSFDETCTRFYTAEIVS 141

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG-IAGTLGY 467
            L +LHG     IIHRD+K  NILL+E +  +I DFG A+ ++P+          GT  Y
Sbjct: 142 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 198

Query: 468 MAPEYLVRGQLTEKA-DVYAFGVLVIEVASGR 498
           ++PE L+  +   K+ D++A G ++ ++ +G 
Sbjct: 199 VSPE-LLTEKSACKSSDLWALGCIIYQLVAGL 229

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 85.5 bits (212), Expect = 4e-18
 Identities = 58/217 (26%), Positives = 89/217 (41%), Gaps = 35/217 (16%)

Query: 300 FDNSRKLGQGGAGSVF----RGTLPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQ 352
           F+  R +G+G  G V       T    +  A+K +       R  V   F E+ ++ G++
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73

Query: 353 HKNVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTI------ICG 405
           H  +V L   S +  E + +V + +    L          + L     F        IC 
Sbjct: 74  HPFLVNLW-YSFQDEEDMFMVVDLLLGGDL----R-----YHLQQNVHFKEETVKLFICE 123

Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTL 465
               L +L      +IIHRD+K  NILLDE     I DF +A  +  +    +  +AGT 
Sbjct: 124 LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTK 178

Query: 466 GYMAPEYLVRGQL---TEKADVYAFGVLVIEVASGRR 499
            YMAPE     +    +   D ++ GV   E+  GRR
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 86.8 bits (215), Expect = 5e-18
 Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 41/220 (18%)

Query: 300 FDNSRKLGQGGAGSVF----RGTLPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQ 352
           F + R LG+GG G VF    + T   G+  A K+L       R+       E  +++ + 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243

Query: 353 HKNVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQR---FT------- 401
            + +V L   + E    L LV   +    +    +     HI +  +    F        
Sbjct: 244 SRFIVSLA-YAFETKTDLCLVMTIMNGGDI---RY-----HIYNVDEDNPGFQEPRAIFY 294

Query: 402 ---IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS 458
              I+ G    L HLH      II+RD+K  N+LLD+    +I+D GLA  +   +T   
Sbjct: 295 TAQIVSG----LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK 347

Query: 459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
              AGT G+MAPE L+  +     D +A GV + E+ + R
Sbjct: 348 G-YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 86.4 bits (214), Expect = 7e-18
 Identities = 65/210 (30%), Positives = 96/210 (45%), Gaps = 24/210 (11%)

Query: 300 FDNSRKLGQGGAGSVF----RGTLPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQ 352
           F   R LG+GG G V     R T   G+  A K+L       R+      NE  ++  + 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242

Query: 353 HKNVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRF---TIICGTAE 408
            + VV L   + E  ++L LV   +    L   ++          +  F    I CG   
Sbjct: 243 SRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCG--- 298

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
            L  LH     +I++RD+K  NILLD+    +I+D GLA HV   +T    G  GT+GYM
Sbjct: 299 -LEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYM 352

Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           APE +   + T   D +A G L+ E+ +G+
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 84.3 bits (209), Expect = 9e-18
 Identities = 59/226 (26%), Positives = 106/226 (46%), Gaps = 39/226 (17%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLF--FNSRQWVDQFFNEV 345
            +E+ +     + +   +G G  GSV        G  +A+K+L   F S  +  + + E+
Sbjct: 19  AWELPKT----YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYREL 74

Query: 346 NLISGIQHKNVVRLLGCSIEGPESL--------LVYEYVPNRSLDQILFVKNT-IHI--L 394
            L+  +QH+NV+ LL   +  P S         LV  ++    L +I+ +K +   I  L
Sbjct: 75  LLLKHMQHENVIGLL--DVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYL 131

Query: 395 SWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK 454
            +Q    ++ G    L ++H      ++HRD+K  N+ ++E    KI DFGLARH   + 
Sbjct: 132 VYQ----MLKG----LKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180

Query: 455 TH-VSTGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGR 498
           T  V      T  Y APE ++      +  D+++ G ++ E+ +G+
Sbjct: 181 TGYVV-----TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 53/208 (25%), Positives = 80/208 (38%), Gaps = 39/208 (18%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRL------FFNSRQWVDQFFNEVNLISGIQHK-- 354
             LG GG GSV+ G  + D   +A+K +       +       +   EV L+  +     
Sbjct: 49  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108

Query: 355 NVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIH---------ILSWQQRFTIIC 404
            V+RLL    E P+S  L+ E        Q LF   T              WQ    ++ 
Sbjct: 109 GVIRLLDW-FERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFWQ----VLE 160

Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAG 463
                + H H      ++HRDIK  NIL+D  +   K+ DFG    +            G
Sbjct: 161 ----AVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DG 210

Query: 464 TLGYMAPEYLVRGQLT-EKADVYAFGVL 490
           T  Y  PE++   +     A V++ G+L
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGIL 238

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 56/172 (32%), Positives = 80/172 (46%), Gaps = 28/172 (16%)

Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT-L 465
           A+G+  L   +  K IHRD+   NILL EK   KI DFGLAR +  D  +V  G A   L
Sbjct: 203 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259

Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSS-----SVLHTVWKHYKA 520
            +MAPE +     T ++DV++FGVL+ E        +FS G+S      +     +  K 
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWE--------IFSLGASPYPGVKIDEEFCRRLKE 311

Query: 521 -NRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
             R    M        P+     + Q  L C     + RP+ +E+V  L N+
Sbjct: 312 GTR----MRA------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 31/154 (20%), Positives = 54/154 (35%), Gaps = 19/154 (12%)

Query: 304 RKLGQGGAGSVFRGTL------PDGRNIAVKRLFFN-SRQWVDQFFNEVNLISGI-QHKN 355
           + LG+G  G V              R +AVK L    +        +E+ ++  I  H N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 356 VVRLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH 414
           VV LLG C+  G   +++ E+    +L   L            +R   +    +G     
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFRQ 137

Query: 415 GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR 448
           G   +  I  D+K     +    +   + F   +
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 83.6 bits (207), Expect = 3e-17
 Identities = 41/208 (19%), Positives = 83/208 (39%), Gaps = 34/208 (16%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLF--FNSRQWVDQFFNEV 345
              + +     +     +G+G  G V+        +N+A+K++   F       +   E+
Sbjct: 21  NVHVPDN----YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREI 76

Query: 346 NLISGIQHKNVVRLLGCSIEGPESL-------LVYEYVPNRSLDQILFVKNT---IHILS 395
            +++ ++   ++RL    +  P+ L       +V E      L ++          HI  
Sbjct: 77  TILNRLKSDYIIRLY--DLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHI-- 131

Query: 396 WQQRFT--IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
             +     ++ G       +H      IIHRD+K +N LL++  + K+ DFGLAR +  +
Sbjct: 132 --KTILYNLLLG----ENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182

Query: 454 K-THVSTGIAGTLGYMAPEYLVRGQLTE 480
           K T++   +            ++ QLT 
Sbjct: 183 KDTNIVNDLEENEEPGPHNKNLKKQLTS 210

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 81.3 bits (201), Expect = 6e-17
 Identities = 50/226 (22%), Positives = 89/226 (39%), Gaps = 55/226 (24%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVK---RLFFNSRQWVD----- 339
           KY  +            LG G  G V+        + + VK   +       W++     
Sbjct: 25  KYSTM----------SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLG 74

Query: 340 QFFNEVNLISGIQHKNVVRLLGCSIEGPESL-LVYEY-----------VPNRSLDQILFV 387
           +   E+ ++S ++H N++++L    E      LV E              +  LD+    
Sbjct: 75  KVTLEIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE---- 129

Query: 388 KNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA 447
               +I   +Q   ++      + +L       IIHRDIK  NI++ E  T K+ DFG A
Sbjct: 130 PLASYIF--RQ---LVSA----VGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSA 177

Query: 448 RHVAPDKT-HVSTGIAGTLGYMAPEYLVRGQLTE--KADVYAFGVL 490
            ++   K  +      GT+ Y APE ++ G      + ++++ GV 
Sbjct: 178 AYLERGKLFYTF---CGTIEYCAPE-VLMGNPYRGPELEMWSLGVT 219

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 81.6 bits (202), Expect = 7e-17
 Identities = 54/225 (24%), Positives = 104/225 (46%), Gaps = 34/225 (15%)

Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLF-FNSRQWVDQFFNEVNL 347
           +++  R    + N   +G+G  G V       +   +A+K++  F  + +  +   E+ +
Sbjct: 23  FDVGPR----YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKI 78

Query: 348 ISGIQHKNVVRLLGCSIEGPESL-------LVYEYVPNRSLDQILFVKN--TIHILSWQQ 398
           +   +H+N++ +    I    ++       +V + +    L ++L  ++    HI     
Sbjct: 79  LLRFRHENIIGIN--DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHI----C 131

Query: 399 RFT--IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH 456
            F   I+ G    L ++H  +   ++HRD+K SN+LL+     KI DFGLAR   PD  H
Sbjct: 132 YFLYQILRG----LKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184

Query: 457 VS--TGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGR 498
               T    T  Y APE ++  +  T+  D+++ G ++ E+ S R
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 80.8 bits (200), Expect = 8e-17
 Identities = 57/210 (27%), Positives = 83/210 (39%), Gaps = 41/210 (19%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRL------FFNSRQWVDQFFNEVN----LISGIQ 352
             LG+GG G+VF G  L D   +A+K +       ++          EV     + +G  
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 353 HKNVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIH---------ILSWQQRFTI 402
           H  V+RLL    E  E   LV E  P  + D  LF   T               Q    +
Sbjct: 97  HPGVIRLLDW-FETQEGFMLVLER-PLPAQD--LFDYITEKGPLGEGPSRCFFGQ----V 148

Query: 403 ICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGI 461
           +      + H H      ++HRDIK  NIL+D  +   K+ DFG    +  +        
Sbjct: 149 VA----AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF--- 198

Query: 462 AGTLGYMAPEYLVRGQLT-EKADVYAFGVL 490
            GT  Y  PE++ R Q     A V++ G+L
Sbjct: 199 DGTRVYSPPEWISRHQYHALPATVWSLGIL 228

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 80.8 bits (200), Expect = 9e-17
 Identities = 45/222 (20%), Positives = 92/222 (41%), Gaps = 40/222 (18%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVK--RLFFNSRQWVDQFFNEV 345
            Y+++          RKLG+G    VF    + +   + VK  +     +        E+
Sbjct: 37  DYQLV----------RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK-----IKREI 81

Query: 346 NLISGIQ-HKNVVRLLGCSIEGPES---LLVYEYVPNRSLDQILFVKNTIHILSWQQRFT 401
            ++  ++   N++ L    ++ P S    LV+E+V N    Q+        I    + + 
Sbjct: 82  KILENLRGGPNIITLADI-VKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDI----RFYM 136

Query: 402 --IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVS 458
             I+      L + H      I+HRD+K  N+++D E    ++ D+GLA    P + +  
Sbjct: 137 YEILKA----LDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-- 187

Query: 459 TGIAGTLGYMAPEYLVRGQLTEKA-DVYAFGVLVIEVASGRR 499
                +  +  PE LV  Q+ + + D+++ G ++  +   + 
Sbjct: 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 54/224 (24%), Positives = 104/224 (46%), Gaps = 36/224 (16%)

Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+       + + + +G G  G+V        G  +A+K+L+  F S  +  + + E+ 
Sbjct: 21  WEVRAV----YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR 76

Query: 347 LISGIQHKNVVRLL-----GCSIEGPESL-LVYEYVPNRSLDQILFVK--NTIHILSWQQ 398
           L+  ++H+NV+ LL       +++      LV  ++    L +++  +      I    Q
Sbjct: 77  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRI----Q 131

Query: 399 RFT--IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT- 455
                ++ G    L ++H      IIHRD+K  N+ ++E    KI DFGLAR    + T 
Sbjct: 132 FLVYQMLKG----LRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG 184

Query: 456 HVSTGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGR 498
           +V      T  Y APE ++     T+  D+++ G ++ E+ +G+
Sbjct: 185 YVV-----TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 78.8 bits (195), Expect = 3e-16
 Identities = 53/230 (23%), Positives = 86/230 (37%), Gaps = 64/230 (27%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVK--------------------------RLFFNSRQ 336
            ++G+G  G V       D    A+K                                R 
Sbjct: 19  DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78

Query: 337 WVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL---LVYEYVPNRSLDQILFVKNTIHI 393
            ++Q + E+ ++  + H NVV+L+   ++ P      +V+E V    + ++         
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPVMEVP-------- 129

Query: 394 LSWQQRFT----------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIAD 443
               +  +          +I G    + +LH     KIIHRDIK SN+L+ E    KIAD
Sbjct: 130 --TLKPLSEDQARFYFQDLIKG----IEYLHY---QKIIHRDIKPSNLLVGEDGHIKIAD 180

Query: 444 FGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTE----KADVYAFGV 489
           FG++         +S    GT  +MAPE  +            DV+A GV
Sbjct: 181 FGVSNEFKGSDALLSN-TVGTPAFMAPE-SLSETRKIFSGKALDVWAMGV 228

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 80.3 bits (198), Expect = 4e-16
 Identities = 48/260 (18%), Positives = 98/260 (37%), Gaps = 39/260 (15%)

Query: 242 GCYVRFSTERFFNPNYQKKETRYKRLSEMRKGQVLLGTVLCTSSLNFKYEILERATDFFD 301
           G     +  +  N   Q   +  ++  + RK              +  ++I +R    ++
Sbjct: 1   GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDR----YE 56

Query: 302 NSRKLGQGGAGSVFRGT-LPDGRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHKNVVR 358
               +G G  G V       + R +A+K++   F       +   E+ +++ + H +VV+
Sbjct: 57  IRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVK 116

Query: 359 LLGCSIEGPESL-------LVYEYVPNRSLDQILFVKNT---IHILSWQQRFT--IICGT 406
           +L   I  P+ +       +V E        ++         +HI    +     ++ G 
Sbjct: 117 VL--DIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHI----KTLLYNLLVG- 168

Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG--- 463
              + ++H      I+HRD+K +N L+++  + K+ DFGLAR V   +   S        
Sbjct: 169 ---VKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222

Query: 464 ---TLGYMAPEYLVRGQLTE 480
               L        ++ QLT 
Sbjct: 223 DDMNLVTFPHTKNLKRQLTG 242

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 78.5 bits (194), Expect = 7e-16
 Identities = 66/224 (29%), Positives = 107/224 (47%), Gaps = 36/224 (16%)

Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+ 
Sbjct: 25  WEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 80

Query: 347 LISGIQHKNVVRLL-----GCSIEGPESL-LVYEYVPNRSLDQILFVK--NTIHILSWQQ 398
           L+  ++H+NV+ LL       S+E    + LV   +    L+ I+  +     H+    Q
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHV----Q 135

Query: 399 RFT--IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT- 455
                I+ G    L ++H      IIHRD+K SN+ ++E    KI DFGLARH A + T 
Sbjct: 136 FLIYQILRG----LKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG 188

Query: 456 HVSTGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGR 498
           +V+     T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 189 YVA-----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 77.9 bits (192), Expect = 2e-15
 Identities = 50/256 (19%), Positives = 100/256 (39%), Gaps = 68/256 (26%)

Query: 293 LERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN-EVNLISG 350
           LE ++  +   + LG G  G V     +  G+  A+K++  + R     + N E++++  
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKV 56

Query: 351 IQHKNVVRLLGC-------------------------------SIEGPESL-------LV 372
           + H N+++L+                                       +        ++
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 373 YEYVP---NRSLDQILFVKNTI---HILSWQQRFT--IICGTAEGLAHLHGGSGIKIIHR 424
            EYVP   ++ L   +    +I    I      +   +       +  +H    + I HR
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLI----SIYIYQLFRA----VGFIHS---LGICHR 165

Query: 425 DIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL-TEKA 482
           DIK  N+L++ +  T K+ DFG A+ + P +  V+  I  +  Y APE ++     T   
Sbjct: 166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAY-IC-SRFYRAPELMLGATEYTPSI 223

Query: 483 DVYAFGVLVIEVASGR 498
           D+++ G +  E+  G+
Sbjct: 224 DLWSIGCVFGELILGK 239

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 76.5 bits (189), Expect = 2e-15
 Identities = 51/207 (24%), Positives = 79/207 (38%), Gaps = 37/207 (17%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVK----RLFFNSRQWVDQFFNEVNLISGIQHKNVVR 358
             LG+G  G V            AVK    +              E+ L+  ++HKNV++
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 359 LLG-CSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILS-------WQQRFTIICGTAEG 409
           L+     E  + + +V EY      +  +                 + Q   +I G    
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQ---LIDG---- 121

Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA---RHVAPDKT-HVSTGIAGTL 465
           L +LH      I+H+DIK  N+LL    T KI+  G+A      A D T   S    G+ 
Sbjct: 122 LEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS---QGSP 175

Query: 466 GYMAPEYLVRGQLT---EKADVYAFGV 489
            +  PE +  G  T    K D+++ GV
Sbjct: 176 AFQPPE-IANGLDTFSGFKVDIWSAGV 201

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 77.4 bits (191), Expect = 2e-15
 Identities = 50/208 (24%), Positives = 93/208 (44%), Gaps = 38/208 (18%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLF--FNSRQWVDQFFNEV 345
              +L +    ++  +KLG+G  G V++      G  +AVK++F  F +     + F E+
Sbjct: 4   DRHVLRK----YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREI 59

Query: 346 NLISGIQ-HKNVVRLLGCSIEGPESL----LVYEYVPN------RSLDQILFVKNTIHIL 394
            +++ +  H+N+V LL  ++   ++     LV++Y+        R+   IL     +H  
Sbjct: 60  MILTELSGHENIVNLL--NVLRADNDRDVYLVFDYMETDLHAVIRA--NIL---EPVHK- 111

Query: 395 SWQQRFT--IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP 452
              Q     +I      + +LH G    ++HRD+K SNILL+ +   K+ADFGL+R    
Sbjct: 112 ---QYVVYQLIKV----IKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161

Query: 453 DKTHVSTGIAGTLGYMAPEYLVRGQLTE 480
            +   +                +  LT+
Sbjct: 162 IRRVTNNIPLSINENTENFDDDQPILTD 189

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 76.1 bits (188), Expect = 4e-15
 Identities = 55/233 (23%), Positives = 100/233 (42%), Gaps = 41/233 (17%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLF-FNSRQWVDQFFNEVN 346
            Y I       F     LG+G  G V   T  P G  +A+K++  F+   +  +   E+ 
Sbjct: 6   VYNISSD----FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK 61

Query: 347 LISGIQHKNVVRLLGCSIEGPESL-------LVYEYVPNRSLDQILFVK--NTIHILSWQ 397
           ++   +H+N++ +   +I+ P+S        ++ E +    L +++  +  +  HI    
Sbjct: 62  ILKHFKHENIITIF--NIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQMLSDDHI---- 114

Query: 398 QRFT--IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT 455
           Q F    +      +  LHG +   +IHRD+K SN+L++     K+ DFGLAR +     
Sbjct: 115 QYFIYQTLRA----VKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167

Query: 456 HVSTGIAGTLG---------YMAPEYLVRGQL-TEKADVYAFGVLVIEVASGR 498
             S       G         Y APE ++     +   DV++ G ++ E+   R
Sbjct: 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 74.5 bits (184), Expect = 6e-15
 Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 39/205 (19%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVK---RLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
             LG G  G V  G     G  +AVK   R    S   V +   E+  +   +H ++++L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 360 LGCSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFT----------IICGTA 407
               I  P    +V EYV    L D I   K+         R            I+    
Sbjct: 77  YQV-ISTPTDFFMVMEYVSGGELFDYI--CKH--------GRVEEMEARRLFQQILSA-- 123

Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGY 467
             + + H      ++HRD+K  N+LLD  +  KIADFGL+  ++  +  + T   G+  Y
Sbjct: 124 --VDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRT-SCGSPNY 176

Query: 468 MAPEYLVRGQLTE--KADVYAFGVL 490
            APE ++ G+L    + D+++ GV+
Sbjct: 177 AAPE-VISGRLYAGPEVDIWSCGVI 200

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 76.3 bits (188), Expect = 6e-15
 Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 38/217 (17%)

Query: 300 FDNSRKLGQGGAGSVF----RGTLPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQ 352
           F+  + LG+G  G V     + T   GR  A+K L      ++  V     E  ++   +
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 206

Query: 353 HKNVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFT---------- 401
           H  +  L   S +  + L  V EY     L    F     H LS ++ F+          
Sbjct: 207 HPFLTALK-YSFQTHDRLCFVMEYANGGEL---FF-----H-LSRERVFSEDRARFYGAE 256

Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGI 461
           I+      L +LH    +  ++RD+K  N++LD+    KI DFGL +    D   + T  
Sbjct: 257 IVSA----LDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-F 309

Query: 462 AGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
            GT  Y+APE L         D +  GV++ E+  GR
Sbjct: 310 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 75.5 bits (186), Expect = 1e-14
 Identities = 53/220 (24%), Positives = 83/220 (37%), Gaps = 36/220 (16%)

Query: 300 FDNSRKLGQGGAGSVF----RGTLPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQ 352
           F+  + +G+G    V     + T   G+  A+K +       R  V  F  E +++    
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD 119

Query: 353 HKNVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICG---TAE 408
            + + +L   + +    L LV EY     L   L       +  + +R          AE
Sbjct: 120 RRWITQLH-FAFQDENYLYLVMEYYVGGDL---LT-----LLSKFGERIPAEMARFYLAE 170

Query: 409 ---GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTL 465
               +  +H    +  +HRDIK  NILLD     ++ADFG    +  D T  S    GT 
Sbjct: 171 IVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTP 227

Query: 466 GYMAPEYLVRGQLTEKADVY-------AFGVLVIEVASGR 498
            Y++PE L           Y       A GV   E+  G+
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 38/215 (17%)

Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRNI-AVKRL----FFNSRQWVDQFFNEVNLISGIQHK 354
           FD  + LG G  G V      +  N  A+K L        +Q ++   NE  ++  +   
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFP 101

Query: 355 NVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFT----------II 403
            +V+L   S +   +L +V EYV    +    F       L    RF+          I+
Sbjct: 102 FLVKLE-FSFKDNSNLYMVMEYVAGGEM----F-----SHLRRIGRFSEPHARFYAAQIV 151

Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG 463
                   +LH    + +I+RD+K  N+L+D++   ++ DFG A+ V   +T     + G
Sbjct: 152 LT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWT---LCG 200

Query: 464 TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           T   +APE ++     +  D +A GVL+ E+A+G 
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 28/199 (14%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVK---RLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
             LG+G  G V   T     + +A+K   R          +   E++ +  ++H ++++L
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 360 LGCSIEGPESL-LVYEYVPNRSLDQI-----LFVKNTIHILSWQQRFTIICGTAEGLAHL 413
               I  P  + +V EY      D I     +           QQ   IIC     + + 
Sbjct: 75  YDV-ITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFF--QQ---IICA----IEYC 124

Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           H     KI+HRD+K  N+LLD+ L  KIADFGL+  +      + T   G+  Y APE +
Sbjct: 125 HR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKT-SCGSPNYAAPE-V 178

Query: 474 VRGQLTE--KADVYAFGVL 490
           + G+L    + DV++ G++
Sbjct: 179 INGKLYAGPEVDVWSCGIV 197

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 74.4 bits (183), Expect = 3e-14
 Identities = 48/222 (21%), Positives = 85/222 (38%), Gaps = 42/222 (18%)

Query: 300 FDNSRKLGQGGAGSVF----RGTLPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQ 352
           F+  + +G+G  G V     +      +  A+K L       R     F  E +++    
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVLVNGD 132

Query: 353 HKNVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFT---------- 401
            K +  L   + +   +L LV +Y     L   L       +  ++ R            
Sbjct: 133 SKWITTLH-YAFQDDNNLYLVMDYYVGGDL---LT-----LLSKFEDRLPEEMARFYLAE 183

Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGI 461
           ++      +  +H    +  +HRDIK  NIL+D     ++ADFG    +  D T  S+  
Sbjct: 184 MVIA----IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA 236

Query: 462 AGTLGYMAPEYLVRGQLTEK-----ADVYAFGVLVIEVASGR 498
            GT  Y++PE L   +  +       D ++ GV + E+  G 
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 74.1 bits (182), Expect = 4e-14
 Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 39/205 (19%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVK---RLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
             LG G  G V  G     G  +AVK   R    S   V +   E+  +   +H ++++L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 360 LGCSIEGPESL-LVYEYVPNRSL-DQILFVKN-------TIHILSWQQRFTIICGTAEGL 410
               I  P  + +V EYV    L D I   KN       +  +   QQ   I+ G    +
Sbjct: 82  YQV-ISTPSDIFMVMEYVSGGELFDYI--CKNGRLDEKESRRLF--QQ---ILSG----V 129

Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD---KTHVSTGIAGTLGY 467
            + H      ++HRD+K  N+LLD  +  KIADFGL+  ++     +T       G+  Y
Sbjct: 130 DYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-----GSPNY 181

Query: 468 MAPEYLVRGQLTE--KADVYAFGVL 490
            APE ++ G+L    + D+++ GV+
Sbjct: 182 AAPE-VISGRLYAGPEVDIWSSGVI 205

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 71.5 bits (176), Expect = 6e-14
 Identities = 58/207 (28%), Positives = 88/207 (42%), Gaps = 44/207 (21%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVD---QFFNEVNLISGIQHKNVVRL 359
           + LG+G  G V           +AVK    + ++ VD       E+ +   + H+NVV+ 
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHENVVKF 70

Query: 360 LGCSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFT----------IICGTA 407
            G          L  EY     L D+I    +                      ++ G  
Sbjct: 71  YGH-RREGNIQYLFLEYCSGGELFDRI--EPD--------IGMPEPDAQRFFHQLMAG-- 117

Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA---RHVAPDKTHVSTGIAGT 464
             + +LHG   I I HRDIK  N+LLDE+   KI+DFGLA   R+   ++        GT
Sbjct: 118 --VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGT 170

Query: 465 LGYMAPEYLVRGQL--TEKADVYAFGV 489
           L Y+APE L++ +    E  DV++ G+
Sbjct: 171 LPYVAPE-LLKRREFHAEPVDVWSCGI 196

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 58/207 (28%), Positives = 88/207 (42%), Gaps = 44/207 (21%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVD---QFFNEVNLISGIQHKNVVRL 359
           + LG+G  G V           +AVK    + ++ VD       E+ +   + H+NVV+ 
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHENVVKF 70

Query: 360 LGCSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFT----------IICGTA 407
            G          L  EY     L D+I    +                      ++ G  
Sbjct: 71  YGH-RREGNIQYLFLEYCSGGELFDRI--EPD--------IGMPEPDAQRFFHQLMAG-- 117

Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA---RHVAPDKTHVSTGIAGT 464
             + +LHG   I I HRDIK  N+LLDE+   KI+DFGLA   R+   ++        GT
Sbjct: 118 --VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGT 170

Query: 465 LGYMAPEYLVRGQL--TEKADVYAFGV 489
           L Y+APE L++ +    E  DV++ G+
Sbjct: 171 LPYVAPE-LLKRREFHAEPVDVWSCGI 196

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 70.6 bits (174), Expect = 2e-13
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 38/215 (17%)

Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRNI-AVKRL----FFNSRQWVDQFFNEVNLISGIQHK 354
           F   R LG G  G V            A+K L        +Q V+   +E  ++S + H 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVTHP 66

Query: 355 NVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFT----------II 403
            ++R+   + +  + + ++ +Y+    L    F      +L   QRF           + 
Sbjct: 67  FIIRMW-GTFQDAQQIFMIMDYIEGGEL----F-----SLLRKSQRFPNPVAKFYAAEVC 116

Query: 404 CGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAG 463
                 L +LH      II+RD+K  NILLD+    KI DFG A++V PD T+  T + G
Sbjct: 117 LA----LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVTY--T-LCG 165

Query: 464 TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           T  Y+APE +      +  D ++FG+L+ E+ +G 
Sbjct: 166 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 53/222 (23%), Positives = 87/222 (39%), Gaps = 57/222 (25%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVD-QFFNEVN 346
           +Y+ +          + +G G  G             +AVK  +      +D     E+ 
Sbjct: 21  RYDFV----------KDIGSGNFGVARLMRDKLTKELVAVK--YIERGAAIDENVQREII 68

Query: 347 LISGIQHKNVVRLLGCSIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFT--- 401
               ++H N+VR     I  P  L ++ EY     L ++I              RF+   
Sbjct: 69  NHRSLRHPNIVRFKEV-ILTPTHLAIIMEYASGGELYERI--CNA--------GRFSEDE 117

Query: 402 -------IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP--KIADFGLARHVAP 452
                  ++ G    +++ H    ++I HRD+K  N LLD    P  KI DFG ++    
Sbjct: 118 ARFFFQQLLSG----VSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170

Query: 453 D---KTHVSTGIAGTLGYMAPEYLVRGQLTE--KADVYAFGV 489
               K+ V     GT  Y+APE ++  Q  +   ADV++ GV
Sbjct: 171 HSQPKSTV-----GTPAYIAPE-VLLRQEYDGKIADVWSCGV 206

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 70.5 bits (173), Expect = 4e-13
 Identities = 52/217 (23%), Positives = 89/217 (41%), Gaps = 35/217 (16%)

Query: 300 FDNSRKLGQGGAGSVF----RGTLPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQ 352
           ++  + +G+G  G V     + T    +  A+K L       R     F+ E ++++   
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 127

Query: 353 HKNVVRLLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICG---TAE 408
              VV+L   + +    L +V EY+P   L         ++++S             TAE
Sbjct: 128 SPWVVQLF-YAFQDDRYLYMVMEYMPGGDL---------VNLMS-NYDVPEKWARFYTAE 176

Query: 409 ---GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTL 465
               L  +H    +  IHRD+K  N+LLD+    K+ADFG    +  +         GT 
Sbjct: 177 VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 233

Query: 466 GYMAPEYL----VRGQLTEKADVYAFGVLVIEVASGR 498
            Y++PE L      G    + D ++ GV + E+  G 
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 69.1 bits (168), Expect = 7e-13
 Identities = 43/298 (14%), Positives = 89/298 (29%), Gaps = 67/298 (22%)

Query: 296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS--------RQWVDQFFNEVNL 347
            T+      K+G+G  G VF+    D   +A+K +            ++  ++   E+ +
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 348 ---------ISGIQHKNVVRLLGCSI---EGPESLL-VYEY----------VPNRSLDQI 384
                        + +  + L          P  LL  +++           P+   D  
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 385 LFV------------KNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNIL 432
           LF+            +    + S     +I+      LA     + ++  HRD+   N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE--ASLRFEHRDLHWGNVL 194

Query: 433 LDEKLTPKIADFGLARHVAPDKTHVSTGIA----------GTLGYM---APEYLVRGQLT 479
           L +    K+      +        +   I           G + +      E L  G   
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGD 254

Query: 480 EKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE 537
            + D+Y            + N+          + +W HY  +++ + M        P 
Sbjct: 255 YQFDIYRL--------MKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPA 304

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 58/211 (27%), Positives = 87/211 (41%), Gaps = 39/211 (18%)

Query: 306 LGQGGAGSVF----RGTLPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQHKNVVR 358
           LG+G  G V     + T   GR  A+K L      ++  V     E  ++   +H  +  
Sbjct: 13  LGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 359 LLGCSIEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFT----------IICGTA 407
           L   + +  + L  V EY     L    F     H LS ++ FT          I+    
Sbjct: 70  LK-YAFQTHDRLCFVMEYANGGEL---FF-----H-LSRERVFTEERARFYGAEIVSA-- 117

Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGY 467
             L +LH      +++RDIK  N++LD+    KI DFGL +    D   + T   GT  Y
Sbjct: 118 --LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEY 171

Query: 468 MAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           +APE L         D +  GV++ E+  GR
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 67.6 bits (166), Expect = 2e-12
 Identities = 39/96 (40%), Positives = 56/96 (58%), Gaps = 7/96 (7%)

Query: 406 TAE---GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIA 462
            AE    L HLH    + II+RD+K  NILLDE+   K+ DFGL++     +    +   
Sbjct: 132 LAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FC 187

Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           GT+ YMAPE + R   T+ AD ++FGVL+ E+ +G 
Sbjct: 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 67.6 bits (166), Expect = 2e-12
 Identities = 35/96 (36%), Positives = 50/96 (52%), Gaps = 7/96 (7%)

Query: 406 TAE---GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIA 462
            AE    L HLH      II+RD+K  NI+L+ +   K+ DFGL +    D T   T   
Sbjct: 127 LAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FC 182

Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           GT+ YMAPE L+R       D ++ G L+ ++ +G 
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 35/98 (35%), Positives = 51/98 (52%), Gaps = 8/98 (8%)

Query: 406 TAE---GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIA 462
             E    L HLH    + II+RDIK  NILLD      + DFGL++    D+T  +    
Sbjct: 165 VGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 221

Query: 463 GTLGYMAPEYLVRGQL--TEKADVYAFGVLVIEVASGR 498
           GT+ YMAP+ +  G     +  D ++ GVL+ E+ +G 
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 66.9 bits (164), Expect = 5e-12
 Identities = 31/96 (32%), Positives = 46/96 (47%), Gaps = 7/96 (7%)

Query: 406 TAE---GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIA 462
            AE    L +LH    + I++RD+K  NILLD +    + DFGL +      +  ST   
Sbjct: 145 AAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FC 200

Query: 463 GTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           GT  Y+APE L +       D +  G ++ E+  G 
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 67.4 bits (164), Expect = 7e-12
 Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 4/90 (4%)

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
           GL  L       II+RD+K  N++LD +   KIADFG+ +    D     T   GT  Y+
Sbjct: 454 GLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYI 509

Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           APE +      +  D +AFGVL+ E+ +G+
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 65.7 bits (161), Expect = 1e-11
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 9/97 (9%)

Query: 406 TAE---GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR-HVAPDKTHVSTGI 461
            AE   GL  L       II+RD+K  N++LD +   KIADFG+ + ++    T   T  
Sbjct: 127 AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT-TKT-F 181

Query: 462 AGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
            GT  Y+APE +      +  D +AFGVL+ E+ +G+
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 65.3 bits (160), Expect = 2e-11
 Identities = 35/97 (36%), Positives = 48/97 (49%), Gaps = 9/97 (9%)

Query: 406 TAE---GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR-HVAPDKTHVSTGI 461
            AE    L  LH      II+RD+K  N+LLD +   K+ADFG+ +  +    T  +T  
Sbjct: 130 AAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT-TAT-F 184

Query: 462 AGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
            GT  Y+APE L         D +A GVL+ E+  G 
Sbjct: 185 CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 65.4 bits (160), Expect = 2e-11
 Identities = 36/97 (37%), Positives = 52/97 (53%), Gaps = 9/97 (9%)

Query: 406 TAE---GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR-HVAPDKTHVSTGI 461
           +AE    L +LH      II+RD+K  N+LLD +   K+ D+G+ +  + P  T  ST  
Sbjct: 159 SAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TST-F 213

Query: 462 AGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
            GT  Y+APE L         D +A GVL+ E+ +GR
Sbjct: 214 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 64.9 bits (159), Expect = 2e-11
 Identities = 36/97 (37%), Positives = 52/97 (53%), Gaps = 9/97 (9%)

Query: 406 TAE---GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR-HVAPDKTHVSTGI 461
           +AE    L +LH      II+RD+K  N+LLD +   K+ D+G+ +  + P  T  ST  
Sbjct: 116 SAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TST-F 170

Query: 462 AGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
            GT  Y+APE L         D +A GVL+ E+ +GR
Sbjct: 171 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 64.2 bits (157), Expect = 3e-11
 Identities = 35/91 (38%), Positives = 52/91 (57%), Gaps = 6/91 (6%)

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR-HVAPDKTHVSTGIAGTLGY 467
           GL  LH      I++RD+K  NILLD+    KIADFG+ + ++  D    +T   GT  Y
Sbjct: 130 GLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNT-FCGTPDY 184

Query: 468 MAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           +APE L+  +     D ++FGVL+ E+  G+
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 52/252 (20%), Positives = 102/252 (40%), Gaps = 57/252 (22%)

Query: 275 VLLGTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFN 333
              G        + +Y ++          RKLG G   +V+    + +  ++A+K +   
Sbjct: 10  AFKGEPY----KDARYILV----------RKLGWGHFSTVWLAKDMVNNTHVAMK-IVRG 54

Query: 334 SRQWVDQFFNEVNLISGIQ-----------HKNVVRLLGC-SIEGPESL---LVYEYVPN 378
            + + +   +E+ L+  +              ++++LL   + +GP  +   +V+E    
Sbjct: 55  DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE---- 110

Query: 379 RSLDQIL--FVKNTIHI---LSWQQRFTI-ICGTAEGLAHLHGGSGIKIIHRDIKTSNIL 432
             L + L   +K   H    L + ++ +  +     GL ++H      IIH DIK  N+L
Sbjct: 111 -VLGENLLALIKKYEHRGIPLIYVKQISKQLL---LGLDYMH--RRCGIIHTDIKPENVL 164

Query: 433 LDE------KLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYA 486
           ++        +  KIAD G A        H +  I  T  Y +PE L+       AD+++
Sbjct: 165 MEIVDSPENLIQIKIADLGNACWY---DEHYTNSIQ-TREYRSPEVLLGAPWGCGADIWS 220

Query: 487 FGVLVIEVASGR 498
              L+ E+ +G 
Sbjct: 221 TACLIFELITGD 232

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 42/169 (24%), Positives = 62/169 (36%), Gaps = 32/169 (18%)

Query: 298 DFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVN-LISGIQHKN 355
           D+   S+ LG G  G V +          A+K L     Q   +   EV       Q  +
Sbjct: 18  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPH 72

Query: 356 VVRLLGC---SIEGPESL-LVYEYVPNRSL-DQILFVKNTIHILSWQQRFT------IIC 404
           +VR++        G + L +V E +    L  +I             Q FT      I+ 
Sbjct: 73  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI--------QDRGDQAFTEREASEIMK 124

Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILL---DEKLTPKIADFGLARHV 450
              E + +LH    I I HRD+K  N+L          K+ DFG A+  
Sbjct: 125 SIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 55.3 bits (133), Expect = 3e-08
 Identities = 60/276 (21%), Positives = 99/276 (35%), Gaps = 81/276 (29%)

Query: 286 LNFKYEILERATDFFDNSRKLGQGGAGSVFRG-TLPDGRNIAVKRLFFNSRQWVDQFFNE 344
            N +Y ++          RKLG G   +V+    +   + +A+K +  ++  + +   +E
Sbjct: 35  FNGRYHVI----------RKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDE 83

Query: 345 VNLISGIQ--------HKNVVRLLGC-SIEGPESL---LVYEYVPNRSLDQILFVKNTIH 392
           + L+  ++         + VV+LL    I G       +V+E V    L + + +K+   
Sbjct: 84  IRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWI-IKSNYQ 141

Query: 393 ILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL------------------- 433
            L       II    +GL +LH  +  +IIH DIK  NILL                   
Sbjct: 142 GLPLPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQR 199

Query: 434 ------------------------------DEKLTPKIADFGLARHVAPDKTHVSTGIAG 463
                                          EKL  KIAD G A      K    T    
Sbjct: 200 SGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW--VHKHF--TEDIQ 255

Query: 464 TLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRR 499
           T  Y + E L+       AD+++   +  E+A+G  
Sbjct: 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDY 291

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 55.1 bits (133), Expect = 4e-08
 Identities = 51/238 (21%), Positives = 100/238 (42%), Gaps = 61/238 (25%)

Query: 286 LNFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVK--RLFFNSRQWVDQFF 342
           + ++YE+L+           +G+G  G V +       +++A+K  R   N +++  Q  
Sbjct: 95  VAYRYEVLK----------VIGKGSFGQVVKAYDHKVHQHVALKMVR---NEKRFHRQAA 141

Query: 343 NEVNLISGIQHK------NVVRLLG--------CSIEGPESLLVYEYVPNR-----SLDQ 383
            E+ ++  ++ +      NV+ +L         C      S+ +YE +        SL  
Sbjct: 142 EEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPL 201

Query: 384 ILFVKNTIHILSWQQRFTI-ICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP--K 440
           +             ++F   I    + L  LH     +IIH D+K  NILL ++     K
Sbjct: 202 V-------------RKFAHSIL---QCLDALHK---NRIIHCDLKPENILLKQQGRSGIK 242

Query: 441 IADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           + DFG + +   +   V T I  +  Y APE ++  +     D+++ G ++ E+ +G 
Sbjct: 243 VIDFGSSCY---EHQRVYTYIQ-SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 54.4 bits (131), Expect = 5e-08
 Identities = 39/242 (16%), Positives = 74/242 (30%), Gaps = 49/242 (20%)

Query: 255 PNYQKKETRYKRLSEMRKGQVLLGTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSV 314
                 ++    L  +  G VL      T     ++++               +   G +
Sbjct: 15  TENLYFQSMTTSLEALPTGTVL------TDKSGRQWKLK----------SFQTRDNQGIL 58

Query: 315 FRGT---------LPDGRNIAVK------RLF----FNSRQWVDQFFNEVNLISGIQHKN 355
           +             P  +  ++K      RLF    F  R       N+   +       
Sbjct: 59  YEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118

Query: 356 VVRLLGC-SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH 414
           +   +G    +     LV   +  RSL       +  H+LS +    + C   + L  LH
Sbjct: 119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLSERSVLQVACRLLDALEFLH 176

Query: 415 GGSGIKIIHRDIKTSNILLDEKLTPKI--ADFGLARHVAPDKTHV------STGIAGTLG 466
                  +H ++   NI +D +   ++  A +G A    P   HV       +   G L 
Sbjct: 177 ENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLE 233

Query: 467 YM 468
           ++
Sbjct: 234 FI 235

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 34/200 (17%), Positives = 64/200 (32%), Gaps = 47/200 (23%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVV---- 357
             +GQGG G ++   +    ++                  F E+           +    
Sbjct: 41  LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100

Query: 358 -----------RLLGCSIEGPESL----LVYEYVPNRSLDQIL------FVKNTIHILSW 396
                      +  G  +          ++ +      L +I       F + T+  LS 
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSL 159

Query: 397 QQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKI--ADFGLARHVAPDK 454
           +    I+    + L ++H       +H DIK SN+LL+ K   ++   D+GLA    P+ 
Sbjct: 160 R----IL----DILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208

Query: 455 THV------STGIAGTLGYM 468
            H            GT+ + 
Sbjct: 209 VHKAYAADPKRCHDGTIEFT 228

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 50.1 bits (120), Expect = 8e-07
 Identities = 48/214 (22%), Positives = 81/214 (37%), Gaps = 54/214 (25%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQH-KNVVRLLG 361
           RK+G G  G ++ GT +  G  +A+K     ++    Q   E  +   +Q    +  +  
Sbjct: 15  RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 72

Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI--ICGTA----EGLAHLHG 415
           C  EG  +++V E +   SL+  LF           ++F++  +   A      + ++H 
Sbjct: 73  CGAEGDYNVMVMELL-GPSLED-LFNFC-------SRKFSLKTVLLLADQMISRIEYIHS 123

Query: 416 GSGIKIIHRDIKTSNILLDEKLTPK---IADFGLARHVAPDKTHV------STGIAGT-- 464
            +    IHRD+K  N L+          I DFGLA+     +TH       +  + GT  
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180

Query: 465 --------------------LGYMAPEYLVRGQL 478
                               LGY+   Y   G L
Sbjct: 181 YASINTHLGIEQSRRDDLESLGYVL-MYFNLGSL 213

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 50.0 bits (120), Expect = 8e-07
 Identities = 42/216 (19%), Positives = 80/216 (37%), Gaps = 56/216 (25%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQH-KNVVRLLG 361
           R++G+G  G +F GT L + + +A+K     S     Q  +E      +     +  +  
Sbjct: 16  RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYY 73

Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI--ICGTAE----GLAHLHG 415
              EG  ++LV + +   SL+  L            ++F++  +   A+     +  +H 
Sbjct: 74  FGQEGLHNVLVIDLLG-PSLED-LLDLC-------GRKFSVKTVAMAAKQMLARVQSIHE 124

Query: 416 GSGIKIIHRDIKTSNILLDEKLTPK-----IADFGLARHVAPDKTHV------STGIAGT 464
            S   +++RDIK  N L+    +       + DFG+ +      T           ++GT
Sbjct: 125 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181

Query: 465 ----------------------LGYMAPEYLVRGQL 478
                                 LG++   Y +RG L
Sbjct: 182 ARYMSINTHLGREQSRRDDLEALGHVFM-YFLRGSL 216

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 50.6 bits (120), Expect = 1e-06
 Identities = 74/462 (16%), Positives = 135/462 (29%), Gaps = 129/462 (27%)

Query: 133 LRYDNYDFFGEAVDPIHDKFNCSARHLDDESLSKQFEEKVIEVITNV-TIVTKSNGRFGQ 191
            +Y   D      D   D F+C  + + D        ++ I+ I      V+ +   F  
Sbjct: 14  HQYQYKDILSVFEDAFVDNFDC--KDVQD-MPKSILSKEEIDHIIMSKDAVSGTLRLFWT 70

Query: 192 VEGKGGIATVY-----ALAQCLKFLDNKGCSQCLDEAALRLKGCSKSGEGRAMFAGCYVR 246
           +  K     V       L    KFL +   ++    + +             M+     R
Sbjct: 71  LLSKQE-EMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMT-----------RMYIEQRDR 118

Query: 247 -FSTERFFNPNY----QKKETRYKRLSEMRKGQ--VLLG------TVLCTSSLNFKYEIL 293
            ++  + F        Q      + L E+R  +  ++ G      T +        Y++ 
Sbjct: 119 LYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCL-SYKVQ 177

Query: 294 ERATDFFDNSRKLGQGGAGSVF-----RGTLPDGRNIAVKRLFF----NSRQWVDQFFNE 344
            +     D            +F         P+     +++L +    N     D   N 
Sbjct: 178 CK----MDFK----------IFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI 223

Query: 345 VNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIIC 404
              I  IQ +  +R L  S      LLV        L     V+N          F + C
Sbjct: 224 KLRIHSIQAE--LRRLLKSKPYENCLLV--------LLN---VQNAKAW----NAFNLSC 266

Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT 464
                          KI+   + T           ++ DF     ++   T   +    +
Sbjct: 267 ---------------KIL---LTTRFK--------QVTDF-----LSAATTTHISLDHHS 295

Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG--RRNSVFSEGSSSVLHTV--WKHYKA 520
           +     E      L +  D      L  EV +   RR S+ +E     L T   WKH   
Sbjct: 296 MTLTPDEVK--SLLLKYLDCRPQD-LPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNC 352

Query: 521 NRITQSM-------DPGLTGR-------FPENE--ASRVLQI 546
           +++T  +       +P    +       FP +    + +L +
Sbjct: 353 DKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSL 394

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.5 bits (104), Expect = 1e-04
 Identities = 31/205 (15%), Positives = 58/205 (28%), Gaps = 63/205 (30%)

Query: 5   VRIPRNLIWVIWMFIIT--LSMFVSRSHSSS----RSSESLY---------KCGPP---- 45
             IP  L+ +IW  +I   + + V++ H  S    +  ES           K        
Sbjct: 385 AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYA 444

Query: 46  --AKVSDNRNFRQNFDAVMGNISEQIMDDHHYHFALHYVVSPAPQVYAYMQCH-EDLSQT 102
               + D+ N  + FD+   ++    +D + Y                +   H +++   
Sbjct: 445 LHRSIVDHYNIPKTFDS--DDLIPPYLDQYFYSH------------IGH---HLKNIEHP 487

Query: 103 DCESCFSA-------LKQK-----ANRCLPSDSARIFLDGCFLRYDNYDFFGEAVDPIHD 150
           +  + F         L+QK                         Y  Y         I D
Sbjct: 488 ERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQ--LKFYKPY---------ICD 536

Query: 151 KFNCSARHLDD-ESLSKQFEEKVIE 174
                 R ++       + EE +I 
Sbjct: 537 NDPKYERLVNAILDFLPKIEENLIC 561

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 44/218 (20%), Positives = 70/218 (32%), Gaps = 60/218 (27%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQH-KNVVRLLG 361
           +K+G G  G +  G  L     +A+K     SR    Q   E      +     + ++  
Sbjct: 15  KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYY 72

Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI--ICGTAEGL------AHL 413
               G  + +V E +   SL+  LF           + F++  +   A  L       H 
Sbjct: 73  FGPCGKYNAMVLELL-GPSLED-LFDLC-------DRTFSLKTVLMIAIQLISRMEYVHS 123

Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPK-----IADFGLARHVAPDKTHV------STGIA 462
                  +I+RD+K  N L+            I DF LA+     +T           + 
Sbjct: 124 KN-----LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLT 178

Query: 463 GT----------------------LGYMAPEYLVRGQL 478
           GT                      LG+M   Y +RG L
Sbjct: 179 GTARYMSINTHLGKEQSRRDDLEALGHMFM-YFLRGSL 215

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 49/238 (20%), Positives = 87/238 (36%), Gaps = 59/238 (24%)

Query: 286 LNFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVK--RLFFNSRQWVDQFF 342
              +YEI             +G+G  G V +     +   +A+K  +   N + +++Q  
Sbjct: 52  WMDRYEIDS----------LIGKGSFGQVVKAYDRVEQEWVAIKIIK---NKKAFLNQAQ 98

Query: 343 NEVNLISGIQH------KNVVRLLG--------CSIEGPESLLVYEYVPNR-----SLDQ 383
            EV L+  +          +V L          C +    S  +Y+ + N      SL+ 
Sbjct: 99  IEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNL 158

Query: 384 ILFVKNTIHILSWQQRFTI-ICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP--K 440
                         ++F   +C     L  L     + IIH D+K  NILL        K
Sbjct: 159 T-------------RKFAQQMC---TALLFLAT-PELSIIHCDLKPENILLCNPKRSAIK 201

Query: 441 IADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
           I DFG +         +   I  +  Y +PE L+        D+++ G +++E+ +G 
Sbjct: 202 IVDFGSSCQ---LGQRIYQYIQ-SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 47.8 bits (114), Expect = 5e-06
 Identities = 33/193 (17%), Positives = 57/193 (29%), Gaps = 36/193 (18%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVN----LISGIQHKNVVR 358
           +K+G GG G ++           A   +    ++     F+E+     +      K  + 
Sbjct: 43  KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQE-NGPLFSELKFYQRVAKKDCIKKWIE 101

Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFV-----KNTIHILSWQQRFTIICGTAEGLA-- 411
                  G            +       V      +   I      F     T   L   
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKK--STVLQLGIR 159

Query: 412 --------HLHGGSGIKIIHRDIKTSNILLDEKLTPKI--ADFGLARHVAPDKTHV---- 457
                   H +       +H DIK +N+LL  K   ++  AD+GL+    P+  H     
Sbjct: 160 MLDVLEYIHENE-----YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQE 214

Query: 458 --STGIAGTLGYM 468
               G  GT+ + 
Sbjct: 215 NPRKGHNGTIEFT 227

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 47/214 (21%), Positives = 79/214 (36%), Gaps = 54/214 (25%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-HKNVVRLLG 361
           RK+G G  G ++ GT +     +A+K     ++    Q   E  +   +Q    +  +  
Sbjct: 13  RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRW 70

Query: 362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI--ICGTA----EGLAHLHG 415
             +EG  ++LV + +   SL+  LF           ++ ++  +   A      +  +H 
Sbjct: 71  FGVEGDYNVLVMDLL-GPSLED-LFNFC-------SRKLSLKTVLMLADQMINRVEFVHS 121

Query: 416 GSGIKIIHRDIKTSNILLDEKLTPK---IADFGLARHVAPDKTHV------STGIAGT-- 464
            S    +HRDIK  N L+          I DFGLA+      TH       +  + GT  
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178

Query: 465 --------------------LGYMAPEYLVRGQL 478
                               LGY+   Y +RG L
Sbjct: 179 YASVNTHLGIEQSRRDDLESLGYVLM-YFLRGSL 211

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540

 Score = 42.3 bits (100), Expect = 4e-04
 Identities = 19/107 (17%), Positives = 39/107 (36%), Gaps = 16/107 (14%)

Query: 343 NEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI 402
            E   ++ ++   +       ++     ++  Y+  +    ++           +    I
Sbjct: 388 REARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVI-----------EDNLDI 436

Query: 403 ICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH 449
                E +  LH      +IH D+ TSN + D+ L   I DFGL + 
Sbjct: 437 AYKIGEIVGKLHKN---DVIHNDLTTSNFIFDKDLY--IIDFGLGKI 478

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	625
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.91
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.89
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.78
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.78
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.76
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.69
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.41
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.24
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.1
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.96
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.79
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.64
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.61
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.54
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.45
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.42
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.17
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.12
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.04
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.91
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.78
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.74
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.57
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.54
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.54
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.46
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.46
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.4
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.28
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.2
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.0
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.61
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.3
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.68
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	87.27
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	85.62
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	83.12

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.1e-55  Score=449.27  Aligned_cols=259  Identities=26%  Similarity=0.387  Sum_probs=216.1

Q ss_pred             cCccccccccccCceEEEEEEeC------CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      ++|.+.++||+|+||+||+|++.      ++..||||++........+.|.+|+++|++++|||||+++|++.+++..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            57888999999999999999863      467899999987777778899999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhhhccC----------CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEE
Q 042149          372 VYEYVPNRSLDQILFVKN----------TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKI  441 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl  441 (625)
                      |||||++|+|.++|....          ....++|.+++.|+.||++||.|||+++   ||||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            999999999999997542          2345999999999999999999999875   999999999999999999999


Q ss_pred             eecccceeeCCCCceee-ecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhh
Q 042149          442 ADFGLARHVAPDKTHVS-TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYK  519 (625)
Q Consensus       442 ~Dfgla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~  519 (625)
                      +|||+++.......... ....||+.|||||++.++.++.++|||||||++|||+| |+.|+.... ..++    .....
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~-~~~~----~~~i~  244 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS-NNEV----IECIT  244 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-HHHH----HHHHH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-HHHH----HHHHH
Confidence            99999987654433322 23568999999999999999999999999999999999 888864321 1111    11111


Q ss_pred             ccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccC
Q 042149          520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY  573 (625)
Q Consensus       520 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  573 (625)
                      .+         ...+.|..++.++.+|+.+||+.||++|||++||++.|+++..
T Consensus       245 ~~---------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          245 QG---------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             HT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cC---------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            11         1223466677889999999999999999999999999988753

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=7.2e-55  Score=449.39  Aligned_cols=259  Identities=27%  Similarity=0.372  Sum_probs=209.9

Q ss_pred             cCccccccccccCceEEEEEEeC------CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      ++|.+.++||+|+||+||+|+++      +++.||||++........+.|.+|+++|++++|||||+++|++.+.+..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            56778889999999999999864      478899999987777778899999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCC------------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCce
Q 042149          372 VYEYVPNRSLDQILFVKNT------------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP  439 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~  439 (625)
                      |||||++|+|.+++.....            ...++|.+++.|+.||++||.|||+++   ||||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            9999999999999875432            235899999999999999999999875   9999999999999999999


Q ss_pred             EEeecccceeeCCCCce-eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHh
Q 042149          440 KIADFGLARHVAPDKTH-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKH  517 (625)
Q Consensus       440 kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~  517 (625)
                      ||+|||+++........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||..... .+    ....
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-~~----~~~~  272 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-TE----AIDC  272 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-HH----HHHH
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-HH----HHHH
Confidence            99999999876543322 2335679999999999999999999999999999999999 8888653221 11    1111


Q ss_pred             hhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccC
Q 042149          518 YKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY  573 (625)
Q Consensus       518 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  573 (625)
                      ...         ....+.|..++.++.+|+.+||+.||++|||++||++.|+.+..
T Consensus       273 i~~---------g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          273 ITQ---------GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             HHH---------TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHc---------CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            111         11233456677889999999999999999999999999988753

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-54  Score=438.64  Aligned_cols=264  Identities=25%  Similarity=0.385  Sum_probs=208.9

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      .+++++.++||+|+||+||+|+++.  .||||++...  ..+..+.|.+|+.+|++++|||||++++++.+ +.++||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            4677889999999999999999753  6999998643  45667889999999999999999999998754 56899999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      ||+||+|.++|....  ..+++.+++.|+.||++||+|||+++   ||||||||+||||++++.+||+|||+|+......
T Consensus       112 y~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          112 WCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             CCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             cCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            999999999996543  34999999999999999999999875   9999999999999999999999999998765332


Q ss_pred             c-eeeecCCCCccccCcccccc---CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          455 T-HVSTGIAGTLGYMAPEYLVR---GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       455 ~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                      . .......||+.|||||++.+   +.|+.++|||||||++|||+||+.||........+.    .......    ..+.
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~----~~~~~~~----~~p~  258 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQII----FMVGRGY----ASPD  258 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH----HHHHTTC----CCCC
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHH----HHHhcCC----CCCC
Confidence            2 23345689999999999964   468999999999999999999999975332211111    1111110    1111


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCCC
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPP  577 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~~  577 (625)
                       ....+.+++..+.+|+.+||+.||++|||+.||++.|+.+...+|.
T Consensus       259 -~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk  304 (307)
T 3omv_A          259 -LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK  304 (307)
T ss_dssp             -STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred             -cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence             1233556778899999999999999999999999999887766653

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.4e-54  Score=443.00  Aligned_cols=257  Identities=23%  Similarity=0.364  Sum_probs=211.9

Q ss_pred             cCccccccccccCceEEEEEEeC------CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  370 (625)
                      +.+++.++||+|+||+||+|++.      +++.||||++... .....+.|.+|+.+|++++|||||+++|++.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            45667889999999999999862      4678999999654 3344678999999999999999999999999999999


Q ss_pred             EEEEecCCCCcchhhhccCC-------------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC
Q 042149          371 LVYEYVPNRSLDQILFVKNT-------------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL  437 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~  437 (625)
                      ||||||++|+|.++|....+             ...++|.+++.|+.||++||+|||+++   ||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            99999999999999965432             235899999999999999999999875   99999999999999999


Q ss_pred             ceEEeecccceeeCCCCc-eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHH
Q 042149          438 TPKIADFGLARHVAPDKT-HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVW  515 (625)
Q Consensus       438 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~  515 (625)
                      .+||+|||+++....... .......||+.|||||++.++.++.++|||||||++|||+| |+.|+.... ..++    .
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~-~~~~----~  257 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-NQDV----V  257 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC-HHHH----H
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC-HHHH----H
Confidence            999999999987643332 22335679999999999999999999999999999999999 788864321 1111    1


Q ss_pred             HhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          516 KHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       516 ~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      .         .+......+.|..++..+.+|+.+||+.||++||||.||++.|+..
T Consensus       258 ~---------~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          258 E---------MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             H---------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             H---------HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            1         1222223345667788899999999999999999999999999764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=6.1e-54  Score=442.83  Aligned_cols=251  Identities=20%  Similarity=0.294  Sum_probs=204.7

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      .++|+++++||+|+||+||+|+++ +|+.||||++...  .....+.+.+|+.+|++|+|||||++++++.+++.+||||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            368999999999999999999975 6999999999754  4556778999999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||++||+|.++|..... ..+++.+++.|+.||+.||.|||+++   ||||||||+||||+.+|.+||+|||+++.....
T Consensus       103 Ey~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             ECCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             eCCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            99999999999965433 34789999999999999999999876   999999999999999999999999999876432


Q ss_pred             CceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                      .. .....+||+.|||||++.+..|+.++|||||||++|||+||+.||....    ..... .......         ..
T Consensus       179 ~~-~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~----~~~~~-~~i~~~~---------~~  243 (350)
T 4b9d_A          179 VE-LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS----MKNLV-LKIISGS---------FP  243 (350)
T ss_dssp             HH-HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHH-HHHHHTC---------CC
T ss_pred             cc-cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHHHH-HHHHcCC---------CC
Confidence            21 2234679999999999999999999999999999999999999975321    11111 1111111         11


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      +.+...+.++.+||.+||+.||++|||++|+++
T Consensus       244 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          244 PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            234456778999999999999999999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.1e-52  Score=431.45  Aligned_cols=262  Identities=23%  Similarity=0.267  Sum_probs=210.8

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      .+.|++.++||+|+||+||+|+++ +|+.||||++.....     ..+|+.+|++++|||||++++++.+++.++|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            456888999999999999999975 689999999975432     25799999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC-ceEEeecccceeeCCCC
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL-TPKIADFGLARHVAPDK  454 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-~~kl~Dfgla~~~~~~~  454 (625)
                      ++||+|.+++...+.   +++.++..++.||+.||.|||+++   ||||||||+||||+.+| .+||+|||+|+.+....
T Consensus       132 ~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          132 LEGGSLGQLIKQMGC---LPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             cCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            999999999976543   999999999999999999999775   99999999999999887 69999999999875433


Q ss_pred             ce----eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          455 TH----VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       455 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                      ..    .....+||+.|||||++.+..++.++|||||||++|||+||+.||...... .+.....    ....       
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~i~----~~~~-------  273 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG-PLCLKIA----SEPP-------  273 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS-CCHHHHH----HSCC-------
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-HHHHHHH----cCCC-------
Confidence            21    122467999999999999999999999999999999999999997543222 2221111    1110       


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCCCCCCC
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQP  581 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~~~~~~  581 (625)
                      .....++..+..+.+++.+||+.||++|||+.|+++.|.....++..-.+|
T Consensus       274 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hP  324 (336)
T 4g3f_A          274 PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSP  324 (336)
T ss_dssp             GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSC
T ss_pred             CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCC
Confidence            001234566778999999999999999999999999887665444433333

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=5e-53  Score=435.32  Aligned_cols=249  Identities=27%  Similarity=0.402  Sum_probs=209.7

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      +.|++.++||+|+||+||+|+++ +|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56999999999999999999975 69999999997665555667899999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      +||+|.+++...    .+++.++..++.||+.||+|||+++   ||||||||+||||+.+|.+||+|||+++.+......
T Consensus       154 ~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  226 (346)
T 4fih_A          154 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  226 (346)
T ss_dssp             TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred             CCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence            999999988642    3899999999999999999999886   999999999999999999999999999987554332


Q ss_pred             eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP  536 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  536 (625)
                       ....+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ..    ........     ..+.  .+.+
T Consensus       227 -~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-~~----~~~~i~~~-----~~~~--~~~~  293 (346)
T 4fih_A          227 -RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-LK----AMKMIRDN-----LPPR--LKNL  293 (346)
T ss_dssp             -BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-HH----HHHHHHHS-----SCCC--CSCG
T ss_pred             -ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-HH----HHHHHHcC-----CCCC--CCcc
Confidence             3457899999999999999999999999999999999999999753211 11    11111111     1111  1223


Q ss_pred             hHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          537 ENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       537 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ...+.++.+|+.+||+.||++|||++|+++
T Consensus       294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          294 HKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            456788999999999999999999999875

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.4e-52  Score=423.97  Aligned_cols=247  Identities=22%  Similarity=0.284  Sum_probs=209.3

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ++|++.++||+|+||+||+|+++ +++.||||++.+.   .....+.+.+|+++|++++|||||++++++.+++.+||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57999999999999999999975 6899999999753   2344678999999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||++||+|.+++...+.   +++.++..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.+...
T Consensus       112 Ey~~gG~L~~~i~~~~~---l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            99999999999975543   999999999999999999999886   999999999999999999999999999987644


Q ss_pred             Cc-eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          454 KT-HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       454 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      .. ......+||+.|||||++.+..++.++|||||||++|||+||+.||.... .    ...........          
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-~----~~~~~~i~~~~----------  250 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-E----GLIFAKIIKLE----------  250 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-H----HHHHHHHHHTC----------
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-H----HHHHHHHHcCC----------
Confidence            33 23346789999999999999999999999999999999999999975321 1    11122221111          


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVV  565 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~  565 (625)
                      ..+|...+.++.+|+.+||+.||++|||++|++
T Consensus       251 ~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          251 YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            123445567889999999999999999998863

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.1e-51  Score=417.09  Aligned_cols=247  Identities=23%  Similarity=0.338  Sum_probs=198.8

Q ss_pred             ccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeee----CCeeEEE
Q 042149          300 FDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE----GPESLLV  372 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lV  372 (625)
                      |++.++||+|+||+||+|++. +++.||||++...  .....+.|.+|+++|++++|||||++++++.+    ++.++||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            366778999999999999975 6899999999654  45556789999999999999999999999875    3468999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC-CCceEEeecccceeeC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE-KLTPKIADFGLARHVA  451 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~-~~~~kl~Dfgla~~~~  451 (625)
                      ||||+||+|.+++....   .+++..+..|+.||+.||+|||+++ .+||||||||+||||+. ++.+||+|||+|+...
T Consensus       108 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            99999999999997544   3899999999999999999999762 34999999999999984 7899999999998643


Q ss_pred             CCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      ..   .....+||+.|||||++. ++++.++|||||||++|||+||+.||........    ..........        
T Consensus       184 ~~---~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~----~~~~i~~~~~--------  247 (290)
T 3fpq_A          184 AS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----IYRRVTSGVK--------  247 (290)
T ss_dssp             TT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH----HHHHHTTTCC--------
T ss_pred             CC---ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH----HHHHHHcCCC--------
Confidence            32   223468999999999885 4699999999999999999999999753222111    1121111110        


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ....+...+.++.+|+.+||+.||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          248 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            01112334567899999999999999999999985

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=8e-52  Score=436.70  Aligned_cols=249  Identities=27%  Similarity=0.411  Sum_probs=209.6

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      +.|++.++||+|+||.||+|+++ +|+.||||++........+.+.+|+.+|+.++|||||++++++.+++.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999999975 69999999998766555677899999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      +||+|.+++...    .+++.++..++.||+.||+|||+++   ||||||||+||||+.+|.+||+|||+++.+......
T Consensus       231 ~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~  303 (423)
T 4fie_A          231 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  303 (423)
T ss_dssp             TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred             CCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence            999999988543    3899999999999999999999886   999999999999999999999999999987544332


Q ss_pred             eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP  536 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  536 (625)
                       ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.....    .. ........     ..+.  ...+
T Consensus       304 -~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~----~~-~~~~i~~~-----~~~~--~~~~  370 (423)
T 4fie_A          304 -RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LK-AMKMIRDN-----LPPR--LKNL  370 (423)
T ss_dssp             -BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HH-HHHHHHHS-----CCCC--CSCT
T ss_pred             -ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----HH-HHHHHHcC-----CCCC--Cccc
Confidence             3457899999999999999999999999999999999999999743211    11 11111111     1111  1123


Q ss_pred             hHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          537 ENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       537 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ...+..+.+|+.+||+.||++|||+.|+++
T Consensus       371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          371 HKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            455678899999999999999999999875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=7.4e-52  Score=430.38  Aligned_cols=265  Identities=29%  Similarity=0.385  Sum_probs=217.0

Q ss_pred             HHHHHHhcCccccccccccCceEEEEEEeCC------CCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCC-Cceeeeeee
Q 042149          291 EILERATDFFDNSRKLGQGGAGSVFRGTLPD------GRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQH-KNVVRLLGC  362 (625)
Q Consensus       291 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-pniv~l~~~  362 (625)
                      ..++.-.++|++.++||+|+||+||+|++..      ++.||||++.... ....+.|.+|+++|+++.| ||||+++|+
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            4455556889999999999999999998532      3679999997653 4456789999999999965 899999999


Q ss_pred             eeeC-CeeEEEEEecCCCCcchhhhccCC-------------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeecc
Q 042149          363 SIEG-PESLLVYEYVPNRSLDQILFVKNT-------------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKT  428 (625)
Q Consensus       363 ~~~~-~~~~lV~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp  428 (625)
                      |.+. +.++||||||++|+|.++|+....             ...+++.+++.++.||++||+|||+++   ||||||||
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~  213 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA  213 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCc
Confidence            8764 578999999999999999975322             244899999999999999999999875   99999999


Q ss_pred             CcEEEcCCCceEEeecccceeeCCCCcee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCC
Q 042149          429 SNILLDEKLTPKIADFGLARHVAPDKTHV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEG  506 (625)
Q Consensus       429 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~  506 (625)
                      +||||++++.+||+|||+|+.+....... .....||+.|||||++.++.++.++|||||||++|||+| |+.||.....
T Consensus       214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~  293 (353)
T 4ase_A          214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  293 (353)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999999775544433 335679999999999999999999999999999999998 8888754332


Q ss_pred             CccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          507 SSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      ...+    ......         ....+.|..++.++.+++.+||+.||++|||+.||++.|+++
T Consensus       294 ~~~~----~~~i~~---------g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          294 DEEF----CRRLKE---------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             SHHH----HHHHHH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHH----HHHHHc---------CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            2221    122211         122334566678899999999999999999999999999775

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.5e-51  Score=416.66  Aligned_cols=269  Identities=25%  Similarity=0.286  Sum_probs=202.5

Q ss_pred             cCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC----eeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP----ESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~lV~  373 (625)
                      ++|.+.++||+|+||+||+|++ +|+.||||++...... ...++.|+..+.+++|||||++++++.+++    .++|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4678889999999999999998 5899999998654332 223445677778899999999999998654    579999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcC-----CCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG-----SGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      ||+++|+|.++|...    .++|..+.+++.|+++||+|||++     ...+||||||||+||||+.++.+||+|||+++
T Consensus        81 Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            999999999999643    389999999999999999999975     13369999999999999999999999999998


Q ss_pred             eeCCCCcee---eecCCCCccccCccccccC------cccccCcEEeehhhhHHHHhCCCCCCCCCCCccch-hhHHHhh
Q 042149          449 HVAPDKTHV---STGIAGTLGYMAPEYLVRG------QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVL-HTVWKHY  518 (625)
Q Consensus       449 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~-~~~~~~~  518 (625)
                      .........   .....||+.|||||++.+.      .++.++|||||||++|||+||+.|+.......... .......
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            876544332   2245799999999998654      57889999999999999999987764332211100 0000000


Q ss_pred             hccccc-cccCCCCCCCCC-----hHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          519 KANRIT-QSMDPGLTGRFP-----ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       519 ~~~~~~-~~i~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      ....+. ...+..+++..|     .+.+..+.+|+.+||+.||++|||+.||++.|+++.
T Consensus       237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~  296 (303)
T 3hmm_A          237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            000000 011222222222     356778999999999999999999999999998764

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.3e-51  Score=408.41  Aligned_cols=245  Identities=21%  Similarity=0.289  Sum_probs=192.2

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ++|++.+.||+|+||+||+|+++ +|+.||||++...   .....+.+.+|+.+|++++|||||++++++.+++..+|||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999965 6999999999654   2344567999999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+ +|+|.+++...+   .+++.++..++.||+.||+|||+++   |+||||||+||||++++.+||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 678988886554   3999999999999999999999876   999999999999999999999999999876543


Q ss_pred             CceeeecCCCCccccCccccccCcc-cccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      ..  ....+||+.|||||++.+..+ +.++|||||||++|||+||+.||....     .....+......          
T Consensus       166 ~~--~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-----~~~~~~~i~~~~----------  228 (275)
T 3hyh_A          166 NF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-----IPVLFKNISNGV----------  228 (275)
T ss_dssp             -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHTC----------
T ss_pred             Cc--cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHHHcCC----------
Confidence            22  234689999999999988776 579999999999999999999974321     111222222211          


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ..+|...+.++.+++.+||+.||++|||++|+++
T Consensus       229 ~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          229 YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1224455678899999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.2e-51  Score=418.74  Aligned_cols=247  Identities=24%  Similarity=0.265  Sum_probs=197.4

Q ss_pred             cCccccccccccCceEEEEEEeC----CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP----DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      ++|++.+.||+|+||+||+|+..    +++.||||++....  ......+.+|+++|++++|||||++++++.+++.++|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999852    47889999986432  2223468899999999999999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||||++||+|.+++.....   +++.++..++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVM---FTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            9999999999999976543   899999999999999999999876   9999999999999999999999999998654


Q ss_pred             CCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      ..... ....+||+.|||||++.+..++.++|||||||++|||+||+.||..... .+    .........         
T Consensus       178 ~~~~~-~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-~~----~~~~i~~~~---------  242 (304)
T 3ubd_A          178 DHEKK-AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-KE----TMTMILKAK---------  242 (304)
T ss_dssp             ---CC-CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HH----HHHHHHHCC---------
T ss_pred             CCCcc-ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-HH----HHHHHHcCC---------
Confidence            43322 2346899999999999999999999999999999999999999753211 11    111111111         


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRPS-----MAEVVH  566 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~  566 (625)
                       ..+|...+.++.+|+.+||+.||++|||     ++|+++
T Consensus       243 -~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          243 -LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             -CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence             1234556778999999999999999998     467764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.5e-50  Score=412.23  Aligned_cols=251  Identities=22%  Similarity=0.311  Sum_probs=192.7

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC-------
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP-------  367 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-------  367 (625)
                      .++|++++.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+       
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            356999999999999999999975 78999999997653 445678999999999999999999999987654       


Q ss_pred             -----eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEe
Q 042149          368 -----ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIA  442 (625)
Q Consensus       368 -----~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~  442 (625)
                           .++|||||+++|+|.+++.........++..++.++.||++||+|||+++   ||||||||+||||+.++.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence                 36999999999999999987766666778889999999999999999875   9999999999999999999999


Q ss_pred             ecccceeeCCCCce-----------eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccch
Q 042149          443 DFGLARHVAPDKTH-----------VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVL  511 (625)
Q Consensus       443 Dfgla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~  511 (625)
                      |||+|+........           ..+..+||+.|||||++.+..|+.++|||||||++|||++   |+...  . +..
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~--~-~~~  234 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ--M-ERV  234 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH--H-HHH
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc--c-HHH
Confidence            99999876543221           1224579999999999999999999999999999999996   43210  0 000


Q ss_pred             hhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          512 HTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       512 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                       ..........         .++........+.+++.+||+.||++|||+.|+++
T Consensus       235 -~~~~~~~~~~---------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          235 -RTLTDVRNLK---------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             -HHHHHHHTTC---------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HHHHHHhcCC---------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             0111111111         11112234456788999999999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=8.4e-47  Score=394.81  Aligned_cols=266  Identities=23%  Similarity=0.291  Sum_probs=201.4

Q ss_pred             HHHHHHHhcCccccccccccCceEEEEEEeC----CCCEEEEEEeecCChHHHHHHHHHHHHHhcC-CCCceeeeeeeee
Q 042149          290 YEILERATDFFDNSRKLGQGGAGSVFRGTLP----DGRNIAVKRLFFNSRQWVDQFFNEVNLISGI-QHKNVVRLLGCSI  364 (625)
Q Consensus       290 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~  364 (625)
                      |+.+-...++|++.++||+|+||+||+|+++    +++.||||++.....  ..++.+|+++|+.+ .|||||++++++.
T Consensus        13 ~~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~   90 (361)
T 4f9c_A           13 YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFR   90 (361)
T ss_dssp             HHHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred             HHhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence            3444456789999999999999999999853    467899999865543  35678999999998 6999999999999


Q ss_pred             eCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCC-CceEEee
Q 042149          365 EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEK-LTPKIAD  443 (625)
Q Consensus       365 ~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~-~~~kl~D  443 (625)
                      +.+.++|||||++|++|.+++.      .+++.++..++.||+.||+|||+++   |+||||||+|||++.+ +.+||+|
T Consensus        91 ~~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~D  161 (361)
T 4f9c_A           91 KNDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVD  161 (361)
T ss_dssp             ETTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred             ECCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECc
Confidence            9999999999999999999882      3899999999999999999999876   9999999999999876 7999999


Q ss_pred             cccceeeCCCCc---------------------------eeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHH
Q 042149          444 FGLARHVAPDKT---------------------------HVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVA  495 (625)
Q Consensus       444 fgla~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~ell  495 (625)
                      ||+|+.......                           ......+||+.|+|||++.+. .++.++||||+||++|||+
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell  241 (361)
T 4f9c_A          162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL  241 (361)
T ss_dssp             CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred             CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence            999986543221                           112245799999999999775 5899999999999999999


Q ss_pred             hCCCCCCCCCCCccchhhHHHhhh------------c----------cccc---------cccCCC---------CCCCC
Q 042149          496 SGRRNSVFSEGSSSVLHTVWKHYK------------A----------NRIT---------QSMDPG---------LTGRF  535 (625)
Q Consensus       496 tG~~p~~~~~~~~~~~~~~~~~~~------------~----------~~~~---------~~i~~~---------~~~~~  535 (625)
                      ||+.||....+..+.+........            .          ....         ....+.         ...+.
T Consensus       242 ~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  321 (361)
T 4f9c_A          242 SGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEG  321 (361)
T ss_dssp             HTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------
T ss_pred             HCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccc
Confidence            999997533322111111110000            0          0000         000000         00011


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ....+.+..+|+.+||+.||++|||++|+++
T Consensus       322 ~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          322 WNEVPDEAYDLLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            1234567889999999999999999999885

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-46  Score=395.83  Aligned_cols=262  Identities=20%  Similarity=0.271  Sum_probs=200.5

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeee------CC
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE------GP  367 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~~  367 (625)
                      .++|+++++||+|+||+||+|+++ +|+.||||++...  .....+.+.+|+.+|+.++|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            367999999999999999999975 7999999999643  34556788999999999999999999998764      36


Q ss_pred             eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccc
Q 042149          368 ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA  447 (625)
Q Consensus       368 ~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla  447 (625)
                      .+|||||||+ |+|.+++....   .+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||++
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence            7899999996 67888885443   4999999999999999999999876   999999999999999999999999999


Q ss_pred             eeeCCCC---ceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcc--
Q 042149          448 RHVAPDK---THVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN--  521 (625)
Q Consensus       448 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~--  521 (625)
                      +.+....   .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||...... +.+..........  
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-~~l~~I~~~~g~p~~  284 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-HQLQLIMMVLGTPSP  284 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCG
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCCh
Confidence            8764322   1223457899999999998875 5699999999999999999999997543211 1111111111000  


Q ss_pred             ---------ccccccCCC-CCCCCC-----hHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          522 ---------RITQSMDPG-LTGRFP-----ENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       522 ---------~~~~~i~~~-~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                               .....+... ...+.+     +..+.++.+|+.+||+.||++|||+.|+++
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                     000000000 000111     123567889999999999999999999885

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=8.3e-46  Score=383.80  Aligned_cols=287  Identities=39%  Similarity=0.627  Sum_probs=243.9

Q ss_pred             ccccHHHHHHHhcCccccccccccCceEEEEEEeCCCCEEEEEEeecCCh-HHHHHHHHHHHHHhcCCCCceeeeeeeee
Q 042149          286 LNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR-QWVDQFFNEVNLISGIQHKNVVRLLGCSI  364 (625)
Q Consensus       286 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~  364 (625)
                      ..++++.++...++|++.++||+|+||.||+|++++++.||||++..... .....+.+|+.+++.++||||+++++++.
T Consensus        18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   97 (326)
T 3uim_A           18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM   97 (326)
T ss_dssp             EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred             ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence            45788899999999999999999999999999988899999999865432 22236889999999999999999999999


Q ss_pred             eCCeeEEEEEecCCCCcchhhhccC-CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEee
Q 042149          365 EGPESLLVYEYVPNRSLDQILFVKN-TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIAD  443 (625)
Q Consensus       365 ~~~~~~lV~e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~D  443 (625)
                      ..+..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+....+|+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D  177 (326)
T 3uim_A           98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD  177 (326)
T ss_dssp             CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred             cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence            9999999999999999999987643 234489999999999999999999987222499999999999999999999999


Q ss_pred             cccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCC----CCCccchhhHHHhhh
Q 042149          444 FGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFS----EGSSSVLHTVWKHYK  519 (625)
Q Consensus       444 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~----~~~~~~~~~~~~~~~  519 (625)
                      ||+++..............||+.|+|||++.+..++.++||||||+++|+|++|+.|+...    ........+......
T Consensus       178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  257 (326)
T 3uim_A          178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK  257 (326)
T ss_dssp             CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred             CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence            9999987655555555667999999999999999999999999999999999999998522    222233344444455


Q ss_pred             ccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       520 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      ...+....+..+....+...+..+.+++.+||+.+|++|||+.||+++|++..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            55666777777777888999999999999999999999999999999998753

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.2e-45  Score=382.01  Aligned_cols=281  Identities=36%  Similarity=0.581  Sum_probs=238.5

Q ss_pred             cHHHHHHHhcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCe
Q 042149          289 KYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPE  368 (625)
Q Consensus       289 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  368 (625)
                      .+..++..+++|++.+.||+|+||.||+|++++++.||||++........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  109 (321)
T 2qkw_B           30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE  109 (321)
T ss_dssp             CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred             cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence            33445567889999999999999999999988899999999987766677889999999999999999999999999999


Q ss_pred             eEEEEEecCCCCcchhhhccC-CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccc
Q 042149          369 SLLVYEYVPNRSLDQILFVKN-TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA  447 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla  447 (625)
                      .++||||+++++|.+++.... ....+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGIS  186 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccc
Confidence            999999999999999986543 2235899999999999999999999875   999999999999999999999999999


Q ss_pred             eeeCCCCc-eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCc--cchhhHHHhhhccccc
Q 042149          448 RHVAPDKT-HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSS--SVLHTVWKHYKANRIT  524 (625)
Q Consensus       448 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~  524 (625)
                      +....... .......||+.|+|||++.+..++.++||||||+++|||++|+.|+.......  ....+.........+.
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (321)
T 2qkw_B          187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE  266 (321)
T ss_dssp             EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred             cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence            87543222 22234568999999999999999999999999999999999999986543322  2333333444555666


Q ss_pred             cccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          525 QSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       525 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      +.+++......+...+..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus       267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l  314 (321)
T 2qkw_B          267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL  314 (321)
T ss_dssp             SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            777777777778899999999999999999999999999999998764

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.6e-45  Score=405.53  Aligned_cols=265  Identities=23%  Similarity=0.293  Sum_probs=209.7

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC------hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS------RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPES  369 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  369 (625)
                      .++|++.++||+|+||+||+|+++ +|+.||||++.+..      ........+++.+++.++|||||+++++|.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            467999999999999999999975 69999999996431      12222334457778888999999999999999999


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      ||||||++||+|.++|...+.   +++..+..++.||+.||+|||+++   ||||||||+||||+.+|.+||+|||+|+.
T Consensus       268 ylVmEy~~GGdL~~~l~~~~~---l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence            999999999999999976543   899999999999999999999775   99999999999999999999999999987


Q ss_pred             eCCCCceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          450 VAPDKTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       450 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      +.....   ...+||+.|||||++.. ..|+.++|||||||++|||++|+.||....... . ..........       
T Consensus       342 ~~~~~~---~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-~-~~i~~~i~~~-------  409 (689)
T 3v5w_A          342 FSKKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-K-HEIDRMTLTM-------  409 (689)
T ss_dssp             CSSCCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-H-HHHHHHHHHC-------
T ss_pred             cCCCCC---CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-H-HHHHHhhcCC-------
Confidence            754332   34689999999999975 579999999999999999999999985332211 1 1111111111       


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH--HHccccC------CCCCCCCCC
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPS-----MAEVVH--MLNNIDY------EIPPPKQPP  582 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~--~L~~~~~------~l~~~~~~~  582 (625)
                         ...+|...+.++.+||.+||+.||++|++     ++||++  .+.++.+      .++||-.|+
T Consensus       410 ---~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~  473 (689)
T 3v5w_A          410 ---AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPP  473 (689)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred             ---CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCC
Confidence               11235566778999999999999999998     688765  3344443      345555443

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.1e-45  Score=409.24  Aligned_cols=252  Identities=21%  Similarity=0.278  Sum_probs=210.5

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      .++|++.++||+|+||+||+|+++ +|+.||||++........+.+.+|+.+|+.++|||||++++++.+...++|||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            478999999999999999999975 6999999999887777778899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCC--CceEEeecccceeeCCC
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEK--LTPKIADFGLARHVAPD  453 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~--~~~kl~Dfgla~~~~~~  453 (625)
                      |+||+|.++|....  ..+++.++..++.||+.||.|||+++   |+||||||+|||++.+  +.+||+|||+++.+...
T Consensus       236 ~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            99999999885432  34899999999999999999999875   9999999999999854  89999999999987654


Q ss_pred             CceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                      ...  ...+||+.|||||++.+..|+.++|||||||++|||++|+.||...... .    .........      .....
T Consensus       311 ~~~--~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-~----~~~~i~~~~------~~~~~  377 (573)
T 3uto_A          311 QSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-E----TLRNVKSCD------WNMDD  377 (573)
T ss_dssp             SEE--EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-H----HHHHHHTTC------CCCCS
T ss_pred             Cce--eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-H----HHHHHHhCC------CCCCc
Confidence            432  3458999999999999999999999999999999999999997532211 1    111111111      01111


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ......+..+.+||.+||+.||++|||+.|+++
T Consensus       378 ~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            122345677899999999999999999999987

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.7e-44  Score=367.38  Aligned_cols=262  Identities=25%  Similarity=0.403  Sum_probs=215.1

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      .++|++.++||+|+||.||+|++. +++.||+|++........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            367899999999999999999975 6899999999777777888999999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+++....  ..+++.+++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        89 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           89 IKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            99999999996533  34899999999999999999999876   99999999999999999999999999987654332


Q ss_pred             ee-------------eecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccc
Q 042149          456 HV-------------STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR  522 (625)
Q Consensus       456 ~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  522 (625)
                      ..             .....||+.|+|||++.+..++.++||||||+++|||++|..|+.................    
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~----  239 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF----  239 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH----
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc----
Confidence            21             1145799999999999999999999999999999999999988754332211111001110    


Q ss_pred             cccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCC
Q 042149          523 ITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEI  575 (625)
Q Consensus       523 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l  575 (625)
                          .+..    .+...+..+.+++.+||+.||++|||+.++++.|+.+...+
T Consensus       240 ----~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          240 ----LDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             ----HHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----cccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence                0001    12344556889999999999999999999999998876543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.5e-43  Score=359.97  Aligned_cols=280  Identities=34%  Similarity=0.565  Sum_probs=230.2

Q ss_pred             ccccHHHHHHHhcCcccc------ccccccCceEEEEEEeCCCCEEEEEEeecC----ChHHHHHHHHHHHHHhcCCCCc
Q 042149          286 LNFKYEILERATDFFDNS------RKLGQGGAGSVFRGTLPDGRNIAVKRLFFN----SRQWVDQFFNEVNLISGIQHKN  355 (625)
Q Consensus       286 ~~~~~~~~~~~~~~y~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~hpn  355 (625)
                      ..|.+..++.++++|...      ++||+|+||.||+|+. +++.||||++...    .....+.+.+|+.++++++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            457888999999998877      9999999999999987 5789999998643    3445678999999999999999


Q ss_pred             eeeeeeeeeeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC
Q 042149          356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE  435 (625)
Q Consensus       356 iv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~  435 (625)
                      |+++++++.+.+..++||||+++++|.+++........+++..++.++.|++.||.|||+.+   |+||||||+||+++.
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~  168 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDE  168 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECT
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcC
Confidence            99999999999999999999999999999876555556999999999999999999999875   999999999999999


Q ss_pred             CCceEEeecccceeeCCCCce-eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhH
Q 042149          436 KLTPKIADFGLARHVAPDKTH-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV  514 (625)
Q Consensus       436 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~  514 (625)
                      ++.+||+|||+++........ ......||+.|+|||.+. +.++.++||||||+++|+|++|+.|+........... .
T Consensus       169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~  246 (307)
T 2nru_A          169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD-I  246 (307)
T ss_dssp             TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT-TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH-H
T ss_pred             CCcEEEeecccccccccccccccccccCCCcCcCChHHhc-CCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH-H
Confidence            999999999999876543322 233457999999999875 4689999999999999999999998765443322222 1


Q ss_pred             HHhhh--ccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          515 WKHYK--ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       515 ~~~~~--~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      .....  ...+...++..+ ...+...+..+.+++.+||+.+|++|||+.+|++.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          247 KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            11111  122333344433 3456788899999999999999999999999999998764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.7e-44  Score=371.26  Aligned_cols=267  Identities=30%  Similarity=0.422  Sum_probs=207.3

Q ss_pred             HhcCccccccccccCceEEEEEEeCCCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ..++|++.++||+|+||+||+|++ +++.||||++...  .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            356899999999999999999987 5789999998654  3555678999999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++++|.+++........+++..++.++.|++.||+|||+.+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  192 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST  192 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence            99999999999976554445899999999999999999999662 23999999999999999999999999999765433


Q ss_pred             CceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                      .. ......||+.|+|||++.+..++.++||||||+++|||++|+.|+...... ..    .....        ......
T Consensus       193 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-~~----~~~~~--------~~~~~~  258 (309)
T 3p86_A          193 FL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA-QV----VAAVG--------FKCKRL  258 (309)
T ss_dssp             ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-HH----HHHHH--------HSCCCC
T ss_pred             cc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HH----HHHHH--------hcCCCC
Confidence            22 223457999999999999999999999999999999999999987532211 00    01000        001112


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCCCC
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPP  578 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~~~  578 (625)
                      ..+...+..+.+++.+||+.+|++|||+.++++.|+.+.....+|
T Consensus       259 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~  303 (309)
T 3p86_A          259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP  303 (309)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred             CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence            334566778999999999999999999999999998886654443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.3e-43  Score=362.54  Aligned_cols=250  Identities=24%  Similarity=0.399  Sum_probs=209.7

Q ss_pred             hcCccccccccccCceEEEEEEe-CCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      .++|++.++||+|+||+||+|++ .+++.||||++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46899999999999999999996 47899999999776555567889999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+++...    .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++........
T Consensus        99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            9999999998643    3899999999999999999999875   99999999999999999999999999987654433


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                      . .....||+.|+|||++.+..++.++||||||+++|||++|+.|+......    ...........        .....
T Consensus       172 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~~~~~~~--------~~~~~  238 (297)
T 3fxz_A          172 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----RALYLIATNGT--------PELQN  238 (297)
T ss_dssp             C-BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHHHCS--------CCCSC
T ss_pred             c-cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhCCC--------CCCCC
Confidence            2 23467999999999999999999999999999999999999997532211    11111111110        11122


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      +...+..+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            4556778999999999999999999999985

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=5.7e-44  Score=369.99  Aligned_cols=259  Identities=26%  Similarity=0.419  Sum_probs=210.6

Q ss_pred             hcCccccccccccCceEEEEEEeC----CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP----DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      .++|++.++||+|+||.||+|++.    .+..||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            467899999999999999999974    3446999999765 45556789999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||||+++++|.+++....  ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       128 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            999999999999985442  34899999999999999999999875   9999999999999999999999999998765


Q ss_pred             CCCcee--eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          452 PDKTHV--STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       452 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      ......  .....+|+.|+|||++.+..++.++||||||+++|||++ |+.|+...... .    ....         +.
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~----~~~~---------~~  268 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-D----VISS---------VE  268 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-H----HHHH---------HH
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-H----HHHH---------HH
Confidence            433222  223456889999999999999999999999999999999 88886432111 1    1111         11


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCC
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYE  574 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  574 (625)
                      .....+.+...+..+.+++.+||+.+|++|||+.+|++.|+.+...
T Consensus       269 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          269 EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence            1122233556677899999999999999999999999999887543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=7e-44  Score=375.93  Aligned_cols=259  Identities=26%  Similarity=0.366  Sum_probs=212.8

Q ss_pred             hcCccccccccccCceEEEEEEeC--------CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeC
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP--------DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEG  366 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  366 (625)
                      .++|++.+.||+|+||.||+|++.        ++..||||++... .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467899999999999999999852        3457999999765 345567899999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCCcchhhhccCC-------------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE
Q 042149          367 PESLLVYEYVPNRSLDQILFVKNT-------------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL  433 (625)
Q Consensus       367 ~~~~lV~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll  433 (625)
                      +..++||||+++++|.+++.....             ...+++.+++.++.||+.||.|||+++   |+||||||+||||
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            999999999999999999976432             234899999999999999999999875   9999999999999


Q ss_pred             cCCCceEEeecccceeeCCCCce-eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccch
Q 042149          434 DEKLTPKIADFGLARHVAPDKTH-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVL  511 (625)
Q Consensus       434 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~  511 (625)
                      +.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||+| |+.|+.... ...+ 
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~-~~~~-  314 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEEL-  314 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-GGGH-
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC-HHHH-
Confidence            99999999999999876543322 1223467889999999999999999999999999999999 888764321 1111 


Q ss_pred             hhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          512 HTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       512 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                         ....         ........+..++..+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus       315 ---~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          315 ---FKLL---------KEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             ---HHHH---------HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHHH---------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence               1111         111222335566778999999999999999999999999998764

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.2e-43  Score=356.78  Aligned_cols=257  Identities=27%  Similarity=0.357  Sum_probs=214.3

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      .++|++.+.||+|+||.||+|+++++..||||++..... ..+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            568999999999999999999998888999999975533 2367899999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      ++++|.+++....  ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.........
T Consensus        86 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           86 SNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             TTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             CCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            9999999986543  24899999999999999999999875   999999999999999999999999999877665544


Q ss_pred             eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                      ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.|+.......     .......         ......
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----~~~~~~~---------~~~~~~  226 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE-----VVLKVSQ---------GHRLYR  226 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----HHHHHHT---------TCCCCC
T ss_pred             cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH-----HHHHHHc---------CCCCCC
Confidence            4445567889999999999999999999999999999999 888864322110     1111111         111122


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccC
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY  573 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  573 (625)
                      +...+..+.+++.+||+.+|++|||+.|+++.|+.+..
T Consensus       227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          227 PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence            33446678999999999999999999999999998764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.2e-43  Score=359.12  Aligned_cols=262  Identities=25%  Similarity=0.370  Sum_probs=208.6

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .++|++.++||+|+||.||+|++. +++.||||++...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            467999999999999999999965 6899999998543   345567899999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+++++|.+++....   .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            99999999999987554   3899999999999999999999876   99999999999999999999999999987654


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      ..........||+.|+|||++.+..++.++||||||+++|||++|+.|+......    ...........      +...
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~----~~~~~~~~~~~------~~~~  233 (294)
T 4eqm_A          164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV----SIAIKHIQDSV------PNVT  233 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH----HHHHHHHSSCC------CCHH
T ss_pred             ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHhhccC------CCcc
Confidence            4433344567999999999999999999999999999999999999997533211    11111111100      0000


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHccccCC
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRP-SMAEVVHMLNNIDYE  574 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~ev~~~L~~~~~~  574 (625)
                      ...+...+..+.+++.+||+.||++|| +++++.+.|..+..+
T Consensus       234 ~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          234 TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence            112334567799999999999999999 899999999876543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.2e-44  Score=358.82  Aligned_cols=256  Identities=25%  Similarity=0.397  Sum_probs=211.5

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      .++|++.+.||+|+||.||+|++.+++.||||++...... .+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            4679999999999999999999988899999999755322 357899999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      ++++|.+++....  ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++........
T Consensus        88 ~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  162 (269)
T 4hcu_A           88 EHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  162 (269)
T ss_dssp             TTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             CCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence            9999999985433  34899999999999999999999876   999999999999999999999999999866543333


Q ss_pred             eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                      ......+++.|+|||++.+..++.++||||||+++|+|++ |+.|+..... .    ........         ......
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-~----~~~~~~~~---------~~~~~~  228 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-S----EVVEDIST---------GFRLYK  228 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-H----HHHHHHHT---------TCCCCC
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-H----HHHHHHhc---------CccCCC
Confidence            3334567889999999999999999999999999999999 8877643211 1    11111111         112222


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      +...+..+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus       229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~  265 (269)
T 4hcu_A          229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  265 (269)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence            4445677999999999999999999999999998764

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=9.9e-44  Score=375.92  Aligned_cols=257  Identities=26%  Similarity=0.355  Sum_probs=210.9

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      .++|.+.++||+|+||.||+|+++ +++.||||++... .....+.+.+|+.+|++++||||+++++++.+.+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            467899999999999999999986 7899999998754 34455678999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+++++|.+++....  ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus       193 ~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             CCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            999999999986543  34899999999999999999999875   9999999999999999999999999998654322


Q ss_pred             ceeee-cCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          455 THVST-GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       455 ~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      ..... ...+++.|+|||++..+.++.++||||||+++|||+| |+.|+......     ...         +.+.....
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-----~~~---------~~~~~~~~  333 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-----QTR---------EFVEKGGR  333 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-----HHH---------HHHHTTCC
T ss_pred             eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHH---------HHHHcCCC
Confidence            11111 1235778999999999999999999999999999999 88776432110     111         11111222


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      .+.+..++..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus       334 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          334 LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            3335556778999999999999999999999999998764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=6e-44  Score=376.79  Aligned_cols=257  Identities=26%  Similarity=0.420  Sum_probs=199.6

Q ss_pred             hcCccccccccccCceEEEEEEeC----CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP----DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      .++|++.+.||+|+||.||+|+++    ++..||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            457999999999999999999864    5778999999765 44556789999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||||+++++|.+++....  ..+++.+++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       124 v~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            999999999999996432  34899999999999999999999875   9999999999999999999999999998765


Q ss_pred             CCCceee--ecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          452 PDKTHVS--TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       452 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      .......  ....+++.|+|||++.+..++.++||||||+++|||++ |+.|+..... ..    ....         +.
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-~~----~~~~---------i~  264 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QD----VIKA---------VD  264 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-HH----HHHH---------HH
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-HH----HHHH---------HH
Confidence            4332211  12345778999999999999999999999999999998 8888643211 11    1111         11


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      .....+.+...+..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus       265 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~  308 (373)
T 2qol_A          265 EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI  308 (373)
T ss_dssp             TTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence            11122234456778999999999999999999999999998774

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.1e-42  Score=357.66  Aligned_cols=261  Identities=26%  Similarity=0.368  Sum_probs=215.2

Q ss_pred             cccHHHHHHHhcC----------ccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCc
Q 042149          287 NFKYEILERATDF----------FDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKN  355 (625)
Q Consensus       287 ~~~~~~~~~~~~~----------y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn  355 (625)
                      .++++.++.+++.          |+..++||+|+||.||+|+++ +|+.||||++........+.+.+|+.++++++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            4677777777754          778889999999999999976 79999999998776666778999999999999999


Q ss_pred             eeeeeeeeeeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC
Q 042149          356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE  435 (625)
Q Consensus       356 iv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~  435 (625)
                      |+++++++...+..++||||+++++|.+++...    .+++..+..++.|++.||.|||+.+   |+||||||+|||++.
T Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~  176 (321)
T 2c30_A          104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL  176 (321)
T ss_dssp             BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred             cceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence            999999999999999999999999999988532    3899999999999999999999875   999999999999999


Q ss_pred             CCceEEeecccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHH
Q 042149          436 KLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVW  515 (625)
Q Consensus       436 ~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~  515 (625)
                      ++.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|||++|+.|+......     ...
T Consensus       177 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~-----~~~  250 (321)
T 2c30_A          177 DGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV-----QAM  250 (321)
T ss_dssp             TCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHH
T ss_pred             CCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHH
Confidence            999999999999876543322 23467999999999999999999999999999999999999987532111     111


Q ss_pred             HhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          516 KHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       516 ~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      ......     ..+..  ..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus       251 ~~~~~~-----~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          251 KRLRDS-----PPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HHHHHS-----SCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHhcC-----CCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111111     11111  1133456778999999999999999999999863

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.4e-43  Score=363.47  Aligned_cols=248  Identities=19%  Similarity=0.280  Sum_probs=208.1

Q ss_pred             hcCccccccccccCceEEEEEEe-CCCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      .++|++.+.||+|+||.||+|++ .+|+.||||++...  .....+.+.+|+.+|+.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            56899999999999999999997 47999999999654  4556778999999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++++|.+++.....   +++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            99999999999866543   899999999999999999999875   999999999999999999999999999866543


Q ss_pred             CceeeecCCCCccccCccccccCccc-ccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLT-EKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      ..  .....||+.|+|||++.+..+. .++||||||+++|+|++|+.|+.....     ...........          
T Consensus       168 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~----------  230 (328)
T 3fe3_A          168 GK--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-----KELRERVLRGK----------  230 (328)
T ss_dssp             CG--GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCC----------
T ss_pred             Cc--cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCC----------
Confidence            32  2346899999999999888765 799999999999999999999753211     11111111111          


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      ...|...+..+.+++.+||+.||++|||++|+++.
T Consensus       231 ~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          231 YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11244456778999999999999999999999863

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=7.1e-44  Score=363.89  Aligned_cols=272  Identities=23%  Similarity=0.353  Sum_probs=212.3

Q ss_pred             hcCccccccccccCceEEEEEEe-----CCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeee--CCee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL-----PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE--GPES  369 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~  369 (625)
                      .++|++.++||+|+||.||+|++     .+++.||||++........+.+.+|+.++++++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            46799999999999999999983     3688999999988777778899999999999999999999998864  3568


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      ++||||+++++|.+++....  ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            99999999999999986543  24899999999999999999999875   99999999999999999999999999987


Q ss_pred             eCCCCce--eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhH----HHhhhcccc
Q 042149          450 VAPDKTH--VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV----WKHYKANRI  523 (625)
Q Consensus       450 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~----~~~~~~~~~  523 (625)
                      .......  ......+++.|+|||++.+..++.++||||||+++|||+||..|+......  .....    ........+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  241 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--FMRMIGNDKQGQMIVFHL  241 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--HHHHHCTTCCTHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH--HHhhhcCccccchhHHHH
Confidence            6543322  122345788899999999999999999999999999999999886432100  00000    000000011


Q ss_pred             ccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCC
Q 042149          524 TQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEI  575 (625)
Q Consensus       524 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l  575 (625)
                      .+.+......+.+..++..+.+++.+||+.+|++|||+.|+++.|+.+...+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            1222223333445667788999999999999999999999999998876544

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.1e-43  Score=384.81  Aligned_cols=263  Identities=27%  Similarity=0.396  Sum_probs=215.1

Q ss_pred             HHHHhcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          293 LERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       293 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      ++...++|++.++||+|+||.||+|.++++..||||++.... ...+.+.+|+.+|++++||||+++++++. .+..++|
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv  260 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII  260 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence            344467899999999999999999999888999999997654 34678999999999999999999999886 6678999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+++|+|.+++..... ..+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus       261 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             ECCCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             EeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            999999999999964422 24789999999999999999999875   99999999999999999999999999987643


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      ..........+++.|+|||++..+.++.++||||||+++|||+| |+.|+..... .+.    .....         ...
T Consensus       337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-~~~----~~~i~---------~~~  402 (454)
T 1qcf_A          337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-PEV----IRALE---------RGY  402 (454)
T ss_dssp             HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHH----HHHHH---------HTC
T ss_pred             CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-HHH----HHHHH---------cCC
Confidence            32222233457889999999999999999999999999999999 8888643211 111    11111         111


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCC
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEI  575 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l  575 (625)
                      ..+.+..++..+.+|+.+||+.||++|||+++|++.|+.+....
T Consensus       403 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence            22335566788999999999999999999999999999886543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.8e-43  Score=382.76  Aligned_cols=265  Identities=26%  Similarity=0.378  Sum_probs=210.6

Q ss_pred             HhcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ..++|++.++||+|+||.||+|.++++..||||++..... ..+.|.+|+.+|++++||||+++++++.+ +..++||||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            4567899999999999999999998888899999976542 34678999999999999999999999876 678999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+++.... ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus       260 ~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          260 MSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             CTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             hcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            99999999996432 234899999999999999999999875   99999999999999999999999999987654333


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                      .......+++.|+|||++..+.++.++||||||+++|||++ |+.|+..... .+    ....         +......+
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-~~----~~~~---------i~~~~~~~  401 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-RE----VLDQ---------VERGYRMP  401 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HH----HHHH---------HHTTCCCC
T ss_pred             ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-HH----HHHH---------HHcCCCCC
Confidence            33334567889999999999999999999999999999999 8877643211 11    1111         11122233


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCCCCCC
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQ  580 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~~~~~  580 (625)
                      .+..++..+.+++.+||+.+|++|||+++|++.|+.+.....+..+
T Consensus       402 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~  447 (452)
T 1fmk_A          402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ  447 (452)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCC
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcccc
Confidence            4556778899999999999999999999999999998766555443

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=7e-43  Score=358.86  Aligned_cols=266  Identities=25%  Similarity=0.395  Sum_probs=208.5

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      .++|++.+.||+|+||.||+|++. ++.||||++...  ...+.+.+|+.++++++||||+++++++.  +..++||||+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~   81 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA   81 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence            357899999999999999999974 688999998643  34578899999999999999999999886  3589999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCc-eEEeecccceeeCCCCc
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLT-PKIADFGLARHVAPDKT  455 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~-~kl~Dfgla~~~~~~~~  455 (625)
                      ++++|.+++........+++..++.++.|+++||.|||+.+..+|+||||||+|||++.++. +||+|||++....... 
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-  160 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-  160 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-
Confidence            99999999976665556889999999999999999999842246999999999999998876 7999999997654322 


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                         ....||+.|+|||++.+..++.++||||||+++|||++|+.|+.......  ....+....          ......
T Consensus       161 ---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~----------~~~~~~  225 (307)
T 2eva_A          161 ---TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA--FRIMWAVHN----------GTRPPL  225 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH--HHHHHHHHT----------TCCCCC
T ss_pred             ---ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH--HHHHHHHhc----------CCCCCc
Confidence               23468999999999999999999999999999999999999975332211  111111111          111222


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCCCCCCCCC
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPF  583 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~~~~~~~~  583 (625)
                      +...+..+.+++.+||+.+|++|||+.++++.|+.+...++.+..|..
T Consensus       226 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~  273 (307)
T 2eva_A          226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ  273 (307)
T ss_dssp             BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCC
T ss_pred             ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCccc
Confidence            344567789999999999999999999999999998777765554443

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.1e-42  Score=360.03  Aligned_cols=269  Identities=25%  Similarity=0.299  Sum_probs=207.5

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC----eeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP----ESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~lV  372 (625)
                      .++|++.++||+|+||.||+|++. ++.||||++..... ....+.+|+.++++++||||+++++++....    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            467999999999999999999875 78999999965543 3445677999999999999999999998754    46999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcC-------CCceEEEeeeccCcEEEcCCCceEEeecc
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG-------SGIKIIHRDIKTSNILLDEKLTPKIADFG  445 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------~~~~iiHrDlkp~NIll~~~~~~kl~Dfg  445 (625)
                      |||+++++|.+++...    .+++..++.++.|++.||.|||+.       ...+|+||||||+|||++.++.+||+|||
T Consensus       101 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg  176 (322)
T 3soc_A          101 TAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG  176 (322)
T ss_dssp             EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence            9999999999999643    389999999999999999999965       01159999999999999999999999999


Q ss_pred             cceeeCCCCcee-eecCCCCccccCcccccc-----CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhh-
Q 042149          446 LARHVAPDKTHV-STGIAGTLGYMAPEYLVR-----GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHY-  518 (625)
Q Consensus       446 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~-  518 (625)
                      +++......... .....||+.|+|||++.+     ..++.++||||||+++|||+||+.|+.......... ...... 
T Consensus       177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-~~~~~~~  255 (322)
T 3soc_A          177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP-FEEEIGQ  255 (322)
T ss_dssp             TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT-THHHHCS
T ss_pred             cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc-hhhhhcc
Confidence            998776543322 234579999999999976     366789999999999999999999976443221111 000000 


Q ss_pred             --hcccccc-ccCCCCCCCC-----ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          519 --KANRITQ-SMDPGLTGRF-----PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       519 --~~~~~~~-~i~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                        ....+.. ..........     ....+..+.+++.+||+.||++|||+.||++.|+++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~  317 (322)
T 3soc_A          256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ  317 (322)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence              0000001 0111111111     2355777999999999999999999999999998764

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.4e-43  Score=383.84  Aligned_cols=258  Identities=27%  Similarity=0.374  Sum_probs=215.7

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      ..++|++.++||+|+||.||+|+++ ++..||||++..... ..+.|.+|+.+|++++||||+++++++.+....+||||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            3567899999999999999999976 488999999875533 35789999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+++++|.+++..... ..+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++......
T Consensus       297 ~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          297 FMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             CCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             ccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            9999999999975433 34899999999999999999999875   9999999999999999999999999998765443


Q ss_pred             ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          455 THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                      ........+++.|+|||++....++.++||||||+++|||+| |+.|+..... ..+    .         +.+......
T Consensus       373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~-~~~----~---------~~~~~~~~~  438 (495)
T 1opk_A          373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQV----Y---------ELLEKDYRM  438 (495)
T ss_dssp             EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-GGH----H---------HHHHTTCCC
T ss_pred             eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH-HHH----H---------HHHHcCCCC
Confidence            333334557889999999999999999999999999999999 8777643221 111    1         112222233


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      ..+..++..+.+|+.+||+.+|++|||+.+|++.|+.+.
T Consensus       439 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            345566788999999999999999999999999998874

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.3e-43  Score=357.82  Aligned_cols=257  Identities=25%  Similarity=0.370  Sum_probs=209.0

Q ss_pred             HhcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ..++|++.++||+|+||.||+|.+.+++.||||++...... .+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            35689999999999999999999988889999999755322 36789999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+++....  ..+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++.......
T Consensus       101 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  175 (283)
T 3gen_A          101 MANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  175 (283)
T ss_dssp             CTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred             cCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence            99999999986532  34899999999999999999999875   99999999999999999999999999986654333


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                      .......+|+.|+|||++.+..++.++||||||+++|+|+| |+.|+...... .    ....         +.......
T Consensus       176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-~----~~~~---------~~~~~~~~  241 (283)
T 3gen_A          176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-E----TAEH---------IAQGLRLY  241 (283)
T ss_dssp             HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-H----HHHH---------HHTTCCCC
T ss_pred             ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-H----HHHH---------HhcccCCC
Confidence            22334567889999999999999999999999999999998 88886432211 0    1111         11111222


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      .+...+..+.+++.+||+.+|++|||+.++++.|.++.
T Consensus       242 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          242 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence            24445677999999999999999999999999997753

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.2e-42  Score=359.74  Aligned_cols=254  Identities=24%  Similarity=0.301  Sum_probs=204.7

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ..++|++.++||+|+||.||+|++. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            3578999999999999999999976 78999999986543 233467889999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++++|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        85 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           85 EYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             ECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            9999999999885443   3899999999999999999999875   999999999999999999999999999865433


Q ss_pred             Cc-eeeecCCCCccccCccccccCcc-cccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          454 KT-HVSTGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       454 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      .. .......||+.|+|||++.+..+ +.++||||||+++|+|++|+.|+.........    ...+....        .
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~~~~~~~--------~  226 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE----YSDWKEKK--------T  226 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH----HHHHHTTC--------T
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH----HHHHhccc--------c
Confidence            22 22235679999999999988765 78999999999999999999997644322111    11111111        1


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      ........+..+.+++.+||+.||++|||+.|+++.
T Consensus       227 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            111123456778899999999999999999999864

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=8.6e-43  Score=358.83  Aligned_cols=259  Identities=26%  Similarity=0.362  Sum_probs=213.5

Q ss_pred             hcCccccccccccCceEEEEEEe------CCCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL------PDGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPES  369 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  369 (625)
                      .++|.+.+.||+|+||.||+|++      .+++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            56799999999999999999985      24578999999754 455667899999999999999999999999999999


Q ss_pred             EEEEEecCCCCcchhhhccCC---------------------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeecc
Q 042149          370 LLVYEYVPNRSLDQILFVKNT---------------------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKT  428 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp  428 (625)
                      ++||||+++++|.+++.....                     ...+++..++.++.||++||.|||+++   |+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence            999999999999999976432                     134889999999999999999999875   99999999


Q ss_pred             CcEEEcCCCceEEeecccceeeCCCCcee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCC
Q 042149          429 SNILLDEKLTPKIADFGLARHVAPDKTHV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEG  506 (625)
Q Consensus       429 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~  506 (625)
                      +|||++.++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |+.|+.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999998775544332 223467889999999999999999999999999999999 8888643221


Q ss_pred             CccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          507 SSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                       ..    ......         .......+...+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       259 -~~----~~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          259 -ER----LFNLLK---------TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             -GG----HHHHHH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HH----HHHHhh---------cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             11    111111         11122334556778999999999999999999999999998764

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.5e-42  Score=353.17  Aligned_cols=261  Identities=25%  Similarity=0.367  Sum_probs=202.8

Q ss_pred             HhcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhc--CCCCceeeeeeeeee----CCee
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISG--IQHKNVVRLLGCSIE----GPES  369 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~~----~~~~  369 (625)
                      ..++|++.++||+|+||.||+|++ +++.||||++....   ...+.+|.+++..  ++||||+++++++..    ....
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            457899999999999999999988 68999999986543   3455566666655  799999999998654    3468


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhh--------cCCCceEEEeeeccCcEEEcCCCceEE
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH--------GGSGIKIIHRDIKTSNILLDEKLTPKI  441 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~iiHrDlkp~NIll~~~~~~kl  441 (625)
                      ++||||+++++|.+++..    ..+++..++.++.|++.||.|||        +.   +|+||||||+|||++.++.+||
T Consensus        82 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             EEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEE
T ss_pred             EEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEE
Confidence            999999999999999943    24899999999999999999999        55   5999999999999999999999


Q ss_pred             eecccceeeCCCCcee---eecCCCCccccCccccccC------cccccCcEEeehhhhHHHHhC----------CCCCC
Q 042149          442 ADFGLARHVAPDKTHV---STGIAGTLGYMAPEYLVRG------QLTEKADVYAFGVLVIEVASG----------RRNSV  502 (625)
Q Consensus       442 ~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~ll~elltG----------~~p~~  502 (625)
                      +|||+++.........   .....||+.|+|||++.+.      .++.++||||||+++|||+||          +.|+.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            9999998765544332   1234799999999999876      667899999999999999999          66654


Q ss_pred             CCCCCccchhhHHHhhhccccccccCCCCC-CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          503 FSEGSSSVLHTVWKHYKANRITQSMDPGLT-GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      ....................    ..+... ...+...+..+.+++.+||+.||++|||+.||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          235 DVVPNDPSFEDMRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             TTSCSSCCHHHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCCCcchhhhhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            33222222222221111111    011111 011345788899999999999999999999999999865

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=4e-43  Score=363.94  Aligned_cols=275  Identities=23%  Similarity=0.294  Sum_probs=216.7

Q ss_pred             hcCccccccccccCceEEEEEEe-----CCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeee--eCCee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL-----PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI--EGPES  369 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~~~  369 (625)
                      .++|++.++||+|+||.||+|++     .+++.||||++........+.+.+|+.++++++||||+++++++.  +....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            36799999999999999999983     368899999998877777788999999999999999999999886  45678


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      ++||||+++++|.+++.....  .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence            999999999999999865332  3899999999999999999999875   99999999999999999999999999987


Q ss_pred             eCCCCcee--eecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccc-hhhHHHhhhccccccc
Q 042149          450 VAPDKTHV--STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSV-LHTVWKHYKANRITQS  526 (625)
Q Consensus       450 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~  526 (625)
                      ........  .....+|+.|+|||++.+..++.++||||||+++|+|++|+.|+......... ............+.+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            75444322  22456888999999999999999999999999999999999886432110000 0000000000112222


Q ss_pred             cCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCC
Q 042149          527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIP  576 (625)
Q Consensus       527 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~  576 (625)
                      +........+...+..+.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus       257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  306 (327)
T 3lxl_A          257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR  306 (327)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred             hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            33333444466677889999999999999999999999999988765443

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.7e-42  Score=359.27  Aligned_cols=252  Identities=21%  Similarity=0.320  Sum_probs=203.4

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC------
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP------  367 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------  367 (625)
                      ..++|++.+.||+|+||.||+|+++ +++.||||++.... ....+.+.+|+.+|++++||||+++++++.+.+      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            4568999999999999999999976 79999999997543 345678999999999999999999999886543      


Q ss_pred             ---------------------------------------------------eeEEEEEecCCCCcchhhhccCCcCCCCH
Q 042149          368 ---------------------------------------------------ESLLVYEYVPNRSLDQILFVKNTIHILSW  396 (625)
Q Consensus       368 ---------------------------------------------------~~~lV~e~~~~~sL~~~l~~~~~~~~l~~  396 (625)
                                                                         ..++||||+++++|.+++..........+
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               37999999999999999987776666788


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce-----------eeecCCCCc
Q 042149          397 QQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH-----------VSTGIAGTL  465 (625)
Q Consensus       397 ~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-----------~~~~~~gt~  465 (625)
                      ..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++........           ......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            889999999999999999875   999999999999999999999999999877654321           123457999


Q ss_pred             cccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHH
Q 042149          466 GYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQ  545 (625)
Q Consensus       466 ~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  545 (625)
                      .|+|||++.+..++.++||||||+++|||++|..|...       ...........         .........+..+.+
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~~~~~~  304 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-------RVRIITDVRNL---------KFPLLFTQKYPQEHM  304 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-------HHHHHHHHHTT---------CCCHHHHHHCHHHHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-------HHHHHHHhhcc---------CCCcccccCChhHHH
Confidence            99999999999999999999999999999998765210       00011111111         111112345567899


Q ss_pred             HHhhccCCCCCCCCCHHHHHH
Q 042149          546 IGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       546 li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ++.+||+.||++|||+.|+++
T Consensus       305 li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          305 MVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCCCCcCCCHHHHhh
Confidence            999999999999999999986

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.4e-42  Score=353.10  Aligned_cols=270  Identities=23%  Similarity=0.314  Sum_probs=215.8

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC--eeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP--ESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~lV  372 (625)
                      .++|++.++||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            467999999999999999999976 58999999986543 334577889999999999999999999988765  77999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE----cCCCceEEeecccce
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL----DEKLTPKIADFGLAR  448 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll----~~~~~~kl~Dfgla~  448 (625)
                      |||+++++|.+++........+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999976655555899999999999999999999886   9999999999999    778889999999998


Q ss_pred             eeCCCCceeeecCCCCccccCccccc--------cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhc
Q 042149          449 HVAPDKTHVSTGIAGTLGYMAPEYLV--------RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKA  520 (625)
Q Consensus       449 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~  520 (625)
                      ........  ....||+.|+|||++.        +..++.++||||||+++|||++|+.|+...................
T Consensus       165 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          165 ELEDDEQF--VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             ECCTTCCB--CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ecCCCCce--eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            77554332  3357999999999986        4688999999999999999999999986443332222222221111


Q ss_pred             c---cccccc-----------CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          521 N---RITQSM-----------DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       521 ~---~~~~~i-----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      .   .+....           +.......+...+..+.+++.+||+.||++|||++|+++...+.
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            1   000000           11112244678888999999999999999999999999987654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.7e-42  Score=371.81  Aligned_cols=271  Identities=19%  Similarity=0.204  Sum_probs=215.5

Q ss_pred             cHHHHHHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeee
Q 042149          289 KYEILERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSI  364 (625)
Q Consensus       289 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  364 (625)
                      ++..++...++|++.++||+|+||+||+|+++ +++.||||++....   ......+.+|+.++..++||||+++++++.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            45555666789999999999999999999976 57889999996532   122334889999999999999999999999


Q ss_pred             eCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeec
Q 042149          365 EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADF  444 (625)
Q Consensus       365 ~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Df  444 (625)
                      +.+..++||||++||+|.+++....  ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+||
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence            9999999999999999999996532  34899999999999999999999875   999999999999999999999999


Q ss_pred             ccceeeCCCCceeeecCCCCccccCccccc-----cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhh
Q 042149          445 GLARHVAPDKTHVSTGIAGTLGYMAPEYLV-----RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK  519 (625)
Q Consensus       445 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~  519 (625)
                      |+++.............+||+.|+|||++.     .+.++.++|||||||++|||++|+.|+...... +......   .
T Consensus       220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-~~~~~i~---~  295 (437)
T 4aw2_A          220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKIM---N  295 (437)
T ss_dssp             TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHH---T
T ss_pred             hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-HHHHhhh---h
Confidence            999887665555555678999999999997     567999999999999999999999997532211 1111111   0


Q ss_pred             ccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCC--CCCHHHHHH--HHccccCC
Q 042149          520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVAL--RPSMAEVVH--MLNNIDYE  574 (625)
Q Consensus       520 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~--~L~~~~~~  574 (625)
                      ...  ...    .+......+..+.+++.+||..+|++  ||+++|+++  .+.++.++
T Consensus       296 ~~~--~~~----~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~  348 (437)
T 4aw2_A          296 HKE--RFQ----FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWD  348 (437)
T ss_dssp             HHH--HCC----CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTT
T ss_pred             ccc--ccc----CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHH
Confidence            000  000    01111235677899999999998888  999999986  34555543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.3e-43  Score=370.45  Aligned_cols=263  Identities=27%  Similarity=0.350  Sum_probs=215.0

Q ss_pred             hcCccccccccccCceEEEEEEeC--------CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeC
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP--------DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEG  366 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  366 (625)
                      .++|.+.++||+|+||.||+|++.        .+..||||++... .......+.+|+++++++ +||||+++++++.+.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            578999999999999999999852        2357999999765 445567899999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCCcchhhhccCC-------------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE
Q 042149          367 PESLLVYEYVPNRSLDQILFVKNT-------------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL  433 (625)
Q Consensus       367 ~~~~lV~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll  433 (625)
                      +..++||||+++++|.+++.....             ...+++..++.++.||+.||.|||+.+   |+||||||+||||
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence            999999999999999999976532             234899999999999999999999875   9999999999999


Q ss_pred             cCCCceEEeecccceeeCCCCc-eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccch
Q 042149          434 DEKLTPKIADFGLARHVAPDKT-HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVL  511 (625)
Q Consensus       434 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~  511 (625)
                      +.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+.....     
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~-----  299 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-----  299 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----
Confidence            9999999999999987654332 22234567899999999999999999999999999999999 8887643211     


Q ss_pred             hhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCC
Q 042149          512 HTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIP  576 (625)
Q Consensus       512 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~  576 (625)
                      ........         .......+...+..+.+++.+||+.+|++|||+.||++.|+.+.....
T Consensus       300 ~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          300 EELFKLLK---------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             HHHHHHHH---------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             HHHHHHHH---------cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            11111111         111222344566789999999999999999999999999988865443

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.7e-42  Score=360.17  Aligned_cols=249  Identities=23%  Similarity=0.260  Sum_probs=207.1

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .++|++.+.||+|+||.||+|+.+ +++.||||++...   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            468999999999999999999975 6899999999654   233456788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||++|++|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            99999999999886543   3899999999999999999999875   99999999999999999999999999986433


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      ... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+.....     ...........          
T Consensus       158 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i~~~~----------  221 (337)
T 1o6l_A          158 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFELILMEE----------  221 (337)
T ss_dssp             TTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCC----------
T ss_pred             CCC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-----HHHHHHHHcCC----------
Confidence            222 22346799999999999999999999999999999999999999743211     11111111111          


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRP-----SMAEVVHM  567 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~  567 (625)
                      ..+|...+..+.+++.+||+.||++||     +++||++.
T Consensus       222 ~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            123445677889999999999999999     89999863

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.2e-43  Score=367.72  Aligned_cols=268  Identities=28%  Similarity=0.367  Sum_probs=215.5

Q ss_pred             cHHHHHHHhcCccccccccccCceEEEEEEe------CCCCEEEEEEeecC-ChHHHHHHHHHHHHHhcC-CCCceeeee
Q 042149          289 KYEILERATDFFDNSRKLGQGGAGSVFRGTL------PDGRNIAVKRLFFN-SRQWVDQFFNEVNLISGI-QHKNVVRLL  360 (625)
Q Consensus       289 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~  360 (625)
                      ....++...++|++.++||+|+||.||+|++      .+++.||||++... .....+.+.+|+++++++ +||||++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            4445556678999999999999999999973      24678999999764 345567899999999999 799999999


Q ss_pred             eeeeeCCe-eEEEEEecCCCCcchhhhccCC-------------------------------------------------
Q 042149          361 GCSIEGPE-SLLVYEYVPNRSLDQILFVKNT-------------------------------------------------  390 (625)
Q Consensus       361 ~~~~~~~~-~~lV~e~~~~~sL~~~l~~~~~-------------------------------------------------  390 (625)
                      +++.+.+. .++||||+++++|.+++.....                                                 
T Consensus        93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (359)
T 3vhe_A           93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS  172 (359)
T ss_dssp             EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred             eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence            99887554 8999999999999999875432                                                 


Q ss_pred             --------------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc-
Q 042149          391 --------------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT-  455 (625)
Q Consensus       391 --------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~-  455 (625)
                                    ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....... 
T Consensus       173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  249 (359)
T 3vhe_A          173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY  249 (359)
T ss_dssp             -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred             cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence                          122889999999999999999999886   99999999999999999999999999987644333 


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                      .......||+.|+|||++.+..++.++||||||+++|||+| |+.|+.........    .......         ....
T Consensus       250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~----~~~~~~~---------~~~~  316 (359)
T 3vhe_A          250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF----CRRLKEG---------TRMR  316 (359)
T ss_dssp             EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH----HHHHHHT---------CCCC
T ss_pred             hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH----HHHHHcC---------CCCC
Confidence            22334578999999999999999999999999999999999 88887543322211    1111111         1122


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      .+...+..+.+++.+||+.+|++|||+.||++.|+.+.
T Consensus       317 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          317 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            24445677999999999999999999999999998753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-43  Score=364.41  Aligned_cols=265  Identities=28%  Similarity=0.384  Sum_probs=214.2

Q ss_pred             HHHhcCccccccccccCceEEEEEEeC------CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC
Q 042149          294 ERATDFFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG  366 (625)
Q Consensus       294 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  366 (625)
                      +...++|++.+.||+|+||.||+|++.      +++.||||++... .....+.+.+|+.++++++||||+++++++.+.
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            344678999999999999999999964      3478999999765 345567899999999999999999999999999


Q ss_pred             CeeEEEEEecCCCCcchhhhccCC---------------------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEee
Q 042149          367 PESLLVYEYVPNRSLDQILFVKNT---------------------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRD  425 (625)
Q Consensus       367 ~~~~lV~e~~~~~sL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrD  425 (625)
                      +..++||||+++++|.+++.....                     ...+++.+++.++.||++||.|||+++   |+|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D  199 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD  199 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence            999999999999999999875421                     145899999999999999999999875   99999


Q ss_pred             eccCcEEEcCCCceEEeecccceeeCCCCc-eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCC
Q 042149          426 IKTSNILLDEKLTPKIADFGLARHVAPDKT-HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVF  503 (625)
Q Consensus       426 lkp~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~  503 (625)
                      |||+|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||+| |+.|+..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            999999999999999999999976543222 12224568999999999999999999999999999999999 8888643


Q ss_pred             CCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCC
Q 042149          504 SEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEI  575 (625)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l  575 (625)
                      ...     ...........         ....+...+..+.+++.+||+.+|++|||+.+|++.|+++...+
T Consensus       280 ~~~-----~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          280 MAH-----EEVIYYVRDGN---------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             SCH-----HHHHHHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             CCh-----HHHHHHHhCCC---------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            211     11111111111         12234556678999999999999999999999999999876443

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6.2e-42  Score=349.07  Aligned_cols=262  Identities=21%  Similarity=0.288  Sum_probs=203.8

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      ++|++.++||+|+||+||+|++. +++.||||++...  .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57999999999999999999975 6899999999754  33445778899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+++ +|.+.+....  ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            9976 4444443322  34899999999999999999999875   9999999999999999999999999998765332


Q ss_pred             ceeeecCCCCccccCccccccCc-ccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccc------ccccc
Q 042149          455 THVSTGIAGTLGYMAPEYLVRGQ-LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR------ITQSM  527 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~i  527 (625)
                      .. .....||+.|+|||++.+.. ++.++||||||+++|||++|+.|+.........+...........      .....
T Consensus       156 ~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (292)
T 3o0g_A          156 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             SC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             cc-ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence            22 23457899999999998765 799999999999999999999886443332222222222111100      00000


Q ss_pred             C---------CCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          528 D---------PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       528 ~---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      +         ........+..+..+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0         00111123345678899999999999999999999985

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=8.8e-43  Score=352.73  Aligned_cols=261  Identities=28%  Similarity=0.412  Sum_probs=212.2

Q ss_pred             HhcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ..++|++.+.||+|+||.||+|++++++.||||++..... ..+.+.+|++++++++||||+++++++. .+..++||||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   88 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY   88 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence            3568999999999999999999988888999999865432 3567899999999999999999999876 4568999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+++.... ...+++..++.++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++........
T Consensus        89 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T 1qpc_A           89 MENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (279)
T ss_dssp             CTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             CCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence            99999999985432 124899999999999999999999876   99999999999999999999999999988765443


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                      .......+++.|+|||++.++.++.++||||||+++|||++ |+.|+..... ..    .......         .....
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~----~~~~~~~---------~~~~~  230 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PE----VIQNLER---------GYRMV  230 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HH----HHHHHHT---------TCCCC
T ss_pred             ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-HH----HHHHHhc---------ccCCC
Confidence            33334567889999999998999999999999999999999 7877643211 11    1111111         11122


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCC
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIP  576 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~  576 (625)
                      .+...+..+.+++.+||+.+|++|||+.++++.|+++.....
T Consensus       231 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  272 (279)
T 1qpc_A          231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE  272 (279)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence            344556789999999999999999999999999988754443

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-42  Score=367.47  Aligned_cols=270  Identities=20%  Similarity=0.210  Sum_probs=213.3

Q ss_pred             cHHHHHHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeee
Q 042149          289 KYEILERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSI  364 (625)
Q Consensus       289 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  364 (625)
                      .++.++...++|++.++||+|+||.||+|+++ +++.||||++....   ....+.+.+|+.++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            34455556789999999999999999999975 68999999996532   223445889999999999999999999999


Q ss_pred             eCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeec
Q 042149          365 EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADF  444 (625)
Q Consensus       365 ~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Df  444 (625)
                      +.+..++||||++||+|.+++...+  ..+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+||
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF  206 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF  206 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence            9999999999999999999996543  24899999999999999999999875   999999999999999999999999


Q ss_pred             ccceeeCCCCceeeecCCCCccccCccccc-------cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHh
Q 042149          445 GLARHVAPDKTHVSTGIAGTLGYMAPEYLV-------RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKH  517 (625)
Q Consensus       445 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~  517 (625)
                      |+++.............+||+.|+|||++.       ...++.++|||||||++|||++|+.|+...... ..    ...
T Consensus       207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~----~~~  281 (412)
T 2vd5_A          207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-ET----YGK  281 (412)
T ss_dssp             TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HH----HHH
T ss_pred             hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-HH----HHH
Confidence            999887665554444568999999999997       357899999999999999999999997532211 11    111


Q ss_pred             hhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCC---CCHHHHHH--HHccccCC
Q 042149          518 YKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALR---PSMAEVVH--MLNNIDYE  574 (625)
Q Consensus       518 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~ev~~--~L~~~~~~  574 (625)
                      ..... ....    .+..+...+.++.++|.+||. +|++|   |+++||++  .+.++.++
T Consensus       282 i~~~~-~~~~----~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~  337 (412)
T 2vd5_A          282 IVHYK-EHLS----LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWD  337 (412)
T ss_dssp             HHTHH-HHCC----CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCST
T ss_pred             HHhcc-cCcC----CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHH
Confidence            11100 0000    011123456778999999999 99998   69999986  34555554

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.2e-42  Score=353.70  Aligned_cols=263  Identities=21%  Similarity=0.289  Sum_probs=202.8

Q ss_pred             HhcCccccccccccCceEEEEEEeCCCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ..++|++.++||+|+||+||+|++.+++.||||++....  ....+.+.+|+.++++++||||+++++++.++...++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            457899999999999999999999889999999986542  334567889999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++ +|.+.+....  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        99 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           99 EFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             ECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             cCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            99975 7777765432  34899999999999999999999875   999999999999999999999999999876533


Q ss_pred             CceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccc---c------
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR---I------  523 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~------  523 (625)
                      ... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.|+......... ...........   +      
T Consensus       173 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          173 VRS-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL-PKIFSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH-HHHHHHHCCCCTTTSGGGTTS
T ss_pred             ccc-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHHCCCChHHhhhhhcc
Confidence            222 234578999999999876 56899999999999999999999988654333221 11111111000   0      


Q ss_pred             -------ccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          524 -------TQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       524 -------~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                             .+...........+..+.++.+++.+||+.||++|||++|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                   0000000000011233567889999999999999999999986

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.5e-42  Score=361.06  Aligned_cols=252  Identities=23%  Similarity=0.278  Sum_probs=205.9

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChH------HHHHHHHHHHHHhcCCCCceeeeeeeeeeCCe
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQ------WVDQFFNEVNLISGIQHKNVVRLLGCSIEGPE  368 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  368 (625)
                      ..+.|++.+.||+|+||.||+|+++ +|+.||||++......      ..+.+.+|+.+|++++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            4578999999999999999999976 6899999999764321      35678999999999999999999999999999


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC----ceEEeec
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL----TPKIADF  444 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~----~~kl~Df  444 (625)
                      .++||||++|++|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+||+||
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            999999999999999985443   4899999999999999999999875   99999999999998776    7999999


Q ss_pred             ccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccc
Q 042149          445 GLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRIT  524 (625)
Q Consensus       445 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  524 (625)
                      |+++.......  .....||+.|+|||++.+..++.++||||||+++|+|++|..|+......     ........... 
T Consensus       164 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-----~~~~~i~~~~~-  235 (361)
T 2yab_A          164 GLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----ETLANITAVSY-  235 (361)
T ss_dssp             SSCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHHHHHHTTCC-
T ss_pred             CCceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhcCC-
Confidence            99987654332  23467999999999999989999999999999999999999997532111     11111111110 


Q ss_pred             cccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          525 QSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       525 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                           ..........+..+.+++.+||+.||++|||+.|+++
T Consensus       236 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          236 -----DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             -----CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -----CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 0000011234567899999999999999999999985

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.2e-42  Score=352.17  Aligned_cols=257  Identities=22%  Similarity=0.303  Sum_probs=197.5

Q ss_pred             HhcCccccccccccCceEEEEEEeCC----CCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLPD----GRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  370 (625)
                      ..++|++.+.||+|+||.||+|++..    +..||||++... .....+.+.+|+.++++++||||+++++++. ++..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            35689999999999999999998642    456999988654 4455678999999999999999999999874 56789


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      +||||+++++|.+++....  ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence            9999999999999986543  24899999999999999999999875   999999999999999999999999999876


Q ss_pred             CCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          451 APDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      ............+++.|+|||++.+..++.++||||||+++|||++ |..|+..... ....    .....         
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~-~~~~----~~i~~---------  232 (281)
T 1mp8_A          167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVI----GRIEN---------  232 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-GGHH----HHHHT---------
T ss_pred             CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH-HHHH----HHHHc---------
Confidence            5443333334467889999999998999999999999999999997 8877643221 1111    11111         


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      ....+.+...+..+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus       233 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          233 GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1112234556778999999999999999999999999998763

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=6.8e-43  Score=362.26  Aligned_cols=257  Identities=23%  Similarity=0.359  Sum_probs=202.3

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCE----EEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRN----IAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  370 (625)
                      .++|++.++||+|+||.||+|++. +++.    ||+|.+... .....+.+.+|+.++++++||||+++++++.+.. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            357999999999999999999964 4443    588877543 3345678999999999999999999999998754 78


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      +|+||+++++|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            9999999999999986543  34899999999999999999999875   999999999999999999999999999876


Q ss_pred             CCCCcee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          451 APDKTHV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       451 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      ....... .....+|+.|+|||++.+..++.++||||||+++|||+| |+.|+......              .+...+.
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------------~~~~~~~  233 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------------EISSILE  233 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------------GHHHHHH
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--------------HHHHHHH
Confidence            5443322 224467889999999999999999999999999999999 88886432111              1111122


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccC
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY  573 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  573 (625)
                      .......+...+..+.+++.+||+.+|++||++.|+++.|+.+..
T Consensus       234 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          234 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             TTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             cCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            222223355567789999999999999999999999999987653

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.8e-42  Score=348.74  Aligned_cols=254  Identities=26%  Similarity=0.385  Sum_probs=197.9

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCC----hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS----RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .++|++.++||+|+||.||+|++. ++.||||++....    ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            467999999999999999999974 7899999986543    23357789999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC--------CCceEEeec
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE--------KLTPKIADF  444 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~--------~~~~kl~Df  444 (625)
                      |||+++++|.+++..    ..+++..++.++.|++.||.|||+++..+|+||||||+|||++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            999999999998842    24899999999999999999999875445999999999999985        678999999


Q ss_pred             ccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccc
Q 042149          445 GLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRIT  524 (625)
Q Consensus       445 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  524 (625)
                      |++........   ....||+.|+|||.+.+..++.++||||||+++|+|++|+.|+......    ......       
T Consensus       161 g~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~-------  226 (271)
T 3dtc_A          161 GLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL----AVAYGV-------  226 (271)
T ss_dssp             CC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH----HHHHHH-------
T ss_pred             Ccccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHhh-------
Confidence            99986543322   2357899999999999999999999999999999999999987532211    011111       


Q ss_pred             cccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          525 QSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       525 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                        .........+...+..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus       227 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          227 --AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             --HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             --hcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence              111122233455667899999999999999999999999999763

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-42  Score=356.23  Aligned_cols=252  Identities=18%  Similarity=0.220  Sum_probs=206.0

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      ..++|++.+.||+|+||.||+|+++ +++.+|+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            3578999999999999999999976 68889999886543 345678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC--CCceEEeecccceeeCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE--KLTPKIADFGLARHVAP  452 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~--~~~~kl~Dfgla~~~~~  452 (625)
                      |+++++|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||+++....
T Consensus        82 ~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           82 FISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             eCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            999999999885432  34899999999999999999999875   999999999999987  78999999999988755


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      ...  .....||+.|+|||++.+..++.++||||||+++|+|++|+.|+......     ............      ..
T Consensus       157 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~i~~~~~~------~~  223 (321)
T 1tki_A          157 GDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----QIIENIMNAEYT------FD  223 (321)
T ss_dssp             TCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHHTCCC------CC
T ss_pred             CCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-----HHHHHHHcCCCC------CC
Confidence            433  23357999999999999988999999999999999999999997532211     111111111100      00


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .......+..+.+++.+||+.||++|||+.|+++
T Consensus       224 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0001234667899999999999999999999987

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.8e-42  Score=373.22  Aligned_cols=251  Identities=25%  Similarity=0.408  Sum_probs=207.8

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC-eeEEEEEe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP-ESLLVYEY  375 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~~~lV~e~  375 (625)
                      .++|++.++||+|+||.||+|.++ ++.||||++....  ..+.|.+|+.+|++++||||+++++++.+.. ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            467899999999999999999985 6899999997543  4568999999999999999999999987765 78999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+++..... ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus       269 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  343 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  343 (450)
T ss_dssp             CTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence            999999999976532 33789999999999999999999875   9999999999999999999999999998643321 


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                         ....+++.|+|||++.+..++.++||||||+++|||+| |+.|+...... +..    ...         ......+
T Consensus       344 ---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-~~~----~~i---------~~~~~~~  406 (450)
T 1k9a_A          344 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVV----PRV---------EKGYKMD  406 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT-THH----HHH---------HTTCCCC
T ss_pred             ---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHH----HHH---------HcCCCCC
Confidence               12357889999999999999999999999999999999 88887543221 111    111         1122233


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      .|..++..+.++|.+||+.+|++|||+.++++.|+.+.
T Consensus       407 ~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~  444 (450)
T 1k9a_A          407 APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR  444 (450)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            45567788999999999999999999999999998764

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4.6e-43  Score=356.37  Aligned_cols=259  Identities=27%  Similarity=0.375  Sum_probs=215.6

Q ss_pred             HHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ...++|++.++||+|+||.||+|+++ +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence            34678999999999999999999976 48889999986543 34678899999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++++|.+++..... ..+++..++.++.+++.||.|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        89 e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           89 EFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             ECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            99999999999865433 44899999999999999999999875   999999999999999999999999999877655


Q ss_pred             CceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      .........+++.|+|||++.+..++.++||||||+++|+|++ |..|+...... ..    .         +.+.....
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-~~----~---------~~~~~~~~  230 (288)
T 3kfa_A          165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QV----Y---------ELLEKDYR  230 (288)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GH----H---------HHHHTTCC
T ss_pred             ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HH----H---------HHHhccCC
Confidence            5444445567889999999999999999999999999999999 77776432211 11    1         11111222


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      ...+...+..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       231 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~  270 (288)
T 3kfa_A          231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  270 (288)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence            2334556778999999999999999999999999997753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.5e-42  Score=361.26  Aligned_cols=254  Identities=23%  Similarity=0.279  Sum_probs=204.1

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~  370 (625)
                      ..++|++.++||+|+||.||+|+++ +++.||||++...   .....+.+.+|..+++.+ +||||+++++++.+.+..+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3578999999999999999999975 6899999999754   234456788999999988 6999999999999999999


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      +||||++|++|.+++.....   +++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus       101 lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSRR---FDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence            99999999999999865543   899999999999999999999875   999999999999999999999999999854


Q ss_pred             CCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          451 APDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                      ..... .....+||+.|+|||++.+..++.++||||||+++|||++|+.|+.....     ...........        
T Consensus       175 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~~--------  240 (353)
T 3txo_A          175 ICNGV-TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFEAILNDE--------  240 (353)
T ss_dssp             CC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCC--------
T ss_pred             ccCCc-cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCC--------
Confidence            33222 23346899999999999999999999999999999999999999753221     11111111111        


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCCH------HHHHH--HHccc
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPSM------AEVVH--MLNNI  571 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~ev~~--~L~~~  571 (625)
                        ..+|...+..+.+++.+||+.||++||++      +|+++  .+.++
T Consensus       241 --~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          241 --VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             --CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence              12244456778999999999999999998      77775  34444

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5.1e-42  Score=365.26  Aligned_cols=265  Identities=19%  Similarity=0.206  Sum_probs=211.6

Q ss_pred             HHHHHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC
Q 042149          291 EILERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG  366 (625)
Q Consensus       291 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  366 (625)
                      +.++...++|++.++||+|+||.||+|+++ +++.||||++....   ....+.+.+|+.+++.++||||+++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            344455688999999999999999999976 58899999986531   12234578999999999999999999999999


Q ss_pred             CeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccc
Q 042149          367 PESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGL  446 (625)
Q Consensus       367 ~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgl  446 (625)
                      ...++||||++||+|.+++...    .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence            9999999999999999988543    3899999999999999999999875   99999999999999999999999999


Q ss_pred             ceeeCCCCceeeecCCCCccccCccccccCc----ccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccc
Q 042149          447 ARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQ----LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR  522 (625)
Q Consensus       447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  522 (625)
                      ++.............+||+.|+|||++.+..    ++.++||||||+++|||++|+.|+..... ...    ........
T Consensus       215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~----~~~i~~~~  289 (410)
T 3v8s_A          215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGT----YSKIMNHK  289 (410)
T ss_dssp             CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH-HHH----HHHHHTHH
T ss_pred             eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh-hhH----HHHHHhcc
Confidence            9887665544445678999999999997654    88999999999999999999999753221 111    11111100


Q ss_pred             cccccCCCCCCCCChHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH--HccccC
Q 042149          523 ITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVAL--RPSMAEVVHM--LNNIDY  573 (625)
Q Consensus       523 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~--L~~~~~  573 (625)
                      . .     +.-+.....+..+.+|+.+||+.+|++  ||+++||++.  +.++.+
T Consensus       290 ~-~-----~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w  338 (410)
T 3v8s_A          290 N-S-----LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  338 (410)
T ss_dssp             H-H-----CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred             c-c-----ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCH
Confidence            0 0     000111234677899999999999999  9999999964  455543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=6.6e-42  Score=362.50  Aligned_cols=253  Identities=22%  Similarity=0.255  Sum_probs=204.6

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l  371 (625)
                      .++|++.++||+|+||.||+|+++ +++.||||++...   .....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            467999999999999999999976 5788999999754   233445688999999887 89999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||||+++|+|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus       131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            999999999999887544   3899999999999999999999876   9999999999999999999999999998633


Q ss_pred             CCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCc----cchhhHHHhhhcccccccc
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSS----SVLHTVWKHYKANRITQSM  527 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~i  527 (625)
                      .... .....+||+.|+|||++.+..++.++||||||+++|||++|+.|+.......    ..............     
T Consensus       205 ~~~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-----  278 (396)
T 4dc2_A          205 RPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-----  278 (396)
T ss_dssp             CTTC-CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-----
T ss_pred             cCCC-ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-----
Confidence            2222 2345689999999999999999999999999999999999999985432211    11111122111111     


Q ss_pred             CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 042149          528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSM------AEVVH  566 (625)
Q Consensus       528 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~ev~~  566 (625)
                           ..+|...+..+.+|+.+||+.||++||++      +||++
T Consensus       279 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          279 -----IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             -----cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence                 12355567788999999999999999985      66665

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-42  Score=360.42  Aligned_cols=265  Identities=25%  Similarity=0.358  Sum_probs=211.1

Q ss_pred             HhcCccccccccccCceEEEEEEe------CCCCEEEEEEeecC-ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCC
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTL------PDGRNIAVKRLFFN-SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGP  367 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  367 (625)
                      ..++|++.+.||+|+||.||+|++      .+++.||||++... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            457899999999999999999985      24568999999654 334457899999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCCcchhhhccCCc--------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeec
Q 042149          368 ESLLVYEYVPNRSLDQILFVKNTI--------------------HILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIK  427 (625)
Q Consensus       368 ~~~lV~e~~~~~sL~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlk  427 (625)
                      ..++||||+++++|.+++......                    ..+++..++.++.||+.||.|||+.+   |+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence            999999999999999999754321                    34789999999999999999999875   9999999


Q ss_pred             cCcEEEcCCCceEEeecccceeeCCCCce-eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCC
Q 042149          428 TSNILLDEKLTPKIADFGLARHVAPDKTH-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSE  505 (625)
Q Consensus       428 p~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~  505 (625)
                      |+|||++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|||+| |+.|+....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            99999999999999999999876543332 2234567889999999999999999999999999999998 888865433


Q ss_pred             CCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCC
Q 042149          506 GSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIP  576 (625)
Q Consensus       506 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~  576 (625)
                      .....    .....         .......+...+..+.+++.+||+.||++|||+.++++.|+.+....+
T Consensus       280 ~~~~~----~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  337 (344)
T 1rjb_A          280 VDANF----YKLIQ---------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE  337 (344)
T ss_dssp             CSHHH----HHHHH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             cHHHH----HHHHh---------cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence            22111    11111         111222344557789999999999999999999999999988765433

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6.8e-42  Score=355.18  Aligned_cols=271  Identities=16%  Similarity=0.189  Sum_probs=212.4

Q ss_pred             hcCccccccccccCceEEEEEEe-CCCCEEEEEEeecCChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      .++|++.++||+|+||.||+|+. .+++.||||++.....  .+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            46799999999999999999996 4789999999865432  24688999999999 89999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCc-----eEEeeccccee
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLT-----PKIADFGLARH  449 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~-----~kl~Dfgla~~  449 (625)
                      |+ +++|.+++....  ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.     +||+|||+++.
T Consensus        86 ~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 999999986542  34899999999999999999999875   999999999999998887     99999999987


Q ss_pred             eCCCCcee------eecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccc
Q 042149          450 VAPDKTHV------STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRI  523 (625)
Q Consensus       450 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  523 (625)
                      ........      .....||+.|+|||++.+..++.++||||||+++|||++|+.|+....... .. ...........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~-~~-~~~~~i~~~~~  237 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT-LK-ERYQKIGDTKR  237 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS-HH-HHHHHHHHHHH
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc-HH-HHHHHHHhhhc
Confidence            65433221      235679999999999999999999999999999999999999976442221 11 11111111110


Q ss_pred             ccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCCCCCCCCC
Q 042149          524 TQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPF  583 (625)
Q Consensus       524 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~~~~~~~~  583 (625)
                      ..... .+    ....+ .+.+++.+||+.+|++||++++|++.|+++...+.......+
T Consensus       238 ~~~~~-~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~  291 (330)
T 2izr_A          238 ATPIE-VL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEY  291 (330)
T ss_dssp             HSCHH-HH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred             cCCHH-HH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCc
Confidence            00000 00    11124 899999999999999999999999999877555444333333

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.7e-42  Score=358.42  Aligned_cols=261  Identities=25%  Similarity=0.360  Sum_probs=195.8

Q ss_pred             HhcCccccccccccCceEEEEEEeCC-C---CEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCee
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLPD-G---RNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPES  369 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  369 (625)
                      ..++|++.+.||+|+||.||+|++.. +   ..||||++...  .....+.+.+|+.++++++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            35679999999999999999999754 3   27999998654  345577899999999999999999999999877655


Q ss_pred             ------EEEEEecCCCCcchhhhccC---CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceE
Q 042149          370 ------LLVYEYVPNRSLDQILFVKN---TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPK  440 (625)
Q Consensus       370 ------~lV~e~~~~~sL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~k  440 (625)
                            ++||||+++++|.+++....   ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence                  99999999999999886432   1224899999999999999999999886   99999999999999999999


Q ss_pred             EeecccceeeCCCCce-eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhh
Q 042149          441 IADFGLARHVAPDKTH-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHY  518 (625)
Q Consensus       441 l~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~  518 (625)
                      |+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...... ..    ....
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~~----~~~~  252 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA-EI----YNYL  252 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GH----HHHH
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH-HH----HHHH
Confidence            9999999876443322 1223457889999999999999999999999999999999 77776432211 11    1111


Q ss_pred             hccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccC
Q 042149          519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY  573 (625)
Q Consensus       519 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  573 (625)
                      ..         ......+...+..+.+++.+||+.||++|||+.++++.|+++..
T Consensus       253 ~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          253 IG---------GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             HT---------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hc---------CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            11         11122344566789999999999999999999999999988753

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=7.9e-43  Score=359.11  Aligned_cols=258  Identities=23%  Similarity=0.358  Sum_probs=197.8

Q ss_pred             hcCccccccccccCceEEEEEEe-CCCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCe----
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPE----  368 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~----  368 (625)
                      .++|++.++||+|+||.||+|++ .+++.||||++...   .......+.+|+.++++++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            57899999999999999999996 47899999999754   34556788999999999999999999999876543    


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      .++||||+++++|.+++.....   +++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            4999999999999999975543   899999999999999999999875   9999999999999999999999999998


Q ss_pred             eeCCCCce--eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccc
Q 042149          449 HVAPDKTH--VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS  526 (625)
Q Consensus       449 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (625)
                      ........  ......||+.|+|||++.+..++.++||||||+++|||++|+.|+.....    ....+.......... 
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~----~~~~~~~~~~~~~~~-  239 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP----VSVAYQHVREDPIPP-  239 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHCCCCCH-
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHhcCCCCCc-
Confidence            76543222  12245689999999999999999999999999999999999998743221    111111111111000 


Q ss_pred             cCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHH-HHHccc
Q 042149          527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVV-HMLNNI  571 (625)
Q Consensus       527 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~-~~L~~~  571 (625)
                            .......+..+.+++.+||+.||++||+..+++ ..|...
T Consensus       240 ------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          240 ------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             ------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence                  000123466789999999999999999766555 455444

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.7e-42  Score=357.80  Aligned_cols=270  Identities=25%  Similarity=0.374  Sum_probs=214.7

Q ss_pred             ccccccccccCceEEEEEEeC-----CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--CeeEE
Q 042149          300 FDNSRKLGQGGAGSVFRGTLP-----DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG--PESLL  371 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~l  371 (625)
                      |++.++||+|+||.||++...     +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            489999999999999988642     67889999997653 45567899999999999999999999999874  67899


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||||+++++|.+++....    +++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       113 v~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            999999999999985432    899999999999999999999876   9999999999999999999999999998876


Q ss_pred             CCCcee--eecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCc-cchhhHHHhhhccccccccC
Q 042149          452 PDKTHV--STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSS-SVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       452 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~i~  528 (625)
                      ......  .....+|+.|+|||++.+..++.++||||||+++|+|++|+.|+....... ..............+.+.+.
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence            544322  234568889999999999999999999999999999999998864321100 00000001111112233333


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCC
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIP  576 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~  576 (625)
                      .......+...+..+.+++.+||+.+|++|||+.|+++.|+.+...+.
T Consensus       266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence            344444566677889999999999999999999999999988765443

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=6e-42  Score=350.23  Aligned_cols=249  Identities=24%  Similarity=0.273  Sum_probs=197.0

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCCh--------------------------HHHHHHHHHHHHHh
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSR--------------------------QWVDQFFNEVNLIS  349 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  349 (625)
                      .++|++.+.||+|+||.||+|++. +++.||||++.....                          ...+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            468999999999999999999965 688999999865421                          12456889999999


Q ss_pred             cCCCCceeeeeeeeee--CCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeec
Q 042149          350 GIQHKNVVRLLGCSIE--GPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIK  427 (625)
Q Consensus       350 ~l~hpniv~l~~~~~~--~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlk  427 (625)
                      +++||||+++++++.+  ....++||||+++++|.+++.    ...+++..++.++.||+.||.|||+++   |+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999986  568899999999999988653    234899999999999999999999875   9999999


Q ss_pred             cCcEEEcCCCceEEeecccceeeCCCCceeeecCCCCccccCccccccCc---ccccCcEEeehhhhHHHHhCCCCCCCC
Q 042149          428 TSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQ---LTEKADVYAFGVLVIEVASGRRNSVFS  504 (625)
Q Consensus       428 p~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlG~ll~elltG~~p~~~~  504 (625)
                      |+|||++.++.+||+|||+++........ .....||+.|+|||++.+..   ++.++||||||+++|+|++|+.|+...
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHHEEECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            99999999999999999999876544332 23467999999999997654   478899999999999999999987432


Q ss_pred             CCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          505 EGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .    . ...........        ...+.....+..+.+++.+||+.||++|||+.|+++
T Consensus       244 ~----~-~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          244 R----I-MCLHSKIKSQA--------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             S----H-HHHHHHHHHCC--------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             c----H-HHHHHHHhccc--------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            1    1 11111111111        111112344667899999999999999999999874

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.9e-43  Score=368.55  Aligned_cols=260  Identities=27%  Similarity=0.336  Sum_probs=209.2

Q ss_pred             hcCccccccccccCceEEEEEEeC------CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPES  369 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  369 (625)
                      .++|++.++||+|+||.||+|++.      +++.||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467899999999999999999842      4678999998654 455566789999999999999999999999999999


Q ss_pred             EEEEEecCCCCcchhhhccCC----cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC---ceEEe
Q 042149          370 LLVYEYVPNRSLDQILFVKNT----IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL---TPKIA  442 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~---~~kl~  442 (625)
                      ++||||+++++|.+++.....    ...+++..++.++.||+.||.|||+++   |+||||||+||||+.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            999999999999999976432    234899999999999999999999886   99999999999999554   59999


Q ss_pred             ecccceeeCCCCc-eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhc
Q 042149          443 DFGLARHVAPDKT-HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKA  520 (625)
Q Consensus       443 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  520 (625)
                      |||+++....... .......||+.|+|||++.+..++.++||||||+++|||++ |..|+..... ..    .....  
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-~~----~~~~i--  299 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QE----VLEFV--  299 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HH----HHHHH--
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-HH----HHHHH--
Confidence            9999975422111 11223467999999999999999999999999999999998 8877643211 11    11111  


Q ss_pred             cccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccC
Q 042149          521 NRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY  573 (625)
Q Consensus       521 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  573 (625)
                             ........+...+..+.+|+.+||+.+|++|||+.+|++.|+.+..
T Consensus       300 -------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          300 -------TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             -------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------HcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence                   1111222345566789999999999999999999999999987643

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=9.3e-42  Score=362.44  Aligned_cols=267  Identities=16%  Similarity=0.225  Sum_probs=205.4

Q ss_pred             hcCcccccccccc--CceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          297 TDFFDNSRKLGQG--GAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       297 ~~~y~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      .++|++.++||+|  +||.||+|+++ +++.||||++...  .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4679999999999  99999999976 6899999999754  35566788999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||||+++++|.+++..... ..+++..+..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||.+....
T Consensus       104 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            9999999999999865432 33899999999999999999999875   9999999999999999999999999986543


Q ss_pred             CCCce------eeecCCCCccccCcccccc--CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhc---
Q 042149          452 PDKTH------VSTGIAGTLGYMAPEYLVR--GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKA---  520 (625)
Q Consensus       452 ~~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~---  520 (625)
                      .....      ......||+.|+|||++.+  ..++.++|||||||++|||++|+.|+...................   
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  259 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence            22111      1123478999999999987  579999999999999999999999985433222211111000000   


Q ss_pred             ------cc-------------cccccC---------CCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          521 ------NR-------------ITQSMD---------PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       521 ------~~-------------~~~~i~---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                            ..             ....+.         .....+.+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                  00             000000         000011233456779999999999999999999999864

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-42  Score=349.29  Aligned_cols=256  Identities=25%  Similarity=0.385  Sum_probs=210.5

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      .++|++.+.||+|+||.||+|++.+++.||||++...... .+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            3678999999999999999999888889999999765332 367899999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      ++++|.+++....  ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.........
T Consensus        86 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  160 (267)
T 3t9t_A           86 EHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  160 (267)
T ss_dssp             TTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             CCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc
Confidence            9999999986543  34899999999999999999999876   999999999999999999999999999866433222


Q ss_pred             eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                      ......+++.|+|||++.+..++.++||||||+++|+|++ |+.|+.....     .........         ......
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~i~~---------~~~~~~  226 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SEVVEDIST---------GFRLYK  226 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHT---------TCCCCC
T ss_pred             ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-----HHHHHHHhc---------CCcCCC
Confidence            2234567889999999998999999999999999999999 7777543211     111111111         111222


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      +...+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus       227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (267)
T 3t9t_A          227 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA  263 (267)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            3445677899999999999999999999999998764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.1e-41  Score=357.44  Aligned_cols=250  Identities=24%  Similarity=0.332  Sum_probs=206.0

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .++|++.+.||+|+||.||+|+++ +++.||||++....   ....+.+.+|+.+|+.++||||+++++++.+....++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467999999999999999999975 68899999986532   33456788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+.|++|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++....
T Consensus        94 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             ECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            99999999999986543   3899999999999999999999876   99999999999999999999999999987654


Q ss_pred             CCceeeecCCCCccccCcccccc---CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVR---GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      ...  .....||+.|+|||++..   ..++.++||||||+++|||++|+.|+.......  ...........        
T Consensus       168 ~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~~~~~~--------  235 (384)
T 4fr4_A          168 ETQ--ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEIVHTFETT--------  235 (384)
T ss_dssp             TCC--BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHHHHHHHHC--------
T ss_pred             CCc--eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHhhc--------
Confidence            332  234689999999999864   458999999999999999999999975432221  11111111111        


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPS-MAEVVH  566 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~ev~~  566 (625)
                        ...+|...+..+.+|+.+||+.||++||+ +++|.+
T Consensus       236 --~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          236 --VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             --ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence              11234556778999999999999999998 777764

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-41  Score=359.42  Aligned_cols=253  Identities=23%  Similarity=0.265  Sum_probs=208.9

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      .++|++.++||+|+||.||+|+.+ +++.||+|++..........+.+|+.+|+.++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            578999999999999999999975 6899999999877666667899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC--CCceEEeecccceeeCCC
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE--KLTPKIADFGLARHVAPD  453 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~--~~~~kl~Dfgla~~~~~~  453 (625)
                      +++++|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||+++.....
T Consensus       130 ~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            99999999885432  34899999999999999999999875   999999999999974  578999999999887654


Q ss_pred             CceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                      ...  ....||+.|+|||++.+..++.++||||||+++|||++|+.|+...... ..    ........      .....
T Consensus       205 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~----~~~i~~~~------~~~~~  271 (387)
T 1kob_A          205 EIV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ET----LQNVKRCD------WEFDE  271 (387)
T ss_dssp             SCE--EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HH----HHHHHHCC------CCCCS
T ss_pred             cce--eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-HH----HHHHHhCC------CCCCc
Confidence            332  2347999999999999999999999999999999999999997532211 11    11111111      01111


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      ......+..+.+++.+||+.||++|||+.|+++.
T Consensus       272 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          272 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            2223456778999999999999999999999864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.9e-42  Score=354.38  Aligned_cols=270  Identities=22%  Similarity=0.366  Sum_probs=210.4

Q ss_pred             hcCccccccccccCceEEEEEEe-----CCCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--Ce
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL-----PDGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG--PE  368 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~  368 (625)
                      .++|++.++||+|+||.||+|++     .+++.||||++... .....+.+.+|+.+++.++||||+++++++.+.  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            35689999999999999999983     36889999998754 334457889999999999999999999999876  67


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      .++||||+++++|.+++....  ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence            899999999999999985443  23899999999999999999999875   9999999999999999999999999998


Q ss_pred             eeCCCCce--eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCc-cchhhHHHhhhcccccc
Q 042149          449 HVAPDKTH--VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSS-SVLHTVWKHYKANRITQ  525 (625)
Q Consensus       449 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~  525 (625)
                      ........  ......+|+.|+|||++.+..++.++||||||+++|+|++|+.|+....... ..............+..
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence            87654432  2234568889999999999999999999999999999999998743210000 00000000011111122


Q ss_pred             ccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          526 SMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       526 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      .+......+.+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       255 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          255 TLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            2222233344566778899999999999999999999999999764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=6.4e-43  Score=362.15  Aligned_cols=258  Identities=24%  Similarity=0.337  Sum_probs=203.4

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCE----EEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRN----IAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  370 (625)
                      .++|++.++||+|+||.||+|++. +++.    ||+|.+.... ......+.+|+.++++++||||+++++++. ++..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            357899999999999999999964 4554    7778774332 333456788999999999999999999886 56789


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      +||||+++++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence            999999999999988643  234889999999999999999999876   999999999999999999999999999876


Q ss_pred             CCCCce-eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          451 APDKTH-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       451 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      ...... ......+++.|+|||++.+..++.++||||||+++|||+| |+.|+...... ..    ......        
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~----~~~~~~--------  232 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-EV----PDLLEK--------  232 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-HH----HHHHHT--------
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-HH----HHHHHc--------
Confidence            544332 2234568889999999999999999999999999999999 99887533211 11    111111        


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCC
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYE  574 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  574 (625)
                       ......+...+..+.+++.+||+.+|++|||+.|+++.|+.+...
T Consensus       233 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          233 -GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             -TCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             -CCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence             111122334455678999999999999999999999999887543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.6e-42  Score=354.21  Aligned_cols=253  Identities=23%  Similarity=0.261  Sum_probs=205.6

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCCh------HHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCe
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSR------QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPE  368 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  368 (625)
                      ..++|++.+.||+|+||.||+|+++ +++.||||++.....      ...+.+.+|+.+|++++||||+++++++.+...
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            3467999999999999999999975 689999999875432      135788999999999999999999999999999


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC----ceEEeec
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL----TPKIADF  444 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~----~~kl~Df  444 (625)
                      .++||||+++++|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++    .+||+||
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            999999999999999985433   4899999999999999999999875   99999999999999877    8999999


Q ss_pred             ccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccc
Q 042149          445 GLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRIT  524 (625)
Q Consensus       445 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  524 (625)
                      |+++.......  .....||+.|+|||++.+..++.++||||||+++|+|++|+.|+...... .    .........  
T Consensus       163 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~----~~~~~~~~~--  233 (326)
T 2y0a_A          163 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-E----TLANVSAVN--  233 (326)
T ss_dssp             TTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-H----HHHHHHHTC--
T ss_pred             CCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-H----HHHHHHhcC--
Confidence            99987754332  23457999999999999899999999999999999999999987432111 1    111111100  


Q ss_pred             cccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          525 QSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       525 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                          ...........+..+.+++.+||+.||++|||+.|+++.
T Consensus       234 ----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          234 ----YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             ----CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ----CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                000000112345678999999999999999999999873

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=8.8e-43  Score=384.94  Aligned_cols=265  Identities=26%  Similarity=0.375  Sum_probs=215.2

Q ss_pred             HHHhcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          294 ERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       294 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      +...++|++.++||+|+||.||+|+++++..||||++..... ..+.|.+|+.+|++++||||+++++++.+ +..+|||
T Consensus       263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~  340 (535)
T 2h8h_A          263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT  340 (535)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             ecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence            344677999999999999999999998888899999976542 34679999999999999999999999876 6789999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++++|.+++.... ...+++.+++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus       341 e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  416 (535)
T 2h8h_A          341 EYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN  416 (535)
T ss_dssp             CCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred             ehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence            9999999999996432 234899999999999999999999875   999999999999999999999999999866432


Q ss_pred             CceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      .........++..|+|||++..+.++.++||||||+++|||++ |+.|+..... .+    .....         .....
T Consensus       417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-~~----~~~~i---------~~~~~  482 (535)
T 2h8h_A          417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-RE----VLDQV---------ERGYR  482 (535)
T ss_dssp             HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-HH----HHHHH---------HTTCC
T ss_pred             ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HH----HHHHH---------HcCCC
Confidence            2222223457889999999999999999999999999999999 8877643211 11    11111         11122


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCCCC
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPP  578 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~~~  578 (625)
                      .+.+..++..+.+||.+||+.+|++|||+++|++.|+.+.....+.
T Consensus       483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~  528 (535)
T 2h8h_A          483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ  528 (535)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCS
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcc
Confidence            2335566778999999999999999999999999999887655443

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-42  Score=348.48  Aligned_cols=261  Identities=22%  Similarity=0.341  Sum_probs=212.3

Q ss_pred             hcCccccc-cccccCceEEEEEEeC---CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          297 TDFFDNSR-KLGQGGAGSVFRGTLP---DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       297 ~~~y~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      .++|.+.+ .||+|+||.||+|++.   ++..||||++... .....+.+.+|+.++++++||||+++++++ ..+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            35566666 8999999999999853   5778999999764 455677899999999999999999999998 5667999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus        87 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            99999999999988533  334899999999999999999999875   9999999999999999999999999998875


Q ss_pred             CCCceee--ecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          452 PDKTHVS--TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       452 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      .......  ....+|+.|+|||++.+..++.++||||||+++|||++ |+.|+...... .    .....         .
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~----~~~~i---------~  227 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-E----VMAFI---------E  227 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-H----HHHHH---------H
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-H----HHHHH---------h
Confidence            4443322  23456899999999998999999999999999999999 99886433211 1    11111         1


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCCC
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPP  577 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~~  577 (625)
                      .......+...+..+.+++.+||+.+|++||++.++++.|+.+..+...
T Consensus       228 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  276 (287)
T 1u59_A          228 QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  276 (287)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             cCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence            1112233556678899999999999999999999999999888655443

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=7.7e-42  Score=367.91  Aligned_cols=255  Identities=23%  Similarity=0.283  Sum_probs=207.5

Q ss_pred             HHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      ...++|++.++||+|+||+||+|.+. +++.+|+|++....  ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            45678999999999999999999865 78999999987543  3446678999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEc---CCCceEEeecccce
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADFGLAR  448 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~---~~~~~kl~Dfgla~  448 (625)
                      ||||+++++|.+.+.....   +++..+..++.||+.||.|||+++   |+||||||+|||++   .++.+||+|||++.
T Consensus        88 v~E~~~gg~L~~~i~~~~~---~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           88 IFDLVTGGELFEDIVAREY---YSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             EECCCBCCBHHHHHHHCSC---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEEeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            9999999999998875543   899999999999999999999886   99999999999998   46789999999998


Q ss_pred             eeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          449 HVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      ........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.|+.....     ............     
T Consensus       162 ~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~~~-----  230 (444)
T 3soa_A          162 EVEGEQQA-WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-----HRLYQQIKAGAY-----  230 (444)
T ss_dssp             CCCTTCCB-CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHTCC-----
T ss_pred             EecCCCce-eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHHhCCC-----
Confidence            76543322 2346799999999999999999999999999999999999998743211     111222222111     


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                       ....+.....+..+.+++.+||+.||++|||+.|+++.
T Consensus       231 -~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          231 -DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             -CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence             01111123456778999999999999999999999873

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.6e-41  Score=346.67  Aligned_cols=272  Identities=15%  Similarity=0.198  Sum_probs=216.9

Q ss_pred             hcCccccccccccCceEEEEEEe-CCCCEEEEEEeecCChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      .++|++.+.||+|+||.||+|++ .+++.||||++.....  .+.+.+|+.+++.+ +|+|++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            46799999999999999999996 5789999998865432  24678899999999 79999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCc-----eEEeeccccee
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLT-----PKIADFGLARH  449 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~-----~kl~Dfgla~~  449 (625)
                      |+ +++|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.     +||+|||+++.
T Consensus        87 ~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           87 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            99 999999996543  24899999999999999999999775   999999999999987765     99999999987


Q ss_pred             eCCCCce------eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCcc--chhhHHHhhhcc
Q 042149          450 VAPDKTH------VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSS--VLHTVWKHYKAN  521 (625)
Q Consensus       450 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~--~~~~~~~~~~~~  521 (625)
                      .......      ......||+.|+|||++.+..++.++||||||+++|||++|+.|+........  ............
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            6544321      12346799999999999999999999999999999999999999765432211  111111111111


Q ss_pred             ccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCCCCCCCCCcc
Q 042149          522 RITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLN  585 (625)
Q Consensus       522 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~~~~~~~~~~  585 (625)
                      .....         ....+..+.+++.+||+.+|++||++++|++.|+++...+......++.+
T Consensus       241 ~~~~~---------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw  295 (298)
T 1csn_A          241 PLREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDW  295 (298)
T ss_dssp             CHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGG
T ss_pred             cHHHH---------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCcccc
Confidence            11110         12345678999999999999999999999999998877666555554443

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.9e-42  Score=352.41  Aligned_cols=261  Identities=27%  Similarity=0.375  Sum_probs=213.2

Q ss_pred             hcCccccccccccCceEEEEEEe------CCCCEEEEEEeecCC-hHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL------PDGRNIAVKRLFFNS-RQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPE  368 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~  368 (625)
                      .++|++.+.||+|+||.||+|++      .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++.+.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            46789999999999999999984      246789999997553 34567899999999999 89999999999999999


Q ss_pred             eEEEEEecCCCCcchhhhccCC---------------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE
Q 042149          369 SLLVYEYVPNRSLDQILFVKNT---------------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL  433 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll  433 (625)
                      .++||||+++++|.+++.....               ...+++..++.++.|++.||.|||+++   |+||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence            9999999999999999875432               124899999999999999999999875   9999999999999


Q ss_pred             cCCCceEEeecccceeeCCCCcee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccch
Q 042149          434 DEKLTPKIADFGLARHVAPDKTHV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVL  511 (625)
Q Consensus       434 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~  511 (625)
                      +.++.+||+|||+++......... .....+|+.|+|||++.+..++.++||||||+++|||+| |+.|+......... 
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-  257 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF-  257 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH-
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH-
Confidence            999999999999998765544322 224457889999999999999999999999999999999 88876543322211 


Q ss_pred             hhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccC
Q 042149          512 HTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY  573 (625)
Q Consensus       512 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  573 (625)
                         ......         ......+...+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus       258 ---~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  307 (313)
T 1t46_A          258 ---YKMIKE---------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (313)
T ss_dssp             ---HHHHHH---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHHhcc---------CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence               111111         11112234556789999999999999999999999999987643

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.9e-42  Score=361.25  Aligned_cols=280  Identities=15%  Similarity=0.178  Sum_probs=213.8

Q ss_pred             hcCccccccccccCceEEEEEEeCC------CCEEEEEEeecCChHHH-----------HHHHHHHHHHhcCCCCceeee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPD------GRNIAVKRLFFNSRQWV-----------DQFFNEVNLISGIQHKNVVRL  359 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpniv~l  359 (625)
                      .++|++.++||+|+||.||+|+++.      ++.||||++........           ..+..|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            5689999999999999999999754      47899999876543211           123456677888899999999


Q ss_pred             eeeeeeC----CeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEc-
Q 042149          360 LGCSIEG----PESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD-  434 (625)
Q Consensus       360 ~~~~~~~----~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~-  434 (625)
                      ++++...    ...+|||||+ +++|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+||||+ 
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~  187 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence            9998765    4589999999 999999986542  34899999999999999999999875   99999999999999 


Q ss_pred             -CCCceEEeecccceeeCCCCcee------eecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCC
Q 042149          435 -EKLTPKIADFGLARHVAPDKTHV------STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGS  507 (625)
Q Consensus       435 -~~~~~kl~Dfgla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~  507 (625)
                       .++.+||+|||+++.+.......      .....||+.|+|||++.+..++.++||||||+++|||+||+.|+......
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             88999999999998765332211      12345999999999999999999999999999999999999998643333


Q ss_pred             ccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCCCCCCCCCccc
Q 042149          508 SSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNA  586 (625)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~~~~~~~~~~~  586 (625)
                      ..........+. ..+...++..+.   +...+..+.+++..||+.+|++||++.+|++.|+++...+..+....+.+.
T Consensus       268 ~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~  342 (364)
T 3op5_A          268 PKYVRDSKIRYR-ENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLS  342 (364)
T ss_dssp             HHHHHHHHHHHH-HCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC-
T ss_pred             HHHHHHHHHHhh-hhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceE
Confidence            222222221111 122222222211   123356789999999999999999999999999888766665555555443

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.9e-41  Score=353.62  Aligned_cols=253  Identities=23%  Similarity=0.255  Sum_probs=206.6

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l  371 (625)
                      .++|++.+.||+|+||.||+|+++ +++.||||++...   .....+.+.+|+.+++++ +||||+++++++.+....++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            367999999999999999999975 6889999999754   445567889999999988 89999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||||+++++|.+++....   .+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        88 v~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            999999999999886543   3899999999999999999999875   9999999999999999999999999998643


Q ss_pred             CCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCc----cchhhHHHhhhcccccccc
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSS----SVLHTVWKHYKANRITQSM  527 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~i  527 (625)
                      .... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+.......    ..............     
T Consensus       162 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~-----  235 (345)
T 3a8x_A          162 RPGD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-----  235 (345)
T ss_dssp             CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-----
T ss_pred             CCCC-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-----
Confidence            3222 2334689999999999999999999999999999999999999985432111    11111111111111     


Q ss_pred             CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCH------HHHHH
Q 042149          528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSM------AEVVH  566 (625)
Q Consensus       528 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~ev~~  566 (625)
                           ..+|...+..+.+++.+||+.||++||++      .|+++
T Consensus       236 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          236 -----IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             -----CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence                 12345567789999999999999999995      66664

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.7e-42  Score=355.81  Aligned_cols=260  Identities=26%  Similarity=0.359  Sum_probs=212.0

Q ss_pred             hcCccccccccccCceEEEEEEeC--------CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeC
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP--------DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEG  366 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  366 (625)
                      .++|++.+.||+|+||.||+|++.        ++..||||++... .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            578999999999999999999863        4678999999755 345567899999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCCcchhhhccCC-------------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE
Q 042149          367 PESLLVYEYVPNRSLDQILFVKNT-------------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL  433 (625)
Q Consensus       367 ~~~~lV~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll  433 (625)
                      +..++||||+++++|.+++.....             ...+++..++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence            999999999999999999975432             234899999999999999999999875   9999999999999


Q ss_pred             cCCCceEEeecccceeeCCCCcee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccch
Q 042149          434 DEKLTPKIADFGLARHVAPDKTHV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVL  511 (625)
Q Consensus       434 ~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~  511 (625)
                      +.++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |+.|+.....     
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----  265 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-----  265 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH-----
Confidence            999999999999998776543322 223467889999999999999999999999999999999 8887643211     


Q ss_pred             hhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccC
Q 042149          512 HTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY  573 (625)
Q Consensus       512 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  573 (625)
                      ..........         .....+...+..+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus       266 ~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          266 EELFKLLKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             HHHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHhcC---------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            1111111111         1122344556789999999999999999999999999988753

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-41  Score=350.10  Aligned_cols=274  Identities=25%  Similarity=0.358  Sum_probs=205.2

Q ss_pred             cHHHHHHHhcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcC--CCCceeeeeeeeeeC
Q 042149          289 KYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI--QHKNVVRLLGCSIEG  366 (625)
Q Consensus       289 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hpniv~l~~~~~~~  366 (625)
                      .....+...++|++.++||+|+||.||+|++. ++.||||++.....   ..+.+|.+++..+  +||||+++++++...
T Consensus        28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            44455566789999999999999999999985 89999999865432   3445566665554  899999999999887


Q ss_pred             ----CeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCC-----CceEEEeeeccCcEEEcCCC
Q 042149          367 ----PESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS-----GIKIIHRDIKTSNILLDEKL  437 (625)
Q Consensus       367 ----~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~iiHrDlkp~NIll~~~~  437 (625)
                          ...++||||+++++|.+++...    .+++..++.++.|++.||.|||+..     ..+|+||||||+|||++.++
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~  179 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG  179 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred             CCCCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence                7899999999999999999543    3899999999999999999999760     11499999999999999999


Q ss_pred             ceEEeecccceeeCCCCceee---ecCCCCccccCccccccCccccc------CcEEeehhhhHHHHhCC----------
Q 042149          438 TPKIADFGLARHVAPDKTHVS---TGIAGTLGYMAPEYLVRGQLTEK------ADVYAFGVLVIEVASGR----------  498 (625)
Q Consensus       438 ~~kl~Dfgla~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~------~Dv~SlG~ll~elltG~----------  498 (625)
                      .+||+|||+++..........   ....||+.|+|||++.+...+.+      +||||||+++|||+||.          
T Consensus       180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~  259 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ  259 (337)
T ss_dssp             CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence            999999999987654333221   24579999999999987665554      99999999999999994          


Q ss_pred             CCCCCCCCCccchhhHHHhhhccccccccCCCCCCC-CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCC
Q 042149          499 RNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR-FPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYE  574 (625)
Q Consensus       499 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  574 (625)
                      .|+....................    ...+..... .+..++..+.+++.+||+.||++|||+.||++.|+++..+
T Consensus       260 ~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  332 (337)
T 3mdy_A          260 LPYHDLVPSDPSYEDMREIVCIK----KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES  332 (337)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ccHhhhcCCCCchhhhHHHHhhh----ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence            44332222211111111111111    111111110 1237788899999999999999999999999999887544

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=9.6e-42  Score=358.44  Aligned_cols=254  Identities=24%  Similarity=0.316  Sum_probs=207.5

Q ss_pred             HHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      ...++|++.+.||+|+||.||+|+++ +++.||||++...  .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            44678999999999999999999975 6899999999754  34556789999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCC---CceEEeecccce
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEK---LTPKIADFGLAR  448 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~---~~~kl~Dfgla~  448 (625)
                      ||||+++++|.+.+....   .+++..+..++.||+.||.|||+++   |+||||||+|||++.+   +.+||+|||++.
T Consensus       106 v~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             EECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            999999999998886443   3899999999999999999999875   9999999999999864   459999999998


Q ss_pred             eeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          449 HVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      .......  .....||+.|+|||++.+..++.++||||||+++|+|++|+.|+.....     ...+........     
T Consensus       180 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-----~~~~~~i~~~~~-----  247 (362)
T 2bdw_A          180 EVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRLYAQIKAGAY-----  247 (362)
T ss_dssp             CCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHTCC-----
T ss_pred             EecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhCCC-----
Confidence            7654332  2346799999999999998999999999999999999999998743211     111222211110     


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                       ..........+..+.+++.+||+.||++|||+.|+++.
T Consensus       248 -~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          248 -DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             -CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             -CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             00111123456788999999999999999999998753

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=8.5e-42  Score=347.56  Aligned_cols=260  Identities=27%  Similarity=0.446  Sum_probs=198.3

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      .++|++.++||+|+||.||+|++..  .||||++...  .....+.+.+|+.++++++||||++++++. ..+..++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            5679999999999999999998643  5999998654  455667899999999999999999999964 5667899999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+++++|.+++....  ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus       100 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A          100 WCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             ecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence            999999999885433  34899999999999999999999875   9999999999999999999999999997654322


Q ss_pred             -ceeeecCCCCccccCccccc---cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          455 -THVSTGIAGTLGYMAPEYLV---RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       455 -~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                       ........||+.|+|||++.   +..++.++||||||+++|+|++|+.|+..........    .........    +.
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~----~~  246 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII----EMVGRGSLS----PD  246 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHH----HHHHHTSCC----CC
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHH----HHhcccccC----cc
Confidence             22223457999999999986   5678889999999999999999999975433222211    111111111    11


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccC
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY  573 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  573 (625)
                       .......++..+.+++.+||+.+|++|||+.++++.|+++..
T Consensus       247 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          247 -LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             -TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             -hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence             111234556789999999999999999999999999988753

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-41  Score=350.93  Aligned_cols=245  Identities=24%  Similarity=0.305  Sum_probs=205.4

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .++|++.+.||+|+||.||+|+.+ +|+.||||++....   ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            467999999999999999999975 68999999997542   23456788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+++++|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        85 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            99999999999997544   3899999999999999999999775   99999999999999999999999999987543


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      .    .....||+.|+|||++.+..++.++||||||+++|||++|+.|+.....    . ..........          
T Consensus       159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~-~~~~~i~~~~----------  219 (318)
T 1fot_A          159 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT----M-KTYEKILNAE----------  219 (318)
T ss_dssp             C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----H-HHHHHHHHCC----------
T ss_pred             c----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----H-HHHHHHHhCC----------
Confidence            2    2246799999999999999999999999999999999999999743211    1 1111111111          


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRP-----SMAEVVH  566 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~  566 (625)
                      ..+|...+..+.+++.+||+.||++||     +++|+++
T Consensus       220 ~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          220 LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            123445567889999999999999999     8899885

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=6.2e-42  Score=358.57  Aligned_cols=254  Identities=20%  Similarity=0.243  Sum_probs=204.2

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-----hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-----RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  370 (625)
                      .+.|++.+.||+|+||.||+|+++ +++.||||++....     ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            467999999999999999999975 68999999986432     123577899999999999999999999999999999


Q ss_pred             EEEEecCCCCcchhhhccC-CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCc---eEEeeccc
Q 042149          371 LVYEYVPNRSLDQILFVKN-TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLT---PKIADFGL  446 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~---~kl~Dfgl  446 (625)
                      +||||+++++|.+.+.... ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999988775432 2334899999999999999999999875   999999999999986554   99999999


Q ss_pred             ceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccc
Q 042149          447 ARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS  526 (625)
Q Consensus       447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (625)
                      ++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.|+....  .    ............  
T Consensus       180 a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~----~~~~~i~~~~~~--  250 (351)
T 3c0i_A          180 AIQLGESGLV-AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--E----RLFEGIIKGKYK--  250 (351)
T ss_dssp             CEECCTTSCB-CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--H----HHHHHHHHTCCC--
T ss_pred             eeEecCCCee-ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--H----HHHHHHHcCCCC--
Confidence            9877554322 234579999999999999999999999999999999999999975321  1    111111111100  


Q ss_pred             cCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       527 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                          .........+..+.+++.+||+.||++|||+.|+++
T Consensus       251 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          251 ----MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             ----CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                000001234567899999999999999999999985

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=350.80  Aligned_cols=266  Identities=20%  Similarity=0.271  Sum_probs=208.9

Q ss_pred             hcCccccccccccCceEEEEEEe-CCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeee----CCeeEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE----GPESLL  371 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~l  371 (625)
                      .++|++.+.||+|+||.||+++. .+++.||||++........+.+.+|+.+++.++||||+++++++..    ....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            46799999999999999999997 4789999999987777778899999999999999999999999873    347899


Q ss_pred             EEEecCCCCcchhhhcc-CCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          372 VYEYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      ||||+++++|.+++... .....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            99999999999988652 22345899999999999999999999875   999999999999999999999999998764


Q ss_pred             CCCCcee--------eecCCCCccccCccccccCc---ccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhh
Q 042149          451 APDKTHV--------STGIAGTLGYMAPEYLVRGQ---LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK  519 (625)
Q Consensus       451 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~  519 (625)
                      .......        .....||+.|+|||++....   ++.++||||||+++|||++|+.|+..........        
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--------  256 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV--------  256 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH--------
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh--------
Confidence            3211100        01235799999999987543   6899999999999999999999864211111000        


Q ss_pred             ccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCCC
Q 042149          520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPP  577 (625)
Q Consensus       520 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~~  577 (625)
                          ...+......+.+...+..+.+++.+||+.||++|||+.++++.|+.+....+.
T Consensus       257 ----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~  310 (317)
T 2buj_A          257 ----ALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG  310 (317)
T ss_dssp             ----HHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred             ----hHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence                000111111122344567899999999999999999999999999987644443

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7e-42  Score=355.24  Aligned_cols=246  Identities=20%  Similarity=0.245  Sum_probs=203.1

Q ss_pred             hcCccccccccccCceEEEEEEe-CCCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .++|.+.+.||+|+||.||+|++ .+++.||||++....   ......+.+|+.+++.++||||+++++++...+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46899999999999999999997 478999999986432   22245788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+ +|+|.+++.....   +++.++..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~E~~-~g~l~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKKR---MTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 6788888765543   899999999999999999999875   99999999999999999999999999987654


Q ss_pred             CCceeeecCCCCccccCccccccCcc-cccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      ...  .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.|+.......              +.+.+... 
T Consensus       161 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--------------~~~~i~~~-  223 (336)
T 3h4j_B          161 GNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN--------------LFKKVNSC-  223 (336)
T ss_dssp             SBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT--------------CBCCCCSS-
T ss_pred             Ccc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH--------------HHHHHHcC-
Confidence            332  234579999999999988776 689999999999999999999975322111              11111111 


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ....|...+..+.+++.+||+.||++|||++|+++
T Consensus       224 ~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          224 VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            11234556778899999999999999999999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-42  Score=357.26  Aligned_cols=257  Identities=23%  Similarity=0.353  Sum_probs=201.0

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCE----EEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRN----IAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  370 (625)
                      .++|++.++||+|+||.||+|++. +++.    ||+|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            467999999999999999999964 4554    477776433 3445678999999999999999999999998754 88


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      +|+||+.+++|.+++....  ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            9999999999999986543  24899999999999999999999875   999999999999999999999999999876


Q ss_pred             CCCCce-eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          451 APDKTH-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       451 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      ...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+...... .             +.+.+.
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~-------------~~~~~~  233 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-E-------------ISSILE  233 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-G-------------HHHHHH
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH-H-------------HHHHHH
Confidence            443322 2223457889999999999999999999999999999999 88886432211 1             111111


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccC
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY  573 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  573 (625)
                      .....+.+...+..+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus       234 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          234 KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            222223355567789999999999999999999999999988753

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=7.1e-42  Score=346.55  Aligned_cols=255  Identities=23%  Similarity=0.319  Sum_probs=204.1

Q ss_pred             hcCccccccccccCceEEEEEEeCC----CCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPD----GRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      .++|++.+.||+|+||.||+|++.+    +..||||.+... .....+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            5689999999999999999998542    335999998765 44556789999999999999999999998764 46789


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||||+++++|.+++....  ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus        90 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            999999999999986543  34899999999999999999999875   9999999999999999999999999998765


Q ss_pred             CCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                      ...........+++.|+|||++.+..++.++||||||+++|||++ |+.|+...... ...    ......         
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-~~~----~~~~~~---------  230 (281)
T 3cc6_A          165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-DVI----GVLEKG---------  230 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-GHH----HHHHHT---------
T ss_pred             cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-HHH----HHHhcC---------
Confidence            443333344567889999999998999999999999999999998 99886533221 111    111111         


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      .....+...+..+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus       231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          231 DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence            11122344567799999999999999999999999999765

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.2e-41  Score=342.36  Aligned_cols=254  Identities=22%  Similarity=0.317  Sum_probs=207.0

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC--CeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG--PESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~--~~~~lV  372 (625)
                      .++|++.++||+|+||.||+|+++ ++.||||++...  .....+.+.+|+.++++++||||+++++++.+.  ...++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            467999999999999999999985 789999999754  345567899999999999999999999999877  788999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ .+|+||||||+||+++.++.++|.|||++.....
T Consensus        88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             EECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             ecccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            999999999999965432 34899999999999999999999652 2399999999999999999999999998754322


Q ss_pred             CCceeeecCCCCccccCccccccCcccc---cCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTE---KADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                            ....||+.|+|||++.+..++.   ++||||||+++|||++|+.|+.......    .....         ...
T Consensus       166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~---------~~~  226 (271)
T 3kmu_A          166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME----IGMKV---------ALE  226 (271)
T ss_dssp             ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH----HHHHH---------HHS
T ss_pred             ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH----HHHHH---------Hhc
Confidence                  2246899999999998766554   7999999999999999999875322110    00111         111


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      ......+...+..+.+++.+||+.||++|||++|+++.|+++.
T Consensus       227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          227 GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            1222334556778999999999999999999999999998764

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.4e-41  Score=353.27  Aligned_cols=269  Identities=16%  Similarity=0.193  Sum_probs=203.1

Q ss_pred             hcCccccccccccCceEEEEEEeC----CCCEEEEEEeecCChHH-----------HHHHHHHHHHHhcCCCCceeeeee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP----DGRNIAVKRLFFNSRQW-----------VDQFFNEVNLISGIQHKNVVRLLG  361 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpniv~l~~  361 (625)
                      .++|++.++||+|+||.||+|++.    ++..+|||++.......           ...+.+|+.+++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            467999999999999999999975    57889999987653211           123667889999999999999999


Q ss_pred             eeee----CCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC
Q 042149          362 CSIE----GPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL  437 (625)
Q Consensus       362 ~~~~----~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~  437 (625)
                      ++..    ....++||||+ +++|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            9987    77899999999 999999986544   4899999999999999999999875   99999999999998777


Q ss_pred             --ceEEeecccceeeCCCCce------eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCcc
Q 042149          438 --TPKIADFGLARHVAPDKTH------VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSS  509 (625)
Q Consensus       438 --~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~  509 (625)
                        .+||+|||+++.+......      ......||+.|+|||++.+..++.++||||||+++|||++|+.|+........
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              9999999999876432211      11345799999999999999999999999999999999999999753322222


Q ss_pred             chhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCC
Q 042149          510 VLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIP  576 (625)
Q Consensus       510 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~  576 (625)
                      ............. ...+.....   ....+..+.+++.+||+.+|++||++.+|++.|++....++
T Consensus       269 ~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  331 (345)
T 2v62_A          269 AVQTAKTNLLDEL-PQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLG  331 (345)
T ss_dssp             HHHHHHHHHHHTT-THHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCC
T ss_pred             HHHHHHHhhcccc-cHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCccc
Confidence            1111111111110 000000000   11345679999999999999999999999999998765443

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.8e-42  Score=355.59  Aligned_cols=262  Identities=26%  Similarity=0.374  Sum_probs=211.3

Q ss_pred             HHHhcCccccccccccCceEEEEEEeC------CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC
Q 042149          294 ERATDFFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG  366 (625)
Q Consensus       294 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  366 (625)
                      +...++|++.+.||+|+||.||+|++.      +++.||||++... .......+.+|+.+++.++||||+++++++.+.
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  100 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG  100 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence            344678999999999999999999854      3678999998754 344556789999999999999999999999999


Q ss_pred             CeeEEEEEecCCCCcchhhhccCC-------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCce
Q 042149          367 PESLLVYEYVPNRSLDQILFVKNT-------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP  439 (625)
Q Consensus       367 ~~~~lV~e~~~~~sL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~  439 (625)
                      +..++||||+++++|.+++.....       ...+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+
T Consensus       101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~  177 (322)
T 1p4o_A          101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV  177 (322)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred             CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeE
Confidence            999999999999999999865321       234789999999999999999999875   9999999999999999999


Q ss_pred             EEeecccceeeCCCCcee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHh
Q 042149          440 KIADFGLARHVAPDKTHV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKH  517 (625)
Q Consensus       440 kl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~  517 (625)
                      ||+|||+++......... .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.|+.... ..    .....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~----~~~~~  252 (322)
T 1p4o_A          178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NE----QVLRF  252 (322)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-HH----HHHHH
T ss_pred             EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC-HH----HHHHH
Confidence            999999998654332221 123456889999999999999999999999999999999 676653221 11    11111


Q ss_pred             hhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          518 YKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       518 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      .....         ....+...+..+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus       253 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          253 VMEGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             HHcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence            11111         12224456678999999999999999999999999998764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-42  Score=354.65  Aligned_cols=258  Identities=28%  Similarity=0.442  Sum_probs=203.0

Q ss_pred             hcCccccccccccCceEEEEEEeCC-----CCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPD-----GRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  370 (625)
                      .++|.+.+.||+|+||.||+|+++.     +..||||++... .......+.+|+.++++++||||+++++++.+.+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            3567888999999999999998642     235999999754 3445667899999999999999999999999999999


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      +||||+++++|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       123 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            9999999999999986542  34899999999999999999999875   999999999999999999999999999876


Q ss_pred             CCCCcee--eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhcccccccc
Q 042149          451 APDKTHV--STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSM  527 (625)
Q Consensus       451 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  527 (625)
                      .......  .....+|+.|+|||++.+..++.++||||||+++|||++ |+.|+.....     ........        
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~~~~~~~~--------  264 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HEVMKAIN--------  264 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHH--------
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-----HHHHHHHH--------
Confidence            5432211  123356889999999998999999999999999999999 8888643211     11111111        


Q ss_pred             CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccC
Q 042149          528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY  573 (625)
Q Consensus       528 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  573 (625)
                       .....+.+...+..+.+++.+||+.+|++||++.++++.|+++..
T Consensus       265 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          265 -DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             -TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -CCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence             111222344567789999999999999999999999999987643

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.3e-41  Score=345.69  Aligned_cols=262  Identities=28%  Similarity=0.379  Sum_probs=206.9

Q ss_pred             hcCccccccccccCceEEEEEEeCC----CCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeee-eCCeeE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPD----GRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSI-EGPESL  370 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~  370 (625)
                      ..+|++.++||+|+||.||+|++.+    ...+|||.+... .....+.+.+|+.++++++||||+++++++. .++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3468889999999999999998642    235899988653 4456678999999999999999999999854 556889


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      +||||+++++|.+++....  ..+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||+++..
T Consensus       104 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence            9999999999999996432  34899999999999999999999875   999999999999999999999999999876


Q ss_pred             CCCCc---eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccccccc
Q 042149          451 APDKT---HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM  527 (625)
Q Consensus       451 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  527 (625)
                      .....   .......+|+.|+|||.+.+..++.++||||||+++|+|++|+.|+..............    .       
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~----~-------  247 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL----Q-------  247 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH----T-------
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh----c-------
Confidence            44322   122345678899999999999999999999999999999997666433322222211111    1       


Q ss_pred             CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCC
Q 042149          528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIP  576 (625)
Q Consensus       528 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~  576 (625)
                        ......+...+..+.+++.+||+.+|++|||+.|+++.|+.+...+.
T Consensus       248 --~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          248 --GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             --CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence              11112234456779999999999999999999999999988765544

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=355.56  Aligned_cols=251  Identities=23%  Similarity=0.381  Sum_probs=200.0

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCC--CceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQH--KNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lV  372 (625)
                      .++|++.++||+|+||.||++...+++.||||++...  .....+.+.+|+.+|++++|  |||+++++++.+....++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            4579999999999999999999988999999998754  45556789999999999986  9999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      || +.+++|.+++....   .+++.++..++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||+++....
T Consensus        88 ~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             Ee-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99 56889999987544   3899999999999999999999875   99999999999997 56899999999987654


Q ss_pred             CCce-eeecCCCCccccCcccccc-----------CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhc
Q 042149          453 DKTH-VSTGIAGTLGYMAPEYLVR-----------GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKA  520 (625)
Q Consensus       453 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~  520 (625)
                      .... ......||+.|+|||++.+           ..++.++||||||+++|||++|+.|+......   ..        
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~--------  228 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---IS--------  228 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---HH--------
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH---HH--------
Confidence            3332 2234679999999999865           67889999999999999999999997432111   00        


Q ss_pred             cccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          521 NRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       521 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                       .+...+++......+...+..+.+++.+||+.||++|||+.|+++.
T Consensus       229 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          229 -KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             -HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence             1111222223333444456678999999999999999999999864

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2e-41  Score=344.58  Aligned_cols=261  Identities=21%  Similarity=0.323  Sum_probs=199.9

Q ss_pred             cCccccccccccCceEEEEEEeCCCCEEEEEEeecCCh--HHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR--QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ++|++.++||+|+||.||+|+..+++.||||++.....  ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            57999999999999999999998899999999965432  2346788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++ +|.+++....  ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             CSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            975 8888875432  34899999999999999999999875   99999999999999999999999999986643222


Q ss_pred             eeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcc------ccc--cc
Q 042149          456 HVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN------RIT--QS  526 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~------~~~--~~  526 (625)
                      . .....||+.|+|||++.+. .++.++||||||+++|||++|+.|+....... .+..........      ...  ..
T Consensus       156 ~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          156 K-YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             c-cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHCCCChhhchhhhcccc
Confidence            1 2235689999999999764 58999999999999999999999875432111 111111111000      000  00


Q ss_pred             cCCCCC-------CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          527 MDPGLT-------GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       527 i~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .++...       .......+..+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            111110       0112335677899999999999999999999985

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.4e-41  Score=355.35  Aligned_cols=245  Identities=22%  Similarity=0.295  Sum_probs=206.2

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .++|++.+.||+|+||.||+|+++ +++.||||++....   ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            367999999999999999999975 68999999996542   23456788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+++++|.+++.....   +++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~e~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EcCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence            999999999999975543   899999999999999999999876   99999999999999999999999999987644


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      ..    ....||+.|+|||++.+..++.++||||||+++|||++|+.|+.....     ...........          
T Consensus       194 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i~~~~----------  254 (350)
T 1rdq_E          194 RT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----IQIYEKIVSGK----------  254 (350)
T ss_dssp             CB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCC----------
T ss_pred             Cc----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-----HHHHHHHHcCC----------
Confidence            32    235799999999999999999999999999999999999998753211     11112211111          


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPS-----MAEVVH  566 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~  566 (625)
                      ..+|...+..+.+++.+||+.||++||+     ++||++
T Consensus       255 ~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          255 VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            1234455678999999999999999998     888875

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=348.73  Aligned_cols=246  Identities=27%  Similarity=0.332  Sum_probs=195.3

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l  371 (625)
                      ..++|++.++||+|+||+||+|++. +++.||||++...  .......+..|+..+.++ +||||+++++++.+++..++
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            3467999999999999999999976 7899999998653  233344555666666555 89999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||||+ +++|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       135 v~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EEECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             EEecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            99999 678888876543  34899999999999999999999875   9999999999999999999999999998764


Q ss_pred             CCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      ....  .....||+.|+|||++.+ .++.++||||||+++|||++|..|+...        ..+.......        .
T Consensus       209 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~--------~~~~~~~~~~--------~  269 (311)
T 3p1a_A          209 TAGA--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG--------EGWQQLRQGY--------L  269 (311)
T ss_dssp             --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH--------HHHHHHTTTC--------C
T ss_pred             cCCC--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc--------cHHHHHhccC--------C
Confidence            4322  234569999999998865 7899999999999999999997765321        1122221111        1


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ....+...+..+.+++.+||+.||++|||+.|+++
T Consensus       270 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          270 PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            11112334677999999999999999999999985

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.1e-42  Score=350.45  Aligned_cols=252  Identities=23%  Similarity=0.379  Sum_probs=205.4

Q ss_pred             hcCccccccccccCceEEEEEEeCC-C-------CEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPD-G-------RNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPE  368 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  368 (625)
                      .++|++.+.||+|+||.||+|++.. +       ..||+|++........+.+.+|+.++++++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            4679999999999999999998653 3       4699999977777777889999999999999999999999999999


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCc--------eE
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLT--------PK  440 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~--------~k  440 (625)
                      .++||||+++++|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            999999999999999996543  33899999999999999999999886   999999999999998876        99


Q ss_pred             EeecccceeeCCCCceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhh
Q 042149          441 IADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK  519 (625)
Q Consensus       441 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~  519 (625)
                      |+|||++......     ....+|+.|+|||++.+ ..++.++||||||+++|||++|+.|+.........    .....
T Consensus       162 l~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~----~~~~~  232 (289)
T 4fvq_A          162 LSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK----LQFYE  232 (289)
T ss_dssp             ECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH----HHHHH
T ss_pred             eccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH----HHHhh
Confidence            9999998654322     22457899999999987 67899999999999999999977664332211111    11111


Q ss_pred             ccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccC
Q 042149          520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY  573 (625)
Q Consensus       520 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  573 (625)
                      .           ....+...+..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus       233 ~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          233 D-----------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             T-----------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             c-----------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            0           001122234568899999999999999999999999988753

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.9e-41  Score=355.19  Aligned_cols=247  Identities=23%  Similarity=0.276  Sum_probs=197.7

Q ss_pred             ccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCCCC
Q 042149          302 NSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRS  380 (625)
Q Consensus       302 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~~s  380 (625)
                      ..+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||||+++++++.+.+..+|||||+++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            3668999999999999964 689999999988776677889999999999999999999999999999999999999999


Q ss_pred             cchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE--cCCCceEEeecccceeeCCCCceee
Q 042149          381 LDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL--DEKLTPKIADFGLARHVAPDKTHVS  458 (625)
Q Consensus       381 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll--~~~~~~kl~Dfgla~~~~~~~~~~~  458 (625)
                      |.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||+  +.++.+||+|||+++........  
T Consensus       173 L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~--  245 (373)
T 2x4f_A          173 LFDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--  245 (373)
T ss_dssp             EHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC--
T ss_pred             HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc--
Confidence            998886432  34899999999999999999999876   9999999999999  56789999999999877544322  


Q ss_pred             ecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChH
Q 042149          459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPEN  538 (625)
Q Consensus       459 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  538 (625)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.|+...... ..    .........      .........
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-~~----~~~i~~~~~------~~~~~~~~~  314 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-ET----LNNILACRW------DLEDEEFQD  314 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-HH----HHHHHHTCC------CSCSGGGTT
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-HH----HHHHHhccC------CCChhhhcc
Confidence            2346999999999999899999999999999999999999987533211 11    111111110      000111123


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          539 EASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       539 ~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .+..+.+++.+||+.||++|||+.|+++
T Consensus       315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          315 ISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            4677899999999999999999999987

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.7e-41  Score=353.37  Aligned_cols=252  Identities=22%  Similarity=0.272  Sum_probs=191.2

Q ss_pred             HHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ...++|++.++||+|+||.||+|+++ +++.||||++....  ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            34678999999999999999999976 58899999987543  3456889999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC---CCceEEeecccceee
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE---KLTPKIADFGLARHV  450 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~---~~~~kl~Dfgla~~~  450 (625)
                      ||+++++|.+++....   .+++.+++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+++..
T Consensus       128 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          128 ELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             CCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             EeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            9999999999886443   3899999999999999999999875   999999999999975   889999999999865


Q ss_pred             CCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          451 APDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                      ....  ......||+.|+|||++.+..++.++||||||+++|||++|+.|+........    ..........      .
T Consensus       202 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~~i~~~~~------~  269 (349)
T 2w4o_A          202 EHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF----MFRRILNCEY------Y  269 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH----HHHHHHTTCC------C
T ss_pred             Cccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH----HHHHHHhCCC------c
Confidence            4322  12345799999999999999999999999999999999999999753322111    1111111110      1


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ...+.....+..+.+++.+||+.||++|||+.|+++
T Consensus       270 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          270 FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111222455678899999999999999999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.3e-41  Score=344.61  Aligned_cols=257  Identities=26%  Similarity=0.367  Sum_probs=207.3

Q ss_pred             hcCccccc-cccccCceEEEEEEe---CCCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeE
Q 042149          297 TDFFDNSR-KLGQGGAGSVFRGTL---PDGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       297 ~~~y~~~~-~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  370 (625)
                      .++|.+.+ .||+|+||.||+|.+   .+++.||||++....  ....+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45688877 999999999999964   246889999986542  34467899999999999999999999998 667889


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      +||||+++++|.+++....   .+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus        94 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            9999999999999997543   3899999999999999999999875   999999999999999999999999999877


Q ss_pred             CCCCceee--ecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhcccccccc
Q 042149          451 APDKTHVS--TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSM  527 (625)
Q Consensus       451 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  527 (625)
                      ........  ....+++.|+|||.+.+..++.++||||||+++|+|++ |+.|+..... .    .......        
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~----~~~~~~~--------  234 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-S----EVTAMLE--------  234 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-H----HHHHHHH--------
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-H----HHHHHHH--------
Confidence            65443322  23356789999999999999999999999999999999 9888643211 1    1111111        


Q ss_pred             CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCC
Q 042149          528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYE  574 (625)
Q Consensus       528 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  574 (625)
                       .......+...+..+.+++.+||+.||++||++.++++.|+++...
T Consensus       235 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          235 -KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             -TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             -cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence             1112233456677899999999999999999999999999887543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.9e-41  Score=353.73  Aligned_cols=253  Identities=22%  Similarity=0.223  Sum_probs=194.8

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      .++|++.++||+|+||+||+++.. +++.||||++..... ..+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            568999999999999999999976 789999999975432 235688999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCc--eEEeecccceeeCCC
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLT--PKIADFGLARHVAPD  453 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~--~kl~Dfgla~~~~~~  453 (625)
                      +++++|.+++.....   +++..++.++.|++.||.|||+++   |+||||||+|||++.++.  +||+|||+++.....
T Consensus        98 ~~~~~L~~~l~~~~~---~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           98 ASGGELYERICNAGR---FSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             CCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            999999998865443   899999999999999999999875   999999999999987665  999999999754322


Q ss_pred             CceeeecCCCCccccCccccccCccccc-CcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLTEK-ADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      ..  .....||+.|+|||++.+..++.+ +||||||+++|+|++|+.|+............... ...        ....
T Consensus       172 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~-~~~--------~~~~  240 (361)
T 3uc3_A          172 SQ--PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR-ILS--------VKYS  240 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHH-HHT--------TCCC
T ss_pred             CC--CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHH-Hhc--------CCCC
Confidence            22  233579999999999988877655 89999999999999999997644333222211111 111        1111


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      .+.....+..+.+|+.+||+.+|++|||+.|+++.
T Consensus       241 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          241 IPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            11122345678999999999999999999999863

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5.4e-42  Score=357.43  Aligned_cols=249  Identities=21%  Similarity=0.271  Sum_probs=204.9

Q ss_pred             HHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCee
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPES  369 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~  369 (625)
                      ...++|++.+.||+|+||.||+|+++ +++.||||++....   ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            34678999999999999999999975 68899999997542   23456788899999877 899999999999999999


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      ++||||++||+|.+++....   .+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        94 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            99999999999999986543   3899999999999999999999875   99999999999999999999999999986


Q ss_pred             eCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          450 VAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      ...... .....+||+.|+|||++.+..++.++||||||+++|||++|+.|+.....     ...+.......       
T Consensus       168 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i~~~~-------  234 (345)
T 1xjd_A          168 NMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----EELFHSIRMDN-------  234 (345)
T ss_dssp             CCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCC-------
T ss_pred             cccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHHhCC-------
Confidence            433222 23346899999999999999999999999999999999999998753211     11112111111       


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMA-EVV  565 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-ev~  565 (625)
                         ..++...+..+.+++.+||+.||++||++. +|+
T Consensus       235 ---~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          235 ---PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ---CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence               123445567889999999999999999997 665

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.4e-41  Score=350.00  Aligned_cols=268  Identities=28%  Similarity=0.369  Sum_probs=214.6

Q ss_pred             cHHHHHHHhcCccccccccccCceEEEEEEe------CCCCEEEEEEeecC-ChHHHHHHHHHHHHHhcC-CCCceeeee
Q 042149          289 KYEILERATDFFDNSRKLGQGGAGSVFRGTL------PDGRNIAVKRLFFN-SRQWVDQFFNEVNLISGI-QHKNVVRLL  360 (625)
Q Consensus       289 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~  360 (625)
                      ....++...++|++.+.||+|+||.||+|++      .+++.||||++... .....+.+.+|+.+++++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3444455568899999999999999999984      25688999999764 344567899999999999 699999999


Q ss_pred             eeeeeCC-eeEEEEEecCCCCcchhhhccCC-------------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeee
Q 042149          361 GCSIEGP-ESLLVYEYVPNRSLDQILFVKNT-------------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDI  426 (625)
Q Consensus       361 ~~~~~~~-~~~lV~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDl  426 (625)
                      +++...+ ..++||||+++++|.+++.....             ...+++..++.++.|++.||.|||+.+   |+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence            9987654 58999999999999999975432             123789999999999999999999875   999999


Q ss_pred             ccCcEEEcCCCceEEeecccceeeCCCCce-eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCC
Q 042149          427 KTSNILLDEKLTPKIADFGLARHVAPDKTH-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFS  504 (625)
Q Consensus       427 kp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~  504 (625)
                      ||+||+++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||+| |+.|+...
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            999999999999999999999876544332 2234567899999999999999999999999999999998 88886543


Q ss_pred             CCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          505 EGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      ......    ........         ....+...+..+.+++.+||+.+|++|||+.|+++.|+.+.
T Consensus       255 ~~~~~~----~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          255 KIDEEF----CRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             CCSHHH----HHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chhHHH----HHHhccCc---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            322211    11111111         11223445677899999999999999999999999998763

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-41  Score=345.34  Aligned_cols=260  Identities=25%  Similarity=0.332  Sum_probs=208.2

Q ss_pred             CccccccccccCceEEEEEEeC-CC---CEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCee-EEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DG---RNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPES-LLV  372 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~-~lV  372 (625)
                      .|...++||+|+||.||+|++. ++   ..+|+|++... .....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4566789999999999999853 22   36999998654 445667899999999999999999999999876655 999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+.+++|.+++....  ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       102 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            99999999999986532  34899999999999999999999876   99999999999999999999999999976543


Q ss_pred             CCc---eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          453 DKT---HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       453 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      ...   .......+++.|+|||.+.+..++.++||||||+++|+|++|+.|+.............             ..
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~-------------~~  243 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL-------------AQ  243 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH-------------HT
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh-------------hc
Confidence            221   11224568899999999999999999999999999999999877754332222211111             11


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCC
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIP  576 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~  576 (625)
                      ......+...+..+.+++.+||+.+|++|||+.++++.|+++...+.
T Consensus       244 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          244 GRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             CCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence            11122344556789999999999999999999999999988865554

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.8e-41  Score=350.22  Aligned_cols=272  Identities=24%  Similarity=0.358  Sum_probs=200.4

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHH--HHHHhcCCCCceeeeeeeeee-----CCee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNE--VNLISGIQHKNVVRLLGCSIE-----GPES  369 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E--~~~l~~l~hpniv~l~~~~~~-----~~~~  369 (625)
                      .++|++.++||+|+||.||+|+. +++.||||++.....   ..+..|  +..+..++||||+++++.+..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            46899999999999999999987 679999999975443   233444  444556899999999985542     3367


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCC------CceEEEeeeccCcEEEcCCCceEEee
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS------GIKIIHRDIKTSNILLDEKLTPKIAD  443 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~iiHrDlkp~NIll~~~~~~kl~D  443 (625)
                      ++||||+++++|.+++....    .++..++.++.||+.||.|||+..      ..+|+||||||+||||+.++.+||+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred             EEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence            89999999999999995443    588999999999999999999760      01499999999999999999999999


Q ss_pred             cccceeeCCCCc-------eeeecCCCCccccCcccccc-------CcccccCcEEeehhhhHHHHhCCCCCCCCCCCcc
Q 042149          444 FGLARHVAPDKT-------HVSTGIAGTLGYMAPEYLVR-------GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSS  509 (625)
Q Consensus       444 fgla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~  509 (625)
                      ||+++.+.....       .......||+.|+|||++.+       ..++.++||||||+++|||++|+.|+........
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  243 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE  243 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence            999987653221       11224579999999999976       4677899999999999999999877644332222


Q ss_pred             chhhHHHhhhcc----cc-----ccccCCCCCC--CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCC
Q 042149          510 VLHTVWKHYKAN----RI-----TQSMDPGLTG--RFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIP  576 (625)
Q Consensus       510 ~~~~~~~~~~~~----~~-----~~~i~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~  576 (625)
                      ............    .+     .....+.+..  ......+..+.+++.+||+.||++|||+.|+++.|+++...+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~  321 (336)
T 3g2f_A          244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE  321 (336)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred             HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence            111111100000    00     0000111111  1123577789999999999999999999999999988765444

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.6e-41  Score=342.30  Aligned_cols=255  Identities=27%  Similarity=0.490  Sum_probs=203.6

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCCh----HH---HHHHHHHHHHHhcCCCCceeeeeeeeeeCCe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSR----QW---VDQFFNEVNLISGIQHKNVVRLLGCSIEGPE  368 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  368 (625)
                      .++|++.+.||+|+||.||+|++. +++.||||++.....    ..   .+.+.+|+.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            467999999999999999999974 789999999865422    11   167899999999999999999999986655 


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCc-----eEEee
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLT-----PKIAD  443 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~-----~kl~D  443 (625)
                       ++||||+++++|.+.+....  ..+++..++.++.|++.||.|||+.+ .+|+||||||+|||++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             79999999999988885443  34899999999999999999999662 23999999999999987776     99999


Q ss_pred             cccceeeCCCCceeeecCCCCccccCcccc--ccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcc
Q 042149          444 FGLARHVAPDKTHVSTGIAGTLGYMAPEYL--VRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN  521 (625)
Q Consensus       444 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  521 (625)
                      ||+++....    ......||+.|+|||++  ....++.++||||||+++|||++|+.|+.........  . .....  
T Consensus       173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~-~~~~~--  243 (287)
T 4f0f_A          173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK--F-INMIR--  243 (287)
T ss_dssp             CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH--H-HHHHH--
T ss_pred             CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH--H-HHHHh--
Confidence            999975433    23346799999999998  4556889999999999999999999997543222110  0 11111  


Q ss_pred             ccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          522 RITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       522 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                            ........+...+..+.+++.+||+.||++|||++|+++.|+++
T Consensus       244 ------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          244 ------EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ------HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ------ccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                  11222233556677899999999999999999999999999764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.5e-41  Score=349.66  Aligned_cols=265  Identities=24%  Similarity=0.379  Sum_probs=201.2

Q ss_pred             HHhcCccccccccccCceEEEEEEeC----CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC-
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLP----DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP-  367 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-  367 (625)
                      ...++|.+.+.||+|+||.||+|.+.    +++.||||++...  .....+.+.+|+.++++++||||+++++++.+.. 
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            34578999999999999999999854    3457999998654  4555678999999999999999999999988755 


Q ss_pred             ----eeEEEEEecCCCCcchhhhcc---CCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceE
Q 042149          368 ----ESLLVYEYVPNRSLDQILFVK---NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPK  440 (625)
Q Consensus       368 ----~~~lV~e~~~~~sL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~k  440 (625)
                          ..++||||+++++|.+++...   .....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+|
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence                359999999999999988532   23345899999999999999999999775   99999999999999999999


Q ss_pred             EeecccceeeCCCCce-eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhh
Q 042149          441 IADFGLARHVAPDKTH-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHY  518 (625)
Q Consensus       441 l~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~  518 (625)
                      |+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..|+..... ...    ....
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~----~~~~  262 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-HEM----YDYL  262 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-GGH----HHHH
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH-HHH----HHHH
Confidence            9999999876443221 1223457889999999999999999999999999999999 7666543221 111    1111


Q ss_pred             hccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCC
Q 042149          519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIP  576 (625)
Q Consensus       519 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~  576 (625)
                      ..         ......+...+..+.+++.+||+.+|++|||+.++++.|+++...+|
T Consensus       263 ~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          263 LH---------GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             HT---------TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             Hc---------CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            11         11122344566789999999999999999999999999988765544

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.5e-41  Score=357.24  Aligned_cols=271  Identities=24%  Similarity=0.308  Sum_probs=215.2

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC--eeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP--ESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~~lV  372 (625)
                      .++|.+.++||+|+||.||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++.+..  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            467999999999999999999976 58999999996542 334567889999999999999999999998765  77999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE----cCCCceEEeecccce
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL----DEKLTPKIADFGLAR  448 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll----~~~~~~kl~Dfgla~  448 (625)
                      |||+++++|.+++........+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999976555455899999999999999999999876   9999999999999    777889999999998


Q ss_pred             eeCCCCceeeecCCCCccccCcccccc--------CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhc
Q 042149          449 HVAPDKTHVSTGIAGTLGYMAPEYLVR--------GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKA  520 (625)
Q Consensus       449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~  520 (625)
                      .......  .....||+.|+|||++.+        ..++.++||||||+++|||++|+.|+...................
T Consensus       165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             ECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             EccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            7654332  234579999999999865        578899999999999999999999986443332222222221111


Q ss_pred             cc---cccc---------c--CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          521 NR---ITQS---------M--DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       521 ~~---~~~~---------i--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      ..   +...         .  +.......+...+..+.+++.+||+.||++||++.|+++.+.++.
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il  308 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence            10   0000         0  111122345778889999999999999999999999998887653

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.7e-41  Score=347.32  Aligned_cols=263  Identities=18%  Similarity=0.189  Sum_probs=201.2

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      ..++|++.++||+|+||.||+|++. +++.||||++...   .....+.+.+|+.++++++||||+++++++..++..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3578999999999999999999975 6889999998654   34446789999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||||+++++|.+++....   .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       112 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            999999999999987554   3899999999999999999999875   9999999999999999999999999998765


Q ss_pred             CCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      ...........|++.|+|||++.+..++.++||||||+++|||++|+.|+.....     ........... .      .
T Consensus       186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~-~------~  253 (309)
T 2h34_A          186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-----SVMGAHINQAI-P------R  253 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-----HHHHHHHHSCC-C------C
T ss_pred             ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-----HHHHHHhccCC-C------C
Confidence            4433333445799999999999999999999999999999999999998753211     11111111100 0      0


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHccccCCCC
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRP-SMAEVVHMLNNIDYEIP  576 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~ev~~~L~~~~~~l~  576 (625)
                      ....+...+..+.+++.+||+.||++|| +++++++.|+.......
T Consensus       254 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          254 PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            0112334566789999999999999999 99999999987754443

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.6e-40  Score=346.36  Aligned_cols=272  Identities=25%  Similarity=0.334  Sum_probs=212.9

Q ss_pred             cccHHHHHHHhcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhc--CCCCceeeeeeeee
Q 042149          287 NFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISG--IQHKNVVRLLGCSI  364 (625)
Q Consensus       287 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpniv~l~~~~~  364 (625)
                      ..+....+...++|.+.+.||+|+||.||+|++ +++.||||++....   ...+.+|++++..  ++||||+++++++.
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            344555667788999999999999999999998 58999999986433   3567788888887  78999999999998


Q ss_pred             eCC----eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhh--------cCCCceEEEeeeccCcEE
Q 042149          365 EGP----ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH--------GGSGIKIIHRDIKTSNIL  432 (625)
Q Consensus       365 ~~~----~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~iiHrDlkp~NIl  432 (625)
                      ...    ..++||||+++++|.+++...    .+++..++.++.|++.||.|||        +.   +|+||||||+|||
T Consensus       107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIl  179 (342)
T 1b6c_B          107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNIL  179 (342)
T ss_dssp             CCCSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEE
T ss_pred             ccCCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEE
Confidence            776    789999999999999999643    3899999999999999999999        55   5999999999999


Q ss_pred             EcCCCceEEeecccceeeCCCCcee---eecCCCCccccCccccccC------cccccCcEEeehhhhHHHHhC------
Q 042149          433 LDEKLTPKIADFGLARHVAPDKTHV---STGIAGTLGYMAPEYLVRG------QLTEKADVYAFGVLVIEVASG------  497 (625)
Q Consensus       433 l~~~~~~kl~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~ll~elltG------  497 (625)
                      |+.++.+||+|||++..........   .....||+.|+|||++.+.      .++.++||||||+++|||+||      
T Consensus       180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~  259 (342)
T 1b6c_B          180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  259 (342)
T ss_dssp             ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred             ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence            9999999999999998776544332   2345799999999999765      455789999999999999999      


Q ss_pred             ----CCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC-CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          498 ----RRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR-FPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       498 ----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                          +.|+.....................    ..+.+... .....+..+.+++.+||+.||++|||+.||++.|+++.
T Consensus       260 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~  335 (342)
T 1b6c_B          260 HEDYQLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  335 (342)
T ss_dssp             CCCCCCTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccccccCccccCcCcccHHHHHHHHHHHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence                4554332222222222222111111    11111111 12367788999999999999999999999999998875


Q ss_pred             C
Q 042149          573 Y  573 (625)
Q Consensus       573 ~  573 (625)
                      .
T Consensus       336 ~  336 (342)
T 1b6c_B          336 Q  336 (342)
T ss_dssp             H
T ss_pred             H
Confidence            3

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.8e-41  Score=358.52  Aligned_cols=250  Identities=23%  Similarity=0.376  Sum_probs=199.5

Q ss_pred             cCccccccccccCceEEEEEEeCCCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCC--CCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQ--HKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~lV~  373 (625)
                      +.|++.++||+|+||.||+|...+++.||||++...  .....+.+.+|+.+|++++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            469999999999999999999888999999998654  4556788999999999996  599999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      | +.+++|.+++....   .+++.++..++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||+++.+...
T Consensus       136 E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             E-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             e-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            9 56889999987554   4889999999999999999999775   99999999999996 579999999999876543


Q ss_pred             Cce-eeecCCCCccccCcccccc-----------CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcc
Q 042149          454 KTH-VSTGIAGTLGYMAPEYLVR-----------GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN  521 (625)
Q Consensus       454 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  521 (625)
                      ... ......||+.|+|||++.+           ..++.++|||||||++|||++|+.|+......   ...        
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~--------  276 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---ISK--------  276 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHH--------
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH---HHH--------
Confidence            322 2234679999999999865           36889999999999999999999997532111   011        


Q ss_pred             ccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          522 RITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       522 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                       +...+++......+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus       277 -~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          277 -LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             -HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence             111222222223333445678999999999999999999999864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.6e-41  Score=352.79  Aligned_cols=260  Identities=22%  Similarity=0.162  Sum_probs=202.2

Q ss_pred             HHHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC-----ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC
Q 042149          293 LERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN-----SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG  366 (625)
Q Consensus       293 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  366 (625)
                      +..+.++|++.+.||+|+||.||+|+.+ +++.||||++...     .....+.+.+|+.++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            4566789999999999999999999975 6889999998653     344567899999999999999999999999999


Q ss_pred             CeeEEEEEecCCCCcchhhhccC-------------------------------------CcCCCCHHHHHHHHHHHHHH
Q 042149          367 PESLLVYEYVPNRSLDQILFVKN-------------------------------------TIHILSWQQRFTIICGTAEG  409 (625)
Q Consensus       367 ~~~~lV~e~~~~~sL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~i~~~  409 (625)
                      +..++||||+++++|.+++....                                     ....+++..++.++.||+.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            99999999999999999884210                                     01124577888999999999


Q ss_pred             HHHhhcCCCceEEEeeeccCcEEEcCCC--ceEEeecccceeeCCCCc---eeeecCCCCccccCcccccc--CcccccC
Q 042149          410 LAHLHGGSGIKIIHRDIKTSNILLDEKL--TPKIADFGLARHVAPDKT---HVSTGIAGTLGYMAPEYLVR--GQLTEKA  482 (625)
Q Consensus       410 L~~LH~~~~~~iiHrDlkp~NIll~~~~--~~kl~Dfgla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~  482 (625)
                      |.|||+.+   |+||||||+|||++.++  .+||+|||+++.+.....   .......||+.|+|||++.+  ..++.++
T Consensus       181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999875   99999999999998766  899999999987643221   12234679999999999975  6789999


Q ss_pred             cEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHH
Q 042149          483 DVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMA  562 (625)
Q Consensus       483 Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~  562 (625)
                      ||||||+++|||++|+.|+.......    ..........       ....+.....+..+.+++.+||+.+|++|||+.
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~----~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  326 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDAD----TISQVLNKKL-------CFENPNYNVLSPLARDLLSNLLNRNVDERFDAM  326 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCC-------CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHH----HHHHHHhccc-------ccCCcccccCCHHHHHHHHHHcCCChhHCCCHH
Confidence            99999999999999999875332111    1111111100       001111223567889999999999999999999


Q ss_pred             HHHH
Q 042149          563 EVVH  566 (625)
Q Consensus       563 ev~~  566 (625)
                      |+++
T Consensus       327 ~~l~  330 (345)
T 3hko_A          327 RALQ  330 (345)
T ss_dssp             HHHH
T ss_pred             HHhc
Confidence            9986

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.1e-41  Score=354.03  Aligned_cols=249  Identities=22%  Similarity=0.242  Sum_probs=205.3

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~  370 (625)
                      ..++|++.+.||+|+||.||+|+.+ +++.||||++....   ....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3578999999999999999999976 47899999997542   23456788999999988 7999999999999999999


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      +||||++||+|.+++....   .+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        98 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            9999999999999987544   3899999999999999999999875   999999999999999999999999999864


Q ss_pred             CCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          451 APDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                      ..... .....+||+.|+|||++.+..++.++||||||+++|||++|+.|+.....     ...........        
T Consensus       172 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~~--------  237 (353)
T 2i0e_A          172 IWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQSIMEHN--------  237 (353)
T ss_dssp             CCTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCC--------
T ss_pred             ccCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhCC--------
Confidence            33222 23346899999999999999999999999999999999999999753211     11111111111        


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPS-----MAEVVH  566 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~  566 (625)
                        ..+|...+..+.+++.+||+.||++||+     +++|++
T Consensus       238 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          238 --VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             --CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             --CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence              1234556778999999999999999995     577764

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.4e-41  Score=350.59  Aligned_cols=248  Identities=25%  Similarity=0.326  Sum_probs=195.3

Q ss_pred             hcCccccccccccCceEEEEEEe----CCCCEEEEEEeecCC----hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL----PDGRNIAVKRLFFNS----RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPE  368 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  368 (625)
                      .++|++.++||+|+||.||+|+.    .+++.||||++....    ......+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46799999999999999999986    478999999986542    2345668899999999999999999999999999


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      .++||||+++++|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            999999999999999886544   3889999999999999999999875   9999999999999999999999999997


Q ss_pred             eeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          449 HVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      ....... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+...... .    .........      
T Consensus       170 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~----~~~~i~~~~------  237 (327)
T 3a62_A          170 ESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK-K----TIDKILKCK------  237 (327)
T ss_dssp             ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-H----HHHHHHHTC------
T ss_pred             ccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH-H----HHHHHHhCC------
Confidence            6433222 223467999999999999989999999999999999999999987532211 1    111111111      


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRP-----SMAEVVH  566 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~  566 (625)
                          ...+...+..+.+++.+||+.||++||     ++.|+++
T Consensus       238 ----~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 ----LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ----CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                122445567889999999999999999     7888876

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.5e-41  Score=352.93  Aligned_cols=262  Identities=27%  Similarity=0.370  Sum_probs=211.0

Q ss_pred             HHhcCccccccccccCceEEEEEEeCC-C-----CEEEEEEeecC-ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeC
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLPD-G-----RNIAVKRLFFN-SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEG  366 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  366 (625)
                      ...++|++.+.||+|+||.||+|.+.. +     +.||||.+... .....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  122 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG  122 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence            345789999999999999999999642 2     47999999755 345567899999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCCcchhhhccCC-----------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC
Q 042149          367 PESLLVYEYVPNRSLDQILFVKNT-----------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE  435 (625)
Q Consensus       367 ~~~~lV~e~~~~~sL~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~  435 (625)
                      +..++||||+++++|.+++.....           ...+++..++.++.|++.||.|||+++   |+||||||+|||++.
T Consensus       123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~  199 (333)
T 2i1m_A          123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN  199 (333)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEG
T ss_pred             CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECC
Confidence            999999999999999999865321           234799999999999999999999875   999999999999999


Q ss_pred             CCceEEeecccceeeCCCCce-eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhh
Q 042149          436 KLTPKIADFGLARHVAPDKTH-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHT  513 (625)
Q Consensus       436 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~  513 (625)
                      ++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||+| |..|+.........   
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---  276 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF---  276 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH---
T ss_pred             CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH---
Confidence            999999999999866443322 2234457889999999999999999999999999999999 77776433222111   


Q ss_pred             HHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          514 VWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       514 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                       ......         ......+...+..+.+++.+||+.+|++|||+.||++.|+++.
T Consensus       277 -~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          277 -YKLVKD---------GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             -HHHHHH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHHHhc---------CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence             111111         1111223344677899999999999999999999999997653

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.1e-41  Score=340.13  Aligned_cols=247  Identities=21%  Similarity=0.266  Sum_probs=205.2

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      ..++|++.++||+|+||.||+|+++ ++..+|+|++........+.+.+|++++++++||||+++++++.+....++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            4567999999999999999999975 578899999987655567889999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE---cCCCceEEeecccceeeC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL---DEKLTPKIADFGLARHVA  451 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll---~~~~~~kl~Dfgla~~~~  451 (625)
                      |+++++|.+++.....   +++..++.++.|++.||.|||+++   |+||||||+||++   +.++.+||+|||++....
T Consensus        87 ~~~~~~L~~~~~~~~~---~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           87 LCTGGELFERVVHKRV---FRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ccCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            9999999998865543   899999999999999999999876   9999999999999   788999999999998765


Q ss_pred             CCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      .....  ....||+.|+|||++.+ .++.++||||||+++|+|++|+.|+......     ..........         
T Consensus       161 ~~~~~--~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~---------  223 (277)
T 3f3z_A          161 PGKMM--RTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS-----EVMLKIREGT---------  223 (277)
T ss_dssp             TTSCB--CCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHCC---------
T ss_pred             Cccch--hccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHhCC---------
Confidence            44322  33579999999998865 4899999999999999999999997532211     1111111111         


Q ss_pred             CCCCCh----HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          532 TGRFPE----NEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       532 ~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                       ...+.    ..+..+.+++.+||+.+|++|||+.++++
T Consensus       224 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          224 -FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             -CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             01121    34677899999999999999999999975

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-41  Score=358.73  Aligned_cols=260  Identities=28%  Similarity=0.380  Sum_probs=197.1

Q ss_pred             CccccccccccCceEEEEEEeC--CC--CEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeee-eCCeeEEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP--DG--RNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSI-EGPESLLV  372 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~~lV  372 (625)
                      .|++.++||+|+||.||+|++.  ++  ..||||.+... .....+.+.+|+.++++++||||+++++++. .++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4677889999999999999863  22  35899988643 4456788999999999999999999999865 45688999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+++++|.+++....  ..+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       170 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence            99999999999996433  34789999999999999999999875   99999999999999999999999999986543


Q ss_pred             CCce---eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          453 DKTH---VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       453 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      ....   ......+|+.|+|||++.+..++.++||||||+++|||+||+.|+.......+.....    ...        
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~----~~~--------  312 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQG--------  312 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH----HTT--------
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH----HcC--------
Confidence            3221   1223467889999999999999999999999999999999555433222222221111    111        


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCC
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIP  576 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~  576 (625)
                       .....+...+..+.+++.+||+.+|++|||+.|+++.|+.+...+.
T Consensus       313 -~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          313 -RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             -CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence             1112244556789999999999999999999999999988765544

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.9e-41  Score=348.26  Aligned_cols=262  Identities=19%  Similarity=0.261  Sum_probs=208.0

Q ss_pred             cHHHHHHHhcCcccc-ccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCC-CCceeeeeeee
Q 042149          289 KYEILERATDFFDNS-RKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQ-HKNVVRLLGCS  363 (625)
Q Consensus       289 ~~~~~~~~~~~y~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~  363 (625)
                      .++..+.+.++|.+. ++||+|+||.||+|+.+ +++.||||++...  .......+.+|+.+++.+. ||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            445567778889888 89999999999999976 6899999998653  2334578899999999995 69999999999


Q ss_pred             eeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC---CCceE
Q 042149          364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE---KLTPK  440 (625)
Q Consensus       364 ~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~---~~~~k  440 (625)
                      .+....++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.   ++.+|
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~k  174 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIK  174 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEE
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEE
Confidence            99999999999999999999885432 244899999999999999999999875   999999999999987   78999


Q ss_pred             EeecccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhc
Q 042149          441 IADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKA  520 (625)
Q Consensus       441 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~  520 (625)
                      |+|||+++.......  .....||+.|+|||++.+..++.++||||||+++|+|++|+.|+.......     .......
T Consensus       175 L~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~~~i~~  247 (327)
T 3lm5_A          175 IVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-----TYLNISQ  247 (327)
T ss_dssp             ECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHH
T ss_pred             EeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHHHHh
Confidence            999999987654322  233579999999999999999999999999999999999999875332111     1111111


Q ss_pred             cccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          521 NRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       521 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      .      ......+.....+..+.+++.+||+.||++|||++|+++.
T Consensus       248 ~------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          248 V------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             T------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             c------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            0      1111122234556778999999999999999999999863

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.6e-41  Score=348.29  Aligned_cols=270  Identities=23%  Similarity=0.343  Sum_probs=213.8

Q ss_pred             hcCccccccccccCceEEEEEEe-----CCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC--ee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL-----PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP--ES  369 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~--~~  369 (625)
                      .++|++.++||+|+||.||+|+.     .+++.||||++........+.+.+|+.++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            45689999999999999999983     368899999998777777788999999999999999999999887544  78


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      ++||||+++++|.+++....  ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            99999999999999986543  24899999999999999999999875   99999999999999999999999999988


Q ss_pred             eCCCCcee--eecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHH----Hhhhcccc
Q 042149          450 VAPDKTHV--STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVW----KHYKANRI  523 (625)
Q Consensus       450 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~----~~~~~~~~  523 (625)
                      ........  .....++..|+|||++.+..++.++||||||+++|||+||..|+.....  .......    .......+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA--EFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH--HHHHHHCTTCCTHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH--HHHHhhccccchhhhHHHH
Confidence            75544322  1234578889999999999999999999999999999999987542210  0000000    00000011


Q ss_pred             ccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccC
Q 042149          524 TQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY  573 (625)
Q Consensus       524 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  573 (625)
                      .+.+......+.+...+..+.+++.+||+.+|++|||+.||++.|+++..
T Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            12222222233455667889999999999999999999999999987643

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=9e-41  Score=338.75  Aligned_cols=252  Identities=24%  Similarity=0.304  Sum_probs=206.4

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      ..++|++.++||+|+||.||+|.++ +++.||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            4678999999999999999999975 6899999998654  445567889999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCc---eEEeeccccee
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLT---PKIADFGLARH  449 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~---~kl~Dfgla~~  449 (625)
                      |||+++++|.+.+....   .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.   +||+|||++..
T Consensus        84 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           84 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            99999999988886554   3899999999999999999999876   999999999999986654   99999999987


Q ss_pred             eCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          450 VAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      ......  .....||+.|+|||++.+..++.++||||||+++|+|++|+.|+......     ............     
T Consensus       158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~-----  225 (284)
T 3kk8_A          158 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-----RLYAQIKAGAYD-----  225 (284)
T ss_dssp             CCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHTCCC-----
T ss_pred             cccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-----HHHHHHHhcccc-----
Confidence            654332  23457999999999999999999999999999999999999997432211     111111111100     


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                       ...+.....+..+.+++.+||+.+|++|||+.|+++
T Consensus       226 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          226 -YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             -CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence             011112344677899999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.4e-41  Score=345.76  Aligned_cols=266  Identities=20%  Similarity=0.325  Sum_probs=202.6

Q ss_pred             hcCccccccccccCceEEEEEEe-CCCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .++|++.+.||+|+||.||+|.. .+++.||||++...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            46799999999999999999996 47899999999752   455667899999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhcc-CCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          373 YEYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      |||+++++|.+++... .....+++..++.++.+++.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999988642 12344899999999999999999999875   9999999999999999999999999988654


Q ss_pred             CCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      ..... .....|++.|+|||++.+..++.++||||||+++|+|++|+.|+.......   ...........        .
T Consensus       188 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~--------~  255 (310)
T 2wqm_A          188 SKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---YSLCKKIEQCD--------Y  255 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH---HHHHHHHHTTC--------S
T ss_pred             CCCcc-ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH---HHHHHHhhccc--------C
Confidence            43222 223568999999999999999999999999999999999999875322111   01111111111        0


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCCC
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPP  577 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~~  577 (625)
                      ....+...+..+.+++.+||+.||++|||+.+|++.|+++......
T Consensus       256 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~  301 (310)
T 2wqm_A          256 PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS  301 (310)
T ss_dssp             CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence            1111234566789999999999999999999999999988655443

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.5e-41  Score=349.34  Aligned_cols=259  Identities=28%  Similarity=0.360  Sum_probs=205.6

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEE--EEEEeecC-ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNI--AVKRLFFN-SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l  371 (625)
                      .++|++.+.||+|+||.||+|++. ++..+  |||++... .....+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            367999999999999999999965 55544  99988653 334456789999999999 89999999999999999999


Q ss_pred             EEEecCCCCcchhhhccC-------------CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCc
Q 042149          372 VYEYVPNRSLDQILFVKN-------------TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLT  438 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~  438 (625)
                      ||||+++++|.+++....             ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence            999999999999986543             2245899999999999999999999875   999999999999999999


Q ss_pred             eEEeecccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHh
Q 042149          439 PKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKH  517 (625)
Q Consensus       439 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~  517 (625)
                      +||+|||+++......  ......+++.|+|||++.+..++.++||||||+++|||++ |+.|+.....     ......
T Consensus       181 ~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~~~~~~  253 (327)
T 1fvr_A          181 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYEK  253 (327)
T ss_dssp             EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHH
T ss_pred             EEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-----HHHHHH
Confidence            9999999987432211  1123457889999999999999999999999999999998 9888643211     111111


Q ss_pred             hhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCC
Q 042149          518 YKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYE  574 (625)
Q Consensus       518 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  574 (625)
                      ..         .......+...+..+.+++.+||+.+|++|||+.|+++.|+.+..+
T Consensus       254 ~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          254 LP---------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             GG---------GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             hh---------cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            11         1112223445667899999999999999999999999999877544

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=352.10  Aligned_cols=262  Identities=24%  Similarity=0.260  Sum_probs=194.4

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCC-CCceeeeeeeee--------eC
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-HKNVVRLLGCSI--------EG  366 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~--------~~  366 (625)
                      ..+|++.++||+|+||.||+|++. +++.||||++........+.+.+|+.+++++. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            457899999999999999999965 78999999998877777888999999999996 999999999984        34


Q ss_pred             CeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccc
Q 042149          367 PESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGL  446 (625)
Q Consensus       367 ~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgl  446 (625)
                      ...++||||+. |+|.+++........+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||+|||+
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  184 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS  184 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence            45899999995 688888865434445999999999999999999999652 2399999999999999999999999999


Q ss_pred             ceeeCCCCcee-----------eecCCCCccccCcccc---ccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchh
Q 042149          447 ARHVAPDKTHV-----------STGIAGTLGYMAPEYL---VRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLH  512 (625)
Q Consensus       447 a~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~  512 (625)
                      ++.........           .....||+.|+|||++   .+..++.++||||||+++|+|++|+.|+......     
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----  259 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-----  259 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-----
Confidence            98765432211           1134689999999998   5667899999999999999999999997432111     


Q ss_pred             hHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCCC
Q 042149          513 TVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPP  577 (625)
Q Consensus       513 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~~  577 (625)
                                  +.+........+...+..+.+++.+||+.+|++|||+.|+++.|+.+....+.
T Consensus       260 ------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~  312 (337)
T 3ll6_A          260 ------------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV  312 (337)
T ss_dssp             ------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred             ------------HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence                        00111111111223344578999999999999999999999999888655443

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.8e-41  Score=366.70  Aligned_cols=248  Identities=22%  Similarity=0.256  Sum_probs=196.1

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .++|++.++||+|+||.||+|+.. +++.||||++...   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999965 6899999999753   344456788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhc-CCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG-GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      |||+++++|.+++....   .+++..+..++.||+.||+|||+ .+   |+||||||+||||+.++.+||+|||+++...
T Consensus       227 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            99999999999886544   38999999999999999999997 64   9999999999999999999999999997643


Q ss_pred             CCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      .... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+......     ..........         
T Consensus       301 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~~~~~i~~~~---------  365 (446)
T 4ejn_A          301 KDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILMEE---------  365 (446)
T ss_dssp             C------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHCC---------
T ss_pred             CCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----HHHHHHHhCC---------
Confidence            3222 233468999999999999999999999999999999999999997432211     1111111111         


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRP-----SMAEVVH  566 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~  566 (625)
                       ..+|...+..+.+++.+||+.||++||     +++|+++
T Consensus       366 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          366 -IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence             123445567889999999999999999     9999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=355.92  Aligned_cols=275  Identities=15%  Similarity=0.192  Sum_probs=212.5

Q ss_pred             hcCccccccccccCceEEEEEEeCC---------CCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceee---------
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPD---------GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVR---------  358 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~---------  358 (625)
                      .++|++.+.||+|+||.||+|++..         ++.||||++...     +.+.+|+.++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3679999999999999999999763         789999998754     35789999999999999987         


Q ss_pred             ------eeeeeee-CCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcE
Q 042149          359 ------LLGCSIE-GPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNI  431 (625)
Q Consensus       359 ------l~~~~~~-~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NI  431 (625)
                            +++++.. +...++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+++   |+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  5667765 67889999999 999999997542 244999999999999999999999885   99999999999


Q ss_pred             EEcCCC--ceEEeecccceeeCCCCce------eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCC
Q 042149          432 LLDEKL--TPKIADFGLARHVAPDKTH------VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVF  503 (625)
Q Consensus       432 ll~~~~--~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~  503 (625)
                      |++.++  .+||+|||+++.+......      ......||+.|+|||++.+..++.++||||||+++|||++|+.|+..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999988  9999999999876533221      11345799999999999999999999999999999999999999765


Q ss_pred             CCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCCCCCCCCC
Q 042149          504 SEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPF  583 (625)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~~~~~~~~  583 (625)
                      .......+......+.. ......+...   .....+..+.+++.+||+.||++|||+++|++.|+++..........++
T Consensus       271 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~  346 (352)
T 2jii_A          271 CLPNTEDIMKQKQKFVD-KPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPI  346 (352)
T ss_dssp             GTTCHHHHHHHHHHHHH-SCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCC
T ss_pred             CCcCHHHHHHHHHhccC-Chhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccc
Confidence            43222222222221111 1111111110   0123357789999999999999999999999999988766655444444


Q ss_pred             cc
Q 042149          584 LN  585 (625)
Q Consensus       584 ~~  585 (625)
                      .+
T Consensus       347 dw  348 (352)
T 2jii_A          347 GL  348 (352)
T ss_dssp             CC
T ss_pred             cC
Confidence            43

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.3e-40  Score=365.95  Aligned_cols=253  Identities=26%  Similarity=0.300  Sum_probs=208.9

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .++|++.+.||+|+||.||+|+++ +|+.||||++....   ......+.+|+.+|+.++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999975 79999999996532   23356788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||++||+|.+++..... ..+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus       263 mEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            999999999998865432 34899999999999999999999875   99999999999999999999999999987754


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      ...  .....||+.|+|||++.+..++.++|||||||++|||++|+.|+........ ...........          .
T Consensus       339 ~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~-~~~i~~~i~~~----------~  405 (576)
T 2acx_A          339 GQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVERLVKEV----------P  405 (576)
T ss_dssp             TCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-HHHHHHHHHHC----------C
T ss_pred             Ccc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-HHHHHHHhhcc----------c
Confidence            433  2345899999999999999999999999999999999999999764332211 11111111111          1


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRP-----SMAEVVH  566 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~  566 (625)
                      ..++...+..+.+|+.+||+.||++||     +++||++
T Consensus       406 ~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          406 EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            123445667899999999999999999     7888875

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=6e-41  Score=339.08  Aligned_cols=249  Identities=22%  Similarity=0.315  Sum_probs=184.7

Q ss_pred             hcCccccccccccCceEEEEEEe-CCCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .++|++.+.||+|+||.||+|+. .+++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            46799999999999999999997 478999999996542   22356789999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            9999999999988643  234899999999999999999999875   99999999999999999999999999987653


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      .... .....||+.|+|||++.+..++.++||||||+++|||++|+.|+.........     .        ......  
T Consensus       165 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~--------~~~~~~--  228 (278)
T 3cok_A          165 PHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-----N--------KVVLAD--  228 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------------CCSSC--
T ss_pred             CCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-----H--------HHhhcc--
Confidence            3222 22356899999999999889999999999999999999999987543221110     0        000001  


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ...+...+..+.+++.+||+.||++|||++++++
T Consensus       229 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          229 YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            1123445677899999999999999999999885

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.7e-41  Score=348.87  Aligned_cols=244  Identities=20%  Similarity=0.242  Sum_probs=203.6

Q ss_pred             HHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCCh--------HHHHHHHHHHHHHhcCCCCceeeeeeeeee
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSR--------QWVDQFFNEVNLISGIQHKNVVRLLGCSIE  365 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  365 (625)
                      ...++|++.+.||+|+||.||+|++. +++.||||++.....        ...+.+.+|+.++++++||||+++++++.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            45678999999999999999999964 688999999975421        133467889999999999999999999999


Q ss_pred             CCeeEEEEEecCCC-CcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeec
Q 042149          366 GPESLLVYEYVPNR-SLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADF  444 (625)
Q Consensus       366 ~~~~~lV~e~~~~~-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Df  444 (625)
                      .+..++||||+.+| +|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence            99999999999776 9998886543   3899999999999999999999875   999999999999999999999999


Q ss_pred             ccceeeCCCCceeeecCCCCccccCccccccCcc-cccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccc
Q 042149          445 GLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRI  523 (625)
Q Consensus       445 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  523 (625)
                      |+++........  ....||+.|+|||++.+..+ +.++||||||+++|+|++|+.|+....                  
T Consensus       175 g~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------------------  234 (335)
T 3dls_A          175 GSAAYLERGKLF--YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------------------  234 (335)
T ss_dssp             TTCEECCTTCCB--CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------------------
T ss_pred             ccceECCCCCce--eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------------------
Confidence            999877554332  23579999999999988776 789999999999999999999974211                  


Q ss_pred             ccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          524 TQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       524 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                       +......  ..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus       235 -~~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          235 -ETVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -GGTTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -HHHhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0011111  1133356678999999999999999999999974

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.5e-40  Score=335.51  Aligned_cols=253  Identities=25%  Similarity=0.308  Sum_probs=206.6

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ..++|++.+.||+|+||.||+|++. +++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            4578999999999999999999975 6899999998654 3345678899999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++++|.+++....   .+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        85 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           85 EYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             ECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            9999999999885432   3899999999999999999999875   999999999999999999999999999865433


Q ss_pred             Cc-eeeecCCCCccccCccccccCcc-cccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          454 KT-HVSTGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       454 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      .. .......|++.|+|||++.+..+ +.++||||||+++|||++|+.|+.........    +..+....        .
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~--------~  226 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE----YSDWKEKK--------T  226 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH----HHHHHTTC--------T
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH----HHHhhhcc--------c
Confidence            22 12234579999999999987665 78999999999999999999997644322111    11111111        0


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ........+..+.+++.+||+.||++|||+.|+++
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            01112345677899999999999999999999885

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.3e-41  Score=356.25  Aligned_cols=247  Identities=20%  Similarity=0.219  Sum_probs=193.6

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHH-HhcCCCCceeeeeeeeeeCCeeEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNL-ISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      .++|++.+.||+|+||.||+|+++ +++.||||++....   ......+.+|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            467999999999999999999976 58899999997542   3344566777777 577899999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||||++|++|.+++....   .+++..+..++.||+.||+|||+++   |+||||||+||||+.+|.+||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            999999999999886544   3889999999999999999999875   9999999999999999999999999998643


Q ss_pred             CCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      .... .....+||+.|+|||++.+..++.++||||||+++|||++|+.|+.....     ...+.......         
T Consensus       191 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~~---------  255 (373)
T 2r5t_A          191 EHNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYDNILNKP---------  255 (373)
T ss_dssp             CCCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-----HHHHHHHHHSC---------
T ss_pred             cCCC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhcc---------
Confidence            3222 23346899999999999999999999999999999999999999743211     11112111111         


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVV  565 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~  565 (625)
                       ..++...+..+.+++.+||+.||++||++.+.+
T Consensus       256 -~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          256 -LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             -CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             -cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence             112344567789999999999999999985433

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.6e-40  Score=338.99  Aligned_cols=273  Identities=18%  Similarity=0.238  Sum_probs=213.3

Q ss_pred             HhcCccccccccccCceEEEEEEe-CCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeee-eeeCCeeEEEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGC-SIEGPESLLVY  373 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~-~~~~~~~~lV~  373 (625)
                      ..++|++.+.||+|+||.||+|++ .+++.||||++......  +.+.+|+.+++.++|++++..+.. ..+....++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            357899999999999999999996 57899999998654332  468899999999998886665554 46777889999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE---cCCCceEEeecccceee
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL---DEKLTPKIADFGLARHV  450 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll---~~~~~~kl~Dfgla~~~  450 (625)
                      ||+ +++|.+++....  ..+++..++.++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||+++..
T Consensus        85 e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Eec-CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            999 999999986433  24899999999999999999999875   9999999999999   47889999999999876


Q ss_pred             CCCCce------eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCc--cchhhHHHhhhccc
Q 042149          451 APDKTH------VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSS--SVLHTVWKHYKANR  522 (625)
Q Consensus       451 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~  522 (625)
                      ......      ......||+.|+|||++.+..++.++||||||+++|||++|+.|+.......  ..............
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            554331      1234579999999999999999999999999999999999999986533221  11111111111100


Q ss_pred             cccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCCCCCCCCCcc
Q 042149          523 ITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLN  585 (625)
Q Consensus       523 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~~~~~~~~~~  585 (625)
                      ...         .+...+..+.+++.+||+.+|++|||+.+|++.|+++......+...++.+
T Consensus       239 ~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw  292 (296)
T 3uzp_A          239 IEV---------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDW  292 (296)
T ss_dssp             HHH---------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGG
T ss_pred             hHH---------HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccc
Confidence            000         012345678999999999999999999999999998876666555544444

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=339.42  Aligned_cols=253  Identities=27%  Similarity=0.349  Sum_probs=202.8

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      +.|.....||+|+||.||+|++. +++.||||++........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            34556668999999999999964 68899999998776666788999999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC-CCceEEeecccceeeCCCCc
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE-KLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~-~~~~kl~Dfgla~~~~~~~~  455 (625)
                      ++++|.+++........+++..+..++.|++.||.|||+.+   |+||||||+||+++. ++.+||+|||++........
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~  178 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP  178 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence            99999999976654445789999999999999999999875   999999999999987 89999999999987654322


Q ss_pred             eeeecCCCCccccCccccccCc--ccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQ--LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                      . .....|++.|+|||++.+..  ++.++||||||+++|+|++|+.|+........   ..+....     .    ....
T Consensus       179 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~-----~----~~~~  245 (295)
T 2clq_A          179 C-TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---AMFKVGM-----F----KVHP  245 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---HHHHHHH-----H----CCCC
T ss_pred             c-ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---HHHhhcc-----c----cccc
Confidence            1 23457899999999997654  78999999999999999999998743221111   0111000     0    1112


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ..+...+..+.+++.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            234556678899999999999999999999985

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.8e-41  Score=342.93  Aligned_cols=251  Identities=25%  Similarity=0.413  Sum_probs=199.0

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC-CeeEEEEEe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG-PESLLVYEY  375 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~lV~e~  375 (625)
                      .++|++.+.||+|+||.||+|+.. ++.||||++....  ..+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            467999999999999999999874 7899999986543  456789999999999999999999987554 478999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++++|.+++..... ..+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++....... 
T Consensus        97 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  171 (278)
T 1byg_A           97 MAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  171 (278)
T ss_dssp             CTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence            999999999865422 23789999999999999999999875   9999999999999999999999999987654322 


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                         ....+++.|+|||++.+..++.++||||||+++|||+| |+.|+..... ..    ....         +.......
T Consensus       172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-~~----~~~~---------~~~~~~~~  234 (278)
T 1byg_A          172 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KD----VVPR---------VEKGYKMD  234 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-GG----HHHH---------HTTTCCCC
T ss_pred             ---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-HH----HHHH---------HhcCCCCC
Confidence               12357889999999999999999999999999999998 8887643221 11    1111         11112223


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      .+...+..+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence            34556778999999999999999999999999998764

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.3e-41  Score=343.38  Aligned_cols=262  Identities=23%  Similarity=0.293  Sum_probs=198.9

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      .++|++.++||+|+||.||+|++. +++.||||++...  .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            468999999999999999999975 5899999988654  3344567889999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++++|.+++....   .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        82 e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           82 EYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             ECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            9999999998875443   3899999999999999999999876   999999999999999999999999999876533


Q ss_pred             CceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHH-----------hhhcc
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWK-----------HYKAN  521 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~-----------~~~~~  521 (625)
                      ... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.|+......... .....           .+...
T Consensus       156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          156 SDY-YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL-YLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCSCCHHHHHHHHTC
T ss_pred             ccc-cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhcccccccccccccc
Confidence            322 234578999999999976 57899999999999999999999987543221111 11100           01111


Q ss_pred             cccccc---CCCCCCC---CChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          522 RITQSM---DPGLTGR---FPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       522 ~~~~~i---~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ......   ++.....   ..+..+..+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            110000   0000000   01234667899999999999999999999986

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=9.2e-41  Score=345.26  Aligned_cols=252  Identities=23%  Similarity=0.269  Sum_probs=205.4

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCCh------HHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCe
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSR------QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPE  368 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  368 (625)
                      ..++|++.+.||+|+||.||+|+++ +++.||||++.....      ...+.+.+|+.++++++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            3567999999999999999999975 689999999975432      135779999999999999999999999999999


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC----ceEEeec
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL----TPKIADF  444 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~----~~kl~Df  444 (625)
                      .++||||+++++|.+++....   .+++..++.++.|++.||.|||+.+   |+||||||+||+++.++    .+||+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence            999999999999999986543   3899999999999999999999875   99999999999999887    7999999


Q ss_pred             ccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccc
Q 042149          445 GLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRIT  524 (625)
Q Consensus       445 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  524 (625)
                      |++........  .....||+.|+|||++.+..++.++||||||+++|+|++|+.|+......     ..........  
T Consensus       164 g~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~--  234 (321)
T 2a2a_A          164 GLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----ETLANITSVS--  234 (321)
T ss_dssp             TTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHHHHHHTTC--
T ss_pred             ccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHhcc--
Confidence            99987654332  23457999999999999999999999999999999999999987432111     1111111110  


Q ss_pred             cccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          525 QSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       525 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                          .......+...+..+.+++.+||+.||++|||+.|+++
T Consensus       235 ----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          235 ----YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             ----CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             ----cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                00000011234567899999999999999999999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=9.5e-41  Score=361.84  Aligned_cols=247  Identities=21%  Similarity=0.285  Sum_probs=205.5

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .++|.+.+.||+|+||.||+|++. +|+.||||++....   ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            367999999999999999999976 79999999996542   23456789999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+++++|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        95 ~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           95 MEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            99999999999986433   4899999999999999999999775   99999999999999999999999999987654


Q ss_pred             CCceeeecCCCCccccCccccccCcc-cccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      ...  .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.|+.....     ...........         
T Consensus       169 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-----~~~~~~i~~~~---------  232 (476)
T 2y94_A          169 GEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-----PTLFKKICDGI---------  232 (476)
T ss_dssp             TCC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-----HHHHHHHHTTC---------
T ss_pred             ccc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHhcCC---------
Confidence            332  234579999999999988765 6899999999999999999998753221     11111111111         


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                       ...|...+..+.+++.+||+.||++|||+.|+++
T Consensus       233 -~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          233 -FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence             1123345667899999999999999999999986

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.8e-41  Score=378.32  Aligned_cols=256  Identities=21%  Similarity=0.329  Sum_probs=203.4

Q ss_pred             Cccccc-cccccCceEEEEEEeC---CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          299 FFDNSR-KLGQGGAGSVFRGTLP---DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       299 ~y~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ++.+.+ +||+|+||.||+|.++   ++..||||++... .....+.+.+|+.+|++++|||||++++++.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            344444 7999999999999864   4567999999764 33456789999999999999999999999876 5689999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++++|.+++...  ...+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus       415 E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             ECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             EeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            999999999998543  344899999999999999999999875   999999999999999999999999999876543


Q ss_pred             Cceee--ecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          454 KTHVS--TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       454 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                      .....  ....+++.|+|||++.+..++.++||||||+++|||++ |+.|+...... ++    ..         .+...
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-~~----~~---------~i~~~  555 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EV----MA---------FIEQG  555 (613)
T ss_dssp             ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-HH----HH---------HHHTT
T ss_pred             CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HH----HH---------HHHcC
Confidence            32221  12345789999999999999999999999999999998 99887533221 11    11         11122


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCC
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYE  574 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  574 (625)
                      .....+..++..+.+||.+||+.+|++||++.+|++.|+.+...
T Consensus       556 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          556 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            22334566778899999999999999999999999999886443

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1e-40  Score=344.38  Aligned_cols=264  Identities=23%  Similarity=0.338  Sum_probs=189.4

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      .++|++.++||+|+||.||+|+.+ +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            467899999999999999999975 68999999997553 2334678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccC---CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          375 YVPNRSLDQILFVKN---TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      |++ ++|.+++....   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 58988876432   2234899999999999999999999875   9999999999999999999999999998764


Q ss_pred             CCCceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcc--c----cc
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN--R----IT  524 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~----~~  524 (625)
                      ..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.|+...... ..+..........  .    ..
T Consensus       160 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          160 IPVNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-EQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             SCCCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CCccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhHhhhhh
Confidence            33222 233578999999999976 46899999999999999999999987543221 1111111110000  0    00


Q ss_pred             c--ccCCCCC------------CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          525 Q--SMDPGLT------------GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       525 ~--~i~~~~~------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .  ...+...            ...+...+..+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            0  0000000            0011234567899999999999999999999885

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.7e-41  Score=342.40  Aligned_cols=254  Identities=23%  Similarity=0.342  Sum_probs=207.0

Q ss_pred             HHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeee--------
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE--------  365 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--------  365 (625)
                      ...++|++.+.||+|+||.||+|++. +++.||||++.....    .+.+|++++++++||||+++++++..        
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            45678999999999999999999976 789999999976543    46789999999999999999998864        


Q ss_pred             --------CCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC
Q 042149          366 --------GPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL  437 (625)
Q Consensus       366 --------~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~  437 (625)
                              ....++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence                    445899999999999999996543 234899999999999999999999875   99999999999999999


Q ss_pred             ceEEeecccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHh
Q 042149          438 TPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKH  517 (625)
Q Consensus       438 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~  517 (625)
                      .+||+|||++.........  ....|++.|+|||++.+..++.++||||||+++|||++|..|+...       ...+..
T Consensus       160 ~~kl~Dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~~~~~  230 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDGKR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------SKFFTD  230 (284)
T ss_dssp             EEEECCCTTCEESSCCSCC--CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------HHHHHH
T ss_pred             CEEECcchhheeccccccc--cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------HHHHHH
Confidence            9999999999876554322  2356999999999999999999999999999999999999874210       111111


Q ss_pred             hhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCCC
Q 042149          518 YKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPP  577 (625)
Q Consensus       518 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~~  577 (625)
                      ....        .    .+...+..+.+++.+||+.||++|||+.|+++.|..+......
T Consensus       231 ~~~~--------~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~  278 (284)
T 2a19_B          231 LRDG--------I----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK  278 (284)
T ss_dssp             HHTT--------C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred             hhcc--------c----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence            1111        1    1223456688999999999999999999999999887655443

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.6e-41  Score=348.14  Aligned_cols=253  Identities=22%  Similarity=0.268  Sum_probs=182.3

Q ss_pred             cCccc---cccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCCeeEEE
Q 042149          298 DFFDN---SRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       298 ~~y~~---~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV  372 (625)
                      ++|++   .++||+|+||.||+|+++ +++.||||++...   ....+.+|+.+++.+. ||||+++++++.+....++|
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv   84 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV   84 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence            34555   378999999999999975 6899999999643   3456788999999997 99999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC---ceEEeeccccee
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL---TPKIADFGLARH  449 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~---~~kl~Dfgla~~  449 (625)
                      |||+++++|.+++....   .+++.++..++.||+.||.|||+++   |+||||||+|||++.++   .+||+|||+++.
T Consensus        85 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           85 MELLNGGELFERIKKKK---HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             ECCCCSCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             EEccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            99999999999987643   3899999999999999999999875   99999999999997665   899999999987


Q ss_pred             eCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCc--cchhhHHHhhhcccccccc
Q 042149          450 VAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSS--SVLHTVWKHYKANRITQSM  527 (625)
Q Consensus       450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~i  527 (625)
                      ....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.|+.......  ...............    
T Consensus       159 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~----  233 (325)
T 3kn6_A          159 KPPDNQP-LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF----  233 (325)
T ss_dssp             CCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC----
T ss_pred             cCCCCCc-ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC----
Confidence            6543332 234578999999999999999999999999999999999999976433211  111111111111110    


Q ss_pred             CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       528 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                        ....+.....+..+.+++.+||+.||++|||++|+++
T Consensus       234 --~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          234 --SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             --CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             --CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence              0011111235678999999999999999999999874

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.2e-40  Score=346.64  Aligned_cols=248  Identities=24%  Similarity=0.302  Sum_probs=206.9

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .++|.+.+.||+|+||.||++++. +++.+|+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467999999999999999999976 5788999998654   345667899999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+++++|.+++....   .+++.+++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus       120 ~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            99999999999886543   3899999999999999999999875   99999999999999999999999999987653


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      .... .....||+.|+|||++.+..++.++||||||+++|+|++|+.|+.....     ...+.......          
T Consensus       194 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~----------  257 (335)
T 2owb_A          194 DGER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----KETYLRIKKNE----------  257 (335)
T ss_dssp             TTCC-BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHHTC----------
T ss_pred             Cccc-ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-----HHHHHHHhcCC----------
Confidence            3322 2345799999999999998999999999999999999999998753221     11111111111          


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ...+...+..+.+++.+||+.||++|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          258 YSIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1123344567889999999999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=9.6e-41  Score=347.93  Aligned_cols=252  Identities=20%  Similarity=0.277  Sum_probs=203.3

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEEEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ..++|++.+.||+|+||.||+|+++ +++.||||++.....    ...+|++++.++ +||||+++++++.+....++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4678999999999999999999976 688999999976543    245688888888 7999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCC----CceEEeeccccee
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEK----LTPKIADFGLARH  449 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~----~~~kl~Dfgla~~  449 (625)
                      ||++|++|.+.+....   .+++..+..++.||+.||.|||+++   |+||||||+|||+.++    +.+||+|||+++.
T Consensus        96 E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             eCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            9999999999886543   3899999999999999999999875   9999999999998533    3599999999987


Q ss_pred             eCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          450 VAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      ....... .....||+.|+|||++.+..++.++||||||+++|||++|+.|+......  ...........+..      
T Consensus       170 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~i~~~~~------  240 (342)
T 2qr7_A          170 LRAENGL-LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEILARIGSGKF------  240 (342)
T ss_dssp             CBCTTCC-BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHHHHHHHHCCC------
T ss_pred             CcCCCCc-eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHHHHHHccCCc------
Confidence            6544332 23457899999999998888999999999999999999999997643211  11222222222211      


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ..........+..+.+++.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          241 SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1112223456778899999999999999999999986

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5.4e-41  Score=350.76  Aligned_cols=247  Identities=26%  Similarity=0.430  Sum_probs=200.3

Q ss_pred             hcCccccccccccCceEEEEEEe-CCCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .+.|++.+.||+|+||.||+|+. .+++.||||++....   ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            35589999999999999999996 478999999997542   34456789999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+. |+|.+++....  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       133 ~e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            99997 57777775332  34899999999999999999999875   99999999999999999999999999976543


Q ss_pred             CCceeeecCCCCccccCccccc---cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLV---RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      .     ....||+.|+|||++.   .+.++.++||||||+++|||++|+.|+.....    .......... .     .+
T Consensus       207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~----~~~~~~~~~~-~-----~~  271 (348)
T 1u5q_A          207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIAQN-E-----SP  271 (348)
T ss_dssp             B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHS-C-----CC
T ss_pred             C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhc-C-----CC
Confidence            2     2357999999999985   56789999999999999999999998743221    1111111111 1     11


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      .   ..+...+..+.+++.+||+.+|++|||++++++.
T Consensus       272 ~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          272 A---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             C---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            1   1123446678999999999999999999999864

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-41  Score=353.52  Aligned_cols=255  Identities=23%  Similarity=0.280  Sum_probs=206.4

Q ss_pred             hcCccccccccccCceEEEEEEe----CCCCEEEEEEeecCC----hHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCC
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL----PDGRNIAVKRLFFNS----RQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGP  367 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~  367 (625)
                      .++|++.++||+|+||.||+|+.    .+++.||||++....    ....+.+.+|+.+++++ +||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            46899999999999999999996    368999999985431    23345678899999999 6999999999999999


Q ss_pred             eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccc
Q 042149          368 ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA  447 (625)
Q Consensus       368 ~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla  447 (625)
                      ..++||||+++++|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            9999999999999999987554   3899999999999999999999875   999999999999999999999999999


Q ss_pred             eeeCCCCceeeecCCCCccccCccccccC--cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccccc
Q 042149          448 RHVAPDKTHVSTGIAGTLGYMAPEYLVRG--QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQ  525 (625)
Q Consensus       448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  525 (625)
                      +.+............||+.|+|||++.+.  .++.++||||||+++|||++|+.|+.......... .........    
T Consensus       207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~~~----  281 (355)
T 1vzo_A          207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA-EISRRILKS----  281 (355)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH-HHHHHHHHC----
T ss_pred             eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH-HHHHHHhcc----
Confidence            87654443334456799999999999863  47899999999999999999999976443322211 111111110    


Q ss_pred             ccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHH
Q 042149          526 SMDPGLTGRFPENEASRVLQIGLLCTQAPVALRP-----SMAEVVHML  568 (625)
Q Consensus       526 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~L  568 (625)
                            ....+...+..+.+++.+||+.||++||     ++.|+++..
T Consensus       282 ------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          282 ------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             ------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                  1123455667789999999999999999     999998754

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.4e-40  Score=339.15  Aligned_cols=272  Identities=18%  Similarity=0.250  Sum_probs=207.3

Q ss_pred             HHhcCccccccccccCceEEEEEEe-CCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeee-eeCCeeEEE
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS-IEGPESLLV  372 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~~~~~~~lV  372 (625)
                      ...++|++.+.||+|+||.||+|++ .+++.||||++.....  .+.+.+|+.+++.++|++++..+..+ ......++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            3467899999999999999999996 4788999998754432  24578899999999988776666554 677888999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE---cCCCceEEeeccccee
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL---DEKLTPKIADFGLARH  449 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll---~~~~~~kl~Dfgla~~  449 (625)
                      |||+ +++|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+++.
T Consensus        84 ~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~  157 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             EECC-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EEcc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence            9999 999999986433  23899999999999999999999876   9999999999999   7889999999999987


Q ss_pred             eCCCCce------eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCcc--chhhHHHhhhcc
Q 042149          450 VAPDKTH------VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSS--VLHTVWKHYKAN  521 (625)
Q Consensus       450 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~--~~~~~~~~~~~~  521 (625)
                      .......      ......||+.|+|||++.+..++.++||||||+++|+|++|+.|+........  ............
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 4hgt_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence            6554331      12346799999999999999999999999999999999999999865432221  111111111000


Q ss_pred             ccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCCCCCCCCC
Q 042149          522 RITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPF  583 (625)
Q Consensus       522 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~~~~~~~~  583 (625)
                      ....         .....+..+.+++.+||+.+|++|||+.+|++.|+++..+...+..-++
T Consensus       238 ~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~  290 (296)
T 4hgt_A          238 PIEV---------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVF  290 (296)
T ss_dssp             CHHH---------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCC
T ss_pred             hhhh---------hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCcc
Confidence            0000         0122356789999999999999999999999999888665554443333

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=9.4e-41  Score=337.93  Aligned_cols=247  Identities=28%  Similarity=0.376  Sum_probs=202.0

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .++|++.+.||+|+||.||+|++. +++.||||++....   ......+.+|+.++++++||||+++++++.+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            568999999999999999999975 57799999986542   22346788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+++++|.+++.....   +++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            999999999998865543   899999999999999999999775   99999999999999999999999998865433


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      ..   .....|++.|+|||++.+..++.++||||||+++|+|++|+.|+.....     ..........          .
T Consensus       162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~----------~  223 (279)
T 3fdn_A          162 SR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----QETYKRISRV----------E  223 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHHT----------C
T ss_pred             cc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-----HHHHHHHHhC----------C
Confidence            22   2345789999999999999999999999999999999999998753211     1111111111          1


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      ...+...+..+.+++.+||+.+|++|||+.|+++.
T Consensus       224 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          224 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            12244456778999999999999999999999973

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.1e-40  Score=363.28  Aligned_cols=255  Identities=23%  Similarity=0.309  Sum_probs=208.7

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .++|++.+.||+|+||.||+|+++ +|+.||||++....   ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999975 69999999996542   23356788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCC-cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          373 YEYVPNRSLDQILFVKNT-IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      |||++|++|.+++..... ...+++..++.++.||+.||.|||+++   |+||||||+||||+.+|.+||+|||+++...
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            999999999998865432 345899999999999999999999875   9999999999999999999999999998765


Q ss_pred             CCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      ..... .....||+.|+|||++.+..++.++|||||||++|||++|+.|+......... ...........         
T Consensus       341 ~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~-~~~~~~i~~~~---------  409 (543)
T 3c4z_A          341 AGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQRVLEQA---------  409 (543)
T ss_dssp             TTCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH-HHHHHHHHHCC---------
T ss_pred             CCCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH-HHHHHHHhhcc---------
Confidence            44332 23458999999999999999999999999999999999999997644322111 11111111111         


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRPSM-----AEVVH  566 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~ev~~  566 (625)
                       ..+|...+..+.+++.+||+.||++||++     ++|++
T Consensus       410 -~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          410 -VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             -CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             -cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence             12345567788999999999999999975     66654

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.2e-40  Score=337.97  Aligned_cols=246  Identities=25%  Similarity=0.326  Sum_probs=202.2

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l  371 (625)
                      ..++|++.+.||+|+||.||+|++. +++.||||++...  .......+.+|+.++..+ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4678999999999999999999976 7899999998754  334456788999999999 89999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCC-cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC---------------
Q 042149          372 VYEYVPNRSLDQILFVKNT-IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE---------------  435 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~---------------  435 (625)
                      ||||+++++|.+++..... ...+++..++.++.||+.||.|||+++   |+||||||+|||++.               
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999865422 134899999999999999999999875   999999999999984               


Q ss_pred             ----CCceEEeecccceeeCCCCceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccc
Q 042149          436 ----KLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSV  510 (625)
Q Consensus       436 ----~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~  510 (625)
                          ...+||+|||++........     ..||+.|+|||++.+. .++.++||||||+++|+|++|.+++....     
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----  235 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-----  235 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSCC-----CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred             ccCCceEEEEcccccccccCCccc-----cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence                44799999999987654322     3589999999999776 66789999999999999999987643211     


Q ss_pred             hhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          511 LHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       511 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                         .+.......         ....+...+..+.+++.+||+.||++|||+.|+++
T Consensus       236 ---~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          236 ---QWHEIRQGR---------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             ---HHHHHHTTC---------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---HHHHHHcCC---------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence               122222111         12234455678999999999999999999999985

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.1e-40  Score=341.49  Aligned_cols=249  Identities=25%  Similarity=0.375  Sum_probs=206.3

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      .+.|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            457999999999999999999864 68999999997553 4456789999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+++++|.+++..    ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus       101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            9999999998853    34899999999999999999999876   9999999999999999999999999998765433


Q ss_pred             ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          455 THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                      .. .....|++.|+|||++.+..++.++||||||+++|+|++|+.|+...... .    ........         ....
T Consensus       174 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~----~~~~~~~~---------~~~~  238 (303)
T 3a7i_A          174 IK-RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM-K----VLFLIPKN---------NPPT  238 (303)
T ss_dssp             CC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-H----HHHHHHHS---------CCCC
T ss_pred             cc-cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH-H----HHHHhhcC---------CCCC
Confidence            22 23457999999999999999999999999999999999999986432111 0    01111111         1112


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      .+...+..+.+++.+||+.+|++|||+.|+++.
T Consensus       239 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          239 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             CccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            233446678999999999999999999999864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.9e-40  Score=338.35  Aligned_cols=249  Identities=24%  Similarity=0.296  Sum_probs=207.2

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .++|.+.+.||+|+||.||+|++. +++.+|+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            467899999999999999999976 5788999998654   345567889999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+++++|.+++....   .+++.+++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            99999999999886543   3899999999999999999999875   99999999999999999999999999987653


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      .... .....||+.|+|||++.+..++.++||||||+++|+|++|+.|+......     ..+.......          
T Consensus       168 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~----------  231 (294)
T 2rku_A          168 DGER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----ETYLRIKKNE----------  231 (294)
T ss_dssp             TTCC-BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHTTC----------
T ss_pred             Cccc-cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhhcc----------
Confidence            3322 23457899999999999888999999999999999999999987532211     1111111111          


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      ...+...+..+.+++.+||+.||++|||++|+++.
T Consensus       232 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          232 YSIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            11234456678999999999999999999999863

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.8e-40  Score=350.91  Aligned_cols=253  Identities=20%  Similarity=0.202  Sum_probs=192.6

Q ss_pred             hcCcccc-ccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHh-cCCCCceeeeeeeeee----CCee
Q 042149          297 TDFFDNS-RKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLIS-GIQHKNVVRLLGCSIE----GPES  369 (625)
Q Consensus       297 ~~~y~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~----~~~~  369 (625)
                      .++|.+. ++||+|+||+||+|+++ +++.||||++...     ..+.+|+.++. ..+||||+++++++..    ...+
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            4567665 78999999999999975 6899999998632     35678888874 4589999999998875    5678


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC---CCceEEeeccc
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE---KLTPKIADFGL  446 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~---~~~~kl~Dfgl  446 (625)
                      +|||||++||+|.+++.... ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence            99999999999999996543 234899999999999999999999875   999999999999997   78999999999


Q ss_pred             ceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccc
Q 042149          447 ARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS  526 (625)
Q Consensus       447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (625)
                      ++.......  .....||+.|+|||++.+..++.++|||||||++|||++|+.|+......... ............   
T Consensus       211 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~i~~~~~---  284 (400)
T 1nxk_A          211 AKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PGMKTRIRMGQY---  284 (400)
T ss_dssp             CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC-CSHHHHHHHTCC---
T ss_pred             ccccCCCCc--cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc-HHHHHHHHcCcc---
Confidence            987653322  23467899999999999999999999999999999999999997543322110 001111111110   


Q ss_pred             cCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       527 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                         ..........+..+.+|+.+||+.||++|||+.|+++.
T Consensus       285 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          285 ---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             ---CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence               01111123456778999999999999999999999974

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.2e-40  Score=347.96  Aligned_cols=269  Identities=23%  Similarity=0.237  Sum_probs=206.8

Q ss_pred             cccHHHHHHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCC-----CCceeeee
Q 042149          287 NFKYEILERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-----HKNVVRLL  360 (625)
Q Consensus       287 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hpniv~l~  360 (625)
                      .++++......++|++.++||+|+||.||+|++. +++.||||++.. .....+.+..|+.+++.++     ||||++++
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~  102 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVKYH  102 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence            3444555556789999999999999999999974 689999999864 3444567788999999986     99999999


Q ss_pred             eeeeeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC-----
Q 042149          361 GCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE-----  435 (625)
Q Consensus       361 ~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~-----  435 (625)
                      +++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.     
T Consensus       103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~  177 (360)
T 3llt_A          103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEK  177 (360)
T ss_dssp             EEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCE
T ss_pred             ceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccc
Confidence            9999999999999999 9999999875443 34899999999999999999999876   999999999999975     


Q ss_pred             --------------------CCceEEeecccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHH
Q 042149          436 --------------------KLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVA  495 (625)
Q Consensus       436 --------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ell  495 (625)
                                          ++.+||+|||+++......    ....||+.|+|||++.+..++.++||||||+++|||+
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  253 (360)
T 3llt_A          178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY  253 (360)
T ss_dssp             EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred             cccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence                                7899999999998654322    2457999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCCCccchhhHHH-----------hhhccccccccCC-CCCCCCC--------------------hHHHHHH
Q 042149          496 SGRRNSVFSEGSSSVLHTVWK-----------HYKANRITQSMDP-GLTGRFP--------------------ENEASRV  543 (625)
Q Consensus       496 tG~~p~~~~~~~~~~~~~~~~-----------~~~~~~~~~~i~~-~~~~~~~--------------------~~~~~~l  543 (625)
                      +|+.|+....... .......           ..........++. ......+                    ......+
T Consensus       254 ~g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (360)
T 3llt_A          254 TGSLLFRTHEHME-HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF  332 (360)
T ss_dssp             HSSCSCCCSSHHH-HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred             HCCCCCCCCcHHH-HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence            9999875432111 1111000           0000000000000 0000000                    0112567


Q ss_pred             HHHHhhccCCCCCCCCCHHHHHH
Q 042149          544 LQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       544 ~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .+++.+||+.||++|||++|+++
T Consensus       333 ~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          333 CDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHhcCChhhCCCHHHHhc
Confidence            89999999999999999999875

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.4e-40  Score=342.81  Aligned_cols=255  Identities=22%  Similarity=0.288  Sum_probs=199.7

Q ss_pred             hcCcccc-ccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEEEE
Q 042149          297 TDFFDNS-RKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       297 ~~~y~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      .+.|++. ++||+|+||.||+|+.. +++.||||++........+.+.+|+.++.++ +||||+++++++.+++..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            5678884 78999999999999964 7899999999776655667899999999985 7999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCc---eEEeecccceee
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLT---PKIADFGLARHV  450 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~---~kl~Dfgla~~~  450 (625)
                      ||+++++|.+++....   .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.   +||+|||++...
T Consensus        91 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            9999999999987653   3899999999999999999999875   999999999999987765   999999998765


Q ss_pred             CCCCc------eeeecCCCCccccCcccccc-----CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccc---------
Q 042149          451 APDKT------HVSTGIAGTLGYMAPEYLVR-----GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSV---------  510 (625)
Q Consensus       451 ~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~---------  510 (625)
                      .....      .......||+.|+|||++..     ..++.++||||||+++|||++|+.|+.........         
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            42211      11123469999999999875     56889999999999999999999997644322100         


Q ss_pred             -hhhHHHhhhccccccccCCCCCCCCCh----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          511 -LHTVWKHYKANRITQSMDPGLTGRFPE----NEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       511 -~~~~~~~~~~~~~~~~i~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                       ............        .  ..+.    ..+..+.+++.+||+.||++|||+.|+++.
T Consensus       245 ~~~~~~~~i~~~~--------~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          245 CQNMLFESIQEGK--------Y--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHHHCC--------C--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHHhccC--------c--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence             001111111111        0  1121    245678999999999999999999999873

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.6e-40  Score=351.19  Aligned_cols=265  Identities=23%  Similarity=0.326  Sum_probs=193.5

Q ss_pred             HHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCC--
Q 042149          294 ERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEGP--  367 (625)
Q Consensus       294 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~--  367 (625)
                      +...++|++.++||+|+||.||+|++. +++.||||++...  .......+.+|+.+++.+. ||||+++++++...+  
T Consensus         5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~   84 (388)
T 3oz6_A            5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR   84 (388)
T ss_dssp             HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred             CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence            456789999999999999999999965 6899999998543  4556678889999999997 999999999997544  


Q ss_pred             eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccc
Q 042149          368 ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA  447 (625)
Q Consensus       368 ~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla  447 (625)
                      ..++||||++ ++|.+++...    .+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        85 ~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a  156 (388)
T 3oz6_A           85 DVYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLS  156 (388)
T ss_dssp             CEEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccc
Confidence            6899999997 5888888542    4899999999999999999999876   999999999999999999999999999


Q ss_pred             eeeCCC--------------------CceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCC
Q 042149          448 RHVAPD--------------------KTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEG  506 (625)
Q Consensus       448 ~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~  506 (625)
                      +.+...                    .....+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST  236 (388)
T ss_dssp             EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            875321                    1112234689999999999976 6789999999999999999999998754321


Q ss_pred             CccchhhHHHhhhcccccc------------------cc---CCCCCCC------------CChHHHHHHHHHHhhccCC
Q 042149          507 SSSVLHTVWKHYKANRITQ------------------SM---DPGLTGR------------FPENEASRVLQIGLLCTQA  553 (625)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~------------------~i---~~~~~~~------------~~~~~~~~l~~li~~cl~~  553 (625)
                      .. .+..............                  ..   .......            .+...+..+.+|+.+||+.
T Consensus       237 ~~-~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          237 MN-QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             HH-HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             HH-HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence            11 1111111000000000                  00   0000000            0113356789999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 042149          554 PVALRPSMAEVVHM  567 (625)
Q Consensus       554 ~p~~RPt~~ev~~~  567 (625)
                      ||++|||++|+++.
T Consensus       316 dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          316 NPNKRISANDALKH  329 (388)
T ss_dssp             SGGGSCCHHHHTTS
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.2e-40  Score=334.89  Aligned_cols=246  Identities=26%  Similarity=0.319  Sum_probs=204.8

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .++|++.+.||+|+||.||+|+.. +++.||||++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            467999999999999999999975 57889999986532   22346789999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+++++|.+++....   .+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            99999999999886554   3899999999999999999999775   99999999999999999999999999976543


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      ..   .....|++.|+|||++.+..++.++||||||+++|+|++|+.|+......     .........          .
T Consensus       167 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~----------~  228 (284)
T 2vgo_A          167 LR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-----ETHRRIVNV----------D  228 (284)
T ss_dssp             SC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHTT----------C
T ss_pred             cc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-----HHHHHHhcc----------c
Confidence            22   22457999999999999999999999999999999999999987532211     111111111          1


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ...+...+..+.+++.+||+.+|++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          229 LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            1234455678899999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=5.3e-41  Score=347.93  Aligned_cols=261  Identities=27%  Similarity=0.348  Sum_probs=205.9

Q ss_pred             HhcCccccccccccCceEEEEEEe------CCCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCe
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTL------PDGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPE  368 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  368 (625)
                      ..++|++.+.||+|+||.||+|++      .+++.||||++... .......+.+|+.++++++||||+++++++.+...
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            357899999999999999999984      25778999998644 44556789999999999999999999999999999


Q ss_pred             eEEEEEecCCCCcchhhhccCC----cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC---CCceEE
Q 042149          369 SLLVYEYVPNRSLDQILFVKNT----IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE---KLTPKI  441 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~---~~~~kl  441 (625)
                      .++||||+++++|.+++.....    ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence            9999999999999999976532    134899999999999999999999875   999999999999984   456999


Q ss_pred             eecccceeeCCCCc-eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhh
Q 042149          442 ADFGLARHVAPDKT-HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYK  519 (625)
Q Consensus       442 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~  519 (625)
                      +|||++........ .......+++.|+|||++.+..++.++||||||+++|+|+| |+.|+..... ..    ......
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~----~~~~~~  259 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QE----VLEFVT  259 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HH----HHHHHH
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-HH----HHHHHh
Confidence            99999875433222 11223467899999999999999999999999999999999 7777643211 11    111111


Q ss_pred             ccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccC
Q 042149          520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY  573 (625)
Q Consensus       520 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  573 (625)
                      .         ......+...+..+.+++.+||+.+|++||++.++++.|+.+..
T Consensus       260 ~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          260 S---------GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             T---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             c---------CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            1         11122344556789999999999999999999999999987643

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=6.5e-41  Score=347.93  Aligned_cols=263  Identities=27%  Similarity=0.386  Sum_probs=200.7

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      .++|++.++||+|+||.||+|++. +++.||||++...  .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            467999999999999999999975 5899999998654  3344567889999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++++|.+++....   .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       104 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            9999999988765443   3899999999999999999999875   999999999999999999999999999866443


Q ss_pred             CceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhH----------HHhhhccc
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV----------WKHYKANR  522 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~----------~~~~~~~~  522 (625)
                      ... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.|+.............          +..+....
T Consensus       178 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          178 GEV-YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             ccc-cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence            322 2345789999999999775 78999999999999999999998875433221111100          01111111


Q ss_pred             c-ccccCCCCCCCC-----ChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          523 I-TQSMDPGLTGRF-----PENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       523 ~-~~~i~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      . .....+......     .+..+..+.+++.+||+.||++|||+.|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0 111111111111     1234678999999999999999999999875

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.5e-40  Score=354.66  Aligned_cols=254  Identities=19%  Similarity=0.237  Sum_probs=193.5

Q ss_pred             HHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--------hHHHHHHHHHHHHHhcCCCCceeeeeeeee
Q 042149          294 ERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--------RQWVDQFFNEVNLISGIQHKNVVRLLGCSI  364 (625)
Q Consensus       294 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  364 (625)
                      ....++|.+.++||+|+||.||+|.+. +++.||||++....        ......+.+|+.+|++++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            456789999999999999999999965 68999999986532        122335789999999999999999999875


Q ss_pred             eCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCC---CceEE
Q 042149          365 EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEK---LTPKI  441 (625)
Q Consensus       365 ~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~---~~~kl  441 (625)
                       .+..++||||+++++|.+++....   .+++..+..++.|++.||.|||+++   |+||||||+|||++.+   +.+||
T Consensus       211 -~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          211 -AEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             -SSEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             -cCceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence             456899999999999999885443   4899999999999999999999875   9999999999999754   45999


Q ss_pred             eecccceeeCCCCceeeecCCCCccccCcccccc---CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhh
Q 042149          442 ADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR---GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHY  518 (625)
Q Consensus       442 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~  518 (625)
                      +|||+++......  ......||+.|+|||++.+   ..++.++||||||+++|+|++|+.|+........+....    
T Consensus       284 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i----  357 (419)
T 3i6u_A          284 TDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI----  357 (419)
T ss_dssp             CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHH----
T ss_pred             eecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHH----
Confidence            9999998764332  2234679999999999863   678899999999999999999999976433322221111    


Q ss_pred             hccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       519 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ......      .........+..+.+++.+||+.||++|||++|+++
T Consensus       358 ~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          358 TSGKYN------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HTTCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hcCCCC------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            111100      000001234667899999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.9e-41  Score=376.73  Aligned_cols=248  Identities=26%  Similarity=0.375  Sum_probs=199.7

Q ss_pred             ccccccCceEEEEEEeC---CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCC
Q 042149          304 RKLGQGGAGSVFRGTLP---DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPN  378 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~  378 (625)
                      ++||+|+||.||+|.+.   .++.||||++...  .....+.+.+|+.+|++++|||||++++++. .+..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence            47999999999999642   4678999999754  3345678999999999999999999999986 4568899999999


Q ss_pred             CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce--
Q 042149          379 RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH--  456 (625)
Q Consensus       379 ~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~--  456 (625)
                      ++|.+++....   .+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.+......  
T Consensus       454 g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            99999996543   3899999999999999999999875   999999999999999999999999999876543322  


Q ss_pred             eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                      ......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+......     .         +.+.+........
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-----~---------~~~~i~~~~~~~~  593 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-----E---------VTAMLEKGERMGC  593 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----H---------HHHHHHTTCCCCC
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----H---------HHHHHHcCCCCCC
Confidence            1223457889999999999999999999999999999998 99886432211     1         1111222223334


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      +..++..+.+||.+||+.||++||++.+|++.|+++.
T Consensus       594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            5567788999999999999999999999999998764

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-40  Score=338.15  Aligned_cols=252  Identities=24%  Similarity=0.289  Sum_probs=197.1

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      .++|.+.++||+|+||.||+|+.. ++..+|+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            467999999999999999999975 68999999987653 3346788999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhcc-CCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE---cCCCceEEeecccceee
Q 042149          375 YVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL---DEKLTPKIADFGLARHV  450 (625)
Q Consensus       375 ~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll---~~~~~~kl~Dfgla~~~  450 (625)
                      |+++++|.+.+... .....+++..++.++.|++.||.|||+.+   |+||||||+||++   +.++.+||+|||++...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999888543 12244899999999999999999999875   9999999999999   45678999999999866


Q ss_pred             CCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          451 APDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                      .....  .....||+.|+|||++. +.++.++||||||+++|||++|+.|+......     ..........      +.
T Consensus       178 ~~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~-----~~~~~~~~~~------~~  243 (285)
T 3is5_A          178 KSDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE-----EVQQKATYKE------PN  243 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHCC------CC
T ss_pred             CCccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH-----HHHhhhccCC------cc
Confidence            44322  23457999999999875 57899999999999999999999987532111     1111111000      00


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ... .....+..+.+++.+||+.||++|||+.|+++
T Consensus       244 ~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          244 YAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000 01123567889999999999999999999985

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.8e-41  Score=341.62  Aligned_cols=259  Identities=24%  Similarity=0.336  Sum_probs=205.3

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeee--CCeeEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE--GPESLL  371 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~l  371 (625)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++...  .....+.+.+|+.++++++||||+++++++.+  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468999999999999999999975 6899999999754  34556789999999999999999999998754  678999


Q ss_pred             EEEecCCCCcchhhhccC-CcCCCCHHHHHHHHHHHHHHHHHhhcCC--CceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          372 VYEYVPNRSLDQILFVKN-TIHILSWQQRFTIICGTAEGLAHLHGGS--GIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      ||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+  ..+|+||||||+||+++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999986532 2334899999999999999999999763  1239999999999999999999999999997


Q ss_pred             eeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          449 HVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      ........ .....|++.|+|||++.+..++.++||||||+++|+|++|+.|+.....     ...........      
T Consensus       165 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~i~~~~------  232 (279)
T 2w5a_A          165 ILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELAGKIREGK------  232 (279)
T ss_dssp             HC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHTC------
T ss_pred             eecccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-----HHHHHHHhhcc------
Confidence            65443221 1234689999999999998999999999999999999999988653321     11111111111      


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcc
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNN  570 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~  570 (625)
                         ....+...+..+.+++.+||+.+|++|||+.||++.+..
T Consensus       233 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          233 ---FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ---cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence               112344556789999999999999999999999976543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.8e-40  Score=340.96  Aligned_cols=256  Identities=18%  Similarity=0.231  Sum_probs=201.5

Q ss_pred             hcCccccccccccCceEEEEEEe-CCCCEEEEEEeecCChHHHHHHHHHHHHHhcCC-CCceeeeeeeeee--CCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-HKNVVRLLGCSIE--GPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~--~~~~~lV  372 (625)
                      .++|++.++||+|+||.||+|++ .+++.||||++....   .+.+.+|+.++++++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            36799999999999999999986 478999999986544   357889999999997 9999999999987  6678999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC-ceEEeecccceeeC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL-TPKIADFGLARHVA  451 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-~~kl~Dfgla~~~~  451 (625)
                      |||+++++|.+++.      .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++ .+||+|||+++...
T Consensus       112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            99999999998873      2789999999999999999999876   99999999999999766 89999999998765


Q ss_pred             CCCceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccccc-----
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQ-----  525 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  525 (625)
                      ....  .....|++.|+|||++.+ ..++.++||||||+++|||++|+.|+.........+.............+     
T Consensus       183 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  260 (330)
T 3nsz_A          183 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  260 (330)
T ss_dssp             TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             CCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence            4433  233578999999999977 67899999999999999999999997543322211111111110000000     


Q ss_pred             ----------c--------cCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          526 ----------S--------MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       526 ----------~--------i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                                .        .........+...+..+.+++.+||+.||++|||++|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                      0        0001111122335778999999999999999999999986

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.1e-40  Score=334.59  Aligned_cols=251  Identities=22%  Similarity=0.267  Sum_probs=201.7

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCCh------HHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSR------QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPES  369 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  369 (625)
                      .++|++.+.||+|+||.||+|+.+ +++.||||.+.....      ...+.+.+|+.++++++||||+++++++.+....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            467999999999999999999976 689999999875421      1357899999999999999999999999999999


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC----ceEEeecc
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL----TPKIADFG  445 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~----~~kl~Dfg  445 (625)
                      ++||||+++++|.+++....   .+++..++.++.|++.||.|||+.+   |+||||||+||+++.++    .+||+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            99999999999999986543   3899999999999999999999875   99999999999998776    89999999


Q ss_pred             cceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccccc
Q 042149          446 LARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQ  525 (625)
Q Consensus       446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  525 (625)
                      ++........  .....|++.|+|||++.+..++.++||||||+++|+|++|+.|+......     ..........   
T Consensus       158 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~---  227 (283)
T 3bhy_A          158 IAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-----ETLTNISAVN---  227 (283)
T ss_dssp             TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHTTC---
T ss_pred             cceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-----HHHHHhHhcc---
Confidence            9987654332  22356899999999999899999999999999999999999987532211     1111111111   


Q ss_pred             ccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          526 SMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       526 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                         ...........+..+.+++.+||+.||++|||+.|+++
T Consensus       228 ---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          228 ---YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             ---CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence               00000011233567899999999999999999999986

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=343.74  Aligned_cols=261  Identities=23%  Similarity=0.294  Sum_probs=193.9

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChH-HHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQ-WVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ++|.+.++||+|+||.||+|+.. +++.||||++...... ....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57999999999999999999976 7899999998654322 122456899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      ++ ++|.+++....  ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             CS-EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            97 58888776543  34899999999999999999999875   99999999999999999999999999976543322


Q ss_pred             eeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcc---ccccc-----
Q 042149          456 HVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN---RITQS-----  526 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~-----  526 (625)
                      . .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.|+...... +............   .+...     
T Consensus       156 ~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          156 T-YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE-EQLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             c-cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHhchhhhcchh
Confidence            2 233568999999999876 56899999999999999999999887543211 1111111111000   00000     


Q ss_pred             ----cCCCCCC----CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          527 ----MDPGLTG----RFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       527 ----i~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                          ..+....    ......+..+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                0000000    011234567899999999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.4e-40  Score=338.49  Aligned_cols=257  Identities=26%  Similarity=0.379  Sum_probs=198.9

Q ss_pred             hcCccccccccccCceEEEEEEeC--CCC--EEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP--DGR--NIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPES  369 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  369 (625)
                      .++|++.++||+|+||.||+|++.  +++  .||||++...   ..+..+.+.+|+.++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            467999999999999999999853  333  6899988654   3455678999999999999999999999988765 8


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      ++||||+++++|.+++....  ..+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence            99999999999999886542  34899999999999999999999875   99999999999999999999999999987


Q ss_pred             eCCCCcee--eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccc
Q 042149          450 VAPDKTHV--STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQS  526 (625)
Q Consensus       450 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (625)
                      ........  .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.|+..... ..    .......      
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~----~~~~~~~------  239 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-SQ----ILHKIDK------  239 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HH----HHHHHHT------
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-HH----HHHHHHc------
Confidence            75544322  223467889999999999999999999999999999999 8888643211 11    1111111      


Q ss_pred             cCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       527 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                        .......+...+..+.+++.+||+.+|++|||+.++++.|+++.
T Consensus       240 --~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          240 --EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             --SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             --cCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence              11112224456778999999999999999999999999998764

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-40  Score=339.37  Aligned_cols=264  Identities=24%  Similarity=0.285  Sum_probs=198.0

Q ss_pred             HHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-----hHHHHHHHHHHHHHhcCC---CCceeeeeeeeee
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-----RQWVDQFFNEVNLISGIQ---HKNVVRLLGCSIE  365 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~  365 (625)
                      ...++|++.++||+|+||+||+|++. +++.||||++....     ......+.+|+.++++++   ||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            34679999999999999999999964 78999999986432     112245667777777664   9999999999987


Q ss_pred             CC-----eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceE
Q 042149          366 GP-----ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPK  440 (625)
Q Consensus       366 ~~-----~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~k  440 (625)
                      ..     ..++||||+. ++|.+++..... ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+|
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence            65     5799999997 599998865443 33899999999999999999999886   99999999999999999999


Q ss_pred             EeecccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhc
Q 042149          441 IADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKA  520 (625)
Q Consensus       441 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~  520 (625)
                      |+|||+++.......  .....||+.|+|||++.+..++.++||||||+++|||++|+.|+...... ............
T Consensus       161 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~  237 (308)
T 3g33_A          161 LADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGL  237 (308)
T ss_dssp             ECSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH-HHHHHHHHHHCC
T ss_pred             EeeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCC
Confidence            999999986543322  23467899999999999999999999999999999999999987533211 111111111110


Q ss_pred             cc---ccc-------ccCCCCC---CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          521 NR---ITQ-------SMDPGLT---GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       521 ~~---~~~-------~i~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ..   +..       ...+...   ....+..+..+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            00   000       0000000   0011234577899999999999999999999985

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.4e-40  Score=345.09  Aligned_cols=259  Identities=21%  Similarity=0.330  Sum_probs=208.0

Q ss_pred             cHHHHHHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--------hHHHHHHHHHHHHHhcC-CCCceee
Q 042149          289 KYEILERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--------RQWVDQFFNEVNLISGI-QHKNVVR  358 (625)
Q Consensus       289 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~hpniv~  358 (625)
                      .+.......++|++.+.||+|+||.||+|+++ +|+.||||++....        ....+.+.+|+.+++++ +||||++
T Consensus        85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~  164 (365)
T 2y7j_A           85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT  164 (365)
T ss_dssp             HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            34455667788999999999999999999975 79999999987543        12346788999999999 7999999


Q ss_pred             eeeeeeeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCc
Q 042149          359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLT  438 (625)
Q Consensus       359 l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~  438 (625)
                      +++++......++||||+++++|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus       165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~  238 (365)
T 2y7j_A          165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQ  238 (365)
T ss_dssp             EEEEEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred             EEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence            9999999999999999999999999986543   3899999999999999999999875   999999999999999999


Q ss_pred             eEEeecccceeeCCCCceeeecCCCCccccCcccccc------CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchh
Q 042149          439 PKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR------GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLH  512 (625)
Q Consensus       439 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~  512 (625)
                      +||+|||++........  .....||+.|+|||++.+      ..++.++||||||+++|+|++|+.|+..... .    
T Consensus       239 ikl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-~----  311 (365)
T 2y7j_A          239 IRLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-I----  311 (365)
T ss_dssp             EEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-H----
T ss_pred             EEEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-H----
Confidence            99999999987754332  234679999999999864      3588999999999999999999998743211 0    


Q ss_pred             hHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          513 TVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       513 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ............      ...+.....+..+.+++.+||+.||++|||+.|+++
T Consensus       312 ~~~~~i~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          312 LMLRMIMEGQYQ------FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHHHHHHTCCC------CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHhCCCC------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111111111100      000000123566899999999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.3e-41  Score=348.36  Aligned_cols=266  Identities=21%  Similarity=0.276  Sum_probs=193.5

Q ss_pred             HHHHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCe
Q 042149          292 ILERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPE  368 (625)
Q Consensus       292 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  368 (625)
                      ......++|++.++||+|+||+||+|++. +++.||||++....  ....+.+.+|+.++++++||||+++++++.++..
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (329)
T 3gbz_A           28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR  107 (329)
T ss_dssp             ----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred             CcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence            34455678999999999999999999965 78999999996543  2335567899999999999999999999999999


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEc-----CCCceEEee
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD-----EKLTPKIAD  443 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~-----~~~~~kl~D  443 (625)
                      .++||||+++ +|.+++.....   +++..++.++.||+.||.|||+++   |+||||||+|||++     .++.+||+|
T Consensus       108 ~~lv~e~~~~-~L~~~~~~~~~---~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~D  180 (329)
T 3gbz_A          108 LHLIFEYAEN-DLKKYMDKNPD---VSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGD  180 (329)
T ss_dssp             EEEEEECCSE-EHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred             EEEEEecCCC-CHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECc
Confidence            9999999975 89888865543   899999999999999999999875   99999999999994     455699999


Q ss_pred             cccceeeCCCCceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccc
Q 042149          444 FGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR  522 (625)
Q Consensus       444 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  522 (625)
                      ||+++........ .....||+.|+|||++.+. .++.++||||||+++|||++|+.|+........+ ...........
T Consensus       181 fg~a~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~  258 (329)
T 3gbz_A          181 FGLARAFGIPIRQ-FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL-FKIFEVLGLPD  258 (329)
T ss_dssp             TTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHHCCCC
T ss_pred             CCCccccCCcccc-cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH-HHHHHHhCCCc
Confidence            9999876433222 2335689999999999874 5899999999999999999999987543221111 11111100000


Q ss_pred             ---c---cc-----ccCCCCCCC-----CChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          523 ---I---TQ-----SMDPGLTGR-----FPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       523 ---~---~~-----~i~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                         .   ..     ...+.....     .+...+..+.+++.+||+.||++|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence               0   00     000000000     01124567899999999999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4.2e-40  Score=346.61  Aligned_cols=251  Identities=16%  Similarity=0.190  Sum_probs=201.8

Q ss_pred             hcCccccccccccCceEEEEEE------eCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCC---CCceeeeeeeeeeCC
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGT------LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ---HKNVVRLLGCSIEGP  367 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~  367 (625)
                      .++|.+.++||+|+||.||+|+      ..+++.||||++.....   ..+.+|+.+++.++   |+||+++++++...+
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~  140 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN  140 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence            4678999999999999999994      34689999999976543   35677777777776   999999999999999


Q ss_pred             eeEEEEEecCCCCcchhhhccC--CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC----------
Q 042149          368 ESLLVYEYVPNRSLDQILFVKN--TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE----------  435 (625)
Q Consensus       368 ~~~lV~e~~~~~sL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~----------  435 (625)
                      ..++||||+++|+|.+++....  ....+++..++.++.||+.||+|||+.+   |+||||||+||||+.          
T Consensus       141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-----
T ss_pred             CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccccc
Confidence            9999999999999999996421  2345999999999999999999999775   999999999999988          


Q ss_pred             -CCceEEeecccceeeCC-CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhh
Q 042149          436 -KLTPKIADFGLARHVAP-DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT  513 (625)
Q Consensus       436 -~~~~kl~Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~  513 (625)
                       ++.+||+|||+++.+.. ..........||+.|+|||++.+..++.++||||||+++|||+||+.|+........    
T Consensus       218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----  293 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC----  293 (365)
T ss_dssp             -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE----
T ss_pred             ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce----
Confidence             89999999999986542 223334457899999999999999999999999999999999999998743222110    


Q ss_pred             HHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCC-CCHHHHHHHHcccc
Q 042149          514 VWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALR-PSMAEVVHMLNNID  572 (625)
Q Consensus       514 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-Pt~~ev~~~L~~~~  572 (625)
                              .    +..... ..  .....+.+++..|++.+|.+| |++.++.+.|++..
T Consensus       294 --------~----~~~~~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l  338 (365)
T 3e7e_A          294 --------K----PEGLFR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF  338 (365)
T ss_dssp             --------E----ECSCCT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred             --------e----echhcc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence                    0    111111 11  125567889999999999998 57888888776653

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.4e-40  Score=358.95  Aligned_cols=259  Identities=24%  Similarity=0.304  Sum_probs=194.2

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC------C
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG------P  367 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~  367 (625)
                      .++|++.++||+|+||+||+|++. +++.||||++...  .....+++.+|+.+|+.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            568999999999999999999965 6899999999754  455677889999999999999999999998654      4


Q ss_pred             eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccc
Q 042149          368 ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA  447 (625)
Q Consensus       368 ~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla  447 (625)
                      ..++||||++++ |.+.+..     .+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||++
T Consensus       141 ~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            579999999765 5554521     2889999999999999999999875   999999999999999999999999999


Q ss_pred             eeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhc-------
Q 042149          448 RHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKA-------  520 (625)
Q Consensus       448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~-------  520 (625)
                      +......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ +.........       
T Consensus       212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~-~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          212 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             -----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCSCCHHHHT
T ss_pred             eecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHH
Confidence            8764432  23346899999999999999999999999999999999999999754321111 1111000000       


Q ss_pred             ---cccccccCC---------------CCCCC---CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          521 ---NRITQSMDP---------------GLTGR---FPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       521 ---~~~~~~i~~---------------~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                         ......+..               .....   .....+..+.+|+.+||+.||++|||++|+++.
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               000000000               00000   011236778999999999999999999999863

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=6.4e-41  Score=354.43  Aligned_cols=242  Identities=16%  Similarity=0.166  Sum_probs=190.3

Q ss_pred             hcCccccccccccCceEEEEEEe-CCCCEEEEEEeecC---ChHHHHHHHHHH---HHHhcCCCCceeeee-------ee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFN---SRQWVDQFFNEV---NLISGIQHKNVVRLL-------GC  362 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~hpniv~l~-------~~  362 (625)
                      .++|++.+.||+|+||.||+|++ .+++.||||++...   .....+.+.+|+   .++++++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46789999999999999999996 46899999999743   445567899999   455566899999998       55


Q ss_pred             eeeCC-----------------eeEEEEEecCCCCcchhhhccCC----cCCCCHHHHHHHHHHHHHHHHHhhcCCCceE
Q 042149          363 SIEGP-----------------ESLLVYEYVPNRSLDQILFVKNT----IHILSWQQRFTIICGTAEGLAHLHGGSGIKI  421 (625)
Q Consensus       363 ~~~~~-----------------~~~lV~e~~~~~sL~~~l~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i  421 (625)
                      +...+                 ..++||||+ +|+|.+++.....    ...+++..++.++.||+.||+|||+++   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            55443                 278999999 6799999875422    112446888899999999999999875   9


Q ss_pred             EEeeeccCcEEEcCCCceEEeecccceeeCCCCceeeecCCCCccccCccccccC-----------cccccCcEEeehhh
Q 042149          422 IHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG-----------QLTEKADVYAFGVL  490 (625)
Q Consensus       422 iHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~SlG~l  490 (625)
                      +||||||+||||+.++.+||+|||+++....    ......| +.|+|||++.+.           .++.++||||||++
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            9999999999999999999999999986332    2334567 999999999887           89999999999999


Q ss_pred             hHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          491 VIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       491 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      +|||++|+.|+........ .             ..+...     ....+..+.+++.+||+.||++|||+.|+++
T Consensus       303 l~elltg~~Pf~~~~~~~~-~-------------~~~~~~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGG-S-------------EWIFRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHSSCCC------CC-S-------------GGGGSS-----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHCCCCCcccccccc-h-------------hhhhhh-----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            9999999999743221111 0             000000     1233567899999999999999999999985

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=8.5e-40  Score=352.01  Aligned_cols=198  Identities=24%  Similarity=0.369  Sum_probs=167.2

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC-----Ce
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG-----PE  368 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~  368 (625)
                      .++|++.++||+|+||.||+|++. +++.||||++...  .....+.+.+|+.+|++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            578999999999999999999975 6889999999653  445567899999999999999999999999776     57


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      .++||||+. ++|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999986 59999886443   3899999999999999999999886   9999999999999999999999999998


Q ss_pred             eeCCCCce---------------------eeecCCCCccccCcccc-ccCcccccCcEEeehhhhHHHHhCCCCC
Q 042149          449 HVAPDKTH---------------------VSTGIAGTLGYMAPEYL-VRGQLTEKADVYAFGVLVIEVASGRRNS  501 (625)
Q Consensus       449 ~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlG~ll~elltG~~p~  501 (625)
                      ........                     ..+...||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            76543221                     12456899999999986 4567999999999999999999865554

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1e-39  Score=332.21  Aligned_cols=249  Identities=24%  Similarity=0.340  Sum_probs=199.2

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeee----CCeeE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE----GPESL  370 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~  370 (625)
                      +.|.+.++||+|+||.||+|.+. ++..||+|++...  .....+.+.+|+.++++++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            34788889999999999999975 6889999998654  45567789999999999999999999998875    45689


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEc-CCCceEEeeccccee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARH  449 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~-~~~~~kl~Dfgla~~  449 (625)
                      +||||+++++|.+++....   .+++..++.++.+++.||.|||+.+ .+|+||||||+|||++ .++.+||+|||++..
T Consensus       106 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            9999999999999996543   3899999999999999999999662 2399999999999998 789999999999975


Q ss_pred             eCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          450 VAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      ......   ....||+.|+|||++. +.++.++||||||+++|+|++|+.|+.........    .........      
T Consensus       182 ~~~~~~---~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~~~------  247 (290)
T 1t4h_A          182 KRASFA---KAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI----YRRVTSGVK------  247 (290)
T ss_dssp             CCTTSB---EESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH----HHHHTTTCC------
T ss_pred             cccccc---ccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH----HHHHhccCC------
Confidence            443322   2357999999999875 56899999999999999999999997543222111    111111110      


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                        ....+...+..+.+++.+||+.+|++|||+.|+++
T Consensus       248 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          248 --PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             --CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence              01112233467899999999999999999999985

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.2e-40  Score=338.43  Aligned_cols=251  Identities=20%  Similarity=0.261  Sum_probs=203.3

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      ..++|.+.+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||||+++++++.+....++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            4567999999999999999999975 789999999986655455678999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE---cCCCceEEeecccceeeC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL---DEKLTPKIADFGLARHVA  451 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll---~~~~~~kl~Dfgla~~~~  451 (625)
                      |+++++|.+++....   .+++..+..++.|++.||.|||+.+   |+||||||+||++   +.++.+||+|||++....
T Consensus        87 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           87 LVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             cCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            999999999886544   3899999999999999999999875   9999999999999   778899999999987643


Q ss_pred             CCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      ...   .....||+.|+|||++.+..++.++||||||+++|+|++|+.|+.....     ............      ..
T Consensus       161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~~------~~  226 (304)
T 2jam_A          161 NGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-----SKLFEKIKEGYY------EF  226 (304)
T ss_dssp             CBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHCCC------CC
T ss_pred             CCc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHcCCC------CC
Confidence            321   1234689999999999999999999999999999999999998643211     111111111110      01


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ..+.....+..+.+++.+||+.||++|||+.|+++
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          227 ESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11223455678999999999999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-39  Score=343.07  Aligned_cols=257  Identities=22%  Similarity=0.358  Sum_probs=195.8

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC------
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP------  367 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------  367 (625)
                      .++|++.+.||+|+||.||+|++. +|+.||||++...  .....+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467999999999999999999974 7899999998543  4455678899999999999999999999987653      


Q ss_pred             eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccc
Q 042149          368 ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA  447 (625)
Q Consensus       368 ~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla  447 (625)
                      ..++||||+ +++|.+++...    .+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            469999999 88999988642    3899999999999999999999875   999999999999999999999999999


Q ss_pred             eeeCCCCceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHH----------
Q 042149          448 RHVAPDKTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWK----------  516 (625)
Q Consensus       448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~----------  516 (625)
                      +.....    .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.|+........ +.....          
T Consensus       176 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          176 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHHH
T ss_pred             cccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHH
Confidence            875432    234578999999999887 6899999999999999999999998754322111 111100          


Q ss_pred             -hhhccccc---cccCC---CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          517 -HYKANRIT---QSMDP---GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       517 -~~~~~~~~---~~i~~---~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                       .+......   ..+..   ..........+..+.+++.+||+.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence             00000000   00000   0001112344677899999999999999999999987

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=8.2e-40  Score=343.67  Aligned_cols=260  Identities=22%  Similarity=0.313  Sum_probs=204.2

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      .++|++.++||+|+||.||+|++. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            467999999999999999999976 6899999999765 44556789999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+++++|.+++.....   +++..+..++.+++.||.|||+..  +|+||||||+|||++.++.+||+|||++...... 
T Consensus       112 ~~~~~~L~~~l~~~~~---~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  185 (360)
T ss_dssp             CCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             CCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence            9999999999965543   899999999999999999999741  3999999999999999999999999998754321 


Q ss_pred             ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHH------------------
Q 042149          455 THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWK------------------  516 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~------------------  516 (625)
                        ......||+.|+|||++.+..++.++||||||+++|+|++|+.|+.......  ......                  
T Consensus       186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE--LELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHH--HHHHHC------------------
T ss_pred             --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccCCCCCCCcccCC
Confidence              1223579999999999999999999999999999999999999975432110  000000                  


Q ss_pred             ---------hhhccc----cccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          517 ---------HYKANR----ITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       517 ---------~~~~~~----~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                               ......    +............+...+..+.+++.+||+.||++|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                     000000    00000011111112234667999999999999999999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-40  Score=342.46  Aligned_cols=265  Identities=21%  Similarity=0.268  Sum_probs=197.1

Q ss_pred             HHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCCh-----HHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCe
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSR-----QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPE  368 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  368 (625)
                      ...++|++.+.||+|+||.||+|++. +++.||||++.....     ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34678999999999999999999975 689999999865322     112467899999999999999999999999999


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      .++||||+++ +|.+++....  ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             eEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence            9999999986 7887775432  34888999999999999999999876   9999999999999999999999999998


Q ss_pred             eeCCCCceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccc---c-
Q 042149          449 HVAPDKTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR---I-  523 (625)
Q Consensus       449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~-  523 (625)
                      ....... ......||+.|+|||++.+. .++.++||||||+++|||++|..|+...... ..+...+.......   + 
T Consensus       161 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          161 SFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQWP  238 (346)
T ss_dssp             TTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTSS
T ss_pred             eccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHcCCCChhhhh
Confidence            7643332 22345789999999999764 5889999999999999999998876433211 11111222111100   0 


Q ss_pred             --cc---ccCCCCCCCCC-----hHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          524 --TQ---SMDPGLTGRFP-----ENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       524 --~~---~i~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                        ..   .+........+     ...+..+.+++.+||+.||++|||+.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence              00   00000011111     2345789999999999999999999999874

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=9e-40  Score=354.76  Aligned_cols=195  Identities=25%  Similarity=0.395  Sum_probs=155.2

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC-----Ce
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG-----PE  368 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~  368 (625)
                      .++|++.++||+|+||+||+|+++ +++.||||++...  .....+.+.+|+.+|++++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            478999999999999999999965 6899999998653  445567899999999999999999999998543     57


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      .++||||+ +++|.+++....   .+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEecc-ccchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            89999998 568888885443   3899999999999999999999875   9999999999999999999999999998


Q ss_pred             eeCCCCc--------------------------eeeecCCCCccccCcccc-ccCcccccCcEEeehhhhHHHHhCC
Q 042149          449 HVAPDKT--------------------------HVSTGIAGTLGYMAPEYL-VRGQLTEKADVYAFGVLVIEVASGR  498 (625)
Q Consensus       449 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlG~ll~elltG~  498 (625)
                      .......                          ...+..+||+.|+|||++ ....++.++|||||||++|||++|.
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~  281 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI  281 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence            7643211                          122346789999999986 4567999999999999999999953

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=334.75  Aligned_cols=253  Identities=27%  Similarity=0.407  Sum_probs=200.5

Q ss_pred             HHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          294 ERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       294 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      +...++|++.+.||+|+||.||+|+++ +++.||||++....  ..+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  102 (314)
T 3com_A           25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV  102 (314)
T ss_dssp             -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            344678999999999999999999975 58999999997543  346788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+++++|.+++....  ..+++..++.++.+++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus       103 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (314)
T 3com_A          103 MEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD  177 (314)
T ss_dssp             EECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred             eecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence            99999999999886332  34899999999999999999999875   99999999999999999999999999987654


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      .... .....|++.|+|||++.+..++.++||||||+++|+|++|+.|+......    ..... .....     .+  .
T Consensus       178 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~~~~-----~~--~  244 (314)
T 3com_A          178 TMAK-RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM----RAIFM-IPTNP-----PP--T  244 (314)
T ss_dssp             TBSC-BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHH-HHHSC-----CC--C
T ss_pred             hccc-cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH----HHHHH-HhcCC-----Cc--c
Confidence            3322 23457899999999999999999999999999999999999987532111    11111 00000     00  1


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ...+...+..+.+++.+||+.||++|||+.++++
T Consensus       245 ~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          245 FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            1123445678999999999999999999999985

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.4e-39  Score=328.56  Aligned_cols=248  Identities=21%  Similarity=0.283  Sum_probs=197.1

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .++|.+.+.||+|+||.||+|++. +++.||||++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            467999999999999999999976 78999999986542   23456789999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+++++|.+++....   .+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            99999999999986554   3899999999999999999999875   99999999999999999999999999987654


Q ss_pred             CCceeeecCCCCccccCccccccCcc-cccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      ...  .....|++.|+|||.+.+..+ +.++||||||+++|+|++|+.|+.....     ...........         
T Consensus       164 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~---------  227 (276)
T 2h6d_A          164 GEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-----PTLFKKIRGGV---------  227 (276)
T ss_dssp             ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCC---------
T ss_pred             Ccc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----HHHHHHhhcCc---------
Confidence            322  223468999999999987765 6899999999999999999988743211     11112111111         


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                       ...+...+..+.+++.+||+.||++|||+.|+++.
T Consensus       228 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          228 -FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             11233446678999999999999999999999973

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=8.4e-40  Score=369.80  Aligned_cols=249  Identities=22%  Similarity=0.248  Sum_probs=207.0

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~  370 (625)
                      ..++|++.++||+|+||.||+|+++ +++.||||++...   .....+.+..|..++..+ +||+|+++++++.+.+.++
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3578999999999999999999975 6889999999753   233456788999999988 6999999999999999999


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      |||||++||+|.+++.....   +++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++..
T Consensus       419 lV~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            99999999999999976543   899999999999999999999875   999999999999999999999999999864


Q ss_pred             CCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          451 APDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                      ..... ......||+.|+|||++.+..++.++||||||+++|||++|+.|+.....     ...........        
T Consensus       493 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-----~~~~~~i~~~~--------  558 (674)
T 3pfq_A          493 IWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQSIMEHN--------  558 (674)
T ss_dssp             CCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHSSC--------
T ss_pred             ccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhCC--------
Confidence            43332 23457899999999999999999999999999999999999999753211     11111111111        


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPSM-----AEVVH  566 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~ev~~  566 (625)
                        ..+|...+.++.+|+.+||+.||++||++     +||++
T Consensus       559 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          559 --VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             --CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             --CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence              12355667889999999999999999997     77764

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=332.18  Aligned_cols=252  Identities=21%  Similarity=0.229  Sum_probs=199.1

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC----hHHHHHHHHHHHHHhcCCCCceeeeeeeee--eCCe
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS----RQWVDQFFNEVNLISGIQHKNVVRLLGCSI--EGPE  368 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~~  368 (625)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++....    ....+.+.+|+.++++++||||+++++++.  +...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            4578999999999999999999975 68899999996542    234578999999999999999999999984  4568


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      .++||||++++ |.+++.... ...+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++.
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence            89999999876 666665433 345899999999999999999999875   9999999999999999999999999998


Q ss_pred             eeCCCC-ceeeecCCCCccccCccccccCc--ccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccccc
Q 042149          449 HVAPDK-THVSTGIAGTLGYMAPEYLVRGQ--LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQ  525 (625)
Q Consensus       449 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  525 (625)
                      ...... ........||+.|+|||++.+..  ++.++||||||+++|||++|+.|+....     ............   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~i~~~~---  229 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-----IYKLFENIGKGS---  229 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHCC---
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-----HHHHHHHHhcCC---
Confidence            765322 22233457999999999987643  4789999999999999999999875321     111112211111   


Q ss_pred             ccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          526 SMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       526 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                             ...+...+..+.+++.+||+.||++|||+.|+++.
T Consensus       230 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 -------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             -------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                   11234456778999999999999999999999964

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.5e-39  Score=353.17  Aligned_cols=261  Identities=18%  Similarity=0.291  Sum_probs=205.9

Q ss_pred             hcCccccccccccCceEEEEEEe-CCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCC-CceeeeeeeeeeCCeeEEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQH-KNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lV~e  374 (625)
                      .++|++.++||+|+||.||+|++ .+++.||||++......  ..+.+|+++++.++| ++|+.+..++.+....+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            57899999999999999999996 46899999988654332  357889999999986 566667777788889999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE---cCCCceEEeecccceeeC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL---DEKLTPKIADFGLARHVA  451 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll---~~~~~~kl~Dfgla~~~~  451 (625)
                      |+ +++|.+++....  ..+++..++.|+.||+.||.|||+++   |+||||||+||||   +.++.+||+|||+++.+.
T Consensus        84 ~~-g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 999999986433  24899999999999999999999875   9999999999999   588999999999998776


Q ss_pred             CCCcee------eecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccccc
Q 042149          452 PDKTHV------STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQ  525 (625)
Q Consensus       452 ~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  525 (625)
                      ......      .....||+.|+|||++.+..++.++||||||+++|||++|+.||.........  ..........+..
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~i~~~~~~~  235 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK--QKYEKISEKKVAT  235 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH--HHHHHHHHHHHHS
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHH--HHHHHHhhccccc
Confidence            543321      22567999999999999999999999999999999999999997654322111  1111111111111


Q ss_pred             ccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          526 SMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       526 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      .+.     ......+.++.+++.+||+.+|++||++.+|++.|+++.
T Consensus       236 ~~~-----~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~  277 (483)
T 3sv0_A          236 SIE-----ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF  277 (483)
T ss_dssp             CHH-----HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             cHH-----HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            000     001233567899999999999999999999999988763

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.3e-39  Score=340.31  Aligned_cols=258  Identities=20%  Similarity=0.266  Sum_probs=204.4

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChH-----------------HHHHHHHHHHHHhcCCCCceeee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQ-----------------WVDQFFNEVNLISGIQHKNVVRL  359 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~hpniv~l  359 (625)
                      .++|++.+.||+|+||.||+|+. +++.||||++......                 ..+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 8999999998653211                 12789999999999999999999


Q ss_pred             eeeeeeCCeeEEEEEecCCCCcchh------hhccCCcCCCCHHHHHHHHHHHHHHHHHhhc-CCCceEEEeeeccCcEE
Q 042149          360 LGCSIEGPESLLVYEYVPNRSLDQI------LFVKNTIHILSWQQRFTIICGTAEGLAHLHG-GSGIKIIHRDIKTSNIL  432 (625)
Q Consensus       360 ~~~~~~~~~~~lV~e~~~~~sL~~~------l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~iiHrDlkp~NIl  432 (625)
                      ++++.+.+..++||||+++++|.++      +... ....+++..++.++.|++.||.|||+ .+   |+||||||+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999998      5332 13458999999999999999999997 64   999999999999


Q ss_pred             EcCCCceEEeecccceeeCCCCceeeecCCCCccccCccccccC-cccc-cCcEEeehhhhHHHHhCCCCCCCCCCCccc
Q 042149          433 LDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG-QLTE-KADVYAFGVLVIEVASGRRNSVFSEGSSSV  510 (625)
Q Consensus       433 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~SlG~ll~elltG~~p~~~~~~~~~~  510 (625)
                      ++.++.+||+|||++......   ......|++.|+|||++.+. .++. ++||||||+++|||++|+.|+.........
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  261 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL  261 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred             EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            999999999999999876443   23446799999999999887 6766 999999999999999999997644332221


Q ss_pred             hhhHHHhhhcccccccc---------CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          511 LHTVWKHYKANRITQSM---------DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       511 ~~~~~~~~~~~~~~~~i---------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                          .............         ............+..+.+++.+||+.||++|||+.|+++
T Consensus       262 ----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          262 ----FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             ----HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ----HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                1111111110000         000000011345678899999999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.7e-40  Score=338.23  Aligned_cols=264  Identities=25%  Similarity=0.322  Sum_probs=186.8

Q ss_pred             HHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      ...++|++.+.||+|+||.||+|++. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            34678999999999999999999964 68999999886543 34456788999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhcc-----CCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccc
Q 042149          373 YEYVPNRSLDQILFVK-----NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA  447 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla  447 (625)
                      |||+++++|.+++...     .....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence            9999999999988641     12345899999999999999999999875   999999999999999999999999998


Q ss_pred             eeeCCCCc----eeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccc
Q 042149          448 RHVAPDKT----HVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR  522 (625)
Q Consensus       448 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  522 (625)
                      ........    .......||+.|+|||++.+ ..++.++||||||+++|||++|+.|+.........    ...... .
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~-~  243 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL----MLTLQN-D  243 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH----HHHHTS-S
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH----HHHhcc-C
Confidence            76543221    11224579999999999876 56899999999999999999999997543221111    111111 0


Q ss_pred             cccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          523 ITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       523 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .................+..+.+++.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            00000000011122334567899999999999999999999985

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=9.5e-40  Score=357.16  Aligned_cols=252  Identities=22%  Similarity=0.270  Sum_probs=202.9

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      ..++|++.++||+|+||+||+|+++ +++.||||++...  .......+.+|+.++++++||||+++++++.+....++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            4578999999999999999999975 7899999998643  223457789999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEc---CCCceEEeeccccee
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADFGLARH  449 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~---~~~~~kl~Dfgla~~  449 (625)
                      |||+++++|.+.+....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++   .++.+||+|||+++.
T Consensus       100 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            99999999998886554   3899999999999999999999876   99999999999995   456799999999986


Q ss_pred             eCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          450 VAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      ......  .....||+.|+|||++.+ .++.++||||||+++|+|++|+.|+..... ..    ...........     
T Consensus       174 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~----~~~~i~~~~~~-----  240 (486)
T 3mwu_A          174 FQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-YD----ILKRVETGKYA-----  240 (486)
T ss_dssp             BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HH----HHHHHHHTCCC-----
T ss_pred             CCCCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HH----HHHHHHhCCCC-----
Confidence            654322  234579999999999865 589999999999999999999999743211 11    11111111100     


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                       ...+.....+..+.+++.+||+.+|++|||+.|+++.
T Consensus       241 -~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          241 -FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             -SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             -CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             0111123456788999999999999999999999974

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.2e-39  Score=356.97  Aligned_cols=251  Identities=23%  Similarity=0.281  Sum_probs=198.8

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      ..+.|++.++||+|+||+||+|+++ ++..||||++....  ......+.+|+.+++.++||||+++++++.+....++|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3567999999999999999999975 68899999987542  33356789999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC---CCceEEeeccccee
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE---KLTPKIADFGLARH  449 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~---~~~~kl~Dfgla~~  449 (625)
                      |||+++++|.+.+.....   +++..+..++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||++..
T Consensus       115 ~e~~~~g~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          115 MECYKGGELFDEIIHRMK---FNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            999999999988865543   899999999999999999999875   999999999999975   45599999999987


Q ss_pred             eCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          450 VAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      ......  .....||+.|+|||++. +.++.++||||||+++|+|++|+.|+.....     .............     
T Consensus       189 ~~~~~~--~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~~~~~-----  255 (494)
T 3lij_A          189 FENQKK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-----QEILRKVEKGKYT-----  255 (494)
T ss_dssp             CBTTBC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHTCCC-----
T ss_pred             CCCCcc--ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCC-----
Confidence            654332  23457999999999875 5799999999999999999999999753221     1111111111100     


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                       ...+.....+..+.+++.+||+.+|++|||+.|+++
T Consensus       256 -~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          256 -FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             -CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence             001111244677899999999999999999999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=9.5e-40  Score=337.76  Aligned_cols=253  Identities=19%  Similarity=0.222  Sum_probs=197.1

Q ss_pred             HHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--------hHHHHHHHHHHHHHhcCCCCceeeeeeeeee
Q 042149          295 RATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--------RQWVDQFFNEVNLISGIQHKNVVRLLGCSIE  365 (625)
Q Consensus       295 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  365 (625)
                      ...++|++.+.||+|+||.||+|++. +++.||||++....        ......+.+|+.++++++||||+++++++..
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   86 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA   86 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence            34578999999999999999999975 68899999986432        1223458899999999999999999999876


Q ss_pred             CCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCc---eEEe
Q 042149          366 GPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLT---PKIA  442 (625)
Q Consensus       366 ~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~---~kl~  442 (625)
                      +. .++||||+++++|.+++....   .+++..++.++.||+.||.|||+++   |+||||||+|||++.++.   +||+
T Consensus        87 ~~-~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~  159 (322)
T 2ycf_A           87 ED-YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  159 (322)
T ss_dssp             SS-EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred             Cc-eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEc
Confidence            55 899999999999999885433   4899999999999999999999875   999999999999987654   9999


Q ss_pred             ecccceeeCCCCceeeecCCCCccccCccccc---cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhh
Q 042149          443 DFGLARHVAPDKTHVSTGIAGTLGYMAPEYLV---RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK  519 (625)
Q Consensus       443 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~  519 (625)
                      |||+++.......  .....||+.|+|||++.   ...++.++||||||+++|+|++|+.|+........+.....    
T Consensus       160 Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----  233 (322)
T 2ycf_A          160 DFGHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT----  233 (322)
T ss_dssp             CCTTCEECCCCHH--HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHH----
T ss_pred             cCccceecccccc--cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHH----
Confidence            9999987643321  22356899999999974   46788999999999999999999999764433322221111    


Q ss_pred             ccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       520 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .....      .........+..+.+++.+||+.||++|||+.++++
T Consensus       234 ~~~~~------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          234 SGKYN------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HTCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hCccc------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            11100      000001234567899999999999999999999985

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.6e-40  Score=349.11  Aligned_cols=261  Identities=21%  Similarity=0.267  Sum_probs=196.6

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC------eeE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP------ESL  370 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------~~~  370 (625)
                      ..+|.+.++||+|+||+||+|++..+..+|+|++.....    ...+|+.+++.++||||+++++++....      ..+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            457999999999999999999988777799999865432    2347999999999999999999986543      378


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEc-CCCceEEeeccccee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARH  449 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~-~~~~~kl~Dfgla~~  449 (625)
                      +||||++++.+............+++..+..++.||+.||.|||+.+   |+||||||+||||+ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999987655444433333345899999999999999999999875   99999999999999 789999999999987


Q ss_pred             eCCCCceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhc--------
Q 042149          450 VAPDKTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKA--------  520 (625)
Q Consensus       450 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~--------  520 (625)
                      .......  ....||+.|+|||++.+. .++.++|||||||++|||++|+.|+........+ ....+....        
T Consensus       192 ~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l-~~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          192 LIAGEPN--VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL-VEIIKVLGTPSREQIKT  268 (394)
T ss_dssp             CCTTCCC--CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHHCCCCHHHHHH
T ss_pred             ccCCCCC--cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHHHh
Confidence            6544332  345789999999998765 5899999999999999999999987543221111 111111000        


Q ss_pred             --cccccccCCCCC-----CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          521 --NRITQSMDPGLT-----GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       521 --~~~~~~i~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                        .......-+...     ..++...+..+.+|+.+||+.||++|||+.|+++.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence              000000000000     01122356789999999999999999999999863

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.3e-39  Score=330.82  Aligned_cols=254  Identities=20%  Similarity=0.286  Sum_probs=205.4

Q ss_pred             HHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---------hHHHHHHHHHHHHHhcCC-CCceeeeeee
Q 042149          294 ERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---------RQWVDQFFNEVNLISGIQ-HKNVVRLLGC  362 (625)
Q Consensus       294 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-hpniv~l~~~  362 (625)
                      ....++|++.+.||+|+||.||+|+++ +++.||||++....         ....+.+.+|+.+++++. ||||++++++
T Consensus        13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            345688999999999999999999975 68899999996543         233567889999999996 9999999999


Q ss_pred             eeeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEe
Q 042149          363 SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIA  442 (625)
Q Consensus       363 ~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~  442 (625)
                      +......++||||+++++|.+++....   .+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~  166 (298)
T 1phk_A           93 YETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLT  166 (298)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred             eccCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEe
Confidence            999999999999999999999986543   3899999999999999999999875   9999999999999999999999


Q ss_pred             ecccceeeCCCCceeeecCCCCccccCccccc------cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHH
Q 042149          443 DFGLARHVAPDKTHVSTGIAGTLGYMAPEYLV------RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWK  516 (625)
Q Consensus       443 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~  516 (625)
                      |||++........  .....|++.|+|||++.      ...++.++||||||+++|+|++|+.|+.....     .....
T Consensus       167 dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~  239 (298)
T 1phk_A          167 DFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-----MLMLR  239 (298)
T ss_dssp             CCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH
T ss_pred             cccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-----HHHHH
Confidence            9999987654332  23457899999999985      45688999999999999999999998743211     01111


Q ss_pred             hhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          517 HYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       517 ~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .......      ....+.....+..+.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          240 MIMSGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHhcCCc------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            1111110      0111112355778999999999999999999999985

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.4e-40  Score=335.49  Aligned_cols=252  Identities=21%  Similarity=0.261  Sum_probs=187.4

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      .++|++.++||+|+||.||+|++. +++.||||++....  ....+.+.++...++.++||||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            578999999999999999999974 78999999996542  233344555666688899999999999999999999999


Q ss_pred             EecCCCCcchhhhcc-CCcCCCCHHHHHHHHHHHHHHHHHhhcC-CCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          374 EYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHLHGG-SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       374 e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~-~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||+++ +|.+++... .....+++..++.++.|++.||.|||++ +   |+||||||+||+++.++.+||+|||+++...
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99975 887776532 2234589999999999999999999976 5   9999999999999999999999999998765


Q ss_pred             CCCceeeecCCCCccccCcccc----ccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccccccc
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYL----VRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM  527 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  527 (625)
                      .....  ....||+.|+|||++    .+..++.++||||||+++|+|++|+.|+.........   .......       
T Consensus       162 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~-------  229 (290)
T 3fme_A          162 DDVAK--DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ---LKQVVEE-------  229 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH---HHHHHHS-------
T ss_pred             ccccc--cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH---HHHHhcc-------
Confidence            43322  234699999999996    4567899999999999999999999997532221111   1111111       


Q ss_pred             CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       528 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                        ......+...+..+.+++.+||+.+|++|||+.|+++
T Consensus       230 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          230 --PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             --CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence              1111112345677899999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=6.3e-40  Score=346.09  Aligned_cols=254  Identities=11%  Similarity=0.055  Sum_probs=183.1

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcC--CCCceeeee-------eee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGI--QHKNVVRLL-------GCS  363 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~hpniv~l~-------~~~  363 (625)
                      ...|.+.++||+|+||.||+|++. +++.||||++....   ....+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345888999999999999999965 78999999998753   34456778885544444  699988755       344


Q ss_pred             eeC-----------------CeeEEEEEecCCCCcchhhhccCCcCCCCHHHH------HHHHHHHHHHHHHhhcCCCce
Q 042149          364 IEG-----------------PESLLVYEYVPNRSLDQILFVKNTIHILSWQQR------FTIICGTAEGLAHLHGGSGIK  420 (625)
Q Consensus       364 ~~~-----------------~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~~~~  420 (625)
                      ...                 ...+|||||++ ++|.+++.....  .+.+..+      +.++.||+.||+|||+++   
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG---  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence            332                 34799999998 899999975422  2455555      677899999999999875   


Q ss_pred             EEEeeeccCcEEEcCCCceEEeecccceeeCCCCceeeecCCCCccccCcccccc--CcccccCcEEeehhhhHHHHhCC
Q 042149          421 IIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR--GQLTEKADVYAFGVLVIEVASGR  498 (625)
Q Consensus       421 iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~ll~elltG~  498 (625)
                      |+||||||+||||+.++.+||+|||+++.....    .....+|+.|+|||++.+  ..++.++||||||+++|||++|+
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence            999999999999999999999999999865421    113457799999999987  67899999999999999999999


Q ss_pred             CCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          499 RNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       499 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .|+........      ..+...............+.....+..+.+++.+||+.||++|||+.|+++
T Consensus       291 ~Pf~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          291 LPFGLVTPGIK------GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             CSTTBCCTTCT------TCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCcCcccc------cchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            99764422110      011111111111111122222356778999999999999999999999874

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.7e-40  Score=338.39  Aligned_cols=253  Identities=23%  Similarity=0.341  Sum_probs=199.3

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            3578999999999999999999976 589999999977666667889999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+++++|.+++....  ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        97 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (302)
T 2j7t_A           97 FCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL  171 (302)
T ss_dssp             CCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred             eCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence            999999999886533  23899999999999999999999875   9999999999999999999999999875322111


Q ss_pred             ceeeecCCCCccccCccccc-----cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          455 THVSTGIAGTLGYMAPEYLV-----RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                       .......||+.|+|||++.     ...++.++||||||+++|+|++|+.|+......    ..... ......     +
T Consensus       172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~~~~~-----~  240 (302)
T 2j7t_A          172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM----RVLLK-IAKSDP-----P  240 (302)
T ss_dssp             -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHH-HHHSCC-----C
T ss_pred             -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH----HHHHH-HhccCC-----c
Confidence             1112346899999999984     567889999999999999999999987533211    11111 111110     0


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                        ....+...+..+.+++.+||+.+|++|||+.++++
T Consensus       241 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          241 --TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             --CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             --ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence              11123455678999999999999999999999875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.1e-39  Score=356.03  Aligned_cols=251  Identities=24%  Similarity=0.305  Sum_probs=200.7

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCCh-------------HHHHHHHHHHHHHhcCCCCceeeeee
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSR-------------QWVDQFFNEVNLISGIQHKNVVRLLG  361 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpniv~l~~  361 (625)
                      ..++|.+.++||+|+||+||+|+++ +++.||||++.....             ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4678999999999999999999975 588999999865321             33567899999999999999999999


Q ss_pred             eeeeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC---c
Q 042149          362 CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL---T  438 (625)
Q Consensus       362 ~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~---~  438 (625)
                      ++.+....++||||+++++|.+.+....   .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence            9999999999999999999999886554   3899999999999999999999875   99999999999998765   6


Q ss_pred             eEEeecccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhh
Q 042149          439 PKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHY  518 (625)
Q Consensus       439 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~  518 (625)
                      +||+|||++........  .....||+.|+|||++. +.++.++||||||+++|+|++|+.|+..... .    ......
T Consensus       188 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~----~~~~~i  259 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND-Q----DIIKKV  259 (504)
T ss_dssp             EEECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-H----HHHHHH
T ss_pred             EEEEECCCCEEcCCCCc--cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-H----HHHHHH
Confidence            99999999987754432  23457999999999986 5699999999999999999999999753221 1    111111


Q ss_pred             hccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       519 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ......      ...+.....+..+.+++.+||+.||++|||+.|+++
T Consensus       260 ~~~~~~------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          260 EKGKYY------FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHCCCC------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HcCCCC------CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            111100      000001234567899999999999999999999985

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=6.3e-40  Score=358.51  Aligned_cols=251  Identities=24%  Similarity=0.292  Sum_probs=204.8

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      ..++|++.++||+|+||.||+|+++ +++.||||++....   ....+.+.+|+.++++++||||+++++++.+....++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3567999999999999999999976 78999999986542   3456789999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE---cCCCceEEeecccce
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL---DEKLTPKIADFGLAR  448 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll---~~~~~~kl~Dfgla~  448 (625)
                      ||||+.+++|.+.+....   .+++..++.++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+++
T Consensus       104 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            999999999999886543   3899999999999999999999875   9999999999999   467899999999998


Q ss_pred             eeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          449 HVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      .......  .....||+.|+|||++.+ .++.++||||||+++|+|++|+.|+......     ............    
T Consensus       178 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~i~~~~~~----  245 (484)
T 3nyv_A          178 HFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY-----DILKKVEKGKYT----  245 (484)
T ss_dssp             HBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHCCCC----
T ss_pred             Ecccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHcCCCC----
Confidence            7654432  223579999999999865 7899999999999999999999997532211     111111111100    


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                        ...+.....+..+.+++.+||+.+|++|||+.|+++
T Consensus       246 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          246 --FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             --CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence              011112345678899999999999999999999985

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.2e-39  Score=342.75  Aligned_cols=270  Identities=21%  Similarity=0.248  Sum_probs=200.1

Q ss_pred             ccHHHHHHHhcCccccccccccCceEEEEEEeCCCCEEEEEEeecC-----------ChHHHHHHHHHHHHHhcCCCCce
Q 042149          288 FKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFN-----------SRQWVDQFFNEVNLISGIQHKNV  356 (625)
Q Consensus       288 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-----------~~~~~~~~~~E~~~l~~l~hpni  356 (625)
                      .....+....++|.+.++||+|+||.||+|++.+++.||||++...           .....+.+.+|+.++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            3456788889999999999999999999999888999999988542           22335789999999999999999


Q ss_pred             eeeeeeeee-----CCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcE
Q 042149          357 VRLLGCSIE-----GPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNI  431 (625)
Q Consensus       357 v~l~~~~~~-----~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NI  431 (625)
                      +++++++..     ....++||||++ ++|.+.+...  ...+++..+..++.||+.||.|||+.+   |+||||||+||
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI  165 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI  165 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence            999999854     336799999997 5777777533  234899999999999999999999875   99999999999


Q ss_pred             EEcCCCceEEeecccceeeCCCCceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccc
Q 042149          432 LLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSV  510 (625)
Q Consensus       432 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~  510 (625)
                      |++.++.+||+|||+++.......  .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.|+....... .
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~  242 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-Q  242 (362)
T ss_dssp             EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-H
T ss_pred             EEcCCCCEEEEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH-H
Confidence            999999999999999975443322  234578999999999877 678999999999999999999999875432111 1


Q ss_pred             hhhHHHhhh-----------ccccccccCCCCCC-------CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          511 LHTVWKHYK-----------ANRITQSMDPGLTG-------RFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       511 ~~~~~~~~~-----------~~~~~~~i~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .........           .....+.+......       ..+...+..+.+++.+||+.||++|||+.|+++
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            111111000           00001111111110       011234567899999999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.6e-40  Score=347.95  Aligned_cols=262  Identities=21%  Similarity=0.289  Sum_probs=195.9

Q ss_pred             HHHhcCccccccccccCceEEEEEEe-CCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeee-------
Q 042149          294 ERATDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE-------  365 (625)
Q Consensus       294 ~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-------  365 (625)
                      +...++|++.++||+|+||+||+|++ .+++.||||++.....    ...+|+.+++.++||||+++++++..       
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            45578899999999999999999996 4789999999865432    23479999999999999999999844       


Q ss_pred             -------------------------------CCeeEEEEEecCCCCcchhhhcc-CCcCCCCHHHHHHHHHHHHHHHHHh
Q 042149          366 -------------------------------GPESLLVYEYVPNRSLDQILFVK-NTIHILSWQQRFTIICGTAEGLAHL  413 (625)
Q Consensus       366 -------------------------------~~~~~lV~e~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~L~~L  413 (625)
                                                     ....++||||++ ++|.+.+... .....+++..+..++.||++||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           334889999998 4777766531 2234589999999999999999999


Q ss_pred             hcCCCceEEEeeeccCcEEEc-CCCceEEeecccceeeCCCCceeeecCCCCccccCccccccC-cccccCcEEeehhhh
Q 042149          414 HGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLV  491 (625)
Q Consensus       414 H~~~~~~iiHrDlkp~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll  491 (625)
                      |+.+   |+||||||+|||++ .++.+||+|||+++........  ....+|+.|+|||++.+. .++.++||||||+++
T Consensus       158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS--VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC--CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC--cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence            9775   99999999999998 6889999999999876544332  335789999999998775 589999999999999


Q ss_pred             HHHHhCCCCCCCCCCCccchhhHHHhhhcc----------ccccccCCCC-----CCCCChHHHHHHHHHHhhccCCCCC
Q 042149          492 IEVASGRRNSVFSEGSSSVLHTVWKHYKAN----------RITQSMDPGL-----TGRFPENEASRVLQIGLLCTQAPVA  556 (625)
Q Consensus       492 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~i~~~~-----~~~~~~~~~~~l~~li~~cl~~~p~  556 (625)
                      |||++|+.|+......+.+ ....+.....          ...+..-+..     ....+...+..+.+|+.+||+.||+
T Consensus       233 ~ell~g~~pf~~~~~~~~~-~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          233 GELILGKPLFSGETSIDQL-VRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHHHHSSCSSCCSSHHHHH-HHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHhCCCCCCCCChHHHH-HHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            9999999887543221111 1111110000          0000000000     0112334567789999999999999


Q ss_pred             CCCCHHHHHH
Q 042149          557 LRPSMAEVVH  566 (625)
Q Consensus       557 ~RPt~~ev~~  566 (625)
                      +|||+.|+++
T Consensus       312 ~R~t~~e~l~  321 (383)
T 3eb0_A          312 LRINPYEAMA  321 (383)
T ss_dssp             GSCCHHHHHT
T ss_pred             hCCCHHHHhc
Confidence            9999999985

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.2e-39  Score=339.15  Aligned_cols=263  Identities=21%  Similarity=0.304  Sum_probs=197.3

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeee--------
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIE--------  365 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--------  365 (625)
                      .++|++.++||+|+||.||+|++. +++.||||++....  ......+.+|+.+++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            467999999999999999999974 78999999886542  2234567899999999999999999999887        


Q ss_pred             CCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecc
Q 042149          366 GPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFG  445 (625)
Q Consensus       366 ~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfg  445 (625)
                      .+..++||||+++ +|.+.+....  ..+++.+++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence            4468999999975 6666664332  34899999999999999999999875   9999999999999999999999999


Q ss_pred             cceeeCCCCc---eeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhH-------
Q 042149          446 LARHVAPDKT---HVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV-------  514 (625)
Q Consensus       446 la~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~-------  514 (625)
                      +++.+.....   .......||+.|+|||++.+ ..++.++||||||+++|||++|+.|+....... .....       
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~  248 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALISQLCGSI  248 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCC
Confidence            9987653221   22234578999999999876 468999999999999999999998875432111 11111       


Q ss_pred             ----HHhhhccccccccCCCCCCCCC-hH------HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          515 ----WKHYKANRITQSMDPGLTGRFP-EN------EASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       515 ----~~~~~~~~~~~~i~~~~~~~~~-~~------~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                          |...........+......... ..      .+..+.+|+.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence                1111111111111000000000 01      1345889999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3e-39  Score=330.19  Aligned_cols=252  Identities=26%  Similarity=0.378  Sum_probs=195.2

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeee---------
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE---------  365 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---------  365 (625)
                      ..++|++.+.||+|+||.||+|++. +++.||||++... ....+.+.+|+.++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            4578999999999999999999975 7899999998643 4456789999999999999999999998865         


Q ss_pred             ----CCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEE
Q 042149          366 ----GPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKI  441 (625)
Q Consensus       366 ----~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl  441 (625)
                          ....++||||+++++|.+++....  ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl  157 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI  157 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence                356899999999999999996543  34788999999999999999999875   999999999999999999999


Q ss_pred             eecccceeeCCCC-------------ceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCC
Q 042149          442 ADFGLARHVAPDK-------------THVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGS  507 (625)
Q Consensus       442 ~Dfgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~  507 (625)
                      +|||++.......             ........||+.|+|||++.+. .++.++||||||+++|||++   |+..... 
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-  233 (303)
T 1zy4_A          158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-  233 (303)
T ss_dssp             CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH-
T ss_pred             eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh-
Confidence            9999997654321             1112245689999999999764 78999999999999999998   3211100 


Q ss_pred             ccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          508 SSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                         ..........      .........+...+..+.+++.+||+.||++|||+.++++
T Consensus       234 ---~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          234 ---RVNILKKLRS------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             ---HHHHHHHHHS------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---HHHHHHhccc------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence               0011111111      1112223345566777899999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=7e-40  Score=369.31  Aligned_cols=257  Identities=22%  Similarity=0.293  Sum_probs=204.7

Q ss_pred             HhcCccccccccccCceEEEEEEeCC----CCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLPD----GRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  370 (625)
                      ..++|++.+.||+|+||.||+|++..    +..||||++... .....+.+.+|+.++++++||||+++++++. ++..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            35679999999999999999998642    457899988654 4455678999999999999999999999985 46789


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      +||||+++++|.+++....  ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       467 lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             EEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            9999999999999986543  24899999999999999999999875   999999999999999999999999999876


Q ss_pred             CCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          451 APDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      ............+|+.|+|||++.+..++.++||||||+++|||++ |..|+..... ..    ........        
T Consensus       542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-~~----~~~~i~~~--------  608 (656)
T 2j0j_A          542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-ND----VIGRIENG--------  608 (656)
T ss_dssp             CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HH----HHHHHHHT--------
T ss_pred             CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-HH----HHHHHHcC--------
Confidence            5444333334567889999999999999999999999999999997 8777643211 11    11111111        


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                       ...+.+...+..+.+++.+||+.||++|||+.+|++.|+++.
T Consensus       609 -~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          609 -ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence             112234566778999999999999999999999999998763

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.5e-39  Score=334.76  Aligned_cols=252  Identities=23%  Similarity=0.370  Sum_probs=198.7

Q ss_pred             HhcCccccccccccCceEEEEEEeCCCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCC--CCceeeeeeeeeeCCeeEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQ--HKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~~~~l  371 (625)
                      ..++|++.+.||+|+||.||++++.+++.||||++...  .....+.+.+|+.++++++  ||||+++++++.+.+..++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            35679999999999999999999888999999999654  4556788999999999997  5999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||| +.+++|.+++....   .+++..++.++.|+++||.|||+.+   |+||||||+|||+++ +.+||+|||+++...
T Consensus       106 v~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~  177 (313)
T 3cek_A          106 VME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ  177 (313)
T ss_dssp             EEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred             EEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence            999 56889999987544   3899999999999999999999875   999999999999975 799999999998765


Q ss_pred             CCCce-eeecCCCCccccCcccccc-----------CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhh
Q 042149          452 PDKTH-VSTGIAGTLGYMAPEYLVR-----------GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK  519 (625)
Q Consensus       452 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~  519 (625)
                      ..... ......|++.|+|||++.+           ..++.++||||||+++|||++|+.|+.......   ..      
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~------  248 (313)
T 3cek_A          178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SK------  248 (313)
T ss_dssp             ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---HH------
T ss_pred             CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH---HH------
Confidence            43322 1224568999999999865           467889999999999999999999874322110   00      


Q ss_pred             ccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       520 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                         +...+++......+...+..+.+++.+||+.||++||++.|+++.
T Consensus       249 ---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          249 ---LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             ---HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence               111122222223344446778999999999999999999999863

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7.3e-40  Score=351.09  Aligned_cols=259  Identities=22%  Similarity=0.289  Sum_probs=193.2

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC------Cee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG------PES  369 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~~  369 (625)
                      ..+|++.++||+|+||.||+|++. +++.||||++.....    ...+|+++|+.++||||+++++++...      ..+
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            346889999999999999999975 689999999865432    245799999999999999999988542      236


Q ss_pred             EEEEEecCCCCcchhhhc-cCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCC-CceEEeecccc
Q 042149          370 LLVYEYVPNRSLDQILFV-KNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEK-LTPKIADFGLA  447 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~-~~~kl~Dfgla  447 (625)
                      ++||||+++ +|.+.+.. ......+++..+..++.||++||.|||+++   |+||||||+||||+.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence            799999976 55554432 122345899999999999999999999775   9999999999999955 67899999999


Q ss_pred             eeeCCCCceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhc------
Q 042149          448 RHVAPDKTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKA------  520 (625)
Q Consensus       448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~------  520 (625)
                      +........  ....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.+. ...+....      
T Consensus       205 ~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~-~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          205 KQLVRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV-EIIKVLGTPTREQI  281 (420)
T ss_dssp             EECCTTCCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-HHHHHHCSCCHHHH
T ss_pred             hhcccCCCc--eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCCHHHH
Confidence            876543322  345789999999999765 78999999999999999999999875432211111 11111000      


Q ss_pred             ----cccccccCCCCCC-----CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          521 ----NRITQSMDPGLTG-----RFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       521 ----~~~~~~i~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                          ....+...+.+..     .++...+.++.+|+.+||+.||++|||+.|+++
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence                0000100011100     012344678999999999999999999999985

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=5e-39  Score=341.78  Aligned_cols=261  Identities=23%  Similarity=0.262  Sum_probs=200.3

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCC--------CCceeeeeeeee---
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ--------HKNVVRLLGCSI---  364 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------hpniv~l~~~~~---  364 (625)
                      .++|++.++||+|+||+||+|++. +++.||||++... ....+.+.+|+.+++.++        ||||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            478999999999999999999964 6889999998643 445678899999999986        788999999987   


Q ss_pred             -eCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC------
Q 042149          365 -EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL------  437 (625)
Q Consensus       365 -~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~------  437 (625)
                       .....++||||+ +++|.+.+.... ...+++..++.++.||+.||.|||++.  +|+||||||+||||+.++      
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhh
Confidence             556889999999 555555554332 234899999999999999999999861  399999999999998775      


Q ss_pred             -------------------------------------------ceEEeecccceeeCCCCceeeecCCCCccccCccccc
Q 042149          438 -------------------------------------------TPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLV  474 (625)
Q Consensus       438 -------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~  474 (625)
                                                                 .+||+|||++......    .....||+.|+|||++.
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~  266 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLI  266 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhc
Confidence                                                       7999999999876433    23357899999999999


Q ss_pred             cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccc-----hhhHHHhhhc--------ccc-ccccCC--------CC-
Q 042149          475 RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSV-----LHTVWKHYKA--------NRI-TQSMDP--------GL-  531 (625)
Q Consensus       475 ~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~-----~~~~~~~~~~--------~~~-~~~i~~--------~~-  531 (625)
                      +..++.++||||||+++|||++|+.|+.........     +.........        ... ......        .. 
T Consensus       267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (397)
T 1wak_A          267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK  346 (397)
T ss_dssp             TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred             CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence            999999999999999999999999998644322110     0000000000        000 000000        00 


Q ss_pred             ----------CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          532 ----------TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       532 ----------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                                ....+...+..+.+|+.+||+.||++|||+.|+++
T Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                      01235677888999999999999999999999985

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-39  Score=335.66  Aligned_cols=254  Identities=23%  Similarity=0.346  Sum_probs=196.5

Q ss_pred             HHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcC-CCCceeeeeeeeee------
Q 042149          294 ERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIE------  365 (625)
Q Consensus       294 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~------  365 (625)
                      ....++|++.+.||+|+||.||+|++. +++.||||++..... ..+.+.+|+.+++++ +||||+++++++..      
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~   98 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   98 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence            345778999999999999999999974 789999999865432 346788999999999 79999999999987      


Q ss_pred             CCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecc
Q 042149          366 GPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFG  445 (625)
Q Consensus       366 ~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfg  445 (625)
                      ....++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg  174 (326)
T 2x7f_A           99 DDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG  174 (326)
T ss_dssp             CCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCT
T ss_pred             cceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCc
Confidence            468899999999999999986542 234899999999999999999999875   9999999999999999999999999


Q ss_pred             cceeeCCCCceeeecCCCCccccCccccc-----cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhc
Q 042149          446 LARHVAPDKTHVSTGIAGTLGYMAPEYLV-----RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKA  520 (625)
Q Consensus       446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~  520 (625)
                      ++......... .....|++.|+|||++.     +..++.++||||||+++|+|++|+.|+......    ........ 
T Consensus       175 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~-  248 (326)
T 2x7f_A          175 VSAQLDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----RALFLIPR-  248 (326)
T ss_dssp             TTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHHH-
T ss_pred             CceecCcCccc-cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH----HHHHHhhc-
Confidence            99865432221 22357899999999987     567889999999999999999999987432111    11111111 


Q ss_pred             cccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          521 NRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       521 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ..     .+.   ..+...+..+.+++.+||+.||++|||+.++++
T Consensus       249 ~~-----~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          249 NP-----APR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             SC-----CCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             Cc-----ccc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            00     011   112334567899999999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.1e-39  Score=339.77  Aligned_cols=259  Identities=24%  Similarity=0.305  Sum_probs=191.6

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC------
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP------  367 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~------  367 (625)
                      .++|++.+.||+|+||.||+|++. +++.||||++...  .....+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            467999999999999999999965 6889999999753  4455678899999999999999999999987654      


Q ss_pred             eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccc
Q 042149          368 ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA  447 (625)
Q Consensus       368 ~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla  447 (625)
                      ..++||||+++ +|.+.+.     ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            78999999975 6777663     23889999999999999999999875   999999999999999999999999999


Q ss_pred             eeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhh--------
Q 042149          448 RHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK--------  519 (625)
Q Consensus       448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~--------  519 (625)
                      +......  ......||+.|+|||++.+..++.++||||||+++|||++|+.|+........ .........        
T Consensus       175 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          175 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFMK  251 (371)
T ss_dssp             -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHC-CCCCCHHHHT
T ss_pred             ccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHH
Confidence            8654322  22345799999999999999999999999999999999999998754321110 000000000        


Q ss_pred             ----------cc-------ccccccCCCCCC---CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          520 ----------AN-------RITQSMDPGLTG---RFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       520 ----------~~-------~~~~~i~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                                ..       ...+.......+   ..+...+..+.+|+.+||+.||++|||++|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                      00       000000000000   0112346789999999999999999999999873

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5.8e-39  Score=337.78  Aligned_cols=261  Identities=21%  Similarity=0.281  Sum_probs=200.6

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC-----Cee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG-----PES  369 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~~  369 (625)
                      .++|++.++||+|+||.||+|++. +++.||||++... .....+.+.+|+.++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999999965 6888999999754 345567899999999999999999999998754     468


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      ++||||+. ++|.+++...    .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            99999997 5888887543    3899999999999999999999876   99999999999999999999999999987


Q ss_pred             eCCCCcee--eecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccc----
Q 042149          450 VAPDKTHV--STGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR----  522 (625)
Q Consensus       450 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----  522 (625)
                      ........  .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.|+........ +...........    
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~  256 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGILGSPSQEDL  256 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH-HHHHHHHHCSCCHHHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH-HHHHHHHhCCCCHHHH
Confidence            65432221  234579999999998765 4589999999999999999999988754332221 111111000000    


Q ss_pred             -------cccccCC-CCCCCC-----ChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          523 -------ITQSMDP-GLTGRF-----PENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       523 -------~~~~i~~-~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                             ....... ......     ....+..+.+++.+||+.||++|||+.|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                   0000000 000001     1234567899999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=342.02  Aligned_cols=271  Identities=20%  Similarity=0.303  Sum_probs=200.1

Q ss_pred             HHHHhcCccccccccccCceEEEEEEeCCCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeE
Q 042149          293 LERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       293 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  370 (625)
                      .+...++|++.+.||+|+||.||+|+++.  .+|||++....  ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  105 (319)
T 2y4i_B           28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLA  105 (319)
T ss_dssp             SSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEE
T ss_pred             ccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceE
Confidence            34446789999999999999999999754  59999886542  233456789999999999999999999999999999


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      +||||+++++|.+++....  ..+++..++.++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||++...
T Consensus       106 iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          106 IITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             EECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             EEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence            9999999999999985432  34889999999999999999999875   99999999999998 679999999998765


Q ss_pred             CCCCc----eeeecCCCCccccCcccccc---------CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHh
Q 042149          451 APDKT----HVSTGIAGTLGYMAPEYLVR---------GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKH  517 (625)
Q Consensus       451 ~~~~~----~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~  517 (625)
                      .....    .......|++.|+|||++..         ..++.++||||||+++|||++|+.|+......     .....
T Consensus       180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~  254 (319)
T 2y4i_B          180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-----AIIWQ  254 (319)
T ss_dssp             --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-----HHHHH
T ss_pred             ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH
Confidence            32111    11223468999999999864         35788999999999999999999987532111     11111


Q ss_pred             hhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCCCCCCCCCc
Q 042149          518 YKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFL  584 (625)
Q Consensus       518 ~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~~~~~~~~~  584 (625)
                      .....     .+..   .+...+..+.+++.+||+.+|++|||+.+++++|+.+.........|...
T Consensus       255 ~~~~~-----~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~  313 (319)
T 2y4i_B          255 MGTGM-----KPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHF  313 (319)
T ss_dssp             HHTTC-----CCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------------
T ss_pred             hccCC-----CCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccc
Confidence            11111     1111   11233456889999999999999999999999999987665544444433

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.4e-39  Score=337.90  Aligned_cols=269  Identities=21%  Similarity=0.263  Sum_probs=190.4

Q ss_pred             HHHHHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCe-
Q 042149          291 EILERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPE-  368 (625)
Q Consensus       291 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-  368 (625)
                      +......++|++.++||+|+||.||+|++. +++.||||++.... .....+.+|+..++.++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            445667889999999999999999999975 68999999886543 223456778888999999999999999876443 


Q ss_pred             ------eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhh--cCCCceEEEeeeccCcEEEcC-CCce
Q 042149          369 ------SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH--GGSGIKIIHRDIKTSNILLDE-KLTP  439 (625)
Q Consensus       369 ------~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~iiHrDlkp~NIll~~-~~~~  439 (625)
                            .++||||++++.+..+.........+++..+..++.|++.||.|||  +.+   |+||||||+||||+. ++.+
T Consensus        95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred             cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence                  7899999987433333222233445899999999999999999999  664   999999999999996 8999


Q ss_pred             EEeecccceeeCCCCceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhh
Q 042149          440 KIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHY  518 (625)
Q Consensus       440 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~  518 (625)
                      ||+|||+++........  ....||+.|+|||++.+. .++.++||||||+++|||++|+.|+........ ........
T Consensus       172 kl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~~~~~~~~  248 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSEPN--VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ-LHEIVRVL  248 (360)
T ss_dssp             EECCCTTCBCCCTTSCC--CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHH
T ss_pred             EEeeCCCceecCCCCCc--ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH-HHHHHHHc
Confidence            99999999876544332  345789999999998765 489999999999999999999988754322111 11111100


Q ss_pred             hcc--ccccccCC----------C------CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          519 KAN--RITQSMDP----------G------LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       519 ~~~--~~~~~i~~----------~------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ...  .....+++          .      .....+...+..+.+|+.+||+.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            000  00000000          0      001122335778999999999999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.6e-38  Score=341.53  Aligned_cols=198  Identities=19%  Similarity=0.242  Sum_probs=170.5

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcC------CCCceeeeeeeeeeCCee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGI------QHKNVVRLLGCSIEGPES  369 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~hpniv~l~~~~~~~~~~  369 (625)
                      ..+|++.++||+|+||.||+|++. +++.||||++... ....+.+.+|+.+++.+      .|+||+++++.+......
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            457999999999999999999865 5889999998643 44456778888888877      577999999999999999


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCc--eEEeecccc
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLT--PKIADFGLA  447 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~--~kl~Dfgla  447 (625)
                      ++||||+. ++|.+++..... ..+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.  +||+|||++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999996 688888865432 34899999999999999999999775   999999999999998887  999999999


Q ss_pred             eeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCC
Q 042149          448 RHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFS  504 (625)
Q Consensus       448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~  504 (625)
                      ......    .....||+.|+|||++.+..++.++|||||||++|||++|+.|+...
T Consensus       250 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          250 CYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             EETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            765432    22357999999999999999999999999999999999999887543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.4e-39  Score=340.76  Aligned_cols=258  Identities=24%  Similarity=0.327  Sum_probs=183.5

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC------C
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG------P  367 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~  367 (625)
                      .++|++.+.||+|+||.||+|.+. +|+.||||++...  .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            468999999999999999999964 6899999998653  345567889999999999999999999998654      5


Q ss_pred             eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccc
Q 042149          368 ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA  447 (625)
Q Consensus       368 ~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla  447 (625)
                      ..++|||++ +++|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            679999999 7899988853    34899999999999999999999875   999999999999999999999999999


Q ss_pred             eeeCCCCceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhh--------
Q 042149          448 RHVAPDKTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHY--------  518 (625)
Q Consensus       448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~--------  518 (625)
                      +.....    .....||+.|+|||++.+ ..++.++|||||||++|||++|+.|+....... .+.......        
T Consensus       180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          180 RHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAELL  254 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHH
T ss_pred             cccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence            865432    234579999999999877 678999999999999999999999875432211 111111100        


Q ss_pred             ---hccccccccCCCC-CCCCC-----hHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          519 ---KANRITQSMDPGL-TGRFP-----ENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       519 ---~~~~~~~~i~~~~-~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                         ........+.... ....+     ...+..+.+|+.+||+.||++|||+.|+++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence               0000000000000 00001     1235678999999999999999999999863

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.1e-38  Score=333.90  Aligned_cols=262  Identities=20%  Similarity=0.290  Sum_probs=199.3

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC-----Ce
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG-----PE  368 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~  368 (625)
                      ..++|++.+.||+|+||.||+|++. +++.||||++... .......+.+|+.++++++||||+++++++...     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            4578999999999999999999975 6889999999654 345566788999999999999999999987654     67


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      .++||||+. ++|.+++...    .+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        89 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            899999997 5888887542    3899999999999999999999875   9999999999999999999999999998


Q ss_pred             eeCCCCcee---------eecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhh
Q 042149          449 HVAPDKTHV---------STGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHY  518 (625)
Q Consensus       449 ~~~~~~~~~---------~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~  518 (625)
                      .........         .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.|+........ ........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~  239 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ-LLLIFGII  239 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHH
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHh
Confidence            765322111         123578999999998765 6789999999999999999999998754321111 00000000


Q ss_pred             hcc------------ccccccCC--CC-CC---CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          519 KAN------------RITQSMDP--GL-TG---RFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       519 ~~~------------~~~~~i~~--~~-~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ...            ...+.+..  .. ..   ......+..+.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000            00000000  00 00   011244677899999999999999999999986

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.7e-39  Score=330.37  Aligned_cols=261  Identities=21%  Similarity=0.318  Sum_probs=194.3

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeee-----------
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSI-----------  364 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-----------  364 (625)
                      .++|++.+.||+|+||.||+|++. +++.||||++........+.+.+|+.++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            468999999999999999999976 58999999998877777889999999999999999999998873           


Q ss_pred             ---eCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEc-CCCceE
Q 042149          365 ---EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPK  440 (625)
Q Consensus       365 ---~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~-~~~~~k  440 (625)
                         +....++||||++ ++|.+++..    ..+++..++.++.|++.||.|||+++   |+||||||+|||++ +++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence               4467899999997 589988843    24899999999999999999999875   99999999999997 567999


Q ss_pred             EeecccceeeCCCCce--eeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHh
Q 042149          441 IADFGLARHVAPDKTH--VSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKH  517 (625)
Q Consensus       441 l~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~  517 (625)
                      |+|||+++........  ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.|+....... ........
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~  240 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-QMQLILES  240 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHH
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh
Confidence            9999999876432211  1223467999999998876 678999999999999999999999875432111 11111110


Q ss_pred             hhc------ccccc----ccCCCCC-C-----CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          518 YKA------NRITQ----SMDPGLT-G-----RFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       518 ~~~------~~~~~----~i~~~~~-~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ...      ..+..    .+..... .     ......+..+.+++.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            000      00000    0000000 0     011234677999999999999999999999986

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.5e-39  Score=338.82  Aligned_cols=257  Identities=23%  Similarity=0.330  Sum_probs=195.9

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCee----
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPES----  369 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~----  369 (625)
                      .++|.+.++||+|+||.||+|++. +++.||||++...  .....+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            467999999999999999999965 6899999999754  444567889999999999999999999999877655    


Q ss_pred             --EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccc
Q 042149          370 --LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA  447 (625)
Q Consensus       370 --~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla  447 (625)
                        ++||||+. ++|.+.+.     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999997 57777662     22899999999999999999999875   999999999999999999999999999


Q ss_pred             eeeCCCCceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhh--------
Q 042149          448 RHVAPDKTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHY--------  518 (625)
Q Consensus       448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~--------  518 (625)
                      +.....    .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.|+........+ .......        
T Consensus       192 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~  266 (371)
T 4exu_A          192 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL-TQILKVTGVPGTEFV  266 (371)
T ss_dssp             ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCCCCHHHH
T ss_pred             cccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCcHHHH
Confidence            865432    234578999999999987 68899999999999999999999987543211111 1110000        


Q ss_pred             ---hcc---ccccccCCCCCCC---CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          519 ---KAN---RITQSMDPGLTGR---FPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       519 ---~~~---~~~~~i~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                         ...   ...+.+.......   ..+..+..+.+|+.+||+.||++|||+.|+++.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence               000   0000000000000   112346778999999999999999999999863

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.4e-38  Score=328.87  Aligned_cols=260  Identities=18%  Similarity=0.234  Sum_probs=203.1

Q ss_pred             HhcCccccccccccCceEEEEEEe-C-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCc------eeeeeeeeeeCC
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTL-P-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKN------VVRLLGCSIEGP  367 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~l~~~~~~~~  367 (625)
                      ..++|++.++||+|+||.||+|.+ . +++.||||++... ....+.+.+|+.+++.++|++      ++++++++...+
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            356899999999999999999986 3 6789999998643 445677889999999987664      999999999999


Q ss_pred             eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC------------
Q 042149          368 ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE------------  435 (625)
Q Consensus       368 ~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~------------  435 (625)
                      ..++||||+ +++|.+++..... ..+++..+..++.||+.||.|||+++   |+||||||+|||++.            
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred             cEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence            999999999 8899998865442 34889999999999999999999875   999999999999987            


Q ss_pred             -------CCceEEeecccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCc
Q 042149          436 -------KLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSS  508 (625)
Q Consensus       436 -------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~  508 (625)
                             ++.+||+|||+++......    ....||+.|+|||++.+..++.++||||||+++|||++|+.|+.......
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             cccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                   6689999999998754322    23578999999999999999999999999999999999999976432211


Q ss_pred             cchhhHHH-----------hhhccccc------------------cccCC-CCCCCCChHHHHHHHHHHhhccCCCCCCC
Q 042149          509 SVLHTVWK-----------HYKANRIT------------------QSMDP-GLTGRFPENEASRVLQIGLLCTQAPVALR  558 (625)
Q Consensus       509 ~~~~~~~~-----------~~~~~~~~------------------~~i~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~R  558 (625)
                      . ......           ........                  ....+ ......+...+..+.+++.+||+.||++|
T Consensus       242 ~-~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          242 H-LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             H-HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             H-HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            1 110000           00000000                  00000 00011244667889999999999999999


Q ss_pred             CCHHHHHH
Q 042149          559 PSMAEVVH  566 (625)
Q Consensus       559 Pt~~ev~~  566 (625)
                      ||+.|+++
T Consensus       321 pt~~ell~  328 (339)
T 1z57_A          321 ITLREALK  328 (339)
T ss_dssp             CCHHHHTT
T ss_pred             cCHHHHhc
Confidence            99999985

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.2e-39  Score=342.50  Aligned_cols=266  Identities=20%  Similarity=0.279  Sum_probs=182.4

Q ss_pred             HhcCccc-cccccccCceEEEEEEeC---CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeee--CCee
Q 042149          296 ATDFFDN-SRKLGQGGAGSVFRGTLP---DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE--GPES  369 (625)
Q Consensus       296 ~~~~y~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~  369 (625)
                      ..+.|++ .++||+|+||.||+|+++   +++.||||++.....  ...+.+|+.+|++++||||+++++++..  ....
T Consensus        18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            3455776 568999999999999965   578999999865432  2467899999999999999999999954  6789


Q ss_pred             EEEEEecCCCCcchhhhccC------CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE----cCCCce
Q 042149          370 LLVYEYVPNRSLDQILFVKN------TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL----DEKLTP  439 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll----~~~~~~  439 (625)
                      ++||||+.+ +|.+++....      ....+++..++.++.||+.||.|||+.+   |+||||||+||||    +.++.+
T Consensus        96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCE
T ss_pred             EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcE
Confidence            999999965 7776664221      1224899999999999999999999876   9999999999999    677899


Q ss_pred             EEeecccceeeCCCCc--eeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCc--------
Q 042149          440 KIADFGLARHVAPDKT--HVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSS--------  508 (625)
Q Consensus       440 kl~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~--------  508 (625)
                      ||+|||+++.......  .......||+.|+|||++.+. .++.++|||||||++|||++|+.|+.......        
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  251 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  251 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence            9999999987653322  222346799999999999874 58999999999999999999999985432210        


Q ss_pred             cchhhHHHhhhccc---cccc------------cCCCCCCC---------CChHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 042149          509 SVLHTVWKHYKANR---ITQS------------MDPGLTGR---------FPENEASRVLQIGLLCTQAPVALRPSMAEV  564 (625)
Q Consensus       509 ~~~~~~~~~~~~~~---~~~~------------i~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~RPt~~ev  564 (625)
                      ..+...........   +...            +.......         .....+..+.+|+.+||+.||++|||++|+
T Consensus       252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~  331 (405)
T 3rgf_A          252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA  331 (405)
T ss_dssp             HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence            01111111000000   0000            00000000         000114567899999999999999999999


Q ss_pred             HHH
Q 042149          565 VHM  567 (625)
Q Consensus       565 ~~~  567 (625)
                      ++.
T Consensus       332 L~h  334 (405)
T 3rgf_A          332 MQD  334 (405)
T ss_dssp             HTS
T ss_pred             hcC
Confidence            874

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=4.4e-38  Score=333.26  Aligned_cols=202  Identities=23%  Similarity=0.272  Sum_probs=171.9

Q ss_pred             HHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCC-CC-----ceeeeeeeeeeC
Q 042149          294 ERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-HK-----NVVRLLGCSIEG  366 (625)
Q Consensus       294 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp-----niv~l~~~~~~~  366 (625)
                      +...++|++.++||+|+||+||+|++. +++.||||++.. .....+.+.+|+.+++.++ |+     +|+++++++...
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            345688999999999999999999975 688999999864 3445667888999988885 44     499999999999


Q ss_pred             CeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEc--CCCceEEeec
Q 042149          367 PESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD--EKLTPKIADF  444 (625)
Q Consensus       367 ~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~--~~~~~kl~Df  444 (625)
                      +..++||||++ ++|.+++..... ..+++..+..++.|++.||.|||.+ ..+|+||||||+||||+  .++.+||+||
T Consensus       129 ~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          129 NHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             TEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             CceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            99999999996 599998865432 3489999999999999999999953 23699999999999994  5788999999


Q ss_pred             ccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCC
Q 042149          445 GLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVF  503 (625)
Q Consensus       445 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~  503 (625)
                      |+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.|+..
T Consensus       206 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~  260 (382)
T 2vx3_A          206 GSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG  260 (382)
T ss_dssp             TTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999876432    2245799999999999999999999999999999999999998764

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.6e-38  Score=329.27  Aligned_cols=255  Identities=24%  Similarity=0.352  Sum_probs=179.7

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC-ChHHHHHHHHHHH-HHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN-SRQWVDQFFNEVN-LISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~-~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      .++|++.+.||+|+||.||+|.++ +++.||||++... .......+..|+. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            468999999999999999999975 6899999999765 3344455666666 778889999999999999999999999


Q ss_pred             EecCCCCcchhhhcc--CCcCCCCHHHHHHHHHHHHHHHHHhhcC-CCceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          374 EYVPNRSLDQILFVK--NTIHILSWQQRFTIICGTAEGLAHLHGG-SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       374 e~~~~~sL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~-~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      ||+++ +|.+++...  .....+++..+..++.+++.||.|||+. +   |+||||||+|||++.++.+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99975 777766531  1234489999999999999999999976 5   999999999999999999999999999876


Q ss_pred             CCCCceeeecCCCCccccCcccc----ccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccc
Q 042149          451 APDKTHVSTGIAGTLGYMAPEYL----VRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS  526 (625)
Q Consensus       451 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (625)
                      .....  .....||+.|+|||++    .+..++.++||||||+++|+|++|+.|+..........         ..+...
T Consensus       177 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---------~~~~~~  245 (327)
T 3aln_A          177 VDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL---------TQVVKG  245 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------CCCCCS
T ss_pred             ccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHH---------HHHhcC
Confidence            43322  2234689999999998    45678999999999999999999999975322111100         000000


Q ss_pred             cCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       527 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ..+.+........+..+.+++.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            1111111122345678999999999999999999999975

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.3e-38  Score=331.69  Aligned_cols=256  Identities=23%  Similarity=0.329  Sum_probs=196.4

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCe-----
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPE-----  368 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-----  368 (625)
                      .++|.+.+.||+|+||.||+|+++ +|+.||||++...  .....+.+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            467899999999999999999975 6899999998653  34456788999999999999999999999987654     


Q ss_pred             -eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccc
Q 042149          369 -SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA  447 (625)
Q Consensus       369 -~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla  447 (625)
                       .++||||+. ++|.+++.     ..+++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 58877763     13899999999999999999999875   999999999999999999999999999


Q ss_pred             eeeCCCCceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhh--------
Q 042149          448 RHVAPDKTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHY--------  518 (625)
Q Consensus       448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~--------  518 (625)
                      +.....    .....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.|+....... .+.......        
T Consensus       174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFV  248 (353)
T ss_dssp             TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHHHCBCCHHHH
T ss_pred             cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence            765432    223578999999999877 678999999999999999999999875432111 111111000        


Q ss_pred             ---hccc---cccccCCC---CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          519 ---KANR---ITQSMDPG---LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       519 ---~~~~---~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                         ....   ..+.+...   .........+..+.+++.+||+.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence               0000   00000000   011223455778999999999999999999999985

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=9.6e-39  Score=330.51  Aligned_cols=263  Identities=24%  Similarity=0.298  Sum_probs=199.9

Q ss_pred             HhcCccccccccccCceEEEEEEe--CCCCEEEEEEeecCC--hHHHHHHHHHHHHHhcC---CCCceeeeeeeee----
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTL--PDGRNIAVKRLFFNS--RQWVDQFFNEVNLISGI---QHKNVVRLLGCSI----  364 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~----  364 (625)
                      ..++|++.+.||+|+||.||+|++  .+++.||||++....  ......+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999997  357889999886432  22223566777777766   8999999999987    


Q ss_pred             -eCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEee
Q 042149          365 -EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIAD  443 (625)
Q Consensus       365 -~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~D  443 (625)
                       .....++||||++ ++|.+++..... ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence             5567899999997 599998865433 34899999999999999999999876   99999999999999999999999


Q ss_pred             cccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcc--
Q 042149          444 FGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN--  521 (625)
Q Consensus       444 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~--  521 (625)
                      ||+++......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.|+....... ............  
T Consensus       164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~  240 (326)
T 1blx_A          164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGE  240 (326)
T ss_dssp             CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCG
T ss_pred             CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCc
Confidence            99997654322  2234578999999999999999999999999999999999999875432211 111111110000  


Q ss_pred             -ccc-------cccC---CCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          522 -RIT-------QSMD---PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       522 -~~~-------~~i~---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                       .+.       ....   ...........+..+.+++.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             000       0000   00011123345677899999999999999999999985

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=9e-39  Score=324.81  Aligned_cols=254  Identities=22%  Similarity=0.268  Sum_probs=203.5

Q ss_pred             HHHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCee
Q 042149          293 LERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPES  369 (625)
Q Consensus       293 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  369 (625)
                      .....++|++.++||+|+||.||+|+.+ +++.||||++...  .....+.+.+|+.++++++||||+++++++.+....
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence            3455678999999999999999999975 6899999998654  234467889999999999999999999999999999


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCC---CceEEeeccc
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEK---LTPKIADFGL  446 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~---~~~kl~Dfgl  446 (625)
                      ++||||+++++|.+.+....   .+++..++.++.||+.||.|||+.+   |+||||||+||+++.+   +.+||+|||+
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCc
Confidence            99999999999998886544   3899999999999999999999875   9999999999999754   4799999999


Q ss_pred             ceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccc
Q 042149          447 ARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS  526 (625)
Q Consensus       447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (625)
                      +.........  ....+++.|+|||.+.+ .++.++||||||+++|+|++|+.|+..... .    ............  
T Consensus       171 ~~~~~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~----~~~~~~~~~~~~--  240 (287)
T 2wei_A          171 STCFQQNTKM--KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-Y----DILKRVETGKYA--  240 (287)
T ss_dssp             GGTBCCCSSC--SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-H----HHHHHHHHCCCC--
T ss_pred             ceeecCCCcc--ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-H----HHHHHHHcCCCC--
Confidence            9866443321  22358999999998865 589999999999999999999998753221 1    111111111110  


Q ss_pred             cCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       527 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                          ...+.....+..+.+++.+||+.+|++|||+.|+++
T Consensus       241 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          241 ----FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             ----CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence                000011234667899999999999999999999987

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3e-38  Score=328.60  Aligned_cols=253  Identities=19%  Similarity=0.217  Sum_probs=174.6

Q ss_pred             HhcCccccc-cccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeee----CCee
Q 042149          296 ATDFFDNSR-KLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE----GPES  369 (625)
Q Consensus       296 ~~~~y~~~~-~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~  369 (625)
                      ..++|.+.+ .||+|+||.||+|+++ +++.||||++.... ..   ..+....++.+.||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            467898855 6999999999999976 68999999986532 21   1222334566789999999999876    4568


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC---CCceEEeeccc
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE---KLTPKIADFGL  446 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~---~~~~kl~Dfgl  446 (625)
                      ++||||+++++|.+++..... ..+++..++.++.||+.||.|||+++   |+||||||+|||++.   ++.+||+|||+
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence            999999999999999975432 35899999999999999999999885   999999999999975   45599999999


Q ss_pred             ceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccc
Q 042149          447 ARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS  526 (625)
Q Consensus       447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (625)
                      ++......   .....||+.|+|||++.+..++.++||||||+++|+|++|+.|+......... .........      
T Consensus       178 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~------  247 (336)
T 3fhr_A          178 AKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS-PGMKRRIRL------  247 (336)
T ss_dssp             CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             ceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh-hhHHHhhhc------
Confidence            98654322   22356899999999999999999999999999999999999997543221100 000000000      


Q ss_pred             cCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       527 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .......+.....+..+.+++.+||+.||++|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          248 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ---CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            0001111112345678899999999999999999999997

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=8.9e-38  Score=329.51  Aligned_cols=260  Identities=20%  Similarity=0.236  Sum_probs=199.7

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCC-----------CCceeeeeeeee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-----------HKNVVRLLGCSI  364 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~l~~~~~  364 (625)
                      .++|++.++||+|+||.||+|++. +++.||||++.. .....+.+.+|+.++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            467999999999999999999964 689999999864 3344567889999999886           899999999988


Q ss_pred             eCC----eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcC-CCceEEEeeeccCcEEEc-----
Q 042149          365 EGP----ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG-SGIKIIHRDIKTSNILLD-----  434 (625)
Q Consensus       365 ~~~----~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-~~~~iiHrDlkp~NIll~-----  434 (625)
                      ...    ..++||||+ +++|.+++..... ..+++..+..++.||+.||.|||++ +   |+||||||+||||+     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence            654    789999999 8999998865433 3389999999999999999999986 5   99999999999994     


Q ss_pred             -CCCceEEeecccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCc-----
Q 042149          435 -EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSS-----  508 (625)
Q Consensus       435 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~-----  508 (625)
                       ..+.+||+|||++......    .....||+.|+|||++.+..++.++||||||+++|||++|+.|+.......     
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence             4458999999999876432    223578999999999999999999999999999999999999986433211     


Q ss_pred             cchhhHHHhhh------------------ccccccccCCC----------CCCCCChHHHHHHHHHHhhccCCCCCCCCC
Q 042149          509 SVLHTVWKHYK------------------ANRITQSMDPG----------LTGRFPENEASRVLQIGLLCTQAPVALRPS  560 (625)
Q Consensus       509 ~~~~~~~~~~~------------------~~~~~~~i~~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt  560 (625)
                      ..+........                  .......+...          .....+...+..+.+|+.+||+.||++|||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence            00101100000                  00000000000          011345778899999999999999999999


Q ss_pred             HHHHHH
Q 042149          561 MAEVVH  566 (625)
Q Consensus       561 ~~ev~~  566 (625)
                      +.|+++
T Consensus       328 ~~ell~  333 (373)
T 1q8y_A          328 AGGLVN  333 (373)
T ss_dssp             HHHHHT
T ss_pred             HHHHhh
Confidence            999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.4e-38  Score=339.57  Aligned_cols=253  Identities=23%  Similarity=0.323  Sum_probs=187.8

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEEEEEe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      .+.|.+.++||+|+||+||.+...+|+.||||++....   .+.+.+|+.+++++ +||||+++++++.+++..++||||
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~   90 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL   90 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence            34566678899999999987766789999999986543   35678999999886 899999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCC----CCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCC-------------Cc
Q 042149          376 VPNRSLDQILFVKNTIHI----LSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEK-------------LT  438 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~----l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~-------------~~  438 (625)
                      +. ++|.+++........    ..+..++.++.||+.||.|||+.+   |+||||||+||||+.+             +.
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~  166 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR  166 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceE
Confidence            95 699999865432211    123345789999999999999875   9999999999999754             48


Q ss_pred             eEEeecccceeeCCCCcee---eecCCCCccccCcccccc-------CcccccCcEEeehhhhHHHHh-CCCCCCCCCCC
Q 042149          439 PKIADFGLARHVAPDKTHV---STGIAGTLGYMAPEYLVR-------GQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGS  507 (625)
Q Consensus       439 ~kl~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~  507 (625)
                      +||+|||+++.........   .....||+.|+|||++.+       ..++.++|||||||++|||+| |+.|+......
T Consensus       167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~  246 (434)
T 2rio_A          167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR  246 (434)
T ss_dssp             EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred             EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence            9999999998876543221   224579999999999975       568999999999999999999 88776432111


Q ss_pred             ccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          508 SSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .   .    .......   ..+......+...+..+.+++.+||+.||++|||+.||++
T Consensus       247 ~---~----~i~~~~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          247 E---S----NIIRGIF---SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             H---H----HHHHTCC---CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H---H----HHhcCCC---CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            0   0    0000000   0011111224567889999999999999999999999985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-38  Score=324.78  Aligned_cols=245  Identities=26%  Similarity=0.331  Sum_probs=192.4

Q ss_pred             HHHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCCh------HHHHHHHHHHHHHhcC----CCCceeeeee
Q 042149          293 LERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSR------QWVDQFFNEVNLISGI----QHKNVVRLLG  361 (625)
Q Consensus       293 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~hpniv~l~~  361 (625)
                      .+...++|++.++||+|+||.||+|++. +++.||||++.....      .....+.+|+.+++++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            4556788999999999999999999964 688999999865432      2233466799999998    8999999999


Q ss_pred             eeeeCCeeEEEEEe-cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEc-CCCce
Q 042149          362 CSIEGPESLLVYEY-VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTP  439 (625)
Q Consensus       362 ~~~~~~~~~lV~e~-~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~-~~~~~  439 (625)
                      ++...+..++|||+ +.+++|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+||+++ .++.+
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence            99999999999999 78999999997644   3899999999999999999999775   99999999999999 88999


Q ss_pred             EEeecccceeeCCCCceeeecCCCCccccCccccccCcc-cccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhh
Q 042149          440 KIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHY  518 (625)
Q Consensus       440 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~  518 (625)
                      ||+|||++.......   .....|++.|+|||++.+..+ +.++||||||+++|||++|+.|+....           ..
T Consensus       180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----------~~  245 (312)
T 2iwi_A          180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----------EI  245 (312)
T ss_dssp             EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------HH
T ss_pred             EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----------HH
Confidence            999999998765432   234569999999999987666 458999999999999999998864210           00


Q ss_pred             hccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       519 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      ...          ....+...+..+.+++.+||+.+|++|||+.|+++.
T Consensus       246 ~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          246 LEA----------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             HHT----------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             hhh----------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000          011234456778999999999999999999999973

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.8e-38  Score=328.02  Aligned_cols=246  Identities=23%  Similarity=0.307  Sum_probs=199.9

Q ss_pred             HHHHHHhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCCh------HHHHHHHHHHHHHhcCC--CCceeeeee
Q 042149          291 EILERATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSR------QWVDQFFNEVNLISGIQ--HKNVVRLLG  361 (625)
Q Consensus       291 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--hpniv~l~~  361 (625)
                      ...+...++|++.++||+|+||.||+|++. +++.||||++.....      ...+.+.+|+.++++++  ||||+++++
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~  115 (320)
T 3a99_A           36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD  115 (320)
T ss_dssp             ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence            344556788999999999999999999964 688999999965421      12245778999999996  599999999


Q ss_pred             eeeeCCeeEEEEEecCC-CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEc-CCCce
Q 042149          362 CSIEGPESLLVYEYVPN-RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTP  439 (625)
Q Consensus       362 ~~~~~~~~~lV~e~~~~-~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~-~~~~~  439 (625)
                      ++...+..++|||++.+ ++|.+++....   .+++..++.++.||+.||.|||+.+   |+||||||+|||++ +++.+
T Consensus       116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~  189 (320)
T 3a99_A          116 WFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL  189 (320)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEE
T ss_pred             EEecCCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCE
Confidence            99999999999999976 89999886544   3899999999999999999999875   99999999999999 78899


Q ss_pred             EEeecccceeeCCCCceeeecCCCCccccCccccccCcc-cccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhh
Q 042149          440 KIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHY  518 (625)
Q Consensus       440 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~  518 (625)
                      ||+|||+++......   .....||+.|+|||++.+..+ +.++||||||+++|||++|+.|+....           ..
T Consensus       190 kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----------~~  255 (320)
T 3a99_A          190 KLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----------EI  255 (320)
T ss_dssp             EECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------HH
T ss_pred             EEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----------hh
Confidence            999999998765432   223579999999999987765 788999999999999999999864210           00


Q ss_pred             hccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       519 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ....          ...+...+..+.+++.+||+.||++|||++||++
T Consensus       256 ~~~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          256 IRGQ----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             HHCC----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hccc----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000          0112334567899999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.3e-37  Score=323.67  Aligned_cols=259  Identities=19%  Similarity=0.217  Sum_probs=198.5

Q ss_pred             hcCccccccccccCceEEEEEEeC-CC-CEEEEEEeecCChHHHHHHHHHHHHHhcCCCCc------eeeeeeeeeeCCe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DG-RNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKN------VVRLLGCSIEGPE  368 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------iv~l~~~~~~~~~  368 (625)
                      .++|++.+.||+|+||.||+|+.. ++ +.||||++... ....+.+.+|+.+++.++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            578999999999999999999975 44 68999998643 445677889999999998766      8999999999999


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE---------------
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL---------------  433 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll---------------  433 (625)
                      .++||||+ +++|.+.+.... ...+++..++.++.||+.||.|||+++   |+||||||+|||+               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence            99999999 556666665433 234899999999999999999999775   9999999999999               


Q ss_pred             ----cCCCceEEeecccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCcc
Q 042149          434 ----DEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSS  509 (625)
Q Consensus       434 ----~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~  509 (625)
                          +.++.+||+|||+++......    ....||+.|+|||++.+..++.++||||||+++|||++|+.|+........
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH  247 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                567899999999998644322    235799999999999999999999999999999999999999754322111


Q ss_pred             chhhHHHh-----------hhccccc------------------cccCC-CCCCCCChHHHHHHHHHHhhccCCCCCCCC
Q 042149          510 VLHTVWKH-----------YKANRIT------------------QSMDP-GLTGRFPENEASRVLQIGLLCTQAPVALRP  559 (625)
Q Consensus       510 ~~~~~~~~-----------~~~~~~~------------------~~i~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RP  559 (625)
                       .......           .......                  ....+ ..........+..+.+|+.+||+.||++||
T Consensus       248 -~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          248 -LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             -HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             -HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence             1100000           0000000                  00000 000011335567899999999999999999


Q ss_pred             CHHHHHH
Q 042149          560 SMAEVVH  566 (625)
Q Consensus       560 t~~ev~~  566 (625)
                      |+.|+++
T Consensus       327 t~~e~l~  333 (355)
T 2eu9_A          327 TLAEALL  333 (355)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHhc
Confidence            9999984

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.9e-38  Score=323.91  Aligned_cols=252  Identities=21%  Similarity=0.298  Sum_probs=180.1

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-h-HHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-R-QWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      .++|++.+.||+|+||.||+|+++ +++.||||++.... . ...+.+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467999999999999999999975 68999999997653 2 22334555566788889999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+ ++.+..+.....  ..+++..++.++.+++.||.|||++  .+|+||||||+||+++.++.+||+|||++......
T Consensus       104 e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             CCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            999 555555543322  3489999999999999999999974  14999999999999999999999999999765443


Q ss_pred             CceeeecCCCCccccCccccc-----cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLV-----RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      ..  .....||+.|+|||++.     ...++.++||||||+++|||++|+.|+.........    ........     .
T Consensus       179 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~-----~  247 (318)
T 2dyl_A          179 KA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV----LTKVLQEE-----P  247 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH----HHHHHHSC-----C
T ss_pred             cc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH----HHHHhccC-----C
Confidence            22  22356899999999984     456889999999999999999999987532221111    11111111     0


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      +..  +.....+..+.+++.+||+.||++|||+.|+++
T Consensus       248 ~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          248 PLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            001  111234567899999999999999999999975

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-37  Score=335.14  Aligned_cols=249  Identities=26%  Similarity=0.319  Sum_probs=185.5

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEEEEEe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ..+|++.++||+|+||+||.....+++.||||++.....   ..+.+|+.+|+++ +|||||++++++.+....+|||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            346888899999999997655566889999999965432   2356899999999 799999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC-----CCceEEeecccceee
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE-----KLTPKIADFGLARHV  450 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~-----~~~~kl~Dfgla~~~  450 (625)
                      +. ++|.+++.....  .+.+..++.++.||+.||.|||+.+   |+||||||+||||+.     ...+||+|||+++..
T Consensus       100 ~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A          100 CA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             CS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             CC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            96 599998865432  2444566789999999999999875   999999999999953     346889999999876


Q ss_pred             CCCCc--eeeecCCCCccccCccccc---cCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccc
Q 042149          451 APDKT--HVSTGIAGTLGYMAPEYLV---RGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRIT  524 (625)
Q Consensus       451 ~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  524 (625)
                      .....  .......||+.|+|||++.   ...++.++|||||||++|||++ |..|+......  .   .........  
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~--~---~~~~~~~~~--  246 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR--Q---ANILLGACS--  246 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH--H---HHHHTTCCC--
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH--H---HHHHhccCC--
Confidence            54322  1223467999999999997   4567889999999999999999 77776322110  0   000000000  


Q ss_pred             cccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          525 QSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       525 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                          .. ....+......+.+|+.+||+.||++|||+.||++
T Consensus       247 ----~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          247 ----LD-CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             ----CT-TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----cc-ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence                00 01113355667889999999999999999999984

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=5e-38  Score=348.68  Aligned_cols=262  Identities=24%  Similarity=0.281  Sum_probs=199.8

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeee------CCe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE------GPE  368 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~~~  368 (625)
                      .++|++.++||+|+||.||+|.+. +|+.||||++... .....+.+.+|+.++++++||||+++++++..      ++.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            468999999999999999999974 6899999988654 45566789999999999999999999998765      677


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCc---eEEeecc
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLT---PKIADFG  445 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~---~kl~Dfg  445 (625)
                      .++||||+++++|.+++........+++..++.++.+++.||.|||+.+   |+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence            8999999999999999976555456899999999999999999999875   999999999999997664   9999999


Q ss_pred             cceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHH----hh-hc
Q 042149          446 LARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWK----HY-KA  520 (625)
Q Consensus       446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~----~~-~~  520 (625)
                      ++........  .....||+.|+|||++.+..++.++||||||+++|+|++|+.|+...............    .. ..
T Consensus       170 ~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  247 (676)
T 3qa8_A          170 YAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY  247 (676)
T ss_dssp             CCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred             cccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence            9987654332  23467999999999999999999999999999999999999997532111000000000    00 00


Q ss_pred             cccccc--c--CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHH
Q 042149          521 NRITQS--M--DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAE  563 (625)
Q Consensus       521 ~~~~~~--i--~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e  563 (625)
                      ......  .  ........+...+..+.+++.+||+.||++|||+.|
T Consensus       248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence            000000  0  001112345567889999999999999999999866

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.2e-37  Score=313.19  Aligned_cols=233  Identities=11%  Similarity=0.042  Sum_probs=184.5

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .++|++.+.||+|+||.||+|++. +++.||||++...   ..+..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            467999999999999999999975 5899999999754   245567899999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||++|++|.+++...     ....++..++.|++.||.|||+++   |+||||||+||||+.++.+||+++|       
T Consensus       110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence            9999999999998421     355678899999999999999886   9999999999999999999997443       


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                                    |++|       ++.++||||||+++|||+||+.|+........+. ..........       ...
T Consensus       175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-~~~~~~~~~~-------~~~  225 (286)
T 3uqc_A          175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-PAERDTAGQP-------IEP  225 (286)
T ss_dssp             --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-ECCBCTTSCB-------CCH
T ss_pred             --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-HHHHHhccCC-------CCh
Confidence                          3333       6889999999999999999999976433221110 0000000000       000


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCC
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYE  574 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  574 (625)
                      .......+..+.+++.+||+.||++| |+.|+++.|+.+...
T Consensus       226 ~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          226 ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            01123456779999999999999999 999999999887543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.7e-37  Score=347.94  Aligned_cols=239  Identities=18%  Similarity=0.234  Sum_probs=192.7

Q ss_pred             hcCccccccccccCceEEEEEEeC--CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCe-----
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP--DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPE-----  368 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-----  368 (625)
                      .++|++.++||+|+||.||+|++.  +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            468999999999999999999975  5899999988654 44556788999999999999999999999987665     


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      .+|||||++|++|.+++..     .+++.+++.++.||+.||.|||+++   |+||||||+||||+.+ .+||+|||+++
T Consensus       159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence            7999999999999987643     4899999999999999999999876   9999999999999986 89999999998


Q ss_pred             eeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          449 HVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      .....     ....||+.|+|||++.++. +.++||||||+++|+|++|..|+......              .    +.
T Consensus       230 ~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------------~----~~  285 (681)
T 2pzi_A          230 RINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD--------------G----LP  285 (681)
T ss_dssp             ETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS--------------S----CC
T ss_pred             hcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc--------------c----cc
Confidence            76543     3357999999999987654 88999999999999999998764311000              0    00


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCCC-HHHHHHHHccc
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPS-MAEVVHMLNNI  571 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~ev~~~L~~~  571 (625)
                         ........+..+.+++.+||+.||++||+ ++++...|..+
T Consensus       286 ---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          286 ---EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             ---TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ---ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence               00011234567899999999999999995 56666666544

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.4e-35  Score=303.20  Aligned_cols=227  Identities=20%  Similarity=0.258  Sum_probs=178.8

Q ss_pred             hcCcccc-ccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHH-hcCCCCceeeeeeeeee----CCee
Q 042149          297 TDFFDNS-RKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLI-SGIQHKNVVRLLGCSIE----GPES  369 (625)
Q Consensus       297 ~~~y~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~hpniv~l~~~~~~----~~~~  369 (625)
                      .++|.+. +.||+|+||.||+|... +++.||||++...     ..+.+|+.++ +.++||||+++++++..    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            4567776 78999999999999974 6899999998642     3567888888 56689999999999887    6788


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC---CCceEEeeccc
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE---KLTPKIADFGL  446 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~---~~~~kl~Dfgl  446 (625)
                      ++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            999999999999999976432 34899999999999999999999876   999999999999997   78999999999


Q ss_pred             ceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccc
Q 042149          447 ARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS  526 (625)
Q Consensus       447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (625)
                      +....                       +..++.++||||||+++|||++|+.|+........          .......
T Consensus       167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~----------~~~~~~~  213 (299)
T 3m2w_A          167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----------SPGMKTR  213 (299)
T ss_dssp             CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------CCSCCS
T ss_pred             ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh----------hHHHHHH
Confidence            86532                       24568899999999999999999999753321110          0000000


Q ss_pred             cCCCCCCCCC----hHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          527 MDPGLTGRFP----ENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       527 i~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      +... ....+    ...+..+.+++.+||+.||++|||+.|+++
T Consensus       214 ~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          214 IRMG-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             SCTT-CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             Hhhc-cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0000 01112    234678999999999999999999999986

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-36  Score=324.40  Aligned_cols=240  Identities=16%  Similarity=0.150  Sum_probs=177.5

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCC-Cceee--------------
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQH-KNVVR--------------  358 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-pniv~--------------  358 (625)
                      ..|...++||+|+||+||+|++. +|+.||||++....   ....+.+.+|+.+++.++| +|...              
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            45777889999999999999954 79999999987432   2336789999999999987 32111              


Q ss_pred             -------eeeeeee-----CCeeEEEEEecCCCCcchhhhc----cCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEE
Q 042149          359 -------LLGCSIE-----GPESLLVYEYVPNRSLDQILFV----KNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII  422 (625)
Q Consensus       359 -------l~~~~~~-----~~~~~lV~e~~~~~sL~~~l~~----~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ii  422 (625)
                             +...+..     ....+++|+++ +++|.+++..    ......+++..++.++.||++||+|||+++   |+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence                   1111111     22456777765 6899988742    122334788899999999999999999875   99


Q ss_pred             EeeeccCcEEEcCCCceEEeecccceeeCCCCceeeecCCCCccccCcccc----------ccCcccccCcEEeehhhhH
Q 042149          423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL----------VRGQLTEKADVYAFGVLVI  492 (625)
Q Consensus       423 HrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~SlG~ll~  492 (625)
                      ||||||+||||+.++.+||+|||+++.....    .....| +.|+|||++          ....++.++|||||||++|
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence            9999999999999999999999998864322    334567 999999999          5556889999999999999


Q ss_pred             HHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042149          493 EVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVV  565 (625)
Q Consensus       493 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~  565 (625)
                      ||++|+.|+....... ..            ...+..      ....+..+.+|+.+||+.||++||++.+++
T Consensus       309 elltg~~Pf~~~~~~~-~~------------~~~~~~------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          309 WIWCADLPNTDDAALG-GS------------EWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHSSCCCCTTGGGS-CS------------GGGGSS------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHCCCCCCCcchhh-hH------------HHHHhh------cccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            9999999975332111 00            001110      112346789999999999999999976664

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.4e-36  Score=315.95  Aligned_cols=240  Identities=15%  Similarity=0.172  Sum_probs=183.0

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCC--------hHHHHHHHHHHHHHhcCC---------CCceeee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS--------RQWVDQFFNEVNLISGIQ---------HKNVVRL  359 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------hpniv~l  359 (625)
                      .++|++.++||+|+||+||+|++ +++.||||++....        ....+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46799999999999999999998 68999999997652        233477889999998886         5555555


Q ss_pred             eee-----------------eee-------------CCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHH
Q 042149          360 LGC-----------------SIE-------------GPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG  409 (625)
Q Consensus       360 ~~~-----------------~~~-------------~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~  409 (625)
                      .+.                 +.+             ....+|||||+++|++.+.+..    ..+++..+..++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            554                 433             6789999999999977666632    348999999999999999


Q ss_pred             HHHhh-cCCCceEEEeeeccCcEEEcCCC--------------------ceEEeecccceeeCCCCceeeecCCCCcccc
Q 042149          410 LAHLH-GGSGIKIIHRDIKTSNILLDEKL--------------------TPKIADFGLARHVAPDKTHVSTGIAGTLGYM  468 (625)
Q Consensus       410 L~~LH-~~~~~~iiHrDlkp~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~  468 (625)
                      |.||| +.+   |+||||||+||||+.++                    .+||+|||+++.....      ...||+.|+
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~  244 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSM  244 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTT
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeeccc
Confidence            99999 775   99999999999999887                    8999999999876532      236999999


Q ss_pred             CccccccCcccccCcEEeehhh-hHHHHhCCCCCCCCCCCccchhhHHHhhhccccccc--cCCCCCCCCChHHHHHHHH
Q 042149          469 APEYLVRGQLTEKADVYAFGVL-VIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS--MDPGLTGRFPENEASRVLQ  545 (625)
Q Consensus       469 aPE~~~~~~~~~~~Dv~SlG~l-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--i~~~~~~~~~~~~~~~l~~  545 (625)
                      |||++.+.. +.++|||||+++ .+++++|..|+..         ..|.......+...  .........+...+.++.+
T Consensus       245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d  314 (336)
T 2vuw_A          245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN---------VLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQE  314 (336)
T ss_dssp             CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH---------HHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHH
T ss_pred             ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc---------hhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHH
Confidence            999998666 889999998776 7889999887521         11211111111110  0111111223467889999


Q ss_pred             HHhhccCCCCCCCCCHHHHH
Q 042149          546 IGLLCTQAPVALRPSMAEVV  565 (625)
Q Consensus       546 li~~cl~~~p~~RPt~~ev~  565 (625)
                      |+.+||+.|     |++|++
T Consensus       315 li~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          315 FHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHGGGSS-----SHHHHH
T ss_pred             HHHHHhccC-----CHHHHH
Confidence            999999976     898888

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=3.6e-31  Score=292.99  Aligned_cols=186  Identities=16%  Similarity=0.210  Sum_probs=132.3

Q ss_pred             ccccccCceEEEEEEe-CCCCEEEEEEeecCC----------hHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEE
Q 042149          304 RKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNS----------RQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~l  371 (625)
                      ..++.|++|.+..++. -.|+.++||.+....          ....++|.+|+++|+++ .|+||++++++++++...||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            3577788887777663 358999999986531          23356799999999999 69999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||||++|++|.++|...+.   ++..   .|+.||+.||+|+|+++   ||||||||+||||+++|.+||+|||+++...
T Consensus       320 VMEyv~G~~L~d~i~~~~~---l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~  390 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEE---IDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP  390 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCC---CCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred             EEecCCCCcHHHHHHhCCC---CCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence            9999999999999976544   5554   48899999999999886   9999999999999999999999999998765


Q ss_pred             CCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCC
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRN  500 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p  500 (625)
                      ..... ....+||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus       391 ~~~~~-~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          391 QDCSW-PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ---CC-SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCCcc-ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            44332 234679999999999864 567889999999999998777544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=1e-26  Score=255.90  Aligned_cols=184  Identities=15%  Similarity=0.199  Sum_probs=144.8

Q ss_pred             cccccccccCceEEEEEEeCCCCEEEEEEeecCC--------hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          301 DNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS--------RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       301 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      ...++||+|+||.||+|.. .++.+++|+.....        ....+++.+|++++++++||||+++..++...+..+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4466899999999999954 57889999875431        11245689999999999999999766666678888999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||++|++|.+++..           +..++.|++++|.|||+++   |+||||||+|||++.  .+||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999998853           5589999999999999875   999999999999998  999999999998754


Q ss_pred             CCcee------eecCCCCccccCcccccc--CcccccCcEEeehhhhHHHHhCCCCC
Q 042149          453 DKTHV------STGIAGTLGYMAPEYLVR--GQLTEKADVYAFGVLVIEVASGRRNS  501 (625)
Q Consensus       453 ~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~ll~elltG~~p~  501 (625)
                      .....      .....||+.|+|||++..  ..|+...|+|+..+-..+-+.++.++
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            33221      124679999999999987  67888999999888888877776553

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.91  E-value=1.4e-24  Score=184.07  Aligned_cols=103  Identities=23%  Similarity=0.441  Sum_probs=86.5

Q ss_pred             ccccccCCCCccCCCchHHHHHHHHHHHHHHHhccCccCceeeeeecCCCCcEEEEEeccCCCChhhhHHHHHHHHHhhh
Q 042149           37 ESLYKCGPPAKVSDNRNFRQNFDAVMGNISEQIMDDHHYHFALHYVVSPAPQVYAYMQCHEDLSQTDCESCFSALKQKAN  116 (625)
Q Consensus        37 ~~~~~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~~~~~~~~~~~~~vygl~qC~~dl~~~~C~~Cl~~~~~~~~  116 (625)
                      .....| +.++++++++|++||+.||+.|+.+++.+..++++....+.++++||||+|||||+++++|..||+.+...+.
T Consensus         5 ~v~~~C-n~~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~   83 (108)
T 3a2e_A            5 FVSSAC-NTQKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRIF   83 (108)
T ss_dssp             EEEEEE-CSSBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHH
T ss_pred             eeeeec-CCCccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHH
Confidence            445667 5679999999999999999999998876544344333444567899999999999999999999997776555


Q ss_pred             -hcCCCCceEEEcceeEEEEecCCC
Q 042149          117 -RCLPSDSARIFLDGCFLRYDNYDF  140 (625)
Q Consensus       117 -~c~~~~~~~~~~~~C~~ry~~~~f  140 (625)
                       .|++++||+||+++|+||||+++|
T Consensus        84 ~~C~~~~g~~i~~~~C~lRY~~~~F  108 (108)
T 3a2e_A           84 SICNNAIGARVQLVDCFIQYEQRSF  108 (108)
T ss_dssp             HHTTSBSSEEEEETTEEEEEESSCC
T ss_pred             HHCCCCceEEEECCCEEEEEeCCcC
Confidence             599999999999999999999998

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=1.1e-23  Score=212.58  Aligned_cols=151  Identities=18%  Similarity=0.128  Sum_probs=121.1

Q ss_pred             HHHHhcCccccccccccCceEEEEEEeCCCCEEEEEEeecCCh------------------HHHHHHHHHHHHHhcCCCC
Q 042149          293 LERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR------------------QWVDQFFNEVNLISGIQHK  354 (625)
Q Consensus       293 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~hp  354 (625)
                      +......|.+.+.||+|+||.||+|++.+|+.||||.+.....                  .....+.+|+.+|++++  
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            3344556778899999999999999997799999999864321                  23567899999999999  


Q ss_pred             ceeeeeeeeeeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEc
Q 042149          355 NVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD  434 (625)
Q Consensus       355 niv~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~  434 (625)
                      | +++.+++. .+..++||||++|++|.+ +..         .....++.|++.||.|||+.+   |+||||||+|||++
T Consensus       163 ~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~  227 (282)
T 1zar_A          163 G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS  227 (282)
T ss_dssp             T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred             C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence            4 66666543 356799999999999988 421         124469999999999999875   99999999999999


Q ss_pred             CCCceEEeecccceeeCCCCceeeecCCCCccccCcccccc
Q 042149          435 EKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR  475 (625)
Q Consensus       435 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~  475 (625)
                       ++.+||+|||+++.              +..++|||++..
T Consensus       228 -~~~vkl~DFG~a~~--------------~~~~~a~e~l~r  253 (282)
T 1zar_A          228 -EEGIWIIDFPQSVE--------------VGEEGWREILER  253 (282)
T ss_dssp             -TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred             -CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence             99999999999863              445789998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.78  E-value=1.2e-19  Score=180.81  Aligned_cols=136  Identities=18%  Similarity=0.179  Sum_probs=105.7

Q ss_pred             ccccccccccCceEEEEEEe-CCCCE--EEEEEeecCCh------------------------HHHHHHHHHHHHHhcCC
Q 042149          300 FDNSRKLGQGGAGSVFRGTL-PDGRN--IAVKRLFFNSR------------------------QWVDQFFNEVNLISGIQ  352 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~------------------------~~~~~~~~E~~~l~~l~  352 (625)
                      |++.+.||+|+||.||+|.+ .+|+.  ||||++.....                        .....+.+|+.+|+++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            67889999999999999997 68888  99998754311                        11236889999999998


Q ss_pred             CCce--eeeeeeeeeCCeeEEEEEecCC-C----CcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhh-cCCCceEEEe
Q 042149          353 HKNV--VRLLGCSIEGPESLLVYEYVPN-R----SLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH-GGSGIKIIHR  424 (625)
Q Consensus       353 hpni--v~l~~~~~~~~~~~lV~e~~~~-~----sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~iiHr  424 (625)
                      |+++  +.+++.    ...+|||||+.+ |    +|.+....      .++..+..++.|++.+|.||| ..+   |+||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr  195 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA  195 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence            8864  444432    367899999942 4    55544321      224467789999999999999 775   9999


Q ss_pred             eeccCcEEEcCCCceEEeecccceee
Q 042149          425 DIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       425 Dlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      ||||+|||++.  .++|+|||++...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999998  8999999999754

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.78  E-value=2.3e-19  Score=151.88  Aligned_cols=100  Identities=17%  Similarity=0.451  Sum_probs=80.9

Q ss_pred             cccccCCCcccChhhHHHHHHHHHHHHHHHHHhhccC-Ccceeeecc-CCcceEEEEecccccCCcccchhhHHHHHhhc
Q 042149          150 DKFNCSARHLDDESLSKQFEEKVIEVITNVTIVTKSN-GRFGQVEGK-GGIATVYALAQCLKFLDNKGCSQCLDEAALRL  227 (625)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~f~~~~~~Ll~~~~~~a~~~-~~f~~~~~~-~~~~~vy~laQC~~dLs~~~C~~CL~~~~~~~  227 (625)
                      ....|+..+.+.   ...|+.++..||..|+..++.+ ..|++.... .+.++||||+||++||++.+|+.||+.++.++
T Consensus         6 v~~~Cn~~~~t~---~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~   82 (108)
T 3a2e_A            6 VSSACNTQKIPS---GSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRI   82 (108)
T ss_dssp             EEEEECSSBCCT---TCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTH
T ss_pred             eeeecCCCccCC---CChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHH
Confidence            344565433222   2469999999999999888754 456665554 56789999999999999999999999999999


Q ss_pred             ccccCCCCC-eEEeeeeeeeccCccc
Q 042149          228 KGCSKSGEG-RAMFAGCYVRFSTERF  252 (625)
Q Consensus       228 ~~c~~~~~g-~~~~~~C~~r~~~~~f  252 (625)
                      +.||+++.| +|++++|++|||+++|
T Consensus        83 ~~~C~~~~g~~i~~~~C~lRY~~~~F  108 (108)
T 3a2e_A           83 FSICNNAIGARVQLVDCFIQYEQRSF  108 (108)
T ss_dssp             HHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred             HHHCCCCceEEEECCCEEEEEeCCcC
Confidence            998777666 9999999999999987

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.69  E-value=7.8e-18  Score=174.50  Aligned_cols=136  Identities=15%  Similarity=0.185  Sum_probs=97.7

Q ss_pred             ccccccccccCceEEEEEEeCCCCEEEEEEeecCCh--------------HHHH--------HHHHHHHHHhcCCCCcee
Q 042149          300 FDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSR--------------QWVD--------QFFNEVNLISGIQHKNVV  357 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~~l~~l~hpniv  357 (625)
                      |++.+.||+|++|.||+|...+|+.||||++.....              ....        ...+|...|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            899999999999999999999999999998743210              0001        123456666666444432


Q ss_pred             eeeeeeeeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC
Q 042149          358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL  437 (625)
Q Consensus       358 ~l~~~~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~  437 (625)
                      -..-+..  ...+|||||++|++|.++...         .....++.|++.+|.+||+.+   ||||||||.||||++++
T Consensus       177 vp~p~~~--~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          177 VPEPIAQ--SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEK  242 (397)
T ss_dssp             CCCEEEE--ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEE
T ss_pred             CCeeeec--cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCC
Confidence            1111111  234799999999888765421         123567889999999999876   99999999999998776


Q ss_pred             ----------ceEEeeccccee
Q 042149          438 ----------TPKIADFGLARH  449 (625)
Q Consensus       438 ----------~~kl~Dfgla~~  449 (625)
                                .+.|+||+-+..
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCEE
T ss_pred             CcccccccccceEEEEeCCccc
Confidence                      389999997654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.41  E-value=5.7e-13  Score=132.53  Aligned_cols=146  Identities=14%  Similarity=0.069  Sum_probs=114.8

Q ss_pred             HHHhcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCCeeEEE
Q 042149          294 ERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       294 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV  372 (625)
                      ....+.|.+...++.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..++++++++.+.+..++|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            445577988999999999999999864 6899999986532122346889999999885 67888999999998999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG------------------------------------  416 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------------------------------------  416 (625)
                      |||++|.+|.+.+.        +......++.+++++|..||+.                                    
T Consensus        89 ~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           89 MSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            99999999877531        1122346778889999999971                                    


Q ss_pred             --------------------CCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          417 --------------------SGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       417 --------------------~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                                          ....++|+|++|.||++++++.+.|+||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                11569999999999999876566799999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.24  E-value=9e-12  Score=123.34  Aligned_cols=139  Identities=17%  Similarity=0.145  Sum_probs=101.6

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCc--eeeeeeeeeeCCeeEEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKN--VVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~~~~~~~~~lV~e  374 (625)
                      ...+.+....+.|..+.||++...+|+.++||.....   ....+.+|+.+++.+.+.+  +++++++....+..++|||
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e   95 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG   95 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred             cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence            3445554444456669999998777888999987543   2245788999999886444  5668888888788999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCC-------------------------------------
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS-------------------------------------  417 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------  417 (625)
                      |++|.+|.  ...      ..   ...++.++++.|..||+..                                     
T Consensus        96 ~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (264)
T 1nd4_A           96 EVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG  164 (264)
T ss_dssp             CCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred             ecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence            99998884  211      11   1245667777777777542                                     


Q ss_pred             ------------------CceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          418 ------------------GIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       418 ------------------~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                                        ...++|+|++|.||++++++.+.|+|||.+..
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                              22499999999999998876677999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.10  E-value=3.5e-10  Score=117.75  Aligned_cols=142  Identities=14%  Similarity=0.192  Sum_probs=107.0

Q ss_pred             ccccccccCceEEEEEEeCCCCEEEEEEee--cCC-hHHHHHHHHHHHHHhcCC--CCceeeeeeeeeeC---CeeEEEE
Q 042149          302 NSRKLGQGGAGSVFRGTLPDGRNIAVKRLF--FNS-RQWVDQFFNEVNLISGIQ--HKNVVRLLGCSIEG---PESLLVY  373 (625)
Q Consensus       302 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~---~~~~lV~  373 (625)
                      ..+.|+.|.++.||+....+ ..+++|+..  ... ......+.+|+.+++.+.  +..+++++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            46679999999999998754 678898775  322 122356788999999997  45688888888766   3589999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCC------------------------------------
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS------------------------------------  417 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------------  417 (625)
                      ||++|..+.+..     ...++..++..++.++++.|..||...                                    
T Consensus       121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999998885422     122677888889999999999999721                                    


Q ss_pred             -------------------CceEEEeeeccCcEEEcCCCc--eEEeeccccee
Q 042149          418 -------------------GIKIIHRDIKTSNILLDEKLT--PKIADFGLARH  449 (625)
Q Consensus       418 -------------------~~~iiHrDlkp~NIll~~~~~--~kl~Dfgla~~  449 (625)
                                         ...++|+|++|.||+++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               257999999999999997653  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.96  E-value=2.1e-10  Score=116.64  Aligned_cols=182  Identities=20%  Similarity=0.247  Sum_probs=120.5

Q ss_pred             cccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCC-CCc--eeeeeeeeeeCC---eeEEEEEec
Q 042149          303 SRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-HKN--VVRLLGCSIEGP---ESLLVYEYV  376 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpn--iv~l~~~~~~~~---~~~lV~e~~  376 (625)
                      ++.++.|....||+..    ..+++|+...  ......+.+|+++|+.+. +..  +++++.......   ..++|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            5568999999999863    5688997642  344577899999998884 332  445555543333   358999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG----------------------------------------  416 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~----------------------------------------  416 (625)
                      +|.+|.+...     ..++..++..++.++++.|..||..                                        
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9998875432     1256667777777777777777751                                        


Q ss_pred             ---------------CCceEEEeeeccCcEEEcC--CCceEEeecccceeeCCCCceeeecCCCCccc---cCcccccc-
Q 042149          417 ---------------SGIKIIHRDIKTSNILLDE--KLTPKIADFGLARHVAPDKTHVSTGIAGTLGY---MAPEYLVR-  475 (625)
Q Consensus       417 ---------------~~~~iiHrDlkp~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y---~aPE~~~~-  475 (625)
                                     ....++|+|++|.||++++  +..+.|+||+.+..-.......     ....+   ..|+.... 
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~-----~~~~~~~~~~~~~~~~~  248 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI-----SLMEDDEEYGMEFVSKI  248 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH-----TTCCTTTSCCHHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH-----HHHhhccccCHHHHHHH
Confidence                           1235899999999999998  5568899999886532211100     00011   12222111 


Q ss_pred             ----C---------cccccCcEEeehhhhHHHHhCCCC
Q 042149          476 ----G---------QLTEKADVYAFGVLVIEVASGRRN  500 (625)
Q Consensus       476 ----~---------~~~~~~Dv~SlG~ll~elltG~~p  500 (625)
                          +         ......+.|+++.++|.+.+|..+
T Consensus       249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~  286 (304)
T 3sg8_A          249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMD  286 (304)
T ss_dssp             HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHH
T ss_pred             HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHH
Confidence                0         112235789999999999999865

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.61  E-value=2.9e-07  Score=93.32  Aligned_cols=136  Identities=18%  Similarity=0.176  Sum_probs=92.4

Q ss_pred             cccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCC---ceeeeeeeee-eCCeeEEEEEecCC
Q 042149          303 SRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHK---NVVRLLGCSI-EGPESLLVYEYVPN  378 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---niv~l~~~~~-~~~~~~lV~e~~~~  378 (625)
                      .+.++.|....||+.    ++.++||+.  ........+.+|+++|+.+.+.   .+++++.+.. ..+..++|||+++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~--~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFP--KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEE--SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEec--CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456888888899988    577899974  3344567889999999999742   3566676664 34567899999999


Q ss_pred             CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 042149          379 RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG------------------------------------------  416 (625)
Q Consensus       379 ~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------------------------------------------  416 (625)
                      .+|.+....     .++..+...++.++++.|..||+.                                          
T Consensus        98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            888763211     023333333334444444333321                                          


Q ss_pred             ---------------CCceEEEeeeccCcEEEcC---CCc-eEEeeccccee
Q 042149          417 ---------------SGIKIIHRDIKTSNILLDE---KLT-PKIADFGLARH  449 (625)
Q Consensus       417 ---------------~~~~iiHrDlkp~NIll~~---~~~-~kl~Dfgla~~  449 (625)
                                     ....++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           2346899999999999987   455 48999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.54  E-value=4e-07  Score=90.34  Aligned_cols=135  Identities=16%  Similarity=0.114  Sum_probs=94.2

Q ss_pred             cccccCce-EEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCCeeEEEEEecCCCCc
Q 042149          305 KLGQGGAG-SVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEGPESLLVYEYVPNRSL  381 (625)
Q Consensus       305 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~e~~~~~sL  381 (625)
                      .+..|..| .||+.... ++..++||+....   ....+.+|..+|+.+. +--++++++++.+.+..++|||+++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            34556555 69988765 4678899976533   3456788999998884 33477889999999999999999999887


Q ss_pred             chhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcC---------------------------------------------
Q 042149          382 DQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG---------------------------------------------  416 (625)
Q Consensus       382 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~---------------------------------------------  416 (625)
                      .+.....       ......+..+++..|..||..                                             
T Consensus       108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            6654211       111223444445555555531                                             


Q ss_pred             ----------CCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          417 ----------SGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       417 ----------~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                                ....++|+|++|.|||+++++.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                      123489999999999999887778999998753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.42  E-value=3.2e-07  Score=95.11  Aligned_cols=81  Identities=10%  Similarity=0.028  Sum_probs=56.6

Q ss_pred             cccc-cccCceEEEEEEeC-------CCCEEEEEEeecCCh--H-HHHHHHHHHHHHhcCC-C--CceeeeeeeeeeC--
Q 042149          303 SRKL-GQGGAGSVFRGTLP-------DGRNIAVKRLFFNSR--Q-WVDQFFNEVNLISGIQ-H--KNVVRLLGCSIEG--  366 (625)
Q Consensus       303 ~~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~--~-~~~~~~~E~~~l~~l~-h--pniv~l~~~~~~~--  366 (625)
                      .+.| +.|....+|+....       +++.+++|+......  . ....+.+|+.+++.+. +  -.+++++.+..+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 88888999988754       267788987643220  0 1245678999888884 3  3577788776654  


Q ss_pred             -CeeEEEEEecCCCCcch
Q 042149          367 -PESLLVYEYVPNRSLDQ  383 (625)
Q Consensus       367 -~~~~lV~e~~~~~sL~~  383 (625)
                       ...++||||++|..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35689999999987764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.17  E-value=4.8e-06  Score=87.53  Aligned_cols=75  Identities=16%  Similarity=0.154  Sum_probs=50.6

Q ss_pred             cccccccCceEEEEEEeC-CCCEEEEEEeecCCh-------HHHHHHHHHHHHHhcCCC--C-ceeeeeeeeeeCCeeEE
Q 042149          303 SRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSR-------QWVDQFFNEVNLISGIQH--K-NVVRLLGCSIEGPESLL  371 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--p-niv~l~~~~~~~~~~~l  371 (625)
                      .+.||.|..+.||++... +++.++||......+       ...+++..|.++|+.+..  | .+++++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            557999999999999864 468899997643221       123456789998887742  3 34566643  4456789


Q ss_pred             EEEecCCC
Q 042149          372 VYEYVPNR  379 (625)
Q Consensus       372 V~e~~~~~  379 (625)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999774

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.12  E-value=1.6e-05  Score=81.36  Aligned_cols=141  Identities=16%  Similarity=0.215  Sum_probs=79.8

Q ss_pred             cccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCC--Cceeeeee------eeeeCCeeEEEEE
Q 042149          303 SRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQH--KNVVRLLG------CSIEGPESLLVYE  374 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~------~~~~~~~~~lV~e  374 (625)
                      .+.|+.|..+.||+....++ .+++|+.... .   +.+..|+.+++.|..  -.+++++.      +....+..++|||
T Consensus        37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EEECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            34566677899999987654 5899988652 2   233445555555431  12333332      1234667899999


Q ss_pred             ecCCCCcch--------------hhhcc-C----C------cCCCCHHHHH-----------------------------
Q 042149          375 YVPNRSLDQ--------------ILFVK-N----T------IHILSWQQRF-----------------------------  400 (625)
Q Consensus       375 ~~~~~sL~~--------------~l~~~-~----~------~~~l~~~~~~-----------------------------  400 (625)
                      |++|..+..              .++.. .    +      .....|...+                             
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            999976531              11111 0    0      0011232211                             


Q ss_pred             --HHHHHHHHHHHHhhc----------CCCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          401 --TIICGTAEGLAHLHG----------GSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       401 --~i~~~i~~~L~~LH~----------~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                        .+...+..++.+|+.          .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence              011123335556652          013469999999999999877889999999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.04  E-value=2.7e-05  Score=78.71  Aligned_cols=138  Identities=17%  Similarity=0.114  Sum_probs=93.1

Q ss_pred             cccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCC---CCceeeeeeeeeeCCeeEEEEEecCCC
Q 042149          303 SRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ---HKNVVRLLGCSIEGPESLLVYEYVPNR  379 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~~~~~~~~~lV~e~~~~~  379 (625)
                      .+.|+.|....+|+... +++.++||+....   ....+..|.+.|+.|.   ...+++++.+....+..++||||++|.
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            56789999999999986 4678899987543   2567889999998884   356888898888788899999999998


Q ss_pred             Ccch-----------hhhccCC-c------------------CCCCHHHHHH---HH----------------HHHHHHH
Q 042149          380 SLDQ-----------ILFVKNT-I------------------HILSWQQRFT---II----------------CGTAEGL  410 (625)
Q Consensus       380 sL~~-----------~l~~~~~-~------------------~~l~~~~~~~---i~----------------~~i~~~L  410 (625)
                      .+..           .|+.... .                  -.-+|...+.   +.                ..+++-+
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            7632           1222111 0                  0124543221   11                1111111


Q ss_pred             -HHhhc-CCCceEEEeeeccCcEEEcCCCceEEeecc
Q 042149          411 -AHLHG-GSGIKIIHRDIKTSNILLDEKLTPKIADFG  445 (625)
Q Consensus       411 -~~LH~-~~~~~iiHrDlkp~NIll~~~~~~kl~Dfg  445 (625)
                       ..|.. .....++|+|+.+.|++++.++ +.|+|+.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             23421 2246799999999999999887 8899974

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.91  E-value=3.9e-05  Score=76.67  Aligned_cols=80  Identities=20%  Similarity=0.193  Sum_probs=58.6

Q ss_pred             CccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCC-C--CceeeeeeeeeeCCeeEEEEEe
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-H--KNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--pniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ....++.+|.|..+.||+.++.+|+.++||+...........|..|++.|+.|. .  --++++++..    ..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            345567899999999999999999999999875544333446788999998884 2  2345555542    34789999


Q ss_pred             cCCCCcc
Q 042149          376 VPNRSLD  382 (625)
Q Consensus       376 ~~~~sL~  382 (625)
                      ++++...
T Consensus        92 l~~~~~~   98 (288)
T 3f7w_A           92 VDERPPT   98 (288)
T ss_dssp             CCCCCCC
T ss_pred             ecccCCC
Confidence            9876553

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.78  E-value=7.5e-05  Score=79.00  Aligned_cols=74  Identities=14%  Similarity=0.146  Sum_probs=46.6

Q ss_pred             ccccccccCceEEEEEEeCCCCEEEEEEeecC-----C--h--HHHHHHHHHHHHHh-cCCCCceeeeeeeeeeCCeeEE
Q 042149          302 NSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFN-----S--R--QWVDQFFNEVNLIS-GIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       302 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-----~--~--~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      ..+.||.|..+.||++.. +++.++||...+.     .  .  .....++.|+..+. ...+..+++++.+.  .+..++
T Consensus        38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l  114 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI  114 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred             EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence            356789999999999975 5678999943221     0  0  02233444444332 22234567777665  567899


Q ss_pred             EEEec-CC
Q 042149          372 VYEYV-PN  378 (625)
Q Consensus       372 V~e~~-~~  378 (625)
                      ||||+ ++
T Consensus       115 v~e~l~~g  122 (420)
T 2pyw_A          115 GMRYLEPP  122 (420)
T ss_dssp             EECCCCTT
T ss_pred             EEeecCCc
Confidence            99999 76

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.74  E-value=0.00011  Score=74.41  Aligned_cols=156  Identities=12%  Similarity=0.074  Sum_probs=86.2

Q ss_pred             HHHHHHHhcCccc-----cccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCc--eeeeeee
Q 042149          290 YEILERATDFFDN-----SRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKN--VVRLLGC  362 (625)
Q Consensus       290 ~~~~~~~~~~y~~-----~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~  362 (625)
                      -+.+......|.+     .+.|+.|....+|+....++ .+++|......  ..+.+..|+.+++.|...+  +++++..
T Consensus         9 ~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~   85 (322)
T 2ppq_A            9 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPR   85 (322)
T ss_dssp             HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred             HHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCC
Confidence            3445555555654     34567788899999987655 68899876521  1234556777777764222  3344321


Q ss_pred             ------eeeCCeeEEEEEecCCCCcchh--------------hhccC----Cc-----CCCCHHHHHHHH----------
Q 042149          363 ------SIEGPESLLVYEYVPNRSLDQI--------------LFVKN----TI-----HILSWQQRFTII----------  403 (625)
Q Consensus       363 ------~~~~~~~~lV~e~~~~~sL~~~--------------l~~~~----~~-----~~l~~~~~~~i~----------  403 (625)
                            ....+..+++|+|++|..+...              ++...    ..     ....|...+.-.          
T Consensus        86 ~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~  165 (322)
T 2ppq_A           86 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG  165 (322)
T ss_dssp             TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred             CCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhh
Confidence                  1234567899999998765321              11110    00     001122211100          


Q ss_pred             --HHHHHHHHHhhc----CCCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          404 --CGTAEGLAHLHG----GSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       404 --~~i~~~L~~LH~----~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                        ..+.+.+..++.    .....++|+|+++.|||+++++.+.|+||+.+.
T Consensus       166 l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          166 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence              012233344432    224579999999999999987656899999775

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.57  E-value=0.0001  Score=78.12  Aligned_cols=74  Identities=16%  Similarity=0.295  Sum_probs=50.4

Q ss_pred             cccccccCceEEEEEEeCC--------CCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCce-eeeeeeeeeCCeeEEEE
Q 042149          303 SRKLGQGGAGSVFRGTLPD--------GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNV-VRLLGCSIEGPESLLVY  373 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lV~  373 (625)
                      .+.|+.|....||+....+        ++.+++|+......  .+.+.+|..+++.|...++ +++++.+.+    .+||
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4567888889999998653        47889998743211  1345579999888853333 566765532    3899


Q ss_pred             EecCCCCcc
Q 042149          374 EYVPNRSLD  382 (625)
Q Consensus       374 e~~~~~sL~  382 (625)
                      ||++|.+|.
T Consensus       152 e~l~G~~l~  160 (429)
T 1nw1_A          152 EYIPSRPLS  160 (429)
T ss_dssp             CCCCEEECC
T ss_pred             EEeCCcccC
Confidence            999875553

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.54  E-value=0.00044  Score=70.23  Aligned_cols=142  Identities=15%  Similarity=0.120  Sum_probs=82.5

Q ss_pred             ccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCc--eeeeeee-----eeeCCeeEEEEEec
Q 042149          304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKN--VVRLLGC-----SIEGPESLLVYEYV  376 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--iv~l~~~-----~~~~~~~~lV~e~~  376 (625)
                      ..|+ |....||+....+|+.+++|....... ..+.+..|..+++.+....  +++++..     ....+..++|||++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4566 888899998877787899998864311 2345667888887774222  3444442     22345668899999


Q ss_pred             CCCCcch----h----------hhcc----C--CcCCCCHHHH----------------------HHHHHHHHHHHHHhh
Q 042149          377 PNRSLDQ----I----------LFVK----N--TIHILSWQQR----------------------FTIICGTAEGLAHLH  414 (625)
Q Consensus       377 ~~~sL~~----~----------l~~~----~--~~~~l~~~~~----------------------~~i~~~i~~~L~~LH  414 (625)
                      +|..+..    .          ++..    .  .....++...                      ...+..++..+..+-
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            8865531    0          1110    0  0111222211                      111112222222221


Q ss_pred             c-CCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          415 G-GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       415 ~-~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      . .....++|+|+++.||+++ + .+.|+||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            1 1244689999999999999 4 899999987653

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.54  E-value=0.00026  Score=73.38  Aligned_cols=142  Identities=20%  Similarity=0.209  Sum_probs=84.1

Q ss_pred             cccccccCceEEEEEEeC--------CCCEEEEEEeecCChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCCeeEEEE
Q 042149          303 SRKLGQGGAGSVFRGTLP--------DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~  373 (625)
                      .+.|..|-...+|+....        +++.+++|+.... ......+.+|..+++.|. +.-.+++++.+.+    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            345777888899999864        2578999986332 123456678999998885 3323666766543    3999


Q ss_pred             EecCCCCcchh-----------------hhccC-C-cCCCC--HHHHHHHHHHHHH-------------------HHH--
Q 042149          374 EYVPNRSLDQI-----------------LFVKN-T-IHILS--WQQRFTIICGTAE-------------------GLA--  411 (625)
Q Consensus       374 e~~~~~sL~~~-----------------l~~~~-~-~~~l~--~~~~~~i~~~i~~-------------------~L~--  411 (625)
                      ||++|.+|..-                 |+... . .+...  +.++.++..++..                   .+.  
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998766421                 11110 0 11122  3455555443321                   122  


Q ss_pred             --Hhhc-CCCceEEEeeeccCcEEEcCC----CceEEeeccccee
Q 042149          412 --HLHG-GSGIKIIHRDIKTSNILLDEK----LTPKIADFGLARH  449 (625)
Q Consensus       412 --~LH~-~~~~~iiHrDlkp~NIll~~~----~~~kl~Dfgla~~  449 (625)
                        .|.. .....++|+|+.+.||+++++    +.+.|+||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence              2221 224679999999999999876    7899999998753

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.46  E-value=0.0002  Score=72.00  Aligned_cols=139  Identities=15%  Similarity=0.138  Sum_probs=76.8

Q ss_pred             ccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCce-eeeeeeeeeCCeeEEEEEec-CCC
Q 042149          302 NSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNV-VRLLGCSIEGPESLLVYEYV-PNR  379 (625)
Q Consensus       302 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lV~e~~-~~~  379 (625)
                      -.+.|+.|....+|+.     +.+++|+........ ....+|+.+++.+...++ +++++..  .+.-++|+||+ +|.
T Consensus        22 ~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           22 GPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ   93 (301)
T ss_dssp             SCEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred             ceeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence            3677889999999998     568888875432221 123568887777742222 4555543  33457899999 776


Q ss_pred             Ccchh------------------hhccCCc--CCCC-HHHHHHHH-----------------HHHHHHH-HHhh-cCCCc
Q 042149          380 SLDQI------------------LFVKNTI--HILS-WQQRFTII-----------------CGTAEGL-AHLH-GGSGI  419 (625)
Q Consensus       380 sL~~~------------------l~~~~~~--~~l~-~~~~~~i~-----------------~~i~~~L-~~LH-~~~~~  419 (625)
                      +|...                  ++.....  .... +.....+.                 ...+..+ ..+. .....
T Consensus        94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~  173 (301)
T 3dxq_A           94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL  173 (301)
T ss_dssp             ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred             cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence            66421                  1111100  0011 11111111                 1111111 1111 12245


Q ss_pred             eEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          420 KIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       420 ~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      .++|+|+.|.||+ ..++.+.|+||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            6999999999999 5566789999998764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.46  E-value=0.0003  Score=75.00  Aligned_cols=75  Identities=8%  Similarity=0.018  Sum_probs=48.7

Q ss_pred             cccccccCceEEEEEEeCC-CCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCce-eeeeeeeeeCCeeEEEEEecCCCC
Q 042149          303 SRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNV-VRLLGCSIEGPESLLVYEYVPNRS  380 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpni-v~l~~~~~~~~~~~lV~e~~~~~s  380 (625)
                      .+.|+.|-...+|+....+ ++.+++|+........++ -.+|..+++.|...++ +++++.+.  +  .+||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id-R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN-REREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC-HHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC-HHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            4568888889999998765 477888876443222111 2578999988864444 56777663  2  35999999866


Q ss_pred             cc
Q 042149          381 LD  382 (625)
Q Consensus       381 L~  382 (625)
                      |.
T Consensus       188 l~  189 (458)
T 2qg7_A          188 LS  189 (458)
T ss_dssp             CC
T ss_pred             CC
Confidence            53

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.40  E-value=0.00054  Score=69.81  Aligned_cols=142  Identities=13%  Similarity=0.101  Sum_probs=72.5

Q ss_pred             cccccccCceE-EEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCC--CceeeeeeeeeeCCeeEEEEEecCCC
Q 042149          303 SRKLGQGGAGS-VFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQH--KNVVRLLGCSIEGPESLLVYEYVPNR  379 (625)
Q Consensus       303 ~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lV~e~~~~~  379 (625)
                      .+.|+.|+... +|+....+++.+++|.......   +.+..|+.+++.+..  -.+++++.+..+.  -++|||++.+.
T Consensus        23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~   97 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDA   97 (333)
T ss_dssp             ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSC
T ss_pred             eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCc
Confidence            44566665554 6677654467788876543321   234456777766642  2355666653332  27899999776


Q ss_pred             CcchhhhccC-----------------------CcCCCCHHHHH-------HHH-------------HHHHHHHHHhh--
Q 042149          380 SLDQILFVKN-----------------------TIHILSWQQRF-------TII-------------CGTAEGLAHLH--  414 (625)
Q Consensus       380 sL~~~l~~~~-----------------------~~~~l~~~~~~-------~i~-------------~~i~~~L~~LH--  414 (625)
                      .+.+.+....                       ....++.....       .+.             ..+...+..+.  
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            6543321100                       00111111000       000             01111122221  


Q ss_pred             -cCCCceEEEeeeccCcEEEcCC----CceEEeeccccee
Q 042149          415 -GGSGIKIIHRDIKTSNILLDEK----LTPKIADFGLARH  449 (625)
Q Consensus       415 -~~~~~~iiHrDlkp~NIll~~~----~~~kl~Dfgla~~  449 (625)
                       ......++|+|+++.||+++.+    +.+.|+||+.+..
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence             1124579999999999999874    6899999998865

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.28  E-value=0.0012  Score=67.42  Aligned_cols=67  Identities=6%  Similarity=0.050  Sum_probs=44.0

Q ss_pred             ccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCC---CCceeeeeee------eeeCCeeEEEEEecCC
Q 042149          308 QGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ---HKNVVRLLGC------SIEGPESLLVYEYVPN  378 (625)
Q Consensus       308 ~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpniv~l~~~------~~~~~~~~lV~e~~~~  378 (625)
                      .|....||+....+| .+++|+......      ..|+.+++.|.   -|++++++..      ....+..++||+|++|
T Consensus        33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G  105 (339)
T 3i1a_A           33 ADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA  105 (339)
T ss_dssp             SCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred             CccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence            333679999998777 899998765432      35666666553   2224454432      2345678999999998


Q ss_pred             CCc
Q 042149          379 RSL  381 (625)
Q Consensus       379 ~sL  381 (625)
                      ..+
T Consensus       106 ~~~  108 (339)
T 3i1a_A          106 PNG  108 (339)
T ss_dssp             CBT
T ss_pred             CcC
Confidence            766

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.20  E-value=0.00057  Score=70.80  Aligned_cols=74  Identities=11%  Similarity=0.124  Sum_probs=45.2

Q ss_pred             cccccccCceEEEEEEeCC---------CCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCc-eeeeeeeeeeCCeeEEE
Q 042149          303 SRKLGQGGAGSVFRGTLPD---------GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKN-VVRLLGCSIEGPESLLV  372 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lV  372 (625)
                      .+.|+.|....+|+....+         ++.+++|+....... ......|..+++.+...+ .+++++..  .  -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            4567788888999998654         267888876543222 122357888888775333 44666543  2  3789


Q ss_pred             EEecCCCCc
Q 042149          373 YEYVPNRSL  381 (625)
Q Consensus       373 ~e~~~~~sL  381 (625)
                      |||++|.++
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999998655

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.61  E-value=0.002  Score=60.34  Aligned_cols=142  Identities=14%  Similarity=0.080  Sum_probs=89.1

Q ss_pred             CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceee
Q 042149          379 RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS  458 (625)
Q Consensus       379 ~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  458 (625)
                      .+|.++|...+.  ++++.++|.++.|.+..|.-+-.... + ..+=+.|..|+|..+|.|.+.+ ..+.          
T Consensus        33 vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           33 LSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc----------
Confidence            478888866543  49999999999999999887621100 1 1233457999999999888764 1110          


Q ss_pred             ecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCChH
Q 042149          459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPEN  538 (625)
Q Consensus       459 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~  538 (625)
                         .....+.|||... ...+.+.=|||||+++|.-+-=..|.                                ..+.+
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e--------------------------------~eE~e  141 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE--------------------------------NEERE  141 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT--------------------------------TEEEC
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc--------------------------------ccchh
Confidence               1122456888753 34467888999999999887533221                                11334


Q ss_pred             HHHHHHHHHhhccCC-------------------------CCCCCCCHHHHHHHHccc
Q 042149          539 EASRVLQIGLLCTQA-------------------------PVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       539 ~~~~l~~li~~cl~~-------------------------~p~~RPt~~ev~~~L~~~  571 (625)
                      .++.|-+||..|...                         .+..|+++++|++.-...
T Consensus       142 LS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~h  199 (229)
T 2yle_A          142 LSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAH  199 (229)
T ss_dssp             CCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHTT
T ss_pred             hCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHhh
Confidence            455566666666544                         356889999999877554

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.30  E-value=0.012  Score=61.80  Aligned_cols=141  Identities=10%  Similarity=0.133  Sum_probs=84.3

Q ss_pred             cccccccCceEEEEEEeCC--------CCEEEEEEeecCChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCCeeEEEE
Q 042149          303 SRKLGQGGAGSVFRGTLPD--------GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ++.|..|-...+|+....+        ++.+++|+........+ ...+|..+++.+. +.-.+++++.+  .  -++||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY-DSKVELDVFRYLSNINIAPNIIADF--P--EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC-CHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc-CHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence            4567778888999998753        57899998654332222 2357888888875 32245556533  2  37899


Q ss_pred             EecCCCCcchh-----------------hhcc--------C--CcCCCCHHHHHHHHHHH-------------------H
Q 042149          374 EYVPNRSLDQI-----------------LFVK--------N--TIHILSWQQRFTIICGT-------------------A  407 (625)
Q Consensus       374 e~~~~~sL~~~-----------------l~~~--------~--~~~~l~~~~~~~i~~~i-------------------~  407 (625)
                      ||++|.+|..-                 |+..        .  .....-|.++.++..++                   .
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            99999765321                 0100        0  11111244443433222                   1


Q ss_pred             HHHHHh----h-----------------cCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          408 EGLAHL----H-----------------GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       408 ~~L~~L----H-----------------~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      ..+..|    .                 ......++|+|+.+.||+ +.++.+.|+||..+..
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            112222    1                 122457999999999999 7788999999998753

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.68  E-value=0.08  Score=55.14  Aligned_cols=31  Identities=32%  Similarity=0.458  Sum_probs=25.9

Q ss_pred             ceEEEeeeccCcEEE------cCCCceEEeeccccee
Q 042149          419 IKIIHRDIKTSNILL------DEKLTPKIADFGLARH  449 (625)
Q Consensus       419 ~~iiHrDlkp~NIll------~~~~~~kl~Dfgla~~  449 (625)
                      ..++|+|+.+.|||+      +++..+.++||..+..
T Consensus       244 ~vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          244 VVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            457899999999999      3467899999998754

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=87.27  E-value=1.8  Score=40.35  Aligned_cols=83  Identities=7%  Similarity=0.046  Sum_probs=60.5

Q ss_pred             CCCceeeeeeeeeeCCeeEEEEEecC-CCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCc
Q 042149          352 QHKNVVRLLGCSIEGPESLLVYEYVP-NRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSN  430 (625)
Q Consensus       352 ~hpniv~l~~~~~~~~~~~lV~e~~~-~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~N  430 (625)
                      .||+++.. .+-.+++.+.|.++.-+ +-++..       ...++...++.++..|+....+++.     -+|--|+|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-------ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-------IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-------GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-------HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence            58888866 45556666666666443 222222       2237889999999999998877763     4788899999


Q ss_pred             EEEcCCCceEEeecccc
Q 042149          431 ILLDEKLTPKIADFGLA  447 (625)
Q Consensus       431 Ill~~~~~~kl~Dfgla  447 (625)
                      |+++.++.+++.--|+-
T Consensus       110 L~f~~~~~p~i~~RGik  126 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQ  126 (215)
T ss_dssp             EEECTTSCEEESCCEET
T ss_pred             EEEcCCCCEEEEEccCc
Confidence            99999999999877753

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=85.62  E-value=0.12  Score=54.86  Aligned_cols=61  Identities=8%  Similarity=0.016  Sum_probs=18.7

Q ss_pred             cccccccccCceEEEEEEeCC-CCEEEE------EEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeee
Q 042149          301 DNSRKLGQGGAGSVFRGTLPD-GRNIAV------KRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSI  364 (625)
Q Consensus       301 ~~~~~lG~G~~g~Vy~~~~~~-~~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  364 (625)
                      .+.++||   ||.||+|.+.. ..+|||      |.....  .++....+.+|..+++.++|||+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            4566777   99999999753 467888      766432  2334457888999999999999999988654

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=83.12  E-value=2.4  Score=39.53  Aligned_cols=82  Identities=10%  Similarity=0.116  Sum_probs=58.8

Q ss_pred             CCCceeeeeeeeeeCCeeEEEEEecCC-CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHH-HhhcCCCceEEEeeeccC
Q 042149          352 QHKNVVRLLGCSIEGPESLLVYEYVPN-RSLDQILFVKNTIHILSWQQRFTIICGTAEGLA-HLHGGSGIKIIHRDIKTS  429 (625)
Q Consensus       352 ~hpniv~l~~~~~~~~~~~lV~e~~~~-~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~-~LH~~~~~~iiHrDlkp~  429 (625)
                      .||++  -..+-.+++.+.|.++.-++ -++.. +      ..++..++++++.+|+.... +++.     -+|--|+|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-I------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-H------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-H------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence            57887  33334666777777775433 22222 2      23788999999999988877 6663     578889999


Q ss_pred             cEEEcCCCceEEeecccc
Q 042149          430 NILLDEKLTPKIADFGLA  447 (625)
Q Consensus       430 NIll~~~~~~kl~Dfgla  447 (625)
                      ||+++.++.++|.-.|+-
T Consensus       114 NL~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVK  131 (219)
T ss_dssp             GEEECTTCCEEESCCEET
T ss_pred             eEEEeCCCcEEEEEcCCc
Confidence            999999999999877753

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	625
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-64
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-64
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-63
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-63
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	9e-63
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-59
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-59
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-57
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-57
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-56
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-56
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-56
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-56
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-55
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-53
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-53
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-53
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-53
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	9e-53
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-52
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-51
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-51
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-51
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-51
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-50
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-50
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-49
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-48
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-47
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-47
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-47
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-46
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-45
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-43
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	9e-42
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-41
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-38
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-38
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-38
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-38
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	7e-38
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	9e-38
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-37
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-36
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-36
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-36
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-36
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-35
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-35
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-35
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-34
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-33
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-33
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-33
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-32
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-30
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-29
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-28
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-27
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-27
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-26
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-24
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-17

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (538), Expect = 2e-64
 Identities = 65/277 (23%), Positives = 130/277 (46%), Gaps = 19/277 (6%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           +++G G  G+V++G       + +  +   + Q +  F NEV ++   +H N++  +G S
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73

Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
              P+  +V ++    SL   L +  T       +   I   TA+G+ +LH      IIH
Sbjct: 74  -TAPQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAK---SIIH 127

Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVSTGIAGTLGYMAPEYLV---RGQLT 479
           RD+K++NI L E LT KI DFGLA   +    +H    ++G++ +MAPE +    +   +
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187

Query: 480 EKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENE 539
            ++DVYAFG+++ E+ +G+    +S  ++     +        ++  +      +   N 
Sbjct: 188 FQSDVYAFGIVLYELMTGQLP--YSNINNR--DQIIFMVGRGYLSPDLS-----KVRSNC 238

Query: 540 ASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIP 576
              + ++   C +     RP   +++  +  +   +P
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (534), Expect = 4e-64
 Identities = 60/272 (22%), Positives = 117/272 (43%), Gaps = 19/272 (6%)

Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
               ++LG G  G V  G      ++A+K +        D+F  E  ++  + H+ +V+L
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQL 64

Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G   +     ++ EY+ N  L   L      H    QQ   +     E + +L      
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLES---K 119

Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLT 479
           + +HRD+   N L++++   K++DFGL+R+V  D+   S G    + +  PE L+  + +
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179

Query: 480 EKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENE 539
            K+D++AFGVL+ E+ S  +               ++ +  +   + +  GL    P   
Sbjct: 180 SKSDIWAFGVLMWEIYSLGK-------------MPYERFTNSETAEHIAQGLRLYRPHLA 226

Query: 540 ASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           + +V  I   C       RP+   ++  + ++
Sbjct: 227 SEKVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (533), Expect = 1e-63
 Identities = 75/268 (27%), Positives = 124/268 (46%), Gaps = 19/268 (7%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
            +LG G  G V+ G       +AVK L        D F  E NL+  +QH+ +VRL    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
            + P   ++ EY+ N SL   L   + I  L+  +   +    AEG+A +        IH
Sbjct: 78  TQEPI-YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEER---NYIH 132

Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +NIL+ + L+ KIADFGLAR +  ++     G    + + APE +  G  T K+D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192

Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRV 543
           V++FG+L+ E+ +  R       +  V+  + + Y+  R             P+N    +
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-------------PDNCPEEL 239

Query: 544 LQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            Q+  LC +     RP+   +  +L + 
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 3e-63
 Identities = 62/272 (22%), Positives = 119/272 (43%), Gaps = 19/272 (6%)

Query: 300 FDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
               +++G G  G V  G   +   +A+K +        + F  E  ++  + H  +V+L
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQL 65

Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G  +E     LV+E++ +  L    +++    + + +    +     EG+A+L      
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEA--- 120

Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLT 479
            +IHRD+   N L+ E    K++DFG+ R V  D+   STG    + + +PE     + +
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180

Query: 480 EKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENE 539
            K+DV++FGVL+ EV S  +    +  +S V+  +   ++                P   
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL-------------YKPRLA 227

Query: 540 ASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           ++ V QI   C +     RP+ + ++  L  I
Sbjct: 228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 9e-63
 Identities = 66/278 (23%), Positives = 118/278 (42%), Gaps = 19/278 (6%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
            KLGQG  G V+ GT      +A+K L        + F  E  ++  ++H+ +V+L    
Sbjct: 23  VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAV- 80

Query: 364 IEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIH 423
           +      +V EY+   SL   L  +   ++    Q   +    A G+A++     +  +H
Sbjct: 81  VSEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVER---MNYVH 136

Query: 424 RDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKAD 483
           RD++ +NIL+ E L  K+ADFGLAR +  ++     G    + + APE  + G+ T K+D
Sbjct: 137 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 196

Query: 484 VYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRV 543
           V++FG+L+ E+ +  R               +       +   ++ G     P      +
Sbjct: 197 VWSFGILLTELTTKGR-------------VPYPGMVNREVLDQVERGYRMPCPPECPESL 243

Query: 544 LQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQP 581
             +   C +     RP+   +   L +      P  QP
Sbjct: 244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  199 bits (506), Expect = 1e-59
 Identities = 70/283 (24%), Positives = 121/283 (42%), Gaps = 19/283 (6%)

Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLI 348
           Y+  E          KLG G  G V+ G        +AVK L  ++ + V++F  E  ++
Sbjct: 9   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVM 67

Query: 349 SGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAE 408
             I+H N+V+LLG     P   ++ E++   +L   L   N    +S      +    + 
Sbjct: 68  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISS 126

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYM 468
            + +L        IHRD+   N L+ E    K+ADFGL+R +  D      G    + + 
Sbjct: 127 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 183

Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMD 528
           APE L   + + K+DV+AFGVL+ E+A+                + +     +++ + ++
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIATYG-------------MSPYPGIDLSQVYELLE 230

Query: 529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
                  PE    +V ++   C Q   + RPS AE+      +
Sbjct: 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  197 bits (502), Expect = 6e-59
 Identities = 79/315 (25%), Positives = 129/315 (40%), Gaps = 45/315 (14%)

Query: 286 LNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFNSRQWV- 338
           LN K   LE   +  +  R +G+G  G VF+   P          +AVK L   +   + 
Sbjct: 1   LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60

Query: 339 DQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI----- 393
             F  E  L++   + N+V+LLG    G    L++EY+    L++ L   +   +     
Sbjct: 61  ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120

Query: 394 ----------------LSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL 437
                           LS  ++  I    A G+A+L      K +HRD+ T N L+ E +
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENM 177

Query: 438 TPKIADFGLARHVAP-DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS 496
             KIADFGL+R++   D        A  + +M PE +   + T ++DV+A+GV++ E+ S
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237

Query: 497 GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVA 556
                 +      V++ V               G     PEN    +  +  LC     A
Sbjct: 238 YGLQPYYGMAHEEVIYYVRD-------------GNILACPENCPLELYNLMRLCWSKLPA 284

Query: 557 LRPSMAEVVHMLNNI 571
            RPS   +  +L  +
Sbjct: 285 DRPSFCSIHRILQRM 299

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  194 bits (493), Expect = 1e-57
 Identities = 66/302 (21%), Positives = 126/302 (41%), Gaps = 36/302 (11%)

Query: 288 FKYEILERATDFFDNS---------RKLGQGGAGSVFRGTLP----DGRNIAVKRLFFN- 333
           F +E    A   F            + +G G  G V  G L         +A+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 334 SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI 393
           + +    F +E +++    H NV+ L G   +    +++ E++ N SLD   F++     
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS--FLRQNDGQ 124

Query: 394 LSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD 453
            +  Q   ++ G A G+ +L     +  +HRD+   NIL++  L  K++DFGL+R +  D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 454 KTHV----STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSS 509
            +      + G    + + APE +   + T  +DV+++G+++ EV S             
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231

Query: 510 VLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLN 569
                +       +  +++       P +  S + Q+ L C Q     RP   ++V+ L+
Sbjct: 232 ---RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288

Query: 570 NI 571
            +
Sbjct: 289 KM 290

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 1e-57
 Identities = 67/269 (24%), Positives = 114/269 (42%), Gaps = 25/269 (9%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCS 363
           + +G+G  G V  G    G  +AVK +   +      F  E ++++ ++H N+V+LLG  
Sbjct: 13  QTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 69

Query: 364 IEGPESL-LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKII 422
           +E    L +V EY+   SL   L       +L             E + +L G      +
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFV 125

Query: 423 HRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKA 482
           HRD+   N+L+ E    K++DFGL +  +  +          + + APE L   + + K+
Sbjct: 126 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEALREKKFSTKS 181

Query: 483 DVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASR 542
           DV++FG+L+ E+ S  R          V+  V K YK                P+     
Sbjct: 182 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-------------DAPDGCPPA 228

Query: 543 VLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
           V ++   C     A+RPS  ++   L +I
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 3e-56
 Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 10/209 (4%)

Query: 293 LERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWV-DQFFNEVNLISG 350
           +E   D F+   +LG G  G VF+ +  P G  +A K +    +  + +Q   E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 351 IQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGL 410
                +V   G      E  +  E++   SLDQ+L        +  Q    +     +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 117

Query: 411 AHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAP 470
            +L      KI+HRD+K SNIL++ +   K+ DFG++  +            GT  YM+P
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSP 172

Query: 471 EYLVRGQLTEKADVYAFGVLVIEVASGRR 499
           E L     + ++D+++ G+ ++E+A GR 
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 4e-56
 Identities = 75/294 (25%), Positives = 127/294 (43%), Gaps = 27/294 (9%)

Query: 287 NFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRN----IAVKRL-FFNSRQWVDQF 341
             ++ ++  ++     +  +G+G  G V+ GTL D        AVK L        V QF
Sbjct: 16  AVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 75

Query: 342 FNEVNLISGIQHKNVVRLLGCSIEGPES-LLVYEYVPNRSLDQILFVKNTIHILSWQQRF 400
             E  ++    H NV+ LLG  +    S L+V  Y+ +  L   +  +   H  + +   
Sbjct: 76  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLI 133

Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK---THV 457
                 A+G+  L      K +HRD+   N +LDEK T K+ADFGLAR +   +    H 
Sbjct: 134 GFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN 190

Query: 458 STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKH 517
            TG    + +MA E L   + T K+DV++FGVL+ E+ +          +  +   + + 
Sbjct: 191 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 250

Query: 518 YKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            +  +             PE     + ++ L C      +RPS +E+V  ++ I
Sbjct: 251 RRLLQ-------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 7e-56
 Identities = 67/280 (23%), Positives = 129/280 (46%), Gaps = 26/280 (9%)

Query: 300 FDNSRKLGQGGAGSVFRGTLPDG-----RNIAVKRLFFNSRQW-VDQFFNEVNLISGIQH 353
               + +G G  G V++G L          +A+K L     +     F  E  ++    H
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
            N++RL G   +    +++ EY+ N +LD+ L  K+     S  Q   ++ G A G+ +L
Sbjct: 69  HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYL 126

Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD--KTHVSTGIAGTLGYMAPE 471
                +  +HRD+   NIL++  L  K++DFGL+R +  D   T+ ++G    + + APE
Sbjct: 127 AN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183

Query: 472 YLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL 531
            +   + T  +DV++FG+++ EV +                  +     + + ++++ G 
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYG-------------ERPYWELSNHEVMKAINDGF 230

Query: 532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
               P +  S + Q+ + C Q   A RP  A++V +L+ +
Sbjct: 231 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 9e-56
 Identities = 64/279 (22%), Positives = 118/279 (42%), Gaps = 27/279 (9%)

Query: 304 RKLGQGGAGSVFRGTLPD---GRNIAVKRLF--FNSRQWVDQFFNEVNLISGIQHKNVVR 358
           ++LG G  G+V +G        + +AVK L    N     D+   E N++  + +  +VR
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
           ++G   E    +LV E      L++ L        +  +    ++   + G+ +L     
Sbjct: 73  MIGI-CEAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES-- 126

Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVST--GIAGTLGYMAPEYLVRG 476
              +HRD+   N+LL  +   KI+DFGL++ +  D+ +          + + APE +   
Sbjct: 127 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 477 QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP 536
           + + K+DV++FGVL+ E  S  +               ++  K + +T  ++ G     P
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQ-------------KPYRGMKGSEVTAMLEKGERMGCP 232

Query: 537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEI 575
                 +  +  LC    V  RP  A V   L N  Y++
Sbjct: 233 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 1e-55
 Identities = 74/294 (25%), Positives = 120/294 (40%), Gaps = 33/294 (11%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFF-NEVNLISGIQHKNVVRLLGC 362
             +G+G  G V+RG    G  +AVK    +SR+    F   E+     ++H+N++  +  
Sbjct: 9   ESIGKGRFGEVWRGKW-RGEEVAVKIF--SSREERSWFREAEIYQTVMLRHENILGFIAA 65

Query: 363 SIEGPESL----LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH---- 414
             +   +     LV +Y  + SL   L        ++ +    +   TA GLAHLH    
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIV 121

Query: 415 -GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS---TGIAGTLGYMAP 470
                  I HRD+K+ NIL+ +  T  IAD GLA         +        GT  YMAP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 471 EYL------VRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV------WKHY 518
           E L         +  ++AD+YA G++  E+A         E      + +       +  
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 519 KANRITQSMDPGLTGRFPENEASRVL-QIGLLCTQAPVALRPSMAEVVHMLNNI 571
           +     Q + P +  R+   EA RV+ +I   C  A  A R +   +   L+ +
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 1e-53
 Identities = 66/327 (20%), Positives = 134/327 (40%), Gaps = 32/327 (9%)

Query: 295 RATDFFDNSRKLGQGGAGSVFRGT-LPDGRN----IAVKRL-FFNSRQWVDQFFNEVNLI 348
           + T+F    + LG G  G+V++G  +P+G      +A+K L    S +   +  +E  ++
Sbjct: 7   KETEF-KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65

Query: 349 SGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAE 408
           + + + +V RLLG  +      L+ + +P   L   +           Q         A+
Sbjct: 66  ASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAK 122

Query: 409 GLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-DKTHVSTGIAGTLGY 467
           G+ +L      +++HRD+   N+L+      KI DFGLA+ +   +K + + G    + +
Sbjct: 123 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179

Query: 468 MAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM 527
           MA E ++    T ++DV+++GV V E+ +                  +    A+ I+  +
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGS-------------KPYDGIPASEISSIL 226

Query: 528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFLNAS 587
           + G     P      V  I + C       RP   E++   + +      P++   +   
Sbjct: 227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM---ARDPQRYLVIQGD 283

Query: 588 VISPSDNSKDSMMSSFKSFVAESPEID 614
                 +  DS  + +++ + E    D
Sbjct: 284 ERMHLPSPTDS--NFYRALMDEEDMDD 308

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 1e-53
 Identities = 55/301 (18%), Positives = 115/301 (38%), Gaps = 25/301 (8%)

Query: 291 EILERATDFFDNSRKLGQGGAGSVFRGTL---PDGRNIAVKRLFFNSRQW-VDQFFNEVN 346
           ++  +  +      +LG G  GSV +G         ++A+K L   + +   ++   E  
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGT 406
           ++  + +  +VRL+G   +    +LV E      L + L  K     +       ++   
Sbjct: 62  IMHQLDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQV 118

Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH--VSTGIAGT 464
           + G+ +L        +HRD+   N+LL  +   KI+DFGL++ +  D ++    +     
Sbjct: 119 SMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175

Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRIT 524
           L + APE +   + + ++DV+++GV + E  S  +               +K  K   + 
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-------------KPYKKMKGPEVM 222

Query: 525 QSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPFL 584
             ++ G     P      +  +   C       RP    V   +    Y +    +    
Sbjct: 223 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHH 282

Query: 585 N 585
           +
Sbjct: 283 H 283

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  182 bits (464), Expect = 2e-53
 Identities = 69/276 (25%), Positives = 114/276 (41%), Gaps = 31/276 (11%)

Query: 297 TDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQ 352
              F + R++G G  G+V+    + +   +A+K++      S +       EV  +  ++
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
           H N ++  GC +    + LV EY    + D +   K     L   +   +  G  +GLA+
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAY 130

Query: 413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEY 472
           LH      +IHRD+K  NILL E    K+ DFG A  +AP  + V     GT  +MAPE 
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEV 182

Query: 473 LV---RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP 529
           ++    GQ   K DV++ G+  IE+A  +        ++              I Q+  P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPP--LFNMNAMSA--------LYHIAQNESP 232

Query: 530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVV 565
            L            +     C Q     RP+   ++
Sbjct: 233 ALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLL 265

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 4e-53
 Identities = 73/311 (23%), Positives = 119/311 (38%), Gaps = 42/311 (13%)

Query: 285 SLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTL------PDGRNIAVKRLFFNSRQW- 337
             + K+E      +     + LG G  G V   T            +AVK L  ++    
Sbjct: 13  PYDHKWEF---PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE 69

Query: 338 VDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI--- 393
            +   +E+ ++S +  H N+V LLG    G  +L++ EY     L   L  K    I   
Sbjct: 70  REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129

Query: 394 ------------LSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKI 441
                       L  +   +     A+G+A L        IHRD+   NILL      KI
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKI 186

Query: 442 ADFGLARHVAPDKTHVSTG-IAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRN 500
            DFGLAR +  D  +V  G     + +MAPE +     T ++DV+++G+ + E+ S   +
Sbjct: 187 CDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246

Query: 501 SVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPS 560
                   S  + + K             G     PE+  + +  I   C  A    RP+
Sbjct: 247 PYPGMPVDSKFYKMIK------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPT 294

Query: 561 MAEVVHMLNNI 571
             ++V ++   
Sbjct: 295 FKQIVQLIEKQ 305

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 9e-53
 Identities = 67/312 (21%), Positives = 114/312 (36%), Gaps = 47/312 (15%)

Query: 287 NFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRN------IAVKRLFFNSRQ-WVD 339
           + K+E      +  +  + LG G  G V   T            +AVK L   +     +
Sbjct: 29  DLKWEF---PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSERE 85

Query: 340 QFFNEVNLISGI-QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKN--------- 389
              +E+ +++ +  H+N+V LLG         L++EY     L   L  K          
Sbjct: 86  ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 145

Query: 390 -----------TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLT 438
                       +++L+++         A+G+  L        +HRD+   N+L+     
Sbjct: 146 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKV 202

Query: 439 PKIADFGLARHVAPDKTHVS-TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG 497
            KI DFGLAR +  D  +V        + +MAPE L  G  T K+DV+++G+L+ E+ S 
Sbjct: 203 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 262

Query: 498 RRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVAL 557
             N        +  + +            +  G     P      +  I   C       
Sbjct: 263 GVNPYPGIPVDANFYKL------------IQNGFKMDQPFYATEEIYIIMQSCWAFDSRK 310

Query: 558 RPSMAEVVHMLN 569
           RPS   +   L 
Sbjct: 311 RPSFPNLTSFLG 322

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 4e-52
 Identities = 67/279 (24%), Positives = 113/279 (40%), Gaps = 24/279 (8%)

Query: 295 RATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNS--RQWVDQFFNEVNLISGI 351
           RA D+ +    +G G  G   +     DG+ +  K L + S          +EVNL+  +
Sbjct: 2   RAEDY-EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 352 QHKNVVRLLGCSIEGPESLL--VYEYVPNRSLDQILF-VKNTIHILSWQQRFTIICGTAE 408
           +H N+VR     I+   + L  V EY     L  ++         L  +    ++     
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 409 GLAHLH--GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG 466
            L   H     G  ++HRD+K +N+ LD K   K+ DFGLAR +  D T  +    GT  
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPY 179

Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS 526
           YM+PE + R    EK+D+++ G L+ E+ +                  +  +    +   
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP--------------PFTAFSQKELAGK 225

Query: 527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVV 565
           +  G   R P   +  + +I           RPS+ E++
Sbjct: 226 IREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 1e-51
 Identities = 66/284 (23%), Positives = 119/284 (41%), Gaps = 27/284 (9%)

Query: 290 YEILER---ATDFFDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEV 345
           YE + R     DF++   +LG G  G V++    +     A K +   S + ++ +  E+
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60

Query: 346 NLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICG 405
           ++++   H N+V+LL          ++ E+    ++D ++        L+  Q   +   
Sbjct: 61  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE--RPLTESQIQVVCKQ 118

Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTL 465
           T + L +LH     KIIHRD+K  NIL       K+ADFG++           +   GT 
Sbjct: 119 TLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTP 174

Query: 466 GYMAPEYLV-----RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKA 520
            +MAPE ++           KADV++ G+ +IE+A         E +   +         
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP--HHELNPMRVL-------- 224

Query: 521 NRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEV 564
            +I +S  P L    P   +S        C +  V  R + +++
Sbjct: 225 LKIAKSEPPTL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 1e-51
 Identities = 65/290 (22%), Positives = 120/290 (41%), Gaps = 37/290 (12%)

Query: 285 SLNFKYEILERATDFFDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLF--FNSRQWVDQF 341
           S + ++   +          ++G+G   +V++G   +    +A   L     ++    +F
Sbjct: 5   SNDGRFLKFDI---------EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRF 55

Query: 342 FNEVNLISGIQHKNVVRLLGCSIEGPES----LLVYEYVPNRSLDQILFVKNTIHILSWQ 397
             E  ++ G+QH N+VR         +     +LV E + + +L   L       ++  +
Sbjct: 56  KEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIK 112

Query: 398 QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL-DEKLTPKIADFGLARHVAPDKTH 456
              +      +GL  LH      IIHRD+K  NI +     + KI D GLA      +  
Sbjct: 113 VLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRAS 168

Query: 457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWK 516
            +  + GT  +MAPE     +  E  DVYAFG+ ++E+A+      +SE          +
Sbjct: 169 FAKAVIGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYP--YSEC-----QNAAQ 220

Query: 517 HYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH 566
            Y+  R+T  + P     F +     V +I   C +     R S+ ++++
Sbjct: 221 IYR--RVTSGVKP---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 2e-51
 Identities = 68/274 (24%), Positives = 105/274 (38%), Gaps = 27/274 (9%)

Query: 304 RKLGQGGAGSVFRGTLP----DGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQHKNV 356
            KLG G  G V RG          ++AVK L     +  + +D F  EVN +  + H+N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           +RL G  +  P   +V E  P  SL   L                     AEG+ +L   
Sbjct: 74  IRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGMGYLES- 129

Query: 417 SGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH--VSTGIAGTLGYMAPEYLV 474
              + IHRD+   N+LL  +   KI DFGL R +  +  H  +         + APE L 
Sbjct: 130 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187

Query: 475 RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR 534
               +  +D + FGV + E+ +  +        S +LH + K             G    
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE------------GERLP 235

Query: 535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVHML 568
            PE+    +  + + C       RP+   +   L
Sbjct: 236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 4e-51
 Identities = 69/290 (23%), Positives = 111/290 (38%), Gaps = 36/290 (12%)

Query: 300 FDNSRKLGQGGAGSVFRGTLPDG---RNIAVKRL-FFNSRQWVDQFFNEVNLISGI-QHK 354
                 +G+G  G V +  +       + A+KR+  + S+     F  E+ ++  +  H 
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 355 NVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIH-------------ILSWQQRFT 401
           N++ LLG         L  EY P+ +L   L     +               LS QQ   
Sbjct: 72  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131

Query: 402 IICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGI 461
                A G+ +L      + IHRD+   NIL+ E    KIADFGL+R          T  
Sbjct: 132 FAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMG 186

Query: 462 AGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN 521
              + +MA E L     T  +DV+++GVL+ E+ S                T +      
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-------------TPYCGMTCA 233

Query: 522 RITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
            + + +  G     P N    V  +   C +     RPS A+++  LN +
Sbjct: 234 ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 3e-50
 Identities = 68/266 (25%), Positives = 110/266 (41%), Gaps = 28/266 (10%)

Query: 304 RKLGQGGAGSVFRGTLP-DGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           R LG+G  G+V+          +A+K L            Q   EV + S ++H N++RL
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G   +     L+ EY P  ++ + L     +     Q+  T I   A  L++ H     
Sbjct: 72  YGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSK--- 125

Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLT 479
           ++IHRDIK  N+LL      KIADFG + H    +      + GTL Y+ PE +      
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIEGRMHD 182

Query: 480 EKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENE 539
           EK D+++ GVL  E   G+    F   +    +         RI++     +   FP+  
Sbjct: 183 EKVDLWSLGVLCYEFLVGKP--PFEANTYQETY--------KRISR-----VEFTFPDFV 227

Query: 540 ASRVLQIGLLCTQAPVALRPSMAEVV 565
                 +     +   + RP + EV+
Sbjct: 228 TEGARDLISRLLKHNPSQRPMLREVL 253

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 6e-50
 Identities = 60/287 (20%), Positives = 110/287 (38%), Gaps = 27/287 (9%)

Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRN----IAVKRL-FFNSRQWVDQFFNE 344
           YEI     +  +  R +G+G  G V +G      N    +A+K      S    ++F  E
Sbjct: 2   YEIQR---ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQE 58

Query: 345 VNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIIC 404
              +    H ++V+L+G   E P   ++ E      L    F++   + L          
Sbjct: 59  ALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRS--FLQVRKYSLDLASLILYAY 115

Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT 464
             +  LA+L      + +HRDI   N+L+      K+ DFGL+R++     + ++     
Sbjct: 116 QLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 172

Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRIT 524
           + +MAPE +   + T  +DV+ FGV + E+            ++ V+  +    +     
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---- 228

Query: 525 QSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
                      P N    +  +   C     + RP   E+   L+ I
Sbjct: 229 ---------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 1e-49
 Identities = 67/277 (24%), Positives = 118/277 (42%), Gaps = 31/277 (11%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNL 347
           KY   E          K+GQG +G+V+    +  G+ +A++++    +   +   NE+ +
Sbjct: 21  KYTRFE----------KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70

Query: 348 ISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTA 407
           +   ++ N+V  L   + G E  +V EY+   SL  ++            Q   +     
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECL 126

Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGY 467
           + L  LH     ++IHRDIK+ NILL    + K+ DFG    + P+++  ST + GT  +
Sbjct: 127 QALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYW 182

Query: 468 MAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM 527
           MAPE + R     K D+++ G++ IE+  G     +   +               I  + 
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP--PYLNENPLRA--------LYLIATNG 232

Query: 528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEV 564
            P L  + PE  ++        C    V  R S  E+
Sbjct: 233 TPEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 5e-48
 Identities = 74/310 (23%), Positives = 130/310 (41%), Gaps = 36/310 (11%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGTL------PDGRNIAVKRLF-FNSRQWVDQF 341
           ++E+   A +    SR+LGQG  G V+ G             +A+K +    S +   +F
Sbjct: 14  EWEV---AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF 70

Query: 342 FNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKN-------TIHIL 394
            NE +++      +VVRLLG   +G  +L++ E +    L   L            +   
Sbjct: 71  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 130

Query: 395 SWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP-D 453
           S  +   +    A+G+A+L+     K +HRD+   N ++ E  T KI DFG+ R +   D
Sbjct: 131 SLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 187

Query: 454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT 513
                      + +M+PE L  G  T  +DV++FGV++ E+A+          +  VL  
Sbjct: 188 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 247

Query: 514 VWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY 573
           V +             G     P+N    + ++  +C Q    +RPS  E++  +     
Sbjct: 248 VME-------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294

Query: 574 EIPPPKQPPF 583
             P  ++  F
Sbjct: 295 --PGFREVSF 302

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  168 bits (427), Expect = 1e-47
 Identities = 65/339 (19%), Positives = 129/339 (38%), Gaps = 31/339 (9%)

Query: 291 EILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLIS 349
            +L+     +D   +LG G  G V R T    G N A K +        +    E+  +S
Sbjct: 23  HVLDH----YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS 78

Query: 350 GIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
            ++H  +V L     +  E +++YE++    L + +  ++  + +S  +    +    +G
Sbjct: 79  VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKG 136

Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTP--KIADFGLARHVAPDKTHVSTGIAGTLGY 467
           L H+H       +H D+K  NI+   K +   K+ DFGL  H+ P ++   T   GT  +
Sbjct: 137 LCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEF 191

Query: 468 MAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSM 527
            APE      +    D+++ GVL   + SG        G  +   T+      +    +M
Sbjct: 192 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS----PFGGENDDETLRNVKSCDW---NM 244

Query: 528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM--LNNIDYEIPPPKQPPFLN 585
           D        E +    ++       A    R ++ + +    L         P +   + 
Sbjct: 245 DDSAFSGISE-DGKDFIR---KLLLADPNTRMTIHQALEHPWLT----PGNAPGRDSQIP 296

Query: 586 ASVISPSDNSKDSMMSSFKSFVAESPEIDHSLKMKAFEP 624
           +S  +   +S  +   ++   +     I +   ++   P
Sbjct: 297 SSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRP 335

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 3e-47
 Identities = 62/280 (22%), Positives = 107/280 (38%), Gaps = 32/280 (11%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL-FFNSRQWVDQFFNEVN 346
            ++++          + LG+G  G V           +AVK +    +    +    E+ 
Sbjct: 6   DWDLV----------QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 55

Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGT 406
           +   + H+NVV+  G   EG    L  EY     L   +        +            
Sbjct: 56  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQL 112

Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-KTHVSTGIAGTL 465
             G+ +LHG   I I HRDIK  N+LLDE+   KI+DFGLA     + +  +   + GTL
Sbjct: 113 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169

Query: 466 GYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRIT 524
            Y+APE L R +   E  DV++ G+++  + +G         S        +        
Sbjct: 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 229

Query: 525 QSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEV 564
           + +D              +L   +L      + R ++ ++
Sbjct: 230 KKIDS---------APLALLH-KILVENP--SARITIPDI 257

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 4e-47
 Identities = 65/306 (21%), Positives = 115/306 (37%), Gaps = 34/306 (11%)

Query: 294 ERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL---FFNSRQWVDQFFNEVNLIS 349
           ++  + F   + LG+G   +V     L   R  A+K L          V     E +++S
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 350 GIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEG 409
            + H   V+L     +  +      Y  N  L + +    +                   
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSA 120

Query: 410 LAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD-KTHVSTGIAGTLGYM 468
           L +LHG     IIHRD+K  NILL+E +  +I DFG A+ ++P+ K   +    GT  Y+
Sbjct: 121 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177

Query: 469 APEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMD 528
           +PE L      + +D++A G ++ ++ +G     F  G+  ++          +I +   
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIF--------QKIIK--- 224

Query: 529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM--------LNNIDYEIPPPKQ 580
             L   FPE    +   +           R    E+             ++ +E    + 
Sbjct: 225 --LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQT 282

Query: 581 PPFLNA 586
           PP L A
Sbjct: 283 PPKLTA 288

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 6e-46
 Identities = 69/307 (22%), Positives = 124/307 (40%), Gaps = 43/307 (14%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGTLP--------DGRNIAVKRLFFN-SRQWVD 339
           ++E+     D     + LG+G  G V                  +AVK L  + + + + 
Sbjct: 7   RWELPR---DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 63

Query: 340 QFFNEVNLISGI-QHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHI----- 393
              +E+ ++  I +HKN++ LLG   +     ++ EY    +L + L  +    +     
Sbjct: 64  DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 123

Query: 394 --------LSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFG 445
                   LS +   +     A G+ +L      K IHRD+   N+L+ E    KIADFG
Sbjct: 124 PSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFG 180

Query: 446 LARHVAPDKTHVST-GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFS 504
           LAR +     +  T      + +MAPE L     T ++DV++FGVL+ E+ +        
Sbjct: 181 LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG----- 235

Query: 505 EGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEV 564
                   + +       + + +  G     P N  + +  +   C  A  + RP+  ++
Sbjct: 236 --------SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 287

Query: 565 VHMLNNI 571
           V  L+ I
Sbjct: 288 VEDLDRI 294

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (404), Expect = 5e-45
 Identities = 77/306 (25%), Positives = 116/306 (37%), Gaps = 41/306 (13%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT------LPDGRNIAVKRLFFNSRQW-VDQF 341
           K+E      D     + LG+G  G V              R +AVK L   +        
Sbjct: 7   KWEFPR---DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 63

Query: 342 FNEVNLISGIQHKNVVRLLG--CSIEGPESLLVYEYVPNRSLDQILFVKNTIHI------ 393
            +E+ ++  I H   V  L   C+  G   +++ E+    +L   L  K    +      
Sbjct: 64  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 123

Query: 394 -------LSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGL 446
                  L+ +         A+G+  L      K IHRD+   NILL EK   KI DFGL
Sbjct: 124 EDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGL 180

Query: 447 ARHVAPDKTHVSTG-IAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSE 505
           AR +  D  +V  G     L +MAPE +     T ++DV++FGVL+ E+ S   +     
Sbjct: 181 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240

Query: 506 GSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVV 565
                     K             G   R P+     + Q  L C     + RP+ +E+V
Sbjct: 241 KIDEEFCRRLKE------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 288

Query: 566 HMLNNI 571
             L N+
Sbjct: 289 EHLGNL 294

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  156 bits (395), Expect = 4e-43
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 10/205 (4%)

Query: 298 DFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNV 356
           D++D   +LG G  G V R      GR    K +            NE+++++ + H  +
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 357 VRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG 416
           + L     +  E +L+ E++    L   +  ++  + +S  +    +    EGL H+H  
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHE- 145

Query: 417 SGIKIIHRDIKTSNILLDEKLTP--KIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLV 474
               I+H DIK  NI+ + K     KI DFGLA  + PD+    T    T  + APE + 
Sbjct: 146 --HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVD 201

Query: 475 RGQLTEKADVYAFGVLVIEVASGRR 499
           R  +    D++A GVL   + SG  
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLS 226

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  152 bits (386), Expect = 9e-42
 Identities = 71/346 (20%), Positives = 119/346 (34%), Gaps = 54/346 (15%)

Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRL---FFNSRQWVDQFFNEVNLIS---GIQ 352
           F   R +G+GG G V+     D G+  A+K L       +Q      NE  ++S      
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 353 HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
              +V +        +   + + +    L   L                       GL H
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---EADMRFYAAEIILGLEH 122

Query: 413 LHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEY 472
           +H      +++RD+K +NILLDE    +I+D GLA   +  K H S    GT GYMAPE 
Sbjct: 123 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 176

Query: 473 LVRGQ-LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL 531
           L +G      AD ++ G ++ ++  G     F +  +   H + +      +        
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHKTKDKHEIDRMTLTMAV-------- 226

Query: 532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVV------H-MLNNIDY------EIPPP 578
               P++ +  +  +     Q  V  R                  ++D+      + PPP
Sbjct: 227 --ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPP 284

Query: 579 KQPPFLNASVISPSDNS------------KDSMMSSFKSFVAESPE 612
             PP    +     D               DS    +++F     E
Sbjct: 285 LIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFPLTISE 330

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  148 bits (375), Expect = 4e-41
 Identities = 70/299 (23%), Positives = 122/299 (40%), Gaps = 38/299 (12%)

Query: 284 SSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL---FFNSRQWVD 339
           S L+ +YE+ E           LG GG   V     L   R++AVK L         +  
Sbjct: 3   SHLSDRYELGE----------ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYL 52

Query: 340 QFFNEVNLISGIQHKNVVRLLGCSIE----GPESLLVYEYVPNRSLDQILFVKNTIHILS 395
           +F  E    + + H  +V +          GP   +V EYV   +L  I+  +     ++
Sbjct: 53  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MT 109

Query: 396 WQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT 455
            ++   +I    + L   H      IIHRD+K +NI++      K+ DFG+AR +A    
Sbjct: 110 PKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 166

Query: 456 HV--STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT 513
            V  +  + GT  Y++PE      +  ++DVY+ G ++ EV +G     F+    S +  
Sbjct: 167 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP--PFTG--DSPVSV 222

Query: 514 VWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRP-SMAEVVHMLNNI 571
            ++H + + I  S          E  ++ +  + L         R  + AE+   L  +
Sbjct: 223 AYQHVREDPIPPS-------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  142 bits (358), Expect = 2e-38
 Identities = 46/212 (21%), Positives = 83/212 (39%), Gaps = 7/212 (3%)

Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQW-VDQFFNEVNL 347
           ++  E   D +D    LG G    V         + +A+K +   + +       NE+ +
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 348 ISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTA 407
           +  I+H N+V L      G    L+ + V    L   +  K      + +    +I    
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVL 117

Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGY 467
           + + +LH    +    +        LDE     I+DFGL++   P    V +   GT GY
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPGY 175

Query: 468 MAPEYLVRGQLTEKADVYAFGVLVIEVASGRR 499
           +APE L +   ++  D ++ GV+   +  G  
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 207

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 2e-38
 Identities = 42/208 (20%), Positives = 84/208 (40%), Gaps = 14/208 (6%)

Query: 298 DFFDN---SRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQH 353
           + ++    +  LG+G  G V R       +    K +             E+++++  +H
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARH 60

Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
           +N++ L        E ++++E++    + + +    +   L+ ++  + +    E L  L
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFL 118

Query: 414 HGGSGIKIIHRDIKTSNILLDEK--LTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           H      I H DI+  NI+   +   T KI +FG AR + P              Y APE
Sbjct: 119 H---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPE 173

Query: 472 YLVRGQLTEKADVYAFGVLVIEVASGRR 499
                 ++   D+++ G LV  + SG  
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGIN 201

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  141 bits (356), Expect = 4e-38
 Identities = 52/200 (26%), Positives = 88/200 (44%), Gaps = 14/200 (7%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQHKNVVRL 359
           R LG G  G V       +GR  A+K L        + V+   +E  ++S + H  ++R+
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 360 LGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGI 419
            G   +  +  ++ +Y+    L  +L           +     +C        L      
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC------LALEYLHSK 123

Query: 420 KIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLT 479
            II+RD+K  NILLD+    KI DFG A++V      V+  + GT  Y+APE +      
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVSTKPYN 179

Query: 480 EKADVYAFGVLVIEVASGRR 499
           +  D ++FG+L+ E+ +G  
Sbjct: 180 KSIDWWSFGILIYEMLAGYT 199

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  140 bits (353), Expect = 6e-38
 Identities = 48/294 (16%), Positives = 103/294 (35%), Gaps = 36/294 (12%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNL 347
           +Y +           RK+G G  G ++ GT +  G  +A+K     ++    Q   E  +
Sbjct: 8   RYRLG----------RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKI 55

Query: 348 ISGIQHKNVVRLLG-CSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGT 406
              +Q    +  +  C  EG  +++V E +     D   F        S +    +    
Sbjct: 56  YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQM 112

Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNIL---LDEKLTPKIADFGLARHVAPDKTHV------ 457
              + ++H       IHRD+K  N L     +     I DFGLA+     +TH       
Sbjct: 113 ISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 169

Query: 458 STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKH 517
           +  + GT  Y +    +  + + + D+ + G +++    G     +    ++     ++ 
Sbjct: 170 NKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP--WQGLKAATKRQKYER 227

Query: 518 YKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
               +++  ++        +   S        C       +P  + +  +  N+
Sbjct: 228 ISEKKMSTPIEV-----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  139 bits (352), Expect = 7e-38
 Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 28/220 (12%)

Query: 299 FFDN---SRKLGQGGAGSVFRGT-LPDGRNIAVKRL---------FFNSRQWVDQFFNEV 345
           F++N      LG+G +  V R    P  +  AVK +             ++  +    EV
Sbjct: 1   FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60

Query: 346 NLISGIQ-HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIIC 404
           +++  +  H N+++L           LV++ +    L   L  K T   LS ++   I+ 
Sbjct: 61  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMR 117

Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT 464
              E +  LH    + I+HRD+K  NILLD+ +  K+ DFG +  + P +      + GT
Sbjct: 118 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGT 172

Query: 465 LGYMAPEYL------VRGQLTEKADVYAFGVLVIEVASGR 498
             Y+APE +            ++ D+++ GV++  + +G 
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 9e-38
 Identities = 50/214 (23%), Positives = 94/214 (43%), Gaps = 12/214 (5%)

Query: 290 YEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL-FFNSRQWVDQFFNEVNL 347
           +++  R    + N   +G+G  G V       +   +A+K++  F  + +  +   E+ +
Sbjct: 4   FDVGPR----YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKI 59

Query: 348 ISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTA 407
           +   +H+N++ +           +   Y+    +   L+       LS       +    
Sbjct: 60  LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQIL 119

Query: 408 EGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS--TGIAGTL 465
            GL ++H      ++HRD+K SN+LL+     KI DFGLAR   PD  H    T    T 
Sbjct: 120 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 176

Query: 466 GYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGR 498
            Y APE ++  +  T+  D+++ G ++ E+ S R
Sbjct: 177 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  137 bits (345), Expect = 5e-37
 Identities = 50/292 (17%), Positives = 104/292 (35%), Gaps = 32/292 (10%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLF--FNSRQWVDQFFNEVN 346
           KY  LE          K+G+G  G V++     G   A+K++               E++
Sbjct: 3   KYHGLE----------KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREIS 52

Query: 347 LISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGT 406
           ++  ++H N+V+L          +LV+E++       +   +     L      + +   
Sbjct: 53  ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQL 109

Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLG 466
             G+A+ H     +++HRD+K  N+L++ +   KIADFGLAR         +  I     
Sbjct: 110 LNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWY 166

Query: 467 YMAPEYLVRGQLTEKADVYAFGVLVIEVASGRR--------------NSVFSEGSSSVLH 512
                 +   + +   D+++ G +  E+ +G                  +    +S    
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226

Query: 513 TVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEV 564
            V +  K +      +P     F +      + +     +     R +  + 
Sbjct: 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  136 bits (344), Expect = 1e-36
 Identities = 43/296 (14%), Positives = 92/296 (31%), Gaps = 38/296 (12%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVNL 347
            Y++           R++G+G  G +F GT L + + +A+K      R    Q  +E   
Sbjct: 6   HYKVG----------RRIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRT 53

Query: 348 ISGIQH-KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGT 406
              +     +  +     EG  ++LV + +     D +          S +         
Sbjct: 54  YKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLL---DLCGRKFSVKTVAMAAKQM 110

Query: 407 AEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP-----KIADFGLARHVAPDKTHV---- 457
              +  +H      +++RDIK  N L+    +       + DFG+ +      T      
Sbjct: 111 LARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPY 167

Query: 458 --STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVW 515
                ++GT  YM+    +  + + + D+ A G + +    G       + ++       
Sbjct: 168 REKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT------- 220

Query: 516 KHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI 571
              K  RI +                   +             P    +  + + +
Sbjct: 221 NKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 1e-36
 Identities = 68/306 (22%), Positives = 106/306 (34%), Gaps = 41/306 (13%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRL---FFNSRQWVDQFFNEVNLIS-GIQHKNVVR 358
           + LG+G  G VF        +  A+K L          V+    E  ++S   +H  +  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 359 LLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSG 418
           +            V EY+    L   +      H     +          GL  LH    
Sbjct: 68  MFCTFQTKENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHS--- 121

Query: 419 IKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL 478
             I++RD+K  NILLD+    KIADFG+ +         +T   GT  Y+APE L+  + 
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLGQKY 180

Query: 479 TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPEN 538
               D ++FGVL+ E+  G+    F       L    +                  +P  
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQS--PFHGQDEEELFHSIRMDNP-------------FYPRW 225

Query: 539 EASRVLQIGLLCTQAPVALRPSMAEVV--H-MLNNIDYE------IPPPKQPPFLNASVI 589
                  + +         R  +   +  H +   I++E      I PP +P      V 
Sbjct: 226 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRP-----KVK 280

Query: 590 SPSDNS 595
           SP D S
Sbjct: 281 SPFDCS 286

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 3e-36
 Identities = 53/215 (24%), Positives = 87/215 (40%), Gaps = 15/215 (6%)

Query: 295 RATDFFDNSRKLGQGGAGSVFRGT--LPDGRNIAVKRLF--FNSRQWVDQFFNEVNL--- 347
           RA   ++   ++G+G  G VF+       GR +A+KR+               EV +   
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 348 ISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQI---LFVKNTIHILSWQQRFTIIC 404
           +   +H NVVRL                +    +DQ       K     +  +    ++ 
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 405 GTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGT 464
               GL  LH     +++HRD+K  NIL+      K+ADFGLAR  +       T +  T
Sbjct: 124 QLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVT 178

Query: 465 LGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRR 499
           L Y APE L++       D+++ G +  E+   + 
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 213

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (342), Expect = 5e-36
 Identities = 63/347 (18%), Positives = 117/347 (33%), Gaps = 44/347 (12%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFNEVN- 346
            Y++  +          LG G  G V +          A+K L     Q   +   EV  
Sbjct: 12  DYKVTSQ---------VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVEL 57

Query: 347 LISGIQHKNVVRLLGC----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTI 402
                Q  ++VR++             L+V E +    L   +         + ++   I
Sbjct: 58  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEI 116

Query: 403 ICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADFGLARHVAPDKTHVST 459
           +    E + +LH    I I HRD+K  N+L          K+ DFG A+      +  + 
Sbjct: 117 MKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 173

Query: 460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK 519
               T  Y+APE L   +  +  D+++ GV++  +  G     F   S+  L        
Sbjct: 174 CY--TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP--PFY--SNHGLAISPGMKT 227

Query: 520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH---MLNNIDYEIP 576
             R+ Q   P         E   +++      +     R ++ E ++   ++ +      
Sbjct: 228 RIRMGQYEFPNPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMNHPWIMQST----- 279

Query: 577 PPKQPPFLNASVISPSDNSKDSMMSSFKSFVAESPEIDHSLKMKAFE 623
              Q P   + V+       + +     S +A        +K+K  E
Sbjct: 280 KVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKKIE 326

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 1e-35
 Identities = 63/312 (20%), Positives = 114/312 (36%), Gaps = 38/312 (12%)

Query: 288 FKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL------FFNSRQWVDQ 340
           F+ E ++   D++D   +LG G    V +      G   A K +              + 
Sbjct: 3   FRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59

Query: 341 FFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRF 400
              EV+++  IQH NV+ L        + +L+ E V    L   L  K ++     ++  
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT---EEEAT 116

Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP----KIADFGLARHVAPDKTH 456
             +     G+ +LH    ++I H D+K  NI+L ++  P    KI DFGLA  +      
Sbjct: 117 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 173

Query: 457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWK 516
               I GT  ++APE +    L  +AD+++ GV+   + SG       +     L  V  
Sbjct: 174 --KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP-FLGDTKQETLANVSA 230

Query: 517 HYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM--LNNIDYE 574
                     ++      +  N ++                R ++ + +    +   D +
Sbjct: 231 ----------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 280

Query: 575 IPPPKQ---PPF 583
                    P F
Sbjct: 281 QALSSAWSHPQF 292

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 6e-35
 Identities = 50/202 (24%), Positives = 88/202 (43%), Gaps = 14/202 (6%)

Query: 304 RKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQ-----FFNEVNLISGIQHKNVV 357
             LG+G   +V++       + +A+K++    R             E+ L+  + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 358 RLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGS 417
            LL          LV++++          +K+   +L+       +  T +GL +LH   
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 418 GIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQ 477
              I+HRD+K +N+LLDE    K+ADFGLA+          T    T  Y APE L   +
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVVTRWYRAPELLFGAR 176

Query: 478 L-TEKADVYAFGVLVIEVASGR 498
           +     D++A G ++ E+    
Sbjct: 177 MYGVGVDMWAVGCILAELLLRV 198

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 6e-35
 Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 10/206 (4%)

Query: 298 DFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVK--RLFFNSRQWVDQFFNEVNLISGIQHK 354
           + F    K+G+G  G V++      G  +A+K  RL   +         E++L+  + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 355 NVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLH 414
           N+V+LL       +  LV+E++       +    + +  +      + +    +GLA  H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 415 GGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE-YL 473
                +++HRD+K  N+L++ +   K+ADFGLAR         +  +  TL Y APE  L
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILL 175

Query: 474 VRGQLTEKADVYAFGVLVIEVASGRR 499
                +   D+++ G +  E+ + R 
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRA 201

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 1e-34
 Identities = 64/313 (20%), Positives = 112/313 (35%), Gaps = 37/313 (11%)

Query: 300 FDNSRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVR 358
           + +++ +G G  G V++  L D G  +A+K++     Q       E+ ++  + H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 77

Query: 359 LLGCSIEGPES------LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAH 412
           L        E        LV +YVP                L        +      LA+
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 413 LHGGSGIKIIHRDIKTSNILLDEK-LTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPE 471
           +H      I HRDIK  N+LLD      K+ DFG A+ +   + +VS     +  Y APE
Sbjct: 138 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRAPE 192

Query: 472 YLVRG-QLTEKADVYAFGVLVIEVASGRR--------------NSVFSEGSSSVLHTVWK 516
            +      T   DV++ G ++ E+  G+                 V    +   +  +  
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252

Query: 517 HYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM-----LNNI 571
           +Y   +  Q      T  F        + +     +     R +  E         L + 
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312

Query: 572 DYEIPPPKQPPFL 584
           + ++P  +  P L
Sbjct: 313 NVKLPNGRDTPAL 325

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 1e-33
 Identities = 52/225 (23%), Positives = 86/225 (38%), Gaps = 29/225 (12%)

Query: 286 LNFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLF------FNSRQWV 338
           L  +Y++             LG GG GSV+ G  + D   +A+K +       +      
Sbjct: 2   LESQYQVG----------PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG 51

Query: 339 DQFFNEVNLISGIQ--HKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSW 396
            +   EV L+  +      V+RLL         +L+ E             +     L  
Sbjct: 52  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQE 109

Query: 397 QQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVAPDKT 455
           +   +      E + H H      ++HRDIK  NIL+D  +   K+ DFG    +   K 
Sbjct: 110 ELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KD 163

Query: 456 HVSTGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGRR 499
            V T   GT  Y  PE++   +     A V++ G+L+ ++  G  
Sbjct: 164 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 208

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 2e-33
 Identities = 51/204 (25%), Positives = 78/204 (38%), Gaps = 11/204 (5%)

Query: 300 FDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL---FFNSRQWVDQFFNEVNLISGIQHKN 355
           FD  + LG+G  G V        GR  A+K L      ++  V     E  ++   +H  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 356 VVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHG 415
           +  L            V EY     L   L   +   + + ++           L +LH 
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHS 123

Query: 416 GSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVR 475
                +++RDIK  N++LD+    KI DFGL +    D         GT  Y+APE L  
Sbjct: 124 ---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLED 179

Query: 476 GQLTEKADVYAFGVLVIEVASGRR 499
                  D +  GV++ E+  GR 
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRL 203

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 8e-33
 Identities = 48/214 (22%), Positives = 84/214 (39%), Gaps = 19/214 (8%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVK--RLFFNSRQWVDQFFNEV 345
           KYE LE          K+G+G  G+VF+         +A+K  RL  +          E+
Sbjct: 3   KYEKLE----------KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI 52

Query: 346 NLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICG 405
            L+  ++HKN+VRL        +  LV+E+               +     +   + +  
Sbjct: 53  CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQ 109

Query: 406 TAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTL 465
             +GL   H      ++HRD+K  N+L++     K+A+FGLAR         S  +    
Sbjct: 110 LLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLW 166

Query: 466 GYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRR 499
                        +   D+++ G +  E+A+  R
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 1e-32
 Identities = 53/226 (23%), Positives = 96/226 (42%), Gaps = 31/226 (13%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLF--FNSRQWVDQFFNEV 345
           KYE L           K+GQG  G VF+      G+ +A+K++        +      E+
Sbjct: 11  KYEKLA----------KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 60

Query: 346 NLISGIQHKNVVRLLGCSIEGPES--------LLVYEYVPNRSLDQILFVKNTIHILSWQ 397
            ++  ++H+NVV L+                  LV+++  +        + N +   +  
Sbjct: 61  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG---LLSNVLVKFTLS 117

Query: 398 QRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT-- 455
           +   ++     GL ++H     KI+HRD+K +N+L+      K+ADFGLAR  +  K   
Sbjct: 118 EIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 174

Query: 456 -HVSTGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGRR 499
            +  T    TL Y  PE L+  +      D++  G ++ E+ +   
Sbjct: 175 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  121 bits (303), Expect = 1e-30
 Identities = 61/321 (19%), Positives = 117/321 (36%), Gaps = 40/321 (12%)

Query: 283 TSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRL---FFNSRQWV 338
           T+ L+ +++ +          + LG G  G V        G + A+K L        + +
Sbjct: 37  TAQLD-QFDRI----------KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQI 85

Query: 339 DQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQ 398
           +   NE  ++  +    +V+L     +     +V EYV    +   L         S   
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPH 142

Query: 399 RFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS 458
                        +LH    + +I+RD+K  N+L+D++   ++ DFG A+ V      + 
Sbjct: 143 ARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC 199

Query: 459 TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHY 518
               GT   +APE ++     +  D +A GVL+ E+A+G            +        
Sbjct: 200 ----GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP---PFFADQPIQIYEKIVS 252

Query: 519 KANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM--LNNIDYEIP 576
              R        L     ++    +LQ+ L  T+    L+  + ++ +       D+   
Sbjct: 253 GKVRFPSHFSSDL-----KDLLRNLLQVDL--TKRFGNLKNGVNDIKNHKWFATTDWIAI 305

Query: 577 PPK--QPPFLNASVISPSDNS 595
             +  + PF+      P D S
Sbjct: 306 YQRKVEAPFI-PKFKGPGDTS 325

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 8e-29
 Identities = 64/323 (19%), Positives = 121/323 (37%), Gaps = 44/323 (13%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLF--FNSRQWVDQFFNEV 345
            +E+       + + + +G G  G+V        G  +A+K+L+  F S  +  + + E+
Sbjct: 13  AWEVRAV----YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYREL 68

Query: 346 NLISGIQHKNVVRLLGCSIEGP------ESLLVYEYVPNRSLDQILFVKNTIHILSWQQR 399
            L+  ++H+NV+ LL             +  LV  ++       +   K     L   + 
Sbjct: 69  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-----LGEDRI 123

Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVST 459
             ++    +GL ++H      IIHRD+K  N+ ++E    KI DFGLAR    +     T
Sbjct: 124 QFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MT 176

Query: 460 GIAGTLGYMAPEYLVRGQ-LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHY 518
           G   T  Y APE ++     T+  D+++ G ++ E+ +G+     S+    +   +    
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236

Query: 519 K-----ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVAL-----------RPSMA 562
                   R+            PE E      I    +   V L           R +  
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296

Query: 563 EVVHM--LNNIDYEIPPPKQPPF 583
           E +      ++      P+   +
Sbjct: 297 EALAHPYFESLHDTEDEPQVQKY 319

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 2e-28
 Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 24/219 (10%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLF--FNSRQWVDQFFNEV 345
            + +L+R    + N + +G G  G V         RN+A+K+L   F ++    + + E+
Sbjct: 12  TFTVLKR----YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67

Query: 346 NLISGIQHKNVVRLLGCSI------EGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQR 399
            L+  + HKN++ LL          E  +  LV E +       I         L  ++ 
Sbjct: 68  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERM 121

Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVST 459
             ++     G+ HLH      IIHRD+K SNI++    T KI DFGLAR      + + T
Sbjct: 122 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMT 176

Query: 460 GIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGR 498
               T  Y APE ++     E  D+++ G ++ E+   +
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  111 bits (277), Expect = 2e-27
 Identities = 52/273 (19%), Positives = 102/273 (37%), Gaps = 34/273 (12%)

Query: 288 FKYEILERATDFFDN---SRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFNSRQWVDQFFN 343
           + YE         D+    RKLG+G    VF    + +   + VK L         +   
Sbjct: 22  WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKR 78

Query: 344 EVNLISGIQ-HKNVVRLLGCSIEGPESL--LVYEYVPNRSLDQILFVKNTIHILSWQQRF 400
           E+ ++  ++   N++ L     +       LV+E+V N    Q+         L+     
Sbjct: 79  EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL------YQTLTDYDIR 132

Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEK-LTPKIADFGLARHVAPDKTHVST 459
             +    + L + H    + I+HRD+K  N+++D +    ++ D+GLA    P + +   
Sbjct: 133 FYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--N 187

Query: 460 GIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGRRNSVFSEGSSS--------- 509
               +  +  PE LV  Q+     D+++ G ++  +   +    F  G  +         
Sbjct: 188 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK--EPFFHGHDNYDQLVRIAK 245

Query: 510 VLHTVWKHYKANRITQSMDPGLTGRFPENEASR 542
           VL T   +   ++    +DP        +   R
Sbjct: 246 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKR 278

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 3e-27
 Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 27/222 (12%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGTL----PDGRNIAVKRL----FFNSRQWVDQ 340
            +E+L          + LG G  G VF          G+  A+K L         +  + 
Sbjct: 25  NFELL----------KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH 74

Query: 341 FFNEVNLISGIQHK-NVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQR 399
              E  ++  I+    +V L        +  L+ +Y+    L   L  +      +  + 
Sbjct: 75  TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR---ERFTEHEV 131

Query: 400 FTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVST 459
              +      L HLH    + II+RDIK  NILLD      + DFGL++    D+T  + 
Sbjct: 132 QIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 188

Query: 460 GIAGTLGYMAPEYLVRGQ--LTEKADVYAFGVLVIEVASGRR 499
              GT+ YMAP+ +  G     +  D ++ GVL+ E+ +G  
Sbjct: 189 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 8e-26
 Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 24/219 (10%)

Query: 289 KYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLF--FNSRQWVDQFFNEV 345
            +E+ ER    + N   +G G  GSV        G  +AVK+L   F S     + + E+
Sbjct: 13  IWEVPER----YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 68

Query: 346 NLISGIQHKNVVRLLGC-----SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRF 400
            L+  ++H+NV+ LL       S+E    + +  ++    L+ I+  +     L+     
Sbjct: 69  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----LTDDHVQ 124

Query: 401 TIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTG 460
            +I     GL ++H      IIHRD+K SN+ ++E    KI DFGLARH         TG
Sbjct: 125 FLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT----DDEMTG 177

Query: 461 IAGTLGYMAPEYLVRGQ-LTEKADVYAFGVLVIEVASGR 498
              T  Y APE ++      +  D+++ G ++ E+ +GR
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  101 bits (252), Expect = 6e-24
 Identities = 47/244 (19%), Positives = 88/244 (36%), Gaps = 41/244 (16%)

Query: 275 VLLGTVLCTSSLNFKYEILERATDFFDNSRKLGQGGAGSVFRGT-LPDGRNIAVKRLFFN 333
              G        + +Y ++          RKLG G   +V+    + +  ++A+K +   
Sbjct: 4   AFKGEPYK----DARYILV----------RKLGWGHFSTVWLAKDMVNNTHVAMKIV-RG 48

Query: 334 SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFV------ 387
            + + +   +E+ L+  +   +  +           LL +      +   ++ V      
Sbjct: 49  DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE 108

Query: 388 -------KNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP- 439
                  K     +       I      GL ++H   G  IIH DIK  N+L++   +P 
Sbjct: 109 NLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPE 166

Query: 440 -----KIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEV 494
                KIAD G A       T+       T  Y +PE L+       AD+++   L+ E+
Sbjct: 167 NLIQIKIADLGNACWYDEHYTNSI----QTREYRSPEVLLGAPWGCGADIWSTACLIFEL 222

Query: 495 ASGR 498
            +G 
Sbjct: 223 ITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 79.4 bits (195), Expect = 1e-17
 Identities = 29/182 (15%), Positives = 60/182 (32%), Gaps = 34/182 (18%)

Query: 304 RKLGQGGAGSVFRGTLPDGRNIAVKRL------FFNSRQWVDQ----FFNEVNLISGIQH 353
           + +G+G   +VF           VK        F   ++  D     F       +  + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 354 KNVVRLLGCSIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHL 413
           + + +L G ++        Y +  N ++   L     ++ +  +    ++    E +A  
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119

Query: 414 HGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYL 473
           +      I+H D+   N+L+ E+    I DF  +  V  +                 E L
Sbjct: 120 Y---HRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEE--------------GWREIL 161

Query: 474 VR 475
            R
Sbjct: 162 ER 163

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	625
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.73
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.18
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.83
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.34
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.05
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.03

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.8e-53  Score=427.34  Aligned_cols=259  Identities=27%  Similarity=0.368  Sum_probs=218.9

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      ..++|++.++||+|+||+||+|+++ +++.||||++..... ..++|.+|+.+|++++|||||++++++.+++..+||||
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            3567899999999999999999976 588999999865433 35689999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+++|+|.+++..... ..+++..++.++.||++||+|||+++   |+||||||+||||++++.+||+|||+++......
T Consensus        94 ~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~  169 (287)
T d1opja_          94 FMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  169 (287)
T ss_dssp             CCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred             cccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence            9999999999865433 45899999999999999999999875   9999999999999999999999999999876655


Q ss_pred             ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          455 THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                      ........|++.|+|||++.++.++.++|||||||++|||++|+.|+........    .+         +.+......+
T Consensus       170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~----~~---------~~i~~~~~~~  236 (287)
T d1opja_         170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VY---------ELLEKDYRME  236 (287)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----HH---------HHHHTTCCCC
T ss_pred             ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH----HH---------HHHhcCCCCC
Confidence            5555556789999999999999999999999999999999998877543222111    11         1222233344


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      .+...+..+.+|+.+||+.||++|||++||++.|+.+.
T Consensus       237 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            56667788999999999999999999999999998764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=418.28  Aligned_cols=256  Identities=25%  Similarity=0.394  Sum_probs=202.8

Q ss_pred             cCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecC
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVP  377 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~  377 (625)
                      ++|++.++||+|+||+||+|++++++.||||++..... ..+.|.+|++++++++|||||+++|++.+++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            47889999999999999999998888999999875432 34679999999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCcee
Q 042149          378 NRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV  457 (625)
Q Consensus       378 ~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  457 (625)
                      +|+|.+++....  ..+++..++.++.||+.||.|||+++   |+||||||+||||++++.+||+|||+++.........
T Consensus        84 ~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          84 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             TCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            999999886443  34899999999999999999999875   9999999999999999999999999998876555444


Q ss_pred             eecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCCh
Q 042149          458 STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPE  537 (625)
Q Consensus       458 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  537 (625)
                      .....||+.|+|||++.+..++.++|||||||++|||+|++.|+..........    .....         ......|.
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~----~~i~~---------~~~~~~p~  225 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV----EDIST---------GFRLYKPR  225 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHH----HHHHH---------TCCCCCCT
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHH----HHHHh---------cCCCCCcc
Confidence            445679999999999999999999999999999999999766643322221111    11111         11222345


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          538 NEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       538 ~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      .++.++.+|+.+||+.||++|||++||++.|+++.
T Consensus       226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence            56778999999999999999999999999998764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=419.73  Aligned_cols=256  Identities=29%  Similarity=0.433  Sum_probs=213.3

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      .++|++.++||+|+||.||+|++++++.||||++..... ..+.|.+|+.+|++++|||||++++++.+ +..++||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            467889999999999999999998888999999965432 34679999999999999999999998754 5679999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      ++|+|.+++..... ..+++..++.++.||++||.|||+++   |+||||||+||||++++.+||+|||+++........
T Consensus        90 ~~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          90 ENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             TTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc
Confidence            99999997754432 34899999999999999999999875   999999999999999999999999999987665555


Q ss_pred             eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP  536 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  536 (625)
                      ......||+.|+|||++.++.++.++|||||||++|||+||+.|+.........    ....         ........|
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~----~~~i---------~~~~~~~~p  232 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV----IQNL---------ERGYRMVRP  232 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH----HHHH---------HTTCCCCCC
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHH----HHHH---------HhcCCCCCc
Confidence            555667999999999999999999999999999999999987765433222111    1111         112223345


Q ss_pred             hHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       537 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      ...+.++.+|+.+||+.||++|||++||++.|+++
T Consensus       233 ~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            56677899999999999999999999999998764

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-52  Score=418.32  Aligned_cols=263  Identities=27%  Similarity=0.432  Sum_probs=208.1

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      .++|++.++||+|+||+||+|+++  ..||||++...  ..+..+.|.+|+.+|++++|||||++++++. ++..+||||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence            467999999999999999999875  36999998644  4556788999999999999999999999875 457899999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+++|+|.+++....  ..+++..++.++.||++||+|||+++   ||||||||+||||+.++.+||+|||+++......
T Consensus        84 y~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             cCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            999999999986443  24899999999999999999999875   9999999999999999999999999998765432


Q ss_pred             c-eeeecCCCCccccCcccccc---CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          455 T-HVSTGIAGTLGYMAPEYLVR---GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       455 ~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                      . .......||+.|+|||++..   +.++.++|||||||++|||+||+.|+.....................        
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~--------  230 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD--------  230 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC--------
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc--------
Confidence            2 23345689999999999864   35889999999999999999999997533222211111111111111        


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCC
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIP  576 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~  576 (625)
                       ....+.+++..+.+|+.+||+.||++|||++||++.|+.+..++|
T Consensus       231 -~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P  275 (276)
T d1uwha_         231 -LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP  275 (276)
T ss_dssp             -GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             -chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence             112244567789999999999999999999999999998876665

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-52  Score=413.66  Aligned_cols=252  Identities=25%  Similarity=0.300  Sum_probs=205.1

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      .++|++.++||+|+||+||+|+++ +|+.||||++.... .+..+.+.+|+.+|++++|||||++++++.+++..+||||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            468999999999999999999975 68999999997653 3345678999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+++|+|.+++....   .+++.++..++.||++||+|||+++   |+||||||+|||+++++.+||+|||+++......
T Consensus        84 y~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          84 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            999999999985443   4899999999999999999999875   9999999999999999999999999998765433


Q ss_pred             c-eeeecCCCCccccCccccccCcc-cccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          455 T-HVSTGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       455 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      . ......+||+.|+|||++.+..+ +.++|||||||++|||+||+.|+..........    ......        ...
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~----~~~~~~--------~~~  225 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY----SDWKEK--------KTY  225 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH----HHHHTT--------CTT
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH----HHHhcC--------CCC
Confidence            2 22345789999999999988776 678999999999999999999985443222111    111111        111


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .......+.++.+|+.+||+.||++|||++|+++
T Consensus       226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1122445677889999999999999999999864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=408.24  Aligned_cols=254  Identities=25%  Similarity=0.379  Sum_probs=214.5

Q ss_pred             cCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecC
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVP  377 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~  377 (625)
                      ++|++.++||+|+||+||+|++++++.||||++...... .+.|.+|+.++++++||||++++|++.+++.+++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~-~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC-HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC-HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            578999999999999999999988889999999765433 4679999999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCcee
Q 042149          378 NRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHV  457 (625)
Q Consensus       378 ~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~  457 (625)
                      +|+|.+++....  ..+++..++.++.|+++||.|||+++   |+||||||+|||+++++.+||+|||+++.........
T Consensus        83 ~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          83 NGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             TEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             CCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            999999875443  34899999999999999999999875   9999999999999999999999999998776555544


Q ss_pred             eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCC
Q 042149          458 STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP  536 (625)
Q Consensus       458 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  536 (625)
                      .....||+.|+|||.+.+..++.++||||||+++|||+| |+.|+.... ..++    ...         +........|
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~-~~~~----~~~---------i~~~~~~~~p  223 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-NSET----AEH---------IAQGLRLYRP  223 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-HHHH----HHH---------HHTTCCCCCC
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC-HHHH----HHH---------HHhCCCCCCc
Confidence            455679999999999999999999999999999999998 777754321 1111    111         1112223345


Q ss_pred             hHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       537 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      ...+..+.+++.+||+.||++|||++||++.|.++
T Consensus       224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            56677899999999999999999999999998653

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-51  Score=412.63  Aligned_cols=249  Identities=24%  Similarity=0.405  Sum_probs=209.5

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      ++|++.++||+|+||+||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+|||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999964 69999999998765555678999999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      +||+|.+++...    .+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+......
T Consensus       100 ~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~  172 (293)
T d1yhwa1         100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (293)
T ss_dssp             TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             CCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence            999999987542    3899999999999999999999875   999999999999999999999999999987544332


Q ss_pred             eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP  536 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  536 (625)
                       .....||+.|+|||++.++.++.++|||||||++|||+||+.||.....    ............        .....+
T Consensus       173 -~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~----~~~~~~~~~~~~--------~~~~~~  239 (293)
T d1yhwa1         173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----LRALYLIATNGT--------PELQNP  239 (293)
T ss_dssp             -BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHHCS--------CCCSSG
T ss_pred             -ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH----HHHHHHHHhCCC--------CCCCCc
Confidence             2346799999999999999999999999999999999999999743211    111111111111        111234


Q ss_pred             hHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          537 ENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       537 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ...+..+.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            566788999999999999999999999874

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-51  Score=417.69  Aligned_cols=256  Identities=26%  Similarity=0.415  Sum_probs=199.6

Q ss_pred             cCccccccccccCceEEEEEEeC-CCC---EEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGR---NIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      ++|++.++||+|+||+||+|+++ +++   .||||++... .....+.|.+|+.+|++++|||||+++|++.+++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            45778899999999999999975 332   5889988654 455667899999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+++|+|.+++....  ..+++.+++.++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus       106 ~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence            99999999999886433  34899999999999999999999875   99999999999999999999999999987654


Q ss_pred             CCcee----eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhcccccccc
Q 042149          453 DKTHV----STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSM  527 (625)
Q Consensus       453 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  527 (625)
                      .....    .....||+.|+|||++.++.++.++|||||||++|||+| |+.|+.... ..++             ...+
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~-~~~~-------------~~~i  246 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT-NQDV-------------INAI  246 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHH-------------HHHH
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC-HHHH-------------HHHH
Confidence            33221    123457999999999999999999999999999999998 787764221 1111             1111


Q ss_pred             CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       528 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      ......+.+.+++..+.+|+.+||+.||++|||+.||++.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l  291 (299)
T d1jpaa_         247 EQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI  291 (299)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            222233445667888999999999999999999999999998763

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-52  Score=414.08  Aligned_cols=255  Identities=24%  Similarity=0.356  Sum_probs=197.1

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeee--CCeeEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE--GPESLL  371 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--~~~~~l  371 (625)
                      .++|++.+.||+|+||+||+|+++ +|+.||||++...  .+...+.+.+|+++|++++|||||++++++.+  ++.+++
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            368999999999999999999975 6899999998654  35556789999999999999999999999865  456899


Q ss_pred             EEEecCCCCcchhhhccC-CcCCCCHHHHHHHHHHHHHHHHHhhcCC--CceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          372 VYEYVPNRSLDQILFVKN-TIHILSWQQRFTIICGTAEGLAHLHGGS--GIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      ||||+++|+|.+++.... ....+++..++.++.||+.||.|||+++  ..+|+||||||+||||+.++.+||+|||+++
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            999999999999886432 2345999999999999999999999753  2359999999999999999999999999998


Q ss_pred             eeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          449 HVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      .+...... .....||+.|+|||++.+..++.++|||||||++|||+||+.|+.....     ...........      
T Consensus       163 ~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-----~~~~~~i~~~~------  230 (269)
T d2java1         163 ILNHDTSF-AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELAGKIREGK------  230 (269)
T ss_dssp             HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHTC------
T ss_pred             ecccCCCc-cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-----HHHHHHHHcCC------
Confidence            76543332 3346899999999999999999999999999999999999998743211     11112222211      


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                         ....+...+.++.+|+.+||+.||++|||++|+++
T Consensus       231 ---~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         231 ---FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence               11234456778999999999999999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=414.71  Aligned_cols=263  Identities=26%  Similarity=0.379  Sum_probs=211.0

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      .++|++.+.||+|+||.||+|++++++.||||++..... ..+.|.+|+.+|++++|||||++++++. ++..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence            468999999999999999999998888999999865433 3467999999999999999999999985 45689999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      ++|+|..++..... ..++|.+++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++........
T Consensus        94 ~~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          94 SKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             TTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCCchhhhhhhccc-ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence            99999988865432 34899999999999999999999875   999999999999999999999999999877555444


Q ss_pred             eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRFP  536 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~  536 (625)
                      ......||+.|+|||++..+.++.++||||||+++|||+||+.|+.......+.+..+             ......+.+
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i-------------~~~~~~~~~  236 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-------------ERGYRMPCP  236 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-------------HTTCCCCCC
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH-------------HhcCCCCCC
Confidence            4445679999999999999999999999999999999999887765443322222111             112223345


Q ss_pred             hHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCCCC
Q 042149          537 ENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPP  578 (625)
Q Consensus       537 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~~~  578 (625)
                      ..++.++.+++.+||+.||++|||+++|+++|++.....+|+
T Consensus       237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~  278 (285)
T d1fmka3         237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ  278 (285)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred             cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCC
Confidence            666788999999999999999999999999998876555443

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-51  Score=404.26  Aligned_cols=245  Identities=28%  Similarity=0.382  Sum_probs=207.6

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ++|++.+.||+|+||+||+|+++ +++.||||++...   .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            67999999999999999999975 6899999998643   2334567899999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++|+|.+++.....   +++.++..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        86 Ey~~~g~L~~~l~~~~~---l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            99999999999875543   899999999999999999999875   999999999999999999999999999876543


Q ss_pred             CceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                      ..   ....||+.|+|||++.+..++.++|||||||++|||++|+.|+.....     ...+.......          .
T Consensus       160 ~~---~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~~----------~  221 (263)
T d2j4za1         160 RR---TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----QETYKRISRVE----------F  221 (263)
T ss_dssp             CC---EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHTTC----------C
T ss_pred             cc---cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCC----------C
Confidence            22   346799999999999999999999999999999999999999743211     11122211111          1


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ..|...++++.+++.+||+.||++|||++|+++
T Consensus       222 ~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         222 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            234556778999999999999999999999985

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-51  Score=409.26  Aligned_cols=255  Identities=22%  Similarity=0.333  Sum_probs=209.5

Q ss_pred             cCccccc-cccccCceEEEEEEeC---CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          298 DFFDNSR-KLGQGGAGSVFRGTLP---DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       298 ~~y~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      ++|.+.+ +||+|+||+||+|.++   ++..||||++... .....+.|.+|+++|++++|||||++++++.. +..+||
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            4566666 4999999999999864   3457999999754 45567889999999999999999999998864 568999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+++|+|.+++...  ...+++..++.++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++.+..
T Consensus        87 mE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence            9999999999987433  234899999999999999999999875   99999999999999999999999999998765


Q ss_pred             CCceee--ecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          453 DKTHVS--TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       453 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      ......  ....||+.|+|||++.++.++.++|||||||++|||+| |+.|+..... .++    ...         +..
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-~~~----~~~---------i~~  227 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEV----MAF---------IEQ  227 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-HHH----HHH---------HHT
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-HHH----HHH---------HHc
Confidence            443322  24568999999999999999999999999999999998 8888653221 111    111         112


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      ....+.|..++.++.+|+.+||+.+|++|||+.+|++.|+...
T Consensus       228 ~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         228 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            2233446677788999999999999999999999999987654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=406.51  Aligned_cols=247  Identities=26%  Similarity=0.373  Sum_probs=201.7

Q ss_pred             ccccccCceEEEEEEeC---CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEecCC
Q 042149          304 RKLGQGGAGSVFRGTLP---DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYVPN  378 (625)
Q Consensus       304 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~~~  378 (625)
                      ++||+|+||+||+|.++   .++.||||++...  +....+.|.+|+.+|++++|||||++++++.. +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            57999999999999864   3568999998643  34456789999999999999999999999864 567899999999


Q ss_pred             CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCceee
Q 042149          379 RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTHVS  458 (625)
Q Consensus       379 ~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  458 (625)
                      |+|.+++.....   +++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++..........
T Consensus        92 g~L~~~l~~~~~---l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhhccC---CCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            999999875443   899999999999999999999875   99999999999999999999999999998765544332


Q ss_pred             --ecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCCCCCCC
Q 042149          459 --TGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGRF  535 (625)
Q Consensus       459 --~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~  535 (625)
                        ....||+.|+|||++.+..++.++|||||||++|||+| |+.|+..... .+    ...         .+......+.
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-~~----~~~---------~i~~~~~~~~  231 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-SE----VTA---------MLEKGERMGC  231 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HH----HHH---------HHHTTCCCCC
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-HH----HHH---------HHHcCCCCCC
Confidence              24578999999999999999999999999999999998 8888643211 11    111         1122223344


Q ss_pred             ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          536 PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       536 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      |..++.++.+|+.+||+.||++|||+++|+++|++.
T Consensus       232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            566778899999999999999999999999988764

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=408.97  Aligned_cols=257  Identities=26%  Similarity=0.442  Sum_probs=205.4

Q ss_pred             cCccccccccccCceEEEEEEeCCC-----CEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLPDG-----RNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      +.|+..++||+|+||.||+|.++..     ..||||++... .......|.+|+.+|++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4688899999999999999986532     36999999654 34455679999999999999999999999999999999


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||||+.+++|.+++....  ..+++.+++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus        87 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            999999999988775443  34899999999999999999999875   9999999999999999999999999998765


Q ss_pred             CCCce--eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          452 PDKTH--VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       452 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      .....  ......||+.|+|||++.++.++.++|||||||++|||++|+.|+........+    .         +.+..
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~----~---------~~i~~  228 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV----M---------KAIND  228 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----H---------HHHHT
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHH----H---------HHHhc
Confidence            43322  223456899999999999999999999999999999999987775433222211    1         12222


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      ....+.+.+++..+.+|+.+||+.+|++|||+.||+++|+++.
T Consensus       229 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~  271 (283)
T d1mqba_         229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  271 (283)
T ss_dssp             TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence            3334456667788999999999999999999999999998764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-51  Score=409.34  Aligned_cols=251  Identities=24%  Similarity=0.322  Sum_probs=207.5

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEec
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEYV  376 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~~  376 (625)
                      +.|+++++||+|+||+||+|+++ +++.||||++.....+..+.+.+|+++|++++|||||++++++.+++..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            57899999999999999999975 68999999998777677788999999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      ++|+|.+++....  ..+++.++..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++....... 
T Consensus        92 ~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-  165 (288)
T d2jfla1          92 AGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-  165 (288)
T ss_dssp             TTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-
T ss_pred             CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCcc-
Confidence            9999999876433  24899999999999999999999876   99999999999999999999999999976532211 


Q ss_pred             eeecCCCCccccCccccc-----cCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          457 VSTGIAGTLGYMAPEYLV-----RGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       457 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      ......||+.|+|||++.     ...++.++|||||||++|||+||+.|+...... +.   .. .......       .
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~-~~---~~-~i~~~~~-------~  233 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM-RV---LL-KIAKSEP-------P  233 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG-GH---HH-HHHHSCC-------C
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH-HH---HH-HHHcCCC-------C
Confidence            122467999999999984     456889999999999999999999987533211 11   11 1111110       1


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ....+...+.++.+|+.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         234 TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11224566788999999999999999999999875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-50  Score=405.01  Aligned_cols=247  Identities=22%  Similarity=0.284  Sum_probs=204.4

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ++|++.+.||+|+||+||+|+++ +++.||||++...   .....+.+.+|+++|++++|||||++++++.+++..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            67999999999999999999975 6899999998653   2334578999999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||++||+|.+++...+.   +++..+..++.|++.||.|||+++   |+||||||+||||++++.+||+|||+++.+...
T Consensus        88 Ey~~gg~L~~~~~~~~~---l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhccCC---CCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            99999999998865543   899999999999999999999875   999999999999999999999999999987543


Q ss_pred             Cc-eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          454 KT-HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       454 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      .. .......||+.|+|||++.+..++.++|||||||++|||+||+.||.....     ...........          
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~~~~~i~~~~----------  226 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----YLIFQKIIKLE----------  226 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHTTC----------
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-----HHHHHHHHcCC----------
Confidence            32 223356799999999999999999999999999999999999999753211     11111111111          


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVV  565 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~  565 (625)
                      ..+|...+.++.+||.+||+.||++|||++|++
T Consensus       227 ~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         227 YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence            123445667889999999999999999999864

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-50  Score=411.63  Aligned_cols=257  Identities=26%  Similarity=0.391  Sum_probs=208.2

Q ss_pred             hcCccccccccccCceEEEEEEeCC-C-----CEEEEEEeecC-ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPD-G-----RNIAVKRLFFN-SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPE  368 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~  368 (625)
                      .++|++.++||+|+||+||+|++.. +     ..||||++... .......+.+|+.+|.++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            4689999999999999999998642 2     36899988654 334456789999999998 89999999999999999


Q ss_pred             eEEEEEecCCCCcchhhhccCC--------------------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeecc
Q 042149          369 SLLVYEYVPNRSLDQILFVKNT--------------------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKT  428 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp  428 (625)
                      .++||||+++|+|.++|.....                    ...+++..++.++.||++||+|||+++   ||||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence            9999999999999999965432                    234899999999999999999999875   99999999


Q ss_pred             CcEEEcCCCceEEeecccceeeCCCCce-eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCC
Q 042149          429 SNILLDEKLTPKIADFGLARHVAPDKTH-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEG  506 (625)
Q Consensus       429 ~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~  506 (625)
                      +|||++.++.+||+|||+++........ ......||+.|+|||++.++.++.++|||||||++|||+| |+.||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999876544433 2334568999999999999999999999999999999998 7888643322


Q ss_pred             CccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHc
Q 042149          507 SSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLN  569 (625)
Q Consensus       507 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~  569 (625)
                      ...+    .+.         +......+.|...+.++.+||.+||+.||++|||++||+++|.
T Consensus       273 ~~~~----~~~---------~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DANF----YKL---------IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SHHH----HHH---------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHH----HHH---------HhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            2111    111         1122233445667788999999999999999999999999984

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-49  Score=396.50  Aligned_cols=247  Identities=23%  Similarity=0.336  Sum_probs=198.3

Q ss_pred             ccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeee----CCeeEEE
Q 042149          300 FDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE----GPESLLV  372 (625)
Q Consensus       300 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~----~~~~~lV  372 (625)
                      |+..++||+|+||+||+|++. +++.||||++...  .....+.+.+|+++|++++|||||++++++.+    +..+++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            356778999999999999975 6889999998654  45566789999999999999999999999865    3467999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEc-CCCceEEeecccceeeC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD-EKLTPKIADFGLARHVA  451 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~-~~~~~kl~Dfgla~~~~  451 (625)
                      |||+++|+|.+++....   .+++..+..++.||++||+|||+++ .+|+||||||+||||+ +++.+||+|||+++...
T Consensus        91 mE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            99999999999996554   3899999999999999999999762 3499999999999996 57899999999998654


Q ss_pred             CCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCC
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGL  531 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~  531 (625)
                      ...   .....||+.|+|||++.+ +++.++|||||||++|||++|+.||........    .......+..        
T Consensus       167 ~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~----~~~~i~~~~~--------  230 (270)
T d1t4ha_         167 ASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----IYRRVTSGVK--------  230 (270)
T ss_dssp             TTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH----HHHHHTTTCC--------
T ss_pred             CCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH----HHHHHHcCCC--------
Confidence            332   234689999999998854 699999999999999999999999753322211    1122111110        


Q ss_pred             CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          532 TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       532 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ....+...+.++.+|+.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         231 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            01112334566899999999999999999999985

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-50  Score=410.93  Aligned_cols=262  Identities=23%  Similarity=0.304  Sum_probs=205.2

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      .++|++.++||+|+||+||+|++. +|+.||||++... .....+++.+|+.+|++++|||||++++++.+++..+||||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            578999999999999999999975 6899999999765 34446789999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |++||+|.+++.....   +++..+..++.|++.||.|||++  .+|+||||||+||||+.++.+||+|||+|+......
T Consensus        85 y~~gg~L~~~l~~~~~---l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  159 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  159 (322)
T ss_dssp             CCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred             cCCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence            9999999999975543   89999999999999999999963  149999999999999999999999999998654322


Q ss_pred             ceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhh-----------hc---
Q 042149          455 THVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHY-----------KA---  520 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~-----------~~---  520 (625)
                         ....+||+.|+|||++.+.+++.++||||+||++|||++|+.||.................           ..   
T Consensus       160 ---~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         160 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             ---C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             ---cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence               2346899999999999999999999999999999999999999864332211000000000           00   


Q ss_pred             -----------ccccc---ccCCCCCCCCC-hHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          521 -----------NRITQ---SMDPGLTGRFP-ENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       521 -----------~~~~~---~i~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                                 ....+   .+........+ ...+.++.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                       00000   00000000111 123567899999999999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.9e-49  Score=406.94  Aligned_cols=253  Identities=21%  Similarity=0.273  Sum_probs=210.7

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      .++|++.++||+|+||+||+|+++ +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+|||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            468999999999999999999975 6899999999877777778899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEc--CCCceEEeecccceeeCCC
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD--EKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~--~~~~~kl~Dfgla~~~~~~  453 (625)
                      ++||+|.+++....  ..+++.++..++.||+.||.|||+++   ||||||||+|||++  .++.+||+|||+++.+...
T Consensus       105 ~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         105 MSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            99999999885432  34999999999999999999999876   99999999999996  4678999999999987654


Q ss_pred             CceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                      ...  ....||+.|+|||++.+..++.++|||||||++|||++|+.|+.... ..+    .........      .....
T Consensus       180 ~~~--~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-~~~----~~~~i~~~~------~~~~~  246 (350)
T d1koaa2         180 QSV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-DDE----TLRNVKSCD------WNMDD  246 (350)
T ss_dssp             SCE--EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHH----HHHHHHHTC------CCSCC
T ss_pred             ccc--ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC-HHH----HHHHHHhCC------CCCCc
Confidence            433  33579999999999999999999999999999999999999974321 111    111111111      01111


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      ......+..+.+|+.+||+.||++|||++|+++.
T Consensus       247 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1223456788999999999999999999999874

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-49  Score=405.83  Aligned_cols=245  Identities=26%  Similarity=0.418  Sum_probs=201.5

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      +.|+.+++||+|+||+||+|++. +++.||||++....   ....+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            35999999999999999999965 68899999997543   345567999999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+++|+|..++....   .+++.+++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        95 E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (309)
T ss_dssp             ECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             EecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence            9999999977665443   3899999999999999999999875   999999999999999999999999999865432


Q ss_pred             CceeeecCCCCccccCcccccc---CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVR---GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                           ....||+.|+|||++.+   +.++.++|||||||++|||++|+.|+.....    ......... ..        
T Consensus       169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~----~~~~~~i~~-~~--------  230 (309)
T d1u5ra_         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIAQ-NE--------  230 (309)
T ss_dssp             -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHH-SC--------
T ss_pred             -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHh-CC--------
Confidence                 23579999999999864   4689999999999999999999998743211    111111111 11        


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .....+...+..+.+|+.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         231 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            111113345677999999999999999999999975

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1e-48  Score=405.49  Aligned_cols=253  Identities=23%  Similarity=0.258  Sum_probs=210.9

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      .++|+++++||+|+||+||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++.++|||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            467999999999999999999964 7999999999877666677889999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEc--CCCceEEeecccceeeCCC
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD--EKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~--~~~~~kl~Dfgla~~~~~~  453 (625)
                      ++||+|.+.+...  ...+++.+++.++.||+.||.|||+++   |+||||||+||||+  .++.+||+|||+++.+...
T Consensus       108 ~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         108 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence            9999998877433  234899999999999999999999875   99999999999998  6789999999999987655


Q ss_pred             CceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                      ...  ....||+.|+|||++.+..++.++|||||||++|||+||+.||...... ..    ........      .....
T Consensus       183 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~----~~~i~~~~------~~~~~  249 (352)
T d1koba_         183 EIV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-ET----LQNVKRCD------WEFDE  249 (352)
T ss_dssp             SCE--EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-HH----HHHHHHCC------CCCCS
T ss_pred             Cce--eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-HH----HHHHHhCC------CCCCc
Confidence            433  3357999999999999999999999999999999999999997432111 11    11111111      11122


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      ......+.++.+|+.+||+.||++|||+.|+++.
T Consensus       250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            2234567788999999999999999999999873

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-49  Score=404.13  Aligned_cols=252  Identities=20%  Similarity=0.270  Sum_probs=192.5

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC-hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS-RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      +.+.|++.+.||+|+||+||+|+++ +++.||||++.... ......+.+|+.+|++++|||||++++++.+++..+|||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4678999999999999999999975 68999999997543 233457889999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEc---CCCceEEeecccceee
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADFGLARHV  450 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~---~~~~~kl~Dfgla~~~  450 (625)
                      ||++||+|.+++....   .+++.++..++.||+.||+|||+++   |+||||||+|||+.   +++.+||+|||+++..
T Consensus        87 E~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          87 QLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             eccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            9999999999996543   3999999999999999999999875   99999999999994   5789999999999876


Q ss_pred             CCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          451 APDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       451 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                      .....  .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ...........      ..
T Consensus       161 ~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~~~~~i~~~~------~~  227 (307)
T d1a06a_         161 DPGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-----AKLFEQILKAE------YE  227 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHTTC------CC
T ss_pred             cCCCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH-----HHHHHHHhccC------CC
Confidence            54332  2346799999999999999999999999999999999999999753211     11111111111      11


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ...+.+...+..+.+++.+||+.||++|||++|+++
T Consensus       228 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            122233456778999999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.7e-50  Score=406.57  Aligned_cols=264  Identities=28%  Similarity=0.397  Sum_probs=214.7

Q ss_pred             HHHHhcCccccccccccCceEEEEEEeC------CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeee
Q 042149          293 LERATDFFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE  365 (625)
Q Consensus       293 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  365 (625)
                      ++.-+++|++.++||+|+||+||+|+++      +++.||||++... ..+..+.|.+|+.+|++++||||+++++++.+
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            3445678999999999999999999853      3578999998754 34456789999999999999999999999999


Q ss_pred             CCeeEEEEEecCCCCcchhhhccCC---------------------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEe
Q 042149          366 GPESLLVYEYVPNRSLDQILFVKNT---------------------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHR  424 (625)
Q Consensus       366 ~~~~~lV~e~~~~~sL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHr  424 (625)
                      ....++||||+++|+|.+++.....                     ...+++..++.++.|++.||+|||+++   ||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHr  164 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR  164 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEee
Confidence            9999999999999999999864321                     234889999999999999999999875   9999


Q ss_pred             eeccCcEEEcCCCceEEeecccceeeCCCCce-eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCC
Q 042149          425 DIKTSNILLDEKLTPKIADFGLARHVAPDKTH-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVF  503 (625)
Q Consensus       425 Dlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~  503 (625)
                      ||||+||||+.++.+||+|||+++........ ......|++.|+|||.+.+..++.++|||||||++|||++|..|+..
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            99999999999999999999999876543332 22346789999999999999999999999999999999999765433


Q ss_pred             CCCCccchhhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          504 SEGSSSVLHTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       504 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      .....+....    ...+         ...+.|..++.++.+|+.+||+.+|++||||.||+++|+++.
T Consensus       245 ~~~~~e~~~~----v~~~---------~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         245 GMAHEEVIYY----VRDG---------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TSCHHHHHHH----HHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCHHHHHHH----HHcC---------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            3222222211    1111         122335566778999999999999999999999999998764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-49  Score=396.62  Aligned_cols=255  Identities=22%  Similarity=0.312  Sum_probs=197.4

Q ss_pred             hcCccccccccccCceEEEEEEeCC----CCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPD----GRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      .++|++.+.||+|+||.||+|++..    +..||||++... .....+.+.+|+.+|++++|||||++++++. ++..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            4689999999999999999998642    346889988644 4455678999999999999999999999985 567899


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      ||||+++|+|.+++....  ..+++..++.++.||++||.|||+++   |+||||||+||+++.++.+||+|||+++...
T Consensus        85 v~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence            999999999998875433  34899999999999999999999875   9999999999999999999999999998776


Q ss_pred             CCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCCC
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPG  530 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  530 (625)
                      ...........||+.|+|||++.++.++.++|||||||++|||+| |.+|+.... ..++.    .....         .
T Consensus       160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~-~~~~~----~~i~~---------~  225 (273)
T d1mp8a_         160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-NNDVI----GRIEN---------G  225 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-GGGHH----HHHHT---------T
T ss_pred             CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC-HHHHH----HHHHc---------C
Confidence            554444455678999999999999999999999999999999998 676654322 11111    11111         1


Q ss_pred             CCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          531 LTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       531 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      ...+.+..++..+.+|+.+||+.||++|||+.||++.|+++
T Consensus       226 ~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         226 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            12234566778899999999999999999999999998765

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=394.54  Aligned_cols=252  Identities=23%  Similarity=0.262  Sum_probs=206.9

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC------hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCe
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS------RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPE  368 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~  368 (625)
                      ..++|++.+.||+|+||+||+|+++ +|+.||||++....      ....+.+.+|+.+|++++|||||++++++.+.+.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            3578999999999999999999974 78999999986532      2235789999999999999999999999999999


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC----ceEEeec
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL----TPKIADF  444 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~----~~kl~Df  444 (625)
                      .+|||||+++|+|.+++....   .+++..++.++.|++.||+|||+.+   |+||||||+|||++.++    .+||+||
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence            999999999999999987654   3999999999999999999999875   99999999999998766    5999999


Q ss_pred             ccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccc
Q 042149          445 GLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRIT  524 (625)
Q Consensus       445 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  524 (625)
                      |+++.......  .....||+.|+|||++.+..++.++|||||||++|||++|+.|+......     ..........  
T Consensus       162 G~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-----~~~~~i~~~~--  232 (293)
T d1jksa_         162 GLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----ETLANVSAVN--  232 (293)
T ss_dssp             TTCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHTTC--
T ss_pred             hhhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-----HHHHHHHhcC--
Confidence            99988754433  23457999999999999999999999999999999999999997532211     1111111111  


Q ss_pred             cccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          525 QSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       525 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                          .......+...+..+.+|+.+||+.||++|||++|+++
T Consensus       233 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         233 ----YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             ----CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                00111112344667899999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-49  Score=393.37  Aligned_cols=251  Identities=25%  Similarity=0.405  Sum_probs=199.6

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeee-CCeeEEEEEe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE-GPESLLVYEY  375 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lV~e~  375 (625)
                      .++|++.++||+|+||.||+|++ +|+.||||++....  ..+.+.+|++++++++||||++++|++.+ .+.+++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            35788899999999999999998 47889999996543  44779999999999999999999998865 4568999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +++|+|.+++..... ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        83 ~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-  157 (262)
T d1byga_          83 MAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  157 (262)
T ss_dssp             CTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             cCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC-
Confidence            999999999865432 24899999999999999999999875   9999999999999999999999999998654322 


Q ss_pred             eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhC-CCCCCCCCCCccchhhHHHhhhccccccccCCCCCCC
Q 042149          456 HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG-RRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTGR  534 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~  534 (625)
                         ....+|+.|+|||++.++.++.++||||||+++|||+|+ +.|+... ...+..             ..+......+
T Consensus       158 ---~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~-~~~~~~-------------~~i~~~~~~~  220 (262)
T d1byga_         158 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVV-------------PRVEKGYKMD  220 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CGGGHH-------------HHHTTTCCCC
T ss_pred             ---ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC-CHHHHH-------------HHHHcCCCCC
Confidence               234688999999999999999999999999999999995 5553322 222211             1122223344


Q ss_pred             CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          535 FPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       535 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      .+...+.++.+|+.+||+.||++|||+.+|+++|+++.
T Consensus       221 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            56666788999999999999999999999999998763

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-48  Score=399.37  Aligned_cols=248  Identities=23%  Similarity=0.259  Sum_probs=208.6

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      .++|++++.||+|+||.||+|+.+ +|+.||||++.+.   .....+.+.+|+.+|++++||||+++++++.+.+.+++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            367999999999999999999974 7999999999754   233467889999999999999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||++||+|.+++.....   +++..++.++.||+.||+|||+++   |+||||||+|||++.+|.+||+|||+++....
T Consensus        84 ~ey~~gg~L~~~~~~~~~---~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          84 MEYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eeccCCCchhhhhhcccC---CcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            999999999998876544   899999999999999999999875   99999999999999999999999999987644


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      ... .....+||+.|+|||++.+..++.++|||||||++|||++|+.|+.....     ....+......          
T Consensus       158 ~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-----~~~~~~i~~~~----------  221 (337)
T d1o6la_         158 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFELILMEE----------  221 (337)
T ss_dssp             TTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCC----------
T ss_pred             CCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-----HHHHHHHhcCC----------
Confidence            332 23346899999999999999999999999999999999999988753321     11112111111          


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPS-----MAEVVH  566 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~  566 (625)
                      ..+|...+.++.+||.+||+.||++||+     ++|+++
T Consensus       222 ~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            1235566778899999999999999995     788875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=398.39  Aligned_cols=258  Identities=28%  Similarity=0.359  Sum_probs=207.0

Q ss_pred             cCccccccccccCceEEEEEEeC-CCC--EEEEEEeecC-ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCeeEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGR--NIAVKRLFFN-SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lV  372 (625)
                      ++|++.++||+|+||+||+|+++ ++.  .||||++... ..+..+.|.+|+++|+++ +|||||++++++.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            67889999999999999999975 444  4788887543 444567899999999999 799999999999999999999


Q ss_pred             EEecCCCCcchhhhcc-------------CCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCce
Q 042149          373 YEYVPNRSLDQILFVK-------------NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTP  439 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~  439 (625)
                      |||+++|+|.++|+..             .....+++..+..++.||++||.|||+.+   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999998654             23355999999999999999999999875   9999999999999999999


Q ss_pred             EEeecccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhh
Q 042149          440 KIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK  519 (625)
Q Consensus       440 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~  519 (625)
                      ||+|||+++........  ....||+.|+|||.+.++.++.++||||||+++|||++|..|+........+.    ..  
T Consensus       167 kl~DfG~a~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~----~~--  238 (309)
T d1fvra_         167 KIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY----EK--  238 (309)
T ss_dssp             EECCTTCEESSCEECCC------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HH--
T ss_pred             EEccccccccccccccc--cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHH----HH--
Confidence            99999999765432221  23468999999999999999999999999999999999876542222211111    11  


Q ss_pred             ccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccC
Q 042149          520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDY  573 (625)
Q Consensus       520 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~  573 (625)
                             +......+.+...+.++.+||.+||+.||++|||++||++.|+++..
T Consensus       239 -------i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         239 -------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             -------GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------HHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                   11122233456677889999999999999999999999999988754

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=399.81  Aligned_cols=255  Identities=23%  Similarity=0.355  Sum_probs=202.3

Q ss_pred             cCccccccccccCceEEEEEEeC-CCC----EEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGR----NIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  371 (625)
                      ++|+++++||+|+||+||+|++. +|+    .||||++... ..+..+.|.+|+.+|++++|||||++++++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46999999999999999999864 444    5889988643 344567899999999999999999999999764 5678


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeC
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVA  451 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~  451 (625)
                      +|||+.+++|.+.+....  ..+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus        88 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            899999999988876543  34899999999999999999999875   9999999999999999999999999998775


Q ss_pred             CCCcee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhccccccccCC
Q 042149          452 PDKTHV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSMDP  529 (625)
Q Consensus       452 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  529 (625)
                      ...... .....||+.|+|||++.++.++.++|||||||++|||+| |+.|+... ....+.    .         .+..
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~-~~~~~~----~---------~i~~  228 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEIS----S---------ILEK  228 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-CGGGHH----H---------HHHH
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC-CHHHHH----H---------HHHc
Confidence            544332 234568999999999999999999999999999999999 56664322 111111    1         1111


Q ss_pred             CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          530 GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       530 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      ....+.|..++..+.+|+.+||+.||++|||+.||++.|..+.
T Consensus       229 ~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         229 GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence            2223445667788999999999999999999999999887664

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=389.52  Aligned_cols=255  Identities=27%  Similarity=0.371  Sum_probs=198.2

Q ss_pred             cCccccccccccCceEEEEEEeC--CC--CEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP--DG--RNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  370 (625)
                      ++|++.+.||+|+||.||+|+++  ++  ..||||++...   ..+..+.|.+|+.+|++++|||||+++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            56999999999999999999853  23  36899988653   34556789999999999999999999999965 5678


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      +||||+++++|.+.+....  ..+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus        87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence            9999999999998876543  24899999999999999999999875   999999999999999999999999999987


Q ss_pred             CCCCcee--eecCCCCccccCccccccCcccccCcEEeehhhhHHHHh-CCCCCCCCCCCccchhhHHHhhhcccccccc
Q 042149          451 APDKTHV--STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVAS-GRRNSVFSEGSSSVLHTVWKHYKANRITQSM  527 (625)
Q Consensus       451 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i  527 (625)
                      .......  .....|++.|+|||++.+..++.++||||||+++|||+| |+.|+.... ..+..   ...         .
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~-~~~~~---~~i---------~  228 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-GSQIL---HKI---------D  228 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHH---HHH---------H
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC-HHHHH---HHH---------H
Confidence            6554432  224568889999999999999999999999999999998 787764221 11111   111         1


Q ss_pred             CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          528 DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       528 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      ......+.+...+..+.+|+.+||+.||++|||+.||++.|++.
T Consensus       229 ~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         229 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            11222334556677899999999999999999999999998753

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.1e-48  Score=394.12  Aligned_cols=249  Identities=24%  Similarity=0.307  Sum_probs=208.2

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ++|++.++||+|+||+||+|+++ +|+.||||++...   .....+.+.+|+.+|++++|||||++++++.+++..++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57999999999999999999975 6899999999653   2334678999999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||++||+|..++.....   +++..+..++.||+.||+|||+++   |+||||||+||||+.+|.+||+|||+++.....
T Consensus        84 E~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCcccccccccccc---ccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            99999999998865554   788999999999999999999775   999999999999999999999999999886543


Q ss_pred             CceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                      .    ....||+.|+|||++.+..++.++|||||||++|||+||+.|+.....     ...........          .
T Consensus       158 ~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~i~~~~----------~  218 (316)
T d1fota_         158 T----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKTYEKILNAE----------L  218 (316)
T ss_dssp             B----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHHCC----------C
T ss_pred             c----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-----HHHHHHHHcCC----------C
Confidence            2    346899999999999999999999999999999999999999753211     11111111111          1


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH--Hccc
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRP-----SMAEVVHM--LNNI  571 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~--L~~~  571 (625)
                      ..|...+.++.+++.+||+.||++||     |++++++.  ++++
T Consensus       219 ~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         219 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence            23445567789999999999999996     89999863  4444

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.4e-48  Score=389.78  Aligned_cols=258  Identities=23%  Similarity=0.348  Sum_probs=203.3

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC----e
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP----E  368 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~  368 (625)
                      .++|++.+.||+|+||+||+|++. +++.||||++...   +.+..+.+.+|+.+|+.++|||||++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            578999999999999999999964 7899999999654   3455678999999999999999999999987654    3


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      .+|||||++|++|.+++...+.   +++.+++.++.||+.||.|||+++   |+||||||+||||+.++.++|+|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~---l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcccCC---CCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            7999999999999998865543   899999999999999999999875   9999999999999999999999999987


Q ss_pred             eeCCCCc--eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccc
Q 042149          449 HVAPDKT--HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS  526 (625)
Q Consensus       449 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (625)
                      .......  .......||+.|+|||++.+..++.++|||||||++|||+||+.||....    ...............  
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~----~~~~~~~~~~~~~~~--  233 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS----PVSVAYQHVREDPIP--  233 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS----HHHHHHHHHHCCCCC--
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC----HHHHHHHHHhcCCCC--
Confidence            6543322  22335679999999999999999999999999999999999999975321    111222222221110  


Q ss_pred             cCCCCCCCCChHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHccc
Q 042149          527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRP-SMAEVVHMLNNI  571 (625)
Q Consensus       527 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~ev~~~L~~~  571 (625)
                           ........+..+.+++.+||+.||++|| |++++++.|.++
T Consensus       234 -----~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         234 -----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             -----GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -----CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence                 0111234567899999999999999999 899998888654

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.3e-47  Score=395.26  Aligned_cols=244  Identities=23%  Similarity=0.305  Sum_probs=206.3

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ++|+++++||+|+||.||+|+++ +|+.||||++...   .....+.+.+|+.+|+.++|||||++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            67999999999999999999975 7999999998643   2334577899999999999999999999999999999999


Q ss_pred             EecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCC
Q 042149          374 EYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPD  453 (625)
Q Consensus       374 e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~  453 (625)
                      ||+.+|+|.+++.....   +++..+..++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+++.+...
T Consensus       121 e~~~~g~l~~~l~~~~~---l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhhcCC---CCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            99999999998876543   899999999999999999999875   999999999999999999999999999987543


Q ss_pred             CceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          454 KTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       454 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                      .    ....||+.|+|||++.+..++.++|||||||++|||+||+.||....    .. ..........          .
T Consensus       195 ~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~----~~-~~~~~i~~~~----------~  255 (350)
T d1rdqe_         195 T----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ----PI-QIYEKIVSGK----------V  255 (350)
T ss_dssp             B----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HH-HHHHHHHHCC----------C
T ss_pred             c----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC----HH-HHHHHHhcCC----------C
Confidence            2    23579999999999999999999999999999999999999975321    11 1111111111          1


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRP-----SMAEVVH  566 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~  566 (625)
                      ..+...+.++.+++.+||+.||++|+     |++|+++
T Consensus       256 ~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            22445667889999999999999994     8999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-47  Score=388.64  Aligned_cols=254  Identities=29%  Similarity=0.404  Sum_probs=205.6

Q ss_pred             cccccccCceEEEEEEeCCC----CEEEEEEeec-CChHHHHHHHHHHHHHhcCCCCceeeeeeeeee-CCeeEEEEEec
Q 042149          303 SRKLGQGGAGSVFRGTLPDG----RNIAVKRLFF-NSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE-GPESLLVYEYV  376 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lV~e~~  376 (625)
                      .++||+|+||+||+|++.++    ..||||++.. ......+.|.+|+++|++++|||||+++|++.+ +...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46799999999999996532    2589999864 356667889999999999999999999999876 45889999999


Q ss_pred             CCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCce
Q 042149          377 PNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKTH  456 (625)
Q Consensus       377 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~~  456 (625)
                      ++++|.+++....  ..+++..++.++.|++.||.|||+.+   |+||||||+||||++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            9999999886443  34788999999999999999999775   999999999999999999999999999876543322


Q ss_pred             e---eecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCCC
Q 042149          457 V---STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLTG  533 (625)
Q Consensus       457 ~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~  533 (625)
                      .   .....||+.|+|||.+..+.++.++||||||+++|||+||+.|+.......+.......             ....
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~-------------g~~~  253 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-------------GRRL  253 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT-------------TCCC
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-------------CCCC
Confidence            2   22457899999999999999999999999999999999998886543333222222211             1122


Q ss_pred             CCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCC
Q 042149          534 RFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYE  574 (625)
Q Consensus       534 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~  574 (625)
                      ..|..++..+.+|+.+||+.||++||++.||++.|+++..+
T Consensus       254 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         254 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            23455667899999999999999999999999999888644

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-47  Score=388.86  Aligned_cols=261  Identities=28%  Similarity=0.375  Sum_probs=200.5

Q ss_pred             HhcCccccccccccCceEEEEEEeC------CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeC-
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEG-  366 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-  366 (625)
                      -.++|++.++||+|+||.||+|++.      +++.||||++... .....+.+.+|..++.++ +||||+.+++++.+. 
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~   90 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   90 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence            3478999999999999999999853      3468999998654 345566788888888877 689999999987654 


Q ss_pred             CeeEEEEEecCCCCcchhhhccCC-------------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE
Q 042149          367 PESLLVYEYVPNRSLDQILFVKNT-------------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL  433 (625)
Q Consensus       367 ~~~~lV~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll  433 (625)
                      ...++||||+++|+|.+++.....             ...+++.+++.++.||++||.|||+++   |+||||||+||||
T Consensus        91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl  167 (299)
T d1ywna1          91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL  167 (299)
T ss_dssp             SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeE
Confidence            568999999999999999865422             234899999999999999999999875   9999999999999


Q ss_pred             cCCCceEEeecccceeeCCCCce-eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchh
Q 042149          434 DEKLTPKIADFGLARHVAPDKTH-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLH  512 (625)
Q Consensus       434 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~  512 (625)
                      ++++.+||+|||+++........ ......||+.|+|||++.++.++.++|||||||++|||+||..|+........   
T Consensus       168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~---  244 (299)
T d1ywna1         168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---  244 (299)
T ss_dssp             CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH---
T ss_pred             CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH---
Confidence            99999999999999876544332 23356799999999999999999999999999999999998654322211111   


Q ss_pred             hHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          513 TVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       513 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      ........+         ...+.+...+.++.+++.+||+.||++|||++||+++|+++
T Consensus       245 ~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         245 EFCRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             HHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHhcC---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            111111111         12233555677899999999999999999999999999875

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.3e-47  Score=381.24  Aligned_cols=251  Identities=21%  Similarity=0.293  Sum_probs=207.0

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC---------hHHHHHHHHHHHHHhcCC-CCceeeeeeeeee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS---------RQWVDQFFNEVNLISGIQ-HKNVVRLLGCSIE  365 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~  365 (625)
                      .++|++.++||+|+||+||+|+++ +++.||||++....         +...+.+.+|+.+|++++ |||||++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            478999999999999999999974 78999999986542         223457889999999997 9999999999999


Q ss_pred             CCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecc
Q 042149          366 GPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFG  445 (625)
Q Consensus       366 ~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfg  445 (625)
                      ++..+|||||+++|+|.+++.....   +++.++..++.||++||+|||+++   |+||||||+||||+.++.+||+|||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~---l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence            9999999999999999999976543   899999999999999999999876   9999999999999999999999999


Q ss_pred             cceeeCCCCceeeecCCCCccccCcccccc------CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhh
Q 042149          446 LARHVAPDKTHVSTGIAGTLGYMAPEYLVR------GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK  519 (625)
Q Consensus       446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~  519 (625)
                      +++.+.....  .....||+.|+|||++.+      ..++.++||||+||++|||++|+.|+.....     ........
T Consensus       156 ~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~-----~~~~~~i~  228 (277)
T d1phka_         156 FSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-----MLMLRMIM  228 (277)
T ss_dssp             TCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHH
T ss_pred             heeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH-----HHHHHHHH
Confidence            9998765432  234679999999999864      3468899999999999999999999753221     11111111


Q ss_pred             ccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          520 ANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       520 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ....      ....+.....+.++.+++.+||+.+|++|||++||++
T Consensus       229 ~~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         229 SGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             hCCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1111      1112223466788999999999999999999999875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-48  Score=390.99  Aligned_cols=258  Identities=26%  Similarity=0.349  Sum_probs=207.1

Q ss_pred             hcCccccccccccCceEEEEEEeCC--------CCEEEEEEeecCC-hHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeC
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPD--------GRNIAVKRLFFNS-RQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEG  366 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~  366 (625)
                      .++|++.++||+|+||.||+|+...        +..||||++.... ......+.+|+..+.++ +|||||++++++.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            4689999999999999999998532        2479999997653 45567889999999888 799999999999999


Q ss_pred             CeeEEEEEecCCCCcchhhhccCC-------------cCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE
Q 042149          367 PESLLVYEYVPNRSLDQILFVKNT-------------IHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL  433 (625)
Q Consensus       367 ~~~~lV~e~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll  433 (625)
                      +..++||||+++|+|.+++.....             ...+++.+++.++.||+.||+|||+.+   ||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            999999999999999999965432             245899999999999999999999875   9999999999999


Q ss_pred             cCCCceEEeecccceeeCCCCce-eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhC-CCCCCCCCCCccch
Q 042149          434 DEKLTPKIADFGLARHVAPDKTH-VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASG-RRNSVFSEGSSSVL  511 (625)
Q Consensus       434 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG-~~p~~~~~~~~~~~  511 (625)
                      +.++.+||+|||+++........ ......+|+.|+|||.+.++.++.++||||||+++|||+++ ..|+.... .    
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~-~----  243 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-V----  243 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-H----
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC-H----
Confidence            99999999999999876543332 22346789999999999999999999999999999999984 55543211 1    


Q ss_pred             hhHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          512 HTVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       512 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                      ...+..+         ......+.|...+..+.+|+.+||+.||++|||+.||++.|+++
T Consensus       244 ~~~~~~i---------~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         244 EELFKLL---------KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             HHHHHHH---------HTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHH---------HcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            1122222         22223344556677899999999999999999999999999876

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=390.47  Aligned_cols=259  Identities=25%  Similarity=0.379  Sum_probs=211.8

Q ss_pred             hcCccccccccccCceEEEEEEeC------CCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP------DGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPES  369 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  369 (625)
                      .++|++.++||+|+||+||+|.++      +++.||||++... ..+....|.+|+.++++++|||||++++++..++..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            468889999999999999999863      3578999999754 445556799999999999999999999999999999


Q ss_pred             EEEEEecCCCCcchhhhcc-------CCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEe
Q 042149          370 LLVYEYVPNRSLDQILFVK-------NTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIA  442 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~-------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~  442 (625)
                      ++||||+++|+|.+++...       .....+++..+..++.++++||.|||+++   |+||||||+||||++++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence            9999999999999987643       22234789999999999999999999875   9999999999999999999999


Q ss_pred             ecccceeeCCCCcee-eecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcc
Q 042149          443 DFGLARHVAPDKTHV-STGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN  521 (625)
Q Consensus       443 Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  521 (625)
                      |||+++......... .....||+.|+|||.+.++.++.++||||||+++|||+||+.|+.........    ...... 
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~----~~~i~~-  250 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV----LRFVME-  250 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH----HHHHHT-
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHh-
Confidence            999998765443332 22446899999999999999999999999999999999997554322221111    111111 


Q ss_pred             ccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          522 RITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       522 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                              ....+.+...+..+.+++.+||+.+|++|||+++|+++|++.
T Consensus       251 --------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         251 --------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             --------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             --------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence                    112333556677899999999999999999999999999775

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-47  Score=388.20  Aligned_cols=260  Identities=27%  Similarity=0.372  Sum_probs=213.9

Q ss_pred             hcCccccccccccCceEEEEEEe------CCCCEEEEEEeecC-ChHHHHHHHHHHHHHhcC-CCCceeeeeeeeeeCCe
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL------PDGRNIAVKRLFFN-SRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIEGPE  368 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~  368 (625)
                      .++|++.++||+|+||.||+|++      .+++.||||++... .......+.+|+.+++++ +|||||++++++.+.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            46888999999999999999985      24678999999764 345566899999999999 69999999999999999


Q ss_pred             eEEEEEecCCCCcchhhhccC---------------CcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEE
Q 042149          369 SLLVYEYVPNRSLDQILFVKN---------------TIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILL  433 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll  433 (625)
                      .++||||+++|+|.+++....               ....+++..+..++.||+.||+|||+++   ++||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence            999999999999999986543               2235899999999999999999999886   9999999999999


Q ss_pred             cCCCceEEeecccceeeCCCCc-eeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchh
Q 042149          434 DEKLTPKIADFGLARHVAPDKT-HVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLH  512 (625)
Q Consensus       434 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~  512 (625)
                      +.++.+||+|||+++....... .......||+.|+|||++.++.++.++||||||+++|||+|++.|+.........+ 
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~-  257 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF-  257 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH-
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH-
Confidence            9999999999999987765443 33345679999999999999999999999999999999999666654333322221 


Q ss_pred             hHHHhhhccccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccc
Q 042149          513 TVWKHYKANRITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNI  571 (625)
Q Consensus       513 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~  571 (625)
                        ++..         ........+...+..+.+||.+||+.||++|||++||+++|++.
T Consensus       258 --~~~i---------~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         258 --YKMI---------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             --HHHH---------HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HHHH---------hcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence              1111         11222333555678899999999999999999999999999764

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=383.10  Aligned_cols=270  Identities=24%  Similarity=0.274  Sum_probs=201.6

Q ss_pred             hcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC----eeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP----ESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~lV  372 (625)
                      .+.|.+.++||+|+||.||+|++ +|+.||||++...... ....+.|+..+..++|||||++++++.+.+    ..++|
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            35678889999999999999997 6789999998644322 222334555667789999999999998654    57999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcC-----CCceEEEeeeccCcEEEcCCCceEEeecccc
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG-----SGIKIIHRDIKTSNILLDEKLTPKIADFGLA  447 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla  447 (625)
                      |||+++|+|.+++...    .++|..++.++.+++.||.|||..     ...+|+||||||+||||+.++.+||+|||++
T Consensus        80 ~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            9999999999999653    389999999999999999999963     1347999999999999999999999999999


Q ss_pred             eeeCCCCcee---eecCCCCccccCccccccC------cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhH-HHh
Q 042149          448 RHVAPDKTHV---STGIAGTLGYMAPEYLVRG------QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV-WKH  517 (625)
Q Consensus       448 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~-~~~  517 (625)
                      +.........   .....||+.|+|||++.+.      .++.++|||||||++|||+||..|+............. ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            9876544332   2356799999999998654      36789999999999999999987764432221100000 000


Q ss_pred             hhcccc-ccccCCCCCCCC-----ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          518 YKANRI-TQSMDPGLTGRF-----PENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       518 ~~~~~~-~~~i~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      .....+ ....+..+.+..     +.+.+..+.+|+.+||+.||++|||+.||++.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            000000 011122222222     2345677999999999999999999999999998764

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.9e-46  Score=390.39  Aligned_cols=249  Identities=22%  Similarity=0.247  Sum_probs=201.5

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCC------hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCee
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNS------RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPES  369 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  369 (625)
                      .++|++.++||+|+||.||+|++. +|+.||||++....      ........+|+.+++.++|||||++++++.+.+..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            368999999999999999999975 68999999986431      11222334457788888999999999999999999


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccccee
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      +|||||++||+|.+++.....   +++..+..++.||+.||.|||+++   ||||||||+||||+.+|.+||+|||+++.
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHHhccc---ccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence            999999999999999976543   889999999999999999999875   99999999999999999999999999987


Q ss_pred             eCCCCceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccC
Q 042149          450 VAPDKTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMD  528 (625)
Q Consensus       450 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~  528 (625)
                      +.....   ....||+.|+|||++.. ..++.++|||||||++|||+||+.||.......  .........         
T Consensus       157 ~~~~~~---~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~~~~~~---------  222 (364)
T d1omwa3         157 FSKKKP---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEIDRMTL---------  222 (364)
T ss_dssp             CSSSCC---CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC--HHHHHHHSS---------
T ss_pred             cCCCcc---cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhcc---------
Confidence            754432   34579999999999975 468999999999999999999999975432221  111111100         


Q ss_pred             CCCCCCCChHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 042149          529 PGLTGRFPENEASRVLQIGLLCTQAPVALRPS-----MAEVVH  566 (625)
Q Consensus       529 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~  566 (625)
                       ......+...+.++.+||.+||+.||++|||     ++|+++
T Consensus       223 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         223 -TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             -SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             -cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence             1112234456778999999999999999999     688875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-47  Score=387.93  Aligned_cols=252  Identities=17%  Similarity=0.226  Sum_probs=205.6

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      +.++|++.+.||+|+||+||+|+++ +++.||||++.....+ ...+.+|+++|+.++|||||++++++.+++.++||||
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            4678999999999999999999975 6889999999765433 4568899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC--CCceEEeecccceeeCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE--KLTPKIADFGLARHVAP  452 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~--~~~~kl~Dfgla~~~~~  452 (625)
                      |++|++|.+++....  ..+++.++..++.||+.||+|||+++   |+||||||+|||++.  ...+||+|||+++....
T Consensus        82 ~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          82 FISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             cCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            999999999885433  24899999999999999999999875   999999999999984  45899999999987654


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      ....  ....+|+.|+|||...+..++.++|||||||++|+|++|+.||......     ...........      ...
T Consensus       157 ~~~~--~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-----~~~~~i~~~~~------~~~  223 (321)
T d1tkia_         157 GDNF--RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----QIIENIMNAEY------TFD  223 (321)
T ss_dssp             TCEE--EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHHTCC------CCC
T ss_pred             CCcc--cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCCC------CCC
Confidence            4332  3357899999999999999999999999999999999999997533211     11111111110      000


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .......+.++.+++.+||+.||++|||+.|+++
T Consensus       224 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0001134567899999999999999999999987

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-47  Score=386.14  Aligned_cols=247  Identities=21%  Similarity=0.290  Sum_probs=204.9

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC---ChHHHHHHHHHHHHHh-cCCCCceeeeeeeeeeCCeeEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN---SRQWVDQFFNEVNLIS-GIQHKNVVRLLGCSIEGPESLLV  372 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~~~~~~lV  372 (625)
                      ++|++.+.||+|+||+||+|+++ +++.||||++.+.   .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            68999999999999999999975 6899999999653   2334566777777765 68999999999999999999999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAP  452 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~  452 (625)
                      |||+++|+|.+++.....   +++.++..++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~~~~~---~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhccCC---CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            999999999999975544   899999999999999999999885   99999999999999999999999999987654


Q ss_pred             CCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccccCCCCC
Q 042149          453 DKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQSMDPGLT  532 (625)
Q Consensus       453 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~  532 (625)
                      .... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.....     ...+.......          
T Consensus       156 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~~~~i~~~~----------  219 (320)
T d1xjda_         156 GDAK-TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----EELFHSIRMDN----------  219 (320)
T ss_dssp             TTCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCC----------
T ss_pred             cccc-ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCC----------
Confidence            3332 3346799999999999999999999999999999999999999753211     11222222111          


Q ss_pred             CCCChHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 042149          533 GRFPENEASRVLQIGLLCTQAPVALRPSMA-EVVH  566 (625)
Q Consensus       533 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-ev~~  566 (625)
                      ..+|...+.++.+|+.+||+.||++|||+. |+++
T Consensus       220 ~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         220 PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            123445677899999999999999999995 6754

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-46  Score=384.69  Aligned_cols=252  Identities=20%  Similarity=0.202  Sum_probs=198.3

Q ss_pred             hcCccccc-cccccCceEEEEEEe-CCCCEEEEEEeecCChHHHHHHHHHHHHHhcC-CCCceeeeeeeeee----CCee
Q 042149          297 TDFFDNSR-KLGQGGAGSVFRGTL-PDGRNIAVKRLFFNSRQWVDQFFNEVNLISGI-QHKNVVRLLGCSIE----GPES  369 (625)
Q Consensus       297 ~~~y~~~~-~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~----~~~~  369 (625)
                      .++|++.. .||+|+||+||+|++ .+++.||||++...     ..+.+|+.++.++ +|||||++++++.+    +..+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            56898875 599999999999996 47899999998542     4567899987654 89999999999875    4678


Q ss_pred             EEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC---CCceEEeeccc
Q 042149          370 LLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE---KLTPKIADFGL  446 (625)
Q Consensus       370 ~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~---~~~~kl~Dfgl  446 (625)
                      +||||||+||+|.+++..... ..+++.++..++.||+.||+|||+.+   |+||||||+|||++.   .+.+||+|||+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence            999999999999999975432 34999999999999999999999875   999999999999985   56799999999


Q ss_pred             ceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccccc
Q 042149          447 ARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQS  526 (625)
Q Consensus       447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (625)
                      ++........  ....||+.|+|||++.+..++.++|||||||++|+|+||+.||........ ...........     
T Consensus       161 a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-~~~~~~~i~~~-----  232 (335)
T d2ozaa1         161 AKETTSHNSL--TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPGMKTRIRMG-----  232 (335)
T ss_dssp             CEECCCCCCC--CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------CCCSC-----
T ss_pred             eeeccCCCcc--ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-HHHHHHHHhcC-----
Confidence            9877654332  346799999999999999999999999999999999999999753322111 00000000000     


Q ss_pred             cCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          527 MDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       527 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                       ......+.....+.++.+|+.+||+.||++|||+.|+++
T Consensus       233 -~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         233 -QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence             000111112345678999999999999999999999987

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-47  Score=383.53  Aligned_cols=257  Identities=21%  Similarity=0.233  Sum_probs=194.3

Q ss_pred             ccccccccCceEEEEEEeC-CCCEEEEEEeecCChH-----HHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          302 NSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQ-----WVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       302 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      .+++||+|+||+||+|+++ +|+.||||++......     ..+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            4678999999999999975 6899999998654321     234688999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +.++++..+...   ...+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          82 METDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             CSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             hcchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            998877766532   234888999999999999999999876   99999999999999999999999999987654433


Q ss_pred             eeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccc---c---ccc--
Q 042149          456 HVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR---I---TQS--  526 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~---~~~--  526 (625)
                      . .....||+.|+|||++... .++.++|||||||++|||+||+.|+...... +.+....+......   .   ...  
T Consensus       156 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-~~l~~i~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ua2a_         156 A-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTRIFETLGTPTEEQWPDMCSLPD  233 (299)
T ss_dssp             C-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             c-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH-HHHHHHHHhcCCCChhhccchhccch
Confidence            2 2345799999999998754 5799999999999999999999886533211 11111111111000   0   000  


Q ss_pred             -cCCCCCCCCC-----hHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          527 -MDPGLTGRFP-----ENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       527 -i~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                       .........+     ...+..+.+|+.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence             0000001111     233567899999999999999999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-46  Score=380.08  Aligned_cols=263  Identities=21%  Similarity=0.293  Sum_probs=198.9

Q ss_pred             cCccccccccccCceEEEEEEe-CCCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      |+|+++++||+|+||+||+|++ .+++.||||++....  ....+++.+|+.+|++++|||||++++++.+++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            6899999999999999999996 478999999996543  2345788999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      |+.++.+. ++... ....+++..+..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~~~~-~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKK-FMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHH-HHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhh-hhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            99765444 34322 2334999999999999999999999876   9999999999999999999999999998765433


Q ss_pred             ceeeecCCCCccccCccccccCc-ccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcc------cccccc
Q 042149          455 THVSTGIAGTLGYMAPEYLVRGQ-LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN------RITQSM  527 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~i  527 (625)
                      .. .....||+.|+|||.+.... ++.++|||||||++|+|++|+.|+...... +.+..........      ......
T Consensus       157 ~~-~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         157 RT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             BC-TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             cc-ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH-HHHHHHHHhcCCCchhhcccccccc
Confidence            32 23457999999999887665 578999999999999999999997543211 1111111110000      000000


Q ss_pred             C--CC----CCCC---CChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          528 D--PG----LTGR---FPENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       528 ~--~~----~~~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                      +  ..    ....   .....+..+.+++.+||+.||++|||++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            0  00    0000   012335678999999999999999999999874

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.2e-45  Score=373.11  Aligned_cols=261  Identities=20%  Similarity=0.283  Sum_probs=200.9

Q ss_pred             cCccccccccccCceEEEEEEeCCCCEEEEEEeecCC--hHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEEe
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS--RQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e~  375 (625)
                      ++|+++++||+|+||+||+|++++|+.||||++....  ....+.+.+|+.+|++++|||||++++++..++..+++||+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            6899999999999999999999999999999996543  33357899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCCc
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDKT  455 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~~  455 (625)
                      +.++.+..+....   +.+++..+..++.||+.||+|||+.+   ||||||||+||||+.++.+||+|||++........
T Consensus        82 ~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            9887776665433   34999999999999999999999875   99999999999999999999999999987654332


Q ss_pred             eeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcc------ccccc--
Q 042149          456 HVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN------RITQS--  526 (625)
Q Consensus       456 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~--  526 (625)
                      . .....+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... +.+..........      ...+.  
T Consensus       156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         156 K-YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-DQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             c-cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH-HHHHHHHHhhCCCChhhccchhhhhh
Confidence            2 2334689999999998764 5689999999999999999999987532211 1111111110000      00000  


Q ss_pred             ----c---CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          527 ----M---DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       527 ----i---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                          .   .+..........+..+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                0   000001122344677899999999999999999999974

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=370.03  Aligned_cols=240  Identities=23%  Similarity=0.313  Sum_probs=196.1

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCCh------HHHHHHHHHHHHHhcCC--CCceeeeeeeeeeCC
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSR------QWVDQFFNEVNLISGIQ--HKNVVRLLGCSIEGP  367 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--hpniv~l~~~~~~~~  367 (625)
                      .++|++.++||+|+||+||+|++. +|+.||||++.....      ....++.+|+.+|++++  |||||++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            467999999999999999999965 789999999864321      11234678999999986  899999999999999


Q ss_pred             eeEEEEEecCC-CCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC-CCceEEeecc
Q 042149          368 ESLLVYEYVPN-RSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE-KLTPKIADFG  445 (625)
Q Consensus       368 ~~~lV~e~~~~-~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~-~~~~kl~Dfg  445 (625)
                      ..++||||+.+ +++.+++....   .+++.++..++.||++||.|||+++   |+||||||+|||++. ++.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence            99999999976 56667765443   3899999999999999999999875   999999999999985 5799999999


Q ss_pred             cceeeCCCCceeeecCCCCccccCccccccCcc-cccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccccc
Q 042149          446 LARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQL-TEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRIT  524 (625)
Q Consensus       446 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  524 (625)
                      +++......   .+...||+.|+|||++.+..+ +.++|||||||++|||+||+.|+....           ......  
T Consensus       157 ~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----------~i~~~~--  220 (273)
T d1xwsa_         157 SGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----------EIIRGQ--  220 (273)
T ss_dssp             TCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------HHHHCC--
T ss_pred             cceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----------HHhhcc--
Confidence            998754332   234679999999999987765 678999999999999999999974211           000000  


Q ss_pred             cccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          525 QSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       525 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                              ...+...+.++.+++.+||+.||++|||++|+++
T Consensus       221 --------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         221 --------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             --------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                    1123344677899999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-45  Score=371.83  Aligned_cols=262  Identities=24%  Similarity=0.289  Sum_probs=196.1

Q ss_pred             hcCccccccccccCceEEEEEEeC-C-CCEEEEEEeecCC--hHHHHHHHHHHHHHhcC---CCCceeeeeeeeee----
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-D-GRNIAVKRLFFNS--RQWVDQFFNEVNLISGI---QHKNVVRLLGCSIE----  365 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~hpniv~l~~~~~~----  365 (625)
                      .++|+++++||+|+||+||+|++. + ++.||||++....  ......+.+|+.+|+.|   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            478999999999999999999974 4 5679999986532  22233466777777665   79999999998853    


Q ss_pred             -CCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeec
Q 042149          366 -GPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADF  444 (625)
Q Consensus       366 -~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Df  444 (625)
                       ....+++|||++++++......  ....+++..+..++.|++.||+|||+++   |+||||||+|||+++++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence             3468999999988777654432  2334899999999999999999999875   999999999999999999999999


Q ss_pred             ccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcc---
Q 042149          445 GLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKAN---  521 (625)
Q Consensus       445 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~---  521 (625)
                      |+++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.+..........   
T Consensus       161 g~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~  237 (305)
T d1blxa_         161 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEE  237 (305)
T ss_dssp             CSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCGG
T ss_pred             hhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhhCCCchh
Confidence            9987654322  233568999999999999999999999999999999999999997533211 1111111110000   


Q ss_pred             c------c-cccc---CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          522 R------I-TQSM---DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       522 ~------~-~~~i---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      .      . ....   ........+...+..+.+|+.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0      0 0000   000111123345677889999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-43  Score=368.71  Aligned_cols=264  Identities=21%  Similarity=0.339  Sum_probs=196.4

Q ss_pred             HhcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC-----
Q 042149          296 ATDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP-----  367 (625)
Q Consensus       296 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----  367 (625)
                      ..++|+++++||+|+||+||+|+++ +|+.||||++...  .....+.+.+|+.+|++++|||||++++++...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            3578999999999999999999965 6999999999653  4455678999999999999999999999997654     


Q ss_pred             -eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeeccc
Q 042149          368 -ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGL  446 (625)
Q Consensus       368 -~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgl  446 (625)
                       .+++||||+ +.+|..++..    ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence             579999999 6677776642    23999999999999999999999876   99999999999999999999999999


Q ss_pred             ceeeCCCCceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhh----------HH
Q 042149          447 ARHVAPDKTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT----------VW  515 (625)
Q Consensus       447 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~----------~~  515 (625)
                      ++......    +...||+.|+|||++.+. .++.++||||+||++|||++|+.|+........+...          .+
T Consensus       168 a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         168 ARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             CEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             eeccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence            98765432    346799999999998764 5689999999999999999999987543211111000          00


Q ss_pred             Hhhhcc---ccccccCC---CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--Hccc
Q 042149          516 KHYKAN---RITQSMDP---GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHM--LNNI  571 (625)
Q Consensus       516 ~~~~~~---~~~~~i~~---~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~--L~~~  571 (625)
                      ......   .....+..   ..........+..+.+|+.+||+.||++|||+.|+++.  ++.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence            000000   00000000   00011123445678899999999999999999999974  4443

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-43  Score=358.20  Aligned_cols=262  Identities=20%  Similarity=0.267  Sum_probs=206.3

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCCeeEEEEE
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lV~e  374 (625)
                      ++|+++++||+|+||+||+|++. +++.||||++...  .....+++.+|+.+|+.++||||+++++++.+....++|||
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999974 7899999998654  34557889999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceeeCCCC
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHVAPDK  454 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~~~~~  454 (625)
                      ++.+++|..++....   .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             ecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            999999888775443   3889999999999999999999875   9999999999999999999999999998865443


Q ss_pred             ceeeecCCCCccccCccccccCc-ccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccc------ccccc
Q 042149          455 THVSTGIAGTLGYMAPEYLVRGQ-LTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR------ITQSM  527 (625)
Q Consensus       455 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~i  527 (625)
                      .. .....+++.|+|||.+.... ++.++|||||||++|||++|+.|+.......+.............      .....
T Consensus       156 ~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (292)
T d1unla_         156 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             SC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             cc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence            32 22346788999999987665 689999999999999999999997433322222222111111000      00000


Q ss_pred             ---------CCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          528 ---------DPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       528 ---------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                               ............+..+.+|+.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                     000111223445667889999999999999999999875

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-44  Score=371.52  Aligned_cols=259  Identities=22%  Similarity=0.282  Sum_probs=195.0

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC------CeeEE
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG------PESLL  371 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~------~~~~l  371 (625)
                      +|+..++||+|+||+||+|++. +|+.||||++.....    .+.+|+++|++++||||+++++++...      ..++|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5888899999999999999975 689999999976532    235799999999999999999998543      35789


Q ss_pred             EEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC-ceEEeecccceee
Q 042149          372 VYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL-TPKIADFGLARHV  450 (625)
Q Consensus       372 V~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-~~kl~Dfgla~~~  450 (625)
                      ||||++++.+..+.........+++.++..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987655554443334445999999999999999999999775   99999999999999765 8999999999877


Q ss_pred             CCCCceeeecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhh----------HHHhhh
Q 042149          451 APDKTHVSTGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHT----------VWKHYK  519 (625)
Q Consensus       451 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~----------~~~~~~  519 (625)
                      ......  ....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.+...          .+....
T Consensus       174 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         174 VRGEPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             CTTSCC--CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             cCCccc--ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence            544332  33579999999998875 57899999999999999999999987543321111110          011110


Q ss_pred             cc----ccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          520 AN----RITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       520 ~~----~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ..    ...+..............+..+.+|+.+||+.||++|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00    000000000001112345667899999999999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-44  Score=368.62  Aligned_cols=263  Identities=20%  Similarity=0.265  Sum_probs=196.5

Q ss_pred             hcCccccccccccCceEEEEEEe-CCCCEEEEEEeecC-ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeCC----eeE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTL-PDGRNIAVKRLFFN-SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEGP----ESL  370 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~----~~~  370 (625)
                      +++|+++++||+|+||+||+|++ .+|+.||||++... .....+.+.+|+.+|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            46799999999999999999986 47999999999654 4556678999999999999999999999987653    335


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccceee
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLARHV  450 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~~~  450 (625)
                      ++++++.+++|.+++...    .+++..+..++.||+.||+|||+++   ||||||||+||||++++.+||+|||+++..
T Consensus        87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            556677799999998543    3899999999999999999999886   999999999999999999999999999876


Q ss_pred             CCCCcee--eecCCCCccccCcccccc-CcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhccc-----
Q 042149          451 APDKTHV--STGIAGTLGYMAPEYLVR-GQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANR-----  522 (625)
Q Consensus       451 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-----  522 (625)
                      .......  .....||+.|+|||++.. ..++.++||||+||++|||++|+.||......+.. ...........     
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~  238 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL-NHILGILGSPSQEDLN  238 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCSCCHHHHH
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH-HHHhhhccCCChhhhh
Confidence            5433221  234679999999999854 56789999999999999999999987533211110 00000000000     


Q ss_pred             ------ccc-ccCCCCCCCC-----ChHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          523 ------ITQ-SMDPGLTGRF-----PENEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       523 ------~~~-~i~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                            ... ..........     ....+.++.+++.+||+.||++|||++|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  000 0000000001     12234578899999999999999999999863

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.1e-43  Score=356.02  Aligned_cols=270  Identities=16%  Similarity=0.206  Sum_probs=209.4

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCC-CceeeeeeeeeeCCeeEEEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQH-KNVVRLLGCSIEGPESLLVYE  374 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lV~e  374 (625)
                      .++|++.++||+|+||+||+|++. +|+.||||++.....  .+.+.+|+++++.++| +|++.+++++.++...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            367999999999999999999965 689999998865432  2457789999999975 899999999999999999999


Q ss_pred             ecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcC-----CCceEEeeccccee
Q 042149          375 YVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDE-----KLTPKIADFGLARH  449 (625)
Q Consensus       375 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~-----~~~~kl~Dfgla~~  449 (625)
                      |+ +++|.+++....  ..+++..+..++.|++.||+|||+++   |+||||||+|||++.     ++.+||+|||+++.
T Consensus        82 ~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            99 789988876543  34899999999999999999999775   999999999999964     57899999999988


Q ss_pred             eCCCCce------eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchh--hHHHhhhcc
Q 042149          450 VAPDKTH------VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLH--TVWKHYKAN  521 (625)
Q Consensus       450 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~--~~~~~~~~~  521 (625)
                      .......      ......||+.|+|||++.+..++.++||||||+++|||+||+.|+...........  .........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            6543221      12346799999999999999999999999999999999999999864433222111  111111111


Q ss_pred             ccccccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHccccCCCCCCCCCCC
Q 042149          522 RITQSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNIDYEIPPPKQPPF  583 (625)
Q Consensus       522 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~~~l~~~~~~~~  583 (625)
                      ...++         +...+.++.+++..|+..+|++||+++.+.+.|+++..........++
T Consensus       236 ~~~~l---------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~  288 (293)
T d1csna_         236 PLREL---------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENF  288 (293)
T ss_dssp             CHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCC
T ss_pred             ChHHh---------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCC
Confidence            11111         123456789999999999999999999998888776544443333333

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-43  Score=363.81  Aligned_cols=253  Identities=22%  Similarity=0.274  Sum_probs=205.7

Q ss_pred             hcCccccccccccCceEEEEEEeC----CCCEEEEEEeecC----ChHHHHHHHHHHHHHhcCCC-CceeeeeeeeeeCC
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP----DGRNIAVKRLFFN----SRQWVDQFFNEVNLISGIQH-KNVVRLLGCSIEGP  367 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~  367 (625)
                      .++|++.++||+|+||+||+|+..    +|+.||||++...    .....+.+.+|+++|++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            377999999999999999999852    4789999988543    22345678899999999976 89999999999999


Q ss_pred             eeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccc
Q 042149          368 ESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLA  447 (625)
Q Consensus       368 ~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla  447 (625)
                      ..++||||+.+++|.+++.....   +.+..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             ceeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccch
Confidence            99999999999999999876554   778899999999999999999875   999999999999999999999999999


Q ss_pred             eeeCCCCceeeecCCCCccccCccccccC--cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhcccccc
Q 042149          448 RHVAPDKTHVSTGIAGTLGYMAPEYLVRG--QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKANRITQ  525 (625)
Q Consensus       448 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  525 (625)
                      +.+............|++.|+|||.+.+.  .++.++|||||||++|||++|+.||....... .............   
T Consensus       177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~-~~~~i~~~~~~~~---  252 (322)
T d1vzoa_         177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILKSE---  252 (322)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHHHHCC---
T ss_pred             hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcccCC---
Confidence            87765544444456799999999999764  46789999999999999999999975443222 2222222211111   


Q ss_pred             ccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 042149          526 SMDPGLTGRFPENEASRVLQIGLLCTQAPVALRP-----SMAEVVH  566 (625)
Q Consensus       526 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~  566 (625)
                             .+.+...+.++.+++.+||+.||++||     |++|+++
T Consensus       253 -------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         253 -------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                   123456678899999999999999999     4788875

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-43  Score=359.71  Aligned_cols=264  Identities=19%  Similarity=0.260  Sum_probs=193.5

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeee--------
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE--------  365 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~--------  365 (625)
                      .++|+++++||+|+||+||+|++. +|+.||||++...  .......+.+|+.+|++++||||+++++.+..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            478999999999999999999974 7999999998544  33345678899999999999999999998754        


Q ss_pred             CCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecc
Q 042149          366 GPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFG  445 (625)
Q Consensus       366 ~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfg  445 (625)
                      +...++||||+.++.+.....   ....+++..+..++.||++||.|||+++   |+||||||+||||+.++.+||+|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence            346899999998877665443   2334889999999999999999999875   9999999999999999999999999


Q ss_pred             cceeeCCCCce---eeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhhc-
Q 042149          446 LARHVAPDKTH---VSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYKA-  520 (625)
Q Consensus       446 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~~-  520 (625)
                      +++.+......   ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ............ 
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~-~~~~~i~~~~~~~  241 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-HQLALISQLCGSI  241 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH-HHHHHHHHhcCCC
Confidence            99876543322   12245799999999998765 6899999999999999999999887432211 111111111000 


Q ss_pred             ----------cccccccCCCCCCCCCh-------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 042149          521 ----------NRITQSMDPGLTGRFPE-------NEASRVLQIGLLCTQAPVALRPSMAEVVHM  567 (625)
Q Consensus       521 ----------~~~~~~i~~~~~~~~~~-------~~~~~l~~li~~cl~~~p~~RPt~~ev~~~  567 (625)
                                ......+........+.       .....+.+|+.+||+.||++|||++|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence                      00000010000111111       113456789999999999999999999863

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.5e-44  Score=362.12  Aligned_cols=258  Identities=19%  Similarity=0.274  Sum_probs=197.9

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCc-eeeeeeeeeeCCeeEEEEEe
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKN-VVRLLGCSIEGPESLLVYEY  375 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~l~~~~~~~~~~~lV~e~  375 (625)
                      ++|++.+.||+|+||.||+|++. +|+.||||++......  +.+..|+++++.++|+| |+.+.+++.+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            57999999999999999999964 6899999988765332  45788999999998766 55556667788899999999


Q ss_pred             cCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEc---CCCceEEeecccceeeCC
Q 042149          376 VPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLD---EKLTPKIADFGLARHVAP  452 (625)
Q Consensus       376 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~---~~~~~kl~Dfgla~~~~~  452 (625)
                      + +++|.+.+....  ..+++..+..++.|++.||+|||+++   |+||||||+|||++   .+..+||+|||+++.+..
T Consensus        85 ~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          85 L-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             C-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             c-CCchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            9 556665554332  34899999999999999999999886   99999999999986   355799999999998764


Q ss_pred             CCce------eeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhH-H-Hhhhccccc
Q 042149          453 DKTH------VSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTV-W-KHYKANRIT  524 (625)
Q Consensus       453 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~-~-~~~~~~~~~  524 (625)
                      ....      ......||+.|+|||++.+..++.++|||||||++|||+||+.|+............. . .........
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  238 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence            4322      2235679999999999999999999999999999999999999986543322211110 0 000000000


Q ss_pred             cccCCCCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHcccc
Q 042149          525 QSMDPGLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVHMLNNID  572 (625)
Q Consensus       525 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~~~  572 (625)
                      .         .....+.++.+++.+||+.+|++||+++++.+.|+++.
T Consensus       239 ~---------~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         239 V---------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             H---------HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             H---------hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence            0         12234567899999999999999999999998887753

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.6e-42  Score=357.01  Aligned_cols=256  Identities=19%  Similarity=0.251  Sum_probs=198.0

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCC-CCceeeeeeeeee--CCeeEEE
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-HKNVVRLLGCSIE--GPESLLV  372 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~--~~~~~lV  372 (625)
                      .++|+++++||+|+||+||+|++. +++.||||++....   .+++.+|+.+|+++. ||||+++++++..  ....++|
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            368999999999999999999974 68999999986544   357889999999995 9999999999874  4568999


Q ss_pred             EEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC-ceEEeecccceeeC
Q 042149          373 YEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL-TPKIADFGLARHVA  451 (625)
Q Consensus       373 ~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~-~~kl~Dfgla~~~~  451 (625)
                      |||+.+++|..+.      +.+++.++..++.||+.||.|||+++   |+||||||+||||+.++ .+||+|||+++...
T Consensus       111 ~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~  181 (328)
T d3bqca1         111 FEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  181 (328)
T ss_dssp             EECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred             EeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence            9999999997754      23899999999999999999999876   99999999999998654 69999999998775


Q ss_pred             CCCceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHH------------hh
Q 042149          452 PDKTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWK------------HY  518 (625)
Q Consensus       452 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~------------~~  518 (625)
                      ....  .....+|+.|+|||.+.+. .++.++||||+|+++|||++|+.|+...............            ..
T Consensus       182 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         182 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             CCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence            4433  2345799999999998765 4799999999999999999999987644332111111000            00


Q ss_pred             hcc---ccccccCC--------CCCCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          519 KAN---RITQSMDP--------GLTGRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       519 ~~~---~~~~~i~~--------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                      ...   ........        ..........+.++.+|+.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000   00000000        0111122345677899999999999999999999985

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-42  Score=356.36  Aligned_cols=258  Identities=24%  Similarity=0.279  Sum_probs=189.7

Q ss_pred             cCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeee------CCe
Q 042149          298 DFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIE------GPE  368 (625)
Q Consensus       298 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~------~~~  368 (625)
                      ++|+++++||+|+||+||+|++. +|+.||||++...  ......++.+|+.+|++++|||||++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67999999999999999999975 6999999999754  45556789999999999999999999999863      368


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      +++||||+.++.+..+.      ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence            89999999776554432      23899999999999999999999876   9999999999999999999999999988


Q ss_pred             eeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCccchh----------hHHHhh
Q 042149          449 HVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLH----------TVWKHY  518 (625)
Q Consensus       449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~----------~~~~~~  518 (625)
                      .......  .....+|+.|+|||++.+..++.++||||+||+++||++|+.||...........          ..|...
T Consensus       168 ~~~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         168 TAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             ccccccc--cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence            6554332  2345799999999999999999999999999999999999988753321100000          000000


Q ss_pred             -------hcc-------ccccccCCCCC---CCCChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          519 -------KAN-------RITQSMDPGLT---GRFPENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       519 -------~~~-------~~~~~i~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                             ...       ...........   .......+..+.+|+.+||+.||++|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                   000       00000100000   1112345778899999999999999999999985

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-42  Score=355.25  Aligned_cols=258  Identities=23%  Similarity=0.308  Sum_probs=193.6

Q ss_pred             hcCccccccccccCceEEEEEEeC-CCCEEEEEEeecC--ChHHHHHHHHHHHHHhcCCCCceeeeeeeeeeC-----Ce
Q 042149          297 TDFFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFN--SRQWVDQFFNEVNLISGIQHKNVVRLLGCSIEG-----PE  368 (625)
Q Consensus       297 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-----~~  368 (625)
                      .++|+++++||+|+||+||+|++. +|+.||||++...  .....+++.+|+.+|++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            568999999999999999999964 7999999999654  345567889999999999999999999988643     34


Q ss_pred             eEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          369 SLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       369 ~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      .+++|+|+.+++|.+++..+    .+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            56777888899999988432    3999999999999999999999886   9999999999999999999999999987


Q ss_pred             eeCCCCceeeecCCCCccccCccccccC-cccccCcEEeehhhhHHHHhCCCCCCCCCCCccchhhHHHhhh--------
Q 042149          449 HVAPDKTHVSTGIAGTLGYMAPEYLVRG-QLTEKADVYAFGVLVIEVASGRRNSVFSEGSSSVLHTVWKHYK--------  519 (625)
Q Consensus       449 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~~~~~~~~~~~--------  519 (625)
                      .....    .....|++.|+|||...+. .++.++|||||||++|+|++|+.||........ .........        
T Consensus       170 ~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         170 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLVGTPGAELLK  244 (348)
T ss_dssp             CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCHHHHT
T ss_pred             ccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCChHHhh
Confidence            64322    2345799999999987765 468999999999999999999998753321110 000000000        


Q ss_pred             ---ccccccccCCCCC-CCC-----ChHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 042149          520 ---ANRITQSMDPGLT-GRF-----PENEASRVLQIGLLCTQAPVALRPSMAEVVH  566 (625)
Q Consensus       520 ---~~~~~~~i~~~~~-~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~  566 (625)
                         ............. ...     ....+..+.+|+.+||+.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence               0000000000000 000     1133566889999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1e-36  Score=317.80  Aligned_cols=261  Identities=20%  Similarity=0.189  Sum_probs=192.7

Q ss_pred             CccccccccccCceEEEEEEeC-CCCEEEEEEeecCChHHHHHHHHHHHHHhcCC-----------CCceeeeeeeeee-
Q 042149          299 FFDNSRKLGQGGAGSVFRGTLP-DGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-----------HKNVVRLLGCSIE-  365 (625)
Q Consensus       299 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpniv~l~~~~~~-  365 (625)
                      +|+++++||+|+||+||+|+.. +|+.||||++... ....+.+.+|+.+++.++           ||||+++++++.. 
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            5999999999999999999974 7999999998654 333567888999988875           5789999988764 


Q ss_pred             -CCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCC------c
Q 042149          366 -GPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKL------T  438 (625)
Q Consensus       366 -~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~------~  438 (625)
                       ....+++|+++..+..............+++..+..++.||+.||.|||+.  .+|+||||||+||||+.++      .
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccce
Confidence             356777888776665544444445555689999999999999999999972  2599999999999998654      4


Q ss_pred             eEEeecccceeeCCCCceeeecCCCCccccCccccccCcccccCcEEeehhhhHHHHhCCCCCCCCCCCcc--c---hhh
Q 042149          439 PKIADFGLARHVAPDKTHVSTGIAGTLGYMAPEYLVRGQLTEKADVYAFGVLVIEVASGRRNSVFSEGSSS--V---LHT  513 (625)
Q Consensus       439 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ll~elltG~~p~~~~~~~~~--~---~~~  513 (625)
                      ++|+|||.+.......    ....||+.|+|||++....++.++||||+||++++|++|+.||........  .   +..
T Consensus       171 ~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~  246 (362)
T d1q8ya_         171 IKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  246 (362)
T ss_dssp             EEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             eeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence            9999999998654322    345799999999999999999999999999999999999999754322110  0   000


Q ss_pred             HHHhh--------h----------ccccccccCCCC----------CCCCChHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042149          514 VWKHY--------K----------ANRITQSMDPGL----------TGRFPENEASRVLQIGLLCTQAPVALRPSMAEVV  565 (625)
Q Consensus       514 ~~~~~--------~----------~~~~~~~i~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~  565 (625)
                      .....        .          .......+....          ....+...+..+.+|+.+||+.||++|||++|++
T Consensus       247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L  326 (362)
T d1q8ya_         247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  326 (362)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            00000        0          000000000000          1223467788899999999999999999999998


Q ss_pred             H
Q 042149          566 H  566 (625)
Q Consensus       566 ~  566 (625)
                      +
T Consensus       327 ~  327 (362)
T d1q8ya_         327 N  327 (362)
T ss_dssp             T
T ss_pred             c
Confidence            5

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=8.5e-24  Score=198.61  Aligned_cols=162  Identities=15%  Similarity=0.150  Sum_probs=120.2

Q ss_pred             cccccccccCceEEEEEEeCCCCEEEEEEeecCC------------------hHHHHHHHHHHHHHhcCCCCceeeeeee
Q 042149          301 DNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNS------------------RQWVDQFFNEVNLISGIQHKNVVRLLGC  362 (625)
Q Consensus       301 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~E~~~l~~l~hpniv~l~~~  362 (625)
                      .+.++||+|+||+||+|++.+|+.||||++....                  ........+|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            4678999999999999998899999999875321                  1112345678999999999999988865


Q ss_pred             eeeCCeeEEEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcCCCceEEEeeeccCcEEEcCCCceEEe
Q 042149          363 SIEGPESLLVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGGSGIKIIHRDIKTSNILLDEKLTPKIA  442 (625)
Q Consensus       363 ~~~~~~~~lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iiHrDlkp~NIll~~~~~~kl~  442 (625)
                      .    ..+++|||+++..+.+          ++......++.|++++|.|||+++   |+||||||+|||++++ .++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred             c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence            3    2479999998865543          233445678999999999999875   9999999999999976 58999


Q ss_pred             ecccceeeCCCCceeeecCCCCccccCcc-----ccccCcccccCcEEeehh
Q 042149          443 DFGLARHVAPDKTHVSTGIAGTLGYMAPE-----YLVRGQLTEKADVYAFGV  489 (625)
Q Consensus       443 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~~Dv~SlG~  489 (625)
                      |||++.........         .|....     .+..++|+.++|+||+.-
T Consensus       145 DFG~a~~~~~~~~~---------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~  187 (191)
T d1zara2         145 DFPQSVEVGEEGWR---------EILERDVRNIITYFSRTYRTEKDINSAID  187 (191)
T ss_dssp             CCTTCEETTSTTHH---------HHHHHHHHHHHHHHHHHHCCCCCHHHHHH
T ss_pred             ECCCcccCCCCCcH---------HHHHHHHHHHHHHHcCCCCCcccHHHHHH
Confidence            99999765432211         111110     012467889999999643

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.73  E-value=1.7e-08  Score=97.39  Aligned_cols=148  Identities=14%  Similarity=0.078  Sum_probs=101.5

Q ss_pred             HHHHHhcCccccccccccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCCeeE
Q 042149          292 ILERATDFFDNSRKLGQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEGPESL  370 (625)
Q Consensus       292 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~  370 (625)
                      +++.....|+..+..+.+..+.||+... +++.++||+...........+.+|...+..+. +--+++++.+..+++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            4566667788777765555679998875 55678889886554444456778888887774 434677888888889999


Q ss_pred             EEEEecCCCCcchhhhccCCcCCCCHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 042149          371 LVYEYVPNRSLDQILFVKNTIHILSWQQRFTIICGTAEGLAHLHGG----------------------------------  416 (625)
Q Consensus       371 lV~e~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~----------------------------------  416 (625)
                      +||++++|.++.+......        ....++.++++.+..||+.                                  
T Consensus        87 lv~~~l~G~~~~~~~~~~~--------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          87 LLMSEADGVLCSEEYEDEQ--------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEECCSSEEHHHHTTTCS--------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             EEEEecccccccccccccc--------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            9999999987755432111        1112233344444444421                                  


Q ss_pred             ----------------------CCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          417 ----------------------SGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       417 ----------------------~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                                            ....++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                  12348999999999999987666799999775

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.18  E-value=4.2e-06  Score=79.64  Aligned_cols=75  Identities=19%  Similarity=0.183  Sum_probs=54.7

Q ss_pred             ccccCc-eEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCC--CceeeeeeeeeeCCeeEEEEEecCCCCcc
Q 042149          306 LGQGGA-GSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQH--KNVVRLLGCSIEGPESLLVYEYVPNRSLD  382 (625)
Q Consensus       306 lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pniv~l~~~~~~~~~~~lV~e~~~~~sL~  382 (625)
                      +..|.. ..||+...+.+..+++|.......   ..+..|+..++.+..  -.+++++.+..+.+..++|||+++|.++.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            444543 689999987888889997654432   246678888777642  33677888888888899999999987764


Q ss_pred             h
Q 042149          383 Q  383 (625)
Q Consensus       383 ~  383 (625)
                      +
T Consensus        95 ~   95 (255)
T d1nd4a_          95 S   95 (255)
T ss_dssp             T
T ss_pred             c
Confidence            4

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.83  E-value=2.7e-05  Score=79.13  Aligned_cols=77  Identities=17%  Similarity=0.167  Sum_probs=50.7

Q ss_pred             cccccccCceEEEEEEeCC-CCEEEEEEeecC-------ChHHHHHHHHHHHHHhcCC-C--CceeeeeeeeeeCCeeEE
Q 042149          303 SRKLGQGGAGSVFRGTLPD-GRNIAVKRLFFN-------SRQWVDQFFNEVNLISGIQ-H--KNVVRLLGCSIEGPESLL  371 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--pniv~l~~~~~~~~~~~l  371 (625)
                      .+.||.|....||+....+ ++.++||.-.+.       .....++...|.+.|+.+. +  ..+++++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            4468999999999998754 678999965431       1112345567888887663 2  346666654  4556789


Q ss_pred             EEEecCCCCc
Q 042149          372 VYEYVPNRSL  381 (625)
Q Consensus       372 V~e~~~~~sL  381 (625)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.34  E-value=0.00037  Score=68.41  Aligned_cols=135  Identities=16%  Similarity=0.115  Sum_probs=79.3

Q ss_pred             eEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCcee-----eee--eeeeeCCeeEEEEEecCCCCcchh
Q 042149          312 GSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKNVV-----RLL--GCSIEGPESLLVYEYVPNRSLDQI  384 (625)
Q Consensus       312 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpniv-----~l~--~~~~~~~~~~lV~e~~~~~sL~~~  384 (625)
                      -.||++..++|+.+++|...+... ..+++..|...+..|...++.     ..-  ..+..+...+.++++++|..++..
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            589999999999999998765422 235677888888877533221     111  133456678899999987544310


Q ss_pred             --------------hhc----c--CCcCCCCHH----------------------HHHHHHHHHHHHHHHh-hcCCCceE
Q 042149          385 --------------LFV----K--NTIHILSWQ----------------------QRFTIICGTAEGLAHL-HGGSGIKI  421 (625)
Q Consensus       385 --------------l~~----~--~~~~~l~~~----------------------~~~~i~~~i~~~L~~L-H~~~~~~i  421 (625)
                                    ++.    .  ......++.                      .....+..+...+.-+ .......+
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence                          000    0  001111111                      1122222333332222 12234579


Q ss_pred             EEeeeccCcEEEcCCCceEEeeccccee
Q 042149          422 IHRDIKTSNILLDEKLTPKIADFGLARH  449 (625)
Q Consensus       422 iHrDlkp~NIll~~~~~~kl~Dfgla~~  449 (625)
                      ||+|++|.|||++++  ..++||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999754  46899997753

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.05  E-value=0.0013  Score=63.96  Aligned_cols=157  Identities=12%  Similarity=0.013  Sum_probs=84.8

Q ss_pred             cHHHHHHHhcCccccccc-----cccCceEEEEEEeCCCCEEEEEEeecCChHHHHHHHHHHHHHhcCCCCc-----eee
Q 042149          289 KYEILERATDFFDNSRKL-----GQGGAGSVFRGTLPDGRNIAVKRLFFNSRQWVDQFFNEVNLISGIQHKN-----VVR  358 (625)
Q Consensus       289 ~~~~~~~~~~~y~~~~~l-----G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-----iv~  358 (625)
                      +-++++.....|.+.+..     ..|---+.|+.+..+|+ +++|+.....  ..+.+..|++++..|...+     .+.
T Consensus         4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~   80 (316)
T d2ppqa1           4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP   80 (316)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence            456677777888775443     35555788999887654 8999875432  1234455677777664322     221


Q ss_pred             ee-e--eeeeCCeeEEEEEecCCCCcchhh--------------hcc----C---CcCC-----------------CCHH
Q 042149          359 LL-G--CSIEGPESLLVYEYVPNRSLDQIL--------------FVK----N---TIHI-----------------LSWQ  397 (625)
Q Consensus       359 l~-~--~~~~~~~~~lV~e~~~~~sL~~~l--------------~~~----~---~~~~-----------------l~~~  397 (625)
                      .. |  +.........++.++.+......-              +..    .   ....                 ....
T Consensus        81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (316)
T d2ppqa1          81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  160 (316)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence            11 1  223345667777777664442210              000    0   0000                 0001


Q ss_pred             HHHHHHHHHHHHHHHhhc-CCCceEEEeeeccCcEEEcCCCceEEeecccce
Q 042149          398 QRFTIICGTAEGLAHLHG-GSGIKIIHRDIKTSNILLDEKLTPKIADFGLAR  448 (625)
Q Consensus       398 ~~~~i~~~i~~~L~~LH~-~~~~~iiHrDlkp~NIll~~~~~~kl~Dfgla~  448 (625)
                      .....+..+...+...+. .-+.++||+|+.++||+++++...-|+||+.+.
T Consensus       161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            111222222233333332 225679999999999999988777899999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.03  E-value=0.00063  Score=68.69  Aligned_cols=74  Identities=18%  Similarity=0.265  Sum_probs=49.4

Q ss_pred             cccccccCceEEEEEEeCCC--------CEEEEEEeecCChHHHHHHHHHHHHHhcCC-CCceeeeeeeeeeCCeeEEEE
Q 042149          303 SRKLGQGGAGSVFRGTLPDG--------RNIAVKRLFFNSRQWVDQFFNEVNLISGIQ-HKNVVRLLGCSIEGPESLLVY  373 (625)
Q Consensus       303 ~~~lG~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lV~  373 (625)
                      ++.|+.|-.-.+|+...+++        +.|++++.. ..... ....+|..+++.+. +.-.+++++++.+    .+||
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~-idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETE-SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCH-HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccchh-hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            45688888899999986532        345555543 33332 34568999998885 4334577777643    6899


Q ss_pred             EecCCCCcc
Q 042149          374 EYVPNRSLD  382 (625)
Q Consensus       374 e~~~~~sL~  382 (625)
                      ||++|.+|.
T Consensus       121 efi~g~~l~  129 (395)
T d1nw1a_         121 EYIPSRPLS  129 (395)
T ss_dssp             CCCCEEECC
T ss_pred             EEeccccCC
Confidence            999886554